Citrus Sinensis ID: 001988

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-----
Protein Sequence
MEMIKVITVRSVIHCLLCLVITVAASNISTDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKHSQPRAQHKSKKTILLLVIFLPLSTTLVIAVALALKRGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSKRIGNLS
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHccccccccccccccccccccccEEEEEcccccccEEEEEcccccccEEccccccccccccEEccccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHHccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccHHHHccccccccccccccccccccHHccccccccEEEcccccccccccHHHHHccccccEEEEcccccEEcccHHHHHHccccEEEccccEEEEEccccccccccccEEEccccccccccccccccccccccccccEEEcccccccccccHHHHHcccccccEEccccEEEEEccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHccccccEEEcccccccccccccccccccccccccccccccccccHHHHccccccEEEcccccccccccHHHHcccccccEEcccccccccccHHHHccccccccccccccccccccHHHHccccccccccccccccccccHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHcccccccccEEEEEEcccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHccccccccccEEccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccHHHcccccccccccccHHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHHHHHHHcHHcccHHHHHHHHHHHHccccccccccccccccccccccEEEEEcccccEEEEEEEccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEcccccccccccHHHHccccccEEEEccccccccccHHHHHHHHcccEEEcccccccccccHHHcccccccEEEcccccccccccHHHcccHHcHEEEEccccccccccHHHccHHHHHEEEEEcccccccccHHHccccccEEEEcccccccccccHHHHHcHHHHcEEEEccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEccccccccccccccccHHHccccccEEEEEccccccccccHHHHccccccEEEEEccccEEccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccEEccccccccccccEEEcccccccEEccccccccccccEEEccccccccccHHHHcccccccEEEccccccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEccccEEEEEccccccHHHccHHHcccccEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHHcccHccEEEccccEEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHHHcccccccEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHHHccccccccccHHHEEEcccccEEEcccccccEEccccccccccHEccccccccccHcEEEEEcccccHEHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHccccHccccccc
Coil and Loop (DISEMBL)
MEMIKVITVRSVIHCLLCLVITVAASNISTDQQALLALKdhitydptnllgtnwtsnasICSWIGIIcdvnshkvttlnlssfnlqgtippeianlsslksldlshnklssnipssiftMSTLKVLYLMDnqlsgslssftfntssILDIRlsknklsgklpenICNHLRYLKHLFLREnmfygkipsslskCKQLQELHlgynnlsgaipkeignLTVLQRISLINNklhgeipqeigylqnldVLQLGfnnltgvvpatifNMSTLKEIFLYnnslsgslpsridlalpnleflnlginsfsgtipssiTNASKLILLEMgsnsfsgfipsaignlrnlkLFDIFFNnltsstpelgflSSLANCKKlrylglggnpldgflpssignlsLSLERLNIAFcnisgnipkaigNLSNLIVLSLggnnlsgsipvtfgglqklqGLDLAFNKLagsipdeiCLLSRLneldlngnkisGSISSCLgnltslqylnlgsnrftfvipstfwnlKDILsfdissnlldgpislaIGNLKAVVGIDlsrnnlsgnipttLEGLKSLQNISLAYnrlegpipesfgnmtslesldlsnnkisgsipvsFEKLSYLKELNLSFNKlkgeiprggpfanftaesfmgnellcglpnlqvppckhsqpraqhkskKTILLLVIFLPLSTTLVIAVALALKrgkrgtmlsndiilssqptirRFSYFELLRAtdnfaenniigigGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMsngsledclhssncalnIFCRLNIMIDIASALEylhfghstpiihcdlkpsnvlldEDMVAHLSDFGMakllsgedestMRTQTLAtigymapdeifVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALEctmespekridAKDTITRLLKIRDTLSKRIGNLS
Flexible Loop (DISEMBL)
MEMIKVITVRSVIHCLLCLVITVAASNISTDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKHSQPRAQHKSKKTILLLVIFLPLSTTLVIAVALALkrgkrgtmlsndiilssqptiRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTmespekridakdtiTRLLKIrdtlskrignls
Low Complexity Region (SEG)
MEMIKVITVRSVIHCLLCLVITVAASNISTDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKHSQPRAQHKSKKTILLLVIFLPLSTTLVIAVALALKRGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSKRIGNLS
Disordered region (IsUnstruct)
***IKVITVRSVIHCLLCLVITVAASNISTDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANL****************IPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPI*******************ISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVP**************KTILLLVIFLPLSTTLVIAVALALKRGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS******MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTME*****IDAKDTITRLLKIR***********
Disordered Region (DISOPRED)
*****VITVRSVIHCLLCLVITVAASNISTDQQALLALKDHIT***********TSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPN*********************LLLVIFLPLSTTLVIAVALAL********************IRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA*TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG*******TQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSKRIG***
Disordered Region (DISEMBL)
MEMIKVITVRSVIHCLLCLVITVAASNISTDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPP************KKTILLLVIFLPLSTTLVIAVALALKRGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSKRIGNLS
Disordered Region (DISPRO)
MEMIKVITVRSVIHCLLCLVITVAASNISTDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVP*******RAQHKSKKTILLLVIFLPLSTTLVIAVALALKRGKR***********SQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR***********
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEMIKVITVRSVIHCLLCLVITVAASNISTDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKHSQPRAQHKSKKTILLLVIFLPLSTTLVIAVALALKRGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSKRIGNLS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	985	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.935	0.911	0.369	1e-161
C0LGT6	1031	LRR receptor-like serine/	no	no	0.940	0.898	0.357	1e-144
Q9SD62	1025	Putative receptor-like pr	no	no	0.911	0.876	0.356	1e-139
Q9FL28	1173	LRR receptor-like serine/	no	no	0.891	0.748	0.351	1e-138
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.899	0.707	0.322	1e-128
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.896	0.706	0.327	1e-127
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.952	0.851	0.316	1e-121
Q8VZG8	1045	Probable LRR receptor-lik	no	no	0.868	0.818	0.325	1e-120
O49318	1124	Probable leucine-rich rep	no	no	0.967	0.847	0.307	1e-119
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.797	0.802	0.339	1e-116

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  568 bits (1464), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 373/1009 (36%), Positives = 544/1009 (53%), Gaps = 88/1009 (8%)

Query: 30   TDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTI 89
            TD+QALL  K  ++ D   +L ++W  +  +C+W G+ C   + +VT L L    L G I
Sbjct: 24   TDRQALLQFKSQVSEDKRVVL-SSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVI 82

Query: 90   PPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILD 149
             P I NLS L SLDL  N     IP  +  +S L+ L +  N L G +    +N S +L+
Sbjct: 83   SPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLN 142

Query: 150  IRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGA 209
            +RL  N+L G                          +PS L     L +L+L  NN+ G 
Sbjct: 143  LRLDSNRLGGS-------------------------VPSELGSLTNLVQLNLYGNNMRGK 177

Query: 210  IPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLK 269
            +P  +GNLT+L++++L +N L GEIP ++  L  +  LQL  NN +GV P  ++N+S+LK
Sbjct: 178  LPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLK 237

Query: 270  EIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSG 329
             + +  N  SG L   + + LPNL   N+G N F+G+IP++++N S L  L M  N+ +G
Sbjct: 238  LLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTG 297

Query: 330  FIPSAIGNLRNLKLFDIFFNNLTS-STPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSI 388
             IP+  GN+ NLKL  +  N+L S S+ +L FL+SL NC +L  LG+G N L G LP SI
Sbjct: 298  SIPT-FGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISI 356

Query: 389  GNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDL 448
             NLS  L  L++    ISG+IP  IGNL NL  L L  N LSG +P + G L  L+ L L
Sbjct: 357  ANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSL 416

Query: 449  AFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPST 508
              N+L+G IP  I  ++ L  LDL+ N   G + + LGN + L  L +G N+    IP  
Sbjct: 417  FSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLE 476

Query: 509  FWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISL 568
               ++ +L  D+S N L G +   IG L+ +  + L  N LSG +P TL    +++++ L
Sbjct: 477  IMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFL 536

Query: 569  AYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRG 628
              N   G IP+  G +  ++ +DLSNN +SGSIP  F   S L+ LNLSFN L+G++P  
Sbjct: 537  EGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVK 595

Query: 629  GPFANFTAESFMGNELLC-GLPNLQVPPCKHSQPRAQHKSKKTILLLVIFLPLSTTLVIA 687
            G F N T  S +GN  LC G+   Q+ PC    P    K    +  +VI + +  TL++ 
Sbjct: 596  GIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLL 655

Query: 688  VALA------LKRGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGS 741
            + +A      L++ K+    +N    + +    + SY +L  AT+ F+ +N++G G FG+
Sbjct: 656  LFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGT 715

Query: 742  VYRA-RLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD----- 795
            VY+A  L +   +A+KV + Q    +KSF AECE +K+IRHRNLVK++++CS+ D     
Sbjct: 716  VYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNE 775

Query: 796  FKALVLEYMSNGSLEDCLHSSNC--------ALNIFCRLNIMIDIASALEYLHFGHSTPI 847
            F+AL+ E+M NGSL+  LH             L +  RLNI ID+AS L+YLH     PI
Sbjct: 776  FRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPI 835

Query: 848  IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ-----TLATIGYMAPD---- 898
             HCDLKPSNVLLD+D+ AH+SDFG+A+LL   DE +   Q        TIGY AP+    
Sbjct: 836  AHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVG 895

Query: 899  ---------------------------EIFVGELSLKRWVNDLLPVSLVEVVDKSLLS-G 930
                                       E+F G  +L  +    LP  ++++VD+S+L  G
Sbjct: 896  GQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIG 955

Query: 931  EEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK 979
                F   E CL  +F + L C  ESP  R+     +  L+ IR+   K
Sbjct: 956  LRVGFPVVE-CLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFK 1003

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  512 bits (1318), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 362/1012 (35%), Positives = 523/1012 (51%), Gaps = 86/1012 (8%)

Query: 17  LCLVITVAASNISTDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVT 76
           +C+      SN  TD QALL  K  ++ +    +  +W  ++  C+WIG+ C     +V 
Sbjct: 18  VCIFAQARFSN-ETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVI 76

Query: 77  TLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGS 136
           +LNL  F L G I P I NLS L+ L+L+ N   S IP  +  +  L+ L +  N L G 
Sbjct: 77  SLNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGR 136

Query: 137 LSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQL 196
           + S   N S +  + LS N               +L H           +PS L    +L
Sbjct: 137 IPSSLSNCSRLSTVDLSSN---------------HLGH----------GVPSELGSLSKL 171

Query: 197 QELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTG 256
             L L  NNL+G  P  +GNLT LQ++    N++ GEIP E+  L  +   Q+  N+ +G
Sbjct: 172 AILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSG 231

Query: 257 VVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASK 316
             P  ++N+S+L+ + L +NS SG+L +     LPNL  L LG N F+G IP ++ N S 
Sbjct: 232 GFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISS 291

Query: 317 LILLEMGSNSFSGFIPSAIGNLRNLKLFDI-FFNNLTSSTPELGFLSSLANCKKLRYLGL 375
           L   ++ SN  SG IP + G LRNL    I   +   +S+  L F+ ++ANC +L YL +
Sbjct: 292 LERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDV 351

Query: 376 GGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPV 435
           G N L G LP+SI NLS +L  L +    ISG IP  IGNL +L  LSL  N LSG +PV
Sbjct: 352 GYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPV 411

Query: 436 TFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLN 495
           +FG L  LQ +DL  N ++G IP     ++RL +L LN N   G I   LG    L  L 
Sbjct: 412 SFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLW 471

Query: 496 LGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPT 555
           + +NR    IP     +  +   D+S+N L G     +G L+ +VG+  S N LSG +P 
Sbjct: 472 MDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQ 531

Query: 556 TLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELN 615
            + G  S++ + +  N  +G IP+    + SL+++D SNN +SG IP     L  L+ LN
Sbjct: 532 AIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLN 590

Query: 616 LSFNKLKGEIPRGGPFANFTAESFMGNELLC-GLPNLQVPPC-KHSQPRAQH--KSKKTI 671
           LS NK +G +P  G F N TA S  GN  +C G+  +Q+ PC   + PR +     +K +
Sbjct: 591 LSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKV 650

Query: 672 LLLVIFLPLSTTLVIAVA---LALKRGKRGTMLSNDIILSSQPTIRRF----SYFELLRA 724
           +  +     S  L+I VA     +KR K+    ++D   S   T+  F    SY EL  A
Sbjct: 651 VSGICIGIASLLLIIIVASLCWFMKRKKKNN--ASDGNPSDSTTLGMFHEKVSYEELHSA 708

Query: 725 TDNFAENNIIGIGGFGSVYRARLEDGVE---IAIKVFHPQCASTLKSFEAECEVIKNIRH 781
           T  F+  N+IG G FG+V++  L  G E   +A+KV +       KSF AECE  K IRH
Sbjct: 709 TSRFSSTNLIGSGNFGNVFKGLL--GPENKLVAVKVLNLLKHGATKSFMAECETFKGIRH 766

Query: 782 RNLVKIISSCSN-----DDFKALVLEYMSNGSLEDCLHSSNC--------ALNIFCRLNI 828
           RNLVK+I+ CS+     +DF+ALV E+M  GSL+  L   +         +L    +LNI
Sbjct: 767 RNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNI 826

Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ- 887
            ID+ASALEYLH     P+ HCD+KPSN+LLD+D+ AH+SDFG+A+LL   D  +   Q 
Sbjct: 827 AIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQF 886

Query: 888 ----TLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD------------------- 924
                  TIGY AP+    G+ S++  V     + L+E+                     
Sbjct: 887 SSAGVRGTIGYAAPEYGMGGQPSIQGDVYS-FGILLLEMFSGKKPTDESFAGDYNLHSYT 945

Query: 925 KSLLSG--EEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR 974
           KS+LSG        A ++ L  +  + ++C+ E P  R+   + +  L+ IR
Sbjct: 946 KSILSGCTSSGGSNAIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIR 997

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  495 bits (1274), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 369/1035 (35%), Positives = 525/1035 (50%), Gaps = 137/1035 (13%)

Query: 30   TDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTI 89
            TD+QALL  K  ++     +LG+ W  +  +CSW G+ C +   +VT ++L         
Sbjct: 39   TDKQALLEFKSQVSETSRVVLGS-WNDSLPLCSWTGVKCGLKHRRVTGVDLGGL------ 91

Query: 90   PPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILD 149
                                                      +L+G +S F  N S +  
Sbjct: 92   ------------------------------------------KLTGVVSPFVGNLSFLRS 109

Query: 150  IRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQEL-----HL--- 201
            + L+ N   G +P  + N  R L++L +  N+F G IP  LS C  L  L     HL   
Sbjct: 110  LNLADNFFHGAIPSEVGNLFR-LQYLNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQG 168

Query: 202  ----------------GYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLD 245
                            G NNL+G  P  +GNLT LQ +  I N++ GEIP +I  L+ + 
Sbjct: 169  VPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMI 228

Query: 246  VLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSG 305
              ++  N   GV P  I+N+S+L  + +  NS SG+L       LPNL+ L +GINSF+G
Sbjct: 229  FFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTG 288

Query: 306  TIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTS-STPELGFLSSL 364
            TIP +++N S L  L++ SN  +G IP + G L+NL L  +  N+L + S+ +L FL +L
Sbjct: 289  TIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGAL 348

Query: 365  ANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSL 424
             NC +L+YL +G N L G LP  I NLS  L  L++    ISG+IP  IGNL +L  L L
Sbjct: 349  TNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDL 408

Query: 425  GGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSC 484
            G N L+G +P + G L +L+ + L  N L+G IP  +  +S L  L L  N   GSI S 
Sbjct: 409  GENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSS 468

Query: 485  LGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDL 544
            LG+ + L  LNLG+N+    IP     L  ++  ++S NLL GP+   IG LK ++ +D+
Sbjct: 469  LGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDV 528

Query: 545  SRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS 604
            S N LSG IP TL    SL+ + L  N   GPIP+  G +T L  LDLS N +SG+IP  
Sbjct: 529  SYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEY 587

Query: 605  FEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLC-GLPNLQVPPCKHSQPRA 663
                S L+ LNLS N   G +P  G F N +A S  GN  LC G+P+LQ+ PC    PR 
Sbjct: 588  MANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRR 647

Query: 664  QHKSKKTILLLVIFLPLSTTLVIAVALALKRGK------RGTMLSNDIILSSQPTI-RRF 716
                +K I + V  +  +  L+    + L   K      R     ND   S   +   + 
Sbjct: 648  HSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKI 707

Query: 717  SYFELLRATDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEV 775
            SY EL + T  F+ +N+IG G FG+V++  L      +AIKV +       KSF AECE 
Sbjct: 708  SYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEA 767

Query: 776  IKNIRHRNLVKIISSCSN-----DDFKALVLEYMSNGSLEDCLHSSNC--------ALNI 822
            +  IRHRNLVK+++ CS+     +DF+ALV E+M NG+L+  LH             L +
Sbjct: 768  LGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGL 827

Query: 823  FCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES 882
            F RLNI ID+ASAL YLH     PI HCD+KPSN+LLD+D+ AH+SDFG+A+LL   D  
Sbjct: 828  FARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRD 887

Query: 883  TMRTQ-----TLATIGYMAPD---------------------EIFVGELSLKRWVNDLLP 916
            T   Q        TIGY AP+                     EIF G+    +   D L 
Sbjct: 888  TFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLT 947

Query: 917  V-----------SLVEVVDKSLLSGE-EKHFAAKEQCLLSIFSLALECTMESPEKRIDAK 964
            +             +++ D+++L G   +HF   E CL  +F + + C+ ESP  RI   
Sbjct: 948  LHSFTKSALQKRQALDITDETILRGAYAQHFNMVE-CLTLVFRVGVSCSEESPVNRISMA 1006

Query: 965  DTITRLLKIRDTLSK 979
            + I++L+ IR++  +
Sbjct: 1007 EAISKLVSIRESFFR 1021

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  493 bits (1269), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 340/968 (35%), Positives = 517/968 (53%), Gaps = 90/968 (9%)

Query: 84   NLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFN 143
            +L G+IP  I  L++L  LDLS N+L+  IP     +  L+ L L +N L G + +   N
Sbjct: 203  HLTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGN 262

Query: 144  TSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGY 203
             SS++ + L  N+L+GK+P  + N L  L+ L + +N     IPSSL +  QL  L L  
Sbjct: 263  CSSLVQLELYDNQLTGKIPAELGN-LVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSE 321

Query: 204  NNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIF 263
            N+L G I +EIG L  L+ ++L +N   GE PQ I  L+NL VL +GFNN++G +PA + 
Sbjct: 322  NHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLG 381

Query: 264  NMSTLKEIFLYNNSLSGSLPSRI---------DLA-------LP------NLEFLNLGIN 301
             ++ L+ +  ++N L+G +PS I         DL+       +P      NL F+++G N
Sbjct: 382  LLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMNLTFISIGRN 441

Query: 302  SFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFL 361
             F+G IP  I N S L  L +  N+ +G +   IG L+ L++  + +N+LT   P     
Sbjct: 442  HFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPR---- 497

Query: 362  SSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIV 421
              + N K L  L L  N   G +P  + NL+L L+ L +   ++ G IP+ + ++  L V
Sbjct: 498  -EIGNLKDLNILYLHSNGFTGRIPREMSNLTL-LQGLRMYSNDLEGPIPEEMFDMKLLSV 555

Query: 422  LSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSI 481
            L L  N  SG IP  F  L+ L  L L  NK  GSIP  +  LS LN  D++ N ++G+I
Sbjct: 556  LDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTI 615

Query: 482  -SSCLGNLTSLQ-YLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAV 539
                L +L ++Q YLN  +N  T  IP     L+ +   D+S+NL  G I  ++   K V
Sbjct: 616  PGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNV 675

Query: 540  VGIDLSRNNLSGNIP-TTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKIS 598
              +D S+NNLSG+IP    +G+  + +++L+ N   G IP+SFGNMT L SLDLS+N ++
Sbjct: 676  FTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLT 735

Query: 599  GSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKH 658
            G IP S   LS LK L L+ N LKG +P  G F N  A   MGN  LCG     + PC  
Sbjct: 736  GEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCG-SKKPLKPCTI 794

Query: 659  SQPRAQHKSKKTILLLVIF-----------LPLSTTLVIAVALALKRGKRGTMLSNDIIL 707
             Q ++ H SK+T ++L+I            L L  T        ++     ++      L
Sbjct: 795  KQ-KSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPD----L 849

Query: 708  SSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQ--CAST 765
             S   ++RF   EL +ATD+F   NIIG     +VY+ +LEDG  IA+KV + +   A +
Sbjct: 850  DSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAES 909

Query: 766  LKSFEAECEVIKNIRHRNLVKIIS-SCSNDDFKALVLEYMSNGSLEDCLHSSNCAL-NIF 823
             K F  E + +  ++HRNLVKI+  +  +   KALVL +M NG+LED +H S   + ++ 
Sbjct: 910  DKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLL 969

Query: 824  CRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST 883
             ++++ + IAS ++YLH G+  PI+HCDLKP+N+LLD D VAH+SDFG A++L   ++ +
Sbjct: 970  EKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGS 1029

Query: 884  MRTQTLA---TIGYMAPDEIFVGELSLKRWV---------------------NDLLPVSL 919
                T A   TIGY+AP+  ++ +++ K  V                      D   ++L
Sbjct: 1030 TTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTL 1089

Query: 920  VEVVDKSLLSGEEKHFAA-------------KEQCLLSIFSLALECTMESPEKRIDAKDT 966
             ++V+KS+ +G +                  +E+ +     L L CT   PE R D  + 
Sbjct: 1090 RQLVEKSIGNGRKGMVRVLDMELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEI 1149

Query: 967  ITRLLKIR 974
            +T L+K+R
Sbjct: 1150 LTHLMKLR 1157

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  460 bits (1183), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 325/1007 (32%), Positives = 510/1007 (50%), Gaps = 121/1007 (12%)

Query: 75   VTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLS 134
            + TLNL   +  G IP ++ +L S++ L+L  N+L   IP  +  ++ L+ L L  N L+
Sbjct: 242  LQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLT 301

Query: 135  GSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCK 194
            G +    +  + +  + L+KN+LSG LP+ IC++   LK LFL E    G+IP+ +S C+
Sbjct: 302  GVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQ 361

Query: 195  QLQELHLGYNNLSGAIPK------------------------EIGNLTVLQRISLINNKL 230
             L+ L L  N L+G IP                          I NLT LQ  +L +N L
Sbjct: 362  SLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNL 421

Query: 231  HGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLAL 290
             G++P+EIG+L  L+++ L  N  +G +P  I N + L+EI  Y N LSG +PS I   L
Sbjct: 422  EGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIG-RL 480

Query: 291  PNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNN 350
             +L  L+L  N   G IP+S+ N  ++ ++++  N  SG IPS+ G L  L+LF I+ N+
Sbjct: 481  KDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNS 540

Query: 351  LTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIP 410
            L  + P+     SL N K L  +    N  +G +    G  S S    ++      G+IP
Sbjct: 541  LQGNLPD-----SLINLKNLTRINFSSNKFNGSISPLCG--SSSYLSFDVTENGFEGDIP 593

Query: 411  KAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNEL 470
              +G  +NL  L LG N  +G IP TFG + +L  LD++ N L+G IP E+ L  +L  +
Sbjct: 594  LELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHI 653

Query: 471  DLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPIS 530
            DLN N +SG I + LG L  L  L L SN+F   +P+  ++L +IL+  +  N L+G I 
Sbjct: 654  DLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIP 713

Query: 531  LAIGNLKAVVGID------------------------LSRNNLSGNIPTTLEGLKSLQN- 565
              IGNL+A+  ++                        LSRN L+G IP  +  L+ LQ+ 
Sbjct: 714  QEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSA 773

Query: 566  ISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEI 625
            + L+YN   G IP +   +  LESLDLS+N++ G +P     +  L  LNLS+N L+G++
Sbjct: 774  LDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKL 833

Query: 626  PRGGPFANFTAESFMGNELLCGLPNLQVPPCKHSQPRAQHK-SKKTILLLVIFLPLSTTL 684
             +   F+ + A++F+GN  LCG P   +  C  +  + Q   S KT++++     L+   
Sbjct: 834  KK--QFSRWQADAFVGNAGLCGSP---LSHCNRAGSKNQRSLSPKTVVIISAISSLAAIA 888

Query: 685  VIAVALAL---------KRGKRGTMLSNDIILSSQPTI-------RRFSYFELLRATDNF 728
            ++ + + L         K+ + G    +    SSQ  +           + +++ AT   
Sbjct: 889  LMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYL 948

Query: 729  AENNIIGIGGFGSVYRARLEDGVEIAI-KVFHPQCASTLKSFEAECEVIKNIRHRNLVKI 787
             E  +IG GG G VY+A L++G  IA+ K+       + KSF  E + +  IRHR+LVK+
Sbjct: 949  NEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKL 1008

Query: 788  ISSCSN--DDFKALVLEYMSNGSLEDCLHSSNCA-----LNIFCRLNIMIDIASALEYLH 840
            +  CS+  D    L+ EYM+NGS+ D LH++        L    RL I + +A  +EYLH
Sbjct: 1009 MGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLH 1068

Query: 841  FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL--ATIGYMAPD 898
            +    PI+H D+K SNVLLD ++ AHL DFG+AK+L+G  ++   + T+   + GY+AP+
Sbjct: 1069 YDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPE 1128

Query: 899  ---------------------EIFVG----------ELSLKRWVNDLLPVSLVEVVDKSL 927
                                 EI  G          E  + RWV  +L         + L
Sbjct: 1129 YAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKL 1188

Query: 928  LSGEEKH-FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI 973
            +  E K     +E+    +  +AL+CT   P++R  ++     LL +
Sbjct: 1189 IDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYLLNV 1235

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  456 bits (1173), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 330/1008 (32%), Positives = 505/1008 (50%), Gaps = 125/1008 (12%)

Query: 78   LNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSL 137
            LNL++ +L G IP ++  +S L+ L L  N+L   IP S+  +  L+ L L  N L+G +
Sbjct: 244  LNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEI 303

Query: 138  SSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQ 197
                +N S +LD+ L+ N LSG LP++IC++   L+ L L      G+IP  LSKC+ L+
Sbjct: 304  PEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLK 363

Query: 198  ELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGV 257
            +L L  N+L+G+IP+ +  L  L  + L NN L G +   I  L NL  L L  NNL G 
Sbjct: 364  QLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGK 423

Query: 258  VPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKL 317
            +P  I  +  L+ +FLY N  SG +P  I     +L+ +++  N F G IP SI    +L
Sbjct: 424  LPKEISALRKLEVLFLYENRFSGEIPQEIG-NCTSLKMIDMFGNHFEGEIPPSIGRLKEL 482

Query: 318  ILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGG 377
             LL +  N   G +P+++GN   L + D+  N L+ S P     SS    K L  L L  
Sbjct: 483  NLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIP-----SSFGFLKGLEQLMLYN 537

Query: 378  NPLDGFLPSSIGNLSLSLERLNIAFCNISG-----------------------NIPKAIG 414
            N L G LP S+ +L  +L R+N++   ++G                        IP  +G
Sbjct: 538  NSLQGNLPDSLISLR-NLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELG 596

Query: 415  NLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNG 474
            N  NL  L LG N L+G IP T G +++L  LD++ N L G+IP ++ L  +L  +DLN 
Sbjct: 597  NSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNN 656

Query: 475  NKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIG 534
            N +SG I   LG L+ L  L L SN+F   +P+  +N   +L   +  N L+G I   IG
Sbjct: 657  NFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIG 716

Query: 535  NLKA--VVGID----------------------LSRNNLSGNIPTTLEGLKSLQN-ISLA 569
            NL A  V+ +D                      LSRN+L+G IP  +  L+ LQ+ + L+
Sbjct: 717  NLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLS 776

Query: 570  YNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGG 629
            YN   G IP + G ++ LE+LDLS+N+++G +P S   +  L  LN+SFN L G++ +  
Sbjct: 777  YNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKK-- 834

Query: 630  PFANFTAESFMGNELLCGLPNLQVPPCK--HSQPRAQHKSKKTILLLVIFLPLSTTLVIA 687
             F+ + A+SF+GN  LCG P   +  C    S  + Q  S ++++++     L+   ++ 
Sbjct: 835  QFSRWPADSFLGNTGLCGSP---LSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMI 891

Query: 688  VALAL---------KRGKRGTMLSNDIILSSQPTIR----------RFSYFELLRATDNF 728
            + +AL         K+   G+        SSQ T +             + +++ AT N 
Sbjct: 892  LVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNL 951

Query: 729  AENNIIGIGGFGSVYRARLEDGVEIAI-KVFHPQCASTLKSFEAECEVIKNIRHRNLVKI 787
            +E  +IG GG G VY+A LE+G  +A+ K+       + KSF  E + +  IRHR+LVK+
Sbjct: 952  SEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKL 1011

Query: 788  ISSCS--NDDFKALVLEYMSNGSLEDCLHSSNCA-------LNIFCRLNIMIDIASALEY 838
            +  CS  ++    L+ EYM NGS+ D LH            L+   RL I + +A  +EY
Sbjct: 1012 MGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEY 1071

Query: 839  LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL--ATIGYMA 896
            LH     PI+H D+K SNVLLD +M AHL DFG+AK+L+   ++   + T    + GY+A
Sbjct: 1072 LHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIA 1131

Query: 897  P-------------------------------DEIFVGELSLKRWVNDLLPVSLVEVVDK 925
            P                               D +F  E+ + RWV   L V+     DK
Sbjct: 1132 PEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVA-GSARDK 1190

Query: 926  SLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI 973
             +    +     +E     +  +AL+CT  SP++R  ++     LL +
Sbjct: 1191 LIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSLLHV 1238

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  435 bits (1119), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 338/1067 (31%), Positives = 503/1067 (47%), Gaps = 129/1067 (12%)

Query: 25   ASNISTDQQALLALKDHITYDPTNLLGTNWTSNASI-CSWIGIICDVNSH--KVTTLNLS 81
             + ++ + Q LL +K        NL   NW SN S+ C W G++C   S   +V +LNLS
Sbjct: 24   TTGLNLEGQYLLEIKSKFVDAKQNL--RNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLS 81

Query: 82   SFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFT 141
            S  L G + P I  L  LK LDLS+N LS  IP  I   S+L++L L +NQ  G +    
Sbjct: 82   SMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEI 141

Query: 142  FNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHL 201
                S+ ++ +  N++SG LP  I N L  L  L    N   G++P S+   K+L     
Sbjct: 142  GKLVSLENLIIYNNRISGSLPVEIGNLLS-LSQLVTYSNNISGQLPRSIGNLKRLTSFRA 200

Query: 202  GYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPAT 261
            G N +SG++P EIG    L  + L  N+L GE+P+EIG L+ L  + L  N  +G +P  
Sbjct: 201  GQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPRE 260

Query: 262  IFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLE 321
            I N ++L+ + LY N L G +P  +   L +LEFL L  N  +GTIP  I N S  I ++
Sbjct: 261  ISNCTSLETLALYKNQLVGPIPKELG-DLQSLEFLYLYRNGLNGTIPREIGNLSYAIEID 319

Query: 322  MGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTP-ELGFLSSLANC------------- 367
               N+ +G IP  +GN+  L+L  +F N LT + P EL  L +L+               
Sbjct: 320  FSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPL 379

Query: 368  -----KKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVL 422
                 + L  L L  N L G +P  +G  S  L  L+++  ++SG IP  +   SN+I+L
Sbjct: 380  GFQYLRGLFMLQLFQNSLSGTIPPKLGWYS-DLWVLDMSDNHLSGRIPSYLCLHSNMIIL 438

Query: 423  SLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSIS 482
            +LG NNLSG+IP      + L  L LA N L G  P  +C    +  ++L  N+  GSI 
Sbjct: 439  NLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIP 498

Query: 483  SCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGI 542
              +GN ++LQ L L  N FT  +P     L  + + +ISSN L G +   I N K +  +
Sbjct: 499  REVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRL 558

Query: 543  DLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIP 602
            D+  NN SG +P+ +  L  L+ + L+ N L G IP + GN++ L  L +  N  +GSIP
Sbjct: 559  DMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIP 618

Query: 603  VSFEKLSYLK-ELNLSFNKLKGEIPR---------------------------------- 627
                 L+ L+  LNLS+NKL GEIP                                   
Sbjct: 619  RELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLG 678

Query: 628  --------GGPFA---NFTAESFMGNELLCGLP---NLQVPPCKHSQ----PRAQHKSKK 669
                     GP     N +  SF+GNE LCG P    +Q  P   SQ    P     SK 
Sbjct: 679  YNFSYNSLTGPIPLLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKI 738

Query: 670  TILLLVIFLPLSTTLVIAVALALKRGKRGTMLSNDIILSSQ-------PTIRRFSYFELL 722
              +   +   +S  L+  +   ++R  R    S      S+       P    F++ +L+
Sbjct: 739  IAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLV 798

Query: 723  RATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA-----STLKSFEAECEVIK 777
             ATDNF E+ ++G G  G+VY+A L  G  +A+K            +   SF AE   + 
Sbjct: 799  AATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLG 858

Query: 778  NIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALE 837
            NIRHRN+VK+   C++     L+ EYM  GSL + LH  +C L+   R  I +  A  L 
Sbjct: 859  NIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRFKIALGAAQGLA 918

Query: 838  YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            YLH      I H D+K +N+LLD+   AH+ DFG+AK++      +M +    + GY+AP
Sbjct: 919  YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSM-SAIAGSYGYIAP 977

Query: 898  D---------------------EIFVGELSLK---------RWVNDLLPVSLVE--VVDK 925
            +                     E+  G+  ++          WV   +    +   V+D 
Sbjct: 978  EYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGVLDA 1037

Query: 926  SLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLK 972
             L   +E+  +     +L++  +AL CT  SP  R   +  +  L++
Sbjct: 1038 RLTLEDERIVSH----MLTVLKIALLCTSVSPVARPSMRQVVLMLIE 1080

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  432 bits (1110), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 321/986 (32%), Positives = 498/986 (50%), Gaps = 131/986 (13%)

Query: 1   MEMIKVITVRSVIHCLLCLVITVAASNISTDQQALLALKDHITYDPTNLLGTNWTS--NA 58
           ++++ +I++  V+ C   +  TV  +N      ALL  K   T   ++   ++W +   +
Sbjct: 28  LQVLLIISI--VLSCSFAVSATVEEAN------ALLKWKSTFTNQTSSSKLSSWVNPNTS 79

Query: 59  SIC-SWIGIICDVNS-----------------------HKVTTLNLSSFNLQGTIPPEIA 94
           S C SW G+ C + S                         +T ++LS     GTI P   
Sbjct: 80  SFCTSWYGVACSLGSIIRLNLTNTGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTISPLWG 139

Query: 95  NLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSK 154
             S L+  DLS N+L   IP  +  +S L  L+L++N+L+GS+ S     + + +I +  
Sbjct: 140 RFSKLEYFDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYD 199

Query: 155 NKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEI 214
           N L+G +P +  N L  L +L+L  N   G IPS +     L+EL L  NNL+G IP   
Sbjct: 200 NLLTGPIPSSFGN-LTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSF 258

Query: 215 GNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLY 274
           GNL  +  +++  N+L GEIP EIG +  LD L L  N LTG +P+T+ N+ TL  + LY
Sbjct: 259 GNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLY 318

Query: 275 NNSLSGSLP-------SRIDL----------------ALPNLEFLNLGINSFSGTIPSSI 311
            N L+GS+P       S IDL                 L  LE+L L  N  SG IP  I
Sbjct: 319 LNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGI 378

Query: 312 TNASKLILLEMGSNSFSGFIPSAI---GNLRNLKLFDIFFNNLTSSTPELGFLSSLANCK 368
            N+++L +L++ +N+F+GF+P  I   G L NL L D   N+     P+     SL +CK
Sbjct: 379 ANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDD---NHFEGPVPK-----SLRDCK 430

Query: 369 KLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNN 428
            L  +   GN   G +  + G +  +L  ++++  N  G +         L+   L  N+
Sbjct: 431 SLIRVRFKGNSFSGDISEAFG-VYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNS 489

Query: 429 LSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNL 488
           ++G+IP     + +L  LDL+ N++ G +P+ I  ++R+++L LNGN++SG I S +  L
Sbjct: 490 ITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLL 549

Query: 489 TSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNN 548
           T+L+YL+L SNRF+  IP T                        + NL  +  ++LSRN+
Sbjct: 550 TNLEYLDLSSNRFSSEIPPT------------------------LNNLPRLYYMNLSRND 585

Query: 549 LSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKL 608
           L   IP  L  L  LQ + L+YN+L+G I   F ++ +LE LDLS+N +SG IP SF+ +
Sbjct: 586 LDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDM 645

Query: 609 SYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQ--VPPCKHSQPRAQHK 666
             L  +++S N L+G IP    F N   ++F GN+ LCG  N    + PC  +  +  HK
Sbjct: 646 LALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHK 705

Query: 667 SKKTILLLVIFLPLSTTLVIAVALA------LKRGKR----------GTMLSNDIILSSQ 710
            +   L++ I +P+   ++I    A       KR K+          G  LS   I S  
Sbjct: 706 DRN--LIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLS---IFSFD 760

Query: 711 PTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQC------AS 764
             +R   Y E+++AT  F    +IG GG G VY+A+L + + +A+K  +          S
Sbjct: 761 GKVR---YQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNAI-MAVKKLNETTDSSISNPS 816

Query: 765 TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA--LNI 822
           T + F  E   +  IRHRN+VK+   CS+     LV EYM  GSL   L + + A  L+ 
Sbjct: 817 TKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDW 876

Query: 823 FCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES 882
             R+N++  +A AL Y+H   S  I+H D+   N+LL ED  A +SDFG AKLL  + +S
Sbjct: 877 GKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLL--KPDS 934

Query: 883 TMRTQTLATIGYMAPDEIFVGELSLK 908
           +  +    T GY+AP+  +  +++ K
Sbjct: 935 SNWSAVAGTYGYVAPELAYAMKVTEK 960

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  430 bits (1105), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 339/1102 (30%), Positives = 525/1102 (47%), Gaps = 149/1102 (13%)

Query: 16   LLCLVITVAASNISTDQQALLALKDHITYDPTNLLGTNWTS-NASICSWIGIICDVNSHK 74
            LL L++  + S +++D Q LL LK+    D  N L  NW   + + C+WIG+ C      
Sbjct: 22   LLTLLVWTSES-LNSDGQFLLELKNRGFQDSLNRL-HNWNGIDETPCNWIGVNCSSQGSS 79

Query: 75   -------VTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLY 127
                   VT+L+LSS NL G + P I  L +L  L+L++N L+ +IP  I   S L+V++
Sbjct: 80   SSSNSLVVTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMF 139

Query: 128  LMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICN-------------------- 167
            L +NQ  GS+       S +    +  NKLSG LPE I +                    
Sbjct: 140  LNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPR 199

Query: 168  ---HLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRIS 224
               +L  L      +N F G IP+ + KC  L+ L L  N +SG +PKEIG L  LQ + 
Sbjct: 200  SLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVI 259

Query: 225  LINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPS 284
            L  NK  G IP++IG L +L+ L L  N+L G +P+ I NM +LK+++LY N L+G++P 
Sbjct: 260  LWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPK 319

Query: 285  RIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLF 344
             +   L  +  ++   N  SG IP  ++  S+L LL +  N  +G IP+ +  LRNL   
Sbjct: 320  ELG-KLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKL 378

Query: 345  DIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCN 404
            D+  N+LT   P  GF     N   +R L L  N L G +P  +G L   L  ++ +   
Sbjct: 379  DLSINSLTGPIPP-GF----QNLTSMRQLQLFHNSLSGVIPQGLG-LYSPLWVVDFSENQ 432

Query: 405  ISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLL 464
            +SG IP  I   SNLI+L+LG N + G+IP      + L  L +  N+L G  P E+C L
Sbjct: 433  LSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKL 492

Query: 465  SRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNL 524
              L+ ++L+ N+ SG +   +G    LQ L+L +N+F+  +P+    L ++++F++SSN 
Sbjct: 493  VNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNS 552

Query: 525  LDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNM 584
            L GPI   I N K +  +DLSRN+  G++P  L  L  L+ + L+ NR  G IP + GN+
Sbjct: 553  LTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNL 612

Query: 585  TSLESLD-------------------------------------------------LSNN 595
            T L  L                                                  L+NN
Sbjct: 613  THLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNN 672

Query: 596  KISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPP 655
             +SG IP +FE LS L   N S+N L G++P    F N T  SF+GN+ LCG       P
Sbjct: 673  HLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDP 732

Query: 656  CKHSQPR------AQHKSKKTILLLVIFLPLSTTLVIAVALALKRG-----------KRG 698
               S P          +  + I+++   +   + L+IA+ +   R            K  
Sbjct: 733  SHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEP 792

Query: 699  TMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVF 758
                +DI    +    RF+  ++L AT  F ++ I+G G  G+VY+A +  G  IA+K  
Sbjct: 793  FFQESDIYFVPK---ERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKL 849

Query: 759  H-------PQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA--LVLEYMSNGSL 809
                        +T  SF AE   +  IRHRN+V++ S C +    +  L+ EYMS GSL
Sbjct: 850  ESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSL 909

Query: 810  EDCLHSSNC-ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLS 868
             + LH     +++   R  I +  A  L YLH      IIH D+K +N+L+DE+  AH+ 
Sbjct: 910  GELLHGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVG 969

Query: 869  DFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK-----------RWVNDLLPV 917
            DFG+AK++      ++ +    + GY+AP+  +  +++ K             +    PV
Sbjct: 970  DFGLAKVIDMPLSKSV-SAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPV 1028

Query: 918  SLVE------------VVDKSLLSGEEKHFAAKEQ------CLLSIFSLALECTMESPEK 959
              +E            + D SL S     +  K +       ++++  +A+ CT  SP  
Sbjct: 1029 QPLEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSD 1088

Query: 960  RIDAKDTITRLLKIRDTLSKRI 981
            R   ++ +  L++  +   K I
Sbjct: 1089 RPTMREVVLMLIESGERAGKVI 1110

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  422 bits (1084), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 302/889 (33%), Positives = 461/889 (51%), Gaps = 103/889 (11%)

Query: 184 GKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNL-TVLQRISLINNKLHGEIPQEIGYLQ 242
           G+I  S++    L  L L  N   G IP EIG+L   L+++SL  N LHG IPQE+G L 
Sbjct: 80  GEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGNIPQELGLLN 139

Query: 243 NLDVLQLGFNNLTGVVPATIF---NMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLG 299
            L  L LG N L G +P  +F   + S+L+ I L NNSL+G +P      L  L FL L 
Sbjct: 140 RLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLW 199

Query: 300 INSFSGTIPSSITNASKLILLEMGSNSFSGFIPS-AIGNLRNLKLFDIFFNNLTS---ST 355
            N  +GT+PSS++N++ L  +++ SN  SG +PS  I  +  L+   + +N+  S   +T
Sbjct: 200 SNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNT 259

Query: 356 PELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIG- 414
               F +SLAN   L+ L L GN L G + SS+ +LS++L ++++    I G+IP  I  
Sbjct: 260 NLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISN 319

Query: 415 -----------------------NLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFN 451
                                   LS L  + L  N+L+G IP+  G + +L  LD++ N
Sbjct: 320 LLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRN 379

Query: 452 KLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIP----S 507
            L+GSIPD    LS+L  L L GN +SG++   LG   +L+ L+L  N  T  IP    S
Sbjct: 380 NLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVS 439

Query: 508 TFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNIS 567
              NLK  L  ++SSN L GPI L +  +  V+ +DLS N LSG IP  L    +L++++
Sbjct: 440 NLRNLK--LYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLN 497

Query: 568 LAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPR 627
           L+ N     +P S G +  L+ LD+S N+++G+IP SF++ S LK LN SFN L G +  
Sbjct: 498 LSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSD 557

Query: 628 GGPFANFTAESFMGNELLCG-LPNLQVPPCKHSQPRAQHKSKKTILLLVIFLPLSTTLVI 686
            G F+  T ESF+G+ LLCG +  +Q    KH            +LL +I  P+      
Sbjct: 558 KGSFSKLTIESFLGDSLLCGSIKGMQACKKKH----KYPSVLLPVLLSLIATPVLCVFGY 613

Query: 687 AVALALKRGKRGTMLSNDIILSSQ------PTIRRFSYFELLRATDNFAENNIIGIGGFG 740
            +    + GK  T+ + + +   +      P   R SY +L+ AT  F  +++IG G FG
Sbjct: 614 PLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFG 673

Query: 741 SVYRARLEDGVEIAIKVFHPQCASTLK-SFEAECEVIKNIRHRNLVKIISSCSNDDFKAL 799
            VY+  L +  ++A+KV  P+ A     SF+ EC+++K  RHRNL++II++CS   F AL
Sbjct: 674 HVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNAL 733

Query: 800 VLEYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSN 856
           VL  M NGSLE  L+    S+  L++   +NI  D+A  + YLH      ++HCDLKPSN
Sbjct: 734 VLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSN 793

Query: 857 VLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA----------TIGYMAPD-------- 898
           +LLD++M A ++DFG+++L+ G +E+     +++          ++GY+AP+        
Sbjct: 794 ILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRAS 853

Query: 899 -------------EIFVGEL----------SLKRWVNDLLPVSLVEVVDKSLLSGEEKHF 935
                        EI  G            SL  ++    P SL  +++++L     K  
Sbjct: 854 THGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQAL--SRWKPQ 911

Query: 936 AAKEQC-------LLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL 977
              E+C       +L +  L L CT  +P  R D  D    + ++++ L
Sbjct: 912 GKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLKEYL 960

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	985
255572272	1089	serine-threonine protein kinase, plant-t	0.975	0.882	0.458	0.0
359483198	1087	PREDICTED: probable LRR receptor-like se	0.917	0.831	0.514	0.0
224139658	1019	predicted protein [Populus trichocarpa]	0.945	0.913	0.456	0.0
359483685	1046	PREDICTED: LRR receptor-like serine/thre	0.955	0.899	0.450	0.0
147776333	1205	hypothetical protein VITISV_000078 [Viti	0.904	0.739	0.489	0.0
255578886	1043	serine-threonine protein kinase, plant-t	0.960	0.906	0.468	0.0
359483677	1229	PREDICTED: LRR receptor-like serine/thre	0.912	0.731	0.482	0.0
147769371	1241	hypothetical protein VITISV_010511 [Viti	0.912	0.724	0.486	0.0
359497186	1140	PREDICTED: LRR receptor-like serine/thre	0.956	0.826	0.431	0.0
147853795	1420	hypothetical protein VITISV_005816 [Viti	0.906	0.628	0.482	0.0

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  844 bits (2181), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 491/1072 (45%), Positives = 646/1072 (60%), Gaps = 111/1072 (10%)

Query: 21   ITVAASNISTDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNL 80
            + +  SN+ TD  ALL LK+H  +DP   +  NW+S  S C W G+ C    ++V  L L
Sbjct: 22   LAIPKSNL-TDLSALLVLKEHSNFDP--FMSKNWSSATSFCHWYGVTCSERHNRVVALTL 78

Query: 81   SSFNLQGTIPP------------------------EIANLSSLKSLDLSHNKLSSNIPSS 116
            S+  ++G +PP                        E+ NL  LK ++ S+N     IPSS
Sbjct: 79   SNMGIKGIVPPHIGNLSFLVHIDMSNNSYSGHLPNELGNLHRLKFMNFSNNSFVGEIPSS 138

Query: 117  -----------------------IFTMSTLKVLYLMDN---------------------- 131
                                   IF ++TL  L L DN                      
Sbjct: 139  LAMLPKLQHLLLANNSLTAGRSSIFNITTLNTLDLNDNLLGGNILDNIGGNLSNLQVLNM 198

Query: 132  ---QLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPS 188
               QLSGS      +  S+  I L  N LSG L E +CN    L+ L L  N  YG+IPS
Sbjct: 199  GLNQLSGSFPPKILDLPSLKFIYLQVNNLSGNLKEILCNQNSKLQLLNLAGNQLYGQIPS 258

Query: 189  SLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQ 248
             L KCK+L+ L L  N  +G+IP+ IGNLT L+ +SL  N L G IP EIG LQNL ++ 
Sbjct: 259  DLYKCKELRSLALHANKFTGSIPRTIGNLTKLKWLSLGRNNLTGRIPLEIGNLQNLQIVH 318

Query: 249  LGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIP 308
            L FNNL G +P  +FN+ST+K I + +N+L G+LP+ + L LPNL +L LGIN  SG IP
Sbjct: 319  LSFNNLNGSIPHALFNISTMKWIAMTSNNLLGNLPTSLGLHLPNLIWLYLGINKLSGPIP 378

Query: 309  SSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTS--STPELGFLSSLAN 366
            S I+NASKL +LE+ SNSF+GFIP ++G+LRNL+   +  N L+S  ++ EL   SSL N
Sbjct: 379  SYISNASKLTILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKTSQELTIFSSLKN 438

Query: 367  CKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGG 426
            C+ L+YL L  NPLDG+LP S+GNLS SLE    +   I G++ ++IGNLS+L  L+LG 
Sbjct: 439  CQNLKYLWLSYNPLDGYLPHSVGNLSNSLESFLASDGLIKGSVHESIGNLSSLTRLNLGN 498

Query: 427  NNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLG 486
            N+L+G IP T G L+ LQGL L  N L GSIP E+C L  L  L+L GNK+SGSI +C  
Sbjct: 499  NDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSIPTCFS 558

Query: 487  NLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSR 546
            NLTSL+ L L SNRF   I ST W LKDIL  +++SN L G +   I NL+AV  I++S+
Sbjct: 559  NLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMINISK 618

Query: 547  NNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFE 606
            N LSG IP ++ GL+ L  + L+ N+L+GPIP+S G++ SLE LDLS+N +SG IP S +
Sbjct: 619  NQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLD 678

Query: 607  KLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKHSQPRA-QH 665
             L YLK  N+SFN L+GEIP GG F+NF+A+SF+GNE LCG   LQV PCK    RA + 
Sbjct: 679  NLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSRATET 738

Query: 666  KSKKTILLLVIFLPLSTTLVIAVALALKRG-KRGTMLSNDIILSSQPTIRRFSYFELLRA 724
               K +L  V+   +    V+A  + LKR  +R    S +    +  TIRR SY EL  A
Sbjct: 739  PGSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDFLALTTIRRISYHELQLA 798

Query: 725  TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
            T+ F E+N +G+G FGSVY+  L DG  IA KVF+ Q     KSF+ ECEV++N+RHRNL
Sbjct: 799  TNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNL 858

Query: 785  VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            VKII+SCS  +FKALVLE+M N SLE  L+S +  LN   RLNIM+D+AS LEYLH G++
Sbjct: 859  VKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYT 918

Query: 845  TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP------- 897
             P+ HCD+KPSNVLL+EDMVA L+DFG++KLL GE+ S M+T TLATIGYMAP       
Sbjct: 919  IPMAHCDIKPSNVLLNEDMVAFLADFGISKLL-GEEGSVMQTMTLATIGYMAPEYGSEGI 977

Query: 898  ------------------------DEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK 933
                                    D++F  +LSLK WV   L   + +V+D +LL  EE 
Sbjct: 978  VSVRGDVYSYGVLLMETFTQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEED 1037

Query: 934  HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSKRIGNLS 985
            H AAK+ C++SI  LAL+C+ + P  RID K  +T L KI+    + I  LS
Sbjct: 1038 HLAAKKDCIVSILKLALQCSADLPHDRIDMKHVVTTLQKIKTKFLRDIRQLS 1089

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  832 bits (2150), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 487/947 (51%), Positives = 618/947 (65%), Gaps = 43/947 (4%)

Query: 71   NSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMD 130
            N +++ +L L + +  GTIPP I N+S L++L L  N L  NIP  I  +ST+K+L +  
Sbjct: 144  NLNRLQSLFLGNNSFTGTIPPSIGNMSMLETLGLGGNHLQGNIPEEIGKLSTMKILDIQS 203

Query: 131  NQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNH-LRYLKHLFLRENMFYGKIPSS 189
            NQL G++ S  FN SS+ +I L+ N LSG LP ++CNH L  L+ + L  N F G IPS+
Sbjct: 204  NQLVGAIPSAIFNISSLQEIALTYNSLSGDLPSSMCNHELSALRGIRLSANRFTGPIPSN 263

Query: 190  LSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQL 249
            LSKC +LQ L+L +N  +G IP+ I +LT L  +SL  N L GE+P EIG L  L+VL +
Sbjct: 264  LSKCGELQTLYLSFNKFTGGIPRSIDSLTKLTMLSLAANSLSGEVPCEIGSLCTLNVLNI 323

Query: 250  GFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPS 309
              N+LTG +P  IFN+S++    L  N+LSG+LP      LPNLE L L IN  SG IPS
Sbjct: 324  EDNSLTGHIPFQIFNISSMVSGSLTRNNLSGNLPPNFGSYLPNLENLILEINWLSGIIPS 383

Query: 310  SITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLT--SSTPELGFLSSLANC 367
            SI NASKL  L+ G N  +G IP A+G+LR L+  ++  NNL   S   EL FL+SL NC
Sbjct: 384  SIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGESYIQELSFLTSLTNC 443

Query: 368  KKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGN 427
            K+LR L L  NPL G LP SIGNLS SL+R     C + GNIP  IGNLSNL +LSL  N
Sbjct: 444  KRLRILYLSFNPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSLNNN 503

Query: 428  NLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGN 487
            +L+G+IP + G LQKLQGL L  NKL GSIP++IC L  L EL L  N++SGSI +CLG 
Sbjct: 504  DLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACLGE 563

Query: 488  LTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRN 547
            LT L++L LGSN+    IPST W+L  ILS D+SSN L G +   +GNLK +V IDLSRN
Sbjct: 564  LTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRN 623

Query: 548  NLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEK 607
             LSG IP+ + GL+ L ++SLA+NR EGPI  SF N+ SLE +DLS+N + G IP S E 
Sbjct: 624  QLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEG 683

Query: 608  LSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKHSQPRAQHKS 667
            L YLK L++SFN L GEIP  GPFANF+AESFM N+ LCG P L++PPC+      +  +
Sbjct: 684  LVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTG---TRWST 740

Query: 668  KKTILLLVIFLP--LSTTLVIAVALALKR-GKRGTMLSNDIILSSQPTIRRFSYFELLRA 724
              + LLL   LP  LST L +A+     R  KR  +L          T RR SY E+ +A
Sbjct: 741  TISWLLLKYILPAILSTLLFLALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQEIFQA 800

Query: 725  TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
            T+ F+  N++G G  GSVYR  L DG   AIKVF+ Q  +  KSF+AECEV+ +IRHRNL
Sbjct: 801  TNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNL 860

Query: 785  VKIISSCSND--DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
            +KI+SSCSN   DFKALVLEY+ NGSLE  L+S N  L+I  RLNIMID+A A+EYLH G
Sbjct: 861  IKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHG 920

Query: 843  HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP----- 897
             STP++HCDLKPSN+LLDED   H+ DFG+AKLL  E+ES   TQTLATIGYMAP     
Sbjct: 921  CSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLLR-EEESIRETQTLATIGYMAPKYVSN 979

Query: 898  --------------------------DEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGE 931
                                      DEIF  E+S+K WV D L  S+ EVVD +LL GE
Sbjct: 980  GIVTTSGDVYSYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGE 1039

Query: 932  EKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS 978
            ++ F AK+QC+  I  LA++C  +SPE+RI  KD +T L KI+  +S
Sbjct: 1040 DEQFMAKKQCISLILGLAMDCVADSPEERIKMKDVVTTLKKIKTHIS 1086

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  829 bits (2141), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 468/1026 (45%), Positives = 636/1026 (61%), Gaps = 95/1026 (9%)

Query: 21   ITVAASNISTDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNL 80
            I++  SN  TDQ ALLA KDHIT+DP N+L  +W+S  S C+W+G+ C +   +VT L+L
Sbjct: 22   ISIPTSNF-TDQSALLAFKDHITFDPQNMLTHSWSSKTSFCNWMGVSCSLRRQRVTALDL 80

Query: 81   SSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLS------ 134
            SS  L GTIPP++ NLS L+ L L +N    ++PS I  +  L+V+ +  N+LS      
Sbjct: 81   SSMGLLGTIPPQLGNLSFLQYLILYNNSFHGDLPSEIGNLRRLQVMDIGSNKLSLVIVPE 140

Query: 135  -------------------GSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHL 175
                               G++ S  FN SS+  + L  N L G LP+N+C+HL  L+ L
Sbjct: 141  SFGNLHRLEELRFDGNNLTGTIPSTIFNISSLKVLDLMFNGLFGSLPKNMCDHLPRLEML 200

Query: 176  FLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIP 235
             L  N   G+IPS L KC++LQ L L YNN +G IP                        
Sbjct: 201  LLSSNQLSGQIPSDLFKCRELQLLWLPYNNFTGVIP------------------------ 236

Query: 236  QEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEF 295
            +E+G+L  L+VL LG N L+G +P +IFNM++L+ + +  N+LSGS+P    + LPNLE 
Sbjct: 237  EELGFLPMLEVLNLGVNMLSGDLPRSIFNMTSLRTMQICCNNLSGSIPQENSIDLPNLEE 296

Query: 296  LNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTS-- 353
            L L +N  +G++P  + N S+L +L++  N  +G +    GNLR L++  +  N+ T+  
Sbjct: 297  LQLNLNGITGSMPRFLGNMSRLEILDLSYNKMTGNVLQEFGNLRALQVLSLQSNSFTNHP 356

Query: 354  STPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAI 413
            S+  L F++SL N ++L+ L +G NPLDG LP+S+GNLS  L +  +    + GNIP  I
Sbjct: 357  SSQTLNFITSLTNSRQLKELHIGDNPLDGMLPNSVGNLSSFLTKFYVYASKLKGNIPGEI 416

Query: 414  GNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLN 473
            GNLSNLIVLSL  N+L G IP T GGL+K+Q L L  N L GSIP +ICL  RL ++ LN
Sbjct: 417  GNLSNLIVLSLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARRLVDITLN 476

Query: 474  GNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAI 533
             N +SG I SC+GNLTSL+ L L  N  +  IP   W+LKD+L  ++ SN L G +   +
Sbjct: 477  NNVLSGEIPSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQV 536

Query: 534  GNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLS 593
            G ++A +GI LS N LSGNIP+T+  L++L   SL+ N  +G IPE+FG + SLE LDLS
Sbjct: 537  GEMEAAIGIRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLS 596

Query: 594  NNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQV 653
             N +SG IP S E L YL+  ++SFN L+GEIPRGGPFANFTA SF+ N+ LCG   LQV
Sbjct: 597  QNNLSGEIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQV 656

Query: 654  PPCKHSQPRAQHKSKKTILLLVIFLPLSTTLVIAVALALKRGKRGTMLSNDIILSSQPTI 713
            PPC   + R   K+K  +L   +    S  LV+A    +   +R      D I  + P  
Sbjct: 657  PPCS-IESRKDSKTKSRLLRFSLPTVASILLVVAFIFLVMGCRR--RYRKDPIPEALPVT 713

Query: 714  ---RRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFE 770
               RR SY ELL AT+ F E+N++GIG FGSVY+ RL DG+ +A+K+F+ Q     +SF+
Sbjct: 714  AIQRRISYLELLHATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFD 773

Query: 771  AECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
             ECE+++NIRHRNLVKII SCSN DFKALVLEYM  GSLE  L+S N  L+I  R+NIMI
Sbjct: 774  TECEIMRNIRHRNLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMI 833

Query: 831  DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            D+ASALEYLH G+ +P++HCDLKPSNVLLDEDMVAH+ DFG+AKLL GE+ES  +T+TLA
Sbjct: 834  DVASALEYLHHGYPSPVVHCDLKPSNVLLDEDMVAHVCDFGIAKLL-GENESFAQTRTLA 892

Query: 891  TIGYMAP-------------------------------DEIFVGELSLKRWVNDLLPVSL 919
            TIGYMAP                               DE+F GE+SLKR V + LP S+
Sbjct: 893  TIGYMAPEYGLDGLVSTKIDVYSFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSV 952

Query: 920  VEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI-----R 974
            +++VD ++L+  + +   KE C+ SI  LAL+C  ESP +R+   + + RL  I     R
Sbjct: 953  IDIVDSNMLNRGDGYSVKKEHCVTSIMELALQCVNESPGERMAMVEILARLKNIKAEFLR 1012

Query: 975  DTLSKR 980
            D+  +R
Sbjct: 1013 DSERRR 1018

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera]

 Score =  820 bits (2117), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 468/1038 (45%), Positives = 635/1038 (61%), Gaps = 97/1038 (9%)

Query: 30   TDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTI 89
             D+ AL+ALK HITYD   +L TNW++ +S C+W GI C+    +V+ +NLS+  L+GTI
Sbjct: 8    VDEFALIALKAHITYDSQGILATNWSTKSSYCNWYGISCNAPQQRVSAINLSNMGLEGTI 67

Query: 90   PPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILD 149
             P++ NLS L SLDL++N  + +IP+ I  +  L+ L L +N L+G + S   +   +  
Sbjct: 68   APQVGNLSFLVSLDLTYNDFTGSIPNGIGNLVELQRLSLRNNSLTGEIPSNLSHCRELRG 127

Query: 150  IRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGA 209
            + LS N+ +G +P+ I   L  L+ L+L  N   G IP  +     L  L LG N +SG 
Sbjct: 128  LSLSINQFTGGIPQAI-GSLSNLEELYLNYNKLTGGIPREIGNLSNLNILQLGSNGISGP 186

Query: 210  IPKEIGNLTVLQRISLIN------------------------------------------ 227
            IP EI  ++ LQRI   N                                          
Sbjct: 187  IPAEIFTVSSLQRIIFANNSLSGSLPMDICKHLPNLQGLYLSQNHLSGQLPTTLSLCREL 246

Query: 228  -------NKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLK----------E 270
                   NK  G IP+EIG L  L+ + L  N+L G +P +  N+ TLK           
Sbjct: 247  LSLALPMNKFTGSIPREIGNLSKLEEIDLSENSLIGSIPTSFGNLMTLKFLSFNISKLQT 306

Query: 271  IFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGF 330
            + L  N LSGSLPS I   LP+LE L +GIN FSGTIP SI+N SKL +L +  NSF+G 
Sbjct: 307  LGLVQNHLSGSLPSSIGTWLPDLEGLYIGINEFSGTIPMSISNMSKLTVLSLSDNSFTGN 366

Query: 331  IPSAIGNLRNLKLFDIFFNNLTSS--TPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSI 388
            +P  + NL  L+  D+ +N LT       +GFL+SL NCK LR L +G NPL G LP+S+
Sbjct: 367  VPKDLCNLTKLQFLDLAYNQLTDEHLASGVGFLTSLTNCKFLRNLWIGYNPLTGTLPNSL 426

Query: 389  GNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDL 448
            GNL ++LE    + C   G IP  IGNL+NLI L LG N+L+GSIP T G LQKLQ L +
Sbjct: 427  GNLPIALEIFIASACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGQLQKLQALSI 486

Query: 449  AFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPST 508
              N++ GSIP+++C L  L  L L+ NK+SGSI SC G+L +L+ L+L SN   F IP +
Sbjct: 487  VGNRIRGSIPNDLCHLKNLGYLRLSYNKLSGSIPSCFGDLPALRELSLDSNVLAFNIPMS 546

Query: 509  FWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISL 568
            FW+L+D+L  ++SSN L G +   +GN+K++  +DLS+N +SG IP+ +  L++L  +SL
Sbjct: 547  FWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKLQNLITLSL 606

Query: 569  AYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRG 628
            + N+L+GPIP  FG++ SLESLDLS N +SG+IP + E L YLK LN+SFNKL+GEIP G
Sbjct: 607  SQNKLQGPIPVEFGDLVSLESLDLSQNNLSGTIPKTLEALIYLKYLNVSFNKLQGEIPNG 666

Query: 629  GPFANFTAESFMGNELLCGLPNLQVPPCKHSQPRAQHKSKKTILLLVIFLPLSTTLVIAV 688
            GPF  FTAESFM NE LCG P+ QV  C  +  R Q    K+ +L  I LP+ +T+ + V
Sbjct: 667  GPFVKFTAESFMFNEALCGAPHFQVMACDKNN-RTQSWKTKSFILKYILLPVGSTVTLVV 725

Query: 689  ALALKRGKRGTMLSNDIILSSQP-TIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARL 747
             + L   +R  M     I S  P T  + S+ +LL AT++F E+N+IG G  G VY+  L
Sbjct: 726  FIVLWIRRRDNMEIPTPIDSWLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVL 785

Query: 748  EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNG 807
             +G+ +AIKVF+ +    L+SF +ECEV++ IRHRNLV+II+ CSN DFKALVL+YM NG
Sbjct: 786  SNGLTVAIKVFNLEFQGALRSFNSECEVMQGIRHRNLVRIITCCSNLDFKALVLKYMPNG 845

Query: 808  SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHL 867
            SLE  L+S    L++  RLNIMID+ASALEYLH   S+ ++HCDLKPSNVLLD+DMVAH+
Sbjct: 846  SLEKLLYSHYYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHV 905

Query: 868  SDFGMAKLLSGEDESTMRTQTLATIGYMAP------------------------------ 897
            +DFG+AKLL+ E ES  +T+TL+TIGYMAP                              
Sbjct: 906  ADFGIAKLLT-ETESMQQTKTLSTIGYMAPEHGSAGIVSTKSDVYSYGILLMEVFARKKP 964

Query: 898  -DEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMES 956
             DE+F G+L+LK WV   L  S+++VVD +LL  E++  A K  CL SI +LAL CT +S
Sbjct: 965  MDEMFTGDLTLKTWVES-LSNSVIQVVDVNLLRREDEDLATKLSCLSSIMALALACTTDS 1023

Query: 957  PEKRIDAKDTITRLLKIR 974
            PE+RID KD +  L K R
Sbjct: 1024 PEERIDMKDAVVELKKSR 1041

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera]

 Score =  815 bits (2104), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 455/929 (48%), Positives = 603/929 (64%), Gaps = 38/929 (4%)

Query: 81   SSFN-LQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSS 139
            SSFN   G IP  I +L +L+ L L+ NKL+  IP  I  +S L +L L  N +SG + +
Sbjct: 275  SSFNQFTGGIPQAIGSLCNLEELYLAFNKLTGGIPREIGNLSNLNILQLGSNGISGPIPA 334

Query: 140  FTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQEL 199
              FN SS+  I  + N LSG LP  IC HL  L+ L+L +N   G++P++LS C +L  L
Sbjct: 335  EIFNISSLQVIDFTNNSLSGSLPMGICKHLPNLQGLYLAQNHLSGQLPTTLSLCGELLFL 394

Query: 200  HLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVP 259
             L +N   G+IP+EIGNL+ L+ I L +N L G IP   G L+ L  L LG N LTG VP
Sbjct: 395  SLSFNKFRGSIPREIGNLSKLEHIDLRSNSLVGSIPTSFGNLKALKFLNLGINFLTGTVP 454

Query: 260  ATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLIL 319
              IFN+S L+ + L  N LSGSLPS I   LP+LE L +G N FSGTIP SI+N SKL +
Sbjct: 455  EAIFNISELQNLALVQNHLSGSLPSSIGTWLPDLEGLYIGANEFSGTIPMSISNMSKLTV 514

Query: 320  LEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSS--TPELGFLSSLANCKKLRYLGLGG 377
            L +  NSF+G +P  + NL  LK  ++  N LT       +GFL+SL NCK LRYL +G 
Sbjct: 515  LSLSDNSFTGNVPKDLCNLTKLKFLNLAHNQLTDEHLASGVGFLTSLTNCKFLRYLWIGY 574

Query: 378  NPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTF 437
            NPL G LP+S+GNL ++LE      C   G IP  IGNL+NLI L LG N+L+GSIP T 
Sbjct: 575  NPLKGTLPNSLGNLPIALESFTAYACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTL 634

Query: 438  GGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLG 497
            G LQKLQ L +A N++ GSIP+++C L  L  L L+ NK+SGS  SC G+L +L+ L L 
Sbjct: 635  GRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYLGLSSNKLSGSTPSCFGDLLALRELFLD 694

Query: 498  SNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTL 557
            SN   F IP++ W+L+D+L  ++SSN L G +   +GN+K++  +DLS+N +SG IP+ +
Sbjct: 695  SNALAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSRM 754

Query: 558  EGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLS 617
              L+ L  +SL+ NRL+GPI   FG++ SLESLDLS+N +SG+IP S E L YLK LN+S
Sbjct: 755  GKLQYLITLSLSQNRLQGPIXVEFGDLVSLESLDLSHNNLSGTIPKSLEALIYLKYLNVS 814

Query: 618  FNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKHSQPRAQHKSKKTILLLVIF 677
            FNKL+GEIP GGPF  FTAESFM NE LCG P+ QV  C  +  R Q    K+ +L  I 
Sbjct: 815  FNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNN-RTQSWKTKSFILKYIL 873

Query: 678  LPLSTTLVIAVALALKRGKRGTM-LSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGI 736
            LP+ +T+ + V + L   +R  M +   I      T  + S+ +LL AT++F E+N+IG 
Sbjct: 874  LPVGSTVTLVVFIVLWIRRRDNMEIPTPIDSWLLGTHEKISHQQLLYATNDFGEDNLIGK 933

Query: 737  GGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDF 796
            G  G VY+  L +G+ +AIKVF+ +    L+SF++ECEV++ IRHRNLV+II+ CSN DF
Sbjct: 934  GSQGMVYKGVLSNGLNVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDF 993

Query: 797  KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSN 856
            KALVLEYM NGSLE  L+S N  L++  RLNIMID+ASALEYLH   S+ ++HCDLKPSN
Sbjct: 994  KALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSN 1053

Query: 857  VLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP------------------- 897
            VLLD+DMVAH++DFG+AKLL+ E ES  +T+TL TIGYMAP                   
Sbjct: 1054 VLLDDDMVAHVADFGIAKLLT-ETESMQQTKTLGTIGYMAPEHGSAGIVSTKSDVYSYGI 1112

Query: 898  ------------DEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSI 945
                        DE+F G+L+LK WV   L  S+++VVD +LL  E++  A K  CL SI
Sbjct: 1113 LLMEVFARKKPMDEMFTGDLTLKTWVES-LSNSVIQVVDVNLLRREDEDLATKLSCLSSI 1171

Query: 946  FSLALECTMESPEKRIDAKDTITRLLKIR 974
             +LAL CT +SP++RID KD +  L K R
Sbjct: 1172 MALALACTTDSPKERIDMKDAVVELKKSR 1200

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  813 bits (2100), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 474/1012 (46%), Positives = 637/1012 (62%), Gaps = 66/1012 (6%)

Query: 21   ITVAASNISTDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNL 80
            I    +NI++DQ ALLALK  I  DP NLL  NW+   S+C+W+G+ C     +VT L+L
Sbjct: 24   IADGVTNIASDQDALLALKVRIIRDPNNLLAANWSITTSVCTWVGVTCGARHGRVTALDL 83

Query: 81   SSFNLQGTIPPEIANLSSL------------------------KSLDLSHNKLSSNIPSS 116
            S   L GTIPP + NLS L                        K+  +S N  S  IPS 
Sbjct: 84   SDMGLTGTIPPHLGNLSFLAFISFYNNRFHGSLPDELSKLRRIKAFGMSTNYFSGEIPSW 143

Query: 117  IFTMSTLKVLYLMDNQLSGSLSSFTFNT--SSILDIRLSKNKLSGKLPENICNHLRYLKH 174
            I + + L+ L L  N+ +G L +   N   SS+  +    N L+G+LP NI  HL  L+ 
Sbjct: 144  IGSFTQLQRLSLSSNKFTGLLPAILANNTISSLWLLDFGTNNLTGRLPPNIFTHLANLRA 203

Query: 175  LFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEI 234
            L+L  N+F G IPS+L  C+QL+ L L +N+  G+I K+IGNLT+LQ + L  N   G I
Sbjct: 204  LYLNSNLFNGPIPSTLMACQQLKLLALSFNHFEGSIHKDIGNLTMLQELYLGGNNFSGTI 263

Query: 235  PQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLE 294
            P EIG L +L+ + L  N L+G+VP+ I+N S +  I L  N LSG LPS  +L  PNLE
Sbjct: 264  PDEIGDLAHLEEIILNVNGLSGLVPSGIYNASKMTAIGLALNQLSGYLPSSSNL--PNLE 321

Query: 295  FLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLT-- 352
            F  +  N+F+G IP S+ NASKL  +++G NSF G IP  +GNL++L++F  + N+LT  
Sbjct: 322  FFIIEDNNFTGPIPVSLFNASKLGNIDLGWNSFYGPIPDELGNLKSLEVFSFWVNHLTVK 381

Query: 353  SSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKA 412
            SS+  L   SSL  CK LR   L  NPL+G LP S+GNLS SLE + I  C I+G IPK 
Sbjct: 382  SSSSGLSLFSSLTKCKHLRRFDLSNNPLNGNLPISVGNLSSSLEVVEIFDCGITGTIPKE 441

Query: 413  IGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDL 472
            IGNLS+L  L LG N+L G+IP T   L KLQ L L +N+L GS P E+C L  L  L L
Sbjct: 442  IGNLSSLSWLDLGANDLRGTIPTTIRKLGKLQELKLHYNRLEGSFPYELCDLQSLAYLYL 501

Query: 473  NGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLA 532
              N +SG I SCLGN+ SL+ L++G N+F+  IPST W L DIL  ++SSN L G +++ 
Sbjct: 502  EVNALSGQIPSCLGNVNSLRTLSMGMNKFSSTIPSTLWRLADILELNLSSNSLSGSLAVD 561

Query: 533  IGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDL 592
            IGNLKAV  IDLS N LSG+IP+++ GLK+L N+SLA NRLEG IP+ FG+  SL+ LDL
Sbjct: 562  IGNLKAVTLIDLSGNQLSGHIPSSIGGLKTLLNLSLAVNRLEGSIPQLFGDAISLQLLDL 621

Query: 593  SNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQ 652
            SNN +SG IP S E+L YL   N+SFN+L+GEIP G  F N +A+SFMGN+ LCG   LQ
Sbjct: 622  SNNNLSGEIPKSLEELRYLTYFNVSFNELQGEIPNGRAFINLSAKSFMGNKGLCGAAKLQ 681

Query: 653  VPPCKHSQPRAQHKSKKTILLL-VIFLPLSTTLVIAVALALKRGKRGTMLSNDIILSSQP 711
            V PC+ S  +    + K  L   ++   L+   V AVA+   R ++  M   + +L    
Sbjct: 682  VQPCETSTHQGSKAASKLALRYGLMATGLTILAVAAVAIIFIRSRKRNMRITEGLL-PLA 740

Query: 712  TIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEA 771
            T++R SY EL +ATD F E N++G G FGSVY+    DG  +A+KVF+ Q     KSF+ 
Sbjct: 741  TLKRISYRELEQATDKFNEMNLLGRGSFGSVYKGTFSDGSSVAVKVFNLQVEGAFKSFDV 800

Query: 772  ECEVIKNIRHRNLVKIISSCS--NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM 829
            ECEV++ IRHRNLVKII+SCS  N DFKALVLE+M N SLE  L S    L +  RLNIM
Sbjct: 801  ECEVLRMIRHRNLVKIITSCSDINIDFKALVLEFMPNYSLEKWLCSPKHFLELLERLNIM 860

Query: 830  IDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
            +D+ASA+EYLH G++ PI+HCDLKPSN+LLDE+MVAH++DFG+AKLL G++ S ++T TL
Sbjct: 861  LDVASAVEYLHHGYAMPIVHCDLKPSNILLDENMVAHVTDFGIAKLL-GDEHSFIQTITL 919

Query: 890  ATIGYMAP-------------------------------DEIFVGELSLKRWVNDLLPVS 918
            AT+GYMAP                               D++F  E+S+K+WV + +P  
Sbjct: 920  ATVGYMAPEYGSEGVVSTGGDIYSFGILLMETFTRKKPTDDMFNEEISMKQWVQESVPGG 979

Query: 919  LVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRL 970
            + ++ D  LL  EE+HF+AK+ C+LS+  +AL+C+ + PE+R + +D +  L
Sbjct: 980  VTQITDPDLLRIEEQHFSAKKDCILSVMQVALQCSADLPEERPNIRDVLNTL 1031

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  812 bits (2098), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 452/936 (48%), Positives = 608/936 (64%), Gaps = 37/936 (3%)

Query: 73   HKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQ 132
             ++  L+LS     G IP  I +LS+L+ L LSHNKL+  IP  I  +S L +L L  N 
Sbjct: 292  RELRVLSLSFNQFTGGIPQAIGSLSNLEELYLSHNKLTGGIPREIGNLSNLNILQLSSNG 351

Query: 133  LSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSK 192
            +SG + +  FN SS+  I  + N LSG LP++IC HL  L+ L L +N   G++P++LS 
Sbjct: 352  ISGPIPAEIFNVSSLQVIAFTDNSLSGSLPKDICKHLPNLQGLSLSQNHLSGQLPTTLSL 411

Query: 193  CKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFN 252
            C +L  L L +N   G+IPKEIGNL+ L++I L  N L G IP   G L+ L  L LG N
Sbjct: 412  CGELLFLSLSFNKFRGSIPKEIGNLSKLEKIYLGTNSLIGSIPTSFGNLKALKFLNLGIN 471

Query: 253  NLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSIT 312
            NLTG VP  IFN+S L+ + +  N LSGSLPS I   L +LE L +  N FSG IP SI+
Sbjct: 472  NLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTWLSDLEGLFIAGNEFSGIIPMSIS 531

Query: 313  NASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSS--TPELGFLSSLANCKKL 370
            N SKL +L + +NSF+G +P  +GNL  LK+ D+  N LT      E+GFL+SL NCK L
Sbjct: 532  NMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHVASEVGFLTSLTNCKFL 591

Query: 371  RYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLS 430
            + L +G NP  G LP+S+GNL ++LE    + C   G IP  IGNL+NLI L LG N+L+
Sbjct: 592  KNLWIGNNPFKGTLPNSLGNLPIALESFIASACQFRGTIPTRIGNLTNLIWLDLGANDLT 651

Query: 431  GSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTS 490
            GSIP T G L+KLQ L +  N+L GSIP+++C L  L  L L+ NK+SGSI SC G+L +
Sbjct: 652  GSIPTTLGRLKKLQKLHIVGNRLRGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPA 711

Query: 491  LQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLS 550
            LQ L L SN   F IP++ W+L+D+L  ++SSN L G +   +GN+K++  +DLS+N +S
Sbjct: 712  LQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVS 771

Query: 551  GNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSY 610
            G+IP  +   ++L  +SL+ N+L+GPIP  FG++ SLESLDLS N +SG+IP S E L Y
Sbjct: 772  GHIPRKMGEQQNLAKLSLSQNKLQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALIY 831

Query: 611  LKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKHSQPRAQHKSKKT 670
            LK LN+S NKL+GEIP GGPF NFTAESFM NE LCG P+ QV  C  +  R Q    K+
Sbjct: 832  LKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNN-RTQSWKTKS 890

Query: 671  ILLLVIFLPLSTTLVIAVALALKRGKRGTMLSNDIILSSQP-TIRRFSYFELLRATDNFA 729
             +L  I LP+ + + + V + L   +R  M     I S  P T  + S+ +LL AT++F 
Sbjct: 891  FILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLPGTHEKISHQQLLYATNDFG 950

Query: 730  ENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIIS 789
            E+N+IG G  G VY+  L +G+ +AIKVF+ +    L+SF++ECEV++ IRHRNLV+II+
Sbjct: 951  EDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIIT 1010

Query: 790  SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
             CSN DFKALVLEYM NGSLE  L+S N  L++  RLNIMID+ASALEYLH   S+ ++H
Sbjct: 1011 CCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVH 1070

Query: 850  CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP------------ 897
            CDLKP+NVLLD+DMVAH++DFG+ KLL+ + ES  +T+TL TIGYMAP            
Sbjct: 1071 CDLKPNNVLLDDDMVAHVADFGITKLLT-KTESMQQTKTLGTIGYMAPEHGSDGIVSTKS 1129

Query: 898  -------------------DEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK 938
                               DE+F G+L+LK WV   L  S+++VVD +LL  E++  A K
Sbjct: 1130 DVYSYGILLMEVFSRKKPMDEMFTGDLTLKTWVES-LSNSVIQVVDANLLRREDEDLATK 1188

Query: 939  EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR 974
              CL SI +LAL CT +SPE+R++ KD +  L K R
Sbjct: 1189 LSCLSSIMALALACTTDSPEERLNMKDAVVELKKSR 1224

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147769371|emb|CAN72496.1| hypothetical protein VITISV_010511 [Vitis vinifera]

 Score =  811 bits (2094), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 455/936 (48%), Positives = 608/936 (64%), Gaps = 37/936 (3%)

Query: 73   HKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQ 132
             ++  L+LS     G IP  I +LS+L+ L LS+NKL+  IP  I  +S L +L L  N 
Sbjct: 304  RELRVLSLSFNQFTGGIPQAIGSLSNLEGLYLSYNKLTGGIPREIGNLSNLNILQLGSNG 363

Query: 133  LSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSK 192
            +SG + +  FN SS+  I  S N LSG LP +IC HL  L+ L+L +N   G++P++LS 
Sbjct: 364  ISGPIPAEIFNISSLQIIDFSNNSLSGSLPMDICKHLPNLQGLYLLQNHLSGQLPTTLSL 423

Query: 193  CKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFN 252
            C +L  L L  N   G+IP+EIGNL+ L+ ISL +N L G IP   G L  L  L LG N
Sbjct: 424  CGELLYLSLAVNKFRGSIPREIGNLSKLEDISLRSNSLVGSIPTSFGNLMALKYLDLGMN 483

Query: 253  NLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSIT 312
             LTG VP  IFN+S L+ + L  N LSGSLP  I   LP+LE L +G N FSGTIP SI+
Sbjct: 484  FLTGTVPEAIFNISELQILVLVQNHLSGSLPPSIGTWLPDLEGLYIGSNKFSGTIPMSIS 543

Query: 313  NASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSS--TPELGFLSSLANCKKL 370
            N SKLI L++  NSF+G +P  +GNL  L++ ++  N LT+      +GFL+SL NCK L
Sbjct: 544  NMSKLIQLQVWDNSFTGNVPKDLGNLTKLEVLNLAANQLTNEHLASGVGFLTSLTNCKFL 603

Query: 371  RYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLS 430
            R+L +  NP  G LP+S+GNL ++LE    + C   G IP  IGNL+NLI L LG N+L+
Sbjct: 604  RHLWIDDNPFKGTLPNSLGNLPIALESFTASACQFRGTIPTGIGNLTNLIELDLGANDLT 663

Query: 431  GSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTS 490
             SIP T G LQKLQ L +A N++ GSIP+++C L  L  L L  NK+SGSI SC G+L +
Sbjct: 664  RSIPTTLGRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYLHLXSNKLSGSIPSCFGDLPA 723

Query: 491  LQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLS 550
            LQ L L SN   F IP++ W+L+D+L  ++SSN L G +   +GN+K++  +DLS+N +S
Sbjct: 724  LQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVS 783

Query: 551  GNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSY 610
            G IP  +   ++L  +SL+ NRL+GPIP  FG++ SLESLDLS N +SG+IP S E L Y
Sbjct: 784  GYIPRRMGEQQNLAKLSLSQNRLQGPIPXEFGDLVSLESLDLSQNNLSGTIPKSLEALIY 843

Query: 611  LKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKHSQPRAQHKSKKT 670
            LK LN+S NKL+GEIP GGPF NFTAESFM NE LCG P+ QV  C  +  R Q    K+
Sbjct: 844  LKYLNVSSNKLQGEIPNGGPFXNFTAESFMFNEALCGAPHFQVMACDKNN-RTQSWKTKS 902

Query: 671  ILLLVIFLPLSTTLVIAVALALKRGKRGTMLSNDIILSSQP-TIRRFSYFELLRATDNFA 729
             +L  I LP+ +T+ + V + L   +R  M     I S  P T  + S+ +LL AT++F 
Sbjct: 903  FILKYILLPVGSTITLVVFIVLWIRRRDNMEIXTPIDSWLPGTHEKISHQQLLYATNDFG 962

Query: 730  ENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIIS 789
            E+N+IG G  G VY+  L +G+ +AIKVF+ +    L+SF++ECEV++ IRHRNLV+II+
Sbjct: 963  EDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIIT 1022

Query: 790  SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
             CSN DFKALVL+YM NGSLE  L+S N  L++  RLNIMID+ASALEYLH   S+ ++H
Sbjct: 1023 CCSNLDFKALVLKYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVH 1082

Query: 850  CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP------------ 897
            CDLKPSNVLLD+BMVAH++DFG+AKLL+ + ES  +T+TL TIGYMAP            
Sbjct: 1083 CDLKPSNVLLDDBMVAHVTDFGIAKLLT-KTESMQQTKTLGTIGYMAPEHGSDGIVSTKS 1141

Query: 898  -------------------DEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK 938
                               DE+F G+L+LK WV   L  S+++VVD +LL  E++  A K
Sbjct: 1142 DVYSYGILLMEVFARKKPMDEMFTGDLTLKTWVES-LSNSVIQVVDVNLLRREDEDLATK 1200

Query: 939  EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR 974
              CL SI +LAL CT +SPE+R+D KD +  L K R
Sbjct: 1201 LSCLSSIMALALACTNDSPEERLDMKDAVVELKKSR 1236

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  806 bits (2083), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 488/1131 (43%), Positives = 648/1131 (57%), Gaps = 189/1131 (16%)

Query: 30   TDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTI 89
             D+ AL+ALK HITYD   +L TNW++ +  CSWIGI C+     V+ +NLS+  L+GTI
Sbjct: 8    VDEFALIALKAHITYDSQGILATNWSTKSPHCSWIGISCNAPQQSVSAINLSNMGLEGTI 67

Query: 90   PPEIANLSSLKSLDLS------------------------HNKLSSNIPSSIFTMSTLKV 125
             P++ NLS L SLDLS                        +NKL   IP +I  +S L+ 
Sbjct: 68   APQVGNLSFLVSLDLSDNYFHGSLPKDIGKCKELQQLNLFNNKLVGGIPEAICNLSKLEE 127

Query: 126  LYLMDNQ------------------------LSGSLSSFTFNTSSILDIRLSKNKLSGKL 161
            LYL +NQ                        L+GS+ +  FN SS+L+I LS N LSG L
Sbjct: 128  LYLGNNQLIGEIPKKMNHLQNLKVLSFPMNNLTGSIPATIFNISSLLNISLSNNNLSGSL 187

Query: 162  PENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQ 221
            P ++C     LK L L  N   GKIP+ L +C QLQ + L YN+ +G+IP  I NL  LQ
Sbjct: 188  PMDMCYANPKLKELNLSSNHLSGKIPTGLGQCIQLQVISLAYNDFTGSIPSGIDNLVELQ 247

Query: 222  RISLIN-------------------------------NKLHGEIPQEI-GYLQNLD---- 245
            R+SL N                               N L G +P++I  +L NL     
Sbjct: 248  RLSLQNNSFTAFKDISKALLFAEIFNVSSLQVIAFTDNSLSGSLPKDICKHLPNLQGLSL 307

Query: 246  --------------------VLQLGFNNLTGVVPATIFNMSTLKEIFLYNNS-------- 277
                                 L L FN   G +P  I N+S L+EI+L  NS        
Sbjct: 308  SQNHLSGQLPTTLSLCGELLFLSLSFNKFRGSIPKEIGNLSKLEEIYLGTNSLIGSIPTS 367

Query: 278  ----------------------------------------LSGSLPSRIDLALPNLEFLN 297
                                                    LSGSLPS I   LP+LE L 
Sbjct: 368  FGNLKALKFLNLGINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTWLPDLEGLF 427

Query: 298  LGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSS--T 355
            +  N FSG IP SI+N SKL +L + +NSF+G +P  +GNL  LK+ D+  N LT     
Sbjct: 428  IAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHVA 487

Query: 356  PELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGN 415
             E+GFL+SL NCK L+ L +G  P  G LP+S+GNL ++LE    + C   G IP  IGN
Sbjct: 488  SEVGFLTSLTNCKFLKNLWIGNIPFKGTLPNSLGNLPIALESFIASACQFRGTIPTGIGN 547

Query: 416  LSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGN 475
            L+NLI L LG N+L+GSIP T G LQKLQ L +A N++ GSIP+++C L  L  L L+ N
Sbjct: 548  LTNLIRLDLGANDLTGSIPTTLGQLQKLQWLYIAGNRIRGSIPNDLCHLKDLGYLFLSSN 607

Query: 476  KISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGN 535
            K+SGSI SC G+L +LQ L L SN   F IP++ W+L+D+L+ ++SSN L G +   +GN
Sbjct: 608  KLSGSIPSCFGDLLALQELFLDSNVLAFNIPTSLWSLRDLLALNLSSNFLTGNLPPEVGN 667

Query: 536  LKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNN 595
            +K++  +DLS+N +SG IP+ +  L+SL  +SL+ NRL+GPIP  FG++ SLESLDLS N
Sbjct: 668  MKSITTLDLSKNLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVSLESLDLSQN 727

Query: 596  KISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPP 655
             +SG+IP S E L YLK LN+S NKL+GEIP GGPF NFTAESFM NE LCG P+ QV  
Sbjct: 728  NLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMA 787

Query: 656  CKHSQPRAQHKSKKTILLLVIFLPLSTTLVIAVALALKRGKRGTMLSNDIILSSQP-TIR 714
            C  +  R Q    K+ +L  I LP+ + + + V + L   +R  M     I S  P T  
Sbjct: 788  CDKNN-RTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLPGTHE 846

Query: 715  RFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECE 774
            + S+ +LL AT++F E+N+IG G  G VY+  L +G+ +AIKVF+ +    L+SF++ECE
Sbjct: 847  KISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECE 906

Query: 775  VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
            V++ IRHRNLV+II+ CSN DFKALVLEYM NGSLE  L+S N  L++  RLNIMID+AS
Sbjct: 907  VMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVAS 966

Query: 835  ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY 894
            ALEYLH   S+ ++HCDLKP+NVLLD+DMVAH++DFG+ KLL+ + ES  +T+TL TIGY
Sbjct: 967  ALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLT-KTESMQQTKTLGTIGY 1025

Query: 895  MAP-------------------------------DEIFVGELSLKRWVNDLLPVSLVEVV 923
            MAP                               DE+F G L+LK WV   L  S+++VV
Sbjct: 1026 MAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGGLTLKTWVES-LSNSVIQVV 1084

Query: 924  DKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR 974
            D +LL  E++  A K  CL SI +LAL CT  SPEKR++ KD +  L K +
Sbjct: 1085 DANLLRREDEDLATKLSCLSSIMALALACTTNSPEKRLNMKDAVVELKKSK 1135

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera]

 Score =  804 bits (2077), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 453/939 (48%), Positives = 603/939 (64%), Gaps = 46/939 (4%)

Query: 73   HKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQ 132
             ++  L+LS     G IP  I +LS+L+ + L++N L+  IP  I  +S L  L L    
Sbjct: 263  RQLRGLSLSLNQFTGGIPQAIGSLSNLEEVYLAYNNLAGGIPREIGNLSNLNSLQLGSCG 322

Query: 133  LSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSK 192
            +SG +    FN SS+  I L+ N L G LP +IC HL  L+ L+L  N   G++P++LS 
Sbjct: 323  ISGPIPPEIFNISSLQMIDLTDNSLHGSLPMDICKHLHNLQGLYLSFNQLSGQLPTTLSL 382

Query: 193  CKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFN 252
            C QL  L L  N  +G IP   GNLTVLQ + L  N + G IP E+G L NL  L+L  N
Sbjct: 383  CGQLLSLSLWGNRFTGNIPPSFGNLTVLQDLELXENNIQGNIPNELGNLINLQNLKLSVN 442

Query: 253  NLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSIT 312
            NLTG++P  IFN+S L+ + L  N  SGSLPS I   LP+LE L +G N FSG IP SI+
Sbjct: 443  NLTGIIPEAIFNISKLQTLXLAQNHFSGSLPSSIGTQLPDLEGLAIGXNEFSGIIPMSIS 502

Query: 313  NASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTS--STPELGFLSSLANCKKL 370
            N S+L +L++ +N F+G +P  +GNLR L+  ++ FN LT   ST E+GFL+SL NCK L
Sbjct: 503  NMSELTVLDIWANFFTGDVPKDLGNLRRLEFLNLGFNQLTDEHSTSEVGFLTSLTNCKFL 562

Query: 371  RYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLS 430
            R L +  NPL G LP+S+GNLS+SLE  + + C   G IP  IGNL NLI L L  N+L+
Sbjct: 563  RRLWIEDNPLKGILPNSLGNLSISLESFDASACQFKGTIPTGIGNLINLIDLRLNDNDLT 622

Query: 431  GSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTS 490
            G IP++FG LQKLQ   ++ N++ GSIP  +C L  L  LDL+ NK+SG+I  C GNLT+
Sbjct: 623  GLIPISFGHLQKLQWFAISGNRIHGSIPSVLCHLRNLGYLDLSSNKLSGTIPGCFGNLTA 682

Query: 491  LQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLS 550
            L+ ++L SN     IPS+ W L+D+L  ++SSN L+  + L +GN+K+++ +DLS+N  S
Sbjct: 683  LRNISLHSNGLASEIPSSLWTLRDLLVLNLSSNFLNCQLPLEVGNMKSLLVLDLSKNQFS 742

Query: 551  GNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSY 610
            GNIP+T+  L++L  + L++N+L+G +P +FG + SLE LDLS N  SG+IP S E L Y
Sbjct: 743  GNIPSTISLLQNLLQLYLSHNKLQGHMPPNFGALVSLEYLDLSGNNFSGTIPTSLEALKY 802

Query: 611  LKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKHSQPRAQHKSKKT 670
            LK LN+SFNKL+GEIP  GPFANFTAESF+ N  LCG P  QV  C+     A+  +K  
Sbjct: 803  LKYLNVSFNKLQGEIPNRGPFANFTAESFISNLALCGAPRFQVMACEKD---ARRNTKSL 859

Query: 671  ILLLVIFLPLSTTLVIAVALALKRGKRGTM----LSNDIILSSQPTIRRF-SYFELLRAT 725
            +L  ++ L +S + +I V L     +R T     +  D++L   P + R  S+ ELL AT
Sbjct: 860  LLKCIVPLSVSLSTMILVVLFTLWKRRQTESESPVQVDLLL---PRMHRLISHQELLYAT 916

Query: 726  DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
              F E N+IG G  G VY+  L DG+ +A+KVF+ +     KSFE ECEV++NIRHRNL 
Sbjct: 917  SYFGEENLIGKGSLGMVYKGVLSDGLIVAVKVFNLELHGAFKSFEVECEVMRNIRHRNLA 976

Query: 786  KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
            KIISSCSN DFKALVLEYM N SLE  L+S N  L+   RL IMID+AS LEYLH  +S 
Sbjct: 977  KIISSCSNLDFKALVLEYMPNESLEKWLYSHNYCLDFIQRLKIMIDVASGLEYLHHDYSN 1036

Query: 846  PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP-------- 897
            P++HCDLKPSNVLLD+DMVAH+SDFG+AKLL G  E   RT+TL TIGYMAP        
Sbjct: 1037 PVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMGS-EFMKRTKTLGTIGYMAPEYGSEGIV 1095

Query: 898  -----------------------DEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH 934
                                   DE+FV EL+LK WV      +++EV+D +LL+ E++ 
Sbjct: 1096 STKCDTYSYGIILMEIFVRKKPTDEMFVEELTLKSWVES-SANNIMEVIDANLLTEEDES 1154

Query: 935  FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI 973
            FA K+ C  SI +LAL+CT+E PEKRI+ KD + RL KI
Sbjct: 1155 FALKQACFSSIMTLALDCTIEPPEKRINMKDVVARLKKI 1193

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	985
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.720	0.702	0.381	4.8e-152
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.720	0.692	0.382	1.3e-151
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.794	0.763	0.409	8.4e-149
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.835	0.701	0.374	5.5e-143
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.721	0.703	0.357	3.9e-142
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.716	0.684	0.375	1.5e-140
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.690	0.836	0.398	1.9e-122
TAIR|locus:2085949	1141	AT3G24240 [Arabidopsis thalian	0.817	0.705	0.352	3.2e-121
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.676	0.533	0.335	3e-120
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.858	0.838	0.323	9.5e-120

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1146 (408.5 bits), Expect = 4.8e-152, Sum P(3) = 4.8e-152
 Identities = 277/727 (38%), Positives = 413/727 (56%)

Query:   102 LDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKL 161
             L+L   +L   I  SI  +S L  L L +N   G++       S +  + +  N L G +
Sbjct:    71 LELGRLQLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPI 130

Query:   162 PENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQ 221
             P  + N  R L +L L  N   G +PS L     L +L+L  NN+ G +P  +GNLT+L+
Sbjct:   131 PLGLYNCSRLL-NLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLE 189

Query:   222 RISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGS 281
             +++L +N L GEIP ++  L  +  LQL  NN +GV P  ++N+S+LK + +  N  SG 
Sbjct:   190 QLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGR 249

Query:   282 LPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNL 341
             L   + + LPNL   N+G N F+G+IP++++N S L  L M  N+ +G IP+  GN+ NL
Sbjct:   250 LRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNL 308

Query:   342 KLFDIFFNNLTS-STPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNI 400
             KL  +  N+L S S+ +L FL+SL NC +L  LG+G N L G LP SI NLS  L  L++
Sbjct:   309 KLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDL 368

Query:   401 AFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDE 460
                 ISG+IP  IGNL NL  L L  N LSG +P + G L  L+ L L  N+L+G IP  
Sbjct:   369 GGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAF 428

Query:   461 ICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDI 520
             I  ++ L  LDL+ N   G + + LGN + L  L +G N+    IP     ++ +L  D+
Sbjct:   429 IGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDM 488

Query:   521 SSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPES 580
             S N L G +   IG L+ +  + L  N LSG +P TL    +++++ L  N   G IP+ 
Sbjct:   489 SGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDL 548

Query:   581 FGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFM 640
              G +  ++ +DLSNN +SGSIP  F   S L+ LNLSFN L+G++P  G F N T  S +
Sbjct:   549 KG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIV 607

Query:   641 GNELLCG-LPNLQVPPCKHSQPRAQHKSKKTILLLVIFLPLSTTLVIAVALA------LK 693
             GN  LCG +   Q+ PC    P    K    +  +VI + +  TL++ + +A      L+
Sbjct:   608 GNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLR 667

Query:   694 RGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARL-EDGVE 752
             + K+    +N    + +    + SY +L  AT+ F+ +N++G G FG+VY+A L  +   
Sbjct:   668 KRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKV 727

Query:   753 IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDF-----KALVLEYMSNG 807
             +A+KV + Q    +KSF AECE +K+IRHRNLVK++++CS+ DF     +AL+ E+M NG
Sbjct:   728 VAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNG 787

Query:   808 SLEDCLH 814
             SL+  LH
Sbjct:   788 SLDMWLH 794

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1143 (407.4 bits), Expect = 1.3e-151, Sum P(3) = 1.3e-151
 Identities = 279/729 (38%), Positives = 402/729 (55%)

Query:   102 LDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKL 161
             +DL   KL+  +   +  +S L+ L L DN   G++ S   N   +  + +S N   G +
Sbjct:    86 VDLGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVI 145

Query:   162 PENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQ 221
             P  + N    L  L L  N     +P       +L  L LG NNL+G  P  +GNLT LQ
Sbjct:   146 PVVLSN-CSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQ 204

Query:   222 RISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGS 281
              +  I N++ GEIP +I  L+ +   ++  N   GV P  I+N+S+L  + +  NS SG+
Sbjct:   205 MLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGT 264

Query:   282 LPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNL 341
             L       LPNL+ L +GINSF+GTIP +++N S L  L++ SN  +G IP + G L+NL
Sbjct:   265 LRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNL 324

Query:   342 KLFDIFFNNLTS-STPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNI 400
              L  +  N+L + S+ +L FL +L NC +L+YL +G N L G LP  I NLS  L  L++
Sbjct:   325 LLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSL 384

Query:   401 AFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDE 460
                 ISG+IP  IGNL +L  L LG N L+G +P + G L +L+ + L  N L+G IP  
Sbjct:   385 GGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSS 444

Query:   461 ICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDI 520
             +  +S L  L L  N   GSI S LG+ + L  LNLG+N+    IP     L  ++  ++
Sbjct:   445 LGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNV 504

Query:   521 SSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPES 580
             S NLL GP+   IG LK ++ +D+S N LSG IP TL    SL+ + L  N   GPIP+ 
Sbjct:   505 SFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDI 564

Query:   581 FGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFM 640
              G +T L  LDLS N +SG+IP      S L+ LNLS N   G +P  G F N +A S  
Sbjct:   565 RG-LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVF 623

Query:   641 GNELLCG-LPNLQVPPCKHSQPRAQHKSKKTILLLVIFLPLSTTLVIAVALA------LK 693
             GN  LCG +P+LQ+ PC    PR +H S + I+ + +   ++  L++ + +       L+
Sbjct:   624 GNINLCGGIPSLQLQPCSVELPR-RHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLR 682

Query:   694 -RGKRGTMLSNDIILSSQPTI-RRFSYFELLRATDNFAENNIIGIGGFGSVYRARL-EDG 750
              +  R     ND   S   +   + SY EL + T  F+ +N+IG G FG+V++  L    
Sbjct:   683 VKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKN 742

Query:   751 VEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN-----DDFKALVLEYMS 805
               +AIKV +       KSF AECE +  IRHRNLVK+++ CS+     +DF+ALV E+M 
Sbjct:   743 KAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMP 802

Query:   806 NGSLEDCLH 814
             NG+L+  LH
Sbjct:   803 NGNLDMWLH 811

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1398 (497.2 bits), Expect = 8.4e-149, Sum P(2) = 8.4e-149
 Identities = 336/820 (40%), Positives = 473/820 (57%)

Query:   104 LSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPE 163
             L  + LS  I  S+  +S L+ L L DN LSG +       S +  + LS N + G +P 
Sbjct:    86 LRSSNLSGIISPSLGNLSFLRELDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPA 145

Query:   164 NICNHLRYLKHLFLRENMFYGKIPSSL-SKCKQLQELHLGYNNLSGAIPKEIGNLTVLQR 222
              I      L  L L  N   G IP  + +  K L  L+L  N LSG IP  +GNLT LQ 
Sbjct:   146 AI-GACTKLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQE 204

Query:   223 ISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSL 282
               L  N+L G IP  +G L +L  + LG NNL+G++P +I+N+S+L+   +  N L G +
Sbjct:   205 FDLSFNRLSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMI 264

Query:   283 PSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNL- 341
             P+     L  LE +++G N F G IP+S+ NAS L ++++  N FSG I S  G LRNL 
Sbjct:   265 PTNAFKTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLT 324

Query:   342 KLFDIFFNNL--TSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLN 399
             +L+   + NL  T    + GF+S L NC KL+ L LG N L G LP+S  NLS SL  L 
Sbjct:   325 ELY--LWRNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLA 382

Query:   400 IAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAF-NKLAGSIP 458
             +    I+G+IPK IGNL  L  L L  NN  GS+P + G L+ L G+ LA+ N L+GSIP
Sbjct:   383 LELNKITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNL-GILLAYENNLSGSIP 441

Query:   459 DEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDI-LS 517
               I  L+ LN L L  NK SG I   L NLT+L  L L +N  +  IPS  +N++ + + 
Sbjct:   442 LAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIM 501

Query:   518 FDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPI 577
              ++S N L+G I   IG+LK +V      N LSG IP TL   + L+ + L  N L G I
Sbjct:   502 INVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSI 561

Query:   578 PESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAE 637
             P + G +  LE+LDLS+N +SG IP S   ++ L  LNLSFN   GE+P  G FA  +  
Sbjct:   562 PSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGI 621

Query:   638 SFMGNELLCG-LPNLQVPPCKHSQPRAQHKSKKTILLLVIFLPLSTTLVIAVALAL---K 693
             S  GN  LCG +P+L +P C    P  +++    +L + + L  +  ++ ++ L +   K
Sbjct:   622 SIQGNAKLCGGIPDLHLPRCC---PLLENRKHFPVLPISVSLAAALAILSSLYLLITWHK 678

Query:   694 RGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI 753
             R K+G        +   P +   SY +L++ATD FA  N++G G FGSVY+ +L     +
Sbjct:   679 RTKKGAPSRTS--MKGHPLV---SYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHV 733

Query:   754 AIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN-----DDFKALVLEYMSNGS 808
             A+KV   +    LKSF AECE ++N+RHRNLVKI++ CS+     +DFKA+V ++M NGS
Sbjct:   734 AVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGS 793

Query:   809 LEDCLH--SSNCA----LNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED 862
             LED +H  +++ A    LN+  R+ I++D+A AL+YLH     P++HCD+K SNVLLD D
Sbjct:   794 LEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSD 853

Query:   863 MVAHLSDFGMAKLL-SGED---ESTMRTQTLATIGYMAPD 898
             MVAH+ DFG+A++L  G     +ST     + TIGY AP+
Sbjct:   854 MVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPE 893

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1344 (478.2 bits), Expect = 5.5e-143, Sum P(2) = 5.5e-143
 Identities = 319/851 (37%), Positives = 479/851 (56%)

Query:    75 VTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLS 134
             +T L+LS   L G IP +  NL +L+SL L+ N L  +IP+ I   S+L  L L DNQL+
Sbjct:   218 LTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLT 277

Query:   135 GSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCK 194
             G + +   N   +  +R+ KNKL+  +P ++   L  L HL L EN   G I   +   +
Sbjct:   278 GKIPAELGNLVQLQALRIYKNKLTSSIPSSLFR-LTQLTHLGLSENHLVGPISEEIGFLE 336

Query:   195 QLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNL 254
              L+ L L  NN +G  P+ I NL  L  +++  N + GE+P ++G L NL  L    N L
Sbjct:   337 SLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLL 396

Query:   255 TGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNA 314
             TG +P++I N + LK + L +N ++G +P        NL F+++G N F+G IP  I N 
Sbjct:   397 TGPIPSSISNCTGLKLLDLSHNQMTGEIPR--GFGRMNLTFISIGRNHFTGEIPDDIFNC 454

Query:   315 SKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLG 374
             S L  L +  N+ +G +   IG L+ L++  + +N+LT   P       + N K L  L 
Sbjct:   455 SNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPR-----EIGNLKDLNILY 509

Query:   375 LGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIP 434
             L  N   G +P  + NL+L L+ L +   ++ G IP+ + ++  L VL L  N  SG IP
Sbjct:   510 LHSNGFTGRIPREMSNLTL-LQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIP 568

Query:   435 VTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSI-SSCLGNLTSLQ- 492
               F  L+ L  L L  NK  GSIP  +  LS LN  D++ N ++G+I    L +L ++Q 
Sbjct:   569 ALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQL 628

Query:   493 YLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGN 552
             YLN  +N  T  IP     L+ +   D+S+NL  G I  ++   K V  +D S+NNLSG+
Sbjct:   629 YLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGH 688

Query:   553 IPTTL-EGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYL 611
             IP  + +G+  + +++L+ N   G IP+SFGNMT L SLDLS+N ++G IP S   LS L
Sbjct:   689 IPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTL 748

Query:   612 KELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKHSQPRAQHKSKKTI 671
             K L L+ N LKG +P  G F N  A   MGN  LCG     + PC   Q ++ H SK+T 
Sbjct:   749 KHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQ-KSSHFSKRTR 806

Query:   672 LLLVIF-----LPLSTTLVIAVALALKRGKRGTMLSNDII--LSSQPTIRRFSYFELLRA 724
             ++L+I      L L   LV+ +    K+ K+    S   +  L S   ++RF   EL +A
Sbjct:   807 VILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQA 866

Query:   725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHR 782
             TD+F   NIIG     +VY+ +LEDG  IA+KV + +   A + K F  E + +  ++HR
Sbjct:   867 TDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHR 926

Query:   783 NLVKIIS-SCSNDDFKALVLEYMSNGSLEDCLHSSNCAL-NIFCRLNIMIDIASALEYLH 840
             NLVKI+  +  +   KALVL +M NG+LED +H S   + ++  ++++ + IAS ++YLH
Sbjct:   927 NLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLH 986

Query:   841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA---TIGYMAP 897
              G+  PI+HCDLKP+N+LLD D VAH+SDFG A++L   ++ +    T A   TIGY+AP
Sbjct:   987 SGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAP 1046

Query:   898 DEIFVGELSLK 908
             +  ++ +++ K
Sbjct:  1047 EFAYMRKVTTK 1057

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1068 (381.0 bits), Expect = 3.9e-142, Sum P(3) = 3.9e-142
 Identities = 260/727 (35%), Positives = 393/727 (54%)

Query:   102 LDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKL 161
             L+L   +L   +  SI  +S L  L L DN   G +     N   +  + ++ N L G +
Sbjct:    71 LNLGGLQLGGIVSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGI 130

Query:   162 PENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQ 221
             P  + N  R L +L L  N     +PS L    +L  L LG NNL G +P+ +GNLT L+
Sbjct:   131 PATLSNCSRLL-NLDLYSNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSLGNLTSLK 189

Query:   222 RISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGS 281
              +   +N + GE+P E+  L  +  L L  N   GV P  I+N+S L+++FL+ +  SGS
Sbjct:   190 SLGFTDNNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGS 249

Query:   282 LPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNL 341
             L       LPN+  LNLG N   G IP++++N S L    +  N  +G I    G + +L
Sbjct:   250 LKPDFGNLLPNIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSL 309

Query:   342 KLFDIFFNNLTSST-PELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNI 400
             +  D+  N L S T  +L F+ SL NC  L+ L +G   L G LP+SI N+S  L  LN+
Sbjct:   310 QYLDLSENPLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNL 369

Query:   401 AFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDE 460
                +  G+IP+ IGNL  L  L LG N L+G +P + G L +L  L L  N+++G IP  
Sbjct:   370 IGNHFFGSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSF 429

Query:   461 ICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDI 520
             I  L++L  L L+ N   G +   LG  + +  L +G N+    IP     +  +++  +
Sbjct:   430 IGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSM 489

Query:   521 SSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPES 580
               N L G +   IG+L+ +V + L  N  SG++P TL    +++ + L  N  +G IP  
Sbjct:   490 EGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPNI 549

Query:   581 FGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFM 640
              G M  +  +DLSNN +SGSIP  F   S L+ LNLS N   G++P  G F N T     
Sbjct:   550 RGLM-GVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVF 608

Query:   641 GNELLCG-LPNLQVPPCKHSQP--RAQHKS--KKTILLLVIFLPLSTTLVIA-VALALKR 694
             GN+ LCG + +L++ PC   +P    +H S  KK  +L+ I + L   LVIA + L   R
Sbjct:   609 GNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFR 668

Query:   695 GKRGTMLSNDIILSSQPTIR-RFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI 753
              +R    +N+++ S       + SY +L  AT+ F+ +N++G G FG+V++A L    +I
Sbjct:   669 KRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKI 728

Query:   754 -AIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDF-----KALVLEYMSNG 807
              A+KV + Q    +KSF AECE +K+ RHRNLVK++++C++ DF     +AL+ EY+ NG
Sbjct:   729 VAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNG 788

Query:   808 SLEDCLH 814
             S++  LH
Sbjct:   789 SVDMWLH 795

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 1109 (395.4 bits), Expect = 1.5e-140, Sum P(3) = 1.5e-140
 Identities = 273/728 (37%), Positives = 395/728 (54%)

Query:   101 SLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGK 160
             SL+L   KL+  I  SI  +S L++L L DN    ++         +  + +S N L G+
Sbjct:    77 SLNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGR 136

Query:   161 LPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVL 220
             +P ++ N  R L  + L  N     +PS L    +L  L L  NNL+G  P  +GNLT L
Sbjct:   137 IPSSLSNCSR-LSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSL 195

Query:   221 QRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSG 280
             Q++    N++ GEIP E+  L  +   Q+  N+ +G  P  ++N+S+L+ + L +NS SG
Sbjct:   196 QKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSG 255

Query:   281 SLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRN 340
             +L +     LPNL  L LG N F+G IP ++ N S L   ++ SN  SG IP + G LRN
Sbjct:   256 NLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRN 315

Query:   341 LKLFDIFFNNL-TSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLN 399
             L    I  N+L  +S+  L F+ ++ANC +L YL +G N L G LP+SI NLS +L  L 
Sbjct:   316 LWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLF 375

Query:   400 IAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPD 459
             +    ISG IP  IGNL +L  LSL  N LSG +PV+FG L  LQ +DL  N ++G IP 
Sbjct:   376 LGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPS 435

Query:   460 EICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFD 519
                 ++RL +L LN N   G I   LG    L  L + +NR    IP     +  +   D
Sbjct:   436 YFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYID 495

Query:   520 ISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPE 579
             +S+N L G     +G L+ +VG+  S N LSG +P  + G  S++ + +  N  +G IP+
Sbjct:   496 LSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD 555

Query:   580 SFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESF 639
                 + SL+++D SNN +SG IP     L  L+ LNLS NK +G +P  G F N TA S 
Sbjct:   556 -ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSV 614

Query:   640 MGNELLCG-LPNLQVPPC-KHSQPRAQHK---SKKTILLLVIFLPLSTTLVIAVALA--L 692
              GN  +CG +  +Q+ PC   + PR +      KK +  + I +     ++I  +L   +
Sbjct:   615 FGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFM 674

Query:   693 KRGKRGTMLSNDIILSSQPTIRRF----SYFELLRATDNFAENNIIGIGGFGSVYRARL- 747
             KR K+    ++D   S   T+  F    SY EL  AT  F+  N+IG G FG+V++  L 
Sbjct:   675 KRKKKNN--ASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLG 732

Query:   748 EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN-----DDFKALVLE 802
              +   +A+KV +       KSF AECE  K IRHRNLVK+I+ CS+     +DF+ALV E
Sbjct:   733 PENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYE 792

Query:   803 YMSNGSLE 810
             +M  GSL+
Sbjct:   793 FMPKGSLD 800

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1204 (428.9 bits), Expect = 1.9e-122, P = 1.9e-122
 Identities = 282/707 (39%), Positives = 408/707 (57%)

Query:   126 LYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGK 185
             L L  + L+G +S    N S +  ++LS N LSGK+P+ + + L  L+ L L  N   G+
Sbjct:    83 LRLRSSNLAGIISPSLGNLSFLRTLQLSDNHLSGKIPQEL-SRLSRLQQLVLNFNSLSGE 141

Query:   186 IPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLD 245
             IP++L     L  L L  N LSGAIP  +G LT L  ++L  N L G IP   G L+ L 
Sbjct:   142 IPAALGNLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRLS 201

Query:   246 VLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSG 305
              L L FNNL+G +P  I+N+S+L    + +N LSG+LP+     LP+L+ + +  N F G
Sbjct:   202 FLSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHG 261

Query:   306 TIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFN-NLTSSTPELGFLSSL 364
              IP+SI NAS + +  +G NSFSG +P  IG +RNL+  ++    +    T +  F+++L
Sbjct:   262 RIPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTAL 321

Query:   365 ANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSL 424
              NC  L+ + LGG    G LP S+ NLS SL  L+I    ISG++P+ IGNL NL  LSL
Sbjct:   322 TNCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLSL 381

Query:   425 GGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSC 484
               N+L+GS+P +F  L+ L+ L +  NKL GS+P  I  L++L  +++  N   G+I S 
Sbjct:   382 ANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPST 441

Query:   485 LGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSF-DISSNLLDGPISLAIGNLKAVVGID 543
             LGNLT L  +NLG N F   IP   +++  +    D+S N L+G I   IG LK +V   
Sbjct:   442 LGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFH 501

Query:   544 LSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPV 603
                N LSG  P+T+   + LQ++ L  N L G IP +   +  L++LDLS N +SG IP+
Sbjct:   502 ADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPM 561

Query:   604 SFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCG-LPNLQVPPCKHSQPR 662
             S   +  L  LNLSFN   GE+P  G FAN +     GN  +CG +P L +P C     +
Sbjct:   562 SLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSL---K 618

Query:   663 AQHKSKKTILLLVIFLPLSTTLVIAVALAL-----KRGKRGTMLSNDIILSSQPTIRRFS 717
             ++ K K  ILLLV+ + L +TL +   L +     KR K+    +    +   P I   +
Sbjct:   619 SRKKKKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRKKEVPATTS--MQGHPMI---T 673

Query:   718 YFELLRATDNFAENNIIGIGGFGSVYRARLE--DGVE---IAIKVFHPQCASTLKSFEAE 772
             Y +L++ATD F+ ++++G G FGSVY+   +  DG     +A++V   +    LKSF AE
Sbjct:   674 YKQLVKATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAE 733

Query:   773 CEVIKNIRHRNLVKIISSCSN-----DDFKALVLEYMSNGSLEDCLH 814
             CE ++N RHRNLVKI++ CS+     +DFKA+V ++M NGSLED LH
Sbjct:   734 CETLRNTRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLH 780

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)]

 Score = 1151 (410.2 bits), Expect = 3.2e-121, Sum P(2) = 3.2e-121
 Identities = 299/849 (35%), Positives = 454/849 (53%)

Query:    78 LNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSL 137
             L+LSS  L G IP  ++ L +L++L L+ N+L+  IP  I   S LK L L DN L+GS+
Sbjct:   134 LDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSI 193

Query:   138 SSFTFNTSSILDIRLSKNK-LSGKLPENI--CNHLRYLKHLFLRENMFYGKIPSSLSKCK 194
              +     S +  IR+  NK +SG++P  I  C++L  L    L E    G +PSSL K K
Sbjct:   194 PTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLG---LAETSVSGNLPSSLGKLK 250

Query:   195 QLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNL 254
             +L+ L +    +SG IP ++GN + L  + L  N L G IP+EIG L  L+ L L  N+L
Sbjct:   251 KLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSL 310

Query:   255 TGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNA 314
              G +P  I N S LK I L  N LSGS+PS I   L  LE   +  N FSG+IP++I+N 
Sbjct:   311 VGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIG-RLSFLEEFMISDNKFSGSIPTTISNC 369

Query:   315 SKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLG 374
             S L+ L++  N  SG IPS +G L  L LF  + N L  S P       LA+C  L+ L 
Sbjct:   370 SSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPP-----GLADCTDLQALD 424

Query:   375 LGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIP 434
             L  N L G +PS +  L  +L +L +   ++SG IP+ IGN S+L+ L LG N ++G IP
Sbjct:   425 LSRNSLTGTIPSGLFMLR-NLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIP 483

Query:   435 VTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYL 494
                G L+K+  LD + N+L G +PDEI   S L  +DL+ N + GS+ + + +L+ LQ L
Sbjct:   484 SGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVL 543

Query:   495 NLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIP 554
             ++ +N+F+  IP++   L  +    +S NL  G I  ++G    +  +DL  N LSG IP
Sbjct:   544 DVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIP 603

Query:   555 TTLEGLKSLQ-NISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKE 613
             + L  +++L+  ++L+ NRL G IP    ++  L  LDLS+N + G +      +  L  
Sbjct:   604 SELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDL-APLANIENLVS 662

Query:   614 LNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKHSQPRAQ--------H 665
             LN+S+N   G +P    F   + +   GN+ LC   + Q   C  +  +           
Sbjct:   663 LNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCS--STQ-DSCFLTYRKGNGLGDDGDAS 719

Query:   666 KSKKTILLLVIFLPLSTTLVIAVALALKRGKRGTMLSNDIILSSQPTIR-RFSYFELLR- 723
             +++K  L L + + L+  L+I  A+A+ R +R      D  L    T + +F+ F+ L  
Sbjct:   720 RTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSELGE--TYKWQFTPFQKLNF 777

Query:   724 ATDNF----AENNIIGIGGFGSVYRARLEDGVEIAIKVFHP---------QCASTLKSFE 770
             + D       E N+IG G  G VYRA +++G  IA+K   P         +  +   SF 
Sbjct:   778 SVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFS 837

Query:   771 AECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIM 829
             AE + +  IRH+N+V+ +  C N + + L+ +YM NGSL   LH     +L+   R  I+
Sbjct:   838 AEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRGSSLDWDLRYRIL 897

Query:   830 IDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
             +  A  L YLH     PI+H D+K +N+L+  D   +++DFG+AKL+   D         
Sbjct:   898 LGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVA 957

Query:   890 ATIGYMAPD 898
              + GY+AP+
Sbjct:   958 GSYGYIAPE 966

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010359 "regulation of anion channel activity" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 868 (310.6 bits), Expect = 3.0e-120, Sum P(2) = 3.0e-120
 Identities = 236/703 (33%), Positives = 366/703 (52%)

Query:    77 TLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMST-LKVLYLMDNQLSG 135
             TL+LS+ NL G IP E  N+S L  L L++N LS ++P SI + +T L+ L L   QLSG
Sbjct:   291 TLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSG 350

Query:   136 SLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQ 195
              +        S+  + LS N L+G +PE +   L  L  L+L  N   G +  S+S    
Sbjct:   351 EIPVELSKCQSLKQLDLSNNSLAGSIPEALFE-LVELTDLYLHNNTLEGTLSPSISNLTN 409

Query:   196 LQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLT 255
             LQ L L +NNL G +PKEI  L  L+ + L  N+  GEIPQEIG   +L ++ +  N+  
Sbjct:   410 LQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFE 469

Query:   256 GVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNAS 315
             G +P +I  +  L  + L  N L G LP+ +      L  L+L  N  SG+IPSS     
Sbjct:   470 GEIPPSIGRLKELNLLHLRQNELVGGLPASLGNC-HQLNILDLADNQLSGSIPSSFGFLK 528

Query:   316 KLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGL 375
              L  L + +NS  G +P ++ +LRNL   ++  N L  +   L        C    YL  
Sbjct:   529 GLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPL--------CGSSSYLSF 580

Query:   376 G--GNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSI 433
                 N  +  +P  +GN S +L+RL +    ++G IP  +G +  L +L +  N L+G+I
Sbjct:   581 DVTNNGFEDEIPLELGN-SQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTI 639

Query:   434 PVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQY 493
             P+     +KL  +DL  N L+G IP  +  LS+L EL L+ N+   S+ + L N T L  
Sbjct:   640 PLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLV 699

Query:   494 LNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNI 553
             L+L  N     IP    NL  +   ++  N   G +  A+G L  +  + LSRN+L+G I
Sbjct:   700 LSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEI 759

Query:   554 PTTLEGLKSLQN-ISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLK 612
             P  +  L+ LQ+ + L+YN   G IP + G ++ LE+LDLS+N+++G +P S   +  L 
Sbjct:   760 PVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLG 819

Query:   613 ELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKHSQPRAQHKSKKTIL 672
              LN+SFN L G++ +   F+ + A+SF+GN  LCG P  +    + S  + Q  S ++++
Sbjct:   820 YLNVSFNNLGGKLKK--QFSRWPADSFLGNTGLCGSPLSRCNRVR-SNNKQQGLSARSVV 876

Query:   673 LLVIFLPLSTT--LVIAVALALKRG----KR---GTMLSNDIILSSQ----PTIRR---- 715
             ++     L+    +++ +AL  K+     K+   G+        SSQ    P  R     
Sbjct:   877 IISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASK 936

Query:   716 --FSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIK 756
                 + +++ AT N +E  +IG GG G VY+A LE+G  +A+K
Sbjct:   937 SDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVK 979

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 1086 (387.4 bits), Expect = 9.5e-120, Sum P(2) = 9.5e-120
 Identities = 294/908 (32%), Positives = 458/908 (50%)

Query:    30 TDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTI 89
             +D+QALL +K  ++    + L   W ++  +CSW  + C     +VT L+L    L G I
Sbjct:    24 SDRQALLEIKSQVSESKRDALSA-WNNSFPLCSWKWVRCGRKHKRVTRLDLGGLQLGGVI 82

Query:    90 PPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILD 149
              P I NLS L  LDLS+N     IP  +  +  LK L +  N L G + +   N S +L 
Sbjct:    83 SPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLSNCSRLLY 142

Query:   150 IRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGA 209
             + L  N L   +P  +   LR L +L+L  N   GK P  +     L  L+LGYN+L G 
Sbjct:   143 LDLFSNNLGDGVPSEL-GSLRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLEGE 201

Query:   210 IPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNM-STL 268
             IP +I  L+ +  ++L  N   G  P     L +L+ L L  N  +G +     N+   +
Sbjct:   202 IPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLPNI 261

Query:   269 KEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFS 328
              E+ L+ N L+G++P+ +   +  LE   +G N  +G+I  +      L  LE+ +NS  
Sbjct:   262 HELSLHGNFLTGAIPTTL-ANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSLG 320

Query:   329 GF------IPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCK-KLRYLGLGGNPLD 381
              +         A+ N  +L    + +N L  + P     +S+ N   +L  L L GN + 
Sbjct:   321 SYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALP-----TSIVNMSTELTVLNLKGNLIY 375

Query:   382 GFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQ 441
             G +P  IGNL + L+ L +A   ++G +P ++GNL  L  L L  N  SG IP   G L 
Sbjct:   376 GSIPHDIGNL-IGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLT 434

Query:   442 KLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRF 501
             +L  L L+ N   G +P  +   S + +L +  NK++G+I   +  + +L +LN+ SN  
Sbjct:   435 QLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSL 494

Query:   502 TFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLK 561
             +  +P+    L++++   + +N L G +   +G   ++  I L  N+  G IP  ++GL 
Sbjct:   495 SGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPD-IKGLM 553

Query:   562 SLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS--FEKLSYLKELNLSFN 619
              ++N+ L+ N L G I E F N + LE L+LS+N   G +P    F+  + +       N
Sbjct:   554 GVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFG---N 610

Query:   620 K-LKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKHSQPRAQHKSKKTILLLVIFL 678
             K L G I                 EL       Q PP +   P      KK  + + + +
Sbjct:   611 KNLCGSI----------------KELKLKPCIAQAPPVETRHPSLL---KKVAIGVSVGI 651

Query:   679 PLSTTLVIAVALALKRGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGG 738
              L   L I      K+ K    ++N    + +    + SY +L  ATD F+ +NI+G G 
Sbjct:   652 ALLLLLFIVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGS 711

Query:   739 FGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDF- 796
             FG+V++A L+ +   +A+KV + Q    +KSF AECE +K+IRHRNLVK++++C++ DF 
Sbjct:   712 FGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQ 771

Query:   797 ----KALVLEYMSNGSLEDCLHSSNC--------ALNIFCRLNIMIDIASALEYLHFGHS 844
                 +AL+ E+M NGSL+  LH             L +  RLNI ID+AS L+YLH    
Sbjct:   772 GNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCH 831

Query:   845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA-----TIGYMAPDE 899
              PI HCDLKPSN+LLD+D+ AH+SDFG+A+LL   D+ +   Q  +     TIGY AP+ 
Sbjct:   832 EPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEY 891

Query:   900 IFVGELSL 907
                G+ S+
Sbjct:   892 GMGGQPSI 899

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGP4	Y3475_ARATH	2, ., 7, ., 1, 1, ., 1	0.3696	0.9350	0.9118	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	985
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-115
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-38
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-38
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-36
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-35
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-34
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-32
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-31
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-28
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-24
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-23
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-21
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-21
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-21
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-20
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-19
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-18
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-18
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-17
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-17
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-16
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-15
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	9e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-14
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-14
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-14
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-14
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-13
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-13
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-13
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-12
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-12
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	8e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-11
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-11
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-10
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-10
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-10
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-09
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-08
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-08
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-08
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-08
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-08
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	9e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-07
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-07
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-07
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-07
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	8e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-06
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-06
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-06
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-06
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	8e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	9e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	9e-06
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-05
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-05
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-05
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-05
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	7e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-04
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-04
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-04
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-04
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-04
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	8e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.001
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	0.001
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.001
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.001
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.001
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.002
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.002
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.002
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.002
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.003
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.003
PRK15370	754	PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl	0.004
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  377 bits (969), Expect = e-115
 Identities = 273/871 (31%), Positives = 439/871 (50%), Gaps = 63/871 (7%)

Query: 35  LLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIA 94
           LL+ K  I  DP   L +NW S+A +C W GI C+ NS +V +++LS  N+ G I   I 
Sbjct: 34  LLSFKSSIN-DPLKYL-SNWNSSADVCLWQGITCN-NSSRVVSIDLSGKNISGKISSAIF 90

Query: 95  NLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSK 154
            L  +++++LS+N+LS  IP  IFT S                       SS+  + LS 
Sbjct: 91  RLPYIQTINLSNNQLSGPIPDDIFTTS-----------------------SSLRYLNLSN 127

Query: 155 NKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEI 214
           N  +G +P      +  L+ L L  NM  G+IP+ +     L+ L LG N L G IP  +
Sbjct: 128 NNFTGSIPRG---SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184

Query: 215 GNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLY 274
            NLT L+ ++L +N+L G+IP+E+G +++L  + LG+NNL+G +P  I  +++L  + L 
Sbjct: 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLV 244

Query: 275 NNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSA 334
            N+L+G +PS +   L NL++L L  N  SG IP SI +  KLI L++  NS SG IP  
Sbjct: 245 YNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPEL 303

Query: 335 IGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLS 394
           +  L+NL++  +F NN T   P      +L +  +L+ L L  N   G +P ++G  + +
Sbjct: 304 VIQLQNLEILHLFSNNFTGKIPV-----ALTSLPRLQVLQLWSNKFSGEIPKNLGKHN-N 357

Query: 395 LERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLA 454
           L  L+++  N++G IP+ + +  NL  L L  N+L G IP + G  + L+ + L  N  +
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417

Query: 455 GSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKD 514
           G +P E   L  +  LD++ N + G I+S   ++ SLQ L+L  N+F   +P +F + K 
Sbjct: 418 GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KR 476

Query: 515 ILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLE 574
           + + D+S N   G +   +G+L  ++ + LS N LSG IP  L   K L ++ L++N+L 
Sbjct: 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS 536

Query: 575 GPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANF 634
           G IP SF  M  L  LDLS N++SG IP +   +  L ++N+S N L G +P  G F   
Sbjct: 537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAI 596

Query: 635 TAESFMGNELLCGLPNLQ-VPPCKHSQPRAQHKSKKTILLLVIFLPLSTTLVIAVALALK 693
            A +  GN  LCG      +PPCK    R +        +           ++A      
Sbjct: 597 NASAVAGNIDLCGGDTTSGLPPCK----RVRKTPSWWFYITCTLGAFLVLALVAFGFVFI 652

Query: 694 RGKRGTML----SNDIILSSQPTIRRFS-YFELLRATDNFAENNIIGIGGFGSVYRAR-L 747
           RG+    L    + D     Q    + S    +     +  E N+I  G  G+ Y+ + +
Sbjct: 653 RGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSI 712

Query: 748 EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNG 807
           ++G++  +K  +    S   S  A+   +  ++H N+VK+I  C ++    L+ EY+   
Sbjct: 713 KNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK 768

Query: 808 SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHL 867
           +L + L +    L+   R  I I IA AL +LH   S  ++  +L P  +++D     HL
Sbjct: 769 NLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824

Query: 868 SDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
                   LS        T+   +  Y+AP+
Sbjct: 825 -------RLSLPGLLCTDTKCFISSAYVAPE 848

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  143 bits (362), Expect = 1e-38
 Identities = 67/174 (38%), Positives = 102/174 (58%), Gaps = 9/174 (5%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQ-CASTLKSFEAECEVIKNIRHRNLVKIISSC 791
           +G GGFG+VY AR  + G ++AIK+   +  +S L+    E E++K + H N+VK+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +++   LV+EY   GSL+D L  +   L+    L I++ I   LEYL   HS  IIH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYL---HSNGIIHRD 117

Query: 852 LKPSNVLLDED-MVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
           LKP N+LLD D     L+DFG++KLL+   + ++    + T  YMAP E+ +G+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAP-EVLLGK 168

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  143 bits (363), Expect = 2e-38
 Identities = 64/175 (36%), Positives = 91/175 (52%), Gaps = 10/175 (5%)

Query: 732 NIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQ-CASTLKSFEAECEVIKNIRHRNLVKIIS 789
             +G G FG VY AR  + G  +AIKV   +      +    E +++K ++H N+V++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
              ++D   LV+EY   G L D L      L+       +  I SALEYLH   S  I+H
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLH---SKGIVH 120

Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
            DLKP N+LLDED    L+DFG+A+ L   D     T  + T  YMAP E+ +G+
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAP-EVLLGK 171

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  136 bits (345), Expect = 6e-36
 Identities = 77/250 (30%), Positives = 115/250 (46%), Gaps = 23/250 (9%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIIS 789
            +G G FG+VY+A+    G  +A+K+   +       ++   E  +++ + H N+V++I 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
           +  + D   LV+EY   G L D L      L+      I + I   LEYLH   S  IIH
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGGP-LSEDEAKKIALQILRGLEYLH---SNGIIH 121

Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DLKP N+LLDE+ V  ++DFG+AK L     S + T    T  YMAP+ +  G     +
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSS-LTTFV-GTPWYMAPEVLLGGNGYGPK 179

Query: 910 WVNDL--LPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPE-----KRID 962
              D+  L V L E     LL+G+           L +    L   +E  E        +
Sbjct: 180 --VDVWSLGVILYE-----LLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEE 232

Query: 963 AKDTITRLLK 972
           AKD I + L 
Sbjct: 233 AKDLIKKCLN 242

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  134 bits (340), Expect = 4e-35
 Identities = 51/173 (29%), Positives = 88/173 (50%), Gaps = 10/173 (5%)

Query: 731 NNIIGIGGFGSVYRARLED-----GVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNL 784
              +G G FG VY+ +L+       VE+A+K          ++ F  E  +++ + H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           VK++  C+ ++   +V+EYM  G L   L  +   L++   L+  + IA  +EYL    S
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL---ES 120

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
              IH DL   N L+ E++V  +SDFG+++ L  +D+   +      I +MAP
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKRGGKLPIRWMAP 172

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  130 bits (330), Expect = 8e-34
 Identities = 51/181 (28%), Positives = 87/181 (48%), Gaps = 9/181 (4%)

Query: 734 IGIGGFGSVYRARL-----EDGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKI 787
           +G G FG VY+  L         ++A+K      +    + F  E  ++K + H N+V++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
           +  C+  +   +V EYM  G L D L      L +   L + + IA  +EYL    S   
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL---ESKNF 123

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSL 907
           +H DL   N L+ E++V  +SDFG+++ +  +D    R      I +MAP+ +  G+ + 
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183

Query: 908 K 908
           K
Sbjct: 184 K 184

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  125 bits (316), Expect = 5e-32
 Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 11/174 (6%)

Query: 731 NNIIGIGGFGSVYRARLEDG-----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNL 784
              +G G FG VY+  L+       VE+A+K          ++ F  E  +++ + H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA-LNIFCRLNIMIDIASALEYLHFGH 843
           VK++  C+ ++   +V+EYM  G L D L  +    L++   L+  + IA  +EYL    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL---E 120

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           S   IH DL   N L+ E++V  +SDFG+++ L  +D+          I +MAP
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAP 173

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  122 bits (308), Expect = 6e-31
 Identities = 59/184 (32%), Positives = 87/184 (47%), Gaps = 22/184 (11%)

Query: 732 NIIGIGGFGSVYRARLED-GVEIAIKV--FHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
            ++G G FGSVY A  +D G  +A+K           L++ E E  ++ +++H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 789 SSCSNDDFKAL--VLEYMSNGSLEDCLHSSNCALNIFCRLNI------MIDIASALEYLH 840
            S  +++   L   LEY+S GSL   L         F +L           I   L YLH
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKK-------FGKLPEPVIRKYTRQILEGLAYLH 118

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
              S  I+H D+K +N+L+D D V  L+DFG AK L   +          T  +MAP E+
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP-EV 174

Query: 901 FVGE 904
             GE
Sbjct: 175 IRGE 178

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  121 bits (307), Expect = 9e-31
 Identities = 79/271 (29%), Positives = 119/271 (43%), Gaps = 42/271 (15%)

Query: 732 NIIGIGGFGSVYRARLEDG----VEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLV 785
             +G G FG VY+ +L+       E+A+K      AS    K F  E  V+K + H N+V
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKE-DASEEERKDFLKEARVMKKLGHPNVV 59

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR--------LNIMIDIASALE 837
           +++  C+ ++   LVLEYM  G L D L  S        +        L+  I IA  +E
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           YL    S   +H DL   N L+ ED+V  +SDFG+++ +  +D    +T     I +MAP
Sbjct: 120 YLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 898 DEIFVGELSLKRWVND------LL---------P---VSLVEVVDKSLLSGEEKHFAAKE 939
           + +  G  + K   +D      LL         P   +S  EV++  L  G        E
Sbjct: 177 ESLKDGIFTSK---SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY-LRKG--YRLPKPE 230

Query: 940 QCLLSIFSLALECTMESPEKRIDAKDTITRL 970
            C   ++ L L C    PE R    + + RL
Sbjct: 231 YCPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  113 bits (286), Expect = 4e-28
 Identities = 64/180 (35%), Positives = 89/180 (49%), Gaps = 15/180 (8%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           IG GGFG VY+AR    G E+AIKV   +     +    E +++K  +H N+VK   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASALEYLHFGHSTPIIH 849
             D   +V+E+ S GSL+D L S+N  L    I     +  ++   LEYLH      IIH
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY---VCKELLKGLEYLHSNG---IIH 121

Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA-TIGYMAPDEIFVGELSLK 908
            D+K +N+LL  D    L DFG++  LS     T    T+  T  +MAP+ I       K
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLS----DTKARNTMVGTPYWMAPEVINGKPYDYK 177

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  104 bits (260), Expect = 1e-24
 Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 33/245 (13%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG V       G ++A+K      ++  ++F AE  V+  +RH NLV+++     
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIF-CRLNIMIDIASALEYLHFGHSTPIIHCDL 852
            +   +V EYM+ GSL D L S   A+     +L   +D+   +EYL        +H DL
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL---EEKNFVHRDL 128

Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR--W 910
              NVL+ ED+VA +SDFG+AK    E      +  L  + + AP+ +   + S K   W
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLP-VKWTAPEALREKKFSTKSDVW 183

Query: 911 VNDLL----------P---VSLVEVVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTME 955
              +L          P   + L +VV        EK +   A E C   ++ +  +C   
Sbjct: 184 SFGILLWEIYSFGRVPYPRIPLKDVVPHV-----EKGYRMEAPEGCPPEVYKVMKDCWEL 238

Query: 956 SPEKR 960
            P KR
Sbjct: 239 DPAKR 243

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 6e-24
 Identities = 71/243 (29%), Positives = 116/243 (47%), Gaps = 24/243 (9%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+        ++A+K   P   S  ++F  E +++K +RH  LV++ + CS 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP-EAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 794 DDFKALVLEYMSNGSLEDCLHS-SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
           ++   +V EYMS GSL D L S     L +   +++   IA  + YL    S   IH DL
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL---ESRNYIHRDL 129

Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR--W 910
              N+L+ E++V  ++DFG+A+L+  +DE T R      I + AP+    G  ++K   W
Sbjct: 130 AARNILVGENLVCKIADFGLARLIE-DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVW 188

Query: 911 VNDLLPVSLVEVVDK-----------SLLSGEEK--HFAAKEQCLLSIFSLALECTMESP 957
              +L   L E+V              +L   E+         C   ++ L L+C  + P
Sbjct: 189 SFGIL---LTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDP 245

Query: 958 EKR 960
           E+R
Sbjct: 246 EER 248

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 1e-23
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 9/172 (5%)

Query: 732 NIIGIGGFGSVYRA-RLEDGVEIAIK--VFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           ++IG G FG VY+   LE G  +AIK           LKS   E +++KN++H N+VK I
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
            S    D   ++LEY  NGSL   +         F    + + +   L+ L + H   +I
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGP----FPESLVAVYVYQVLQGLAYLHEQGVI 121

Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H D+K +N+L  +D V  L+DFG+A  L+   +       + T  +MAP+ I
Sbjct: 122 HRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVI 171

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score =  104 bits (260), Expect = 8e-23
 Identities = 50/118 (42%), Positives = 69/118 (58%), Gaps = 4/118 (3%)

Query: 541 GIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGS 600
           G+ L    L G IP  +  L+ LQ+I+L+ N + G IP S G++TSLE LDLS N  +GS
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 601 IPVSFEKLSYLKELNLSFNKLKGEIPR--GGPFANFTAESFMGNELLCGLPNLQVPPC 656
           IP S  +L+ L+ LNL+ N L G +P   GG   +  + +F  N  LCG+P L    C
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RAC 537

Length = 623

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 98.0 bits (245), Expect = 1e-22
 Identities = 49/178 (27%), Positives = 79/178 (44%), Gaps = 14/178 (7%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKV--FHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           IG G FG VY  R   DG    +K            +    E +++K + H N++K   S
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67

Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR---LNIMIDIASALEYLHFGHSTPI 847
                   +V+EY   G L   +         F     L+  + +  AL+YLH   S  I
Sbjct: 68  FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKI 124

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA-TIGYMAPDEIFVGE 904
           +H D+KP N+ L  + +  L DFG++K+LS   +     +T+  T  Y++P E+   +
Sbjct: 125 LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL---AKTVVGTPYYLSP-ELCQNK 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 96.3 bits (239), Expect = 5e-22
 Identities = 69/243 (28%), Positives = 117/243 (48%), Gaps = 25/243 (10%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V EYMS GSL D L         + RL  ++D    IAS + Y+        +H
Sbjct: 73  EPI-YIVTEYMSKGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 125

Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K 
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 185 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 244

Query: 958 EKR 960
           E+R
Sbjct: 245 EER 247

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 93.9 bits (234), Expect = 4e-21
 Identities = 59/179 (32%), Positives = 87/179 (48%), Gaps = 12/179 (6%)

Query: 732 NIIGIGGFGSVYRA-RLEDGVEIAIKV--FHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           N IG G FG VY A  L+ G  +A+K          T+K    E +V++ ++H NLVK  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
               + +   + +EY S G+LE+ L           R+   + +   L YLH   S  I+
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV-YTLQLLEGLAYLH---SHGIV 121

Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG---YMAPDEIFVGE 904
           H D+KP+N+ LD + V  L DFG A  L   + +TM  +  +  G   YMAP E+  G 
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLK-NNTTTMGEEVQSLAGTPAYMAP-EVITGG 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 61/170 (35%), Positives = 80/170 (47%), Gaps = 12/170 (7%)

Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFE---AECEVIKNIRHRNLVKIIS 789
           +G G FG V   R +D G   A+KV   +     K  E    E  ++  I H  +VK+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
           +   ++   LVLEY   G L   L       +         +I  ALEYLH   S  II+
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGR-FSEERARFYAAEIVLALEYLH---SLGIIY 116

Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA-TIGYMAPD 898
            DLKP N+LLD D    L+DFG+AK LS E     RT T   T  Y+AP+
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPE 163

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 93.6 bits (233), Expect = 5e-21
 Identities = 63/246 (25%), Positives = 110/246 (44%), Gaps = 30/246 (12%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+     +   +A+K   P      K F AE +++K +RH  L+++ + C+ 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           ++   +V E M  GSL + L           +L  +ID    +AS + YL    +   IH
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGAGRA---LKLPQLIDMAAQVASGMAYL---EAQNYIH 126

Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL   NVL+ E+ +  ++DFG+A+++  ED    R      I + AP+       S+K 
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185

Query: 910 --WVNDLLPVSLVEVV-----------DKSLLSGEEKHF--AAKEQCLLSIFSLALECTM 954
             W   +L   L E+V           +  +L   ++ +       C   ++ + L+C  
Sbjct: 186 DVWSFGIL---LTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWK 242

Query: 955 ESPEKR 960
           E P+ R
Sbjct: 243 EDPDDR 248

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 94.0 bits (234), Expect = 5e-21
 Identities = 72/279 (25%), Positives = 112/279 (40%), Gaps = 51/279 (18%)

Query: 734 IGIGGFGSVYRARLEDGVE------IAIKVFHPQCASTL-KSFEAECEVIKNIRHRNLVK 786
           +G G FG V+               +A+K      ++   K FE E E++ N +H N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCL--HSSNCA-----------LNIFCRLNIMIDIA 833
               C+  D   +V EYM +G L   L  H  + A           L +   L I + IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 834 SALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
           S + YL   HF      +H DL   N L+  D+V  + DFGM++ +   D   +   T+ 
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 891 TIGYMAPDEIFVGELSLKR--WVNDLLPVSLVEV---------------VDKSLLSGEEK 933
            I +M P+ I   + + +   W      V L E+               V + +  G   
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWS---FGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL 243

Query: 934 HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLK 972
                  C   ++ + L C    P++RI+ KD   RL K
Sbjct: 244 Q--RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 96.0 bits (237), Expect = 6e-21
 Identities = 81/257 (31%), Positives = 120/257 (46%), Gaps = 24/257 (9%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQ---CASTLKSFEAECEVIKNIRH-RNLVKIIS 789
           +G G FG VY AR  D   +A+KV   +    +  ++ F  E +++ ++ H  N+VK+  
Sbjct: 8   LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 790 SCSNDDFKALVLEYMSNGSLED--CLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
              ++    LV+EY+  GSLED          L+    L I+  I SALEYLH   S  I
Sbjct: 66  FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGI 122

Query: 848 IHCDLKPSNVLLDED-MVAHLSDFGMAKLLSGEDESTMRTQTLA----TIGYMAPDEIFV 902
           IH D+KP N+LLD D  V  L DFG+AKLL     ++      +    T GYMAP+ +  
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182

Query: 903 GELSLKRWVNDL--LPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKR 960
             L+     +D+  L ++L E++        EK+ +A  Q L  I  L            
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242

Query: 961 I------DAKDTITRLL 971
                   A D + +LL
Sbjct: 243 NPELISKAASDLLKKLL 259

Length = 384

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 52/146 (35%), Positives = 74/146 (50%), Gaps = 12/146 (8%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTL-----KSFEAECEVIKNIRHRNLVKII 788
           IG G FG VY+  L+   E+A+K     C STL     + F  E E++K   H N+VK+I
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKT----CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58

Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
             C       +V+E +  GSL   L      L +   L + +D A+ +EYL    S   I
Sbjct: 59  GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL---ESKNCI 115

Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAK 874
           H DL   N L+ E+ V  +SDFGM++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 89.9 bits (224), Expect = 1e-19
 Identities = 87/268 (32%), Positives = 123/268 (45%), Gaps = 33/268 (12%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFE---AECEVIKNIRH 781
           D+F     +G G FG V   R +   +  A+K+        LK  E    E  ++++IRH
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LV +  S  +D    LV+EY+  G L   L  S        R      +  ALEYLH 
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA-QVVLALEYLH- 118

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  I++ DLKP N+LLD D    ++DFG AK + G      RT TL  T  Y+AP EI
Sbjct: 119 --SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLCGTPEYLAP-EI 169

Query: 901 FVGE---LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESP 957
            + +    ++  W    L + + E     +L+G    F       + I+   LE  +  P
Sbjct: 170 ILSKGYGKAVDWWA---LGILIYE-----MLAGYPP-FFDDNP--IQIYEKILEGKVRFP 218

Query: 958 EKR-IDAKDTITRLLKIRDTLSKRIGNL 984
                DAKD I  LL+  D L+KR+GNL
Sbjct: 219 SFFSPDAKDLIRNLLQ-VD-LTKRLGNL 244

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 63/254 (24%), Positives = 111/254 (43%), Gaps = 24/254 (9%)

Query: 723 RATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHR 782
           R  + F     +G G FG V+    ++ V +AIK+         + F+ E + +K +RH+
Sbjct: 3   RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHK 62

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNC-ALNIFCRLNIMIDIASALEYLHF 841
           +L+ + + CS  +   ++ E M  GSL   L S     L +   +++   +A  + YL  
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
            +    IH DL   N+L+ ED+V  ++DFG+A+L+  +++  + +       + AP+   
Sbjct: 123 QN---SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAAS 177

Query: 902 VGELSLKR--WVNDLLPVSLVEVVDKSLL--SGEEKHFA-----------AKEQCLLSIF 946
            G  S K   W   +L   L E+     +   G   H                +C   I+
Sbjct: 178 HGTFSTKSDVWSFGIL---LYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIY 234

Query: 947 SLALECTMESPEKR 960
            + LEC    PE R
Sbjct: 235 KIMLECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 87.4 bits (216), Expect = 6e-19
 Identities = 66/240 (27%), Positives = 119/240 (49%), Gaps = 19/240 (7%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+        ++A+K   P   S  +SF  E +++K +RH  LV++ +  S 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 794 DDFKALVLEYMSNGSLEDCLHSSNC-ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
           +    +V EYMS GSL D L      AL +   +++   +A+ + Y+        IH DL
Sbjct: 73  EPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 128

Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR--W 910
           + +N+L+ + +V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K   W
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 911 VNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESPEKR 960
              +L   LV         + ++ +L   E+ +     + C +S+  L L+C  + PE+R
Sbjct: 188 SFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEER 247

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 87.4 bits (216), Expect = 7e-19
 Identities = 61/240 (25%), Positives = 117/240 (48%), Gaps = 19/240 (7%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+        ++AIK   P      ++F  E +++K +RH  LV + +  S 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-EYLHFGHSTPIIHCDL 852
           +    +V E+M  GSL D L   +     + +L  ++D+A+ + + + +      IH DL
Sbjct: 73  EPI-YIVTEFMGKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDL 128

Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR--W 910
           + +N+L+ +++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K   W
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 911 VNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESPEKR 960
              +L   LV         +V++ +L   E+ +     + C  S+  L   C  + P++R
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDER 247

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 58/176 (32%), Positives = 83/176 (47%), Gaps = 22/176 (12%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSC 791
            +G G +GSVY+A   E G  +AIKV        L+    E  ++K      +VK   S 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASALEYLHFGHSTPII 848
             +    +V+EY   GS+ D +  +N  L    I     I+      LEYLH       I
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA---ILYQTLKGLEYLHSNK---KI 121

Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR-TQTLATIG---YMAPDEI 900
           H D+K  N+LL+E+  A L+DFG    +SG+   TM    T+  IG   +MAP+ I
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFG----VSGQLTDTMAKRNTV--IGTPFWMAPEVI 171

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 86.9 bits (216), Expect = 2e-18
 Identities = 57/183 (31%), Positives = 85/183 (46%), Gaps = 19/183 (10%)

Query: 725 TDNFAENNIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRN 783
            + +     IG G  G VY+A     G E+AIK    +     +    E  ++K+ +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN------IMIDIASALE 837
           +V    S    D   +V+EYM  GSL D +  +      F R+N      +  ++   LE
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDII--TQN----FVRMNEPQIAYVCREVLQGLE 130

Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           YLH   S  +IH D+K  N+LL +D    L+DFG A  L+ E     R   + T  +MAP
Sbjct: 131 YLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAP 185

Query: 898 DEI 900
           + I
Sbjct: 186 EVI 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 85.5 bits (212), Expect = 4e-18
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 11/158 (6%)

Query: 732 NIIGIGGFGSVYRARLE-----DGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLV 785
             +G G FG V   R +      G ++A+K  +       +S FE E E+++ + H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 786 KIISSCSNDDFKA--LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           K    C     ++  L++EY+ +GSL D L      +N+   L     I   ++YL    
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE 881
           S   IH DL   N+L++ + +  +SDFG+AK+L  + +
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD 164

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 84.7 bits (210), Expect = 5e-18
 Identities = 55/183 (30%), Positives = 91/183 (49%), Gaps = 20/183 (10%)

Query: 727 NFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQ-CAST--LKSFEAECEVIKNIRHR 782
           +F    +IG G FG V   +  D  ++ A+K  + Q C     +++   E  +++ + H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSL----EDCLHSSNCALNIFCRLNIMIDIASALEY 838
            LV +  S  +++   LV++ +  G L       +  S   +  +     + +I  ALEY
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFW-----ICEIVLALEY 115

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           LH   S  IIH D+KP N+LLDE    H++DF +A  ++ +   T+ T T  T GYMAP 
Sbjct: 116 LH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTTSTSGTPGYMAP- 168

Query: 899 EIF 901
           E+ 
Sbjct: 169 EVL 171

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 84.6 bits (210), Expect = 6e-18
 Identities = 54/177 (30%), Positives = 79/177 (44%), Gaps = 16/177 (9%)

Query: 734 IGIGGFGSVYRARL-EDGVEIAIKVFH-PQCASTLKSFEAECEVIKNIRHRNLVKIISSC 791
           +G G  G VY+ R    G   A+K  H        K    E + +++     +VK    C
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64

Query: 792 SNDDFK----ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
               +K    ++VLEYM  GSL D L              I   I   L+YLH      I
Sbjct: 65  YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLHTKRH--I 121

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
           IH D+KPSN+L++      ++DFG++K+L  E+        + T+ YM+P E   GE
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSP-ERIQGE 175

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 84.3 bits (208), Expect = 7e-18
 Identities = 61/243 (25%), Positives = 117/243 (48%), Gaps = 24/243 (9%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+     +  ++A+K   P   S +++F  E  ++K ++H  LV++ +  + 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL-NIMIDIASALEYLHFGHSTPIIHCDL 852
           ++   ++ EYM+ GSL D L S      +  +L +    IA  + Y+        IH DL
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI---ERKNYIHRDL 129

Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR--W 910
           + +NVL+ E ++  ++DFG+A+++  ++E T R      I + AP+ I  G  ++K   W
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188

Query: 911 VNDLLPVSLVEVV-----------DKSLLSGEEKHFAAK--EQCLLSIFSLALECTMESP 957
              +L   L E+V           +  ++S  ++ +     E C   ++ +   C  E  
Sbjct: 189 SFGIL---LYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKA 245

Query: 958 EKR 960
           E+R
Sbjct: 246 EER 248

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 84.6 bits (210), Expect = 8e-18
 Identities = 53/185 (28%), Positives = 83/185 (44%), Gaps = 33/185 (17%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFH--------PQCASTLKSFEAECEVIKNIRHRNL 784
           IG G  G V++A+  E G  +A+K           P  A        E + ++  +H  +
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR------EIKALQACQHPYV 61

Query: 785 VKII------SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           VK++      S         LV+EYM    L + L      L      + M  +   + Y
Sbjct: 62  VKLLDVFPHGSGFV------LVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           +H   +  I+H DLKP+N+L+  D V  ++DFG+A+L S E+      Q +AT  Y AP 
Sbjct: 115 MH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAP- 169

Query: 899 EIFVG 903
           E+  G
Sbjct: 170 ELLYG 174

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 84.0 bits (208), Expect = 8e-18
 Identities = 68/252 (26%), Positives = 110/252 (43%), Gaps = 43/252 (17%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+  +    +++AIK+      S     E E +V+  + H NLV++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE-EAKVMMKLSHPNLVQLYGVCTK 70

Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
                +V EYM+NG L + L      L     L++  D+  A+EYL    S   IH DL 
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL---ESNGFIHRDLA 127

Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD--------------- 898
             N L+ ED V  +SDFG+A+ +  +D+ T    T   + +  P+               
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS 186

Query: 899 ------EIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSG---EEKHFAAKEQCLLSIFSL 948
                 E+F  G++  +R+ N        EVV+ S+ +G        A  E     ++++
Sbjct: 187 FGVLMWEVFSEGKMPYERFSNS-------EVVE-SVSAGYRLYRPKLAPTE-----VYTI 233

Query: 949 ALECTMESPEKR 960
              C  E PE R
Sbjct: 234 MYSCWHEKPEDR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 63/182 (34%), Positives = 90/182 (49%), Gaps = 21/182 (11%)

Query: 733 IIGIGGFGSV----YRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
            IG G FG V    YR     G ++A+K       +T ++F AE  V+  +RH NLV+++
Sbjct: 13  TIGKGEFGDVMLGDYR-----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLL 65

Query: 789 SSCSNDDFKA-LVLEYMSNGSLEDCLHS-SNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
                +     +V EYM+ GSL D L S     L   C L   +D+  A+EYL    +  
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANN 122

Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELS 906
            +H DL   NVL+ ED VA +SDFG+ K    E  ST  T  L  + + AP+ +   + S
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLP-VKWTAPEALREKKFS 177

Query: 907 LK 908
            K
Sbjct: 178 TK 179

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 83.8 bits (208), Expect = 1e-17
 Identities = 55/170 (32%), Positives = 77/170 (45%), Gaps = 23/170 (13%)

Query: 726 DNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSF---EAECEVIKN--- 778
           D+F    IIG G F +V  A+  E   E AIK+         K     E + + +K    
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL-------DKRQLIKEKKVKYVKIEKE 53

Query: 779 -----IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
                  H  ++K+  +  +++    VLEY  NG L   +      L+  C      +I 
Sbjct: 54  VLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS-LDEKCTRFYAAEIL 112

Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST 883
            ALEYLH   S  IIH DLKP N+LLD+DM   ++DFG AK+L       
Sbjct: 113 LALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 51/179 (28%), Positives = 92/179 (51%), Gaps = 7/179 (3%)

Query: 732 NIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           + +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
           C+ +    ++ E+M+ G+L D L   N   +N    L +   I+SA+EYL   +    IH
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127

Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
            DL   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIK 185

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 66/243 (27%), Positives = 117/243 (48%), Gaps = 25/243 (10%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+        ++AIK       S  ++F AE  ++K ++H  LV++ +  + 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-EAFLAEANLMKQLQHPRLVRLYAVVTQ 72

Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-EYLHFGHSTPIIHCDL 852
           +    ++ EYM NGSL D L +      I   +N +ID+A+ + E + F      IH DL
Sbjct: 73  EPI-YIITEYMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKNYIHRDL 128

Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR--W 910
           + +N+L+ E +   ++DFG+A+L+  ++E T R      I + AP+ I  G  ++K   W
Sbjct: 129 RAANILVSETLCCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187

Query: 911 VNDLLPVSLVEVV-----------DKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
              +L   L E+V           +  ++   E+ +     + C   ++ L   C  E P
Sbjct: 188 SFGIL---LTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKP 244

Query: 958 EKR 960
           E+R
Sbjct: 245 EER 247

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 83.3 bits (207), Expect = 2e-17
 Identities = 55/183 (30%), Positives = 87/183 (47%), Gaps = 26/183 (14%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFH--------PQCASTLKSFEAECEVIKNIRHRN 783
            +G G +G VY+AR  + G  +A+K           P  ++ L+    E  ++K ++H N
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP--STALR----EISLLKELKHPN 59

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +VK++     +    LV EY     L+  L      L+     +IM  +   L Y H   
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH--- 115

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR--TQTLATIGYMAPDEIF 901
           S  I+H DLKP N+L++ D V  L+DFG+A+         +R  T  + T+ Y AP EI 
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFG----IPLRTYTHEVVTLWYRAP-EIL 170

Query: 902 VGE 904
           +G 
Sbjct: 171 LGS 173

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 83.3 bits (206), Expect = 2e-17
 Identities = 69/274 (25%), Positives = 123/274 (44%), Gaps = 43/274 (15%)

Query: 734 IGIGGFGSVYRARL------EDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVK 786
           +G G FG VY+  L           +AIK         ++  F  E E++ +++H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCL--HSSNC-------------ALNIFCRLNIMID 831
           ++  C+ +    ++ EY+++G L + L  +S +              +L+    L+I I 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           IA+ +EYL   H    +H DL   N L+ E +   +SDFG+++ +   D   +++++L  
Sbjct: 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 892 IGYMAPDEIFVGELSLKR--WVNDLLPVSLVEVVDKSL-----LSGEEKHF--------A 936
           + +M P+ I  G+ + +   W      V L E+    L      S +E            
Sbjct: 190 VRWMPPEAILYGKFTTESDIWS---FGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP 246

Query: 937 AKEQCLLSIFSLALECTMESPEKRIDAKDTITRL 970
             E C   +++L +EC  E P +R   KD  TRL
Sbjct: 247 CPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 82.3 bits (203), Expect = 3e-17
 Identities = 68/255 (26%), Positives = 117/255 (45%), Gaps = 29/255 (11%)

Query: 733 IIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           IIG G FG+V +     G ++A+K    +C  T ++F  E  V+  + H+NLV+++    
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCAL-NIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
           ++    +V+E MS G+L + L +   AL ++   L   +D+A  +EYL    S  ++H D
Sbjct: 70  HNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRD 125

Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-- 909
           L   N+L+ ED VA +SDFG+A++      S     +   + + AP+ +   + S K   
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDV 180

Query: 910 WVNDLL------------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESP 957
           W   +L            P   ++ V + +  G        E C   ++ L   C    P
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG--YRMEPPEGCPADVYVLMTSCWETEP 238

Query: 958 EKRIDAKDTITRLLK 972
           +KR        +L K
Sbjct: 239 KKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 81.2 bits (201), Expect = 8e-17
 Identities = 54/174 (31%), Positives = 84/174 (48%), Gaps = 11/174 (6%)

Query: 732 NIIGIGGFGSVYRARLEDGVE-IAIKVFH-PQCASTLKSFEAECEVIKNIRHRNLVKIIS 789
            +IG+G    VY A      E +AIK     +C +++     E + +    H N+VK  +
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCA--LNIFCRLNIMIDIASALEYLH-FGHSTP 846
           S    D   LV+ Y+S GSL D + SS     L+      ++ ++   LEYLH  G    
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123

Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLL--SGEDESTMRTQTLATIGYMAPD 898
            IH D+K  N+LL ED    ++DFG++  L   G+    +R   + T  +MAP+
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 47/188 (25%), Positives = 79/188 (42%), Gaps = 30/188 (15%)

Query: 732 NIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFE-----AECEVIKNIRHRNLV 785
             IG G FG+V +  R  DG  +  K         +   E     +E  +++ ++H N+V
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEI---DYGNMTEKEKQQLVSEVNILRELKHPNIV 62

Query: 786 KIISSCSNDDFKAL--VLEYMSNGSLEDCLHSSNCALN--------IFCRLNIMIDIASA 835
           +      +   + L  V+EY   G L   +    C           I     I+  +  A
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKERKYIEEEFI---WRILTQLLLA 117

Query: 836 LEYLHFGH--STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT-LATI 892
           L   H        ++H DLKP+N+ LD +    L DFG+AK+L      +   +T + T 
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL---GHDSSFAKTYVGTP 174

Query: 893 GYMAPDEI 900
            YM+P+++
Sbjct: 175 YYMSPEQL 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 80.1 bits (197), Expect = 3e-16
 Identities = 61/272 (22%), Positives = 112/272 (41%), Gaps = 50/272 (18%)

Query: 734 IGIGGFGSVYRAR------LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKI 787
           +G G FG V+ A        +D + +A+K       +  K F+ E E++ N++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHS---------------SNCALNIFCRLNIMIDI 832
              C + D   +V EYM +G L   L +               +   L +   L+I   I
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           AS + YL   H    +H DL   N L+  +++  + DFGM++ +   D   +   T+  I
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 893 GYMAPDEIFVGELSLKR-------------------WVNDLLPVSLVEVVDKSLLSGEEK 933
            +M P+ I   + + +                    W   L    ++E + +  +  E  
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ-LSNTEVIECITQGRVL-ERP 247

Query: 934 HFAAKEQCLLSIFSLALECTMESPEKRIDAKD 965
               KE     ++ + L C    P++R++ K+
Sbjct: 248 RVCPKE-----VYDIMLGCWQREPQQRLNIKE 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 78.8 bits (194), Expect = 4e-16
 Identities = 50/175 (28%), Positives = 85/175 (48%), Gaps = 5/175 (2%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG V+     +  ++AIK    + A + + F  E +V+  + H  LV++   C+ 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
                LV E+M +G L D L +     +    L + +D+   + YL    S+ +IH DL 
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL---ESSNVIHRDLA 127

Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
             N L+ E+ V  +SDFGM + +  +D+ T  T T   + + +P+     + S K
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 79.3 bits (195), Expect = 5e-16
 Identities = 63/277 (22%), Positives = 113/277 (40%), Gaps = 47/277 (16%)

Query: 734 IGIGGFGSVYRARL------EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKI 787
           +G G FG V+ A        +D + +A+K       S  + F+ E E++  ++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR--------------LNIMIDIA 833
              C+      +V EYM +G L   L S      I                 L I   IA
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 834 SALEY---LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
           S + Y   LHF      +H DL   N L+ + +V  + DFGM++ +   D   +  +T+ 
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 891 TIGYMAPDEIFVGELSLKR--WVNDLL-------------PVSLVEVVDKSLLSGEEKHF 935
            I +M P+ I   + + +   W   ++              +S  E ++  +  G E   
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE-CITQGRE--L 243

Query: 936 AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLK 972
                C   ++++   C    P++R+  KD  +RL  
Sbjct: 244 ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.3 bits (193), Expect = 7e-16
 Identities = 55/186 (29%), Positives = 91/186 (48%), Gaps = 14/186 (7%)

Query: 727 NFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFH-----PQCASTLKSFEAECEVIKNIR 780
           N+    ++G G FG VY    ++ G E+A+K        P+    + + E E +++KN++
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H  +V+      +D+  ++ +EYM  GS++D L +         R      I   +EYLH
Sbjct: 63  HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH 121

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST--MRTQTLATIGYMAPD 898
              S  I+H D+K +N+L D      L DFG +K L     S   M++ T  T  +M+P 
Sbjct: 122 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSP- 176

Query: 899 EIFVGE 904
           E+  GE
Sbjct: 177 EVISGE 182

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 77.8 bits (192), Expect = 9e-16
 Identities = 53/186 (28%), Positives = 80/186 (43%), Gaps = 21/186 (11%)

Query: 734 IGIGGFGSV----YRARLEDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKII 788
           +G G FGSV    Y  +    VE+A+K    +  +  K  F  E  V+  + H  +V++I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 789 SSCSNDDFKALVLEYMSNGSLEDCL--HSSNCALNIFCRLNIMIDIASALEYL---HFGH 843
             C  +    LV+E    G L   L         ++     +   +A  + YL   HF  
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKHF-- 116

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAPDEIFV 902
               +H DL   NVLL     A +SDFGM++ L +G D     T     + + AP+ I  
Sbjct: 117 ----VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 903 GELSLK 908
           G+ S K
Sbjct: 173 GKFSSK 178

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 58/185 (31%), Positives = 90/185 (48%), Gaps = 19/185 (10%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRN 783
            D   E  ++G G +G VY AR L   V IAIK    + +  ++    E  +   ++HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHS-------SNCALNIFCRLNIMIDIASAL 836
           +V+ + S S + F  + +E +  GSL   L S       +   +  + +      I   L
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----QILEGL 121

Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYM 895
           +YL   H   I+H D+K  NVL++    V  +SDFG +K L+G +  T  T T  T+ YM
Sbjct: 122 KYL---HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT-ETFT-GTLQYM 176

Query: 896 APDEI 900
           AP+ I
Sbjct: 177 APEVI 181

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 21/183 (11%)

Query: 732 NIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA--ECEVIKNIRHRNLVKII 788
             IG G +G VY+AR  + G  +A+K    +         A  E ++++ +RH N+V++ 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 789 ----SSCSNDDFKALVLEYMSNGSLEDCLHSSNCAL---NIFCRLNIMIDIASALEYLHF 841
               S      +  +V EYM +  L   L S         I C    M  +   L+YLH 
Sbjct: 65  EIVTSKGKGSIY--MVFEYMDH-DLTGLLDSPEVKFTESQIKC---YMKQLLEGLQYLH- 117

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
             S  I+H D+K SN+L++ D V  L+DFG+A+  +  + +   T  + T+ Y  P E+ 
Sbjct: 118 --SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY-TNRVITLWYRPP-ELL 173

Query: 902 VGE 904
           +G 
Sbjct: 174 LGA 176

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 63/245 (25%), Positives = 105/245 (42%), Gaps = 25/245 (10%)

Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKIISSC 791
           IG G FG V+  RL  D   +A+K         LK+ F  E  ++K   H N+V++I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
           +      +V+E +  G     L +    L +   + ++ + A+ +EYL   H    IH D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---IHRD 119

Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT----LATIGYMAPDEIFVGELSL 907
           L   N L+ E  V  +SDFGM++    E+E  +   T       + + AP+ +  G  S 
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175

Query: 908 KR--WVNDLL---PVSLVEVVDKSLLSGEEKHFAAK-------EQCLLSIFSLALECTME 955
           +   W   +L     SL  V   +L + + +    +       E C  +++ L   C   
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEY 235

Query: 956 SPEKR 960
            P +R
Sbjct: 236 DPGQR 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 56/177 (31%), Positives = 85/177 (48%), Gaps = 20/177 (11%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           IG G +G VY+AR +  G  +AIKV   +     +  + E  ++K  RH N+V    S  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALN-----IFCRLNIMIDIASALEYLHFGHSTPI 847
             D   +V+EY   GSL+D    +   L+       CR          L+ L + H T  
Sbjct: 71  RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR--------ETLKGLAYLHETGK 122

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM--RTQTLATIGYMAPDEIFV 902
           IH D+K +N+LL ED    L+DFG++  L+    +T+  R   + T  +MAP+   V
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLT----ATIAKRKSFIGTPYWMAPEVAAV 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 77.1 bits (190), Expect = 4e-15
 Identities = 63/175 (36%), Positives = 84/175 (48%), Gaps = 15/175 (8%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFE-----AECEV-IKNIRHRNLV 785
           +IG G FG V  A+   DG   A+KV   Q  + LK  E     AE  V +KN++H  LV
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVL--QKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
            +  S    D    VL+Y++ G L   L           R     +IASAL YLH   S 
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SL 115

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            II+ DLKP N+LLD      L+DFG+ K   G + S   +    T  Y+AP+ +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVL 168

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 76.7 bits (189), Expect = 4e-15
 Identities = 57/183 (31%), Positives = 85/183 (46%), Gaps = 10/183 (5%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVF--HPQCASTLKSFEAECEVIKNIRHRNLVKIIS 789
           ++G G +G V + +  E G  +AIK F          K    E  ++K +RH NLV +I 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
                    LV E++ +  L+D     N  L+       +  I   +E+ H   S  IIH
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIH 123

Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            D+KP N+L+ +  V  L DFG A+ L+   E    T  +AT  Y AP E+ VG+    R
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAP-ELLVGDTKYGR 180

Query: 910 WVN 912
            V+
Sbjct: 181 AVD 183

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 75.4 bits (185), Expect = 9e-15
 Identities = 67/276 (24%), Positives = 114/276 (41%), Gaps = 47/276 (17%)

Query: 734 IGIGGFGSVYRARL-----EDGVEIAIKVFHP-QCASTLKSFEAECEVIKNIRHRNLVKI 787
           +G   FG +Y+  L     +    +AIK             F+ E  ++  + H N+V +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR----------------LNIMID 831
           +   + +    ++ EY++ G L + L   +   ++ C                 L+I I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 832 IASALEYL--HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
           IA+ +EYL  HF      +H DL   N+L+ E +   +SD G+++ +   D   ++ ++L
Sbjct: 133 IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 890 ATIGYMAPDEIFVGELSLKR--WVNDLLPVSLVEVVDKSL-----LSGEE--------KH 934
             I +M P+ I  G+ S     W      V L E+    L      S +E        + 
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWS---FGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244

Query: 935 FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRL 970
               E C   ++SL  EC  E P +R   KD  TRL
Sbjct: 245 LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.1 bits (184), Expect = 9e-15
 Identities = 63/243 (25%), Positives = 117/243 (48%), Gaps = 25/243 (10%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+ A      ++A+K   P   S +++F AE  V+K ++H  LVK+ +  + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL-NIMIDIASALEYLHFGHSTPIIHCDL 852
           +    ++ E+M+ GSL D L S   +     +L +    IA  + ++        IH DL
Sbjct: 73  EPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDL 128

Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR--W 910
           + +N+L+   +V  ++DFG+A+++  ++E T R      I + AP+ I  G  ++K   W
Sbjct: 129 RAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187

Query: 911 VNDLLPVSLV-------------EVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESP 957
              +L + +V             EV+ ++L  G        E C   ++++ + C    P
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPEVI-RALERG--YRMPRPENCPEELYNIMMRCWKNRP 244

Query: 958 EKR 960
           E+R
Sbjct: 245 EER 247

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 9e-15
 Identities = 57/173 (32%), Positives = 82/173 (47%), Gaps = 9/173 (5%)

Query: 734 IGIGGFGSVYRARLEDGVEI-AIKVFH--PQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V + R +   EI AIK F          K+   E +V++ +RH N+V +  +
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68

Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHC 850
                   LV EY+    LE  L +S   L      + +  +  A+ Y H   S  IIH 
Sbjct: 69  FRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHR 124

Query: 851 DLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG 903
           D+KP N+L+ E  V  L DFG A+ L     S + T  +AT  Y AP E+ VG
Sbjct: 125 DIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAP-ELLVG 175

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 1e-14
 Identities = 60/251 (23%), Positives = 109/251 (43%), Gaps = 32/251 (12%)

Query: 733 IIGIGGFGSVYRAR---LEDGVEI--AIKVFHPQCASTLKSFEA---ECEVIKNIRHRNL 784
           ++G G FG+VY+       + V+I  AIKV      ++ K+ +    E  V+ ++ H ++
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE--ETSPKANKEILDEAYVMASVDHPHV 71

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           V+++  C +     L+ + M  G L D + +    +     LN  + IA  + YL     
Sbjct: 72  VRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR- 129

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
             ++H DL   NVL+       ++DFG+AKLL  +++          I +MA + I    
Sbjct: 130 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187

Query: 905 LSLKR--W-----VNDLLP--------VSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLA 949
            + K   W     V +L+         +  VE+    LL   E+       C + ++ + 
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI--PDLLEKGER-LPQPPICTIDVYMVL 244

Query: 950 LECTMESPEKR 960
           ++C M   E R
Sbjct: 245 VKCWMIDAESR 255

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 52/173 (30%), Positives = 79/173 (45%), Gaps = 13/173 (7%)

Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVF-----HPQCASTLKSFEAECEVIKNIRHRNLVKI 787
           +G G FGSVY    L+DG   A+K              +K  E E  ++  ++H N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
           + +   +D   + LE +  GSL   L           RL     I   LEYLH       
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLEYLH---DRNT 123

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           +H D+K +N+L+D + V  L+DFGMAK +    E +       +  +MAP+ I
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVV---EFSFAKSFKGSPYWMAPEVI 173

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 45/169 (26%), Positives = 75/169 (44%), Gaps = 8/169 (4%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTL-KSFEAECEVIKNIRHRNLVKIISSC 791
           +G G  G V +      G  +A+K    +    + K    E +++       +V    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            N+   ++ +EYM  GSL+  L      +       I + +   L YLH  H   IIH D
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126

Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           +KPSN+L++      L DFG    +SG+  +++    + T  YMAP+ I
Sbjct: 127 VKPSNILVNSRGQIKLCDFG----VSGQLVNSLAKTFVGTSSYMAPERI 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 9/177 (5%)

Query: 733 IIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLK-SFEAECEVIKNIRHRNLVKIISSC 791
           ++G G FG V++  L+D   +A+K         LK  F +E  ++K   H N+VK+I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
           +      +V+E +  G     L      L     +   +D A+ + YL    S   IH D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL---ESKNCIHRD 118

Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEIFVGELS 906
           L   N L+ E+ V  +SDFGM++    ED+    +  L    I + AP+ +  G  S
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 74.3 bits (182), Expect = 3e-14
 Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 21/186 (11%)

Query: 734 IGIGGFGSVYRARL------EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKI 787
           +G G FG V+ A        +D + +A+K       +  K F  E E++ N++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSN------------CALNIFCRLNIMIDIASA 835
              C   D   +V EYM +G L   L +                L     L+I   IA+ 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYM 895
           + YL   H    +H DL   N L+ E+++  + DFGM++ +   D   +   T+  I +M
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 896 APDEIF 901
            P+ I 
Sbjct: 190 PPESIM 195

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 57/180 (31%), Positives = 84/180 (46%), Gaps = 15/180 (8%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFE---AECEVIKNIRH 781
           D+      +G G FG V+  R        A+KV        LK  +    E  V+K + H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             ++++  +  +  F  +++EY+  G L   L +S    N         +I  ALEYLH 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH- 118

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  I++ DLKP N+LLD++    L+DFG AK L        RT TL  T  Y+AP+ I
Sbjct: 119 --SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD------RTWTLCGTPEYLAPEVI 170

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 18/177 (10%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQ------CASTLKSFEAECEVIKNIRHRNLVK 786
           IG G +G VY+AR    G  +AIK    +        + L+    E +++K + H N++K
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62

Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
           ++    +     LV E+M    L   +      L      + +  +   L + H   S  
Sbjct: 63  LLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118

Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG 903
           I+H DLKP N+L++ + V  L+DFG+A+           T  + T  Y AP E+ +G
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVTRWYRAP-ELLLG 172

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 73.4 bits (181), Expect = 4e-14
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 15/181 (8%)

Query: 734 IGIGGFGSVYRARLEDGVEI-AIKVF---HPQCASTLKSFEAECEVIKNIRHRNLVKIIS 789
           I  G +G V+ A+ +   +I AIKV         + +     E +++   +   +VK+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
           S        LV+EY+  G L   L +    L+       + +I  ALEYLH   S  IIH
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH---SNGIIH 116

Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKL------LSGEDESTMRTQTLATIGYMAPDEIFVG 903
            DLKP N+L+D +    L+DFG++K+      ++  D+     + + T  Y+AP E+ +G
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP-EVILG 175

Query: 904 E 904
           +
Sbjct: 176 Q 176

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 74.9 bits (184), Expect = 4e-14
 Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 28/230 (12%)

Query: 678 LPL-STTLVIAVALALKRGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGI 736
           LPL      +AV L L      +  S+    S        S  EL R        N IG 
Sbjct: 32  LPLPQRDPSLAVPLPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERV-------NRIGS 84

Query: 737 GGFGSVYRARLE-DGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           G  G+VY+      G   A+KV    H    +  +    E E+++++ H N+VK      
Sbjct: 85  GAGGTVYKVIHRPTGRLYALKVIYGNHED--TVRRQICREIEILRDVNHPNVVKCHDMFD 142

Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
           ++    ++LE+M  GSLE    +    L    R      I S + YLH  H   I+H D+
Sbjct: 143 HNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-----QILSGIAYLHRRH---IVHRDI 194

Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR--TQTLATIGYMAPDEI 900
           KPSN+L++      ++DFG++++L+     TM     ++ TI YM+P+ I
Sbjct: 195 KPSNLLINSAKNVKIADFGVSRILA----QTMDPCNSSVGTIAYMSPERI 240

Length = 353

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 5e-14
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 6/166 (3%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G FG VY+A+  E G+  A K+   +    L+ F  E +++   +H N+V +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
            ++   +++E+   G+L+  +      L       +   +  AL +LH   S  +IH DL
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           K  N+LL  D    L+DFG++       +   R   + T  +MAP+
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPE 173

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 73.3 bits (180), Expect = 5e-14
 Identities = 68/290 (23%), Positives = 116/290 (40%), Gaps = 55/290 (18%)

Query: 731 NNI-----IGIGGFGSVYRARL------EDGVEIAIKVFHPQC-ASTLKSFEAECEVIKN 778
           NNI     IG G FG V++AR       E    +A+K+   +  A     F+ E  ++  
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCL--------HSSN------------- 817
             H N+VK++  C+      L+ EYM+ G L + L         S +             
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 818 CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS 877
             L+   +L I   +A+ + YL        +H DL   N L+ E+MV  ++DFG+++ + 
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 878 GEDESTMRTQTLATIGYMAPDEIFVGELSLKR--WVNDLLPVSLVEVVDKSL-----LSG 930
             D           I +M P+ IF    + +   W      V L E+    +     ++ 
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWA---YGVVLWEIFSYGMQPYYGMAH 238

Query: 931 EE--KH------FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLK 972
           EE   +       +  + C L +++L   C  + P  R      I R+L+
Sbjct: 239 EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFAS-INRILQ 287

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 72.9 bits (179), Expect = 5e-14
 Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 20/165 (12%)

Query: 733 IIGIGGFGSVYRARL--EDGV--EIAIKVFH-PQCAST-LKSFEAECEVIKNIRHRNLVK 786
           I+G G FGSV   +L  +DG   ++A+K         + ++ F +E   +K+  H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 787 IISSC----SNDDFKA--LVLEYMSNGSLEDCLHSSNCALNIF-----CRLNIMIDIASA 835
           +I  C    S        ++L +M +G L   L  S              L  M+DIA  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED 880
           +EYL    +   IH DL   N +L EDM   ++DFG++K +   D
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 73.9 bits (182), Expect = 6e-14
 Identities = 57/187 (30%), Positives = 91/187 (48%), Gaps = 30/187 (16%)

Query: 733 IIGIGGFGSVYRA-RLEDGVEIAIK----VFH-PQCAS-TLKSFEAECEVIKNIRHRNLV 785
            IG G +G V  A     G ++AIK     F  P  A  TL+    E +++++ +H N++
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR----ELKILRHFKHDNII 67

Query: 786 KI--ISSCSNDDFKA--LVLEYMSNGSLEDCLHS----SNCALNIFCRLNIMIDIASALE 837
            I  I      DFK   +V++ M +  L   +HS    +   +  F     +  +   L+
Sbjct: 68  AIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYF-----LYQLLRGLK 121

Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL--SGEDESTMRTQTLATIGYM 895
           Y+H   S  +IH DLKPSN+L++ED    + DFGMA+ L  S  +     T+ +AT  Y 
Sbjct: 122 YIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178

Query: 896 APDEIFV 902
           AP+ +  
Sbjct: 179 APELLLS 185

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 73.0 bits (179), Expect = 6e-14
 Identities = 54/152 (35%), Positives = 73/152 (48%), Gaps = 19/152 (12%)

Query: 734 IGIGGFGSV--YR---ARLEDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKI 787
           +G G FG V  Y    A    G  +A+K    +C     S ++ E  ++K + H N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 788 ISSCSNDDFKA--LVLEYMSNGSLEDCL--HSSNCA-LNIFCRLNIMIDIASALEYLHFG 842
              CS    K   L++EY+  GSL D L  H  N A L +F +      I   + YLH  
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQ-----QICEGMAYLHSQ 126

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK 874
           H    IH DL   NVLLD D +  + DFG+AK
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 73.0 bits (180), Expect = 8e-14
 Identities = 56/179 (31%), Positives = 88/179 (49%), Gaps = 19/179 (10%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIK---VFHPQCASTLKSFEA--ECEVIKNIRHRNLVKI 787
           +G G +  VY+AR  E G  +AIK   +   + A    +F A  E ++++ ++H N++ +
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCAL---NIFCRLNIMIDIASALEYLHFGHS 844
           +    +     LV E+M    LE  +   +  L   +I      M+     LEYLH   S
Sbjct: 68  LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKS---YMLMTLRGLEYLH---S 120

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG 903
             I+H DLKP+N+L+  D V  L+DFG+A+   G     M  Q + T  Y AP E+  G
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQ-VVTRWYRAP-ELLFG 176

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 73.3 bits (181), Expect = 8e-14
 Identities = 51/182 (28%), Positives = 84/182 (46%), Gaps = 23/182 (12%)

Query: 732 NIIGIGGFGSVYRAR-LEDGVEIAIKVFHP------QCASTLKSFEAECEVIKNIRHRNL 784
             IG G +G V  A     G ++AIK               L+    E ++++++RH N+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61

Query: 785 VK---IISSCSNDDFKAL--VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           +    I+   S +DF  +  V E M    L   + S     +   +   +  I   L+YL
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119

Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAPD 898
           H  +   +IH DLKPSN+L++ +    + DFG+A+ +   EDE    T+ + T  Y AP 
Sbjct: 120 HSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP- 175

Query: 899 EI 900
           E+
Sbjct: 176 EL 177

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 74.5 bits (183), Expect = 1e-13
 Identities = 33/80 (41%), Positives = 51/80 (63%)

Query: 407 GNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSR 466
           G IP  I  L +L  ++L GN++ G+IP + G +  L+ LDL++N   GSIP+ +  L+ 
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 467 LNELDLNGNKISGSISSCLG 486
           L  L+LNGN +SG + + LG
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 9/178 (5%)

Query: 729 AENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRN 783
            +  +IG G FG V+R  L+      V +AIK   P      +  F +E  ++    H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           ++++    +      ++ EYM NG+L+  L   +   + +  + ++  IA+ ++YL    
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS--- 124

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ-TLATIGYMAPDEI 900
               +H DL   N+L++ ++   +SDFG++++L  + E T  T      I + AP+ I
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 48/178 (26%), Positives = 74/178 (41%), Gaps = 13/178 (7%)

Query: 727 NFAENNIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFEA--ECEVIKNIRHRN 783
           +F   N IG G FG V++  R  D    A+K       +  +  EA  E  V+  +    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALEYLH 840
           +++   S  +     +V+EY  NG L   L          +   R  I I +      L 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG-----LA 115

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             HS  I+H D+K  N+ LD      + D G+AKLLS  D +      + T  Y++P+
Sbjct: 116 HLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPE 171

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 9/162 (5%)

Query: 731 NNIIGIGGFGSVYRARL----EDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLV 785
             +IG G FG V R RL    +  +++AIK      +   +  F  E  ++    H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
           ++    +      ++ EYM NGSL+  L  ++    +   + ++  IAS ++YL      
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EM 125

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ 887
             +H DL   N+L++ ++V  +SDFG+++ L  + E+T  T+
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRL-EDSEATYTTK 166

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 54/170 (31%), Positives = 83/170 (48%), Gaps = 21/170 (12%)

Query: 728 FAENNIIGIGGFGSVYRARL--EDG--VEIAIKVFHPQ--CASTLKSFEAECEVIKNIRH 781
           F    ++G G FGSV  A+L  EDG   ++A+K+       +S ++ F  E   +K   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 782 RNLVKIISSCSNDDFKA------LVLEYMSNGSLEDCLHSSNCALNIF-----CRLNIMI 830
            N++K+I        K       ++L +M +G L   L  S      F       +  MI
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGE 879
           DIAS +EYL    S   IH DL   N +L+E+M   ++DFG++ K+ SG+
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 71.5 bits (175), Expect = 3e-13
 Identities = 61/173 (35%), Positives = 84/173 (48%), Gaps = 15/173 (8%)

Query: 733 IIGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFE-----AECEVI-KNIRHRNLV 785
           +IG G FG V  A R  DG   A+KV   +  + LK  E     AE  V+ KN++H  LV
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKK--TILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
            +  S    +    VL+Y++ G L   L    C L    R     ++ASA+ YLH   S 
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
            II+ DLKP N+LLD      L+DFG+ K   G +     +    T  Y+AP+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 69.9 bits (171), Expect = 4e-13
 Identities = 47/175 (26%), Positives = 78/175 (44%), Gaps = 5/175 (2%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V   +     ++AIK+      S  +  E E +V+  + H  LV++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMKLSHEKLVQLYGVCTK 70

Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
                +V EYMSNG L + L            L +  D+   + YL    S   IH DL 
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL---ESKQFIHRDLA 127

Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
             N L+D+     +SDFG+++ +  +DE T    +   + +  P+ +   + S K
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 70.0 bits (172), Expect = 4e-13
 Identities = 75/266 (28%), Positives = 118/266 (44%), Gaps = 39/266 (14%)

Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRHRNLVKIIS 789
           +G+GGFG V   +++      A+K     H       +   +E E+++   H  +VK+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGHSTP 846
           +  +  +  +++EY   G L   L      +     F        IA  +    + H+  
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFY-------IACVVLAFEYLHNRG 113

Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEIFVGE- 904
           II+ DLKP N+LLD +    L DFG AK L     S  +T T   T  Y+AP EI + + 
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLK----SGQKTWTFCGTPEYVAP-EIILNKG 168

Query: 905 --LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECT--MESPEKR 960
              S+  W    L + L E     LL+G    F   ++  + I++  L+    +E P   
Sbjct: 169 YDFSVDYWS---LGILLYE-----LLTGRPP-FGEDDEDPMEIYNDILKGNGKLEFP-NY 218

Query: 961 ID--AKDTITRLLKIRDTLSKRIGNL 984
           ID  AKD I +LL  R    +R+GNL
Sbjct: 219 IDKAAKDLIKQLL--RRNPEERLGNL 242

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 70.3 bits (172), Expect = 7e-13
 Identities = 55/171 (32%), Positives = 83/171 (48%), Gaps = 18/171 (10%)

Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           IG G  G+VY A  +  G E+AIK  + Q     +    E  V++  +H N+V  + S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 793 NDDFKALVLEYMSNGSLED-----CLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
             D   +V+EY++ GSL D     C+     A    CR     +   ALE+LH   S  +
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA--AVCR-----ECLQALEFLH---SNQV 136

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           IH D+K  N+LL  D    L+DFG    ++   E + R+  + T  +MAP+
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPE 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 70.1 bits (171), Expect = 7e-13
 Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 20/173 (11%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G FG VY+A+  E G   A KV   +    L+ +  E E++    H  +VK++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALN-----IFCRLNIMIDIASALEYLHFGHSTPI 847
            D    +++E+   G+++  +   +  L      + CR          LE L + HS  I
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICR--------QMLEALQYLHSMKI 131

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM--RTQTLATIGYMAPD 898
           IH DLK  NVLL  D    L+DFG    +S ++  T+  R   + T  +MAP+
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFG----VSAKNVKTLQRRDSFIGTPYWMAPE 180

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.2 bits (177), Expect = 8e-13
 Identities = 33/86 (38%), Positives = 53/86 (61%), Gaps = 2/86 (2%)

Query: 201 LGYNN--LSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVV 258
           LG +N  L G IP +I  L  LQ I+L  N + G IP  +G + +L+VL L +N+  G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 259 PATIFNMSTLKEIFLYNNSLSGSLPS 284
           P ++  +++L+ + L  NSLSG +P+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPA 508

Length = 623

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 69.3 bits (170), Expect = 8e-13
 Identities = 43/174 (24%), Positives = 68/174 (39%), Gaps = 11/174 (6%)

Query: 734 IGIGGFGSVYRAR----LEDGVEIAIKVFHP-QCASTLKSFEAECEVIKNIRHRNLVKII 788
           +G G FG V R          + +A+K     + +  +  F  E  ++ ++ H NL+++ 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL-NIMIDIASALEYLHFGHSTPI 847
                     +V E    GSL D L        +   L +  + IA+ + YL        
Sbjct: 63  GVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---F 118

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFG-MAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           IH DL   N+LL  D    + DFG M  L   ED   M         + AP+ +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 69.4 bits (170), Expect = 9e-13
 Identities = 51/183 (27%), Positives = 90/183 (49%), Gaps = 23/183 (12%)

Query: 733 IIGIGGFGSVYRA-RLEDGVEIAIK-VFHPQCA---------STLKSFEAECEVIKNIRH 781
           +IG G +G VY A  +  G  +A+K V  P              +K+  +E E +K++ H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
            N+V+ +   + +++ ++ LEY+  GS+  CL +         R      +   L YLH 
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQVLEGLAYLH- 125

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK----LLSGEDESTMRTQTLATIGYMAP 897
             S  I+H DLK  N+L+D D +  +SDFG++K    +   +   +M+     ++ +MAP
Sbjct: 126 --SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ----GSVFWMAP 179

Query: 898 DEI 900
           + I
Sbjct: 180 EVI 182

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 9e-13
 Identities = 56/183 (30%), Positives = 79/183 (43%), Gaps = 37/183 (20%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVI-KNIRHRNLVKIISSC 791
           IG G FG VY+A        +AIKV        L+  E E E I + I      + +S C
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVID------LEEAEDEIEDIQQEI------QFLSQC 56

Query: 792 SN-----------DDFK-ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
            +              K  +++EY   GS  D L              I+ ++   LEYL
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIA--FILREVLLGLEYL 114

Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM--RTQTLATIGYMAP 897
           H       IH D+K +N+LL E+    L+DFG    +SG+  STM  R   + T  +MAP
Sbjct: 115 H---EEGKIHRDIKAANILLSEEGDVKLADFG----VSGQLTSTMSKRNTFVGTPFWMAP 167

Query: 898 DEI 900
           + I
Sbjct: 168 EVI 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 53/181 (29%), Positives = 84/181 (46%), Gaps = 12/181 (6%)

Query: 727 NFAENNIIGIGGFGSVYRAR-LEDGVEIAIK---VFHPQCASTLKSFEAECEVIKNIRHR 782
           NF     IG G F  VYRA  L DGV +A+K   +F    A        E +++K + H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNI---MIDIASALEYL 839
           N++K  +S   D+   +VLE    G L   +        +     +    + + SALE++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
           H   S  ++H D+KP+NV +    V  L D G+ +  S   ++T     + T  YM+P+ 
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPER 177

Query: 900 I 900
           I
Sbjct: 178 I 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 48/183 (26%), Positives = 87/183 (47%), Gaps = 23/183 (12%)

Query: 727 NFAENNIIGIGGFGSVYRA-RLEDGVEIAIKVF--HPQCASTLKSFEAECEVIKNIRHRN 783
            + +  ++G G FG V+   R  D   + IK             + + EC+V+K + H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY----- 838
           +++   +   D    +V+EY   G+L + +           R N ++D  + L +     
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQK---------RCNSLLDEDTILHFFVQIL 111

Query: 839 --LHFGHSTPIIHCDLKPSNVLLDE-DMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYM 895
             LH  H+  I+H DLK  N+LLD+  MV  + DFG++K+LS + ++      + T  Y+
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYI 168

Query: 896 APD 898
           +P+
Sbjct: 169 SPE 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 52/195 (26%), Positives = 87/195 (44%), Gaps = 29/195 (14%)

Query: 727 NFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECE-VIKNIR---- 780
            + +   +G G F S Y+AR ++ G  +A+K       +T    E   E + K IR    
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQV-TYVRNTSSEQEEVVEALRKEIRLMAR 59

Query: 781 --HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHS----SNCALNIFCRLNIMIDIAS 834
             H ++++++ +   D    L +E+M+ GS+   L          +  +        +  
Sbjct: 60  LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTE-----QLLR 114

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHLSDFG----MAKLLSGEDESTMRTQTL 889
            L YL   H   IIH D+K +N+L+D       ++DFG    +A   +G  E   + Q L
Sbjct: 115 GLSYL---HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQGQLL 169

Query: 890 ATIGYMAPDEIFVGE 904
            TI +MAP E+  GE
Sbjct: 170 GTIAFMAP-EVLRGE 183

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 58/186 (31%), Positives = 85/186 (45%), Gaps = 12/186 (6%)

Query: 727 NFAENNIIGIGGFGSVYRARLED-GVEIAIKV--FHPQCASTLKSFEA-ECEV--IKNIR 780
           N+    ++G G FG VY     D G E+A+K   F P    T K   A ECE+  +KN+R
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 781 HRNLVKIISSCSNDDFKALVL--EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           H  +V+      + + K L +  EYM  GS++D L +   AL           I   + Y
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSY 121

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           LH   S  I+H D+K +N+L D      L DFG +K +     S    +++    Y    
Sbjct: 122 LH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 899 EIFVGE 904
           E+  GE
Sbjct: 179 EVISGE 184

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 14/184 (7%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIA---IKVFHPQCASTLKSFEAECEVIKNIR 780
             NF     IG G F  VY+A  L DG  +A   +++F    A   +    E +++K + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCL-HSSNCALNIFCRL--NIMIDIASALE 837
           H N++K ++S   ++   +VLE    G L   + H       I  R      + + SALE
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMA 896
           ++H   S  I+H D+KP+NV +    V  L D G+ +  S +   T    +L  T  YM+
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK---TTAAHSLVGTPYYMS 174

Query: 897 PDEI 900
           P+ I
Sbjct: 175 PERI 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 73/276 (26%), Positives = 117/276 (42%), Gaps = 38/276 (13%)

Query: 734 IGIGGFGSVYRAR---LED--GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +G G FGSV   R   L+D  G  +A+K      A  L+ FE E E++K+++H N+VK  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 789 SSCSNDDFKA--LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
             C +   +   LV+EY+  GSL D L      L+    L     I   +EYL    S  
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL---GSKR 128

Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPDEIFVGEL 905
            +H DL   N+L++ +    + DFG+ K+L  + E   +R    + I + AP+ +   + 
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF 188

Query: 906 SLKR--WVNDLLPVSLVEVVDKSL--------LSGEEK-------HFA----------AK 938
           S+    W   ++   L    DKS         + G +K       H            A 
Sbjct: 189 SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAP 248

Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR 974
             C   I+++  EC    P +R    +   ++  IR
Sbjct: 249 PGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 43/168 (25%), Positives = 86/168 (51%), Gaps = 15/168 (8%)

Query: 751 VEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSL 809
           V +A+K+       T ++ F  E +++  +++ N+++++  C +DD   ++ EYM NG L
Sbjct: 45  VLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104

Query: 810 EDCL----------HSSNC-ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVL 858
              L          H++N  +++I   L + + IAS ++YL    S   +H DL   N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161

Query: 859 LDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELS 906
           +       ++DFGM++ L   D   ++ + +  I +MA + I +G+ +
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT 209

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 69.6 bits (170), Expect = 3e-12
 Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 11/284 (3%)

Query: 352 TSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPK 411
            SS   L   SSL+    L  L   G      L  S   L+L          N   +   
Sbjct: 54  LSSNTLLLLPSSLSRLLSLDLLSPSGI---SSLDGSENLLNLLPLPSLDLNLNRLRSNIS 110

Query: 412 AIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELD 471
            +  L+NL  L L  NN++   P+       L+ LDL+ NK+  S+P  +  L  L  LD
Sbjct: 111 ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLD 169

Query: 472 LNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISL 531
           L+ N +S  +   L NL++L  L+L  N+ +  +P     L  +   D+S+N +   +  
Sbjct: 170 LSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLS 226

Query: 532 AIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLD 591
           ++ NLK + G++LS NN   ++P ++  L +L+ + L+ N++      S G++T+L  LD
Sbjct: 227 SLSNLKNLSGLELS-NNKLEDLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELD 283

Query: 592 LSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFT 635
           LS N +S ++P+    L  L EL L+       +          
Sbjct: 284 LSGNSLSNALPLIA-LLLLLLELLLNLLLTLKALELKLNSILLN 326

Length = 394

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 46/182 (25%), Positives = 77/182 (42%), Gaps = 21/182 (11%)

Query: 734 IGIGGFGSVYR---ARLEDGV---EIAIKVFHPQCASTLK--SFEAECEVIKNIRHRNLV 785
           +G G FG VY      +  G     +AIK  +   AS  +   F  E  V+K     ++V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNE-NASMRERIEFLNEASVMKEFNCHHVV 72

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHS------SNCALNIFCRLNIM---IDIASAL 836
           +++   S      +V+E M+ G L+  L S      +N  L        +    +IA  +
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
            YL    +   +H DL   N ++ ED+   + DFGM + +   D      + L  + +MA
Sbjct: 133 AYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 897 PD 898
           P+
Sbjct: 190 PE 191

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 69.8 bits (171), Expect = 4e-12
 Identities = 31/79 (39%), Positives = 51/79 (64%)

Query: 184 GKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQN 243
           G IP+ +SK + LQ ++L  N++ G IP  +G++T L+ + L  N  +G IP+ +G L +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 244 LDVLQLGFNNLTGVVPATI 262
           L +L L  N+L+G VPA +
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 62/191 (32%), Positives = 92/191 (48%), Gaps = 22/191 (11%)

Query: 727 NFAENNIIGIGGFGSVYRA-RLEDGVEIAIKV--FHPQCASTLKSFEA-ECEV--IKNIR 780
           N+    ++G G FG VY    ++ G E+A K   F P+   T K   A ECE+  +KN++
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 781 HRNLVKIISSCSNDDFKALV--LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           H  +V+      +   K L   +EYM  GS++D L +   AL           I   + Y
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSY 121

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-----SGEDESTMRTQTLATIG 893
           LH   S  I+H D+K +N+L D      L DFG +K L     SG   + +R+ T  T  
Sbjct: 122 LH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSG---TGIRSVT-GTPY 174

Query: 894 YMAPDEIFVGE 904
           +M+P E+  GE
Sbjct: 175 WMSP-EVISGE 184

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 67.9 bits (166), Expect = 5e-12
 Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 23/183 (12%)

Query: 727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFE---AECEVIKNIRHR 782
           +F     +G G FG V  A+ +  G   AIK    +    +K  +    E  ++  + H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSS----NCALNIFCRLNIMIDIASALEY 838
            +V ++ S  +++    +LE++  G L   L  +    N     +       ++  A EY
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH-----AELVLAFEY 133

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAP 897
           LH   S  II+ DLKP N+LLD      ++DFG AK      +   RT TL  T  Y+AP
Sbjct: 134 LH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK------KVPDRTFTLCGTPEYLAP 184

Query: 898 DEI 900
           + I
Sbjct: 185 EVI 187

Length = 329

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 67.1 bits (164), Expect = 5e-12
 Identities = 47/188 (25%), Positives = 90/188 (47%), Gaps = 14/188 (7%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA----RLEDGVEIAIKVFHPQCASTLKS-FEAEC 773
           +E+ R  ++      IG G FG VY+        + + +A+K      + +++  F  E 
Sbjct: 1   YEIQR--EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEA 58

Query: 774 EVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
            +++   H ++VK+I   + ++   +V+E    G L   L  +  +L++   +     ++
Sbjct: 59  YIMRQFDHPHIVKLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLS 117

Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR-TQTLATI 892
           +AL YL    S   +H D+   NVL+       L DFG+++ L  EDES  + ++    I
Sbjct: 118 TALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPI 172

Query: 893 GYMAPDEI 900
            +MAP+ I
Sbjct: 173 KWMAPESI 180

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 67.3 bits (164), Expect = 5e-12
 Identities = 50/185 (27%), Positives = 89/185 (48%), Gaps = 26/185 (14%)

Query: 732 NIIGIGGFGSVYRARLE-DGVEI--AIKVFHPQCAST-LKSFEAECEVIKNI-RHRNLVK 786
           ++IG G FG V RA ++ DG+++  AIK+     +    + F  E EV+  +  H N++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCL---------------HSSNCALNIFCRLNIMID 831
           ++ +C N  +  + +EY   G+L D L               H +   L     L    D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           +A+ ++YL        IH DL   NVL+ E++ + ++DFG+++   GE+    +T     
Sbjct: 128 VATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181

Query: 892 IGYMA 896
           + +MA
Sbjct: 182 VRWMA 186

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 6e-12
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 60/222 (27%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVF-----HPQCASTLKSFEAECEVIKNI 779
           D+F    +IG G FG V+  R +D  ++ A+KV        +         AE +++ + 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRAERDILADA 58

Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID-------- 831
               +VK+  S  +++   LV+EYM  G L          +N+  R ++  +        
Sbjct: 59  DSPWIVKLYYSFQDEEHLYLVMEYMPGGDL----------MNLLIRKDVFPEETARFYIA 108

Query: 832 -IASALEYLH-FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK--------------- 874
            +  AL+ +H  G     IH D+KP N+L+D D    L+DFG+ K               
Sbjct: 109 ELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164

Query: 875 ---------LLSGEDESTMRTQTLATIG---YMAPDEIFVGE 904
                    L+   D    R +  +T+G   Y+AP E+  G 
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP-EVLRGT 205

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 67.1 bits (164), Expect = 6e-12
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 15/205 (7%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTL-KSFEAECEVIKNIRHRN 783
           +   E + +G G  GSV + RL++   I A+K         L K    E E+ K+ +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 784 LVKIISSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA-SALEYLH 840
           +VK   +  ++      + +EY   GSL D ++             ++  IA S L+ L 
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           + HS  IIH D+KPSN+LL       L DFG    +SGE  +++      T  YMAP+ I
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFG----VSGELVNSLAGTFTGTSFYMAPERI 175

Query: 901 FVGELSLKR--WVNDLLPVSLVEVV 923
                S+    W    L ++L+EV 
Sbjct: 176 QGKPYSITSDVWS---LGLTLLEVA 197

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 66.9 bits (163), Expect = 6e-12
 Identities = 44/180 (24%), Positives = 86/180 (47%), Gaps = 16/180 (8%)

Query: 732 NIIGIGGFGSVYRARLEDGVEIAIK--VFHPQCAST----LKSFEAECEVIKNIRHRNLV 785
            ++G G +G+VY      G  IA+K                +  + E +++K+++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNI-FCRLNIMIDIASALEYLHFGHS 844
           + + +C +D+  ++ +E++  GS+   L+         FC+    I     L+ + + H+
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI-----LDGVAYLHN 120

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS----GEDESTMRTQTLATIGYMAPDEI 900
             ++H D+K +NV+L  + +  L DFG A+ L+        S M      T  +MAP+ I
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 66.8 bits (163), Expect = 6e-12
 Identities = 51/191 (26%), Positives = 81/191 (42%), Gaps = 22/191 (11%)

Query: 732 NIIGIGGFGSVYRARLED-------GVEIAIKVFHP-QCASTLKSFEAECEVIKNIRHRN 783
           N +G G FG VY     D        + +A+K           K F  E  ++ N  H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA------LNIFCRLNIMIDIASALE 837
           +VK++  C  ++ + +++E M  G L   L  +         L +   L+I +D+A    
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 838 YLHFGHSTPIIHCDLKPSNVLLDE-----DMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           YL   H    IH DL   N L+ E     D V  + DFG+A+ +   D      + L  +
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 893 GYMAPDEIFVG 903
            +MAP+ +  G
Sbjct: 178 RWMAPESLLDG 188

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.7 bits (168), Expect = 8e-12
 Identities = 35/86 (40%), Positives = 55/86 (63%), Gaps = 1/86 (1%)

Query: 373 LGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGS 432
           LGL    L GF+P+ I  L   L+ +N++  +I GNIP ++G++++L VL L  N+ +GS
Sbjct: 423 LGLDNQGLRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 433 IPVTFGGLQKLQGLDLAFNKLAGSIP 458
           IP + G L  L+ L+L  N L+G +P
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 66.5 bits (162), Expect = 8e-12
 Identities = 46/174 (26%), Positives = 83/174 (47%), Gaps = 9/174 (5%)

Query: 733 IIGIGGFGSVYRARLE----DGVEIAIKVFHP-QCASTLKSFEAECEVIKNIRHRNLVKI 787
           +IG G FG V   RL+      + +AIK           + F +E  ++    H N++ +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
               +      +V EYM NGSL+  L   +    +   + ++  IAS ++YL        
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGY 127

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ-TLATIGYMAPDEI 900
           +H DL   N+L++ ++V  +SDFG++++L  + E+   T+     I + AP+ I
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 66.6 bits (162), Expect = 8e-12
 Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 7/166 (4%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           IG G +G VY+AR +  G   AIKV   +        + E  ++K+ +H N+V    S  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
             D   + +E+   GSL+D  H +           I       L+ L++ HS   +H D+
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKGKMHRDI 132

Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           K +N+LL ++    L+DFG++  ++       R   + T  +MAP+
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPE 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 66.4 bits (162), Expect = 9e-12
 Identities = 58/194 (29%), Positives = 93/194 (47%), Gaps = 22/194 (11%)

Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE--IAIK---VFHPQCASTL----KSFE---AECE 774
            +A    +G G FG VY+ R ++  +  +A+K   V +P          KS     +E  
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 775 VIK-NIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFC--RL-NIMI 830
           +IK  +RH N+V+   +   +D   +V++ +    L +  +S       F   R+ NI +
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            +  AL YLH      I+H DL P+N++L ED    ++DFG+AK    + ES + T  + 
Sbjct: 121 QMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKL-TSVVG 175

Query: 891 TIGYMAPDEIFVGE 904
           TI Y  P EI   E
Sbjct: 176 TILYSCP-EIVKNE 188

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 66.6 bits (162), Expect = 9e-12
 Identities = 67/288 (23%), Positives = 121/288 (42%), Gaps = 45/288 (15%)

Query: 720 ELLRATDNFAENNIIGIGGFGSVYRARL------EDGVEIAIKVFHPQCASTLKS-FEAE 772
           E+  +T  F E   +G   FG VY+  L      E    +AIK    +    L+  F+ E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCL-----HSS----------N 817
             +   ++H N+V ++   + +   +++  Y S+  L + L     HS            
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 818 CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS 877
             L     ++I+  IA+ +E+L   H   ++H DL   NVL+ + +   +SD G+ + + 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 878 GEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLV--EVVDKSL-------- 927
             D   +   +L  I +M+P+ I  G+ S+    +D+    +V  EV    L        
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSID---SDIWSYGVVLWEVFSYGLQPYCGYSN 232

Query: 928 -----LSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRL 970
                +    +     + C   +++L LEC  E P +R   KD  +RL
Sbjct: 233 QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 17/184 (9%)

Query: 727 NFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA--ECEVIKNIRHRN 783
           NF +   IG G +G VY+AR    G  +A+K       +      A  E  ++K + H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 784 LVKIISSCSNDDFKALVLEYMSNG--SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
           +VK++     ++   LV E++        D    S   L +     I   +   L+ L F
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPL-----IKSYLFQLLQGLAF 115

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT--LATIGYMAPDE 899
            HS  ++H DLKP N+L++ +    L+DFG+A+         +RT T  + T+ Y AP E
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVVTLWYRAP-E 170

Query: 900 IFVG 903
           I +G
Sbjct: 171 ILLG 174

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 49/186 (26%), Positives = 90/186 (48%), Gaps = 31/186 (16%)

Query: 733 IIGIGGFGSVYRARLE----DGVEIAIKVFHPQCASTLKS---------FEAECEVIKNI 779
           +IG G FG V R RL+      + +AIK        TLKS         F +E  ++   
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIK--------TLKSGYTEKQRRDFLSEASIMGQF 62

Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
            H N++ +    +      ++ E+M NG+L+  L  ++    +   + ++  IA+ ++YL
Sbjct: 63  DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122

Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA-----TIGY 894
                   +H DL   N+L++ ++V  +SDFG+++ L  ED+++  T T +      I +
Sbjct: 123 S---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSSLGGKIPIRW 177

Query: 895 MAPDEI 900
            AP+ I
Sbjct: 178 TAPEAI 183

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 19/172 (11%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY+AR L  G   A+K+   +        + E  ++K  +H N+V    S  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 793 NDDFKALVLEYMSNGSLEDCLHS----SNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
           + +   + +EY   GSL+D  H     S   +   CR          L+ L + HS   +
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR--------ETLQGLAYLHSKGKM 128

Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM--RTQTLATIGYMAPD 898
           H D+K +N+LL ++    L+DFG+A  ++    +T+  R   + T  +MAP+
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKIT----ATIAKRKSFIGTPYWMAPE 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.5 bits (165), Expect = 2e-11
 Identities = 24/67 (35%), Positives = 46/67 (68%)

Query: 73  HKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQ 132
             + ++NLS  +++G IPP + +++SL+ LDLS+N  + +IP S+  +++L++L L  N 
Sbjct: 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501

Query: 133 LSGSLSS 139
           LSG + +
Sbjct: 502 LSGRVPA 508

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.5 bits (165), Expect = 2e-11
 Identities = 33/88 (37%), Positives = 50/88 (56%), Gaps = 1/88 (1%)

Query: 152 LSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIP 211
           L    L G +P +I + LR+L+ + L  N   G IP SL     L+ L L YN+ +G+IP
Sbjct: 425 LDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483

Query: 212 KEIGNLTVLQRISLINNKLHGEIPQEIG 239
           + +G LT L+ ++L  N L G +P  +G
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)

Query: 734 IGIGGFGSVYRARLE-----DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKI 787
           +G G FG V   R +      G ++A+K   P+   + +   + E E+++N+ H N+VK 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 788 ISSCSNDDFKA--LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
              C+ D      L++E++ +GSL++ L  +   +N+  +L   + I   ++YL    S 
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE 881
             +H DL   NVL++ +    + DFG+ K +  + E
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 65.7 bits (161), Expect = 2e-11
 Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 43/194 (22%)

Query: 728 FAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFH--------PQCASTLKSFEAECEVIKN 778
           + E   IG G +G+VY+AR L  G  +A+K           P   STL+    E  ++K 
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPL--STLR----EIALLKQ 54

Query: 779 IR---HRNLVKIISSCSNDDFK-----ALVLEYMSNGSLEDC-LHS--SNCA---LNIFC 824
           +    H N+V+++  C            LV E++      D  L +  S C    L    
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV------DQDLATYLSKCPKPGLPPET 108

Query: 825 RLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
             ++M  +   +++LH   S  I+H DLKP N+L+  D    ++DFG+A++ S      M
Sbjct: 109 IKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS----FEM 161

Query: 885 R-TQTLATIGYMAP 897
             T  + T+ Y AP
Sbjct: 162 ALTSVVVTLWYRAP 175

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 55/194 (28%), Positives = 82/194 (42%), Gaps = 23/194 (11%)

Query: 721 LLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI 779
           L   T  F    +IG G +G VY+AR  + G  +AIK+         +  + E  +++  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKY 59

Query: 780 -RHRNLVKII------SSCSNDDFKALVLEYMSNGSLEDC---LHSSNCALNIFCRLNIM 829
             H N+          +   NDD   LV+E    GS+ D    L      L       I+
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119

Query: 830 IDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
            +    L YLH      +IH D+K  N+LL ++    L DFG++  L   D +  R  T 
Sbjct: 120 RETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRNT- 172

Query: 890 ATIG---YMAPDEI 900
             IG   +MAP+ I
Sbjct: 173 -FIGTPYWMAPEVI 185

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 55/180 (30%), Positives = 86/180 (47%), Gaps = 18/180 (10%)

Query: 733 IIGIGGFGSVYRA-RLEDGVEIAIK-VFHP--------QCASTLKSFEAECEVIKNIRHR 782
           +IG G FGSVY       G  +A+K V  P        +  S L +   E  ++K ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+V+ + S  + D   + LEY+  GS+   L++         R N +  I   L YLH  
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH-- 123

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST----MRTQTLATIGYMAPD 898
            +  IIH D+K +N+L+D      +SDFG++K L     ST     R     ++ +MAP+
Sbjct: 124 -NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 54/182 (29%), Positives = 84/182 (46%), Gaps = 24/182 (13%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFE---------AECEVIKNIRHRN 783
           IG G +G V++ R  E G  +AIK F       ++S +          E  ++K ++H N
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF-------VESEDDPVIKKIALREIRMLKQLKHPN 61

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           LV +I          LV EY  +  L + L  +   +       I   I   L+ ++F H
Sbjct: 62  LVNLIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVP---EHLIKKIIWQTLQAVNFCH 117

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG 903
               IH D+KP N+L+ +     L DFG A++L+G  +    T  +AT  Y AP E+ VG
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAP-ELLVG 174

Query: 904 EL 905
           + 
Sbjct: 175 DT 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 12/181 (6%)

Query: 727 NFAENNIIGIGGFGSVYRAR-LEDGVEIAIK---VFHPQCASTLKSFEAECEVIKNIRHR 782
           NF     IG G F  VYRA  L D   +A+K   +F    A   +    E +++K + H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNI---MIDIASALEYL 839
           N++K + S   D+   +VLE    G L   +        +     +    + + SA+E++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
           H   S  ++H D+KP+NV +    V  L D G+ +  S   ++T     + T  YM+P+ 
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPER 177

Query: 900 I 900
           I
Sbjct: 178 I 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 62/193 (32%), Positives = 95/193 (49%), Gaps = 26/193 (13%)

Query: 727 NFAENNIIGIGGFGSVYRARLED-GVEIAIKV--FHPQCASTLKSFEA-ECEV--IKNIR 780
           N+    ++G G FG VY     D G E+A+K   F P+   T K   A ECE+  +KN+ 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 781 HRNLVKIISSCSNDDFK---ALVLEYMSNGSLEDCLHSSNCAL-NIFCRLNIMIDIASAL 836
           H  +V+    C  D  +   ++ +E+M  GS++D L S      N+  +    I     L
Sbjct: 63  HERIVQYYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----L 116

Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK-----LLSGEDESTMRTQTLAT 891
           E + + HS  I+H D+K +N+L D      L DFG +K      LSG   + M++ T  T
Sbjct: 117 EGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSG---TGMKSVT-GT 172

Query: 892 IGYMAPDEIFVGE 904
             +M+P E+  GE
Sbjct: 173 PYWMSP-EVISGE 184

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 51/179 (28%), Positives = 89/179 (49%), Gaps = 11/179 (6%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G FG VY+A+  E GV  A KV   +    L+ +  E +++ +  H N+VK++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
            ++   +++E+ + G+++  +      L       I +     LE L++ H   IIH DL
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHENKIIHRDL 129

Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM--RTQTLATIGYMAPDEIFVGELSLKR 909
           K  N+L   D    L+DFG    +S ++  T+  R   + T  +MAP E+ + E S  R
Sbjct: 130 KAGNILFTLDGDIKLADFG----VSAKNTRTIQRRDSFIGTPYWMAP-EVVMCETSKDR 183

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 63/173 (36%), Positives = 85/173 (49%), Gaps = 15/173 (8%)

Query: 733 IIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFE-----AECEVI-KNIRHRNLV 785
           +IG G FG V  AR + +    A+KV   Q  + LK  E     +E  V+ KN++H  LV
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVL--QKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
            +  S    D    VL+Y++ G L   L    C L    R     +IASAL YLH   S 
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SL 115

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
            I++ DLKP N+LLD      L+DFG+ K  + E   T  T    T  Y+AP+
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTST-FCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 65.1 bits (158), Expect = 3e-11
 Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 32/236 (13%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           IG G  G+VY A  +  G E+AI+  + Q     +    E  V++  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 793 NDDFKALVLEYMSNGSLED-----CLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
             D   +V+EY++ GSL D     C+     A    CR          L+ L F HS  +
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA--AVCR--------ECLQALEFLHSNQV 137

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSL 907
           IH D+K  N+LL  D    L+DFG    ++   E + R+  + T  +MAP+ +       
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 908 KR--WVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECT--MESPEK 959
           K   W   ++ + ++E        GE  +    E  L +++ +A   T  +++PEK
Sbjct: 196 KVDIWSLGIMAIEMIE--------GEPPYL--NENPLRALYLIATNGTPELQNPEK 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.8 bits (163), Expect = 4e-11
 Identities = 33/86 (38%), Positives = 48/86 (55%)

Query: 422 LSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSI 481
           L L    L G IP     L+ LQ ++L+ N + G+IP  +  ++ L  LDL+ N  +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 482 SSCLGNLTSLQYLNLGSNRFTFVIPS 507
              LG LTSL+ LNL  N  +  +P+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPA 508

Length = 623

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 65.1 bits (158), Expect = 4e-11
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 35/252 (13%)

Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           IG G  G+VY A  +  G E+AIK  + Q     +    E  V++  ++ N+V  + S  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 793 NDDFKALVLEYMSNGSLED-----CLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
             D   +V+EY++ GSL D     C+     A    CR          L+ L F HS  +
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA--AVCR--------ECLQALDFLHSNQV 136

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSL 907
           IH D+K  N+LL  D    L+DFG    ++   E + R+  + T  +MAP+ +       
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 908 KR--WVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECT--MESPEKRIDA 963
           K   W   ++ + +VE        GE  +    E  L +++ +A   T  +++PE R+ A
Sbjct: 195 KVDIWSLGIMAIEMVE--------GEPPYL--NENPLRALYLIATNGTPELQNPE-RLSA 243

Query: 964 --KDTITRLLKI 973
             +D + R L++
Sbjct: 244 VFRDFLNRCLEM 255

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.8 bits (158), Expect = 4e-11
 Identities = 60/196 (30%), Positives = 92/196 (46%), Gaps = 25/196 (12%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARL----EDGVEIAIKVFHP----QCASTLKSFE 770
           FELLR         ++G G +G V+  R     + G   A+KV       Q A T +   
Sbjct: 2   FELLR---------VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTR 52

Query: 771 AECEVIKNIRHRN-LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM 829
            E +V++ +R    LV +  +   D    L+L+Y++ G L   L+          R+ I 
Sbjct: 53  TERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA 112

Query: 830 IDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
            +I  AL++LH      II+ D+K  N+LLD +    L+DFG++K    E+E   R  + 
Sbjct: 113 -EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE--RAYSF 166

Query: 890 -ATIGYMAPDEIFVGE 904
             TI YMAP+ I  G 
Sbjct: 167 CGTIEYMAPEVIRGGS 182

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 65.0 bits (158), Expect = 4e-11
 Identities = 50/185 (27%), Positives = 91/185 (49%), Gaps = 26/185 (14%)

Query: 732 NIIGIGGFGSVYRARL-EDGVEI--AIKVFHPQCAST-LKSFEAECEVIKNI-RHRNLVK 786
           ++IG G FG V +AR+ +DG+ +  AIK      +    + F  E EV+  +  H N++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCL---------------HSSNCALNIFCRLNIMID 831
           ++ +C +  +  L +EY  +G+L D L               +S+   L+    L+   D
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           +A  ++YL        IH DL   N+L+ E+ VA ++DFG+++   G++    +T     
Sbjct: 133 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186

Query: 892 IGYMA 896
           + +MA
Sbjct: 187 VRWMA 191

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 46/180 (25%), Positives = 87/180 (48%), Gaps = 14/180 (7%)

Query: 733 IIGIGGFGSVYRA-RLEDG----VEIAIKVFHPQCASTLKSFEAECE---VIKNIRHRNL 784
           ++G G FG+V++   + +G    + +AIK    Q  S  ++F+   +    + ++ H  +
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAMGSLDHAYI 71

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           V+++  C     + LV +    GSL D +     +L+    LN  + IA  + YL     
Sbjct: 72  VRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---E 127

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
             ++H +L   N+LL  D +  ++DFG+A LL  +D+    ++    I +MA + I  G 
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 65.0 bits (158), Expect = 5e-11
 Identities = 60/173 (34%), Positives = 81/173 (46%), Gaps = 11/173 (6%)

Query: 733 IIGIGGFGSVYRA-RLEDGVEIAIKVFHPQCA---STLKSFEAECEVI-KNIRHRNLVKI 787
           +IG G FG V  A R  DG   A+KV   +        K   AE  V+ KN++H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
             S    +    VL++++ G L   L           R     +IASAL YLH   S  I
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           ++ DLKP N+LLD      L+DFG+ K   G  +S   T    T  Y+AP+ I
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVI 168

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 64.7 bits (158), Expect = 5e-11
 Identities = 42/167 (25%), Positives = 77/167 (46%), Gaps = 14/167 (8%)

Query: 753 IAIKVFHPQCAST-LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLED 811
           +A+KV  P  +    + F  E +++  +   N+ +++  C+ D    +++EYM NG L  
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 812 CLHS-----SNCALNIF-----CRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE 861
            L       S  A N         L +   IAS + YL    S   +H DL   N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGK 165

Query: 862 DMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
           +    ++DFGM++ L   D   ++ +    I +MA + + +G+ + K
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK 212

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 64.4 bits (157), Expect = 5e-11
 Identities = 47/193 (24%), Positives = 85/193 (44%), Gaps = 28/193 (14%)

Query: 733 IIGIGGFGSVYRARL------EDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRNL 784
            +G G FG V +A         +   +A+K+         L    +E E++K I +H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI-------------- 830
           + ++  C+ +    +V+EY ++G+L D L  +      +   +                 
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLR-ARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 831 --DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +E+L    S   IH DL   NVL+ ED V  ++DFG+A+ +   D     T  
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194

Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 195 RLPVKWMAPEALF 207

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 64.7 bits (157), Expect = 5e-11
 Identities = 48/193 (24%), Positives = 90/193 (46%), Gaps = 28/193 (14%)

Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        + ++ V +A+K+         L    +E E++K I +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHS---------------SNCALNIFCRLNI 828
           ++ ++ +C+ D    +++EY S G+L + L +                +  +     ++ 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ E+ V  ++DFG+A+ ++  D     T  
Sbjct: 143 TYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 200 RLPVKWMAPEALF 212

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 50/189 (26%), Positives = 93/189 (49%), Gaps = 26/189 (13%)

Query: 732 NIIGIGGFGSVYRARLE-DGVEI--AIKVFHPQCAST-LKSFEAECEVIKNI-RHRNLVK 786
           ++IG G FG V +AR++ DG+ +  AIK      +    + F  E EV+  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCL---------------HSSNCALNIFCRLNIMID 831
           ++ +C +  +  L +EY  +G+L D L               +S+   L+    L+   D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           +A  ++YL        IH DL   N+L+ E+ VA ++DFG+++   G++    +T     
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174

Query: 892 IGYMAPDEI 900
           + +MA + +
Sbjct: 175 VRWMAIESL 183

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 64.0 bits (155), Expect = 7e-11
 Identities = 66/236 (27%), Positives = 109/236 (46%), Gaps = 32/236 (13%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           IG G  G+V+ A  +  G E+AIK  + Q     +    E  V+K +++ N+V  + S  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 793 NDDFKALVLEYMSNGSLED-----CLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
             D   +V+EY++ GSL D     C+  +  A    CR          L+ L F H+  +
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTETCMDEAQIA--AVCR--------ECLQALEFLHANQV 136

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSL 907
           IH D+K  NVLL  D    L+DFG    ++   E + R+  + T  +MAP+ +       
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 908 KR--WVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECT--MESPEK 959
           K   W   ++ + +VE        GE  +    E  L +++ +A   T  +++PEK
Sbjct: 195 KVDIWSLGIMAIEMVE--------GEPPYL--NENPLRALYLIATNGTPELQNPEK 240

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 64.5 bits (158), Expect = 7e-11
 Identities = 51/131 (38%), Positives = 73/131 (55%), Gaps = 18/131 (13%)

Query: 781 HRNLVKIIS--SCSNDDFKALVLEYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASA 835
           H N+VK+++     ND    LV EYM     E  LH+   +N   ++  R  IM  +  A
Sbjct: 66  HPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKA 119

Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS---GEDESTMRTQTLATI 892
           L+Y+H G+   +IH DLKPSN+LL+ D    L+DFG+A+ LS      E+ + T  +AT 
Sbjct: 120 LKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 893 GYMAPDEIFVG 903
            Y AP EI +G
Sbjct: 177 WYRAP-EILLG 186

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 63.9 bits (155), Expect = 1e-10
 Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 28/193 (14%)

Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        +    V +A+K+         L    +E E++K I +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHS----------SNCAL---NIFCR--LNI 828
           ++ ++ +C+ D    +++EY S G+L + L +            C L    +  +  ++ 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ ED V  ++DFG+A+ +   D     T  
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 197 RLPVKWMAPEALF 209

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 64.0 bits (156), Expect = 1e-10
 Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 12/147 (8%)

Query: 734 IGIGGFGSVYRARLEDGVEI-AIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIIS 789
           +G GG+G V+ A+ +D  EI A+K          + ++    E +++   +   LVK++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNI--MIDIASALEYLHFGHSTPI 847
           +  +D++  L +EY+  G     L++         R  +  M +   AL      H    
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL------HELGY 122

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAK 874
           IH DLKP N L+D      L+DFG++K
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSK 149

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 25/198 (12%)

Query: 723 RATDNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEA--ECEVIKNI 779
           R  D F     IG G +G VY+AR +D G  +A+K              A  E ++++ +
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 63

Query: 780 RHRNLVKIISSCSND----DFKA------LVLEYMSN---GSLEDCLHSSNCALNIFCRL 826
            HRN+V +    ++     DFK       LV EYM +   G LE  L         F   
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH-------FSED 116

Query: 827 NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
           +I   +   LE L++ H    +H D+K SN+LL+      L+DFG+A+L +  +ES   T
Sbjct: 117 HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN-SEESRPYT 175

Query: 887 QTLATIGYMAPDEIFVGE 904
             + T+ Y  P E+ +GE
Sbjct: 176 NKVITLWYRPP-ELLLGE 192

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 64.1 bits (156), Expect = 2e-10
 Identities = 36/104 (34%), Positives = 60/104 (57%), Gaps = 4/104 (3%)

Query: 63  WIGIICDVNSHK----VTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIF 118
           W G  C  +S K    +  L L +  L+G IP +I+ L  L+S++LS N +  NIP S+ 
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463

Query: 119 TMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLP 162
           ++++L+VL L  N  +GS+       +S+  + L+ N LSG++P
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 63.3 bits (154), Expect = 2e-10
 Identities = 55/178 (30%), Positives = 89/178 (50%), Gaps = 22/178 (12%)

Query: 733 IIGIGGFGSVYRARLEDGVE----IAIKVFHPQCASTLKS------FEAECEVIKNIRHR 782
           ++G GG+G V++ R   G +     A+KV   + A+ +++       +AE  +++ ++H 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVL--KKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCAL-NIFCRLNIMIDIASALEYLHF 841
            +V +I +        L+LEY+S G L   L      + +  C    + +I+ ALE+LH 
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY--LSEISLALEHLH- 117

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPD 898
                II+ DLKP N+LLD      L+DFG+ K    E      T T   TI YMAP+
Sbjct: 118 --QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT---VTHTFCGTIEYMAPE 170

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 28/201 (13%)

Query: 726 DNFAENNIIGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVI 776
           D       +G G FG V RA        R +  V +A+K+         L    +E E++
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 777 KNI-RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLH---------------SSNCAL 820
           K I +H+N++ ++  C+ +    +++EY + G+L + L                     L
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 821 NIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED 880
           +    ++    +A  +EYL    S   IH DL   NVL+ ED V  ++DFG+A+ +   D
Sbjct: 132 SFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188

Query: 881 ESTMRTQTLATIGYMAPDEIF 901
                +     + +MAP+ +F
Sbjct: 189 YYKKTSNGRLPVKWMAPEALF 209

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 6/168 (3%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+  +    +++AIK  + + A + + F  E +V+  + H  LV++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
                +V E+M NG L + L      L+    L++  D+   +EYL        IH DL 
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLA 127

Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
             N L+    V  +SDFGM + +  +DE T  +     + +  P E+F
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPP-EVF 173

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 53/178 (29%), Positives = 79/178 (44%), Gaps = 16/178 (8%)

Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRHRNLVKIIS 789
           +G GGFG V   +++  G   A K    +     K  +    E ++++ +  R +V +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI---DIASALEYLHFGHSTP 846
           +    D   LV+  M+ G L+   H  N     F     +     I   LE+LH      
Sbjct: 61  AFETKDDLCLVMTLMNGGDLK--YHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRR 115

Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
           I++ DLKP NVLLD+     +SD G+A  L G  +   R     T GYMAP E+  GE
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAP-EVLQGE 169

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 64.5 bits (157), Expect = 2e-10
 Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 16/165 (9%)

Query: 748 EDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRHRNLVKIISS-CSNDDFKALVLEY 803
             G E+AIK+     P+       F  E  +   + H N+V ++ S  +       V EY
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL---D 860
           +   +L + L +++ AL       +M+ +  AL      H+  I+H DLKP N+++    
Sbjct: 61  VPGRTLREVL-AADGALPAGETGRLMLQVLDALAC---AHNQGIVHRDLKPQNIMVSQTG 116

Query: 861 EDMVAHLSDFGMAKLLSGEDES-----TMRTQTLATIGYMAPDEI 900
               A + DFG+  LL G  ++     T  T+ L T  Y AP+++
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 62.2 bits (152), Expect = 3e-10
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 28/195 (14%)

Query: 723 RATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFEA---------- 771
           R+ D + + N I  G +G VYRAR +   EI A+K         LK  +           
Sbjct: 2   RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--------KLKMEKEKEGFPITSLR 53

Query: 772 ECEVIKNIRHRNLVKI--ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM 829
           E  ++  ++H N+V +  +   SN D   +V+EY+ +  L+  + +            +M
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112

Query: 830 IDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
           + + S + +LH      I+H DLK SN+LL+   +  + DFG+A+   G       TQ +
Sbjct: 113 LQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPY-TQLV 167

Query: 890 ATIGYMAPDEIFVGE 904
            T+ Y AP E+ +G 
Sbjct: 168 VTLWYRAP-ELLLGA 181

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 3e-10
 Identities = 45/161 (27%), Positives = 66/161 (40%), Gaps = 14/161 (8%)

Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCAST---LKSFEAECEVIKNIRHRNLVKIIS 789
           +G G  G V+  RL+  G   A+KV   +       +K    E E++  + H  L  + +
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS---ALEYLH-FGHST 845
           S   + +  LV++Y   G L   L                   A    ALEYLH  G   
Sbjct: 69  SFQTETYLCLVMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG--- 123

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
            I++ DLKP N+LL E     LSDF ++K    E     + 
Sbjct: 124 -IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 62.4 bits (152), Expect = 3e-10
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 27/193 (13%)

Query: 722 LRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFH--------PQCASTLKSFEAE 772
            R+   F + N IG G +G VYRAR     EI A+K           P   S+L+    E
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIP--ISSLR----E 56

Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKA--LVLEYMSN--GSLEDCLHSSNCALNIFCRLNI 828
             ++ N+RH N+V++          +  LV+EY      SL D + +      + C   +
Sbjct: 57  ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC---L 113

Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
           M+ +   L+YLH      IIH DLK SN+LL +     ++DFG+A+      +    T  
Sbjct: 114 MLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPK 168

Query: 889 LATIGYMAPDEIF 901
           + T+ Y AP+ + 
Sbjct: 169 VVTLWYRAPELLL 181

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.3 bits (154), Expect = 4e-10
 Identities = 30/83 (36%), Positives = 59/83 (71%), Gaps = 2/83 (2%)

Query: 359 GFL-SSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLS 417
           GF+ + ++  + L+ + L GN + G +P S+G+++ SLE L++++ + +G+IP+++G L+
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSIT-SLEVLDLSYNSFNGSIPESLGQLT 490

Query: 418 NLIVLSLGGNNLSGSIPVTFGGL 440
           +L +L+L GN+LSG +P   GG 
Sbjct: 491 SLRILNLNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 61.9 bits (150), Expect = 4e-10
 Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 33/205 (16%)

Query: 727 NFAENNIIGIGGFGSVYRAR------LEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI 779
           N      +G G FG V +A             +A+K+     +S+ L+   +E  ++K +
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNC--------------------- 818
            H +++K+  +CS D    L++EY   GSL   L  S                       
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 819 --ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL 876
             AL +   ++    I+  ++YL       ++H DL   NVL+ E     +SDFG+++ +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 877 SGEDESTMRTQTLATIGYMAPDEIF 901
             ED    R++    + +MA + +F
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLF 202

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 4e-10
 Identities = 51/202 (25%), Positives = 89/202 (44%), Gaps = 40/202 (19%)

Query: 728 FAENNIIGIGGFGSVYRARL---EDGVEIAIKVFHPQC-------ASTLKSFEAECEVIK 777
           +     IG G +G VY+A+    +DG E AIK F            S  +    E  +++
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR----EIALLR 57

Query: 778 NIRHRNLVKIISSCSNDDFKA--LVLEYMSNGSLEDC-LHSSNCALNIFCRL--NIMIDI 832
            ++H N+V ++        K+  L+ +Y  +   +    H     ++I   +  +++  I
Sbjct: 58  ELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117

Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLL----DEDMVAHLSDFGMA-------KLLSGEDE 881
            + + YLH   S  ++H DLKP+N+L+     E  V  + D G+A       K L+  D 
Sbjct: 118 LNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD- 173

Query: 882 STMRTQTLATIGYMAPDEIFVG 903
                  + TI Y AP E+ +G
Sbjct: 174 -----PVVVTIWYRAP-ELLLG 189

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 60.9 bits (148), Expect = 5e-10
 Identities = 45/171 (26%), Positives = 81/171 (47%), Gaps = 11/171 (6%)

Query: 733 IIGIGGFGS--VYRARLEDGVEIAIKVFHPQCASTLKSFEA--ECEVIKNIRHRNLVKII 788
           ++G G FG   +YR R ED   +  K  +    S  +  +A  E  ++  ++H N++   
Sbjct: 7   VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 789 SSCSNDDFKALVLEYMSNGSLEDCL-HSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
           +   +D+   + +EY + G+L D +             L  +  I SA+ Y+H      I
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGI 122

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           +H D+K  N+ L +  +  L DFG++K+L    E +M    + T  YM+P+
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILG--SEYSMAETVVGTPYYMSPE 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.9 bits (153), Expect = 6e-10
 Identities = 30/93 (32%), Positives = 55/93 (59%), Gaps = 1/93 (1%)

Query: 219 VLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSL 278
            +  + L N  L G IP +I  L++L  + L  N++ G +P ++ ++++L+ + L  NS 
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 279 SGSLPSRIDLALPNLEFLNLGINSFSGTIPSSI 311
           +GS+P  +   L +L  LNL  NS SG +P+++
Sbjct: 479 NGSIPESLGQ-LTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 60.9 bits (148), Expect = 6e-10
 Identities = 45/177 (25%), Positives = 84/177 (47%), Gaps = 14/177 (7%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRH---RNLVKI 787
           +IG G +G+VYR + +  G  +A+K+ +       +   + E  ++  +R     N+ K 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
             S        +++EY   GS+   L  +      +  + I+ ++  AL+Y+H      +
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVR-TLMKAGPIAEKYISV-IIREVLVALKYIH---KVGV 122

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY-MAPDEIFVG 903
           IH D+K +N+L+       L DFG+A LL+   +++ +  T     Y MAP+ I  G
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLN---QNSSKRSTFVGTPYWMAPEVITEG 176

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 11/174 (6%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIIS 789
           ++G G +G V   R   DG +  IK  + + AS    K+ E E +++  ++H N+V    
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 790 SCSNDD-FKALVLEYMSNGSLEDCLHSSNCALNIFCR-LNIMIDIASALEYLHFGHSTPI 847
           S   +D    +V+ +   G L   L      L    + +   + IA AL+YLH  H   I
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---I 123

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
           +H DLK  NV L    +  + D G+A++L  E++  M +  + T  YM+P E+F
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSP-ELF 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.2 bits (148), Expect = 7e-10
 Identities = 80/275 (29%), Positives = 120/275 (43%), Gaps = 38/275 (13%)

Query: 727 NFAENNIIGIGGFGSVYRARL----EDGVEIAIKVFHP----QCASTLKSFEAECEVIKN 778
           NF    ++G G +G V+  R     + G   A+KV       Q A T +    E +V+++
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 779 IRHRN-LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI---DIAS 834
           IR    LV +  +   D    L+L+Y++ G L   L         F    + I   +I  
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVL 116

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           ALE+LH      II+ D+K  N+LLD +    L+DFG++K    EDE         TI Y
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEY 172

Query: 895 MAPDEIFVGEL----SLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
           MAPD +  G+     ++  W   +L   L+       + GE+   A   + +L       
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK------ 226

Query: 951 ECTMESP---EKRIDAKDTITRLLKIRDTLSKRIG 982
               E P   E    AKD I RLL ++D   KR+G
Sbjct: 227 ---SEPPYPQEMSALAKDIIQRLL-MKDP-KKRLG 256

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.5 bits (152), Expect = 8e-10
 Identities = 28/89 (31%), Positives = 51/89 (57%)

Query: 494 LNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNI 553
           L L +      IP+    L+ + S ++S N + G I  ++G++ ++  +DLS N+ +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 554 PTTLEGLKSLQNISLAYNRLEGPIPESFG 582
           P +L  L SL+ ++L  N L G +P + G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 61.2 bits (148), Expect = 8e-10
 Identities = 49/193 (25%), Positives = 87/193 (45%), Gaps = 28/193 (14%)

Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        +     ++A+K+         L    +E E++K I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR---------------LNI 828
           ++ ++ +C+ D    +++EY S G+L + L +       +C                ++ 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ ED V  ++DFG+A+ +   D     T  
Sbjct: 146 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 203 RLPVKWMAPEALF 215

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 60.2 bits (146), Expect = 9e-10
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 13/178 (7%)

Query: 727 NFAENNIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFEA--ECEVIKNIRHRN 783
           +F     +G G +GSVY+  RL D    A+K       S  +  +A  E  ++ ++ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR---LNIMIDIASALEYLH 840
           ++    +  + +   +V+EY   G L   +        +        I I +   L+ LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
                 I+H DLK +N+LL  + +  + D G++K+L     +  +TQ   T  YMAP+
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK---NMAKTQI-GTPHYMAPE 171

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.1 bits (151), Expect = 1e-09
 Identities = 34/90 (37%), Positives = 55/90 (61%), Gaps = 3/90 (3%)

Query: 249 LGFNN--LTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGT 306
           LG +N  L G +P  I  +  L+ I L  NS+ G++P  +  ++ +LE L+L  NSF+G+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG-SITSLEVLDLSYNSFNGS 481

Query: 307 IPSSITNASKLILLEMGSNSFSGFIPSAIG 336
           IP S+   + L +L +  NS SG +P+A+G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 48/163 (29%), Positives = 84/163 (51%), Gaps = 19/163 (11%)

Query: 734 IGIGGFGSVYRARL--EDGV-EIAIKVFHPQ-CA-STLKSFEAECEVIKNIRHRNLVKII 788
           +G G FGSV   +L  +D + ++A+K      C  S ++ F +E   +K   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 789 SSC----SNDDFKA--LVLEYMSNGSLEDCLHSS---NCALNIFCRL--NIMIDIASALE 837
             C     ++ + +  ++L +M +G L   L  S   +C   +  ++    M DIAS +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED 880
           YL    S   IH DL   N +L+E+M   ++DFG++K +   D
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 54/198 (27%), Positives = 84/198 (42%), Gaps = 23/198 (11%)

Query: 724 ATDNFAENNIIGIGGFGSVY----RARLEDGVE--IAIKVFHPQCASTLKS-FEAECEVI 776
             D+      +G G FG VY    R R  D VE  +A+K     C+   +S F  E  ++
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63

Query: 777 KNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSN------CALNIFCRLNIMI 830
               H+N+V++I        + ++LE M+ G L+  L  +        +L +   L    
Sbjct: 64  SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123

Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLSGEDESTMRTQ 887
           D+A   +YL   H    IH D+   N LL       VA ++DFGMA+ +          +
Sbjct: 124 DVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180

Query: 888 TLATIGYMAP----DEIF 901
            +  I +M P    D IF
Sbjct: 181 AMLPIKWMPPEAFLDGIF 198

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.0 bits (148), Expect = 2e-09
 Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 11/117 (9%)

Query: 296 LNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSST 355
           L L      G IP+ I+    L  + +  NS  G IP ++G++ +L++ D+ +N+   S 
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 356 PE-LGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNI----AFCNISG 407
           PE LG L+S      LR L L GN L G +P+++G   L     N       C I G
Sbjct: 483 PESLGQLTS------LRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.0 bits (148), Expect = 2e-09
 Identities = 33/90 (36%), Positives = 50/90 (55%)

Query: 445 GLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFV 504
           GL L    L G IP++I  L  L  ++L+GN I G+I   LG++TSL+ L+L  N F   
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 505 IPSTFWNLKDILSFDISSNLLDGPISLAIG 534
           IP +   L  +   +++ N L G +  A+G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 60.4 bits (147), Expect = 2e-09
 Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 32/183 (17%)

Query: 734 IGIGGFGSVYRARL-EDGVEIAIKVF-HP-QCASTLKSFEAECEVIKNIRHRNLVKIIS- 789
           +G G +G V  A   + G ++AIK    P Q A   K    E  ++K++ H N++ ++  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 790 ---SCSNDDFKA--LVLEYMSNGSLEDCLHSSNCALNIFCRLN------IMIDIASALEY 838
              + S +DF+   LV   M    L + +           +L+      ++  I   L+Y
Sbjct: 83  FTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ--------KLSDDHIQFLVYQILRGLKY 133

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           +H   S  IIH DLKPSN+ ++ED    + DFG+A+    E    M T  +AT  Y AP+
Sbjct: 134 IH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----M-TGYVATRWYRAPE 185

Query: 899 EIF 901
            + 
Sbjct: 186 IML 188

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 33/196 (16%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVE----IAIKVFHP----QCASTLKSFE 770
           FELL+         ++G G +G V+  R   G +     A+KV       Q A T++   
Sbjct: 2   FELLK---------VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR 52

Query: 771 AECEVIKNIRHRN-LVKIISSCSNDDFKALVLEYMSNGSLEDCL----HSSNCALNIFCR 825
            E  V++++R    LV +  +   +    L+L+Y+S G +   L    + S   +  +  
Sbjct: 53  TERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG 112

Query: 826 LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK-LLSGEDESTM 884
                +I  ALE+LH      I++ D+K  N+LLD +    L+DFG++K  LS E E T 
Sbjct: 113 -----EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY 164

Query: 885 RTQTLATIGYMAPDEI 900
                 TI YMAP+ I
Sbjct: 165 --SFCGTIEYMAPEII 178

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 55/183 (30%), Positives = 84/183 (45%), Gaps = 19/183 (10%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKII-- 788
           ++G G +G VY+ R ++ G   AIKV         +  + E  ++K    HRN+      
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 789 ----SSCSNDDFKALVLEYMSNGSLEDCLHSS--NCALNIFCRLNIMIDIASALEYLHFG 842
               S   +DD   LV+E+   GS+ D + ++  N  L       I  +I   L +LH  
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICREILRGLAHLHAH 140

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT-LATIGYMAPDEIF 901
               +IH D+K  NVLL E+    L DFG++  L   D +  R  T + T  +MAP+ I 
Sbjct: 141 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIA 194

Query: 902 VGE 904
             E
Sbjct: 195 CDE 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 57/175 (32%), Positives = 82/175 (46%), Gaps = 20/175 (11%)

Query: 733 IIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-------ASTLKSFEAECEVIKNIRHRNL 784
           ++G G FG V   R +  G   A+K+   +        A TL     E  V+KN RH  L
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTL----TESRVLKNTRHPFL 57

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
             +  S    D    V+EY++ G L   L           R     +I SAL+YLH G  
Sbjct: 58  TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSGK- 115

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG-EDESTMRTQTLATIGYMAPD 898
             I++ DLK  N++LD+D    ++DFG+ K   G  D +TM+T    T  Y+AP+
Sbjct: 116 --IVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKT-FCGTPEYLAPE 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 22/176 (12%)

Query: 733 IIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-------ASTLKSFEAECEVIKNIRHRNL 784
           ++G G FG V   R +  G   A+K+   +        A T+     E  V++N RH  L
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----TESRVLQNTRHPFL 57

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM-IDIASALEYLHFGH 843
             +  +    D    V+EY + G L    H S   +    R      +I SALEYLH   
Sbjct: 58  TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH--- 112

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG-EDESTMRTQTLATIGYMAPD 898
           S  +++ D+K  N++LD+D    ++DFG+ K   G  D +TM+T    T  Y+AP+
Sbjct: 113 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKT-FCGTPEYLAPE 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 59.3 bits (144), Expect = 3e-09
 Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 18/186 (9%)

Query: 732 NIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFEA--ECEVIKNIRHRNLVKII 788
             IG G FG V++AR +   +I A+K    +         A  E ++++ ++H N+V +I
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 789 SSCSN-----DDFKA---LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
             C       + +K    LV E+  +  L   L + N    +     +M  + + L Y+ 
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYI- 135

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK--LLSGEDESTMRTQTLATIGYMAPD 898
             H   I+H D+K +N+L+ +D +  L+DFG+A+   LS   +    T  + T+ Y  P 
Sbjct: 136 --HRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP- 192

Query: 899 EIFVGE 904
           E+ +GE
Sbjct: 193 ELLLGE 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 59.1 bits (143), Expect = 4e-09
 Identities = 54/176 (30%), Positives = 84/176 (47%), Gaps = 24/176 (13%)

Query: 734 IGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFE---AECEVIKNIRHRNLVKIIS 789
           IG G FG+VY AR     E+ AIK        + + ++    E   ++ +RH N ++   
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY-K 81

Query: 790 SCSNDDFKA-LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS----ALEYLHFGHS 844
            C   +  A LV+EY        CL S++  L +  +    ++IA+    AL+ L + HS
Sbjct: 82  GCYLREHTAWLVMEY--------CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
              IH D+K  N+LL E     L+DFG A L+S  +        + T  +MAP+ I
Sbjct: 134 HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN------SFVGTPYWMAPEVI 183

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 58.6 bits (142), Expect = 4e-09
 Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 13/132 (9%)

Query: 772 ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNC---ALNIFCRLNI 828
           E  ++++ +H N+V++ SS    D   +V+E++  G+L D +  +      +   C    
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCL--- 122

Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +  AL +LH   +  +IH D+K  ++LL  D    LSDFG    +S   E   R   
Sbjct: 123 --AVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS--KEVPRRKSL 175

Query: 889 LATIGYMAPDEI 900
           + T  +MAP+ I
Sbjct: 176 VGTPYWMAPEVI 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 42/155 (27%), Positives = 78/155 (50%), Gaps = 10/155 (6%)

Query: 733 IIGIGGFGSVYRA-RLEDG----VEIAIKVFHPQCASTLK-SFEAECEVIKNIRHRNLVK 786
           ++G G FG+VY+   + +G    + +AIK+ +          F  E  ++ ++ H +LV+
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
           ++  C +   + LV + M +G L D +H     +     LN  + IA  + YL       
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129

Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE 881
           ++H DL   NVL+       ++DFG+A+LL G+++
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 58.5 bits (141), Expect = 5e-09
 Identities = 39/127 (30%), Positives = 65/127 (51%), Gaps = 6/127 (4%)

Query: 772 ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID 831
           E  ++KN++H N+V +      +    LV EY+ +  L+  L   NC  N+    N+ I 
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYL--DNCG-NLMSMHNVKIF 108

Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           +   L  L + H   I+H DLKP N+L++E     L+DFG+A+  S   ++   +  + T
Sbjct: 109 MFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY--SNEVVT 166

Query: 892 IGYMAPD 898
           + Y  PD
Sbjct: 167 LWYRPPD 173

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 58.7 bits (142), Expect = 5e-09
 Identities = 43/185 (23%), Positives = 86/185 (46%), Gaps = 12/185 (6%)

Query: 726 DNFAENNIIGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLK-SFEAECEVIKN 778
           +N +    +G G FG V  A      + +  +++A+K+  P   S+ + +  +E +++ +
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 779 I-RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHS-SNCALNIFCRLNIMIDIASAL 836
           +  H N+V ++ +C+      ++ EY   G L + L       L +   L+    +A  +
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154

Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
            +L    S   IH DL   NVLL    +  + DFG+A+ +  +    ++      + +MA
Sbjct: 155 AFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211

Query: 897 PDEIF 901
           P+ IF
Sbjct: 212 PESIF 216

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 57.9 bits (141), Expect = 5e-09
 Identities = 51/156 (32%), Positives = 71/156 (45%), Gaps = 30/156 (19%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAEC----EVIKNIR----HRNL 784
           +G G FGSVY AR  E G  +AIK           S+E EC    EV K++R    H N+
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWE-ECMNLREV-KSLRKLNEHPNI 60

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCAL--NIFCRLNIMIDIASALEYLH-- 840
           VK+      +D    V EYM  G+L   +             R +I+  I   L ++H  
Sbjct: 61  VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR-SIIYQILQGLAHIHKH 118

Query: 841 --FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK 874
             F       H DLKP N+L+    V  ++DFG+A+
Sbjct: 119 GFF-------HRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 6e-09
 Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 37/188 (19%)

Query: 732 NIIGIGGFGSVYRA-RLEDGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLV 785
           + IG G +G V  A     GV++AIK   P      C  TL+    E ++++  +H N++
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENII 66

Query: 786 KI---ISSCSNDDFKA--LVLEYMSNGSLEDCLHS-------SNCALNIFCRLNIMIDIA 833
            I   I   S + F    +V E M     E  L+        SN  +  F     +  I 
Sbjct: 67  GILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIKTQHLSNDHIQYF-----LYQIL 116

Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL-LSGEDESTMRTQTLATI 892
             L+Y+H   S  ++H DLKPSN+LL+ +    + DFG+A++     D +   T+ +AT 
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 893 GYMAPDEI 900
            Y AP EI
Sbjct: 174 WYRAP-EI 180

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 57.5 bits (139), Expect = 7e-09
 Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 15/172 (8%)

Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHPQ---CASTLKSFEAECEVIKNIRHR-NLVKII 788
           I  G FGSVY A+    G   AIKV         + + + +AE  ++        + K+ 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
            S  + D+  LV+EY++ G     + +       + +   + ++   +E LH      II
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH---QRGII 119

Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H D+KP N+L+D+     L+DFG+++   G        + + T  Y+AP+ I
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN--GL----ENKKFVGTPDYLAPETI 165

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 57.8 bits (140), Expect = 7e-09
 Identities = 28/73 (38%), Positives = 40/73 (54%), Gaps = 5/73 (6%)

Query: 828 IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ 887
           + + I  AL YL   H   +IH D+KPSN+LLD      L DFG++  L    +S  +T+
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTR 173

Query: 888 TLATIGYMAPDEI 900
           +     YMAP+ I
Sbjct: 174 SAGCAAYMAPERI 186

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 57.9 bits (140), Expect = 8e-09
 Identities = 55/178 (30%), Positives = 81/178 (45%), Gaps = 26/178 (14%)

Query: 733 IIGIGGFGSVYRARLEDGVEI-AIKVFHP-------QCASTLKSFEAECEVIKNIRHRNL 784
           ++G G FG V   R +   +  A+K+          + A TL     E  V++N RH  L
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTL----TESRVLQNTRHPFL 57

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM-IDIASALEYLHFGH 843
             +  S    D    V+EY + G L    H S   +    R      +I SAL YLH   
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYLH--- 112

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES---TMRTQTLATIGYMAPD 898
           S  +++ DLK  N++LD+D    ++DFG+ K    E  S   TM+T    T  Y+AP+
Sbjct: 113 SCDVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKT-FCGTPEYLAPE 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 98/345 (28%), Positives = 144/345 (41%), Gaps = 26/345 (7%)

Query: 78  LNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSL 137
            +  S N    +       ++ +S++L  N   SN+ S       L +       L  SL
Sbjct: 9   KSALSSNTLREVLSSNTYHTTPQSINL--NFPDSNLESVAVNRLALNLSSNTLLLLPSSL 66

Query: 138 SSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMF-YGKIPSSLSKCKQL 196
           S              S         +   N L  L    L  N+       S L +   L
Sbjct: 67  SRLLSLDLLSPSGISS--------LDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNL 118

Query: 197 QELHLGYNNLSGAIPKEIGNLTV-LQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLT 255
             L L  NN++  IP  IG L   L+ + L +NK+   +P  +  L NL  L L FN+L+
Sbjct: 119 TSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS 176

Query: 256 GVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNAS 315
             +P  + N+S L  + L  N +S  LP  I+L L  LE L+L  NS    + SS++N  
Sbjct: 177 -DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIEL-LSALEELDLSNNSII-ELLSSLSNLK 232

Query: 316 KLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGL 375
            L  LE+ +N     +P +IGNL NL+  D+  N ++S       +SSL +   LR L L
Sbjct: 233 NLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS-------ISSLGSLTNLRELDL 284

Query: 376 GGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLI 420
            GN L   LP     L L    LN+     +  +      L+N I
Sbjct: 285 SGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNI 329

Length = 394

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 57.6 bits (139), Expect = 1e-08
 Identities = 42/173 (24%), Positives = 85/173 (49%), Gaps = 22/173 (12%)

Query: 753 IAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLED 811
           +A+K+  P      ++ F  E +++  ++  N+++++  C ++D   ++ EYM NG L  
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 812 CLHS----------------SNCALNIFCR--LNIMIDIASALEYLHFGHSTPIIHCDLK 853
            L S                ++C   I     L++ + IAS ++YL    S   +H DL 
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLA 165

Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELS 906
             N L+ E++   ++DFGM++ L   D   ++ + +  I +MA + I +G+ +
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT 218

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 57.4 bits (138), Expect = 1e-08
 Identities = 51/182 (28%), Positives = 85/182 (46%), Gaps = 22/182 (12%)

Query: 728 FAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFH---PQCASTLKSFEAECEVIKNIRHRN 783
           F++   IG G FG+VY AR + +   +AIK       Q     +    E   ++ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS----ALEYL 839
            ++       +    LV+EY        CL S++  L +  +    ++IA+    AL+ L
Sbjct: 77  TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+K  N+LL E  +  L DFG A +++  +        + T  +MAP+ 
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEV 182

Query: 900 IF 901
           I 
Sbjct: 183 IL 184

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 21/185 (11%)

Query: 733 IIGIGGFGSVYRARLE----DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKI 787
           I+G G FG + R  L+      + +AI      C     + F AE   +    H N+V++
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL-HFGHSTP 846
               +  +   +V EYMSNG+L+  L      L     + ++  +AS ++YL   G+   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128

Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-----STMRTQTLATIGYMAPDEIF 901
            +H  L    VL++ D+V  +S F   +    ED+     +TM  ++     + AP+ I 
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVL--WAAPEAIQ 181

Query: 902 VGELS 906
               S
Sbjct: 182 YHHFS 186

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 57.7 bits (139), Expect = 2e-08
 Identities = 77/275 (28%), Positives = 127/275 (46%), Gaps = 9/275 (3%)

Query: 45  DPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDL 104
             + LL  +  S  S  S +    ++ +         + N   +   E+  L++L SLDL
Sbjct: 65  SLSRLLSLDLLSP-SGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDL 123

Query: 105 SHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPEN 164
            +N ++   P      S LK L L DN++  SL S   N  ++ ++ LS N LS  LP+ 
Sbjct: 124 DNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKL 181

Query: 165 ICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRIS 224
           + N    L +L L  N     +P  +     L+EL L  N++   +   + NL  L  + 
Sbjct: 182 LSNLSN-LNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLE 238

Query: 225 LINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPS 284
           L NNKL  ++P+ IG L NL+ L L  N ++ +    + +++ L+E+ L  NSLS +LP 
Sbjct: 239 LSNNKL-EDLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL 295

Query: 285 RIDLALPNLEFLNLGINSFSGTIPSSITNASKLIL 319
              L L     LNL +   +  +  +    +  IL
Sbjct: 296 IALLLLLLELLLNLLLTLKALELKLNSILLNNNIL 330

Length = 394

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 51/176 (28%), Positives = 82/176 (46%), Gaps = 11/176 (6%)

Query: 728 FAENNIIGIGGFGSVYRARLEDGVE--IAIKVFH-PQCASTLKSFEAECEVIKNIRHRNL 784
           F +   IG G FG V++  +++  +  +AIK+    +    ++  + E  V+       +
Sbjct: 6   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            K   S   D    +++EY+  GS  D L      L+      I+ +I   L+YLH   S
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---S 119

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
              IH D+K +NVLL E     L+DFG+A  L+  D    R   + T  +MAP+ I
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 173

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 52/172 (30%), Positives = 80/172 (46%), Gaps = 18/172 (10%)

Query: 734 IGIGGFGSVYRARLEDG--VEIAIKVFHPQCASTLKSFE---AECEVIKNIRHRNLVKII 788
           +G G FG V  A  ++     +AIK F        K  +   +E +++  I H   V + 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALN-IFCRLNIMIDIASALEYLHFGHSTPI 847
            S  ++ +  LVLE++  G     L  +    N + C     I +    EYL    S  I
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI--FEYLQ---SLNI 152

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPD 898
           ++ DLKP N+LLD+D    ++DFG AK++        RT TL  T  Y+AP+
Sbjct: 153 VYRDLKPENLLLDKDGFIKMTDFGFAKVVD------TRTYTLCGTPEYIAPE 198

Length = 340

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 45/186 (24%), Positives = 85/186 (45%), Gaps = 11/186 (5%)

Query: 721 LLRATDNFAENNIIGIGGFGSVYRAR-LEDG----VEIAIKVFHPQCASTL-KSFEAECE 774
           +L+ T+ F +  ++G G FG+VY+   + +G    + +AIK      +    K    E  
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  + IA 
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY 894
            + YL       ++H DL   NVL+       ++DFG+AKLL  +++          I +
Sbjct: 121 GMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177

Query: 895 MAPDEI 900
           MA + I
Sbjct: 178 MALESI 183

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 11/176 (6%)

Query: 728 FAENNIIGIGGFGSVYRARLEDGVE--IAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNL 784
           F +   IG G FG V++  +++  +  +AIK+   + A   ++  + E  V+       +
Sbjct: 6   FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            K   S        +++EY+  GS  D L +     + F    ++ +I   L+YLH   S
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---S 119

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
              IH D+K +NVLL E     L+DFG+A  L+  D    R   + T  +MAP+ I
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 173

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 56.1 bits (135), Expect = 3e-08
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 17/181 (9%)

Query: 728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRHRN 783
           F +  ++G GGFG V   ++   G   A K    +     K       E ++++ +  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI---DIASALEYLH 840
           +V +  +    D   LVL  M+ G L+   H  N     F     +    +I   LE LH
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFEEERALFYAAEILCGLEDLH 119

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDESTMRTQTLATIGYMAPDE 899
                  ++ DLKP N+LLD+     +SD G+A K+  GE   ++R + + T+GYMAP+ 
Sbjct: 120 ---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGR-VGTVGYMAPEV 172

Query: 900 I 900
           +
Sbjct: 173 L 173

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 59/236 (25%), Positives = 108/236 (45%), Gaps = 15/236 (6%)

Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL-KSFEAECEVIKNIRHRNLVKIISSC 791
           +G G  GSV +   +  G  +A KV H    S++ K    E +++   R   +V    + 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            N++   + +E+M  GSL D ++     + +     I + +   L YL+  H   I+H D
Sbjct: 73  LNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRD 129

Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-- 909
           +KPSN+L++      L DFG    +SGE  +++    + T  YM+P+ I  G+ ++K   
Sbjct: 130 IKPSNILVNSRGQIKLCDFG----VSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDV 185

Query: 910 WVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKD 965
           W    L +S++E+                +   + I  L L+  ++ P  R+ + D
Sbjct: 186 WS---LGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-LQQIVQEPPPRLPSSD 237

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 46/181 (25%), Positives = 84/181 (46%), Gaps = 11/181 (6%)

Query: 734 IGIGGFGSV----YRARLEDGVEIAIKVFHPQCASTLK-SFEAECEVIKNIRHRNLVKII 788
           +G G FG V    Y+ R +  +++AIKV   +   +++     E E++  + +  +V++I
Sbjct: 3   LGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
             C  +    LV+E  S G L   L      + +   + +M  ++  ++YL        +
Sbjct: 62  GVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117

Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPDEIFVGELSL 907
           H DL   NVLL     A +SDFG++K L  +D     R+     + + AP+ I   + S 
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 908 K 908
           +
Sbjct: 178 R 178

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 52/175 (29%), Positives = 78/175 (44%), Gaps = 9/175 (5%)

Query: 728 FAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLV 785
           F +   IG G FG VY+       E+ AIK+   + A   ++  + E  V+       + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
           +   S        +++EY+  GS  D L      L       I+ +I   L+YLH   S 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SE 120

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
             IH D+K +NVLL E     L+DFG+A  L+  D    R   + T  +MAP+ I
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 173

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 55.7 bits (134), Expect = 4e-08
 Identities = 34/149 (22%), Positives = 72/149 (48%), Gaps = 13/149 (8%)

Query: 769 FEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSL---------EDCLHSSNCA 819
           F  E +++  ++  N++++++ C   D   ++ EYM NG L         ++    ++  
Sbjct: 66  FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125

Query: 820 LNIFCRLNIM-IDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG 878
              +  L  M   IAS ++YL    S   +H DL   N L+ ++    ++DFGM++ L  
Sbjct: 126 TISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Query: 879 EDESTMRTQTLATIGYMAPDEIFVGELSL 907
            D   ++ + +  I +M+ + I +G+ + 
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTT 211

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 4e-08
 Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 37/187 (19%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECE-----------VIKNIRH 781
           IG G +G VY+AR    G  +A+K             E E E           ++K + H
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIR---------LETEDEGVPSTAIREISLLKELNH 57

Query: 782 RNLVKIISSCSNDDFKALVLEYMS---NGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
            N+V+++    +++   LV E++       ++    +      I   L  +      L+ 
Sbjct: 58  PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQL------LQG 111

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT--LATIGYMA 896
           + + HS  ++H DLKP N+L+D +    L+DFG+A+         +RT T  + T+ Y A
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFG----VPVRTYTHEVVTLWYRA 167

Query: 897 PDEIFVG 903
           P EI +G
Sbjct: 168 P-EILLG 173

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 55.9 bits (135), Expect = 4e-08
 Identities = 52/185 (28%), Positives = 83/185 (44%), Gaps = 31/185 (16%)

Query: 734 IGIGGFGSVYRARLED-GVEIAIK-VFHPQCASTLKSFEAECEVIKNIRHRNLVKII--- 788
           +G G  G V+ A   D    +A+K +      S +K    E ++I+ + H N+VK+    
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS-VKHALREIKIIRRLDHDNIVKVYEVL 71

Query: 789 ---SSCSNDDFKAL--------VLEYMSNG---SLEDCLHSSNCALNIFCRLNIMIDIAS 834
               S   +D  +L        V EYM       LE    S   A     RL  M  +  
Sbjct: 72  GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA-----RL-FMYQLLR 125

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHLSDFGMAKLLSGE-DESTMRTQTLATI 892
            L+Y+H   S  ++H DLKP+NV ++ ED+V  + DFG+A+++          ++ L T 
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 893 GYMAP 897
            Y +P
Sbjct: 183 WYRSP 187

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 11/173 (6%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCAST----LKSFEAECEVIKNIRHRNLVKIIS 789
           IG G FG V    +  G   A  V      S        F  E +  ++++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM----IDIASALEYLHFGHST 845
            C+      LV+E+   G L+  L S   A  +      +     +IA  L +LH     
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IH DL   N LL  D+   + D+G++     ED      Q    + ++AP+
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 50.2 bits (121), Expect = 4e-08
 Identities = 21/60 (35%), Positives = 35/60 (58%)

Query: 562 SLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKL 621
           +L+++ L+ NRL      +F  + +L+ LDLS N ++   P +F  L  L+ L+LS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 55.4 bits (133), Expect = 5e-08
 Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 17/178 (9%)

Query: 733 IIGIGGFGSVYRARLEDGVEI-AIKVFHPQ------CASTLKSFEAECEVIKNIRHRNLV 785
           ++G G +G V + R ++  EI AIK F           +TL+    E ++++ ++  N+V
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR----ELKMLRTLKQENIV 63

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
           ++  +        LV EY+    LE      N       R  I       ++ +H+ H  
Sbjct: 64  ELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIY----QLIKAIHWCHKN 119

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG 903
            I+H D+KP N+L+  + V  L DFG A+ LS E  +   T+ +AT  Y +P E+ +G
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSP-ELLLG 175

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 54.8 bits (132), Expect = 6e-08
 Identities = 49/182 (26%), Positives = 86/182 (47%), Gaps = 22/182 (12%)

Query: 727 NFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA-------ECEVIKN 778
           NF +   +G G + +VY+ R    G  +A+K  H      L + E        E  ++K 
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIH------LDAEEGTPSTAIREISLMKE 54

Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCL--HSSNCALNIFCRLNIMIDIASAL 836
           ++H N+V++      ++   LV EYM    L+  +  H    AL+     +    +   L
Sbjct: 55  LKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQL---L 110

Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
           + + F H   ++H DLKP N+L+++     L+DFG+A+   G   +T   + + T+ Y A
Sbjct: 111 KGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF-GIPVNTFSNEVV-TLWYRA 168

Query: 897 PD 898
           PD
Sbjct: 169 PD 170

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 55.0 bits (132), Expect = 6e-08
 Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 31/219 (14%)

Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
           +N+ +   IG G  G V  AR +  G ++A+K+   +     +    E  ++++ +H+N+
Sbjct: 24  ENYIK---IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNV 80

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN---IMIDIASALEYLHF 841
           V++  S    +   +++E++  G+L D +  +        RLN   I     S L+ L +
Sbjct: 81  VEMYKSYLVGEELWVLMEFLQGGALTDIVSQT--------RLNEEQIATVCESVLQALCY 132

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI- 900
            HS  +IH D+K  ++LL  D    LSDFG    +S   +   R   + T  +MAP+ I 
Sbjct: 133 LHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS--KDVPKRKSLVGTPYWMAPEVIS 190

Query: 901 ---FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA 936
              +  E+ +  W    L + ++E+VD     GE  +F+
Sbjct: 191 RTPYGTEVDI--WS---LGIMVIEMVD-----GEPPYFS 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 48.9 bits (117), Expect = 9e-08
 Identities = 17/43 (39%), Positives = 27/43 (62%), Gaps = 2/43 (4%)

Query: 28 ISTDQQALLALKDHITYDPTNLLGTNWTSNAS-ICSWIGIICD 69
          ++ D+ ALLA K  +  DP+  L ++W  ++S  CSW G+ CD
Sbjct: 1  LNDDRDALLAFKSSLNGDPSGAL-SSWNPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 54.4 bits (131), Expect = 9e-08
 Identities = 41/197 (20%), Positives = 85/197 (43%), Gaps = 19/197 (9%)

Query: 727 NFAENNIIGIGGFGSVYRARL----EDGVE--IAIKVF-HPQCASTLKSFEAECEVIKNI 779
           N  E   +G G FG V+ A+     E+G E  + +K     +  +    F  E ++ + +
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA--------LNIFCRLNIMID 831
            H+N+V+++  C   +   ++LEY   G L+  L ++           L+   ++ +   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           IA  +++L        +H DL   N L+       +S   ++K +   +   +R   L  
Sbjct: 126 IALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR-NALIP 181

Query: 892 IGYMAPDEIFVGELSLK 908
           + ++AP+ +   + S K
Sbjct: 182 LRWLAPEAVQEDDFSTK 198

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 54.7 bits (131), Expect = 1e-07
 Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 22/182 (12%)

Query: 728 FAENNIIGIGGFGSVYRARLEDGVEI-AIKVFH---PQCASTLKSFEAECEVIKNIRHRN 783
           F +   IG G FG+VY AR     E+ AIK       Q     +    E + ++ I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS----ALEYL 839
            ++       +    LV+EY        CL S++  L +  +    ++IA+    AL+ L
Sbjct: 87  SIEYKGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGL 138

Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+K  N+LL E     L+DFG A + S  +        + T  +MAP+ 
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN------SFVGTPYWMAPEV 192

Query: 900 IF 901
           I 
Sbjct: 193 IL 194

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 13/177 (7%)

Query: 728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEA----ECEVIKNIRHR 782
           F +  ++G GGFG V   ++   G   A K    +     K  E+    E ++++ +  R
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG-ESMALNEKQILEKVNSR 60

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLE-DCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
            +V +  +    D   LVL  M+ G L+    H           +    +I   LE LH 
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH- 119

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
                I++ DLKP N+LLD+     +SD G+A  +   +  T++ + + T+GYMAP+
Sbjct: 120 --QERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAPE 171

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 42/187 (22%)

Query: 733 IIGIGGFGSVYRAR----LEDGVEIAIKVFHPQCASTLK-----SFEAECEVIKNIRHRN 783
           ++G G FG V+  R     + G   A+KV      +TLK       + E +++  + H  
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLK---KATLKVRDRVRTKMERDILAEVNHPF 59

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN--IMI----------D 831
           +VK+  +   +    L+L+++  G L             F RL+  +M           +
Sbjct: 60  IVKLHYAFQTEGKLYLILDFLRGGDL-------------FTRLSKEVMFTEEDVKFYLAE 106

Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           +A AL++LH   S  II+ DLKP N+LLDE+    L+DFG++K     D          T
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGT 161

Query: 892 IGYMAPD 898
           + YMAP+
Sbjct: 162 VEYMAPE 168

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 46/172 (26%), Positives = 83/172 (48%), Gaps = 18/172 (10%)

Query: 734 IGIGGFGSVYRAR---LEDGVEIA-IKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIIS 789
           +G G + +V++ R    E+ V +  I++ H + A    +   E  ++K+++H N+V +  
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPC--TAIREVSLLKDLKHANIVTLHD 71

Query: 790 SCSNDDFKALVLEYMSNG---SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
               D    LV EY+       ++DC        NI    N+ I +   L  L + H   
Sbjct: 72  IVHTDKSLTLVFEYLDKDLKQYMDDCG-------NIMSMHNVKIFLYQILRGLAYCHRRK 124

Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           ++H DLKP N+L++E     L+DFG+A+  S   ++   +  + T+ Y  PD
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY--SNEVVTLWYRPPD 174

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 50/178 (28%), Positives = 76/178 (42%), Gaps = 21/178 (11%)

Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTL-----KSFEAECEVIKNIRH-RNLVK 786
           IG G FG+V +   +  G  +A+K    +  ST+     K    + +V+        +VK
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVK----RIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67

Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA----SALEYLHFG 842
              +   +    + +E M   SL+         L       I+  IA     AL YL   
Sbjct: 68  FYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE 126

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
               IIH D+KPSN+LLD +    L DFG++  L    +S  +T+      YMAP+ I
Sbjct: 127 LK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERI 179

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 53/180 (29%), Positives = 87/180 (48%), Gaps = 19/180 (10%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIK-VFHPQCASTL-KSFEAECEVIKNIRH 781
           T+ + +   +G+G FG V  AR    G  +AIK +  P     L K    E +++K++RH
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 782 RNLV---KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
            N++    I  S   D +   V E +    L   L S       F +   +  I   L+Y
Sbjct: 69  ENIISLSDIFISPLEDIY--FVTELLGT-DLHRLLTSRPLEKQ-FIQY-FLYQILRGLKY 123

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           +H   S  ++H DLKPSN+L++E+    + DFG+A++     +  M T  ++T  Y AP+
Sbjct: 124 VH---SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQM-TGYVSTRYYRAPE 175

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 54.5 bits (131), Expect = 1e-07
 Identities = 50/177 (28%), Positives = 82/177 (46%), Gaps = 21/177 (11%)

Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFEA--ECEVIKNIRHRNLVKII-- 788
           +G G +GSV  A     G ++AIK       S + +  A  E  ++K+++H N++ ++  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 789 --SSCSNDDFKA--LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
             S+ S D+F+   LV+ YM    L+  +              +   +   L  L + HS
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP------LSEDKVQYLVYQMLCGLKYIHS 135

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
             IIH DLKP N+ ++ED    + DFG+A+    E      T  + T  Y AP+ I 
Sbjct: 136 AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVIL 187

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 30/184 (16%)

Query: 734 IGIGGFGSVYRARLEDGVE-IAIKVFH--------PQCASTLKSFEAECEVIKNIRHRNL 784
           IG G +G VY+AR     E IA+K           P  A        E  ++K ++H N+
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR------EISLLKEMQHGNI 63

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID--IASALEYLHFG 842
           V++     ++    LV EY+    L+   H  +     F +   +I   +   L  + + 
Sbjct: 64  VRLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYC 118

Query: 843 HSTPIIHCDLKPSNVLLDEDMVA-HLSDFGMAKLLSGEDESTMRTQT--LATIGYMAPDE 899
           HS  ++H DLKP N+L+D    A  L+DFG+A+         +RT T  + T+ Y AP E
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG----IPVRTFTHEVVTLWYRAP-E 173

Query: 900 IFVG 903
           I +G
Sbjct: 174 ILLG 177

Length = 294

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 54/186 (29%), Positives = 86/186 (46%), Gaps = 16/186 (8%)

Query: 725 TDNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHR 782
           TD +     IG G +G VY+    +DG   A+K+  P  +   +  EAE  +++++  H 
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP-ISDVDEEIEAEYNILQSLPNHP 79

Query: 783 NLVKIISSCSNDDFKA-----LVLEYMSNGSLEDCLHSSNCALNIFCRLN---IMIDIAS 834
           N+VK        D        LVLE  + GS+ + +      L    RL+   I   +  
Sbjct: 80  NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYG 136

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           AL  L   H+  IIH D+K +N+LL  +    L DFG++  L+       R  ++ T  +
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFW 194

Query: 895 MAPDEI 900
           MAP+ I
Sbjct: 195 MAPEVI 200

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 43/149 (28%), Positives = 69/149 (46%), Gaps = 9/149 (6%)

Query: 732 NIIGIGGFGSVYRARL--EDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRHRNLVK 786
            +IG G FG VY   L   DG +I   V      + L+  E    E  ++K+  H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 787 IISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
           ++  C   +   LV L YM +G L + + S      +   +   + +A  +EYL    S 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SK 117

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAK 874
             +H DL   N +LDE     ++DFG+A+
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 52/182 (28%), Positives = 79/182 (43%), Gaps = 20/182 (10%)

Query: 733 IIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFEAECEVIKN------IRHRNLV 785
           ++G G FG V  A L+   E  AIK         L+  + EC +++         H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDV--VLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM-IDIASALEYLHFGHS 844
            +  +    +    V+EY++ G L    H  +       R      +I   L++LH    
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLH---K 114

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL-LSGEDESTMRTQTLATIGYMAPDEIFVG 903
             II+ DLK  NVLLD+D    ++DFGM K  ++GE      +    T  Y+AP EI  G
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKASTFCGTPDYIAP-EILKG 170

Query: 904 EL 905
           + 
Sbjct: 171 QK 172

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 48/176 (27%), Positives = 83/176 (47%), Gaps = 11/176 (6%)

Query: 726 DNFAENNIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
           D+F +   IG G  G V  A     G ++A+K    +     +    E  ++++  H N+
Sbjct: 25  DSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV 81

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           V + +S    D   +V+E++  G+L D +  ++  +N      + + +  AL YLH   +
Sbjct: 82  VDMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLH---N 136

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
             +IH D+K  ++LL  D    LSDFG    +S   E   R   + T  +MAP+ I
Sbjct: 137 QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS--KEVPKRKSLVGTPYWMAPEVI 190

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.1 bits (128), Expect = 3e-07
 Identities = 49/179 (27%), Positives = 85/179 (47%), Gaps = 23/179 (12%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIK----VF--HPQCASTLKSFEAECEVIKNIRHRNLVK 786
           IG G +G V  A+  E   ++AIK     F        TL+    E ++++++ H N++ 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR----EIKLLRHLDHENVIA 68

Query: 787 ---IISSCSNDDFKA--LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              I+     + F    +V E M    L   + SS    +  C+   +  +   L+Y+H 
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQY-FLYQLLRGLKYIH- 125

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
             S  ++H DLKPSN+LL+ +    + DFG+A+  + E    M T+ + T  Y AP+ +
Sbjct: 126 --SANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFM-TEYVVTRWYRAPELL 180

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 47/177 (26%), Positives = 83/177 (46%), Gaps = 19/177 (10%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCA------STLKSFEAECEVIKNIRHRNLVK 786
           IG+G +G+VY+AR    G  +A+K    Q        ST++   A  + ++   H N+V+
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREV-ALLKRLEAFDHPNIVR 66

Query: 787 IISSC----SNDDFK-ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
           ++  C    ++ + K  LV E++               L      ++M      L++LH 
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH- 125

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             +  I+H DLKP N+L+       L+DFG+A++ S +      T  + T+ Y AP+
Sbjct: 126 --ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYRAPE 177

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 53.2 bits (128), Expect = 3e-07
 Identities = 55/184 (29%), Positives = 81/184 (44%), Gaps = 26/184 (14%)

Query: 733 IIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFEAECEVI-KNI-----RHRNLV 785
           ++G G FG V  A L+   E+ A+KV        L+  + EC +  K +     +H  L 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDV--ILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNC---ALNIFCRLNIMIDIASALEYLHFG 842
           ++ S     D    V+EY++ G L   +  S         F       +I   L++LH  
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF----YAAEIVLGLQFLH-- 113

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK--LLSGEDESTMRTQTLATIGYMAPDEI 900
               II+ DLK  NVLLD +    ++DFGM K  +L G   ST       T  Y+AP EI
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF----CGTPDYIAP-EI 167

Query: 901 FVGE 904
              +
Sbjct: 168 LSYQ 171

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 54/180 (30%), Positives = 81/180 (45%), Gaps = 17/180 (9%)

Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRHRNLVKIIS 789
           +G GGFG V   ++   G   A K  + +     K +E    E  ++  +  R +V +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
           +        LV+  M+ G L   +++    N              I S LE+LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117

Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDESTMRTQTLA-TIGYMAPDEIFVGE 904
           II+ DLKP NVLLD D    +SD G+A +L  G+     +T+  A T G+MAP E+  GE
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS----KTKGYAGTPGFMAP-ELLQGE 172

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 53.0 bits (127), Expect = 4e-07
 Identities = 48/178 (26%), Positives = 86/178 (48%), Gaps = 22/178 (12%)

Query: 734 IGIGGFGSV-YRARLEDGVEIAIKVFHPQCASTLKSFEA--ECEVIKNIRHRNLVKII-- 788
           +G G +G+V        G ++AIK  +    S L +  A  E  ++K+++H N++ ++  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 789 --SSCSNDDFKA--LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI-DIASALEYLHFGH 843
                S D F    LV+ +M    L   +     + +   R+  ++  +   L+Y+H   
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLSED---RIQFLVYQMLKGLKYIH--- 135

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
           +  IIH DLKP N+ ++ED    + DFG+A+    + +S M T  + T  Y AP+ I 
Sbjct: 136 AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEM-TGYVVTRWYRAPEVIL 188

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 52.7 bits (127), Expect = 4e-07
 Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 27/163 (16%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA--------ECEVIKNIRHRNL 784
           +G G FG VY+AR ++ G  +A+K         + + +         E +++K ++H N+
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKI------LMHNEKDGFPITALREIKILKKLKHPNV 69

Query: 785 VKII------SSCSNDDFKA--LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL 836
           V +I         S     +  +V  YM +  L   L + +  L        M+ +   +
Sbjct: 70  VPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGI 128

Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE 879
            YLH  H   I+H D+K +N+L+D   +  ++DFG+A+   G 
Sbjct: 129 NYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 4e-07
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 30/179 (16%)

Query: 734 IGIGGFGSV---YRARLEDGVEIAIKVFHP-QCASTLKSFEAECEVIKNIRHRNLVKIIS 789
           +G G +GSV   Y  RL   V +  K+  P Q     +    E  ++K+++H N++ ++ 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVK-KLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81

Query: 790 ----SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYL 839
               + S ++F  + L     G+           LN   +   + D      I   L  L
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGA----------DLNNIVKCQKLSDEHVQFLIYQLLRGL 131

Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
            + HS  IIH DLKPSNV ++ED    + DFG+A+    +DE    T  +AT  Y AP+
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDE---MTGYVATRWYRAPE 185

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 51.9 bits (124), Expect = 6e-07
 Identities = 46/172 (26%), Positives = 85/172 (49%), Gaps = 18/172 (10%)

Query: 734 IGIGGFGSVY--RARLEDGVEI--AIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIIS 789
           +G G + +VY  R++L D +     I++ H + A    +   E  ++K+++H N+V +  
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPC--TAIREVSLLKDLKHANIVTLHD 71

Query: 790 SCSNDDFKALVLEYMSNG---SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
               +    LV EY+       L+DC +S N         N+ + +   L  L++ H   
Sbjct: 72  IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMH-------NVKLFLFQLLRGLNYCHRRK 124

Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           ++H DLKP N+L++E     L+DFG+A+  S   ++   +  + T+ Y  PD
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--SNEVVTLWYRPPD 174

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 51.9 bits (124), Expect = 6e-07
 Identities = 49/176 (27%), Positives = 81/176 (46%), Gaps = 22/176 (12%)

Query: 734 IGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFE---AECEVIKNIRHRNLVKIIS 789
           IG G FG+VY A      E+ A+K        T + ++    E + ++ ++H N ++   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS----ALEYLHFGHST 845
               +    LV+EY        CL S++  L +  +    ++IA+    AL+ L + HS 
Sbjct: 89  CYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
            +IH D+K  N+LL E     L+DFG A   S  +        + T  +MAP+ I 
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN------SFVGTPYWMAPEVIL 190

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 52.3 bits (125), Expect = 7e-07
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)

Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 85  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 138

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 187

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 51.5 bits (123), Expect = 7e-07
 Identities = 46/178 (25%), Positives = 76/178 (42%), Gaps = 25/178 (14%)

Query: 733 IIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS-- 790
           IIG GGFG VY  R  D      K++  +C    +    + E +  +  R ++ ++S+  
Sbjct: 1   IIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETLA-LNERIMLSLVSTGD 55

Query: 791 -----CSNDDFKA-----LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
                C    F        +L+ M+ G L    H       +F    +       +  L 
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDL----HYHLSQHGVFSEKEMRFYATEIILGLE 111

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             H+  +++ DLKP+N+LLDE     +SD G+A   S +        ++ T GYMAP+
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPE 165

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.8 bits (124), Expect = 8e-07
 Identities = 50/173 (28%), Positives = 74/173 (42%), Gaps = 15/173 (8%)

Query: 733 IIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFEAECEVI-KNI-----RHRNLV 785
           ++G G FG V  A L+   E+ AIKV        L+  + +C +  K I     +H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKD--VILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
            +       D    V+EY++ G L   +  S        R     ++  AL +LH     
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RH 115

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
            +I+ DLK  N+LLD +    L+DFGM K   G       T    T  Y+AP+
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 51.8 bits (124), Expect = 9e-07
 Identities = 56/176 (31%), Positives = 78/176 (44%), Gaps = 21/176 (11%)

Query: 733 IIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVI-KNI-----RHRNLV 785
           ++G G FG V  ARL E G   A+KV        L+  + EC +  K I      H  L 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDV--ILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM-IDIASALEYLHFGHS 844
           ++       D    V+E+++ G L    H          R      +I SAL +LH    
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLH---D 114

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAK--LLSGEDESTMRTQTLATIGYMAPD 898
             II+ DLK  NVLLD +    L+DFGM K  + +G+  ST       T  Y+AP+
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF----CGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 30/73 (41%), Positives = 41/73 (56%), Gaps = 5/73 (6%)

Query: 828 IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ 887
           I + I  ALEYLH   S  +IH D+KPSNVL++ +    L DFG++  L    +S  +T 
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTI 162

Query: 888 TLATIGYMAPDEI 900
                 YMAP+ I
Sbjct: 163 DAGCKPYMAPERI 175

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 11/178 (6%)

Query: 726 DNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRN 783
           D+F + + +G G  G V++ +    G+ +A K+ H +    +++    E +V+       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFG 842
           +V    +  +D   ++ +E+M  GSL+  L  +      I  +++I +     L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 122

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H D+KPSN+L++      L DFG    +SG+   +M    + T  YM+P+ +
Sbjct: 123 HK--IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERL 174

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 22/182 (12%)

Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEA--ECEVIKNIRHR 782
           D++ +   +G G + +VY+ + + +G  +A+KV   Q       F A  E  ++K ++H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ-EEEGTPFTAIREASLLKGLKHA 63

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLE------DCLHSSNCALNIFCRLNIMIDIASAL 836
           N+V +       +   LV EY+     +        LH  N  L +F            L
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLF----------QLL 113

Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
             L + H   I+H DLKP N+L+ +     L+DFG+A+  S    S   +  + T+ Y  
Sbjct: 114 RGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSHTYSNEVVTLWYRP 171

Query: 897 PD 898
           PD
Sbjct: 172 PD 173

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 15/175 (8%)

Query: 733 IIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVI--KNIRHRNLVKIIS 789
            IG G FG +Y A+ + D     IK          +   ++ EVI    ++H N+V   +
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM---IDIASALEYLHFGHSTP 846
           S   +    +V+EY   G L   ++     L  F    I+   + I+  L+++H      
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVL--FSEDQILSWFVQISLGLKHIH---DRK 121

Query: 847 IIHCDLKPSNVLLDED-MVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           I+H D+K  N+ L ++ MVA L DFG+A+ L   ++S     T     Y    EI
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAYTCVGTPYYLSPEI 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (123), Expect = 1e-06
 Identities = 56/178 (31%), Positives = 79/178 (44%), Gaps = 25/178 (14%)

Query: 734 IGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFEAECEVIKNIRHRN--------- 783
           IG G FG VY+ R +D   I A+KV       + K   A+ EV   I  RN         
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNILVRTLLDE 54

Query: 784 ---LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
              +V +  S   D    LV +YMS G L   L           +  I  ++  ALE+LH
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH 113

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
                 I++ DLKP N+LLD      L DFG++K    ++++T       T  Y+AP+
Sbjct: 114 ---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT--NTFCGTTEYLAPE 166

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 51.7 bits (124), Expect = 1e-06
 Identities = 30/72 (41%), Positives = 43/72 (59%), Gaps = 5/72 (6%)

Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           I   L+YLH   S  I+H D+KP N+L++ + V  + DFG+A+ +   DES   TQ + T
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVT 167

Query: 892 IGYMAPDEIFVG 903
             Y AP EI +G
Sbjct: 168 QYYRAP-EILMG 178

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 17/179 (9%)

Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
           DNF +   IG G  G V  A ++  G  +A+K    +     +    E  ++++ +H N+
Sbjct: 23  DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN---IMIDIASALEYLHF 841
           V++ +S    D   +V+E++  G+L D +  +        R+N   I     + L+ L  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--------RMNEEQIAAVCLAVLKALSV 131

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            H+  +IH D+K  ++LL  D    LSDFG    +S   E   R   + T  +MAP+ I
Sbjct: 132 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--KEVPRRKSLVGTPYWMAPELI 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 50.9 bits (121), Expect = 1e-06
 Identities = 53/187 (28%), Positives = 83/187 (44%), Gaps = 27/187 (14%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISS 790
           ++G G +G VY+ R ++ G   AIKV         +  + E  ++K    HRN+     +
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 791 C------SNDDFKALVLEYMSNGSLEDCLHSSNCA------LNIFCRLNIMIDIASALEY 838
                    DD   LV+E+   GS+ D + ++         +   CR     +I   L +
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR-----EILRGLSH 126

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT-LATIGYMAP 897
           LH      +IH D+K  NVLL E+    L DFG++  L   D +  R  T + T  +MAP
Sbjct: 127 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAP 180

Query: 898 DEIFVGE 904
           + I   E
Sbjct: 181 EVIACDE 187

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 34/159 (21%), Positives = 66/159 (41%), Gaps = 20/159 (12%)

Query: 731 NNIIGIGGFGSVYRAR-LEDGVEIAIKVFH----PQCASTLKSFEAEC----------EV 775
              +G G +G V +A     G  +AIK           +  +     C          ++
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 776 IKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASA 835
           +  I+H N++ ++      DF  LV++ M+   L+  +      L       I++ I + 
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV-DRKIRLTESQVKCILLQILNG 131

Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK 874
           L  LH       +H DL P+N+ ++   +  ++DFG+A+
Sbjct: 132 LNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 19/175 (10%)

Query: 733 IIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-------ASTLKSFEAECEVIKNIRHRNL 784
           ++G G FG V   + +  G   A+K+   +        A TL     E  V++N RH  L
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL----TENRVLQNSRHPFL 57

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
             +  S    D    V+EY + G L   L           R     +I SAL+YLH    
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--SE 114

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG-EDESTMRTQTLATIGYMAPD 898
             +++ DLK  N++LD+D    ++DFG+ K   G +D +TM+T    T  Y+AP+
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKT-FCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 23/178 (12%)

Query: 734 IGIGGFGSVYRARLEDGVEI-AIK-VFHPQCASTLKSFEA-ECEVIKNIRHRNLVKIISS 790
           IG G +G+V++A+  +  EI A+K V        + S    E  ++K ++H+N+V++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHC 850
             +D    LV EY  +  L+    S N  ++     + M  +   L+ L F HS  ++H 
Sbjct: 68  LHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQL---LKGLAFCHSHNVLHR 123

Query: 851 DLKPSNVLLDEDMVAHLSDFGMA-------KLLSGEDESTMRTQTLATIGYMAPDEIF 901
           DLKP N+L++++    L+DFG+A       +  S E         + T+ Y  PD +F
Sbjct: 124 DLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE---------VVTLWYRPPDVLF 172

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (121), Expect = 2e-06
 Identities = 53/175 (30%), Positives = 77/175 (44%), Gaps = 13/175 (7%)

Query: 734 IGIGGFGSVYRARLEDGVEI----AIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIIS 789
           IG G FG V + R  D   I     I+  H    S +    AE  V+  +    +V +  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
           S  + +   LVL +++ G L   L           R     ++  ALE LH      +I+
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLH---KFNVIY 116

Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEIFVG 903
            DLKP N+LLD      L DFG+ KL   +D+   +T T   T  Y+AP E+ +G
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAP-ELLLG 167

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 20/178 (11%)

Query: 734 IGIGGFGSVYRAR-LEDGVE-IAIKVFHPQCA------STLKSFEAECEVIKNIRHRNLV 785
           IG G +G V++AR L++G   +A+K    Q        ST++   A    ++   H N+V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETFEHPNVV 67

Query: 786 KIISSC--SNDDFKA---LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           ++   C  S  D +    LV E++               +      ++M  +   L++LH
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              S  ++H DLKP N+L+       L+DFG+A++ S +      T  + T+ Y AP+
Sbjct: 128 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPE 179

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 47/175 (26%), Positives = 78/175 (44%), Gaps = 24/175 (13%)

Query: 734 IGIGGFGSVYR--ARLEDGVEIAIKVFHPQCASTLKSFEA--ECEVIKNIRHRNLVKIIS 789
           +G G + +VY+  +R+ +G  +A+KV   +    +  F A  E  ++K ++H N+V +  
Sbjct: 13  LGEGSYATVYKGISRI-NGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHD 70

Query: 790 SCSNDDFKALVLEYMSNGSLE------DCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
                +    V EYM     +        LH  N  L        M  +   L Y+H  H
Sbjct: 71  IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-------FMFQLLRGLAYIHGQH 123

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I+H DLKP N+L+       L+DFG+A+  +    S   +  + T+ Y  PD
Sbjct: 124 ---ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPD 173

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 54/180 (30%), Positives = 84/180 (46%), Gaps = 19/180 (10%)

Query: 728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEA----ECEVIKNIRHR 782
           F    ++G GGFG V   ++   G   A K    +     K  EA    E ++++ +  R
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG-EAMALNEKQILEKVNSR 60

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI---DIASALEYL 839
            +V +  +    D   LVL  M+ G L+   H  N     F     +    +I   LE L
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLK--FHIYNMGNPGFDEERAVFYAAEITCGLEDL 118

Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDESTMRTQTLATIGYMAPD 898
           H      I++ DLKP N+LLD+     +SD G+A ++  GE   T+R + + T+GYMAP+
Sbjct: 119 H---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGR-VGTVGYMAPE 171

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 51.0 bits (122), Expect = 2e-06
 Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 22/150 (14%)

Query: 734 IGIGGFGSVYRARLEDGVEI-AIK------VFHPQCASTLKSFEAECEVIKNIRHRNLVK 786
           IGIG FG V   R  D   + A+K      V     A+ +K   AE +++    +  +VK
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVK---AERDILAEADNEWVVK 65

Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIF----CRLNIMIDIASALEYLHFG 842
           +  S  + D    V++Y+  G +   L      L IF     R  I  ++  A+E +H  
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLL----IRLGIFEEDLARFYIA-ELTCAIESVH-- 118

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGM 872
                IH D+KP N+L+D D    L+DFG+
Sbjct: 119 -KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 50/183 (27%), Positives = 80/183 (43%), Gaps = 10/183 (5%)

Query: 725 TDNFAENNIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HR 782
           +D +     IG G +G V++    ++G + A+K+  P      +  EAE  ++K +  H 
Sbjct: 17  SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHP 75

Query: 783 NLVKIISSCSNDDFKA-----LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALE 837
           N+VK        D K      LVLE  + GS+ D +              I   +  AL 
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135

Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            L   H    IH D+K +N+LL  +    L DFG++  L+       R  ++ T  +MAP
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAP 193

Query: 898 DEI 900
           + I
Sbjct: 194 EVI 196

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 46/184 (25%), Positives = 80/184 (43%), Gaps = 21/184 (11%)

Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLKSFE--AECEVIKNIRHRNLV 785
           +G G FG VY        + E    +AIK  + + AS  +  E   E  V+K     ++V
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASAL 836
           +++   S      +++E M+ G L+  L S      N  +     L  MI    +IA  +
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
            YL+   +   +H DL   N ++ ED    + DFGM + +   D      + L  + +M+
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189

Query: 897 PDEI 900
           P+ +
Sbjct: 190 PESL 193

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 34/137 (24%), Positives = 61/137 (44%), Gaps = 7/137 (5%)

Query: 737 GGFGSVYRARLEDGVEIAIKVFHPQCAST--LKSFEAECEVIKNIRHRNLVKIISSCSND 794
                + + +  + + +A+K  +    S   LK  + E    + ++H N++  ++S   D
Sbjct: 13  LMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71

Query: 795 DFKALVLEYMSNGSLEDCLHSSNC-ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
               +V   M+ GS ED L +     L       I+ D+ +AL+Y+   HS   IH  +K
Sbjct: 72  SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYI---HSKGFIHRSVK 128

Query: 854 PSNVLLDEDMVAHLSDF 870
            S++LL  D    LS  
Sbjct: 129 ASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 25/178 (14%)

Query: 733 IIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS-- 790
           IIG GGFG VY  R  D      K++  +C    +    + E +  +  R ++ ++S+  
Sbjct: 1   IIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETLA-LNERIMLSLVSTGD 55

Query: 791 -----CSNDDFK-----ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
                C +  F      + +L+ M+ G L    H       +F    +    A  +  L 
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEAEMRFYAAEIILGLE 111

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             H+  +++ DLKP+N+LLDE     +SD G+A   S +        ++ T GYMAP+
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPE 165

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 45/178 (25%), Positives = 85/178 (47%), Gaps = 11/178 (6%)

Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRN 783
           D+F   + +G G  G V + + +  G+ +A K+ H +    +++    E +V+       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCL-HSSNCALNIFCRLNIMIDIASALEYLHFG 842
           +V    +  +D   ++ +E+M  GSL+  L  +      I  +++I +     L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAYLREK 122

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H D+KPSN+L++      L DFG    +SG+   +M    + T  YM+P+ +
Sbjct: 123 HQ--IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERL 174

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 52/188 (27%), Positives = 83/188 (44%), Gaps = 38/188 (20%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA--------ECEVIKNIRHRNL 784
           IG G +G VY+ R  + G  +A+K         L+S E         E  ++K ++H N+
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIR------LESEEEGVPSTAIREISLLKELQHPNI 61

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH---- 840
           V +      +    L+ E++S   L+  L S              +D      YL+    
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSM-DLKKYLDS--------LPKGQYMDAELVKSYLYQILQ 112

Query: 841 ---FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR--TQTLATIGYM 895
              F HS  ++H DLKP N+L+D   V  L+DFG+A+         +R  T  + T+ Y 
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG----IPVRVYTHEVVTLWYR 168

Query: 896 APDEIFVG 903
           AP E+ +G
Sbjct: 169 AP-EVLLG 175

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 7/101 (6%)

Query: 799 LVLEYMSNGSLE-DCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNV 857
           LV+  M+ G L+    +     L +   ++    I   + +LH   S  I++ D+KP NV
Sbjct: 70  LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENV 126

Query: 858 LLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           LLD+     LSD G+A  L      T R     T GYMAP+
Sbjct: 127 LLDDQGNCRLSDLGLAVELKDGKTITQRA---GTNGYMAPE 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 19/182 (10%)

Query: 728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEA----ECEVIKNIRHR 782
           F    ++G GGFG V   ++   G   A K    +     K  EA    E  +++ +  R
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG-EAMALNEKRILEKVNSR 60

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI---DIASALEYL 839
            +V +  +    D   LVL  M+ G L+   H  N     F     +    ++   LE L
Sbjct: 61  FVVSLAYAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118

Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDESTMRTQTLATIGYMAPD 898
                  I++ DLKP N+LLD+     +SD G+A ++  GE   T+R + + T+GYMAP+
Sbjct: 119 Q---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGR-VGTVGYMAPE 171

Query: 899 EI 900
            I
Sbjct: 172 VI 173

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 50/174 (28%), Positives = 85/174 (48%), Gaps = 19/174 (10%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA--ECEVIKNIRHRNLVKIISS 790
           IG G FG     +  EDG +  IK  +    S  +  E+  E  V+ N++H N+V+   S
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67

Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM---IDIASALEYLHFGHSTPI 847
              +    +V++Y   G L   +++    L  F    I+   + I  AL+++H      I
Sbjct: 68  FEENGNLYIVMDYCEGGDLYKKINAQRGVL--FPEDQILDWFVQICLALKHVH---DRKI 122

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM---RTQTLATIGYMAPD 898
           +H D+K  N+ L +D    L DFG+A++L+    ST+   RT  + T  Y++P+
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLN----STVELART-CIGTPYYLSPE 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.1 bits (105), Expect = 6e-06
 Identities = 22/56 (39%), Positives = 32/56 (57%)

Query: 542 IDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKI 597
           +DLS N L+       +GL +L+ + L+ N L    PE+F  + SL SLDLS N +
Sbjct: 5   LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 48.7 bits (116), Expect = 6e-06
 Identities = 42/173 (24%), Positives = 73/173 (42%), Gaps = 11/173 (6%)

Query: 734 IGIGGFGSVYRARLEDGVEIA-IKVFHPQCASTLK---SFEAECEVIKNIRHRNLVKIIS 789
           IG G FG V       G+  A + V   + ++T      F  E +  + + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR----LNIMIDIASALEYLHFGHST 845
            C       LVLE+   G L++ L S+   +    +      +  ++AS L +LH     
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IH DL   N  L  D+   + D+G+A     ED    +      + ++AP+
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPE 172

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 46.6 bits (111), Expect = 8e-06
 Identities = 28/144 (19%), Positives = 61/144 (42%), Gaps = 19/144 (13%)

Query: 733 IIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV--KIISS 790
           ++  G    VY    +D  +  +K+   +        E E  +++ +  + L   K+++S
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKINPSREKGAD--REREVAILQLLARKGLPVPKVLAS 61

Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI--- 847
             +D +  L++E++   +L++               +I   +A  L  LH     P+   
Sbjct: 62  GESDGWSYLLMEWIEGETLDEVSEEEK--------EDIAEQLAELLAKLH---QLPLLVL 110

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFG 871
            H DL P N+L+D+  +  + D+ 
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.7 bits (104), Expect = 9e-06
 Identities = 19/60 (31%), Positives = 29/60 (48%)

Query: 466 RLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLL 525
            L  LDL+ N+++         L +L+ L+L  N  T + P  F  L  + S D+S N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.7 bits (104), Expect = 9e-06
 Identities = 23/60 (38%), Positives = 33/60 (55%)

Query: 394 SLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKL 453
           +L+ L+++   ++     A   L NL VL L GNNL+   P  F GL  L+ LDL+ N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 48.4 bits (115), Expect = 9e-06
 Identities = 53/190 (27%), Positives = 80/190 (42%), Gaps = 38/190 (20%)

Query: 733 IIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKN------IRHRNLV 785
           ++G G FG V+ A L+      AIK         L   + EC +++         H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDV--VLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY------- 838
            +  +    +    V+EY++ G L    H  +C            D+  A  Y       
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCH---------KFDLPRATFYAAEIICG 108

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM---RTQTL-ATIGY 894
           L F HS  I++ DLK  N+LLD D    ++DFGM K      E+ +   +T T   T  Y
Sbjct: 109 LQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCK------ENMLGDAKTCTFCGTPDY 162

Query: 895 MAPDEIFVGE 904
           +AP EI +G+
Sbjct: 163 IAP-EILLGQ 171

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 48.3 bits (115), Expect = 1e-05
 Identities = 29/68 (42%), Positives = 37/68 (54%), Gaps = 7/68 (10%)

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK--LLSGEDESTMRTQTLATIGYMA 896
           L+F H   II+ DLK  NVLLD +    L+D+GM K  +  G+  ST       T  Y+A
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF----CGTPNYIA 164

Query: 897 PDEIFVGE 904
           P EI  GE
Sbjct: 165 P-EILRGE 171

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 14/176 (7%)

Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSC 791
           +G G +GSVY+      GV +A+K    +   S       E +++       +V    + 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASA----LEYLHFGHSTPI 847
             +    + +EYM  GSL D L++   A       +++  I  A    L++L   H+  I
Sbjct: 69  FIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPE-DVLRRITYAVVKGLKFLKEEHN--I 124

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG 903
           IH D+KP+NVL++ +    L DFG    +SG   +++    +    YMAP+ I  G
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFG----VSGNLVASLAKTNIGCQSYMAPERIKSG 176

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 44/175 (25%), Positives = 76/175 (43%), Gaps = 10/175 (5%)

Query: 733 IIGIGGFGSVYRA-RLEDG----VEIAIKVFHPQCASTL-KSFEAECEVIKNIRHRNLVK 786
           ++G G FG+VY+   + DG    + +AIKV     +    K    E  V+  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
           ++  C     + LV + M  G L D +  +   +     LN  + IA  + YL       
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
           ++H DL   NVL+       ++DFG+A+LL  ++           I +MA + I 
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 28/187 (14%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFEAEC-----EVIKNI 779
           ++F    +IG G FG V   +L++  ++ A+K+ +      LK  E  C     +V+ N 
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW--EMLKRAETACFREERDVLVNG 58

Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSL-------EDCLHSSNCALNIFCRLNIMIDI 832
            ++ +  +  +  +++   LV++Y   G L       ED L   + A      + I ID 
Sbjct: 59  DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL-PEDMARFYLAEMVIAIDS 117

Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDESTMRTQTLAT 891
              L Y         +H D+KP N+L+D +    L+DFG   KL+  ED +   +  + T
Sbjct: 118 VHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGT 166

Query: 892 IGYMAPD 898
             Y++P+
Sbjct: 167 PDYISPE 173

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 46/184 (25%), Positives = 80/184 (43%), Gaps = 21/184 (11%)

Query: 734 IGIGGFGSVYRARLEDGVE------IAIKVFHPQCASTLKSFE--AECEVIKNIRHRNLV 785
           +G G FG VY     D ++      +A+K  + + AS  +  E   E  V+K     ++V
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASAL 836
           +++   S      +V+E M++G L+  L S      N        L  MI    +IA  +
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
            YL+   +   +H DL   N ++  D    + DFGM + +   D      + L  + +MA
Sbjct: 133 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 897 PDEI 900
           P+ +
Sbjct: 190 PESL 193

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 47.8 bits (114), Expect = 2e-05
 Identities = 27/70 (38%), Positives = 41/70 (58%), Gaps = 7/70 (10%)

Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS---GEDESTMRTQT 888
           I   L+Y+H   S  ++H DLKP N+L++ D    + DFG+A+  S   GE+   M T+ 
Sbjct: 114 ILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEY 169

Query: 889 LATIGYMAPD 898
           +AT  Y AP+
Sbjct: 170 VATRWYRAPE 179

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 43/173 (24%), Positives = 73/173 (42%), Gaps = 9/173 (5%)

Query: 734 IGIGGFGSVYRARLEDGV-EIAIKVFHPQCASTLKSFEA-----ECEVIKNIRHRNLVKI 787
           +G G FG+VY  + +  V E  +KV        L   E      E +++  + H  +VK 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
            +S    D   ++ EY     L+  L              +       L  +H+ H   I
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           +H DLK  N+ L  +++  + DFG+++LL G     + T    T  YM+P+ +
Sbjct: 128 LHRDLKAKNIFLKNNLL-KIGDFGVSRLLMG--SCDLATTFTGTPYYMSPEAL 177

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 9/99 (9%)

Query: 801 LEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL 859
           +E+M  GSL+  L  +     NI  +  I I +   L YL   H   I+H D+KPSN+L+
Sbjct: 78  MEHMDGGSLDQVLKKAGRIPENILGK--ISIAVLRGLTYLREKHK--IMHRDVKPSNILV 133

Query: 860 DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           +      L DFG    +SG+   +M    + T  YM+P+
Sbjct: 134 NSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPE 168

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 8/149 (5%)

Query: 728 FAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQ---CASTLKSFEAECEVIKNIRHRN 783
           F +   +GIG FG V  AR  D     A+K    +     + +   +AE +++    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +V++  S  + D    V++Y+  G +   L           R  I  ++  A+E +H   
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVH--- 118

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGM 872
               IH D+KP N+L+D D    L+DFG+
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 54/179 (30%), Positives = 77/179 (43%), Gaps = 16/179 (8%)

Query: 733 IIGIGGFGSVYRARLEDGVEI-AIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKII 788
           +IG G +  V   RL+   +I A+KV   +       +   + E  V +       +  +
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 789 SSCSNDDFKA-LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
            SC     +  LV+EY++ G L   +           R     +I  AL +LH      I
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERGI 117

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAK--LLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
           I+ DLK  NVLLD D    L+D+GM K  L  G+  ST       T  Y+AP EI  GE
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF----CGTPNYIAP-EILRGE 171

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 46/174 (26%), Positives = 76/174 (43%), Gaps = 16/174 (9%)

Query: 733 IIGIGGFGSVYRARLEDGVEI-AIKVFHPQC------ASTLKSFEAECEVIKNIRHRNLV 785
           ++G G FG V  A  +   E+ AIK              +L   +   E   + RH  LV
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
            + +    +D    V+EY + G L   +H+     ++F     +   A  +  L + H  
Sbjct: 66  NLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN 120

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPD 898
            I++ DLK  N+LLD +    ++DFG+ K   G  +   RT T   T  ++AP+
Sbjct: 121 KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---RTSTFCGTPEFLAPE 171

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.0 bits (112), Expect = 3e-05
 Identities = 24/58 (41%), Positives = 32/58 (55%), Gaps = 3/58 (5%)

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           HS  IIH DLKPSN+++  D    + DFG+A+       S M T  + T  Y AP+ I
Sbjct: 135 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 189

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 47.3 bits (112), Expect = 3e-05
 Identities = 54/163 (33%), Positives = 78/163 (47%), Gaps = 24/163 (14%)

Query: 732 NIIGIGGFGSVYRARLEDGVE-IAIK--VFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           NIIG G FG VY A   D  E +AIK  +  PQ  +       E  ++KN+ H N++ + 
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR------ELLIMKNLNHINIIFLK 125

Query: 789 SSCSNDDFKA--------LVLEYMSNGSLEDCLHSS--NCALNIFCRLNIMIDIASALEY 838
                + FK         +V+E++     +   H +  N AL +F        +  AL Y
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAK-LLSGE 879
           +H   S  I H DLKP N+L+D +     L DFG AK LL+G+
Sbjct: 186 IH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225

Length = 440

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.4 bits (111), Expect = 3e-05
 Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 5/95 (5%)

Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           + N +K+  S +      L+++Y+ +G L D L           +  I+  +  AL  LH
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVK-KIIRQLVEALNDLH 126

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMV-AHLSDFGMAK 874
             +   IIH D+K  NVL D      +L D+G+ K
Sbjct: 127 KHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158

Length = 267

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 46.8 bits (111), Expect = 4e-05
 Identities = 49/181 (27%), Positives = 76/181 (41%), Gaps = 19/181 (10%)

Query: 733 IIGIGGFGSV-YRARLEDGVEIAIKVFHPQCASTLKSFEAECEV--IKNIRHRNLVKIIS 789
           ++G G  G+V    R+ DG   A+KV   +  S      A+ EV  + N    ++VK   
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK--- 95

Query: 790 SCSNDDFK------------ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALE 837
            C  D  K            ALVL+Y + G L   + S       F      +     L 
Sbjct: 96  -CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154

Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            +H  HS  +IH D+K +N+LL  + +  L DFG +K+ +      +      T  Y+AP
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214

Query: 898 D 898
           +
Sbjct: 215 E 215

Length = 496

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 46.0 bits (109), Expect = 5e-05
 Identities = 45/171 (26%), Positives = 76/171 (44%), Gaps = 14/171 (8%)

Query: 732 NIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL-KSFEAECEVIKNIRHRNLVKIIS 789
            I+G G  G+VY+A  L     +A+KV        L K   +E E++       ++    
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
           +   ++  ++  E+M  GSL+         L       I + +   L YL    S  I+H
Sbjct: 67  AFFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYLW---SLKILH 118

Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            D+KPSN+L++      L DFG++  L     +++    + T  YMAP+ I
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERI 165

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.2 bits (109), Expect = 6e-05
 Identities = 43/160 (26%), Positives = 80/160 (50%), Gaps = 18/160 (11%)

Query: 750 GVEIAIK-VFHP-QCASTLKSFEAECEVIKNIRHRNLVKIIS----SCSNDDFKA--LVL 801
           G+ +A+K +  P Q  +  K    E  ++K + H+N++ +++      S ++F+   LV+
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE 861
           E M + +L   +H     L+      ++  +   +++LH   S  IIH DLKPSN+++  
Sbjct: 106 ELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 158

Query: 862 DMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
           D    + DFG+A+       + M T  + T  Y AP+ I 
Sbjct: 159 DCTLKILDFGLARTAC---TNFMMTPYVVTRYYRAPEVIL 195

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.9 bits (109), Expect = 6e-05
 Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 28/187 (14%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFEAEC-----EVIKNI 779
           D+F    +IG G FG V   ++++  ++ A+K+ +      LK  E  C     +V+ N 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKW--EMLKRAETACFREERDVLVNG 58

Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSL-------EDCLHSSNCALNIFCRLNIMIDI 832
             R +  +  +  +++   LV++Y   G L       ED L      +  F    +++ I
Sbjct: 59  DRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED---MARFYLAEMVLAI 115

Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDESTMRTQTLAT 891
            S +  L +      +H D+KP NVLLD++    L+DFG   +LL   D +      + T
Sbjct: 116 DS-VHQLGY------VHRDIKPDNVLLDKNGHIRLADFGSCLRLL--ADGTVQSNVAVGT 166

Query: 892 IGYMAPD 898
             Y++P+
Sbjct: 167 PDYISPE 173

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.2 bits (109), Expect = 6e-05
 Identities = 38/149 (25%), Positives = 68/149 (45%), Gaps = 8/149 (5%)

Query: 728 FAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRN 783
           F +   +GIG FG V  A  ++     A+K    +     + +   +AE +++    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +VK+  S  + D    V++Y+  G +   L        +  R  I  ++  A+E +H   
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVH--- 118

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGM 872
               IH D+KP N+L+D D    L+DFG+
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 46.7 bits (111), Expect = 7e-05
 Identities = 51/200 (25%), Positives = 83/200 (41%), Gaps = 41/200 (20%)

Query: 733 IIGIGGFGSVYRARLEDGV---EIAIKVFHPQCAST---LKSFEAECEVIKNIRHRNLVK 786
           +IG GG G VY A   D V    +A+K      +      K F  E ++  ++ H  +V 
Sbjct: 9   LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCL------------HSSNCALNIFCRLNIMIDIAS 834
           + S CS+ D     + Y+   +L+  L             +   ++  F  L+I   I +
Sbjct: 67  VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF--LSIFHKICA 124

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES------------ 882
            +EY+H   S  ++H DLKP N+LL       + D+G A     E+E             
Sbjct: 125 TIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 883 ----TMRTQTLATIGYMAPD 898
               T+  + + T  YMAP+
Sbjct: 182 YSSMTIPGKIVGTPDYMAPE 201

Length = 932

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 45.1 bits (107), Expect = 9e-05
 Identities = 31/109 (28%), Positives = 50/109 (45%), Gaps = 16/109 (14%)

Query: 772 ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNG---SLEDC---LHSSNCALNIFCR 825
           E  ++K+++H N+V +           LV EY+       ++DC   L   N  L +F  
Sbjct: 53  EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLF-- 110

Query: 826 LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK 874
                     L  L + H   ++H DLKP N+L+ E     L+DFG+A+
Sbjct: 111 --------QLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.0 bits (107), Expect = 1e-04
 Identities = 44/160 (27%), Positives = 69/160 (43%), Gaps = 22/160 (13%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFEAECEVIKNIR-HRN 783
           D+F    +IG G FG V   + +D   I A+K          KS   E E + ++R  R+
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL-------RKSEMLEKEQVAHVRAERD 53

Query: 784 L---------VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           +         VK+  S  ++++  L++EY+  G +   L   +     F        IA 
Sbjct: 54  ILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD----TFTEEETRFYIAE 109

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK 874
            +  +   H    IH D+KP N+LLD      LSDFG+  
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 35/137 (25%), Positives = 65/137 (47%), Gaps = 16/137 (11%)

Query: 734 IGIGGFGSVYRARL-----EDG------VEIAIKVFHPQCASTLKSFEAECEVIKNIRHR 782
           +G G F ++Y+  L      D       V + +KV       +L  FE    + + + H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQ-LSHK 61

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           +LVK+   C  D+   +V EY+  G L+  LH     +++  +L++   +ASAL YL   
Sbjct: 62  HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL--- 117

Query: 843 HSTPIIHCDLKPSNVLL 859
               ++H ++   N+L+
Sbjct: 118 EDKKLVHGNVCGKNILV 134

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 45.1 bits (106), Expect = 1e-04
 Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 24/195 (12%)

Query: 717 SYFELLRATDNFAENNIIGIGGFGSV---YRARLEDGVEIAIKVFHP-QCASTLKSFEAE 772
           S F +L+   N      IG G  G V   Y A L+  V I  K+  P Q  +  K    E
Sbjct: 11  STFTVLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRE 66

Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN----- 827
             ++K + H+N++ +++  +        LE   +  L   L  +N    I   L+     
Sbjct: 67  LVLMKCVNHKNIISLLNVFTPQK----SLEEFQDVYLVMELMDANLCQVIQMELDHERMS 122

Query: 828 -IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
            ++  +   +++LH   S  IIH DLKPSN+++  D    + DFG+A+       S M T
Sbjct: 123 YLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMT 176

Query: 887 QTLATIGYMAPDEIF 901
             + T  Y AP+ I 
Sbjct: 177 PYVVTRYYRAPEVIL 191

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 8/177 (4%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQ---CASTLKSFEAECEVIKNIRH 781
            +F   +++G G FG V   R +   +I A+KV          T+  FE E +++     
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             + ++  +  + D   LV+EY   G L   L   N   + F        +A  +  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIHS 117

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
            H    +H D+KP NVL+D      L+DFG A  L+  ++       + T  Y+AP+
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT-ANKMVNSKLPVGTPDYIAPE 173

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 14/175 (8%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHP--QCASTLKSFEAECEVIKNIRHRNLVK--- 786
           +IG G +G V  A     G ++AIK  +   +  S       E ++++ +RH ++V+   
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 787 IISSCSNDDFKAL--VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           I+   S  +FK +  V E M     E  LH    A +     +    +   L  L + H+
Sbjct: 67  IMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT 121

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM-RTQTLATIGYMAPD 898
             + H DLKP N+L + D    + DFG+A++   +  + +  T  +AT  Y AP+
Sbjct: 122 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.2 bits (95), Expect = 2e-04
 Identities = 23/60 (38%), Positives = 29/60 (48%)

Query: 418 NLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKI 477
           NL  L L  N L+      F GL  L+ LDL+ N L    P+    L  L  LDL+GN +
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 44.5 bits (105), Expect = 2e-04
 Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 36/188 (19%)

Query: 733 IIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKN----IRHRN--LV 785
           ++G G FG V  A L+   E  A+K         L   + EC +++     +   N  L 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDV--VLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 786 KIISSCSNDDFKALVLEYMSNGSLE---------DCLHSSNCALNIFCRLNIMIDIASAL 836
            +  +    +    V+E+++ G L          D   ++  A  I C L          
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGL---------- 109

Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL-LSGEDESTMRTQTLATIGYM 895
               F HS  II+ DLK  NV+LD D    ++DFGM K  + G++ ++       T  Y+
Sbjct: 110 ---QFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST---FCGTPDYI 163

Query: 896 APDEIFVG 903
           AP EI  G
Sbjct: 164 AP-EILQG 170

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.3 bits (107), Expect = 2e-04
 Identities = 29/83 (34%), Positives = 46/83 (55%), Gaps = 16/83 (19%)

Query: 799 LVLEYMSNGSLEDCLHSSNCALNIF------CRLNIMIDIASALEYLHFGHSTPIIHCDL 852
           LV+EY+  G ++  LH       I+        +  + ++A AL+YLH  H   IIH DL
Sbjct: 81  LVMEYLIGGDVKSLLH-------IYGYFDEEMAVKYISEVALALDYLH-RHG--IIHRDL 130

Query: 853 KPSNVLLDEDMVAHLSDFGMAKL 875
           KP N+L+  +    L+DFG++K+
Sbjct: 131 KPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 29/80 (36%), Positives = 38/80 (47%), Gaps = 16/80 (20%)

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK---------LLSGEDESTMR 885
           ALEYLH   +  I+H DLKP N+L+       L+DFG++K         L  G  E   R
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 886 ----TQTLATIGYMAPDEIF 901
                Q   T  Y+AP+ I 
Sbjct: 170 EFLDKQVCGTPEYIAPEVIL 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 45/179 (25%), Positives = 80/179 (44%), Gaps = 12/179 (6%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFEAEC-----EVIKNI 779
           D+F    +IG G FG V   +++    I A+K+ +      LK  E  C      V+ N 
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW--EMLKRAETACFREERNVLVNG 58

Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
             + +  +  +  ++++  LV++Y   G L   L      L        + ++  A+  +
Sbjct: 59  DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118

Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           H  H    +H D+KP NVLLD +    L+DFG   L   +D +   +  + T  Y++P+
Sbjct: 119 HQLH---YVHRDIKPDNVLLDMNGHIRLADFGSC-LKMNQDGTVQSSVAVGTPDYISPE 173

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 47/171 (27%), Positives = 81/171 (47%), Gaps = 12/171 (7%)

Query: 733 IIGIGGFGSVYRARLEDGVEI-AIKV---FHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +IG G FG V   R +   ++ A+K+   F     S    F  E +++       +V++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
            +  +D +  +V+EYM  G L + L S+      + R     ++  AL+ +H   S   I
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH---SMGFI 164

Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT-LATIGYMAPD 898
           H D+KP N+LLD+     L+DFG    +    E  +R  T + T  Y++P+
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPE 213

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 59/240 (24%), Positives = 92/240 (38%), Gaps = 45/240 (18%)

Query: 410 PKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQK---LQGLDLAFNKLAGSIPDEIC---- 462
            + +     L  L L  N L          L +   LQ L L  N L       +     
Sbjct: 74  LQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLK 133

Query: 463 -LLSRLNELDLNGNKISG----SISSCLGNLTSLQYLNLGSNRFT-FVIPSTFWNLKD-- 514
            L   L +L L  N++ G    +++  L     L+ LNL +N      I +    LK   
Sbjct: 134 DLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANC 193

Query: 515 -ILSFDISSNLL----DGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLA 569
            +   D+++N L       ++  + +LK++  ++L  NNL      T  G  +L +  L+
Sbjct: 194 NLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNL------TDAGAAALASALLS 247

Query: 570 YNRLEGPIPESFGNMTSLESLDLSNNKI--SGSIPVS---FEKLSYLKELNLSFNKLKGE 624
            N              SL +L LS N I   G+  ++    EK S L EL+L  NK   E
Sbjct: 248 PNI-------------SLLTLSLSCNDITDDGAKDLAEVLAEKES-LLELDLRGNKFGEE 293

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.4 bits (93), Expect = 3e-04
 Identities = 22/61 (36%), Positives = 30/61 (49%), Gaps = 2/61 (3%)

Query: 442 KLQGLDLAFNKLAGSIPDEICL-LSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNR 500
            L+ LDL+ N+L   IPD     L  L  LDL+GN ++         L SL+ L+L  N 
Sbjct: 1   NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 501 F 501
            
Sbjct: 60  L 60

Length = 60

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 44.3 bits (104), Expect = 3e-04
 Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 36/201 (17%)

Query: 717 SYFELLRATDNFAENNIIGIGGFGSV---YRARLEDGVEIAIKVFHP-QCASTLKSFEAE 772
           S F +L+   N      IG G  G V   Y A LE  V I  K+  P Q  +  K    E
Sbjct: 18  STFTVLKRYQNLKP---IGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRE 73

Query: 773 CEVIKNIRHRNLVKIIS----SCSNDDFKAL--VLEYMSNGSLEDCLHSSNCALNIFCRL 826
             ++K + H+N++ +++      S ++F+ +  V+E M           +N    I   L
Sbjct: 74  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----------ANLCQVIQMEL 123

Query: 827 N------IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED 880
           +      ++  +   +++LH   S  IIH DLKPSN+++  D    + DFG+A+      
Sbjct: 124 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--- 177

Query: 881 ESTMRTQTLATIGYMAPDEIF 901
            S M T  + T  Y AP+ I 
Sbjct: 178 TSFMMTPYVVTRYYRAPEVIL 198

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.1 bits (104), Expect = 3e-04
 Identities = 33/118 (27%), Positives = 48/118 (40%), Gaps = 27/118 (22%)

Query: 767 KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL-----------EYMSNGSLEDCLHS 815
           K+   E +++K I HR ++ +I +        +V+           +      LE     
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQ---- 186

Query: 816 SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA 873
              A+ I  RL         LE L + H   IIH D+K  N+ LDE   A L DFG A
Sbjct: 187 ---AITIQRRL---------LEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA 232

Length = 392

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 43.9 bits (103), Expect = 3e-04
 Identities = 53/179 (29%), Positives = 79/179 (44%), Gaps = 16/179 (8%)

Query: 733 IIGIGGFGSVYRARLEDGVEI-AIKVFHPQCAST---LKSFEAECEVIKNIRHRNLVKII 788
           +IG G +  V   RL+    I A+KV   +  +    +   + E  V +   +   +  +
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 789 SSCSNDDFKAL-VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
            SC   + +   V+EY++ G L   +           R     +I+ AL YLH      I
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 117

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAK--LLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
           I+ DLK  NVLLD +    L+D+GM K  L  G+  ST       T  Y+AP EI  GE
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF----CGTPNYIAP-EILRGE 171

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 42.6 bits (100), Expect = 5e-04
 Identities = 41/167 (24%), Positives = 74/167 (44%), Gaps = 25/167 (14%)

Query: 734 IGIGGFGSVYRA--RLEDGVE-IAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKII 788
           +G G FG+V +   +++   + +A+K+        +       E  V++ + +  +V++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------F 841
             C  + +  LV+E    G L           N F + N  +   +  E +H       +
Sbjct: 63  GICEAESW-MLVMELAELGPL-----------NKFLQKNKHVTEKNITELVHQVSMGMKY 110

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              T  +H DL   NVLL     A +SDFG++K L G DE+  + +T
Sbjct: 111 LEETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKT 156

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 42.7 bits (100), Expect = 7e-04
 Identities = 48/172 (27%), Positives = 83/172 (48%), Gaps = 14/172 (8%)

Query: 733 IIGIGGFGSVYRARLEDGVEI-AIKV---FHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +IG G FG V   R +   ++ A+K+   F     S    F  E +++       +V++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
            +  +D +  +V+EYM  G L + +  SN  +          ++  AL+ +H   S  +I
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIH---SMGLI 164

Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM-RTQT-LATIGYMAPD 898
           H D+KP N+LLD+     L+DFG    +   DE+ M R  T + T  Y++P+
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKM---DETGMVRCDTAVGTPDYISPE 213

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 42.5 bits (100), Expect = 8e-04
 Identities = 28/70 (40%), Positives = 39/70 (55%), Gaps = 5/70 (7%)

Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
           +IA  L +LH   S  II+ DLK  NV+LD +    ++DFGM K      ++T RT    
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT-RT-FCG 163

Query: 891 TIGYMAPDEI 900
           T  Y+AP+ I
Sbjct: 164 TPDYIAPEII 173

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 42.1 bits (99), Expect = 8e-04
 Identities = 35/134 (26%), Positives = 60/134 (44%), Gaps = 11/134 (8%)

Query: 734 IGIGGFGSVYRA-RLEDG-------VEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           +G G F  +++  R E G        E+ +KV      +  +SF     ++  + H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
                C   D   +V EY+  GSL+  L  +   +NI  +L +   +A AL +L      
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL---EDK 119

Query: 846 PIIHCDLKPSNVLL 859
            + H ++   NVLL
Sbjct: 120 GLTHGNVCAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 42.0 bits (99), Expect = 8e-04
 Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 29/153 (18%)

Query: 737 GGFGSVYRARLED---GVEIAIKVFHPQCASTLKSFEAECEV---------IKNIRHRNL 784
           G FG ++   L D   G E  + V       T+K   +E +V         +  + H+N+
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFV------KTVKDHASEIQVTLLLQESCLLYGLSHQNI 70

Query: 785 VKIISSCSNDDFKALVLE-YMSNGSL----EDCLHSS-NCALNIFCR--LNIMIDIASAL 836
           + I+  C  D     VL  YM+ G+L    + C     N    +  +  +++ I IA  +
Sbjct: 71  LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130

Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSD 869
            YLH      +IH D+   N ++DE++   ++D
Sbjct: 131 SYLH---KRGVIHKDIAARNCVIDEELQVKITD 160

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 42.3 bits (99), Expect = 0.001
 Identities = 47/195 (24%), Positives = 77/195 (39%), Gaps = 26/195 (13%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFEAECEVIKNIRHRN- 783
           D+F    +IG G FG V   + +D   I A+K+         K+   E E + +IR    
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERD 53

Query: 784 ---------LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
                    +VK+  S  +     L++E++  G +   L   +              IA 
Sbjct: 54  ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD----TLSEEATQFYIAE 109

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY 894
            +  +   H    IH D+KP N+LLD      LSDFG+   L    +   RT+    + +
Sbjct: 110 TVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL----KKAHRTEFYRNLTH 165

Query: 895 MAPDEIFVGELSLKR 909
             P +     ++ KR
Sbjct: 166 NPPSDFSFQNMNSKR 180

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 34/150 (22%), Positives = 66/150 (44%), Gaps = 10/150 (6%)

Query: 733 IIGIGGFGS--VYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           ++G G FG   + +    D      ++  P+ +S ++    E  ++  ++H N+V    S
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR---LNIMIDIASALEYLHFGHSTPI 847
              D    +V+EY   G L   +      L  F     L   + +   ++++H      +
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKL--FPEDTILQWFVQMCLGVQHIH---EKRV 121

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLS 877
           +H D+K  N+ L ++    L DFG A+LL+
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLT 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 42.0 bits (98), Expect = 0.001
 Identities = 48/190 (25%), Positives = 86/190 (45%), Gaps = 29/190 (15%)

Query: 734 IGIGGFGSVYRARLEDGV---EIAIKVFHPQCASTLKSFEA--ECEVIKNIRHRNLVKII 788
           +G G +G VY+A+ +DG    E A+K    Q   T  S  A  E  +++ ++H N++ + 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALK----QIEGTGISMSACREIALLRELKHPNVIALQ 64

Query: 789 SS-CSNDDFKA-LVLEYMSNGSLEDCLH--------SSNCALNIFCRLNIMIDIASALEY 838
               S+ D K  L+ +Y  +    D  H         +N       R  +   +   L+ 
Sbjct: 65  KVFLSHSDRKVWLLFDYAEH----DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 839 LHFGHSTPIIHCDLKPSNVLL----DEDMVAHLSDFGMAKLLSGEDESTMRTQ-TLATIG 893
           +H+ H+  ++H DLKP+N+L+     E     ++D G A+L +   +        + T  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 894 YMAPDEIFVG 903
           Y AP E+ +G
Sbjct: 181 YRAP-ELLLG 189

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 42.2 bits (100), Expect = 0.001
 Identities = 23/85 (27%), Positives = 38/85 (44%), Gaps = 14/85 (16%)

Query: 797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSN 856
           K +V+EY+    L+D L              ++  +   +  LH      I+H DL  SN
Sbjct: 411 KTIVMEYIGGKDLKDVLEG---------NPELVRKVGEIVAKLH---KAGIVHGDLTTSN 458

Query: 857 VLLDEDMVAHLSDFGMAKLLSGEDE 881
            ++ +D + +L DFG+ K  S   E
Sbjct: 459 FIVRDDRL-YLIDFGLGK-YSDLIE 481

Length = 535

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.8 bits (98), Expect = 0.001
 Identities = 44/197 (22%), Positives = 78/197 (39%), Gaps = 26/197 (13%)

Query: 726 DNFAENNIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKS----------FEAECE 774
           ++F    +IG G FG V    + + G   A+K       + LKS           +AE +
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK-------TLLKSEMFKKDQLAHVKAERD 53

Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           V+       +V +  S  +  +  L++E++  G L   L   +       R   M +   
Sbjct: 54  VLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVL 112

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST----MRTQTLA 890
           A+E +H       IH D+KP N+L+D      LSDFG++     + +S     +      
Sbjct: 113 AIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSN 169

Query: 891 TIGYMAPDEIFVGELSL 907
                  + + V  ++L
Sbjct: 170 KNRIDNRNSVAVDSINL 186

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 46/199 (23%), Positives = 83/199 (41%), Gaps = 35/199 (17%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
           D + +   IG G +G VY+AR    G  +A+K        T    + E      +R  +L
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALK-------KTRLEMDEEGIPPTALREISL 53

Query: 785 VKIISSC------------SNDDFKA---LVLEYMSNGSLEDCLHS----SNCALNIFCR 825
           ++++S                 + K    LV EY+ +  L+  + S        L     
Sbjct: 54  LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTI 112

Query: 826 LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAKLLSGEDESTM 884
            + M  +   + + H      ++H DLKP N+L+D+   +  ++D G+ +  S   +S  
Sbjct: 113 KSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY- 168

Query: 885 RTQTLATIGYMAPDEIFVG 903
            T  + T+ Y AP E+ +G
Sbjct: 169 -THEIVTLWYRAP-EVLLG 185

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.002
 Identities = 22/61 (36%), Positives = 32/61 (52%), Gaps = 2/61 (3%)

Query: 74  KVTTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQ 132
            + +L+LS+ N    IP      L +LK LDLS N L+S  P +   + +L+ L L  N 
Sbjct: 1   NLKSLDLSN-NRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 133 L 133
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 41.1 bits (96), Expect = 0.002
 Identities = 18/47 (38%), Positives = 30/47 (63%), Gaps = 3/47 (6%)

Query: 827 NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA 873
           NIM D+ + LEY+H      I H D+KP N+++D +   ++ D+G+A
Sbjct: 130 NIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.5 bits (97), Expect = 0.002
 Identities = 22/76 (28%), Positives = 38/76 (50%), Gaps = 3/76 (3%)

Query: 826 LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR 885
           L+    +A  +E+L    S   +H DL   NVLL +  +  + DFG+A+ +  +     +
Sbjct: 240 LSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296

Query: 886 TQTLATIGYMAPDEIF 901
             T   + +MAP+ IF
Sbjct: 297 GSTFLPVKWMAPESIF 312

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 41.1 bits (96), Expect = 0.002
 Identities = 22/70 (31%), Positives = 37/70 (52%), Gaps = 3/70 (4%)

Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           +A  +E+L    S   IH DL   N+LL E+ V  + DFG+A+ +  + +   +      
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 892 IGYMAPDEIF 901
           + +MAP+ IF
Sbjct: 240 LKWMAPESIF 249

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 22/70 (31%), Positives = 37/70 (52%), Gaps = 3/70 (4%)

Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           +A  +E+L    S   IH DL   N+LL E+ V  + DFG+A+ +  + +   +      
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 892 IGYMAPDEIF 901
           + +MAP+ IF
Sbjct: 245 LKWMAPETIF 254

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 16/190 (8%)

Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKS-----FEAECEVIKNI 779
           ++F    +IG G FG V   + +D G   A+K+     A  L+        AE +++   
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRK--ADMLEKEQVGHIRAERDILVEA 58

Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
               +VK+  S  +     L++E++  G +   L   +              IA  +  +
Sbjct: 59  DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAI 114

Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
              H    IH D+KP N+LLD      LSDFG+   L    +   RT+    + +  P +
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL----KKAHRTEFYRNLNHSLPSD 170

Query: 900 IFVGELSLKR 909
                ++ KR
Sbjct: 171 FTFQNMNSKR 180

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.0 bits (96), Expect = 0.003
 Identities = 25/97 (25%), Positives = 47/97 (48%), Gaps = 3/97 (3%)

Query: 805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV 864
           S+ S ++     +  L++   L     +A  +++L    S   IH D+   NVLL +  V
Sbjct: 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRV 250

Query: 865 AHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
           A + DFG+A+ +  +    ++      + +MAP+ IF
Sbjct: 251 AKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 287

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 40.1 bits (94), Expect = 0.003
 Identities = 34/144 (23%), Positives = 64/144 (44%), Gaps = 11/144 (7%)

Query: 741 SVYRARLEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRHRNLVKI----ISSCSN 793
           S+Y+    +  E+ I+ F   H      +   E E + ++ I   N++KI    I    +
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
               +L+LEY + G L + L      L+   +L++ ID    L  L+   + P  + +L 
Sbjct: 94  LPRLSLILEYCTRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150

Query: 854 PSNVLLDEDMVAHLSDFGMAKLLS 877
             + L+ E+    +   G+ K+LS
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILS 174

Length = 283

>gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional

 Score = 40.8 bits (95), Expect = 0.004
 Identities = 46/189 (24%), Positives = 82/189 (43%), Gaps = 42/189 (22%)

Query: 147 ILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNL 206
           I  + L  N+L   LPEN+  ++   K L+   N     IP++L     +QE+ L  N +
Sbjct: 201 ITTLILDNNELK-SLPENLQGNI---KTLYANSNQL-TSIPATLPD--TIQEMELSINRI 253

Query: 207 SGAIPKEIGNLTVLQRISLINNKLHG---EIPQEIGYLQNLDVLQLGFNNLTGVVPATIF 263
           +  +P+ +   + LQ + L +NK+      +P+E   L+ L V     N++   +PA + 
Sbjct: 254 T-ELPERLP--SALQSLDLFHNKISCLPENLPEE---LRYLSVYD---NSIR-TLPAHL- 302

Query: 264 NMSTLKEIFLYNNSLSG--------------------SLPSRIDLALPNLEFLNLGINSF 303
             S +  + + +NSL+                     SLP+ +   L  L+     I   
Sbjct: 303 -PSGITHLNVQSNSLTALPETLPPGLKTLEAGENALTSLPASLPPELQVLDVSKNQITVL 361

Query: 304 SGTIPSSIT 312
             T+P +IT
Sbjct: 362 PETLPPTIT 370

Length = 754

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.9 bits (93), Expect = 0.004
 Identities = 25/115 (21%), Positives = 53/115 (46%), Gaps = 3/115 (2%)

Query: 748 EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNG 807
           E  +++ +KV  P       +F     +++ + H+++V +   C  D    +V E++  G
Sbjct: 30  EKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFG 89

Query: 808 SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED 862
            L+  +H  +  L    +  +   +ASAL YL       ++H ++   N+LL  +
Sbjct: 90  PLDLFMHRKSDVLTTPWKFKVAKQLASALSYL---EDKDLVHGNVCTKNILLARE 141

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	985
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.98
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.98
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.98
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.98
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.98
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.98
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.98
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.98
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.98
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.98
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.98
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.98
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.98
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.98
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.98
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.98
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.98
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.98
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.98
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.98
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.98
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.98
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.98
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.98
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.98
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.98
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.98
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.98
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.98
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.98
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.98
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.98
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.98
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.98
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.98
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.98
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.98
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.98
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.98
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.98
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.98
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.98
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.98
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.98
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.98
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.98
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.98
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.98
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.98
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.98
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.98
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.98
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.98
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.98
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.98
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.98
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.97
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
KOG0610	459	consensus Putative serine/threonine protein kinase	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
PTZ00284	467	protein kinase; Provisional	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.97
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.96
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.96
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.96
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.96
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.96
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.96
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.96
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
PHA03210	501	serine/threonine kinase US3; Provisional	99.96
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.96
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.96
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.96
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.96
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.96
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.96
PLN00009	294	cyclin-dependent kinase A; Provisional	99.96
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.96
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.96
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.96
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.96
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.96
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.96
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.96
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.96
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.96
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.96
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.96
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.96
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.96
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.96
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.96
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.96
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.96
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.96
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.96
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.96
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.96
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.96
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.96
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.95
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.95
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.95
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.95
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.95
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.95
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.95
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.95
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.94
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.94
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.94
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.94
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.94
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.94
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.94
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.94
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.92
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.92
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.92
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
KOG1152	772	consensus Signal transduction serine/threonine kin	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.9
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.89
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.89
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.88
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.84
PLN00181	793	protein SPA1-RELATED; Provisional	99.84
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.78
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.78
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.78
PRK10345	210	hypothetical protein; Provisional	99.77
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.75
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.75
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.74
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.73
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.73
smart00090	237	RIO RIO-like kinase.	99.72
PRK14879	211	serine/threonine protein kinase; Provisional	99.7
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.69
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.69
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.68
PLN03150	623	hypothetical protein; Provisional	99.67
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.65
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.61
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.59
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.55
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.52
PLN03150	623	hypothetical protein; Provisional	99.49
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.47
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.46
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.46
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.44
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.44
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.41
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.37
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.34
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.27
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.25
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.23
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.22
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.22
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.21
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.18
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.16
KOG1243	690	consensus Protein kinase [General function predict	99.15
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.11
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.1
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.09
KOG3087	229	consensus Serine/threonine protein kinase [General	99.08
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.07
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.06
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.06
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.04
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.04
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.02
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.02
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.98
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.94
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.9
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.86
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.81
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.8
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.79
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.74
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.61
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.56
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.55
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.55
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.54
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.52
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.5
PRK09902	216	hypothetical protein; Provisional	98.48
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	98.42
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.36

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.1e-115  Score=1106.81  Aligned_cols=892  Identities=32%  Similarity=0.532  Sum_probs=706.1

Q ss_pred             ccCChhHHHHHHHHHHhcccCCCCcccCCCCCCCCcceeeeEEEeCCCCeEEEEEecCCcccccCchhcccccccceecc
Q 001988           25 ASNISTDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDL  104 (985)
Q Consensus        25 ~~~~~~~~~aLl~~k~~~~~~~~~~~~s~w~~~~~~c~w~gv~c~~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L  104 (985)
                      .+..+.|++||++||+++. ||.+.+.+ |+.+.+||.|.||+|+. +++|+.|||++++++|.+++.+..+++|+.|+|
T Consensus        24 ~~~~~~~~~~l~~~~~~~~-~~~~~~~~-w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~L  100 (968)
T PLN00113         24 SMLHAEELELLLSFKSSIN-DPLKYLSN-WNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINL  100 (968)
T ss_pred             cCCCHHHHHHHHHHHHhCC-CCcccCCC-CCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEEC
Confidence            3445789999999999995 78777766 98888999999999985 468999999999999999999999999999999


Q ss_pred             cCCcCCCCCCcccc-cCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccceecccCcccc
Q 001988          105 SHNKLSSNIPSSIF-TMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFY  183 (985)
Q Consensus       105 ~~n~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~  183 (985)
                      ++|+++|.+|..++ .+++|++|+|++|.++|.+|.  ..+++|++|+|++|.+++.+|..+ +++++|++|+|++|.+.
T Consensus       101 s~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~-~~l~~L~~L~L~~n~l~  177 (968)
T PLN00113        101 SNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDI-GSFSSLKVLDLGGNVLV  177 (968)
T ss_pred             CCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHH-hcCCCCCEEECccCccc
Confidence            99999999999887 899999999999999987775  346777778888877777777766 56777777777777777


Q ss_pred             ccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCccccc
Q 001988          184 GKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIF  263 (985)
Q Consensus       184 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  263 (985)
                      +.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..++++++|++|++++|++++.+|..+.
T Consensus       178 ~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~  257 (968)
T PLN00113        178 GKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG  257 (968)
T ss_pred             ccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHh
Confidence            77777777777777777777777777777777777777777777777777777777777777777777777777777777


Q ss_pred             CCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCce
Q 001988          264 NMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKL  343 (985)
Q Consensus       264 ~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~  343 (985)
                      ++++|++|+|++|++.+.+|..+. .+++|+.|+|++|++++.+|..+.++++|+.|++++|.+.+..|..++.+++   
T Consensus       258 ~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~---  333 (968)
T PLN00113        258 NLKNLQYLFLYQNKLSGPIPPSIF-SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR---  333 (968)
T ss_pred             CCCCCCEEECcCCeeeccCchhHh-hccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCC---
Confidence            777777777777777766666553 5666666666666666666666666666666666666666655555555544   


Q ss_pred             EeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEE
Q 001988          344 FDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLS  423 (985)
Q Consensus       344 L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  423 (985)
                                                |+.|++++|.+.+.+|..+..++ +|+.|++++|++++.+|..+..+++|+.|+
T Consensus       334 --------------------------L~~L~L~~n~l~~~~p~~l~~~~-~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~  386 (968)
T PLN00113        334 --------------------------LQVLQLWSNKFSGEIPKNLGKHN-NLTVLDLSTNNLTGEIPEGLCSSGNLFKLI  386 (968)
T ss_pred             --------------------------CCEEECcCCCCcCcCChHHhCCC-CCcEEECCCCeeEeeCChhHhCcCCCCEEE
Confidence                                      55555555555555666666655 677777777777777788888888888899


Q ss_pred             ccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeee
Q 001988          424 LGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTF  503 (985)
Q Consensus       424 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  503 (985)
                      +++|++.+.+|..++.+++|+.|++++|++++.+|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|++.+
T Consensus       387 l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~  466 (968)
T PLN00113        387 LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFG  466 (968)
T ss_pred             CcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeee
Confidence            99998888888888888899999999999988888888889999999999999998888888889999999999999988


Q ss_pred             ecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhc
Q 001988          504 VIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGN  583 (985)
Q Consensus       504 ~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  583 (985)
                      .+|..+ ..++|+.|++++|++.+..|..+.++++|+.|+|++|++.+.+|..++++++|++|+|++|++++.+|..|.+
T Consensus       467 ~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  545 (968)
T PLN00113        467 GLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSE  545 (968)
T ss_pred             ecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhC
Confidence            888765 4588999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCeEecCCCcccCCCCccccccccccccccccccccCCCCCCCCCcccccccccCCccccCCCC-CCCCCCCCCCCC
Q 001988          584 MTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPN-LQVPPCKHSQPR  662 (985)
Q Consensus       584 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~-~~~~~~~~~~~~  662 (985)
                      +++|++|||++|++++.+|..+..+++|+.|++++|+++|.+|..+++.++...++.||+.+||.+. ...+||....  
T Consensus       546 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~--  623 (968)
T PLN00113        546 MPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR--  623 (968)
T ss_pred             cccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc--
Confidence            9999999999999999999999999999999999999999999999999999999999999999653 3456774321  


Q ss_pred             cccccccceehhHhhHhHHHHHHHHHHHHHhcCCCcc-ccC--c-cccc----cCCCcccccCHHHHHHHhcCccCCcee
Q 001988          663 AQHKSKKTILLLVIFLPLSTTLVIAVALALKRGKRGT-MLS--N-DIIL----SSQPTIRRFSYFELLRATDNFAENNII  734 (985)
Q Consensus       663 ~~~~s~~~~~i~~~~~~~~~~~~~~~~~~~~r~~~~~-~~~--~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~i  734 (985)
                        ......++++++++++++++++++++.++|+++.. ...  . +...    ......+.+++.++   ...|...+.|
T Consensus       624 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~i  698 (968)
T PLN00113        624 --KTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVI  698 (968)
T ss_pred             --ccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcccEE
Confidence              11112223332222222222223333333332211 110  0 0000    00001112333333   3457788899


Q ss_pred             eccCceeEEEEEE-cCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCChHHHh
Q 001988          735 GIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCL  813 (985)
Q Consensus       735 g~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l  813 (985)
                      |+|+||.||+|+. .+++.||||+++.....    ...|++++++++|||||+++++|.+.+..++||||+++|+|.+++
T Consensus       699 g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l  774 (968)
T PLN00113        699 SRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL  774 (968)
T ss_pred             ccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHH
Confidence            9999999999986 48899999998644221    235688999999999999999999999999999999999999999


Q ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecccccccc
Q 001988          814 HSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG  893 (985)
Q Consensus       814 ~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~  893 (985)
                      +.    ++|..+.+++.|+|+|++|||+.++++|+|||+||+||+++.++.+++. ||.+.....      .....+|+.
T Consensus       775 ~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~  843 (968)
T PLN00113        775 RN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSA  843 (968)
T ss_pred             hc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCcccccc
Confidence            63    7899999999999999999976558899999999999999999988876 665543321      112358899


Q ss_pred             cccccccccCccchhhhcccccccchhhhcccccccCcch-----------------------------hhhhHHHHHHH
Q 001988          894 YMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK-----------------------------HFAAKEQCLLS  944 (985)
Q Consensus       894 y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~-----------------------------~~~~~~~~~~~  944 (985)
                      |||||++.+..++.++|| |++|++++|+++++.+.....                             .......+..+
T Consensus       844 y~aPE~~~~~~~~~~sDv-~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (968)
T PLN00113        844 YVAPETRETKDITEKSDI-YGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVE  922 (968)
T ss_pred             ccCcccccCCCCCcccch-hhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHH
Confidence            999999999999999999 999999999999886642110                             00112234567


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          945 IFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       945 l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      +.+++.+||+.+|++||+|.|++++|+++.+..
T Consensus       923 ~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        923 VMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             HHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            889999999999999999999999999987643

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.2e-62  Score=625.23  Aligned_cols=518  Identities=35%  Similarity=0.554  Sum_probs=404.1

Q ss_pred             cccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccc-cCCccceeeeccccccCCCChhHhhhcccccee
Q 001988           97 SSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHL  175 (985)
Q Consensus        97 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L  175 (985)
                      ..++.|||++|.++|.+|..+..+++|++|+|++|+++|.+|..++ .+++|++|+|++|+++|.+|.   +.+++|++|
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~---~~l~~L~~L  145 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR---GSIPNLETL  145 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc---cccCCCCEE
Confidence            4688999999999999999999999999999988888766655444 556666666666666655554   235555666


Q ss_pred             cccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCc
Q 001988          176 FLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLT  255 (985)
Q Consensus       176 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  255 (985)
                      +|++|.+++.+|..++++++|++|+|++|.+.+.+|..++++++|++|+|++|++.+.+|..++++++|++|+|++|+++
T Consensus       146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~  225 (968)
T PLN00113        146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS  225 (968)
T ss_pred             ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence            66666555555555555556666666655555555555555555555555555555555555555555555555555555


Q ss_pred             ccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcc
Q 001988          256 GVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAI  335 (985)
Q Consensus       256 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l  335 (985)
                      +.+|..+.++++|++|++++|++++                         .+|..++++++|+.|++++|++.+.+|..+
T Consensus       226 ~~~p~~l~~l~~L~~L~L~~n~l~~-------------------------~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l  280 (968)
T PLN00113        226 GEIPYEIGGLTSLNHLDLVYNNLTG-------------------------PIPSSLGNLKNLQYLFLYQNKLSGPIPPSI  280 (968)
T ss_pred             CcCChhHhcCCCCCEEECcCceecc-------------------------ccChhHhCCCCCCEEECcCCeeeccCchhH
Confidence            5555555555555555555555554                         444444445555555555555555555555


Q ss_pred             cCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCC
Q 001988          336 GNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGN  415 (985)
Q Consensus       336 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~  415 (985)
                      .++++|++|++++|++.+..+.     .+.++++|++|++++|.+.+..|..+..++ +|+.|++++|.+++.+|..++.
T Consensus       281 ~~l~~L~~L~Ls~n~l~~~~p~-----~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~  354 (968)
T PLN00113        281 FSLQKLISLDLSDNSLSGEIPE-----LVIQLQNLEILHLFSNNFTGKIPVALTSLP-RLQVLQLWSNKFSGEIPKNLGK  354 (968)
T ss_pred             hhccCcCEEECcCCeeccCCCh-----hHcCCCCCcEEECCCCccCCcCChhHhcCC-CCCEEECcCCCCcCcCChHHhC
Confidence            5555555555555555433222     245566777777777777777888888887 8999999999999999999999


Q ss_pred             CCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEe
Q 001988          416 LSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLN  495 (985)
Q Consensus       416 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  495 (985)
                      +++|+.|++++|++++.+|..+..+++|+.|++++|.+.+.+|..+..+++|+.|+|++|++++.+|..|.++++|+.|+
T Consensus       355 ~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  434 (968)
T PLN00113        355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLD  434 (968)
T ss_pred             CCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEE
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceecc
Q 001988          496 LGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEG  575 (985)
Q Consensus       496 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  575 (985)
                      +++|++++.+|..+..+++|+.|++++|++.+..|..+ ..++|+.|++++|++++.+|..|.++++|+.|+|++|++++
T Consensus       435 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  513 (968)
T PLN00113        435 ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSG  513 (968)
T ss_pred             CcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCccee
Confidence            99999999999999999999999999999998888765 45899999999999999999999999999999999999999


Q ss_pred             chhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCCCCCC-CCCcccccccccCCccccCCC
Q 001988          576 PIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRG-GPFANFTAESFMGNELLCGLP  649 (985)
Q Consensus       576 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~  649 (985)
                      .+|..+.++++|++|+|++|++++.+|..|..+++|+.|+|++|+++|.+|.. ..+..+....+.+|+..+..|
T Consensus       514 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p  588 (968)
T PLN00113        514 EIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP  588 (968)
T ss_pred             eCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence            99999999999999999999999999999999999999999999999999974 345566777778887665444

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=393.03  Aligned_cols=262  Identities=39%  Similarity=0.604  Sum_probs=224.5

Q ss_pred             cccccCHHHHHHHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeee
Q 001988          712 TIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSC  791 (985)
Q Consensus       712 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~  791 (985)
                      ..+.|++.|+..||++|...+.||+|+||.||+|..++|+.||||++.........+|.+|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            46789999999999999999999999999999999999999999988766433146699999999999999999999999


Q ss_pred             ecCC-ceEEEEeccCCCChHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 001988          792 SNDD-FKALVLEYMSNGSLEDCLHSSNC-ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSD  869 (985)
Q Consensus       792 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~D  869 (985)
                      .+.+ +.++||||+++|+|.++++.... .++|..|++||.++|+||+|||+...+.||||||||+|||+|+++.+||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9998 59999999999999999998766 889999999999999999999876677899999999999999999999999


Q ss_pred             ccCceeccCCCCcceeccc-ccccccccccccccCccchhhhcccccccchhhhcccccccCcch---------------
Q 001988          870 FGMAKLLSGEDESTMRTQT-LATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK---------------  933 (985)
Q Consensus       870 fGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~---------------  933 (985)
                      ||+|+.....  ....... .||.+|+|||++..+..+.++|| |+||++++|+++++.......               
T Consensus       221 FGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDV-ySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  221 FGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDV-YSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             ccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCccccc-ccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            9999765321  1111112 79999999999999999999999 999999999999874332110               


Q ss_pred             -----------h---hhhH-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          934 -----------H---FAAK-EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       934 -----------~---~~~~-~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                                 .   .... .++...+..++.+|++.+|.+||+|.||++.|+.+...
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence                       0   0011 14567789999999999999999999999999666543

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=2.5e-47  Score=392.91  Aligned_cols=488  Identities=27%  Similarity=0.401  Sum_probs=290.2

Q ss_pred             EEEEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeecc
Q 001988           75 VTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSK  154 (985)
Q Consensus        75 v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~  154 (985)
                      ...+++++|.++ .+.+.+.+|..|++|++++|+++ ..|++++.+..++.|+.|+|.++ .+|.....+.++..|+.|+
T Consensus        47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~  123 (565)
T KOG0472|consen   47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS  123 (565)
T ss_pred             hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence            567889999988 67788999999999999999998 68999999999999999999887 2333444444455555555


Q ss_pred             ccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCc
Q 001988          155 NKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEI  234 (985)
Q Consensus       155 n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  234 (985)
                      |.+. .+|+++ +.+..|+.|+..+|+++ ..|+.++.+.+|..|++.+|++....|..+ +++.|++||+..|-+. .+
T Consensus       124 n~~~-el~~~i-~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-tl  198 (565)
T KOG0472|consen  124 NELK-ELPDSI-GRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-TL  198 (565)
T ss_pred             ccee-ecCchH-HHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-cC
Confidence            5554 444444 33444555555555554 444445555555555555555542222222 2555555555555444 44


Q ss_pred             hhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCC
Q 001988          235 PQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNA  314 (985)
Q Consensus       235 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  314 (985)
                      |..++.+.+|+.|+|.+|+|. ..| .|.+++.|++|+++.|+|+ .+|......                        +
T Consensus       199 P~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~------------------------L  251 (565)
T KOG0472|consen  199 PPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKH------------------------L  251 (565)
T ss_pred             ChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcc------------------------c
Confidence            445555555555555555554 333 4445555555555555554 444444444                        4


Q ss_pred             CCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchh-h
Q 001988          315 SKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLS-L  393 (985)
Q Consensus       315 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~  393 (985)
                      .++.+|||+.|+++ ..|..+.-+++|.+||+++|.|++.+..      ++++ +|+.|.+.+|++...-.+-+..-+ .
T Consensus       252 ~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~s------Lgnl-hL~~L~leGNPlrTiRr~ii~~gT~~  323 (565)
T KOG0472|consen  252 NSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYS------LGNL-HLKFLALEGNPLRTIRREIISKGTQE  323 (565)
T ss_pred             ccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcc------cccc-eeeehhhcCCchHHHHHHHHcccHHH
Confidence            55555555555554 4455555555555555555555555543      4455 566666666665422111111100 0


Q ss_pred             cccceec--cccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccC---CC
Q 001988          394 SLERLNI--AFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSR---LN  468 (985)
Q Consensus       394 ~L~~L~L--~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~  468 (985)
                      -|++|.=  ..-.++..-..      .-..-+    ...+..| ....+.+.+.|+++.-+++ .+|+....-.+   ..
T Consensus       324 vLKyLrs~~~~dglS~se~~------~e~~~t----~~~~~~~-~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt  391 (565)
T KOG0472|consen  324 VLKYLRSKIKDDGLSQSEGG------TETAMT----LPSESFP-DIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVT  391 (565)
T ss_pred             HHHHHHHhhccCCCCCCccc------ccccCC----CCCCccc-chhhhhhhhhhcccccccc-cCCHHHHHHhhhcceE
Confidence            1222211  00011100000      000000    0011111 1233455666666666666 45544443333   56


Q ss_pred             eEEccCCccccccCCCCcCcCcCce-EeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCC
Q 001988          469 ELDLNGNKISGSISSCLGNLTSLQY-LNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRN  547 (985)
Q Consensus       469 ~L~L~~N~l~~~~~~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  547 (985)
                      ..+++.|++. .+|..+..+..+.. +.+++|.++ .+|..++.+++|..|++++|-+.. +|..++.+..|+.||+|.|
T Consensus       392 ~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln~-LP~e~~~lv~Lq~LnlS~N  468 (565)
T KOG0472|consen  392 SVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLND-LPEEMGSLVRLQTLNLSFN  468 (565)
T ss_pred             EEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhhh-cchhhhhhhhhheeccccc
Confidence            6677777776 45665655555444 344444443 566666777777777777777664 4556777777888888888


Q ss_pred             ccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcccccccccccccccccccc
Q 001988          548 NLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLK  622 (985)
Q Consensus       548 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  622 (985)
                      .+. .+|..+..+..|+.+-.++|++....|+.+.+|.+|.+|||.+|.|. .+|..+++|++|++|+++||+++
T Consensus       469 rFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  469 RFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            887 78888888888888888889998777777999999999999999998 78889999999999999999998

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=358.73  Aligned_cols=235  Identities=25%  Similarity=0.340  Sum_probs=205.6

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCC-ceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDD-FKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~lv~e~  803 (985)
                      +.+..+.||+|..|+||+++++ +++.+|+|++...... ..+++.+|+++++.++||+||.+||+|..++ ...|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3445678999999999999976 7888999999655333 4678999999999999999999999999998 59999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      |++|+|++.+... +.+++...-+++.+|++||.|||  ++++||||||||+|||++..|+|||||||.++.+.+.    
T Consensus       160 MDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh--~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLH--EERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----  232 (364)
T ss_pred             cCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh--hccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence            9999999999876 36899999999999999999996  4699999999999999999999999999999887533    


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcc-----------------hhhhhHHH-HHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEE-----------------KHFAAKEQ-CLLSI  945 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~-----------------~~~~~~~~-~~~~l  945 (985)
                      ...+.+||..|||||.+.++.|+.++|+ |++|..++|+..|+.+....                 +.+..+++ +++++
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDI-WSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef  311 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDI-WSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEF  311 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccce-ecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence            4456789999999999999999999999 99999999999998766553                 11122343 88999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHH
Q 001988          946 FSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      ..++..|+++||.+||++.|+++.
T Consensus       312 ~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  312 RSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcC
Confidence            999999999999999999998864

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=4.2e-46  Score=383.85  Aligned_cols=480  Identities=27%  Similarity=0.398  Sum_probs=372.4

Q ss_pred             cccCCccceeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCcccccccccccc
Q 001988          141 TFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVL  220 (985)
Q Consensus       141 ~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  220 (985)
                      +|.-..++.|.+++|.+. .+-+.+ .++..|.+|++.+|+++ +.|++++.+..++.|+.++|+++ .+|+.++++.+|
T Consensus        41 wW~qv~l~~lils~N~l~-~l~~dl-~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l  116 (565)
T KOG0472|consen   41 WWEQVDLQKLILSHNDLE-VLREDL-KNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISL  116 (565)
T ss_pred             hhhhcchhhhhhccCchh-hccHhh-hcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhh
Confidence            344455666666666666 444444 46778888888888887 77888888888888888888887 778888888888


Q ss_pred             ceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecC
Q 001988          221 QRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGI  300 (985)
Q Consensus       221 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~  300 (985)
                      ..|+++.|.+. ++|++++.+-.|+.|+..+|+++ ..|+.++++.+|..+++.+|++. .+|.... .++.|++||...
T Consensus       117 ~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i-~m~~L~~ld~~~  192 (565)
T KOG0472|consen  117 VKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHI-AMKRLKHLDCNS  192 (565)
T ss_pred             hhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHH-HHHHHHhcccch
Confidence            88888888887 67777888888888888888887 67777788888888888888887 5555443 377888888888


Q ss_pred             ccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCC
Q 001988          301 NSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPL  380 (985)
Q Consensus       301 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l  380 (985)
                      |.++ .+|..++.+.+|+.|+|..|++. ..| .|.++..|++|++..|+|.-++.+     .+.+++++..||+.+|++
T Consensus       193 N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae-----~~~~L~~l~vLDLRdNkl  264 (565)
T KOG0472|consen  193 NLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAE-----HLKHLNSLLVLDLRDNKL  264 (565)
T ss_pred             hhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHH-----Hhcccccceeeecccccc
Confidence            8876 78888888888888888888887 556 788888888888888888877654     356788888899999988


Q ss_pred             CccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccc--cccceec-------ccc
Q 001988          381 DGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQ--KLQGLDL-------AFN  451 (985)
Q Consensus       381 ~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L-------s~N  451 (985)
                      . ..|+.+..+. +|++||+++|.|+ ..|..++++ .|+.|-+.+|.+..+-.+-+.+-+  -|++|.=       |.-
T Consensus       265 k-e~Pde~clLr-sL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~s  340 (565)
T KOG0472|consen  265 K-EVPDEICLLR-SLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQS  340 (565)
T ss_pred             c-cCchHHHHhh-hhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCC
Confidence            7 6788888776 7999999999998 567789999 899999999988633222222111  1232211       111


Q ss_pred             c---------ccCCchhhhhhccCCCeEEccCCccccccCCCCcCc--CcCceEeeccceeeeecCCCccCccceeEEee
Q 001988          452 K---------LAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNL--TSLQYLNLGSNRFTFVIPSTFWNLKDILSFDI  520 (985)
Q Consensus       452 ~---------l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  520 (985)
                      +         ..+.. .....+.+.+.|++++-+++.++.+.|..-  .-.+..+++.|++.. +|..+..+..+.+.-+
T Consensus       341 e~~~e~~~t~~~~~~-~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~e-lPk~L~~lkelvT~l~  418 (565)
T KOG0472|consen  341 EGGTETAMTLPSESF-PDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCE-LPKRLVELKELVTDLV  418 (565)
T ss_pred             cccccccCCCCCCcc-cchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhh-hhhhhHHHHHHHHHHH
Confidence            0         01111 223456779999999999995444444322  227889999999984 7777777777655444


Q ss_pred             cCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCC
Q 001988          521 SSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGS  600 (985)
Q Consensus       521 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  600 (985)
                      ..|+..+-+|..++.+++|+.|+|++|-+. .+|.+++.+..|+.||+|.|+|. .+|..+..+..|+++-.++|++..+
T Consensus       419 lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~v  496 (565)
T KOG0472|consen  419 LSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSV  496 (565)
T ss_pred             hhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcccccccc
Confidence            444444567788999999999999999998 78999999999999999999999 7999999999999999999999988


Q ss_pred             CCccccccccccccccccccccCCCCCCCCCcccccccccCCcc
Q 001988          601 IPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNEL  644 (985)
Q Consensus       601 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~  644 (985)
                      .|..+.+|.+|++|||.+|.+...+|..+.++++......|||+
T Consensus       497 d~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf  540 (565)
T KOG0472|consen  497 DPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPF  540 (565)
T ss_pred             ChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCcc
Confidence            88889999999999999999999999999999999999999986

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=372.64  Aligned_cols=245  Identities=28%  Similarity=0.436  Sum_probs=211.5

Q ss_pred             cCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcch--HHHHHHHHHHHHhcCCCCeeeEEeeeecCC-ceEEEEeccC
Q 001988          729 AENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAST--LKSFEAECEVIKNIRHRNLVKIISSCSNDD-FKALVLEYMS  805 (985)
Q Consensus       729 ~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~lv~e~~~  805 (985)
                      ...+.+|+|+||+||+|.++....||||++.......  .++|.+|+.+|.+++|||||+++|+|.+.. ..++||||++
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            3445699999999999999744449999998664333  458999999999999999999999999887 7899999999


Q ss_pred             CCChHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeCCCCCCCEEEcCCC-cEEEecccCceeccCCCCc
Q 001988          806 NGSLEDCLHS-SNCALNIFCRLNIMIDIASALEYLHFGHSTP-IIHCDLKPSNVLLDEDM-VAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       806 ~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~-ivHrDlk~~Nill~~~~-~~kl~DfGla~~~~~~~~~  882 (985)
                      +|+|.++++. ....+++..++++|.|||+||.||   |+.+ ||||||||+|||++.++ ++||+|||+++......  
T Consensus       124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YL---H~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--  198 (362)
T KOG0192|consen  124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYL---HSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--  198 (362)
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH---hcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence            9999999988 366899999999999999999999   7888 99999999999999998 99999999998864322  


Q ss_pred             ceecccccccccccccccc--cCccchhhhcccccccchhhhcccccccCcch-------------hhhhHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIF--VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK-------------HFAAKEQCLLSIFS  947 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~-------------~~~~~~~~~~~l~~  947 (985)
                      ...+...||+.|||||++.  ...++.++|| |+||+++||+++++.++....             ++..+..|+..+..
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~Dv-ySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~  277 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDV-YSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSS  277 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchh-hhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence            2233367999999999999  6699999999 999999999999987665432             22234458899999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          948 LALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                      +|.+||..||..||++.+++..++.+......
T Consensus       278 l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  278 LMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             HHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            99999999999999999999999999876554

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-41  Score=352.66  Aligned_cols=238  Identities=26%  Similarity=0.352  Sum_probs=204.5

Q ss_pred             HhcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcc-------hHHHHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCAS-------TLKSFEAECEVIKNIRHRNLVKIISSCSNDD  795 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~-------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~  795 (985)
                      ..+.|...+.+|+|+||.|-+|.. ++|+.||||+++++...       ....+++|++||++++|||||+++++++.++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456788899999999999999984 58999999999876221       1234679999999999999999999999999


Q ss_pred             ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC---CcEEEecccC
Q 001988          796 FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED---MVAHLSDFGM  872 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~---~~~kl~DfGl  872 (985)
                      +.||||||++||+|.+.+-.++ .+.+....-++.|++.|+.||   |+.||+||||||+|||+..+   ..+||+|||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYL---H~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYL---HSQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHH---HHcCcccccCCcceEEeccCCcceEEEecccch
Confidence            9999999999999999998775 567778888999999999999   89999999999999999765   7899999999


Q ss_pred             ceeccCCCCcceecccccccccccccccccCccch---hhhcccccccchhhhcccccccCcchhh--------------
Q 001988          873 AKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSL---KRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------  935 (985)
Q Consensus       873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------  935 (985)
                      |+...   +.....+.||||.|.|||++..+.+..   +.|+ |++|++++-+++|.+++.+....              
T Consensus       326 AK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDi-WSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f  401 (475)
T KOG0615|consen  326 AKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDI-WSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF  401 (475)
T ss_pred             hhccc---cceehhhhcCCccccChhheecCCeecccchhee-eeccceEEEEeccCCCcccccCCccHHHHHhcCcccc
Confidence            99863   455667789999999999998766544   5599 99999999999998877654222              


Q ss_pred             --hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          936 --AAKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       936 --~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                        ....+..++..+++.+|+..||++||++.|+++.
T Consensus       402 ~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  402 GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence              2345578899999999999999999999999864

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-41  Score=366.17  Aligned_cols=245  Identities=29%  Similarity=0.444  Sum_probs=213.2

Q ss_pred             cCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccC
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      +.+...+.||+|-||+||.|.++...+||+|.++.. ......|.+|+.+|++++|++||+++++|...+..+||||||+
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            344556789999999999999987779999999876 3445788899999999999999999999999889999999999


Q ss_pred             CCChHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          806 NGSLEDCLHS-SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       806 ~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      .|+|.++++. .+..+...+.+.++.|||+|++||   +++++|||||.++|||++++..+||+|||+|+... ++.+..
T Consensus       285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YL---es~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~~Y~~  360 (468)
T KOG0197|consen  285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYL---ESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG-DDEYTA  360 (468)
T ss_pred             cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHH---HhCCccchhhhhhheeeccCceEEEcccccccccC-CCceee
Confidence            9999999997 566789999999999999999999   89999999999999999999999999999999553 344444


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhccccccc-Ccc------------hhhhhHHHHHHHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLS-GEE------------KHFAAKEQCLLSIFSLALE  951 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~-~~~------------~~~~~~~~~~~~l~~l~~~  951 (985)
                      .....-...|+|||.+..+.++.++|| |+||+.++|++++.-.. +.-            .+.+.|+.|++++.++|..
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDV-WSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~  439 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDV-WSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKS  439 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccce-eehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHH
Confidence            444456778999999999999999999 99999999999864322 221            2445677899999999999


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          952 CTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       952 cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      ||+.+|++|||+..+...++++...
T Consensus       440 CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  440 CWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             HhhCCcccCCCHHHHHHHHHHhhhc
Confidence            9999999999999999988887653

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-42  Score=367.48  Aligned_cols=376  Identities=22%  Similarity=0.243  Sum_probs=178.6

Q ss_pred             eecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCc
Q 001988          174 HLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNN  253 (985)
Q Consensus       174 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  253 (985)
                      .||+++|.++..-+..|.++++|+++++.+|.++ .||...+...+|+.|+|.+|.|+..-.+++..++.|+.||||.|.
T Consensus        82 ~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~  160 (873)
T KOG4194|consen   82 TLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNL  160 (873)
T ss_pred             eeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhch
Confidence            3444444444444444445555555555555554 444433333344555555555444444444444445555555554


Q ss_pred             CcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCC
Q 001988          254 LTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPS  333 (985)
Q Consensus       254 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  333 (985)
                      |+...-.+|..-.++++|+|++|+|+ .+...-|..+.+|..|.|+.|+++-..+..|.++++|+.|+|..|++.-..--
T Consensus       161 is~i~~~sfp~~~ni~~L~La~N~It-~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~l  239 (873)
T KOG4194|consen  161 ISEIPKPSFPAKVNIKKLNLASNRIT-TLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGL  239 (873)
T ss_pred             hhcccCCCCCCCCCceEEeecccccc-ccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhh
Confidence            44322222322233333333333333 22222222233333333333333322222333333333333333333322222


Q ss_pred             cccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcC
Q 001988          334 AIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAI  413 (985)
Q Consensus       334 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~  413 (985)
                      .|.+|++|+.|.|..|++..+..+     .|..|.++++|+|+.|++.                         ..-..++
T Consensus       240 tFqgL~Sl~nlklqrN~I~kL~DG-----~Fy~l~kme~l~L~~N~l~-------------------------~vn~g~l  289 (873)
T KOG4194|consen  240 TFQGLPSLQNLKLQRNDISKLDDG-----AFYGLEKMEHLNLETNRLQ-------------------------AVNEGWL  289 (873)
T ss_pred             hhcCchhhhhhhhhhcCcccccCc-----ceeeecccceeecccchhh-------------------------hhhcccc
Confidence            344444444444444444433332     1333444444444444443                         3334444


Q ss_pred             CCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCce
Q 001988          414 GNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQY  493 (985)
Q Consensus       414 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  493 (985)
                      .+++.|+.|+||+|.|..+.++.....++|++|+|++|+|+...+..|..+++|++|.|++|+|+..-...|..+++|++
T Consensus       290 fgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~  369 (873)
T KOG4194|consen  290 FGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHK  369 (873)
T ss_pred             cccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhh
Confidence            44555555555555555444554444555555555555555444455555555555555555555444445555555555


Q ss_pred             EeeccceeeeecCC---CccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeee--
Q 001988          494 LNLGSNRFTFVIPS---TFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISL--  568 (985)
Q Consensus       494 L~L~~N~l~~~~p~---~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L--  568 (985)
                      |||++|.++..+.+   .|.++++|+.|++.+|+|..+...+|..+++|+.|||.+|.|..+-|++|..+ .|++|.+  
T Consensus       370 LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS  448 (873)
T KOG4194|consen  370 LDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS  448 (873)
T ss_pred             hcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence            55555555544332   45556666666666666666666666666677777777777766667777766 6666654  


Q ss_pred             ----ecceeccchhhhhhc
Q 001988          569 ----AYNRLEGPIPESFGN  583 (985)
Q Consensus       569 ----s~N~l~~~~p~~~~~  583 (985)
                          .+|+|. -.++|+.+
T Consensus       449 ssflCDCql~-Wl~qWl~~  466 (873)
T KOG4194|consen  449 SSFLCDCQLK-WLAQWLYR  466 (873)
T ss_pred             cceEEeccHH-HHHHHHHh
Confidence                456665 45556543

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-42  Score=368.11  Aligned_cols=369  Identities=25%  Similarity=0.297  Sum_probs=296.8

Q ss_pred             ceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccC
Q 001988          196 LQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYN  275 (985)
Q Consensus       196 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~  275 (985)
                      -+.||+++|+++..-+..|.++++|+++++.+|.++ .||...+...+|+.|+|.+|.|+.+-.+.+.-++.|+.||||.
T Consensus        80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr  158 (873)
T KOG4194|consen   80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR  158 (873)
T ss_pred             eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence            345777777777666677777777777777777777 6676555556677777777777766667777777777777777


Q ss_pred             CcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCC
Q 001988          276 NSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSST  355 (985)
Q Consensus       276 N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  355 (985)
                      |.|+ .+|..-|..-.++++|+|++|+|+..-...|.++.+|..|.|++|+++...+..|.+|++|+.|+|.+|+|... 
T Consensus       159 N~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iriv-  236 (873)
T KOG4194|consen  159 NLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIV-  236 (873)
T ss_pred             chhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeee-
Confidence            7776 56655555556677777777777766666666666666666666666655555566666666666555555432 


Q ss_pred             CcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCc
Q 001988          356 PELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPV  435 (985)
Q Consensus       356 ~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  435 (985)
                                                  --..|..++ +|+.|.|..|.|+..-..+|..+.++++|+|+.|+++..-.+
T Consensus       237 ----------------------------e~ltFqgL~-Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g  287 (873)
T KOG4194|consen  237 ----------------------------EGLTFQGLP-SLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEG  287 (873)
T ss_pred             ----------------------------hhhhhcCch-hhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcc
Confidence                                        223344444 677777777777777778999999999999999999988899


Q ss_pred             cccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccce
Q 001988          436 TFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDI  515 (985)
Q Consensus       436 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  515 (985)
                      ++.++++|+.|+||+|.|..+.++.+...++|++|+|+.|+|+...+..|..+..|++|+|++|+++.+...+|..+.+|
T Consensus       288 ~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL  367 (873)
T KOG4194|consen  288 WLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSL  367 (873)
T ss_pred             cccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eEEeecCCcccCCccc---cccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEec
Q 001988          516 LSFDISSNLLDGPISL---AIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDL  592 (985)
Q Consensus       516 ~~L~ls~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  592 (985)
                      +.|||++|.|...+.+   .|..+++|+.|+|.+|+|..+.-.+|.+++.|+.|||.+|.|..+-|++|..| .|++|.+
T Consensus       368 ~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~  446 (873)
T KOG4194|consen  368 HKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVM  446 (873)
T ss_pred             hhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhh
Confidence            9999999999876554   58889999999999999997777899999999999999999999999999999 9999987


Q ss_pred             CCCcc
Q 001988          593 SNNKI  597 (985)
Q Consensus       593 s~N~l  597 (985)
                      +.-.+
T Consensus       447 nSssf  451 (873)
T KOG4194|consen  447 NSSSF  451 (873)
T ss_pred             cccce
Confidence            65433

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=346.85  Aligned_cols=199  Identities=30%  Similarity=0.487  Sum_probs=179.9

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccC--CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      ..++|...+.||+|+||+||+|+++ ++..||||.+.+.  .....+.+..|+++|+.++|||||++++++..++..|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            3467888888999999999999975 7899999999877  444566788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC------CcEEEecccCce
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED------MVAHLSDFGMAK  874 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~------~~~kl~DfGla~  874 (985)
                      ||||.||||.++++..+ .+++.+.+.++.|+|.||++|   |+++||||||||+|||++..      -.+||+|||+|+
T Consensus        88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L---~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFL---HENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999999875 789999999999999999999   89999999999999999764      468999999999


Q ss_pred             eccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccC
Q 001988          875 LLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSG  930 (985)
Q Consensus       875 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~  930 (985)
                      .+.   ........||+|.|||||+++.++|+.+.|+ |+.|+.++++++|+.++.
T Consensus       164 ~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADL-WSiG~Ilyq~l~g~~Pf~  215 (429)
T KOG0595|consen  164 FLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADL-WSIGTILYQCLTGKPPFD  215 (429)
T ss_pred             hCC---chhHHHHhhCCccccCHHHHHhccccchhhH-HHHHHHHHHHHhCCCCcc
Confidence            985   3334566899999999999999999999999 999999999999998766

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-40  Score=361.04  Aligned_cols=237  Identities=23%  Similarity=0.322  Sum_probs=211.0

Q ss_pred             cCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccC---CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQ---CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      .+|..++.||+|||+.||.++. .+|..||+|++.+.   .....+.+.+||+|.++++|||||+++++|++.+++|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5789999999999999999997 79999999999874   2344577899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      |+|+.++|..+++ .++.+++.+++.++.||+.||.||   |+++|+|||||..|+|++++.++||+|||+|+.+..+++
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYL---H~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYL---HSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHH---HhcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            9999999999988 456899999999999999999999   899999999999999999999999999999999864433


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh-----------hhhHHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-----------FAAKEQCLLSIFSLAL  950 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-----------~~~~~~~~~~l~~l~~  950 (985)
                        ...+.||||.|+|||++.....++..|+ |++||+++-++.|+.++.....           +..|.....+..++|.
T Consensus       174 --rk~TlCGTPNYIAPEVl~k~gHsfEvDi-WSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~  250 (592)
T KOG0575|consen  174 --RKKTLCGTPNYIAPEVLNKSGHSFEVDI-WSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIR  250 (592)
T ss_pred             --ccceecCCCcccChhHhccCCCCCchhh-hhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHH
Confidence              3456899999999999999999999999 9999999999999887765421           2223345677889999


Q ss_pred             HccCCCCCCCCCHHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~  969 (985)
                      ++++++|.+||++++|+..
T Consensus       251 ~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  251 KLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             HHhcCCcccCCCHHHHhcC
Confidence            9999999999999999863

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-41  Score=333.57  Aligned_cols=243  Identities=23%  Similarity=0.339  Sum_probs=201.7

Q ss_pred             cCccCCceeeccCceeEEEEE-EcCCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEe-eeecCCc-eEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIIS-SCSNDDF-KALV  800 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~-~~~~~~~-~~lv  800 (985)
                      .+|++.++||+|.||+||++. ..+|..||.|.++...  ....+....|+.+|++++|||||++++ .+.++.. .+||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            457778899999999999997 5689999999998553  334567889999999999999999999 4555444 8999


Q ss_pred             EeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          801 LEYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALEYLHFGHSTP--IIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~--ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      ||||.+|+|...++.   .++.+++.++++++.|++.||..+|+.- ++  |+||||||.||+++.+|.|||+|||+++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            999999999998863   4667999999999999999999995311 44  88999999999999999999999999999


Q ss_pred             ccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh------------hhH-HHHH
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF------------AAK-EQCL  942 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~------------~~~-~~~~  942 (985)
                      +.  ...+...+.+|||.||+||.+.+.+|++++|+ |++|++++||..-..++......            +.+ +-.+
T Consensus       178 l~--s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDi-WslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS  254 (375)
T KOG0591|consen  178 LS--SKTTFAHSLVGTPYYMSPERIHESGYNFKSDI-WSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYS  254 (375)
T ss_pred             hc--chhHHHHhhcCCCcccCHHHHhcCCCCcchhH-HHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhh
Confidence            85  34455677889999999999999999999999 99999999998765544332211            122 4577


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 001988          943 LSIFSLALECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       943 ~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                      ..+.+++..|+.+||+.||+...++..+..
T Consensus       255 ~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  255 TDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             hHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            889999999999999999986555555443

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.9e-39  Score=365.05  Aligned_cols=252  Identities=28%  Similarity=0.469  Sum_probs=219.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  797 (985)
                      ..+....+.||+|+||+||+|+..      +...||||.++..... ...+|++|++++..++|||||+++|+|.+++.+
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            344556688999999999999753      4566999999877655 678999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHhhcC---------CCC----CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc
Q 001988          798 ALVLEYMSNGSLEDCLHSS---------NCA----LNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV  864 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~---------~~~----~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~  864 (985)
                      +||+|||..|||.++|...         +..    ++..+.+.||.|||.|++||   .++.+|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YL---s~~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYL---SSHHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCcccccchhhhhceeccceE
Confidence            9999999999999999753         122    78899999999999999999   8899999999999999999999


Q ss_pred             EEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcc------------
Q 001988          865 AHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEE------------  932 (985)
Q Consensus       865 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~------------  932 (985)
                      |||+|||+++.+...+.+.......-..+||+||.++.++++.++|| |++|+++||++++.......            
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDV-Ws~GVvLWEIFsyG~QPy~glSn~EVIe~i~~  720 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDV-WSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA  720 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhh-hhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence            99999999998876666665545566889999999999999999999 99999999999977543322            


Q ss_pred             -hhhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhccc
Q 001988          933 -KHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSKR  980 (985)
Q Consensus       933 -~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~~  980 (985)
                       ...+.++.|+.++++||..||+..|.+||+++||-.+|+...++....
T Consensus       721 g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~  769 (774)
T KOG1026|consen  721 GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKY  769 (774)
T ss_pred             CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccc
Confidence             123467789999999999999999999999999999999988765543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=330.59  Aligned_cols=232  Identities=27%  Similarity=0.322  Sum_probs=198.3

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ..++|+..+.||+|+||+||.++.+ +++.||+|+++++.   ..+.+..++|..|+.+++||+||+++..|++.+..|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            3578899999999999999999855 78889999998762   2346778999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      |+||+.||+|+.++.+.+ .+++....-++.+|+.||.||   |++||||||+||+|||+|.+|+++|+|||+++..-. 
T Consensus       103 Vld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~L---H~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-  177 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYL---HSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-  177 (357)
T ss_pred             EEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHH---HhCCeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence            999999999999999775 688888889999999999999   899999999999999999999999999999986432 


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh------------hHHHHHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------AKEQCLLSIFS  947 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------~~~~~~~~l~~  947 (985)
                       ....+..+|||+.|||||++.+.+++..+|. |++|+.++||++|..++.......            .+.-...+.++
T Consensus       178 -~~~~t~tfcGT~eYmAPEil~~~gy~~~vDW-WsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ard  255 (357)
T KOG0598|consen  178 -DGDATRTFCGTPEYMAPEILLGKGYDKAVDW-WSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARD  255 (357)
T ss_pred             -CCCccccccCCccccChHHHhcCCCCcccch-HhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHH
Confidence             2233455899999999999999999988887 999999999999987665432111            11114567888


Q ss_pred             HHHHccCCCCCCCCC
Q 001988          948 LALECTMESPEKRID  962 (985)
Q Consensus       948 l~~~cl~~~P~~RPt  962 (985)
                      ++++.+..+|++|-.
T Consensus       256 ll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  256 LLKKLLKRDPRQRLG  270 (357)
T ss_pred             HHHHHhccCHHHhcC
Confidence            889999999998853

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.9e-38  Score=316.68  Aligned_cols=236  Identities=22%  Similarity=0.321  Sum_probs=199.9

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      +.|+...++|+|+||.||+++.+ +|+.||||++.....  .-.+-..+|+++|++++|+|+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45777889999999999999976 799999999975422  224557899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      ||+. ++.+-++......+...+.++++|++.|+.|+   |++++|||||||+|||++.+|.+||||||+|+.+..++  
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~c---Hk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--  155 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFC---HKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--  155 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhh---hhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc--
Confidence            9966 77777777766788999999999999999999   89999999999999999999999999999999986433  


Q ss_pred             ceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh------------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA------------------------  937 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~------------------------  937 (985)
                      ...+..+.|.+|+|||.+.+ .+|....|+ |+.|+++.|+++|+.++....+.++                        
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDi-WAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDI-WAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccc-hhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            33456789999999998887 788999999 9999999999999876654432211                        


Q ss_pred             ---------------H---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 ---------------K---EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 ---------------~---~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                     +   .....-++++++.|+..||++|++-+|++.
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                           0   113356788999999999999999988764

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=344.19  Aligned_cols=236  Identities=27%  Similarity=0.359  Sum_probs=211.5

Q ss_pred             cCccCCceeeccCceeEEEEE-EcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      ..|..-.+||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|...++.|+||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            346666789999999999997 4588999999999887777788899999999999999999999998889999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      +||+|.|.+...  .+++.++..|++++++||+||   |.+||+|||||.+|||++.+|.+||+|||+|..+...  ...
T Consensus       353 ~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fL---H~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~--~~K  425 (550)
T KOG0578|consen  353 EGGSLTDVVTKT--RMTEGQIAAICREILQGLKFL---HARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE--QSK  425 (550)
T ss_pred             CCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHH---HhcceeeeccccceeEeccCCcEEEeeeeeeeccccc--cCc
Confidence            999999999876  489999999999999999999   8999999999999999999999999999999987533  335


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcccccccCcc--------------hhhhhHHHHHHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEE--------------KHFAAKEQCLLSIFSLAL  950 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~--------------~~~~~~~~~~~~l~~l~~  950 (985)
                      ....+|||+|||||++....|.++.|+ |++|++++||+.|+.++-..              +....++..+.++.+++.
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDI-WSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~  504 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDI-WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLD  504 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccc-hhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHH
Confidence            567789999999999999999999999 99999999999999866532              233456678889999999


Q ss_pred             HccCCCCCCCCCHHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~  969 (985)
                      +|+..||.+||+|.|+++.
T Consensus       505 ~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  505 RCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             HHhhcchhcCCCHHHHhcC
Confidence            9999999999999999863

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-39  Score=338.51  Aligned_cols=238  Identities=24%  Similarity=0.296  Sum_probs=202.0

Q ss_pred             HhcCccCCceeeccCceeEEEEE-EcCCcEEEEEEeccCCcchH-HHHHHHHHHHHhcC-CCCeeeEEeeeecCC-ceEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTL-KSFEAECEVIKNIR-HRNLVKIISSCSNDD-FKAL  799 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vAvK~~~~~~~~~~-~~~~~E~~il~~l~-h~niv~l~~~~~~~~-~~~l  799 (985)
                      .-++|...++||.|.||.||+|+ .+++..||||+++++...-. ..=.+|+..|++++ |||||++.+++.+.+ ..++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            34678889999999999999998 45889999999987754432 23368999999998 999999999999888 9999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      |||||+. +|.+.++..++.+++.+++.|+.||++||+|+   |.+|+.|||+||+|||+.....+||+|||+|+.+...
T Consensus        88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hi---Hk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHI---HKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHH---HhcCcccccCChhheEecccceeEecccccccccccC
Confidence            9999954 99999999988999999999999999999999   8999999999999999999999999999999987644


Q ss_pred             CCcceecccccccccccccccc-cCccchhhhcccccccchhhhcccccccCcchhhhh---------------------
Q 001988          880 DESTMRTQTLATIGYMAPDEIF-VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA---------------------  937 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~---------------------  937 (985)
                      ..   .+..+.|.+|+|||++. .+.|+.+.|+ |++|++++|+..-+.++....+.++                     
T Consensus       164 pP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~-wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  164 PP---YTEYVSTRWYRAPEVLLRSGYYSSPVDM-WAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             CC---cchhhhcccccchHHhhhccccCCchHH-HHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            43   34567999999999876 4678999999 9999999999876554433221111                     


Q ss_pred             --------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          938 --------------------KEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       938 --------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                          ...+..+..+++.+|+.+||++||||.+.++.
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                                01156788999999999999999999998864

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=342.22  Aligned_cols=253  Identities=25%  Similarity=0.412  Sum_probs=216.1

Q ss_pred             HHHHHHHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 001988          718 YFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDD  795 (985)
Q Consensus       718 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~  795 (985)
                      ..++....+.+..++.||+|+||+||+|+|.  -.||||++.....  ...+.|++|+.++++-+|.||+-|.|||..+.
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            3566666777888999999999999999986  2599999986643  34678999999999999999999999999988


Q ss_pred             ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          796 FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      . .||+.+|+|.+|..+++..+..++..+.+.||+|||+|+.||   |+++|||||+|..||++.++++|||+|||++..
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YL---HAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYL---HAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhh---hhhhhhhhhccccceEEccCCcEEEecccceee
Confidence            7 899999999999999998877899999999999999999999   899999999999999999999999999999976


Q ss_pred             ccCCCCcceeccccccccccccccccc---CccchhhhcccccccchhhhcccccccCcchhh----------------h
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFV---GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF----------------A  936 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~----------------~  936 (985)
                      -..-..........|..-|||||++..   -+|++.+|| |+||+++||++++.+++......                .
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDV-YaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~  616 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDV-YAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK  616 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccch-hhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh
Confidence            432222222333458888999998874   468999999 99999999999999987743221                1


Q ss_pred             hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          937 AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       937 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      ....|+.++.+|+..||..++++||.+.+++.+|+++....
T Consensus       617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  617 IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence            23458889999999999999999999999999998887743

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=376.03  Aligned_cols=482  Identities=30%  Similarity=0.391  Sum_probs=245.2

Q ss_pred             EEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccc
Q 001988           78 LNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKL  157 (985)
Q Consensus        78 l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l  157 (985)
                      +|++...+. .||..+..-..++.|+++.|.+-...-+++.+..+|+.|||++|++. ..|..+-.++.|..|++|.|.+
T Consensus         3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i   80 (1081)
T KOG0618|consen    3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI   80 (1081)
T ss_pred             cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence            455555555 56766666666778888877665322233444445777777777765 2223333344444444444444


Q ss_pred             cCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhh
Q 001988          158 SGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQE  237 (985)
Q Consensus       158 ~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  237 (985)
                      . .+|.++ +++++|++|.|.+|.+. ..|.++..+++|++|++|+|++. .+|..+..++.+..+..++|...    ..
T Consensus        81 ~-~vp~s~-~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~----~~  152 (1081)
T KOG0618|consen   81 R-SVPSSC-SNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKI----QR  152 (1081)
T ss_pred             h-hCchhh-hhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhh----hh
Confidence            4 444333 44555555555555544 45555555555555555555554 45555555555555555555111    11


Q ss_pred             hcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCc
Q 001988          238 IGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKL  317 (985)
Q Consensus       238 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  317 (985)
                      ++... .+.+++..|.+.+.++..+.+++.  .|+|+.|.+.                            -..+.++.+|
T Consensus       153 lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~----------------------------~~dls~~~~l  201 (1081)
T KOG0618|consen  153 LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME----------------------------VLDLSNLANL  201 (1081)
T ss_pred             hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh----------------------------hhhhhhccch
Confidence            11111 444444455544444444444443  4444444443                            1223344444


Q ss_pred             cEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccc
Q 001988          318 ILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLER  397 (985)
Q Consensus       318 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~  397 (985)
                      +.|....|+++...    -..++|+.|+.++|.++.....       .--.+|++++++.|++++ +|+|+..+. +|+.
T Consensus       202 ~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~-------p~p~nl~~~dis~n~l~~-lp~wi~~~~-nle~  268 (1081)
T KOG0618|consen  202 EVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVH-------PVPLNLQYLDISHNNLSN-LPEWIGACA-NLEA  268 (1081)
T ss_pred             hhhhhhhcccceEE----ecCcchheeeeccCcceeeccc-------cccccceeeecchhhhhc-chHHHHhcc-cceE
Confidence            44444444444221    1224455555555555432211       112345555555555552 345555554 5555


Q ss_pred             eeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhh-hhcc-CCCeEEccCC
Q 001988          398 LNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEI-CLLS-RLNELDLNGN  475 (985)
Q Consensus       398 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~-~L~~L~L~~N  475 (985)
                      ++..+|+++ .+|..+...++|+.|....|.+. -+|....+++.|++|||..|+|. ..|+.+ .-+. +|+.|..+.|
T Consensus       269 l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n  345 (1081)
T KOG0618|consen  269 LNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSN  345 (1081)
T ss_pred             ecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhc
Confidence            555555553 44555555555555555555555 23334445555555555555555 233322 2222 2455555555


Q ss_pred             ccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCch
Q 001988          476 KISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPT  555 (985)
Q Consensus       476 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  555 (985)
                      ++.......=..++.|+.|++.+|+++...-..+.+..+|+.|+|++|++...+...+.++..|++|+||+|+++ .+|.
T Consensus       346 ~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~  424 (1081)
T KOG0618|consen  346 KLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPD  424 (1081)
T ss_pred             cccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhH
Confidence            554322222233455666666666665544444555566666666666666555555666666666666666666 4556


Q ss_pred             hhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCC-CCcccccccccccccccccc
Q 001988          556 TLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGS-IPVSFEKLSYLKELNLSFNK  620 (985)
Q Consensus       556 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~ls~N~  620 (985)
                      ++..++.|++|...+|+|. ..| .+.+++.|+.+|+|.|+|+.. +|.... -++|++|||+||.
T Consensus       425 tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  425 TVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP-SPNLKYLDLSGNT  487 (1081)
T ss_pred             HHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCC-CcccceeeccCCc
Confidence            6666666666666666665 344 566666666666666666543 222222 2566666666665

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=328.87  Aligned_cols=245  Identities=29%  Similarity=0.393  Sum_probs=204.2

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCC--ceEEEEe
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD--FKALVLE  802 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~--~~~lv~e  802 (985)
                      .++..++.||+|+||.||++... +|...|||.+........+.+.+|+.+|++++|||||+++|......  ..++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45677899999999999999865 58999999987664444677899999999999999999999855544  5889999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-CCcEEEecccCceeccCCC-
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHLSDFGMAKLLSGED-  880 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~-~~~~kl~DfGla~~~~~~~-  880 (985)
                      |+++|+|.+++...+..+++..+.+++.||++||+||   |++|||||||||+|||++. ++.+||+|||+++...... 
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~yl---Hs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYL---HSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            9999999999998765789999999999999999999   8999999999999999999 7999999999998875311 


Q ss_pred             CcceecccccccccccccccccCc-cchhhhcccccccchhhhcccccccCcc-h-------------hhhhHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGE-LSLKRWVNDLLPVSLVEVVDKSLLSGEE-K-------------HFAAKEQCLLSI  945 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~~~~g~~~~~i~~~~~~~~~~-~-------------~~~~~~~~~~~l  945 (985)
                      .........||+.|||||++..+. ...++|+ |++|+.+.||+++..++... .             .+..++..+++.
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDi-WSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a  252 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDI-WSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA  252 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchh-hhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence            122234567999999999998643 3358999 99999999999987655441 0             112234466789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhH
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~  974 (985)
                      .+++.+|+..+|++||||.+++...-...
T Consensus       253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence            99999999999999999999998765433

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.6e-37  Score=305.51  Aligned_cols=237  Identities=24%  Similarity=0.358  Sum_probs=202.3

Q ss_pred             cCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcch--HHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          726 DNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCAST--LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ++|...+.+|+|.||.||+|++ ++|+.||||+++.....+  .....+|++.|+.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4678889999999999999984 589999999998664332  3467899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |++. +|+..++.....++..++..++.++.+|++|+   |++.|+|||+||.|+|++.+|.+||+|||+|+.+......
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~---H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYC---HSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHH---HhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9965 99999999988999999999999999999999   8999999999999999999999999999999998755443


Q ss_pred             ceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh------------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA------------------------  937 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~------------------------  937 (985)
                      .  +..+-|.+|+|||.+++ ..|+...|+ |+.||.+.|++-+..+.....+.++                        
T Consensus       158 ~--~~~V~TRWYRAPELLfGsr~Yg~~VDm-WavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  158 Q--THQVVTRWYRAPELLFGSRQYGTGVDM-WAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             c--ccceeeeeccChHHhccchhcCCcchh-hhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence            3  23378999999999886 568889999 9999999999877655443321111                        


Q ss_pred             ---------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          938 ---------------KEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       938 ---------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                     ...+.....+++..++.++|.+|++++|+++.
T Consensus       235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                           01145667999999999999999999999864

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=374.04  Aligned_cols=485  Identities=28%  Similarity=0.392  Sum_probs=398.6

Q ss_pred             ecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccceecccCcc
Q 001988          102 LDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENM  181 (985)
Q Consensus       102 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~  181 (985)
                      +|.+..+++ .||..+..-..|+.|++++|-+                        - ..|-......-+|+.||+++|+
T Consensus         3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~------------------------l-~~pl~~~~~~v~L~~l~lsnn~   56 (1081)
T KOG0618|consen    3 VDASDEQLE-LIPEQILNNEALQILNLRRNSL------------------------L-SRPLEFVEKRVKLKSLDLSNNQ   56 (1081)
T ss_pred             cccccccCc-ccchhhccHHHHHhhhcccccc------------------------c-cCchHHhhheeeeEEeeccccc
Confidence            455555555 4666554443455555555544                        3 4444444444458889999888


Q ss_pred             ccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCccc
Q 001988          182 FYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPAT  261 (985)
Q Consensus       182 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  261 (985)
                      +. ..|..+..+.+|+.|.++.|.|. ..|.+.+++.+|++|.|.+|++. ..|..+..+++|++||+++|++. .+|..
T Consensus        57 ~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~  132 (1081)
T KOG0618|consen   57 IS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLV  132 (1081)
T ss_pred             cc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchh
Confidence            87 88888999999999999999998 78888889999999999999988 78999999999999999999997 78888


Q ss_pred             ccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCC
Q 001988          262 IFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNL  341 (985)
Q Consensus       262 l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L  341 (985)
                      +..++.++++..++|.....++.      ..++.++|..|.+.+.++..+.++..  .|+|++|.+.   -..+.++.+|
T Consensus       133 i~~lt~~~~~~~s~N~~~~~lg~------~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l  201 (1081)
T KOG0618|consen  133 IEVLTAEEELAASNNEKIQRLGQ------TSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANL  201 (1081)
T ss_pred             HHhhhHHHHHhhhcchhhhhhcc------ccchhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccch
Confidence            99999999999999933323332      23888999999999999988888777  8999999997   3357788999


Q ss_pred             ceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccE
Q 001988          342 KLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIV  421 (985)
Q Consensus       342 ~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  421 (985)
                      +.+....|++.....         .-++|+.|+.++|.++...+..   .+.+|+++++++|++++ +|++++.+.+|+.
T Consensus       202 ~~l~c~rn~ls~l~~---------~g~~l~~L~a~~n~l~~~~~~p---~p~nl~~~dis~n~l~~-lp~wi~~~~nle~  268 (1081)
T KOG0618|consen  202 EVLHCERNQLSELEI---------SGPSLTALYADHNPLTTLDVHP---VPLNLQYLDISHNNLSN-LPEWIGACANLEA  268 (1081)
T ss_pred             hhhhhhhcccceEEe---------cCcchheeeeccCcceeecccc---ccccceeeecchhhhhc-chHHHHhcccceE
Confidence            999999999986543         3478999999999998544332   23479999999999994 5699999999999


Q ss_pred             EEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCc-CceEeeccce
Q 001988          422 LSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTS-LQYLNLGSNR  500 (985)
Q Consensus       422 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~  500 (985)
                      ++..+|++. .+|..+...++|+.|++..|.++ .+|+....++.|+.|+|..|+|...++..|.-+.. |..|+.+.|+
T Consensus       269 l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~  346 (1081)
T KOG0618|consen  269 LNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNK  346 (1081)
T ss_pred             ecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcc
Confidence            999999996 78888899999999999999999 67888888999999999999998655545555444 8889999999


Q ss_pred             eeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhh
Q 001988          501 FTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPES  580 (985)
Q Consensus       501 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  580 (985)
                      +.....-.=..+..|+.|++.+|.++...-..+.+...|+.|+|++|+|.......+.++..|++|+||+|+|+ .+|+.
T Consensus       347 l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~t  425 (1081)
T KOG0618|consen  347 LSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDT  425 (1081)
T ss_pred             ccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHH
Confidence            88654222235678999999999999877678899999999999999999776678899999999999999999 68999


Q ss_pred             hhcccccCeEecCCCcccCCCCccccccccccccccccccccC-CCCCCCCCcccccccccCCccc
Q 001988          581 FGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKG-EIPRGGPFANFTAESFMGNELL  645 (985)
Q Consensus       581 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~~~~~~~~~~~n~~l  645 (985)
                      +.++..|++|...+|+|. ..| .+..++.|+.+|+|.|+|+- .+|..-+..++..+.+.||.++
T Consensus       426 va~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  426 VANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             HHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            999999999999999998 778 89999999999999999984 4555556678888889999863

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=334.56  Aligned_cols=242  Identities=27%  Similarity=0.383  Sum_probs=210.4

Q ss_pred             HHHhcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccC---CcchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCc
Q 001988          722 LRATDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQ---CASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDF  796 (985)
Q Consensus       722 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~  796 (985)
                      .+...+|..++.||.|+|++||+|+. +++++||||++.++   .....+-+.+|-++|.++ .||.|++++..|++...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            34457888999999999999999985 47899999999765   223345678899999999 89999999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      .|+|+||+++|+|.+++++.+ .+++.+.+-+|.+|+.|++||   |++|||||||||+|||+|++|++||+|||.|+.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleyl---H~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYL---HSNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            999999999999999999875 789999999999999999999   8999999999999999999999999999999987


Q ss_pred             cCCCCc---------c--eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------
Q 001988          877 SGEDES---------T--MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------  936 (985)
Q Consensus       877 ~~~~~~---------~--~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------  936 (985)
                      .+....         .  ....++||..|++||.+.++..+..+|+ |++||++++|+.|..++....++.         
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDi-WAlGCilyQmlaG~PPFra~NeyliFqkI~~l~  303 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDL-WALGCILYQMLAGQPPFRAANEYLIFQKIQALD  303 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccch-HHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence            643211         1  1255889999999999999999999999 999999999999998776654333         


Q ss_pred             --hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 --AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 --~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                        .++..++.+.+|+++.+..||.+|++..+|.+
T Consensus       304 y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  304 YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             ccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence              23445678999999999999999999987765

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-37  Score=321.06  Aligned_cols=241  Identities=24%  Similarity=0.348  Sum_probs=207.6

Q ss_pred             HhcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ..+.|+..+.||.|..++||+|+. ..+..||||++..+.. .+.+.+++|+..|+.++||||++++..|..+...|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            346788899999999999999984 5789999999986643 34688999999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          802 EYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       802 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      .||.+|++.+.++.. ...+++..+..|.++++.||.||   |.+|.||||||+.|||++.+|.|||+|||....+-+.+
T Consensus       104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YL---H~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYL---HQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHH---HhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999999875 44589999999999999999999   89999999999999999999999999999765554333


Q ss_pred             C-ccee-cccccccccccccccc--cCccchhhhcccccccchhhhcccccccCcch---------------------hh
Q 001988          881 E-STMR-TQTLATIGYMAPDEIF--VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK---------------------HF  935 (985)
Q Consensus       881 ~-~~~~-~~~~gt~~y~aPE~~~--~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~---------------------~~  935 (985)
                      . .... ...+||+.|||||+++  ...|++++|+ |+||+.+.|+.+|..++...+                     ..
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDI-wSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~  259 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADI-WSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK  259 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhh-hhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence            2 2222 5568999999999965  3679999999 999999999999998876654                     22


Q ss_pred             hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          936 AAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       936 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +........+.+++..|+..||.+||||+++++
T Consensus       260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            233445678999999999999999999999985

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-37  Score=328.15  Aligned_cols=238  Identities=24%  Similarity=0.326  Sum_probs=201.5

Q ss_pred             hcCccCCceeeccCceeEEEEE-EcCCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecC--CceEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSND--DFKAL  799 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~l  799 (985)
                      .+.|...++||+|+||.||+|+ ..+|+.||+|+++.+..  ....-..+||.||++++||||+++.+...+.  +..||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3557777899999999999998 56899999999987753  3345567999999999999999999998776  68999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      |+|||+. ||.-++...+-.+++.++..++.|+++||+|+   |.+||+|||||.+|||||.+|.+||+|||+|+++...
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~c---H~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYC---HSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHH---hhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999976 99999988777899999999999999999999   8999999999999999999999999999999998755


Q ss_pred             CCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh---------------------
Q 001988          880 DESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA---------------------  937 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~---------------------  937 (985)
                      .... .+..+-|.+|.|||.+.+ ..|+.+.|+ |+.||++.|++.|+.......+..+                     
T Consensus       272 ~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDl-WS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  272 GSAP-YTSRVVTLWYRPPELLLGATSYGTAVDL-WSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCcc-cccceEEeeccChHHhcCCcccccceee-hhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            4433 556679999999998876 568999999 9999999999988754332211110                     


Q ss_pred             -------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 -------------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 -------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                         ....+...++++..++..||.+|.||.++++
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                               1123466788999999999999999999875

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-37  Score=340.39  Aligned_cols=243  Identities=22%  Similarity=0.406  Sum_probs=209.8

Q ss_pred             cCCceeeccCceeEEEEEEc----CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          729 AENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       729 ~~~~~ig~G~~g~V~~~~~~----~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .+.++||.|-||+||+|+++    ....||||.++.... ....+|..|+.||.++.||||+++.|+.......+||+||
T Consensus       632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy  711 (996)
T KOG0196|consen  632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY  711 (996)
T ss_pred             EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence            55789999999999999976    345699999986643 3456899999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc-
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES-  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-  882 (985)
                      |++|+|..+|+.+.+.+++.+...+.++||.|++||   .+.++|||||.++|||++.+-.+|++|||+++.+.++.+. 
T Consensus       712 MENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYL---sdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~  788 (996)
T KOG0196|consen  712 MENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYL---SDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA  788 (996)
T ss_pred             hhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHH---hhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence            999999999999988899999999999999999999   8999999999999999999999999999999988654422 


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhccccc-ccC------------cchhhhhHHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSL-LSG------------EEKHFAAKEQCLLSIFSLA  949 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~-~~~------------~~~~~~~~~~~~~~l~~l~  949 (985)
                      ..+..-.-..+|.|||.+...+++.++|| |++|+++||++.+.- ++.            ...+.+.+.+|+..+.++|
T Consensus       789 ytt~GGKIPiRWTAPEAIa~RKFTsASDV-WSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLM  867 (996)
T KOG0196|consen  789 YTTLGGKIPIRWTAPEAIAYRKFTSASDV-WSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLM  867 (996)
T ss_pred             ccccCCccceeecChhHhhhcccCchhhc-cccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHH
Confidence            22222223578999999999999999999 999999999987532 211            1124456778999999999


Q ss_pred             HHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          950 LECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                      ..||++|-.+||.+.+++..|.++-.
T Consensus       868 ldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  868 LDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             HHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence            99999999999999999999998653

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-36  Score=298.40  Aligned_cols=231  Identities=28%  Similarity=0.315  Sum_probs=189.9

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcch---HHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAST---LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|+..+.+|.|+||+|.+++.+ +|..+|+|++.++.--.   .+...+|..+|+.+.||+++++++.|.+.+..||||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            56777889999999999999965 78899999998763333   345678999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||++||.|+.+++..+ ++++...+-+|.||+.|++||   |+.+|++||+||+|||+|.+|.+||+|||+|+...+   
T Consensus       124 eyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleyl---H~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYL---HSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---  196 (355)
T ss_pred             eccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHH---HhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence            9999999999999875 788999999999999999999   899999999999999999999999999999998742   


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhhHHHHHHHHHHHHHHccCCCCCCCC
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI  961 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP  961 (985)
                        .+...||||.|+|||.+....+..+.|. |++|+.++||+.|..++......       .-..+|+..=+..-+---|
T Consensus       197 --rT~TlCGTPeYLAPEii~sk~ynkavDW-WalGVLIYEMlaG~pPF~~~~~~-------~iY~KI~~~~v~fP~~fs~  266 (355)
T KOG0616|consen  197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDW-WALGVLIYEMLAGYPPFYDDNPI-------QIYEKILEGKVKFPSYFSS  266 (355)
T ss_pred             --cEEEecCCccccChHHhhcCCCCcchhH-HHHHHHHHHHHcCCCCCcCCChH-------HHHHHHHhCcccCCcccCH
Confidence              2456899999999999999999877776 99999999999998876654321       1122222222333333355


Q ss_pred             CHHHHHHHHHHh
Q 001988          962 DAKDTITRLLKI  973 (985)
Q Consensus       962 t~~ev~~~L~~i  973 (985)
                      .+.++++.|.++
T Consensus       267 ~~kdLl~~LL~v  278 (355)
T KOG0616|consen  267 DAKDLLKKLLQV  278 (355)
T ss_pred             HHHHHHHHHHhh
Confidence            566666555443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.5e-36  Score=336.30  Aligned_cols=249  Identities=22%  Similarity=0.356  Sum_probs=202.4

Q ss_pred             HhcCccCCceeeccCceeEEEEEE------cCCcEEEEEEeccCCc-chHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARL------EDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLVKIISSCSND-  794 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~-  794 (985)
                      ..++|...+.||+|+||.||+|..      .+++.||+|+++.... .....+.+|+++++++ +||||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            456889999999999999999974      2456799999875432 3346789999999999 899999999998764 


Q ss_pred             CceEEEEeccCCCChHHHhhcCC---------------------------------------------------------
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSN---------------------------------------------------------  817 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------  817 (985)
                      +..++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            45789999999999999987531                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecccccccc
Q 001988          818 ----CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG  893 (985)
Q Consensus       818 ----~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~  893 (985)
                          ..+++.+..+++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++.+.............+++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                2367888899999999999999   789999999999999999999999999999987643322222233346788


Q ss_pred             cccccccccCccchhhhcccccccchhhhcc-cccccCcchhh-------------hhHHHHHHHHHHHHHHccCCCCCC
Q 001988          894 YMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF-------------AAKEQCLLSIFSLALECTMESPEK  959 (985)
Q Consensus       894 y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~-------------~~~~~~~~~l~~l~~~cl~~~P~~  959 (985)
                      |+|||.+.+..++.++|+ |++|++++++++ +..+.......             ..+..+++++.+++.+||+.||++
T Consensus       242 y~aPE~~~~~~~~~~sDi-wslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  320 (338)
T cd05102         242 WMAPESIFDKVYTTQSDV-WSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE  320 (338)
T ss_pred             ccCcHHhhcCCCCcccCH-HHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence            999999999999999999 999999999986 65544321110             112235678999999999999999


Q ss_pred             CCCHHHHHHHHHHhHhh
Q 001988          960 RIDAKDTITRLLKIRDT  976 (985)
Q Consensus       960 RPt~~ev~~~L~~i~~~  976 (985)
                      ||++.|+++.|+++.++
T Consensus       321 RPs~~el~~~l~~~~~~  337 (338)
T cd05102         321 RPTFSALVEILGDLLQE  337 (338)
T ss_pred             CcCHHHHHHHHHHHHhc
Confidence            99999999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-36  Score=321.80  Aligned_cols=244  Identities=25%  Similarity=0.408  Sum_probs=209.6

Q ss_pred             cCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcch-HHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      +.....++||+|-||+|.+++...+..||||.++...... ..+|.+|+++|.+++|||||+++|+|..++..++|+||+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            3445678899999999999999888999999999875554 488999999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          805 SNGSLEDCLHSSNCA-LNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      ++|+|.+++.++..+ .+.....+|+.|||.|++||   .+.++||||+.++|+|+|.++++||+|||+++-+...+.+.
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYL---es~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYL---ESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHH---HhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence            999999999887433 35556678999999999999   89999999999999999999999999999999776666666


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhccccc--ccC-----------------cc--hhhhhHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSL--LSG-----------------EE--KHFAAKEQCL  942 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~--~~~-----------------~~--~~~~~~~~~~  942 (985)
                      .....+-..+|||||.+..++++.++|+ |.||+.+||++...-  ++.                 ..  -....+..|+
T Consensus       695 vqgr~vlpiRwmawEsillgkFttaSDv-WafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp  773 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESILLGKFTTASDV-WAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP  773 (807)
T ss_pred             eecceeeeeeehhHHHHHhccccchhhh-hhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence            6666677899999999999999999999 999999999876321  111                 10  0122345589


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          943 LSIFSLALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       943 ~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                      .+++++|.+||+.+..+||+++++...|.+.
T Consensus       774 ~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  774 QGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            9999999999999999999999999988764

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=355.86  Aligned_cols=249  Identities=25%  Similarity=0.414  Sum_probs=214.1

Q ss_pred             cCccCCceeeccCceeEEEEEEc--CCc----EEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE--DGV----EIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~--~~~----~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      ++....+.||+|+||.||.|...  ++.    .||||.+++.. .++..+|.+|..+|++++|||||+++|+|.+.+..+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            34556678999999999999865  343    49999998763 456778999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccC
Q 001988          799 LVLEYMSNGSLEDCLHSS------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGM  872 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGl  872 (985)
                      |++|||+||+|..++++.      ...++..+.+.++.|||+|+.||   +++++|||||.++|+|++....|||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YL---e~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYL---ESKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHH---HhCCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999987      56789999999999999999999   899999999999999999999999999999


Q ss_pred             ceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhccc-ccccCcc------------hhhhhHH
Q 001988          873 AKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDK-SLLSGEE------------KHFAAKE  939 (985)
Q Consensus       873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~-~~~~~~~------------~~~~~~~  939 (985)
                      |+.+.+.+.+.......-...|||||.+.++.++.++|| |+||+.+||+++. ..+++..            .+.+.+.
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDv-WsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~  927 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDV-WSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS  927 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccch-hhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC
Confidence            997655554443333345678999999999999999999 9999999999973 3333322            1445677


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          940 QCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       940 ~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                      .|++.++++|..||+.+|++||++..+++++..+.++..
T Consensus       928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence            799999999999999999999999999999998887643

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=329.45  Aligned_cols=244  Identities=24%  Similarity=0.310  Sum_probs=208.6

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccC----Cc-chHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCc
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ----CA-STLKSFEAECEVIKNIR-HRNLVKIISSCSNDDF  796 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~----~~-~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~  796 (985)
                      ..++|..++.||+|+||.|+.|... +++.||+|++.++    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            4578999999999999999999754 7899999987664    11 23456778999999999 9999999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-CcEEEecccCcee
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAKL  875 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~-~~~kl~DfGla~~  875 (985)
                      .++||||+.||+|.+++.. ..++.+....++++|++.|++|+   |++||+||||||+||++|.+ +++||+|||++..
T Consensus        95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~---H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYC---HSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999999999998 55788899999999999999999   89999999999999999999 9999999999998


Q ss_pred             ccCCCCcceecccccccccccccccccCc-cc-hhhhcccccccchhhhcccccccCcchh-----------hhhHHHH-
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFVGE-LS-LKRWVNDLLPVSLVEVVDKSLLSGEEKH-----------FAAKEQC-  941 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~dv~~~~g~~~~~i~~~~~~~~~~~~-----------~~~~~~~-  941 (985)
                      ..  .........+||+.|+|||++.+.. |. .+.|+ |++|++++.|+.|..++.....           +..+..+ 
T Consensus       171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDv-WS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~  247 (370)
T KOG0583|consen  171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADV-WSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL  247 (370)
T ss_pred             cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhh-hhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC
Confidence            63  2233455678999999999999877 75 67788 9999999999999998876431           1123334 


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          942 LLSIFSLALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       942 ~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                      ..++..++.+|+..+|.+|+++.+++ .-.-+++
T Consensus       248 S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~  280 (370)
T KOG0583|consen  248 SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK  280 (370)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence            78889999999999999999999998 4444443

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=312.29  Aligned_cols=248  Identities=25%  Similarity=0.344  Sum_probs=201.5

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHh--cCCCCeeeEEeeeecCC----ceE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKN--IRHRNLVKIISSCSNDD----FKA  798 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~--l~h~niv~l~~~~~~~~----~~~  798 (985)
                      .+..+..++||+|+||.||+|.+. ++.||||++...   +.+.|..|-+|++.  ++|+||++|+++-...+    +++
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            345556688999999999999996 699999999744   45678888888775  58999999999876655    789


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh------cCCCCeEeCCCCCCCEEEcCCCcEEEecccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF------GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGM  872 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~------~h~~~ivHrDlk~~Nill~~~~~~kl~DfGl  872 (985)
                      +|+||.+.|+|.++++.+  ..+|....+|+.-+++||+|||+      .|+++|+|||||++|||+..|+++.|+|||+
T Consensus       285 LVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             EEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            999999999999999986  58999999999999999999996      3678899999999999999999999999999


Q ss_pred             ceeccCCCCcceeccccccccccccccccc------Cccchhhhcccccccchhhhccccccc--Ccchhhhh-------
Q 001988          873 AKLLSGEDESTMRTQTLATIGYMAPDEIFV------GELSLKRWVNDLLPVSLVEVVDKSLLS--GEEKHFAA-------  937 (985)
Q Consensus       873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~dv~~~~g~~~~~i~~~~~~~--~~~~~~~~-------  937 (985)
                      |..+............+||.+|||||++.+      ...-.+.|| |++|.++||++..-...  +..+.+..       
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~Dv-YamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDV-YAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHH-HHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            999876555555556789999999998643      122234588 99999999998754332  22211110       


Q ss_pred             ----H----------------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          938 ----K----------------------EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       938 ----~----------------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                          .                      ...+..+.+.+..||..||+.|.|+.=+.+++.++..-.+.
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence                0                      01346678899999999999999999999999998875543

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=324.80  Aligned_cols=234  Identities=24%  Similarity=0.378  Sum_probs=206.4

Q ss_pred             ccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCC
Q 001988          728 FAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNG  807 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  807 (985)
                      ....+.+|.|+.|.||+|+.+ ++.||||+++.-.       +.+|+=|++++||||+.|.|+|...-.++||||||+.|
T Consensus       126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            345678999999999999997 7889999876331       35778899999999999999999999999999999999


Q ss_pred             ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecc
Q 001988          808 SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ  887 (985)
Q Consensus       808 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~  887 (985)
                      -|...++... .++......|..+||.|+.||   |.+.|||||||.-||||..+..|||+|||-++...+.   .....
T Consensus       198 qL~~VLka~~-~itp~llv~Wsk~IA~GM~YL---H~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS  270 (904)
T KOG4721|consen  198 QLYEVLKAGR-PITPSLLVDWSKGIAGGMNYL---HLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS  270 (904)
T ss_pred             cHHHHHhccC-ccCHHHHHHHHHHhhhhhHHH---HHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence            9999999865 677888889999999999999   7889999999999999999999999999999876533   33456


Q ss_pred             cccccccccccccccCccchhhhcccccccchhhhcccccccCcch-------------hhhhHHHHHHHHHHHHHHccC
Q 001988          888 TLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK-------------HFAAKEQCLLSIFSLALECTM  954 (985)
Q Consensus       888 ~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~-------------~~~~~~~~~~~l~~l~~~cl~  954 (985)
                      ++||..|||||++...+.+.+.|+ |+||+++|||+++++++.+..             ..+.+..|++.+.-+++.||+
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDI-wSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~  349 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDI-WSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN  349 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccce-ehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence            789999999999999999999999 999999999999998876542             334577899999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHHhHhhh
Q 001988          955 ESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       955 ~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      .+|..||++++++..|.-+..++
T Consensus       350 sKpRNRPSFrqil~HldIa~pel  372 (904)
T KOG4721|consen  350 SKPRNRPSFRQILLHLDIASPEL  372 (904)
T ss_pred             cCCCCCccHHHHHHHHhhcCHHH
Confidence            99999999999999997766544

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-35  Score=324.76  Aligned_cols=247  Identities=26%  Similarity=0.401  Sum_probs=206.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc--CC---cEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE--DG---VEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDF  796 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~--~~---~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  796 (985)
                      -++....++||+|+||+||+|+++  ++   ..||||..+...   .....++.+|+++|++++|||||++||++.....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            344555689999999999999865  22   238999988532   3456789999999999999999999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      .++|||+|+||+|.+++...+..++..++.+++.++|.||+||   |++++|||||.++|+|++.++.+||+|||+++.-
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YL---h~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYL---HSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHH---HHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            9999999999999999999877899999999999999999999   8999999999999999999999999999998753


Q ss_pred             cCCCCcceec-ccccccccccccccccCccchhhhcccccccchhhhccc-ccccCcch-------------hhhhHHHH
Q 001988          877 SGEDESTMRT-QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDK-SLLSGEEK-------------HFAAKEQC  941 (985)
Q Consensus       877 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~-~~~~~~~~-------------~~~~~~~~  941 (985)
                      .   ...... ...-..+|+|||.+..+.++.++|| |++|+.+||++.. .-++..-.             +...+...
T Consensus       313 ~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV-~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~  388 (474)
T KOG0194|consen  313 S---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDV-WSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKT  388 (474)
T ss_pred             c---ceeeccccccCcceecChhhhccCccccccch-hheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCC
Confidence            2   111111 2235678999999999999999999 8999999999883 22222111             11223456


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          942 LLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       942 ~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                      +.++..++.+||..+|++||+|.++.+.++.+.+...
T Consensus       389 p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  389 PKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             HHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            7889999999999999999999999999999887644

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4e-36  Score=322.16  Aligned_cols=235  Identities=26%  Similarity=0.338  Sum_probs=205.1

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+...  .+.+.+++|++|++.++|||||.++++|+...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46778889999999999999865 778899999976533  346678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |+.| +|+.++...+ .++++.+..++.|++.||.||   |+.+|+|||+||+||+++..|++|++|||+|+.+..  ..
T Consensus        82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yL---hs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYL---HSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT  154 (808)
T ss_pred             hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHH---HhcCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence            9976 9999998765 688999999999999999999   899999999999999999999999999999998753  34


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh-----------hhHHHHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-----------AAKEQCLLSIFSLALE  951 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~  951 (985)
                      ...+.+.|||.|||||.+.++.|+..+|. |++|++++|+..|+.++-.....           ..+......+..+++.
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDl-WslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~g  233 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDL-WSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQG  233 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhH-HHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHH
Confidence            45677889999999999999999999999 99999999999988765433111           1223456778999999


Q ss_pred             ccCCCCCCCCCHHHHHH
Q 001988          952 CTMESPEKRIDAKDTIT  968 (985)
Q Consensus       952 cl~~~P~~RPt~~ev~~  968 (985)
                      .+..||.+|.+..+++.
T Consensus       234 LL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  234 LLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HhhcChhhcccHHHHhc
Confidence            99999999999988764

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.4e-35  Score=316.54  Aligned_cols=233  Identities=23%  Similarity=0.300  Sum_probs=193.7

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ..++|....+||+|+||+||+|+-+ +|..+|+|++++...   ...+.++.|-.+|....+|.||++|..|++.++.|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            5578999999999999999999854 799999999987632   335667899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+||||+...|...+ .+++.....++.+++-|++.+   |..|+|||||||+|+|||..|++||+|||+++-+...
T Consensus       219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~i---H~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESI---HQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHH---HHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            999999999999998775 788899999999999999999   8999999999999999999999999999998543210


Q ss_pred             ----------------------CCc-----------------------ceecccccccccccccccccCccchhhhcccc
Q 001988          880 ----------------------DES-----------------------TMRTQTLATIGYMAPDEIFVGELSLKRWVNDL  914 (985)
Q Consensus       880 ----------------------~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~  914 (985)
                                            +..                       ......+|||.|||||++.+..|+..+|. |+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw-WS  373 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW-WS  373 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH-HH
Confidence                                  000                       00123579999999999999999888887 99


Q ss_pred             cccchhhhcccccccCcchhh---------------hhHHHHHHHHHHHHHHccCCCCCCCCC
Q 001988          915 LPVSLVEVVDKSLLSGEEKHF---------------AAKEQCLLSIFSLALECTMESPEKRID  962 (985)
Q Consensus       915 ~g~~~~~i~~~~~~~~~~~~~---------------~~~~~~~~~l~~l~~~cl~~~P~~RPt  962 (985)
                      +|++++|++.|..++......               +....+.++..++|.+|+. ||++|-.
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            999999999887765443211               1122345778888888887 8888876

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.6e-37  Score=334.93  Aligned_cols=368  Identities=27%  Similarity=0.458  Sum_probs=205.2

Q ss_pred             ceEEEcccccCC-CccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEcc
Q 001988          196 LQELHLGYNNLS-GAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLY  274 (985)
Q Consensus       196 L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~  274 (985)
                      .+-.|+++|.++ +..|.....+++++.|.|...++. .+|++++.+++|++|.+++|++. .+-..+..++.|+.+++.
T Consensus         9 VrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R   86 (1255)
T KOG0444|consen    9 VRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVR   86 (1255)
T ss_pred             eecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhh
Confidence            344455555554 334445555555555555555554 45555555555555555555554 333444455555555555


Q ss_pred             CCcCcc-cCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccC
Q 001988          275 NNSLSG-SLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTS  353 (985)
Q Consensus       275 ~N~l~~-~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  353 (985)
                      +|++.. -+|..+| .+..|+.||||+|++. ..|..+....++.+|+||+|+|..+..+.|-+|+.|-.|||++|++..
T Consensus        87 ~N~LKnsGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~  164 (1255)
T KOG0444|consen   87 DNNLKNSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEM  164 (1255)
T ss_pred             ccccccCCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhh
Confidence            555542 2444443 4555555555555555 455555666666666666666664444555666666666666666666


Q ss_pred             CCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCC-CC
Q 001988          354 STPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLS-GS  432 (985)
Q Consensus       354 ~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~  432 (985)
                      ++|.      ...+..|++|+|++|++...--                         ..+..+++|++|.+++.+=+ ..
T Consensus       165 LPPQ------~RRL~~LqtL~Ls~NPL~hfQL-------------------------rQLPsmtsL~vLhms~TqRTl~N  213 (1255)
T KOG0444|consen  165 LPPQ------IRRLSMLQTLKLSNNPLNHFQL-------------------------RQLPSMTSLSVLHMSNTQRTLDN  213 (1255)
T ss_pred             cCHH------HHHHhhhhhhhcCCChhhHHHH-------------------------hcCccchhhhhhhcccccchhhc
Confidence            5553      3455566666666666543211                         11223455556666555432 24


Q ss_pred             CCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCc
Q 001988          433 IPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNL  512 (985)
Q Consensus       433 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  512 (985)
                      +|.++.++.+|..+|||.|.+. .+|+.+.++++|+.|+||+|+|+ ....+.....+|+.|+||.|+++ .+|.++..+
T Consensus       214 ~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL  290 (1255)
T KOG0444|consen  214 IPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKL  290 (1255)
T ss_pred             CCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhh
Confidence            5666777777777777777776 67777777777777777777776 34445555667777777777776 356655555


Q ss_pred             cceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEec
Q 001988          513 KDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDL  592 (985)
Q Consensus       513 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  592 (985)
                      +.|+.|++.+|+++-.                       -+|..++.|.+|+.+..++|.+. .+|+.+..+..|+.|.|
T Consensus       291 ~kL~kLy~n~NkL~Fe-----------------------GiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L  346 (1255)
T KOG0444|consen  291 TKLTKLYANNNKLTFE-----------------------GIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKL  346 (1255)
T ss_pred             HHHHHHHhccCccccc-----------------------CCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcc
Confidence            5555555555555311                       23444555555555555555554 45555555555555555


Q ss_pred             CCCcccCCCCccccccccccccccccccccCCCC
Q 001988          593 SNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIP  626 (985)
Q Consensus       593 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p  626 (985)
                      +.|+|. .+|+.+.-|+.|+.||+..|+=--.+|
T Consensus       347 ~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP  379 (1255)
T KOG0444|consen  347 DHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP  379 (1255)
T ss_pred             ccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence            555554 455555555555555555554443333

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.8e-34  Score=319.01  Aligned_cols=242  Identities=24%  Similarity=0.420  Sum_probs=197.1

Q ss_pred             cCccCCceeeccCceeEEEEEEcC-----------------CcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLED-----------------GVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKI  787 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~-----------------~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l  787 (985)
                      ++|...+.||+|+||.||+|.+++                 +..||+|.+...... ....+.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            568888999999999999997532                 346999998765333 34678999999999999999999


Q ss_pred             EeeeecCCceEEEEeccCCCChHHHhhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 001988          788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSN------------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIH  849 (985)
Q Consensus       788 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH  849 (985)
                      ++++.+.+..++||||+++|+|.+++....                  ..+++....+++.|++.||+||   |+.||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH---HHCCccc
Confidence            999999999999999999999999886431                  2467888999999999999999   7899999


Q ss_pred             CCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhccc--cc
Q 001988          850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDK--SL  927 (985)
Q Consensus       850 rDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~--~~  927 (985)
                      |||||+||++++++.+||+|||+++.+.............++..|+|||.+..+.++.++|+ |++|+.+++++++  ..
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-~slG~~l~el~~~~~~~  240 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV-WAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhh-HHHHHHHHHHHHccCCC
Confidence            99999999999999999999999987643332222333456889999999998999999999 9999999998753  22


Q ss_pred             ccCcchhhh-------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 001988          928 LSGEEKHFA-------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLL  971 (985)
Q Consensus       928 ~~~~~~~~~-------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~  971 (985)
                      +........                   .+..++..+.+++.+||+.+|.+||++.++.+.|+
T Consensus       241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            222111100                   11234577999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-36  Score=314.82  Aligned_cols=237  Identities=26%  Similarity=0.336  Sum_probs=204.5

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ..|...+.||+|.||.||+|... +++.||+|++..... .+...+++|+.++.+++++||.++|+.+..+...+++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45677789999999999999854 788899999987643 3467789999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +.||++.+.++... .+++....-++.++..|+.|+   |.++.+|||||+.||++..+|.||++|||.+..+...  ..
T Consensus        93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~yl---H~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYL---HSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--VK  166 (467)
T ss_pred             hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhh---hhcceecccccccceeEeccCcEEEEecceeeeeech--hh
Confidence            99999999998764 447777788999999999999   8999999999999999999999999999999876432  23


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcch------------hhhhHHHHHHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK------------HFAAKEQCLLSIFSLALE  951 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~------------~~~~~~~~~~~l~~l~~~  951 (985)
                      ....++|||.|||||++....|+.+.|+ |++|+.++|+..|+.+.....            .+.....+...+.+++..
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADI-WSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~  245 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADI-WSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEA  245 (467)
T ss_pred             ccccccccccccchhhhccccccchhhh-hhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHH
Confidence            3467889999999999999999999999 999999999999987654321            111122577889999999


Q ss_pred             ccCCCCCCCCCHHHHHHH
Q 001988          952 CTMESPEKRIDAKDTITR  969 (985)
Q Consensus       952 cl~~~P~~RPt~~ev~~~  969 (985)
                      |+..+|+.||+|.++++.
T Consensus       246 CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  246 CLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             HhhcCcccCcCHHHHhhh
Confidence            999999999999998863

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-35  Score=322.25  Aligned_cols=237  Identities=25%  Similarity=0.297  Sum_probs=207.5

Q ss_pred             cCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      +-|+.++-||+|+.|.|-+|++ .+|+.+|||++.+...   .....+++|+-||+.++|||++++|++|+...++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4577788899999999999985 5999999999987622   22466899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||++||.|++++-.++ .+++.+..++++||+.|+.|+   |..+|+|||+||+|+|+|..+.+||+|||+|..-   .+
T Consensus        92 Eyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yC---H~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYC---HAFNICHRDLKPENLLLDVKNNIKIADFGMASLE---VP  164 (786)
T ss_pred             EecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHH---hhhcceeccCCchhhhhhcccCEeeeccceeecc---cC
Confidence            9999999999998876 677778888999999999999   8899999999999999999999999999999873   23


Q ss_pred             cceecccccccccccccccccCccc-hhhhcccccccchhhhcccccccCcch-----------hhhhHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELS-LKRWVNDLLPVSLVEVVDKSLLSGEEK-----------HFAAKEQCLLSIFSLA  949 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~dv~~~~g~~~~~i~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~  949 (985)
                      .......||+|.|.|||++++.+|. .++|| |+-|++++.+++|+++++++.           .++-+...+.+..+++
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDV-WSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLL  243 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDV-WSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLL  243 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCcccc-chhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHH
Confidence            3445667899999999999999885 67888 999999999999999988663           2233445678899999


Q ss_pred             HHccCCCCCCCCCHHHHHHHH
Q 001988          950 LECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~~L  970 (985)
                      ++|+..||++|.|+.||.+.-
T Consensus       244 r~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  244 RRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             HHHhccCccccccHHHHhhCc
Confidence            999999999999999998754

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-35  Score=322.17  Aligned_cols=232  Identities=23%  Similarity=0.268  Sum_probs=200.6

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~  798 (985)
                      ..++|...++||+|.||+|++|..+ +++.+|||++++..   ..+.+..+.|.+|+... +||.+++++.+|++.++.|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            4477888999999999999999976 78889999999873   34567788999998887 5999999999999999999


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +||||+.||++..+.+  ...+++....-+|..|+.||+||   |++||||||||.+|||+|.+|++||+|||+++.-- 
T Consensus       446 fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fL---H~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-  519 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFL---HENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-  519 (694)
T ss_pred             EEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHH---HhcCceeeecchhheEEcccCcEEecccccccccC-
Confidence            9999999999544433  34689999999999999999999   89999999999999999999999999999998742 


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSIFS  947 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l~~  947 (985)
                       .....+.++||||.|||||++.+..|+.+.|. |++|+.++||+.|+.++..+.+.+.           |..++.+...
T Consensus       520 -~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDW-W~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~  597 (694)
T KOG0694|consen  520 -GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDW-WGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIA  597 (694)
T ss_pred             -CCCCccccccCChhhcChhhhccCcccchhhH-HHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHH
Confidence             23345678999999999999999999988887 9999999999999987765433322           2236788999


Q ss_pred             HHHHccCCCCCCCCCH
Q 001988          948 LALECTMESPEKRIDA  963 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~  963 (985)
                      ++++.+..+|++|-.+
T Consensus       598 il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  598 IMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHhccCcccccCC
Confidence            9999999999999977

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2e-34  Score=327.08  Aligned_cols=245  Identities=21%  Similarity=0.347  Sum_probs=200.2

Q ss_pred             hcCccCCceeeccCceeEEEEEE------cCCcEEEEEEeccCC-cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL------EDGVEIAIKVFHPQC-ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDF  796 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~  796 (985)
                      .++|+..+.||+|+||.||+|.+      +++..||||+++... ....+.+.+|+++++.+ +||||++++++|.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45788899999999999999963      246689999987543 23456788999999999 89999999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcCC-----------------------------------------------------------
Q 001988          797 KALVLEYMSNGSLEDCLHSSN-----------------------------------------------------------  817 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------------  817 (985)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986431                                                           


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          818 ---------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       818 ---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                                     ..+++..+.+++.||++||+||   |+++|+||||||+||++++++.+||+|||+++.+......
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           1467888999999999999999   7899999999999999999999999999999876433322


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh-------------hhHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF-------------AAKEQCLLSIFSL  948 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~-------------~~~~~~~~~l~~l  948 (985)
                      .......++..|+|||.+.+..++.++|+ |++|+.++++++ +..+.......             ..+...+.++.++
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi-~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  349 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDV-WSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDI  349 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCH-HHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHH
Confidence            22222345678999999999999999999 999999999986 55443221111             0112245679999


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          949 ALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                      +.+||+.||++||++.|+++.|++.
T Consensus       350 i~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         350 MKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHHccCChhHCcCHHHHHHHHHhh
Confidence            9999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-35  Score=318.96  Aligned_cols=238  Identities=25%  Similarity=0.324  Sum_probs=209.7

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCc-eEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDF-KALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~lv~  801 (985)
                      ++|...+.+|+|+||.++.++++ +++.||+|.+....  ........+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999999865 78899999987653  3345578899999999999999999999999988 99999


Q ss_pred             eccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          802 EYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      +||+||++.+.+.... ..+++..+..|+.|++.|+.||   |+.+|+|||||++||++++++.|||+|||+|+.+....
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~yl---H~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYL---HENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH---HhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999998764 6789999999999999999999   79999999999999999999999999999999985333


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh------------hhhHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH------------FAAKEQCLLSIFSL  948 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~------------~~~~~~~~~~l~~l  948 (985)
                        ....+.+||+.||.||.+.+.+|..++|+ |++|++++|+.+-+..+....-            .+.+..+..++..+
T Consensus       161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDi-WsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l  237 (426)
T KOG0589|consen  161 --SLASTVVGTPYYMCPEILSDIPYNEKSDI-WSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL  237 (426)
T ss_pred             --hhhheecCCCcccCHHHhCCCCCCccCcc-hhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence              34566789999999999999999999999 9999999999987765544321            22345567889999


Q ss_pred             HHHccCCCCCCCCCHHHHHHH
Q 001988          949 ALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      +..|++.+|..||++.+++.+
T Consensus       238 v~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  238 VKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHHhhcCCccCCCHHHHhhC
Confidence            999999999999999999988

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.6e-35  Score=294.95  Aligned_cols=237  Identities=23%  Similarity=0.272  Sum_probs=196.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecC--CceEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSND--DFKAL  799 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~l  799 (985)
                      .++|+..+.|++|+||.||+|+++ +++.||+|+++.+...  ..-...+||.+|.+++|||||.+-.+....  +..||
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            356777899999999999999965 7888999999866322  233457999999999999999999887543  56899


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      |||||+. ||...++.-..++...++..++.|+++|++||   |...|+|||+|++|+|+...|.+||+|||+|+.+..+
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~l---H~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHL---HDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHH---hhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            9999976 99999998878899999999999999999999   8999999999999999999999999999999998643


Q ss_pred             CCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhhH--------------------
Q 001988          880 DESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK--------------------  938 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~--------------------  938 (985)
                      .  ...+..+-|.+|+|||.+.+ ..|+.+.|+ |++||++.|++.++.........++.                    
T Consensus       231 ~--k~~T~lVVTLWYRaPELLLG~~tyst~iDM-WSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  231 L--KPYTPLVVTLWYRAPELLLGAKTYSTAVDM-WSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             c--ccCcceEEEeeecCHHHhcCCcccCcchhh-hhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            2  23455678999999998876 568899999 99999999998876544332211100                    


Q ss_pred             ---------------------H--HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          939 ---------------------E--QCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       939 ---------------------~--~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                           .  ...+.-++++...+.+||.+|.||.|.++
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                                 0  02366788999999999999999999875

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=7.8e-37  Score=329.70  Aligned_cols=372  Identities=29%  Similarity=0.443  Sum_probs=275.7

Q ss_pred             ccccccceecccCCcCC-CCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhcccc
Q 001988           94 ANLSSLKSLDLSHNKLS-SNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYL  172 (985)
Q Consensus        94 ~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L  172 (985)
                      +-|+..+..|+++|.|+ +.+|.....+++++.|.|...++.                         .+|+++ +++.+|
T Consensus         4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-------------------------~vPeEL-~~lqkL   57 (1255)
T KOG0444|consen    4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-------------------------QVPEEL-SRLQKL   57 (1255)
T ss_pred             cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-------------------------hChHHH-HHHhhh
Confidence            44667778888888888 468888888888888888777765                         778887 678888


Q ss_pred             ceecccCccccccCCcccCCCCCceEEEcccccCC-CccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecC
Q 001988          173 KHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLS-GAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGF  251 (985)
Q Consensus       173 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  251 (985)
                      ++|.+++|++. .+-..++.|+.|+.+++..|++. .-||..+-.+..|..||||+|+++ +.|..+..-+++-+|+||+
T Consensus        58 EHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~  135 (1255)
T KOG0444|consen   58 EHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSY  135 (1255)
T ss_pred             hhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEccc
Confidence            88888888887 66777888888888888888885 347777888888888888888888 7888888888888888888


Q ss_pred             CcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccc-cc
Q 001988          252 NNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFS-GF  330 (985)
Q Consensus       252 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~  330 (985)
                      |+|..+....|-+++.|-.||||+|++. .+|..+- .+.+|++|+|++|.+.-.--..+..+++|++|.+++.+=+ ..
T Consensus       136 N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~R-RL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N  213 (1255)
T KOG0444|consen  136 NNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIR-RLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDN  213 (1255)
T ss_pred             CccccCCchHHHhhHhHhhhccccchhh-hcCHHHH-HHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhc
Confidence            8888444444557888888888888887 6776653 6778888888888766444445556677777777775532 35


Q ss_pred             cCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccC
Q 001988          331 IPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIP  410 (985)
Q Consensus       331 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~  410 (985)
                      +|..+..|.+|..+|++.|++...+.      .+-++++|+.|+||+|+|+ .+....+.+. +|++|+++.|+++ .+|
T Consensus       214 ~Ptsld~l~NL~dvDlS~N~Lp~vPe------cly~l~~LrrLNLS~N~it-eL~~~~~~W~-~lEtLNlSrNQLt-~LP  284 (1255)
T KOG0444|consen  214 IPTSLDDLHNLRDVDLSENNLPIVPE------CLYKLRNLRRLNLSGNKIT-ELNMTEGEWE-NLETLNLSRNQLT-VLP  284 (1255)
T ss_pred             CCCchhhhhhhhhccccccCCCcchH------HHhhhhhhheeccCcCcee-eeeccHHHHh-hhhhhccccchhc-cch
Confidence            67777788888888888887776553      3566777788888888776 3334444444 6777777777777 667


Q ss_pred             CcCCCCCCccEEEccCCCCC-CCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcC
Q 001988          411 KAIGNLSNLIVLSLGGNNLS-GSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLT  489 (985)
Q Consensus       411 ~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  489 (985)
                      ++++.++.|+.|++.+|+++ .-+|..++.+.+|+.+..++|.+. .+|+.+|.+..|+.|.|+.|++- ..|.++.-++
T Consensus       285 ~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~  362 (1255)
T KOG0444|consen  285 DAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLP  362 (1255)
T ss_pred             HHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcC
Confidence            77777777777777777765 235677777777777777777776 77777777777777777777775 5677777777


Q ss_pred             cCceEeeccceeeeecC
Q 001988          490 SLQYLNLGSNRFTFVIP  506 (985)
Q Consensus       490 ~L~~L~L~~N~l~~~~p  506 (985)
                      .|+.|||..|.=--..|
T Consensus       363 ~l~vLDlreNpnLVMPP  379 (1255)
T KOG0444|consen  363 DLKVLDLRENPNLVMPP  379 (1255)
T ss_pred             CcceeeccCCcCccCCC
Confidence            77777777775433333

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=8.9e-34  Score=309.35  Aligned_cols=234  Identities=21%  Similarity=0.258  Sum_probs=198.3

Q ss_pred             CceeeccCceeEEEEEEcCCcEEEEEEeccCCcch---HHHHHHHHHHHHhcCCCCeeeEEeeeec----CCceEEEEec
Q 001988          731 NNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAST---LKSFEAECEVIKNIRHRNLVKIISSCSN----DDFKALVLEY  803 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~lv~e~  803 (985)
                      ...||+|++|.||+|.+ +|+.||||+++......   .+.+.+|++++++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            46799999999999998 58999999997653332   4677899999999999999999999876    3467899999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS-TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      +++|+|.+++.... .+++....+++.|++.|++|+   |+ .+++||||||+||++++++.+||+|||+++.+....  
T Consensus       104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~l---H~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNL---YKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHH---HhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            99999999998754 688999999999999999999   55 588999999999999999999999999998754322  


Q ss_pred             ceeccccccccccccccccc--CccchhhhcccccccchhhhcccccccCcchhhh-------------hHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFV--GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------AKEQCLLSIFS  947 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------~~~~~~~~l~~  947 (985)
                         ....++..|+|||.+.+  ..++.++|+ |++|+.+++++++..++.......             .+..+++++.+
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di-~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~  253 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDI-YSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKC  253 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhh-hHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHH
Confidence               22458899999999876  788999999 999999999999987765432111             12246788999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          948 LALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                      ++.+||+.||++||++.|+++.|+....
T Consensus       254 li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        254 IVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             HHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999988764

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.1e-34  Score=324.19  Aligned_cols=247  Identities=21%  Similarity=0.333  Sum_probs=201.1

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhc-CCCCeeeEEeeeecCC
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNI-RHRNLVKIISSCSNDD  795 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~  795 (985)
                      ..++|+..+.||+|+||.||+|+..      ++..||+|+++..... ....+.+|+++++++ +|+||++++++|...+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            3457889999999999999998742      3457999999765332 345688999999999 8999999999999999


Q ss_pred             ceEEEEeccCCCChHHHhhcCC----------------------------------------------------------
Q 001988          796 FKALVLEYMSNGSLEDCLHSSN----------------------------------------------------------  817 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  817 (985)
                      ..++||||+++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999886421                                                          


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          818 -----------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       818 -----------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                                 ..+++....+++.||++||+||   |++||+||||||+||++++++.+||+|||+++.+..........
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                       2367888899999999999999   78999999999999999999999999999998764332222222


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh-------------hHHHHHHHHHHHHHHc
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA-------------AKEQCLLSIFSLALEC  952 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~-------------~~~~~~~~l~~l~~~c  952 (985)
                      ...+++.|||||++....++.+.|+ |++|+.++++++ +..++.......             .+...+.++.+++.+|
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~Dv-wSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  351 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDV-WSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC  351 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccH-HHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence            2335678999999999999999999 999999999986 665443221100             1112357899999999


Q ss_pred             cCCCCCCCCCHHHHHHHHHHhH
Q 001988          953 TMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       953 l~~~P~~RPt~~ev~~~L~~i~  974 (985)
                      |..||.+||++.++++.|+++.
T Consensus       352 l~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         352 WNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             cCCChhhCcCHHHHHHHHHHHh
Confidence            9999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.4e-34  Score=308.73  Aligned_cols=237  Identities=33%  Similarity=0.527  Sum_probs=193.8

Q ss_pred             CCceeeccCceeEEEEEEc-----CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          730 ENNIIGIGGFGSVYRARLE-----DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       730 ~~~~ig~G~~g~V~~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ..+.||.|+||.||+|.+.     .+..||||.++..... ..+.+.+|++++++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999876     3577999999654333 467899999999999999999999999988889999999


Q ss_pred             cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      +++|+|.+++... ...+++.++.+|+.||++||+||   |+.+++||||+++||+++.++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~L---h~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYL---HSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHH---HHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999987 66789999999999999999999   6789999999999999999999999999999887433333


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFSLA  949 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~l~  949 (985)
                      ...........|+|||.+....++.++|| |++|+.++|+++ +..+.......            ..+..++..+.+++
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDV-ysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDV-YSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI  238 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHH-HHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence            33344457889999999999999999999 999999999999 45544332111            12334678899999


Q ss_pred             HHccCCCCCCCCCHHHHHHHH
Q 001988          950 LECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~~L  970 (985)
                      .+||..+|++||++.+++++|
T Consensus       239 ~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  239 QQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHHT-SSGGGS--HHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHhcC
Confidence            999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.4e-34  Score=309.32  Aligned_cols=244  Identities=22%  Similarity=0.320  Sum_probs=202.0

Q ss_pred             hcCccCCceeeccCceeEEEEEEc----CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ..+|+..+.||+|+||.||+|.++    .+..||+|.++.... .....+.+|+.++++++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356888899999999999999753    456899999886533 234578899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++|+|.+++......+++.+++.++.|++.|++||   |++|++||||||+||+++.++.+|++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~l---H~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            9999999999999987656789999999999999999999   7899999999999999999999999999987653221


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSIF  946 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l~  946 (985)
                      . ........++..|+|||.+..+.++.++|+ |++|+.+++++. ++.+......            .+.+..++..+.
T Consensus       161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (266)
T cd05064         161 A-IYTTMSGKSPVLWAAPEAIQYHHFSSASDV-WSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH  238 (266)
T ss_pred             c-hhcccCCCCceeecCHHHHhhCCccchhHH-HHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence            1 111122335678999999999999999999 999999999764 6654432211            112334678899


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          947 SLALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                      +++.+||+.+|.+||++.++.+.|.++
T Consensus       239 ~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         239 QLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-35  Score=315.91  Aligned_cols=251  Identities=24%  Similarity=0.394  Sum_probs=215.1

Q ss_pred             HHHHHHhcCccCCceeeccCceeEEEEEEcC-CcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCce
Q 001988          719 FELLRATDNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       719 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  797 (985)
                      ++|+....+...-.+||-|-||.||.|.|+. ...||||.++.+ .....+|.+|..+|+.++|||+|+++|+|...-.+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            3444444556667889999999999999873 567999999866 45678999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          798 ALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      |||+|||..|+|.+|+++. +..++.-..+.+|.||+.|++||   ..+++|||||.++|+|+.++..|||+|||+++++
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYL---EkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHH---HHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            9999999999999999876 33466667788999999999999   8999999999999999999999999999999998


Q ss_pred             cCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcc-------------hhhhhHHHHHH
Q 001988          877 SGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEE-------------KHFAAKEQCLL  943 (985)
Q Consensus       877 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~-------------~~~~~~~~~~~  943 (985)
                      .++. ++......-...|.|||-+....++.++|| |.||+.+||+.++.+.....             .+.+.++.|++
T Consensus       416 tgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDV-WAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPp  493 (1157)
T KOG4278|consen  416 TGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDV-WAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPP  493 (1157)
T ss_pred             cCCc-eecccCccCcccccCcccccccccccchhh-HHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCH
Confidence            6433 333333445678999999999999999999 99999999999988743322             24456788999


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          944 SIFSLALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                      .++++|+.||++.|.+||++.|+-+.++.+-+
T Consensus       494 kVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  494 KVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             HHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            99999999999999999999999999987654

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.9e-35  Score=299.36  Aligned_cols=238  Identities=24%  Similarity=0.310  Sum_probs=203.6

Q ss_pred             cCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      -+|...+.+|+|.||.|-+|.. ..|+.||||.++++.   .++.-.+++|++||..++||||+++|.+|+..+...|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            3566677899999999999984 689999999998763   334556899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||..+|.|.||+.+.+ .+++.+...+++||+.|+.|+   |.++++|||+|.+|||+|+++++||+|||++..+.+   
T Consensus       133 EYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYC---HknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---  205 (668)
T KOG0611|consen  133 EYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYC---HKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---  205 (668)
T ss_pred             EecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHH---hhccceecccchhheeecCCCCeeeeccchhhhhcc---
Confidence            9999999999999875 688999999999999999999   899999999999999999999999999999988753   


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhhHHH----------HHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQ----------CLLSIFSLALE  951 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~~~----------~~~~l~~l~~~  951 (985)
                      ......+||+|-|.+||.+.+.+|....-.-|++|+.++-++-|.+++....+.....+          .+....-+|+.
T Consensus       206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRw  285 (668)
T KOG0611|consen  206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRW  285 (668)
T ss_pred             ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHH
Confidence            33456789999999999999998865544449999999999999988776533221111          23446669999


Q ss_pred             ccCCCCCCCCCHHHHHHHH
Q 001988          952 CTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       952 cl~~~P~~RPt~~ev~~~L  970 (985)
                      |+..+|++|.|..||....
T Consensus       286 mLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  286 MLMVNPERRATIEDIASHW  304 (668)
T ss_pred             HHhcCcccchhHHHHhhhh
Confidence            9999999999999998765

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.1e-33  Score=315.19  Aligned_cols=230  Identities=25%  Similarity=0.276  Sum_probs=194.4

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNG  807 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  807 (985)
                      +.||+|+||.||+|+.. +|+.||+|++++..   ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 78999999997542   223456788999999999999999999999999999999999999


Q ss_pred             ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecc
Q 001988          808 SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ  887 (985)
Q Consensus       808 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~  887 (985)
                      +|.+++...+ .+++.....++.||+.||+||   |+.||+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~  154 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYL---HSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence            9999987654 688999999999999999999   78999999999999999999999999999987642221  12234


Q ss_pred             cccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHHHccCCC
Q 001988          888 TLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLALECTMES  956 (985)
Q Consensus       888 ~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~~cl~~~  956 (985)
                      .+||+.|+|||.+.+..++.++|+ |++|++++++++|..+........           .+...+.++.+++.+|+..|
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~Di-wSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~d  233 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDW-WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKD  233 (323)
T ss_pred             eecCccccChhhhcCCCCCccccC-cccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCC
Confidence            569999999999999999999999 999999999999987654322111           12235678899999999999


Q ss_pred             CCCCC-----CHHHHHH
Q 001988          957 PEKRI-----DAKDTIT  968 (985)
Q Consensus       957 P~~RP-----t~~ev~~  968 (985)
                      |++||     ++.++++
T Consensus       234 P~~R~~~~~~~~~~ll~  250 (323)
T cd05571         234 PKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHcCCCCCCCHHHHHc
Confidence            99999     7888865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.6e-33  Score=303.30  Aligned_cols=239  Identities=23%  Similarity=0.365  Sum_probs=200.5

Q ss_pred             cCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccC
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      ++|...+.||+|+||.||+|+++++..+|+|.+... ......+.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            457788999999999999999988889999988644 2334678899999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCccee
Q 001988          806 NGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR  885 (985)
Q Consensus       806 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~  885 (985)
                      +|+|.++++.....+++..+..++.|++.||+||   |+.||+||||||+||++++++.+|++|||.++....... ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL---ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ecc
Confidence            9999999986555689999999999999999999   789999999999999999999999999999886532221 112


Q ss_pred             cccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh------------hHHHHHHHHHHHHHHc
Q 001988          886 TQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA------------AKEQCLLSIFSLALEC  952 (985)
Q Consensus       886 ~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~------------~~~~~~~~l~~l~~~c  952 (985)
                      ....++..|+|||.+....++.++|+ |++|+.++++++ ++.+........            .+...+.++.+++.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di-~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDV-WSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSC  237 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhh-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence            22335678999999988889999999 999999999998 665443321111            1222456789999999


Q ss_pred             cCCCCCCCCCHHHHHHHH
Q 001988          953 TMESPEKRIDAKDTITRL  970 (985)
Q Consensus       953 l~~~P~~RPt~~ev~~~L  970 (985)
                      |..+|++||++.|+++.|
T Consensus       238 ~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         238 WHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ccCCcccCcCHHHHHHhh
Confidence            999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.8e-34  Score=298.42  Aligned_cols=231  Identities=26%  Similarity=0.373  Sum_probs=187.9

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCC-----ceEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD-----FKAL  799 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-----~~~l  799 (985)
                      -.|...+++|+|+||.||+|... ++.+||||++-.+..    ---+|+.+|+++.|||||++..+|....     ...+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            35677889999999999999854 678999999865522    1247999999999999999998885432     3458


Q ss_pred             EEeccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-CcEEEecccCcee
Q 001988          800 VLEYMSNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAKL  875 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~-~~~kl~DfGla~~  875 (985)
                      ||||+|. +|.+.++..   +..++...++-+.+||.+||+||   |+.||+||||||+|+|+|.+ |.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yL---h~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYL---HSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHH---HhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999976 999988852   45677778888999999999999   78999999999999999976 8999999999999


Q ss_pred             ccCCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh-----------------
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------------  937 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------------  937 (985)
                      +......   .....|..|+|||.+++ ..|+.+.|+ ||.|+++.|++.|...+......++                 
T Consensus       176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDi-WSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDI-WSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             eccCCCc---eeEEEeccccCHHHHcCccccCceeEE-hhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            8654443   33458899999998886 679999999 9999999999988875544321110                 


Q ss_pred             -----------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 -----------------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 -----------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                             ....+.+..+++.+++.++|.+|.++.|++.
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                                   0114578899999999999999999999875

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.5e-33  Score=313.25  Aligned_cols=248  Identities=21%  Similarity=0.350  Sum_probs=204.8

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCc----EEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGV----EIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      .+|+..+.||+|+||.||+|++. ++.    .||+|.++.... ....++.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46888999999999999999853 333    489999875432 3456788999999999999999999999765 4679


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      |+||+++|+|.+++......+++...++++.||+.||+||   |+++|+||||||+||++++++.+||+|||+++.+...
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            9999999999999988766788999999999999999999   7999999999999999999999999999999887543


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIF  946 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~  946 (985)
                      ..........++..|+|||.+....++.++|+ |++|+.++++++ +..+....+..            +.+..++.++.
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di-~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDV-WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY  241 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhh-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence            33222223335678999999999999999999 999999999886 65554332211            11223567899


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          947 SLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                      +++.+||..+|.+||++.+++..+.++.++..
T Consensus       242 ~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~  273 (316)
T cd05108         242 MIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  273 (316)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence            99999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.7e-34  Score=322.10  Aligned_cols=248  Identities=22%  Similarity=0.365  Sum_probs=202.9

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcC-CCCeeeEEeeeecCC
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIR-HRNLVKIISSCSNDD  795 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~  795 (985)
                      ..++|...+.||+|+||.||+|...      .+..||||+++.... ...+.+.+|+++++++. ||||++++++|.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3568889999999999999999753      234699999975533 23467899999999996 999999999999999


Q ss_pred             ceEEEEeccCCCChHHHhhcCC----------------------------------------------------------
Q 001988          796 FKALVLEYMSNGSLEDCLHSSN----------------------------------------------------------  817 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  817 (985)
                      ..++||||+++|+|.++++...                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999999886431                                                          


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc
Q 001988          818 -------------------------------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD  860 (985)
Q Consensus       818 -------------------------------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~  860 (985)
                                                           ..+++..+.+++.|+++|++||   |+.+|+||||||+||+++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChHhEEEe
Confidence                                                 2367788899999999999999   789999999999999999


Q ss_pred             CCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcch------
Q 001988          861 EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEK------  933 (985)
Q Consensus       861 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~------  933 (985)
                      +++.+||+|||+++.+.............+++.|+|||.+.+..++.++|+ |++|++++++++ +..+.....      
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-wSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDV-WSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhH-HHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence            999999999999987643333222333457788999999999999999999 999999999975 544432210      


Q ss_pred             -------hhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          934 -------HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       934 -------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                             ....+..++.++.+++.+||..+|++||++.++++.|+++.+
T Consensus       351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                   011223456789999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-33  Score=304.70  Aligned_cols=244  Identities=22%  Similarity=0.391  Sum_probs=204.2

Q ss_pred             cCccCCceeeccCceeEEEEEEc----CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      ++|+..+.||+|+||.||+|.+.    +...||||.++..... ....+.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            56888999999999999999874    2457999998755332 346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++++|.+++......+++..+.+++.|++.|++||   |+++|+||||||+||++++++.+||+|||+++.+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            999999999999987666789999999999999999999   78999999999999999999999999999999875222


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFS  947 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~  947 (985)
                      .........+++.|+|||.+....++.++|+ |++|++++++++ +..+.......            +.+..+++.+.+
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv-~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  239 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDV-WSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ  239 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccch-HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            2222222345678999999998899999999 999999999886 65543221111            122345678999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          948 LALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                      ++.+|++.+|++||++.|+++.|.++
T Consensus       240 li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         240 LMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=294.44  Aligned_cols=234  Identities=25%  Similarity=0.333  Sum_probs=208.3

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      |.+.+++|+|+||.||+|.++ +|..||||.+..+  .+.+++.+|+.|++++..|++|++||.+......|||||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            455678999999999999865 7999999998754  5678999999999999999999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      |+..+.++..++.+++.++..++...+.||+||   |...-||||||+-|||++.+|.+|++|||.|-.+.+  .-....
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YL---H~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRN  187 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYL---HDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRN  187 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHH---HHHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhC
Confidence            999999999988999999999999999999999   678889999999999999999999999999877642  222345


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcc--------------hhhhhHHHHHHHHHHHHHHc
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEE--------------KHFAAKEQCLLSIFSLALEC  952 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~--------------~~~~~~~~~~~~l~~l~~~c  952 (985)
                      .+.|||.|||||++..-.|..+.|+ |++|+...||..|+.++.+.              +.+..++..+.++-++++.|
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADI-WSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C  266 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADI-WSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC  266 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhH-hhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence            5679999999999999999999999 99999999999988765432              34456888999999999999


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 001988          953 TMESPEKRIDAKDTITR  969 (985)
Q Consensus       953 l~~~P~~RPt~~ev~~~  969 (985)
                      +-.+|++|-||-++.+.
T Consensus       267 LiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  267 LIKKPEERKTALRLCEH  283 (502)
T ss_pred             hcCCHHHHHHHHHHhhh
Confidence            99999999999887653

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.4e-33  Score=307.36  Aligned_cols=249  Identities=26%  Similarity=0.419  Sum_probs=207.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      ..+|...+.||+|+||.||++...      ++..||+|.+..........+.+|++++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            356888899999999999999742      35669999987665555678999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHhhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEE
Q 001988          799 LVLEYMSNGSLEDCLHSSN------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH  866 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~k  866 (985)
                      +||||+++++|.+++...+            ..+++.+++.++.|++.||+||   |++|++||||||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~l---H~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccCcceEEEccCCcEE
Confidence            9999999999999987542            2489999999999999999999   789999999999999999999999


Q ss_pred             EecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh----------
Q 001988          867 LSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF----------  935 (985)
Q Consensus       867 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~----------  935 (985)
                      |+|||+++...............+++.|+|||.+....++.++|+ |++|+.++++++ +..+.......          
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi-wslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~  239 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV-WSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR  239 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999987643332222233446788999999998899999999 999999999997 66543322111          


Q ss_pred             --hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          936 --AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       936 --~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                        ..+..++.++.+++.+||+.+|.+||++.|+.+.|+++.++.
T Consensus       240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence              112235678999999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.7e-33  Score=308.02  Aligned_cols=235  Identities=22%  Similarity=0.279  Sum_probs=197.3

Q ss_pred             CccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          727 NFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+.....   .....+.+|++++++++|++|+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367788999999999999986 4799999999875422   223457889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          803 YMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       803 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      |+++|+|.+++... ...+++..+..++.|++.||+||   |+++|+||||||+||++++++.+||+|||++....... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL---QRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            99999999887653 33688999999999999999999   89999999999999999999999999999998764222 


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQCLLSIF  946 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~~~~~l~  946 (985)
                        ......||+.|+|||.+.+..++.+.|+ |++|++++++++|+.++.......               .+...+.++.
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~Dv-wslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  233 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDW-WGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAK  233 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCc-hhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHH
Confidence              1234569999999999999999999999 999999999999987765322110               1122456789


Q ss_pred             HHHHHccCCCCCCCCC-----HHHHHH
Q 001988          947 SLALECTMESPEKRID-----AKDTIT  968 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt-----~~ev~~  968 (985)
                      +++++||+.||.+||+     +.++++
T Consensus       234 ~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         234 SICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             HHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            9999999999999997     777776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-33  Score=315.79  Aligned_cols=233  Identities=23%  Similarity=0.270  Sum_probs=197.9

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|...+.||+|+||.||+|+.+ +++.||+|+++...   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57888899999999999999875 68899999987542   223456889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++|+|.+++...+ .+++.....++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...... 
T Consensus        98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  172 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYL---HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-  172 (329)
T ss_pred             cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence            9999999999998654 678888899999999999999   78999999999999999999999999999998764221 


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSIFSLAL  950 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l~~l~~  950 (985)
                          ....||+.|+|||.+.+..++.++|+ |++|+++++++++..+.........           +...+.++.+++.
T Consensus       173 ----~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  247 (329)
T PTZ00263        173 ----FTLCGTPEYLAPEVIQSKGHGKAVDW-WTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVK  247 (329)
T ss_pred             ----ceecCChhhcCHHHHcCCCCCCccee-echHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHH
Confidence                23469999999999999999999999 9999999999999876543321111           1124567889999


Q ss_pred             HccCCCCCCCCC-----HHHHHH
Q 001988          951 ECTMESPEKRID-----AKDTIT  968 (985)
Q Consensus       951 ~cl~~~P~~RPt-----~~ev~~  968 (985)
                      +||..||.+||+     +.|++.
T Consensus       248 ~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        248 GLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhc
Confidence            999999999997     566663

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.9e-33  Score=312.78  Aligned_cols=238  Identities=22%  Similarity=0.310  Sum_probs=199.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .++|+..+.||+|+||.||+|+.. ++..||+|.+..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367899999999999999999875 788899999876532 234678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |+++|+|.+++.... .+++..+..++.|++.||.|||  +..+|+||||||+||+++.++.+||+|||++......   
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH--~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  157 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh--hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence            999999999997654 5788999999999999999994  2346999999999999999999999999998765322   


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh--------------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--------------------------  936 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--------------------------  936 (985)
                       ......||+.|+|||.+.+..++.++|+ |++|++++++++|+.+........                          
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~Di-wslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDI-WSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP  235 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence             1233469999999999999999999999 999999999999886653211000                          


Q ss_pred             ---------------------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 001988          937 ---------------------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       937 ---------------------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L  970 (985)
                                                       .....+.++.+++.+||+.||++||++.|+++.-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                             0001356789999999999999999999998764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=298.93  Aligned_cols=245  Identities=27%  Similarity=0.340  Sum_probs=197.7

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---------c-----hHHHHHHHHHHHHhcCCCCeeeE
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---------S-----TLKSFEAECEVIKNIRHRNLVKI  787 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---------~-----~~~~~~~E~~il~~l~h~niv~l  787 (985)
                      +..++|...+.||+|.||.|-+|+.. +++.||||++.+...         .     ..+.+++||.||+++.|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            34578999999999999999999965 789999999975411         1     12478999999999999999999


Q ss_pred             EeeeecC--CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcE
Q 001988          788 ISSCSND--DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  865 (985)
Q Consensus       788 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~  865 (985)
                      +++..+.  +..|||+|||..|.+...=.. ...++..+.++++++++.||+||   |.+|||||||||+|+|++++|+|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYL---H~QgiiHRDIKPsNLLl~~~g~V  249 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYL---HYQGIIHRDIKPSNLLLSSDGTV  249 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEEcCCCcE
Confidence            9999875  678999999999877644322 22388999999999999999999   88999999999999999999999


Q ss_pred             EEecccCceeccCC---CCcceecccccccccccccccccCc----cchhhhcccccccchhhhcccccccCcchhhh--
Q 001988          866 HLSDFGMAKLLSGE---DESTMRTQTLATIGYMAPDEIFVGE----LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--  936 (985)
Q Consensus       866 kl~DfGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--  936 (985)
                      ||+|||.+..+...   +........+|||.|+|||...++.    .+.+.|+ |++|+.++-++.|+.++.......  
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~Di-WalGVTLYCllfG~~PF~~~~~~~l~  328 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDI-WALGVTLYCLLFGQLPFFDDFELELF  328 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhh-hhhhhhHHHhhhccCCcccchHHHHH
Confidence            99999998876322   1122234468999999999887743    2466788 999999999999988766543222  


Q ss_pred             -----------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 001988          937 -----------AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       937 -----------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                                 ..++..+.+.+++.+++..||++|.+..||......
T Consensus       329 ~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  329 DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence                       112346778999999999999999999998765543

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=315.11  Aligned_cols=234  Identities=21%  Similarity=0.272  Sum_probs=200.3

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|...+.||+|+||.||+|+.. +++.||+|++++..   ......+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999976 68899999997542   223456789999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++|+|.+++...+ .+++.....++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....   
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDAL---HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            9999999999997654 678899999999999999999   789999999999999999999999999999986532   


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-------------H------HHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-------------K------EQCL  942 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-------------~------~~~~  942 (985)
                        ......||+.|+|||.+.+..++.++|+ |++|+++++++++..+.........             +      ...+
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv-wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s  230 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDY-WSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS  230 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccce-ecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccC
Confidence              2234569999999999999999999999 9999999999998876543211110             0      1236


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          943 LSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       943 ~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      +++.+++.+|+..+|.+||++.++++.
T Consensus       231 ~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         231 DEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            788999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.5e-34  Score=295.14  Aligned_cols=242  Identities=24%  Similarity=0.322  Sum_probs=198.5

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCC-eeeEEeeeecCC------
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRN-LVKIISSCSNDD------  795 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~n-iv~l~~~~~~~~------  795 (985)
                      ..|...++||+|+||+||+|+.. +|+.||+|+++-....  ......+|+.++++++|+| ||++++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            44666678999999999999854 8899999999866432  3456789999999999999 999999998776      


Q ss_pred             ceEEEEeccCCCChHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccC
Q 001988          796 FKALVLEYMSNGSLEDCLHSSN---CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGM  872 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGl  872 (985)
                      ..++|+||++ -+|.+++....   ...+...++.+++|++.||+||   |+++|+||||||+||+++++|.+||+|||+
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~---H~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFL---HSHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCcceEEECCCCcEeeeccch
Confidence            7889999995 59999998765   3577788999999999999999   899999999999999999999999999999


Q ss_pred             ceeccCCCCcceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhhh--------------
Q 001988          873 AKLLSGEDESTMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA--------------  937 (985)
Q Consensus       873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~--------------  937 (985)
                      |+.+.-+..  ..+..++|..|.|||++++. .|+...|+ |++|+.+.||++++.++....+.++              
T Consensus       167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDi-Ws~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDI-WSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcch-HhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            997652222  24456799999999999987 78899999 9999999999987654433211110              


Q ss_pred             --------------------HH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHhH
Q 001988          938 --------------------KE-------QCLLSIFSLALECTMESPEKRIDAKDTITR--LLKIR  974 (985)
Q Consensus       938 --------------------~~-------~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~--L~~i~  974 (985)
                                          +.       .......+++.+|++++|.+|.++..++..  +.++.
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence                                00       012478899999999999999999999886  55543

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=309.41  Aligned_cols=243  Identities=23%  Similarity=0.426  Sum_probs=208.8

Q ss_pred             CccCCceeeccCceeEEEEEEcC---Cc--EEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          727 NFAENNIIGIGGFGSVYRARLED---GV--EIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~~---~~--~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .....++||.|-||.||+|.+.+   |.  .||||.-+.+. ..+.+.|..|..+|++++|||||+++|+|.+. ..|||
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence            34556789999999999998642   33  38999888753 34567899999999999999999999999865 57899


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      ||+++-|.|..+++.+...++..+...++.||+.||+||   |+.++|||||.++|||+.....||++|||+++.+.+..
T Consensus       469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYL---eSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYL---ESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHH---HhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            999999999999999888899999999999999999999   89999999999999999999999999999999887555


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhccccc--ccCc-----------chhhhhHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSL--LSGE-----------EKHFAAKEQCLLSIFS  947 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~--~~~~-----------~~~~~~~~~~~~~l~~  947 (985)
                      .+.. +...-...|||||-+...+++.++|| |+||+++||++.-.+  +.+-           ..+.+.++.|+..++.
T Consensus       546 yYka-S~~kLPIKWmaPESINfRrFTtASDV-WMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYs  623 (974)
T KOG4257|consen  546 YYKA-SRGKLPIKWMAPESINFRRFTTASDV-WMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYS  623 (974)
T ss_pred             hhhc-cccccceeecCccccchhcccchhhH-HHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHH
Confidence            4433 33345678999999999999999999 999999999976332  2221           1355677889999999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          948 LALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                      +|.+||.++|.+||++.++...|.++.+
T Consensus       624 lmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  624 LMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             HHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            9999999999999999999999999887

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.6e-33  Score=300.59  Aligned_cols=242  Identities=24%  Similarity=0.412  Sum_probs=204.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .++|+..++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            46788899999999999999998888899999987542 34568899999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          805 SNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       805 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      ++|+|.+++... ...+++..+..++.|+++|++||   |+.+++||||||+||++++++.+||+|||+++....... .
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI---ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T  159 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence            999999998754 44678899999999999999999   789999999999999999999999999999987643221 1


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFSLAL  950 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~l~~  950 (985)
                      ......++..|+|||.+..+.++.+.|+ |++|++++++++ +..+.......            +....+++++.+++.
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDV-WSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMK  238 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhh-hhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            1222346778999999988889999999 999999999997 66654322111            111235678999999


Q ss_pred             HccCCCCCCCCCHHHHHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                      +|+..+|++||+++++.+.|++
T Consensus       239 ~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         239 TCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             HHccCCcccCcCHHHHHHHHhc
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-34  Score=292.81  Aligned_cols=240  Identities=25%  Similarity=0.310  Sum_probs=200.6

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEec--cCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeec-----CC
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN-----DD  795 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~--~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-----~~  795 (985)
                      ....|...+.||+|+||.|+.|..+ +|+.||||++.  .+.....++..+|+++++.++|+||+.+.+.+..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3455666789999999999999864 89999999997  4455567888999999999999999999998865     34


Q ss_pred             ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          796 FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      ..|+|+|+| +-+|...++.+. .++.....-+++|+++||.|+   |+.+|+|||+||+|++++.++..||+|||+|+.
T Consensus       100 DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyi---HSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYI---HSANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchh---hcccccccccchhheeeccCCCEEeccccceee
Confidence            689999999 558998888763 588999999999999999999   899999999999999999999999999999999


Q ss_pred             ccCCCCcceecccccccccccccccc-cCccchhhhcccccccchhhhcccccccCcchhhhhH----------------
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIF-VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK----------------  938 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~----------------  938 (985)
                      ..........+..+.|.+|.|||.+. ...|+...|+ |+.||.+.||++++..+......++.                
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDi-WSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDI-WSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhh-hhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            86543344557778999999999875 4778999999 99999999999988755443211110                


Q ss_pred             --------------------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          939 --------------------------EQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       939 --------------------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                                .......++++.+|+..||.+|+|+.|+++.
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                                      0133567889999999999999999998763

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.8e-33  Score=327.31  Aligned_cols=238  Identities=19%  Similarity=0.183  Sum_probs=201.5

Q ss_pred             CccCCceeeccCceeEEEEEEc-C-CcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-D-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~-~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .|...+.||+|+||.||+|... + ++.||+|.+..........+++|+.+++.++|||||++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888899999999999999754 4 6789999876554455567889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          805 SNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       805 ~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ++|+|.+++...   ...+++.....++.|++.||+|+   |+++|+||||||+||+++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV---HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988642   34688999999999999999999   789999999999999999999999999999998754333


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh------------hHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------AKEQCLLSIFSLA  949 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------~~~~~~~~l~~l~  949 (985)
                      .......+||+.|+|||++.+..++.++|+ |++|+++++++++..+........            .+..++.++.+++
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv-~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  303 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADM-WSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALL  303 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHH
Confidence            233445679999999999999999999999 999999999999877654321111            1223567899999


Q ss_pred             HHccCCCCCCCCCHHHHHH
Q 001988          950 LECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+||..+|++||++.+++.
T Consensus       304 ~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        304 DPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHhccChhhCcCHHHHHh
Confidence            9999999999999999875

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.9e-33  Score=305.59  Aligned_cols=236  Identities=21%  Similarity=0.296  Sum_probs=195.0

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ++|...+.||+|+||.||+|+.+ +++.||+|+++.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56888999999999999999865 788999999875432 2345678999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +++ +|.+++...+..+++.....++.|+++||+||   |++||+||||||+||++++++.+||+|||+++.......  
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--  158 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC---HKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--  158 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence            975 99999887666688999999999999999999   789999999999999999999999999999976532221  


Q ss_pred             eeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhh--------------------------
Q 001988          884 MRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--------------------------  936 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--------------------------  936 (985)
                      ......+++.|+|||.+.+ ..++.++|+ |++|+.+++++++..++.......                          
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di-wslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDM-WGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            1233468999999998865 568889999 999999999999876543211000                          


Q ss_pred             ---------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 ---------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 ---------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                     .......+..+++.+|+..||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                           00012456789999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-33  Score=310.68  Aligned_cols=234  Identities=25%  Similarity=0.301  Sum_probs=198.5

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|+..+.||+|+||.||+|... +++.||+|++.....   .....+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999875 789999999865421   23456889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++|+|.+++...+ .+++.....++.|++.||+||   |++||+||||||+||++++++.+||+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYL---HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            9999999999998654 678899999999999999999   7899999999999999999999999999999876321  


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLAL  950 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~  950 (985)
                         .....||+.|+|||.+.+..++.++|+ |++|+++++++++..+........           .+......+.++++
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~  230 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDW-WALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIK  230 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHH
Confidence               123469999999999998889999999 999999999999887654432111           11224567899999


Q ss_pred             HccCCCCCCCCC-----HHHHHHH
Q 001988          951 ECTMESPEKRID-----AKDTITR  969 (985)
Q Consensus       951 ~cl~~~P~~RPt-----~~ev~~~  969 (985)
                      +|+..||.+||+     +.|+++.
T Consensus       231 ~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         231 KLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             HHcCCCHHHccCCccCCHHHHhcC
Confidence            999999999995     7777654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.8e-33  Score=305.53  Aligned_cols=248  Identities=25%  Similarity=0.416  Sum_probs=207.3

Q ss_pred             cCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      .+|...+.||+|+||.||+|+..      ++..||+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45778889999999999999742      456699999876655556789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc
Q 001988          800 VLEYMSNGSLEDCLHSSN---------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV  864 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~  864 (985)
                      ||||+++++|.+++....               ..+++..+++++.|++.|++||   |++||+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccCcceEEEccCCc
Confidence            999999999999997542               2478999999999999999999   8999999999999999999999


Q ss_pred             EEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh--------
Q 001988          865 AHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF--------  935 (985)
Q Consensus       865 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~--------  935 (985)
                      +||+|||+++...............++..|+|||.+....++.++|+ |++|++++++++ +..+.......        
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  240 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV-WSFGVILWEIFTYGKQPWFQLSNTEVIECITQ  240 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence            99999999986543322222233457889999999999999999999 999999999997 66654322111        


Q ss_pred             ----hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          936 ----AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       936 ----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                          ..+..++..+.+++.+||..+|++||++.++++.|.++.+..
T Consensus       241 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~  286 (291)
T cd05094         241 GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT  286 (291)
T ss_pred             CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence                112235678999999999999999999999999999997754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.7e-33  Score=306.25  Aligned_cols=243  Identities=26%  Similarity=0.473  Sum_probs=201.4

Q ss_pred             cCccCCceeeccCceeEEEEEEcC------CcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLED------GVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~------~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      ++|+..+.||+|+||.||+|....      ...||+|.+..... .....+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467888999999999999998642      25799999875533 23456889999999999999999999999988999


Q ss_pred             EEEeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC
Q 001988          799 LVLEYMSNGSLEDCLHSSN---------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM  863 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~  863 (985)
                      ++|||+++|+|.+++....               ..+++.....++.|++.||+||   |+.+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~l---H~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccccceEEEcCCC
Confidence            9999999999999987541               3578889999999999999999   789999999999999999999


Q ss_pred             cEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcch---------
Q 001988          864 VAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEK---------  933 (985)
Q Consensus       864 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~---------  933 (985)
                      .+||+|||+++...............+++.|+|||.+..+.++.++|+ |++|+.++++++ +..+.....         
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv-~slG~il~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDI-WSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR  240 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999987643333223334457889999999998999999999 999999999986 543322111         


Q ss_pred             ---hhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 001988          934 ---HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       934 ---~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                         ....+..++.++.+++.+||+.+|.+||++.|++++|+.
T Consensus       241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence               011234567899999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.2e-33  Score=310.00  Aligned_cols=231  Identities=26%  Similarity=0.299  Sum_probs=194.6

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNG  807 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  807 (985)
                      +.||+|+||.||+|+.. +++.||+|++.+..   ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 78999999997542   233457788999999999999999999999999999999999999


Q ss_pred             ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecc
Q 001988          808 SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ  887 (985)
Q Consensus       808 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~  887 (985)
                      +|.+++.... .+++.+...++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.....  ......
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~  154 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYL---HSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKT  154 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccccc
Confidence            9999887653 688999999999999999999   7999999999999999999999999999998764221  112234


Q ss_pred             cccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHHHHHHHHccCCC
Q 001988          888 TLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSIFSLALECTMES  956 (985)
Q Consensus       888 ~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l~~l~~~cl~~~  956 (985)
                      .+||+.|+|||.+.+..++.++|+ |++|++++++++|..++........           +...+.++.+++.+|+..|
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~Di-wslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~d  233 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDW-WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKD  233 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCc-cccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCC
Confidence            569999999999999999999999 9999999999999877643321111           1224567899999999999


Q ss_pred             CCCCC-----CHHHHHHH
Q 001988          957 PEKRI-----DAKDTITR  969 (985)
Q Consensus       957 P~~RP-----t~~ev~~~  969 (985)
                      |.+||     ++.|+++.
T Consensus       234 P~~R~~~~~~~~~~il~h  251 (328)
T cd05593         234 PNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             HHHcCCCCCCCHHHHhcC
Confidence            99997     88888754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=284.80  Aligned_cols=238  Identities=24%  Similarity=0.343  Sum_probs=199.2

Q ss_pred             HhcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccC--CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      ..+.|+.-+.||+|+|+.||++.. .+|+.+|+|++...  ...+.+.+.+|++|.+.++||||+++++.+.+.+..|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            456777888999999999999975 48999999988644  334567889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc---CCCcEEEecccCceecc
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~---~~~~~kl~DfGla~~~~  877 (985)
                      +|+|.|++|..-+-.. ...++...-.+++||++||.|+   |.++|||||+||+|+++.   ..-.+|++|||+|..+.
T Consensus        89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yC---H~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYC---HSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            9999999998766544 3567888888999999999999   899999999999999994   34479999999999885


Q ss_pred             CCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCc-chh--------------hhhHHHHH
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGE-EKH--------------FAAKEQCL  942 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~-~~~--------------~~~~~~~~  942 (985)
                         ........+|||+|||||++...+|+-..|+ |+-|++++-++.|.+++.. ...              .+......
T Consensus       165 ---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDi-W~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is  240 (355)
T KOG0033|consen  165 ---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDI-WACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVT  240 (355)
T ss_pred             ---CccccccccCCCcccCHHHhhcCCCCCcchh-hhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCC
Confidence               3344567789999999999999999999999 7788888888777765544 210              11223356


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          943 LSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       943 ~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      ++..+++++|+..||.+|.|+.|.+..
T Consensus       241 ~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  241 PEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             HHHHHHHHHHhccChhhhccHHHHhCC
Confidence            788999999999999999999998753

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-33  Score=310.65  Aligned_cols=228  Identities=24%  Similarity=0.251  Sum_probs=191.3

Q ss_pred             eeccCceeEEEEEEc-CCcEEEEEEeccC---CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCCh
Q 001988          734 IGIGGFGSVYRARLE-DGVEIAIKVFHPQ---CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSL  809 (985)
Q Consensus       734 ig~G~~g~V~~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  809 (985)
                      ||+|+||.||+|+.. +++.||+|+++..   .......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999865 6889999998753   223345678899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecccc
Q 001988          810 EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL  889 (985)
Q Consensus       810 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  889 (985)
                      .+++...+ .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......  ......+
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~  154 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENL---HKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC  154 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence            99997654 688999999999999999999   78999999999999999999999999999988643222  2233456


Q ss_pred             cccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHHHccCCCCC
Q 001988          890 ATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLALECTMESPE  958 (985)
Q Consensus       890 gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~~cl~~~P~  958 (985)
                      ||+.|+|||.+.+..++.++|+ |++|++++++++|..++.......           .+...+.++.+++.+||..||.
T Consensus       155 gt~~y~aPE~~~~~~~~~~~Dv-wslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  233 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDW-WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPT  233 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccce-echhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHH
Confidence            9999999999999999999999 999999999999987754332111           1223557789999999999999


Q ss_pred             CCCC---HHHHHH
Q 001988          959 KRID---AKDTIT  968 (985)
Q Consensus       959 ~RPt---~~ev~~  968 (985)
                      +||+   +.|++.
T Consensus       234 ~R~~~~~~~e~l~  246 (312)
T cd05585         234 RRLGYNGAQEIKN  246 (312)
T ss_pred             HcCCCCCHHHHHc
Confidence            9985   555543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.6e-33  Score=303.94  Aligned_cols=243  Identities=28%  Similarity=0.447  Sum_probs=202.1

Q ss_pred             hcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  797 (985)
                      .++|...+.||+|+||.||+|...      +++.||+|.++..... ..+.+.+|++++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            356778899999999999999863      3478999998765444 457899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc
Q 001988          798 ALVLEYMSNGSLEDCLHSSN-------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV  864 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~  864 (985)
                      ++||||+++++|.+++...+             ..+++.+...++.|++.|++||   |++|++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeeccccccceEEEcCCCe
Confidence            99999999999999997542             3478889999999999999999   8899999999999999999999


Q ss_pred             EEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh--------
Q 001988          865 AHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF--------  935 (985)
Q Consensus       865 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~--------  935 (985)
                      +||+|||+++...............+++.|+|||.+..+.++.++|+ |++|+.++++++ +..+.......        
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV-WSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ  239 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            99999999986543322222233346788999999999999999999 999999999997 66554321111        


Q ss_pred             ----hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 001988          936 ----AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLL  971 (985)
Q Consensus       936 ----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~  971 (985)
                          ..+..++..+.+++.+||..+|++||++.|++++|+
T Consensus       240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                112235678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.7e-33  Score=297.62  Aligned_cols=236  Identities=24%  Similarity=0.362  Sum_probs=195.0

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCCh
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSL  809 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  809 (985)
                      +.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999864 789999998865433 2346789999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecccc
Q 001988          810 EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL  889 (985)
Q Consensus       810 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  889 (985)
                      .+++...+..+++.+++.++.|+++||+||   |+.|++||||||+||+++.++.+||+|||++................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYL---ESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            999987666789999999999999999999   79999999999999999999999999999987653221111111112


Q ss_pred             cccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHHHHHHHHccCCC
Q 001988          890 ATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSIFSLALECTMES  956 (985)
Q Consensus       890 gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l~~l~~~cl~~~  956 (985)
                      .+..|+|||.+..+.++.++|+ |++|+.++++++ +..+......            ...++.++.++.+++.+|+..+
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv-~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDV-WSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYD  236 (252)
T ss_pred             CceeecCchhhcCCCCChHHHH-HHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCC
Confidence            3567999999999999999999 999999999986 5544322111            1112335678999999999999


Q ss_pred             CCCCCCHHHHHHHHH
Q 001988          957 PEKRIDAKDTITRLL  971 (985)
Q Consensus       957 P~~RPt~~ev~~~L~  971 (985)
                      |++||++.++.++|+
T Consensus       237 p~~Rps~~~~~~~l~  251 (252)
T cd05084         237 PGQRPSFSTVHQELQ  251 (252)
T ss_pred             hhhCcCHHHHHHHHh
Confidence            999999999999876

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.4e-33  Score=310.96  Aligned_cols=230  Identities=25%  Similarity=0.282  Sum_probs=193.5

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNG  807 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  807 (985)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999864 78999999997542   223456778999999999999999999999999999999999999


Q ss_pred             ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecc
Q 001988          808 SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ  887 (985)
Q Consensus       808 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~  887 (985)
                      +|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~  154 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence            9999887654 688999999999999999999   78999999999999999999999999999987532211  12234


Q ss_pred             cccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHHHccCCC
Q 001988          888 TLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLALECTMES  956 (985)
Q Consensus       888 ~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~~cl~~~  956 (985)
                      ..||+.|+|||.+.++.++.++|+ |++|+++++++++..+........           .+...++++.+++.+|+..|
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~Di-wSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~d  233 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDW-WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD  233 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhch-hhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCC
Confidence            569999999999999999999999 999999999999887654332111           12235678899999999999


Q ss_pred             CCCCC-----CHHHHHH
Q 001988          957 PEKRI-----DAKDTIT  968 (985)
Q Consensus       957 P~~RP-----t~~ev~~  968 (985)
                      |++||     ++.++++
T Consensus       234 P~~R~~~~~~~~~~~l~  250 (323)
T cd05595         234 PKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHhCCCCCCCHHHHHc
Confidence            99998     7888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.4e-33  Score=306.19  Aligned_cols=237  Identities=21%  Similarity=0.259  Sum_probs=195.7

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ++|...+.||+|+||.||+|+.+ +++.||+|++.....  ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888999999999999999975 688899999875422  234567899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |++++.+..+.. ....+++..+..++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++.+..... 
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  155 (287)
T cd07848          81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWC---HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-  155 (287)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence            999876665443 344688999999999999999999   789999999999999999999999999999987643221 


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-------------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-------------------------  937 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-------------------------  937 (985)
                      .......|++.|+|||.+.+..++.++|+ |++|+.++++++|+.++........                         
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-wslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDM-WSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhH-HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            12234568999999999999899999999 9999999999998865532211000                         


Q ss_pred             ------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 ------------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 ------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                        ....+.++.+++++|++.||++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                              0013456899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.1e-33  Score=304.29  Aligned_cols=245  Identities=28%  Similarity=0.397  Sum_probs=200.4

Q ss_pred             cCccCCceeeccCceeEEEEEEc-----CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeec--CCceE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-----DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN--DDFKA  798 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~  798 (985)
                      .+|+..+.||+|+||.||+|..+     +++.||+|.+........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46778899999999999999742     578999999886655556788999999999999999999998754  34678


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +||||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||++++++.+||+|||+++....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~L---H~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            99999999999999987655789999999999999999999   789999999999999999999999999999987643


Q ss_pred             CCCcce-ecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh----------------------
Q 001988          879 EDESTM-RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF----------------------  935 (985)
Q Consensus       879 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~----------------------  935 (985)
                      ...... .....++..|+|||.+.+..++.++|+ |++|+++++++++..........                      
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDV-WSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHH-HHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            322211 112224456999999988899999999 99999999998854322111000                      


Q ss_pred             ------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhH
Q 001988          936 ------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       936 ------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~  974 (985)
                            +.+..++.++.+++.+||..+|++||||.|+++.|+.++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence                  011234568999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-33  Score=298.67  Aligned_cols=242  Identities=24%  Similarity=0.412  Sum_probs=204.1

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .++|+..+.||+|+||.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688899999999999999998878899999987543 33567899999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          805 SNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       805 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      ++++|.+++.... ..+++..+.+++.|++.|+.||   |+.||+||||||+||++++++.+||+|||+++.+..... .
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL---EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E  159 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence            9999999997653 5689999999999999999999   789999999999999999999999999999988752221 1


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFSLAL  950 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~l~~  950 (985)
                      .......+..|+|||.+....++.++|+ |++|+.++++++ ++.+.......            +.+..++..+.+++.
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDV-WSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIML  238 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence            1122223467999999998999999999 999999999998 76654332111            112335688999999


Q ss_pred             HccCCCCCCCCCHHHHHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                      +|++.+|.+||++.++++.|++
T Consensus       239 ~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         239 DCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             HHhhcCcccCCCHHHHHHHHhc
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.3e-33  Score=302.91  Aligned_cols=245  Identities=26%  Similarity=0.435  Sum_probs=208.2

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      +...+|...+.||.|+||.||+|...+++.||+|.+..........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34567888999999999999999988899999999987655556788999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          803 YMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       803 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      |+++|+|.+++... +..+++..+.+++.|++.|++||   |++|++||||||+||++++++.+||+|||.+........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL---EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999999864 44689999999999999999999   789999999999999999999999999999987643221


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFSL  948 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~l  948 (985)
                        ......++..|+|||.+....++.++|+ |++|++++++++ +..+.......            +.+..+++.+.++
T Consensus       160 --~~~~~~~~~~~~~PE~~~~~~~~~~~Di-wslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (261)
T cd05148         160 --LSSDKKIPYKWTAPEAASHGTFSTKSDV-WSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKI  236 (261)
T ss_pred             --cccCCCCceEecCHHHHccCCCCchhhH-HHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHH
Confidence              1223346778999999988899999999 999999999997 56554332111            1123456789999


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          949 ALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                      +.+||..+|.+||++.++++.|+.+
T Consensus       237 i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         237 MLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             HHHHcCCCchhCcCHHHHHHHHhcC
Confidence            9999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.6e-33  Score=309.90  Aligned_cols=237  Identities=22%  Similarity=0.308  Sum_probs=197.4

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .++|+..+.||+|+||.||+|... ++..||+|.+..... .....+.+|++++++++||||+++++++.++++.++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468899999999999999999876 788899998876532 234678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |+++|+|.+++...+ .+++.....++.|++.|++|||  +..+|+||||||+||+++.++.+||+|||++..+....  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH--~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--  158 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  158 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--
Confidence            999999999997654 5788899999999999999994  24579999999999999999999999999987653221  


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-------------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-------------------------  937 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-------------------------  937 (985)
                        .....|+..|+|||.+.+..++.++|+ |++|+.++++++++.+.........                         
T Consensus       159 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv-wslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (333)
T cd06650         159 --ANSFVGTRSYMSPERLQGTHYSVQSDI-WSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG  235 (333)
T ss_pred             --cccCCCCccccCHHHhcCCCCCcHHHH-HHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence              223468999999999998889999999 9999999999998765432110000                         


Q ss_pred             -------------------H-------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          938 -------------------K-------------EQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       938 -------------------~-------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                         .             .....++.+++.+||+.||++||++.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                               0             0123568899999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7.5e-33  Score=305.80  Aligned_cols=237  Identities=22%  Similarity=0.310  Sum_probs=194.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .++|...+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999975 788999999875432 223467889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |++ +++.+++......+++..+..++.|++.||+||   |++||+||||||+||++++++.+||+|||+++......  
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI---HQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence            995 688888877666788999999999999999999   78999999999999999999999999999987653222  


Q ss_pred             ceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhh-h-----------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-A-----------------------  937 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-~-----------------------  937 (985)
                      .......+|+.|+|||.+.+ ..++.++|+ |++|+.++++++|..++....... .                       
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di-wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDM-WGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence            12233468999999998865 457888999 999999999999876654321100 0                       


Q ss_pred             -----------H---H------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 -----------K---E------QCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 -----------~---~------~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                 +   .      .....+.+++.+|+..||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                       0   0      01245778999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.9e-33  Score=300.97  Aligned_cols=247  Identities=21%  Similarity=0.361  Sum_probs=201.9

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCc----EEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGV----EIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ++|+..+.||+|+||.||+|.+. +++    +||+|.+..... ....++..|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46788899999999999999864 444    478888754422 234567888889999999999999999864 45678


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ++||+++|+|.+++......+++.....++.|++.||+||   |+++++||||||+||++++++.+||+|||+++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL---EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            9999999999999987766789999999999999999999   7899999999999999999999999999999876433


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIF  946 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~  946 (985)
                      ..........++..|+|||.+..+.++.++|+ |++|+.++++++ +..+.......            ..+..++..+.
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv-~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDV-WSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVY  241 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHH
Confidence            33222334457788999999999999999999 999999999987 66544322111            11223566788


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          947 SLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      +++.+||..+|.+||++.|+++.+..+.++.
T Consensus       242 ~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         242 MVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             HHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.3e-33  Score=297.99  Aligned_cols=239  Identities=22%  Similarity=0.346  Sum_probs=200.2

Q ss_pred             cCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccC
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      ++|...+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4577888999999999999998777789999987543 334678999999999999999999999999889999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCccee
Q 001988          806 NGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR  885 (985)
Q Consensus       806 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~  885 (985)
                      +|+|.+++......+++..+++++.|++.|++||   |+.|++||||||+||++++++.+||+|||.++....... ...
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL---ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS  158 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence            9999999987655789999999999999999999   789999999999999999999999999999887643221 111


Q ss_pred             cccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh------------hHHHHHHHHHHHHHHc
Q 001988          886 TQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA------------AKEQCLLSIFSLALEC  952 (985)
Q Consensus       886 ~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~------------~~~~~~~~l~~l~~~c  952 (985)
                      ....++..|+|||......++.++|+ |++|+.++++++ +..+........            .+...++.+.+++.+|
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di-~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDV-WAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSC  237 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHH-HHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            22335678999999988889999999 999999999987 665543321111            1122456799999999


Q ss_pred             cCCCCCCCCCHHHHHHHH
Q 001988          953 TMESPEKRIDAKDTITRL  970 (985)
Q Consensus       953 l~~~P~~RPt~~ev~~~L  970 (985)
                      |+.+|.+||++.++++.+
T Consensus       238 l~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         238 WHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             cCCCcccCCCHHHHHHhh
Confidence            999999999999999876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.5e-33  Score=312.24  Aligned_cols=248  Identities=24%  Similarity=0.364  Sum_probs=201.4

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLVKIISSCSND-  794 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~-  794 (985)
                      ..++|+..+.||+|+||.||+|+..      +++.||+|+++.... ...+.+.+|+.+++++ +|+||++++++|... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3457889999999999999999632      357899999875432 2345678899999999 899999999988654 


Q ss_pred             CceEEEEeccCCCChHHHhhcCC---------------------------------------------------------
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSN---------------------------------------------------------  817 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------  817 (985)
                      ...+++|||+++|+|.+++....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            56789999999999999886421                                                         


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceeccccccccc
Q 001988          818 ---CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY  894 (985)
Q Consensus       818 ---~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  894 (985)
                         ..+++..+.+++.||+.||+||   |+.||+||||||+||++++++.+||+|||+++.+.............++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~l---H~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence               2578999999999999999999   7899999999999999999999999999999876433322223334467789


Q ss_pred             ccccccccCccchhhhcccccccchhhhcc-cccccCcchh-h------------hhHHHHHHHHHHHHHHccCCCCCCC
Q 001988          895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH-F------------AAKEQCLLSIFSLALECTMESPEKR  960 (985)
Q Consensus       895 ~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~-~------------~~~~~~~~~l~~l~~~cl~~~P~~R  960 (985)
                      +|||++.+..++.++|+ |++|++++++++ +..++..... .            ..+..+.+++.+++.+||..+|++|
T Consensus       242 ~aPE~~~~~~~~~~~Di-~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R  320 (337)
T cd05054         242 MAPESIFDKVYTTQSDV-WSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR  320 (337)
T ss_pred             cCcHHhcCCCCCccccH-HHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence            99999999999999999 999999999986 6654432110 0            0112345789999999999999999


Q ss_pred             CCHHHHHHHHHHhHh
Q 001988          961 IDAKDTITRLLKIRD  975 (985)
Q Consensus       961 Pt~~ev~~~L~~i~~  975 (985)
                      |++.|+++.|+++.+
T Consensus       321 Ps~~ell~~l~~~~~  335 (337)
T cd05054         321 PTFSELVEILGDLLQ  335 (337)
T ss_pred             cCHHHHHHHHHHHHh
Confidence            999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.5e-33  Score=303.49  Aligned_cols=245  Identities=21%  Similarity=0.336  Sum_probs=199.7

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCc
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDF  796 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  796 (985)
                      ..++|+..+.||+|+||.||+|...      ++..||+|++..... ....++.+|+.++++++||||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999999753      356799999865422 234568899999999999999999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEE
Q 001988          797 KALVLEYMSNGSLEDCLHSSN---------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHL  867 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl  867 (985)
                      .++||||+++|+|.+++....         ..+++..+..++.|++.|++||   |+.+++||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999987532         2357788899999999999999   7899999999999999999999999


Q ss_pred             ecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh-----------
Q 001988          868 SDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF-----------  935 (985)
Q Consensus       868 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~-----------  935 (985)
                      +|||+++...............+++.|+|||.+.++.++.++|+ |++|+.++++++ +..+.......           
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV-WSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL  239 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence            99999876543222221222345788999999999999999999 999999999997 45443222110           


Q ss_pred             -hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 001988          936 -AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       936 -~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                       ..+..+++.+.+++.+|++.+|++||++.|+++.+++
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence             1123356789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.3e-33  Score=311.52  Aligned_cols=235  Identities=22%  Similarity=0.244  Sum_probs=198.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-C-CcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-D-GVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~-~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      .++|...+.||+|+||.||+|..+ + +..||+|++....   ......+.+|+++++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            357888999999999999999854 3 3689999986432   2234567899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+||   |+.||+||||||+|||++.++.+||+|||+++.+...
T Consensus       109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYL---QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999998654 688999999999999999999   7899999999999999999999999999999876421


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSL  948 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l  948 (985)
                           .....||+.|+|||++.+..++.++|+ |++|+.++++++|..+........           .+...+..+.++
T Consensus       185 -----~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  258 (340)
T PTZ00426        185 -----TYTLCGTPEYIAPEILLNVGHGKAADW-WTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL  258 (340)
T ss_pred             -----cceecCChhhcCHHHHhCCCCCccccc-cchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence                 123569999999999998889999999 999999999999987665432211           112245678899


Q ss_pred             HHHccCCCCCCCC-----CHHHHHHH
Q 001988          949 ALECTMESPEKRI-----DAKDTITR  969 (985)
Q Consensus       949 ~~~cl~~~P~~RP-----t~~ev~~~  969 (985)
                      +++|++.+|.+|+     ++.++.+.
T Consensus       259 i~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        259 MKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            9999999999995     78887653

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-33  Score=297.44  Aligned_cols=239  Identities=26%  Similarity=0.378  Sum_probs=199.4

Q ss_pred             cCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccC
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      .+|...+.||+|+||.||+|.++++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            3577788999999999999998877889999986543 234578889999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCccee
Q 001988          806 NGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR  885 (985)
Q Consensus       806 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~  885 (985)
                      +++|.+++......+++..+..++.|++.|++||   |+.+++||||||+||++++++.+||+|||+++...+... ...
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~  158 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL---ESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSS  158 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCcccccccHhhEEECCCCcEEECCcccceecccccc-ccc
Confidence            9999999987655789999999999999999999   789999999999999999999999999999986532211 111


Q ss_pred             cccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh------------hHHHHHHHHHHHHHHc
Q 001988          886 TQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA------------AKEQCLLSIFSLALEC  952 (985)
Q Consensus       886 ~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~------------~~~~~~~~l~~l~~~c  952 (985)
                      ....++..|+|||.+....++.++|+ |++|++++++++ +..+........            .+..++.++.+++.+|
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di-~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDV-WSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSC  237 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhH-HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence            12224567999999998999999999 999999999997 565543221111            1123567899999999


Q ss_pred             cCCCCCCCCCHHHHHHHH
Q 001988          953 TMESPEKRIDAKDTITRL  970 (985)
Q Consensus       953 l~~~P~~RPt~~ev~~~L  970 (985)
                      |..+|++||++.|+++.|
T Consensus       238 l~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         238 WHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             hcCChhhCcCHHHHHHHh
Confidence            999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.8e-33  Score=301.96  Aligned_cols=249  Identities=21%  Similarity=0.346  Sum_probs=204.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCc----EEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGV----EIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      .++|...+.||+|+||.||+|.+. +++    +||+|+++.... .....+.+|+.+++.+.||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            457888899999999999999853 444    489999875533 3356788999999999999999999999754 467


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      ++|||+++|+|.+++......+++.+++.++.|+++||+||   |+++|+||||||+||++++++.+||+|||+++.+..
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL---EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            99999999999999987666789999999999999999999   799999999999999999999999999999987753


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSI  945 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l  945 (985)
                      ...........+++.|+|||...+..++.++|+ |++|+.++|+++ +..+......            .+.+..++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di-~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDV-WSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence            332222222335678999999999999999999 999999999887 5554432211            11123356788


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                      .+++.+||..||++||++.++++.+.++.....
T Consensus       241 ~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05109         241 YMIMVKCWMIDSECRPRFRELVDEFSRMARDPS  273 (279)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence            999999999999999999999999988876553

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.5e-33  Score=307.91  Aligned_cols=231  Identities=25%  Similarity=0.270  Sum_probs=193.3

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNG  807 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  807 (985)
                      +.||+|+||.||+|... +++.||+|++++..   ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 78999999997542   223456778999999999999999999999999999999999999


Q ss_pred             ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          808 SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS-TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       808 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      +|.+++.... .+++..+..++.|++.||+||   |+ .||+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~l---H~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYL---HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK  154 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence            9999887654 688999999999999999999   65 7999999999999999999999999999876432221  223


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHHHccCC
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLALECTME  955 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~~cl~~  955 (985)
                      ...||+.|+|||.+.+..++.++|+ |++|++++++++|..++.......           .+...+.++.+++.+|+..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~  233 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDW-WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKK  233 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCcccc-ccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhc
Confidence            4569999999999999999999999 999999999999987654332211           1123467789999999999


Q ss_pred             CCCCCC-----CHHHHHHH
Q 001988          956 SPEKRI-----DAKDTITR  969 (985)
Q Consensus       956 ~P~~RP-----t~~ev~~~  969 (985)
                      ||++|+     ++.++++.
T Consensus       234 dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         234 DPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CHHHhCCCCCCCHHHHhcC
Confidence            999997     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-32  Score=288.45  Aligned_cols=246  Identities=26%  Similarity=0.389  Sum_probs=196.2

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhc--CCCCeeeEEeeeecC----Cc
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI--RHRNLVKIISSCSND----DF  796 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l--~h~niv~l~~~~~~~----~~  796 (985)
                      ....+....+.||+|.||+||+|.++ |..||||+|..   .+++.+.+|.+|++.+  +|+||+.|++.-..+    .+
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            34456778899999999999999997 89999999974   3557788999999875  999999999887544    35


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEeCCCCCCCEEEcCCCcEEEeccc
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF-----GHSTPIIHCDLKPSNVLLDEDMVAHLSDFG  871 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~-----~h~~~ivHrDlk~~Nill~~~~~~kl~DfG  871 (985)
                      .++|++|.+.|||+|+|...  .++....++++.-+|.||++||.     .-++.|.|||||++|||+.+++.+.|+|+|
T Consensus       284 LwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            78999999999999999974  68899999999999999999984     246779999999999999999999999999


Q ss_pred             CceeccCCCCc--ceecccccccccccccccccCc-----cchh-hhcccccccchhhhcccccccCcc-----------
Q 001988          872 MAKLLSGEDES--TMRTQTLATIGYMAPDEIFVGE-----LSLK-RWVNDLLPVSLVEVVDKSLLSGEE-----------  932 (985)
Q Consensus       872 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-----~~~~-~dv~~~~g~~~~~i~~~~~~~~~~-----------  932 (985)
                      +|.........  ......+||.+|||||++-..-     -+++ .|+ |+||.++||+...-.-.+..           
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADI-YafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADI-YAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHH-HHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            99887543221  1234567999999999874322     1233 466 99999999987533221110           


Q ss_pred             hhhh----------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          933 KHFA----------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       933 ~~~~----------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                      +..+                      ....+...+.++|+.||..+|..|-||-.+-++|.++.+
T Consensus       441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            1111                      122356789999999999999999999999999999875

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-32  Score=313.36  Aligned_cols=248  Identities=23%  Similarity=0.346  Sum_probs=201.5

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcC-CCCeeeEEeeeecC
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIR-HRNLVKIISSCSND  794 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~-h~niv~l~~~~~~~  794 (985)
                      ...++|...+.||+|+||.||+|++.      .++.||+|+++..... ....+.+|++++.++. ||||++++++|...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            34457888899999999999999853      3467999999765332 3457889999999997 99999999999999


Q ss_pred             CceEEEEeccCCCChHHHhhcCC---------------------------------------------------------
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSN---------------------------------------------------------  817 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------  817 (985)
                      +..++||||+++|+|.++++..+                                                         
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            99999999999999999986531                                                         


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCE
Q 001988          818 ----------------------------------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNV  857 (985)
Q Consensus       818 ----------------------------------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Ni  857 (985)
                                                              ..+++....+++.|++.||+||   |+.+++||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHH---hcCCcCcccCCcceE
Confidence                                                    1356777889999999999999   789999999999999


Q ss_pred             EEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh
Q 001988          858 LLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA  936 (985)
Q Consensus       858 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~  936 (985)
                      ++++++.+||+|||+++.+.............+++.|+|||.+....++.+.|+ |++|+.++|+++ +..+....+...
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-wslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDV-WSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHH-HHHHHHHHHHHHcCCCCCCCCCchH
Confidence            999999999999999987543222222223457889999999998889999999 999999999987 554433221111


Q ss_pred             -------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhH
Q 001988          937 -------------AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       937 -------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~  974 (985)
                                   .+..++.++.+++.+||..+|.+||+++|+++.|+++.
T Consensus       350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                         11224578999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-34  Score=275.64  Aligned_cols=238  Identities=22%  Similarity=0.267  Sum_probs=204.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccC---CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ---CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|..++.+|+|-||.||.|+.+ ++-.||+|++.+.   ......++++|++|-..++||||.++|+++.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            467889999999999999999865 6778999998654   233467899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          801 LEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      +||.++|++...+... ...+++.....+..|+|.|+.|+   |.++||||||||+|+|++.++..|++|||-+..-.  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~---h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYC---HLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHh---ccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            9999999999999855 34588888899999999999999   89999999999999999999999999999876532  


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSL  948 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l  948 (985)
                        .......|||..|.+||.+.+...+...|+ |++|+..+|++.|..++.......           .+...+.+..++
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~-w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dl  252 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDL-WSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADL  252 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhH-HHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHH
Confidence              334566789999999999999999999999 999999999988876654432111           223356788999


Q ss_pred             HHHccCCCCCCCCCHHHHHHHH
Q 001988          949 ALECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~~L  970 (985)
                      +.+|+..+|.+|.+..|++..-
T Consensus       253 I~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  253 ISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             HHHHhccCccccccHHHHhhhH
Confidence            9999999999999999998753

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.7e-33  Score=309.60  Aligned_cols=237  Identities=21%  Similarity=0.258  Sum_probs=199.5

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|...+.||+|+||.||+|+.. +++.||+|+++....   ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999865 789999999975422   23456889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++|+|.+++......+++.....++.|++.||+||   |+++|+||||||+||+++.++.+||+|||++..+.....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV---HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            99999999999987756789999999999999999999   789999999999999999999999999999987653332


Q ss_pred             cceecccccccccccccccc------cCccchhhhcccccccchhhhcccccccCcchhhh---------------hHHH
Q 001988          882 STMRTQTLATIGYMAPDEIF------VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQ  940 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~  940 (985)
                      . ......||+.|+|||.+.      ...++.++|+ |++|++++++++|..+........               ....
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di-wslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (330)
T cd05601         158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDW-WSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK  235 (330)
T ss_pred             e-eeecccCCccccCHHHhccccccccCCCCCccee-ecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCC
Confidence            2 223346999999999886      4567789999 999999999999887654322111               1112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          941 CLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+.++.+++..|+. +|.+||++.+++.
T Consensus       236 ~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         236 VSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            46778999999997 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.2e-32  Score=301.26  Aligned_cols=243  Identities=26%  Similarity=0.413  Sum_probs=199.8

Q ss_pred             cCccCCceeeccCceeEEEEEE-----cCCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARL-----EDGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ++|+..+.||+|+||.||+|..     .+++.||+|.+..... .....+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4677889999999999999974     2567899999875432 234678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC
Q 001988          800 VLEYMSNGSLEDCLHSS----------------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM  863 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~----------------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~  863 (985)
                      ||||+++++|.+++...                ...+++.+...++.|++.||+||   |++|++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhcCeehhccccceEEEcCCC
Confidence            99999999999998532                12467888999999999999999   789999999999999999999


Q ss_pred             cEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh--------
Q 001988          864 VAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH--------  934 (985)
Q Consensus       864 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~--------  934 (985)
                      .+||+|||+++...............++..|+|||.+.++.++.++|+ |++|+.++++++ +..+......        
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-~slG~il~el~~~g~~p~~~~~~~~~~~~~~  240 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDI-WSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR  240 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhh-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999987643332222333446778999999988889999999 999999999997 6544322111        


Q ss_pred             ----hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 001988          935 ----FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       935 ----~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                          ...++.+++++.+++.+||..+|++||++.++.+++..
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                11123357789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.2e-32  Score=302.75  Aligned_cols=248  Identities=25%  Similarity=0.386  Sum_probs=202.6

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLVKIISSCSND  794 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~  794 (985)
                      ...++|+..+.||+|+||.||+|...      +...||+|.+..... .....+.+|+++++++ +|+||+++++++..+
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            34567888999999999999999864      236799999875432 3345688999999999 799999999999999


Q ss_pred             CceEEEEeccCCCChHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE
Q 001988          795 DFKALVLEYMSNGSLEDCLHSS---------------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL  859 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill  859 (985)
                      +..++||||+++|+|.++++..               ...+++..+++++.|++.|++||   |+++|+||||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHCCccccccceeeEEE
Confidence            9999999999999999998642               34688999999999999999999   78999999999999999


Q ss_pred             cCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh---
Q 001988          860 DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF---  935 (985)
Q Consensus       860 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~---  935 (985)
                      ++++.+||+|||+++.+.............++..|+|||.+....++.++|+ |++|+.++++++ +..+.......   
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~el~~~g~~p~~~~~~~~~~  244 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDV-WSFGVLLWEIFTLGGSPYPGIPVEELF  244 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccce-eehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence            9999999999999987654332222222335678999999998999999999 999999999886 54433221110   


Q ss_pred             ---------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhH
Q 001988          936 ---------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       936 ---------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~  974 (985)
                               ..+..++.++.+++.+|+.++|++||++.|+++.|+.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                     112234678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-33  Score=306.05  Aligned_cols=230  Identities=29%  Similarity=0.381  Sum_probs=202.8

Q ss_pred             eeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCChHH
Q 001988          733 IIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLED  811 (985)
Q Consensus       733 ~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  811 (985)
                      ++|+|.||+||.|++. +...+|||.+..+.....+.+..||..-++++|+|||+++|.|.++++.-|.||-+|||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999965 566799999988877778889999999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc-CCCcEEEecccCceeccCCCCcceeccc
Q 001988          812 CLHSSNCAL--NIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHLSDFGMAKLLSGEDESTMRTQT  888 (985)
Q Consensus       812 ~l~~~~~~~--~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~  888 (985)
                      .++...+++  .+.+.--+..||++||.||   |+..|||||||-+|||++ -.|.+||+|||-++++.+..  +.+..+
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYL---Hen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYL---HENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhh---hhcceeeccccCCcEEEeeccceEEecccccchhhccCC--cccccc
Confidence            999886677  6778888999999999999   899999999999999995 67899999999999886433  345567


Q ss_pred             ccccccccccccccCc--cchhhhcccccccchhhhcccccccCcc--------------hhhhhHHHHHHHHHHHHHHc
Q 001988          889 LATIGYMAPDEIFVGE--LSLKRWVNDLLPVSLVEVVDKSLLSGEE--------------KHFAAKEQCLLSIFSLALEC  952 (985)
Q Consensus       889 ~gt~~y~aPE~~~~~~--~~~~~dv~~~~g~~~~~i~~~~~~~~~~--------------~~~~~~~~~~~~l~~l~~~c  952 (985)
                      .||..|||||++-.|+  |..+.|+ |++|+.+.||.+|+.++.+-              .+++.+++..++...++.+|
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADI-WS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc  815 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADI-WSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC  815 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhh-hhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence            7999999999997654  6778899 99999999999999765432              24456778889999999999


Q ss_pred             cCCCCCCCCCHHHHHH
Q 001988          953 TMESPEKRIDAKDTIT  968 (985)
Q Consensus       953 l~~~P~~RPt~~ev~~  968 (985)
                      +.+||.+||+|+++++
T Consensus       816 Fepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  816 FEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cCCCcccCccHHHhcc
Confidence            9999999999999885

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1e-33  Score=278.31  Aligned_cols=239  Identities=25%  Similarity=0.321  Sum_probs=198.9

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--------hHHHHHHHHHHHHhc-CCCCeeeEEeeee
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--------TLKSFEAECEVIKNI-RHRNLVKIISSCS  792 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l-~h~niv~l~~~~~  792 (985)
                      ..-..|...+++|.|..+.|-++.++ +|.++|+|++......        -.+...+|++||+++ .||+|+++.++++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            34566788889999999999998754 8899999998643211        134567899999998 6999999999999


Q ss_pred             cCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccC
Q 001988          793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGM  872 (985)
Q Consensus       793 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGl  872 (985)
                      .+..+++|+|.|+.|.|+|++.... .+++....+|+.|+.+|++||   |.++|||||+||+|||+|++.++||+|||+
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeyl---Ha~~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYL---HARNIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHH---HHhhhhhcccChhheeeccccceEEeccce
Confidence            9999999999999999999999864 688999999999999999999   899999999999999999999999999999


Q ss_pred             ceeccCCCCcceecccccccccccccccc------cCccchhhhcccccccchhhhcccccccCcc--------------
Q 001988          873 AKLLSGEDESTMRTQTLATIGYMAPDEIF------VGELSLKRWVNDLLPVSLVEVVDKSLLSGEE--------------  932 (985)
Q Consensus       873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~--------------  932 (985)
                      |+.+....   .....||||+|.|||.+.      ...|+-..|. |+.|+.++-++.|..++-..              
T Consensus       170 a~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~-Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky  245 (411)
T KOG0599|consen  170 ACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDE-WACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY  245 (411)
T ss_pred             eeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhH-HHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence            99875333   345689999999999774      3456777788 88888888877766443221              


Q ss_pred             -hhhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          933 -KHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       933 -~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                       ...+...+..+...+++.+|++.||.+|.|+.|+++.
T Consensus       246 qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  246 QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence             1223455667888999999999999999999999863

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-32  Score=306.37  Aligned_cols=230  Identities=26%  Similarity=0.319  Sum_probs=192.4

Q ss_pred             ceeeccCceeEEEEEE----cCCcEEEEEEeccCC----cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          732 NIIGIGGFGSVYRARL----EDGVEIAIKVFHPQC----ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +.||+|+||.||+++.    .+++.||+|+++...    ......+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999975    367889999987531    22345678899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +++|+|.+++...+ .+.+.....++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHL---HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--T  155 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--C
Confidence            99999999997654 577888888999999999999   78999999999999999999999999999987643222  1


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHHHc
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLALEC  952 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~~c  952 (985)
                      ......||+.|+|||.+.+..++.++|+ |++|++++++++|..+........           .+...++++.+++.+|
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  234 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDW-WSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKL  234 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCccee-cccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            2234569999999999998889999999 999999999999987655432211           1223457789999999


Q ss_pred             cCCCCCCCC-----CHHHHHH
Q 001988          953 TMESPEKRI-----DAKDTIT  968 (985)
Q Consensus       953 l~~~P~~RP-----t~~ev~~  968 (985)
                      +..+|++||     ++.++++
T Consensus       235 l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         235 LKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             cccCHhHcCCCCCCCHHHHhc
Confidence            999999999     7777765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-32  Score=296.29  Aligned_cols=242  Identities=24%  Similarity=0.410  Sum_probs=201.7

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .+|...+.||+|+||.||+|..+ +++.||+|.+... .....++.+|++++++++||||+++++++...+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            35777889999999999999865 6888999998754 334567899999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          805 SNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       805 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      ++++|.+++... ...+++..++.++.|+++||+||   |+.|++||||||+||++++++.+||+|||++........ .
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-e
Confidence            999999998764 34589999999999999999999   789999999999999999999999999999987643221 1


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSIFSLAL  950 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l~~l~~  950 (985)
                      ......++..|+|||.+.+..++.++|+ |++|+.++++++ +..+......            ...++.++.++.+++.
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  239 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDV-WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMR  239 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence            1122234668999999998999999999 999999999997 5544332111            1122335678999999


Q ss_pred             HccCCCCCCCCCHHHHHHHHHHh
Q 001988          951 ECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                      +||..+|++||++.++++.|+.+
T Consensus       240 ~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         240 ACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHccCCcccCCCHHHHHHHHHhh
Confidence            99999999999999999998864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.1e-32  Score=311.86  Aligned_cols=238  Identities=21%  Similarity=0.255  Sum_probs=194.6

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .|...+.||+|+||+||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999864 78899999997542   2234568899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC-
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-  881 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~-  881 (985)
                      |+++|+|.+++...+ .+++.....++.|++.||+||   |+.||+||||||+||+++.++++||+|||+++.+..... 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~L---H~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESV---HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            999999999987654 578888899999999999999   789999999999999999999999999999864321000 


Q ss_pred             --------------------------------------------cceecccccccccccccccccCccchhhhccccccc
Q 001988          882 --------------------------------------------STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPV  917 (985)
Q Consensus       882 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~  917 (985)
                                                                  .......+||+.|+|||.+.+..++.++|+ |++|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di-wSlG~  236 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW-WSVGV  236 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce-eehhh
Confidence                                                        000123469999999999998889999999 99999


Q ss_pred             chhhhcccccccCcchhhhh---------------HHHHHHHHHHHHHH--ccCCCCCCCCCHHHHHHH
Q 001988          918 SLVEVVDKSLLSGEEKHFAA---------------KEQCLLSIFSLALE--CTMESPEKRIDAKDTITR  969 (985)
Q Consensus       918 ~~~~i~~~~~~~~~~~~~~~---------------~~~~~~~l~~l~~~--cl~~~P~~RPt~~ev~~~  969 (985)
                      +++++++|..++........               ....+.++.+++.+  |+..+|..||++.|+++.
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            99999999877643321110               01235678888888  556667779999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-33  Score=318.99  Aligned_cols=250  Identities=24%  Similarity=0.291  Sum_probs=205.1

Q ss_pred             cCccCCceeeccCceeEEEEEEcCC-cEEEEEEeccCCcchHHHHHHHHHHHHhcC-CCCeeeEEee-eec------CCc
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDG-VEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKIISS-CSN------DDF  796 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~-~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~-~~~------~~~  796 (985)
                      -++.+.+.|.+|||+.||.|....+ .+||+|++-.........+++||++|++++ |+|||.|++. ...      .-+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            3556778899999999999997655 999999988777777888999999999996 9999999993 321      135


Q ss_pred             eEEEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          797 KALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      ++|.||||+||.|-|++... ...+++.++++|+.|+++|+++||+ ....|||||||.+|||++.+|..||||||.|+-
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt  195 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATT  195 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence            77999999999999999854 3359999999999999999999976 566799999999999999999999999999875


Q ss_pred             ccCCCCcce-------eccccccccccccccc---ccCccchhhhcccccccchhhhcccccccCcch---------hhh
Q 001988          876 LSGEDESTM-------RTQTLATIGYMAPDEI---FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK---------HFA  936 (985)
Q Consensus       876 ~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~---------~~~  936 (985)
                      .-...+...       .-...-|+.|+|||++   .+...+.++|+ |++||++|-+.-+..++....         ..+
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDI-WALGclLYkLCy~t~PFe~sg~laIlng~Y~~P  274 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDI-WALGCLLYKLCYFTTPFEESGKLAILNGNYSFP  274 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHH-HHHHHHHHHHHHhCCCcCcCcceeEEeccccCC
Confidence            432221111       0112368999999965   47788999999 999999999887777665441         222


Q ss_pred             hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          937 AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       937 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      ....+...+.+||+.||.++|.+||++-+|++.+.++....
T Consensus       275 ~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  275 PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence            33467888999999999999999999999999999988653

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=9.2e-33  Score=302.79  Aligned_cols=247  Identities=20%  Similarity=0.305  Sum_probs=199.5

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCc
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDF  796 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  796 (985)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.+..... .....+.+|+.++++++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999999753      245799998865432 234467889999999999999999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEE
Q 001988          797 KALVLEYMSNGSLEDCLHSSN---------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHL  867 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl  867 (985)
                      .++||||+++|+|.+++....         ...++....+++.|++.||+||   |+++|+||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL---NAKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999997531         2346778889999999999999   7899999999999999999999999


Q ss_pred             ecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcch------------h
Q 001988          868 SDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEK------------H  934 (985)
Q Consensus       868 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~------------~  934 (985)
                      +|||+++...............++..|+|||.+.++.++.++|+ |++|++++++++ +..+.....            .
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv-wslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDM-WSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY  239 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHH-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999986543222222222345678999999999999999999 999999999987 443332111            0


Q ss_pred             hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhH
Q 001988          935 FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       935 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~  974 (985)
                      ...++.+++.+.+++.+|++.+|++||++.++++.+++..
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            1112345678999999999999999999999998887654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.1e-32  Score=296.56  Aligned_cols=243  Identities=24%  Similarity=0.324  Sum_probs=203.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|...+.||+|+||.||+|+.. +++.||||.++...   ......+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57888999999999999999864 78999999886432   223456889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          802 EYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       802 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      ||+++|+|.+++..   ....+++.....++.|++.||+||   |+++++||||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988853   234578899999999999999999   899999999999999999999999999999987643


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh---------------hhhHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH---------------FAAKEQCLL  943 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~---------------~~~~~~~~~  943 (985)
                      ..  .......+++.|+|||.+.+..++.++|+ |++|+.+++++++..+......               ....+..+.
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di-~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08228         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDI-WSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSE  235 (267)
T ss_pred             hh--HHHhcCCCCccccChhhhccCCCCchhhH-HHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCH
Confidence            22  11223458889999999998889999999 9999999999988765432210               001234567


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHHhH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~  974 (985)
                      .+.+++.+||..+|++||++.++++.++.++
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            7999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-32  Score=300.05  Aligned_cols=244  Identities=24%  Similarity=0.429  Sum_probs=200.5

Q ss_pred             cCccCCceeeccCceeEEEEEE-----cCCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecC--Cce
Q 001988          726 DNFAENNIIGIGGFGSVYRARL-----EDGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSND--DFK  797 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~  797 (985)
                      ..|+..+.||+|+||.||+|..     .++..||+|.++.... .....+.+|++++++++|||++++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3467889999999999999974     3578899999875532 2346789999999999999999999999775  567


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ++||||+++++|.+++......+++.++..++.|++.||+||   |++|++||||||+||+++.++.+||+|||+++.+.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~l---H~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            899999999999999977655689999999999999999999   78999999999999999999999999999998765


Q ss_pred             CCCCc-ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcc------------------------
Q 001988          878 GEDES-TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEE------------------------  932 (985)
Q Consensus       878 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~------------------------  932 (985)
                      ..... .......++..|+|||.+.+..++.++|+ |++|+++++++++.......                        
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di-~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDV-WSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccc-hhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence            33221 12223456778999999988889999999 99999999998754321100                        


Q ss_pred             ---hhhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          933 ---KHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       933 ---~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                         ...+.+..++.++.+++.+|++.+|++||++.++++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence               00111223567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=312.80  Aligned_cols=237  Identities=21%  Similarity=0.277  Sum_probs=196.9

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|+..+.||+|+||.||+|+.. +++.||||++....   ......+.+|+++++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888999999999999999865 78999999997542   223456788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSI---HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            9999999999998654 688999999999999999999   789999999999999999999999999999876532111


Q ss_pred             cc------------------------------------eecccccccccccccccccCccchhhhcccccccchhhhccc
Q 001988          882 ST------------------------------------MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDK  925 (985)
Q Consensus       882 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~  925 (985)
                      ..                                    .....+||+.|+|||++....++.++|+ |++|++++++++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlG~il~el~~G  235 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW-WSLGVIMYEMLVG  235 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeee-ecchhHHHHhhcC
Confidence            00                                    0112469999999999999999999999 9999999999998


Q ss_pred             ccccCcchhhhh---------------HHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 001988          926 SLLSGEEKHFAA---------------KEQCLLSIFSLALECTMESPEKRID---AKDTIT  968 (985)
Q Consensus       926 ~~~~~~~~~~~~---------------~~~~~~~l~~l~~~cl~~~P~~RPt---~~ev~~  968 (985)
                      ..++........               ....++++.+++.+|+. +|.+|++   +.|+++
T Consensus       236 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         236 YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            876543321110               01235678899999996 9999998   888866

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-33  Score=311.70  Aligned_cols=238  Identities=24%  Similarity=0.312  Sum_probs=201.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|...+.||+|+||.||+|+.. +++.||||+++...   ......+.+|+++++.++||||+++++++.++++.++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999975 78999999997542   234567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC-
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED-  880 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~-  880 (985)
                      ||+++|+|.+++... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+.... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~L---H~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSV---HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999999876 4688999999999999999999   78999999999999999999999999999998764332 


Q ss_pred             --------------------------CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh
Q 001988          881 --------------------------ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH  934 (985)
Q Consensus       881 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~  934 (985)
                                                .........||+.|+|||.+.+..++.++|+ |++|++++++++|..+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDW-WSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceee-EecchhhhhhccCCCCCCCCCH
Confidence                                      0011234469999999999999999999999 9999999999999876544321


Q ss_pred             hh---------------hHHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 001988          935 FA---------------AKEQCLLSIFSLALECTMESPEKRID-AKDTITR  969 (985)
Q Consensus       935 ~~---------------~~~~~~~~l~~l~~~cl~~~P~~RPt-~~ev~~~  969 (985)
                      ..               .....++++.+++.+|+. +|.+||+ +.|+++.
T Consensus       236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            11               011136788999999997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-32  Score=321.70  Aligned_cols=243  Identities=22%  Similarity=0.260  Sum_probs=202.1

Q ss_pred             HHhcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCC----
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD----  795 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----  795 (985)
                      ...++|...+.||+|+||.||+|+. .+++.||||++....  ......+.+|+.++..++|+|++++++.+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3457899999999999999999985 479999999987553  234556789999999999999999988775432    


Q ss_pred             ----ceEEEEeccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 001988          796 ----FKALVLEYMSNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLS  868 (985)
Q Consensus       796 ----~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~  868 (985)
                          ..++||||+++|+|.++++..   ...+++.....++.|++.||.|+   |+++|+||||||+||+++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~l---H~~~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV---HSKHMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEeCCCCEEEE
Confidence                367999999999999998753   34688999999999999999999   88999999999999999999999999


Q ss_pred             cccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh------------h
Q 001988          869 DFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF------------A  936 (985)
Q Consensus       869 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~------------~  936 (985)
                      |||+++.+............+||+.|+|||.+.+..++.++|+ |++|++++++++++.++......            +
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DV-wSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~  264 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADM-FSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP  264 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHH-HHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence            9999987654332333345679999999999999999999999 99999999999988765432211            1


Q ss_pred             hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          937 AKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       937 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      .+..+++++.+++.+||+.+|.+||++.++++.
T Consensus       265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            123456789999999999999999999999763

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.3e-32  Score=304.40  Aligned_cols=249  Identities=24%  Similarity=0.371  Sum_probs=203.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEc--------CCcEEEEEEeccCC-cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE--------DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNI-RHRNLVKIISSCSND  794 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~  794 (985)
                      .++|.+.+.||+|+||.||+|+..        ++..||+|.++... ......+..|+++++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            367899999999999999999752        23569999998653 23456788899999999 799999999999999


Q ss_pred             CceEEEEeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSN---------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL  859 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill  859 (985)
                      +..++||||+++|+|.+++....               ..+++.++.+++.|++.||+||   |+.|++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---HHCCcccccccHHheEE
Confidence            99999999999999999997542               2478899999999999999999   78999999999999999


Q ss_pred             cCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh----
Q 001988          860 DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH----  934 (985)
Q Consensus       860 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~----  934 (985)
                      ++++.+||+|||.++...............+++.|+|||.+.+..++.++|+ |++|++++++++ +..+....+.    
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-wslG~~l~el~~~g~~p~~~~~~~~~~  252 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV-WSFGVLLWEIFTLGGSPYPGVPVEELF  252 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHH-HHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence            9999999999999886643221111222234578999999998889999999 999999999987 5444332211    


Q ss_pred             --------hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          935 --------FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       935 --------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                              ...+..++.++.+++.+|+..+|++||++.++++.|.++.+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         253 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence                    1122345678999999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.7e-32  Score=301.61  Aligned_cols=249  Identities=24%  Similarity=0.373  Sum_probs=203.3

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc--------CCcEEEEEEeccCC-cchHHHHHHHHHHHHhc-CCCCeeeEEeeeec
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE--------DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNI-RHRNLVKIISSCSN  793 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~  793 (985)
                      ..++|...+.||+|+||.||+|+..        ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3467888899999999999999741        34579999987543 23456789999999999 89999999999999


Q ss_pred             CCceEEEEeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEE
Q 001988          794 DDFKALVLEYMSNGSLEDCLHSSN---------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVL  858 (985)
Q Consensus       794 ~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nil  858 (985)
                      .+..++||||+++|+|.+++....               ..+++.++..++.|+++||+||   |++|++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH---HHCCeeecccccceEE
Confidence            999999999999999999987531               2467888999999999999999   7899999999999999


Q ss_pred             EcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh--
Q 001988          859 LDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF--  935 (985)
Q Consensus       859 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~--  935 (985)
                      +++++.+||+|||+++.+.............+++.|+|||++.+..++.++|+ |++|+.++++++ +..+....+..  
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV-WSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhH-HHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            99999999999999987653332222233346778999999998889999999 999999999987 44332211111  


Q ss_pred             ----------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          936 ----------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       936 ----------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                                ..+..++.++.+++.+||+.+|.+||++.|+++.|.++..-
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         249 FKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence                      11223567899999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-32  Score=304.23  Aligned_cols=237  Identities=24%  Similarity=0.287  Sum_probs=205.7

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc---hHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~  798 (985)
                      ..+.|...+.||+|.||.||+++.+ +|+.+|+|.+.+....   +...+.+|+.+|+++. |||||++++++++.+..+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3456888899999999999999976 5999999999876443   3468899999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC----CCcEEEecccCce
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE----DMVAHLSDFGMAK  874 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~----~~~~kl~DfGla~  874 (985)
                      +|||++.||.|++.+...  .+++.....++.|++++++||   |+.||+|||+||+|+|+..    ++.+|++|||++.
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~l---H~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYL---HSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHH---HhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999999876  389999999999999999999   8899999999999999953    3589999999999


Q ss_pred             eccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcch---------------hhhhHH
Q 001988          875 LLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK---------------HFAAKE  939 (985)
Q Consensus       875 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~---------------~~~~~~  939 (985)
                      ....   .......+||+.|+|||++....++...|+ |+.|+..+.++.|..++....               ..+..+
T Consensus       188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~Di-WS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~  263 (382)
T KOG0032|consen  188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDV-WSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWD  263 (382)
T ss_pred             EccC---CceEeeecCCccccCchhhcCCCCCcccch-hHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcc
Confidence            8754   334567889999999999999999999999 999999999988776544332               111233


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          940 QCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       940 ~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      ...+...++++.|+..||.+|+++.++++.
T Consensus       264 ~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  264 DISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            457889999999999999999999999984

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.7e-32  Score=302.87  Aligned_cols=252  Identities=24%  Similarity=0.377  Sum_probs=203.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc--------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE--------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLVKIISSCSND  794 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~  794 (985)
                      .++|...+.||+|+||.||+|+..        ....||+|.++.... .....+.+|+++++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            467888999999999999999742        345699999875432 3356788999999999 699999999999999


Q ss_pred             CceEEEEeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSN---------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL  859 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill  859 (985)
                      +..++||||+++|+|.+++....               ..+++.++.+++.|++.||+||   |++|++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH---HHCCeeeccccceeEEE
Confidence            99999999999999999996532               3478899999999999999999   78999999999999999


Q ss_pred             cCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh---
Q 001988          860 DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF---  935 (985)
Q Consensus       860 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~---  935 (985)
                      ++++.+||+|||.++...............++..|+|||.+..+.++.++|+ |++|+.++++++ +..+....+..   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-wslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDV-WSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchh-hHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999987643222221222234567999999999999999999 999999999987 54433221110   


Q ss_pred             ---------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhccc
Q 001988          936 ---------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSKR  980 (985)
Q Consensus       936 ---------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~~  980 (985)
                               ..+..++.++.+++.+|+..+|++||++.|+++.|.++......+
T Consensus       247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~  300 (314)
T cd05099         247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEE  300 (314)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCC
Confidence                     112234568999999999999999999999999999988755443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.7e-32  Score=304.41  Aligned_cols=227  Identities=23%  Similarity=0.236  Sum_probs=188.1

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999865 67889999997542   22334556677777654 899999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      |+|.+++...+ .+++.....++.|++.||+||   |+++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFL---HKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            99999987654 688999999999999999999   78999999999999999999999999999998653222  2233


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHHHccCC
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLALECTME  955 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~~cl~~  955 (985)
                      ..+||+.|+|||.+.+..++.++|+ |++|++++++++|..+........           .+..++.++.+++.+||..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~Dv-wslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDW-WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFER  233 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccc-hhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccC
Confidence            4579999999999999899999999 999999999999987654332111           1122456788999999999


Q ss_pred             CCCCCCCHHH
Q 001988          956 SPEKRIDAKD  965 (985)
Q Consensus       956 ~P~~RPt~~e  965 (985)
                      +|.+||++.+
T Consensus       234 ~P~~R~~~~~  243 (316)
T cd05592         234 DPTKRLGVDG  243 (316)
T ss_pred             CHHHcCCChH
Confidence            9999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-32  Score=305.89  Aligned_cols=227  Identities=24%  Similarity=0.282  Sum_probs=190.8

Q ss_pred             ceeeccCceeEEEEEE----cCCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccC
Q 001988          732 NIIGIGGFGSVYRARL----EDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~----~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      +.||+|+||.||+++.    .+|+.||+|++.....  .....+..|++++++++||||+++++++.+++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    3688999999975422  233457789999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCccee
Q 001988          806 NGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR  885 (985)
Q Consensus       806 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~  885 (985)
                      +|+|.+++.... .+++..+..++.|+++||+||   |+.+|+||||||+||++++++.+||+|||+++......  ...
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~  155 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA  155 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence            999999987653 689999999999999999999   78999999999999999999999999999988653321  223


Q ss_pred             cccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHHHccC
Q 001988          886 TQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLALECTM  954 (985)
Q Consensus       886 ~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~~cl~  954 (985)
                      ....||+.|+|||.+.+..++.++|+ |++|+.++++++|..+........           .+...+.++.+++++||.
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~Di-wslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~  234 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADW-WSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFK  234 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccce-eccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence            34579999999999988889999999 999999999999887654332111           122346778999999999


Q ss_pred             CCCCCCCCHHH
Q 001988          955 ESPEKRIDAKD  965 (985)
Q Consensus       955 ~~P~~RPt~~e  965 (985)
                      .||.+||++.+
T Consensus       235 ~~P~~R~~a~~  245 (318)
T cd05582         235 RNPANRLGAGP  245 (318)
T ss_pred             cCHhHcCCCCC
Confidence            99999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.2e-32  Score=296.35  Aligned_cols=244  Identities=23%  Similarity=0.406  Sum_probs=201.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc----CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      ++|+..+.||+|+||.||+|+..    ++..||+|.++.... ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56788899999999999999863    234799999875432 2346789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++++|.+++......+++.+...++.|++.|++||   |+.+++||||||+||+++.++.+|++|||++..+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            999999999999987766789999999999999999999   78999999999999999999999999999998765332


Q ss_pred             Ccce-ecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHHH
Q 001988          881 ESTM-RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSIF  946 (985)
Q Consensus       881 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l~  946 (985)
                      .... .....++..|+|||.+....++.+.|+ |++|+.+++++. +..+......            .+.+..++..+.
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv-~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDV-WSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH  239 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhh-HHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence            2111 112234568999999998899999999 999999999775 6654432211            111223567889


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          947 SLALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                      +++.+|++.+|.+||++.++++.|.++
T Consensus       240 ~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         240 QLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.9e-32  Score=304.85  Aligned_cols=231  Identities=23%  Similarity=0.225  Sum_probs=192.1

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||.||+|+.. +++.||+|++.+..   ......+..|.++++.+ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36899999999999865 67899999987542   22345677899998876 799999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      |+|.+++...+ .+++.....++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFL---HRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTT  154 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--cccc
Confidence            99999987654 688899999999999999999   78999999999999999999999999999987643222  2233


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhhH-----------HHHHHHHHHHHHHccCC
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK-----------EQCLLSIFSLALECTME  955 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~-----------~~~~~~l~~l~~~cl~~  955 (985)
                      ...||+.|+|||.+.+..++.++|+ |++|+.++++++|..+..........           ..++.++.+++.+|+..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~Dv-wslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~  233 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDW-WALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTK  233 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccce-echhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcc
Confidence            4569999999999998899999999 99999999999998776543222111           12357789999999999


Q ss_pred             CCCCCC-------CHHHHHHH
Q 001988          956 SPEKRI-------DAKDTITR  969 (985)
Q Consensus       956 ~P~~RP-------t~~ev~~~  969 (985)
                      +|++||       ++.++++.
T Consensus       234 dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         234 NPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CHHHcCCCCCCCCCHHHHhcC
Confidence            999999       67777643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.1e-32  Score=298.71  Aligned_cols=242  Identities=25%  Similarity=0.415  Sum_probs=201.1

Q ss_pred             cCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ++|...++||+|+||.||+|...      ++..||+|.+..........+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46777899999999999999642      466799999876655566789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcE
Q 001988          800 VLEYMSNGSLEDCLHSSN--------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  865 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~  865 (985)
                      ||||+++|+|.+++....              ..+++..++.++.|++.|++||   |++|++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHH---HHCCeecccccHhhEEEcCCCCE
Confidence            999999999999987643              2478899999999999999999   78999999999999999999999


Q ss_pred             EEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh----------
Q 001988          866 HLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH----------  934 (985)
Q Consensus       866 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~----------  934 (985)
                      ||+|||+++.+.............+++.|+|||.+.+..++.++|+ |++|+.++++++ +..+......          
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDI-WSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG  240 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhH-HHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence            9999999986543222222223345788999999999999999999 999999999987 5554322111          


Q ss_pred             --hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 001988          935 --FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLL  971 (985)
Q Consensus       935 --~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~  971 (985)
                        ...+..++..+.+++.+||..+|.+||++.|+.+.|+
T Consensus       241 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         241 RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence              1112345688999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-34  Score=305.15  Aligned_cols=232  Identities=25%  Similarity=0.330  Sum_probs=196.7

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc---hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      |...+.||+|+||.||-|+.. +...||||++.....+   ....+.+|++.|++++|||+|.+-|+|......|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            555677999999999999854 7788999999755333   345788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      | -|+-.|.+.-..+++.+.++..|+.+.++||+||   |+++.||||||+-|||+++.|.|||+|||.|....+     
T Consensus       108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYL---HS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----  178 (948)
T KOG0577|consen  108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----  178 (948)
T ss_pred             H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHH---HHhhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence            9 5688888887777888999999999999999999   899999999999999999999999999999987532     


Q ss_pred             eecccccccccccccccc---cCccchhhhcccccccchhhhcccccccCc--------------chhhhhHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIF---VGELSLKRWVNDLLPVSLVEVVDKSLLSGE--------------EKHFAAKEQCLLSIF  946 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~--------------~~~~~~~~~~~~~l~  946 (985)
                       ...++|||+|||||++.   .|.|+.+.|| |++|+...|+...+.+...              .|.. ...++.+.+.
T Consensus       179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDv-WSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtL-qs~eWS~~F~  255 (948)
T KOG0577|consen  179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDV-WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL-QSNEWSDYFR  255 (948)
T ss_pred             -hhcccCCccccchhHheeccccccCCccce-eeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCC-CCchhHHHHH
Confidence             23568999999999875   5889999999 9999998888876543221              1111 2345788899


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHH
Q 001988          947 SLALECTMESPEKRIDAKDTITRLL  971 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~~L~  971 (985)
                      +++..|++.-|.+|||..++++.--
T Consensus       256 ~Fvd~CLqKipqeRptse~ll~H~f  280 (948)
T KOG0577|consen  256 NFVDSCLQKIPQERPTSEELLKHRF  280 (948)
T ss_pred             HHHHHHHhhCcccCCcHHHHhhcch
Confidence            9999999999999999999876543

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.3e-32  Score=298.78  Aligned_cols=245  Identities=26%  Similarity=0.382  Sum_probs=201.0

Q ss_pred             CccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          727 NFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      +|+..+.||+|+||.||+|...      ....||+|.+..... .....+.+|+.++++++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677889999999999999753      235689998875532 234678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 001988          800 VLEYMSNGSLEDCLHSS-----------------------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSN  856 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~-----------------------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~N  856 (985)
                      ||||+++|+|.+++...                       ...+++.++..++.|++.|++||   |+++|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHH---HHCCeehhhhhhhe
Confidence            99999999999987642                       12478889999999999999999   78999999999999


Q ss_pred             EEEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh
Q 001988          857 VLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF  935 (985)
Q Consensus       857 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~  935 (985)
                      |++++++.+||+|||+++...............++..|+|||.+.+..++.++|+ |++|++++++++ +..+.......
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di-~slG~~l~el~t~g~~p~~~~~~~  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDV-WSFGVLLWEIVTLGGNPYPGIAPE  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHH-HHHHHHHHHHHhcCCCCCCCCCHH
Confidence            9999999999999999987543332222223346778999999988889999999 999999999997 66544322111


Q ss_pred             ------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          936 ------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       936 ------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                                  +.+..++.++.+++.+|++.+|++||++.++++.|+++-.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         237 RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                        1123356789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-32  Score=299.74  Aligned_cols=243  Identities=23%  Similarity=0.377  Sum_probs=196.0

Q ss_pred             cCccCCceeeccCceeEEEEEEcC---------------CcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEe
Q 001988          726 DNFAENNIIGIGGFGSVYRARLED---------------GVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIIS  789 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~---------------~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~  789 (985)
                      ++|+..+.||+|+||.||+|+...               ...||+|.++..... ....+.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578888999999999999987542               234899998765332 3457899999999999999999999


Q ss_pred             eeecCCceEEEEeccCCCChHHHhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEE
Q 001988          790 SCSNDDFKALVLEYMSNGSLEDCLHSSN-----------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVL  858 (985)
Q Consensus       790 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nil  858 (985)
                      ++...+..++||||+++++|.+++....           ..+++..+++++.|++.|++||   |+.+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHH---HhcCeeccccChhhEE
Confidence            9999999999999999999999986532           2367889999999999999999   7899999999999999


Q ss_pred             EcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhccc--ccccCcchhh-
Q 001988          859 LDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDK--SLLSGEEKHF-  935 (985)
Q Consensus       859 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~--~~~~~~~~~~-  935 (985)
                      +++++.+||+|||++................++..|+|||.+..+.++.++|+ |++|+.++++++.  ..+....... 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-wSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDV-WAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhH-HHHHHHHHHHHHcCCCCCCcccChHH
Confidence            99999999999999986543322222223345778999999999999999999 9999999999863  2222111000 


Q ss_pred             ------------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 001988          936 ------------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       936 ------------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                                        ..+..+++.+.+++.+||..+|++||++.+|++.|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence                              0011245779999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=9e-33  Score=311.76  Aligned_cols=233  Identities=25%  Similarity=0.353  Sum_probs=190.2

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ++|...+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34566788999999999999865 7899999998654322 346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +++|+|.+..     ..++.....++.||+.||+||   |+.||+||||||+||++++++.+||+|||+++.+.....  
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  223 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYL---HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--  223 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence            9999987532     345677888999999999999   789999999999999999999999999999987643221  


Q ss_pred             eeccccccccccccccccc-----CccchhhhcccccccchhhhcccccccCcchhh---------------hhHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFV-----GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AAKEQCLL  943 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~~~~~~~  943 (985)
                      ......||..|+|||.+..     ...+.++|+ |++|++++++++++.++......               ..+..++.
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dv-wslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDI-WSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR  302 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhH-HHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence            1233569999999998743     233468899 99999999999998766422110               01223467


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      ++.+++.+||..+|++||++.|+++.
T Consensus       303 ~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        303 EFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcC
Confidence            89999999999999999999999874

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.7e-32  Score=306.37  Aligned_cols=248  Identities=22%  Similarity=0.350  Sum_probs=199.0

Q ss_pred             hcCccCCceeeccCceeEEEEEE------cCCcEEEEEEeccCCc-chHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-C
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL------EDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLVKIISSCSND-D  795 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~-~  795 (985)
                      .++|+..+.||+|+||.||+|.+      .+++.||||+++.... .....+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46789999999999999999973      3578899999976532 2345688999999999 689999999988654 4


Q ss_pred             ceEEEEeccCCCChHHHhhcCC----------------------------------------------------------
Q 001988          796 FKALVLEYMSNGSLEDCLHSSN----------------------------------------------------------  817 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  817 (985)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999986431                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecccc
Q 001988          818 --------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL  889 (985)
Q Consensus       818 --------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  889 (985)
                              ..+++....+++.|+++||+||   |+++|+||||||+||++++++.+||+|||+++.+.............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    2357788899999999999999   78999999999999999999999999999998754332222222234


Q ss_pred             cccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh-------------hhHHHHHHHHHHHHHHccCC
Q 001988          890 ATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF-------------AAKEQCLLSIFSLALECTME  955 (985)
Q Consensus       890 gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~-------------~~~~~~~~~l~~l~~~cl~~  955 (985)
                      +++.|+|||.+....++.++|+ |++|+.++++++ +..+.......             ..+...++++.+++.+||..
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~  321 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDV-WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG  321 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhH-HHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence            5678999999999999999999 999999999985 55443221100             01112346789999999999


Q ss_pred             CCCCCCCHHHHHHHHHHhHhh
Q 001988          956 SPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       956 ~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      +|++||++.|+++.|+.+.++
T Consensus       322 ~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         322 EPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             ChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999988764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-32  Score=311.03  Aligned_cols=231  Identities=18%  Similarity=0.194  Sum_probs=191.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ..+|+..+.||+|+||.||+|... +++.||+|....      ..+.+|++++++++||||+++++++...+..++|||+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999864 788999997532      3467899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +. ++|.+++.... .+++..++.++.|+++||+||   |++||+||||||+||+++.++.+||+|||+|+...... ..
T Consensus       165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yl---H~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~  238 (391)
T PHA03212        165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYL---HENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN  238 (391)
T ss_pred             CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence            95 68988887653 678999999999999999999   78999999999999999999999999999997543221 11


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhccccccc-Ccc----------------------h-hh----
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLS-GEE----------------------K-HF----  935 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~-~~~----------------------~-~~----  935 (985)
                      .....+||+.|+|||++.+..++.++|+ |++|+++++++++..+. ...                      + ..    
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDI-WSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHH-HHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            2234579999999999999999999999 99999999999876321 100                      0 00    


Q ss_pred             -------------------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          936 -------------------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       936 -------------------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                               ......+.++.+++.+|++.||.+|||+.|+++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                                     001123567889999999999999999999985

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-32  Score=308.23  Aligned_cols=237  Identities=21%  Similarity=0.277  Sum_probs=191.5

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----CceE
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSND-----DFKA  798 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~~  798 (985)
                      +|...+.||+|+||.||+|+.. +++.||||++....  ......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999865 78999999987432  22345688999999999999999999988543     2479


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +||||++ ++|.+++.... .+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYI---HTANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 68999887654 588999999999999999999   789999999999999999999999999999986532


Q ss_pred             CCC-cceeccccccccccccccccc--CccchhhhcccccccchhhhcccccccCcchhhhh------------------
Q 001988          879 EDE-STMRTQTLATIGYMAPDEIFV--GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA------------------  937 (985)
Q Consensus       879 ~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~------------------  937 (985)
                      ... ........||+.|+|||.+.+  ..++.++|+ |++|++++++++|+.+.........                  
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~Dv-wSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDI-WSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHH-HHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            222 112234579999999998865  678899999 9999999999998865432210000                  


Q ss_pred             ------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          938 ------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       938 ------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                              ....+..+.+++.+|+..+|++||++.|+++.
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                                    00123557899999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.7e-32  Score=293.57  Aligned_cols=242  Identities=26%  Similarity=0.418  Sum_probs=201.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .++|...+.||+|+||.||+|...++..||+|.++.... ..+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            356888999999999999999987777899999875432 34678999999999999999999998754 5578999999


Q ss_pred             CCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          805 SNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       805 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      ++|+|.+++... ...+++..+..++.|+++||+|+   |+.+++||||||+||++++++.+||+|||.++.+..... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcccEEEcCCCcEEeccCCceeecccccc-c
Confidence            999999999764 34578999999999999999999   789999999999999999999999999999987643322 1


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSIFSLAL  950 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l~~l~~  950 (985)
                      ......++..|+|||....+.++.++|+ |++|+.++++++ +..+......            ......++..+.+++.
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv-wslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  237 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDV-WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC  237 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhH-HHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence            2223346778999999988999999999 999999999998 6654432211            1112346788999999


Q ss_pred             HccCCCCCCCCCHHHHHHHHHHh
Q 001988          951 ECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                      +|++.+|++||++.++.+.|++.
T Consensus       238 ~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         238 QCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             HHccCCcccCCCHHHHHHHHHHh
Confidence            99999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.9e-32  Score=298.44  Aligned_cols=243  Identities=24%  Similarity=0.399  Sum_probs=199.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEcC-----------------CcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeee
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLED-----------------GVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVK  786 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~-----------------~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~  786 (985)
                      .++|...+.||+|+||.||+|...+                 +..||+|.+..... ...+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578889999999999999987542                 34689999876533 34567899999999999999999


Q ss_pred             EEeeeecCCceEEEEeccCCCChHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 001988          787 IISSCSNDDFKALVLEYMSNGSLEDCLHSSN----------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSN  856 (985)
Q Consensus       787 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~N  856 (985)
                      +++++..++..++||||+++++|.+++....          ..+++..++.++.|++.||+||   |+.+|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~L---H~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHH---HHcCccccccchhc
Confidence            9999999999999999999999999987643          2578999999999999999999   78999999999999


Q ss_pred             EEEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc--cccccCcchh
Q 001988          857 VLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD--KSLLSGEEKH  934 (985)
Q Consensus       857 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~--~~~~~~~~~~  934 (985)
                      |+++.++.++|+|||+++...............+++.|+|||.+..+.++.++|+ |++|+.++++++  +..+......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDV-WAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchh-hhhHHHHHHHHhcCCCCCCCCcCh
Confidence            9999999999999999987643332222334456789999999988899999999 999999999886  3322221111


Q ss_pred             h-------------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 001988          935 F-------------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLL  971 (985)
Q Consensus       935 ~-------------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~  971 (985)
                      .                   ..+..+++++.+++.+|++.+|.+||++.|+++.|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            0                   011123578999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-32  Score=310.16  Aligned_cols=238  Identities=22%  Similarity=0.265  Sum_probs=194.1

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|...+.||+|+||.||+|+.. +++.||||++.+..   ....+.+.+|++++++++||||+++++++.+.++.|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888999999999999999864 78999999986532   223456889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++|+|.+++...+ .+++.....++.|++.||+||   |+.||+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~L---H~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAV---HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            9999999999997653 678888999999999999999   899999999999999999999999999999964321100


Q ss_pred             c---------------------------------------------ceecccccccccccccccccCccchhhhcccccc
Q 001988          882 S---------------------------------------------TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLP  916 (985)
Q Consensus       882 ~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g  916 (985)
                      .                                             ......+||+.|+|||.+.+..++.++|+ |++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlG  235 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW-WSLG  235 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee-Eecc
Confidence            0                                             00012469999999999999999999999 9999


Q ss_pred             cchhhhcccccccCcchhhhh---------------HHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 001988          917 VSLVEVVDKSLLSGEEKHFAA---------------KEQCLLSIFSLALECTMESPEKR---IDAKDTITR  969 (985)
Q Consensus       917 ~~~~~i~~~~~~~~~~~~~~~---------------~~~~~~~l~~l~~~cl~~~P~~R---Pt~~ev~~~  969 (985)
                      ++++++++|..++........               ......++.+++.+|+. +|.+|   +++.|++..
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            999999999876543221110               01234678899999997 66664   599888764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.7e-32  Score=305.51  Aligned_cols=236  Identities=24%  Similarity=0.259  Sum_probs=193.7

Q ss_pred             CccCCceeeccCceeEEEEEE----cCCcEEEEEEeccCC----cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCce
Q 001988          727 NFAENNIIGIGGFGSVYRARL----EDGVEIAIKVFHPQC----ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~  797 (985)
                      +|+..+.||+|+||.||+|+.    .+++.||+|++.+..    ....+.+..|+.+++++ +||+|+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999975    368899999987531    22345678899999999 589999999999999999


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ++||||+++|+|.+++.... .+++.....++.|++.||+||   |++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHL---HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999987653 588999999999999999999   78999999999999999999999999999998754


Q ss_pred             CCCCcceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhh---------------hhHHHH
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AAKEQC  941 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~~~~~  941 (985)
                      .... ......+||+.|+|||.+.+. .++.++|+ |++|++++++++|..+.......               ..+...
T Consensus       157 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di-wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd05614         157 SEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDW-WSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFI  234 (332)
T ss_pred             ccCC-CccccccCCccccCHHHhcCCCCCCCcccc-ccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence            3222 222345799999999998765 47788999 99999999999998765421110               011124


Q ss_pred             HHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 001988          942 LLSIFSLALECTMESPEKRI-----DAKDTIT  968 (985)
Q Consensus       942 ~~~l~~l~~~cl~~~P~~RP-----t~~ev~~  968 (985)
                      +..+.+++.+|+..||++||     ++.++++
T Consensus       235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            56788999999999999999     6667764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2e-32  Score=304.41  Aligned_cols=225  Identities=24%  Similarity=0.245  Sum_probs=189.0

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||.||+|+.+ +++.||+|++.+..   ......+..|.++++.. +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 68899999987542   23345677888888876 699999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      |+|.+++...+ .+++..+..++.|++.||+||   |+++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~l---H~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS  154 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence            99999887654 688999999999999999999   78999999999999999999999999999987642222  1223


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHHHccCC
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLALECTME  955 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~~cl~~  955 (985)
                      ...||+.|+|||.+.+..++.++|+ |++|++++++++|..++.......           .+...+.++.+++.+|++.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~  233 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDW-WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTK  233 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccch-hhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccc
Confidence            4569999999999998899999999 999999999999987765432211           1122467789999999999


Q ss_pred             CCCCCCCH
Q 001988          956 SPEKRIDA  963 (985)
Q Consensus       956 ~P~~RPt~  963 (985)
                      ||.+||++
T Consensus       234 dP~~R~~~  241 (320)
T cd05590         234 NPTMRLGS  241 (320)
T ss_pred             CHHHCCCC
Confidence            99999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.9e-32  Score=295.81  Aligned_cols=244  Identities=22%  Similarity=0.398  Sum_probs=200.0

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CC---cEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DG---VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~---~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .+|+..+.||+|+||.||+|... ++   ..||+|.+.... .....++..|+.++++++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            35778899999999999999865 33   369999987552 23456789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++|+|.+++......+++.+++.++.|++.|++||   |++|++||||||+||+++.++.+|++|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~l---H~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            999999999999987666789999999999999999999   78999999999999999999999999999987664322


Q ss_pred             Ccceec-ccc--cccccccccccccCccchhhhcccccccchhhhcc-cccccCcch------------hhhhHHHHHHH
Q 001988          881 ESTMRT-QTL--ATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEK------------HFAAKEQCLLS  944 (985)
Q Consensus       881 ~~~~~~-~~~--gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~------------~~~~~~~~~~~  944 (985)
                      ...... ...  .+..|+|||.+..+.++.++|+ |++|+.++++++ +..+.....            ..+.+.+++..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv-wslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDV-WSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA  239 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhh-hhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence            211111 111  2457999999999999999999 999999999775 554432211            11123346778


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          945 IFSLALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       945 l~~l~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                      +.+++.+||..+|.+||++.+++..|+++
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         240 LHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            99999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2e-32  Score=299.50  Aligned_cols=242  Identities=24%  Similarity=0.375  Sum_probs=197.8

Q ss_pred             CccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          727 NFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      +|...+.||+|+||.||+|...      +++.||+|+++..... ....+.+|+.++++++||||+++++++.+.+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4666788999999999999853      3578999999755332 24568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc
Q 001988          800 VLEYMSNGSLEDCLHSS---------------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV  864 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~  864 (985)
                      ++||+++++|.+++...               ...+++..+.+++.|++.||+|+   |++||+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~l---H~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHcCccccccchhheEecCCCc
Confidence            99999999999998532               12478888999999999999999   7899999999999999999999


Q ss_pred             EEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh---------
Q 001988          865 AHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH---------  934 (985)
Q Consensus       865 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~---------  934 (985)
                      +||+|||+++...............+++.|+|||.+..+.++.++|+ |++|+.++++++ +..+......         
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDI-WSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN  241 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            99999999887643332222233446789999999998999999999 999999999987 4433222111         


Q ss_pred             ---hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 001988          935 ---FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       935 ---~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                         ...+.+++..+.+++.+||+.+|++||++.+++++|+.
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         242 RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence               01123467789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.8e-32  Score=295.94  Aligned_cols=249  Identities=21%  Similarity=0.316  Sum_probs=205.2

Q ss_pred             HhcCccCCceeeccCceeEEEEEEcC-----CcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeec-CCc
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLED-----GVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSN-DDF  796 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~  796 (985)
                      ..++|...+.||+|+||.||+|...+     +..||+|++..... .....+.+|+.++++++||||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35678889999999999999998765     68899998875432 335668899999999999999999998866 567


Q ss_pred             eEEEEeccCCCChHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 001988          797 KALVLEYMSNGSLEDCLHSSN-------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSD  869 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~D  869 (985)
                      .++++||+++|+|.+++....       ..+++.++..++.|++.||+||   |+.+++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL---HKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccCHhhEEEcCCCcEEECC
Confidence            899999999999999987542       4588999999999999999999   789999999999999999999999999


Q ss_pred             ccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------h
Q 001988          870 FGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------A  936 (985)
Q Consensus       870 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~  936 (985)
                      ||+++.+.............++..|+|||.+....++.++|+ |++|+.++++++ ++.+.......            .
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di-~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  239 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDV-WSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA  239 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhH-HHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence            999987643332222223346778999999988889999999 999999999997 66654322111            1


Q ss_pred             hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          937 AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       937 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      ....+++++.+++.+||+.+|++||++.++++.|..+.+.
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            1223567899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4e-32  Score=307.58  Aligned_cols=239  Identities=21%  Similarity=0.233  Sum_probs=193.4

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|+..+.||+|+||+||+|+.. +++.||+|++++..   ......+++|++++.+++||+|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47888999999999999999865 68899999997542   123356788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++|+|.+++...+ .+++.....++.|++.||+||   |++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~l---H~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSI---HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            9999999999998654 688999999999999999999   899999999999999999999999999999876532110


Q ss_pred             c---------------------------------ceecccccccccccccccccCccchhhhcccccccchhhhcccccc
Q 001988          882 S---------------------------------TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLL  928 (985)
Q Consensus       882 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~  928 (985)
                      .                                 ......+||+.|+|||.+.+..++.++|+ |++|++++++++|..+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~Dv-wSlGvil~ell~G~~P  235 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDW-WSLGVIMYEMLIGYPP  235 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhh-hhhHHHHHHHHhCCCC
Confidence            0                                 00123579999999999999999999999 9999999999999877


Q ss_pred             cCcchhhhh-------------H--HHHHHHHHHHHHHccC--CCCCCCCCHHHHHHH
Q 001988          929 SGEEKHFAA-------------K--EQCLLSIFSLALECTM--ESPEKRIDAKDTITR  969 (985)
Q Consensus       929 ~~~~~~~~~-------------~--~~~~~~l~~l~~~cl~--~~P~~RPt~~ev~~~  969 (985)
                      +........             +  ....++..+++.+++.  .++..||++.|+++.
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         236 FCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            643221110             0  0124566777776433  234467899999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.8e-32  Score=298.92  Aligned_cols=246  Identities=23%  Similarity=0.350  Sum_probs=201.9

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhc-CCCCeeeEEeeeecCC
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLVKIISSCSNDD  795 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~  795 (985)
                      ..++|...+.||+|+||.||+|...      ++..||+|.++.... ...+.+.+|+++++++ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            3457889999999999999999741      355799999875532 2345788999999999 7999999999999999


Q ss_pred             ceEEEEeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCce
Q 001988          796 FKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK  874 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~  874 (985)
                      ..++||||+++|+|.++++... ..+++.++..++.|++.|++||   |+.+|+||||||+||+++.++.+|++|||+++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999997643 3489999999999999999999   78999999999999999999999999999998


Q ss_pred             eccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh-------------hhHHH
Q 001988          875 LLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF-------------AAKEQ  940 (985)
Q Consensus       875 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~-------------~~~~~  940 (985)
                      .+.............++..|+|||.+..+.++.++|+ |++|+.++++++ +..+.......             ..+..
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-wslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  268 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV-WSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH  268 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHH-HHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCC
Confidence            7643322222223346788999999999999999999 999999999987 65543221110             01112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          941 CLLSIFSLALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                      .++++.+++.+|+.++|++||++.|+++.|+++
T Consensus       269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         269 APAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            457799999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.7e-32  Score=304.14  Aligned_cols=233  Identities=23%  Similarity=0.271  Sum_probs=191.5

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHH---hcCCCCeeeEEeeeecCCceEEE
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIK---NIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~---~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      |+..+.||+|+||.||+|... +++.||||++++..   ....+.+.+|++++.   +++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            566789999999999999865 78999999997542   223455667776654   56799999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++|+|..++...  .+++.....++.|++.||+||   |+.||+||||||+||++++++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~l---H~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYL---HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999999999888653  589999999999999999999   78999999999999999999999999999987543221


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLA  949 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~  949 (985)
                        ......+|++.|+|||.+.+..++.++|+ |++|+.++++++|..+........           .+...+..+.+++
T Consensus       156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~Di-wslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  232 (324)
T cd05589         156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDW-WGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIM  232 (324)
T ss_pred             --CcccccccCccccCHhHhcCCCCCcccch-hhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence              22334579999999999999999999999 999999999999987765432111           1123467789999


Q ss_pred             HHccCCCCCCCCC-----HHHHHH
Q 001988          950 LECTMESPEKRID-----AKDTIT  968 (985)
Q Consensus       950 ~~cl~~~P~~RPt-----~~ev~~  968 (985)
                      .+|+..||.+||+     +.++++
T Consensus       233 ~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         233 RRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             HHHhhcCHhHcCCCCCCCHHHHhh
Confidence            9999999999994     555554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.3e-32  Score=289.17  Aligned_cols=235  Identities=23%  Similarity=0.351  Sum_probs=195.4

Q ss_pred             ceeeccCceeEEEEEEcCCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCChH
Q 001988          732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLE  810 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  810 (985)
                      ++||+|+||.||+|..++++.||+|.++..... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            368999999999999888999999998765433 2346889999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceeccccc
Q 001988          811 DCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA  890 (985)
Q Consensus       811 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g  890 (985)
                      +++......+++..+..++.|++.||.|+   |++|++||||||+||++++++.+||+|||++........ .......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYL---ESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence            99987665689999999999999999999   789999999999999999999999999999876432211 11112234


Q ss_pred             ccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHHHHHHccCCCC
Q 001988          891 TIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFSLALECTMESP  957 (985)
Q Consensus       891 t~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~l~~~cl~~~P  957 (985)
                      +..|+|||++..+.++.++|+ |++|+.++++++ +..+.......            ..+..++..+.+++.+|+..+|
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di-~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  235 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDV-WSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP  235 (250)
T ss_pred             cccccCHHHhccCCCCchhHH-HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence            677999999998999999999 999999999987 55443221110            1122356789999999999999


Q ss_pred             CCCCCHHHHHHHHH
Q 001988          958 EKRIDAKDTITRLL  971 (985)
Q Consensus       958 ~~RPt~~ev~~~L~  971 (985)
                      ++||++.|+++.|.
T Consensus       236 ~~Rp~~~~l~~~l~  249 (250)
T cd05085         236 ENRPKFSELQKELA  249 (250)
T ss_pred             ccCCCHHHHHHHhc
Confidence            99999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-32  Score=293.99  Aligned_cols=248  Identities=23%  Similarity=0.365  Sum_probs=204.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCc----EEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGV----EIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ++|+..+.||+|+||.||+|..+ +|.    .||+|....... .....+.+|+.++++++||||+++++++.. +..++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            56788899999999999999864 333    589998876543 234678899999999999999999999987 77899


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++|+|.+++......+++.....++.|++.|++||   |+.+++||||||+||++++++.+||+|||.++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL---EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            9999999999999988766789999999999999999999   7899999999999999999999999999999876533


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIF  946 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~  946 (985)
                      ..........++..|+|||.+....++.++|+ |++|+.++++++ +..+.......            +.+..++..+.
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di-~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDV-WSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVY  241 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCchhhH-HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence            22222222234678999999988899999999 999999999997 66654432211            11222456788


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          947 SLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                      +++.+||..+|.+||++.++++.+.++.++..
T Consensus       242 ~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05057         242 MVLVKCWMIDAESRPTFKELINEFSKMARDPQ  273 (279)
T ss_pred             HHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence            99999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-32  Score=297.80  Aligned_cols=243  Identities=23%  Similarity=0.346  Sum_probs=200.9

Q ss_pred             hcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  797 (985)
                      .++|...+.||+|+||.||+|...      ++..||+|.+..... .....+.+|+.+++.++||||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            357888899999999999999864      246799999875532 3345788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 001988          798 ALVLEYMSNGSLEDCLHSSN---------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLS  868 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~  868 (985)
                      ++||||+++|+|.+++....         ..+++..+..++.|++.||+||   |+.+++||||||+||++++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999986531         2367889999999999999999   78999999999999999999999999


Q ss_pred             cccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcch------------hh
Q 001988          869 DFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEK------------HF  935 (985)
Q Consensus       869 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~------------~~  935 (985)
                      |||+++.+.............++..|+|||.+..+.++.++|+ |++|++++++++ +..+.....            ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDV-WSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL  240 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccch-HHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence            9999987643332222233456789999999998899999999 999999999997 555432211            11


Q ss_pred             hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 001988          936 AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLL  971 (985)
Q Consensus       936 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~  971 (985)
                      ..+..++.++.+++.+||..+|++|||+.++++.|+
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            123335788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.98  E-value=1.9e-32  Score=305.71  Aligned_cols=225  Identities=23%  Similarity=0.248  Sum_probs=187.3

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||.||+|+.. +++.||+|++++..   ......+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 68899999997642   22345678899988877 799999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      |+|.+++.... .+++..+..++.|++.||+||   |+++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cccc
Confidence            99999887653 688999999999999999999   78999999999999999999999999999987542221  1223


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcc-----hh---------------hhhHHHHHHHHH
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEE-----KH---------------FAAKEQCLLSIF  946 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~-----~~---------------~~~~~~~~~~l~  946 (985)
                      ...||+.|+|||.+.+..++.++|+ |++|++++++++|..+....     +.               ...+...+.++.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~  233 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDW-WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA  233 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccce-ecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHH
Confidence            4579999999999999999999999 99999999999998765311     00               001223456788


Q ss_pred             HHHHHccCCCCCCCCCH
Q 001988          947 SLALECTMESPEKRIDA  963 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~  963 (985)
                      +++.+|+..||++||++
T Consensus       234 ~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         234 SVLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHHhcCCHHHcCCC
Confidence            99999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.98  E-value=5.9e-32  Score=291.72  Aligned_cols=241  Identities=26%  Similarity=0.448  Sum_probs=200.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .++|++.+.||+|+||.||+|..+++..||+|.++.... ..+.+.+|+.++++++|++++++++++.. +..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence            357888899999999999999988888999999876533 34678999999999999999999998854 5678999999


Q ss_pred             CCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          805 SNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       805 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      ++++|.+++... ...+++.+++.++.|++.|++||   |+.+++||||||+||++++++.+||+|||++..+...... 
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI---ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence            999999999764 34589999999999999999999   7889999999999999999999999999999876432211 


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFSLAL  950 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~l~~  950 (985)
                      ......++..|+|||......++.++|+ |++|+.++++++ +..+.......            +.+...+..+.+++.
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDV-WSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELML  237 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhh-HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence            1222335678999999988899999999 999999999998 66544322111            112335678999999


Q ss_pred             HccCCCCCCCCCHHHHHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                      +|+.++|++||++.++.+.|++
T Consensus       238 ~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         238 QCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHcccCcccCcCHHHHHHHHhc
Confidence            9999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.98  E-value=7e-32  Score=293.42  Aligned_cols=242  Identities=26%  Similarity=0.400  Sum_probs=197.1

Q ss_pred             ccCCceeeccCceeEEEEEEc-C---CcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCc-----
Q 001988          728 FAENNIIGIGGFGSVYRARLE-D---GVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDF-----  796 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~---~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-----  796 (985)
                      |...+.||+|+||.||+|... +   +..||+|+++....  .....+.+|++++++++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            456788999999999999864 2   36799999875432  334678999999999999999999998866544     


Q ss_pred             -eEEEEeccCCCChHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 001988          797 -KALVLEYMSNGSLEDCLHSS-----NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDF  870 (985)
Q Consensus       797 -~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~Df  870 (985)
                       .++||||+++|+|.+++...     ...+++.....++.|++.||+||   |+.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCeeccccchheEEECCCCeEEECCc
Confidence             78999999999999988543     23578999999999999999999   7899999999999999999999999999


Q ss_pred             cCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhh
Q 001988          871 GMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAA  937 (985)
Q Consensus       871 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~  937 (985)
                      |+++.+.............++..|+|||.+....++.++|+ |++|++++|+++ +..+......            ...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv-~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  236 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDV-WAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ  236 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccch-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99987653332222222335678999999988889999999 999999999987 5554432211            112


Q ss_pred             HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          938 KEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       938 ~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                      +..++.++.+++.+||..+|++||++.|+++.|+++
T Consensus       237 ~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            234567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.98  E-value=1.9e-32  Score=305.88  Aligned_cols=230  Identities=22%  Similarity=0.229  Sum_probs=190.8

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||.||+|+.. +++.||+|++++...   ...+.+..|..+++++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999865 788999999976422   2345678899999998 799999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      |+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence            99999887653 689999999999999999999   79999999999999999999999999999987532111  1223


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcch-----hh---------------hhHHHHHHHHH
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK-----HF---------------AAKEQCLLSIF  946 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~-----~~---------------~~~~~~~~~l~  946 (985)
                      ..+||+.|+|||.+.+..++.++|+ |++|+.++++++|..++....     ..               ..+...+.++.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  233 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDW-WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAS  233 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccce-echHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence            4579999999999999999999999 999999999999987764210     00               01122456788


Q ss_pred             HHHHHccCCCCCCCCC------HHHHHH
Q 001988          947 SLALECTMESPEKRID------AKDTIT  968 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt------~~ev~~  968 (985)
                      +++.+|++.||.+||+      +.++++
T Consensus       234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         234 SVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            9999999999999997      566653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.98  E-value=2.9e-32  Score=302.51  Aligned_cols=229  Identities=21%  Similarity=0.247  Sum_probs=189.6

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||.||+|+.+ +++.||+|.++...   ......+..|.+++... +||+|+++++++.+.++.++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999875 78899999997542   22345567788888765 899999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      |+|.+++.... .+++.....++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFL---HSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence            99999987653 678999999999999999999   78999999999999999999999999999987532111  1233


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHHHHHHHHccCC
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSIFSLALECTME  955 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l~~l~~~cl~~  955 (985)
                      ..+||+.|+|||.+.+..++.++|+ |++|++++++++|..+.........           +..+..++.+++.+|+..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~Di-wslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  233 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDW-WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFER  233 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccch-hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccC
Confidence            4569999999999999999999999 9999999999999876544322111           112456788999999999


Q ss_pred             CCCCCCCHH-HHH
Q 001988          956 SPEKRIDAK-DTI  967 (985)
Q Consensus       956 ~P~~RPt~~-ev~  967 (985)
                      ||++||++. ++.
T Consensus       234 dP~~R~~~~~~~~  246 (316)
T cd05620         234 DPTRRLGVVGNIR  246 (316)
T ss_pred             CHHHcCCChHHHH
Confidence            999999985 444

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.98  E-value=6.8e-32  Score=291.28  Aligned_cols=241  Identities=25%  Similarity=0.415  Sum_probs=201.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .++|+..++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            467888999999999999999988899999999875533 3467899999999999999999999874 45689999999


Q ss_pred             CCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          805 SNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       805 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      ++++|.+++... +..+++.++..++.|++.||+||   |+.|++||||||+||++++++.++++|||++........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI---ERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-c
Confidence            999999998754 44688999999999999999999   889999999999999999999999999999987642221 1


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFSLAL  950 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~l~~  950 (985)
                      ......++..|+|||.+..+.++.++|+ |++|+.++++++ ++.+.......            +.+...+.++.+++.
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di-~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDV-WSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMR  237 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccch-HHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            2223346778999999988889999999 999999999997 77655422111            112234578999999


Q ss_pred             HccCCCCCCCCCHHHHHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                      +|+..+|++||+++++...|+.
T Consensus       238 ~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         238 LCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHccCChhhCCCHHHHHHHhhc
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.98  E-value=4.6e-32  Score=295.47  Aligned_cols=244  Identities=23%  Similarity=0.368  Sum_probs=198.6

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCc
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDF  796 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  796 (985)
                      .+++|...+.||+|+||.||+|.+.      .+..||+|.+...... ....+.+|+.++++++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3567888999999999999999875      3567999988654322 34568899999999999999999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC---cEEE
Q 001988          797 KALVLEYMSNGSLEDCLHSSN------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM---VAHL  867 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~---~~kl  867 (985)
                      .++||||+++++|.++++..+      ..+++..+.+++.||+.|++||   |+++++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL---EENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchheEEEeccCCCcceEe
Confidence            999999999999999997653      2588999999999999999999   789999999999999998765   6999


Q ss_pred             ecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh-----------
Q 001988          868 SDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF-----------  935 (985)
Q Consensus       868 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~-----------  935 (985)
                      +|||+++.+..............+..|+|||++.+..++.++|+ |++|++++++++ +..+.......           
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-wslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~  239 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDV-WSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR  239 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence            99999987633222111122234568999999999999999999 999999999886 66544322111           


Q ss_pred             -hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 001988          936 -AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLL  971 (985)
Q Consensus       936 -~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~  971 (985)
                       ..+..++.++.+++.+|++.+|++||++.++++.|.
T Consensus       240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence             112234578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.98  E-value=7e-32  Score=297.15  Aligned_cols=247  Identities=24%  Similarity=0.394  Sum_probs=200.5

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCc--EEEEEEeccCC-cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGV--EIAIKVFHPQC-ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~--~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv  800 (985)
                      ++|+..+.||+|+||.||+|..+ ++.  .+|+|.++... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            57888999999999999999865 333  47888887432 23346788999999999 799999999999999999999


Q ss_pred             EeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcE
Q 001988          801 LEYMSNGSLEDCLHSSN---------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  865 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~  865 (985)
                      |||+++|+|.+++....               ..+++.....++.|++.|++||   |++||+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCcCCcceEEECCCCeE
Confidence            99999999999997532               2478889999999999999999   78999999999999999999999


Q ss_pred             EEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh---------
Q 001988          866 HLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF---------  935 (985)
Q Consensus       866 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~---------  935 (985)
                      ||+|||++.....   .........+..|+|||.+....++.++|+ |++|+.++++++ +..++......         
T Consensus       159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-wSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~  234 (297)
T cd05089         159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDV-WSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  234 (297)
T ss_pred             EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence            9999999864321   111111223567999999988889999999 999999999986 65544322111         


Q ss_pred             ---hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          936 ---AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       936 ---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                         ..+..++.++.+++.+||+.+|.+||++.++++.++.+.+....
T Consensus       235 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence               11223567899999999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.98  E-value=4.9e-32  Score=296.50  Aligned_cols=245  Identities=25%  Similarity=0.392  Sum_probs=203.5

Q ss_pred             cCccCCceeeccCceeEEEEEEc-----CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeec--CCce
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-----DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSN--DDFK  797 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~  797 (985)
                      +.|+..+.||+|+||.||+|.+.     ++..||||.+...... ....+.+|++++++++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45677789999999999999854     4678999999866443 46789999999999999999999999977  5578


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ++||||+++++|.+++......+++..+..++.|++.||+||   |+.|++||||||+||+++.++.+||+|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL---GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            999999999999999987765789999999999999999999   78999999999999999999999999999998875


Q ss_pred             CCCCcc-eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh----------------------
Q 001988          878 GEDEST-MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH----------------------  934 (985)
Q Consensus       878 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~----------------------  934 (985)
                      ...... ......++..|+|||......++.++|+ |++|+.+++++++..+......                      
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di-~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDV-WSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccch-HHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            322211 1112335667999999988899999999 9999999999997754332110                      


Q ss_pred             -----hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhH
Q 001988          935 -----FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       935 -----~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~  974 (985)
                           .+.+..++.++.+++.+||+.+|.+||+|.|++++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence                 0112235678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.98  E-value=7e-32  Score=293.26  Aligned_cols=241  Identities=25%  Similarity=0.367  Sum_probs=193.2

Q ss_pred             cCCceeeccCceeEEEEEEcC-Cc--EEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecC------Cce
Q 001988          729 AENNIIGIGGFGSVYRARLED-GV--EIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSND------DFK  797 (985)
Q Consensus       729 ~~~~~ig~G~~g~V~~~~~~~-~~--~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~~~  797 (985)
                      ..++.||+|+||.||+|+..+ +.  .||+|.++...  ....+.+.+|++++++++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999998753 32  69999887542  23456788999999999999999999987432      246


Q ss_pred             EEEEeccCCCChHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccC
Q 001988          798 ALVLEYMSNGSLEDCLHSS-----NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGM  872 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGl  872 (985)
                      ++||||+++|+|.+++...     ...+++.....++.|++.||+||   |+++|+||||||+||++++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999887432     23578999999999999999999   789999999999999999999999999999


Q ss_pred             ceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHH
Q 001988          873 AKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKE  939 (985)
Q Consensus       873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~  939 (985)
                      ++.+.............+++.|+|||......++.+.|+ |++|+.++++++ ++.+.......            ..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di-~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDV-WSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP  237 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            987643332211222346778999999999999999999 999999999987 55543321110            1122


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          940 QCLLSIFSLALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       940 ~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                      .+++.+.+++.+||..+|++||++.++++.|+++
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            3567799999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.98  E-value=3.6e-32  Score=303.12  Aligned_cols=230  Identities=23%  Similarity=0.213  Sum_probs=191.6

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCC-CCeeeEEeeeecCCceEEEE
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRH-RNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~lv~  801 (985)
                      +|...+.||+|+||.||+|+.. +++.||+|++.+..   ....+.+..|.++++.++| ++|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999865 67889999987542   2334567889999999976 56888999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++|+|.+++.... .+++.....++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-  155 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence            9999999999987654 578899999999999999999   78999999999999999999999999999987532211 


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLAL  950 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~  950 (985)
                       ......+||+.|+|||++.+..++.++|+ |++|++++++++|+.+........           .+...+.++.+++.
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~  233 (324)
T cd05587         156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDW-WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICK  233 (324)
T ss_pred             -CceeeecCCccccChhhhcCCCCCcccch-hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence             12234569999999999999999999999 999999999999987764332111           12234567889999


Q ss_pred             HccCCCCCCCCCH
Q 001988          951 ECTMESPEKRIDA  963 (985)
Q Consensus       951 ~cl~~~P~~RPt~  963 (985)
                      +|+..+|.+||+.
T Consensus       234 ~~l~~~P~~R~~~  246 (324)
T cd05587         234 GLLTKHPAKRLGC  246 (324)
T ss_pred             HHhhcCHHHcCCC
Confidence            9999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.98  E-value=3.3e-32  Score=303.34  Aligned_cols=226  Identities=29%  Similarity=0.291  Sum_probs=186.5

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHH-HHHhcCCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECE-VIKNIRHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||+||+|+.. +++.||+|++.+..   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999975 78999999987542   122344555555 45778999999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      |+|.+++.... .+++.....++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYL---HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS  154 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence            99999987654 678889999999999999999   78999999999999999999999999999987542211  2233


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHHHccCC
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLALECTME  955 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~~cl~~  955 (985)
                      ..+||+.|+|||.+.+..++.++|+ |++|+.+++++++..++.......           .+...+.++.+++.+|++.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~Dv-wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~  233 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDW-WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQK  233 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccc-cccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence            4569999999999999999999999 999999999999887654322111           1122467789999999999


Q ss_pred             CCCCCCCHH
Q 001988          956 SPEKRIDAK  964 (985)
Q Consensus       956 ~P~~RPt~~  964 (985)
                      +|.+||++.
T Consensus       234 ~p~~R~~~~  242 (323)
T cd05575         234 DRTKRLGAK  242 (323)
T ss_pred             CHHhCCCCC
Confidence            999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.98  E-value=7e-32  Score=291.28  Aligned_cols=229  Identities=19%  Similarity=0.313  Sum_probs=187.0

Q ss_pred             ceeeccCceeEEEEEEcC-------------CcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          732 NIIGIGGFGSVYRARLED-------------GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~~-------------~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      +.||+|+||.||+|...+             ..+||+|.+..........+..|+.++++++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            358999999999997532             2358999887655445567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc-------EEEeccc
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV-------AHLSDFG  871 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~-------~kl~DfG  871 (985)
                      +||||+++|+|..++......+++..+.+++.||++|++||   |+++|+||||||+||+++.++.       +|++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL---EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHh---hhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            99999999999999887666789999999999999999999   8999999999999999987664       8999999


Q ss_pred             CceeccCCCCcceecccccccccccccccc-cCccchhhhcccccccchhhhc-ccccccCcchhhhh----------HH
Q 001988          872 MAKLLSGEDESTMRTQTLATIGYMAPDEIF-VGELSLKRWVNDLLPVSLVEVV-DKSLLSGEEKHFAA----------KE  939 (985)
Q Consensus       872 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~dv~~~~g~~~~~i~-~~~~~~~~~~~~~~----------~~  939 (985)
                      ++......      ....++..|+|||.+. ...++.++|+ |++|+.+++++ .+..+.........          ..
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Di-wslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~  230 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADK-WSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVT  230 (262)
T ss_pred             CCccccCc------ccccccccccChhhhcCCCCCCchhHH-HHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCC
Confidence            98765321      2235788999999886 4668889999 99999999997 45554332211110          00


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 001988          940 QCLLSIFSLALECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       940 ~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L  970 (985)
                      ...+++.+++.+||+.||.+||++.++++.+
T Consensus       231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         231 PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            1246789999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.98  E-value=9.4e-32  Score=289.46  Aligned_cols=235  Identities=23%  Similarity=0.364  Sum_probs=192.4

Q ss_pred             eeccCceeEEEEEEc---CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCCh
Q 001988          734 IGIGGFGSVYRARLE---DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSL  809 (985)
Q Consensus       734 ig~G~~g~V~~~~~~---~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  809 (985)
                      ||+|+||.||+|.+.   ++..||+|++...... ..+.+.+|+.++++++||||+++++++.. +..++||||+++|+|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence            899999999999764   4567999998765332 34568999999999999999999999864 467899999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce-eccc
Q 001988          810 EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM-RTQT  888 (985)
Q Consensus       810 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~-~~~~  888 (985)
                      .+++......+++.++.+++.|++.|++||   |++|++||||||+||+++.++.+||+|||++..+........ ....
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          82 NKFLSGKKDEITVSNVVELMHQVSMGMKYL---EGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            999987666789999999999999999999   789999999999999999999999999999986543322111 1122


Q ss_pred             ccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHHHHHHccCC
Q 001988          889 LATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFSLALECTME  955 (985)
Q Consensus       889 ~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~l~~~cl~~  955 (985)
                      .+++.|+|||.+....++.++|+ |++|++++++++ +..+.......            ..+..+++++.+++.+||..
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~  237 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSRSDV-WSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY  237 (257)
T ss_pred             CCCcccCCHHHHccCCCCchhhH-HHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            24578999999988889999999 999999999886 66554322111            11223567899999999999


Q ss_pred             CCCCCCCHHHHHHHHHHh
Q 001988          956 SPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       956 ~P~~RPt~~ev~~~L~~i  973 (985)
                      +|++||++.+|.+.|+.+
T Consensus       238 ~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         238 KWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             ChhhCcCHHHHHHHHhhh
Confidence            999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.98  E-value=4.8e-32  Score=296.35  Aligned_cols=240  Identities=26%  Similarity=0.387  Sum_probs=196.9

Q ss_pred             cCCceeeccCceeEEEEEE-----cCCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecC--CceEEE
Q 001988          729 AENNIIGIGGFGSVYRARL-----EDGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSND--DFKALV  800 (985)
Q Consensus       729 ~~~~~ig~G~~g~V~~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lv  800 (985)
                      +..+.||+|+||+||++..     .+++.||+|.++.... .....+.+|++++++++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            7889999999999988653     3678899999876532 2456788999999999999999999988653  457899


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++|+|.+++...  .+++.++..++.|++.|++||   |+++|+||||||+||++++++.+||+|||+++.+....
T Consensus        87 ~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          87 MEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYL---HSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             ecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHH---HHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            9999999999999764  489999999999999999999   78999999999999999999999999999998764322


Q ss_pred             Ccc-eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh---------------h---------
Q 001988          881 EST-MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH---------------F---------  935 (985)
Q Consensus       881 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~---------------~---------  935 (985)
                      ... ......++..|+|||.+....++.++|+ |++|+.+++++++..+....+.               .         
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di-~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKENKFSYASDV-WSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhcccCCCccccc-HHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence            211 1122335667999999988889999999 9999999999998654322110               0         


Q ss_pred             ---hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhH
Q 001988          936 ---AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       936 ---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~  974 (985)
                         +.+..++.++.+++.+||+.+|++||+++++++.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence               001224578999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.98  E-value=4.7e-32  Score=323.42  Aligned_cols=247  Identities=24%  Similarity=0.299  Sum_probs=202.0

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|...++||+|+||.||+|+.. +++.||+|+++....   ...+++.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57888999999999999999865 689999999975422   23457889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEeccc
Q 001988          802 EYMSNGSLEDCLHSS----------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFG  871 (985)
Q Consensus       802 e~~~~gsL~~~l~~~----------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfG  871 (985)
                      ||++||+|.+++...          ....++...++++.||++||+||   |++||+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yL---Hs~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV---HSKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHH---HHCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988642          12356678889999999999999   78999999999999999999999999999


Q ss_pred             CceeccCCCC----------------cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh
Q 001988          872 MAKLLSGEDE----------------STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF  935 (985)
Q Consensus       872 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~  935 (985)
                      +++.......                .......+||+.|||||.+.+..++.++|+ |++|+.++++++|..+.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDI-WSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDI-YALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHH-HHHHHHHHHHHHCCCCCCCcchh
Confidence            9987621110                011123469999999999999999999999 99999999999988765332110


Q ss_pred             h--------------hHHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHhHhh
Q 001988          936 A--------------AKEQCLLSIFSLALECTMESPEKRI-DAKDTITRLLKIRDT  976 (985)
Q Consensus       936 ~--------------~~~~~~~~l~~l~~~cl~~~P~~RP-t~~ev~~~L~~i~~~  976 (985)
                      .              .....+..+.+++.+|+..||++|| ++.++.+.++...+.
T Consensus       238 ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        238 KISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            0              1123456789999999999999996 677777778776553

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.98  E-value=3.8e-32  Score=294.54  Aligned_cols=238  Identities=22%  Similarity=0.317  Sum_probs=198.2

Q ss_pred             hcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++..........+++|+.++++++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35788999999999999999986 47889999999766545556788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +++++|.++++..+ .+++..+..++.|++.|++||   |+++|+|||+||+||++++++.+||+|||++..+....  .
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~  161 (267)
T cd06646          88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYL---HSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--A  161 (267)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCCEEECcCccceeecccc--c
Confidence            99999999987653 678999999999999999999   78999999999999999999999999999998763221  1


Q ss_pred             eecccccccccccccccc---cCccchhhhcccccccchhhhcccccccCcchh----------------hhhHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIF---VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH----------------FAAKEQCLLS  944 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~----------------~~~~~~~~~~  944 (985)
                      ......+++.|+|||.+.   ...++.++|+ |++|+.+++++++..+......                .......+.+
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dv-ws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDI-WAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST  240 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhH-HHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence            123346889999999874   4557788999 9999999999988764321110                0011234578


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          945 IFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       945 l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      +.+++++||..+|++||++.++++.
T Consensus       241 ~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         241 FHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhcC
Confidence            9999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.98  E-value=4.4e-32  Score=300.87  Aligned_cols=229  Identities=23%  Similarity=0.269  Sum_probs=189.5

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||.||+|+.. +++.||||+++...   ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 67899999997642   23345567788888765 899999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      |+|.+++.... .+++.+...++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~L---H~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFL---HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTC  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Ccee
Confidence            99999987643 678899999999999999999   78999999999999999999999999999987642211  1223


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHHHccCC
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLALECTME  955 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~~cl~~  955 (985)
                      ...||+.|+|||.+.+..++.++|+ |++|+.++++++|..+........           .+.....++.+++.+|+..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~Dv-wslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~  233 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDW-WSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVR  233 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhh-hhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhcc
Confidence            4569999999999999899999999 999999999999887654332111           1112456788999999999


Q ss_pred             CCCCCCCHH-HHH
Q 001988          956 SPEKRIDAK-DTI  967 (985)
Q Consensus       956 ~P~~RPt~~-ev~  967 (985)
                      +|++||++. ++.
T Consensus       234 ~P~~R~~~~~~l~  246 (316)
T cd05619         234 EPERRLGVKGDIR  246 (316)
T ss_pred             CHhhcCCChHHHH
Confidence            999999997 553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.98  E-value=6.6e-32  Score=299.14  Aligned_cols=236  Identities=20%  Similarity=0.297  Sum_probs=194.9

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ++|...+.||+|+||.||+|+.+ +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999865 678899999875432 2334677899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +++ ++.+++...+..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.......  
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  159 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC---HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--  159 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence            975 89888877666788999999999999999999   789999999999999999999999999999976532221  


Q ss_pred             eeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhh--------------------------
Q 001988          884 MRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--------------------------  936 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--------------------------  936 (985)
                      ......+++.|+|||.+.+ ..++.++|+ |++|++++++++|..++.......                          
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di-wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDM-WGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            1223457899999998865 457889999 999999999999886543221000                          


Q ss_pred             ---------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 ---------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 ---------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                     .....+.++.+++.+|+..||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence                           00113457789999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.98  E-value=7.5e-32  Score=297.65  Aligned_cols=245  Identities=25%  Similarity=0.403  Sum_probs=198.1

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCc--EEEEEEeccCC-cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGV--EIAIKVFHPQC-ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~--~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l  799 (985)
                      .++|+..+.||+|+||.||+|.++ ++.  .+|+|.++... ......+.+|++++.++ +||||+++++++.+++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357788899999999999999864 454  46888776432 23456788999999999 89999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc
Q 001988          800 VLEYMSNGSLEDCLHSSN---------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV  864 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~  864 (985)
                      ||||+++|+|.++++..+               ..+++.+++.++.|++.|++||   |++|++||||||+||++++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEecCCCc
Confidence            999999999999997542               2578899999999999999999   7899999999999999999999


Q ss_pred             EEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh--------
Q 001988          865 AHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF--------  935 (985)
Q Consensus       865 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~--------  935 (985)
                      +||+|||+++...   .........++..|+|||.+....++.++|+ |++|+.++++++ +..+.......        
T Consensus       163 ~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  238 (303)
T cd05088         163 AKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDV-WSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  238 (303)
T ss_pred             EEeCccccCcccc---hhhhcccCCCcccccCHHHHhccCCcccccc-hhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence            9999999986431   1111112234668999999988888999999 999999999997 55543221111        


Q ss_pred             ----hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          936 ----AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       936 ----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                          ..+..++.++.+++.+||+.+|++||++.++++.+..+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                11122457789999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.98  E-value=2.9e-32  Score=308.79  Aligned_cols=239  Identities=19%  Similarity=0.228  Sum_probs=197.5

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ..++|...+.||+|+||.||+|+.. +++.||+|++.+..   ......+.+|+++++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4567889999999999999999865 78899999986431   2234457889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++|+|.+++...  .+++.....++.|++.||+||   |++||+||||||+|||++.++.+||+|||+++.....
T Consensus       121 v~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999998754  477888889999999999999   7899999999999999999999999999999876432


Q ss_pred             CCcceecccccccccccccccccC----ccchhhhcccccccchhhhcccccccCcchhhh---------------hHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVG----ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQ  940 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~  940 (985)
                      .. ......+||+.|+|||.+...    .++.++|+ |++|+.++++++|..++.......               ....
T Consensus       196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di-wSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  273 (370)
T cd05596         196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW-WSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE  273 (370)
T ss_pred             Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceee-eehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCC
Confidence            21 122345699999999988653    47889999 999999999999987654432111               1112


Q ss_pred             HHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 001988          941 CLLSIFSLALECTMESPEK--RIDAKDTITR  969 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~~--RPt~~ev~~~  969 (985)
                      .+.++.+++.+|+..+|.+  ||++.|++..
T Consensus       274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            4678899999999999987  9999999653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=4.8e-32  Score=296.44  Aligned_cols=236  Identities=22%  Similarity=0.286  Sum_probs=197.3

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      +|+..+.||+|+||.||++... +++.||+|++.....   .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4777899999999999999864 789999999875422   123456789999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          803 YMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       803 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      |+++|+|.+++... ...+++..+..++.|++.|++||   |+.+|+||||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL---HRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            99999999988654 34689999999999999999999   789999999999999999999999999999987542221


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQCLLSIF  946 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~~~~~l~  946 (985)
                         .....|++.|+|||.+.+..++.++|+ |++|++++++++|..+........               .+...+..+.
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di-ws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd05605         158 ---IRGRVGTVGYMAPEVVKNERYTFSPDW-WGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR  233 (285)
T ss_pred             ---cccccCCCCccCcHHhcCCCCCccccc-hhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHH
Confidence               223468999999999998889999999 999999999999887665332110               1123567789


Q ss_pred             HHHHHccCCCCCCCC-----CHHHHHHH
Q 001988          947 SLALECTMESPEKRI-----DAKDTITR  969 (985)
Q Consensus       947 ~l~~~cl~~~P~~RP-----t~~ev~~~  969 (985)
                      +++.+||..||++||     ++.++++.
T Consensus       234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         234 SICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             HHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            999999999999999     78888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.98  E-value=8.8e-32  Score=295.44  Aligned_cols=235  Identities=24%  Similarity=0.344  Sum_probs=189.8

Q ss_pred             cCccCCceeeccCceeEEEEEEc--CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhc---CCCCeeeEEeeee-----c
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE--DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNI---RHRNLVKIISSCS-----N  793 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~--~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l---~h~niv~l~~~~~-----~  793 (985)
                      ++|...+.||+|+||.||+|+..  +++.||+|+++.....  ....+.+|+.+++++   +||||++++++|.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888899999999999999863  4688999998754322  234566788887766   6999999999985     2


Q ss_pred             CCceEEEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccC
Q 001988          794 DDFKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGM  872 (985)
Q Consensus       794 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGl  872 (985)
                      ....++||||++ ++|.+++... ...+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456889999996 6899998754 34588999999999999999999   789999999999999999999999999999


Q ss_pred             ceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh---------------
Q 001988          873 AKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA---------------  937 (985)
Q Consensus       873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~---------------  937 (985)
                      ++.....   .......||+.|+|||.+....++.++|+ |++|+.+++++++..+.........               
T Consensus       157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-wslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDL-WSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             eEeccCC---cccccccccccccChHHHhCCCCCCccch-HHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            9876432   22334568999999999988899999999 9999999999988765543211000               


Q ss_pred             -----------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 -----------------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 -----------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                             ....++.+.+++.+|++.||++||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                                   0113456689999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.98  E-value=9.7e-32  Score=291.48  Aligned_cols=245  Identities=23%  Similarity=0.441  Sum_probs=202.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CC---cEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DG---VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~---~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      .++|...+.||+|+||.||+|... ++   ..||+|.++... ....+.+.+|++++++++|||++++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            356778899999999999999864 33   369999987553 2335678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++++|.+++......+++.++..++.|++.|++||   |+.|++||||||+||++++++.+|++|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            9999999999999987666789999999999999999999   7899999999999999999999999999999876433


Q ss_pred             CCccee-cccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHH
Q 001988          880 DESTMR-TQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSI  945 (985)
Q Consensus       880 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l  945 (985)
                      ...... .....++.|+|||.+....++.+.|+ |++|+.++++++ +..+......            .+....++.++
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv-~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  239 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDV-WSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAV  239 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHH-HHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHH
Confidence            222111 11223567999999988889999999 999999999886 6655432211            11123356789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                      .+++.+||..+|++||++.++++.|.++
T Consensus       240 ~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         240 YQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            9999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.98  E-value=5.7e-32  Score=294.59  Aligned_cols=230  Identities=24%  Similarity=0.285  Sum_probs=190.9

Q ss_pred             eeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCCh
Q 001988          734 IGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSL  809 (985)
Q Consensus       734 ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  809 (985)
                      ||+|+||.||+++.+ +|+.||+|.+.....   .....+..|++++++++||||+++++++..+.+.++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999865 789999999864321   2234566799999999999999999999999999999999999999


Q ss_pred             HHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceeccc
Q 001988          810 EDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT  888 (985)
Q Consensus       810 ~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~  888 (985)
                      .+++... ...+++..+..++.|++.|++||   |+.||+||||||+||++++++.+||+|||++..+....   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHL---HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            9888654 33588999999999999999999   78999999999999999999999999999998764322   22334


Q ss_pred             ccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh----------------HHHHHHHHHHHHHHc
Q 001988          889 LATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA----------------KEQCLLSIFSLALEC  952 (985)
Q Consensus       889 ~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~----------------~~~~~~~l~~l~~~c  952 (985)
                      .|++.|+|||++....++.++|+ |++|+.+++++++..+.........                ....+.++.+++.+|
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Dv-wslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  233 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDW-FAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLF  233 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhH-HHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHH
Confidence            68999999999999999999999 9999999999998876543211000                012457789999999


Q ss_pred             cCCCCCCCCCHHHHHHHH
Q 001988          953 TMESPEKRIDAKDTITRL  970 (985)
Q Consensus       953 l~~~P~~RPt~~ev~~~L  970 (985)
                      ++.+|.+||++.|+++.+
T Consensus       234 L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         234 LAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             hccCHhhCCCCccchhhh
Confidence            999999999998766443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.98  E-value=4.2e-32  Score=301.62  Aligned_cols=230  Identities=24%  Similarity=0.242  Sum_probs=192.9

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||.||+|+.. +++.||||++++..   ......+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 67899999997542   23345677899999888 699999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      |+|.+++...+ .+++..+..++.|++.||+||   |+.+|+||||||+||++++++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFL---HERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTS  154 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cccc
Confidence            99999887654 689999999999999999999   79999999999999999999999999999987532222  1223


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHHHccCC
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLALECTME  955 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~~cl~~  955 (985)
                      ..+||+.|+|||.+.+..++.++|+ |++|+.++++++|..+........           .+..+++++.+++.+||..
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~Di-wslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~  233 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDW-WALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTK  233 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhh-hhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccC
Confidence            4569999999999999999999999 999999999999887654332111           1123567889999999999


Q ss_pred             CCCCCCCH-----HHHHH
Q 001988          956 SPEKRIDA-----KDTIT  968 (985)
Q Consensus       956 ~P~~RPt~-----~ev~~  968 (985)
                      ||++||++     .++++
T Consensus       234 dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         234 NPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CHHHcCCCCCCCHHHHhc
Confidence            99999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.98  E-value=3.9e-32  Score=296.34  Aligned_cols=229  Identities=25%  Similarity=0.270  Sum_probs=190.8

Q ss_pred             eeccCceeEEEEEEc-CCcEEEEEEeccCCcc---hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCCh
Q 001988          734 IGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSL  809 (985)
Q Consensus       734 ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  809 (985)
                      ||+|+||+||+|... +++.||+|.+......   ..+.+..|++++++++||||+++++++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999865 7889999998754222   235677899999999999999999999999999999999999999


Q ss_pred             HHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          810 EDCLHS---SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       810 ~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      .+++..   ....+++..+..++.|++.||+||   |+++|+||||||+||++++++.+||+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHL---HQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            988753   234689999999999999999999   789999999999999999999999999999987643221  223


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh---------------hhHHHHHHHHHHHHHH
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AAKEQCLLSIFSLALE  951 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~~~~~~~~l~~l~~~  951 (985)
                      ...||+.|+|||.+.+..++.++|+ |++|++++++++++.++......               ..++..++.+.+++.+
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~Dv-wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDY-FALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEA  234 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccH-HHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHH
Confidence            4568999999999999999999999 99999999999988765432110               0122356789999999


Q ss_pred             ccCCCCCCCC-----CHHHHHH
Q 001988          952 CTMESPEKRI-----DAKDTIT  968 (985)
Q Consensus       952 cl~~~P~~RP-----t~~ev~~  968 (985)
                      |++.||++||     ++.++++
T Consensus       235 ~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         235 LLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HhcCCHHHhcCCCCCCHHHHhc
Confidence            9999999999     6666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.98  E-value=1e-31  Score=289.23  Aligned_cols=238  Identities=28%  Similarity=0.424  Sum_probs=201.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .++|+..+.||+|+||.||+|... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            457888899999999999999875 78999999976643 5678899999999999999999999999889999999999


Q ss_pred             CCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          805 SNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       805 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      ++++|.+++.... ..+++..+..++.|++.|+.||   |+++++||||||+||+++.++.+||+|||.++.......  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL---EEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            9999999997653 3689999999999999999999   789999999999999999999999999999987632111  


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh------------hHHHHHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA------------AKEQCLLSIFSLAL  950 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~------------~~~~~~~~l~~l~~  950 (985)
                         ...++..|+|||.+..+.++.++|+ |++|+.++++++ +..+....+...            .+..+++++.+++.
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di-~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  233 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDV-WSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMK  233 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHH
Confidence               2235668999999988899999999 999999999986 655443322111            12235678999999


Q ss_pred             HccCCCCCCCCCHHHHHHHHHHh
Q 001988          951 ECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                      +|+..+|++||++.|++++|..+
T Consensus       234 ~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         234 DCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             HHhccChhhCcCHHHHHHHHhcC
Confidence            99999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.98  E-value=8e-32  Score=296.60  Aligned_cols=243  Identities=23%  Similarity=0.407  Sum_probs=196.7

Q ss_pred             cCccCCceeeccCceeEEEEEEc-----------------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-----------------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKI  787 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-----------------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l  787 (985)
                      ++|+..+.||+|+||.||++...                 +...||+|+++.... .....+.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56888999999999999998532                 244699999875532 335678999999999999999999


Q ss_pred             EeeeecCCceEEEEeccCCCChHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCE
Q 001988          788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSN----------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNV  857 (985)
Q Consensus       788 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Ni  857 (985)
                      ++++...+..++||||+++|+|.+++....          ..+++.+...++.|++.|++||   |+.|++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHH---HHCCeecccCChheE
Confidence            999999999999999999999999987542          2367788999999999999999   789999999999999


Q ss_pred             EEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc--cccccCcchh-
Q 001988          858 LLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD--KSLLSGEEKH-  934 (985)
Q Consensus       858 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~--~~~~~~~~~~-  934 (985)
                      ++++++.+||+|||+++.+.............+++.|+|||....+.++.++|+ |++|+.++++++  +..+...... 
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di-wSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDV-WAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhh-hHHHHHHHHHHHhCCCCCccccChH
Confidence            999999999999999987643222221222335678999999888899999999 999999999987  3333221110 


Q ss_pred             ------------------hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 001988          935 ------------------FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       935 ------------------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                                        .+.+..++..+.+++.+||+.+|++||++.|+.+.|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                              01112356789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.98  E-value=5.8e-32  Score=290.15  Aligned_cols=236  Identities=28%  Similarity=0.407  Sum_probs=196.9

Q ss_pred             ceeeccCceeEEEEEEcCCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCChH
Q 001988          732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLE  810 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  810 (985)
                      ++||+|+||.||+|...+++.||+|.+...... ....+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999999877999999998765443 4567899999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceeccccc
Q 001988          811 DCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA  890 (985)
Q Consensus       811 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g  890 (985)
                      +++......+++..+..++.+++.|++||   |+.+++||||||+||+++.++.+||+|||.++...............+
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~l---H~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYL---ESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            99987655788999999999999999999   889999999999999999999999999999986542221111112234


Q ss_pred             ccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHHHHHHHHccCCCC
Q 001988          891 TIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSIFSLALECTMESP  957 (985)
Q Consensus       891 t~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l~~l~~~cl~~~P  957 (985)
                      +..|+|||.+.++.++.++|+ |++|++++++++ +..+......            ...++.++.++.+++.+|+..+|
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di-~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  236 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDV-WSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP  236 (251)
T ss_pred             eeccCChHhhccCCCCcchhH-HHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence            667999999998899999999 999999999997 5544322110            11223456789999999999999


Q ss_pred             CCCCCHHHHHHHHH
Q 001988          958 EKRIDAKDTITRLL  971 (985)
Q Consensus       958 ~~RPt~~ev~~~L~  971 (985)
                      .+||++.|+++.|.
T Consensus       237 ~~Rp~~~ell~~l~  250 (251)
T cd05041         237 ENRPSFSEIYNELQ  250 (251)
T ss_pred             hhCcCHHHHHHHhh
Confidence            99999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.98  E-value=1.3e-31  Score=288.99  Aligned_cols=240  Identities=25%  Similarity=0.404  Sum_probs=199.3

Q ss_pred             cCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccC
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      ++|...+.||+|+||.||+|..+++..||+|.+.... ...+.+.+|++++++++|||++++++++.. +..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            5688889999999999999998777789999886543 234678899999999999999999998854 56789999999


Q ss_pred             CCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          806 NGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       806 ~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      +|+|.+++... ...+++..+..++.|+++||+||   |+.|++||||||+||++++++.+||+|||+++....... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI---ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence            99999999764 34578999999999999999999   789999999999999999999999999999987643221 12


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFSLALE  951 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~l~~~  951 (985)
                      .....++..|+|||......++.++|+ |++|++++++++ +..+.......            ..++..+..+.+++.+
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di-~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  238 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDV-WSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKL  238 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHH-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHH
Confidence            222346778999999988899999999 999999999998 66654332111            1123456789999999


Q ss_pred             ccCCCCCCCCCHHHHHHHHHH
Q 001988          952 CTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       952 cl~~~P~~RPt~~ev~~~L~~  972 (985)
                      ||..+|.+||++.++++.|++
T Consensus       239 ~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         239 CWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HccCCcccCcCHHHHHHHHhc
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.98  E-value=4.4e-32  Score=309.05  Aligned_cols=238  Identities=21%  Similarity=0.258  Sum_probs=194.1

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      .+|++.+.||+|+||.||+|+.. +++.||||++.+..   ......+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36888999999999999999864 78999999986532   123456789999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC-
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED-  880 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~-  880 (985)
                      ||+++|+|.+++...+ .+++.....++.||+.||+||   |++||+||||||+||+++.++.+||+|||+|..+.... 
T Consensus        81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            9999999999997654 578888889999999999999   78999999999999999999999999999985431000 


Q ss_pred             ----------------------------------------CcceecccccccccccccccccCccchhhhcccccccchh
Q 001988          881 ----------------------------------------ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLV  920 (985)
Q Consensus       881 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~  920 (985)
                                                              ........+||+.|||||++.+..++.++|+ |++|++++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlGvily  235 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW-WSVGVILY  235 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee-eeccceee
Confidence                                                    0000123469999999999999999999999 99999999


Q ss_pred             hhcccccccCcchhhhh---------------HHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 001988          921 EVVDKSLLSGEEKHFAA---------------KEQCLLSIFSLALECTMESPEKRI---DAKDTITR  969 (985)
Q Consensus       921 ~i~~~~~~~~~~~~~~~---------------~~~~~~~l~~l~~~cl~~~P~~RP---t~~ev~~~  969 (985)
                      ++++|+.++........               ....+.++.+++.+|+ .+|.+|+   ++.|++..
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99999876543321110               1123566788888876 5999999   88888754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.98  E-value=3.9e-32  Score=302.96  Aligned_cols=232  Identities=28%  Similarity=0.302  Sum_probs=188.9

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHH-HHHhcCCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECE-VIKNIRHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||.||+|+.. +|+.||+|++.+..   ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            36999999999999864 78999999987542   223345556655 46778999999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      |+|.+++.... .+++.....++.||+.||+||   |+.||+||||||+||++++++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~l---H~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYL---HSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTT  154 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcc
Confidence            99999887653 688999999999999999999   78999999999999999999999999999987532211  2233


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHHHHHHHHccCC
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSIFSLALECTME  955 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l~~l~~~cl~~  955 (985)
                      ..+||+.|+|||.+.+..++.++|+ |++|+.++++++|..+.........           ....+.++.+++.+|+..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~Dv-wslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~  233 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDW-WCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEK  233 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCcc-ccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhcc
Confidence            4569999999999999999999999 9999999999998876543321111           112456788999999999


Q ss_pred             CCCCCCCHHHHHHHH
Q 001988          956 SPEKRIDAKDTITRL  970 (985)
Q Consensus       956 ~P~~RPt~~ev~~~L  970 (985)
                      +|.+||++.+.++.+
T Consensus       234 ~p~~R~~~~~~~~~i  248 (325)
T cd05604         234 DRQRRLGAKEDFLEI  248 (325)
T ss_pred             CHHhcCCCCCCHHHH
Confidence            999999887544443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=9.5e-33  Score=302.52  Aligned_cols=238  Identities=21%  Similarity=0.350  Sum_probs=202.6

Q ss_pred             cCCceeeccCceeEEEEEEc----CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          729 AENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       729 ~~~~~ig~G~~g~V~~~~~~----~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ...++||+|.||.|++|.|.    +...||||.++..... ....|.+|+.+|.+++|||++++||+..+ ...+||||+
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            34578999999999999875    3346899999877554 67899999999999999999999999987 566799999


Q ss_pred             cCCCChHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHS-SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      ++.|+|.+++++ ....+-......++.|||.|+.||   .+++.||||+..+|+++.....|||+|||+.+.+...+..
T Consensus       192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YL---eskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYL---ESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            999999999998 455677788889999999999999   8999999999999999999999999999999998765544


Q ss_pred             ce-ecccccccccccccccccCccchhhhcccccccchhhhccccc-cc-C-----------cchhhhhHHHHHHHHHHH
Q 001988          883 TM-RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSL-LS-G-----------EEKHFAAKEQCLLSIFSL  948 (985)
Q Consensus       883 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~-~~-~-----------~~~~~~~~~~~~~~l~~l  948 (985)
                      .. .....-.+.|+|||.+....++-++|| |++|+.+|||+++.- ++ +           .....+.++.|++.++++
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDv-WmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~i  347 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRHRKFSHASDV-WMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQI  347 (1039)
T ss_pred             eEecCCCcCcccccCHhHhccccccccchh-hhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHH
Confidence            33 333345678999999999999999999 999999999998642 21 1           112344567799999999


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHH
Q 001988          949 ALECTMESPEKRIDAKDTITRLL  971 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~~L~  971 (985)
                      |..||..+|.+||++.++.+.+-
T Consensus       348 mk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  348 MKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             HHHhccCCccccccHHHHHHhHH
Confidence            99999999999999999985543

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.98  E-value=5.4e-32  Score=306.15  Aligned_cols=239  Identities=19%  Similarity=0.227  Sum_probs=195.6

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccC---CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ---CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|++.+.   .......+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            4578899999999999999999975 6889999998643   12234567899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++|+|.+++...  .+++.....++.|++.||+||   |+++|+||||||+|||+++++.+||+|||+|+.+...
T Consensus       121 v~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~L---H~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAI---HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            99999999999998754  478888999999999999999   7899999999999999999999999999999876432


Q ss_pred             CCcceecccccccccccccccccCc----cchhhhcccccccchhhhcccccccCcchhhh---------------hHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGE----LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQ  940 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~  940 (985)
                      .. ......+||+.|+|||.+....    ++.++|+ |++|++++++++|..++.......               ....
T Consensus       196 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~Di-wSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  273 (370)
T cd05621         196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW-WSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE  273 (370)
T ss_pred             Cc-eecccCCCCcccCCHHHHhccCCCCCCCcccCE-EeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCccc
Confidence            21 1223457999999999987543    6788999 999999999999987654332110               1112


Q ss_pred             HHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 001988          941 CLLSIFSLALECTMESPEK--RIDAKDTITR  969 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~~--RPt~~ev~~~  969 (985)
                      .+..+.+++..|+..+|.+  ||++.|+++.
T Consensus       274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            3566888999999755543  8899998875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.98  E-value=9.8e-32  Score=289.13  Aligned_cols=237  Identities=19%  Similarity=0.252  Sum_probs=200.4

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccC-CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ-CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      +|+..+.||.|+||.||++... +++.||+|.++.. .....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4777899999999999999865 7899999998643 2334567889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          805 SNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       805 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      ++|+|.+++... ...+++.....++.|++.|+.||   |++||+|+||||+||++++++.++++|||.+........  
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI---HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence            999999988753 44578999999999999999999   899999999999999999999999999999987643222  


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh------------hhHHHHHHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF------------AAKEQCLLSIFSLALE  951 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~------------~~~~~~~~~l~~l~~~  951 (985)
                      ......+++.|+|||.+....++.++|+ |++|+.+++++++..+.......            ..+..++..+.+++.+
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv-~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDI-WSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ  234 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhh-hhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence            2233568899999999988889999999 99999999999987765433211            1123356678999999


Q ss_pred             ccCCCCCCCCCHHHHHHH
Q 001988          952 CTMESPEKRIDAKDTITR  969 (985)
Q Consensus       952 cl~~~P~~RPt~~ev~~~  969 (985)
                      ||..+|++||++.+++.+
T Consensus       235 ~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         235 MFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHhCCcccCCCHHHHhhc
Confidence            999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.98  E-value=8.9e-33  Score=269.34  Aligned_cols=246  Identities=20%  Similarity=0.231  Sum_probs=203.1

Q ss_pred             HhcCccCCceeeccCceeEEEEE-EcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----Cce
Q 001988          724 ATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSND-----DFK  797 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~  797 (985)
                      ..++|.+.+.+|.|||+-||+++ ..++..||+|++.....++.+..++|++..++++|||++++++++..+     .+.
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            45688999999999999999998 568899999999888777788899999999999999999999987433     458


Q ss_pred             EEEEeccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCEEEcCCCcEEEecccC
Q 001988          798 ALVLEYMSNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGHSTP--IIHCDLKPSNVLLDEDMVAHLSDFGM  872 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~--ivHrDlk~~Nill~~~~~~kl~DfGl  872 (985)
                      |++++|...|+|.+.+...   +..+++.+.+.|+.++++||++|   |+..  ++||||||.||++.+++.+++.|||.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~l---H~~~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEAL---HEKEPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHH---hccCCcccccCCCcceeEecCCCceEEEeccC
Confidence            9999999999999998653   55789999999999999999999   6666  99999999999999999999999999


Q ss_pred             ceeccCCCCc-------ceecccccccccccccccc---cCccchhhhcccccccchhhhcccccccCcch---------
Q 001988          873 AKLLSGEDES-------TMRTQTLATIGYMAPDEIF---VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK---------  933 (985)
Q Consensus       873 a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~---------  933 (985)
                      ++...-.-..       ........|..|+|||.+.   ....+.+.|+ |++|+.+++++-+..++....         
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDI-WSLGCtLYa~mf~~sPfe~~~~~GgSlaLA  254 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDI-WSLGCTLYAMMFGESPFERIYQQGGSLALA  254 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccch-hhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence            8765321111       1122334789999999774   4556789999 999999999988765543221         


Q ss_pred             ------hhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          934 ------HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       934 ------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                            ..+.....++.+.++++.|+++||.+||++.+++.++...
T Consensus       255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                  1112223678899999999999999999999999998764

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.98  E-value=5.6e-32  Score=291.38  Aligned_cols=234  Identities=21%  Similarity=0.308  Sum_probs=192.8

Q ss_pred             eeeccCceeEEEEEEc---CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCC
Q 001988          733 IIGIGGFGSVYRARLE---DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNG  807 (985)
Q Consensus       733 ~ig~G~~g~V~~~~~~---~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  807 (985)
                      .||+|+||.||+|.++   ++..||+|+++....  ...+++.+|+.++++++||||+++++++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999753   678899999875432  235678999999999999999999999864 4678999999999


Q ss_pred             ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce-ec
Q 001988          808 SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM-RT  886 (985)
Q Consensus       808 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~-~~  886 (985)
                      +|.+++.... .+++....+++.|++.|++|+   |++||+||||||+||++++++.+||+|||+++.+........ ..
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYL---EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999997653 688999999999999999999   789999999999999999999999999999987643322111 12


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHHHHHHHHcc
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSIFSLALECT  953 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l~~l~~~cl  953 (985)
                      ...++..|+|||.+....++.++|+ |++|+.++++++ +..++.....            .+.+..++.++.+++.+||
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~  235 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDV-WSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCW  235 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHH-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHh
Confidence            2234678999999988888999999 999999999997 6655443211            1123346788999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHH
Q 001988          954 MESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       954 ~~~P~~RPt~~ev~~~L~~  972 (985)
                      +++|++||++.+|++.|+.
T Consensus       236 ~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         236 TYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             ccCchhCcCHHHHHHHHhc
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.98  E-value=1.1e-31  Score=290.86  Aligned_cols=243  Identities=25%  Similarity=0.329  Sum_probs=204.8

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|+..+.||+|+||.||+|... +++.||+|.++...   ....+.+.+|++++++++|++++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999976 89999999886432   223567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          802 EYMSNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       802 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      ||+++|+|.+++...   ...+++..+..++.+++.|++||   |+.||+||||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM---HSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988642   34578999999999999999999   789999999999999999999999999999887543


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh--------------hhhH-HHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH--------------FAAK-EQCLL  943 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~--------------~~~~-~~~~~  943 (985)
                      ...  ......+++.|+|||.+.+..++.++|+ |++|+.+++++++..+......              .+.+ +..+.
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDI-WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE  235 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcH-HHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCH
Confidence            221  1223458889999999998889999999 9999999999988765422110              0111 24566


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHHhH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~  974 (985)
                      .+.+++.+||..+|++||++.++++.++++.
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            8999999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.98  E-value=1.1e-31  Score=291.28  Aligned_cols=245  Identities=23%  Similarity=0.357  Sum_probs=202.3

Q ss_pred             cCccCCceeeccCceeEEEEEEcC----CcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLED----GVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      ++|...+.||+|+||.||+|...+    ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457788999999999999998643    3469999887654 3345678999999999999999999999875 457899


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++|+|.+++......+++..+..++.|++.|++|+   |+.+++||||||+||+++.++.+|++|||+++......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL---ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            999999999999987655689999999999999999999   78999999999999999999999999999998765332


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSIFS  947 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l~~  947 (985)
                      .. ......++..|+|||.+....++.++|+ |++|+.++++++ +..++.....            ...+..++.++.+
T Consensus       162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (270)
T cd05056         162 YY-KASKGKLPIKWMAPESINFRRFTSASDV-WMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  239 (270)
T ss_pred             ce-ecCCCCccccccChhhhccCCCCchhhh-HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence            21 1222335568999999988889999999 999999999875 6554332211            1122346788999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          948 LALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      ++.+|+.++|.+||++.++++.|.+++++
T Consensus       240 li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         240 LMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.98  E-value=4.7e-32  Score=297.29  Aligned_cols=244  Identities=25%  Similarity=0.409  Sum_probs=198.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  797 (985)
                      .++|+..+.||+|+||.||+|...      ++..||+|.+..... ....++.+|+.++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467888999999999999999863      467899999875532 2356788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 001988          798 ALVLEYMSNGSLEDCLHSSN---------------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSN  856 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~N  856 (985)
                      ++||||+++|+|.+++....                     ..+++..++.++.|++.||+||   |+++++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~l---H~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhCCeecccccHhh
Confidence            99999999999999987431                     2467888899999999999999   78999999999999


Q ss_pred             EEEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-ccccc-Ccchh
Q 001988          857 VLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLS-GEEKH  934 (985)
Q Consensus       857 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~-~~~~~  934 (985)
                      |++++++.+||+|||+++.+..............+..|+|||.+....++.++|+ |++|+.++++++ +..+. +....
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDV-WAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHH-HHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999886543222211222335678999999988999999999 999999999986 43222 11110


Q ss_pred             h-----------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 001988          935 F-----------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       935 ~-----------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                      .           ..++.++.++.+++.+|++.+|.+||++.|+++.|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            0           1123356789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.98  E-value=7.1e-32  Score=291.49  Aligned_cols=240  Identities=23%  Similarity=0.400  Sum_probs=193.2

Q ss_pred             ceeeccCceeEEEEEEc----CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeee-cCCceEEEEeccC
Q 001988          732 NIIGIGGFGSVYRARLE----DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCS-NDDFKALVLEYMS  805 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  805 (985)
                      +.||+|+||.||+|...    +...||+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    34579999986432 234567889999999999999999999875 4556789999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc--
Q 001988          806 NGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST--  883 (985)
Q Consensus       806 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~--  883 (985)
                      +|+|.+++.......++..+..++.|+++|++||   |+.+++||||||+||++++++.+||+|||+++.+.......  
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            9999999987655678888899999999999999   78999999999999999999999999999998654322111  


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhccc-ccccCcchh------------hhhHHHHHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDK-SLLSGEEKH------------FAAKEQCLLSIFSLAL  950 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~-~~~~~~~~~------------~~~~~~~~~~l~~l~~  950 (985)
                      ......++..|+|||.+....++.++|+ |++|+++++++++ ..+......            ...++.++..+.+++.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  236 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDV-WSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVML  236 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence            1122346778999999988899999999 9999999999885 333221110            1112234678999999


Q ss_pred             HccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          951 ECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                      +||..+|++||++.|+++.++++..
T Consensus       237 ~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         237 SCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             HHcCCChhhCCCHHHHHHHHHHHhc
Confidence            9999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.98  E-value=1.4e-31  Score=288.76  Aligned_cols=236  Identities=31%  Similarity=0.479  Sum_probs=200.4

Q ss_pred             ceeeccCceeEEEEEEcC----CcEEEEEEeccCCcch-HHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLED----GVEIAIKVFHPQCAST-LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~~----~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||.||+|...+    +..||+|.++...... .+.+.+|++++++++|+|++++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999998753    7889999998664433 67889999999999999999999999999999999999999


Q ss_pred             CChHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          807 GSLEDCLHSS--------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       807 gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      ++|.+++...        ...+++..+.+++.|++.|++||   |+++++||||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL---ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHH---HcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        46789999999999999999999   889999999999999999999999999999988754


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhccc-ccccCcchhh------------hhHHHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDK-SLLSGEEKHF------------AAKEQCLLSI  945 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~-~~~~~~~~~~------------~~~~~~~~~l  945 (985)
                      ...........+++.|+|||.+....++.++|+ |++|+++++++++ ..+.......            ..+..++.++
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDV-WSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDEL  236 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhcc-HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHH
Confidence            332223344557889999999988899999999 9999999999874 5443322111            1233456889


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHH
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLL  971 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~  971 (985)
                      .+++.+|+..+|.+||++.|+++.|+
T Consensus       237 ~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         237 YELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHHHHHccCCcccCcCHHHHHHhhC
Confidence            99999999999999999999998763

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.98  E-value=4.8e-32  Score=293.67  Aligned_cols=243  Identities=26%  Similarity=0.338  Sum_probs=203.7

Q ss_pred             cCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|+..+.||+|+||.||+|+. .+++.||||.+....   .....++.+|++++++++||||+++++++.+++..++||
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677889999999999999985 489999999886532   223457889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          802 EYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       802 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      ||+++++|.+++..   ....+++...+.++.|++.|++||   |+.|++|+||||+||+++.++.++++|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998864   234688999999999999999999   799999999999999999999999999999887643


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh---------------hhHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AAKEQCLL  943 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~~~~~~~  943 (985)
                      ...  ......++..|+|||.+.+..++.++|+ |++|+++++++++..+.......               ......++
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDI-WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE  235 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhH-HHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccH
Confidence            221  1233468899999999988889999999 99999999999987654322110               01123567


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHHhH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~  974 (985)
                      ++.+++.+||..+|.+||||.+|++.++++.
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            8999999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.98  E-value=9.5e-32  Score=299.59  Aligned_cols=230  Identities=23%  Similarity=0.224  Sum_probs=192.2

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEE
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      +|...+.||+|+||.||+|+.. +++.||+|++.+...   .....+..|..++..+ .|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999865 678999999875422   2334567788888877 5899999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++|+|.+++...+ .+++.++..++.|++.||+||   |++||+||||||+||++++++.+||+|||+++...... 
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-  155 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-  155 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence            9999999999987654 588999999999999999999   78999999999999999999999999999997643211 


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSIFSLAL  950 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l~~l~~  950 (985)
                       ......+||+.|+|||.+....++.++|+ |++|+.++++++|..+.........           +...+.++.+++.
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  233 (323)
T cd05616         156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDW-WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK  233 (323)
T ss_pred             -CccccCCCChhhcCHHHhcCCCCCCccch-hchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence             12334569999999999999999999999 9999999999999877654322111           1234577899999


Q ss_pred             HccCCCCCCCCCH
Q 001988          951 ECTMESPEKRIDA  963 (985)
Q Consensus       951 ~cl~~~P~~RPt~  963 (985)
                      +|++.+|.+|+++
T Consensus       234 ~~l~~~p~~R~~~  246 (323)
T cd05616         234 GLMTKHPGKRLGC  246 (323)
T ss_pred             HHcccCHHhcCCC
Confidence            9999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.98  E-value=1.6e-31  Score=287.64  Aligned_cols=236  Identities=28%  Similarity=0.393  Sum_probs=196.4

Q ss_pred             cCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeee-cCCceEEEEecc
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS-NDDFKALVLEYM  804 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~-~~~~~~lv~e~~  804 (985)
                      ++|...+.||+|+||.||+|..+ +..||+|.++..  ...+.+.+|+.++++++|+|++++++++. .++..++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888899999999999999875 788999998644  23467889999999999999999999764 556789999999


Q ss_pred             CCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          805 SNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       805 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      ++++|.+++.... ..+++....+++.|++.||+||   |++|++||||||+||++++++.+|++|||+++......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            9999999998653 3478999999999999999999   78999999999999999999999999999988653221   


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFSLAL  950 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~l~~  950 (985)
                        ....++..|+|||++....++.++|+ |++|++++++++ ++.+.......            ..++.++..+.+++.
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv-~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  233 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDV-WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMK  233 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhh-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence              12235678999999988889999999 999999999986 66543322111            112235678999999


Q ss_pred             HccCCCCCCCCCHHHHHHHHHHh
Q 001988          951 ECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                      +|++.+|++||++.++++.|+++
T Consensus       234 ~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         234 QCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHhcCChhhCcCHHHHHHHHhcC
Confidence            99999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.1e-33  Score=303.39  Aligned_cols=235  Identities=23%  Similarity=0.318  Sum_probs=204.1

Q ss_pred             ccCCceeeccCceeEEEEEEcC-CcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          728 FAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      |.+...+|.|+||.||+|..++ +...|.|++..+.......+.-||+||..+.||+||++++.|...+..+|..|||+|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            4455679999999999998763 445688888877777888999999999999999999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      |-....+-.-+..+++.++.-+++|++.||.||   |+.+|||||+|+-|||++-+|.++|+|||.+....  .......
T Consensus       114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~L---Hs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRD  188 (1187)
T KOG0579|consen  114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWL---HSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRD  188 (1187)
T ss_pred             chHhHHHHHhccccchHHHHHHHHHHHHHHHHH---hhcchhhhhccccceEEEecCcEeeecccccccch--hHHhhhc
Confidence            999988888788899999999999999999999   89999999999999999999999999999875432  2333456


Q ss_pred             ccccccccccccccc-----cCccchhhhcccccccchhhhcccccccCcc--------------hhhhhHHHHHHHHHH
Q 001988          887 QTLATIGYMAPDEIF-----VGELSLKRWVNDLLPVSLVEVVDKSLLSGEE--------------KHFAAKEQCLLSIFS  947 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~-----~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~--------------~~~~~~~~~~~~l~~  947 (985)
                      .+.|||+|||||+++     +.+|.+++|+ |++|+.+.||...+.+....              |..-++..+...+.+
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDi-WSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D  267 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADI-WSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD  267 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhH-HhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence            778999999999875     6789999999 99999999999887655433              233355667888999


Q ss_pred             HHHHccCCCCCCCCCHHHHHH
Q 001988          948 LALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ++.+|+..+|..||++.++++
T Consensus       268 fLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  268 FLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHHHHHhcCCccCCCHHHHhh
Confidence            999999999999999999875

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.98  E-value=1.1e-31  Score=288.73  Aligned_cols=237  Identities=23%  Similarity=0.262  Sum_probs=201.7

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccC--CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +|...+.||+|+||.||+|... +++.||+|.+...  .......+.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677789999999999999865 7899999998654  233456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      +++++|.+++... ...+++..+..++.|++.|+.||   |+.|++||||||+||+++.++.+||+|||+++.+..... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL---HSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999999875 45788999999999999999999   789999999999999999999999999999987653322 


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh------------hhHHHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF------------AAKEQCLLSIFSLAL  950 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~------------~~~~~~~~~l~~l~~  950 (985)
                       ......|++.|+|||+...+.++.++|+ |++|+++++++++..+.......            ..+...+.++.+++.
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDV-WALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLID  234 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccch-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHH
Confidence             1233468899999999999999999999 99999999999988765433211            112245678999999


Q ss_pred             HccCCCCCCCCCHHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~  969 (985)
                      +||+.+|++||++.++++.
T Consensus       235 ~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         235 QCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             HHccCCcccCcCHHHHhhC
Confidence            9999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.98  E-value=9.2e-32  Score=297.02  Aligned_cols=249  Identities=22%  Similarity=0.372  Sum_probs=202.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCc----EEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGV----EIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      .++|+..+.||+|+||.||+|.+. ++.    .||+|.+...... ...++.+|+.++++++||||++++++|... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356778899999999999999864 444    5799988755332 234688999999999999999999998764 467


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +++||+++|+|.+++......+++..+..++.|++.||+||   |+++|+||||||+||++++++.+||+|||+++.+..
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---hhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            89999999999999987766788999999999999999999   789999999999999999999999999999987654


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSI  945 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l  945 (985)
                      ...........++..|+|||.+.+..++.++|+ |++|++++++++ +..+....+..            +.+..++..+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di-wslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDV-WSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV  240 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHH-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence            332222233346778999999988999999999 999999999886 44443221110            1112245678


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                      .+++.+||..+|++||++.++++.+.++.++..
T Consensus       241 ~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         241 YMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence            999999999999999999999999999876544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.98  E-value=1.4e-31  Score=288.19  Aligned_cols=239  Identities=25%  Similarity=0.373  Sum_probs=199.7

Q ss_pred             cCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccC
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      .+|+..+.||+|+||.||+|.+.+++.+|+|.+..... ....+.+|++++++++||+++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46777899999999999999987788999998875432 34678999999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCccee
Q 001988          806 NGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR  885 (985)
Q Consensus       806 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~  885 (985)
                      +++|.+++......+++..+..++.|++.|++||   |+.+++||||||+||+++.++.+||+|||.++....... ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~  158 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL---ESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-ccc
Confidence            9999999987655788999999999999999999   789999999999999999999999999999887542211 111


Q ss_pred             cccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh------------hHHHHHHHHHHHHHHc
Q 001988          886 TQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA------------AKEQCLLSIFSLALEC  952 (985)
Q Consensus       886 ~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~------------~~~~~~~~l~~l~~~c  952 (985)
                      ....++.+|+|||.+..+.++.++|+ |++|+.++++++ +..+........            .+...++.+.+++.+|
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv-~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  237 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDV-WSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHC  237 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHH-HHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence            22335678999999998899999999 999999999987 665543221111            1112467799999999


Q ss_pred             cCCCCCCCCCHHHHHHHH
Q 001988          953 TMESPEKRIDAKDTITRL  970 (985)
Q Consensus       953 l~~~P~~RPt~~ev~~~L  970 (985)
                      |..+|++||++.|+++.|
T Consensus       238 l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         238 WKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             cccChhhCCCHHHHHHhh
Confidence            999999999999999886

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.98  E-value=6e-32  Score=308.51  Aligned_cols=236  Identities=20%  Similarity=0.281  Sum_probs=191.8

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .|...+.||+|+||.||+|+.. +++.||+|++.+..   ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788899999999999999864 78899999987542   2234568899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC-
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-  881 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~-  881 (985)
                      |+++|+|.+++...+ .+++.....++.|++.||+||   |++||+||||||+|||++.++.+||+|||+|+.+..... 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~l---H~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            999999999987653 578888899999999999999   789999999999999999999999999999754321000 


Q ss_pred             --------------------------------------------cceecccccccccccccccccCccchhhhccccccc
Q 001988          882 --------------------------------------------STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPV  917 (985)
Q Consensus       882 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~  917 (985)
                                                                  .......+||+.|+|||++.+..++.++|+ |++|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di-wSlGv  236 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW-WSVGV  236 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE-EechH
Confidence                                                        000123469999999999999999999999 99999


Q ss_pred             chhhhcccccccCcchhhh---------------hHHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 001988          918 SLVEVVDKSLLSGEEKHFA---------------AKEQCLLSIFSLALECTMESPEKRID---AKDTIT  968 (985)
Q Consensus       918 ~~~~i~~~~~~~~~~~~~~---------------~~~~~~~~l~~l~~~cl~~~P~~RPt---~~ev~~  968 (985)
                      +++++++|..++.......               ......++..+++.+++ .+|.+|++   +.|+++
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            9999999987765332111               01123566777787776 49999997   777654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.98  E-value=1.2e-31  Score=300.48  Aligned_cols=247  Identities=25%  Similarity=0.371  Sum_probs=201.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc--------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE--------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLVKIISSCSND  794 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~  794 (985)
                      ..+|.+.+.||+|+||.||+|+..        ++..||+|.++.... ...+++.+|+++++++ +||||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            356888999999999999999742        123689998875432 2356789999999999 799999999999999


Q ss_pred             CceEEEEeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSN---------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL  859 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill  859 (985)
                      +..++||||+++|+|.+++....               ..+++.++..++.|+++||+||   |++|++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---HHCCeeccccccceEEE
Confidence            99999999999999999987531               2478889999999999999999   78999999999999999


Q ss_pred             cCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh---
Q 001988          860 DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF---  935 (985)
Q Consensus       860 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~---  935 (985)
                      ++++.+||+|||+++...............++..|+|||.+....++.++|+ |++|++++++++ +..+....+..   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~el~~~g~~p~~~~~~~~~~  246 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV-WSFGVLLWEIFTLGGSPYPGIPVEELF  246 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhh-HHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            9999999999999987643322222222334578999999999999999999 999999999987 54433221111   


Q ss_pred             ---------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          936 ---------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       936 ---------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                               +.+..++.++.+++.+||+.+|++||++.|+++.|+++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         247 KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence                     1122346789999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.98  E-value=7.9e-32  Score=290.93  Aligned_cols=243  Identities=27%  Similarity=0.455  Sum_probs=204.0

Q ss_pred             HhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ..++|...+.||+|+||.||+|..++++.||||.+.... ...+++.+|+.++++++|+||+++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            356788999999999999999998888899999987553 3456789999999999999999999999998899999999


Q ss_pred             cCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      +++++|.+++.... ..+++.++..++.|++.|++||   |+.+++||||||+||++++++.+|++|||.++.+.... .
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~l---h~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~  158 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL---ESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-Y  158 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcchheEEEcCCCCEEECccccceeccchh-h
Confidence            99999999998653 4689999999999999999999   78999999999999999999999999999998764321 1


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFSLA  949 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~l~  949 (985)
                      ........+..|+|||.+.+..++.++|+ |++|+.++++++ +..+.......            ..+..++.++.+++
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di-~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDV-WSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLM  237 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHH-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            11122234568999999998889999999 999999999997 66654322111            11223467899999


Q ss_pred             HHccCCCCCCCCCHHHHHHHHHH
Q 001988          950 LECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                      .+|+..+|.+||++.++.+.|+.
T Consensus       238 ~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         238 LQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHcccCcccCCCHHHHHHHHhc
Confidence            99999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.98  E-value=1.4e-31  Score=288.32  Aligned_cols=235  Identities=23%  Similarity=0.351  Sum_probs=196.8

Q ss_pred             ceeeccCceeEEEEEEcC--C--cEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLED--G--VEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~~--~--~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||.||+|.+.+  +  ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998642  2  3699999987755 456788999999999999999999999988 888999999999


Q ss_pred             CChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc-e
Q 001988          807 GSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST-M  884 (985)
Q Consensus       807 gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~  884 (985)
                      |+|.+++.... ..+++.....++.|++.||+||   |+++++||||||+||+++.++.+||+|||+++.+....... .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL---ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHH---HhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999998764 5689999999999999999999   78999999999999999999999999999998875432221 1


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh-------------hhHHHHHHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF-------------AAKEQCLLSIFSLAL  950 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~-------------~~~~~~~~~l~~l~~  950 (985)
                      .....++..|+|||.+....++.++|+ |++|++++++++ |..+.......             ..++..+..+.+++.
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di-~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDV-WMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML  235 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhh-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHH
Confidence            223457789999999998899999999 999999999997 66654221111             112235678999999


Q ss_pred             HccCCCCCCCCCHHHHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTITRLL  971 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~L~  971 (985)
                      +|++.+|++||++.|+++.|.
T Consensus       236 ~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         236 QCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HHCCCCcccCCCHHHHHHHhc
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.98  E-value=1.4e-31  Score=294.18  Aligned_cols=238  Identities=24%  Similarity=0.314  Sum_probs=200.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .+.|+..+.||+|+||.||+|+.. +++.||+|.+..........+.+|++++++++||||+++++++..++..++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            367888899999999999999875 6889999999876555667889999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +++++|..++......+++..+..++.|++.|++||   |+.+++||||||+||+++.++.+||+|||++......  ..
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~  165 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL---HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ  165 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hcCCeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence            999999998876656789999999999999999999   8899999999999999999999999999998764322  11


Q ss_pred             eecccccccccccccccc-----cCccchhhhcccccccchhhhcccccccCcchhh--------------hhHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIF-----VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQCLLS  944 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~~~~  944 (985)
                      ......+++.|+|||.+.     ...++.++|+ |++|+.+++++++..+.......              ..+..++.+
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv-~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADI-WSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME  244 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhh-HhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHH
Confidence            123345888999999884     3456778999 99999999999988765432110              112234567


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHH
Q 001988          945 IFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       945 l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +.+++.+||+.+|++||++.|+++
T Consensus       245 ~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         245 FRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhc
Confidence            899999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.98  E-value=6.8e-32  Score=301.05  Aligned_cols=231  Identities=28%  Similarity=0.276  Sum_probs=187.8

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHH-HHHhcCCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECE-VIKNIRHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999865 67889999987542   122234444444 56778999999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      |+|.+++...+ .+.+.....++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~  154 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTS  154 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcc
Confidence            99999997654 567888888999999999999   78999999999999999999999999999997643222  1233


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHHHccCC
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLALECTME  955 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~~cl~~  955 (985)
                      ..+||+.|+|||++.+..++.++|+ |++|+.+++++++..++.......           .....+..+.+++.+|++.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~  233 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDW-WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQK  233 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCcccc-ccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHccc
Confidence            4569999999999999999999999 999999999999987654332111           1123567789999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 001988          956 SPEKRIDAKDTITR  969 (985)
Q Consensus       956 ~P~~RPt~~ev~~~  969 (985)
                      +|.+||++.+.+..
T Consensus       234 ~p~~R~~~~~~~~~  247 (325)
T cd05602         234 DRTKRLGAKDDFME  247 (325)
T ss_pred             CHHHCCCCCCCHHH
Confidence            99999998754443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=1.1e-31  Score=293.46  Aligned_cols=236  Identities=22%  Similarity=0.318  Sum_probs=197.8

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      |+..+.||+|+||.||+|... ++..+|+|.+..........+.+|+++++.++|||++++++++...+..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            566788999999999999865 6788999998766555567788999999999999999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      ++|..++......+++..+..++.|+++||+||   |+.|++||||||+||+++.++.+||+|||++.......  ....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~L---H~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~  161 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYL---HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD  161 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence            999998876555789999999999999999999   78999999999999999999999999999987653221  1223


Q ss_pred             ccccccccccccccc-----cCccchhhhcccccccchhhhcccccccCcchhh--------------hhHHHHHHHHHH
Q 001988          887 QTLATIGYMAPDEIF-----VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQCLLSIFS  947 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~-----~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~~~~l~~  947 (985)
                      ...+++.|+|||.+.     ...++.++|+ |++|+++++++++..+.......              ..+..++.++.+
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv-~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADV-WSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD  240 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchh-hhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence            456899999999874     4557788999 99999999999988665432111              112235678999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHH
Q 001988          948 LALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      ++.+||+.+|.+||++.++++.
T Consensus       241 li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         241 FLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             HHHHHccCChhhCcCHHHHhcC
Confidence            9999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.97  E-value=1.1e-31  Score=295.11  Aligned_cols=236  Identities=25%  Similarity=0.327  Sum_probs=201.4

Q ss_pred             cCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          726 DNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .+|...+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.++++++|||++++++++....+.++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            4688889999999999999985 478999999998765556677899999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      ++++|.+++...  .+++.++..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||++........  .
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~L---H~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~  172 (296)
T cd06654         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  172 (296)
T ss_pred             CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--c
Confidence            999999998754  478899999999999999999   789999999999999999999999999999876532221  1


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh--------------hhhHHHHHHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH--------------FAAKEQCLLSIFSLAL  950 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~--------------~~~~~~~~~~l~~l~~  950 (985)
                      .....+++.|+|||.+.+..++.++|+ |++|+.++++++++.++.....              ...++..+..+.+++.
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv-~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  251 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAYGPKVDI-WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (296)
T ss_pred             cCcccCCccccCHHHHcCCCCCccchH-HHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence            223468899999999988889999999 9999999999998876533211              0112345577899999


Q ss_pred             HccCCCCCCCCCHHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~  969 (985)
                      +||.++|++||++.|+++.
T Consensus       252 ~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         252 RCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             HHCcCCcccCcCHHHHhhC
Confidence            9999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=1.2e-31  Score=290.80  Aligned_cols=241  Identities=29%  Similarity=0.359  Sum_probs=199.3

Q ss_pred             HHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          722 LRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       722 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      +.+++++.....||+|+||.||+|... +++.||+|.+........+.+.+|++++++++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            345666777789999999999999854 6788999998876656667899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-CCcEEEecccCceecc
Q 001988          801 LEYMSNGSLEDCLHSSNCAL--NIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHLSDFGMAKLLS  877 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~--~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~-~~~~kl~DfGla~~~~  877 (985)
                      |||+++++|.+++......+  ++..+..++.|++.|++||   |++||+||||||+||+++. ++.+||+|||.+..+.
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYL---HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99999999999998754445  7888889999999999999   7899999999999999976 6799999999988764


Q ss_pred             CCCCcceecccccccccccccccccCc--cchhhhcccccccchhhhcccccccCcchhh--------------hhHHHH
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFVGE--LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQC  941 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~  941 (985)
                      ....  ......+++.|+|||.+....  ++.++|+ |++|+++++++++..+.......              ..+..+
T Consensus       161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv-~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06624         161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADI-WSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESL  237 (268)
T ss_pred             cCCC--ccccCCCCccccChhhhccccccCCchhhh-HHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCccc
Confidence            3221  122335889999999986544  6789999 99999999999987664322110              112235


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          942 LLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       942 ~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+++.+++.+||..+|++||++.|+++
T Consensus       238 ~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         238 SAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             CHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            577899999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=1.6e-31  Score=290.51  Aligned_cols=228  Identities=21%  Similarity=0.331  Sum_probs=183.5

Q ss_pred             eeeccCceeEEEEEEc-------------------------CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeE
Q 001988          733 IIGIGGFGSVYRARLE-------------------------DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKI  787 (985)
Q Consensus       733 ~ig~G~~g~V~~~~~~-------------------------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l  787 (985)
                      .||+|+||.||+|...                         ....||+|++..........+.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            5899999999999742                         123589999876544445678889999999999999999


Q ss_pred             EeeeecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC----
Q 001988          788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM----  863 (985)
Q Consensus       788 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~----  863 (985)
                      ++++.+....++||||+++|+|..++......+++..+.+++.|+++||+||   |+++|+||||||+||++++.+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYL---EDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999987666789999999999999999999   789999999999999997654    


Q ss_pred             ---cEEEecccCceeccCCCCcceeccccccccccccccccc-Cccchhhhcccccccchhhhc-ccccccCcchhhh--
Q 001988          864 ---VAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVV-DKSLLSGEEKHFA--  936 (985)
Q Consensus       864 ---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~-~~~~~~~~~~~~~--  936 (985)
                         .+|++|||.+......      ....++..|+|||.+.+ ..++.++|+ |++|+.+++++ ++..+........  
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv-~slG~~l~el~~~g~~p~~~~~~~~~~  231 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADK-WSFGTTLLEICFDGEVPLKERTPSEKE  231 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHH-HHHHHHHHHHHhCCCCCccccChHHHH
Confidence               4899999987654211      12347788999998865 567899999 99999999984 5554432211110  


Q ss_pred             --------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 001988          937 --------AKEQCLLSIFSLALECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       937 --------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L  970 (985)
                              .++....++.+++.+||..+|++||++.++++.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         232 RFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence                    0111235689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-31  Score=298.02  Aligned_cols=239  Identities=21%  Similarity=0.241  Sum_probs=194.4

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccC---CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ---CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++.+.   .....+.+.+|+.+++.++|+||+++++++.++++.++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999865 6889999998742   1223456889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++|+|.+++......+++..+..++.||+.||+||   |+++|+||||||+||+++.++.+||+|||++..+.....
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV---HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            99999999999987656788999999999999999999   899999999999999999999999999999977643222


Q ss_pred             cceeccccccccccccccccc-----CccchhhhcccccccchhhhcccccccCcchhhh----------------hHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFV-----GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA----------------AKEQ  940 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~----------------~~~~  940 (985)
                       .......||+.|+|||++..     +.++.++|+ |++|++++++++|..+........                ....
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di-wslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  235 (331)
T cd05597         158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDW-WSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD  235 (331)
T ss_pred             -ccccceeccccccCHHHHhhccccccCCCCccee-ehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCC
Confidence             11223469999999999863     456788999 999999999999887654321110                1112


Q ss_pred             HHHHHHHHHHHccCCCC--CCCCCHHHHHHH
Q 001988          941 CLLSIFSLALECTMESP--EKRIDAKDTITR  969 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P--~~RPt~~ev~~~  969 (985)
                      .++++.+++++|+..++  ..||++.+++..
T Consensus       236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            46778889998775533  347899888765

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.97  E-value=1e-31  Score=299.13  Aligned_cols=226  Identities=26%  Similarity=0.275  Sum_probs=185.0

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHH-HHHhcCCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECE-VIKNIRHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||.||+|+.. +++.||+|++.+...   .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 688999999875421   22344555554 57888999999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      |+|.+++.... .+++.....++.||++||+||   |+.||+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYL---HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS  154 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence            99998887643 578888899999999999999   78999999999999999999999999999987532221  2233


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHHHccCC
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLALECTME  955 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~~cl~~  955 (985)
                      ..+||+.|+|||.+.+..++.++|+ |++|++++++++|..+........           .+.....++.+++.+|++.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~  233 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDW-WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHK  233 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcc-cccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccC
Confidence            4569999999999998889999999 999999999999987654332111           1122456788999999999


Q ss_pred             CCCCCCCHH
Q 001988          956 SPEKRIDAK  964 (985)
Q Consensus       956 ~P~~RPt~~  964 (985)
                      +|.+||++.
T Consensus       234 ~p~~R~~~~  242 (321)
T cd05603         234 DQRRRLGAK  242 (321)
T ss_pred             CHhhcCCCC
Confidence            999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.7e-31  Score=287.15  Aligned_cols=239  Identities=25%  Similarity=0.330  Sum_probs=200.1

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-----chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-----STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-----~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ++|...+.||+|+||.||+|... ++++||+|.+.....     ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57888999999999999999864 789999999865422     123568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++++|.+++.... .+++....+++.|++.|++||   |+.|++||||||+||++++++.++|+|||+++.....
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999987654 578889999999999999999   7899999999999999999999999999999875432


Q ss_pred             CCcce-ecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh-------------hhHHHHHHHH
Q 001988          880 DESTM-RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-------------AAKEQCLLSI  945 (985)
Q Consensus       880 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-------------~~~~~~~~~l  945 (985)
                      ..... .....++..|+|||.+.+..++.++|+ |++|++++++++++.+.......             ..++.++..+
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADV-WSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA  236 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhh-HHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHH
Confidence            21111 123457889999999999989999999 99999999999988765332111             1123456789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHH
Q 001988          946 FSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      .+++.+||..+|.+||++.|+++.
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         237 RNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHHHHHHhhcCcccCCCHHHHhhC
Confidence            999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.97  E-value=1.3e-31  Score=304.66  Aligned_cols=236  Identities=23%  Similarity=0.324  Sum_probs=192.7

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCC-----ceE
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD-----FKA  798 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-----~~~  798 (985)
                      +|+..+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+++++.++||||+++++++...+     +.+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999864 78999999986542  223467889999999999999999999998776     789


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +||||++ ++|.+.+... ..+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYL---HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999996 5888887654 3688999999999999999999   789999999999999999999999999999987542


Q ss_pred             CCCcceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhhh--------------------
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA--------------------  937 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~--------------------  937 (985)
                      ... .......+++.|+|||.+.+. .++.++|+ |++|++++++++|+.++........                    
T Consensus       156 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di-wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         156 DES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDI-WSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             Ccc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHH-HhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            221 222334688999999998764 47889999 9999999999998875532211000                    


Q ss_pred             -----------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          938 -----------------------KEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       938 -----------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                             .....+++.+++.+|+..||++||++.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                                   01124568899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=9e-32  Score=309.18  Aligned_cols=234  Identities=18%  Similarity=0.177  Sum_probs=191.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ..+|...+.||+|+||.||+|... +++.||||....      ..+.+|++++++++|+|||++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            346888999999999999999875 678899996432      3457899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      + .++|.+++......+++.++..++.|++.||+||   |++||+||||||+|||++.++.+||+|||+++.+.......
T Consensus       242 ~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 Y-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYI---HGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            9 4799998877655799999999999999999999   78999999999999999999999999999998765433322


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhccccc--ccCcc-----hhhh--------------------
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSL--LSGEE-----KHFA--------------------  936 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~--~~~~~-----~~~~--------------------  936 (985)
                      ......||+.|+|||++.+..++.++|+ |++|++++|++.+..  +....     +...                    
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDv-wSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDI-WSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHH-HHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            3334579999999999999999999999 999999999876432  11100     0000                    


Q ss_pred             --------------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          937 --------------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       937 --------------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                                ........+.+++.+|++.||.+||++.|+++.
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                                      000112367889999999999999999999863

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.97  E-value=9.9e-32  Score=298.46  Aligned_cols=233  Identities=22%  Similarity=0.309  Sum_probs=195.9

Q ss_pred             cCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-C-----CCeeeEEeeeecCCceE
Q 001988          726 DNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-H-----RNLVKIISSCSNDDFKA  798 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h-----~niv~l~~~~~~~~~~~  798 (985)
                      .+|.+.+.||+|+||.|.+|.. ++++.||||+++.+ .....+...|+.+|..++ |     -|+|++++++..+++.|
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            3789999999999999999985 47999999999865 344567789999999996 3     48999999999999999


Q ss_pred             EEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC--cEEEecccCcee
Q 001988          799 LVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM--VAHLSDFGMAKL  875 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~--~~kl~DfGla~~  875 (985)
                      ||+|.+ .-+|.++++.+ ...++...++.|+.||+.||.+|   |+.+||||||||+|||+.+.+  .+||+|||.|+.
T Consensus       265 iVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L---~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFL---HELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            999999 45999999987 34689999999999999999999   899999999999999996543  799999999987


Q ss_pred             ccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-------------------
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------------  936 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------------  936 (985)
                      .....    . ..+-+..|+|||++.+.+|+.+.|+ |++||++.|+++|..++......+                   
T Consensus       341 ~~q~v----y-tYiQSRfYRAPEVILGlpY~~~IDm-WSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  341 ESQRV----Y-TYIQSRFYRAPEVILGLPYDTAIDM-WSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             cCCcc----e-eeeeccccccchhhccCCCCCccce-eehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            53211    1 4567889999999999999999999 999999999999876544331110                   


Q ss_pred             --------------------------------------------hH----------H-HHHHHHHHHHHHccCCCCCCCC
Q 001988          937 --------------------------------------------AK----------E-QCLLSIFSLALECTMESPEKRI  961 (985)
Q Consensus       937 --------------------------------------------~~----------~-~~~~~l~~l~~~cl~~~P~~RP  961 (985)
                                                                  .+          + .....+.+++++|+.+||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence                                                        00          0 1245689999999999999999


Q ss_pred             CHHHHHHH
Q 001988          962 DAKDTITR  969 (985)
Q Consensus       962 t~~ev~~~  969 (985)
                      |+.++++.
T Consensus       495 tp~qal~H  502 (586)
T KOG0667|consen  495 TPAQALNH  502 (586)
T ss_pred             CHHHHhcC
Confidence            99998864

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.3e-31  Score=287.38  Aligned_cols=237  Identities=27%  Similarity=0.359  Sum_probs=202.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      ++|...+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888899999999999999864 67889999998765556678999999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      ++++|.+++......+++..+..++.|++.|++||   |+.+++||||||+||++++++.+||+|||.+..+....  ..
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~  157 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL---HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AK  157 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hc
Confidence            99999999987655789999999999999999999   78999999999999999999999999999988754221  12


Q ss_pred             ecccccccccccccccccC---ccchhhhcccccccchhhhcccccccCcchhh----------------hhHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIFVG---ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF----------------AAKEQCLLSI  945 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~---~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~----------------~~~~~~~~~l  945 (985)
                      .....++..|+|||.+...   .++.++|+ |++|+.+++++++..+.......                ......+.++
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di-~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDI-WALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF  236 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhh-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence            2334688899999998776   88899999 99999999999988765432100                1123346779


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHH
Q 001988          946 FSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+++.+||..+|.+||++.+++.
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         237 HDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHhc
Confidence            99999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=1.4e-31  Score=298.08  Aligned_cols=230  Identities=22%  Similarity=0.215  Sum_probs=191.5

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceEEEE
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~  801 (985)
                      +|...+.||+|+||.||+|+.. +++.||+|++.+..   ......+..|.++++.+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667789999999999999865 78999999987542   223456778999998886 577888999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++|+|.+++...+ .+++.++..++.|++.||+||   |++||+||||||+||++++++.+||+|||+++...... 
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~l---H~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-  155 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFL---HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-  155 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence            9999999999987654 688999999999999999999   78999999999999999999999999999987643222 


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLAL  950 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~  950 (985)
                       .......||+.|+|||.+.+..++.++|+ |++|++++++++|..+........           .+...+.++.+++.
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  233 (323)
T cd05615         156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDW-WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICK  233 (323)
T ss_pred             -ccccCccCCccccCHHHHcCCCCCCccch-hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence             12334569999999999998899999999 999999999999988765432211           12234667889999


Q ss_pred             HccCCCCCCCCCH
Q 001988          951 ECTMESPEKRIDA  963 (985)
Q Consensus       951 ~cl~~~P~~RPt~  963 (985)
                      +|+..+|.+|++.
T Consensus       234 ~~l~~~p~~R~~~  246 (323)
T cd05615         234 GLMTKHPSKRLGC  246 (323)
T ss_pred             HHcccCHhhCCCC
Confidence            9999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.97  E-value=1.9e-31  Score=301.80  Aligned_cols=237  Identities=22%  Similarity=0.276  Sum_probs=192.5

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++...   ......+++|++++.+++||+|+++++++.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888899999999999999865 78999999987532   223456788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++|+|.+++...+ .+++.....++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~l---H~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAI---HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            9999999999997654 688999999999999999999   799999999999999999999999999999875432110


Q ss_pred             c---------------------------------ceecccccccccccccccccCccchhhhcccccccchhhhcccccc
Q 001988          882 S---------------------------------TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLL  928 (985)
Q Consensus       882 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~  928 (985)
                      .                                 ......+||+.|+|||++.+..++.++|+ |++|++++++++|..+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~Di-wSlGvilyel~tG~~P  235 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDW-WSLGVIMYEMLIGYPP  235 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCccee-ccccceeeecccCCCC
Confidence            0                                 00123469999999999999999999999 9999999999998876


Q ss_pred             cCcchhhhh-------------HH--HHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 001988          929 SGEEKHFAA-------------KE--QCLLSIFSLALECTMESPEKRID---AKDTIT  968 (985)
Q Consensus       929 ~~~~~~~~~-------------~~--~~~~~l~~l~~~cl~~~P~~RPt---~~ev~~  968 (985)
                      .........             +.  ..+++..+++.+|+ .+|.+|++   +.|+.+
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         236 FCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            543221110             00  13456788888877 49999986   455544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.9e-32  Score=294.21  Aligned_cols=239  Identities=23%  Similarity=0.333  Sum_probs=202.1

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .++|.+.+.||+|+||.||+|... ++..||+|.+........+.+.+|++++++++||||+++++++..++..++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            356888899999999999999864 6889999999766555667889999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +++++|.+++...+..+++.....++.|++.|+.||   |+.+|+||||||+||+++.++.++|+|||++.......  .
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~  158 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL---HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q  158 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence            999999999987666789999999999999999999   78999999999999999999999999999987653222  1


Q ss_pred             eecccccccccccccccc-----cCccchhhhcccccccchhhhcccccccCcchh--------------hhhHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIF-----VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH--------------FAAKEQCLLS  944 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~--------------~~~~~~~~~~  944 (985)
                      ......+++.|+|||.+.     ...++.++|+ |++|+.++++++++.+......              ...+..++.+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADI-WSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSS  237 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccH-HHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHH
Confidence            223446899999999875     3446778999 9999999999998876543211              1122345678


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          945 IFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       945 l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      +.+++.+||..+|.+||++.++++.
T Consensus       238 ~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         238 FNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhcC
Confidence            9999999999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=2.9e-31  Score=287.91  Aligned_cols=235  Identities=22%  Similarity=0.278  Sum_probs=186.1

Q ss_pred             ceeeccCceeEEEEEEc---CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCC
Q 001988          732 NIIGIGGFGSVYRARLE---DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNG  807 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~---~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  807 (985)
                      +.||+|+||.||+|...   ++..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            35899999999999864   346799998876533 23457889999999999999999999999999999999999999


Q ss_pred             ChHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          808 SLEDCLHSSN----CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       808 sL~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +|.+++....    ...++....+++.|++.|++||   |+.+++||||||+||+++.++.+||+|||.++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL---HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999997532    2456778888999999999999   78999999999999999999999999999997653322222


Q ss_pred             eecccccccccccccccccC-------ccchhhhcccccccchhhhcc-cccccCcchhhhh-----------------H
Q 001988          884 MRTQTLATIGYMAPDEIFVG-------ELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFAA-----------------K  938 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~~-----------------~  938 (985)
                      ......++..|+|||.+...       .++.++|+ |++|+.++++++ +..+.........                 .
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Di-wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNV-WSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK  236 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchh-HHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence            22334578889999987542       35678899 999999999985 7655432211100                 0


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 001988          939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLL  971 (985)
Q Consensus       939 ~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~  971 (985)
                      ....+.+.+++..|| .+|++||++.|+++.|.
T Consensus       237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            123466888999999 68999999999998864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=3e-31  Score=286.18  Aligned_cols=242  Identities=24%  Similarity=0.431  Sum_probs=201.3

Q ss_pred             HhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ..++|+..+.||+|+||.||+|...++..||+|.+... ....+.+.+|++++++++|+||+++++++.+ ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            34678899999999999999999877888999988754 2345678899999999999999999999887 778999999


Q ss_pred             cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      +++++|.+++... ....++..+..++.|++.||+||   |+.|++||||||+||+++.++.+||+|||.+..+..... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  157 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-  157 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence            9999999999764 44578889999999999999999   789999999999999999999999999999987643221 


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFSLA  949 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~l~  949 (985)
                      .......++..|+|||.+..+.++.++|+ |++|+.++++++ +..+.......            +.....+.++.+++
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di-~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  236 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDV-WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM  236 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccc-hHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHH
Confidence            12222345678999999988889999999 999999999997 66654322111            11223457899999


Q ss_pred             HHccCCCCCCCCCHHHHHHHHHH
Q 001988          950 LECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                      .+|+..+|++||++.++.+.|+.
T Consensus       237 ~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         237 MRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HHHcccCcccCcCHHHHHHHHhc
Confidence            99999999999999999998874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.97  E-value=1.8e-31  Score=302.27  Aligned_cols=244  Identities=19%  Similarity=0.218  Sum_probs=198.0

Q ss_pred             HHHHHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 001988          719 FELLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSND  794 (985)
Q Consensus       719 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~  794 (985)
                      .++....++|...+.||+|+||.||+|+.+ +++.||+|++.+..   ......+.+|+.+++.++||||+++++++.++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344456689999999999999999999875 78899999986431   22345578899999999999999999999999


Q ss_pred             CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCce
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK  874 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~  874 (985)
                      +..++||||+++|+|.+++...  .++......++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            9999999999999999998754  478888899999999999999   79999999999999999999999999999998


Q ss_pred             eccCCCCcceecccccccccccccccccC----ccchhhhcccccccchhhhcccccccCcchhh---------------
Q 001988          875 LLSGEDESTMRTQTLATIGYMAPDEIFVG----ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------  935 (985)
Q Consensus       875 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------  935 (985)
                      ....... ......+||+.|+|||.+...    .++.++|+ |++|++++++++|..+.......               
T Consensus       191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~Di-wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~  268 (371)
T cd05622         191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW-WSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF  268 (371)
T ss_pred             EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccce-eehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccC
Confidence            7643221 122345799999999998653    37788999 99999999999998766543211               


Q ss_pred             hhHHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 001988          936 AAKEQCLLSIFSLALECTMESPEK--RIDAKDTITR  969 (985)
Q Consensus       936 ~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~ev~~~  969 (985)
                      +.....+.++.+++..|+...+.+  ||++.|+.+.
T Consensus       269 ~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         269 PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            111235677889999999844433  7788888874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=2e-31  Score=293.31  Aligned_cols=235  Identities=25%  Similarity=0.329  Sum_probs=201.6

Q ss_pred             cCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          726 DNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..+++.++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            6788899999999999999986 479999999998665556677889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      ++++|.+++...  .+++.++..++.|++.||.||   |+.|++||||||+||+++.++.+||+|||++........  .
T Consensus        99 ~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~L---H~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~  171 (297)
T cd06656          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALDFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  171 (297)
T ss_pred             CCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--C
Confidence            999999998754  478889999999999999999   789999999999999999999999999999887543221  1


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcccccccCcch--------------hhhhHHHHHHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK--------------HFAAKEQCLLSIFSLAL  950 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~--------------~~~~~~~~~~~l~~l~~  950 (985)
                      .....+++.|+|||.+.+..++.++|+ |++|+.+++++++..+.....              ....+...+..+.+++.
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTRKAYGPKVDI-WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN  250 (297)
T ss_pred             cCcccCCccccCHHHHcCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence            223468899999999999889999999 999999999999887543211              11123345677899999


Q ss_pred             HccCCCCCCCCCHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~  968 (985)
                      +||..+|++||++.++++
T Consensus       251 ~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         251 RCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             HHccCChhhCcCHHHHhc
Confidence            999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=2.9e-31  Score=300.38  Aligned_cols=235  Identities=23%  Similarity=0.295  Sum_probs=191.9

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCC-----
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD-----  795 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-----  795 (985)
                      ..++|+..+.||+|+||.||+|... +++.||+|++....  ......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3578999999999999999999864 78999999997542  233567789999999999999999999986543     


Q ss_pred             -ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCce
Q 001988          796 -FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK  874 (985)
Q Consensus       796 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~  874 (985)
                       ..++||||+++ ++.+.+..   .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~L---H~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             46899999965 67666643   467888899999999999999   78999999999999999999999999999997


Q ss_pred             eccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------------
Q 001988          875 LLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------------  937 (985)
Q Consensus       875 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------------  937 (985)
                      .....   .......||+.|+|||.+.+..++.++|+ |++|++++++++|..++........                 
T Consensus       172 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di-wSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         172 TACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDI-WSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             ccccC---ccCCCCcccCCCCCchhccCCCCCcchhh-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence            64321   12234568999999999999999999999 9999999999998876543211000                 


Q ss_pred             ------------------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          938 ------------------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       938 ------------------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                                          .....+++.+++.+|+..||++|||+.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                                                00013567899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.9e-31  Score=284.77  Aligned_cols=237  Identities=27%  Similarity=0.372  Sum_probs=194.7

Q ss_pred             ceeeccCceeEEEEEEc-C---CcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLE-D---GVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~---~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      ++||+|+||.||+|.+. .   +..||+|.+..... ...+++.+|+.+++++.||||+++++++.. +..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            46999999999999753 2   26899999886643 245678999999999999999999998864 467999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce-e
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM-R  885 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~-~  885 (985)
                      |+|.+++.... .+++..+..++.|+++|++||   |+.+++||||||+||+++.++.+||+|||+++.+........ .
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYL---ESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHH---hhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999998765 689999999999999999999   789999999999999999999999999999987643332111 1


Q ss_pred             cccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHHHHHHc
Q 001988          886 TQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFSLALEC  952 (985)
Q Consensus       886 ~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~l~~~c  952 (985)
                      ....++..|+|||.+....++.++|+ |++|+.++++++ +..+.......            ..+..++..+.+++.+|
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  234 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDV-WSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSC  234 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchH-HHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence            11223567999999998999999999 999999999997 66654332111            12234567899999999


Q ss_pred             cCCCCCCCCCHHHHHHHHHHhH
Q 001988          953 TMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       953 l~~~P~~RPt~~ev~~~L~~i~  974 (985)
                      |..+|++||++.++++.|+++.
T Consensus       235 l~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         235 WKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             hcCChhhCcCHHHHHHHHHhcc
Confidence            9999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=9e-32  Score=289.89  Aligned_cols=229  Identities=22%  Similarity=0.280  Sum_probs=187.6

Q ss_pred             ceeeccCceeEEEEEEc-C-------CcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          732 NIIGIGGFGSVYRARLE-D-------GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~-------~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +.||+|+||.||+|... +       ..+||+|.+........+.+..|+.+++++.||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            46899999999999764 2       234888888655444556788999999999999999999999998999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc--------EEEecccCcee
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV--------AHLSDFGMAKL  875 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~--------~kl~DfGla~~  875 (985)
                      +++|+|.++++..+..+++..+.+++.|++.|++||   |++||+||||||+||+++.++.        ++++|||.+..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL---EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            999999999987766789999999999999999999   7999999999999999987765        69999998876


Q ss_pred             ccCCCCcceeccccccccccccccccc-Cccchhhhcccccccchhhhcccc-cccCcchhhh----------hHHHHHH
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKS-LLSGEEKHFA----------AKEQCLL  943 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~-~~~~~~~~~~----------~~~~~~~  943 (985)
                      ...      .....+++.|+|||.+.+ ..++.++|+ |++|+.+++++++. .+........          .+.....
T Consensus       158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di-wslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (258)
T cd05078         158 VLP------KEILLERIPWVPPECIENPQNLSLAADK-WSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWT  230 (258)
T ss_pred             cCC------chhccccCCccCchhccCCCCCCchhhH-HHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcH
Confidence            432      122458889999999876 457889999 99999999999974 3322211110          0111336


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~~L  970 (985)
                      ++.+++.+||+.+|++||+++++++.|
T Consensus       231 ~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         231 ELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=3.3e-31  Score=296.06  Aligned_cols=239  Identities=19%  Similarity=0.231  Sum_probs=194.9

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|...+.||+|+||.||+++.. +++.||+|++.+..   ......+.+|+.++..++|++|+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47888999999999999999865 68889999986531   223445788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||++||+|.+++......+++.....++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~l---H~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI---HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            99999999999987555788999999999999999999   789999999999999999999999999999987643222


Q ss_pred             cceeccccccccccccccccc-----CccchhhhcccccccchhhhcccccccCcchhhh----------------hHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFV-----GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA----------------AKEQ  940 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~----------------~~~~  940 (985)
                       .......||+.|+|||++.+     +.++.++|+ |++|++++++++|..+........                ....
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di-wSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  235 (331)
T cd05624         158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDW-WSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD  235 (331)
T ss_pred             -eeeccccCCcccCCHHHHhccccCCCCCCCcccE-EeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcccc
Confidence             12233569999999998865     567888999 999999999999987654321110                1122


Q ss_pred             HHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 001988          941 CLLSIFSLALECTMESPEK--RIDAKDTITR  969 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~~--RPt~~ev~~~  969 (985)
                      .++++.+++.+|+..++.+  |+++.++.+.
T Consensus       236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            4678899999998865544  4678777653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=2.6e-31  Score=288.44  Aligned_cols=236  Identities=26%  Similarity=0.423  Sum_probs=191.1

Q ss_pred             ceeeccCceeEEEEEEc-CCc--EEEEEEeccCC-cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGV--EIAIKVFHPQC-ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~--~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||.||+|... ++.  .+|+|.++... ......+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999875 443  47888887543 23446788999999999 799999999999999999999999999


Q ss_pred             CChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEeccc
Q 001988          807 GSLEDCLHSSN---------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFG  871 (985)
Q Consensus       807 gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfG  871 (985)
                      |+|.+++....               ..+++.++..++.|++.|++||   |++|++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999987532               2478899999999999999999   78999999999999999999999999999


Q ss_pred             CceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhH
Q 001988          872 MAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAK  938 (985)
Q Consensus       872 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~  938 (985)
                      ++....   ..........+..|+|||.+....++.+.|+ |++|+.++++++ +..+......            .+.+
T Consensus       158 l~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di-~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~  233 (270)
T cd05047         158 LSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDV-WSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP  233 (270)
T ss_pred             Cccccc---hhhhccCCCCccccCChHHHccCCCCchhhH-HHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCC
Confidence            986421   1111111234567999999988889999999 999999999986 6554322110            1112


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhH
Q 001988          939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       939 ~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~  974 (985)
                      ..++.++.+++.+||..+|.+||++.|++..|.++.
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         234 LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            234577999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.97  E-value=1.4e-31  Score=298.43  Aligned_cols=226  Identities=23%  Similarity=0.249  Sum_probs=188.3

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||.||+|+.. +++.||+|++++...   ...+.+.+|+.++.++ +||+|+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 678999999986522   2345678999999888 699999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      |+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFL---HERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS  154 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence            99999887653 689999999999999999999   78999999999999999999999999999987532222  1223


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh---h---------------hhHHHHHHHHHHH
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH---F---------------AAKEQCLLSIFSL  948 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~---~---------------~~~~~~~~~l~~l  948 (985)
                      ..+||+.|+|||.+.+..++.++|+ |++|++++++++|..+......   .               ..+...+..+.++
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~Di-wslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l  233 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDW-WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHV  233 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchhee-ehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            4579999999999999999999999 9999999999999877632110   0               0112235678899


Q ss_pred             HHHccCCCCCCCCCHH
Q 001988          949 ALECTMESPEKRIDAK  964 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~  964 (985)
                      +.+|+..||++||++.
T Consensus       234 i~~~L~~dP~~R~~~~  249 (327)
T cd05617         234 LKGFLNKDPKERLGCQ  249 (327)
T ss_pred             HHHHhccCHHHcCCCC
Confidence            9999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=2.2e-31  Score=307.70  Aligned_cols=233  Identities=23%  Similarity=0.320  Sum_probs=186.1

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecC--------C
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSND--------D  795 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--------~  795 (985)
                      .++|...+.||+|+||.||+|... +++.||||++....    ....+|+.++++++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457999999999999999999864 78899999886432    2345799999999999999998876432        2


Q ss_pred             ceEEEEeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-cEEEeccc
Q 001988          796 FKALVLEYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFG  871 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~-~~kl~DfG  871 (985)
                      ..++||||+++ ++.+++..   ....+++.....++.|++.||+||   |+++|+||||||+||+++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yL---H~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI---HSKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            46789999975 77776653   345688999999999999999999   789999999999999999665 79999999


Q ss_pred             CceeccCCCCcceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhhh-------------
Q 001988          872 MAKLLSGEDESTMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-------------  937 (985)
Q Consensus       872 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-------------  937 (985)
                      +|+.+.....   .....||+.|+|||.+.+. .++.++|+ |++|++++++++|..++........             
T Consensus       217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDL-WSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9987643221   2235689999999988754 68999999 9999999999998866543211000             


Q ss_pred             ---------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          938 ---------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       938 ---------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                                 +...++++.+++.+||.+||.+||++.|+++.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                                       01134678999999999999999999998843

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=1.7e-31  Score=288.14  Aligned_cols=234  Identities=29%  Similarity=0.437  Sum_probs=196.1

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHH--HHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLK--SFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~--~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      |+..+.||+|+||.||+|+.. +++.||+|.+.........  ...+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567789999999999999976 5678999999877443322  3456999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      ++++|.+++... ..+++..+..++.|+++||++|   |+.+|+||||||+||++++++.++|+|||.+....  .....
T Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~L---h~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYL---HSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNEN  154 (260)
T ss_dssp             TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHH---HHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSE
T ss_pred             cccccccccccc-cccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--ccccc
Confidence            999999999833 3679999999999999999999   67899999999999999999999999999998652  22223


Q ss_pred             ecccccccccccccccc-cCccchhhhcccccccchhhhcccccccCcch---hhhhH---------H------HHHHHH
Q 001988          885 RTQTLATIGYMAPDEIF-VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK---HFAAK---------E------QCLLSI  945 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~-~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~---~~~~~---------~------~~~~~l  945 (985)
                      .....++..|+|||.+. ...++.++|+ |++|+.+++++++..+.....   .....         .      ....++
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di-~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDI-WSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL  233 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHH-HHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred             cccccccccccccccccccccccccccc-cccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence            44566899999999988 8889999999 999999999999887665431   11000         0      013789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHH
Q 001988          946 FSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+++.+|++.+|++||++.++++
T Consensus       234 ~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  234 RDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             HHHHHHHccCChhHCcCHHHHhc
Confidence            99999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=1.9e-31  Score=289.78  Aligned_cols=239  Identities=23%  Similarity=0.321  Sum_probs=196.4

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeecC------
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSND------  794 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~------  794 (985)
                      .+++.|...+.||+|+||.||+|... +++.||+|.+.... .....+..|+.+++++ +||||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35677888899999999999999865 68889999987543 3446788999999998 699999999998653      


Q ss_pred             CceEEEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCc
Q 001988          795 DFKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA  873 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla  873 (985)
                      ...++||||+++|+|.+++... ...+++..+..++.|++.|++||   |+++|+||||||+||++++++.+||+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~L---H~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL---HQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            4578999999999999998864 34688999999999999999999   7889999999999999999999999999999


Q ss_pred             eeccCCCCcceecccccccccccccccc-----cCccchhhhcccccccchhhhcccccccCcchhhh------------
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIF-----VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------  936 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------  936 (985)
                      .......  .......|++.|+|||++.     +..++.++|+ |++|+++++++++..+........            
T Consensus       159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv-~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (272)
T cd06637         159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDL-WSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR  235 (272)
T ss_pred             eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhH-HHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC
Confidence            8754222  1223456899999999886     3457889999 999999999999887654321110            


Q ss_pred             -hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 -AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 -~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                       ....++.++.+++.+||..+|.+||++.|+++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence             11234578999999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=1.4e-31  Score=290.11  Aligned_cols=236  Identities=24%  Similarity=0.311  Sum_probs=196.5

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46777788999999999999864 78899999987665455567889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      ++++|.+++...+ .+++.+...++.|++.|++||   |+.|++||||||+||+++.++.+||+|||++.......  ..
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~  162 (267)
T cd06645          89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYL---HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK  162 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence            9999999987654 688999999999999999999   78899999999999999999999999999987764221  12


Q ss_pred             ecccccccccccccccc---cCccchhhhcccccccchhhhcccccccCcchhh----------------hhHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIF---VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF----------------AAKEQCLLSI  945 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~---~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~----------------~~~~~~~~~l  945 (985)
                      .....|++.|+|||.+.   .+.++.++|+ |++|+.+++++++..+.......                .....++..+
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv-wSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDI-WAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF  241 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhh-HHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence            23446899999999874   4567889999 99999999999987653221100                0011244678


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHH
Q 001988          946 FSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+++.+|+..+|++||++.++++
T Consensus       242 ~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         242 HHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             HHHHHHHccCCchhCcCHHHHhc
Confidence            89999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=2.6e-31  Score=289.82  Aligned_cols=231  Identities=22%  Similarity=0.302  Sum_probs=193.6

Q ss_pred             cCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          726 DNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ++|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577889999999999999985 478899999987553 23346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +++++|..+.     .+++.....++.|++.|++||   |+.||+||||||+||+++.++.+||+|||++..+...    
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----  148 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----  148 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence            9999997652     357888899999999999999   7899999999999999999999999999999876422    


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh------hh--------------HHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF------AA--------------KEQCLL  943 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~------~~--------------~~~~~~  943 (985)
                      ......++..|+|||.+.+..++.++|+ |++|+.++++++|..++......      ..              ....+.
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-wslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDV-WSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSE  227 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchH-HHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCH
Confidence            1233568999999999999999999999 99999999999988765321100      00              012346


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      ++.+++.+|+..+|++||++.|+++.
T Consensus       228 ~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         228 KFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            78999999999999999999999765

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=2.8e-31  Score=285.69  Aligned_cols=235  Identities=27%  Similarity=0.348  Sum_probs=201.8

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      ++|...+.||+|+||.||+|... +++.||+|.+.....  .+++.+|++++++++||||+++++++.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            57888899999999999999976 478999999875532  678999999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      ++++|.+++......+++.....++.|++.|+.||   |+.+++||||+|+||++++++.+||+|||++........  .
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~  155 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL---HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K  155 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence            99999999987666789999999999999999999   788999999999999999999999999999887643221  2


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh--------------hhhHHHHHHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH--------------FAAKEQCLLSIFSLAL  950 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~--------------~~~~~~~~~~l~~l~~  950 (985)
                      .....++..|+|||.+.+..++.++|+ |++|+.+++++++..+......              ...+.....++.+++.
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di-~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGYNNKADI-WSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK  234 (256)
T ss_pred             cccccCCccccCHHHHhcCCCCchhhH-HHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence            233458889999999998899999999 9999999999998875443211              1122334567999999


Q ss_pred             HccCCCCCCCCCHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~  968 (985)
                      +||+.+|++||++.|+++
T Consensus       235 ~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         235 KCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             HHHhcChhhCcCHHHHhc
Confidence            999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.2e-31  Score=280.07  Aligned_cols=239  Identities=23%  Similarity=0.290  Sum_probs=196.8

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      +.|+..+.||+|.-|+||+++.+ ++..+|+|++.+...   ....+++.|.+||+.+.||.++.+|..++.++..++||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            34556678999999999999976 458899999987633   33557788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC-
Q 001988          802 EYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-  879 (985)
Q Consensus       802 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~-  879 (985)
                      |||+||+|....+.+ ++.+++...+-+|.+++-||+||   |..|||+|||||+|||+-++|++-|+||.++...... 
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYL---HmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYL---HMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHH---HhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            999999999988766 56799999999999999999999   8999999999999999999999999999987542110 


Q ss_pred             --------------------------------CC---------------------cceecccccccccccccccccCccc
Q 001988          880 --------------------------------DE---------------------STMRTQTLATIGYMAPDEIFVGELS  906 (985)
Q Consensus       880 --------------------------------~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~  906 (985)
                                                      ..                     .......+||-.|+|||++.+..-+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                            00                     0112345799999999999998888


Q ss_pred             hhhhcccccccchhhhcccccccCcch-------------hhhhHHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 001988          907 LKRWVNDLLPVSLVEVVDKSLLSGEEK-------------HFAAKEQCLLSIFSLALECTMESPEKRID----AKDTIT  968 (985)
Q Consensus       907 ~~~dv~~~~g~~~~~i~~~~~~~~~~~-------------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt----~~ev~~  968 (985)
                      .+.|. |.+|++++||+-|.-++....             .++.....+....++|++.+..||.+|..    |.||-+
T Consensus       314 sAVDW-WtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  314 SAVDW-WTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             chhhH-HHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence            88776 999999999998876554332             11122245678999999999999999997    666643

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=3.9e-31  Score=292.68  Aligned_cols=236  Identities=22%  Similarity=0.295  Sum_probs=196.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ++|+..+.||+|+||.||+|... ++..||+|.++..... ...++.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999865 6888999998755322 345688999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS-TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      +++++|.++++.. ..+++.....++.|+++||+||   |+ .+++||||||+||++++++.+||+|||++......   
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~l---H~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYL---REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            9999999999865 3678999999999999999999   54 68999999999999999999999999998765322   


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh--------------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--------------------------  936 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--------------------------  936 (985)
                       ......+++.|+|||.+.+..++.+.|+ |++|+++++++++..+........                          
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di-wslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDI-WSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchH-HHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence             1233468999999999888888999999 999999999999876532110000                          


Q ss_pred             ---h--------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 001988          937 ---A--------------------KEQCLLSIFSLALECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       937 ---~--------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L  970 (985)
                         .                    ....+.++.+++.+|+..+|++||++.++++.-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence               0                    001345789999999999999999999998763

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=4.1e-31  Score=295.58  Aligned_cols=239  Identities=19%  Similarity=0.224  Sum_probs=194.9

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|...+.||+|+||.||+++.+ +++.||+|++.+..   ......+..|+.++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999865 67889999986431   122345788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++|+|.+++......+++.....++.|++.|++||   |+++|+||||||+||+++.++.+||+|||++..+.....
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~l---H~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            99999999999987655789999999999999999999   789999999999999999999999999999976542222


Q ss_pred             cceecccccccccccccccc-----cCccchhhhcccccccchhhhcccccccCcchhh----------------hhHHH
Q 001988          882 STMRTQTLATIGYMAPDEIF-----VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF----------------AAKEQ  940 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~----------------~~~~~  940 (985)
                       ......+||+.|+|||++.     .+.++.++|+ |++|++++++++|+.++......                .....
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dv-wSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  235 (332)
T cd05623         158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDW-WSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD  235 (332)
T ss_pred             -ceecccccCccccCHHHHhccccCCCCCCCcCCE-EeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcccc
Confidence             2223456999999999886     3567889999 99999999999988765432111                11123


Q ss_pred             HHHHHHHHHHHccCCCCC--CCCCHHHHHHH
Q 001988          941 CLLSIFSLALECTMESPE--KRIDAKDTITR  969 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~--~RPt~~ev~~~  969 (985)
                      ++.++.+++++|+..+++  .|+++.|+++.
T Consensus       236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            567788999998865444  37889888766

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=6.4e-31  Score=286.21  Aligned_cols=241  Identities=20%  Similarity=0.342  Sum_probs=198.7

Q ss_pred             cCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      ++|+..+.||+|+||.||+|+.+      +.+.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888899999999999999864      3467999988755333 3567899999999999999999999999989999


Q ss_pred             EEEeccCCCChHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 001988          799 LVLEYMSNGSLEDCLHSSN--------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDF  870 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~Df  870 (985)
                      +||||+++|+|.+++....        ..+++..+..++.|++.||+||   |+.+|+||||||+||++++++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHh---hhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997653        1589999999999999999999   8999999999999999999999999999


Q ss_pred             cCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh-------------hh
Q 001988          871 GMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH-------------FA  936 (985)
Q Consensus       871 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~-------------~~  936 (985)
                      |++....... ........++..|+|||.+.++.++.++|+ |++|+.++++++ +..+......             ..
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di-~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~  239 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDV-WSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP  239 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhH-HHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence            9987543221 122233456788999999988888999999 999999999987 4433322111             11


Q ss_pred             hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 001988          937 AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLL  971 (985)
Q Consensus       937 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~  971 (985)
                      .+..++..+.+++.+|++.+|.+||++.|+++.|.
T Consensus       240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            12235678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.9e-31  Score=296.76  Aligned_cols=224  Identities=24%  Similarity=0.223  Sum_probs=181.3

Q ss_pred             eeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhc---CCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          734 IGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNI---RHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       734 ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      ||+|+||.||+|+.. +++.||||++.+...   .....+..|..++.+.   +||+|+++++++.+++..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999865 689999999865321   2233455677777665   699999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      |+|.+++...+ .+++.....++.||++||+||   |++||+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~L---H~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~  154 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHL---HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTN  154 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCcc
Confidence            99999987653 688999999999999999999   78999999999999999999999999999987642221  1223


Q ss_pred             ccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhhh------------HHHHHHHHHHHHHHcc
Q 001988          887 QTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA------------KEQCLLSIFSLALECT  953 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~------------~~~~~~~l~~l~~~cl  953 (985)
                      ..+||+.|+|||.+.+. .++.++|+ |++|+.++++++|..+.........            ....++++.+++.+|+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~Dv-wslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L  233 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDF-WSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLL  233 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccce-eccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence            45699999999998764 47889999 9999999999998876543211110            0124577889999999


Q ss_pred             CCCCCCCCCHH
Q 001988          954 MESPEKRIDAK  964 (985)
Q Consensus       954 ~~~P~~RPt~~  964 (985)
                      ..+|.+||++.
T Consensus       234 ~~~P~~R~~~~  244 (330)
T cd05586         234 NRNPQHRLGAH  244 (330)
T ss_pred             CCCHHHCCCCC
Confidence            99999999543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.2e-31  Score=304.24  Aligned_cols=234  Identities=21%  Similarity=0.208  Sum_probs=193.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc---CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE---DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ..+|...+.||+|+||.||+|...   +++.||+|.+...     ....+|++++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999753   4678999987643     34568999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+. ++|.+++... ..+++.+++.++.|++.||+||   |++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus       166 e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~L---H~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYL---HGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9995 6898888543 4789999999999999999999   789999999999999999999999999999987654433


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--------------------h-----
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------------A-----  936 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------------~-----  936 (985)
                      ........||+.|+|||.+....++.++|+ |++|+++++++++..+.......                    +     
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv-wslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDI-WSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhH-HHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence            333345679999999999999999999999 99999999999877544221000                    0     


Q ss_pred             ------------------hH-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          937 ------------------AK-----EQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       937 ------------------~~-----~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                        .+     ...+.++.+++.+|+..||.+||++.|++..
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                              00     0123467789999999999999999999875

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=2.5e-31  Score=290.65  Aligned_cols=234  Identities=23%  Similarity=0.296  Sum_probs=196.0

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc---hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      |+..+.||+|+||.||+|... +++.||+|.+......   ....+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999865 7899999998754222   234577899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      +++++|.+++... ...+++..+..++.|++.||.||   |+++|+||||||+||++++++.++|+|||++........ 
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL---HQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-  157 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence            9999999988654 33588999999999999999999   789999999999999999999999999999876532221 


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh---------------hhHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AAKEQCLLSIFS  947 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~~~~~~~~l~~  947 (985)
                        .....|++.|+|||.+.+..++.++|+ |++|+.++++++|..+.......               ..+..++.++.+
T Consensus       158 --~~~~~g~~~y~aPE~~~~~~~~~~~Di-wslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd05630         158 --IKGRVGTVGYMAPEVVKNERYTFSPDW-WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARS  234 (285)
T ss_pred             --ccCCCCCccccChHHHcCCCCCCcccc-HHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHH
Confidence              123468999999999999999999999 99999999999998776532110               001124567899


Q ss_pred             HHHHccCCCCCCCCC-----HHHHHH
Q 001988          948 LALECTMESPEKRID-----AKDTIT  968 (985)
Q Consensus       948 l~~~cl~~~P~~RPt-----~~ev~~  968 (985)
                      ++.+||..||++||+     +.|+++
T Consensus       235 li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         235 LCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             HHHHHhhcCHHHccCCCCCchHHHHc
Confidence            999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=4.5e-31  Score=286.41  Aligned_cols=234  Identities=21%  Similarity=0.264  Sum_probs=183.8

Q ss_pred             eeeccCceeEEEEEEc---CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCC
Q 001988          733 IIGIGGFGSVYRARLE---DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGS  808 (985)
Q Consensus       733 ~ig~G~~g~V~~~~~~---~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  808 (985)
                      .||+|+||.||+|...   ....+|+|.+..... .....+.+|+++++.++||||+++++++.+.+..++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            5899999999999754   335688888764432 234567899999999999999999999999999999999999999


Q ss_pred             hHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          809 LEDCLHSSN----CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       809 L~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      |.+++....    ...++.....++.|++.|++||   |+++|+||||||+||++++++.+||+|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL---HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHH---HhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999997642    2346777889999999999999   789999999999999999999999999999876432222111


Q ss_pred             ecccccccccccccccc-------cCccchhhhcccccccchhhhcc-cccccCcchhh-----------------hhHH
Q 001988          885 RTQTLATIGYMAPDEIF-------VGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF-----------------AAKE  939 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~-------~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~-----------------~~~~  939 (985)
                      .....+++.|+|||.+.       ...++.++|+ |++|+.++++++ +..+.......                 ..+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Di-wslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNI-WSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL  237 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHH-HHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence            23334677899999864       3456788999 999999999987 55443322111                 0112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 001988          940 QCLLSIFSLALECTMESPEKRIDAKDTITRLL  971 (985)
Q Consensus       940 ~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~  971 (985)
                      .++..+.+++..|| .||++||++.||++.+.
T Consensus       238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         238 KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            34567788999999 59999999999998863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=7.2e-31  Score=284.46  Aligned_cols=237  Identities=25%  Similarity=0.344  Sum_probs=197.6

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc---------hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCc
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS---------TLKSFEAECEVIKNIRHRNLVKIISSCSNDDF  796 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~---------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  796 (985)
                      +|.....||+|+||.||+|... +++.||+|.+......         ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3677889999999999999864 6889999988654222         12467899999999999999999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      .++||||+++++|.+++...+ .+++.....++.|++.|++||   |+.|++||||+|+||++++++.+||+|||.++.+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~l---H~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYL---HNRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHH---HhcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            999999999999999997653 678889999999999999999   7899999999999999999999999999999876


Q ss_pred             cCCCCc----ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh------------hhHHH
Q 001988          877 SGEDES----TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF------------AAKEQ  940 (985)
Q Consensus       877 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~------------~~~~~  940 (985)
                      ......    .......|+..|+|||.+.+..++.++|+ |++|+++++++++..+.......            ..+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADI-WSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSN  235 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhh-HHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcc
Confidence            522111    11123458889999999988889999999 99999999999988765432111            11233


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          941 CLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+..+.+++++||+.+|.+||++.|+++
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         236 ISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             cCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            5678899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=4.6e-31  Score=289.14  Aligned_cols=247  Identities=24%  Similarity=0.307  Sum_probs=199.5

Q ss_pred             cCHHHHHHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeee-
Q 001988          716 FSYFELLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCS-  792 (985)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~-  792 (985)
                      +.++.+..+.++|+..+.||+|+||.||+|... +++.||+|++... ......+.+|+.+++++ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            444556667889999999999999999999864 6889999987653 22346688999999999 6999999999874 


Q ss_pred             ----cCCceEEEEeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcE
Q 001988          793 ----NDDFKALVLEYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  865 (985)
Q Consensus       793 ----~~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~  865 (985)
                          .++..++||||+++++|.+++..   ....+++..+..++.|+++|+.||   |+.+++||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL---HVNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHH---HhCCccccCCCHHhEEECCCCCE
Confidence                34568999999999999998763   234678889999999999999999   78999999999999999999999


Q ss_pred             EEecccCceeccCCCCcceecccccccccccccccc-----cCccchhhhcccccccchhhhcccccccCcchhhh----
Q 001988          866 HLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF-----VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA----  936 (985)
Q Consensus       866 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~----  936 (985)
                      ||+|||+++.+.....  ......|++.|+|||.+.     ...++.++|+ |++|+.++++++++.+........    
T Consensus       164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv-~slGvi~~el~~g~~p~~~~~~~~~~~~  240 (286)
T cd06638         164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDV-WSLGITAIELGDGDPPLADLHPMRALFK  240 (286)
T ss_pred             EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhh-hhHHHHHHHHhcCCCCCCCCchhHHHhh
Confidence            9999999987643221  223346899999999875     3457889999 999999999999876543221110    


Q ss_pred             ----------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          937 ----------AKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       937 ----------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                .++.+..++.+++.+||+.+|++||++.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         241 IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence                      112235679999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=3.8e-31  Score=286.28  Aligned_cols=237  Identities=21%  Similarity=0.342  Sum_probs=198.3

Q ss_pred             CccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCc------chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          727 NFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA------STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      +|...+.||+|+||.||+|...+++.||+|.+.....      .....+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4778899999999999999988899999998875421      1235688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++++|.+++.... .+++..+..++.|++.|++||   |+.+|+|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYL---HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999997654 578899999999999999999   78999999999999999999999999999987653211


Q ss_pred             C----cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--------------hhHHHHH
Q 001988          881 E----STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQCL  942 (985)
Q Consensus       881 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~~  942 (985)
                      .    ........++..|+|||.+.+..++.++|+ |++|+.+++++++..+.......              ..+..++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv-~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDI-WSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS  235 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhH-HHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC
Confidence            1    111223458999999999998889999999 99999999999988765432111              1122346


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          943 LSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       943 ~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +++.+++++||..+|.+||++.|+++
T Consensus       236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         236 AAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            77899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=8.3e-31  Score=282.09  Aligned_cols=237  Identities=22%  Similarity=0.300  Sum_probs=200.8

Q ss_pred             CccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +|+..+.||.|+||.||.++. ++++.||+|.+....  ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478889999999999999985 478899999987542  33456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      +++|+|.+++... ...+++.++..++.|++.|++||   |+.+++||||||+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI---HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999865 45689999999999999999999   789999999999999999999999999999987643331 


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh------------hHHHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------AKEQCLLSIFSLAL  950 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------~~~~~~~~l~~l~~  950 (985)
                       ......+++.|+|||...+..++.++|+ |++|+.+++++++..+........            ....++.++.+++.
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv-~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDI-WALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVH  234 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchh-HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHH
Confidence             2234568999999999988888899999 999999999998876543321111            11234677999999


Q ss_pred             HccCCCCCCCCCHHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~  969 (985)
                      +||+.+|.+||++.|+++.
T Consensus       235 ~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         235 SLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             HHcccCcccCCCHHHHhhC
Confidence            9999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=5.9e-31  Score=287.88  Aligned_cols=235  Identities=22%  Similarity=0.270  Sum_probs=195.7

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      |+..+.||+|+||+||+|... +++.||+|.+.....   .....+.+|++++++++|++|+++++++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999864 789999999865422   2234567899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      +++++|.+++... ...+++.....++.|++.||+||   |+++|+||||||+||++++++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL---HRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            9999999988654 34689999999999999999999   78999999999999999999999999999987653221  


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQCLLSIFS  947 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~~~~~l~~  947 (985)
                       ......|+..|+|||.+.+..++.++|+ |++|+.+++++++..+........               .+...+.++.+
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di-~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDY-WGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKS  234 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccch-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHH
Confidence             1233468999999999998999999999 999999999999987765432111               11234567899


Q ss_pred             HHHHccCCCCCCCCC-----HHHHHHH
Q 001988          948 LALECTMESPEKRID-----AKDTITR  969 (985)
Q Consensus       948 l~~~cl~~~P~~RPt-----~~ev~~~  969 (985)
                      ++..|++.+|++||+     +.+++..
T Consensus       235 li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         235 ICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             HHHHHccCCHhHcCCCcccChHHHHcC
Confidence            999999999999999     6666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=3.5e-31  Score=291.12  Aligned_cols=235  Identities=26%  Similarity=0.340  Sum_probs=201.1

Q ss_pred             cCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          726 DNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .+|+..+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++|||++++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688889999999999999985 478999999997665555678899999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      ++++|.+++...  .+++.++..++.|++.|++||   |+.|++||||||+||+++.++.+||+|||++........  .
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~L---H~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~  171 (296)
T cd06655          99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFL---HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K  171 (296)
T ss_pred             CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence            999999988754  578999999999999999999   789999999999999999999999999999876543221  1


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--------------hhHHHHHHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQCLLSIFSLAL  950 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~~~~l~~l~~  950 (985)
                      .....+++.|+|||.+....++.++|+ |++|+.+++++++..+.......              ..+..++..+.+++.
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv-~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDI-WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLN  250 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHH
Confidence            223468899999999998889999999 99999999999988755432111              122335677899999


Q ss_pred             HccCCCCCCCCCHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~  968 (985)
                      +||..+|.+||++.++++
T Consensus       251 ~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         251 RCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             HHhhcChhhCCCHHHHhh
Confidence            999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=3.2e-31  Score=299.12  Aligned_cols=188  Identities=20%  Similarity=0.239  Sum_probs=163.5

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ...+|...+.||+|+||.||+|+.. +++.||+|+....      ....|+.++++++||||+++++++...+..++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            4467999999999999999999875 6778999975432      23569999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |+ .++|.+++......+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++.....   
T Consensus       138 ~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  210 (357)
T PHA03209        138 HY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL---HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---  210 (357)
T ss_pred             cc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence            99 4689999887766789999999999999999999   7899999999999999999999999999998753211   


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhccc
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDK  925 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~  925 (985)
                      .......||+.|+|||.+.+..++.++|+ |++|+++++++++
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlGvvl~ell~~  252 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADI-WSAGIVLFEMLAY  252 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhH-HHHHHHHHHHHHc
Confidence            12234569999999999999999999999 9999999999864

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=4.5e-31  Score=286.40  Aligned_cols=237  Identities=25%  Similarity=0.416  Sum_probs=193.9

Q ss_pred             ceeeccCceeEEEEEEcC-------CcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          732 NIIGIGGFGSVYRARLED-------GVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~~-------~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +.||+|+||.||+|+..+       ++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            358999999999998642       2579999886543 23456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-----cEEEecccC
Q 001988          804 MSNGSLEDCLHSS------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM-----VAHLSDFGM  872 (985)
Q Consensus       804 ~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~-----~~kl~DfGl  872 (985)
                      +++++|.+++...      ...+++.+++.++.|++.|++||   |+.+++||||||+||+++.++     .+|++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL---EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHH---HhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998753      23478899999999999999999   789999999999999999887     899999999


Q ss_pred             ceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHH
Q 001988          873 AKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKE  939 (985)
Q Consensus       873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~  939 (985)
                      ++...............++..|+|||.+.++.++.++|+ |++|+.++++++ +..+......            ...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDV-WSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPE  236 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhH-HHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcc
Confidence            976543322222223346788999999999999999999 999999999987 6654332111            11223


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 001988          940 QCLLSIFSLALECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       940 ~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                      ..+..+.+++.+||..+|.+||++.++.+.|++
T Consensus       237 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         237 NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             cchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            456789999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=8.5e-31  Score=285.52  Aligned_cols=235  Identities=24%  Similarity=0.325  Sum_probs=199.9

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4667788999999999999865 68899999987543 334567889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      ++|+|.+++...  .+++.+...++.|++.|++|+   |+.+++|+||+|+||+++.++.++++|||++..+....  ..
T Consensus        85 ~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~l---h~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06640          85 GGGSALDLLRAG--PFDEFQIATMLKEILKGLDYL---HSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--cc
Confidence            999999998754  578889999999999999999   78999999999999999999999999999998764322  12


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcccccccCcch------------hhhhHHHHHHHHHHHHHHc
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK------------HFAAKEQCLLSIFSLALEC  952 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~------------~~~~~~~~~~~l~~l~~~c  952 (985)
                      .....++..|+|||.+.+..++.++|+ |++|+.++++++|..+.....            .......++..+.+++.+|
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv-~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADI-WSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC  236 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHH-HHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHH
Confidence            233458889999999988889999999 999999999999987654221            1112335677899999999


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 001988          953 TMESPEKRIDAKDTITR  969 (985)
Q Consensus       953 l~~~P~~RPt~~ev~~~  969 (985)
                      |+.+|++||++.++++.
T Consensus       237 l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         237 LNKDPSFRPTAKELLKH  253 (277)
T ss_pred             cccCcccCcCHHHHHhC
Confidence            99999999999999776

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=6.2e-31  Score=290.26  Aligned_cols=236  Identities=20%  Similarity=0.284  Sum_probs=194.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ++|...+.||+|+||.||+|+.+ +++.||+|.++.... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57888999999999999999865 688999999875432 2345678899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      ++ ++|.+++......+++..+..++.|+++||+||   |+.+|+||||||+||++++++.+||+|||++........  
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--  159 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC---HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--  159 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence            96 599999887666788999999999999999999   789999999999999999999999999999876532221  


Q ss_pred             eeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhh--------------------------
Q 001988          884 MRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--------------------------  936 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--------------------------  936 (985)
                      ......+++.|+|||.+.+ ..++.++|+ |++|++++++++|..+........                          
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv-~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDM-WGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence            1223457889999998765 347788999 999999999999886543221100                          


Q ss_pred             ---------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 ---------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 ---------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                     ..+.++..+.+++.+|+..||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                           00113456789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=6.9e-31  Score=283.18  Aligned_cols=227  Identities=22%  Similarity=0.352  Sum_probs=186.1

Q ss_pred             ceeeccCceeEEEEEEcCC-----------cEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          732 NIIGIGGFGSVYRARLEDG-----------VEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~~~-----------~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      +.||+|+||.||+|...+.           ..||+|.+...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            4689999999999987633           25788877654322 6788999999999999999999999988 778999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-------cEEEecccCc
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM-------VAHLSDFGMA  873 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~-------~~kl~DfGla  873 (985)
                      |||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL---EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---hhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            999999999999987665789999999999999999999   899999999999999999888       8999999999


Q ss_pred             eeccCCCCcceecccccccccccccccccC--ccchhhhcccccccchhhhccc-ccccCcchhhhh----------HHH
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFVG--ELSLKRWVNDLLPVSLVEVVDK-SLLSGEEKHFAA----------KEQ  940 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~dv~~~~g~~~~~i~~~-~~~~~~~~~~~~----------~~~  940 (985)
                      +....      .....++..|+|||++...  .++.++|+ |++|+.+++++.+ ..+.........          +..
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di-~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  228 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADK-WSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMP  228 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHH-HHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCC
Confidence            87532      1223467789999998776  78899999 9999999999874 433222110000          001


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 001988          941 CLLSIFSLALECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L  970 (985)
                      ....+.+++.+||..+|.+||++.|+++.|
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         229 DCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            126788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=295.85  Aligned_cols=245  Identities=22%  Similarity=0.361  Sum_probs=210.5

Q ss_pred             cCCceeeccCceeEEEEEE-cCC----cEEEEEEeccC-CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          729 AENNIIGIGGFGSVYRARL-EDG----VEIAIKVFHPQ-CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       729 ~~~~~ig~G~~g~V~~~~~-~~~----~~vAvK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      +..++||+|+||+||+|.+ .+|    .+||||++... ......++..|+-+|.+++|||+++++++|.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            4567899999999999975 343    35899988755 3345678999999999999999999999998776 789999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |+|.|+|.|+++.++..+-....+.|..|||+||.||   |++++|||||.++|||+..-..+|+.|||+|+....++..
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YL---e~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYL---EEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHH---HhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            9999999999999888888999999999999999999   8999999999999999999999999999999998766666


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhccccc-ccCcc------------hhhhhHHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSL-LSGEE------------KHFAAKEQCLLSIFSLA  949 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~-~~~~~------------~~~~~~~~~~~~l~~l~  949 (985)
                      .......-.+.|||-|.+....++.++|| |++|+.+||+++-.- +....            .+..+++-|...++.+|
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDV-WsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m  933 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDV-WSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM  933 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhh-hhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence            55555556778999999999999999999 999999999987322 11111            13445666889999999


Q ss_pred             HHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          950 LECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                      .+||+.|++.||+++++...+.++.++..
T Consensus       934 vkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  934 VKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             HHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence            99999999999999999999998876543

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.97  E-value=7.6e-31  Score=287.26  Aligned_cols=235  Identities=23%  Similarity=0.327  Sum_probs=191.8

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +|+..+.||+|+||.||+|+.. +++.||+|+++....  .....+.+|+.++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4777889999999999999865 789999999875422  2346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          804 MSNGSLEDCLHSS--NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       804 ~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ++ ++|.+++...  +..+++..+..++.|+++||+||   |+++++||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC---HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 6898888653  24689999999999999999999   78999999999999999999999999999987653221 


Q ss_pred             cceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhhh-----------------------
Q 001988          882 STMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------------------  937 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------------------  937 (985)
                       .......+++.|+|||.+.+. .++.++|+ |++|+.+++++++..+.........                       
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv-~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDI-WSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHH-HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence             112233578899999987654 46889999 9999999999998765432211000                       


Q ss_pred             -----------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 -----------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 -----------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                       ...+++++.+++++|+..||.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                             0113466789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=9e-31  Score=287.12  Aligned_cols=234  Identities=25%  Similarity=0.346  Sum_probs=188.3

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhc---CCCCeeeEEeeeec-----CC
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNI---RHRNLVKIISSCSN-----DD  795 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l---~h~niv~l~~~~~~-----~~  795 (985)
                      +|+..+.||+|+||.||+|+.. +++.||+|.++.....  ....+.+|+++++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999865 7889999998754322  234566788877766   69999999998864     24


Q ss_pred             ceEEEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCce
Q 001988          796 FKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK  874 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~  874 (985)
                      ..++||||++ ++|.+++... ...+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            5789999997 4898888764 33589999999999999999999   78999999999999999999999999999998


Q ss_pred             eccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh------------------
Q 001988          875 LLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------------  936 (985)
Q Consensus       875 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------------  936 (985)
                      .+....   ......+|+.|+|||.+.+..++.++|+ |++|+.+++++++..+........                  
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di-wslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDM-WSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             cccCcc---cCCCccccccccCchHhhCCCCCCcchh-hhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            764222   1233468999999999999999999999 999999999998776543221100                  


Q ss_pred             --------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 --------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 --------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                          ....+++++.+++.+|+++||++||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                                00123566789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8e-31  Score=285.30  Aligned_cols=235  Identities=24%  Similarity=0.319  Sum_probs=200.4

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ++|+..+.||.|+||.||+|... +++.||+|.+.... ......+.+|++++++++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36778889999999999999865 78899999987653 33456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +++++|.+++...  .+++.....++.|++.|++||   |+++++||||+|+||++++++.++++|||+++.+....  .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYL---HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            9999999999865  688999999999999999999   78999999999999999999999999999998875332  1


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh------------hHHH-HHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------AKEQ-CLLSIFSLAL  950 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------~~~~-~~~~l~~l~~  950 (985)
                      ......+++.|+|||.+.+..++.++|+ |++|+.++++++|..+........            ..+. .+..+.+++.
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv-~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  232 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADI-WSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVS  232 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhH-HHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHH
Confidence            2234468889999999999889999999 999999999999887654321110            0111 4677999999


Q ss_pred             HccCCCCCCCCCHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~  968 (985)
                      +|+..+|++||+++++++
T Consensus       233 ~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         233 LCLNKDPKERPSAKELLK  250 (274)
T ss_pred             HHhhCChhhCcCHHHHhh
Confidence            999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=5.6e-31  Score=297.63  Aligned_cols=235  Identities=22%  Similarity=0.260  Sum_probs=191.6

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecC------
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSND------  794 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------  794 (985)
                      ..++|+..+.||+|+||.||+|... +++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999864 68899999987542  22345678899999999999999999988643      


Q ss_pred             CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCce
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK  874 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~  874 (985)
                      ...++||||+++ ++.+.+..   .+++..+..++.|+++||+||   |++||+||||||+||++++++.+||+|||+++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~L---H~~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            346899999965 67776653   478888899999999999999   78999999999999999999999999999998


Q ss_pred             eccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------------
Q 001988          875 LLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------------  937 (985)
Q Consensus       875 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------------  937 (985)
                      .....   .......||+.|+|||.+.+..++.++|+ |++|++++++++++.++........                 
T Consensus       168 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di-wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDI-WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             cCCCc---cccCCccccCCccCHHHHcCCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            65322   12234568999999999999899999999 9999999999998865432210000                 


Q ss_pred             ------------------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          938 ------------------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       938 ------------------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                                          ......++.+++.+|+..||.+|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                                                00013457899999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=1.6e-30  Score=279.98  Aligned_cols=237  Identities=29%  Similarity=0.482  Sum_probs=197.1

Q ss_pred             cCCceeeccCceeEEEEEEcC-----CcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          729 AENNIIGIGGFGSVYRARLED-----GVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       729 ~~~~~ig~G~~g~V~~~~~~~-----~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ...+.||.|+||.||+|+..+     +..||+|.+...... ..+.+..|++++++++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            456889999999999998753     378999999766443 56788999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          803 YMSNGSLEDCLHSSNCA-LNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      |+++++|.+++...... +++..+..++.|++.|++||   |+.+++||||||+||++++++.++++|||+++.......
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l---h~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL---ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHH---hcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            99999999999876434 89999999999999999999   899999999999999999999999999999987653322


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFSL  948 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~l  948 (985)
                      ... ....+++.|+|||.+....++.++|+ |++|++++++++ +..+.......            ..+..++.++.++
T Consensus       159 ~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di-~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (258)
T smart00219      159 YKK-KGGKLPIRWMAPESLKDGKFTSKSDV-WSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL  236 (258)
T ss_pred             ccc-ccCCCcccccChHHhccCCCCcchhH-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence            211 12236789999999988889999999 999999999987 44433221111            1122356789999


Q ss_pred             HHHccCCCCCCCCCHHHHHHHH
Q 001988          949 ALECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~~L  970 (985)
                      +.+|+..+|.+||++.|+++.|
T Consensus       237 i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      237 MLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHHHCcCChhhCcCHHHHHhhC
Confidence            9999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=9.4e-31  Score=296.75  Aligned_cols=235  Identities=21%  Similarity=0.247  Sum_probs=191.5

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecC------
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSND------  794 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------  794 (985)
                      ..++|...+.||+|+||.||+|... +++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999864 68899999987542  23346678999999999999999999987543      


Q ss_pred             CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCce
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK  874 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~  874 (985)
                      ...++||||+++ ++.+.+..   .+++.....++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHH---hhCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            357999999965 77777753   467888999999999999999   89999999999999999999999999999998


Q ss_pred             eccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhhH----------------
Q 001988          875 LLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK----------------  938 (985)
Q Consensus       875 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~----------------  938 (985)
                      .....   .......+|+.|+|||.+.+..++.++|+ |++|++++++++|..++.........                
T Consensus       175 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di-wSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         175 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDI-WSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             ccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhH-HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            65321   12234568999999999999999999999 99999999999988655322110000                


Q ss_pred             -------------------------------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          939 -------------------------------------EQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       939 -------------------------------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                                           .....++.+++.+|+..||.+|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                                                 0012457899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=5.5e-31  Score=288.13  Aligned_cols=237  Identities=22%  Similarity=0.308  Sum_probs=199.5

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ++|+..+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56778889999999999999865 68899999886543 23356789999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +++++|.+++...+ .+++.....++.+++.|+.|||  +.++++||||||+||++++++.++|+|||++.......   
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---  158 (284)
T cd06620          85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---  158 (284)
T ss_pred             CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH--HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence            99999999987653 6889999999999999999995  34689999999999999999999999999987653221   


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh-----------h-------------hHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-----------A-------------AKE  939 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-----------~-------------~~~  939 (985)
                       .....|+..|+|||.+.++.++.++|+ |++|+.+++++++..+.......           .             ...
T Consensus       159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di-~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd06620         159 -ADTFVGTSTYMSPERIQGGKYTVKSDV-WSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS  236 (284)
T ss_pred             -cCccccCcccCCHHHHccCCCCccchH-HHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence             223468999999999988899999999 99999999999988765432110           0             011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 001988          940 QCLLSIFSLALECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       940 ~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L  970 (985)
                      .++.++.+++.+|+..||++||++.|+++..
T Consensus       237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             hcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            2556789999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=4.1e-31  Score=288.04  Aligned_cols=235  Identities=25%  Similarity=0.338  Sum_probs=197.5

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3556678999999999999864 67889999987543 234567889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      ++++|.+++...  .+++..+..++.|+++|+.||   |+++++|+||+|+||++++++.+|++|||++..+....  ..
T Consensus        85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~l---H~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06642          85 GGGSALDLLKPG--PLEETYIATILREILKGLDYL---HSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHH---hcCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence            999999988753  578999999999999999999   78999999999999999999999999999998764322  11


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh------------hhHHHHHHHHHHHHHHc
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF------------AAKEQCLLSIFSLALEC  952 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~------------~~~~~~~~~l~~l~~~c  952 (985)
                      .....++..|+|||.+.+..++.++|+ |++|+.++++++|..+.......            .....++.++.+++.+|
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv-~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADI-WSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEAC  236 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhH-HHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHH
Confidence            223458889999999999899999999 99999999999988765322111            11123567799999999


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 001988          953 TMESPEKRIDAKDTITR  969 (985)
Q Consensus       953 l~~~P~~RPt~~ev~~~  969 (985)
                      |+.+|++||++.++++.
T Consensus       237 l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         237 LNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ccCCcccCcCHHHHHHh
Confidence            99999999999999983

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=6.5e-31  Score=287.94  Aligned_cols=237  Identities=22%  Similarity=0.306  Sum_probs=196.7

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ++|+..+.||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36778899999999999999876 789999998875422 2346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          804 MSNGSLEDCLHSS--NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       804 ~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      +++++|.+++...  ...+++..+..++.|++.|+.|||  ++.+|+||||||+||+++.++.+||+|||++..+.... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK--EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH--hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            9999999988764  236899999999999999999995  35699999999999999999999999999987653221 


Q ss_pred             cceecccccccccccccccccCc------cchhhhcccccccchhhhcccccccCcchh---------------hhhHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGE------LSLKRWVNDLLPVSLVEVVDKSLLSGEEKH---------------FAAKEQ  940 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~---------------~~~~~~  940 (985)
                         .....+++.|+|||.+.+..      ++.++|+ |++|+.+++++++..+......               ...+..
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di-wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDV-WSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG  233 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccch-HhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence               22345888999999885543      4788999 9999999999998876532211               111233


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          941 CLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      ++.++.+++.+|+..+|++||++.+++..
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            56788999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.97  E-value=2e-30  Score=279.25  Aligned_cols=237  Identities=24%  Similarity=0.328  Sum_probs=197.0

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeec-CCceEEEEe
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSN-DDFKALVLE  802 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~~lv~e  802 (985)
                      +|+..+.||+|+||.||++..+ +++.||+|.+.....  ...+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4778899999999999999865 678899999875432  334578899999999999999999998764 446789999


Q ss_pred             ccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          803 YMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       803 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      |+++++|.+++... ...+++.++..++.|++.|++|+   |+.|++||||||+||+++.++.++|+|||++..+.... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~l---H~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL---HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            99999999999864 34589999999999999999999   78999999999999999999999999999998764322 


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh------------hHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------AKEQCLLSIFSLA  949 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------~~~~~~~~l~~l~  949 (985)
                       .......+++.|+|||...+..++.++|+ |++|++++++++++.+........            .+...++++.+++
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  234 (257)
T cd08223         157 -DMASTLIGTPYYMSPELFSNKPYNYKSDV-WALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELI  234 (257)
T ss_pred             -CccccccCCcCccChhHhcCCCCCchhhh-HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHH
Confidence             12234468899999999999999999999 999999999999876543321111            1123457799999


Q ss_pred             HHccCCCCCCCCCHHHHHHH
Q 001988          950 LECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~~  969 (985)
                      .+|+..+|++||++.++++.
T Consensus       235 ~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         235 ATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             HHHhccCcccCCCHHHHhcC
Confidence            99999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=1.5e-30  Score=279.78  Aligned_cols=234  Identities=28%  Similarity=0.424  Sum_probs=194.4

Q ss_pred             cCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccC
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      ++|...+.||+|+||.||+|.. +++.||+|.++...  ....+.+|+.++++++|||++++++++...+ .++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCC
Confidence            4688889999999999999975 57889999986542  3467889999999999999999999987654 689999999


Q ss_pred             CCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          806 NGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       806 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      +++|.+++.... ..+++..+.+++.|++.|++||   |+.|++||||||+||+++.++.+||+|||++.......    
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----  154 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL---ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----  154 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence            999999997653 3578999999999999999999   78999999999999999999999999999987643211    


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSIFSLALE  951 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l~~l~~~  951 (985)
                       .....+..|+|||.+..+.++.+.|+ |++|+.++++++ +..+......            ...++.+++++.+++.+
T Consensus       155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv-~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  232 (254)
T cd05083         155 -DNSKLPVKWTAPEALKHKKFSSKSDV-WSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTS  232 (254)
T ss_pred             -CCCCCCceecCHHHhccCCcCchhhH-HHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHH
Confidence             12234568999999988899999999 999999999986 6554332211            01123356789999999


Q ss_pred             ccCCCCCCCCCHHHHHHHHHH
Q 001988          952 CTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       952 cl~~~P~~RPt~~ev~~~L~~  972 (985)
                      ||+.+|++||++.++++.|++
T Consensus       233 ~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         233 CWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HcCCChhhCcCHHHHHHHHcc
Confidence            999999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.2e-31  Score=294.34  Aligned_cols=229  Identities=23%  Similarity=0.359  Sum_probs=190.3

Q ss_pred             CceeeccCceeEEEEEEc-CCcEEEEEEeccC----CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCc--eEEEEec
Q 001988          731 NNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ----CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDF--KALVLEY  803 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~----~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~--~~lv~e~  803 (985)
                      .++||+|+|-+||+|.+. +|.+||.-.++..    ......+|..|+++|+.++|||||++|.+|.+...  ..+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            457999999999999864 7888876555422    33445789999999999999999999999987655  6789999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc-CCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~-~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      +..|+|+.|.++.+ ..+....+.|++||+.||.|||. |.++|||||||-+||||+ .-|.|||+|+|+|+....    
T Consensus       125 ~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~----  198 (632)
T KOG0584|consen  125 FTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK----  198 (632)
T ss_pred             ccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhc----
Confidence            99999999998775 67889999999999999999997 888999999999999996 568999999999998642    


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhhH--------------HHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK--------------EQCLLSIFSL  948 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~--------------~~~~~~l~~l  948 (985)
                      .....+.|||.|||||.+- ..|....|| |+||++++||++++-++..=....+.              .-..+++.++
T Consensus       199 s~aksvIGTPEFMAPEmYE-E~YnE~VDV-YaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~f  276 (632)
T KOG0584|consen  199 SHAKSVIGTPEFMAPEMYE-ENYNELVDV-YAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREF  276 (632)
T ss_pred             cccceeccCccccChHHHh-hhcchhhhh-hhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHH
Confidence            2334478999999999755 889999999 99999999999988665432111110              1124678999


Q ss_pred             HHHccCCCCCCCCCHHHHHH
Q 001988          949 ALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~  968 (985)
                      |.+|+.. ..+||++.|++.
T Consensus       277 IekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  277 IEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHHhcC-chhccCHHHHhh
Confidence            9999999 999999999985

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=9e-31  Score=306.26  Aligned_cols=236  Identities=19%  Similarity=0.241  Sum_probs=188.5

Q ss_pred             HHHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCC------CCeeeEEeeeec
Q 001988          721 LLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRH------RNLVKIISSCSN  793 (985)
Q Consensus       721 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h------~niv~l~~~~~~  793 (985)
                      +...+++|+..+.||+|+||.||+|... +++.||||+++.. ......+..|+.++++++|      ++++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3345688999999999999999999864 6788999998643 2233456778888887754      458889998876


Q ss_pred             C-CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEEcCCC--------
Q 001988          794 D-DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS-TPIIHCDLKPSNVLLDEDM--------  863 (985)
Q Consensus       794 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivHrDlk~~Nill~~~~--------  863 (985)
                      . ++.++|||++ +++|.+++...+ .+++..+..++.||+.||+||   |+ .|||||||||+|||++.++        
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yL---H~~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYF---HTELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhcCCeecCCCCHHHEEEecCCcccccccc
Confidence            4 5788999998 779999887653 688999999999999999999   55 6999999999999998765        


Q ss_pred             --------cEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh
Q 001988          864 --------VAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF  935 (985)
Q Consensus       864 --------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~  935 (985)
                              .+||+|||.+....     ......+||+.|+|||++.+..++.++|+ |++|++++|+++|+.++......
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~Di-wSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDM-WSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             cccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCChH
Confidence                    49999999876432     12234579999999999999999999999 99999999999998876432110


Q ss_pred             hh---------------------------------------HH--------------HHHHHHHHHHHHccCCCCCCCCC
Q 001988          936 AA---------------------------------------KE--------------QCLLSIFSLALECTMESPEKRID  962 (985)
Q Consensus       936 ~~---------------------------------------~~--------------~~~~~l~~l~~~cl~~~P~~RPt  962 (985)
                      ..                                       +.              .....+.+++.+|+.+||++||+
T Consensus       352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            00                                       00              01234678999999999999999


Q ss_pred             HHHHHH
Q 001988          963 AKDTIT  968 (985)
Q Consensus       963 ~~ev~~  968 (985)
                      +.|+++
T Consensus       432 a~e~L~  437 (467)
T PTZ00284        432 ARQMTT  437 (467)
T ss_pred             HHHHhc
Confidence            999986

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=1.6e-30  Score=289.30  Aligned_cols=231  Identities=20%  Similarity=0.271  Sum_probs=181.7

Q ss_pred             CceeeccCceeEEEEEEc---CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeec--CCceEEEEeccC
Q 001988          731 NNIIGIGGFGSVYRARLE---DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN--DDFKALVLEYMS  805 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  805 (985)
                      +++||+|+||+||+|+..   +++.||+|.+....  ....+.+|++++++++||||+++++++..  +...++||||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999864   56789999987542  23457889999999999999999998854  456789999995


Q ss_pred             CCChHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE----cCCCcEEEecccCc
Q 001988          806 NGSLEDCLHSS--------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL----DEDMVAHLSDFGMA  873 (985)
Q Consensus       806 ~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill----~~~~~~kl~DfGla  873 (985)
                       ++|.+++...        ...+++.....++.|++.||+||   |+.||+||||||+||++    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             5888877532        22478889999999999999999   89999999999999999    46689999999999


Q ss_pred             eeccCCCCc-ceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchh-----------------
Q 001988          874 KLLSGEDES-TMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-----------------  934 (985)
Q Consensus       874 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-----------------  934 (985)
                      +.+...... .......||+.|+|||.+.+ ..++.++|+ |++|+++++++++..+......                 
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDI-WAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhH-HHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            876533221 12234568999999999876 457889999 9999999999998765431100                 


Q ss_pred             -------hhhHH----------------------------------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          935 -------FAAKE----------------------------------QCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       935 -------~~~~~----------------------------------~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                             ....+                                  ....++.+++.+|+..||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence                   00000                                  00134678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.97  E-value=1.8e-30  Score=284.35  Aligned_cols=236  Identities=23%  Similarity=0.325  Sum_probs=194.4

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ++|+..+.||+|+||.||+|+.+ +++.||+|++.....  ...+.+.+|++++++++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999876 689999999864421  233567899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |++++++..+.... ..+++..+..++.|++.||+||   |+.+++||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~L---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFC---HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            99998888776544 3689999999999999999999   789999999999999999999999999999987653322 


Q ss_pred             ceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh------------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA------------------------  937 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~------------------------  937 (985)
                       ......++..|+|||.+.+ ..++.++|+ |++|+.++++++++.+.........                        
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di-~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDV-WAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhh-HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence             1223457889999999875 557889999 9999999999998865432211000                        


Q ss_pred             ------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 ------------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 ------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                        ....+..+.+++.+||..+|++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                              0123466889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=2.1e-30  Score=280.82  Aligned_cols=239  Identities=26%  Similarity=0.360  Sum_probs=201.5

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ++|+..+.||.|+||.||+|... ++..||+|++.... ....+.+.+|+++++.++|+|++++++.+..++..++||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999854 68899999987543 23457789999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          804 MSNGSLEDCLHSSN--CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       804 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      +++++|.+++....  ..+++.....++.|++.|++||   |+.|++||||||+||++++++.+||+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---h~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL---HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999997642  3688999999999999999999   799999999999999999999999999999887654333


Q ss_pred             cc--eecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhh--------------h---HHHH
Q 001988          882 ST--MRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--------------A---KEQC  941 (985)
Q Consensus       882 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--------------~---~~~~  941 (985)
                      ..  ......|+..|+|||.+... .++.++|+ |++|+.++++++|+.+........              .   ....
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv-~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADI-WSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY  236 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccch-HhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccc
Confidence            21  22344689999999998877 78899999 999999999999987654322110              0   0134


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          942 LLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       942 ~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +.++.+++.+|+..+|++||++.++++
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         237 SKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            577899999999999999999999876

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=1.7e-30  Score=279.66  Aligned_cols=237  Identities=21%  Similarity=0.298  Sum_probs=199.5

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccC--CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +|+..+.||+|+||.||++... +++.||+|.+...  .....+++.+|++++++++||||+++++++.+.++.++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4778899999999999999854 7899999998643  223456789999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      +++++|.+++... ...+++.++.+++.|++.|++||   |+.+++|+||+|+||+++.++.++++|||++..+..... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV---HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            9999999998764 33578999999999999999999   789999999999999999999999999999987643221 


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh------------hhHHHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF------------AAKEQCLLSIFSLAL  950 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~------------~~~~~~~~~l~~l~~  950 (985)
                       ......|++.|+|||...+..++.++|+ |++|+.+++++++..+.......            ..+...+.++.+++.
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv-~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  234 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDI-WALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVS  234 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccch-hHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHH
Confidence             1223458889999999998889999999 99999999999987654332111            112335677999999


Q ss_pred             HccCCCCCCCCCHHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~  969 (985)
                      +||+.+|++||++.|+++.
T Consensus       235 ~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         235 QLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             HHhhCChhhCcCHHHHhhC
Confidence            9999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=7.4e-31  Score=314.17  Aligned_cols=242  Identities=19%  Similarity=0.269  Sum_probs=194.9

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeec--CCce
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSN--DDFK  797 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~  797 (985)
                      ...++|.+.+.||+|+||.||+|... ++..||+|.+....  ......+..|+.++++++|||||++++++..  ....
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            35578999999999999999999865 67789999987542  2335678899999999999999999998854  4568


Q ss_pred             EEEEeccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEeCCCCCCCEEEcC---------
Q 001988          798 ALVLEYMSNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGH----STPIIHCDLKPSNVLLDE---------  861 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h----~~~ivHrDlk~~Nill~~---------  861 (985)
                      ||||||+++|+|.+++...   ...+++..++.|+.||+.||+|||...    ..+||||||||+|||++.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999998753   346899999999999999999995321    256999999999999964         


Q ss_pred             --------CCcEEEecccCceeccCCCCcceeccccccccccccccccc--CccchhhhcccccccchhhhcccccccCc
Q 001988          862 --------DMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV--GELSLKRWVNDLLPVSLVEVVDKSLLSGE  931 (985)
Q Consensus       862 --------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~dv~~~~g~~~~~i~~~~~~~~~  931 (985)
                              .+.+||+|||++..+....   ......||+.|+|||++..  ..++.++|+ |++|+++++++++..++..
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDV-WSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDM-WALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHH-HHHHHHHHHHHHCCCCCCc
Confidence                    2358999999998764222   2234569999999999864  457889999 9999999999999877643


Q ss_pred             chhhhh------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          932 EKHFAA------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       932 ~~~~~~------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ......            ....+.++.+++..||..+|.+||++.|++.
T Consensus       246 ~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        246 ANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            321111            1124577999999999999999999999984

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.97  E-value=2e-30  Score=285.96  Aligned_cols=236  Identities=23%  Similarity=0.332  Sum_probs=193.8

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS-----TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      +|...+.||+|+||.||+|... +++.||||.++.....     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4677889999999999999865 7899999999765322     234567899999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+ +|+|.+++......+++..+.+++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL---HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 8999999987654689999999999999999999   88999999999999999999999999999998764332


Q ss_pred             Ccceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhh-----------------------
Q 001988          881 ESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------------------  936 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------------------  936 (985)
                      .  ......+++.|+|||.+.+ ..++.+.|+ |++|+.+++++++..+........                       
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv-~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDM-WSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             c--cccccccceeeeCHHHHhCCCCCCcHHHH-HHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence            1  1222346888999998864 456888999 999999999998854332111000                       


Q ss_pred             ----------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          937 ----------------AKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       937 ----------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                      .....+.++.+++.+||+.+|++||++.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                            001134678899999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.4e-30  Score=292.95  Aligned_cols=235  Identities=22%  Similarity=0.287  Sum_probs=191.1

Q ss_pred             HHhcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSND-----  794 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----  794 (985)
                      ...++|...+.||+|+||.||+|.. .+++.||||++.....  .....+.+|++++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3457899999999999999999986 4788999999875422  2345677899999999999999999987543     


Q ss_pred             -CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCc
Q 001988          795 -DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA  873 (985)
Q Consensus       795 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla  873 (985)
                       ...+++||++ +++|.+++...  .+++..+..++.|+++||+||   |++||+||||||+||++++++.+||+|||++
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~L---H~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYI---HSAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence             3568999998 78998887643  588999999999999999999   7899999999999999999999999999999


Q ss_pred             eeccCCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh------------H--
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA------------K--  938 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~------------~--  938 (985)
                      +.....     .....||+.|+|||.+.+ ..++.++|+ |++|+++++++++..+.........            +  
T Consensus       166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         166 RQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDI-WSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             eecCCC-----cCCccccccccCchHhcCCccCCchhhh-HhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            876422     223468999999999876 568889999 9999999999998765432210000            0  


Q ss_pred             ----------------------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          939 ----------------------------EQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       939 ----------------------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                                  ....+.+.+++.+|+..||.+||++.|++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                                        0112346789999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.97  E-value=2.4e-30  Score=283.45  Aligned_cols=236  Identities=23%  Similarity=0.331  Sum_probs=196.7

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +|+..+.||.|+||.||+|... +++.||+|++....  ......+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999864 78999999987654  23356789999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      + +++|.+++......+++.+++.++.|+++||+||   |+++++||||||+||++++++.++++|||.+........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM---HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 9999999987666789999999999999999999   789999999999999999999999999999987653322 1


Q ss_pred             eecccccccccccccccccCc-cchhhhcccccccchhhhcccccccCcchhhh--------------------------
Q 001988          884 MRTQTLATIGYMAPDEIFVGE-LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--------------------------  936 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--------------------------  936 (985)
                      ......++..|+|||.+.+.. ++.++|+ |++|+.+++++++..+........                          
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di-~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDL-WAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHH-HHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence            123346899999999886544 5889999 999999999999865432211000                          


Q ss_pred             ---------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 ---------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 ---------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                     ...+.+.++.+++++|+..+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                           00123577899999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=1.8e-30  Score=281.48  Aligned_cols=234  Identities=20%  Similarity=0.286  Sum_probs=181.2

Q ss_pred             eeeccCceeEEEEEEcCC---cEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCC
Q 001988          733 IIGIGGFGSVYRARLEDG---VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGS  808 (985)
Q Consensus       733 ~ig~G~~g~V~~~~~~~~---~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  808 (985)
                      .||+|+||.||+|+..++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999975433   346677766443 2345678999999999999999999999999999999999999999


Q ss_pred             hHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCccee
Q 001988          809 LEDCLHSSN---CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR  885 (985)
Q Consensus       809 L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~  885 (985)
                      |.+++....   ...++.....++.|+++||+||   |+.+++||||||+||+++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM---HKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999997642   2456677788999999999999   7899999999999999999999999999998653222211222


Q ss_pred             ccccccccccccccccc-------Cccchhhhcccccccchhhhccc-ccccCcchhhh-----------------hHHH
Q 001988          886 TQTLATIGYMAPDEIFV-------GELSLKRWVNDLLPVSLVEVVDK-SLLSGEEKHFA-----------------AKEQ  940 (985)
Q Consensus       886 ~~~~gt~~y~aPE~~~~-------~~~~~~~dv~~~~g~~~~~i~~~-~~~~~~~~~~~-----------------~~~~  940 (985)
                      ....++..|+|||++..       ..++.+.|+ |++|+.+++++++ ..+........                 ....
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Di-wslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNV-WALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP  237 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchh-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence            34568889999998743       235678899 9999999999864 32222111100                 0112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 001988          941 CLLSIFSLALECTMESPEKRIDAKDTITRLL  971 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~  971 (985)
                      ..+.+.+++..|| .+|++||++.++++.|.
T Consensus       238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         238 YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            3566888999999 67999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=2.1e-30  Score=281.68  Aligned_cols=237  Identities=24%  Similarity=0.378  Sum_probs=195.0

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc----------hHHHHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS----------TLKSFEAECEVIKNIRHRNLVKIISSCSNDD  795 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~----------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~  795 (985)
                      +|...+.||.|+||.||+|... +++.||+|.++.....          ..+.+.+|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677889999999999999854 7899999988642111          1245788999999999999999999999999


Q ss_pred             ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          796 FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      ..++||||+++++|.+++...+ .+++..+..++.|++.|+.||   |+++++||||+|+||+++.++.++++|||+++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYL---HSKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHH---hhCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            9999999999999999998764 688899999999999999999   789999999999999999999999999999976


Q ss_pred             ccCCCCcceecccccccccccccccccCc--cchhhhcccccccchhhhcccccccCcchhhh-----------------
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFVGE--LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------------  936 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------------  936 (985)
                      ..............++..|+|||.+....  ++.++|+ |++|+++++++++..+........                 
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv-~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDI-WSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD  236 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchh-HHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcc
Confidence            54322222233445889999999987655  7889999 999999999999876653221110                 


Q ss_pred             hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ....++.++.+++.+|+.++|++||++.++++
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         237 VSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            01124678999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.97  E-value=2.5e-30  Score=278.57  Aligned_cols=234  Identities=24%  Similarity=0.325  Sum_probs=197.8

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-----cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-----ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      +|+..+.||+|+||.||+|... +++.||+|.+....     ....+.+.+|++++++++|+||+++++++......++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999976 78999999986543     12346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++++|.+++.... .+++..+..++.|+++|++||   |+.|++||||+|+||+++.++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYL---HDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999997654 578999999999999999999   78999999999999999999999999999988754322


Q ss_pred             CcceecccccccccccccccccCc-cchhhhcccccccchhhhcccccccCcchhhh-------------hHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGE-LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------AKEQCLLSIF  946 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------~~~~~~~~l~  946 (985)
                         ......+++.|+|||.+.... ++.++|+ |++|+.+++++++..+........             .++.+.+.+.
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~-~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADI-WSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAK  232 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhh-HHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHH
Confidence               223456889999999987776 8899999 999999999999887654432111             1122457789


Q ss_pred             HHHHHccCCCCCCCCCHHHHHH
Q 001988          947 SLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +++.+||..+|++||++.++++
T Consensus       233 ~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         233 DFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             HHHHHHhhcCcccCcCHHHHhc
Confidence            9999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.97  E-value=3.1e-30  Score=279.31  Aligned_cols=237  Identities=25%  Similarity=0.319  Sum_probs=192.5

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-----chHHHHHHHHHHHHhcCCCCeeeEEeeeec--CCce
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-----STLKSFEAECEVIKNIRHRNLVKIISSCSN--DDFK  797 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-----~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~  797 (985)
                      .+|...+.||+|+||.||+|... +++.||+|++.....     .....+.+|+.++++++||||+++++++.+  .+..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888999999999999999864 689999998864421     223568899999999999999999998865  3567


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      +++|||+++++|.+++.... .+++.....++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++...
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~L---H~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            89999999999999997654 578899999999999999999   78999999999999999999999999999987653


Q ss_pred             CCCC-cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-------------hHHHHHH
Q 001988          878 GEDE-STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------AKEQCLL  943 (985)
Q Consensus       878 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------~~~~~~~  943 (985)
                      .... ........++..|+|||.+.+..++.++|+ |++|+.++++++|+.+........             .+....+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADV-WSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE  236 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhh-HHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCH
Confidence            2111 111223458899999999998889999999 999999999999887654321111             1223345


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+.+++ .||..+|++||++.|+++
T Consensus       237 ~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         237 HARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HHHHHH-HHhcCChhhCcCHHHHhc
Confidence            566677 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=3.5e-30  Score=279.45  Aligned_cols=238  Identities=23%  Similarity=0.330  Sum_probs=196.8

Q ss_pred             CccCCceeeccCceeEEEEEEcC--CcEEEEEEeccCC----------cchHHHHHHHHHHHHh-cCCCCeeeEEeeeec
Q 001988          727 NFAENNIIGIGGFGSVYRARLED--GVEIAIKVFHPQC----------ASTLKSFEAECEVIKN-IRHRNLVKIISSCSN  793 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~~--~~~vAvK~~~~~~----------~~~~~~~~~E~~il~~-l~h~niv~l~~~~~~  793 (985)
                      +|+..+.||+|+||.||+|..+.  ++.+|+|.+....          .....++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            46778899999999999999764  6789999885331          1223456778888865 799999999999999


Q ss_pred             CCceEEEEeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCeEeCCCCCCCEEEcCCCcEEEec
Q 001988          794 DDFKALVLEYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALEYLHFGH-STPIIHCDLKPSNVLLDEDMVAHLSD  869 (985)
Q Consensus       794 ~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h-~~~ivHrDlk~~Nill~~~~~~kl~D  869 (985)
                      ++..++||||+++++|.+++..   ....+++..+++++.|++.|+.||   | ..+++||||||+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYL---HKEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHh---ccCCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988743   345688999999999999999999   6 47899999999999999999999999


Q ss_pred             ccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-------------
Q 001988          870 FGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------  936 (985)
Q Consensus       870 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------  936 (985)
                      ||.+.......   ......++..|+|||.+..+.++.++|+ |++|+.+++++++..+........             
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv-~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  233 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADV-WAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL  233 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHH-HHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC
Confidence            99998764332   2334568899999999998889999999 999999999999876644321110             


Q ss_pred             hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 001988          937 AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLL  971 (985)
Q Consensus       937 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~  971 (985)
                      ....++.++.+++.+||+.||++||++.|+..+++
T Consensus       234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11134678999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=7.3e-31  Score=288.01  Aligned_cols=234  Identities=23%  Similarity=0.285  Sum_probs=196.7

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      |.....||+|+||.||++... ++..||||.+........+.+.+|+.++++++||||+++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            334467999999999999864 6889999998765555566789999999999999999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      ++|.+++...  .+++.++..++.|++.|++||   |+++|+||||||+||++++++.+||+|||++........  ...
T Consensus       104 ~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~  176 (292)
T cd06658         104 GALTDIVTHT--RMNEEQIATVCLSVLRALSYL---HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK  176 (292)
T ss_pred             CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence            9999988653  578999999999999999999   788999999999999999999999999999876542221  223


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh--------------hHHHHHHHHHHHHHHc
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--------------AKEQCLLSIFSLALEC  952 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--------------~~~~~~~~l~~l~~~c  952 (985)
                      ...++..|+|||......++.++|+ |++|+++++++++..+........              .....++.+.+++.+|
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv-~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  255 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDI-WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM  255 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence            3468999999999988889999999 999999999999887654322111              1112456788999999


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 001988          953 TMESPEKRIDAKDTITR  969 (985)
Q Consensus       953 l~~~P~~RPt~~ev~~~  969 (985)
                      +..+|.+||++.|+++.
T Consensus       256 l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         256 LVREPSQRATAQELLQH  272 (292)
T ss_pred             ccCChhHCcCHHHHhhC
Confidence            99999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=1.4e-30  Score=290.94  Aligned_cols=234  Identities=16%  Similarity=0.236  Sum_probs=188.6

Q ss_pred             Cceeecc--CceeEEEEEE-cCCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccC
Q 001988          731 NNIIGIG--GFGSVYRARL-EDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       731 ~~~ig~G--~~g~V~~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      .++||+|  +|++||++.. .+|+.||+|+++....  .....+.+|+++++.++||||+++++++..++..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4679999  7889999986 4889999999976532  234567889999999999999999999999999999999999


Q ss_pred             CCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc-
Q 001988          806 NGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST-  883 (985)
Q Consensus       806 ~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-  883 (985)
                      +|+|.+++... ...+++..+..++.|++.||+||   |+++|+||||||+||+++.++.++++||+.+.......... 
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            99999998754 34588999999999999999999   78999999999999999999999999998754432111110 


Q ss_pred             ----eeccccccccccccccccc--CccchhhhcccccccchhhhcccccccCcchhhh---------------------
Q 001988          884 ----MRTQTLATIGYMAPDEIFV--GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------------  936 (985)
Q Consensus       884 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------------  936 (985)
                          ......++..|+|||++..  ..++.++|+ |++|+++++++++..++.......                     
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di-wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI-YSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhH-HHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                1122346778999999876  458899999 999999999999887653211000                     


Q ss_pred             ------------------------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 ------------------------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 ------------------------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                          .......++.+++.+|++.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                                                00123457889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=6.2e-31  Score=287.80  Aligned_cols=235  Identities=21%  Similarity=0.298  Sum_probs=191.5

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +|+..+.||+|+||.||+|+.. +|+.||+|+++....  .....+.+|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777889999999999999865 789999999875422  2235678899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      ++ ++|.+++......+++...+.++.||++||+||   |+++|+||||||+||+++.++.+||+|||+++.+.....  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC---HSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence            96 588888876555789999999999999999999   789999999999999999999999999999986542221  


Q ss_pred             eecccccccccccccccccCc-cchhhhcccccccchhhhcccccccCcchhh-h-------------------------
Q 001988          884 MRTQTLATIGYMAPDEIFVGE-LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-A-------------------------  936 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-~-------------------------  936 (985)
                      ......+++.|+|||.+.+.. ++.++|+ |++|+.+++++++..+....... .                         
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di-wslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDM-WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHH-HHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence            122345788999999887644 6889999 99999999999876542111000 0                         


Q ss_pred             ---------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 ---------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 ---------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                     ......+++.+++++|+..||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                           00113467789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.1e-32  Score=315.10  Aligned_cols=240  Identities=25%  Similarity=0.306  Sum_probs=200.5

Q ss_pred             HhcCccCCceeeccCceeEEEEE-EcCCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .+-+++.+..||.|.||.||-|. .++|.-.|+|.++.+.  ....+.+.+|..++..++|||+|++||+-..++..+|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            45567888999999999999998 5678889999887552  33456788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      ||||++|+|.+.+...+ ..++.....+..|++.|++||   |++|||||||||+||+++.+|.+|++|||.|..+....
T Consensus      1313 MEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~L---H~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYL---HEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHH---HhcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            99999999999998764 556677777899999999999   89999999999999999999999999999999886542


Q ss_pred             C--cceecccccccccccccccccCc---cchhhhcccccccchhhhcccccccCcch-------------hhhhHHHHH
Q 001988          881 E--STMRTQTLATIGYMAPDEIFVGE---LSLKRWVNDLLPVSLVEVVDKSLLSGEEK-------------HFAAKEQCL  942 (985)
Q Consensus       881 ~--~~~~~~~~gt~~y~aPE~~~~~~---~~~~~dv~~~~g~~~~~i~~~~~~~~~~~-------------~~~~~~~~~  942 (985)
                      .  .......+||+.|||||++.+..   -..+.|+ |++||++.||++|+-++....             .+..|+...
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~Di-WslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls 1467 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADI-WSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLS 1467 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhh-hcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhh
Confidence            1  12234567999999999987533   3456677 999999999999987665432             223456677


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          943 LSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       943 ~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+-.+++.+|+..||++|.++.|+++
T Consensus      1468 ~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1468 SEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             HhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            88899999999999999998887654

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=1.8e-30  Score=283.74  Aligned_cols=245  Identities=23%  Similarity=0.309  Sum_probs=199.0

Q ss_pred             CHHHHHHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeec-
Q 001988          717 SYFELLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSN-  793 (985)
Q Consensus       717 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~-  793 (985)
                      +..++..+.+.|+..+.||+|+||.||+|... +++.||+|.+.... ....++..|+.+++++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            44555567788999999999999999999864 78899999986542 3346788999999998 69999999999853 


Q ss_pred             -----CCceEEEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEE
Q 001988          794 -----DDFKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHL  867 (985)
Q Consensus       794 -----~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl  867 (985)
                           .+..++||||+++|+|.+++... ...+++..+..++.|++.|++||   |+.+|+||||||+||++++++.++|
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL---HAHKVIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEE
Confidence                 45789999999999999998764 34578888899999999999999   7899999999999999999999999


Q ss_pred             ecccCceeccCCCCcceecccccccccccccccc-----cCccchhhhcccccccchhhhcccccccCcchhhh------
Q 001988          868 SDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF-----VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------  936 (985)
Q Consensus       868 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------  936 (985)
                      +|||++........  ......|++.|+|||.+.     ...++.++|+ |++|+.+++++++..+........      
T Consensus       163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dv-wslG~~l~el~~g~~p~~~~~~~~~~~~~~  239 (282)
T cd06636         163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDI-WSLGITAIEMAEGAPPLCDMHPMRALFLIP  239 (282)
T ss_pred             eeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccch-hHHHHHHHHHHhCCCCccccCHHhhhhhHh
Confidence            99999876532111  123356899999999875     3557788999 999999999999887653321110      


Q ss_pred             -------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 -------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 -------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                             ....++.++.+++.+||+.+|.+||++.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         240 RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                   11235678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=3.7e-30  Score=279.91  Aligned_cols=242  Identities=25%  Similarity=0.395  Sum_probs=193.7

Q ss_pred             ccCCceeeccCceeEEEEEEc----CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCC------
Q 001988          728 FAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD------  795 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~----~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------  795 (985)
                      |...+.||+|+||.||+|...    +++.||||++....  ....+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456788999999999999753    46889999987653  233567889999999999999999999886532      


Q ss_pred             ceEEEEeccCCCChHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 001988          796 FKALVLEYMSNGSLEDCLHSS-----NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDF  870 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~Df  870 (985)
                      ..++++||+++|+|.+++...     ...+++....+++.|++.|++||   |+.+|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccchhhEEEcCCCCEEECcc
Confidence            247899999999999887532     22478889999999999999999   7899999999999999999999999999


Q ss_pred             cCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh------------h
Q 001988          871 GMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA------------A  937 (985)
Q Consensus       871 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~------------~  937 (985)
                      |.++...............+++.|++||.+....++.++|+ |++|++++++++ +..+........            .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi-~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  236 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDV-WAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ  236 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhh-HHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence            99987643322222223346678999999998889999999 999999999987 544432221110            1


Q ss_pred             HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          938 KEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       938 ~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                      +..++..+.+++.+|++.+|++||++.++++.|+++
T Consensus       237 ~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            123457899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=3.6e-30  Score=282.77  Aligned_cols=236  Identities=22%  Similarity=0.326  Sum_probs=192.7

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ++|+..+.||+|+||.||+|..+ +++.||+|.+...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67888999999999999999875 7899999998754322 234567899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +++ +|.+++......+++.....++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--  158 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC---HQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--  158 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence            974 99999887666789999999999999999999   789999999999999999999999999999876432111  


Q ss_pred             eeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhh-hh------------------------
Q 001988          884 MRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-AA------------------------  937 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-~~------------------------  937 (985)
                      ......++..|+|||.+.+ ..++.++|+ |++|+++++++++..+....... ..                        
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv-~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDM-WGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHH-HHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            1122346889999998875 457889999 99999999999987655322100 00                        


Q ss_pred             ------------H-----HHHH--HHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 ------------K-----EQCL--LSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 ------------~-----~~~~--~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                  +     ....  .+..+++.+|++.+|++||++.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                        0     0011  56779999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-31  Score=278.33  Aligned_cols=236  Identities=22%  Similarity=0.273  Sum_probs=202.9

Q ss_pred             CccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      =|...+-||+|.|+.|-+|++ -+|.+||||++.+....  ....+.+|++.|+.++|||||++|++.......|+|+|+
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            355566799999999999985 48999999999876443  345788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE-cCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL-DEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill-~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      -++|+|+||+.++...+.+....+++.||+.|+.|+   |...+||||+||+||.+ .+-|-|||.|||++..+.+.   
T Consensus        99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YC---HqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG---  172 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYC---HQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG---  172 (864)
T ss_pred             cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHH---hhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc---
Confidence            999999999998887899999999999999999999   67789999999999877 56789999999999887432   


Q ss_pred             ceecccccccccccccccccCccch-hhhcccccccchhhhcccccccCcchhh-----------hhHHHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSL-KRWVNDLLPVSLVEVVDKSLLSGEEKHF-----------AAKEQCLLSIFSLAL  950 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~-~~dv~~~~g~~~~~i~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~  950 (985)
                      ......||+..|-|||++.+..|.. +.|+ |++|+.++.++-|..++....+.           ..+..+..+..++|.
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDi-WSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~  251 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDI-WSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQ  251 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhh-hHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHH
Confidence            2345678999999999999999875 5566 99999999999998877654322           234456788999999


Q ss_pred             HccCCCCCCCCCHHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~  969 (985)
                      .|+..||++|.+..||+..
T Consensus       252 sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  252 SMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             HHHhcCchhhccHHHHhcc
Confidence            9999999999999998753

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.97  E-value=1.4e-30  Score=285.39  Aligned_cols=236  Identities=25%  Similarity=0.358  Sum_probs=194.3

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ++|+..+.||+|+||.||+|..+ +++.||+|++......  ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888899999999999999975 6899999998654322  34568899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |++++++.++..... .+++..+..++.|+++|++||   |+.+++|||++|+||++++++.+||+|||++..+..... 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~L---H~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07846          81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFC---HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  155 (286)
T ss_pred             cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence            999998888766543 589999999999999999999   788999999999999999999999999999987643321 


Q ss_pred             ceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhh-------------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------------------  936 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------------------  936 (985)
                       ......++..|+|||.+.+ ..++.++|+ |++|+.++++++|..+........                         
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv-~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         156 -VYTDYVATRWYRAPELLVGDTKYGRAVDI-WAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             -ccCcccceeeccCcHHhccccccCchHhH-HHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence             2233458899999998875 446788999 999999999999875443211100                         


Q ss_pred             -----------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 -----------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 -----------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                       .....+..+.+++.+||..+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                             00123567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=2.3e-31  Score=310.10  Aligned_cols=241  Identities=25%  Similarity=0.310  Sum_probs=188.5

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeec-------
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSN-------  793 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-------  793 (985)
                      +...+|.+.+.||+||||.||+++.+ ||+.||||++.... ......+.+|+..+++++|||||+|+..|.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34567778889999999999999977 99999999998664 2234567899999999999999999865410       


Q ss_pred             ------------------------------------------------C-------------------------------
Q 001988          794 ------------------------------------------------D-------------------------------  794 (985)
Q Consensus       794 ------------------------------------------------~-------------------------------  794 (985)
                                                                      .                               
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                            0                               


Q ss_pred             ---------------------------------CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 001988          795 ---------------------------------DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF  841 (985)
Q Consensus       795 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~  841 (985)
                                                       ...||.||||+..++.+.++.+...-.....++++++|++||+|+  
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI--  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI--  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH--
Confidence                                             124688999999888888877643324667788999999999999  


Q ss_pred             cCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc----------------CCCCcceecccccccccccccccccCc-
Q 001988          842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS----------------GEDESTMRTQTLATIGYMAPDEIFVGE-  904 (985)
Q Consensus       842 ~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~-  904 (985)
                       |++|||||||||.||++|+++.|||+|||+|+...                ........+..+||.-|+|||.+.+.. 
T Consensus       714 -H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  714 -HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             -HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence             89999999999999999999999999999998721                011122456678999999999987654 


Q ss_pred             --cchhhhcccccccchhhhcccccccC-------------cchhh-hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          905 --LSLKRWVNDLLPVSLVEVVDKSLLSG-------------EEKHF-AAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       905 --~~~~~dv~~~~g~~~~~i~~~~~~~~-------------~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                        |+.+.|+ |++|++++||+.. +.+.             ..|.. .........-.++++.+++.||.+||||.|++.
T Consensus       793 ~~Yn~KiDm-YSLGIVlFEM~yP-F~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  793 NKYNSKIDM-YSLGIVLFEMLYP-FGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ccccchhhh-HHHHHHHHHHhcc-CCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence              9999999 9999999999865 2111             11111 111223444577999999999999999999874

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=4.7e-30  Score=281.83  Aligned_cols=238  Identities=22%  Similarity=0.294  Sum_probs=192.6

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++++|...+.||+|+||.||+|... +++.||+|++...... ....+.+|++++++++|+||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999864 7899999998755322 2346788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||++ +++.+++......+.+.....++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI---HGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9995 688777765545678888899999999999999   788999999999999999999999999999876432221


Q ss_pred             cceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhh-hh----------------------
Q 001988          882 STMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-AA----------------------  937 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-~~----------------------  937 (985)
                        ......+++.|+|||.+.+. .++.++|+ |++|+++++++++..+....... ..                      
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv-~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         159 --TYSSEVVTLWYRPPDVLLGATDYSSALDI-WGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             --CCCCccccccccCCceeecCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence              12234578899999988753 57888999 99999999999988754321100 00                      


Q ss_pred             ---------------H------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 ---------------K------EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 ---------------~------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                     .      ...+.++.+++.+|+..||++|||+.|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                           0      001356788999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=1.1e-30  Score=282.70  Aligned_cols=235  Identities=23%  Similarity=0.331  Sum_probs=198.9

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      +|+..+.||+|+||.||+|..+ +++.||+|.+..... ....++.+|++++++++||||+++++++...+..++|+||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5677788999999999999876 688999999876533 34567889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS-TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      ++++|.+++......+++....+++.|+++|++|+   |+ .+++||||||+||++++++.+||+|||.+........  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  156 (265)
T cd06605          82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYL---HEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--  156 (265)
T ss_pred             CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHH---cCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence            99999999987655788999999999999999999   78 9999999999999999999999999999876532211  


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcch----h-h------------hhHH-HHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK----H-F------------AAKE-QCLLSI  945 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~----~-~------------~~~~-~~~~~l  945 (985)
                        ....++..|+|||.+.+..++.++|+ |++|+++++++++..+.....    . .            ..+. ..+.++
T Consensus       157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv-~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd06605         157 --KTFVGTSSYMAPERIQGNDYSVKSDI-WSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF  233 (265)
T ss_pred             --hcccCChhccCHHHHcCCCCCchhhH-HHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence              12568899999999999999999999 999999999999876553321    0 0            0111 156779


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHH
Q 001988          946 FSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      .+++.+||..+|++||++.++++.
T Consensus       234 ~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         234 QDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             HHHHHHHcCCCchhCcCHHHHhhC
Confidence            999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=2.5e-30  Score=285.99  Aligned_cols=242  Identities=21%  Similarity=0.258  Sum_probs=196.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|+..+.||+|+||.||+|... +++.||+|.+.....   .....+.+|+++++.++||||+++++++..+++.++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888899999999999999865 678999999876532   23456789999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC-
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED-  880 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~-  880 (985)
                      ||++|++|.+++...+ .+++.....++.|++.|++||   |+.+++||||||+||+++.++.+|++|||+++...... 
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYL---HNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            9999999999997654 678899999999999999999   78999999999999999999999999999986421100 


Q ss_pred             ------------CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh------------
Q 001988          881 ------------ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------  936 (985)
Q Consensus       881 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------  936 (985)
                                  .........++..|+|||.+....++.++|+ |++|+++++++++..+........            
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDW-WAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  235 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Confidence                        0001112357889999999988899999999 899999999999887654221110            


Q ss_pred             --hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 001988          937 --AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       937 --~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                        ....++.++.+++.+||+.+|++||++.++.+.++.
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence              011246779999999999999999997655555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=2.2e-30  Score=284.43  Aligned_cols=246  Identities=24%  Similarity=0.305  Sum_probs=199.0

Q ss_pred             cCHHHHHHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeec
Q 001988          716 FSYFELLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSN  793 (985)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~  793 (985)
                      +.+.++..++++|...+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            334555567889999999999999999999864 78899999986542 2346678899999999 89999999999865


Q ss_pred             C-----CceEEEEeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcE
Q 001988          794 D-----DFKALVLEYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  865 (985)
Q Consensus       794 ~-----~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~  865 (985)
                      .     +..++||||+++|+|.++++.   ....+++..++.++.|++.||+||   |+.+++||||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL---HNNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEcCCCCE
Confidence            3     357999999999999998863   244688999999999999999999   78999999999999999999999


Q ss_pred             EEecccCceeccCCCCcceecccccccccccccccccC-----ccchhhhcccccccchhhhcccccccCcchhh-----
Q 001988          866 HLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG-----ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-----  935 (985)
Q Consensus       866 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-----  935 (985)
                      ||+|||++........  ......++..|+|||.+...     .++.++|+ |++|+.++++++|+.+.......     
T Consensus       168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di-~slGvi~~el~~g~~p~~~~~~~~~~~~  244 (291)
T cd06639         168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDV-WSLGITAIELGDGDPPLFDMHPVKTLFK  244 (291)
T ss_pred             EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccch-HHHHHHHHHHhhCCCCCCCCcHHHHHHH
Confidence            9999999887542221  12234588999999987543     35789999 99999999999988654432111     


Q ss_pred             ---------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          936 ---------AAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       936 ---------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                               ..++.....+.+++.+||..+|++||++.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         245 IPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                     112234567889999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=8.7e-31  Score=288.17  Aligned_cols=231  Identities=23%  Similarity=0.292  Sum_probs=195.2

Q ss_pred             CceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCCh
Q 001988          731 NNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSL  809 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  809 (985)
                      ...||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++..++..++||||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            456999999999999864 7899999998765545566788999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecccc
Q 001988          810 EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL  889 (985)
Q Consensus       810 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  889 (985)
                      .+++...  .+++..+..++.|++.||+||   |+.+++||||||+||+++.++.+||+|||++..+....  .......
T Consensus       106 ~~~~~~~--~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~  178 (297)
T cd06659         106 TDIVSQT--RLNEEQIATVCESVLQALCYL---HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLV  178 (297)
T ss_pred             HHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccccee
Confidence            9987653  578999999999999999999   78999999999999999999999999999987654222  1223356


Q ss_pred             cccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh--------------hHHHHHHHHHHHHHHccCC
Q 001988          890 ATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--------------AKEQCLLSIFSLALECTME  955 (985)
Q Consensus       890 gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--------------~~~~~~~~l~~l~~~cl~~  955 (985)
                      +++.|+|||.+.+..++.++|+ |++|+.++++++++.+........              .....+..+.+++.+|+..
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv-~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~  257 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDI-WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR  257 (297)
T ss_pred             cCccccCHHHHccCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcC
Confidence            8999999999998899999999 999999999999887643221111              1112356789999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 001988          956 SPEKRIDAKDTITR  969 (985)
Q Consensus       956 ~P~~RPt~~ev~~~  969 (985)
                      +|++||++.++++.
T Consensus       258 ~P~~Rps~~~ll~~  271 (297)
T cd06659         258 EPQERATAQELLDH  271 (297)
T ss_pred             CcccCcCHHHHhhC
Confidence            99999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=5e-30  Score=279.46  Aligned_cols=235  Identities=25%  Similarity=0.332  Sum_probs=198.1

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      -|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3667788999999999999864 78899999886442 233467889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      ++++|.+++...  .+++.....++.|++.|++||   |+.|++|+||||+||+++.++.++++|||++..+....  ..
T Consensus        85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06641          85 GGGSALDLLEPG--PLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---ccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hh
Confidence            999999998753  578999999999999999999   89999999999999999999999999999987764322  11


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh------------hHHHHHHHHHHHHHHc
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------AKEQCLLSIFSLALEC  952 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------~~~~~~~~l~~l~~~c  952 (985)
                      .....++..|+|||.+....++.++|+ |++|+.+++++++..+........            ....++.++.+++.+|
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv-~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADI-WSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC  236 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhH-HHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence            223458889999999988888999999 999999999999987654322111            1123457799999999


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 001988          953 TMESPEKRIDAKDTITR  969 (985)
Q Consensus       953 l~~~P~~RPt~~ev~~~  969 (985)
                      ++.+|.+||++.++++.
T Consensus       237 l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         237 LNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ccCChhhCcCHHHHHhC
Confidence            99999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=2.9e-30  Score=279.93  Aligned_cols=237  Identities=24%  Similarity=0.383  Sum_probs=197.5

Q ss_pred             CccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCc------chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          727 NFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCA------STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      +|+..+.||+|+||.||+|.. .+++.||+|++.....      ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999985 5789999999875421      124678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-cEEEecccCceeccC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAKLLSG  878 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~~~~~  878 (985)
                      ||||+++++|.+++...+ .+++..+..++.|++.||+||   |++|++||||||+||+++.++ .+||+|||.+..+..
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~L---H~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYL---HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999997654 678999999999999999999   789999999999999998776 699999999887653


Q ss_pred             CCCc--ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh----------------hhHHH
Q 001988          879 EDES--TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF----------------AAKEQ  940 (985)
Q Consensus       879 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~----------------~~~~~  940 (985)
                      ....  .......++..|+|||.+.+..++.++|+ |++|++++++++++.+.......                ..++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv-~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDV-WSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH  235 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccch-HHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchh
Confidence            3211  11223468899999999988888999999 99999999999988765432111                11223


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          941 CLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+.++.+++.+|+..+|++||++.|+++
T Consensus       236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         236 LSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             hCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            5577899999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=5.9e-30  Score=283.24  Aligned_cols=233  Identities=26%  Similarity=0.312  Sum_probs=194.4

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ..|+..+.||+|+||.||+|... +++.||+|.+.....   ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45778899999999999999865 789999999864422   23456889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||++ |++.+.+......+++..+..++.|++.||.||   |+.+|+||||+|+||++++++.+||+|||++......  
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~L---H~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYL---HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            9996 578777765555789999999999999999999   7899999999999999999999999999998765321  


Q ss_pred             cceecccccccccccccccc---cCccchhhhcccccccchhhhcccccccCcchh-------------hhhHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIF---VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-------------FAAKEQCLLSI  945 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-------------~~~~~~~~~~l  945 (985)
                          ....+++.|+|||.+.   .+.++.++|+ |++|+.++++++|..+......             ......++.++
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv-~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (307)
T cd06607         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDV-WSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF  243 (307)
T ss_pred             ----CCccCCccccCceeeeccCCCCCCcccch-HHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH
Confidence                1245888999999874   4668889999 9999999999998865432111             01123466789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHH
Q 001988          946 FSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      .+++.+||+.+|++||++.+++..
T Consensus       244 ~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         244 RNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HHHHHHHhcCChhhCcCHHHHhcC
Confidence            999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=3.3e-30  Score=283.04  Aligned_cols=236  Identities=27%  Similarity=0.335  Sum_probs=200.3

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      ++|...+.||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            67888899999999999999854 78899999987654555677899999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      ++++|.+++...  .+++..+..++.|++.|+.||   |+.|++||||||+||+++.++.+||+|||++........  .
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~L---H~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~  171 (293)
T cd06647          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  171 (293)
T ss_pred             CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--c
Confidence            999999998764  468889999999999999999   799999999999999999999999999999876543222  2


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcccccccCcch--------------hhhhHHHHHHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK--------------HFAAKEQCLLSIFSLAL  950 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~--------------~~~~~~~~~~~l~~l~~  950 (985)
                      .....+++.|+|||.+..+.++.++|+ |++|+.+++++++..+.....              ....++..+..+.+++.
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv-~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDI-WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  250 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhH-HHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence            233468899999999988889999999 999999999999886543221              11122334567889999


Q ss_pred             HccCCCCCCCCCHHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~  969 (985)
                      +||..+|.+||++.+++..
T Consensus       251 ~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         251 RCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HHccCChhhCcCHHHHhcC
Confidence            9999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=3.8e-30  Score=286.41  Aligned_cols=231  Identities=20%  Similarity=0.286  Sum_probs=181.4

Q ss_pred             CceeeccCceeEEEEEEc---CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeec--CCceEEEEeccC
Q 001988          731 NNIIGIGGFGSVYRARLE---DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN--DDFKALVLEYMS  805 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  805 (985)
                      +.+||+|+||.||+|+..   +++.||+|.+....  ....+.+|++++++++||||+++++++..  +...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            468999999999999865   45789999987542  23467899999999999999999999854  457789999996


Q ss_pred             CCChHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE----cCCCcEEEecccCc
Q 001988          806 NGSLEDCLHSS--------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL----DEDMVAHLSDFGMA  873 (985)
Q Consensus       806 ~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill----~~~~~~kl~DfGla  873 (985)
                       ++|.+++...        ...+++..+..++.|++.||+||   |+.+|+||||||+||++    ++++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             4787776422        22478889999999999999999   78999999999999999    56789999999999


Q ss_pred             eeccCCCCc-ceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhh----------------
Q 001988          874 KLLSGEDES-TMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF----------------  935 (985)
Q Consensus       874 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~----------------  935 (985)
                      +.+...... .......+|+.|+|||.+.+ ..++.++|+ |++|+++++++++..++......                
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDI-WAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHH-HhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            876433221 12234568999999999876 457889999 99999999999988664321100                


Q ss_pred             -----------h---------h-HH---------------------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          936 -----------A---------A-KE---------------------QCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       936 -----------~---------~-~~---------------------~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                 .         . ..                     .....+.+++.+|+..||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence                       0         0 00                     01234778999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=3.8e-30  Score=282.32  Aligned_cols=232  Identities=26%  Similarity=0.306  Sum_probs=196.9

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|...+.||+|+||.||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888899999999999999865 68999999986542   223466889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++++|.+++.... .+++..+..++.|+++||+||   |+.|++||||+|+||+++.++.+||+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~l---H~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYL---HSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            9999999999997763 688999999999999999999   7899999999999999999999999999999876432  


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLAL  950 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~  950 (985)
                         .....+++.|+|||.+.....+.++|+ |++|+++++++++..+........           .+...+..+.+++.
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  230 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDW-WALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIR  230 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHH
Confidence               233468999999999988888899999 999999999999887654332111           11224577899999


Q ss_pred             HccCCCCCCCC-----CHHHHH
Q 001988          951 ECTMESPEKRI-----DAKDTI  967 (985)
Q Consensus       951 ~cl~~~P~~RP-----t~~ev~  967 (985)
                      +||..+|.+||     ++.|++
T Consensus       231 ~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         231 NLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             HHccCCHHHccCcccCCHHHHH
Confidence            99999999999     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=3.2e-30  Score=282.05  Aligned_cols=234  Identities=24%  Similarity=0.283  Sum_probs=196.9

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccC
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      .|...+.||+|++|.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++...++.++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3455678999999999999864 788999999876554555678899999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCccee
Q 001988          806 NGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR  885 (985)
Q Consensus       806 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~  885 (985)
                      +++|.+++..  ..+++..+..++.|++.|++||   |++|++||||+|+||+++.++.++++|||.+.......  ...
T Consensus       100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~  172 (285)
T cd06648         100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFL---HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRR  172 (285)
T ss_pred             CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--ccc
Confidence            9999999887  3578999999999999999999   78999999999999999999999999999887653222  122


Q ss_pred             cccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--------------hhHHHHHHHHHHHHHH
Q 001988          886 TQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQCLLSIFSLALE  951 (985)
Q Consensus       886 ~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~~~~l~~l~~~  951 (985)
                      ....|++.|+|||...+..++.++|+ |++|+++++++++..+.......              .....++..+.+++.+
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv-~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDI-WSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR  251 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccH-HHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence            33458999999999988889999999 99999999999987654321100              0111245789999999


Q ss_pred             ccCCCCCCCCCHHHHHH
Q 001988          952 CTMESPEKRIDAKDTIT  968 (985)
Q Consensus       952 cl~~~P~~RPt~~ev~~  968 (985)
                      ||..+|++||++.++++
T Consensus       252 ~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         252 MLVRDPAQRATAAELLN  268 (285)
T ss_pred             HcccChhhCcCHHHHcc
Confidence            99999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=5.7e-30  Score=274.51  Aligned_cols=235  Identities=31%  Similarity=0.418  Sum_probs=201.8

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccC
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      +|...+.||+|++|.||+|... +++.||+|++........+.+.+|++++++++|++++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4677889999999999999975 788999999987655566789999999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCccee
Q 001988          806 NGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR  885 (985)
Q Consensus       806 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~  885 (985)
                      +++|.+++......+++..+..++.|+++|++||   |++|++||||+|+||++++++.++|+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL---HSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHh---hcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            9999999987655789999999999999999999   789999999999999999999999999999987643321   2


Q ss_pred             cccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh--------------hHHHHHHHHHHHHHH
Q 001988          886 TQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--------------AKEQCLLSIFSLALE  951 (985)
Q Consensus       886 ~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--------------~~~~~~~~l~~l~~~  951 (985)
                      ....++..|+|||.+....++.+.|+ |++|+++++++++..+........              ....++.++.+++.+
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  233 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADI-WSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK  233 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccH-HHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence            34468899999999988888999999 999999999999886554331110              111125779999999


Q ss_pred             ccCCCCCCCCCHHHHHH
Q 001988          952 CTMESPEKRIDAKDTIT  968 (985)
Q Consensus       952 cl~~~P~~RPt~~ev~~  968 (985)
                      |+..+|++||++.|+++
T Consensus       234 ~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         234 CLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             HccCChhhCCCHHHHhc
Confidence            99999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.7e-30  Score=279.22  Aligned_cols=238  Identities=24%  Similarity=0.329  Sum_probs=196.5

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCC------
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDD------  795 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~------  795 (985)
                      ++++|+..+.||+|+||.||+|..+ +++.||+|++.... ...+.+.+|+++++++ +|+||+++++++.+..      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            5688999999999999999999975 67899999987653 3446789999999999 6999999999997644      


Q ss_pred             ceEEEEeccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccC
Q 001988          796 FKALVLEYMSNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGM  872 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGl  872 (985)
                      ..++||||+++++|.+++...   +..+++..+..++.|+++||+||   |+.+++||||+|+||++++++.+||+|||.
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL---HENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            489999999999999988653   35789999999999999999999   899999999999999999999999999999


Q ss_pred             ceeccCCCCcceeccccccccccccccccc-----CccchhhhcccccccchhhhcccccccCcchh-------------
Q 001988          873 AKLLSGEDESTMRTQTLATIGYMAPDEIFV-----GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-------------  934 (985)
Q Consensus       873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-------------  934 (985)
                      +.......  .......+++.|+|||.+..     ..++.++|+ |++|+++++++++..+......             
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  236 (275)
T cd06608         160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDV-WSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP  236 (275)
T ss_pred             ceecccch--hhhcCccccccccCHhHhcccccccCCccccccH-HHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence            88754222  22233458999999998753     346778999 9999999999998876543211             


Q ss_pred             -hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          935 -FAAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       935 -~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                       ...+...+.++.+++.+|+..||++||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             1112235568899999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=6.2e-30  Score=276.55  Aligned_cols=237  Identities=25%  Similarity=0.358  Sum_probs=202.7

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++|+|++++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36788899999999999999876 699999999886644 3457889999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS-TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      +++++|.+++... ..+++..+..++.|+++|++|+   |+ .+++||||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~l---h~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYL---HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---hccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999999999865 4689999999999999999999   88 99999999999999999999999999999876432221


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcch---hh------------hhHHH-HHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK---HF------------AAKEQ-CLLSIF  946 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~---~~------------~~~~~-~~~~l~  946 (985)
                        .....++..|+|||.+....++.++|+ |++|+++++++++..+.....   ..            ..+.. +++.+.
T Consensus       157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv-~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  233 (264)
T cd06623         157 --CNTFVGTVTYMSPERIQGESYSYAADI-WSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFR  233 (264)
T ss_pred             --ccceeecccccCHhhhCCCCCCchhhH-HHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHH
Confidence              123458889999999999999999999 999999999999876654331   01            11122 567899


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHH
Q 001988          947 SLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      +++.+|+..+|++||++.++++.
T Consensus       234 ~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         234 DFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             HHHHHHccCChhhCCCHHHHHhC
Confidence            99999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=4.5e-30  Score=282.35  Aligned_cols=236  Identities=24%  Similarity=0.294  Sum_probs=192.9

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecC--CceEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSND--DFKALV  800 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lv  800 (985)
                      ++|+..+.||+|+||.||+|..+ +++.||+|.++.....  ....+.+|++++++++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888899999999999999976 6889999998754322  234567899999999999999999999877  889999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||++ ++|.+.+......+++.....++.|++.||+||   |+.+++||||||+||+++.++.+||+|||+++.+....
T Consensus        85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL---HDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            99997 599999887655789999999999999999999   78999999999999999999999999999998765332


Q ss_pred             CcceecccccccccccccccccCc-cchhhhcccccccchhhhcccccccCcchhhhh----------------------
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGE-LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA----------------------  937 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~----------------------  937 (985)
                      .  ......+++.|+|||.+.+.. ++.++|+ |++|+.+++++++..+.........                      
T Consensus       161 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di-~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         161 K--PYTQLVVTLWYRAPELLLGAKEYSTAIDM-WSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             c--ccccccccccccCchhhcCCccccchhhH-HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            1  122345788999999887544 5788999 9999999999998765432111000                      


Q ss_pred             -------------------HHH--HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 -------------------KEQ--CLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 -------------------~~~--~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                         ...  ..+.+.+++++|++.+|++||++.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                               000  2566889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=5.9e-30  Score=277.00  Aligned_cols=237  Identities=24%  Similarity=0.265  Sum_probs=193.2

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-----chHHHHHHHHHHHHhcCCCCeeeEEeeeecC--Cce
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-----STLKSFEAECEVIKNIRHRNLVKIISSCSND--DFK  797 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-----~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~  797 (985)
                      .+|...+.||+|+||.||+|... +++.||+|.+.....     .....+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888999999999999999864 689999998864321     1245678899999999999999999998764  467


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ++||||+++++|.+++.... .+++....+++.|++.||+||   |+.+++||||||+||++++++.+||+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYL---HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999987653 578888999999999999999   78999999999999999999999999999988654


Q ss_pred             CCCCc-ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh-------------hhhHHHHHH
Q 001988          878 GEDES-TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-------------FAAKEQCLL  943 (985)
Q Consensus       878 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-------------~~~~~~~~~  943 (985)
                      ..... .......++..|+|||.+.+..++.++|+ |++|+.++++++++.+......             ...+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADI-WSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD  236 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhH-HHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCH
Confidence            22111 11223458899999999988889999999 9999999999998876543211             112233456


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+.+++.+|+. +|++||++.|+++
T Consensus       237 ~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         237 HCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            78889999994 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-31  Score=277.81  Aligned_cols=232  Identities=23%  Similarity=0.280  Sum_probs=195.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .+.|+.-++||+||||+||-++.+ +|+.||+|.+.++.   ........+|-.|+++++.+.||.+-.+|++.+..++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            356778899999999999999855 89999999986542   22345578899999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          801 LEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      +..|.||+|.-++...+ ..+++....-+|.+|+.||++|   |+.+||+||+||+|||+|+.|+++|+|.|+|..+.+.
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehl---H~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHL---HRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHH---HhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999998887653 4689999999999999999999   8999999999999999999999999999999998644


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh---------------HHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA---------------KEQCLLS  944 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~---------------~~~~~~~  944 (985)
                      ..   ....+||.+|||||++..+.|++..|. |++|+.++||+.|+.++.....-..               ++..+++
T Consensus       341 ~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dw-f~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~e  416 (591)
T KOG0986|consen  341 KP---IRGRVGTVGYMAPEVLQNEVYDFSPDW-FSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEE  416 (591)
T ss_pred             Cc---cccccCcccccCHHHHcCCcccCCccH-HHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHH
Confidence            33   234579999999999999999988876 9999999999999876654321111               1234567


Q ss_pred             HHHHHHHccCCCCCCCCCH
Q 001988          945 IFSLALECTMESPEKRIDA  963 (985)
Q Consensus       945 l~~l~~~cl~~~P~~RPt~  963 (985)
                      ..++.+..+..||++|-.-
T Consensus       417 akslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  417 AKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             HHHHHHHHHccCHHHhccC
Confidence            7788888899999888643

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=5.1e-30  Score=277.28  Aligned_cols=237  Identities=28%  Similarity=0.348  Sum_probs=198.9

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +|+..+.||+|+||.||+|... +++.||+|.++.....  ..+.+..|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778899999999999999864 7899999998766443  567889999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +++++|.+++.... .+++..+..++.|+++|++||   |+.|++||||+|+||++++++.+||+|||++..........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYL---HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999998753 578889999999999999999   78999999999999999999999999999998765433221


Q ss_pred             e--ecccccccccccccccccCc---cchhhhcccccccchhhhcccccccCcch-h--------------hhhHHHHHH
Q 001988          884 M--RTQTLATIGYMAPDEIFVGE---LSLKRWVNDLLPVSLVEVVDKSLLSGEEK-H--------------FAAKEQCLL  943 (985)
Q Consensus       884 ~--~~~~~gt~~y~aPE~~~~~~---~~~~~dv~~~~g~~~~~i~~~~~~~~~~~-~--------------~~~~~~~~~  943 (985)
                      .  .....+++.|+|||.+....   .+.++|+ |++|+.+++++++..+..... .              .+....++.
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv-~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADI-WSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP  235 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccch-HHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCH
Confidence            1  12345788999999988766   7889999 999999999999887653221 0              011112367


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+.+++.+||+.+|.+||++.|++.
T Consensus       236 ~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         236 EGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhc
Confidence            7889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=6.5e-30  Score=275.04  Aligned_cols=235  Identities=24%  Similarity=0.351  Sum_probs=196.6

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +|+..+.||+|+||.||+|... +++.||+|.+....  ......+.+|++++++++|||++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4778899999999999999864 78889999987542  23456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-CcEEEecccCceeccCCCC
Q 001988          804 MSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       804 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~-~~~kl~DfGla~~~~~~~~  881 (985)
                      +++++|.+++... +..+++..+.+++.+++.|++||   |++|++||||||+||+++++ +.+|++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV---HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            9999999999865 34588999999999999999999   78999999999999999855 4689999999987643221


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh------------hhhHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH------------FAAKEQCLLSIFSLA  949 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~------------~~~~~~~~~~l~~l~  949 (985)
                         .....++..|+|||.+....++.++|+ |++|++++++++++.+......            .+.++.++.++.+++
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv-~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  233 (256)
T cd08220         158 ---AYTVVGTPCYISPELCEGKPYNQKSDI-WALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLI  233 (256)
T ss_pred             ---ccccccCCcccCchhccCCCCCcccch-HHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHH
Confidence               223458899999999988888999999 9999999999987765433211            011223567799999


Q ss_pred             HHccCCCCCCCCCHHHHHH
Q 001988          950 LECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+||..+|++||++.|+++
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             HHHccCChhhCCCHHHHhh
Confidence            9999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=6.6e-30  Score=279.93  Aligned_cols=238  Identities=28%  Similarity=0.361  Sum_probs=203.0

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .++.|...+.||+|+||.||+|..+ ++..||+|++..... ....+.+|++++++++|+|++++++++...+..++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888889999999999999976 788999999976544 45778899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |+++++|.+++......+++..+..++.|++.||+||   |+.|++|+||+|+||+++.++.++|+|||++........ 
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL---HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence            9999999999987655789999999999999999999   789999999999999999999999999999876543221 


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--------------hhHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQCLLSIFSL  948 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~~~~l~~l  948 (985)
                       ......+++.|+|||.+.+..++.++|+ |++|+++++++++..+.......              .....++.++.++
T Consensus       172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv-~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  249 (286)
T cd06614         172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDI-WSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF  249 (286)
T ss_pred             -hhccccCCcccCCHhHhcCCCCCCcccc-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence             1223457889999999988889999999 99999999999988654432111              1122256789999


Q ss_pred             HHHccCCCCCCCCCHHHHHH
Q 001988          949 ALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +.+|++.+|.+||++.++++
T Consensus       250 i~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         250 LNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HHHHhccChhhCcCHHHHhh
Confidence            99999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=9.7e-30  Score=275.07  Aligned_cols=240  Identities=20%  Similarity=0.300  Sum_probs=197.6

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeec--CCceEEEE
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSN--DDFKALVL  801 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lv~  801 (985)
                      +|+..+.||.|+||.||+|... +++.||+|.+....  ....+++..|++++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4777889999999999999854 78899999987542  2335578899999999999999999998754  45678999


Q ss_pred             eccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          802 EYMSNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGH--STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       802 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h--~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      ||+++++|.+++...   ...+++...+.++.|++.|++|||..+  +.+++||||||+||+++.++.+|++|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998753   456899999999999999999993322  899999999999999999999999999999876


Q ss_pred             cCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh------------hhHHHHHHH
Q 001988          877 SGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF------------AAKEQCLLS  944 (985)
Q Consensus       877 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~------------~~~~~~~~~  944 (985)
                      .....  ......+++.|+|||.+....++.++|+ |++|+.+++++++..+.......            ..+...+.+
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDI-WSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSE  237 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHH-HHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHH
Confidence            43221  1233468999999999998889999999 99999999999987665433111            112335678


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          945 IFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       945 l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      +.+++.+|+..+|++||++.++++.
T Consensus       238 ~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         238 LNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HHHHHHHHccCCcccCCCHHHHhhC
Confidence            9999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.97  E-value=3.9e-30  Score=282.04  Aligned_cols=237  Identities=25%  Similarity=0.341  Sum_probs=195.5

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ++|+..+.||+|+||.||+|..+ +++.||+|+++...  ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888899999999999999875 68899999987542  2234678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |++++.+..+... ...+++.+...++.|++.|++||   |+.+++|||++|+||++++++.+||+|||++.........
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYC---HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            9998766655544 34588999999999999999999   7889999999999999999999999999999876543321


Q ss_pred             ceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhh-------------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------------------  936 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------------------  936 (985)
                       ......++..|+|||.+... .++.++|+ |++|+++++++++..+........                         
T Consensus       157 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv-~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         157 -PLTDYVATRWYRAPELLVGDTNYGKPVDV-WAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             -cccCcccccCCcCCchhcCCCCcCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence             22335688999999999888 88899999 999999999999876543211000                         


Q ss_pred             ------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 ------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 ------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                        .+..++.++.+++++||..+|++||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                              00113677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.8e-30  Score=278.45  Aligned_cols=235  Identities=23%  Similarity=0.379  Sum_probs=196.6

Q ss_pred             CccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCC-cchHHHHHHHHHHHHhcC---CCCeeeEEeeeecCCceEEEE
Q 001988          727 NFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIR---HRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~lv~  801 (985)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+.... .....++.+|+.++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            366778899999999999986 478999999987653 234567889999999996   999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++++|.+++...  .+++.....++.|+++|+.||   |+.||+||||+|+||++++++.++++|||++..+.....
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYI---HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            999999999998764  688999999999999999999   789999999999999999999999999999987753331


Q ss_pred             cceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhh------------h-HHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------A-KEQCLLSIFS  947 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------~-~~~~~~~l~~  947 (985)
                        ......|+..|+|||.+..+ .++.++|+ |++|+++++++++..+........            . ....+.++.+
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv-~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (277)
T cd06917         157 --KRSTFVGTPYWMAPEVITEGKYYDTKADI-WSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE  233 (277)
T ss_pred             --ccccccCCcceeCHHHhccCCccccchhH-HHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHH
Confidence              22334689999999988754 45789999 999999999999887654332111            0 1125678999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHH
Q 001988          948 LALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      ++.+||+.+|++||++.|+++.
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhhC
Confidence            9999999999999999999763

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=3.2e-30  Score=283.18  Aligned_cols=238  Identities=26%  Similarity=0.305  Sum_probs=203.0

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      ....|.....||+|.|+.|.+|++. ++..||||.+++....  ....+.+|+++|+.++|||||+++.+.......|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            4567888899999999999999865 7999999999876333  335588999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+.+|.+++++...+...+ .....++.|+.+|++|+   |+++|||||||++||+++.++.+||+|||++..+.   
T Consensus       134 ~eya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYc---H~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYC---HSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---  206 (596)
T ss_pred             EEeccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHH---hhcceeccccchhhcccccccceeeeccccceeec---
Confidence            999999999999998874444 77888999999999999   89999999999999999999999999999999985   


Q ss_pred             CcceecccccccccccccccccCccc-hhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELS-LKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSL  948 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l  948 (985)
                      ........+|++.|.|||.+.+.++. +..|+ |++|++++.++.|.+++....-..           .+.-...+..++
T Consensus       207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~-Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~l  285 (596)
T KOG0586|consen  207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDI-WSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDL  285 (596)
T ss_pred             ccccccccCCCCCccChHhhcCcccCCcceeh-hhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHH
Confidence            23334567899999999999988875 45566 999999999999998776542111           122234567889


Q ss_pred             HHHccCCCCCCCCCHHHHHHH
Q 001988          949 ALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      +++++-.+|.+|++.+++.+.
T Consensus       286 Lrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  286 LRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             HHHhhccCccccCCHHHhhhh
Confidence            999999999999999998764

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=5.3e-30  Score=280.38  Aligned_cols=235  Identities=24%  Similarity=0.347  Sum_probs=191.3

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +|+..+.||.|+||.||+|+.. +++.||||+++.....  ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778899999999999999865 7899999998754322  235788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      ++ ++|.+++... ...+++..+..++.|+++|++||   |+.+++||||+|+||++++++.+||+|||+++.+..... 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---h~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            95 6899888754 34688999999999999999999   789999999999999999999999999999876532211 


Q ss_pred             ceecccccccccccccccccCc-cchhhhcccccccchhhhcccccccCcchhhhh------------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFVGE-LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA------------------------  937 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~------------------------  937 (985)
                       ......+++.|+|||.+.+.. ++.++|+ |++|+.++++++++.+.........                        
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv-~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDI-WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             -ccccccccccccCCeEEecCCCCCcHHHH-HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence             122334788999999876644 5788999 9999999999998865432211000                        


Q ss_pred             ----------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 ----------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 ----------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                      ......++.+++.+|++.||++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                            0012456778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-30  Score=275.16  Aligned_cols=230  Identities=23%  Similarity=0.353  Sum_probs=191.5

Q ss_pred             CceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCC
Q 001988          731 NNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNG  807 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  807 (985)
                      .+.+|+|-||+||-|.++ +|+.||||++.+-..  ....++++|+.||+++.||.||.+...|++.+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            478999999999999854 899999999976533  23578899999999999999999999999999999999999554


Q ss_pred             ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC---CcEEEecccCceeccCCCCcce
Q 001988          808 SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED---MVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       808 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~---~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      =|+-.+.....++++.....+..||+.||.||   |-++|||+|+||+|||+...   -.+||||||+|+.+.   +...
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~L---H~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg---EksF  722 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYL---HFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG---EKSF  722 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHh---hhcceeeccCCchheeeccCCCCCceeeccccceeecc---hhhh
Confidence            44444555566788888888999999999999   78999999999999999543   479999999999974   3345


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-------------hHHHHHHHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------AKEQCLLSIFSLALE  951 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------~~~~~~~~l~~l~~~  951 (985)
                      ...++|||.|.|||++..+.|...-|+ |+.|+.++--+.|.+++.++.+..             ...+...+.+++|..
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDM-WSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~  801 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDM-WSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINN  801 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccc-eeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence            567889999999999999999999999 999999999999988877653322             233456677888888


Q ss_pred             ccCCCCCCCCCHHHHH
Q 001988          952 CTMESPEKRIDAKDTI  967 (985)
Q Consensus       952 cl~~~P~~RPt~~ev~  967 (985)
                      .++.+=.+|.+..+-+
T Consensus       802 LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  802 LLQVKMRKRYSVDKSL  817 (888)
T ss_pred             HHHHHHHHhcchHhhc
Confidence            8888878887776554

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2e-30  Score=278.94  Aligned_cols=239  Identities=21%  Similarity=0.270  Sum_probs=197.9

Q ss_pred             HhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccC--CcchHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv  800 (985)
                      ....|++.+.||+||.+.||++...+.+.||+|++...  .......|.+|++.|.+++ |.+||++++|-..++..|||
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            34567888999999999999999988889999987644  2334678999999999994 99999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||= ..+|..++.+.........++.+-.|++.|+.++   |.+||||.||||.|+++- +|.+||+|||+|..+....
T Consensus       439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~I---H~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTI---HQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHH---HHhceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence            9986 4599999998865555447788999999999999   899999999999999985 4789999999999987666


Q ss_pred             CcceecccccccccccccccccCc-----------cchhhhcccccccchhhhcccccccCcchhhhh-------H----
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGE-----------LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-------K----  938 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-------~----  938 (985)
                      .......-+||+.||+||.+..-.           .+.++|| |++||.+++|+-++.+++.......       +    
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDv-WSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I  592 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDV-WSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI  592 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccch-hhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence            555666778999999999886322           5688999 9999999999998877765431100       0    


Q ss_pred             ---H-HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          939 ---E-QCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       939 ---~-~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                         + -...++.++|+.|+..||++||+..|+++
T Consensus       593 efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  593 EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence               0 01234899999999999999999999875

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=9.6e-30  Score=278.22  Aligned_cols=235  Identities=23%  Similarity=0.316  Sum_probs=189.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHH-HHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEV-IKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~i-l~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|+++.... ....++..|+.+ ++..+||||+++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888899999999999999865 799999999876532 234456667665 556689999999999999999999999


Q ss_pred             ccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          803 YMSNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGHST-PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       803 ~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~-~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      |++ |+|.+++...   ...+++..++.++.|++.|++||   |++ +++||||||+||+++.++.+||+|||++..+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL---HSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---hhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 6888777542   34689999999999999999999   676 999999999999999999999999999987532


Q ss_pred             CCCcceeccccccccccccccccc----CccchhhhcccccccchhhhcccccccCcchh-hh-------------hHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFV----GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-FA-------------AKEQ  940 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-~~-------------~~~~  940 (985)
                      ..   ......++..|+|||.+..    ..++.++|+ |++|+.+++++++..+...... ..             ..+.
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di-~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDV-WSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK  232 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccc-hhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccc
Confidence            21   1223458889999998754    456788999 9999999999998876542110 00             0123


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          941 CLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +++++.+++.+||..+|++||++.++++
T Consensus       233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            5678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-29  Score=282.50  Aligned_cols=239  Identities=25%  Similarity=0.285  Sum_probs=197.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc---hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|+..+.||+|+||.||+|... +++.||+|.+......   ..+.+..|++++++++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999875 5899999999765332   3456889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          802 EYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       802 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      ||+++++|.+++... ...+++.....++.|+++||+||   |+.|++||||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL---HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999999998764 34689999999999999999999   78999999999999999999999999999987653221


Q ss_pred             Cc---------------------------ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcch
Q 001988          881 ES---------------------------TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK  933 (985)
Q Consensus       881 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~  933 (985)
                      ..                           .......|+..|+|||.+.+..++.++|+ |++|+++++++++..+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di-~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDW-WTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHH-HHHHHHHHHHhhCCCCCCCCc
Confidence            10                           01113358889999999998889999999 999999999999887653321


Q ss_pred             hhh-------------hHHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 001988          934 HFA-------------AKEQCLLSIFSLALECTMESPEKRID----AKDTIT  968 (985)
Q Consensus       934 ~~~-------------~~~~~~~~l~~l~~~cl~~~P~~RPt----~~ev~~  968 (985)
                      ...             .....++.+.+++.+|+..+|++||+    +.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            111             11114678999999999999999999    555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=1.2e-29  Score=277.99  Aligned_cols=235  Identities=26%  Similarity=0.314  Sum_probs=194.8

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecC--CceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSND--DFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lv~  801 (985)
                      ++|...+.||.|++|.||+|... +++.||+|.+..... ....++.+|++++++++||||+++++++.+.  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36778899999999999999975 688899999875432 3456789999999999999999999998653  4689999


Q ss_pred             eccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          802 EYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       802 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      ||+++++|.+++..   ....++......++.|+++||+||   |+.+++||||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL---HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988653   244678889999999999999999   789999999999999999999999999999876532


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh-----hh-----------hH----
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-----FA-----------AK----  938 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-----~~-----------~~----  938 (985)
                      ..    .....++..|+|||.+.+..++.++|+ |++|+.++++++|..+......     ..           ..    
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDV-WSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP  232 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhH-HHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC
Confidence            21    123457889999999999999999999 9999999999998876543310     00           00    


Q ss_pred             ---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          939 ---EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       939 ---~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                         ...++.+.+++.+||..+|.+||++.|+++
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence               123467899999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=2.9e-30  Score=278.26  Aligned_cols=233  Identities=26%  Similarity=0.323  Sum_probs=198.4

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      +|+..+.||.|+||.||+|... ++..||+|.+.....   ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999875 689999999975432   345678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |+++++|.+++... ..+++.....++.|+++||+||   |+.+++|+||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYL---HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999999876 4688999999999999999999   78899999999999999999999999999988754322  


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh--------------hhhHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH--------------FAAKEQCLLSIFSL  948 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~--------------~~~~~~~~~~l~~l  948 (985)
                       ......|+..|+|||.+....++.++|+ |++|+.++++++|..+......              ...+...+..+.++
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di-~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDW-WSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDA  232 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccc-hhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHH
Confidence             2233458889999999988889999999 9999999999998876554321              11122356789999


Q ss_pred             HHHccCCCCCCCCCH--HHHH
Q 001988          949 ALECTMESPEKRIDA--KDTI  967 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~--~ev~  967 (985)
                      +.+||+.+|.+||++  .|+.
T Consensus       233 i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         233 INKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             HHHHccCChhHcCCccHHHHh
Confidence            999999999999999  5544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-30  Score=288.55  Aligned_cols=242  Identities=27%  Similarity=0.342  Sum_probs=196.4

Q ss_pred             ccCCceeeccCceeEEEEE-EcCCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCC------ceEE
Q 001988          728 FAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDD------FKAL  799 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------~~~l  799 (985)
                      +...+.||+||||.||+|+ .++|+.||||.++.... ...+...+|++++++++|+|||+++++-++..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            3445779999999999999 55899999999987533 34567789999999999999999999876543      5679


Q ss_pred             EEeccCCCChHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc--CCC--cEEEecccCc
Q 001988          800 VLEYMSNGSLEDCLHSS--NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD--EDM--VAHLSDFGMA  873 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~--~~~--~~kl~DfGla  873 (985)
                      |||||.||||+..+...  ...+++.+.+.+..+++.||.||   |++|||||||||.||++-  .+|  ..||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~L---rEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHL---RENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHH---HHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            99999999999999864  45699999999999999999999   899999999999999993  334  5899999999


Q ss_pred             eeccCCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhh----------------
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA----------------  936 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~----------------  936 (985)
                      +.++++.   .....+||+.|.+||.+.. +.|+.-.|. |++|+.+++.++|.+++-......                
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDL-WS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDL-WSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeeh-hhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            9886444   4566889999999999885 777888888 999999999999998654321110                


Q ss_pred             ------------------------hHHHHHHHHHHHHHHccCCCCCCCC--CHHHHHHHHHHhHhh
Q 001988          937 ------------------------AKEQCLLSIFSLALECTMESPEKRI--DAKDTITRLLKIRDT  976 (985)
Q Consensus       937 ------------------------~~~~~~~~l~~l~~~cl~~~P~~RP--t~~ev~~~L~~i~~~  976 (985)
                                              ........+-.+...++..+|.+|.  ...+....+..|...
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence                                    0112345566678888888899988  777777777776653

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.96  E-value=1.6e-29  Score=276.61  Aligned_cols=235  Identities=23%  Similarity=0.327  Sum_probs=192.7

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      +|+..+.||.|++|.||+|+.. +|+.||||.++..... ....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999975 6889999998765332 3456788999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          805 SNGSLEDCLHSSN--CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       805 ~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      ++ +|.+++....  ..+++..+..++.|+++||+||   |+.|++||||||+||++++++.+|++|||+++....... 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC---HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            75 8988887543  4689999999999999999999   789999999999999999999999999999976532211 


Q ss_pred             ceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhh-------------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------------------  936 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------------------  936 (985)
                       ......+++.|+|||.+.+. .++.++|+ |++|+++++++++..+........                         
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv-~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDI-WSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence             12234578899999987654 46788999 999999999999876543221100                         


Q ss_pred             ---------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 ---------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 ---------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                     ..+..+..+.+++.+|++.+|.+||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                           00123466789999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.96  E-value=1.4e-29  Score=278.63  Aligned_cols=236  Identities=22%  Similarity=0.301  Sum_probs=189.8

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCc-----
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIR-HRNLVKIISSCSNDDF-----  796 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~-----  796 (985)
                      ++|+..+.||+|+||.||+|... +++.||+|.++.....  ....+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999865 7899999998754322  2356888999999995 6999999999977665     


Q ss_pred             eEEEEeccCCCChHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-CCcEEEeccc
Q 001988          797 KALVLEYMSNGSLEDCLHSS----NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHLSDFG  871 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~-~~~~kl~DfG  871 (985)
                      .++||||+++ ++.+++...    ...+++...+.++.||+.||+||   |+++|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC---HKHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 898887653    23579999999999999999999   7899999999999999998 8999999999


Q ss_pred             CceeccCCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhh--------------
Q 001988          872 MAKLLSGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--------------  936 (985)
Q Consensus       872 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--------------  936 (985)
                      +++.+......  .....+++.|+|||.+.+ ..++.++|+ |++|+.+++++++..+........              
T Consensus       157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di-~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  233 (295)
T cd07837         157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDI-WSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE  233 (295)
T ss_pred             cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHH-HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            99876432211  122347889999998765 456889999 999999999999876543211000              


Q ss_pred             -------------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 -------------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 -------------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                               ..+..+.++.+++.+|+.++|.+||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                                     00124567889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.96  E-value=1.9e-29  Score=271.60  Aligned_cols=237  Identities=27%  Similarity=0.348  Sum_probs=202.0

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecC--CceEEEE
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSND--DFKALVL  801 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lv~  801 (985)
                      +|...+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++++++++||||+++++.+...  +..++||
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999976 789999999876542  3467889999999999999999999999988  8899999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++++|.+++.... .+++..+..++.|++.|++||   |+.+++||||+|+||+++.++.+||+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~l---h~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYL---HSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999998765 789999999999999999999   789999999999999999999999999999988754332


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcch--------------hhhhHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK--------------HFAAKEQCLLSIFS  947 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~--------------~~~~~~~~~~~l~~  947 (985)
                      ........++..|+|||.......+.++|+ |++|+++++++++..+.....              ....++..+..+.+
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADI-WSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD  235 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHH
Confidence            112334568899999999988889999999 999999999999776543321              11122334678999


Q ss_pred             HHHHccCCCCCCCCCHHHHHH
Q 001988          948 LALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ++.+|+..+|++||++.|++.
T Consensus       236 ~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         236 FLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             HHHHhCcCChhhCCCHHHHhh
Confidence            999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.96  E-value=1.9e-29  Score=271.51  Aligned_cols=236  Identities=24%  Similarity=0.337  Sum_probs=201.3

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +|...+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|++++++++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777889999999999999865 689999999976533  4556788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          804 MSNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       804 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      +++++|.+++...   ...+++.....++.+++.|+.||   |+.|++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---h~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL---HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999999865   36789999999999999999999   78899999999999999999999999999998764332


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh------------hHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------AKEQCLLSIFSL  948 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------~~~~~~~~l~~l  948 (985)
                        .......|++.|+|||......++.+.|+ |++|+.+++++.+..+........            .+..++.++.++
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv-~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDI-WSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNL  234 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccH-HHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence              22334468999999999988889999999 999999999998876654331111            112355789999


Q ss_pred             HHHccCCCCCCCCCHHHHHH
Q 001988          949 ALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +.+|+..+|++||++.|+++
T Consensus       235 i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         235 VSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             HHHHcCCChhhCcCHHHHhc
Confidence            99999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4e-29  Score=268.50  Aligned_cols=235  Identities=28%  Similarity=0.385  Sum_probs=199.8

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +|+..+.||+|++|.||+|... +++.||+|.+.....  ...+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4777899999999999999865 678999999986643  3556789999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +++++|.+++... ..+++..+..++.|++.|+.||   |+.|++||||||+||+++.++.+||+|||.+......... 
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYL---HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            9999999998765 4689999999999999999999   8999999999999999999999999999999887533321 


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh------------hHHHHHHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------AKEQCLLSIFSLALE  951 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------~~~~~~~~l~~l~~~  951 (985)
                       .....++..|+|||...+..++.+.|+ |++|+.+++++++..+........            .+...++.+.+++.+
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv-~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  233 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDI-WSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQ  233 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhH-HHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence             233458899999999888888889999 999999999999876543321111            112345789999999


Q ss_pred             ccCCCCCCCCCHHHHHH
Q 001988          952 CTMESPEKRIDAKDTIT  968 (985)
Q Consensus       952 cl~~~P~~RPt~~ev~~  968 (985)
                      |+..+|++||++.+++.
T Consensus       234 ~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         234 CFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             HHhCChhhCcCHHHHhc
Confidence            99999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.3e-31  Score=264.42  Aligned_cols=230  Identities=25%  Similarity=0.257  Sum_probs=194.6

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      -++|...+++|+|.||.|.+++-+ +++.||+|++++..-   .+......|-++|+..+||.+..+-..++..+..++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            356778889999999999999865 899999999987732   3344556799999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+.||.|+-++...+ .+++....-+-..|+.||.||   |+++||+||+|.+|.|+|++|++||+|||+++.-  ..
T Consensus       247 MeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YL---Hs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYL---HSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE--IK  320 (516)
T ss_pred             EEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhh---hhCCeeeeechhhhheeccCCceEeeecccchhc--cc
Confidence            99999999998887654 677777777899999999999   8899999999999999999999999999999762  23


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLA  949 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~  949 (985)
                      ........||||.|.|||++.+..|....|. |.+|++++||+-|++++....+..           .+....++...++
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDW-WG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLL  399 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDW-WGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLL  399 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeeh-hhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHH
Confidence            3345677899999999999999999887776 999999999999998776543222           1223456778899


Q ss_pred             HHccCCCCCCCC
Q 001988          950 LECTMESPEKRI  961 (985)
Q Consensus       950 ~~cl~~~P~~RP  961 (985)
                      ...+..||++|.
T Consensus       400 sGLL~kdP~kRL  411 (516)
T KOG0690|consen  400 SGLLKKDPKKRL  411 (516)
T ss_pred             HHHhhcChHhhc
Confidence            999999999997

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=9e-30  Score=302.79  Aligned_cols=248  Identities=26%  Similarity=0.404  Sum_probs=205.8

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc----C----CcEEEEEEeccCCc-chHHHHHHHHHHHHhc-CCCCeeeEEeeeec
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE----D----GVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLVKIISSCSN  793 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~----~----~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~  793 (985)
                      ..++....+.+|+|+||.|++|...    .    ...||||.++.... .+.+.+..|+++|+.+ +|+||+.++|+|..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3344455669999999999999743    1    45699999986533 4567899999999999 69999999999999


Q ss_pred             CCceEEEEeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEE
Q 001988          794 DDFKALVLEYMSNGSLEDCLHSSN---------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVL  858 (985)
Q Consensus       794 ~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nil  858 (985)
                      ++..++|+||++.|+|.++++..+               ..++..+.+.+++|||.|++||   ++.++||||+.++||+
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L---~~~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYL---ASVPCVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHH---hhCCccchhhhhhhEE
Confidence            999999999999999999998876               3488899999999999999999   8999999999999999


Q ss_pred             EcCCCcEEEecccCceeccCCCCcceeccc-ccccccccccccccCccchhhhcccccccchhhhccccc-ccCcc----
Q 001988          859 LDEDMVAHLSDFGMAKLLSGEDESTMRTQT-LATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSL-LSGEE----  932 (985)
Q Consensus       859 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~-~~~~~----  932 (985)
                      +.++..+||+|||+|+.....+.+...... .-...|||||.+....++.++|| |++|++++|+++... +....    
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDV-WSfGI~L~EifsLG~~PYp~~~~~~  529 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDV-WSFGILLWEIFTLGGTPYPGIPPTE  529 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchh-hHHHHHHHHHhhCCCCCCCCCCcHH
Confidence            999999999999999976544443322211 12445999999999999999999 999999999987432 22221    


Q ss_pred             ---------hhhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          933 ---------KHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       933 ---------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                               .+...|+.|.++++++|+.||+.+|++||++.++++.++...+
T Consensus       530 ~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  530 ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence                     1234556689999999999999999999999999999998543

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.96  E-value=1.1e-29  Score=273.34  Aligned_cols=237  Identities=22%  Similarity=0.289  Sum_probs=196.5

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +|...+.||+|+||.||+|..+ +|..||+|.+....  ....+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4777889999999999999865 68899999986542  23446788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-cEEEecccCceeccCCCC
Q 001988          804 MSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       804 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~~~~~~~~  881 (985)
                      +++++|.+++.... ..+++..+..++.|+++|++||   |+.+++||||||+||++++++ .+|++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI---HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999987643 3578999999999999999999   789999999999999999886 569999999987643221


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh------------hHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------AKEQCLLSIFSLA  949 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------~~~~~~~~l~~l~  949 (985)
                        ......|++.|+|||......++.++|+ |++|+.+++++++..+........            .....+.++.+++
T Consensus       158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  234 (257)
T cd08225         158 --LAYTCVGTPYYLSPEICQNRPYNNKTDI-WSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLI  234 (257)
T ss_pred             --cccccCCCccccCHHHHcCCCCCchhhH-HHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHH
Confidence              1223458899999999988889999999 999999999999876654321111            1112356799999


Q ss_pred             HHccCCCCCCCCCHHHHHHH
Q 001988          950 LECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~~  969 (985)
                      .+|+..+|++||++.|+++.
T Consensus       235 ~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         235 SQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             HHHhccChhhCcCHHHHhhC
Confidence            99999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=3.6e-29  Score=278.18  Aligned_cols=233  Identities=25%  Similarity=0.323  Sum_probs=193.5

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      |...+.||+|+||.||+|+.. ++..||+|.+.....   .....+.+|++++++++|||++++++++.+++..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            666788999999999999864 788999999874422   2345788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      ++ |++.+.+......+++.++..++.|++.|+.||   |+.+|+||||+|+||+++.++.+||+|||++......    
T Consensus       107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----  178 (317)
T cd06635         107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----  178 (317)
T ss_pred             CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence            96 588888766556789999999999999999999   7899999999999999999999999999998764321    


Q ss_pred             eecccccccccccccccc---cCccchhhhcccccccchhhhcccccccCcchhh-------------hhHHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIF---VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-------------AAKEQCLLSIFS  947 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-------------~~~~~~~~~l~~  947 (985)
                        ....+++.|+|||.+.   .+.++.++|+ |++|+++++++++..+.......             .....++..+.+
T Consensus       179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv-~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  255 (317)
T cd06635         179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDV-WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN  255 (317)
T ss_pred             --ccccCCccccChhhhhcCCCCCCCccccH-HHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHH
Confidence              2235888999999874   4668889999 99999999999988654322110             112235677899


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHH
Q 001988          948 LALECTMESPEKRIDAKDTITRLL  971 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~~ev~~~L~  971 (985)
                      ++.+|++.+|.+||++.++++...
T Consensus       256 li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         256 FVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             HHHHHccCCcccCcCHHHHHhChh
Confidence            999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=9e-30  Score=298.69  Aligned_cols=239  Identities=16%  Similarity=0.148  Sum_probs=182.5

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc--CCcEEEEEEe--------------cc---CCcchHHHHHHHHHHHHhcCCCCe
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE--DGVEIAIKVF--------------HP---QCASTLKSFEAECEVIKNIRHRNL  784 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vAvK~~--------------~~---~~~~~~~~~~~E~~il~~l~h~ni  784 (985)
                      ..++|++.+.||+|+||+||+|..+  ++..+++|.+              .+   ........+.+|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            4578999999999999999998754  2222222211              11   111234567899999999999999


Q ss_pred             eeEEeeeecCCceEEEEeccCCCChHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc
Q 001988          785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSN----CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD  860 (985)
Q Consensus       785 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~  860 (985)
                      +++++++...+..|+|+|++. +++.+++....    ..........++.|++.||+||   |++|||||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yL---H~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYI---HDKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEC
Confidence            999999999999999999994 57877765431    1233556778999999999999   789999999999999999


Q ss_pred             CCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCc-ch-h----
Q 001988          861 EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGE-EK-H----  934 (985)
Q Consensus       861 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~-~~-~----  934 (985)
                      .++.+||+|||+++.+..... .......||+.|+|||.+.+..++.++|+ |++|+++++++++...... .. .    
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDI-WSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHH-HHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            999999999999988753322 22234579999999999999999999999 9999999999987643211 00 0    


Q ss_pred             --------------hhh--------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          935 --------------FAA--------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       935 --------------~~~--------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                    .+.                          ....+..+.+++.+|+..||.+||++.|++.
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence                          000                          0001234566789999999999999999986

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.96  E-value=3.9e-29  Score=270.10  Aligned_cols=227  Identities=25%  Similarity=0.336  Sum_probs=191.6

Q ss_pred             eeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCCh
Q 001988          734 IGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSL  809 (985)
Q Consensus       734 ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  809 (985)
                      ||.|+||.||+|+.. +++.||+|++.+...   ...+.+.+|+.++++++||||+++++++.+++..++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999975 589999999875432   2346789999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecccc
Q 001988          810 EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL  889 (985)
Q Consensus       810 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  889 (985)
                      .+++.... .+++..+..++.|+++||+|+   |+++++|+||+|+||+++.++.+||+|||+++......   ......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~l---H~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYL---HNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            99998653 578999999999999999999   88999999999999999999999999999998764322   122346


Q ss_pred             cccccccccccccCccchhhhcccccccchhhhcccccccCcch--hhh-------------hHHHHHHHHHHHHHHccC
Q 001988          890 ATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK--HFA-------------AKEQCLLSIFSLALECTM  954 (985)
Q Consensus       890 gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~--~~~-------------~~~~~~~~l~~l~~~cl~  954 (985)
                      +++.|+|||.+....++.++|+ |++|+++++++++..+.....  ...             .+...++++.+++.+||.
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  232 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDY-WSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLR  232 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhh-hhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHcc
Confidence            8899999999988889999999 999999999999887665432  110             111235789999999999


Q ss_pred             CCCCCCCC-----HHHHHH
Q 001988          955 ESPEKRID-----AKDTIT  968 (985)
Q Consensus       955 ~~P~~RPt-----~~ev~~  968 (985)
                      .+|++||+     +.|+++
T Consensus       233 ~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         233 RNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CChhhCcCCcccCHHHHhc
Confidence            99999999     566554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.2e-31  Score=303.91  Aligned_cols=207  Identities=24%  Similarity=0.296  Sum_probs=178.7

Q ss_pred             HHHHHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccC---CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 001988          719 FELLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ---CASTLKSFEAECEVIKNIRHRNLVKIISSCSND  794 (985)
Q Consensus       719 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~  794 (985)
                      .++....++|.+.++||+|+||.|..++.+ +++.||+|++.+.   ...+..-|..|-++|..-+.+-|++++.+|++.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            345556688999999999999999999975 7788999999863   234567799999999999999999999999999


Q ss_pred             CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCce
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK  874 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~  874 (985)
                      .+.|+||||++||+|...+...+ .+++.....++..|+.||.-+   |+.|+|||||||+|||+|..|++||+|||.|.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldsl---H~mgyVHRDiKPDNvLld~~GHikLADFGsCl  223 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSL---HSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL  223 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHH---HhccceeccCCcceeEecccCcEeeccchhHH
Confidence            99999999999999999998877 788888899999999999999   89999999999999999999999999999998


Q ss_pred             eccCCCCcceeccccccccccccccccc-----CccchhhhcccccccchhhhcccccccCc
Q 001988          875 LLSGEDESTMRTQTLATIGYMAPDEIFV-----GELSLKRWVNDLLPVSLVEVVDKSLLSGE  931 (985)
Q Consensus       875 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~dv~~~~g~~~~~i~~~~~~~~~  931 (985)
                      .+..++ .......+|||.|++||++..     +.|+..+|. |++|+++|||+-|+-++..
T Consensus       224 km~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDw-WSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  224 KMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDW-WSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             hcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccch-hhhHHHHHHHHcCCCcchH
Confidence            886444 334456679999999998862     456666665 9999999999988766544

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=2.5e-29  Score=278.64  Aligned_cols=238  Identities=26%  Similarity=0.298  Sum_probs=192.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecC--CceEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSND--DFKAL  799 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~l  799 (985)
                      .++|+..+.||+|+||.||+|... +|+.||+|.++.....  ....+.+|+.++++++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467899999999999999999865 6899999998754322  223567899999999999999999998754  56899


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||++ ++|.+++......+++.++..++.|++.|++||   |+.|++||||||+||++++++.+||+|||.+..+...
T Consensus        86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYL---HENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            999996 589888876656789999999999999999999   7899999999999999999999999999999876533


Q ss_pred             CCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh---------------------
Q 001988          880 DESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA---------------------  937 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~---------------------  937 (985)
                      ..  ......+++.|+|||.+.+ ..++.++|+ |++|+.+++++++..+.........                     
T Consensus       162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv-wslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         162 AK--PMTPKVVTLWYRAPELLLGCTTYTTAIDM-WAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             cC--CCCcccccccccChhhhcCCCCcCchHHH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence            21  1122346788999998865 457889999 9999999999998765432110000                     


Q ss_pred             --------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          938 --------------------KEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       938 --------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                          .....+++.+++.+|++.||++||++.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                                00125667889999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.96  E-value=3.5e-29  Score=274.31  Aligned_cols=235  Identities=24%  Similarity=0.321  Sum_probs=193.1

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecC--CceEEEEe
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSND--DFKALVLE  802 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lv~e  802 (985)
                      |...+.||+|+||.||+|... +++.||+|++....  ......+.+|++++++++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            566788999999999999876 58899999998663  23345688999999999999999999999887  88999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |+++ +|.+++......+++..++.++.|+++|++||   |+.|++|+||||+||++++++.+||+|||++........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~L---H~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL---HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9974 89998877655789999999999999999999   788999999999999999999999999999987754332 


Q ss_pred             ceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhh-------------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------------------  936 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------------------  936 (985)
                      .......++..|+|||.+.+ ..++.++|+ |++|+.+++++++..+........                         
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv-~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDM-WSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHH-HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence            11233457889999997764 457889999 999999999999876543211100                         


Q ss_pred             ----------------hHHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 ----------------AKEQ-CLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 ----------------~~~~-~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                      .... ++.++.+++.+|++.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                            0001 2667889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.96  E-value=1.1e-29  Score=274.56  Aligned_cols=232  Identities=27%  Similarity=0.303  Sum_probs=193.3

Q ss_pred             eeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCCh
Q 001988          734 IGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSL  809 (985)
Q Consensus       734 ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  809 (985)
                      ||+|+||.||+|+.. +++.||+|.+.....   .....+.+|++++++++||||+++++.+......++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 599999999875533   3456788999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC------cc
Q 001988          810 EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE------ST  883 (985)
Q Consensus       810 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~------~~  883 (985)
                      .+++...+ .+++..+..++.|+++||+||   |+.+++||||+|+||++++++.+||+|||++........      ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYL---HSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99998755 689999999999999999999   789999999999999999999999999999876432211      11


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHH--HHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQC--LLSIFSLAL  950 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~--~~~l~~l~~  950 (985)
                      ......++..|+|||.......+.+.|+ |++|+.+++++++..+........           .++.+  +..+.+++.
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv-~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  235 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDW-WSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLIS  235 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhh-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHH
Confidence            2234568889999999988889999999 999999999999887654332111           11122  678999999


Q ss_pred             HccCCCCCCCCCHHHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~L  970 (985)
                      +|++.+|++||++.++.+.+
T Consensus       236 ~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         236 KLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             HHhcCCHhhcCCCccHHHHh
Confidence            99999999999995555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=3.3e-29  Score=282.86  Aligned_cols=235  Identities=23%  Similarity=0.287  Sum_probs=191.6

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecC------
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSND------  794 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------  794 (985)
                      ..++|+..+.||+|+||.||+|... +++.||+|.+....  ......+.+|++++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999865 78999999986532  23345677899999999999999999988643      


Q ss_pred             CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCce
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK  874 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~  874 (985)
                      ...++||||++ ++|.+.+...   ++......++.|++.||+||   |+.||+||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            35699999995 5888887643   78888999999999999999   78999999999999999999999999999998


Q ss_pred             eccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------------
Q 001988          875 LLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------------  937 (985)
Q Consensus       875 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------------  937 (985)
                      ......   ......+++.|+|||.+.+..++.+.|+ |++|+.++++++++.+.........                 
T Consensus       167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-wslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         167 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDI-WSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             eCCCCC---CCCCCcccccccCHHHHhCCCCCCchhh-HhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            754221   1223458899999999999999999999 9999999999988765432110000                 


Q ss_pred             -------------------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          938 -------------------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       938 -------------------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                                           ....++++.+++.+|++.||++||++.|++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                                                 00124567899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.96  E-value=4.6e-30  Score=252.98  Aligned_cols=232  Identities=23%  Similarity=0.279  Sum_probs=190.4

Q ss_pred             CCceeeccCceeEEEEEEc-CCcEEEEEEeccC-CcchHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceEEEEeccCC
Q 001988          730 ENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ-CASTLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       730 ~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      ....+|.|..|.||+++.+ +|..+|||.+.+. +..+.+++...++++.+.. +|.||+-+|||..+..++|-||.|. 
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-  174 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-  174 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence            3466999999999999865 6889999999765 3445677888888877764 8999999999999999999999984 


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      -..+..++.-.+++++.-.-++..-++.||.||.  ..++|+|||+||+|||+|+.|.+|+||||++-++.+...   .+
T Consensus       175 ~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLK--eKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---ht  249 (391)
T KOG0983|consen  175 TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---HT  249 (391)
T ss_pred             HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHH--HhcceeecccCccceEEccCCCEEeecccccceeecccc---cc
Confidence            3566666666667888888889999999999997  677899999999999999999999999999987754333   33


Q ss_pred             ccccccccccccccc---cCccchhhhcccccccchhhhcccccccCcc---------------hhhhhHHHHHHHHHHH
Q 001988          887 QTLATIGYMAPDEIF---VGELSLKRWVNDLLPVSLVEVVDKSLLSGEE---------------KHFAAKEQCLLSIFSL  948 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~---~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~---------------~~~~~~~~~~~~l~~l  948 (985)
                      ..+|.+.|||||.+-   ...|..++|| |++|+.++|++++..++..-               +..+.....+..+.++
T Consensus       250 rsAGC~~YMaPERidp~~~~kYDiRaDV-WSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~f  328 (391)
T KOG0983|consen  250 RSAGCAAYMAPERIDPPDKPKYDIRADV-WSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSF  328 (391)
T ss_pred             cccCCccccCccccCCCCCCccchhhhh-hhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHH
Confidence            456999999999874   4678999999 99999999999988765431               1111222356789999


Q ss_pred             HHHccCCCCCCCCCHHHHHH
Q 001988          949 ALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +..|+..|+.+||...++++
T Consensus       329 v~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  329 VKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             HHHHhhcCcccCcchHHHhc
Confidence            99999999999999998875

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=4.6e-29  Score=272.67  Aligned_cols=232  Identities=22%  Similarity=0.279  Sum_probs=187.9

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcC-CCCeeeEEeeeecC--CceEEEEe
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIR-HRNLVKIISSCSND--DFKALVLE  802 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~--~~~~lv~e  802 (985)
                      |+..+.||+|+||.||+|... +++.||+|+++.... .......+|+.+++++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            556788999999999999864 788999999875422 22334457888999885 99999999999887  88999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |++ |++.+.+......+++.++..++.|++.||+||   |+.|++||||||+||+++. +.+||+|||+++........
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM---HRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            996 588888877655789999999999999999999   7899999999999999999 99999999999876432221


Q ss_pred             ceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhh-------------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------------------  936 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------------------  936 (985)
                         ....++..|+|||.+.. +.++.++|+ |++|+.+++++++..+........                         
T Consensus       156 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di-~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         156 ---TEYISTRWYRAPECLLTDGYYGPKMDI-WAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             ---CCCCCCcccCChhHhhcCCCCCcchhH-HHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence               22457889999997654 556889999 999999999998765443211000                         


Q ss_pred             ---------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 ---------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 ---------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                     .....+.++.+++.+|++++|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                           01134578999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=4.3e-29  Score=276.92  Aligned_cols=239  Identities=23%  Similarity=0.313  Sum_probs=189.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecCC------
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSNDD------  795 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------  795 (985)
                      .++|+..+.||+|+||.||+|... +++.||||.+......  ....+.+|++++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457889999999999999999865 7899999988654222  2345678999999999999999999987654      


Q ss_pred             --ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCc
Q 001988          796 --FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA  873 (985)
Q Consensus       796 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla  873 (985)
                        ..++||||++ +++.+.+......+++.+...++.|++.||+||   |++|++||||||+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYI---HRNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence              3499999996 588888877655789999999999999999999   7889999999999999999999999999999


Q ss_pred             eeccCCCCc--ceecccccccccccccccccCc-cchhhhcccccccchhhhcccccccCcchhhhh-------------
Q 001988          874 KLLSGEDES--TMRTQTLATIGYMAPDEIFVGE-LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-------------  937 (985)
Q Consensus       874 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-------------  937 (985)
                      ..+......  .......++..|+|||.+.+.. ++.++|+ |++|+.+++++++..+.........             
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di-~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDM-WGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhh-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            876433221  1112345788999999876543 6788999 9999999999987654322110000             


Q ss_pred             -------------------------HH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 -------------------------KE-----QCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 -------------------------~~-----~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                               ..     .....+.+++.+|+..+|.+||++.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                                     00     01245678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-29  Score=234.85  Aligned_cols=234  Identities=23%  Similarity=0.314  Sum_probs=188.0

Q ss_pred             CccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +|...++||+|.||+||+|+. ++++.||+|+++.+..  .-.....+|+-+++.++|+|||++++....+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            567788999999999999984 5788899999876532  3356788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      |. .+|..+...-.+.++......++.|+.+||.|+   |++++.|||+||+|.+++.+|+.|++|||+|+.+.-+.  .
T Consensus        83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fc---hshnvlhrdlkpqnllin~ngelkladfglarafgipv--r  156 (292)
T KOG0662|consen   83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFC---HSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--R  156 (292)
T ss_pred             hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhh---hhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--E
Confidence            94 589999988877899999999999999999999   89999999999999999999999999999999875322  2


Q ss_pred             eecccccccccccccccccCc-cchhhhcccccccchhhhccc-cc-ccCcchhhhh-----------------------
Q 001988          884 MRTQTLATIGYMAPDEIFVGE-LSLKRWVNDLLPVSLVEVVDK-SL-LSGEEKHFAA-----------------------  937 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~~~~g~~~~~i~~~-~~-~~~~~~~~~~-----------------------  937 (985)
                      ..+..+-|..|.+|+++++.. |+...|+ |+.|+.+.|+... .. +.+.+ ..++                       
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidm-wsagcifaelanagrplfpg~d-vddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDM-WSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHh-hhcchHHHHHhhcCCCCCCCCc-HHHHHHHHHHHhCCCccccCCccccCC
Confidence            234456899999999988754 6778888 8889888887652 22 22221 1110                       


Q ss_pred             -----------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 -----------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 -----------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                       .......-+++.++.+.-+|.+|.++.+.++
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence                             0111223456788888888999999988764

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.96  E-value=2.8e-29  Score=281.76  Aligned_cols=239  Identities=25%  Similarity=0.330  Sum_probs=193.0

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccC--CcchHHHHHHHHHHHHhc-CCCCeeeEEeeeecC--Cce
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ--CASTLKSFEAECEVIKNI-RHRNLVKIISSCSND--DFK  797 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~--~~~  797 (985)
                      ..++|...+.||+|+||.||+|... +++.||+|++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4567888899999999999999875 6889999988643  223345677899999999 999999999998654  367


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ++||||++ ++|.+++...  .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+.
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~L---H~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYI---HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            99999997 5999988765  678899999999999999999   78999999999999999999999999999998764


Q ss_pred             CCCCc---ceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhh-----------------
Q 001988          878 GEDES---TMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------------  936 (985)
Q Consensus       878 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------------  936 (985)
                      .....   .......|++.|+|||.+.. ..++.++|+ |++|+++++++++..+........                 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi-~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDM-WSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchH-HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            33221   22334568999999998765 457788999 999999999999886543211000                 


Q ss_pred             -------------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          937 -------------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       937 -------------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                               ....++.++.+++.+||+.+|.+||++.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                                     000135668899999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.96  E-value=2.6e-29  Score=279.57  Aligned_cols=237  Identities=22%  Similarity=0.319  Sum_probs=189.3

Q ss_pred             CccCCceeeccCceeEEEEEEc---CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecC--CceE
Q 001988          727 NFAENNIIGIGGFGSVYRARLE---DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSND--DFKA  798 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~---~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~  798 (985)
                      +|...+.||+|+||.||+|...   +++.||+|.+....   ......+.+|+.++++++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4677889999999999999864   47899999998642   23345678899999999999999999999888  7899


Q ss_pred             EEEeccCCCChHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC----CCcEEEecc
Q 001988          799 LVLEYMSNGSLEDCLHSS----NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE----DMVAHLSDF  870 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~----~~~~kl~Df  870 (985)
                      +||||+++ ++.+.+...    ...+++..+..++.|++.|++||   |+.+|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL---HSNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999965 677766432    23678899999999999999999   7999999999999999999    999999999


Q ss_pred             cCceeccCCCC-cceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhh------------
Q 001988          871 GMAKLLSGEDE-STMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------  936 (985)
Q Consensus       871 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------  936 (985)
                      |+++.+..... ........+++.|+|||.+.+. .++.++|+ |++|+.+++++++..+........            
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv-~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDI-WAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHH-HHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            99987643322 1122344688999999987664 47888999 999999999998776543211000            


Q ss_pred             --------------------------------------hHH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 --------------------------------------AKE-------QCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 --------------------------------------~~~-------~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                            ...       ....++.+++.+|++++|++||++.|+++
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                                                  000       12346888999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=1.3e-29  Score=277.93  Aligned_cols=236  Identities=23%  Similarity=0.290  Sum_probs=189.7

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +|...+.||+|+||.||++... +++.||+|.+..... .....+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4555678999999999999865 689999999875432 34567889999999996 99999999999998899999999


Q ss_pred             cCCCChHHHh---hc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          804 MSNGSLEDCL---HS-SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       804 ~~~gsL~~~l---~~-~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ++. ++.++.   .. ....+++....+++.+++.||+|||  |+.+++||||||+||+++.++.+||+|||+++.+...
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            854 554432   22 2356889999999999999999995  4569999999999999999999999999999765432


Q ss_pred             CCcceecccccccccccccccccC---ccchhhhcccccccchhhhcccccccCcchhh-----------------hhHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVG---ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-----------------AAKE  939 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-----------------~~~~  939 (985)
                      ..   .....|++.|+|||.+...   .++.++|+ |++|++++++++|+.+.......                 ....
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di-~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd06616         162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDV-WSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER  237 (288)
T ss_pred             Cc---cccccCccCccCHHHhccccccCCcchhhh-hHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence            21   1223588999999998766   68889999 99999999999988765432100                 0011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          940 QCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       940 ~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      .++.++.+++.+||+.+|++||++.++++.
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         238 EFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            256778999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.96  E-value=2.5e-29  Score=281.89  Aligned_cols=244  Identities=23%  Similarity=0.321  Sum_probs=194.4

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----Cce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSND-----DFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~  797 (985)
                      +++|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            578999999999999999999854 78999999986432 22345678899999999999999999987544     357


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ++||||++ +++.+.+...  .+++..+..++.|+++||+||   |+.||+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~L---H~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            99999996 5888877653  588999999999999999999   78999999999999999999999999999998764


Q ss_pred             CCCCcc-eeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhh-------------------
Q 001988          878 GEDEST-MRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------------  936 (985)
Q Consensus       878 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------------  936 (985)
                      ...... ......|++.|+|||.+.+ ..++.++|+ |++|+.++++++|+.+........                   
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv-wslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDI-WSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC  236 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            322211 1233468999999998754 567889999 999999999999886553211000                   


Q ss_pred             -----------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHhHh
Q 001988          937 -----------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTITR--LLKIRD  975 (985)
Q Consensus       937 -----------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~--L~~i~~  975 (985)
                                             .....+.++.+++.+||+.+|++||++.|+++.  ++...+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence                                   001124568899999999999999999999886  554443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.96  E-value=1.7e-29  Score=277.06  Aligned_cols=229  Identities=24%  Similarity=0.282  Sum_probs=193.5

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCChH
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLE  810 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  810 (985)
                      ..||+|+||.||+|... +++.||||++..........+.+|+.++++++|+|++++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            56999999999999864 78999999987555455667899999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceeccccc
Q 001988          811 DCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA  890 (985)
Q Consensus       811 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g  890 (985)
                      +++...  .+++.....++.|++.|++||   |+.|++||||+|+||++++++.++|+|||++........  ......+
T Consensus       106 ~~~~~~--~~~~~~~~~~~~ql~~~l~~l---H~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~  178 (292)
T cd06657         106 DIVTHT--RMNEEQIAAVCLAVLKALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVG  178 (292)
T ss_pred             HHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccccc
Confidence            987643  478899999999999999999   788999999999999999999999999999876543221  1233458


Q ss_pred             ccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh--------------hHHHHHHHHHHHHHHccCCC
Q 001988          891 TIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--------------AKEQCLLSIFSLALECTMES  956 (985)
Q Consensus       891 t~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--------------~~~~~~~~l~~l~~~cl~~~  956 (985)
                      ++.|+|||.+....++.++|+ |++|+++++++++..+........              ....++..+.+++.+||..+
T Consensus       179 ~~~y~~pE~~~~~~~~~~~Dv-~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  257 (292)
T cd06657         179 TPYWMAPELISRLPYGPEVDI-WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD  257 (292)
T ss_pred             CccccCHHHhcCCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence            899999999888888999999 999999999999877543221110              11224567889999999999


Q ss_pred             CCCCCCHHHHHH
Q 001988          957 PEKRIDAKDTIT  968 (985)
Q Consensus       957 P~~RPt~~ev~~  968 (985)
                      |.+||++.++++
T Consensus       258 P~~R~~~~~ll~  269 (292)
T cd06657         258 PAQRATAAELLK  269 (292)
T ss_pred             cccCcCHHHHhc
Confidence            999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.96  E-value=4.8e-29  Score=275.46  Aligned_cols=240  Identities=24%  Similarity=0.313  Sum_probs=193.6

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCC----
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDD----  795 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----  795 (985)
                      ...++|+..+.||+|+||.||+|... +++.||+|+++....  .....+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999975 688999999875432  23356778999999999999999999987654    


Q ss_pred             ------ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 001988          796 ------FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSD  869 (985)
Q Consensus       796 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~D  869 (985)
                            ..++||||+++ ++.+.+......+++..+..++.|++.||+||   |+.||+||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYC---HKKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999976 77777776555789999999999999999999   788999999999999999999999999


Q ss_pred             ccCceeccCCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhh-------------
Q 001988          870 FGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-------------  935 (985)
Q Consensus       870 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-------------  935 (985)
                      ||++..+...... ......++..|+|||.+.. ..++.++|+ |++|+.+++++++..+.......             
T Consensus       160 fg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di-~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (302)
T cd07864         160 FGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDV-WSCGCILGELFTKKPIFQANQELAQLELISRLCGSP  237 (302)
T ss_pred             ccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHH-HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999876533321 1122346788999998764 346888999 99999999999887544321100             


Q ss_pred             ----------------------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          936 ----------------------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       936 ----------------------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                  ...+..+..+.+++.+||..+|.+||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                                        001124577899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.96  E-value=5.4e-29  Score=273.89  Aligned_cols=236  Identities=25%  Similarity=0.329  Sum_probs=189.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ++|+..+.||+|++|.||+|... +++.||+|.+.....  ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999865 789999999865432  234568899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-CCcEEEecccCceeccCCC
Q 001988          803 YMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       803 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~-~~~~kl~DfGla~~~~~~~  880 (985)
                      |++ +++.+++... ....++.....++.||+.||+||   |+++++||||+|+||++++ ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC---HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 5888877654 23367888889999999999999   7899999999999999985 5679999999997653221


Q ss_pred             Ccceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhh-----------------------
Q 001988          881 ESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------------------  936 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------------------  936 (985)
                        .......+++.|+|||.+.+ ..++.++|+ |++|+.+++++++..+........                       
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv-~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDI-WSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             --cccccCceeecccCHHHHhCCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence              11123357889999998766 357889999 999999999999876543211100                       


Q ss_pred             -----------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 -----------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 -----------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                       .....++++.+++.+|+..+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                             00123466789999999999999999999986

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.96  E-value=2.7e-29  Score=273.64  Aligned_cols=228  Identities=24%  Similarity=0.281  Sum_probs=188.8

Q ss_pred             eeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCCh
Q 001988          734 IGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSL  809 (985)
Q Consensus       734 ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  809 (985)
                      ||+|+||+||+|... +|+.||+|.+....   ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999854 78999999987542   12244567899999999999999999999999999999999999999


Q ss_pred             HHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceeccc
Q 001988          810 EDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT  888 (985)
Q Consensus       810 ~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~  888 (985)
                      .+++.... ..+++..+..++.|++.|+.||   |+.|++||||+|+||++++++.+||+|||.+......   ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHL---HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence            99987653 3688999999999999999999   7899999999999999999999999999998765421   112234


Q ss_pred             ccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh---------------hhHHHHHHHHHHHHHHcc
Q 001988          889 LATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AAKEQCLLSIFSLALECT  953 (985)
Q Consensus       889 ~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~~~~~~~~l~~l~~~cl  953 (985)
                      .++..|+|||.+.++.++.++|+ |++|+.++++++++.+.......               ..+...++.+.+++.+||
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  233 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDW-FALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALL  233 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhh-HHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHc
Confidence            57889999999988889999999 99999999999988765432110               111234677899999999


Q ss_pred             CCCCCCCC-----CHHHHHH
Q 001988          954 MESPEKRI-----DAKDTIT  968 (985)
Q Consensus       954 ~~~P~~RP-----t~~ev~~  968 (985)
                      +.+|.+||     ++.+++.
T Consensus       234 ~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         234 QKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCChhHccCCCcccHHHHHh
Confidence            99999999     5555653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.96  E-value=5.8e-29  Score=272.07  Aligned_cols=234  Identities=24%  Similarity=0.355  Sum_probs=190.5

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      |+..+.||.|++|.||+|... +|+.||+|++.....  .....+.+|++++++++|||++++++++.+.+..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999864 799999999875532  22356889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          805 SNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       805 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      + ++|.+++.... ..+++..+..++.|+++||+||   |+++++||||+|+||++++++.++|+|||+++.+.....  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~l---H~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC---HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 68999987653 3589999999999999999999   788999999999999999999999999999976532211  


Q ss_pred             eecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhh--------------------------
Q 001988          884 MRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--------------------------  936 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--------------------------  936 (985)
                      ......+++.|+|||.+.+. .++.++|+ |++|+.+++++++..+........                          
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di-~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDI-WSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            11223468899999987664 46888999 999999999999876543211100                          


Q ss_pred             --------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 --------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 --------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                    .....+.++.+++.+|++.+|++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                          00112356889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=3.6e-29  Score=272.76  Aligned_cols=228  Identities=23%  Similarity=0.236  Sum_probs=183.4

Q ss_pred             eeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHh---cCCCCeeeEEeeeecCCceEEEEeccC
Q 001988          733 IIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKN---IRHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       733 ~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~---l~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      .||+|+||.||+|... +++.||+|.+.+...   .....+.+|..+++.   .+||+|+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999864 688999999875422   122334455544443   379999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCccee
Q 001988          806 NGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR  885 (985)
Q Consensus       806 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~  885 (985)
                      +|+|.+++...+ .+++.....++.|++.||+||   |+.+|+||||||+||++++++.+|++|||++.......    .
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~l---H~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~  152 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence            999999987654 589999999999999999999   78999999999999999999999999999987653221    1


Q ss_pred             ccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchh--h------------hhHHHHHHHHHHHHH
Q 001988          886 TQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH--F------------AAKEQCLLSIFSLAL  950 (985)
Q Consensus       886 ~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~--~------------~~~~~~~~~l~~l~~  950 (985)
                      ....|+..|+|||.... ..++.++|+ |++|+.+++++++..++.....  .            ..++..+.++.+++.
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di-~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  231 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADW-FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLE  231 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhh-HHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHH
Confidence            23458999999998864 557889999 9999999999998876542211  0            112235678899999


Q ss_pred             HccCCCCCCCC-----CHHHHHHH
Q 001988          951 ECTMESPEKRI-----DAKDTITR  969 (985)
Q Consensus       951 ~cl~~~P~~RP-----t~~ev~~~  969 (985)
                      +|+..+|.+||     ++.|+++.
T Consensus       232 ~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         232 GLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             HHhcCCHHHhcCCCCCCHHHHHhC
Confidence            99999999999     58888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.96  E-value=3.6e-29  Score=269.21  Aligned_cols=234  Identities=21%  Similarity=0.267  Sum_probs=198.0

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +|+..+.||+|+||.||++... +++.+|+|.+....  ......+.+|++++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4777889999999999999754 78899999987543  23345678899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          804 MSNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       804 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      +++++|.+++...   +..+++...+.++.|+++|++||   |+.|++||||+|+||++++++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---h~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL---HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999998762   34678999999999999999999   8999999999999999999999999999999876433 


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh------------hhHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF------------AAKEQCLLSIFSL  948 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~------------~~~~~~~~~l~~l  948 (985)
                         ......+++.|+|||...+..++.++|+ |++|+++++++++..+.......            ..+...+.++.++
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~-~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  232 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDI-WSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNF  232 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHH
Confidence               2223458889999999999889999999 99999999999987654432111            1223456789999


Q ss_pred             HHHccCCCCCCCCCHHHHHH
Q 001988          949 ALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +.+|++.+|++||++.|+++
T Consensus       233 i~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         233 IRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             HHHHcCCCcccCCCHHHHhc
Confidence            99999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.96  E-value=5.9e-29  Score=271.91  Aligned_cols=234  Identities=24%  Similarity=0.327  Sum_probs=195.3

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      |...+.||+|++|.||+|... +++.+|+|.+......  ....+.+|++++++++|+||+++++++..++..++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566788999999999999864 7889999998765332  3567889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      ++ ++.+++......+++..+..++.|+++|++||   |+.+|+||||||+||++++++.+||+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC---HSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHH---HHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            75 89888877656789999999999999999999   78999999999999999999999999999998765332  11


Q ss_pred             ecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhh----------------------------
Q 001988          885 RTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF----------------------------  935 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~----------------------------  935 (985)
                      .....++..|+|||.+... .++.++|+ |++|+.+++++++..+.......                            
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di-~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDI-WSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence            2234578899999998776 78899999 99999999999987544221100                            


Q ss_pred             -------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          936 -------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       936 -------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                   ...+..+.++.+++.+||.++|.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                         011235678999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.96  E-value=9.8e-29  Score=267.48  Aligned_cols=235  Identities=20%  Similarity=0.201  Sum_probs=190.1

Q ss_pred             HHHHHHHhcCccCCcee--eccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeec
Q 001988          718 YFELLRATDNFAENNII--GIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSN  793 (985)
Q Consensus       718 ~~~~~~~~~~~~~~~~i--g~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~  793 (985)
                      ..+.....++|...+.+  |+|+||.||+++.+ +++.+|+|.+.......     .|+.+...+ +||||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence            34455556677777776  99999999999864 78889999987542221     123333223 79999999999999


Q ss_pred             CCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-cEEEecccC
Q 001988          794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGM  872 (985)
Q Consensus       794 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~-~~kl~DfGl  872 (985)
                      .+..++||||+++|+|.+++.... .+++.+...++.|+++|++||   |+.|++||||||+||+++.++ .++|+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDL---HKHNIIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            999999999999999999998764 789999999999999999999   789999999999999999998 999999999


Q ss_pred             ceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh---------------hh
Q 001988          873 AKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AA  937 (985)
Q Consensus       873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~  937 (985)
                      ++......      ...++..|+|||.+.+..++.++|+ |++|+.+++++++..+.......               ..
T Consensus       157 ~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv-wslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  229 (267)
T PHA03390        157 CKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDW-WAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPF  229 (267)
T ss_pred             ceecCCCc------cCCCCCcccChhhhcCCCCCchhhH-HHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCc
Confidence            88753221      2358899999999998899999999 99999999999988765422110               11


Q ss_pred             HHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 001988          938 KEQCLLSIFSLALECTMESPEKRID-AKDTIT  968 (985)
Q Consensus       938 ~~~~~~~l~~l~~~cl~~~P~~RPt-~~ev~~  968 (985)
                      ....+..+.+++.+|++.+|.+||+ +.|+++
T Consensus       230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        230 IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            1235678899999999999999996 588763

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.4e-28  Score=266.02  Aligned_cols=237  Identities=24%  Similarity=0.290  Sum_probs=194.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-----cchHHHHHHHHHHHHhcCCCCeeeEEeeeecC--Cce
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-----ASTLKSFEAECEVIKNIRHRNLVKIISSCSND--DFK  797 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~  797 (985)
                      .+|...+.||+|+||.||+|... +++.||+|.+....     ......+.+|++++++++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888999999999999999864 68999999875331     22345788999999999999999999998764  457


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ++||||+++++|.+++...+ .+++....+++.|++.|++||   |+.|++||||||+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            89999999999999987654 478889999999999999999   79999999999999999999999999999998754


Q ss_pred             CCCC-cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh-------------hhHHHHHH
Q 001988          878 GEDE-STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-------------AAKEQCLL  943 (985)
Q Consensus       878 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-------------~~~~~~~~  943 (985)
                      .... ........++..|+|||.+.+..++.++|+ |++|+.++++++++.+.......             ..+....+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~  236 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADV-WSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD  236 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccH-HHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCH
Confidence            2111 111223458999999999988888999999 99999999999988765433211             12334567


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ++.+++.+|+. +|..||++.+++.
T Consensus       237 ~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         237 ACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHHHHHHHHhc-CcccCccHHHHhc
Confidence            79999999998 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=9.8e-29  Score=271.45  Aligned_cols=240  Identities=20%  Similarity=0.238  Sum_probs=181.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEcC----CcEEEEEEeccCCcchH-----------HHHHHHHHHHHhcCCCCeeeEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLED----GVEIAIKVFHPQCASTL-----------KSFEAECEVIKNIRHRNLVKIIS  789 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vAvK~~~~~~~~~~-----------~~~~~E~~il~~l~h~niv~l~~  789 (985)
                      .++|...+.||+|+||.||+|...+    +..+|+|+.........           .....+...+..+.|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3578999999999999999998754    34567776443322110           01122333455668999999999


Q ss_pred             eeecCC----ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcE
Q 001988          790 SCSNDD----FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  865 (985)
Q Consensus       790 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~  865 (985)
                      ++....    ..++++|++. .++.+.+.... ..++.....++.|++.||+||   |+++|+||||||+|||++.++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYI---HEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCcE
Confidence            876543    3468888874 46666665432 356788899999999999999   78999999999999999999999


Q ss_pred             EEecccCceeccCCCCc-----ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh-----
Q 001988          866 HLSDFGMAKLLSGEDES-----TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-----  935 (985)
Q Consensus       866 kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-----  935 (985)
                      ||+|||+|+.+......     .......||+.|+|||...+..++.++|+ |++|+.+++++++..++......     
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~Di-wSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDL-ESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHH-HHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            99999999876432211     11223469999999999999999999999 99999999999998776433110     


Q ss_pred             -------h-------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 001988          936 -------A-------AKEQCLLSIFSLALECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       936 -------~-------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L  970 (985)
                             .       ....+++++.+++..|+..+|++||++.++.+.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        245 AAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence                   0       1123567899999999999999999999999876

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=5.2e-30  Score=256.95  Aligned_cols=242  Identities=23%  Similarity=0.283  Sum_probs=191.8

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc---C--CcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeec-CC
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE---D--GVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSN-DD  795 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~---~--~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~  795 (985)
                      ....|+....||+|.||.||+|..+   +  ++.+|+|+++....  .-.....+|+..++.++|||++.+..++.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3457888999999999999999643   3  33799999975522  224567899999999999999999999877 77


Q ss_pred             ceEEEEeccCCCChHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC----CcEEE
Q 001988          796 FKALVLEYMSNGSLEDCLHSS----NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED----MVAHL  867 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~----~~~kl  867 (985)
                      ..++++||.+. +|.+.++..    .+.++...+..|++||+.|+.||   |+.-|+|||+||.|||+..+    |.|||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YL---H~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYL---HSNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHH---hhhheeeccCCcceEEEeccCCccCeeEe
Confidence            88999999976 898888754    34678889999999999999999   89999999999999999877    89999


Q ss_pred             ecccCceeccCCCCcc-eeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcch------------
Q 001988          868 SDFGMAKLLSGEDEST-MRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEK------------  933 (985)
Q Consensus       868 ~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~------------  933 (985)
                      +|||+|+.+...-... ....++-|..|.|||.+.+ ..|+.+.|+ |+.||.+.|+++-+..+....            
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDv-WAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d  256 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDV-WAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD  256 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhh-HHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence            9999999986543322 3455678999999998876 568999999 999999999988654332210            


Q ss_pred             ---------------hhhhHH------------------------------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          934 ---------------HFAAKE------------------------------QCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       934 ---------------~~~~~~------------------------------~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                     ..+..+                              ..++.-+++..+++.+||.+|.|+.+.++
T Consensus       257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence                           000000                              01233677999999999999999999876


Q ss_pred             HH
Q 001988          969 RL  970 (985)
Q Consensus       969 ~L  970 (985)
                      ..
T Consensus       337 h~  338 (438)
T KOG0666|consen  337 HP  338 (438)
T ss_pred             cc
Confidence            53

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.96  E-value=3.6e-29  Score=280.37  Aligned_cols=239  Identities=24%  Similarity=0.313  Sum_probs=193.6

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeec----CCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSN----DDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~  797 (985)
                      .++|+..+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            378888999999999999999864 79999999987542  2334667889999999999999999998753    3467


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ++||||+. |+|.+++.... .+++..+..++.|+++||+||   |+++|+||||||+||++++++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYI---HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999995 68999887654 589999999999999999999   78999999999999999999999999999998764


Q ss_pred             CCCCc--ceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhh-------------------
Q 001988          878 GEDES--TMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-------------------  935 (985)
Q Consensus       878 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-------------------  935 (985)
                      .....  .......++..|+|||.+.. ..++.++|+ |++|+.++++++++.++......                   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di-~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDM-WSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccch-HHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            32221  11233468999999998765 457889999 99999999999888765321100                   


Q ss_pred             -----------------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          936 -----------------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       936 -----------------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                             ......++++.+++.+|++.+|.+||++.+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                                   0001235778999999999999999999998873

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.96  E-value=7.1e-29  Score=277.76  Aligned_cols=248  Identities=22%  Similarity=0.312  Sum_probs=202.2

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCC-----ceE
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD-----FKA  798 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-----~~~  798 (985)
                      +|...+.||.|+||.||+|+.. ++..||+|++....  ....+.+.+|++++++++||||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999965 58999999987653  334567899999999999999999999998765     789


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +||||++ ++|.+++.... .+++..+..++.|++.||+||   |+.||+||||||+||+++.++.++|+|||++.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~L---H~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYL---HSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 58999887654 789999999999999999999   789999999999999999999999999999988654


Q ss_pred             CCCc-ceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhh--------------------
Q 001988          879 EDES-TMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--------------------  936 (985)
Q Consensus       879 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--------------------  936 (985)
                      .... .......+++.|+|||.+.+. .++.++|+ |++|+++++++++..++.......                    
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi-~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDI-WSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhH-HHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            3211 122334588899999999887 78899999 999999999999876543211000                    


Q ss_pred             ----------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHhHhhhccc
Q 001988          937 ----------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTITR--LLKIRDTLSKR  980 (985)
Q Consensus       937 ----------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~--L~~i~~~~~~~  980 (985)
                                            .....+.++.+++.+||+.+|.+||++.+++..  ++.+++...+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~  302 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEP  302 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCC
Confidence                                  001134668899999999999999999999984  66666544333

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.96  E-value=1.1e-28  Score=275.67  Aligned_cols=239  Identities=18%  Similarity=0.280  Sum_probs=188.3

Q ss_pred             eeecc--CceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCC
Q 001988          733 IIGIG--GFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNG  807 (985)
Q Consensus       733 ~ig~G--~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  807 (985)
                      .||+|  +||+||+|+.. +|+.||+|++.....  ...+.+++|+.+++.++||||+++++++..++..++||||+++|
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  99999999864 799999999875432  23467889999999999999999999999999999999999999


Q ss_pred             ChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc---
Q 001988          808 SLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST---  883 (985)
Q Consensus       808 sL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~---  883 (985)
                      ++.+++... ...+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+|++||+.+..........   
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYL---HQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            999998764 23588999999999999999999   78999999999999999999999999998654432211110   


Q ss_pred             --eecccccccccccccccccC--ccchhhhcccccccchhhhcccccccCcchh-------------------------
Q 001988          884 --MRTQTLATIGYMAPDEIFVG--ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-------------------------  934 (985)
Q Consensus       884 --~~~~~~gt~~y~aPE~~~~~--~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-------------------------  934 (985)
                        ......++..|+|||++.++  .++.++|+ |++|+++++++++..+......                         
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di-wslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDI-YSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhH-HHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence              00112356679999998763  46789999 9999999999988765432110                         


Q ss_pred             ---------------------------------hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhHh
Q 001988          935 ---------------------------------FAAKEQCLLSIFSLALECTMESPEKRIDAKDTIT--RLLKIRD  975 (985)
Q Consensus       935 ---------------------------------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~--~L~~i~~  975 (985)
                                                       .+....+.+.+.+++++||..||++|||+.|+++  .+..+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                             0012235677999999999999999999999974  3344444

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.96  E-value=5.2e-29  Score=271.88  Aligned_cols=238  Identities=26%  Similarity=0.368  Sum_probs=199.5

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv  800 (985)
                      ++|...+.||+|+||.||+|... +++.||+|++....   ....+.+.+|.+++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888899999999999999865 79999999987532   233467889999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++++|.+++...+ .+++.....++.|++.||+||   |+.|++|+||+|+||+++.++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~L---h~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYL---HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999998764 689999999999999999999   78999999999999999999999999999998765332


Q ss_pred             Cc------------------ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh------
Q 001988          881 ES------------------TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------  936 (985)
Q Consensus       881 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------  936 (985)
                      ..                  .......++..|+|||......++.++|+ |++|+.+++++++..+........      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di-~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  235 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDL-WALGCIIYQMLTGKPPFRGSNEYLTFQKIL  235 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhH-HHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence            21                  12233457899999999988889999999 999999999999877654332111      


Q ss_pred             -----hHHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 001988          937 -----AKEQCLLSIFSLALECTMESPEKRIDA----KDTIT  968 (985)
Q Consensus       937 -----~~~~~~~~l~~l~~~cl~~~P~~RPt~----~ev~~  968 (985)
                           .+...++.+.+++.+|++.+|.+||++    .++++
T Consensus       236 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                 122345678999999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.96  E-value=5.1e-29  Score=273.21  Aligned_cols=240  Identities=25%  Similarity=0.271  Sum_probs=195.1

Q ss_pred             CccCCceeeccCceeEEEEEE----cCCcEEEEEEeccCC----cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCce
Q 001988          727 NFAENNIIGIGGFGSVYRARL----EDGVEIAIKVFHPQC----ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~  797 (985)
                      +|+..+.||+|+||.||+|+.    .+++.||||.+++..    ....+.+.+|+++++++ +||||+++++++..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            367788999999999999974    257889999987532    12345678999999999 599999999999999999


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ++||||+++|+|.+++.... .+++.....++.|+++||+||   |+.+++||||||+||+++.++.++|+|||+++.+.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~l---H~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHL---HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            99999999999999987653 578899999999999999999   78999999999999999999999999999988764


Q ss_pred             CCCCcceecccccccccccccccccCc--cchhhhcccccccchhhhcccccccCcchhh---------------hhHHH
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFVGE--LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AAKEQ  940 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~~~~  940 (985)
                      .... .......|+..|+|||.+.+..  .+.++|+ |++|+.+++++++..+.......               +.+..
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv-~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd05583         157 AEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDW-WSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT  234 (288)
T ss_pred             cccc-cccccccCCccccCHHHhcCCCCCCcchhhh-HHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcc
Confidence            3321 1223346889999999987655  6788999 99999999999988765321110               01122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 001988          941 CLLSIFSLALECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                      .+..+.+++.+|++.+|++|||+.++.+.+..
T Consensus       235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            45678999999999999999999888776644

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.96  E-value=1.5e-28  Score=272.10  Aligned_cols=234  Identities=24%  Similarity=0.312  Sum_probs=192.6

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .|...+.||+|+||.||+|+.. ++..||+|.+....   .....++.+|++++++++|+|++++++++...+..++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3666788999999999999865 67889999986432   2234567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |+. |++.+.+......+++.++..++.|++.|+.||   |+.+++||||||+||+++.++.+||+|||++......   
T Consensus        96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence            996 688888766555689999999999999999999   7899999999999999999999999999998765321   


Q ss_pred             ceecccccccccccccccc---cCccchhhhcccccccchhhhcccccccCcchhh-------------hhHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIF---VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-------------AAKEQCLLSIF  946 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-------------~~~~~~~~~l~  946 (985)
                         ....+++.|+|||.+.   .+.++.++|+ |++|+++++++++..+.......             .....++..+.
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di-~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDV-WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR  244 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccch-HHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHH
Confidence               2245888999999875   3567889999 99999999999988654322110             01223567789


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHH
Q 001988          947 SLALECTMESPEKRIDAKDTITRLL  971 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~~L~  971 (985)
                      +++.+||..+|++||++.++++.-.
T Consensus       245 ~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         245 NFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             HHHHHHhhCCcccCCCHHHHhhCcc
Confidence            9999999999999999999987643

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.96  E-value=2.2e-28  Score=271.31  Aligned_cols=231  Identities=25%  Similarity=0.305  Sum_probs=190.7

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      |...+.||+|+||.||+|+.. +++.||+|++.....   .....+.+|++++++++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            566778999999999999864 788999999875422   2335678899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      ++ |++.+++......+++.++..++.|++.|++||   |+.|++||||||+||++++++.+||+|||++.....     
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            95 588888876666789999999999999999999   788999999999999999999999999999864321     


Q ss_pred             eecccccccccccccccc---cCccchhhhcccccccchhhhcccccccCcchhhh-------------hHHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIF---VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------AKEQCLLSIFS  947 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------~~~~~~~~l~~  947 (985)
                       .....|+..|+|||.+.   .+.++.++|+ |++|+.+++++++..+........             .....+..+.+
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv-~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  251 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDV-WSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG  251 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhH-HHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHH
Confidence             12346889999999874   4668889999 999999999998886543221100             11224467899


Q ss_pred             HHHHccCCCCCCCCCHHHHHHH
Q 001988          948 LALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      ++.+|++++|.+||++.++++.
T Consensus       252 li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         252 FVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             HHHHHccCChhhCcCHHHHhcC
Confidence            9999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.96  E-value=1.1e-28  Score=274.27  Aligned_cols=234  Identities=18%  Similarity=0.212  Sum_probs=185.5

Q ss_pred             CceeeccCceeEEEEEEcCCcEEEEEEeccC--CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCC
Q 001988          731 NNIIGIGGFGSVYRARLEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGS  808 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  808 (985)
                      ++.+|.|+++.||++.. +++.||+|++...  .....+.+.+|++++++++||||+++++++.+.+..+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            33445555555555544 6899999998765  23345689999999999999999999999999999999999999999


Q ss_pred             hHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc-----
Q 001988          809 LEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES-----  882 (985)
Q Consensus       809 L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-----  882 (985)
                      +.+++... ...+++.....++.|+++||+||   |+++|+||||||+||+++.++.+|++|||.+..+......     
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~L---H~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYI---HSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            99999864 34578899999999999999999   7899999999999999999999999999998765432211     


Q ss_pred             ceeccccccccccccccccc--CccchhhhcccccccchhhhcccccccCcchhhh------------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFV--GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------------------  936 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------------------  936 (985)
                      .......++..|+|||.+..  ..++.++|+ |++|+.+++++++..++.......                        
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di-ws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDI-YSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence            11123457788999998865  357889999 999999999998876654221000                        


Q ss_pred             ---------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          937 ---------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       937 ---------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                           .......++.+++.+||..+|++||++.++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                                 011234578889999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.1e-28  Score=266.26  Aligned_cols=228  Identities=25%  Similarity=0.278  Sum_probs=185.1

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc---hHHHHHHHHHHHH-hcCCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS---TLKSFEAECEVIK-NIRHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~il~-~l~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||.||+|... +++.||+|.+++....   ....+..|..++. ..+|+|++++++++..++..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999864 6899999998754221   1233445555443 45899999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      ++|.+++.... .+++..+.+++.|++.||.||   |+.+++||||+|+||++++++.+||+|||+++....      ..
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDL---HQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            99999997654 578899999999999999999   789999999999999999999999999999876432      22


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hHHHHHHHHHHHHHH
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQCLLSIFSLALE  951 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~~~~~l~~l~~~  951 (985)
                      ...+++.|+|||.+.+..++.++|+ |++|+.++++++|..+........               ..+.++.++.+++.+
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  230 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDW-WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINR  230 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhh-HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHH
Confidence            3458889999999988888999999 999999999999887654321111               112356789999999


Q ss_pred             ccCCCCCCCCCHHHHHHHH
Q 001988          952 CTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       952 cl~~~P~~RPt~~ev~~~L  970 (985)
                      |+..+|++||++.++.+.+
T Consensus       231 ~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         231 LLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             HccCCHHHccCCCcHHHHH
Confidence            9999999999886655543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=1.5e-28  Score=268.79  Aligned_cols=233  Identities=24%  Similarity=0.298  Sum_probs=189.8

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceEEEEecc
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      |...+.||+|+||.||+|... +++.||||++...... ......+|+..+++++ |||++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566788999999999999975 5788999998755332 2334567999999998 999999999999999999999999


Q ss_pred             CCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          805 SNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       805 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                       +|+|.+++.... ..+++..+..++.|++.||.||   |+.+++|+||+|+||++++++.++|+|||.++.......  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI---HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             789999887653 5689999999999999999999   789999999999999999999999999999987643222  


Q ss_pred             eeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh-------------------------
Q 001988          884 MRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-------------------------  937 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-------------------------  937 (985)
                       .....++..|+|||.+.. ..++.++|+ |++|+.+++++++..+.........                         
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di-~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 -YTDYVSTRWYRAPEILLRSTSYSSPVDI-WALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             -cCCCCCcccccCceeeecCcCcCCccch-hhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence             123458889999998754 457889999 9999999999998754422110000                         


Q ss_pred             ----------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 ----------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 ----------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                      ....+..+.+++++||..+|.+||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                            0011367889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.96  E-value=6.6e-29  Score=273.40  Aligned_cols=238  Identities=25%  Similarity=0.323  Sum_probs=192.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceEEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~  801 (985)
                      .++|...+.||+|+||.||+|..+ +++.||||.++.... .....+..|+.++.+.. ||||+++++++.+....++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            366788899999999999999976 489999999975432 23455667887777764 999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS-TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      ||++ +++.+........+++..+.+++.|++.|++||   |+ .||+||||+|+||++++++.+||+|||++..+....
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYL---KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9985 578777766555789999999999999999999   54 699999999999999999999999999987764322


Q ss_pred             CcceecccccccccccccccccCc----cchhhhcccccccchhhhcccccccCcchh-h--------------hhHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGE----LSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-F--------------AAKEQC  941 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-~--------------~~~~~~  941 (985)
                      ..   ....++..|+|||.+....    ++.++|+ |++|+.++++++++.+...... .              +....+
T Consensus       170 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di-~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (296)
T cd06618         170 AK---TRSAGCAAYMAPERIDPPDPNPKYDIRADV-WSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGF  245 (296)
T ss_pred             cc---cCCCCCccccCHhhcCCCCCccccccchhH-HHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCC
Confidence            21   2234788999999986543    7889999 9999999999998876543111 0              001124


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 001988          942 LLSIFSLALECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       942 ~~~l~~l~~~cl~~~P~~RPt~~ev~~~L  970 (985)
                      ++++.+++.+||..+|.+||++.++++.-
T Consensus       246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         246 SPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            67799999999999999999999998653

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=5.8e-29  Score=278.95  Aligned_cols=243  Identities=23%  Similarity=0.301  Sum_probs=195.9

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----Cc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSND-----DF  796 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~  796 (985)
                      .++|...+.||+|+||.||+|+.. +++.||||.++...  ......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457889999999999999999864 78999999987542  23345678899999999999999999988644     35


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      .++||||+. ++|.+++...+ .+++.....++.|++.||.||   |+++++||||||+||+++.++.+||+|||+++..
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYI---HSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999995 68998887653 689999999999999999999   7899999999999999999999999999999876


Q ss_pred             cCCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchh---------------------
Q 001988          877 SGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH---------------------  934 (985)
Q Consensus       877 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~---------------------  934 (985)
                      ....  .......++..|+|||.+.. ..++.++|+ |++|+.+++++++..+......                     
T Consensus       159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di-wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDV-WSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             CCCc--ccccccccccCccChHHHhcCCCCCCcccH-HHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            4322  12233457889999998765 468889999 9999999999988765432100                     


Q ss_pred             ---------------------hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHhHh
Q 001988          935 ---------------------FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITR--LLKIRD  975 (985)
Q Consensus       935 ---------------------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~--L~~i~~  975 (985)
                                           ....+.++.++.+++++|+..+|++||++.|+++.  +..+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence                                 00011345678899999999999999999999876  555443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.96  E-value=1.8e-28  Score=269.11  Aligned_cols=236  Identities=25%  Similarity=0.289  Sum_probs=191.3

Q ss_pred             CccCCceeeccCceeEEEEEE----cCCcEEEEEEeccCCc----chHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCce
Q 001988          727 NFAENNIIGIGGFGSVYRARL----EDGVEIAIKVFHPQCA----STLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~----~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~  797 (985)
                      +|+..+.||+|+||.||+|+.    .+|+.||+|++.....    ...+.+.+|+++++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467788999999999999986    3789999999875422    2346678999999999 589999999999999999


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ++||||+++++|.+++.... .+++.....++.|+++||+||   |+.|++||||||+||+++.++.+||+|||++..+.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999998654 578888999999999999999   78999999999999999999999999999998764


Q ss_pred             CCCCcceecccccccccccccccccC--ccchhhhcccccccchhhhcccccccCcchhh---------------hhHHH
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFVG--ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AAKEQ  940 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~~~~  940 (985)
                      .... .......|+..|+|||.+...  .++.+.|+ |++|+.+++++++..+.......               +.+..
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv-~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (290)
T cd05613         157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDW-WSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  234 (290)
T ss_pred             cccc-cccccccCCcccCChhhccCCCCCCCccccH-HHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCcc
Confidence            3221 122334688999999998753  46778999 99999999999988665321100               01122


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 001988          941 CLLSIFSLALECTMESPEKRI-----DAKDTIT  968 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~~RP-----t~~ev~~  968 (985)
                      ....+.+++.+|+..+|++||     ++.++..
T Consensus       235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            456788999999999999997     5666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.96  E-value=1.8e-28  Score=274.92  Aligned_cols=237  Identities=21%  Similarity=0.294  Sum_probs=189.5

Q ss_pred             cCcc-CCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcch--------------HHHHHHHHHHHHhcCCCCeeeEEe
Q 001988          726 DNFA-ENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAST--------------LKSFEAECEVIKNIRHRNLVKIIS  789 (985)
Q Consensus       726 ~~~~-~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~--------------~~~~~~E~~il~~l~h~niv~l~~  789 (985)
                      ++|. ..+.||+|+||.||+|... +++.||||++.......              ...+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 3567999999999999865 78999999986542221              124778999999999999999999


Q ss_pred             eeecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 001988          790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSD  869 (985)
Q Consensus       790 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~D  869 (985)
                      ++...+..++||||++ |+|.+++.... .+++.....++.|++.||+||   |+.|++||||||+||+++.++.+|++|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~L---H~~~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVL---HKWYFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHHeEECCCCCEEECC
Confidence            9999999999999996 69999887543 588999999999999999999   789999999999999999999999999


Q ss_pred             ccCceeccCCC------------CcceecccccccccccccccccCc-cchhhhcccccccchhhhcccccccCcchhhh
Q 001988          870 FGMAKLLSGED------------ESTMRTQTLATIGYMAPDEIFVGE-LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA  936 (985)
Q Consensus       870 fGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~  936 (985)
                      ||.++.+....            .........+++.|+|||.+.+.. ++.++|+ |++|+.+++++++..+........
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv-~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDM-WSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99998764111            011112234688899999987643 6889999 999999999999876543221100


Q ss_pred             ---------------------------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 ---------------------------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 ---------------------------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                             ....+++++.+++.+|+..+|++||++.|++.
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence                                                   00123567889999999999999999999986

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.6e-29  Score=251.64  Aligned_cols=232  Identities=21%  Similarity=0.256  Sum_probs=189.9

Q ss_pred             ceeeccCceeEEEEE-EcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceEEEEeccCCCCh
Q 001988          732 NIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALVLEYMSNGSL  809 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL  809 (985)
                      +.+|+|+|+.|--+. ..+|.+||||++.++......++.+|++++.+++ |+||++++++|++++.+|+|||-|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            679999999999987 6789999999999886667788999999999995 99999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC---cEEEecccCceeccCC-----CC
Q 001988          810 EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM---VAHLSDFGMAKLLSGE-----DE  881 (985)
Q Consensus       810 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~---~~kl~DfGla~~~~~~-----~~  881 (985)
                      ..++.+.. .+++.+..++..+|+.||.||   |.+||.|||+||+|||..+..   .+||+||.++.-+.-.     ..
T Consensus       164 LshI~~~~-~F~E~EAs~vvkdia~aLdFl---H~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas  239 (463)
T KOG0607|consen  164 LSHIQKRK-HFNEREASRVVKDIASALDFL---HTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS  239 (463)
T ss_pred             HHHHHHhh-hccHHHHHHHHHHHHHHHHHH---hhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence            99998764 688889999999999999999   899999999999999996544   6899999887543321     12


Q ss_pred             cceecccccccccccccccc-----cCccchhhhcccccccchhhhcccccccCcch-----------------------
Q 001988          882 STMRTQTLATIGYMAPDEIF-----VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK-----------------------  933 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~-----------------------  933 (985)
                      .+.....+|+..|||||++-     ...|.-++|. |++|++++-|+.|..++...=                       
T Consensus       240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDl-wSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI  318 (463)
T KOG0607|consen  240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDL-WSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI  318 (463)
T ss_pred             CccccCcccchhhcchhHHhhhccccccccccccH-HHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence            23345568999999999652     2345667788 999999999998876543210                       


Q ss_pred             ---h----hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          934 ---H----FAAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       934 ---~----~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                         .    .......+.+..+++...+..||.+|-++.+++.
T Consensus       319 QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  319 QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence               0    0112235667778899999999999999988876

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.96  E-value=1.5e-28  Score=272.76  Aligned_cols=239  Identities=21%  Similarity=0.291  Sum_probs=190.0

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecCC------
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSNDD------  795 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------  795 (985)
                      .++|...+.||+|+||.||+|... +++.||+|++......  ....+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999865 6899999998654322  2345788999999999999999999875433      


Q ss_pred             --ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCc
Q 001988          796 --FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA  873 (985)
Q Consensus       796 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla  873 (985)
                        ..++||||++ +++.+.+......+++..+..++.|+++||+||   |+.||+||||||+||++++++.+||+|||++
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYL---HENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence              4689999996 478887776656799999999999999999999   7899999999999999999999999999999


Q ss_pred             eeccCCCCcc---------eecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhhh------
Q 001988          874 KLLSGEDEST---------MRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA------  937 (985)
Q Consensus       874 ~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~------  937 (985)
                      +.........         ......+++.|+|||.+.+. .++.++|+ |++|++++++++|..+.........      
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv-~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDI-WGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHh-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            8754322111         11234578889999987654 57889999 9999999999998765432111000      


Q ss_pred             -----------------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 -----------------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 -----------------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                         .......+.+++.+|+..+|.+||++.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                                               0112256889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.7e-28  Score=275.73  Aligned_cols=238  Identities=23%  Similarity=0.298  Sum_probs=190.9

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCC------
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDD------  795 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------  795 (985)
                      .++|...+.||+|+||.||+|... +++.||+|++.....  .....+.+|++++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            378999999999999999999864 789999999875422  22356789999999999999999999986543      


Q ss_pred             ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          796 FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      ..++|+||++. ++.++..   ..+++..+..++.|++.||+||   |+.+++||||||+||+++.++.+||+|||+++.
T Consensus        94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYI---HSAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            45899999964 7776653   2578899999999999999999   789999999999999999999999999999876


Q ss_pred             ccCCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh-----------------
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------------  937 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------------  937 (985)
                      ....     .....+++.|+|||.+.+ ..++.++|+ |++|++++++++|+.+.........                 
T Consensus       167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv-~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         167 ADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDI-WSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCCC-----CCCceeeecccChhhhcCccccCchHHH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            5321     123457889999999876 457889999 9999999999998865543211000                 


Q ss_pred             -------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHhHh
Q 001988          938 -------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTITR--LLKIRD  975 (985)
Q Consensus       938 -------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~--L~~i~~  975 (985)
                                               ....+.++.+++.+|+..||.+||++.+++..  ++.+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                                     00123567899999999999999999999954  666654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.96  E-value=4e-28  Score=265.94  Aligned_cols=233  Identities=24%  Similarity=0.330  Sum_probs=188.9

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhc---CCCCeeeEEeeeecCCc-----
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNI---RHRNLVKIISSCSNDDF-----  796 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l---~h~niv~l~~~~~~~~~-----  796 (985)
                      |+..+.||+|+||.||+|+.+ +++.||+|+++.....  ....+.+|+.+++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            566789999999999999976 5899999999754322  234566788887766   59999999999988776     


Q ss_pred             eEEEEeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          797 KALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      .+++|||++ ++|.+++.... ..+++..+..++.|+++||+||   |+.+++||||+|+||++++++.+||+|||.+..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~L---H~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL---HSHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999996 48998887643 3589999999999999999999   788999999999999999999999999999988


Q ss_pred             ccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--------------------
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------------  935 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------------  935 (985)
                      +.....   .....++..|+|||.+.+..++.++|+ |++|+.+++++++..+.......                    
T Consensus       157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di-~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDM-WSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             ccCCcc---cccccccccccChHHhccCCCCCcchh-hhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            643322   122347889999999999999999999 99999999999876543221100                    


Q ss_pred             ------------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          936 ------------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       936 ------------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                        .........+.+++.+||..||.+||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                              001123467789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.96  E-value=1.9e-28  Score=273.22  Aligned_cols=236  Identities=24%  Similarity=0.350  Sum_probs=192.4

Q ss_pred             HHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeec-CCce
Q 001988          722 LRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSN-DDFK  797 (985)
Q Consensus       722 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~  797 (985)
                      ...+++|+..+.||.|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++.. .+..
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            346788999999999999999999855 88999999886532  2234678899999999999999999999865 5578


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ++||||+ +++|.+++...  .+++.....++.|+++||+||   |+.+|+||||+|+||++++++.+||+|||.+....
T Consensus        86 ~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~L---H~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          86 YFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYV---HSAGVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             EEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            8999998 56898888753  467888889999999999999   78999999999999999999999999999987643


Q ss_pred             CCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhh---------------------
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------------  935 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------------  935 (985)
                      ..     .....++..|+|||.+.+ ..++.++|+ |++|+.+++++++..+.......                     
T Consensus       160 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv-~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         160 PQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDI-WSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             CC-----cCCCcccccccCceeeeccCCcCcHHHH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            21     122357889999998766 568899999 99999999999987654321100                     


Q ss_pred             ------------------h---hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          936 ------------------A---AKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       936 ------------------~---~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                        +   ....+++++.+++++|++.+|++||++.+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                              0   001235678999999999999999999998765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=2.2e-28  Score=266.51  Aligned_cols=227  Identities=23%  Similarity=0.259  Sum_probs=183.2

Q ss_pred             eeeccCceeEEEEEEc-CCcEEEEEEeccCCcc---hHHHHHHHHHH---HHhcCCCCeeeEEeeeecCCceEEEEeccC
Q 001988          733 IIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS---TLKSFEAECEV---IKNIRHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       733 ~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~i---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      .||+|+||.||+|... +++.||+|.+.+....   ....+..|..+   ++...||+|+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 6889999998754221   12223444443   344579999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCccee
Q 001988          806 NGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR  885 (985)
Q Consensus       806 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~  885 (985)
                      ||+|.+++...+ .+++..+..++.|++.|++||   |+++|+||||||+||+++.++.+||+|||+++.+....    .
T Consensus        81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~  152 (278)
T cd05606          81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (278)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence            999999887653 689999999999999999999   78999999999999999999999999999987653222    1


Q ss_pred             cccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchh---h-----------hhHHHHHHHHHHHHH
Q 001988          886 TQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH---F-----------AAKEQCLLSIFSLAL  950 (985)
Q Consensus       886 ~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~---~-----------~~~~~~~~~l~~l~~  950 (985)
                      ....|+..|+|||.+..+ .++.+.|+ |++|+++++++++..+......   .           ..+..++.++.+++.
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di-~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  231 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADW-FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE  231 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccch-HhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHH
Confidence            234689999999998754 57888999 9999999999999876543210   0           011224578999999


Q ss_pred             HccCCCCCCCC-----CHHHHHH
Q 001988          951 ECTMESPEKRI-----DAKDTIT  968 (985)
Q Consensus       951 ~cl~~~P~~RP-----t~~ev~~  968 (985)
                      +|+..+|.+||     ++.++++
T Consensus       232 ~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         232 GLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             HHhhcCHHhccCCCCCCHHHHHh
Confidence            99999999999     8999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-28  Score=275.32  Aligned_cols=243  Identities=24%  Similarity=0.348  Sum_probs=203.7

Q ss_pred             HHHHHHhcCccCCceeeccCceeEEEEE-EcCCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeec---
Q 001988          719 FELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSN---  793 (985)
Q Consensus       719 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~---  793 (985)
                      +.+...++.|.+.+.||.|.||.||+++ .++++.+|+|+..... ...++++.|.++++.. .|||++.++|++..   
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            3334456778889999999999999998 4588999999988763 3446788899999887 69999999999853   


Q ss_pred             --CCceEEEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 001988          794 --DDFKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDF  870 (985)
Q Consensus       794 --~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~Df  870 (985)
                        ++..|+|||||.+|+..|.++.. +..+.|..+.-|++.++.|+.+|   |...++|||||-.|||++.++.||++||
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HL---H~nkviHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHL---HNNKVIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHH---hhcceeeecccCceEEEeccCcEEEeee
Confidence              57899999999999999998754 56789999999999999999999   8899999999999999999999999999


Q ss_pred             cCceeccCCCCcceeccccccccccccccccc-----CccchhhhcccccccchhhhcccccccC--------------c
Q 001988          871 GMAKLLSGEDESTMRTQTLATIGYMAPDEIFV-----GELSLKRWVNDLLPVSLVEVVDKSLLSG--------------E  931 (985)
Q Consensus       871 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~dv~~~~g~~~~~i~~~~~~~~--------------~  931 (985)
                      |.+...+.  +.......+|||.|||||++..     ..|+.++|+ |++|+...|+.+|..+..              .
T Consensus       168 GvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~-WsLGITaIEladG~PPl~DmHPmraLF~IpRNP  244 (953)
T KOG0587|consen  168 GVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDL-WSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP  244 (953)
T ss_pred             eeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccch-hhccceeehhcCCCCCccCcchhhhhccCCCCC
Confidence            99887742  3333455679999999998863     346778899 999999999998875432              2


Q ss_pred             chhhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          932 EKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       932 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ++....++...+++.++|..|+..|-.+||++.++++
T Consensus       245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            2333457788999999999999999999999998864

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.96  E-value=4.2e-28  Score=272.70  Aligned_cols=242  Identities=22%  Similarity=0.283  Sum_probs=194.1

Q ss_pred             cCHHHHHHHhcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 001988          716 FSYFELLRATDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCS  792 (985)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~  792 (985)
                      ....++..+.++|...+.||+|+||.||+|.. .+++.||+|++.....  ...+.+.+|++++++++||||+++++++.
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            33455666889999999999999999999985 4789999999875422  22456788999999999999999999885


Q ss_pred             cC------CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEE
Q 001988          793 ND------DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH  866 (985)
Q Consensus       793 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~k  866 (985)
                      ..      ...+++++++ +++|.+++...  .+++..+..++.|+++|++||   |+.||+||||||+||++++++.+|
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHHEEEcCCCCEE
Confidence            43      3467888887 78998887654  588999999999999999999   789999999999999999999999


Q ss_pred             EecccCceeccCCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh--------
Q 001988          867 LSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA--------  937 (985)
Q Consensus       867 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~--------  937 (985)
                      |+|||+++.....     .....++..|+|||.+.+ ..++.++|+ |++|+.++++++++.+.........        
T Consensus       161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv-wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (345)
T cd07877         161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDI-WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV  234 (345)
T ss_pred             Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            9999998764321     223458889999998766 567888999 9999999999998765432111000        


Q ss_pred             ---------------H-------------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          938 ---------------K-------------------EQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       938 ---------------~-------------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                     .                   .....++.+++.+|++.+|.+||++.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                           0                   0123567899999999999999999998864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.96  E-value=4e-29  Score=249.61  Aligned_cols=233  Identities=23%  Similarity=0.222  Sum_probs=190.2

Q ss_pred             hcCccCC-ceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeec----CCce
Q 001988          725 TDNFAEN-NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSN----DDFK  797 (985)
Q Consensus       725 ~~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~----~~~~  797 (985)
                      +++|++. ++||-|-.|.|..+..+ +++++|+|++..     ....++|++.--.. .|||||+++++++.    ....
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            4555543 57999999999999865 888999998753     25668899886655 69999999998854    3557


Q ss_pred             EEEEeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc---CCCcEEEecccCc
Q 001988          798 ALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMA  873 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~---~~~~~kl~DfGla  873 (985)
                      .+|||.++||.|++.+.+.+ ..+++.+.-+|+.||+.|+.||   |+.+|.||||||+|+|..   .+..+||+|||+|
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~l---H~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA  211 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYL---HSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA  211 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHH---HhcchhhccCChhheeeecCCCCcceEecccccc
Confidence            79999999999999998774 4699999999999999999999   899999999999999996   4558999999999


Q ss_pred             eeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcch-------------------h
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK-------------------H  934 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~-------------------~  934 (985)
                      +.-.   ........+.||+|.|||++-..+|+-.+|+ |++|+.++-++-|..++-...                   .
T Consensus       212 K~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdm-wSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP  287 (400)
T KOG0604|consen  212 KETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDM-WSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP  287 (400)
T ss_pred             cccC---CCccccCCcccccccCHHHhCchhcCCCCCc-cchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence            8742   2334556789999999999999999999999 999999888877654332110                   1


Q ss_pred             hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          935 FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       935 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      .+....+++...++++..++.+|.+|.|..+++..
T Consensus       288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            12345678889999999999999999999998753

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.96  E-value=3.4e-28  Score=273.19  Aligned_cols=233  Identities=23%  Similarity=0.306  Sum_probs=189.9

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecCC-----
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSNDD-----  795 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-----  795 (985)
                      ..++|+..+.||+|+||.||+|... +++.||||++......  ....+.+|++++++++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4678999999999999999999854 7899999998654222  2456789999999999999999999987653     


Q ss_pred             -ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCce
Q 001988          796 -FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK  874 (985)
Q Consensus       796 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~  874 (985)
                       ..++||||+ +++|.+++...  .+++..+..++.|+++|++||   |+.||+||||||+||+++.++.+|++|||++.
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~L---H~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence             358999999 77998888653  588999999999999999999   78999999999999999999999999999988


Q ss_pred             eccCCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh----------------
Q 001988          875 LLSGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA----------------  937 (985)
Q Consensus       875 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~----------------  937 (985)
                      .....     .....+++.|+|||.+.. ..++.++|+ |++|+.+++++++..+.........                
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di-~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07880         167 QTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDI-WSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV  240 (343)
T ss_pred             ccccC-----ccccccCCcccCHHHHhCCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            65321     123357889999998876 457888999 9999999999998765432211000                


Q ss_pred             --------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 --------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 --------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                .+.+...+.+++.+|+..||.+||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                                      0123456789999999999999999999983

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=3.2e-28  Score=265.92  Aligned_cols=234  Identities=25%  Similarity=0.342  Sum_probs=193.3

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      |+..+.||+|+||.||+|... +++.||+|.+....  ....+.+..|++++++++|+|++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456678999999999999865 68999999998653  223466788999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      + ++|.+++......+++..+.+++.|++.|++||   |+.||+||||+|+||++++++.+||+|||.++.......  .
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC---HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            7 599999987645789999999999999999999   788999999999999999999999999999987643221  1


Q ss_pred             ecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhh---------------------------
Q 001988          885 RTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------------------  936 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------------------  936 (985)
                      .....++..|+|||.+... .++.+.|+ |++|+.+++++++..+........                           
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv-~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDI-WSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccH-HHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            2223467789999998776 78889999 999999999999865543221100                           


Q ss_pred             -------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 -------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 -------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                   .....+..+.+++.+|+..+|++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                         00012457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.95  E-value=5.2e-28  Score=270.71  Aligned_cols=236  Identities=22%  Similarity=0.250  Sum_probs=186.6

Q ss_pred             CccCCceeeccCceeEEEEEEc-C--CcEEEEEEeccCC--cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecC----Cc
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-D--GVEIAIKVFHPQC--ASTLKSFEAECEVIKNI-RHRNLVKIISSCSND----DF  796 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~--~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~----~~  796 (985)
                      +|...+.||+|+||.||+|+.. +  +..||+|++....  ....+.+.+|+++++++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677889999999999999865 4  7789999987532  22345678899999999 599999999875432    45


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      .++++||++ ++|.+++... ..+++..+..++.|++.||+||   |+.||+||||||+||++++++.+||+|||+++.+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~L---H~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYI---HSANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            788999985 6899988754 3688999999999999999999   7899999999999999999999999999999876


Q ss_pred             cCCCCc--ceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhh-----------------
Q 001988          877 SGEDES--TMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------------  936 (985)
Q Consensus       877 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------------  936 (985)
                      ......  .......|++.|+|||.+.+ ..++.++|+ |++|+.+++++.+..+........                 
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di-~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDV-WSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHH-HHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            432211  11233468999999998765 467889999 999999999998876543211000                 


Q ss_pred             -------------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 -------------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 -------------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                               ....+...+.+++.+|++.+|.+||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                                     00012457889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.95  E-value=2e-28  Score=264.14  Aligned_cols=235  Identities=21%  Similarity=0.281  Sum_probs=190.6

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-----cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-----ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      +|...+.||+|+||.||+|... .+..+++|.++...     .....++..|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4778899999999999999865 34456666654321     22334577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          801 LEYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      |||+++++|.+++..   ....+++...+.++.|+++|++||   |+.|++||||||+||++++ +.+||+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM---HQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHH---HHcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998864   245689999999999999999999   7899999999999999975 569999999998764


Q ss_pred             CCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh------------hhhHHHHHHHH
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH------------FAAKEQCLLSI  945 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~------------~~~~~~~~~~l  945 (985)
                      ....  ......+++.|+|||......++.+.|+ |++|+++++++++..+......            ...+..++.++
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv-~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDI-WSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQL  233 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhH-HHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHH
Confidence            3222  2223458889999999888888889999 9999999999987765432211            11233466789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHH
Q 001988          946 FSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+++.+|+..+|++||++.|+++
T Consensus       234 ~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         234 NSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHHHHHHhcCChhhCcCHHHHhh
Confidence            99999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.95  E-value=7.4e-30  Score=250.79  Aligned_cols=235  Identities=24%  Similarity=0.297  Sum_probs=187.3

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEEecc
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .+....||.|+||+|++-.++ .|+..|||+++...- .+.+++..|.+...+- +.||||++||++...+..||-||+|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            334567999999999998865 899999999987644 5677888999876555 6899999999999989999999999


Q ss_pred             CCCChHHHhh---c-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          805 SNGSLEDCLH---S-SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       805 ~~gsL~~~l~---~-~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      . -++..+.+   . +...+++.-.-.|+...+.||.||.  .+..|||||+||+|||+|..|.+||||||++-.+.+  
T Consensus       146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK--~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--  220 (361)
T KOG1006|consen  146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLK--EELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--  220 (361)
T ss_pred             h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHH--HHhhhhhccCChhheEEecCCCEeeecccchHhHHH--
Confidence            4 46654432   1 2345777777788888899999997  566799999999999999999999999999866532  


Q ss_pred             Ccceecccccccccccccccc--cCccchhhhcccccccchhhhcccccccCcchh-hh--------------hHHH---
Q 001988          881 ESTMRTQTLATIGYMAPDEIF--VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-FA--------------AKEQ---  940 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-~~--------------~~~~---  940 (985)
                       ....+.-+|...|||||.+.  +..+..++|+ |++|+.++|+.+|..+...... .+              .+.+   
T Consensus       221 -SiAkT~daGCrpYmAPERi~p~~~gyDiRSDv-WSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~  298 (361)
T KOG1006|consen  221 -SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDV-WSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVH  298 (361)
T ss_pred             -HHHhhhccCCccccChhccCCccCCcchhhhh-hhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccc
Confidence             22334456999999999874  4568999999 9999999999999877654321 11              1222   


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          941 CLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      ....+..++..|+..|-..||.+.++.+.
T Consensus       299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  299 YSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            45678999999999999999999988653

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.95  E-value=3.6e-28  Score=273.05  Aligned_cols=237  Identities=21%  Similarity=0.302  Sum_probs=189.1

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecC---------
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSND---------  794 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~---------  794 (985)
                      ..+|...+.||.|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            367889999999999999999864 7899999998766555667788999999999999999999876543         


Q ss_pred             -----CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc-CCCcEEEe
Q 001988          795 -----DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHLS  868 (985)
Q Consensus       795 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~-~~~~~kl~  868 (985)
                           ...++||||++ ++|.+++...  .+++...+.++.|+++||+||   |+.||+||||||+||+++ +++.+|++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~L---H~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYI---HSANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEcCCCceEEEC
Confidence                 35789999996 5898888653  578999999999999999999   789999999999999997 45678999


Q ss_pred             cccCceeccCCCCcc-eeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhh----------
Q 001988          869 DFGMAKLLSGEDEST-MRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA----------  936 (985)
Q Consensus       869 DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~----------  936 (985)
                      |||.++......... ......++..|+|||.+.. ..++.++|+ |++|+.+++++++..+........          
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di-wSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDM-WAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999998754221111 1122357889999998754 457788999 999999999999886553211000          


Q ss_pred             -------------------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 -------------------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 -------------------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                     .......++.+++.+|+..||.+||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                                           00113456788999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6e-29  Score=257.35  Aligned_cols=232  Identities=23%  Similarity=0.225  Sum_probs=190.7

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~  798 (985)
                      ...+|....+||+|+||.|.+|..+ +.+.||||+++++.-   .+.+-.+.|-++|+.- +-|.+++++.+++..+..|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            3457888999999999999999866 566799999987732   2334456777888766 5789999999999999999


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      .||||+.||+|--++.+-+ .+.+....-+|..||-||-+|   |++|||+||+|.+|||+|.+|++||+|||+++.-- 
T Consensus       427 FVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFL---h~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-  501 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-  501 (683)
T ss_pred             eEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhh---hcCCeeeeeccccceEeccCCceEeeecccccccc-
Confidence            9999999999998888765 566777888999999999999   89999999999999999999999999999997532 


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSIFS  947 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l~~  947 (985)
                       -....+...+|||.|+|||++..++|.-..|. |++|+.++||+.|..+.....+...           +...+.+...
T Consensus       502 -~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDW-Wa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~  579 (683)
T KOG0696|consen  502 -FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW-WAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVA  579 (683)
T ss_pred             -cCCcceeeecCCCcccccceEEecccccchhH-HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHH
Confidence             22344567899999999999999999766665 9999999999999887665433221           2234567778


Q ss_pred             HHHHccCCCCCCCCC
Q 001988          948 LALECTMESPEKRID  962 (985)
Q Consensus       948 l~~~cl~~~P~~RPt  962 (985)
                      +.+..+...|.+|..
T Consensus       580 ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  580 ICKGLLTKHPGKRLG  594 (683)
T ss_pred             HHHHHhhcCCccccC
Confidence            888889999988863

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.95  E-value=4.2e-28  Score=272.58  Aligned_cols=233  Identities=24%  Similarity=0.314  Sum_probs=191.2

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCc----
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDF----  796 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~----  796 (985)
                      ..++|...+.||+|+||.||+|+.. +++.||+|++....  ......+.+|+.++++++|||++++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4578999999999999999999875 68899999987542  2234567789999999999999999998866554    


Q ss_pred             --eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCce
Q 001988          797 --KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK  874 (985)
Q Consensus       797 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~  874 (985)
                        .++|+||+ +++|.+++...  .+++..+..++.|+++|++||   |+.||+||||||+||++++++.+||+|||++.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYI---HSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence              89999999 67999988763  589999999999999999999   78999999999999999999999999999998


Q ss_pred             eccCCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh----------------
Q 001988          875 LLSGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA----------------  937 (985)
Q Consensus       875 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~----------------  937 (985)
                      .....     .....++..|+|||.+.. ..++.++|+ |++|+.++++++|..+.........                
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv-wslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         167 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDI-WSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             ccccc-----ccCCcccccccCHHHHhCCCCCCchHhH-HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            75322     223457889999998765 367889999 9999999999998865432211000                


Q ss_pred             --------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 --------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 --------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                ....++++.+++.+|+..+|++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                                      0113567889999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.95  E-value=5.3e-28  Score=259.20  Aligned_cols=225  Identities=29%  Similarity=0.301  Sum_probs=190.5

Q ss_pred             eeccCceeEEEEEEc-CCcEEEEEEeccCCcc---hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCCh
Q 001988          734 IGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSL  809 (985)
Q Consensus       734 ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  809 (985)
                      ||+|+||.||++... +++.||+|.+......   ....+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999865 6899999998765322   355788999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecccc
Q 001988          810 EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL  889 (985)
Q Consensus       810 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  889 (985)
                      .+++.... .+++.....++.|+++|+.|+   |+.+++|+||+|+||+++.++.++|+|||.+.......  .......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---h~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYL---HSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC  154 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence            99998764 578999999999999999999   78999999999999999999999999999998764322  1223446


Q ss_pred             cccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHHHccCCCCC
Q 001988          890 ATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLALECTMESPE  958 (985)
Q Consensus       890 gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~~cl~~~P~  958 (985)
                      ++..|+|||...+...+.++|+ |++|+.+++++++..+........           .+...+.++.+++++|+..+|+
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~-~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~  233 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDW-WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPT  233 (250)
T ss_pred             CCccccChHHhCCCCCCchhhH-HHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHh
Confidence            8889999999988888999999 999999999999887654332111           1222367789999999999999


Q ss_pred             CCCCHHH
Q 001988          959 KRIDAKD  965 (985)
Q Consensus       959 ~RPt~~e  965 (985)
                      +||++.+
T Consensus       234 ~R~~~~~  240 (250)
T cd05123         234 KRLGSGG  240 (250)
T ss_pred             hCCCccc
Confidence            9999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=6.9e-30  Score=248.72  Aligned_cols=239  Identities=22%  Similarity=0.331  Sum_probs=189.0

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeec--------C
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSN--------D  794 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--------~  794 (985)
                      ..|....+||+|.||+||+|+.+ +|++||+|++-.+.  ........+|+++++.++|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            44566678999999999999865 78889999764332  2334567899999999999999999998843        3


Q ss_pred             CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCce
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK  874 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~  874 (985)
                      ...|+||++|+. +|...+......++..++.+++.++.+||.|+   |+..|+|||+||+|++|+.+|.+||+|||+|+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~i---Hr~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYI---HRNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHH---HHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            458999999976 89988887767899999999999999999999   89999999999999999999999999999998


Q ss_pred             eccCCCC--cceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhh----------------
Q 001988          875 LLSGEDE--STMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF----------------  935 (985)
Q Consensus       875 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~----------------  935 (985)
                      .+...+.  ....+..+-|..|.+||.+.+ ..++.+.|+ |..|+++.||.++..........                
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDi-WgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDI-WGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchh-HhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            8764332  223445567999999998875 668899999 88888888888765432211000                


Q ss_pred             --h----------------------hHHH------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          936 --A----------------------AKEQ------CLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       936 --~----------------------~~~~------~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                        +                      ..+.      ..++..+++..++..||.+|+++++++..
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence              0                      0011      12367789999999999999999998754

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.95  E-value=5.4e-28  Score=256.76  Aligned_cols=214  Identities=20%  Similarity=0.120  Sum_probs=176.1

Q ss_pred             cCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCChHHHhhc
Q 001988          737 GGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHS  815 (985)
Q Consensus       737 G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  815 (985)
                      |.||.||+++.. +++.||+|+++...     .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999865 78999999987542     234455555666799999999999999999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecccccccccc
Q 001988          816 SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYM  895 (985)
Q Consensus       816 ~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~  895 (985)
                      .. .+++.....++.|+++||+|+   |+++|+||||||+||+++.++.++++|||.+.......     ....++..|+
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~  149 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDAL---HREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYC  149 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcccc
Confidence            53 588999999999999999999   78999999999999999999999999999876653211     2234677899


Q ss_pred             cccccccCccchhhhcccccccchhhhcccccccCcchh-------hhhHHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 001988          896 APDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-------FAAKEQCLLSIFSLALECTMESPEKRIDAKD  965 (985)
Q Consensus       896 aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~e  965 (985)
                      |||......++.++|+ |++|++++++++|..+....+.       ...+...++.+.+++.+|++.||++||++.+
T Consensus       150 aPE~~~~~~~~~~~Dv-wslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         150 APEVGGISEETEACDW-WSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             CCcccCCCCCCchhhH-HHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence            9999988888999999 9999999999998754322111       1122345677899999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=2.1e-27  Score=287.23  Aligned_cols=145  Identities=29%  Similarity=0.452  Sum_probs=130.8

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|.+.+.||+|+||.||+|+.. +++.||||+++....   .....+..|+.+++.++||||+++++++...++.|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            67888999999999999999976 789999999975422   22467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCce
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK  874 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~  874 (985)
                      ||+++++|.+++...+ .+++...++++.||+.||+||   |+++||||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yL---H~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYL---HRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999997654 578889999999999999999   78899999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.95  E-value=9.9e-28  Score=248.54  Aligned_cols=233  Identities=21%  Similarity=0.265  Sum_probs=191.6

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-C-C----CeeeEEeeeecCCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-H-R----NLVKIISSCSNDDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h-~----niv~l~~~~~~~~~~  797 (985)
                      +.+|.+...+|+|.||.|..+.+. .+..||+|+++.- ..-.+..+-|+++++++. + |    -+|++.+|+...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            678889999999999999999854 5788999998632 333456788999999993 2 3    388899999999999


Q ss_pred             EEEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---------------
Q 001988          798 ALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE---------------  861 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~---------------  861 (985)
                      +||+|.+ |.++.+++..+ ..+++..++..|++|++++++||   |+.+++|-|+||+||++.+               
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fL---h~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFL---HDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHH---HhcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999998 77999999986 45688999999999999999999   8999999999999999932               


Q ss_pred             -----CCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh
Q 001988          862 -----DMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA  936 (985)
Q Consensus       862 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~  936 (985)
                           +..+||+|||.|+.-.     .....++.|..|.|||++++-+++.++|| ||+|+.+.|+.+|+.++......+
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGwS~pCDv-WSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGWSQPCDV-WSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             eccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCcCCccCc-eeeeeEEEEeeccceecccCCcHH
Confidence                 3368999999998742     22356789999999999999999999999 999999999988875432111000


Q ss_pred             ---------------------------------------------------------hHHHHHHHHHHHHHHccCCCCCC
Q 001988          937 ---------------------------------------------------------AKEQCLLSIFSLALECTMESPEK  959 (985)
Q Consensus       937 ---------------------------------------------------------~~~~~~~~l~~l~~~cl~~~P~~  959 (985)
                                                                               ..+....++++++++|+.+||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence                                                                     00113567999999999999999


Q ss_pred             CCCHHHHHH
Q 001988          960 RIDAKDTIT  968 (985)
Q Consensus       960 RPt~~ev~~  968 (985)
                      |+|+.|++.
T Consensus       397 RiTl~EAL~  405 (415)
T KOG0671|consen  397 RITLREALS  405 (415)
T ss_pred             cccHHHHhc
Confidence            999999875

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7.1e-28  Score=266.23  Aligned_cols=231  Identities=22%  Similarity=0.236  Sum_probs=194.1

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      +++.|.....+|.|+|+.|-.+... +++..|+|++.+..    .+..+|+.++... +||||+++.+.+.+..+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            3566777788999999999999854 78889999997662    3345678777666 6999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE-cCCCcEEEecccCceeccCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL-DEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill-~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |++.|+-+.+.+..... .. .++..|+.+|+.|+.||   |++||||||+||+|||+ ++.++++|+|||.++..... 
T Consensus       396 e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~L---H~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYL---HEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHH---HhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            99999998888876542 22 56677999999999999   88999999999999999 69999999999999876432 


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh----------HHHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA----------KEQCLLSIFSLAL  950 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~----------~~~~~~~l~~l~~  950 (985)
                          ....+-|..|.|||++...+++.++|+ |++|+++++|++|..+....+....          .+..+++..++++
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~-WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~  544 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDW-WSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQ  544 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhh-HHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHH
Confidence                334468899999999999999999999 9999999999999987765543311          1446788999999


Q ss_pred             HccCCCCCCCCCHHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~  969 (985)
                      .|++.||.+||+|.++...
T Consensus       545 ~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  545 QLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             HhccCChhhCcChhhhccC
Confidence            9999999999999998764

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.94  E-value=4.6e-27  Score=276.85  Aligned_cols=237  Identities=22%  Similarity=0.247  Sum_probs=164.0

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-C----CcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEee------ee
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-D----GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS------CS  792 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~----~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~------~~  792 (985)
                      ..++|...+.||+|+||.||+|++. +    +..||+|++......  +....|  .++...+.+++.+...      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            5678999999999999999999975 4    689999987643211  111111  1112222222222221      24


Q ss_pred             cCCceEEEEeccCCCChHHHhhcCCCCC-------------------CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 001988          793 NDDFKALVLEYMSNGSLEDCLHSSNCAL-------------------NIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK  853 (985)
Q Consensus       793 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk  853 (985)
                      .....++||||+++++|.+++.......                   ....+..++.|++.||+||   |+++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yL---H~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGL---HSTGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHH---HHCCEEeCcCC
Confidence            5667899999999999999987543111                   1234567999999999999   78999999999


Q ss_pred             CCCEEEcC-CCcEEEecccCceeccCCCCcceecccccccccccccccccCc----------------------cchhhh
Q 001988          854 PSNVLLDE-DMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE----------------------LSLKRW  910 (985)
Q Consensus       854 ~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------------------~~~~~d  910 (985)
                      |+|||+++ ++.+||+|||+|+.+.... ........+++.|||||.+....                      ++.+.|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 6899999999998764322 22234467899999999654322                      233459


Q ss_pred             cccccccchhhhcccccccCcch------------hhhh---------HHH----------HHHHHHHHHHHccCCCCCC
Q 001988          911 VNDLLPVSLVEVVDKSLLSGEEK------------HFAA---------KEQ----------CLLSIFSLALECTMESPEK  959 (985)
Q Consensus       911 v~~~~g~~~~~i~~~~~~~~~~~------------~~~~---------~~~----------~~~~l~~l~~~cl~~~P~~  959 (985)
                      + |++|++++|++.+.+......            ....         ..+          ......+++.+|+..||.+
T Consensus       362 V-wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k  440 (566)
T PLN03225        362 I-YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ  440 (566)
T ss_pred             c-HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence            9 999999999987654322110            0000         000          0122447999999999999


Q ss_pred             CCCHHHHHHH
Q 001988          960 RIDAKDTITR  969 (985)
Q Consensus       960 RPt~~ev~~~  969 (985)
                      |||+.|+++.
T Consensus       441 R~ta~e~L~H  450 (566)
T PLN03225        441 RISAKAALAH  450 (566)
T ss_pred             CCCHHHHhCC
Confidence            9999999874

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=2.4e-27  Score=257.35  Aligned_cols=211  Identities=22%  Similarity=0.319  Sum_probs=173.4

Q ss_pred             CHHHHHHHh---cCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEe
Q 001988          717 SYFELLRAT---DNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIIS  789 (985)
Q Consensus       717 ~~~~~~~~~---~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~  789 (985)
                      .|..+.++.   .-|.+.+-||-|+||+|.+++. ++...||.|.+++...   .....++.|-+||+.-..+-||++|.
T Consensus       617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy  696 (1034)
T KOG0608|consen  617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY  696 (1034)
T ss_pred             hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence            345555554   3477888999999999999974 4556699999986632   23456788999999999999999999


Q ss_pred             eeecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 001988          790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSD  869 (985)
Q Consensus       790 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~D  869 (985)
                      .|++++.+|+||||++||++-..|...+ .+.+.....++.++..|+++.   |..|+|||||||+|||||.+|++||.|
T Consensus       697 SFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesV---HkmGFIHRDiKPDNILIDrdGHIKLTD  772 (1034)
T KOG0608|consen  697 SFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIKLTD  772 (1034)
T ss_pred             EeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHH---HhccceecccCccceEEccCCceeeee
Confidence            9999999999999999999999988765 677777788889999999999   899999999999999999999999999


Q ss_pred             ccCceecc--------CCCCc--------------------------------ceecccccccccccccccccCccchhh
Q 001988          870 FGMAKLLS--------GEDES--------------------------------TMRTQTLATIGYMAPDEIFVGELSLKR  909 (985)
Q Consensus       870 fGla~~~~--------~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~  909 (985)
                      ||+++=+.        ..+..                                ......+||+.|+|||++....++-.+
T Consensus       773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c  852 (1034)
T KOG0608|consen  773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC  852 (1034)
T ss_pred             ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence            99986421        00000                                011235799999999999999998777


Q ss_pred             hcccccccchhhhcccccccCcc
Q 001988          910 WVNDLLPVSLVEVVDKSLLSGEE  932 (985)
Q Consensus       910 dv~~~~g~~~~~i~~~~~~~~~~  932 (985)
                      |. |+.|++++||+.|..++...
T Consensus       853 dw-ws~gvil~em~~g~~pf~~~  874 (1034)
T KOG0608|consen  853 DW-WSVGVILYEMLVGQPPFLAD  874 (1034)
T ss_pred             hh-hHhhHHHHHHhhCCCCccCC
Confidence            76 99999999999998876543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-27  Score=266.80  Aligned_cols=230  Identities=27%  Similarity=0.391  Sum_probs=184.9

Q ss_pred             ccCCceeeccCcee-EEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEEeccC
Q 001988          728 FAENNIIGIGGFGS-VYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       728 ~~~~~~ig~G~~g~-V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      |...+++|.|+.|+ ||+|..+ |++||||++-..   ..+.+++|+..++.- +|||||++++.-+++...||..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            45556789999887 8999995 899999988643   345678999999988 69999999999999999999999995


Q ss_pred             CCChHHHhhcCCCCC---CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---C--CcEEEecccCceecc
Q 001988          806 NGSLEDCLHSSNCAL---NIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE---D--MVAHLSDFGMAKLLS  877 (985)
Q Consensus       806 ~gsL~~~l~~~~~~~---~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~---~--~~~kl~DfGla~~~~  877 (985)
                       .+|.++++......   .....+.+..|++.||++|   |+.+|||||+||.||||+.   +  .+++|+|||+++.+.
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHL---Hsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHL---HSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHH---HhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             59999998741111   1133467889999999999   8999999999999999975   3  479999999999987


Q ss_pred             CCCCcc-eecccccccccccccccccCccchhhhcccccccchhhhccc-ccccCcchhhh--------------hHHHH
Q 001988          878 GEDEST-MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDK-SLLSGEEKHFA--------------AKEQC  941 (985)
Q Consensus       878 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~-~~~~~~~~~~~--------------~~~~~  941 (985)
                      ...... ......||-+|+|||++....-+.+.|+ +++|++++-++++ ..+++.....+              ..++|
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDi-FslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~  741 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDI-FSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDC  741 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccch-hhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchH
Confidence            544332 3456679999999999999888889999 9999998888876 55555432221              11222


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          942 LLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       942 ~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                        +..++|.+|+.++|..||+|.+|+.
T Consensus       742 --eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  742 --EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             --HHHHHHHHhcCCCcccCCCHHHHhC
Confidence              7889999999999999999999963

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.1e-26  Score=266.08  Aligned_cols=240  Identities=18%  Similarity=0.224  Sum_probs=175.9

Q ss_pred             HhcCccCCceeeccCceeEEEEEE-----------------cCCcEEEEEEeccCCcchHH--------------HHHHH
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARL-----------------EDGVEIAIKVFHPQCASTLK--------------SFEAE  772 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~-----------------~~~~~vAvK~~~~~~~~~~~--------------~~~~E  772 (985)
                      ..++|+..++||+|+||.||+|..                 .+++.||||++........+              ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999964                 24567999998754332222              23457


Q ss_pred             HHHHHhcCCCCe-----eeEEeeeec--------CCceEEEEeccCCCChHHHhhcCC----------------------
Q 001988          773 CEVIKNIRHRNL-----VKIISSCSN--------DDFKALVLEYMSNGSLEDCLHSSN----------------------  817 (985)
Q Consensus       773 ~~il~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~----------------------  817 (985)
                      +.++.+++|.++     ++++++|..        .+..++||||+++|+|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777876554     677787753        356899999999999999987431                      


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceeccccccccccc
Q 001988          818 -CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA  896 (985)
Q Consensus       818 -~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a  896 (985)
                       ...++..+..++.|+++||+|+   |+.+|+||||||+||+++.++.+||+|||+++.+..... .......+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~l---H~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKL---HRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence             1235677889999999999999   788999999999999999999999999999976542211 11122235889999


Q ss_pred             ccccccCcc----------------------chhhhcccccccchhhhcccccccCcc-h--------------------
Q 001988          897 PDEIFVGEL----------------------SLKRWVNDLLPVSLVEVVDKSLLSGEE-K--------------------  933 (985)
Q Consensus       897 PE~~~~~~~----------------------~~~~dv~~~~g~~~~~i~~~~~~~~~~-~--------------------  933 (985)
                      ||.+.....                      ....|+ |++|+++++|+.+.+..... .                    
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~Dv-wSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~  457 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDS-YTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK  457 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccch-hhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence            998764321                      123588 99999999999876522110 0                    


Q ss_pred             ----hhhhHHHHHHHHHHHHHHccCCCC---CCCCCHHHHHH
Q 001988          934 ----HFAAKEQCLLSIFSLALECTMESP---EKRIDAKDTIT  968 (985)
Q Consensus       934 ----~~~~~~~~~~~l~~l~~~cl~~~P---~~RPt~~ev~~  968 (985)
                          ..+..+.+.+...+++.+++..+|   .+|+++.|+++
T Consensus       458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence                011112345678889999999765   68999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-28  Score=260.68  Aligned_cols=229  Identities=21%  Similarity=0.283  Sum_probs=194.4

Q ss_pred             cCccCCceeeccCceeEEEEEEcCCc-EEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDGV-EIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~~-~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      .+++...-+|-||||.|-++..+... .+|+|.+++..   ....+.+..|-.||..++.|.||++|..|.+..+.|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            44555667999999999999876333 48999887652   233456788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      |-|-||.+...++..+ .++..+...++..+++|++||   |++|||+||+||+|.++|.+|.+||.|||+|+.+.... 
T Consensus       500 EaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYL---H~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-  574 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYL---HRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-  574 (732)
T ss_pred             HhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHH---HhcCceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence            9999999999998875 688888888999999999999   89999999999999999999999999999999885433 


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh-------------hhHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-------------AAKEQCLLSIFSL  948 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-------------~~~~~~~~~l~~l  948 (985)
                        .+..+||||.|.|||++....-..+.|. |++|+.++|+++|..++......             .-|........++
T Consensus       575 --KTwTFcGTpEYVAPEIILnKGHD~avDy-WaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L  651 (732)
T KOG0614|consen  575 --KTWTFCGTPEYVAPEIILNKGHDRAVDY-WALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL  651 (732)
T ss_pred             --ceeeecCCcccccchhhhccCcchhhHH-HHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence              3456899999999999999999999999 99999999999998876554221             1233456677889


Q ss_pred             HHHccCCCCCCCCC
Q 001988          949 ALECTMESPEKRID  962 (985)
Q Consensus       949 ~~~cl~~~P~~RPt  962 (985)
                      |++.++.+|.+|-.
T Consensus       652 ik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  652 IKKLCRDNPTERLG  665 (732)
T ss_pred             HHHHHhcCcHhhhc
Confidence            99999999999875

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-27  Score=239.56  Aligned_cols=231  Identities=23%  Similarity=0.230  Sum_probs=189.8

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~  798 (985)
                      ...+|...++||+|+|+.|..++++ +.+.||+|++++...   .+.+.++.|-.+..+. +||.+|-++.+++.....+
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            3467888999999999999999965 678899999987632   3455677888888776 7999999999999999999


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +|.||++||+|--++..++ .++++....+...|.-||.||   |++|||+||+|.+||++|..|++|+.|+|+++.-- 
T Consensus       328 fvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~fl---h~rgiiyrdlkldnvlldaeghikltdygmcke~l-  402 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-  402 (593)
T ss_pred             EEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHH---hhcCeeeeeccccceEEccCCceeecccchhhcCC-
Confidence            9999999999987777664 577888888999999999999   89999999999999999999999999999998632 


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcch---hhhhHHH---------------
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK---HFAAKEQ---------------  940 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~---~~~~~~~---------------  940 (985)
                       .....++..+|||.|+|||.+.+..|.+..|. |++|+.++||+.|+.++....   .....++               
T Consensus       403 -~~gd~tstfcgtpnyiapeilrgeeygfsvdw-walgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr  480 (593)
T KOG0695|consen  403 -GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW-WALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR  480 (593)
T ss_pred             -CCCcccccccCCCcccchhhhcccccCceehH-HHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc
Confidence             33345677899999999999999999998876 999999999999987654321   1111111               


Q ss_pred             -HHHHHHHHHHHccCCCCCCCC
Q 001988          941 -CLLSIFSLALECTMESPEKRI  961 (985)
Q Consensus       941 -~~~~l~~l~~~cl~~~P~~RP  961 (985)
                       .+.....+++.-+..||++|.
T Consensus       481 slsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  481 SLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             eeehhhHHHHHHhhcCCcHHhc
Confidence             223344577888888998875

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3e-27  Score=246.61  Aligned_cols=241  Identities=26%  Similarity=0.353  Sum_probs=194.0

Q ss_pred             hcCccCCceeeccCceeEEEEE-EcCCcEEEEEEeccCCcc-------hHHHHHHHHHHHHhcCCCCeeeEEeeee-cCC
Q 001988          725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAS-------TLKSFEAECEVIKNIRHRNLVKIISSCS-NDD  795 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vAvK~~~~~~~~-------~~~~~~~E~~il~~l~h~niv~l~~~~~-~~~  795 (985)
                      .++|-...++|+|||++||+|. ....+.||||+-......       -.+...+|.+|-+.+.||.||++|+|+. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            4567778899999999999997 456788999986543211       1345689999999999999999999996 456


Q ss_pred             ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc---CCCcEEEecccC
Q 001988          796 FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGM  872 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~---~~~~~kl~DfGl  872 (985)
                      .++-|+|||+|-+|.-+++.+. .+++.+...|+.||+.||.||.. -+.+|||=|+||.|||+.   ..|.+||.|||+
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            7889999999999999998764 68899999999999999999954 577899999999999994   568999999999


Q ss_pred             ceeccCCCCc-----ceecccccccccccccccccC----ccchhhhcccccccchhhhcccccccCcchhh--------
Q 001988          873 AKLLSGEDES-----TMRTQTLATIGYMAPDEIFVG----ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------  935 (985)
Q Consensus       873 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------  935 (985)
                      ++.++++...     ..+...+||++|++||.+.-+    ..+-+.|| |+.|+.++..+-|+.+++..-.-        
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDV-WSvGVIFyQClYGrKPFGhnqsQQdILqeNT  698 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDV-WSVGVIFYQCLYGRKPFGHNQSQQDILQENT  698 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceee-EeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence            9998765443     234667899999999987654    35678899 99999999999888777654211        


Q ss_pred             ---------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          936 ---------AAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       936 ---------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                               +....+..+...+|++|+.+.-++|....++..
T Consensus       699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence                     112235567788999999998888887777653

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.94  E-value=6e-27  Score=241.62  Aligned_cols=255  Identities=19%  Similarity=0.249  Sum_probs=204.5

Q ss_pred             HHHHHHhcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeee
Q 001988          719 FELLRATDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSC  791 (985)
Q Consensus       719 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~  791 (985)
                      .++.....+++....+.+|.||+||+|.+.      +.+.|-+|.++....+ ....+..|--.+..+.|||+.++.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            344445566777788999999999999654      3445677777644222 345567888888888999999999998


Q ss_pred             ecC-CceEEEEeccCCCChHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC
Q 001988          792 SND-DFKALVLEYMSNGSLEDCLHSS-------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM  863 (985)
Q Consensus       792 ~~~-~~~~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~  863 (985)
                      .+. +..++.+.+..-|+|..++...       .+.++..+...++.|++.|++||   |++||||.||.++|.+||+.-
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl---h~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL---HNHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH---HhcCcccchhhhhcceehhhe
Confidence            654 5678889999999999999822       23466677788999999999999   899999999999999999999


Q ss_pred             cEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcc----------
Q 001988          864 VAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEE----------  932 (985)
Q Consensus       864 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~----------  932 (985)
                      .+||+|=.+++.+-+.+........-....||+||.+....++.++|+ |+||+.+||+++ |+.+..+.          
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDv-WsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDV-WSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhh-HHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence            999999999988755554443333446778999999999999999999 999999999987 33333322          


Q ss_pred             --hhhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          933 --KHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       933 --~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                        .+..++-.|+++++.+|.-||...|++||++++++.-|.++...+
T Consensus       513 dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  513 DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence              123355669999999999999999999999999999999876543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.94  E-value=2.7e-26  Score=244.31  Aligned_cols=223  Identities=32%  Similarity=0.400  Sum_probs=189.4

Q ss_pred             CceeEEEEEEc-CCcEEEEEEeccCCcch-HHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCChHHHhhc
Q 001988          738 GFGSVYRARLE-DGVEIAIKVFHPQCAST-LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHS  815 (985)
Q Consensus       738 ~~g~V~~~~~~-~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  815 (985)
                      +||.||+|... +++.||+|++....... .+.+.+|++.+++++|+|++++++++......+++|||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 58999999998765444 67899999999999999999999999998999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecccccccccc
Q 001988          816 SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYM  895 (985)
Q Consensus       816 ~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~  895 (985)
                      .. .+++.....++.++++++.||   |+.+++|+||+|+||++++++.++++|||.+.......   ......++..|+
T Consensus        81 ~~-~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RG-RLSEDEARFYARQILSALEYL---HSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             cc-CCCHHHHHHHHHHHHHHHHHH---HHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            54 378999999999999999999   78899999999999999999999999999998764322   223445888999


Q ss_pred             cccccccCccchhhhcccccccchhhhcccccccCcchhhh------------h-HHH--HHHHHHHHHHHccCCCCCCC
Q 001988          896 APDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------A-KEQ--CLLSIFSLALECTMESPEKR  960 (985)
Q Consensus       896 aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------~-~~~--~~~~l~~l~~~cl~~~P~~R  960 (985)
                      |||......++.+.|+ |++|+.+++++++..+........            . ...  ++.++.+++.+|+..+|++|
T Consensus       154 ~pE~~~~~~~~~~~Di-~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R  232 (244)
T smart00220      154 APEVLLGKGYGKAVDV-WSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR  232 (244)
T ss_pred             CHHHHccCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence            9999988889999999 899999999999876543311110            0 001  56789999999999999999


Q ss_pred             CCHHHHHH
Q 001988          961 IDAKDTIT  968 (985)
Q Consensus       961 Pt~~ev~~  968 (985)
                      |++.++++
T Consensus       233 p~~~~~~~  240 (244)
T smart00220      233 LTAEEALQ  240 (244)
T ss_pred             cCHHHHhh
Confidence            99999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=4.5e-27  Score=258.06  Aligned_cols=237  Identities=24%  Similarity=0.355  Sum_probs=197.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .++|...+.+|.|.||.||||+.. +++..|+|+++.....+.+.+++|+-+++.++|||||.++|.+..++..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            467888899999999999999854 7899999999988777778889999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      |.||+|++.-+..+ ++++.++..+++...+|++||   |+.|-+|||||-.||++++.|.+|++|||.+..+.  ....
T Consensus        94 cgggslQdiy~~Tg-plselqiayvcRetl~gl~yl---hs~gk~hRdiKGanilltd~gDvklaDfgvsaqit--ati~  167 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYL---HSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT--ATIA  167 (829)
T ss_pred             cCCCcccceeeecc-cchhHHHHHHHhhhhccchhh---hcCCcccccccccceeecccCceeecccCchhhhh--hhhh
Confidence            99999999877654 788888888899999999999   89999999999999999999999999999987663  2223


Q ss_pred             eecccccccccccccccc---cCccchhhhcccccccchhhhcccc--cccC--------------cchhhhhHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIF---VGELSLKRWVNDLLPVSLVEVVDKS--LLSG--------------EEKHFAAKEQCLLS  944 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~~~~g~~~~~i~~~~--~~~~--------------~~~~~~~~~~~~~~  944 (985)
                      ....+.||++|||||+..   .+.|...+|+ |+.|+.+.|.-.-.  ++.-              ..+.........+.
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdi-wa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~  246 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDI-WALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF  246 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccc-cccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence            345678999999999764   6778899999 88887766653311  1111              11222334456788


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHH
Q 001988          945 IFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       945 l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +.++++.|+..+|++||++..++.
T Consensus       247 fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhhee
Confidence            999999999999999999987765

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.93  E-value=7.6e-25  Score=227.39  Aligned_cols=210  Identities=37%  Similarity=0.548  Sum_probs=183.3

Q ss_pred             eeccCceeEEEEEEc-CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCChHH
Q 001988          734 IGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLED  811 (985)
Q Consensus       734 ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  811 (985)
                      ||+|++|.||++... +++++++|++...... ..+.+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999976 4899999999866432 34678999999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-CCcEEEecccCceeccCCCCcceeccccc
Q 001988          812 CLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHLSDFGMAKLLSGEDESTMRTQTLA  890 (985)
Q Consensus       812 ~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~g  890 (985)
                      ++......+++..+..++.++++++++|   |+.|++|+||+|.||+++. ++.++++|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYL---HSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            9987644688999999999999999999   7889999999999999999 89999999999987643321  1223457


Q ss_pred             ccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          891 TIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       891 t~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      ...|++||..... ..+.+.|+ |++|++++++                    +.+.+++..|+..+|++||++.++++.
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~-~~lg~~~~~l--------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDI-WSLGVILYEL--------------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             CCCccChhHhcccCCCCchhhh-HHHHHHHHHH--------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence            8899999998777 77888899 8999999988                    568999999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=1.7e-27  Score=246.63  Aligned_cols=390  Identities=23%  Similarity=0.216  Sum_probs=208.1

Q ss_pred             eEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccC-CcCcccCChhhhhcCCCCcEEEecC
Q 001988          222 RISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYN-NSLSGSLPSRIDLALPNLEFLNLGI  300 (985)
Q Consensus       222 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~~l~~L~~L~Ls~  300 (985)
                      .++|..|+|+...|.+|+.+++|+.||||+|+|+.+-|.+|.++.+|.+|-+.+ |+|+ .+|...|.+|..|+.|.+.-
T Consensus        71 eirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNa  149 (498)
T KOG4237|consen   71 EIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNA  149 (498)
T ss_pred             EEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcCh
Confidence            344444444433333444444444444444444444444444444444333333 4444 44444444455555555555


Q ss_pred             ccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCc------c-cccccccccCcccEE
Q 001988          301 NSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPE------L-GFLSSLANCKKLRYL  373 (985)
Q Consensus       301 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~------~-~~~~~l~~l~~L~~L  373 (985)
                      |++.....+.|..+++|..|.+..|.+..+.-..|..+..++.+.+..|.+...-.-      . .....++..+...-.
T Consensus       150 n~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~  229 (498)
T KOG4237|consen  150 NHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPY  229 (498)
T ss_pred             hhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchH
Confidence            555544444555555555555555555433333455555555555555442210000      0 000012222233333


Q ss_pred             EecCCCCCccCCCCccchhhcccceecccccccccc-CCcCCCCCCccEEEccCCCCCCCCCccccccccccceeccccc
Q 001988          374 GLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNI-PKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNK  452 (985)
Q Consensus       374 ~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  452 (985)
                      .+.++++..+-+..+.....++..=..+.+...++- ...|..+++|+.|+|++|+|+++.+.+|.++..++.|.|..|+
T Consensus       230 rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~  309 (498)
T KOG4237|consen  230 RLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNK  309 (498)
T ss_pred             HHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcch
Confidence            344444443333333222112211122223232232 2457788888888888888888888888888888888888888


Q ss_pred             ccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeee-----cCCCc-----------cCcccee
Q 001988          453 LAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFV-----IPSTF-----------WNLKDIL  516 (985)
Q Consensus       453 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-----~p~~~-----------~~l~~L~  516 (985)
                      |...-...|.++..|+.|+|.+|+|+..-|.+|..+.+|..|+|-.|.+.--     ..+|+           ..-..++
T Consensus       310 l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~  389 (498)
T KOG4237|consen  310 LEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVR  389 (498)
T ss_pred             HHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCchhc
Confidence            8766666777888888888888888877788888888888888877765320     00111           1112344


Q ss_pred             EEeecCCcccCC---cccccc---------CCCccc-EEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhc
Q 001988          517 SFDISSNLLDGP---ISLAIG---------NLKAVV-GIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGN  583 (985)
Q Consensus       517 ~L~ls~N~l~~~---~~~~~~---------~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  583 (985)
                      .++++.+.+...   .|+..+         ..+-+. ...-|++.++ .+|..+-  ..-.+|++.+|.++ .+|.+  .
T Consensus       390 ~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~  463 (498)
T KOG4237|consen  390 QIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--L  463 (498)
T ss_pred             cccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--H
Confidence            555555444221   111111         011111 1123333333 3333322  23567889999998 56666  5


Q ss_pred             ccccCeEecCCCcccCCCCccccccccccccccccc
Q 001988          584 MTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFN  619 (985)
Q Consensus       584 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  619 (985)
                      +.+| .+|||+|+++..-..+|.+|++|.+|-||+|
T Consensus       464 ~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  464 LRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             Hhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            6778 8999999998777778999999999988887

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.92  E-value=1e-25  Score=213.90  Aligned_cols=199  Identities=23%  Similarity=0.314  Sum_probs=162.9

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEEe
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ++......||+|+||.|-+-++. +|...|+|.++... .+..++..+|+++..+. .+|.+|++||...+.+..+|.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            44455678999999999988754 89999999997653 34456777888876655 79999999999999999999999


Q ss_pred             ccCCCChHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          803 YMSNGSLEDCLH---SSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       803 ~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      .|.- +|..+-+   ..+...++...-+||.-+.+||.|||  ....+||||+||+|||++.+|++|+||||.+-.+.+.
T Consensus       126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~--~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLH--SKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHH--HHhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            9954 7766543   24667899999999999999999998  6788999999999999999999999999998766432


Q ss_pred             CCcceecccccccccccccccc----cCccchhhhcccccccchhhhcccccccCc
Q 001988          880 DESTMRTQTLATIGYMAPDEIF----VGELSLKRWVNDLLPVSLVEVVDKSLLSGE  931 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~  931 (985)
                      -   ..+-..|...|||||.+.    ...|+.++|+ |++|+.+.|+...+.++..
T Consensus       203 i---Akt~daGCkpYmaPEri~~e~n~~gY~vksDv-WSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  203 I---AKTMDAGCKPYMAPERINPELNQKGYSVKSDV-WSLGITMIEMAILRFPYES  254 (282)
T ss_pred             h---HHHHhcCCCccCChhhcCcccCcccceeehhh-hhhhhhhhhhhhccccccc
Confidence            2   122245888999999764    4579999999 9999999999998876554

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.7e-26  Score=227.27  Aligned_cols=197  Identities=22%  Similarity=0.333  Sum_probs=161.8

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccC--CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCC-----ceEE
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD-----FKAL  799 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-----~~~l  799 (985)
                      .+..+.||-|+||.||.+.+. +|+.||.|++..-  .....+.+.+|++++..++|.|++..++..+-..     +.|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            344577999999999999864 8999999998643  2234678899999999999999999988776543     4678


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ++|.+ ..+|.+.+-. ...++...+.-+.+||++||.||   |+.+|.||||||-|.+++.+...||+|||+|+... .
T Consensus       135 ~TELm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYL---HsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee-~  208 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYL---HTANILHRDIKPGNLLVNSNCILKICDFGLARTWD-Q  208 (449)
T ss_pred             HHHHH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHH---hhcchhhccCCCccEEeccCceEEecccccccccc-h
Confidence            88888 4577766654 34678888888999999999999   89999999999999999999999999999999754 3


Q ss_pred             CCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCc
Q 001988          880 DESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGE  931 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~  931 (985)
                      +.....+..+-|.+|.|||.+++ ..|+...|+ |+.|+.+.|++..++++..
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDi-WSVGCIFaELLgRrILFQA  260 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDI-WSVGCIFAELLQRKILFQA  260 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccce-ehhhHHHHHHHhhhhhhhc
Confidence            33344556678999999999987 458888999 9999999999887775543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.92  E-value=9.6e-26  Score=216.98  Aligned_cols=240  Identities=19%  Similarity=0.329  Sum_probs=187.7

Q ss_pred             HhcCccCCceeeccCceeEEEEE-EcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-CCCeeeEEeeeecCC--ceEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKIISSCSNDD--FKAL  799 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~--~~~l  799 (985)
                      ..++|+..+++|+|.|++||.|. ..+.++++||++++-   ..+.+.+|+.||+.+. ||||+++++...++.  ...+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            34678888999999999999998 457889999999743   4577899999999996 999999999997764  5679


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-CcEEEecccCceeccC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAKLLSG  878 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~-~~~kl~DfGla~~~~~  878 (985)
                      |+||+.+.+......    .++...+.-++.+++.||.|+   |+.||+|||+||.|+|+|.. -..+|+|+|+|..+..
T Consensus       113 iFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyC---HS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYC---HSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             HhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHH---HhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            999998877665543    356777888999999999999   89999999999999999865 4799999999998865


Q ss_pred             CCCcceeccccccccccccccccc-Cccchhhhcccccccchhhhccccc-ccCcchhhhh-------------------
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSL-LSGEEKHFAA-------------------  937 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~-~~~~~~~~~~-------------------  937 (985)
                      ..+..   -.+.+..|-.||.+.+ ..+...-|+ |++|+++.+|+..+- ++......++                   
T Consensus       186 ~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~-WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  186 GKEYN---VRVASRYFKGPELLVDYQMYDYSLDM-WSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             Cceee---eeeehhhcCCchheeechhccccHHH-HHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence            44433   2457888999998875 556778888 999999888876443 3222211110                   


Q ss_pred             --------H---------------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHhHhhh
Q 001988          938 --------K---------------------EQCLLSIFSLALECTMESPEKRIDAKDTITR--LLKIRDTL  977 (985)
Q Consensus       938 --------~---------------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~--L~~i~~~~  977 (985)
                              .                     .-..++..+++.+.+.+|..+||||.|.+..  +..++++.
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~  332 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAE  332 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHh
Confidence                    0                     0034788999999999999999999998753  34444433

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=8.7e-27  Score=241.46  Aligned_cols=400  Identities=22%  Similarity=0.246  Sum_probs=258.3

Q ss_pred             ceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceee-eccccccCCCChhHhhhccccceeccc
Q 001988          100 KSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIR-LSKNKLSGKLPENICNHLRYLKHLFLR  178 (985)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~-ls~n~l~g~lp~~~~~~l~~L~~L~L~  178 (985)
                      +.++|..|+|+...|.+|..+++||.||||+|+|+-.-|+.|..+.++..|. +++|+|+ .+|...|+.|.+|+.|.+.
T Consensus        70 veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllN  148 (498)
T KOG4237|consen   70 VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLN  148 (498)
T ss_pred             eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcC
Confidence            3444445555533333444455555555555555554455555554444333 2335555 7788888888888888888


Q ss_pred             CccccccCCcccCCCCCceEEEcccccCCCcccc-ccccccccceEeecccc------------ccCCchhhhcCCCCCC
Q 001988          179 ENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPK-EIGNLTVLQRISLINNK------------LHGEIPQEIGYLQNLD  245 (985)
Q Consensus       179 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~------------l~~~~p~~~~~l~~L~  245 (985)
                      -|++.-...+.|..+++|..|.|.+|.+. .+++ .|..+..++.+.++.|.            .....|.+++...-..
T Consensus       149 an~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~  227 (498)
T KOG4237|consen  149 ANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS  227 (498)
T ss_pred             hhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence            88887666777888888888888888887 4555 77788888888888777            2234455566666666


Q ss_pred             EEEecCCcCcccCcccccCC-CCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccC
Q 001988          246 VLQLGFNNLTGVVPATIFNM-STLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGS  324 (985)
Q Consensus       246 ~L~Ls~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  324 (985)
                      -..+.++++...-+..|..- ..+..-..+.+...+.-|..-|..+++|+.|+|++|+|++.-+.+|..+.+++.|.|..
T Consensus       228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~  307 (498)
T KOG4237|consen  228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR  307 (498)
T ss_pred             hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence            66677777776555555432 22322234455555678888889999999999999999999999999999999999999


Q ss_pred             cccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCcc-CCCCccchhhcccceecccc
Q 001988          325 NSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGF-LPSSIGNLSLSLERLNIAFC  403 (985)
Q Consensus       325 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~~L~~L~L~~n  403 (985)
                      |++..+....|.++..|+.|+|+.|+|+...+.     +|..+..|.+|.|-.|++.-- --.|++.+        |..+
T Consensus       308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~-----aF~~~~~l~~l~l~~Np~~CnC~l~wl~~W--------lr~~  374 (498)
T KOG4237|consen  308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPG-----AFQTLFSLSTLNLLSNPFNCNCRLAWLGEW--------LRKK  374 (498)
T ss_pred             chHHHHHHHhhhccccceeeeecCCeeEEEecc-----cccccceeeeeehccCcccCccchHHHHHH--------HhhC
Confidence            999988888899999999999999999988765     478888999999999887521 11222222        1122


Q ss_pred             ccccccCCcCCCCCCccEEEccCCCCCCC---CCcccc---------cccccc-ceecccccccCCchhhhhhccCCCeE
Q 001988          404 NISGNIPKAIGNLSNLIVLSLGGNNLSGS---IPVTFG---------GLQKLQ-GLDLAFNKLAGSIPDEICLLSRLNEL  470 (985)
Q Consensus       404 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~~~---------~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L  470 (985)
                      ...|..|  -+.-..++.+.++++.+...   .|+..+         ..+-+. +...|++.++ .+|..+  ...-.+|
T Consensus       375 ~~~~~~~--Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~i--P~d~tel  449 (498)
T KOG4237|consen  375 SVVGNPR--CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGI--PVDVTEL  449 (498)
T ss_pred             CCCCCCC--CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCC--CchhHHH
Confidence            2121111  11222344455554443211   111111         112222 2234444444 444322  2345677


Q ss_pred             EccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCC
Q 001988          471 DLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSN  523 (985)
Q Consensus       471 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  523 (985)
                      ++.+|.++ .+|..  .+.+| .+|+++|+++......|.++.+|.+|-+|+|
T Consensus       450 yl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  450 YLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             hcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            88888887 44544  55667 7888888888777778888888888888776

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.92  E-value=2.6e-25  Score=240.26  Aligned_cols=195  Identities=22%  Similarity=0.292  Sum_probs=163.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--------chHHHHHHHHHHHHhcC---CCCeeeEEeeee
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--------STLKSFEAECEVIKNIR---HRNLVKIISSCS  792 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--------~~~~~~~~E~~il~~l~---h~niv~l~~~~~  792 (985)
                      ..+|...+.+|.|+||.|+.|.++ +...|+||.+.+..-        +..-.+-.|+.||.+++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            356889999999999999999976 556799998875521        11223567999999997   999999999999


Q ss_pred             cCCceEEEEecc-CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEeccc
Q 001988          793 NDDFKALVLEYM-SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFG  871 (985)
Q Consensus       793 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfG  871 (985)
                      +++++||+||-. +|.+|++++..+. .+++.+..-|+.||+.|+++|   |+.||||||||-+||.++.+|-+||+|||
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hl---h~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHL---HDQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccc---cccCceecccccccEEEecCCeEEEeecc
Confidence            999999999975 4559999998764 688999999999999999999   99999999999999999999999999999


Q ss_pred             CceeccCCCCcceecccccccccccccccccCccchhh-hcccccccchhhhcccccc
Q 001988          872 MAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-WVNDLLPVSLVEVVDKSLL  928 (985)
Q Consensus       872 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-dv~~~~g~~~~~i~~~~~~  928 (985)
                      .|...+...    ...++||..|.|||++.+..|-.+. |+ |++|+.++-++-++-+
T Consensus       716 saa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdi-walgillytivykenp  768 (772)
T KOG1152|consen  716 SAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDI-WALGILLYTIVYKENP  768 (772)
T ss_pred             chhhhcCCC----cceeeeeccccchhhhCCCccCCCcchh-hhhhheeeEEEeccCC
Confidence            987654322    2346799999999999988886554 55 9999998888766543

>PLN03210 Resistant to P

Probab=99.91  E-value=1.1e-23  Score=269.13  Aligned_cols=314  Identities=22%  Similarity=0.278  Sum_probs=161.3

Q ss_pred             cccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEe
Q 001988          170 RYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQL  249 (985)
Q Consensus       170 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  249 (985)
                      .+|+.|++.++.+. .+|..| ...+|++|+|++|++. .+|..+..+++|+.|+|++|...+.+|+ ++.+++|+.|+|
T Consensus       589 ~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L  664 (1153)
T PLN03210        589 PKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKL  664 (1153)
T ss_pred             cccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEe
Confidence            34666666665554 555555 3456666666666665 4555555666666666665543334553 555666666666


Q ss_pred             cCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCccccc
Q 001988          250 GFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSG  329 (985)
Q Consensus       250 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  329 (985)
                      ++|.....+|..+.++++|+.|++++|..-+.+|..+  .+++|+.|++++|...+.+|..   ..+|+.|++++|.+. 
T Consensus       665 ~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i--~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-  738 (1153)
T PLN03210        665 SDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI--NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-  738 (1153)
T ss_pred             cCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC--CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-
Confidence            6655444566666666666666666654334555443  4556666666665544344432   234556666666654 


Q ss_pred             ccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceecccccccccc
Q 001988          330 FIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNI  409 (985)
Q Consensus       330 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~  409 (985)
                      .+|..+ .+++|++|++..+........                      +.. ++......+++|+.|++++|...+.+
T Consensus       739 ~lP~~~-~l~~L~~L~l~~~~~~~l~~~----------------------~~~-l~~~~~~~~~sL~~L~Ls~n~~l~~l  794 (1153)
T PLN03210        739 EFPSNL-RLENLDELILCEMKSEKLWER----------------------VQP-LTPLMTMLSPSLTRLFLSDIPSLVEL  794 (1153)
T ss_pred             cccccc-cccccccccccccchhhcccc----------------------ccc-cchhhhhccccchheeCCCCCCcccc
Confidence            334333 355555555544322111000                      000 00001111124555555555544455


Q ss_pred             CCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcC
Q 001988          410 PKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLT  489 (985)
Q Consensus       410 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  489 (985)
                      |..++++++|+.|+|++|..-+.+|... .+++|+.|++++|..-..+|..   .++|+.|+|++|.|+ .+|..+..++
T Consensus       795 P~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~  869 (1153)
T PLN03210        795 PSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFS  869 (1153)
T ss_pred             ChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCC
Confidence            5555555556666665554333444433 4555666666655433333332   245666666666665 3455566666


Q ss_pred             cCceEeecc-ceeeeecCCCccCccceeEEeecCC
Q 001988          490 SLQYLNLGS-NRFTFVIPSTFWNLKDILSFDISSN  523 (985)
Q Consensus       490 ~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ls~N  523 (985)
                      +|++|+|++ |+++. +|..+..+++|+.++++++
T Consensus       870 ~L~~L~L~~C~~L~~-l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        870 NLSFLDMNGCNNLQR-VSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             CCCEEECCCCCCcCc-cCcccccccCCCeeecCCC
Confidence            666666665 34443 4444555666666666554

syringae 6; Provisional

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.91  E-value=7.7e-25  Score=221.89  Aligned_cols=231  Identities=24%  Similarity=0.274  Sum_probs=188.1

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccC--CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecC------Cc
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRNLVKIISSCSND------DF  796 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~~  796 (985)
                      .+|.....+|.|+- .|..|.+. .+++||+|+....  .....++..+|...+..++|+||++++.++.-.      ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46777788999988 56666543 6899999988644  334457788999999999999999999998543      35


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      .|+||||+ .++|...+..   .++..+...+.+|++.|++||   |+.||+||||||+||++..++.+||.|||+|+.-
T Consensus        96 ~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~l---hs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHL---HSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHH---HhcceeecccCcccceecchhheeeccchhhccc
Confidence            78999999 5689888873   467788899999999999999   8999999999999999999999999999999863


Q ss_pred             cCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhhH------------------
Q 001988          877 SGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK------------------  938 (985)
Q Consensus       877 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~------------------  938 (985)
                      .   .....+..+.|..|.|||++.+-.+....|+ |+.||.+.|++.+.+...+....++.                  
T Consensus       169 ~---~~~~mtpyVvtRyyrapevil~~~~ke~vdi-wSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  169 D---TDFMMTPYVVTRYYRAPEVILGMGYKENVDI-WSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             C---cccccCchhheeeccCchheeccCCcccchh-hhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            2   2245567789999999999999889999999 99999999999988765543211100                  


Q ss_pred             -----------------------------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          939 -----------------------------------EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       939 -----------------------------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                         ........+++.+|+-.+|++|.+++++++
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                                               001234677999999999999999999986

>PLN03210 Resistant to P

Probab=99.90  E-value=3.7e-23  Score=264.44  Aligned_cols=337  Identities=23%  Similarity=0.303  Sum_probs=199.0

Q ss_pred             cccCCCCCCEEEccCCc------CcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCc
Q 001988          261 TIFNMSTLKEIFLYNNS------LSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSA  334 (985)
Q Consensus       261 ~l~~l~~L~~L~L~~N~------l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  334 (985)
                      +|.++.+|+.|.+.++.      +...+|..+..-.++|+.|++.+|.+. .+|..+ ...+|+.|++++|++. .+|..
T Consensus       553 aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~  629 (1153)
T PLN03210        553 AFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDG  629 (1153)
T ss_pred             HHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccc
Confidence            34444555555443332      122334433322234555665555554 444444 3455666666666655 34555


Q ss_pred             ccCCCCCceEeccCCc-ccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcC
Q 001988          335 IGNLRNLKLFDIFFNN-LTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAI  413 (985)
Q Consensus       335 l~~l~~L~~L~L~~N~-l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~  413 (985)
                      +..+++|+.|+|+++. +..++       .+..+++|+.|+|++|.....+|..+..+. +|+.|++++|..-+.+|..+
T Consensus       630 ~~~l~~Lk~L~Ls~~~~l~~ip-------~ls~l~~Le~L~L~~c~~L~~lp~si~~L~-~L~~L~L~~c~~L~~Lp~~i  701 (1153)
T PLN03210        630 VHSLTGLRNIDLRGSKNLKEIP-------DLSMATNLETLKLSDCSSLVELPSSIQYLN-KLEDLDMSRCENLEILPTGI  701 (1153)
T ss_pred             cccCCCCCEEECCCCCCcCcCC-------ccccCCcccEEEecCCCCccccchhhhccC-CCCEEeCCCCCCcCccCCcC
Confidence            5566666666666543 22222       144556666666666655556666666665 56666666654444555444


Q ss_pred             CCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccc-------cccCCCCc
Q 001988          414 GNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKIS-------GSISSCLG  486 (985)
Q Consensus       414 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-------~~~~~~~~  486 (985)
                       ++++|+.|++++|.....+|..   ..+|+.|++++|.+. .+|..+ .+++|++|++.++...       ...+..+.
T Consensus       702 -~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~  775 (1153)
T PLN03210        702 -NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTM  775 (1153)
T ss_pred             -CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhh
Confidence             5666777777766544444432   345666777777765 445443 4566666666653321       11122223


Q ss_pred             CcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceee
Q 001988          487 NLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNI  566 (985)
Q Consensus       487 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  566 (985)
                      ..++|+.|+|++|.....+|..+.++++|+.|++++|..-+.+|..+ ++++|+.|++++|..-..+|..   ..+|+.|
T Consensus       776 ~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L  851 (1153)
T PLN03210        776 LSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDL  851 (1153)
T ss_pred             ccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEe
Confidence            34567777777776666677777777777777777764333344444 6777888888876554445543   3567888


Q ss_pred             eeecceeccchhhhhhcccccCeEecCC-CcccCCCCcccccccccccccccccc
Q 001988          567 SLAYNRLEGPIPESFGNMTSLESLDLSN-NKISGSIPVSFEKLSYLKELNLSFNK  620 (985)
Q Consensus       567 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ls~N~  620 (985)
                      +|++|.++ .+|.++..+++|+.|+|++ |++. .+|..+..+++|+.++++++.
T Consensus       852 ~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        852 NLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             ECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            88888887 5777888888888888887 4555 567777788888888888774

syringae 6; Provisional

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.89  E-value=1.2e-23  Score=224.43  Aligned_cols=235  Identities=23%  Similarity=0.319  Sum_probs=192.1

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcC------CCCeeeEEeeeecCCc
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIR------HRNLVKIISSCSNDDF  796 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~------h~niv~l~~~~~~~~~  796 (985)
                      -..+|.+....|+|-|++|.+|... -|..||||++.... .-.+.=.+|++||++++      -.++++++..|....+
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            4568988999999999999999854 57899999997552 22344468999999995      3589999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-CcEEEecccCc
Q 001988          797 KALVLEYMSNGSLEDCLHSSNC--ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMA  873 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~-~~~kl~DfGla  873 (985)
                      +|||+|-+ .-+|.+.++.-+.  .+....+..++.|+.-||..|   -..||+|+||||+|||+.+. ...||||||.|
T Consensus       509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklL---K~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLL---KKCGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHH---HhcCeeecccCccceEeccCcceeeeccCccc
Confidence            99999988 4589999987643  477888999999999999999   89999999999999999865 47899999999


Q ss_pred             eeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcch--------------------
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK--------------------  933 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~--------------------  933 (985)
                      .....+.-.    ...-+..|.|||++.+..|....|+ |+.||.++|+.+|++++....                    
T Consensus       585 ~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~-WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml  659 (752)
T KOG0670|consen  585 SFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDT-WSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML  659 (752)
T ss_pred             ccccccccc----HHHHHHhccCcceeecCcccCCccc-eeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence            887543322    2345678999999999999999999 999999999999987654331                    


Q ss_pred             --------hhh-------------------------------------------hHHHHHHHHHHHHHHccCCCCCCCCC
Q 001988          934 --------HFA-------------------------------------------AKEQCLLSIFSLALECTMESPEKRID  962 (985)
Q Consensus       934 --------~~~-------------------------------------------~~~~~~~~l~~l~~~cl~~~P~~RPt  962 (985)
                              +++                                           .......++.+++..|+..||++|.+
T Consensus       660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit  739 (752)
T KOG0670|consen  660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT  739 (752)
T ss_pred             hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence                    000                                           01113466888999999999999999


Q ss_pred             HHHHHH
Q 001988          963 AKDTIT  968 (985)
Q Consensus       963 ~~ev~~  968 (985)
                      .+++++
T Consensus       740 ~nqAL~  745 (752)
T KOG0670|consen  740 VNQALK  745 (752)
T ss_pred             HHHHhc
Confidence            999875

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=4.8e-23  Score=226.32  Aligned_cols=183  Identities=21%  Similarity=0.211  Sum_probs=138.7

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEc--CCcEEEEEEeccCC-----cchHHHHHHHHHHHHhcCCCCeee-EEeeeecC
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLE--DGVEIAIKVFHPQC-----ASTLKSFEAECEVIKNIRHRNLVK-IISSCSND  794 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vAvK~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~-l~~~~~~~  794 (985)
                      ...++|...+.||+|+||+||+|+++  +++.||||++....     ......+.+|++++++++|+|++. ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            45578999999999999999999864  57778999875331     113456899999999999999985 4432    


Q ss_pred             CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC-CCCCEEEcCCCcEEEecccCc
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL-KPSNVLLDEDMVAHLSDFGMA  873 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDl-k~~Nill~~~~~~kl~DfGla  873 (985)
                      +..++||||++|++|... ...+       ...++.++++||+|+   |++||+|||| ||+|||++.++.+||+|||+|
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~~~~-------~~~~~~~i~~aL~~l---H~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-RPHG-------DPAWFRSAHRALRDL---HRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-Cccc-------hHHHHHHHHHHHHHH---HHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            457999999999999732 2111       146788999999999   7899999999 999999999999999999999


Q ss_pred             eeccCCCCcce------ecccccccccccccccccCcc------chhhhcccccccchh
Q 001988          874 KLLSGEDESTM------RTQTLATIGYMAPDEIFVGEL------SLKRWVNDLLPVSLV  920 (985)
Q Consensus       874 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~------~~~~dv~~~~g~~~~  920 (985)
                      +.+........      .....+++.|+|||.+...+.      +...|-|+.-|...+
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW~~TGDlg~  218 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIWLATGKKVY  218 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcEEeCCCEEE
Confidence            98764332111      135568899999998754332      234556666665443

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=6.2e-23  Score=242.76  Aligned_cols=263  Identities=24%  Similarity=0.309  Sum_probs=121.9

Q ss_pred             CCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEec
Q 001988          267 TLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDI  346 (985)
Q Consensus       267 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  346 (985)
                      .-..|+|++|.|+ .+|..+.   ++|+.|++++|+++. +|..   +++|++|++++|+|+. +|..   .+       
T Consensus       202 ~~~~LdLs~~~Lt-sLP~~l~---~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~-------  262 (788)
T PRK15387        202 GNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTS-LPVL---PP-------  262 (788)
T ss_pred             CCcEEEcCCCCCC-cCCcchh---cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCc-ccCc---cc-------
Confidence            3456777777776 5666543   356666666666663 3321   2445555555555542 2221   12       


Q ss_pred             cCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccC
Q 001988          347 FFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGG  426 (985)
Q Consensus       347 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  426 (985)
                                            +|+.|++++|.+.. +|.    ++.+|+.|++++|+++. +|.   .+++|++|+|++
T Consensus       263 ----------------------sL~~L~Ls~N~L~~-Lp~----lp~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~  311 (788)
T PRK15387        263 ----------------------GLLELSIFSNPLTH-LPA----LPSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSD  311 (788)
T ss_pred             ----------------------ccceeeccCCchhh-hhh----chhhcCEEECcCCcccc-ccc---cccccceeECCC
Confidence                                  34444444444431 221    11234445555555442 222   124556666666


Q ss_pred             CCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecC
Q 001988          427 NNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIP  506 (985)
Q Consensus       427 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  506 (985)
                      |+|++. |..   ..+|+.|++++|+|++ +|.   ...+|+.|+|++|+|++ +|...   .+|+.|++++|+|+. +|
T Consensus       312 N~L~~L-p~l---p~~L~~L~Ls~N~L~~-LP~---lp~~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~~-LP  378 (788)
T PRK15387        312 NQLASL-PAL---PSELCKLWAYNNQLTS-LPT---LPSGLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLTS-LP  378 (788)
T ss_pred             CccccC-CCC---cccccccccccCcccc-ccc---cccccceEecCCCccCC-CCCCC---cccceehhhcccccc-Cc
Confidence            666532 221   1245555666666653 332   12356666666666653 33221   345555666666553 23


Q ss_pred             CCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccc
Q 001988          507 STFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTS  586 (985)
Q Consensus       507 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  586 (985)
                      ..   ..+|+.|++++|+|+++++ .   .++|+.|++++|+|++ +|..   ..+|+.|++++|+|+ .+|..+.++++
T Consensus       379 ~l---~~~L~~LdLs~N~Lt~LP~-l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~  446 (788)
T PRK15387        379 AL---PSGLKELIVSGNRLTSLPV-L---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSS  446 (788)
T ss_pred             cc---ccccceEEecCCcccCCCC-c---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccC
Confidence            21   1234455555555443221 1   1334445555555542 3322   123444444444444 34444444444


Q ss_pred             cCeEecCCCcccCCCCcc
Q 001988          587 LESLDLSNNKISGSIPVS  604 (985)
Q Consensus       587 L~~L~Ls~N~l~~~~p~~  604 (985)
                      |+.|+|++|+|++.+|..
T Consensus       447 L~~LdLs~N~Ls~~~~~~  464 (788)
T PRK15387        447 ETTVNLEGNPLSERTLQA  464 (788)
T ss_pred             CCeEECCCCCCCchHHHH
Confidence            444444444444444433

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=6.6e-23  Score=242.55  Aligned_cols=263  Identities=26%  Similarity=0.322  Sum_probs=131.1

Q ss_pred             cceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecC
Q 001988          172 LKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGF  251 (985)
Q Consensus       172 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  251 (985)
                      -..|+|++|.++ .+|+.+.  ++|+.|++++|+|+ .+|..   +++|++|++++|+|+ .+|..   .++|+.|+|++
T Consensus       203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~  271 (788)
T PRK15387        203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS  271 (788)
T ss_pred             CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence            455666666666 5666554  35666666666666 34432   355666666666666 34432   24566666666


Q ss_pred             CcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCccccccc
Q 001988          252 NNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFI  331 (985)
Q Consensus       252 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  331 (985)
                      |.++ .+|..   ..+|+.|++++|+++ .+|.    .+++|+.|+|++|+|++ +|..   ..+|+.|++++|++++ +
T Consensus       272 N~L~-~Lp~l---p~~L~~L~Ls~N~Lt-~LP~----~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-L  337 (788)
T PRK15387        272 NPLT-HLPAL---PSGLCKLWIFGNQLT-SLPV----LPPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-L  337 (788)
T ss_pred             Cchh-hhhhc---hhhcCEEECcCCccc-cccc----cccccceeECCCCcccc-CCCC---cccccccccccCcccc-c
Confidence            6665 23332   234556666666665 4443    13456666666666653 2321   1234455555555543 2


Q ss_pred             CCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCC
Q 001988          332 PSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPK  411 (985)
Q Consensus       332 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~  411 (985)
                      |..   ..+|+.|+|++|+|+.++..         ..+|+.|++++|+                         |+. +|.
T Consensus       338 P~l---p~~Lq~LdLS~N~Ls~LP~l---------p~~L~~L~Ls~N~-------------------------L~~-LP~  379 (788)
T PRK15387        338 PTL---PSGLQELSVSDNQLASLPTL---------PSELYKLWAYNNR-------------------------LTS-LPA  379 (788)
T ss_pred             ccc---ccccceEecCCCccCCCCCC---------Ccccceehhhccc-------------------------ccc-Ccc
Confidence            321   12445555555555443321         1234444444444                         442 222


Q ss_pred             cCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcC
Q 001988          412 AIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSL  491 (985)
Q Consensus       412 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  491 (985)
                      .   .++|+.|+|++|+|++ +|..   .++|+.|++++|+|++ +|..   ..+|+.|+|++|+|+ .+|..+.++++|
T Consensus       380 l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L  447 (788)
T PRK15387        380 L---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSE  447 (788)
T ss_pred             c---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCC
Confidence            1   1345555555555553 2221   1345555555555553 3332   234455555555555 345555555556


Q ss_pred             ceEeeccceeeeecCCCc
Q 001988          492 QYLNLGSNRFTFVIPSTF  509 (985)
Q Consensus       492 ~~L~L~~N~l~~~~p~~~  509 (985)
                      +.|+|++|+|++..+..+
T Consensus       448 ~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        448 TTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             CeEECCCCCCCchHHHHH
Confidence            666666666555444433

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=8.6e-23  Score=217.33  Aligned_cols=131  Identities=25%  Similarity=0.426  Sum_probs=112.0

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-----C---CCeeeEEeeeecC-
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-----H---RNLVKIISSCSND-  794 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-----h---~niv~l~~~~~~~-  794 (985)
                      ..+|.+.++||-|-|++||+|.+. +.+.||+|+.+.. ..-.+....||++|++++     |   ..||++++.|... 
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            378889999999999999999864 6788999998754 233456789999999993     3   4699999999653 


Q ss_pred             ---CceEEEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE
Q 001988          795 ---DFKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL  859 (985)
Q Consensus       795 ---~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill  859 (985)
                         .+++||+|++ |..|..++... .+.++...+.+|++||+.||.|||  .+.||||-||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH--~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLH--RECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHH--HhcCccccCCCcceeee
Confidence               4899999999 77999998765 446889999999999999999998  67899999999999999

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.89  E-value=8.5e-23  Score=243.59  Aligned_cols=341  Identities=19%  Similarity=0.324  Sum_probs=165.7

Q ss_pred             HHHhccCChhHHHHHHHHHHhcccCCCC-cccCCCCCCCCcceeee----------------EEEeCCCCeEEEEEecCC
Q 001988           21 ITVAASNISTDQQALLALKDHITYDPTN-LLGTNWTSNASICSWIG----------------IICDVNSHKVTTLNLSSF   83 (985)
Q Consensus        21 ~~~~~~~~~~~~~aLl~~k~~~~~~~~~-~~~s~w~~~~~~c~w~g----------------v~c~~~~~~v~~l~L~~~   83 (985)
                      |+..+...+.|.+.+++..+.+.+.+.- ...+.|++++++|-=.+                |.|.  ...||.+..-+.
T Consensus        54 ~~~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~--~~~vt~l~~~g~  131 (754)
T PRK15370         54 CHPPETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGG--GKSVTYTRVTES  131 (754)
T ss_pred             hCCCCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecC--CCcccccccccc
Confidence            4555666688999999999999655431 12335998899996544                5564  345666665543


Q ss_pred             cccccCchhcccccccceeccc-----CCcCCCCCC---ccc-----ccCCCCcEEEccCcccCCCCccccccCCcccee
Q 001988           84 NLQGTIPPEIANLSSLKSLDLS-----HNKLSSNIP---SSI-----FTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDI  150 (985)
Q Consensus        84 ~l~g~~~~~l~~l~~L~~L~L~-----~n~l~~~~p---~~~-----~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L  150 (985)
                      -....-..+   -.. ..-+..     .+.-.+.-+   ..+     +-..+.+.|+++++.++. +|..+  ..+|+.|
T Consensus       132 ~~~~~~~~~---~~~-~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lts-LP~~I--p~~L~~L  204 (754)
T PRK15370        132 EQASSASGS---KDA-VNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTT-IPACI--PEQITTL  204 (754)
T ss_pred             cccccCCCC---CCh-hhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCc-CCccc--ccCCcEE
Confidence            222111000   000 000000     010000000   001     111345667777666663 22222  1244555


Q ss_pred             eeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccc
Q 001988          151 RLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKL  230 (985)
Q Consensus       151 ~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  230 (985)
                      +|++|+++ .+|..++   ++|++|++++|+|+ .+|..+.  .+|+.|+|++|+++ .+|..+.  ++|+.|++++|+|
T Consensus       205 ~Ls~N~Lt-sLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L  274 (754)
T PRK15370        205 ILDNNELK-SLPENLQ---GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKI  274 (754)
T ss_pred             EecCCCCC-cCChhhc---cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCcc
Confidence            55555555 4554442   34555555555555 3444332  24555555555555 3444432  2455555555555


Q ss_pred             cCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCcc
Q 001988          231 HGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSS  310 (985)
Q Consensus       231 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~  310 (985)
                      + .+|+.+.  ++|+.|+|++|+++                         .+|..+.   ++|+.|++++|+++. +|..
T Consensus       275 ~-~LP~~l~--~sL~~L~Ls~N~Lt-------------------------~LP~~lp---~sL~~L~Ls~N~Lt~-LP~~  322 (754)
T PRK15370        275 S-CLPENLP--EELRYLSVYDNSIR-------------------------TLPAHLP---SGITHLNVQSNSLTA-LPET  322 (754)
T ss_pred             C-ccccccC--CCCcEEECCCCccc-------------------------cCcccch---hhHHHHHhcCCcccc-CCcc
Confidence            4 3444332  24555555555444                         2332221   234444555554442 2322


Q ss_pred             ccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccc
Q 001988          311 ITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGN  390 (985)
Q Consensus       311 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  390 (985)
                      +.  ++|+.|++++|.+++ +|..+.  ++|+.|++++|+++.++...        .++|++|++++|+++. +|..+. 
T Consensus       323 l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~LP~~l--------p~~L~~LdLs~N~Lt~-LP~~l~-  387 (754)
T PRK15370        323 LP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITVLPETL--------PPTITTLDVSRNALTN-LPENLP-  387 (754)
T ss_pred             cc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCcCChhh--------cCCcCEEECCCCcCCC-CCHhHH-
Confidence            21  345555555555553 333332  45666666666666543321        1467777777777763 444332 


Q ss_pred             hhhcccceeccccccccccCCcC----CCCCCccEEEccCCCCC
Q 001988          391 LSLSLERLNIAFCNISGNIPKAI----GNLSNLIVLSLGGNNLS  430 (985)
Q Consensus       391 l~~~L~~L~L~~n~l~~~~~~~~----~~l~~L~~L~L~~N~l~  430 (985)
                        .+|+.|++++|+++ .+|..+    ..++++..|++.+|.++
T Consensus       388 --~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        388 --AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             --HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence              25666777777666 334322    33455666666666655

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.88  E-value=8.2e-23  Score=201.86  Aligned_cols=234  Identities=17%  Similarity=0.204  Sum_probs=179.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEe-eeecCCceEEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIIS-SCSNDDFKALVL  801 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~-~~~~~~~~~lv~  801 (985)
                      .+.|.+.+.+|+|.||.+-+++++ +.+.+|+|.++.. ....++|.+|...--.+ .|.||+.-|+ .|+..+..+++|
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            466888899999999999999976 6678999998755 44568899998876556 4899998776 467788888999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc--CCCcEEEecccCceeccCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD--EDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~--~~~~~kl~DfGla~~~~~~  879 (985)
                      ||+|.|+|.+-+...+  +-+....+++.|+++|+.||   |++++||||||.+|||+-  +..++||||||..+..+..
T Consensus       102 E~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fM---HsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFM---HSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             ccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHh---hccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            9999999999888754  66778889999999999999   899999999999999993  4458999999998764211


Q ss_pred             CCcceecccccccccccccccccC-----ccchhhhcccccccchhhhcccccccCcch----hhhhHH-----------
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVG-----ELSLKRWVNDLLPVSLVEVVDKSLLSGEEK----HFAAKE-----------  939 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~----~~~~~~-----------  939 (985)
                      .     ...-.+-.|.|||.....     ...+..|+ |.||++++.+++|.++.....    .+...+           
T Consensus       177 V-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~-WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P  250 (378)
T KOG1345|consen  177 V-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDI-WQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP  250 (378)
T ss_pred             e-----hhhhhhcccCCcHHHhhccccceEecccccc-hheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence            1     122356679999965422     24567788 999999999999988765321    111111           


Q ss_pred             ----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 001988          940 ----QCLLSIFSLALECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       940 ----~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L  970 (985)
                          ...+...++.++-+.++|++|--..++.+..
T Consensus       251 ~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  251 KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence                1346677788899999999995554444443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.88  E-value=3.4e-22  Score=210.19  Aligned_cols=198  Identities=30%  Similarity=0.386  Sum_probs=170.2

Q ss_pred             ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccC
Q 001988          728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      |...+.||+|++|.||+|... +++++|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            456788999999999999976 4889999999876554 56788999999999999999999999999899999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCccee
Q 001988          806 NGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR  885 (985)
Q Consensus       806 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~  885 (985)
                      +++|.+++......+++.....++.+++.++.+|   |+.+++|+|++|+||+++.++.++|+|||.+..+..... ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYL---HSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence            9999999987643378999999999999999999   788999999999999999999999999999988754321 122


Q ss_pred             ccccccccccccccc-ccCccchhhhcccccccchhhhcccccccC
Q 001988          886 TQTLATIGYMAPDEI-FVGELSLKRWVNDLLPVSLVEVVDKSLLSG  930 (985)
Q Consensus       886 ~~~~gt~~y~aPE~~-~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~  930 (985)
                      ....++..|++||.. ....++.++|+ |++|+.++++++++.+..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv-~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDI-WSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhH-HHHHHHHHHHHHCCCCcc
Confidence            334578889999988 66777788999 999999999999876653

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=3.9e-21  Score=195.38  Aligned_cols=247  Identities=20%  Similarity=0.203  Sum_probs=204.6

Q ss_pred             HhcCccCCceeeccCceeEEEEE-EcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceEEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ..-.|+++++||+|.||+.+.|. .-++++||||.-..+  .+..+++.|.+.++.+. .++|.++|.+..++-+-.+|+
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            34578999999999999999997 457999999976544  34578899999999985 699999999999988889999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-----cEEEecccCceec
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM-----VAHLSDFGMAKLL  876 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~-----~~kl~DfGla~~~  876 (985)
                      |++ |.+|+|.+.-.+..++..++..+|.|+..-++|+   |++..|+|||||+|+||...+     .+.++|||+|+.+
T Consensus       104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~v---H~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYV---HEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHH---HhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            999 8899999988888999999999999999999999   899999999999999997544     6899999999998


Q ss_pred             cCCCCc-----ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh----------------
Q 001988          877 SGEDES-----TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF----------------  935 (985)
Q Consensus       877 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~----------------  935 (985)
                      .++.+.     .......||.+||+-...++.+.+.+.|. -++|-+++-.+.|.+++......                
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDL-EaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDL-EALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhH-HHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            765543     23455679999999999999999999888 88888888888888766443211                


Q ss_pred             ---hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          936 ---AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       936 ---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                         ...+..++++..-++-.-+.+-.+-|...=+...+..+.++.
T Consensus       259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~  303 (449)
T KOG1165|consen  259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL  303 (449)
T ss_pred             CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence               122335778888777777788888899888877777776653

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.86  E-value=6.7e-22  Score=208.55  Aligned_cols=193  Identities=26%  Similarity=0.363  Sum_probs=157.0

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc----CCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~  798 (985)
                      ....|...++||.|.|++||+|...    ..+.||+|.+.....  ...+.+|++.|..+ .+.||+++.+++..++...
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            3456888999999999999999743    467899999876543  46789999999999 5999999999999999999


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-CCcEEEecccCceecc
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHLSDFGMAKLLS  877 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~-~~~~kl~DfGla~~~~  877 (985)
                      +|+||++..+..++...    ++......+++.+..||+++   |..|||||||||.|++.+. .++-.|+|||+|..+.
T Consensus       112 ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~---h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHL---HKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             EEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhh---hccCccccCCCccccccccccCCceEEechhHHHHH
Confidence            99999999888888774    45788888999999999999   8999999999999999974 5678999999997321


Q ss_pred             CCC------------------------------------------Ccceeccccccccccccccccc-Cccchhhhcccc
Q 001988          878 GED------------------------------------------ESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDL  914 (985)
Q Consensus       878 ~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~  914 (985)
                      ...                                          ........+||++|.|||+++. +..+.+.|+ |+
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi-ws  263 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI-WS  263 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce-ee
Confidence            100                                          0001123469999999999875 567889999 88


Q ss_pred             cccchhhhcccc
Q 001988          915 LPVSLVEVVDKS  926 (985)
Q Consensus       915 ~g~~~~~i~~~~  926 (985)
                      .|+.++.+++..
T Consensus       264 ~GVI~Lslls~~  275 (418)
T KOG1167|consen  264 AGVILLSLLSRR  275 (418)
T ss_pred             ccceeehhhccc
Confidence            888877666543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=5.1e-21  Score=186.16  Aligned_cols=245  Identities=20%  Similarity=0.196  Sum_probs=197.8

Q ss_pred             HhcCccCCceeeccCceeEEEEE-EcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCC-CCeeeEEeeeecCCceEEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRH-RNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~lv~  801 (985)
                      ....|...++||+|+||.+|.|. ..+|.+||||.-.....  ..++..|.++.+.+++ ..|.++..+..+.++-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            34689999999999999999997 56899999998765432  2567789999999976 78888888999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---CCcEEEecccCceeccC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE---DMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~---~~~~kl~DfGla~~~~~  878 (985)
                      |.. |.+|++.+.-....++..+++-.|-|++.-++|+   |.+++|||||||+|+|..-   ...+.++|||+|+.+.+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyv---H~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYV---HLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHH---HhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            999 8899999887777899999999999999999999   8999999999999999964   34689999999999876


Q ss_pred             CCCcc-----eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh----------------
Q 001988          879 EDEST-----MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA----------------  937 (985)
Q Consensus       879 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~----------------  937 (985)
                      ..+..     ......||.+|.+-....+.+.+.+.|+ -++|+++.-.-.|.+++........                
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDm-eSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i  245 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDM-ESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI  245 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhh-hhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence            44322     2344569999999988888888888888 8888888888777776654321111                


Q ss_pred             ---HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          938 ---KEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       938 ---~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                         .+..|.++.-.+.-|-..--++-|+..=+.+.+.-+..
T Consensus       246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence               11246778888888988888888988777666655443

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=1.4e-21  Score=233.17  Aligned_cols=260  Identities=24%  Similarity=0.385  Sum_probs=154.7

Q ss_pred             eeeeEEEeCCCCeEEEEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCcccc
Q 001988           62 SWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFT  141 (985)
Q Consensus        62 ~w~gv~c~~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~  141 (985)
                      -|.-..|-.  ..++.|++++++++ .+|..+.  ++|+.|+|++|+++ .+|..+.  ++|++|+|++|+|+. +|..+
T Consensus       169 ~~r~~~Cl~--~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l  239 (754)
T PRK15370        169 VQRMRDCLK--NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS-IPATL  239 (754)
T ss_pred             HHHHHhhcc--cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc-CChhh
Confidence            344445643  34688999999888 5777664  57899999999998 5777664  589999999998874 33322


Q ss_pred             ccCCccceeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccc
Q 001988          142 FNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQ  221 (985)
Q Consensus       142 ~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  221 (985)
                        ..+|+.|+|++|.+. .+|..+.   ++|+.|++++|+++ .+|+.+.  ++|+.|+|++|+|+ .+|..+.  ++|+
T Consensus       240 --~~~L~~L~Ls~N~L~-~LP~~l~---s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~  307 (754)
T PRK15370        240 --PDTIQEMELSINRIT-ELPERLP---SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGIT  307 (754)
T ss_pred             --hccccEEECcCCccC-cCChhHh---CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHH
Confidence              235677777777776 6666553   45677777777776 4666554  36677777777766 3454433  3566


Q ss_pred             eEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCc
Q 001988          222 RISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGIN  301 (985)
Q Consensus       222 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N  301 (985)
                      .|++++|+++ .+|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|+|++|+++ .+|..+   .++|+.|+|++|
T Consensus       308 ~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l---p~~L~~LdLs~N  377 (754)
T PRK15370        308 HLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL---PPTITTLDVSRN  377 (754)
T ss_pred             HHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh---cCCcCEEECCCC
Confidence            6666666666 3444332  456666666666653 444432  45555666655555 344432   134555555555


Q ss_pred             cCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCC
Q 001988          302 SFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLD  381 (985)
Q Consensus       302 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~  381 (985)
                      +++ .+|.                        .+.  ..|+.|++++|+++.++..+  ...+..++.+..|++.+|+++
T Consensus       378 ~Lt-~LP~------------------------~l~--~sL~~LdLs~N~L~~LP~sl--~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        378 ALT-NLPE------------------------NLP--AALQIMQASRNNLVRLPESL--PHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             cCC-CCCH------------------------hHH--HHHHHHhhccCCcccCchhH--HHHhhcCCCccEEEeeCCCcc
Confidence            544 2232                        222  23555555555555443321  112234466777777777765

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=5.4e-21  Score=193.59  Aligned_cols=140  Identities=19%  Similarity=0.204  Sum_probs=110.0

Q ss_pred             CceeeccCceeEEEEEEcCCcEEEEEEeccCCcc--h-------H-----------------HHHHHHHHHHHhcCCCCe
Q 001988          731 NNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAS--T-------L-----------------KSFEAECEVIKNIRHRNL  784 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~--~-------~-----------------~~~~~E~~il~~l~h~ni  784 (985)
                      .+.||+|+||.||+|...+|++||||+++.....  .       .                 .....|+++++++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999889999999999754221  1       0                 122459999999988776


Q ss_pred             eeEEeeeecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc
Q 001988          785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV  864 (985)
Q Consensus       785 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~  864 (985)
                      .....+...  ..+|||||++|+++....... ..++.....+++.|++.+|+|+|  |+.||+||||||+||+++ ++.
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~--H~~giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILY--QDCRLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHH--HhCCcccCCCCHHHEEEE-CCc
Confidence            443333222  237999999988776543322 36788999999999999999997  788999999999999998 478


Q ss_pred             EEEecccCceec
Q 001988          865 AHLSDFGMAKLL  876 (985)
Q Consensus       865 ~kl~DfGla~~~  876 (985)
                      ++|+|||+|...
T Consensus       156 v~LiDFG~a~~~  167 (190)
T cd05147         156 LYIIDVSQSVEH  167 (190)
T ss_pred             EEEEEccccccC
Confidence            999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=3.7e-20  Score=205.06  Aligned_cols=245  Identities=23%  Similarity=0.259  Sum_probs=194.1

Q ss_pred             CccCCceeeccCceeEEEEEEcCC--cEEEEEEeccCCcchHHHHHHHHHHHHhcCC----CCeeeEEeee-ecCCceEE
Q 001988          727 NFAENNIIGIGGFGSVYRARLEDG--VEIAIKVFHPQCASTLKSFEAECEVIKNIRH----RNLVKIISSC-SNDDFKAL  799 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~~~--~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h----~niv~l~~~~-~~~~~~~l  799 (985)
                      +|.+.+.||+|+||.||.|...+.  ..+|+|............+..|+.++..+..    +++.++++.. ......+|
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997643  5789998765533333378889999998873    6899999998 57788899


Q ss_pred             EEeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-----CcEEEecccCc
Q 001988          800 VLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED-----MVAHLSDFGMA  873 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~-----~~~kl~DfGla  873 (985)
                      ||+.+ |.+|.+...... ..++..+..+++.|++.+|+++   |+.|++||||||+|++++..     ..+++.|||+|
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~l---H~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDL---HSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHH---HhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99998 889999876554 6899999999999999999999   89999999999999999865     46999999999


Q ss_pred             e--eccCCCCc----ce--ecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh--------
Q 001988          874 K--LLSGEDES----TM--RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA--------  937 (985)
Q Consensus       874 ~--~~~~~~~~----~~--~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~--------  937 (985)
                      +  .+......    ..  .....||.+|+++....+.+.+.+.|+ |++.+++.++..+.+++........        
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDl-es~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDL-ESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhh-hhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            9  43322211    11  223459999999999999999999898 8888899999988766533211100        


Q ss_pred             --------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          938 --------KEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       938 --------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                              ....+.++.+++..+-+.+..++|....+...+++...+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence                    011346677788888888999999999999998776654

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.84  E-value=1.6e-21  Score=242.44  Aligned_cols=186  Identities=17%  Similarity=0.143  Sum_probs=136.6

Q ss_pred             hcCC-CCeeeEEeeee-------cCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 001988          778 NIRH-RNLVKIISSCS-------NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIH  849 (985)
Q Consensus       778 ~l~h-~niv~l~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH  849 (985)
                      .++| +||++++++|.       ..+.++.+|||+ +++|.+++......+++.+++.++.||++||+||   |++||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAA---HSQGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHH---HhCCeee
Confidence            3455 57778888772       234567788987 6699999987666789999999999999999999   8999999


Q ss_pred             CCCCCCCEEEcCC-------------------CcEEEecccCceeccCCCC--------------cceeccccccccccc
Q 001988          850 CDLKPSNVLLDED-------------------MVAHLSDFGMAKLLSGEDE--------------STMRTQTLATIGYMA  896 (985)
Q Consensus       850 rDlk~~Nill~~~-------------------~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y~a  896 (985)
                      |||||+|||++..                   +.+|++|||+++.......              .......+||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            9999999999654                   4556666666654211000              000112358999999


Q ss_pred             ccccccCccchhhhcccccccchhhhcccccccCcchhh----------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 001988          897 PDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF----------AAKEQCLLSIFSLALECTMESPEKRIDAKDT  966 (985)
Q Consensus       897 PE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev  966 (985)
                      ||++.+..++.++|+ |++|++++|++++..........          +.......+...++.+||.++|.+||+|.|+
T Consensus       184 PE~~~~~~~~~~sDV-wSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei  262 (793)
T PLN00181        184 PEEDNGSSSNCASDV-YRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSEL  262 (793)
T ss_pred             hhhhccCCCCchhhh-hhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence            999999999999999 99999999999865433221000          0001123446678899999999999999999


Q ss_pred             HH
Q 001988          967 IT  968 (985)
Q Consensus       967 ~~  968 (985)
                      ++
T Consensus       263 l~  264 (793)
T PLN00181        263 LQ  264 (793)
T ss_pred             hh
Confidence            75

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.81  E-value=3.5e-21  Score=189.93  Aligned_cols=234  Identities=20%  Similarity=0.267  Sum_probs=185.5

Q ss_pred             CceeeccCceeEEEEEEcCCcEEEEEEeccC--CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCC
Q 001988          731 NNIIGIGGFGSVYRARLEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGS  808 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  808 (985)
                      ..+|.....|+.|+|++. |..+++|++..+  .....+.|..|.-.++-+.||||..++|.|..+-+..++..|||.|+
T Consensus       195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            346788899999999996 666777887654  22334678899999999999999999999999999999999999999


Q ss_pred             hHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecc
Q 001988          809 LEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ  887 (985)
Q Consensus       809 L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~  887 (985)
                      |...+++. ....+..+..+++.++|+|++|||.. ++-|.---+.+..|++|++.+++|+- +-++      .......
T Consensus       274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~k------fsfqe~g  345 (448)
T KOG0195|consen  274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTK------FSFQEVG  345 (448)
T ss_pred             HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccce------eeeeccc
Confidence            99999987 33567788899999999999999642 23344556889999999999888761 1111      1122233


Q ss_pred             cccccccccccccccCccc---hhhhcccccccchhhhcccccccCcchhh-------------hhHHHHHHHHHHHHHH
Q 001988          888 TLATIGYMAPDEIFVGELS---LKRWVNDLLPVSLVEVVDKSLLSGEEKHF-------------AAKEQCLLSIFSLALE  951 (985)
Q Consensus       888 ~~gt~~y~aPE~~~~~~~~---~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-------------~~~~~~~~~l~~l~~~  951 (985)
                      ....|.||+||.++..+..   ...|+ |+|.+.+||+.+.++++.+.+..             ..+.+....+.++|.-
T Consensus       346 r~y~pawmspealqrkped~n~raadm-wsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~i  424 (448)
T KOG0195|consen  346 RAYSPAWMSPEALQRKPEDLNIRAADM-WSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNI  424 (448)
T ss_pred             cccCcccCCHHHHhcCchhcchhhhhH-HHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHH
Confidence            4578899999999876643   45677 99999999999999887765432             2344566788999999


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHhH
Q 001988          952 CTMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       952 cl~~~P~~RPt~~ev~~~L~~i~  974 (985)
                      |...||.+||.+..++-.|+++.
T Consensus       425 cmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  425 CMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             HhcCCCCcCCCcceehhhHHHhc
Confidence            99999999999999999998864

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=3.1e-19  Score=181.71  Aligned_cols=140  Identities=22%  Similarity=0.263  Sum_probs=110.9

Q ss_pred             CceeeccCceeEEEEEEcCCcEEEEEEeccCCcch--------------------------HHHHHHHHHHHHhcCCCCe
Q 001988          731 NNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAST--------------------------LKSFEAECEVIKNIRHRNL  784 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~--------------------------~~~~~~E~~il~~l~h~ni  784 (985)
                      .+.||+|+||.||+|...+|+.||||+++......                          ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46799999999999998789999999988652110                          1123678999999999987


Q ss_pred             eeEEeeeecCCceEEEEeccCCCChHHH-hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC
Q 001988          785 VKIISSCSNDDFKALVLEYMSNGSLEDC-LHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM  863 (985)
Q Consensus       785 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~  863 (985)
                      .....+...  ..++||||++|+++... +..  ..++.....+++.|++.++.++|  +..||+||||||+||+++ ++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH--~~~givHrDlkP~NIll~-~~  154 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY--QEAGLVHGDLSEYNILYH-DG  154 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH--HhCCEecCCCChhhEEEE-CC
Confidence            554444333  24899999998865443 332  35677888999999999999994  339999999999999999 89


Q ss_pred             cEEEecccCceecc
Q 001988          864 VAHLSDFGMAKLLS  877 (985)
Q Consensus       864 ~~kl~DfGla~~~~  877 (985)
                      .++|+|||+|+...
T Consensus       155 ~~~liDFG~a~~~~  168 (190)
T cd05145         155 KPYIIDVSQAVELD  168 (190)
T ss_pred             CEEEEEcccceecC
Confidence            99999999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=4.1e-19  Score=176.67  Aligned_cols=187  Identities=17%  Similarity=0.130  Sum_probs=142.3

Q ss_pred             cCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcc----hHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceEEEEec
Q 001988          729 AENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAS----TLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       729 ~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .+...+++|+||+||.+.. ++.+++.+.+......    ....+++|+++|+++. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3467899999999998777 6788887777644221    1225789999999995 5889999886    346899999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC-CCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL-KPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDl-k~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      ++|.+|.+.....        ...++.|++++++++   |++||+|||| ||+||+++.++.++|+|||+|.........
T Consensus        80 I~G~~L~~~~~~~--------~~~~~~qi~~~L~~l---H~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPRG--------DLAYFRAARRLLQQL---HRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhhh--------hHHHHHHHHHHHHHH---HHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            9999987643211        134778999999999   8999999999 799999999999999999999865433210


Q ss_pred             ----c-------eeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCc
Q 001988          883 ----T-------MRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGE  931 (985)
Q Consensus       883 ----~-------~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~  931 (985)
                          .       .+.-..+++.|++|+.... ...++..-+|++.|..++.++++.++.-.
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                0       0111236888999986543 35566777889999999999999887544

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.78  E-value=4.4e-19  Score=180.91  Aligned_cols=169  Identities=15%  Similarity=0.148  Sum_probs=131.2

Q ss_pred             HhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHH---------HHHHHHHHHhcCCCCeeeEEeeeecC
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKS---------FEAECEVIKNIRHRNLVKIISSCSND  794 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~---------~~~E~~il~~l~h~niv~l~~~~~~~  794 (985)
                      -..+|+..+++|.|+||.||++.. ++..+|+|.+++........         +++|+..+.+++||+|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            357899999999999999999766 57789999998664433222         68999999999999999998886533


Q ss_pred             --------CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEE
Q 001988          795 --------DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH  866 (985)
Q Consensus       795 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~k  866 (985)
                              +..++||||++|.+|.++..     .+.    ....+++.++..+   |+.|++|||+||+||+++++| ++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~l---H~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESL---HQHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHH---HHcCCccCCCChHHEEEeCCC-EE
Confidence                    35789999999999988732     222    2456899999999   899999999999999999998 99


Q ss_pred             EecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhh
Q 001988          867 LSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVE  921 (985)
Q Consensus       867 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~  921 (985)
                      ++|||..+........              ...++...+..+.|+ |++|+.+.-
T Consensus       175 liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di-~~lg~~~~~  214 (232)
T PRK10359        175 IIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEI-KDLGYYLLI  214 (232)
T ss_pred             EEECCCcccccchhhH--------------HHHHHHhHhcccccc-cceeEeehH
Confidence            9999987654211111              013445556678888 888877554

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.78  E-value=2e-20  Score=208.38  Aligned_cols=277  Identities=24%  Similarity=0.291  Sum_probs=136.5

Q ss_pred             EEEecCCccc-ccCchhcccccccceecccCCcCCCC----CCcccccCCCCcEEEccCcccCC------CCccccccCC
Q 001988           77 TLNLSSFNLQ-GTIPPEIANLSSLKSLDLSHNKLSSN----IPSSIFTMSTLKVLYLMDNQLSG------SLSSFTFNTS  145 (985)
Q Consensus        77 ~l~L~~~~l~-g~~~~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~------~~~~~~~~~~  145 (985)
                      .|+|..+.++ +.....+..++.|+.|+++++.++..    ++..+...+.|++|+++++.+.+      .++..+..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            3566666666 34455566667777888877777532    45555666677777777776652      1222333444


Q ss_pred             ccceeeeccccccCCCChhHhhhccc---cceecccCccccc----cCCcccCCC-CCceEEEcccccCCCc----cccc
Q 001988          146 SILDIRLSKNKLSGKLPENICNHLRY---LKHLFLRENMFYG----KIPSSLSKC-KQLQELHLGYNNLSGA----IPKE  213 (985)
Q Consensus       146 ~L~~L~ls~n~l~g~lp~~~~~~l~~---L~~L~L~~n~l~~----~~p~~l~~l-~~L~~L~L~~N~l~~~----~p~~  213 (985)
                      +|+.|++++|.+.+..+..+ ..+.+   |++|++++|.+++    .+...+..+ ++|++|+|++|.+++.    ++..
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~-~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~  160 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVL-ESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA  160 (319)
T ss_pred             ceeEEEccCCCCChhHHHHH-HHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence            55555555555544333322 22332   5555555555442    122333344 4555555555555522    1222


Q ss_pred             cccccccceEeeccccccCC----chhhhcCCCCCCEEEecCCcCccc----CcccccCCCCCCEEEccCCcCcccCChh
Q 001988          214 IGNLTVLQRISLINNKLHGE----IPQEIGYLQNLDVLQLGFNNLTGV----VPATIFNMSTLKEIFLYNNSLSGSLPSR  285 (985)
Q Consensus       214 ~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~  285 (985)
                      +..+++|++|++++|.+++.    ++..+..+++|++|++++|.+++.    ++..+..+                    
T Consensus       161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~--------------------  220 (319)
T cd00116         161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASL--------------------  220 (319)
T ss_pred             HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhccc--------------------
Confidence            33334455555555544421    222233334455555555544321    12223333                    


Q ss_pred             hhhcCCCCcEEEecCccCCCcCCcccc-----CCCCccEEEccCccccc----ccCCcccCCCCCceEeccCCcccCCCC
Q 001988          286 IDLALPNLEFLNLGINSFSGTIPSSIT-----NASKLILLEMGSNSFSG----FIPSAIGNLRNLKLFDIFFNNLTSSTP  356 (985)
Q Consensus       286 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~~  356 (985)
                           ++|++|++++|.+++.....+.     ...+|+.|++++|.++.    .+...+..+++|+++++++|.++..+.
T Consensus       221 -----~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~  295 (319)
T cd00116         221 -----KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGA  295 (319)
T ss_pred             -----CCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHH
Confidence                 4455555555554432222111     12455666666665541    223344555667777777777765432


Q ss_pred             ccccccccccc-CcccEEEecCCCC
Q 001988          357 ELGFLSSLANC-KKLRYLGLGGNPL  380 (985)
Q Consensus       357 ~~~~~~~l~~l-~~L~~L~L~~N~l  380 (985)
                      .. +...+... +.|++|++.+|++
T Consensus       296 ~~-~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         296 QL-LAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             HH-HHHHHhhcCCchhhcccCCCCC
Confidence            11 11223333 5777888777753

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.78  E-value=6.2e-19  Score=177.87  Aligned_cols=151  Identities=24%  Similarity=0.229  Sum_probs=124.9

Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      |+|.++++..+..+++.++..++.|++.||+||   |+.+      ||+||+++.++.+|+  ||.++......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~l---H~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALREL---HRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH---HhcC------CcccEeEcCccceee--ccceEeecccc------
Confidence            689999987666799999999999999999999   5665      999999999999999  99998764221      


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-------------------hHHHHHH--HH
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------------AKEQCLL--SI  945 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------------~~~~~~~--~l  945 (985)
                       ..||+.|||||++.+..++.++|+ |++|++++++++++.+........                   ......+  ++
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~Di-wSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  141 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADI-YSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSF  141 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhH-HHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhH
Confidence             258999999999999999999999 999999999999887654321100                   1122223  68


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      .+++.+||..+|.+||++.|+++.+..+...
T Consensus       142 ~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      142 ADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             HHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            9999999999999999999999998877644

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=4e-18  Score=173.86  Aligned_cols=137  Identities=16%  Similarity=0.252  Sum_probs=107.6

Q ss_pred             ccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhc-----CCCCeeeEEeeeecCC---ceE-
Q 001988          728 FAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI-----RHRNLVKIISSCSNDD---FKA-  798 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-----~h~niv~l~~~~~~~~---~~~-  798 (985)
                      +...+.||+|+||.||. .-.++.. +||++........+.+.+|+++++++     .||||++++|+++++.   ..+ 
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34567899999999996 3334444 79998766455567899999999999     5799999999998863   433 


Q ss_pred             EEEec--cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEeCCCCCCCEEEcCC----CcEEEeccc
Q 001988          799 LVLEY--MSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-EYLHFGHSTPIIHCDLKPSNVLLDED----MVAHLSDFG  871 (985)
Q Consensus       799 lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L-~~Lh~~h~~~ivHrDlk~~Nill~~~----~~~kl~DfG  871 (985)
                      +||||  +++|+|.+++...  .+++.  ..++.+++.++ +||   |+++|+||||||+||+++..    +.++|+||+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yL---h~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYL---LDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            78999  5679999999764  34444  35677888777 999   89999999999999999743    379999954


Q ss_pred             Cc
Q 001988          872 MA  873 (985)
Q Consensus       872 la  873 (985)
                      .+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            33

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=4e-20  Score=205.96  Aligned_cols=285  Identities=21%  Similarity=0.276  Sum_probs=145.4

Q ss_pred             eeeccccccCCCChhHhhhccccceecccCcccccc----CCcccCCCCCceEEEcccccCCC------ccccccccccc
Q 001988          150 IRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGK----IPSSLSKCKQLQELHLGYNNLSG------AIPKEIGNLTV  219 (985)
Q Consensus       150 L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~------~~p~~~~~l~~  219 (985)
                      |+|+.+.+++.--..++..+.+|++|+++++.++..    ++..+...++|++|+++++.+.+      .++..+..+++
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~   82 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG   82 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence            445555555443344556667777777777776432    55566677777888887777662      23334555666


Q ss_pred             cceEeeccccccCCchhhhcCCCC---CCEEEecCCcCcc----cCcccccCC-CCCCEEEccCCcCcccCChhhhhcCC
Q 001988          220 LQRISLINNKLHGEIPQEIGYLQN---LDVLQLGFNNLTG----VVPATIFNM-STLKEIFLYNNSLSGSLPSRIDLALP  291 (985)
Q Consensus       220 L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~----~~p~~l~~l-~~L~~L~L~~N~l~~~~p~~~~~~l~  291 (985)
                      |+.|++++|.+.+..+..+..+.+   |++|++++|++++    .+...+..+ ++|++|++++|.+++.....      
T Consensus        83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~------  156 (319)
T cd00116          83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEA------  156 (319)
T ss_pred             eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHH------
Confidence            666666666666555555555444   6666666666652    222333444 55566666666555322111      


Q ss_pred             CCcEEEecCccCCCcCCccccCCCCccEEEccCccccc----ccCCcccCCCCCceEeccCCcccCCCCccccccccccc
Q 001988          292 NLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSG----FIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANC  367 (985)
Q Consensus       292 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l  367 (985)
                                     ++..+..+.+|+.|++++|.+++    .++..+..+++|+.|++++|.++..... .+...+..+
T Consensus       157 ---------------~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~-~l~~~~~~~  220 (319)
T cd00116         157 ---------------LAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS-ALAETLASL  220 (319)
T ss_pred             ---------------HHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH-HHHHHhccc
Confidence                           11222333344444444444432    1222333444555555555555432211 122234456


Q ss_pred             CcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCC----CCCccccccccc
Q 001988          368 KKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSG----SIPVTFGGLQKL  443 (985)
Q Consensus       368 ~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L  443 (985)
                      ++|++|++++|++++.....+...                 .+   ...+.|++|++++|.++.    .+...+..+++|
T Consensus       221 ~~L~~L~ls~n~l~~~~~~~l~~~-----------------~~---~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L  280 (319)
T cd00116         221 KSLEVLNLGDNNLTDAGAAALASA-----------------LL---SPNISLLTLSLSCNDITDDGAKDLAEVLAEKESL  280 (319)
T ss_pred             CCCCEEecCCCcCchHHHHHHHHH-----------------Hh---ccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCc
Confidence            667777777766653211111100                 00   123456666666666542    122334444566


Q ss_pred             cceecccccccCC----chhhhhhc-cCCCeEEccCCc
Q 001988          444 QGLDLAFNKLAGS----IPDEICLL-SRLNELDLNGNK  476 (985)
Q Consensus       444 ~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~L~~N~  476 (985)
                      +++++++|.+...    ....+... +.|++|++.+|.
T Consensus       281 ~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         281 LELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS  318 (319)
T ss_pred             cEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence            6666666666633    22333333 566677766664

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=1.3e-18  Score=204.37  Aligned_cols=233  Identities=19%  Similarity=0.190  Sum_probs=179.7

Q ss_pred             CCceeeccCceeEEEEEEc-CCcEEEEEEeccC--Ccch----HHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          730 ENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ--CAST----LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       730 ~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~--~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ...++|.|++|.|+.+... .....+.|.++.+  ....    ...+..|..+-..+.|||++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4578999999988887643 4444555544311  1111    1225567777778899999888877776665555699


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      ||++ +|+..+.... .+...++..++.|+..|++|+   |..||.|||+|++|++++.+|.+||+|||.+..+.-..+.
T Consensus       402 ~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~---h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYL---HSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             cccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHH---HhcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            9999 9999998763 577788888999999999999   8999999999999999999999999999999887544443


Q ss_pred             --ceecccccccccccccccccCccch-hhhcccccccchhhhcccccccCcchhh--------------------hhHH
Q 001988          883 --TMRTQTLATIGYMAPDEIFVGELSL-KRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------------AAKE  939 (985)
Q Consensus       883 --~~~~~~~gt~~y~aPE~~~~~~~~~-~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------------~~~~  939 (985)
                        .....++|+..|+|||.+...+|.+ ..|+ |+.|+++..|+.++.++......                    ....
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDi-wS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  555 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDV-WSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS  555 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhh-hhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence              4567788999999999999988865 4566 88888888888876654322111                    1123


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          940 QCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       940 ~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ..+.+...++.++++++|.+|.|+.+|++
T Consensus       556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  556 LLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             hchhhHHHHHHHHccCChhheecHHHHhh
Confidence            35677888999999999999999999975

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.75  E-value=2.4e-17  Score=184.38  Aligned_cols=236  Identities=32%  Similarity=0.442  Sum_probs=189.1

Q ss_pred             ccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcc---hHHHHHHHHHHHHhcCCC-CeeeEEeeeecCCceEEEEec
Q 001988          728 FAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHR-NLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~h~-niv~l~~~~~~~~~~~lv~e~  803 (985)
                      |...+.||.|+||.||++...  ..+|+|.+......   ....+.+|+.+++.+.|+ +++++++.+......++++||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566788999999999999986  78999999866433   367789999999999988 799999999877778999999


Q ss_pred             cCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-cEEEecccCceeccCCC
Q 001988          804 MSNGSLEDCLHSSN--CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAKLLSGED  880 (985)
Q Consensus       804 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~~~~~~~  880 (985)
                      +.++++.+++....  ..+.......++.|++.+++|+   |+.+++|||+||+||+++..+ .++++|||.++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL---HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997776654  2688889999999999999999   899999999999999999998 79999999998664333


Q ss_pred             Ccc----eeccccccccccccccccc---CccchhhhcccccccchhhhcccccccCcchh----hhhH---H-------
Q 001988          881 EST----MRTQTLATIGYMAPDEIFV---GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH----FAAK---E-------  939 (985)
Q Consensus       881 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~----~~~~---~-------  939 (985)
                      ...    ......|+..|+|||.+..   ..+....|+ |++|+.+++++.+..+......    ....   .       
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~-~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDI-WSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL  235 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhH-HHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence            221    2355679999999999987   578889999 6888888887776654322211    0000   0       


Q ss_pred             ------H----HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          940 ------Q----CLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       940 ------~----~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                            .    ....+.+++..|+..+|..|.++.+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence                  0    01467889999999999999988887765

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.74  E-value=7.7e-20  Score=168.80  Aligned_cols=163  Identities=33%  Similarity=0.546  Sum_probs=139.4

Q ss_pred             hcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccc
Q 001988           92 EIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRY  171 (985)
Q Consensus        92 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~  171 (985)
                      .+.++.+.+.|-||+|.++ .+|+.|..|.+|++|++++|+++                         .+|.++ +.+++
T Consensus        28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-------------------------~lp~~i-ssl~k   80 (264)
T KOG0617|consen   28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-------------------------ELPTSI-SSLPK   80 (264)
T ss_pred             cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-------------------------hcChhh-hhchh
Confidence            3567778888888898888 67888888888888888888887                         677777 67888


Q ss_pred             cceecccCccccccCCcccCCCCCceEEEcccccCC-CccccccccccccceEeeccccccCCchhhhcCCCCCCEEEec
Q 001988          172 LKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLS-GAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLG  250 (985)
Q Consensus       172 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  250 (985)
                      |+.|+++-|++. ..|..|+.++.|+.|||.+|+++ ..+|..|-.++.|+.|+|++|.+. .+|..++++++|+.|.+.
T Consensus        81 lr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lr  158 (264)
T KOG0617|consen   81 LRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLR  158 (264)
T ss_pred             hhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeec
Confidence            999999988887 88999999999999999999887 467888888999999999999998 888889999999999999


Q ss_pred             CCcCcccCcccccCCCCCCEEEccCCcCcccCChh
Q 001988          251 FNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSR  285 (985)
Q Consensus       251 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~  285 (985)
                      .|.+- ..|..++.+++|++|.+.+|+++ .+|..
T Consensus       159 dndll-~lpkeig~lt~lrelhiqgnrl~-vlppe  191 (264)
T KOG0617|consen  159 DNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPE  191 (264)
T ss_pred             cCchh-hCcHHHHHHHHHHHHhcccceee-ecChh
Confidence            99887 68888999999999999999888 55544

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.73  E-value=1.3e-19  Score=167.27  Aligned_cols=161  Identities=26%  Similarity=0.494  Sum_probs=88.4

Q ss_pred             ccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEE
Q 001988          439 GLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSF  518 (985)
Q Consensus       439 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  518 (985)
                      .+.+++.|.||+|+++ .+|+.+..+.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++. +.|..|+.++.|+.|
T Consensus        31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl  107 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL  107 (264)
T ss_pred             chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence            3455566666666666 55556666666666666666665 45666666677777777666665 456666666666666


Q ss_pred             eecCCcccC-CccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcc
Q 001988          519 DISSNLLDG-PISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKI  597 (985)
Q Consensus       519 ~ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  597 (985)
                      |+.+|++.. ..|..|..++.|+.|+|++|.+. .+|..++.+++|+.|.+.+|.+- ..|.+++.++.|++|++.+|++
T Consensus       108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl  185 (264)
T KOG0617|consen  108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL  185 (264)
T ss_pred             hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence            666655542 23333444444444444444443 44444444555555555444444 3444444444444455555444


Q ss_pred             cCCCCccc
Q 001988          598 SGSIPVSF  605 (985)
Q Consensus       598 ~~~~p~~~  605 (985)
                      + .+|..+
T Consensus       186 ~-vlppel  192 (264)
T KOG0617|consen  186 T-VLPPEL  192 (264)
T ss_pred             e-ecChhh
Confidence            4 334333

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=7.6e-18  Score=200.63  Aligned_cols=244  Identities=19%  Similarity=0.173  Sum_probs=184.1

Q ss_pred             HHHHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcC---CCCeeeEEeeeecCCce
Q 001988          721 LLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR---HRNLVKIISSCSNDDFK  797 (985)
Q Consensus       721 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~  797 (985)
                      .....+.|.+.+.||+|+||.||+|...+|+.||+|+-++....+   |.-=.+++.+++   -+-|.++..++...+..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            344567888899999999999999998889999999987765543   111222333333   24566777777777888


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc-------CCCcEEEecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD-------EDMVAHLSDF  870 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~-------~~~~~kl~Df  870 (985)
                      ++|+||.+.|+|.+++... +.++|.-++.++.|++..++.|   |..+|||+||||+|+|+.       +...++|+||
T Consensus       770 ~lv~ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~l---H~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHL---HAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             eeeeeccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHH---HhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence            8999999999999999844 4789999999999999999999   899999999999999993       2346899999


Q ss_pred             cCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcc----------hhhhhHHH
Q 001988          871 GMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEE----------KHFAAKEQ  940 (985)
Q Consensus       871 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~----------~~~~~~~~  940 (985)
                      |.+..+.--...+.-...++|-.+-.+|...+..+++..|. +.+...++-|+.|+-.....          +++...  
T Consensus       846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~Dy-fGlAa~~h~mLFG~y~q~~~g~~~~~~~~~~Ry~~~--  922 (974)
T KOG1166|consen  846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDY-FGLAATVHVMLFGKYMEVKNGSSWMVKTNFPRYWKR--  922 (974)
T ss_pred             ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhh-HHHHHHHHHHHHHHHHHhcCCcceeccccchhhhhH--
Confidence            99977654344445566789999999999999999999999 66655666666655432110          111111  


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          941 CLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                        +-..++...+|..|-..=|...++...++++...
T Consensus       923 --~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~  956 (974)
T KOG1166|consen  923 --DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE  956 (974)
T ss_pred             --HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence              2244466667777777778888888888887654

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=3.9e-17  Score=171.16  Aligned_cols=147  Identities=21%  Similarity=0.190  Sum_probs=114.0

Q ss_pred             HHHHhcCccCCceeeccCceeEEEEE--EcCCcEEEEEEeccCCcc------------------------hHHHHHHHHH
Q 001988          721 LLRATDNFAENNIIGIGGFGSVYRAR--LEDGVEIAIKVFHPQCAS------------------------TLKSFEAECE  774 (985)
Q Consensus       721 ~~~~~~~~~~~~~ig~G~~g~V~~~~--~~~~~~vAvK~~~~~~~~------------------------~~~~~~~E~~  774 (985)
                      +.....-|...+.||+|+||.||+|.  ..+|++||+|+++.....                        ....+.+|++
T Consensus        23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            33444457788999999999999998  568999999998754210                        0123578999


Q ss_pred             HHHhcCCC--CeeeEEeeeecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeCC
Q 001988          775 VIKNIRHR--NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP-IIHCD  851 (985)
Q Consensus       775 il~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~-ivHrD  851 (985)
                      +++++.+.  .+.+++++    ...++||||++|+++....... ..........++.|++++++++   |..| |+|||
T Consensus       103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~L---H~~g~iiH~D  174 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKL---YKEGELVHGD  174 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHH---HhcCCEEeCC
Confidence            99999753  34455543    2347999999998887765332 2455666778999999999999   7899 99999


Q ss_pred             CCCCCEEEcCCCcEEEecccCceec
Q 001988          852 LKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       852 lk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      |||+||+++ ++.++|+|||.|...
T Consensus       175 ikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      175 LSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CChhhEEEE-CCCEEEEEChhhhcc
Confidence            999999999 889999999998764

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=1.1e-16  Score=166.49  Aligned_cols=134  Identities=25%  Similarity=0.354  Sum_probs=114.2

Q ss_pred             ceeeccCceeEEEEEEcCCcEEEEEEeccCCcc--------hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAS--------TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +.||+|++|.||+|.. +|..|++|+.......        ....+.+|++++..+.|++++....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5689999999999988 6788999987654221        123577899999999999988877777777788999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      ++|++|.+++....    + .+..++.+++.++.++   |+.+++|||++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~l---H~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKL---HSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHH---HhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999987542    2 7788999999999999   789999999999999999 78999999998765

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.69  E-value=1.4e-16  Score=163.76  Aligned_cols=143  Identities=23%  Similarity=0.213  Sum_probs=111.9

Q ss_pred             HHHHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcc----------------------hHHHHHHHHHHHHh
Q 001988          721 LLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAS----------------------TLKSFEAECEVIKN  778 (985)
Q Consensus       721 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~----------------------~~~~~~~E~~il~~  778 (985)
                      +.+....|...+.||+|+||.||+|..++|+.||||+++.....                      ....+..|..++.+
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            33444447888999999999999999888999999987643210                      11235778999999


Q ss_pred             cCCC--CeeeEEeeeecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 001988          779 IRHR--NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSN  856 (985)
Q Consensus       779 l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~N  856 (985)
                      +.|+  .++..++.    +..++||||++|++|.+....       ....+++.+++.++.++   |+.||+||||||+|
T Consensus        90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~l---h~~gi~H~Dl~p~N  155 (198)
T cd05144          90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKA---YKHGIIHGDLSEFN  155 (198)
T ss_pred             HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHH---HHCCCCcCCCCccc
Confidence            9877  44445442    345899999999998775431       23456889999999999   67999999999999


Q ss_pred             EEEcCCCcEEEecccCceecc
Q 001988          857 VLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       857 ill~~~~~~kl~DfGla~~~~  877 (985)
                      |++++++.++|+|||.+....
T Consensus       156 ill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         156 ILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             EEEcCCCcEEEEECCccccCC
Confidence            999999999999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.69  E-value=2.8e-16  Score=186.12  Aligned_cols=138  Identities=22%  Similarity=0.328  Sum_probs=112.8

Q ss_pred             HhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCC-c-------chHHHHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQC-A-------STLKSFEAECEVIKNIRHRNLVKIISSCSNDD  795 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~-~-------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~  795 (985)
                      ....|...+.||+|+||.||+|.+.+ ..+++|+..... .       .....+.+|++++++++|++++....++....
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            34456678999999999999998754 344555432221 1       11346789999999999999998888887777


Q ss_pred             ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          796 FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      ..++||||++|++|.+++.         ....++.++++++.||   |+.+++|||+||+||++ +++.++|+|||+++.
T Consensus       410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~l---H~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKL---HKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHH---HhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            7899999999999999876         3467899999999999   78999999999999999 678999999999876

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.68  E-value=2.3e-16  Score=162.57  Aligned_cols=130  Identities=25%  Similarity=0.391  Sum_probs=107.3

Q ss_pred             eeeccCceeEEEEEEcCCcEEEEEEeccCCcc--------hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          733 IIGIGGFGSVYRARLEDGVEIAIKVFHPQCAS--------TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       733 ~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .||+|+||.||+|.+ ++.+|++|........        ...++.+|+++++.++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999996 5789999986543211        1355778999999999887665555555666778999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      +|++|.+.+.....        .++.+++.++.++   |+.|++|||++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~l---H~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKL---HKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHH---HHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999998765321        7899999999999   899999999999999999 89999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PLN03150 hypothetical protein; Provisional

Probab=99.67  E-value=1.9e-16  Score=189.17  Aligned_cols=151  Identities=28%  Similarity=0.447  Sum_probs=117.7

Q ss_pred             cCChhHHHHHHHHHHhcccCCCCcccCCCCCCCCcc----eeeeEEEeC--CC--CeEEEEEecCCcccccCchhccccc
Q 001988           26 SNISTDQQALLALKDHITYDPTNLLGTNWTSNASIC----SWIGIICDV--NS--HKVTTLNLSSFNLQGTIPPEIANLS   97 (985)
Q Consensus        26 ~~~~~~~~aLl~~k~~~~~~~~~~~~s~w~~~~~~c----~w~gv~c~~--~~--~~v~~l~L~~~~l~g~~~~~l~~l~   97 (985)
                      .+.+.|.+||++||+++. +|..  . +|.+ .+||    .|.||.|+.  .+  .+|+.|+|++++++|.+|+.++.|+
T Consensus       368 ~t~~~~~~aL~~~k~~~~-~~~~--~-~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~  442 (623)
T PLN03150        368 KTLLEEVSALQTLKSSLG-LPLR--F-GWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLR  442 (623)
T ss_pred             ccCchHHHHHHHHHHhcC-Cccc--C-CCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCC
Confidence            455789999999999985 4432  2 4974 3442    799999953  22  2699999999999999999999999


Q ss_pred             ccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccceecc
Q 001988           98 SLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFL  177 (985)
Q Consensus        98 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L  177 (985)
                      +|+.|+|++|.++|.+|..++.+++|++|+|++|+++|.+|+.+.++++|+.|+|++|+++|.+|..+.....++..+++
T Consensus       443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~  522 (623)
T PLN03150        443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF  522 (623)
T ss_pred             CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEe
Confidence            99999999999999999999999999999999999998888777777777777777777777777665433334444444


Q ss_pred             cCcc
Q 001988          178 RENM  181 (985)
Q Consensus       178 ~~n~  181 (985)
                      .+|.
T Consensus       523 ~~N~  526 (623)
T PLN03150        523 TDNA  526 (623)
T ss_pred             cCCc
Confidence            4443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.65  E-value=3.3e-17  Score=182.19  Aligned_cols=217  Identities=24%  Similarity=0.261  Sum_probs=171.2

Q ss_pred             eeccCceeEEEEE----EcCCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceEEEEeccCC
Q 001988          734 IGIGGFGSVYRAR----LEDGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       734 ig~G~~g~V~~~~----~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +|+|+||.|++++    .+.|.-+|.|+.++....  .......|..++..++ ||.+|+++..++.+...+++++|..|
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            6899999999874    234667899988765322  1224567888888886 99999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceec
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT  886 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  886 (985)
                      |++...+.... .++......+...++-+++++   |+.+|+|||+|++||+++.+|++|+.|||+++..-+.+..    
T Consensus        82 g~lft~l~~~~-~f~~~~~~~~~aelaLald~l---h~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----  153 (612)
T KOG0603|consen   82 GDLFTRLSKEV-MFDELDVAFYLAELALALDHL---HKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----  153 (612)
T ss_pred             chhhhccccCC-chHHHHHHHHHHHHHHHHhhc---chhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence            99999888764 456666666777888899999   9999999999999999999999999999998876432221    


Q ss_pred             ccccccccccccccccCccchhhhcccccccchhhhcccccccCcch-------hhhhHHHHHHHHHHHHHHccCCCCCC
Q 001988          887 QTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK-------HFAAKEQCLLSIFSLALECTMESPEK  959 (985)
Q Consensus       887 ~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~-------~~~~~~~~~~~l~~l~~~cl~~~P~~  959 (985)
                        |||..|||||++.  .. ...-.||++|+.+++++++...+...-       ....+.+......+++..+...+|..
T Consensus       154 --cgt~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~n  228 (612)
T KOG0603|consen  154 --CGTYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGGDTMKRILKAELEMPRELSAEARSLFRQLFKRNPEN  228 (612)
T ss_pred             --ccchhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCchHHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHH
Confidence              8999999999987  22 334455999999999999988766521       12233445566777888888888888


Q ss_pred             CCCH
Q 001988          960 RIDA  963 (985)
Q Consensus       960 RPt~  963 (985)
                      |-..
T Consensus       229 rLg~  232 (612)
T KOG0603|consen  229 RLGA  232 (612)
T ss_pred             Hhcc
Confidence            7755

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.63  E-value=7e-17  Score=187.64  Aligned_cols=238  Identities=21%  Similarity=0.226  Sum_probs=173.8

Q ss_pred             CccCCceeeccCceeEEEEEEcCCcEEEEEEeccCC-cchHHHHHHHHHH--HHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQC-ASTLKSFEAECEV--IKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~i--l~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      +|...+.+|++.|=+|.+|+++.|. |+||++-++. .-..+.+.++++-  ...++|||++++.-+-......|||=+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5666788999999999999998888 9999987664 2234455444443  4445899999999888777788888899


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc--CCCC
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS--GEDE  881 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~--~~~~  881 (985)
                      +. .+|.|.+.... .+...+.+=|++|+..|+..+   |..||+|||||.+|||++.=.-+.|+||..-+...  .+.+
T Consensus       103 vk-hnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qc---H~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  103 VK-HNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQC---HKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             Hh-hhhhhhhccch-HHHHHHHHHHHHHHHHHHHHH---HHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            84 48999887653 566677777999999999999   89999999999999999999999999997654321  1111


Q ss_pred             cc---eecccccccccccccccccCc-----------cchhhhcccccccchhhhccc-ccccCc------chh-hhhHH
Q 001988          882 ST---MRTQTLATIGYMAPDEIFVGE-----------LSLKRWVNDLLPVSLVEVVDK-SLLSGE------EKH-FAAKE  939 (985)
Q Consensus       882 ~~---~~~~~~gt~~y~aPE~~~~~~-----------~~~~~dv~~~~g~~~~~i~~~-~~~~~~------~~~-~~~~~  939 (985)
                      ..   .-.....-.-|.|||.+....           .+++.|+ +++|+++.|++.. ..++.-      ... ...++
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDI-FS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e  256 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDI-FSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPE  256 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhh-hhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHH
Confidence            11   111111233599999765311           5678899 9999999998764 322210      000 11222


Q ss_pred             H-----HHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 001988          940 Q-----CLLSIFSLALECTMESPEKRIDAKDTITRLL  971 (985)
Q Consensus       940 ~-----~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~  971 (985)
                      .     ....++.++..|++.||.+|-+|.+.++.-.
T Consensus       257 ~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  257 QLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             HHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence            2     2346888999999999999999999998843

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=2.3e-15  Score=147.50  Aligned_cols=134  Identities=20%  Similarity=0.283  Sum_probs=115.4

Q ss_pred             CceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCC--CCeeeEEeeeecCCceEEEEeccCCCC
Q 001988          731 NNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRH--RNLVKIISSCSNDDFKALVLEYMSNGS  808 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gs  808 (985)
                      .+.||+|.++.||++...+ ..+++|.......  ...+.+|+.+++.++|  ..+++++++....+..+++|||++++.
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            4679999999999999864 7899999876533  4678899999999976  589999999888888999999999887


Q ss_pred             hHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          809 LEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       809 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      +...        +......++.+++++++++|..+..+++|||++|+||++++.+.++++|||.++.
T Consensus        80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            7654        4566778899999999999766667899999999999999999999999999875

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.61  E-value=8.6e-16  Score=171.72  Aligned_cols=198  Identities=27%  Similarity=0.362  Sum_probs=157.5

Q ss_pred             HHhcCCCCeeeEEeeeecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 001988          776 IKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPS  855 (985)
Q Consensus       776 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~  855 (985)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+......+++.-...+..+|+.||+|+|  ++....|+.+++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh--~s~i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH--NSPIGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh--cCcceeeeeeccc
Confidence            35678999999999999999999999999999999999988778999999999999999999996  5555599999999


Q ss_pred             CEEEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccC-------ccchhhhcccccccchhhhcccccc
Q 001988          856 NVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG-------ELSLKRWVNDLLPVSLVEVVDKSLL  928 (985)
Q Consensus       856 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~dv~~~~g~~~~~i~~~~~~  928 (985)
                      |.++|..+.+|++|||+.................-..-|.|||.+...       ..+.+.|+ |++|++++|++...-+
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdi-Ys~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDI-YSFGIIMYEILFRSGP  157 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCe-ehHHHHHHHHHhccCc
Confidence            999999999999999998776431111112222345569999987653       14566788 9999999999886654


Q ss_pred             cCcchh----------------------hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          929 SGEEKH----------------------FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       929 ~~~~~~----------------------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      +.....                      .....+..+++..++.+||..+|.+||++.++-..++.+.+.
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            433110                      001113455789999999999999999999999998877654

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.59  E-value=6.6e-15  Score=150.03  Aligned_cols=136  Identities=24%  Similarity=0.270  Sum_probs=98.9

Q ss_pred             CceeeccCceeEEEEEEcCCcEEEEEEeccCCcch--HHH----------------------HHHHHHHHHhcCCC--Ce
Q 001988          731 NNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAST--LKS----------------------FEAECEVIKNIRHR--NL  784 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~--~~~----------------------~~~E~~il~~l~h~--ni  784 (985)
                      .+.||+|+||.||+|...++++||||+++......  ...                      ...|.+.+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998889999999987542211  111                      13566666666443  24


Q ss_pred             eeEEeeeecCCceEEEEeccCCCChHHH-hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEEcCC
Q 001988          785 VKIISSCSNDDFKALVLEYMSNGSLEDC-LHSSNCALNIFCRLNIMIDIASALEYLHFGHS-TPIIHCDLKPSNVLLDED  862 (985)
Q Consensus       785 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivHrDlk~~Nill~~~  862 (985)
                      .+.+++    ...++||||++++++... +....  .. .....++.+++.++.++   |. ++|+|||+||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~l---h~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKL---YREAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHH---hhccCcCcCCCChhhEEEE-C
Confidence            445443    235899999999543321 11111  01 55678999999999999   66 9999999999999999 8


Q ss_pred             CcEEEecccCceecc
Q 001988          863 MVAHLSDFGMAKLLS  877 (985)
Q Consensus       863 ~~~kl~DfGla~~~~  877 (985)
                      +.++++|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            999999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.59  E-value=3.1e-15  Score=157.45  Aligned_cols=225  Identities=22%  Similarity=0.291  Sum_probs=143.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcC----------CCCeeeEEeee
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIR----------HRNLVKIISSC  791 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~----------h~niv~l~~~~  791 (985)
                      ..+..++.||.|+++.||.+++. +++++|+|++.....   .+.+++++|.-....+.          |-.++..++..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            34566789999999999999975 689999999864432   23455666664444432          21222222211


Q ss_pred             e---------cC---C-----ceEEEEeccCCCChHHHhhc---CCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 001988          792 S---------ND---D-----FKALVLEYMSNGSLEDCLHS---SNC---ALNIFCRLNIMIDIASALEYLHFGHSTPII  848 (985)
Q Consensus       792 ~---------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~---~~~~~~~~~i~~~i~~~L~~Lh~~h~~~iv  848 (985)
                      .         ..   .     ..+++|+-+ -+||.+.+..   ...   ......+..+..|+++.+++|   |+.|+|
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~L---h~~GlV  167 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANL---HSYGLV  167 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH---HHTTEE
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHH---hhcceE
Confidence            1         11   1     235677777 4588877542   111   234556677789999999999   789999


Q ss_pred             eCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceeccccccccccccccccc--------Cccchhhhcccccccchh
Q 001988          849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV--------GELSLKRWVNDLLPVSLV  920 (985)
Q Consensus       849 HrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~dv~~~~g~~~~  920 (985)
                      |+||||+|++++++|.++|+||+.....+   . .... ...+..|.+||....        -.++.+.|. |.+|+.++
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g---~-~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~Da-W~LG~~ly  241 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAG---T-RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDA-WQLGITLY  241 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETT---E-EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHH-HHHHHHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecC---c-eeec-cCCCcccCChhhhhhhcccCcccceeeeccCH-HHHHHHHH
Confidence            99999999999999999999999877642   1 1111 235577999986643        247888899 99999999


Q ss_pred             hhcccccccCcch-------hhhhHHHHHHHHHHHHHHccCCCCCCC
Q 001988          921 EVVDKSLLSGEEK-------HFAAKEQCLLSIFSLALECTMESPEKR  960 (985)
Q Consensus       921 ~i~~~~~~~~~~~-------~~~~~~~~~~~l~~l~~~cl~~~P~~R  960 (985)
                      .+.-++++.+...       ......+.++.+.+++..+++++|.+|
T Consensus       242 ~lWC~~lPf~~~~~~~~~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  242 SLWCGRLPFGLSSPEADPEWDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHSS-STCCCGGGSTSGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHccCCCCCCCccccccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            9998887765321       112222678899999999999999987

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.55  E-value=3.9e-14  Score=148.89  Aligned_cols=136  Identities=20%  Similarity=0.277  Sum_probs=106.9

Q ss_pred             Cceee-ccCceeEEEEEEcCCcEEEEEEeccCC-------------cchHHHHHHHHHHHHhcCCCCe--eeEEeeeecC
Q 001988          731 NNIIG-IGGFGSVYRARLEDGVEIAIKVFHPQC-------------ASTLKSFEAECEVIKNIRHRNL--VKIISSCSND  794 (985)
Q Consensus       731 ~~~ig-~G~~g~V~~~~~~~~~~vAvK~~~~~~-------------~~~~~~~~~E~~il~~l~h~ni--v~l~~~~~~~  794 (985)
                      ...|| .||.|+||.+... +..+|+|.+....             ......+.+|++++++++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            46788 8999999999885 7789999885421             1123567889999999998775  6777765433


Q ss_pred             C----ceEEEEeccCC-CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 001988          795 D----FKALVLEYMSN-GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSD  869 (985)
Q Consensus       795 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~D  869 (985)
                      .    ..++||||++| .+|.+++...  .++..    .+.++++++.+|   |++||+||||||.|||++.++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~l---H~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARF---HDAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHH---HHCCCCCCCCCchhEEEcCCCCEEEEE
Confidence            2    23599999997 6999888653  34433    356899999999   899999999999999999999999999


Q ss_pred             ccCceec
Q 001988          870 FGMAKLL  876 (985)
Q Consensus       870 fGla~~~  876 (985)
                      ||.++..
T Consensus       186 fg~~~~~  192 (239)
T PRK01723        186 FDRGELR  192 (239)
T ss_pred             CCCcccC
Confidence            9988763

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=3.1e-14  Score=148.65  Aligned_cols=184  Identities=20%  Similarity=0.161  Sum_probs=132.4

Q ss_pred             CCCCeeeEEeeeec---------------------------CCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHH
Q 001988          780 RHRNLVKIISSCSN---------------------------DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI  832 (985)
Q Consensus       780 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i  832 (985)
                      +|||||++.++|.+                           +...|+||..++. +|.+++....  .+.....-+..|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            59999999887642                           2357899998854 9999998763  4556667789999


Q ss_pred             HHHHHHHHhcCCCCeEeCCCCCCCEEE--cCCC--cEEEecccCceeccCC----CCcceecccccccccccccccccCc
Q 001988          833 ASALEYLHFGHSTPIIHCDLKPSNVLL--DEDM--VAHLSDFGMAKLLSGE----DESTMRTQTLATIGYMAPDEIFVGE  904 (985)
Q Consensus       833 ~~~L~~Lh~~h~~~ivHrDlk~~Nill--~~~~--~~kl~DfGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~  904 (985)
                      ++|+.||   |.+||.|||+|++||++  |+|+  ...|+|||.+---+..    ..........|....||||+....+
T Consensus       351 LEav~hL---~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHL---HKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHH---HHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            9999999   89999999999999999  4444  5788999976432110    1111222334777899999875433


Q ss_pred             c------chhhhcccccccchhhhcccccccCcch-------------hhhhHHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 001988          905 L------SLKRWVNDLLPVSLVEVVDKSLLSGEEK-------------HFAAKEQCLLSIFSLALECTMESPEKRIDAKD  965 (985)
Q Consensus       905 ~------~~~~dv~~~~g~~~~~i~~~~~~~~~~~-------------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~e  965 (985)
                      -      -.+.|. |..|...+|++...-++-...             -+..++.|+..+.+++...++.||.+|++++-
T Consensus       428 Gp~avvny~kAD~-WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i  506 (598)
T KOG4158|consen  428 GPNAVVNYEKADT-WAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI  506 (598)
T ss_pred             CCceeeccchhhh-hhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence            2      135576 888889999887554332210             11234568889999999999999999998776


Q ss_pred             HHHHH
Q 001988          966 TITRL  970 (985)
Q Consensus       966 v~~~L  970 (985)
                      ....+
T Consensus       507 AANvl  511 (598)
T KOG4158|consen  507 AANVL  511 (598)
T ss_pred             HHhHH
Confidence            55444

>PLN03150 hypothetical protein; Provisional

Probab=99.49  E-value=4.1e-14  Score=169.22  Aligned_cols=118  Identities=40%  Similarity=0.649  Sum_probs=97.3

Q ss_pred             cccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccc
Q 001988          538 AVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLS  617 (985)
Q Consensus       538 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls  617 (985)
                      .++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+.++++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            36778888888888888888888888999999998888888888888899999999999988888888888899999999


Q ss_pred             cccccCCCCCCC--CCcccccccccCCccccCCCCCCCCCCC
Q 001988          618 FNKLKGEIPRGG--PFANFTAESFMGNELLCGLPNLQVPPCK  657 (985)
Q Consensus       618 ~N~l~~~~p~~~--~~~~~~~~~~~~n~~lc~~~~~~~~~~~  657 (985)
                      +|+++|.+|..-  ...+.....+.+|+.+|+.|.  .++|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~  538 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACG  538 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCc
Confidence            999998888641  223445567889999999774  35775

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.47  E-value=3.4e-15  Score=162.65  Aligned_cols=177  Identities=34%  Similarity=0.543  Sum_probs=94.3

Q ss_pred             CCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEe
Q 001988          416 LSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLN  495 (985)
Q Consensus       416 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  495 (985)
                      ++.-...||+.|++. .+|..+..+..|+.+.|..|.+. .+|..++++..|.+|||+.|+++ ..|..++.|+ |+.|-
T Consensus        74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli  149 (722)
T KOG0532|consen   74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI  149 (722)
T ss_pred             ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence            333344555555554 44555555555555555555555 45555555555555555555554 3444444443 45555


Q ss_pred             eccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceecc
Q 001988          496 LGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEG  575 (985)
Q Consensus       496 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  575 (985)
                      +++|+++. +|.                        .++.+..|..||.|.|.|. .+|..++++.+|+.|++..|++. 
T Consensus       150 ~sNNkl~~-lp~------------------------~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-  202 (722)
T KOG0532|consen  150 VSNNKLTS-LPE------------------------EIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-  202 (722)
T ss_pred             EecCcccc-CCc------------------------ccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-
Confidence            55555542 333                        4444555555555555555 44555566666666666666665 


Q ss_pred             chhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCCC
Q 001988          576 PIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEI  625 (985)
Q Consensus       576 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~  625 (985)
                      ..|+++..| .|..||+|.|+++ .+|..|.+|+.|++|-|.+|+|+..+
T Consensus       203 ~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPP  250 (722)
T KOG0532|consen  203 DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPP  250 (722)
T ss_pred             hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCCh
Confidence            344445533 3555666666665 55666666666666666666665433

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.46  E-value=1.3e-14  Score=158.72  Aligned_cols=163  Identities=26%  Similarity=0.334  Sum_probs=127.3

Q ss_pred             CceEEEEeccCCCChHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccC
Q 001988          795 DFKALVLEYMSNGSLEDCLHSS--NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGM  872 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGl  872 (985)
                      .+.||.|++|...+|.+|+...  ....++.....++.|++.|++|      ++.+|||+||.||+...+..+||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            3578999999999999999644  4457888899999999999999      7899999999999999999999999999


Q ss_pred             ceeccCCC----CcceecccccccccccccccccCccchhhhcccccccchhhhccccccc------------Ccchhhh
Q 001988          873 AKLLSGED----ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLS------------GEEKHFA  936 (985)
Q Consensus       873 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~------------~~~~~~~  936 (985)
                      ........    .....+.-+||..||+||++.+..|+.+.|+ |++|.+++|++...-..            +..+ ..
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdI-yaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip-~~  480 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDI-YALGLILAELLIQFSTQFERIATLTDIRDGIIP-PE  480 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcch-hhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCC-hH
Confidence            98876444    1223455579999999999999999999999 99999999987622110            1111 00


Q ss_pred             hHHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 001988          937 AKEQCLLSIFSLALECTMESPEKRIDAKDT  966 (985)
Q Consensus       937 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev  966 (985)
                      ...+. ++=..++.+++++.|.+||++.++
T Consensus       481 ~~~d~-p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  481 FLQDY-PEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             HhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence            11111 223568889999999999944443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.46  E-value=2.7e-13  Score=155.01  Aligned_cols=141  Identities=23%  Similarity=0.327  Sum_probs=100.8

Q ss_pred             CceeeccCceeEEEEEEcCCcEEEEEEeccCCcchH----------------------------------------HHHH
Q 001988          731 NNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTL----------------------------------------KSFE  770 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~----------------------------------------~~~~  770 (985)
                      .+.||+|++|.||+|+.++|+.||||+.++......                                        -.+.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999999999999999876531110                                        0244


Q ss_pred             HHHHHHHhcC-----CCCeeeEEeeeecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHH-HHHHHhcCC
Q 001988          771 AECEVIKNIR-----HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASA-LEYLHFGHS  844 (985)
Q Consensus       771 ~E~~il~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~-L~~Lh~~h~  844 (985)
                      +|.+.+.+++     ++++.-..-++...+..++||||++|+++.+.........   .+.+++..++.+ +..+   |.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql---~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQV---LR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHH---Hh
Confidence            5666555552     3333322222233445789999999999988765432122   234566666653 5556   78


Q ss_pred             CCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       845 ~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      .|++|||+||.||++++++.++++|||++..++
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999999999998864

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.44  E-value=2.9e-14  Score=166.35  Aligned_cols=196  Identities=23%  Similarity=0.271  Sum_probs=133.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .+|..++.|..|+||.||.++++ +.+++|+| +.++.-    -+++   ++.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----ilRn---ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----ILRN---ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccch----hhhc---cccccCCccee-------------------
Confidence            57888999999999999999877 45678884 433311    0111   22233334333                   


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC-----
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-----  879 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~-----  879 (985)
                        ||=...++.-+ .++.        +++.+++|+   |+.||+|||+||+|.+|+.-|++|+.|||+.+.....     
T Consensus       136 --gDc~tllk~~g-~lPv--------dmvla~Eyl---h~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 --GDCATLLKNIG-PLPV--------DMVLAVEYL---HSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             --chhhhhcccCC-CCcc--------hhhHHhHhh---ccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence              23333333222 1111        127789999   8999999999999999999999999999998652211     


Q ss_pred             --------CCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcc-h-------------hhhh
Q 001988          880 --------DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEE-K-------------HFAA  937 (985)
Q Consensus       880 --------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~-~-------------~~~~  937 (985)
                              .......+++|||.|+|||++....|.-..|. |++|++.++.+.+..+...+ +             +.+.
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdw-wamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~  280 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDW-WAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE  280 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccH-HHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence                    11122356689999999999999999877776 99999999988877654433 1             1112


Q ss_pred             HHHHHHHHHHHHHHccCCCCCCCCCH
Q 001988          938 KEQCLLSIFSLALECTMESPEKRIDA  963 (985)
Q Consensus       938 ~~~~~~~l~~l~~~cl~~~P~~RPt~  963 (985)
                      .+..+.+..+++.+.++.+|..|--.
T Consensus       281 dea~p~Ea~dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  281 DEALPPEAQDLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             CcCCCHHHHHHHHHHHHhChHhhccc
Confidence            22345677888888888888887633

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.44  E-value=7.2e-15  Score=160.16  Aligned_cols=183  Identities=28%  Similarity=0.458  Sum_probs=141.7

Q ss_pred             ccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccc
Q 001988           94 ANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLK  173 (985)
Q Consensus        94 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~  173 (985)
                      ..|+.-...||+.|++. .+|..+..+..|..|.|.+|.+. .+|..+.++..|++|||+.|+++ .+|..++  .--|+
T Consensus        72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC--~lpLk  146 (722)
T KOG0532|consen   72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLC--DLPLK  146 (722)
T ss_pred             ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhh--cCcce
Confidence            34445555666666665 56666666666666666666655 34555556666666666666666 7787775  23489


Q ss_pred             eecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCc
Q 001988          174 HLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNN  253 (985)
Q Consensus       174 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  253 (985)
                      .|-+++|+++ .+|+.++.+..|..||.+.|++. .+|..++++.+|+.|.+..|++. .+|+++..| .|..||+|.|+
T Consensus       147 vli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNk  222 (722)
T KOG0532|consen  147 VLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNK  222 (722)
T ss_pred             eEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCc
Confidence            9999999998 89999999999999999999998 78889999999999999999998 678888855 68899999999


Q ss_pred             CcccCcccccCCCCCCEEEccCCcCcccCChhhh
Q 001988          254 LTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRID  287 (985)
Q Consensus       254 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~  287 (985)
                      ++ .+|..|.+|+.|++|.|.+|.|. +-|..+.
T Consensus       223 is-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC  254 (722)
T KOG0532|consen  223 IS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC  254 (722)
T ss_pred             ee-ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence            98 89999999999999999999998 6666654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.41  E-value=3.5e-14  Score=167.14  Aligned_cols=239  Identities=22%  Similarity=0.243  Sum_probs=186.7

Q ss_pred             cCccCCceeeccCceeEEEEEEc--CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE--DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~--~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv  800 (985)
                      ..|...+-||+|+|+.|-.+...  ....+|+|.+....  .........|..+-+.+. |+|++++++.....+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            45667777999999999998753  34456777665442  223445556887777776 99999999999999999999


Q ss_pred             EeccCCCChHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCeEeCCCCCCCEEEcCCC-cEEEecccCceecc
Q 001988          801 LEYMSNGSLEDCL-HSSNCALNIFCRLNIMIDIASALEYLHFGH-STPIIHCDLKPSNVLLDEDM-VAHLSDFGMAKLLS  877 (985)
Q Consensus       801 ~e~~~~gsL~~~l-~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h-~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~~~~  877 (985)
                      +||..|+++.+.+ +......+......+..|+..++.|+   | ..++.|||+||+|.+++..+ ..|++|||+|..+.
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~---H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYL---HPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCcccc---CcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999998 54432556666778999999999999   8 99999999999999999999 99999999999987


Q ss_pred             C-CCCcceeccccc-ccccccccccccCccc-hhhhcccccccchhhhcccccccCcchh----------------hhhH
Q 001988          878 G-EDESTMRTQTLA-TIGYMAPDEIFVGELS-LKRWVNDLLPVSLVEVVDKSLLSGEEKH----------------FAAK  938 (985)
Q Consensus       878 ~-~~~~~~~~~~~g-t~~y~aPE~~~~~~~~-~~~dv~~~~g~~~~~i~~~~~~~~~~~~----------------~~~~  938 (985)
                      . .+........+| ++.|+|||...+..+. ...|+ |+.|+.+..+.++...+.....                ....
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~-~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDV-WSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW  255 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCccc-ccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence            6 555555666788 9999999998885444 45555 9999999999888776543311                1112


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          939 EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       939 ~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ........++..+++..+|..|.+.+++..
T Consensus       256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  256 NSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ccCChhhhhcccccccCCchhccccccccc
Confidence            234566778888999999999998877643

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.37  E-value=5.3e-13  Score=153.06  Aligned_cols=196  Identities=37%  Similarity=0.495  Sum_probs=102.6

Q ss_pred             EEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCC-CCcEEEccCcccCCCCccccccCCccceeeecccc
Q 001988           78 LNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMS-TLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNK  156 (985)
Q Consensus        78 l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~  156 (985)
                      +++..+.+... ...+..++.++.|++.+|.++ .+|+..+.++ +|++|++++|++.                      
T Consensus        98 l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~----------------------  153 (394)
T COG4886          98 LDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE----------------------  153 (394)
T ss_pred             eeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh----------------------
Confidence            55555544322 223444455666666666665 4555555553 5555555555554                      


Q ss_pred             ccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchh
Q 001988          157 LSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQ  236 (985)
Q Consensus       157 l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  236 (985)
                         .+|..+ ..+++|+.|++++|+++ .+|...+.+++|+.|++++|+++ .+|..++.+..|++|.+++|++. ..+.
T Consensus       154 ---~l~~~~-~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~  226 (394)
T COG4886         154 ---SLPSPL-RNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLS  226 (394)
T ss_pred             ---hhhhhh-hccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecch
Confidence               333233 44555555555555555 45555545555666666666665 45554444455566666665433 3444


Q ss_pred             hhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCC
Q 001988          237 EIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIP  308 (985)
Q Consensus       237 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p  308 (985)
                      .+.++.++..+.+++|++. .++..+..++++++|++++|+++ .++.  ...+.+++.|++++|.+....|
T Consensus       227 ~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~--~~~~~~l~~L~~s~n~~~~~~~  294 (394)
T COG4886         227 SLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS--LGSLTNLRELDLSGNSLSNALP  294 (394)
T ss_pred             hhhhcccccccccCCceee-eccchhccccccceecccccccc-cccc--ccccCccCEEeccCccccccch
Confidence            5555555555555555554 23445555555555555555555 3333  2344555555555555544333

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.34  E-value=1.6e-12  Score=149.07  Aligned_cols=201  Identities=36%  Similarity=0.494  Sum_probs=117.5

Q ss_pred             ecccCccccccCCcccCCCCCceEEEcccccCCCcccccccccc-ccceEeeccccccCCchhhhcCCCCCCEEEecCCc
Q 001988          175 LFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLT-VLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNN  253 (985)
Q Consensus       175 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  253 (985)
                      ++++.|.+. ..+..+..++.++.|++.+|.++ .+|...+.+. +|+.|++++|++. .+|..++.+++|+.|++++|+
T Consensus        98 l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~  174 (394)
T COG4886          98 LDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND  174 (394)
T ss_pred             eeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence            444444443 12222333455555555555555 4555455553 5566666666655 444555566666666666666


Q ss_pred             CcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCC
Q 001988          254 LTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPS  333 (985)
Q Consensus       254 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  333 (985)
                      ++ .+|.....++.|+.|++++|+++ .+|..+. ....|++|.+++|++. ..+..+.++.++..+.+.+|++.. .+.
T Consensus       175 l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~-~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~  249 (394)
T COG4886         175 LS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIE-LLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPE  249 (394)
T ss_pred             hh-hhhhhhhhhhhhhheeccCCccc-cCchhhh-hhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccc
Confidence            65 34444445556666666666665 5554331 2334666666666433 455566666777777777777663 366


Q ss_pred             cccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccc
Q 001988          334 AIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGN  390 (985)
Q Consensus       334 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  390 (985)
                      .++.++++++|++++|+++....       +....+++.|++++|.+....|.....
T Consensus       250 ~~~~l~~l~~L~~s~n~i~~i~~-------~~~~~~l~~L~~s~n~~~~~~~~~~~~  299 (394)
T COG4886         250 SIGNLSNLETLDLSNNQISSISS-------LGSLTNLRELDLSGNSLSNALPLIALL  299 (394)
T ss_pred             hhccccccceecccccccccccc-------ccccCccCEEeccCccccccchhhhcc
Confidence            67777778888888887776653       456677888888888777665554433

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.27  E-value=9.5e-12  Score=143.49  Aligned_cols=147  Identities=19%  Similarity=0.267  Sum_probs=96.7

Q ss_pred             cCccCCceeeccCceeEEEEEEcC-CcEEEEEEeccCCcch----------------------------------HH---
Q 001988          726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCAST----------------------------------LK---  767 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~-~~~vAvK~~~~~~~~~----------------------------------~~---  767 (985)
                      ..|.. +.||+|++|.||+|++++ |++||||+.++.....                                  .+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34665 789999999999999887 9999999998652110                                  01   


Q ss_pred             ---HHHHHHHHHHhcC----CCCeeeEEeee-ecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 001988          768 ---SFEAECEVIKNIR----HRNLVKIISSC-SNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL  839 (985)
Q Consensus       768 ---~~~~E~~il~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~L  839 (985)
                         .+.+|+.-+.+++    +...+.+-.++ ......++||||++|+.+.+.-.......+.   ..++...++.  |+
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~---~~la~~~v~~--~~  273 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDM---KLLAERGVEV--FF  273 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCH---HHHHHHHHHH--HH
Confidence               2344555444442    33333333333 2245578999999999998753211111222   2233333322  22


Q ss_pred             HhcCCCCeEeCCCCCCCEEEcCCC----cEEEecccCceeccC
Q 001988          840 HFGHSTPIIHCDLKPSNVLLDEDM----VAHLSDFGMAKLLSG  878 (985)
Q Consensus       840 h~~h~~~ivHrDlk~~Nill~~~~----~~kl~DfGla~~~~~  878 (985)
                      ++....|++|+|+||.||+++.++    .++++|||++..++.
T Consensus       274 ~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        274 TQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            333678999999999999999988    999999999987643

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.25  E-value=2.5e-11  Score=121.43  Aligned_cols=128  Identities=25%  Similarity=0.264  Sum_probs=96.0

Q ss_pred             CceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCee-eEEeeeecCCceEEEEeccCCCCh
Q 001988          731 NNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV-KIISSCSNDDFKALVLEYMSNGSL  809 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL  809 (985)
                      .+.++.|.++.||+++.. +..|++|....... ....+.+|+++++.+.+.+++ +++.+..  +..++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            356889999999999875 78899998765432 223567899999998655544 4555433  345799999999887


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          810 EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP-----IIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       810 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~-----ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      .+. .        .....++.+++++++.|   |+.+     ++|||++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~-~--------~~~~~~~~~l~~~l~~L---H~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE-D--------FSDPENLEKIAKLLKKL---HSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc-c--------ccCHHHHHHHHHHHHHH---hCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            653 0        11133567899999999   5555     59999999999999 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.23  E-value=4e-13  Score=139.19  Aligned_cols=229  Identities=23%  Similarity=0.268  Sum_probs=130.5

Q ss_pred             CCCCceEEEcccccCCC----ccccccccccccceEeeccc---cccCCchh-------hhcCCCCCCEEEecCCcCccc
Q 001988          192 KCKQLQELHLGYNNLSG----AIPKEIGNLTVLQRISLINN---KLHGEIPQ-------EIGYLQNLDVLQLGFNNLTGV  257 (985)
Q Consensus       192 ~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N---~l~~~~p~-------~~~~l~~L~~L~Ls~N~l~~~  257 (985)
                      .+..+++|+||+|.|..    .+.+.+.+.++|+..++++-   ++...+|+       .+...++|++||||.|-+.-.
T Consensus        28 ~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~  107 (382)
T KOG1909|consen   28 PMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPK  107 (382)
T ss_pred             ccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCcc
Confidence            34445555555555432    12223334444555554432   22233443       344566889999999988754


Q ss_pred             Cccc----ccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCccccccc--
Q 001988          258 VPAT----IFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFI--  331 (985)
Q Consensus       258 ~p~~----l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--  331 (985)
                      .+..    +..++.|++|+|.||.+.-.-...+...|..|.     .|+       -..+-++|+++..++|++....  
T Consensus       108 g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~-----~~k-------k~~~~~~Lrv~i~~rNrlen~ga~  175 (382)
T KOG1909|consen  108 GIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELA-----VNK-------KAASKPKLRVFICGRNRLENGGAT  175 (382)
T ss_pred             chHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHH-----HHh-------ccCCCcceEEEEeeccccccccHH
Confidence            4433    456788999999999886322222222221111     121       2334567888888888886533  


Q ss_pred             --CCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceecccccccccc
Q 001988          332 --PSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNI  409 (985)
Q Consensus       332 --p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~  409 (985)
                        ...|...+.|+.+.++.|.|..... .....+|..|++|+.|||.+|-++..-..                     .+
T Consensus       176 ~~A~~~~~~~~leevr~~qN~I~~eG~-~al~eal~~~~~LevLdl~DNtft~egs~---------------------~L  233 (382)
T KOG1909|consen  176 ALAEAFQSHPTLEEVRLSQNGIRPEGV-TALAEALEHCPHLEVLDLRDNTFTLEGSV---------------------AL  233 (382)
T ss_pred             HHHHHHHhccccceEEEecccccCchh-HHHHHHHHhCCcceeeecccchhhhHHHH---------------------HH
Confidence              2345566788888888888765443 23455678888888888888877632111                     22


Q ss_pred             CCcCCCCCCccEEEccCCCCCCCCCcccc-----ccccccceeccccccc
Q 001988          410 PKAIGNLSNLIVLSLGGNNLSGSIPVTFG-----GLQKLQGLDLAFNKLA  454 (985)
Q Consensus       410 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~  454 (985)
                      ..++..+++|++|++++|.+...-..+|.     ..++|+.|.+.+|.|+
T Consensus       234 akaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt  283 (382)
T KOG1909|consen  234 AKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT  283 (382)
T ss_pred             HHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence            34555666777777777776643332221     2455666666666554

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.22  E-value=3.4e-12  Score=128.76  Aligned_cols=136  Identities=25%  Similarity=0.259  Sum_probs=105.0

Q ss_pred             CcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccce
Q 001988          485 LGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQ  564 (985)
Q Consensus       485 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  564 (985)
                      ......|+++|||+|.|+. +.+...-++.++.|++|+|.|..+..  +..+++|+.||||+|.++ .+..+=..|.+++
T Consensus       280 ~dTWq~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~~v~n--La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIK  355 (490)
T KOG1259|consen  280 ADTWQELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIRTVQN--LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIK  355 (490)
T ss_pred             cchHhhhhhccccccchhh-hhhhhhhccceeEEeccccceeeehh--hhhcccceEeecccchhH-hhhhhHhhhcCEe
Confidence            3445567777777777774 45556667777888888888775443  677888899999999887 4445556688999


Q ss_pred             eeeeecceeccchhhhhhcccccCeEecCCCcccCC-CCccccccccccccccccccccCCCC
Q 001988          565 NISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGS-IPVSFEKLSYLKELNLSFNKLKGEIP  626 (985)
Q Consensus       565 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~p  626 (985)
                      .|.|+.|.|..  -..+.++-+|..||+++|+|... --..+++||-|+.+.|.+|++.+.+-
T Consensus       356 tL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  356 TLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             eeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            99999999973  45688899999999999999742 22468999999999999999997654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.22  E-value=2.3e-10  Score=114.65  Aligned_cols=137  Identities=22%  Similarity=0.223  Sum_probs=99.8

Q ss_pred             CceeeccCceeEEEEEEcC-------CcEEEEEEeccCCc----------------------chHHH----HHHHHHHHH
Q 001988          731 NNIIGIGGFGSVYRARLED-------GVEIAIKVFHPQCA----------------------STLKS----FEAECEVIK  777 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~-------~~~vAvK~~~~~~~----------------------~~~~~----~~~E~~il~  777 (985)
                      ...||.|--+.||.|...+       +..+|||+++....                      ...+.    .++|.+.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998553       47899999853210                      01122    348999999


Q ss_pred             hcCC--CCeeeEEeeeecCCceEEEEeccCCCChHH-HhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCC
Q 001988          778 NIRH--RNLVKIISSCSNDDFKALVLEYMSNGSLED-CLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKP  854 (985)
Q Consensus       778 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~  854 (985)
                      ++..  -++.+.+++    ...++||||+.++.+.. .++.  ..++..+...+..+++.++.+++  |..|+||||+++
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~--H~~glVHGDLs~  153 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLY--KECNLVHADLSE  153 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHH--HhCCeecCCCCH
Confidence            9853  456667765    34679999997654422 2222  13444556678899999999996  789999999999


Q ss_pred             CCEEEcCCCcEEEecccCceec
Q 001988          855 SNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       855 ~Nill~~~~~~kl~DfGla~~~  876 (985)
                      .||+++ ++.++++|||.+...
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeC
Confidence            999997 468999999988765

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=1.2e-11  Score=126.79  Aligned_cols=195  Identities=19%  Similarity=0.206  Sum_probs=142.0

Q ss_pred             HHHHhcCCCCeeeEEeeeecCC-----ceEEEEeccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 001988          774 EVIKNIRHRNLVKIISSCSNDD-----FKALVLEYMSNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGHST  845 (985)
Q Consensus       774 ~il~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~  845 (985)
                      .-+-++.|.|+|+++.||.+..     ...++.||+..|++..+|++.   ...+......+|+.||..||.|||. .++
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence            3344567999999999996543     467899999999999999764   4457778889999999999999986 788


Q ss_pred             CeEeCCCCCCCEEEcCCCcEEEecccCc--eeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhc
Q 001988          846 PIIHCDLKPSNVLLDEDMVAHLSDFGMA--KLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVV  923 (985)
Q Consensus       846 ~ivHrDlk~~Nill~~~~~~kl~DfGla--~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~  923 (985)
                      .|+|+++..+-|++..+|-+|++----.  ...........+....+-++|.|||.-.....+.+.|+ |.+|..++++.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dI-y~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDI-YKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhh-hhhhHHHHHHH
Confidence            8999999999999999999987521110  00000000111122246789999998888888889999 99999999999


Q ss_pred             ccccccCcchhhhhHHHH---------HHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 001988          924 DKSLLSGEEKHFAAKEQC---------LLSIFSLALECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~---------~~~l~~l~~~cl~~~P~~RPt~~ev~~~L  970 (985)
                      .+++...........++.         ...=+..+++|+...|..||+|++++...
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             HheeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence            888875443211111110         11123478899999999999999987654

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.18  E-value=2.4e-10  Score=109.68  Aligned_cols=131  Identities=22%  Similarity=0.369  Sum_probs=102.4

Q ss_pred             ceeeccCceeEEEEEEcCCcEEEEEEeccCCcc--------hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAS--------TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ..+++|+-+.+|.+.+. |.++++|.-.++...        ......+|++++.+++--.|...+=+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999875 555777755444222        123567899999998766666666666677778899999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      ++|-.|.+.+...        ...++..+-+-+.-|   |..||||+|+.++||++..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~l---H~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKL---HKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHH---HhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9998999888765        244667777888889   899999999999999998765 99999999864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.16  E-value=3.7e-11  Score=134.73  Aligned_cols=236  Identities=25%  Similarity=0.253  Sum_probs=176.6

Q ss_pred             CccCCceeec--cCceeEEEEEE---cCCcEEEEEEeccCCc--chHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceE
Q 001988          727 NFAENNIIGI--GGFGSVYRARL---EDGVEIAIKVFHPQCA--STLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       727 ~~~~~~~ig~--G~~g~V~~~~~---~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~  798 (985)
                      .|.....+|.  |.+|.||.+..   +++..+|+|+-+....  .....=.+|+...+++ .|++.++.+..+.+++..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4556778999  99999999976   3788899998443322  2222335677777777 4999999999999999999


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEeCCCCCCCEEEcCC-CcEEEecccCc
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS----ALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMA  873 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~----~L~~Lh~~h~~~ivHrDlk~~Nill~~~-~~~kl~DfGla  873 (985)
                      +-+|++ +.++.++.+.....++....+.+..+..+    |+.++   |+.+++|-|+||.||+...+ ...+++|||+.
T Consensus       195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~---hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHL---HSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhccccccccc---CCCcccccccchhheecccccceeecCCccee
Confidence            999999 57888888876656777788888888888    99999   99999999999999999999 89999999999


Q ss_pred             eeccCCCCcce---ecccccccccccccccccCccchhhhcccccccchhhhcccccccCcc---------hhhhhHHHH
Q 001988          874 KLLSGEDESTM---RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEE---------KHFAAKEQC  941 (985)
Q Consensus       874 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~---------~~~~~~~~~  941 (985)
                      ..+.+..-...   .....|...|++||. ..+.++...|+ +++|.++.+.+.+.......         ..+.+.+.|
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~  348 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC  348 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhh-hccccchHhhh-cchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence            98865442211   122257788999986 45667788888 88888877766544322111         111222222


Q ss_pred             ---HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          942 ---LLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       942 ---~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                         ..++...+..+++.+|..|++++.+..
T Consensus       349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence               345556889999999999998877653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.15  E-value=2.2e-10  Score=129.31  Aligned_cols=215  Identities=19%  Similarity=0.193  Sum_probs=150.0

Q ss_pred             EcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHH
Q 001988          747 LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL  826 (985)
Q Consensus       747 ~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~  826 (985)
                      ..++.+|.|...+...........+-++-++.++||||++|++.++..+..|+|+|-+.  .|..++++.+    .....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~  107 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC  107 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence            44788999998887655445567888999999999999999999999999999999984  5777776543    44555


Q ss_pred             HHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccc
Q 001988          827 NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELS  906 (985)
Q Consensus       827 ~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  906 (985)
                      -.++||+.||.|||  +..+++|++|.-+-|+++..|+.||++|.++....+...  ......---.|..|+.+....  
T Consensus       108 ~Gl~qIl~AL~FL~--~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--  181 (690)
T KOG1243|consen  108 LGLFQILAALSFLN--DDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--  181 (690)
T ss_pred             HHHHHHHHHHHHHh--ccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence            57899999999997  799999999999999999999999999998876543322  111111223466776543333  


Q ss_pred             hhhhcccccccchhhhcccccccCcchhhh--hHH--------------HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 001988          907 LKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--AKE--------------QCLLSIFSLALECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       907 ~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--~~~--------------~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L  970 (985)
                      +..|. |.+|+++++++.+...........  .+.              .......+.+..|...-+-.|=.+-+++..|
T Consensus       182 ~s~D~-~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~~~~~gff~n~fvd~~~fL  260 (690)
T KOG1243|consen  182 WSIDS-WGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCKKLGATELKRPNKLRFILECRLLGGFFRNDFVDTLLFL  260 (690)
T ss_pred             cchhh-hhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHHHhccccccccchhhHHHHHHhccccccchHHHHHHHH
Confidence            44566 889999999999844332221100  000              0011144566666666666666666666666


Q ss_pred             HHhH
Q 001988          971 LKIR  974 (985)
Q Consensus       971 ~~i~  974 (985)
                      ++++
T Consensus       261 eel~  264 (690)
T KOG1243|consen  261 EELR  264 (690)
T ss_pred             Hhcc
Confidence            5543

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.11  E-value=2e-11  Score=129.99  Aligned_cols=215  Identities=23%  Similarity=0.263  Sum_probs=127.7

Q ss_pred             CCCCceEEEcccccCCCccc--cccccccccceEeeccccccCCc--hhhhcCCCCCCEEEecCCcCcccCcccc-cCCC
Q 001988          192 KCKQLQELHLGYNNLSGAIP--KEIGNLTVLQRISLINNKLHGEI--PQEIGYLQNLDVLQLGFNNLTGVVPATI-FNMS  266 (985)
Q Consensus       192 ~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~  266 (985)
                      ++++|++..|.+..+. ..+  .....+++++.|||+.|-+....  -.....|++|+.|+|+.|++........ ..++
T Consensus       119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~  197 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS  197 (505)
T ss_pred             hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence            4555666666665554 222  23445666666666666665322  2334567777777777777653221111 2466


Q ss_pred             CCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCccccccc-CCcccCCCCCceEe
Q 001988          267 TLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFI-PSAIGNLRNLKLFD  345 (985)
Q Consensus       267 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~  345 (985)
                      +|+.|.|+.|.++..--.++...+|+|+.|+|..|...+.-......+..|+.|||++|++-... -...+.++.|+.|+
T Consensus       198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln  277 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN  277 (505)
T ss_pred             hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence            78888888888874444455567888888999888643344445555778888888888876432 14567788888888


Q ss_pred             ccCCcccCCCCc-ccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEc
Q 001988          346 IFFNNLTSSTPE-LGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSL  424 (985)
Q Consensus       346 L~~N~l~~~~~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  424 (985)
                      ++.+.+.++... .+.......+++|++|+++.|++...                        ..-..+..+++|+.|.+
T Consensus       278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w------------------------~sl~~l~~l~nlk~l~~  333 (505)
T KOG3207|consen  278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDW------------------------RSLNHLRTLENLKHLRI  333 (505)
T ss_pred             ccccCcchhcCCCccchhhhcccccceeeecccCccccc------------------------cccchhhccchhhhhhc
Confidence            888887765321 11111233445555555555555321                        01123444566777777


Q ss_pred             cCCCCCC
Q 001988          425 GGNNLSG  431 (985)
Q Consensus       425 ~~N~l~~  431 (985)
                      ..|.++.
T Consensus       334 ~~n~ln~  340 (505)
T KOG3207|consen  334 TLNYLNK  340 (505)
T ss_pred             ccccccc
Confidence            7777764

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.10  E-value=9.7e-12  Score=132.32  Aligned_cols=210  Identities=20%  Similarity=0.228  Sum_probs=124.5

Q ss_pred             cCCCCcEEEccCcccCCCCc-cccccCCccceeeeccccccCCCC-hhHhhhccccceecccCccccccCCccc-CCCCC
Q 001988          119 TMSTLKVLYLMDNQLSGSLS-SFTFNTSSILDIRLSKNKLSGKLP-ENICNHLRYLKHLFLRENMFYGKIPSSL-SKCKQ  195 (985)
Q Consensus       119 ~l~~L~~L~Ls~n~l~~~~~-~~~~~~~~L~~L~ls~n~l~g~lp-~~~~~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~  195 (985)
                      ++.+|++.-|.+........ +....++++++||||.|-|...-| -.+...|++|+.|+|+.|.+.-.+.+.. ..+++
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~  198 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH  198 (505)
T ss_pred             hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence            45666666666655542111 344456666666666666654333 2455667777777777777653332221 24566


Q ss_pred             ceEEEcccccCCCc-cccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCc--ccccCCCCCCEEE
Q 001988          196 LQELHLGYNNLSGA-IPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVP--ATIFNMSTLKEIF  272 (985)
Q Consensus       196 L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~L~  272 (985)
                      |+.|.|+.|.++.. +-.....+++|+.|+|..|...+........++.|+.|||++|++-. .+  ...+.++.|+.|.
T Consensus       199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~Ln  277 (505)
T KOG3207|consen  199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQLN  277 (505)
T ss_pred             hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhhhh
Confidence            77777777777622 22234456777777777775333334445556677777777777652 33  4456677777777


Q ss_pred             ccCCcCccc-CChh----hhhcCCCCcEEEecCccCCCc-CCccccCCCCccEEEccCccccc
Q 001988          273 LYNNSLSGS-LPSR----IDLALPNLEFLNLGINSFSGT-IPSSITNASKLILLEMGSNSFSG  329 (985)
Q Consensus       273 L~~N~l~~~-~p~~----~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~  329 (985)
                      ++.+.+... +|+.    ....+++|++|+++.|+|... .-..+..+.+|+.|....|.++.
T Consensus       278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             ccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence            777777621 2221    123567888888888888532 12344556677777777887764

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.09  E-value=4.7e-11  Score=120.61  Aligned_cols=131  Identities=31%  Similarity=0.395  Sum_probs=78.4

Q ss_pred             cccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEe
Q 001988          440 LQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFD  519 (985)
Q Consensus       440 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  519 (985)
                      .+.|+++|||+|.|+ .+.++..-.+.++.|++++|.|..+  ..+..+++|+.||||+|.++.. ..            
T Consensus       283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~-~G------------  346 (490)
T KOG1259|consen  283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAEC-VG------------  346 (490)
T ss_pred             Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhh-hh------------
Confidence            344555555555555 3444444455555555555555421  1144445555555555544421 22            


Q ss_pred             ecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccch-hhhhhcccccCeEecCCCccc
Q 001988          520 ISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPI-PESFGNMTSLESLDLSNNKIS  598 (985)
Q Consensus       520 ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~  598 (985)
                                  +-..+.+.+.|.|+.|.|...  ..++.|-+|..||+++|+|.... ...+++++-|+.|.|.+|.|.
T Consensus       347 ------------wh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~  412 (490)
T KOG1259|consen  347 ------------WHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA  412 (490)
T ss_pred             ------------hHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence                        223445566666666666422  45667778888888888887432 456899999999999999998


Q ss_pred             CC
Q 001988          599 GS  600 (985)
Q Consensus       599 ~~  600 (985)
                      +.
T Consensus       413 ~~  414 (490)
T KOG1259|consen  413 GS  414 (490)
T ss_pred             cc
Confidence            54

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.08  E-value=1.3e-09  Score=103.85  Aligned_cols=142  Identities=22%  Similarity=0.228  Sum_probs=105.8

Q ss_pred             CCceeeccCceeEEEEEEcCCcEEEEEEeccCCcc--------hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          730 ENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAS--------TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       730 ~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ....+-+|+-+.|+++.+. |+.+.||.-..+...        ..++..+|++++.++.--.|.-..=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4578899999999999985 888888854333211        2346678999999987555555444555555667999


Q ss_pred             eccCC-CChHHHhhcCCCCCCHHH-HHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC---cEEEecccCcee
Q 001988          802 EYMSN-GSLEDCLHSSNCALNIFC-RLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM---VAHLSDFGMAKL  875 (985)
Q Consensus       802 e~~~~-gsL~~~l~~~~~~~~~~~-~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~---~~kl~DfGla~~  875 (985)
                      ||++| .++.+++......-.... ...++..|-+.+.-|   |..+|||+||..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igkl---H~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKL---HDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHh---hhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 478888776532222223 367889999999999   899999999999999996655   468999999754

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.07  E-value=1.3e-09  Score=114.42  Aligned_cols=142  Identities=20%  Similarity=0.253  Sum_probs=110.5

Q ss_pred             ceeeccCceeEEEEEEcCCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCC--CCeeeEEeeeecC---CceEEEEeccC
Q 001988          732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRH--RNLVKIISSCSND---DFKALVLEYMS  805 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h--~niv~l~~~~~~~---~~~~lv~e~~~  805 (985)
                      +.++.|.++.||++...+|+.+++|....... .....+..|.++++.+.+  ..+.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999987778999998765422 134578899999999975  3467778877654   36689999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 001988          806 NGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG-------------------------------------------  842 (985)
Q Consensus       806 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~-------------------------------------------  842 (985)
                      |+++.+.+..  ..++......++.++++++.+||..                                           
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9888776542  2456777778888888888888731                                           


Q ss_pred             ----------CCCCeEeCCCCCCCEEEcC--CCcEEEecccCcee
Q 001988          843 ----------HSTPIIHCDLKPSNVLLDE--DMVAHLSDFGMAKL  875 (985)
Q Consensus       843 ----------h~~~ivHrDlk~~Nill~~--~~~~kl~DfGla~~  875 (985)
                                -...++|+|++|.||+++.  ++.+.++||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                      0255799999999999998  67789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.06  E-value=2.2e-11  Score=139.71  Aligned_cols=215  Identities=34%  Similarity=0.399  Sum_probs=152.7

Q ss_pred             cccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEcc
Q 001988          394 SLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLN  473 (985)
Q Consensus       394 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  473 (985)
                      .++.+++..|.|.. +-..+..+++|+.|++.+|+|..+.. .+..+++|++|++++|.|+...  .+..++.|+.|+++
T Consensus        73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~  148 (414)
T KOG0531|consen   73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLS  148 (414)
T ss_pred             hHHhhccchhhhhh-hhcccccccceeeeeccccchhhccc-chhhhhcchheecccccccccc--chhhccchhhheec
Confidence            45666677776663 33456777888888888888874332 2667888888888888888553  35667778888888


Q ss_pred             CCccccccCCCCcCcCcCceEeeccceeeeecC-CCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCcc
Q 001988          474 GNKISGSISSCLGNLTSLQYLNLGSNRFTFVIP-STFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGN  552 (985)
Q Consensus       474 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  552 (985)
                      +|.|+..  ..+..++.|+.+++++|+++.+.+ . ...+.+++.+++.+|.+..+.  .+..+..+..+++..|.++..
T Consensus       149 ~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~--~~~~~~~l~~~~l~~n~i~~~  223 (414)
T KOG0531|consen  149 GNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIE--GLDLLKKLVLLSLLDNKISKL  223 (414)
T ss_pred             cCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhccc--chHHHHHHHHhhcccccceec
Confidence            8888742  446668888888888888886655 2 466777888888888887443  344455566668888888744


Q ss_pred             Cchhhccccc--ceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcccccccccccccccccccc
Q 001988          553 IPTTLEGLKS--LQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLK  622 (985)
Q Consensus       553 ~p~~~~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  622 (985)
                      -+  +..+..  |+.+++++|++. .++..+..+..+..||+++|++...  ..+.....+..+..+.|++.
T Consensus       224 ~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~  290 (414)
T KOG0531|consen  224 EG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA  290 (414)
T ss_pred             cC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence            22  223333  888999999888 3446777888889999999988754  23556677788888888776

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.06  E-value=1e-11  Score=128.85  Aligned_cols=138  Identities=22%  Similarity=0.260  Sum_probs=65.7

Q ss_pred             CCCCEEEecCCcCccc----CcccccCCCCCCEEEccCCcCcccC---ChhhhhcCCCCcEEEecCccCCCc----CCcc
Q 001988          242 QNLDVLQLGFNNLTGV----VPATIFNMSTLKEIFLYNNSLSGSL---PSRIDLALPNLEFLNLGINSFSGT----IPSS  310 (985)
Q Consensus       242 ~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~---p~~~~~~l~~L~~L~Ls~N~l~~~----~p~~  310 (985)
                      +.|+++..++|++..-    +...|...+.|+++.++.|.|...-   -..-+..+++|+.|||..|-|+-.    +.+.
T Consensus       157 ~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Laka  236 (382)
T KOG1909|consen  157 PKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKA  236 (382)
T ss_pred             cceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHH
Confidence            4566666666665421    2233444455666666666554111   111233455666666666655532    2234


Q ss_pred             ccCCCCccEEEccCcccccccCCcc-----cCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCC
Q 001988          311 ITNASKLILLEMGSNSFSGFIPSAI-----GNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPL  380 (985)
Q Consensus       311 ~~~l~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l  380 (985)
                      ++.+++|+.|++++|.++.....++     ...++|+.|.+.+|.++...... ...+....+.|+.|+|++|.+
T Consensus       237 L~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~-la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  237 LSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALA-LAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             hcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHH-HHHHHhcchhhHHhcCCcccc
Confidence            4445556666666666554322222     22455666666666655432111 111233345555555555555

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.04  E-value=1.9e-11  Score=140.30  Aligned_cols=247  Identities=26%  Similarity=0.298  Sum_probs=138.2

Q ss_pred             cCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCC
Q 001988          336 GNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGN  415 (985)
Q Consensus       336 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~  415 (985)
                      ..+..++.+++..|.+....      ..+..+++|+.|++.+|++.....                          .+..
T Consensus        69 ~~l~~l~~l~l~~n~i~~~~------~~l~~~~~l~~l~l~~n~i~~i~~--------------------------~l~~  116 (414)
T KOG0531|consen   69 ESLTSLKELNLRQNLIAKIL------NHLSKLKSLEALDLYDNKIEKIEN--------------------------LLSS  116 (414)
T ss_pred             HHhHhHHhhccchhhhhhhh------cccccccceeeeeccccchhhccc--------------------------chhh
Confidence            34555666667777666521      124455666666666666653221                          1344


Q ss_pred             CCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccC-CCCcCcCcCceE
Q 001988          416 LSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSIS-SCLGNLTSLQYL  494 (985)
Q Consensus       416 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L  494 (985)
                      +++|++|+|++|.|+.+.+  +..++.|+.|++++|.|+..  ..+..+++|+.+++++|+++...+ . ...+.+++.+
T Consensus       117 ~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l  191 (414)
T KOG0531|consen  117 LVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEEL  191 (414)
T ss_pred             hhcchheeccccccccccc--hhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHH
Confidence            5555555555555553322  33344455555555555522  223335555555555555553322 1 3455555666


Q ss_pred             eeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCC--cccEEEccCCccCccCchhhcccccceeeeeecce
Q 001988          495 NLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLK--AVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNR  572 (985)
Q Consensus       495 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  572 (985)
                      ++.+|.+..+  ..+..+..+..+++..|.+....+  +..+.  .|+.+++++|.+. ..+..+..+..+..|++++|+
T Consensus       192 ~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~  266 (414)
T KOG0531|consen  192 DLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNR  266 (414)
T ss_pred             hccCCchhcc--cchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcc
Confidence            6666655432  223334444444555565553322  11222  2677788888877 334566777888888888888


Q ss_pred             eccchhhhhhcccccCeEecCCCcccCC---CCcc-ccccccccccccccccccCCCC
Q 001988          573 LEGPIPESFGNMTSLESLDLSNNKISGS---IPVS-FEKLSYLKELNLSFNKLKGEIP  626 (985)
Q Consensus       573 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~-~~~l~~L~~L~ls~N~l~~~~p  626 (985)
                      +...  ..+.....+..+.++.|.+...   .... ....+.+..+.+.+|+.....+
T Consensus       267 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  267 ISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             cccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence            8743  2355666777888888887632   2222 5566778888888888876655

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.04  E-value=1.6e-10  Score=113.30  Aligned_cols=102  Identities=25%  Similarity=0.327  Sum_probs=40.6

Q ss_pred             ccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhh-cccccceeeeeecceeccc-hhhhhhcccccCe
Q 001988          512 LKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTL-EGLKSLQNISLAYNRLEGP-IPESFGNMTSLES  589 (985)
Q Consensus       512 l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~  589 (985)
                      +.+|+.||+|+|.|+.+.  .+..++.|+.|++++|+|+.. +..+ ..+++|+.|+|++|+|... .-..++.+++|+.
T Consensus        41 l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~  117 (175)
T PF14580_consen   41 LDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRV  117 (175)
T ss_dssp             -TT--EEE-TTS--S--T--T----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--E
T ss_pred             hcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCcc-ccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcce
Confidence            344444444444444332  244566666666677766643 3333 3567777777777777642 1245677788888


Q ss_pred             EecCCCcccCCCCc----cccccccccccccc
Q 001988          590 LDLSNNKISGSIPV----SFEKLSYLKELNLS  617 (985)
Q Consensus       590 L~Ls~N~l~~~~p~----~~~~l~~L~~L~ls  617 (985)
                      |+|.+|.++.. +.    .+..+|+|+.||-.
T Consensus       118 L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~~  148 (175)
T PF14580_consen  118 LSLEGNPVCEK-KNYRLFVIYKLPSLKVLDGQ  148 (175)
T ss_dssp             EE-TT-GGGGS-TTHHHHHHHH-TT-SEETTE
T ss_pred             eeccCCcccch-hhHHHHHHHHcChhheeCCE
Confidence            88888888743 32    36678888887754

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.02  E-value=2.5e-10  Score=112.03  Aligned_cols=61  Identities=30%  Similarity=0.447  Sum_probs=9.9

Q ss_pred             CCCCCceEEEcccccCCCccccccc-cccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCc
Q 001988          191 SKCKQLQELHLGYNNLSGAIPKEIG-NLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLT  255 (985)
Q Consensus       191 ~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  255 (985)
                      .+..++++|+|++|.|+ .+ +.++ .+.+|+.|+|++|.|+. ++ .+..+++|+.|++++|+|+
T Consensus        16 ~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~   77 (175)
T PF14580_consen   16 NNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS   77 (175)
T ss_dssp             ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred             ccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC
Confidence            33445566666666665 22 2343 34555555555555552 21 3444455555555555554

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.02  E-value=3e-10  Score=127.55  Aligned_cols=242  Identities=22%  Similarity=0.126  Sum_probs=175.9

Q ss_pred             HHhcCccCCceeeccCceeEEEEEE--cCCcEEEEEEeccCCcchHHHH--HHHHHHHHhc-CCCCeeeEEeeeecCCce
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARL--EDGVEIAIKVFHPQCASTLKSF--EAECEVIKNI-RHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~~vAvK~~~~~~~~~~~~~--~~E~~il~~l-~h~niv~l~~~~~~~~~~  797 (985)
                      ....+|.....||.|.|+.|+....  .++..||+|...........++  ..|+.+...+ .|.++++++..|......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            3456788889999999999999864  4788899998876644433332  4566666666 599999999999888888


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-CcEEEecccCceec
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAKLL  876 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~-~~~kl~DfGla~~~  876 (985)
                      |+--|||++++......- ...++...++++..|++.++.++   |++.++|+|+||+||++..+ +..+++|||.++.+
T Consensus       342 ~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i---~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVI---HSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             cCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccc---cchhhhcccccccceeeccchhhhhcccccccccc
Confidence            899999999988766522 23466777888899999999999   89999999999999999886 88999999998753


Q ss_pred             cCCCCcceecccccccccc--cccccccCccchhhhcccccccchhhhcccccccCcchh--------hhhHHHHHHHHH
Q 001988          877 SGEDESTMRTQTLATIGYM--APDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH--------FAAKEQCLLSIF  946 (985)
Q Consensus       877 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~--------~~~~~~~~~~l~  946 (985)
                      .-..     ....++-+++  +|+......+..+.|+ ++++.-+.+.+++..+......        .........++.
T Consensus       418 ~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~-~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~~p~~~~~~~~~q  491 (524)
T KOG0601|consen  418 AFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADI-FSLGLSVDEAITGSPLSESGVQSLTIRSGDTPNLPGLKLQLQ  491 (524)
T ss_pred             ceec-----ccccccccccccchhhcccccccccccc-ccccccccccccCcccCcccccceeeecccccCCCchHHhhh
Confidence            2111     1112334444  4444444556667777 8998888888887765543211        111122236677


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHhH
Q 001988          947 SLALECTMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~~L~~i~  974 (985)
                      .+.+.+..+++..||.+.+....-+..+
T Consensus       492 ~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  492 VLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             hhhhhhcCCccccchhhhhhcccchhhh
Confidence            7888999999999999988776554433

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.98  E-value=3.9e-09  Score=105.52  Aligned_cols=126  Identities=23%  Similarity=0.284  Sum_probs=84.3

Q ss_pred             eEEEEEEcCCcEEEEEEeccCCc-------------c-------------hHHHHHHHHHHHHhcCCC--CeeeEEeeee
Q 001988          741 SVYRARLEDGVEIAIKVFHPQCA-------------S-------------TLKSFEAECEVIKNIRHR--NLVKIISSCS  792 (985)
Q Consensus       741 ~V~~~~~~~~~~vAvK~~~~~~~-------------~-------------~~~~~~~E~~il~~l~h~--niv~l~~~~~  792 (985)
                      .||.|...+|.+||+|+.+....             .             .....++|.+.|.++...  ++.+++++- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999999999999999854210             0             123467899999999765  466666553 


Q ss_pred             cCCceEEEEeccC--CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 001988          793 NDDFKALVLEYMS--NGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDF  870 (985)
Q Consensus       793 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~Df  870 (985)
                         ..++||||++  |..+.......   ++......++.+++..+..++  |..||+|+|+.+.||+++++ .+.++||
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~--~~~givHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKML--HKAGIVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHH--HCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHH--HhcCceecCCChhhEEeecc-eEEEEec
Confidence               3469999998  54444332221   112334567778888777764  79999999999999999988 9999999


Q ss_pred             cCceec
Q 001988          871 GMAKLL  876 (985)
Q Consensus       871 Gla~~~  876 (985)
                      |.+...
T Consensus       151 ~qav~~  156 (188)
T PF01163_consen  151 GQAVDS  156 (188)
T ss_dssp             TTEEET
T ss_pred             Ccceec
Confidence            988764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.94  E-value=6.2e-10  Score=82.08  Aligned_cols=40  Identities=43%  Similarity=0.985  Sum_probs=30.6

Q ss_pred             hhHHHHHHHHHHhcccCCCCcccCCCCCC--CCcceeeeEEEe
Q 001988           29 STDQQALLALKDHITYDPTNLLGTNWTSN--ASICSWIGIICD   69 (985)
Q Consensus        29 ~~~~~aLl~~k~~~~~~~~~~~~s~w~~~--~~~c~w~gv~c~   69 (985)
                      +.|++||++||+++..+|.+.+.+ |+.+  ++||+|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~-W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSS-WNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT---TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCccccc-CCCcCCCCCeeeccEEeC
Confidence            579999999999998778777776 9976  799999999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.90  E-value=8.6e-10  Score=134.79  Aligned_cols=93  Identities=29%  Similarity=0.346  Sum_probs=70.3

Q ss_pred             CCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhc
Q 001988          160 KLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIG  239 (985)
Q Consensus       160 ~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  239 (985)
                      .++..+|..++.|++|||++|.=-+.+|+++++|-+||+|+|++..++ .+|..+++|..|.+|++..+.-...+|....
T Consensus       561 ~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~  639 (889)
T KOG4658|consen  561 EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILL  639 (889)
T ss_pred             hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhh
Confidence            566666777888888888877665678888888888888888888887 6788888888888888887776555666666


Q ss_pred             CCCCCCEEEecCCc
Q 001988          240 YLQNLDVLQLGFNN  253 (985)
Q Consensus       240 ~l~~L~~L~Ls~N~  253 (985)
                      .|++|++|.+-.-.
T Consensus       640 ~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  640 ELQSLRVLRLPRSA  653 (889)
T ss_pred             hcccccEEEeeccc
Confidence            77888887776554

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.86  E-value=3.1e-08  Score=105.27  Aligned_cols=141  Identities=15%  Similarity=0.117  Sum_probs=102.1

Q ss_pred             CceeeccCceeEEEEEEcCCcEEEEEEeccCCcch-----------HHHHHHHHHHHHhcCCCCe--eeEEeeeec----
Q 001988          731 NNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAST-----------LKSFEAECEVIKNIRHRNL--VKIISSCSN----  793 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~-----------~~~~~~E~~il~~l~h~ni--v~l~~~~~~----  793 (985)
                      ++.+-......|+++.. +|+.|.||.........           ...+.+|.+.+.++...+|  ++.+++.+.    
T Consensus        27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            35555555566778776 57899999775432110           1147899999988853333  344445432    


Q ss_pred             -CCceEEEEeccCCC-ChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-------CC
Q 001988          794 -DDFKALVLEYMSNG-SLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE-------DM  863 (985)
Q Consensus       794 -~~~~~lv~e~~~~g-sL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~-------~~  863 (985)
                       ....++|||++++. +|.+++... ....+...+..++.+++..+.-|   |..||+|+|++++|||++.       ++
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L---H~~Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM---HAAGINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HHCcCccCCCChhhEEEeccccCCCCCc
Confidence             23468999999886 899887542 22445667778999999999999   8999999999999999975       46


Q ss_pred             cEEEecccCcee
Q 001988          864 VAHLSDFGMAKL  875 (985)
Q Consensus       864 ~~kl~DfGla~~  875 (985)
                      .+.++||+.+..
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            899999998754

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.81  E-value=6.5e-09  Score=127.18  Aligned_cols=277  Identities=22%  Similarity=0.219  Sum_probs=127.4

Q ss_pred             CCceEEEcccccCCCccccccccccccceEeecccc--ccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEE
Q 001988          194 KQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNK--LHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEI  271 (985)
Q Consensus       194 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L  271 (985)
                      ...+...+-+|.+. .++....+ +.|+.|-+..|.  +....++.|..++.|++|||++|.=-+.+|..++.+-+|++|
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL  600 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL  600 (889)
T ss_pred             hheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence            44555555555554 33333222 245556666654  332333345556666666666655445566666655555555


Q ss_pred             EccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcc
Q 001988          272 FLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNL  351 (985)
Q Consensus       272 ~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  351 (985)
                      +|++..++ .+|..+. .|..|.+||+..+.-.                        ..+|.....|.+|++|.+.....
T Consensus       601 ~L~~t~I~-~LP~~l~-~Lk~L~~Lnl~~~~~l------------------------~~~~~i~~~L~~Lr~L~l~~s~~  654 (889)
T KOG4658|consen  601 DLSDTGIS-HLPSGLG-NLKKLIYLNLEVTGRL------------------------ESIPGILLELQSLRVLRLPRSAL  654 (889)
T ss_pred             cccCCCcc-ccchHHH-HHHhhheecccccccc------------------------ccccchhhhcccccEEEeecccc
Confidence            55555555 4444442 3444555555444433                        33344444455555554443331


Q ss_pred             cCCCCcccccccccccCcccEEEecCCCCCc-cCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCC
Q 001988          352 TSSTPELGFLSSLANCKKLRYLGLGGNPLDG-FLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLS  430 (985)
Q Consensus       352 ~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  430 (985)
                      ..-..   .+..+.++.+|+.+......... .-......+....+.+.+..+... ..+..+..+.+|+.|.+.++.+.
T Consensus       655 ~~~~~---~l~el~~Le~L~~ls~~~~s~~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~  730 (889)
T KOG4658|consen  655 SNDKL---LLKELENLEHLENLSITISSVLLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGIS  730 (889)
T ss_pred             ccchh---hHHhhhcccchhhheeecchhHhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCc
Confidence            11000   11122333344444332222100 000111111112223333333322 34556777888888888888876


Q ss_pred             CCCCccccccc------cccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeee
Q 001988          431 GSIPVTFGGLQ------KLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTF  503 (985)
Q Consensus       431 ~~~~~~~~~l~------~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  503 (985)
                      .....++....      ++..+...+...- ..+...-..++|+.|++..+.....+.+....+..+..+-+..+.+.+
T Consensus       731 e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~  808 (889)
T KOG4658|consen  731 EIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEG  808 (889)
T ss_pred             hhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEeccccccc
Confidence            44433322222      2222222222111 122223345778888887776655555555555555555555554443

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.80  E-value=3.7e-09  Score=85.29  Aligned_cols=59  Identities=36%  Similarity=0.580  Sum_probs=28.7

Q ss_pred             cccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCc
Q 001988          538 AVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNK  596 (985)
Q Consensus       538 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  596 (985)
                      +|+.|++++|+|+...+..|.++++|++|++++|+++...|..|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            34444444444444444444455555555555555544444445555555555555544

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.79  E-value=8e-09  Score=83.32  Aligned_cols=60  Identities=35%  Similarity=0.541  Sum_probs=36.8

Q ss_pred             CCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcc
Q 001988          466 RLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLL  525 (985)
Q Consensus       466 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l  525 (985)
                      +|++|++++|+|+...+..|.++++|++|++++|+++.+.|.+|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            456666666666655555666666666666666666666666666666666666665553

...

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.74  E-value=5.4e-08  Score=99.33  Aligned_cols=135  Identities=24%  Similarity=0.234  Sum_probs=100.4

Q ss_pred             ccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCc----------------------chHHHHHHHHHHHHhcCCC--C
Q 001988          728 FAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA----------------------STLKSFEAECEVIKNIRHR--N  783 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~----------------------~~~~~~~~E~~il~~l~h~--n  783 (985)
                      ...+..||-|--+.||.|....|.++|||.-+....                      -.....++|.++|+++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            455788999999999999999999999997542210                      0123468899999999644  6


Q ss_pred             eeeEEeeeecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC
Q 001988          784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM  863 (985)
Q Consensus       784 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~  863 (985)
                      +.+.+++    +...+||||++|-.|...-      ++......++..|++-+...   -..||||+|+++-||+++++|
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~---~~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKA---YRRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHH---HHcCccccCCchheEEEecCC
Confidence            6666665    3457999999886665431      12333444666666666666   578999999999999999999


Q ss_pred             cEEEecccCcee
Q 001988          864 VAHLSDFGMAKL  875 (985)
Q Consensus       864 ~~kl~DfGla~~  875 (985)
                      .++++||--+..
T Consensus       240 ~~~vIDwPQ~v~  251 (304)
T COG0478         240 DIVVIDWPQAVP  251 (304)
T ss_pred             CEEEEeCccccc
Confidence            999999965543

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.61  E-value=5.1e-09  Score=94.38  Aligned_cols=113  Identities=19%  Similarity=0.285  Sum_probs=73.4

Q ss_pred             cceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEec
Q 001988          513 KDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDL  592 (985)
Q Consensus       513 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  592 (985)
                      ..|+..++++|.+...++..-...+.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|..||.
T Consensus        53 ~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds  130 (177)
T KOG4579|consen   53 YELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS  130 (177)
T ss_pred             ceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence            34455555555555444433334456777777777777 56777888888888888888877 56667777777888888


Q ss_pred             CCCcccCCCCccccccccccccccccccccCCCCCC
Q 001988          593 SNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRG  628 (985)
Q Consensus       593 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  628 (985)
                      .+|.+. .+|..+-.-......++.++++.+..|..
T Consensus       131 ~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~k  165 (177)
T KOG4579|consen  131 PENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKK  165 (177)
T ss_pred             CCCccc-cCcHHHhccccHHHHHhcCCcccccCccc
Confidence            888776 44544333344455566777777776654

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.56  E-value=2.8e-09  Score=119.95  Aligned_cols=178  Identities=29%  Similarity=0.329  Sum_probs=89.6

Q ss_pred             CCcCCCCCCccEEEccCCCCCCCCCcccccc-ccccceecccccccCCchhhh----hh------ccCCCeEEccCCccc
Q 001988          410 PKAIGNLSNLIVLSLGGNNLSGSIPVTFGGL-QKLQGLDLAFNKLAGSIPDEI----CL------LSRLNELDLNGNKIS  478 (985)
Q Consensus       410 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~----~~------l~~L~~L~L~~N~l~  478 (985)
                      |-.+..+..|++|.|.++.|+.  ...+..+ ..|+.|.-+ |.+. .+-+.|    +.      -..|...+.+.|++.
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~-Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~  177 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLD-ALRHVFASCGGDISNSPVWNKLATASFSYNRLV  177 (1096)
T ss_pred             CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHH-HHHHHHHHhccccccchhhhhHhhhhcchhhHH
Confidence            4566778889999999888863  1112222 245555332 3322 111111    11      123556666666665


Q ss_pred             cccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhc
Q 001988          479 GSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLE  558 (985)
Q Consensus       479 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  558 (985)
                       .....+.-++.|+.|+|++|+++.+.  .+..++.|+.||+++|.+..+.-.....+. |+.|.+++|.++..  ..+.
T Consensus       178 -~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie  251 (1096)
T KOG1859|consen  178 -LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIE  251 (1096)
T ss_pred             -hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHH
Confidence             34445555666677777777666542  455566666666666666544333333333 55555555555422  2344


Q ss_pred             ccccceeeeeecceeccch-hhhhhcccccCeEecCCCcc
Q 001988          559 GLKSLQNISLAYNRLEGPI-PESFGNMTSLESLDLSNNKI  597 (985)
Q Consensus       559 ~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l  597 (985)
                      +|.+|+.||+++|-|.+.- -.-+..|..|..|+|.+|.+
T Consensus       252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl  291 (1096)
T KOG1859|consen  252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL  291 (1096)
T ss_pred             hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence            4555555555555544321 11133344444444444444

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.55  E-value=5.3e-07  Score=92.88  Aligned_cols=107  Identities=22%  Similarity=0.258  Sum_probs=84.4

Q ss_pred             HHHHHHHHHHHHhcCCC--CeeeEEeeeecC----CceEEEEeccCCC-ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 001988          766 LKSFEAECEVIKNIRHR--NLVKIISSCSND----DFKALVLEYMSNG-SLEDCLHSSNCALNIFCRLNIMIDIASALEY  838 (985)
Q Consensus       766 ~~~~~~E~~il~~l~h~--niv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~  838 (985)
                      ...+.+|...+.++...  ..++.+++.+..    ...++|+|++++. +|.+++..... .+......++.++++.++-
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence            34678899988888533  344566666543    2357999999884 89998886432 5566778899999999999


Q ss_pred             HHhcCCCCeEeCCCCCCCEEEcCCC---cEEEecccCceec
Q 001988          839 LHFGHSTPIIHCDLKPSNVLLDEDM---VAHLSDFGMAKLL  876 (985)
Q Consensus       839 Lh~~h~~~ivHrDlk~~Nill~~~~---~~kl~DfGla~~~  876 (985)
                      |   |..||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       134 l---H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 L---HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             H---HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9   899999999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.55  E-value=1.5e-08  Score=119.58  Aligned_cols=236  Identities=23%  Similarity=0.225  Sum_probs=162.5

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccC---CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ---CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ..+.+...+-+.+|+++.++.+.-. .|...++|.....   .....+....+-.+.-...||-+++....+.-....++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4466777778889999999988643 3323333333211   11122233333333333456777766655555667789


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC-
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG-  878 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~-  878 (985)
                      |++|+.++++...++..+ ..+..........+..+.+||   |+..++|||++|.|.+...+++.++.|||......- 
T Consensus       882 ~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L---~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESL---HSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhcc---ccchhhcccccccchhhcccCCcccCccccccccccc
Confidence            999999999999998765 334444445666788899999   888899999999999999999999999984332110 


Q ss_pred             -----C---------------C--------CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccC
Q 001988          879 -----E---------------D--------ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSG  930 (985)
Q Consensus       879 -----~---------------~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~  930 (985)
                           .               .        .........||+.|.|||...+.......| ||..|+.+++.+.+.....
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad-~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAAD-WWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcch-hhhhhhhhhhhhcCCCCCC
Confidence                 0               0        001133456999999999998888877777 7999999999998876544


Q ss_pred             cc--------------hhhhhHHHHHHHHHHHHHHccCCCCCCCCCHH
Q 001988          931 EE--------------KHFAAKEQCLLSIFSLALECTMESPEKRIDAK  964 (985)
Q Consensus       931 ~~--------------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~  964 (985)
                      ..              ++...++....+..+++...+..+|.+|-.|.
T Consensus      1037 a~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            32              22233444567778888888888888887765

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.54  E-value=2.9e-07  Score=105.85  Aligned_cols=140  Identities=22%  Similarity=0.296  Sum_probs=100.5

Q ss_pred             ceeeccCceeEEEEEEcCCcEEEEEEeccCCcch----------------------------------------HHHHHH
Q 001988          732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAST----------------------------------------LKSFEA  771 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~----------------------------------------~~~~~~  771 (985)
                      +.|+.++-|.||+|++++|++||||+.++.....                                        +-.+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6799999999999999999999999987653110                                        012455


Q ss_pred             HHHHHHhcC-----CCCeeeEEeeeecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHH-HHHHHhcCCC
Q 001988          772 ECEVIKNIR-----HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASA-LEYLHFGHST  845 (985)
Q Consensus       772 E~~il~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~-L~~Lh~~h~~  845 (985)
                      |..-+.+++     .+.+.-..=|++..+...++|||++|-.+.+.........+   +..++..++++ +..+   -..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f~~q~---~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAFLRQL---LRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHHHHHH---Hhc
Confidence            666665552     45554444455556677899999999888887433323344   33455555544 3333   458


Q ss_pred             CeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       846 ~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      |+.|+|..|-||+++.+|++.+.|||+...++
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            99999999999999999999999999987764

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.52  E-value=1.9e-06  Score=94.88  Aligned_cols=208  Identities=16%  Similarity=0.147  Sum_probs=142.0

Q ss_pred             ceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeec----CCceEEEEeccCC-CChHHH
Q 001988          739 FGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN----DDFKALVLEYMSN-GSLEDC  812 (985)
Q Consensus       739 ~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~  812 (985)
                      -.+.|++... ||..|++|+++.........-..-+++++++.|+|+|++.+++..    +...++||+|.|+ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            4568999854 899999999965433332233456788999999999999998863    3467899999987 477665


Q ss_pred             hhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          813 LHSS--------------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       813 l~~~--------------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      ....              +...++...|.++.|+..||.++   |+.|..-+-+.+.+|+++.+.+++|+.-|..-.+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sI---HssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSI---HSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHH---HhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            4321              23456788999999999999999   889999999999999999999999998887655432


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh------hhhHHHHHHHHHHHHHHc
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH------FAAKEQCLLSIFSLALEC  952 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~c  952 (985)
                      ++.              +|  +...   -+.|. -.+|.+++.+.++..-+....-      .........++++++.-.
T Consensus       446 d~~--------------~~--le~~---Qq~D~-~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~~yS~D~rn~v~yl  505 (655)
T KOG3741|consen  446 DPT--------------EP--LESQ---QQNDL-RDLGLLLLALATGTENSNRTDSTQSSHLTRITTTYSTDLRNVVEYL  505 (655)
T ss_pred             CCC--------------cc--hhHH---hhhhH-HHHHHHHHHHhhcccccccccchHHHHHHHhhhhhhHHHHHHHHHH
Confidence            221              11  1111   12233 5567778887777543222111      111223556677777777


Q ss_pred             cCCCCCCCCCHHHHHHHH
Q 001988          953 TMESPEKRIDAKDTITRL  970 (985)
Q Consensus       953 l~~~P~~RPt~~ev~~~L  970 (985)
                      ....+++ -+..+++.++
T Consensus       506 ~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  506 ESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             HhcCccc-ccHHHHHHHH
Confidence            7777775 4566655544

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.50  E-value=3.2e-09  Score=119.48  Aligned_cols=179  Identities=31%  Similarity=0.350  Sum_probs=124.4

Q ss_pred             CCCccchhhcccceeccccccccccCCcCCCC-CCccEEEccCCCCC----------CCCCccccccccccceecccccc
Q 001988          385 PSSIGNLSLSLERLNIAFCNISGNIPKAIGNL-SNLIVLSLGGNNLS----------GSIPVTFGGLQKLQGLDLAFNKL  453 (985)
Q Consensus       385 p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~----------~~~~~~~~~l~~L~~L~Ls~N~l  453 (985)
                      |-.+..+. +|+.|.|.+|.|..  ...+..+ ..|+.|.- +|.+.          |.+-.++ ...+|.+.+.++|++
T Consensus       102 pi~ifpF~-sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~-~Wn~L~~a~fsyN~L  176 (1096)
T KOG1859|consen  102 PISIFPFR-SLRVLELRGCDLST--AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSP-VWNKLATASFSYNRL  176 (1096)
T ss_pred             Cceecccc-ceeeEEecCcchhh--hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccch-hhhhHhhhhcchhhH
Confidence            54555665 79999999998873  1112111 23444432 22221          1111111 134788889999999


Q ss_pred             cCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccc
Q 001988          454 AGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAI  533 (985)
Q Consensus       454 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~  533 (985)
                      . .+..++.-++.|+.|+|++|+++...  .+..++.|++|||+.|.++.+.--...+.. |..|.+++|.++...  .+
T Consensus       177 ~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL~--gi  250 (1096)
T KOG1859|consen  177 V-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTLR--GI  250 (1096)
T ss_pred             H-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhhh--hH
Confidence            8 67778888899999999999998643  788889999999999999864333333333 899999999887643  46


Q ss_pred             cCCCcccEEEccCCccCccCc-hhhcccccceeeeeecceec
Q 001988          534 GNLKAVVGIDLSRNNLSGNIP-TTLEGLKSLQNISLAYNRLE  574 (985)
Q Consensus       534 ~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~  574 (985)
                      .++.+|+.||+|.|-|.+.-. ..++.|..|+.|+|.+|.+-
T Consensus       251 e~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  251 ENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             HhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            788899999999998876422 34566788999999999886

>PRK09902 hypothetical protein; Provisional

Probab=98.48  E-value=2.4e-06  Score=85.73  Aligned_cols=138  Identities=17%  Similarity=0.130  Sum_probs=102.2

Q ss_pred             eeccCceeEEEEEEcCCcEEEEEEeccCC------cchHHHHHHHHHHHHhcCC--CCeeeEEeeeec--C--CceEEEE
Q 001988          734 IGIGGFGSVYRARLEDGVEIAIKVFHPQC------ASTLKSFEAECEVIKNIRH--RNLVKIISSCSN--D--DFKALVL  801 (985)
Q Consensus       734 ig~G~~g~V~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~E~~il~~l~h--~niv~l~~~~~~--~--~~~~lv~  801 (985)
                      -|+||-+.|++.... |..+=+|+-....      +-....|.+|...++++..  -.+.+...+...  +  -..+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            477999999998875 4468888754111      2245689999999999853  224444422211  1  2357999


Q ss_pred             eccCC-CChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc--EEEecccCcee
Q 001988          802 EYMSN-GSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV--AHLSDFGMAKL  875 (985)
Q Consensus       802 e~~~~-gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~--~kl~DfGla~~  875 (985)
                      |-++| -+|.+++.... .+.+...+..+..+++.+++-|   |..|+.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~L---H~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKM---HSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            98754 48999886542 2457778889999999999999   8999999999999999986666  99999986654

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=98.42  E-value=1.3e-08  Score=102.14  Aligned_cols=134  Identities=22%  Similarity=0.207  Sum_probs=80.6

Q ss_pred             hhhcCCCCCCEEEecCCcCcccCccc----ccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccc
Q 001988          236 QEIGYLQNLDVLQLGFNNLTGVVPAT----IFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSI  311 (985)
Q Consensus       236 ~~~~~l~~L~~L~Ls~N~l~~~~p~~----l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  311 (985)
                      ..+.++++|+..+||.|.+....|..    +...+.|++|.|+||.+...-...+...+-.     |..|+       -.
T Consensus        86 ~aLlkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~-----la~nK-------Ka  153 (388)
T COG5238          86 KALLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFH-----LAYNK-------KA  153 (388)
T ss_pred             HHHhcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHH-----HHHHh-------hh
Confidence            34566788888888888887655544    3456778888888887752222222211111     12221       23


Q ss_pred             cCCCCccEEEccCcccccccCC----cccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCC
Q 001988          312 TNASKLILLEMGSNSFSGFIPS----AIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLD  381 (985)
Q Consensus       312 ~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~  381 (985)
                      .+-+.|++.....|++......    .+..-.+|+.+.+..|.|.......-.+-.+..+.+|+.|||.+|.++
T Consensus       154 a~kp~Le~vicgrNRlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft  227 (388)
T COG5238         154 ADKPKLEVVICGRNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFT  227 (388)
T ss_pred             ccCCCceEEEeccchhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchh
Confidence            4556788888888887632211    122235788888888887644322222334567788888888888776

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.36  E-value=2.2e-08  Score=90.37  Aligned_cols=108  Identities=25%  Similarity=0.324  Sum_probs=62.2

Q ss_pred             ceecccCCcCCCCCCcccccC---CCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccceec
Q 001988          100 KSLDLSHNKLSSNIPSSIFTM---STLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLF  176 (985)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l---~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~  176 (985)
                      ..+||+++++- .+++....+   ..|+..+|++|.+....+.+....+.+++|+|++|.++ .+|.++ ..++.|+.|+
T Consensus        30 h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~-Aam~aLr~lN  106 (177)
T KOG4579|consen   30 HFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEEL-AAMPALRSLN  106 (177)
T ss_pred             hhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHH-hhhHHhhhcc
Confidence            34444444442 233333322   33444455566555544455555555555555555555 677773 5677777777


Q ss_pred             ccCccccccCCcccCCCCCceEEEcccccCCCcccc
Q 001988          177 LRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPK  212 (985)
Q Consensus       177 L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~  212 (985)
                      ++.|.+. ..|..+..|.+|-.|+..+|.+. .+|-
T Consensus       107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~  140 (177)
T KOG4579|consen  107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDV  140 (177)
T ss_pred             cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcH
Confidence            7777776 56666666777777777777666 4443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	985
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-56
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		4e-56
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-29
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-29
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-28
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-23
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-22
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-21
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-21
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		9e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-18
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-17
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-15
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-15
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-15
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-15
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-15
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-15
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-15
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		9e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		9e-13
3iok_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-12
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-12
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-12
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-12
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-12
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-12
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-12
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-12
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-12
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-12
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-12
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-12
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-12
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		9e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-12
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		9e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-11
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-11
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-11
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-11
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-11
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-11
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-11
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-11
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-11
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-11
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-11
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-11
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		3e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-11
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		7e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-11
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-11
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-10
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-10
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		2e-10
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		1e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-10
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		3e-10
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		6e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-10
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		4e-10
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		1e-07
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-10
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		4e-10
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		1e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		9e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-09
2a0z_A	705	The Molecular Structure Of Toll-like Receptor 3 Lig		1e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-09
1ziw_A	680	Human Toll-Like Receptor 3 Extracellular Domain Str		2e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-09
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		2e-09
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		1e-07
3ulu_A	694	Structure Of Quaternary Complex Of Human Tlr3ecd Wi		2e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-09
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		6e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-09
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		8e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-09
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-09
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-08
3zyn_A	321	Crystal Structure Of The N-Terminal Leucine Rich Re		2e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-08
3zyj_A	440	Netring1 In Complex With Ngl1 Length = 440		4e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		4e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		4e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		4e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-08
3zyo_A	411	Crystal Structure Of The N-Terminal Leucine Rich Re		5e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
1w8a_A	192	Third Lrr Domain Of Drosophila Slit Length = 192		1e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-07
2id5_A	477	Crystal Structure Of The Lingo-1 Ectodomain Length		3e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-07
3v47_A	455	Crystal Structure Of The N-Tetminal Fragment Of Zeb		3e-07
3o6n_A	390	Crystal Structure Of Apl1 Leucine-Rich Repeat Domai		4e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-07
3soa_A	444	Full-Length Human Camkii Length = 444		7e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-07
3cig_A	697	Crystal Structure Of Mouse Tlr3 Ectodomain Length =		9e-07
3cig_A	697	Crystal Structure Of Mouse Tlr3 Ectodomain Length =		5e-05
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		9e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		9e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-06
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-06
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-06
3oja_B	597	Crystal Structure Of Lrim1APL1C COMPLEX Length = 59		2e-06
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-06
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-06
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-06
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-06
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-06
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-06
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-06
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-06
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-06
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		8e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-06
1ozn_A	285	1.5a Crystal Structure Of The Nogo Receptor Ligand		9e-06
1ozn_A	285	1.5a Crystal Structure Of The Nogo Receptor Ligand		1e-04
1p8t_A	285	Crystal Structure Of Nogo-66 Receptor Length = 285		9e-06
1p8t_A	285	Crystal Structure Of Nogo-66 Receptor Length = 285		1e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		9e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-05
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		1e-05
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		1e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-05
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-05
2z66_A	306	Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A		1e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-05
3vq1_A	606	Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLE		2e-05
3vq1_A	606	Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLE		2e-04
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-05
2z64_A	599	Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Comp		2e-05
2z64_A	599	Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Comp		2e-04
4fmz_A	347	Crystal Structure Of An Internalin (Inlf) From List		2e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-05
3a79_B	562	Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len		2e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-05
3rfs_A	272	Design Of A Binding Scaffold Based On Variable Lymp		4e-05
3rfs_A	272	Design Of A Binding Scaffold Based On Variable Lymp		7e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-05
3fxi_A	605	Crystal Structure Of The Human Tlr4-Human Md-2-E.Co		5e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-05
3rg1_A	612	Crystal Structure Of The Rp105MD-1 Complex Length =		5e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-05
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		7e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		7e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-05
3t6q_A	606	Crystal Structure Of Mouse Rp105MD-1 Complex Length		8e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
3kj4_A	286	Structure Of Rat Nogo Receptor Bound To 1d9 Antagon		1e-04
3kj4_A	286	Structure Of Rat Nogo Receptor Bound To 1d9 Antagon		7e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-04
3v44_A	407	Crystal Structure Of The N-Terminal Fragment Of Zeb		1e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-04
3b2d_A	603	Crystal Structure Of Human Rp105MD-1 Complex Length		2e-04
3b2d_A	603	Crystal Structure Of Human Rp105MD-1 Complex Length		6e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-04
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-04
2o6s_A	208	Structural Diversity Of The Hagfish Variable Lympho		2e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-04
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-04
1xcd_A	329	Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo		3e-04
4g8a_A	635	Crystal Structure Of Human Tlr4 Polymorphic Variant		3e-04
1xku_A	330	Crystal Structure Of The Dimeric Protein Core Of De		3e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-04
1m10_B	290	Crystal Structure Of The Complex Of Glycoprotein Ib		3e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-04
3ula_A	279	Crystal Structure Of The Tv3 Mutant F63w-Md-2-Erito		3e-04
3ul7_A	278	Crystal Structure Of The Tv3 Mutant F63w Length = 2		3e-04
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-04
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		3e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-04
3j0a_A	844	Homology Model Of Human Toll-Like Receptor 5 Fitted		4e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-04
2z62_A	276	Crystal Structure Of The Tv3 Hybrid Of Human Tlr4 A		4e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-04
2z63_A	570	Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A		4e-04
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-04
3e6j_A	229	Crystal Structure Of Variable Lymphocyte Receptor (		6e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		7e-04
3ul8_A	279	Crystal Structure Of The Tv3 Mutant V134l Length =		7e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-04
2ft3_A	332	Crystal Structure Of The Biglycan Dimer Core Protei		7e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  217 bits (552), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 196/634 (30%), Positives = 317/634 (50%), Gaps = 42/634 (6%)
Query: 50  LGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKL 109
           L  N  S A++  W+  + D    ++  L +S   + G +  +++   +L+ LD+S N  
Sbjct: 155 LSANSISGANVVGWV--LSD-GCGELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNF 209
Query: 110 SSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHL 169
           S+ IP  +   S L+ L +  N+LSG  S      + +  + +S N+  G +P      L
Sbjct: 210 STGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL---PL 265
Query: 170 RYLKHLFLRENMFYGKIPSSLS-KCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINN 228
           + L++L L EN F G+IP  LS  C  L  L L  N+  GA+P   G+ ++L+ ++L +N
Sbjct: 266 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 325
Query: 229 KLHGEIPQE-IGYLQNLDVLQLGFNNLTGVVPATIFNMS-TLKEIFLYNNSLSGS-LPSR 285
              GE+P + +  ++ L VL L FN  +G +P ++ N+S +L  + L +N+ SG  LP+ 
Sbjct: 326 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 385
Query: 286 IDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFD 345
                  L+ L L  N F+G IP +++N S+L+ L +  N  SG IPS++G+L  L+   
Sbjct: 386 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 445
Query: 346 IFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNI 405
           ++ N L    P+      L   K L  L L  N L G +PS + N + +L  ++++   +
Sbjct: 446 LWLNMLEGEIPQ-----ELMYVKTLETLILDFNDLTGEIPSGLSNCT-NLNWISLSNNRL 499
Query: 406 SGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLS 465
           +G IPK IG L NL +L L  N+ SG+IP   G  + L  LDL  N   G+IP  +   S
Sbjct: 500 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS 559
Query: 466 -RLNELDLNGNKI-----SGSISSCLGNLTSLQYLNLGS---NRFTFVIPSTFWNLKDIL 516
            ++    + G +       G    C G    L++  + S   NR +   P          
Sbjct: 560 GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPC--------- 610
Query: 517 SFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGP 576
             +I+S +  G  S    N  +++ +D+S N LSG IP  +  +  L  ++L +N + G 
Sbjct: 611 --NITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGS 668
Query: 577 IPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTA 636
           IP+  G++  L  LDLS+NK+ G IP +   L+ L E++LS N L G IP  G F  F  
Sbjct: 669 IPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPP 728
Query: 637 ESFMGNELLCGLPNLQVPPCKHSQPRAQHKSKKT 670
             F+ N  LCG P   +P C  S        +++
Sbjct: 729 AKFLNNPGLCGYP---LPRCDPSNADGYAHHQRS 759

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  216 bits (551), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 196/623 (31%), Positives = 314/623 (50%), Gaps = 42/623 (6%)
Query: 50  LGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKL 109
           L  N  S A++  W+  + D    ++  L +S   + G +  +++   +L+ LD+S N  
Sbjct: 158 LSANSISGANVVGWV--LSD-GCGELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNF 212
Query: 110 SSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHL 169
           S+ IP  +   S L+ L +  N+LSG  S      + +  + +S N+  G +P      L
Sbjct: 213 STGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL---PL 268
Query: 170 RYLKHLFLRENMFYGKIPSSLS-KCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINN 228
           + L++L L EN F G+IP  LS  C  L  L L  N+  GA+P   G+ ++L+ ++L +N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 229 KLHGEIPQE-IGYLQNLDVLQLGFNNLTGVVPATIFNMS-TLKEIFLYNNSLSGS-LPSR 285
              GE+P + +  ++ L VL L FN  +G +P ++ N+S +L  + L +N+ SG  LP+ 
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388
Query: 286 IDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFD 345
                  L+ L L  N F+G IP +++N S+L+ L +  N  SG IPS++G+L  L+   
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448
Query: 346 IFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNI 405
           ++ N L    P+      L   K L  L L  N L G +PS + N + +L  ++++   +
Sbjct: 449 LWLNMLEGEIPQ-----ELMYVKTLETLILDFNDLTGEIPSGLSNCT-NLNWISLSNNRL 502
Query: 406 SGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLS 465
           +G IPK IG L NL +L L  N+ SG+IP   G  + L  LDL  N   G+IP  +   S
Sbjct: 503 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS 562
Query: 466 -RLNELDLNGNKI-----SGSISSCLGNLTSLQYLNLGS---NRFTFVIPSTFWNLKDIL 516
            ++    + G +       G    C G    L++  + S   NR +   P          
Sbjct: 563 GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPC--------- 613
Query: 517 SFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGP 576
             +I+S +  G  S    N  +++ +D+S N LSG IP  +  +  L  ++L +N + G 
Sbjct: 614 --NITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGS 671
Query: 577 IPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTA 636
           IP+  G++  L  LDLS+NK+ G IP +   L+ L E++LS N L G IP  G F  F  
Sbjct: 672 IPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPP 731
Query: 637 ESFMGNELLCGLPNLQVPPCKHS 659
             F+ N  LCG P   +P C  S
Sbjct: 732 AKFLNNPGLCGYP---LPRCDPS 751

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  129 bits (323), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/202 (39%), Positives = 112/202 (55%), Gaps = 7/202 (3%)
Query: 712 TIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLK-SFE 770
            ++RFS  EL  A+DNF+  NI+G GGFG VY+ RL DG  +A+K    +     +  F+
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 771 AECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLH---SSNCALNIFCRLN 827
            E E+I    HRNL+++   C     + LV  YM+NGS+  CL     S   L+   R  
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 828 IMIDIASALEYLHFGHSTP-IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
           I +  A  L YLH  H  P IIH D+K +N+LLDE+  A + DFG+AKL+  +D      
Sbjct: 144 IALGSARGLAYLH-DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA 202
Query: 887 QTLATIGYMAPDEIFVGELSLK 908
               TIG++AP+ +  G+ S K
Sbjct: 203 -VRGTIGHIAPEYLSTGKSSEK 223

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score =  128 bits (321), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 97/276 (35%), Positives = 143/276 (51%), Gaps = 34/276 (12%)
Query: 384 LPSSIGNLSLSLERLNIA-FCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQK 442
           +PSS+ NL   L  L I    N+ G IP AI  L+ L  L +   N+SG+IP     ++ 
Sbjct: 68  IPSSLANLPY-LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 443 LQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSL-QYLNLGSNRF 501
           L  LD ++N L+G++P  I  L  L  +  +GN+ISG+I    G+ + L   + +  NR 
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
Query: 502 TFVIPSTFWNLKDILSF-DISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGL 560
           T  IP TF NL   L+F D+S N+L+G  S+  G+ K    I L++N+L+ +        
Sbjct: 187 TGKIPPTFANLN--LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD-------- 236
Query: 561 KSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNK 620
             L  + L+ N               L  LDL NN+I G++P    +L +L  LN+SFN 
Sbjct: 237 --LGKVGLSKN---------------LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 621 LKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPC 656
           L GEIP+GG    F   ++  N+ LCG P   +P C
Sbjct: 280 LCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  125 bits (313), Expect = 1e-28,   Method: Composition-based stats.
 Identities = 98/307 (31%), Positives = 144/307 (46%), Gaps = 48/307 (15%)
Query: 713 IRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLK-SFEA 771
           ++RFS  EL  A+DNF   NI+G GGFG VY+ RL DG  +A+K    +     +  F+ 
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQT 76
Query: 772 ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLH---SSNCALNIFCRLNI 828
           E E+I    HRNL+++   C     + LV  YM+NGS+  CL     S   L+   R  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 829 MIDIASALEYLHFGHSTP-IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ 887
            +  A  L YLH  H  P IIH D+K +N+LLDE+  A + DFG+AKL+  +D       
Sbjct: 137 ALGSARGLAYLH-DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA- 194
Query: 888 TLATIGYMAPDEIFVGELSLKR----------------------------------WVND 913
               IG++AP+ +  G+ S K                                   WV  
Sbjct: 195 VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 914 LLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI 973
           LL    +E +    L G       K++ +  +  +AL CT  SP +R    + + R+L+ 
Sbjct: 255 LLKEKKLEALVDVDLQGN-----YKDEEVEQLIQVALLCTQSSPMERPKMSE-VVRMLE- 307
Query: 974 RDTLSKR 980
            D L++R
Sbjct: 308 GDGLAER 314

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 69/197 (35%), Positives = 109/197 (55%), Gaps = 6/197 (3%)
Query: 715 RFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECE 774
           R    +L  AT+NF    +IG G FG VY+  L DG ++A+K   P+ +  ++ FE E E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSN---CALNIFCRLNIMID 831
            +   RH +LV +I  C   +   L+ +YM NG+L+  L+ S+    +++   RL I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
            A  L YL   H+  IIH D+K  N+LLDE+ V  ++DFG++K  +  D++ +      T
Sbjct: 148 AARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGT 204
Query: 892 IGYMAPDEIFVGELSLK 908
           +GY+ P+    G L+ K
Sbjct: 205 LGYIDPEYFIKGRLTEK 221

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  104 bits (259), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 108/197 (54%), Gaps = 6/197 (3%)
Query: 715 RFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECE 774
           R    +L  AT+NF    +IG G FG VY+  L DG ++A+K   P+ +  ++ FE E E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSN---CALNIFCRLNIMID 831
            +   RH +LV +I  C   +   L+ +YM NG+L+  L+ S+    +++   RL I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
            A  L YL   H+  IIH D+K  N+LLDE+ V  ++DFG++K  +   ++ +      T
Sbjct: 148 AARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGT 204
Query: 892 IGYMAPDEIFVGELSLK 908
           +GY+ P+    G L+ K
Sbjct: 205 LGYIDPEYFIKGRLTEK 221

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/213 (33%), Positives = 108/213 (50%), Gaps = 19/213 (8%)
Query: 709 SQPTIRRFSYFELLRATDNFAEN------NIIGIGGFGSVYRARLEDGVEIAIKVFHPQC 762
           S      FS++EL   T+NF E       N +G GGFG VY+  + +   +A+K      
Sbjct: 8   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMV 66
Query: 763 ASTL----KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLED---CLHS 815
             T     + F+ E +V+   +H NLV+++   S+ D   LV  YM NGSL D   CL  
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126
Query: 816 SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL 875
           +   L+   R  I    A+ + +LH  H    IH D+K +N+LLDE   A +SDFG+A+ 
Sbjct: 127 TP-PLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 876 LSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
                ++ M ++ + T  YMAP E   GE++ K
Sbjct: 183 SEKFAQTVMXSRIVGTTAYMAP-EALRGEITPK 214

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/213 (33%), Positives = 107/213 (50%), Gaps = 19/213 (8%)
Query: 709 SQPTIRRFSYFELLRATDNFAEN------NIIGIGGFGSVYRARLEDGVEIAIKVFHPQC 762
           S      FS++EL   T+NF E       N +G GGFG VY+  + +   +A+K      
Sbjct: 8   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMV 66
Query: 763 ASTL----KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLED---CLHS 815
             T     + F+ E +V+   +H NLV+++   S+ D   LV  YM NGSL D   CL  
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126
Query: 816 SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL 875
           +   L+   R  I    A+ + +LH  H    IH D+K +N+LLDE   A +SDFG+A+ 
Sbjct: 127 TP-PLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 876 LSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
                ++ M  + + T  YMAP E   GE++ K
Sbjct: 183 SEKFAQTVMXXRIVGTTAYMAP-EALRGEITPK 214

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Composition-based stats.
 Identities = 72/213 (33%), Positives = 106/213 (49%), Gaps = 19/213 (8%)
Query: 709 SQPTIRRFSYFELLRATDNFAEN------NIIGIGGFGSVYRARLEDGVEIAIKVFHPQC 762
           S      FS++EL   T+NF E       N +G GGFG VY+  + +   +A+K      
Sbjct: 2   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMV 60
Query: 763 ASTL----KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLED---CLHS 815
             T     + F+ E +V+   +H NLV+++   S+ D   LV  YM NGSL D   CL  
Sbjct: 61  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 120
Query: 816 SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL 875
           +   L+   R  I    A+ + +LH  H    IH D+K +N+LLDE   A +SDFG+A+ 
Sbjct: 121 TP-PLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 176
Query: 876 LSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
                +  M  + + T  YMAP E   GE++ K
Sbjct: 177 SEKFAQXVMXXRIVGTTAYMAP-EALRGEITPK 208

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 117/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V EYMS GSL D L         + RL  ++D    IAS + Y+        +H
Sbjct: 334 EPI-YIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 386
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K 
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 505
Query: 958 EKR 960
           E+R
Sbjct: 506 EER 508

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 117/240 (48%), Gaps = 19/240 (7%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY-LHFGHSTPIIHCDL 852
           +    +V EYMS GSL D L         + RL  ++D+A+ +   + +      +H DL
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 306
Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR--W 910
           + +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K   W
Sbjct: 307 RAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 911 VNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESPEKR 960
              +L   L          +V++ +L   E+ +      +C  S+  L  +C  + PE+R
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 425

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 117/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V EYMS GSL D L         + RL  ++D    IAS + Y+        +H
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K 
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 422
Query: 958 EKR 960
           E+R
Sbjct: 423 EER 425

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 117/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V EYMS GSL D L         + RL  ++D    IAS + Y+        +H
Sbjct: 251 EPI-YIVGEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K 
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 422
Query: 958 EKR 960
           E+R
Sbjct: 423 EER 425

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 9e-19,   Method: Composition-based stats.
 Identities = 69/243 (28%), Positives = 119/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V+EYMS GSL D L      +  + RL  ++D    IAS + Y+        +H
Sbjct: 85  EPI-YIVIEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K 
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIE-DNEXTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 958 EKR 960
           E+R
Sbjct: 257 EER 259

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 117/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V EYMS GSL D L      +  + RL  ++D    IAS + Y+        +H
Sbjct: 252 EPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 304
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL+ +N+L+ E++V  ++DFG+ +L+  ++E T R      I + AP+    G  ++K 
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 363
Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 364 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 423
Query: 958 EKR 960
           E+R
Sbjct: 424 EER 426

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 69/243 (28%), Positives = 119/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V+EYMS GSL D L      +  + RL  ++D    IAS + Y+        +H
Sbjct: 85  EPI-YIVIEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K 
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 958 EKR 960
           E+R
Sbjct: 257 EER 259

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 70/243 (28%), Positives = 118/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K IRH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V EYMS GSL D L      +  + RL  ++D    IAS + Y+        +H
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K 
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 958 EKR 960
           E+R
Sbjct: 257 EER 259

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 69/243 (28%), Positives = 117/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V EYMS GSL D L         + RL  ++D    IAS + Y+        +H
Sbjct: 75  EPI-XIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 127
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K 
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIE-DNEXTARQGAKFPIKWTAPEAALYGRFTIKS 186
Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 187 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 246
Query: 958 EKR 960
           E+R
Sbjct: 247 EER 249

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V EYMS GSL D L      +  + RL  ++D    IAS + Y+        +H
Sbjct: 74  EPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 126
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K 
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 185
Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 186 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 245
Query: 958 EKR 960
           E+R
Sbjct: 246 EER 248

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V EYMS GSL D L      +  + RL  ++D    IAS + Y+        +H
Sbjct: 76  EPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 128
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K 
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 188 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 247
Query: 958 EKR 960
           E+R
Sbjct: 248 EER 250

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V EYMS GSL D L      +  + RL  ++D    IAS + Y+        +H
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K 
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 958 EKR 960
           E+R
Sbjct: 257 EER 259

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V EYMS GSL D L      +  + RL  ++D    IAS + Y+        +H
Sbjct: 85  EPI-YIVCEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K 
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 958 EKR 960
           E+R
Sbjct: 257 EER 259

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 716 FSYFELLRATDNFAEN------NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTL--- 766
           FS++EL   T+NF E       N  G GGFG VY+  + +   +A+K        T    
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 767 -KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLED---CLHSSNCALNI 822
            + F+ E +V    +H NLV+++   S+ D   LV  Y  NGSL D   CL  +   L+ 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTP-PLSW 123
Query: 823 FCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES 882
             R  I    A+ + +LH  H    IH D+K +N+LLDE   A +SDFG+A+      + 
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 883 TMRTQTLATIGYMAPDEIFVGELSLK 908
              ++ + T  Y AP E   GE++ K
Sbjct: 181 VXXSRIVGTTAYXAP-EALRGEITPK 205

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Composition-based stats.
 Identities = 68/243 (27%), Positives = 118/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V+EYMS G L D L      +  + RL  ++D    IAS + Y+        +H
Sbjct: 85  EPI-YIVMEYMSKGCLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K 
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 958 EKR 960
           E+R
Sbjct: 257 EER 259

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 69/243 (28%), Positives = 117/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V EYMS GSL D L         + RL  ++D    IAS + Y+        +H
Sbjct: 78  EPI-YIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 130
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K 
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 189
Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 190 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 249
Query: 958 EKR 960
           E+R
Sbjct: 250 EER 252

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Composition-based stats.
 Identities = 69/243 (28%), Positives = 117/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V EYMS GSL D L      +  + RL  ++D    IAS + Y+        +H
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL  +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K 
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 958 EKR 960
           E+R
Sbjct: 257 EER 259

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 68/243 (27%), Positives = 117/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V EYMS G L D L      +  + RL  ++D    IAS + Y+        +H
Sbjct: 85  EPI-YIVTEYMSKGCLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K 
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 958 EKR 960
           E+R
Sbjct: 257 EER 259

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 68/243 (27%), Positives = 117/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V EYM+ GSL D L         + RL  ++D    IAS + Y+        +H
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGET---GKYLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K 
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 194 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 253
Query: 958 EKR 960
           E+R
Sbjct: 254 EER 256

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 68/243 (27%), Positives = 117/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV++ +  S 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID----IASALEYLHFGHSTPIIH 849
           +    +V EYM+ GSL D L         + RL  ++D    IAS + Y+        +H
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGET---GKYLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K 
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIE-DNEWTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 910 --WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESP 957
             W   +L   L          +V++ +L   E+ +      +C  S+  L  +C  + P
Sbjct: 194 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 253
Query: 958 EKR 960
           E+R
Sbjct: 254 EER 256

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 51/146 (34%), Positives = 82/146 (56%), Gaps = 6/146 (4%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRNLVKIISSC 791
           IG G FG+V+RA    G ++A+K+   Q   A  +  F  E  ++K +RH N+V  + + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSNC--ALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
           +     ++V EY+S GSL   LH S     L+   RL++  D+A  + YLH   + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKL 875
            DLK  N+L+D+     + DFG+++L
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRL 188

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Composition-based stats.
 Identities = 55/169 (32%), Positives = 91/169 (53%), Gaps = 8/169 (4%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRNLVKIISSC 791
           IG G FG+V+RA    G ++A+K+   Q   A  +  F  E  ++K +RH N+V  + + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSNC--ALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
           +     ++V EY+S GSL   LH S     L+   RL++  D+A  + YLH   + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
            +LK  N+L+D+     + DFG+++L +    S+       T  +MAP+
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPE 209

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Composition-based stats.
 Identities = 63/240 (26%), Positives = 117/240 (48%), Gaps = 19/240 (7%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+        ++AIK   P   S  +SF  E +++K ++H  LV++ +  S 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP-ESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNC-ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
           +    +V EYM+ GSL D L      AL +   +++   +A+ + Y+        IH DL
Sbjct: 76  EPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 131
Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR--W 910
           + +N+L+   ++  ++DFG+A+L+  ++E T R      I + AP+    G  ++K   W
Sbjct: 132 RSANILVGNGLICKIADFGLARLIE-DNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 911 VNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESPEKR 960
              +L   LV         + ++ +L   E+ +     + C +S+  L + C  + PE+R
Sbjct: 191 SFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHCWKKDPEER 250

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 119/243 (48%), Gaps = 25/243 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+ A      ++A+K   P   S +++F AE  V+K ++H  LVK+ +  + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-EYLHFGHSTPIIHCDL 852
           +    ++ E+M+ GSL D L S   +     +L   ID ++ + E + F      IH DL
Sbjct: 255 EPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKL---IDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR--W 910
           + +N+L+   +V  ++DFG+A+++  ++E T R      I + AP+ I  G  ++K   W
Sbjct: 311 RAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 911 VNDLLPVSLV-------------EVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESP 957
              +L + +V             EV+ ++L  G        E C   ++++ + C    P
Sbjct: 370 SFGILLMEIVTYGRIPYPGMSNPEVI-RALERG--YRMPRPENCPEELYNIMMRCWKNRP 426
Query: 958 EKR 960
           E+R
Sbjct: 427 EER 429

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 62/240 (25%), Positives = 119/240 (49%), Gaps = 19/240 (7%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+ A      ++A+K   P   S +++F AE  V+K ++H  LVK+ +  + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-EYLHFGHSTPIIHCDL 852
           +    ++ E+M+ GSL D L S   +     +L   ID ++ + E + F      IH DL
Sbjct: 82  EPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKL---IDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR--W 910
           + +N+L+   +V  ++DFG+A+++  ++E T R      I + AP+ I  G  ++K   W
Sbjct: 138 RAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 196
Query: 911 VNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSIFSLALECTMESPEKR 960
              +L + +V         + +  ++   E+ +     E C   ++++ + C    PE+R
Sbjct: 197 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEER 256

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 65/255 (25%), Positives = 124/255 (48%), Gaps = 21/255 (8%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKN 778
           +E+ R T    E   +G G FG V+        ++A+K    Q + +  +F AE  ++K 
Sbjct: 16  WEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 72
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-E 837
           ++H+ LV++ +  + +    ++ EYM NGSL D L + +    I   +N ++D+A+ + E
Sbjct: 73  LQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAE 128
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            + F      IH DL+ +N+L+ + +   ++DFG+A+L+  ++E T R      I + AP
Sbjct: 129 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAP 187
Query: 898 DEIFVGELSLKR--WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSI 945
           + I  G  ++K   W   +L   +V         + +  ++   E+ +     + C   +
Sbjct: 188 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 247
Query: 946 FSLALECTMESPEKR 960
           + L   C  E PE R
Sbjct: 248 YQLMRLCWKERPEDR 262

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 65/255 (25%), Positives = 124/255 (48%), Gaps = 21/255 (8%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKN 778
           +E+ R T    E   +G G FG V+        ++A+K    Q + +  +F AE  ++K 
Sbjct: 8   WEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 64
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-E 837
           ++H+ LV++ +  + +    ++ EYM NGSL D L + +    I   +N ++D+A+ + E
Sbjct: 65  LQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAE 120
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            + F      IH DL+ +N+L+ + +   ++DFG+A+L+  ++E T R      I + AP
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAP 179
Query: 898 DEIFVGELSLKR--WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSI 945
           + I  G  ++K   W   +L   +V         + +  ++   E+ +     + C   +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239
Query: 946 FSLALECTMESPEKR 960
           + L   C  E PE R
Sbjct: 240 YQLMRLCWKERPEDR 254

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 65/255 (25%), Positives = 124/255 (48%), Gaps = 21/255 (8%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKN 778
           +E+ R T    E   +G G FG V+        ++A+K    Q + +  +F AE  ++K 
Sbjct: 8   WEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 64
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-E 837
           ++H+ LV++ +  + +    ++ EYM NGSL D L + +    I   +N ++D+A+ + E
Sbjct: 65  LQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAE 120
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            + F      IH DL+ +N+L+ + +   ++DFG+A+L+  ++E T R      I + AP
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAP 179
Query: 898 DEIFVGELSLKR--WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSI 945
           + I  G  ++K   W   +L   +V         + +  ++   E+ +     + C   +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239
Query: 946 FSLALECTMESPEKR 960
           + L   C  E PE R
Sbjct: 240 YQLMRLCWKERPEDR 254

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 65/255 (25%), Positives = 124/255 (48%), Gaps = 21/255 (8%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKN 778
           +E+ R T    E   +G G FG V+        ++A+K    Q + +  +F AE  ++K 
Sbjct: 14  WEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 70
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-E 837
           ++H+ LV++ +  + +    ++ EYM NGSL D L + +    I   +N ++D+A+ + E
Sbjct: 71  LQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAE 126
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            + F      IH DL+ +N+L+ + +   ++DFG+A+L+  ++E T R      I + AP
Sbjct: 127 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAP 185
Query: 898 DEIFVGELSLKR--WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSI 945
           + I  G  ++K   W   +L   +V         + +  ++   E+ +     + C   +
Sbjct: 186 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 245
Query: 946 FSLALECTMESPEKR 960
           + L   C  E PE R
Sbjct: 246 YQLMRLCWKERPEDR 260

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 65/255 (25%), Positives = 124/255 (48%), Gaps = 21/255 (8%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKN 778
           +E+ R T    E   +G G FG V+        ++A+K    Q + +  +F AE  ++K 
Sbjct: 9   WEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 65
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-E 837
           ++H+ LV++ +  + +    ++ EYM NGSL D L + +    I   +N ++D+A+ + E
Sbjct: 66  LQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAE 121
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            + F      IH DL+ +N+L+ + +   ++DFG+A+L+  ++E T R      I + AP
Sbjct: 122 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAP 180
Query: 898 DEIFVGELSLKR--WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSI 945
           + I  G  ++K   W   +L   +V         + +  ++   E+ +     + C   +
Sbjct: 181 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 240
Query: 946 FSLALECTMESPEKR 960
           + L   C  E PE R
Sbjct: 241 YQLMRLCWKERPEDR 255

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 65/255 (25%), Positives = 124/255 (48%), Gaps = 21/255 (8%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKN 778
           +E+ R T    E   +G G FG V+        ++A+K    Q + +  +F AE  ++K 
Sbjct: 10  WEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 66
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-E 837
           ++H+ LV++ +  + +    ++ EYM NGSL D L + +    I   +N ++D+A+ + E
Sbjct: 67  LQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAE 122
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            + F      IH DL+ +N+L+ + +   ++DFG+A+L+  ++E T R      I + AP
Sbjct: 123 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAP 181
Query: 898 DEIFVGELSLKR--WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSI 945
           + I  G  ++K   W   +L   +V         + +  ++   E+ +     + C   +
Sbjct: 182 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 241
Query: 946 FSLALECTMESPEKR 960
           + L   C  E PE R
Sbjct: 242 YQLMRLCWKERPEDR 256

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 65/255 (25%), Positives = 124/255 (48%), Gaps = 21/255 (8%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKN 778
           +E+ R T    E   +G G FG V+        ++A+K    Q + +  +F AE  ++K 
Sbjct: 17  WEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 73
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-E 837
           ++H+ LV++ +  + +    ++ EYM NGSL D L + +    I   +N ++D+A+ + E
Sbjct: 74  LQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAE 129
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            + F      IH DL+ +N+L+ + +   ++DFG+A+L+  ++E T R      I + AP
Sbjct: 130 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAP 188
Query: 898 DEIFVGELSLKR--WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSI 945
           + I  G  ++K   W   +L   +V         + +  ++   E+ +     + C   +
Sbjct: 189 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 248
Query: 946 FSLALECTMESPEKR 960
           + L   C  E PE R
Sbjct: 249 YQLMRLCWKERPEDR 263

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 65/255 (25%), Positives = 124/255 (48%), Gaps = 21/255 (8%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKN 778
           +E+ R T    E   +G G FG V+        ++A+K    Q + +  +F AE  ++K 
Sbjct: 14  WEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 70
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-E 837
           ++H+ LV++ +  + +    ++ EYM NGSL D L + +    I   +N ++D+A+ + E
Sbjct: 71  LQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAE 126
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            + F      IH DL+ +N+L+ + +   ++DFG+A+L+  ++E T R      I + AP
Sbjct: 127 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAP 185
Query: 898 DEIFVGELSLKR--WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSI 945
           + I  G  ++K   W   +L   +V         + +  ++   E+ +     + C   +
Sbjct: 186 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 245
Query: 946 FSLALECTMESPEKR 960
           + L   C  E PE R
Sbjct: 246 YQLMRLCWKERPEDR 260

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 65/255 (25%), Positives = 124/255 (48%), Gaps = 21/255 (8%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKN 778
           +E+ R T    E   +G G FG V+        ++A+K    Q + +  +F AE  ++K 
Sbjct: 18  WEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 74
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-E 837
           ++H+ LV++ +  + +    ++ EYM NGSL D L + +    I   +N ++D+A+ + E
Sbjct: 75  LQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAE 130
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            + F      IH DL+ +N+L+ + +   ++DFG+A+L+  ++E T R      I + AP
Sbjct: 131 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAP 189
Query: 898 DEIFVGELSLKR--WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSI 945
           + I  G  ++K   W   +L   +V         + +  ++   E+ +     + C   +
Sbjct: 190 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 249
Query: 946 FSLALECTMESPEKR 960
           + L   C  E PE R
Sbjct: 250 YQLMRLCWKERPEDR 264

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 65/255 (25%), Positives = 124/255 (48%), Gaps = 21/255 (8%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKN 778
           +E+ R T    E   +G G FG V+        ++A+K    Q + +  +F AE  ++K 
Sbjct: 8   WEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 64
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-E 837
           ++H+ LV++ +  + +    ++ EYM NGSL D L + +    I   +N ++D+A+ + E
Sbjct: 65  LQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAE 120
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            + F      IH DL+ +N+L+ + +   ++DFG+A+L+  ++E T R      I + AP
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAP 179
Query: 898 DEIFVGELSLKR--WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSI 945
           + I  G  ++K   W   +L   +V         + +  ++   E+ +     + C   +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239
Query: 946 FSLALECTMESPEKR 960
           + L   C  E PE R
Sbjct: 240 YQLMRLCWKERPEDR 254

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 65/255 (25%), Positives = 124/255 (48%), Gaps = 21/255 (8%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKN 778
           +E+ R T    E   +G G FG V+        ++A+K    Q + +  +F AE  ++K 
Sbjct: 3   WEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 59
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-E 837
           ++H+ LV++ +  + +    ++ EYM NGSL D L + +    I   +N ++D+A+ + E
Sbjct: 60  LQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAE 115
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            + F      IH DL+ +N+L+ + +   ++DFG+A+L+  ++E T R      I + AP
Sbjct: 116 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAP 174
Query: 898 DEIFVGELSLKR--WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSI 945
           + I  G  ++K   W   +L   +V         + +  ++   E+ +     + C   +
Sbjct: 175 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 234
Query: 946 FSLALECTMESPEKR 960
           + L   C  E PE R
Sbjct: 235 YQLMRLCWKERPEDR 249

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 65/255 (25%), Positives = 124/255 (48%), Gaps = 21/255 (8%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKN 778
           +E+ R T    E   +G G FG V+        ++A+K    Q + +  +F AE  ++K 
Sbjct: 13  WEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 69
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-E 837
           ++H+ LV++ +  + +    ++ EYM NGSL D L + +    I   +N ++D+A+ + E
Sbjct: 70  LQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAE 125
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            + F      IH DL+ +N+L+ + +   ++DFG+A+L+  ++E T R      I + AP
Sbjct: 126 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAP 184
Query: 898 DEIFVGELSLKR--WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSI 945
           + I  G  ++K   W   +L   +V         + +  ++   E+ +     + C   +
Sbjct: 185 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 244
Query: 946 FSLALECTMESPEKR 960
           + L   C  E PE R
Sbjct: 245 YQLMRLCWKERPEDR 259

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 10/204 (4%)
Query: 698 GTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAI-K 756
           GT   N I    Q   R  SY+  + A++      I G G FG+VY+ +    V + I K
Sbjct: 12  GTQEKNKIRPRGQ---RDSSYYWEIEASEVMLSTRI-GSGSFGTVYKGKWHGDVAVKILK 67
Query: 757 VFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSS 816
           V  P      ++F  E  V++  RH N++  +   + D+  A+V ++    SL   LH  
Sbjct: 68  VVDPT-PEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNL-AIVTQWCEGSSLYKHLHVQ 125
Query: 817 NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL 876
                +F  ++I    A  ++YLH   +  IIH D+K +N+ L E +   + DFG+A + 
Sbjct: 126 ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182
Query: 877 SGEDESTMRTQTLATIGYMAPDEI 900
           S    S    Q   ++ +MAP+ I
Sbjct: 183 SRWSGSQQVEQPTGSVLWMAPEVI 206

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 123/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 149
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP-ELL 206
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF+  ++   + PEK  
Sbjct: 207 TEKSAXKS--SDLWALGCIIY---QLVAGLPPFRAGNEGL---IFAKIIKLEYDFPEKFF 258
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 259 PKARDLVEKLLVLDAT--KRLG 278

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 123/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 149
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP-ELL 206
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF+  ++   + PEK  
Sbjct: 207 TEKSACKS--SDLWALGCIIY---QLVAGLPPFRAGNEGL---IFAKIIKLEYDFPEKFF 258
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 259 PKARDLVEKLLVLDAT--KRLG 278

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 146
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 147 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP-ELL 203
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF   ++   + PEK  
Sbjct: 204 TEKSACKS--SDLWALGCIIY---QLVAGLPPFRAGNEYL---IFQKIIKLEYDFPEKFF 255
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 256 PKARDLVEKLLVLDAT--KRLG 275

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 150
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP-ELL 207
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF   ++   + PEK  
Sbjct: 208 TEKSACKS--SDLWALGCIIY---QLVAGLPPFRAGNEYL---IFQKIIKLEYDFPEKFF 259
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 260 PKARDLVEKLLVLDAT--KRLG 279

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 126
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 127 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP-ELL 183
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF   ++   + PEK  
Sbjct: 184 TEKSACKS--SDLWALGCIIY---QLVAGLPPFRAGNEYL---IFQKIIKLEYDFPEKFF 235
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 236 PKARDLVEKLLVLDAT--KRLG 255

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 127
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 128 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP-ELL 184
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF   ++   + PEK  
Sbjct: 185 TEKSACKS--SDLWALGCIIY---QLVAGLPPFRAGNEYL---IFQKIIKLEYDFPEKFF 236
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 237 PKARDLVEKLLVLDAT--KRLG 256

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 125
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 126 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP-ELL 182
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF   ++   + PEK  
Sbjct: 183 TEKSACKS--SDLWALGCIIY---QLVAGLPPFRAGNEYL---IFQKIIKLEYDFPEKFF 234
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 235 PKARDLVEKLLVLDAT--KRLG 254

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 124
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 125 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP-ELL 181
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF   ++   + PEK  
Sbjct: 182 TEKSACKS--SDLWALGCIIY---QLVAGLPPFRAGNEYL---IFQKIIKLEYDFPEKFF 233
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 234 PKARDLVEKLLVLDAT--KRLG 253

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 147
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP-ELL 204
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF   ++   + PEK  
Sbjct: 205 TEKSACKS--SDLWALGCIIY---QLVAGLPPFRAGNEYL---IFQKIIKLEYDFPEKFF 256
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 257 PKARDLVEKLLVLDAT--KRLG 276

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 149
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP-ELL 206
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF   ++   + PEK  
Sbjct: 207 TEKSACKS--SDLWALGCIIY---QLVAGLPPFRAGNEYL---IFQKIIKLEYDFPEKFF 258
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 259 PKARDLVEKLLVLDAT--KRLG 278

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 149
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP-ELL 206
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF   ++   + PEK  
Sbjct: 207 TEKSACKS--SDLWALGCIIY---QLVAGLPPFRAGNEYL---IFQKIIKLEYDFPEKFF 258
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 259 PKARDLVEKLLVLDAT--KRLG 278

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 131
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 132 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP-ELL 188
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF   ++   + PEK  
Sbjct: 189 TEKSACKS--SDLWALGCIIY---QLVAGLPPFRAGNEYL---IFQKIIKLEYDFPEKFF 240
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 241 PKARDLVEKLLVLDAT--KRLG 260

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 146
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 147 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP-ELL 203
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF   ++   + PEK  
Sbjct: 204 TEKSACKS--SDLWALGCIIY---QLVAGLPPFRAGNEYL---IFQKIIKLEYDFPEKFF 255
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 256 PKARDLVEKLLVLDAT--KRLG 275

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 147
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP-ELL 204
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF   ++   + PEK  
Sbjct: 205 TEKSACKS--SDLWALGCIIY---QLVAGLPPFRAGNEYL---IFQKIIKLEYDFPEKFF 256
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 257 PKARDLVEKLLVLDAT--KRLG 276

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 150
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP-ELL 207
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF   ++   + PEK  
Sbjct: 208 TEKSACKS--SDLWALGCIIY---QLVAGLPPFRAGNEYL---IFQKIIKLEYDFPEKFF 259
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 260 PKARDLVEKLLVLDAT--KRLG 279

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 149
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP-ELL 206
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF   ++   + PEK  
Sbjct: 207 TEKSACKS--SDLWALGCIIY---QLVAGLPPFRAGNEYL---IFQKIIKLEYDFPEKFF 258
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 259 PKARDLVEKLLVLDAT--KRLG 278

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 147
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSP-ELL 204
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF   ++   + PEK  
Sbjct: 205 TEKSACKS--SDLWALGCIIY---QLVAGLPPFRAGNEYL---IFQKIIKLEYDFPEKFF 256
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 257 PKARDLVEKLLVLDAT--KRLG 276

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 149
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P+   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE--L 205
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
           + E S  +  +DL  +  +      L++G     A  E     IF   ++   + PEK  
Sbjct: 206 LTEKSASK-SSDLWALGCIIY---QLVAGLPPFRAGNEYL---IFQKIIKLEYDFPEKFF 258
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 259 PKARDLVEKLLVLDAT--KRLG 278

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Composition-based stats.
 Identities = 49/176 (27%), Positives = 93/176 (52%), Gaps = 6/176 (3%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+     +  ++A+K   P   S +++F  E  ++K ++H  LV++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL-NIMIDIASALEYLHFGHSTPIIHCDL 852
           ++   ++ EYM+ GSL D L S      +  +L +    IA  + Y+        IH DL
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI---ERKNYIHRDL 136
Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
           + +NVL+ E ++  ++DFG+A+++  ++E T R      I + AP+ I  G  ++K
Sbjct: 137 RAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGCFTIK 191

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Composition-based stats.
 Identities = 64/255 (25%), Positives = 124/255 (48%), Gaps = 21/255 (8%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKN 778
           +E+ R T    E   +G G FG V+        ++A+K    Q + +  +F AE  ++K 
Sbjct: 4   WEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 60
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-E 837
           ++H+ LV++ +  + +    ++ EYM NGSL D L + +    I   +N ++D+A+ + E
Sbjct: 61  LQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAE 116
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            + F      IH +L+ +N+L+ + +   ++DFG+A+L+  ++E T R      I + AP
Sbjct: 117 GMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAP 175
Query: 898 DEIFVGELSLKR--WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSI 945
           + I  G  ++K   W   +L   +V         + +  ++   E+ +     + C   +
Sbjct: 176 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 235
Query: 946 FSLALECTMESPEKR 960
           + L   C  E PE R
Sbjct: 236 YQLMRLCWKERPEDR 250

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 56/172 (32%), Positives = 89/172 (51%), Gaps = 13/172 (7%)
Query: 734 IGIGGFGSVYRARLED---GVEIAIK-VFHP--QCASTLKSFEAECEVIKNIRHRNLVKI 787
           +G GG  +VY A  ED    +++AIK +F P  +   TLK FE E      + H+N+V +
Sbjct: 19  LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
           I     DD   LV+EY+   +L + + S    L++   +N    I   +++    H   I
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKH---AHDMRI 132
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
           +H D+KP N+L+D +    + DFG+AK LS E   T     L T+ Y +P++
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQ 183

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 79/262 (30%), Positives = 121/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+     +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 154
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 155 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP-ELL 211
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF   ++   + PEK  
Sbjct: 212 TEKSACKS--SDLWALGCIIY---QLVAGLPPFRAGNEYL---IFQKIIKLEYDFPEKFF 263
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 264 PKARDLVEKLLVLDAT--KRLG 283

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 78/262 (29%), Positives = 121/262 (46%), Gaps = 20/262 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +   AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 147
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P E+ 
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP-ELL 204
Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             + + K   +DL  +  +      L++G     A  E     IF   ++   + PEK  
Sbjct: 205 TEKSACKS--SDLWALGCIIY---QLVAGLPPFRAGNEYL---IFQKIIKLEYDFPEKFF 256
Query: 962 -DAKDTITRLLKIRDTLSKRIG 982
             A+D + +LL +  T  KR+G
Sbjct: 257 PKARDLVEKLLVLDAT--KRLG 276

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 121/269 (44%), Gaps = 25/269 (9%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K    +    ++ F  E  V+K I+H NLV+++  C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    ++ E+M+ G+L D L   N   +N    L +   I+SA+EYL        IH +
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRN 382
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-- 909
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K   
Sbjct: 383 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 441
Query: 910 WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK 959
           W   +L          P   +++     L  ++      E C   ++ L   C   +P  
Sbjct: 442 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 501
Query: 960 RI------DAKDTITRLLKIRDTLSKRIG 982
           R        A +T+ +   I D + K +G
Sbjct: 502 RPSFAEIHQAFETMFQESSISDEVEKELG 530

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 58/177 (32%), Positives = 86/177 (48%), Gaps = 8/177 (4%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECEVIKNIRH 781
           ++F    I+G G F +V  AR L    E AIK+    H    + +     E +V+  + H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
              VK+  +  +D+     L Y  NG L   +     + +  C      +I SALEYLH 
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 152
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
                IIH DLKP N+LL+EDM   ++DFG AK+LS E +       + T  Y++P+
Sbjct: 153 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 57/189 (30%), Positives = 90/189 (47%), Gaps = 22/189 (11%)
Query: 727 NFAE---NNIIGIGGFGSVYRARLEDGVEIAIKVFH----PQCASTLKSFEAECEVIKNI 779
           +FAE     IIGIGGFG VYRA    G E+A+K          + T+++   E ++   +
Sbjct: 5   DFAELTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           +H N++ +   C  +    LV+E+   G L   L       +I   +N  + IA  + YL
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYL 121
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDM--------VAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           H     PIIH DLK SN+L+ + +        +  ++DFG+A+    E   T +      
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGA 177
Query: 892 IGYMAPDEI 900
             +MAP+ I
Sbjct: 178 YAWMAPEVI 186

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 48/176 (27%), Positives = 93/176 (52%), Gaps = 6/176 (3%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+     +  ++A+K   P   S +++F  E  ++K ++H  LV++ +  + 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL-NIMIDIASALEYLHFGHSTPIIHCDL 852
           ++   ++ E+M+ GSL D L S      +  +L +    IA  + Y+        IH DL
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 135
Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
           + +NVL+ E ++  ++DFG+A+++  ++E T R      I + AP+ I  G  ++K
Sbjct: 136 RAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGCFTIK 190

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 67/269 (24%), Positives = 121/269 (44%), Gaps = 25/269 (9%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    +++E+M+ G+L D L   N   +N    L +   I+SA+EYL        IH D
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRD 137
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-- 909
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K   
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 910 WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK 959
           W   +L          P   +++     L  ++      E C   ++ L   C   +P  
Sbjct: 197 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 256
Query: 960 RID------AKDTITRLLKIRDTLSKRIG 982
           R        A +T+ +   I D + K +G
Sbjct: 257 RPSFAEIHQAFETMFQESSISDEVEKELG 285

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 64/255 (25%), Positives = 122/255 (47%), Gaps = 21/255 (8%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKN 778
           +E+ R T    E   +G G  G V+        ++A+K    Q + +  +F AE  ++K 
Sbjct: 8   WEVPRETLKLVER--LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 64
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-E 837
           ++H+ LV++ +  + +    ++ EYM NGSL D L + +    I   +N ++D+A+ + E
Sbjct: 65  LQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAE 120
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            + F      IH DL+ +N+L+ + +   ++DFG+A+L+  + E T R      I + AP
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DAEXTAREGAKFPIKWTAP 179
Query: 898 DEIFVGELSLKR--WVNDLLPVSLVE--------VVDKSLLSGEEKHF--AAKEQCLLSI 945
           + I  G  ++K   W   +L   +V         + +  ++   E+ +     + C   +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239
Query: 946 FSLALECTMESPEKR 960
           + L   C  E PE R
Sbjct: 240 YQLMRLCWKERPEDR 254

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 9/203 (4%)
Query: 708 SSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTL 766
           S  P+   +  +E+ R   +    + +G G +G VY    +   + +A+K         +
Sbjct: 2   SMDPSSPNYDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-V 58
Query: 767 KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCR 825
           + F  E  V+K I+H NLV+++  C+ +    +++E+M+ G+L D L   N   +N    
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVL 118
Query: 826 LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR 885
           L +   I+SA+EYL        IH DL   N L+ E+ +  ++DFG+++L++G D  T  
Sbjct: 119 LYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAH 174
Query: 886 TQTLATIGYMAPDEIFVGELSLK 908
                 I + AP+ +   + S+K
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIK 197

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 120/269 (44%), Gaps = 25/269 (9%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    ++ E+M+ G+L D L   N   ++    L +   I+SA+EYL        IH +
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRN 343
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-- 909
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K   
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 910 WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK 959
           W   +L          P   +++     L  ++      E C   ++ L   C   +P  
Sbjct: 403 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 462
Query: 960 RI------DAKDTITRLLKIRDTLSKRIG 982
           R        A +T+ +   I D + K +G
Sbjct: 463 RPSFAEIHQAFETMFQESSISDEVEKELG 491

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 63/181 (34%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 734 IGIGGFGSV----YRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIIS 789
           IG G FG V    YR     G ++A+K       +T ++F AE  V+  +RH NLV+++ 
Sbjct: 20  IGKGEFGDVMLGDYR-----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLG 72
Query: 790 SCSNDDFKA-LVLEYMSNGSLEDCLHS-SNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
               +     +V EYM+ GSL D L S     L   C L   +D+  A+EYL        
Sbjct: 73  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 129
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSL 907
           +H DL   NVL+ ED VA +SDFG+ K    E  ST  T  L  + + AP+ +     S 
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLP-VKWTAPEALREAAFST 184
Query: 908 K 908
           K
Sbjct: 185 K 185

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 63/181 (34%), Positives = 89/181 (49%), Gaps = 21/181 (11%)
Query: 734 IGIGGFGSV----YRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIIS 789
           IG G FG V    YR     G ++A+K       +T ++F AE  V+  +RH NLV+++ 
Sbjct: 14  IGKGEFGDVMLGDYR-----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 790 SCSNDDFKA-LVLEYMSNGSLEDCLHS-SNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
               +     +V EYM+ GSL D L S     L   C L   +D+  A+EYL        
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 123
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSL 907
           +H DL   NVL+ ED VA +SDFG+ K    E  ST  T  L  + + AP+ +   + S 
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLP-VKWTAPEALREKKFST 178
Query: 908 K 908
           K
Sbjct: 179 K 179

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 63/181 (34%), Positives = 89/181 (49%), Gaps = 21/181 (11%)
Query: 734 IGIGGFGSV----YRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIIS 789
           IG G FG V    YR     G ++A+K       +T ++F AE  V+  +RH NLV+++ 
Sbjct: 29  IGKGEFGDVMLGDYR-----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 790 SCSNDDFKA-LVLEYMSNGSLEDCLHS-SNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
               +     +V EYM+ GSL D L S     L   C L   +D+  A+EYL        
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 138
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSL 907
           +H DL   NVL+ ED VA +SDFG+ K    E  ST  T  L  + + AP+ +   + S 
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLP-VKWTAPEALREKKFST 193
Query: 908 K 908
           K
Sbjct: 194 K 194

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 4/167 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG+VY+ +    V + +          L++F+ E  V++  RH N++  +   + 
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
               A+V ++    SL   LH+S     +   ++I    A  ++YLH   +  IIH DLK
Sbjct: 80  PQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLK 135
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            +N+ L ED    + DFG+A + S    S    Q   +I +MAP+ I
Sbjct: 136 SNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 182

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/183 (34%), Positives = 90/183 (49%), Gaps = 21/183 (11%)
Query: 732 NIIGIGGFGSV----YRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKI 787
             IG G FG V    YR     G ++A+K    +  +T ++F AE  V+  +RH NLV++
Sbjct: 199 QTIGKGEFGDVMLGDYR-----GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 788 ISSCSNDDFK-ALVLEYMSNGSLEDCLHS-SNCALNIFCRLNIMIDIASALEYLHFGHST 845
           +     +     +V EYM+ GSL D L S     L   C L   +D+  A+EYL      
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GN 308
Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGEL 905
             +H DL   NVL+ ED VA +SDFG+ K    E  ST  T  L  + + AP+ +   + 
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLP-VKWTAPEALREKKF 363
Query: 906 SLK 908
           S K
Sbjct: 364 STK 366

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 67/269 (24%), Positives = 120/269 (44%), Gaps = 25/269 (9%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    ++ E+M+ G+L D L   N   +N    L +   I+SA+EYL        IH D
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRD 149
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-- 909
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K   
Sbjct: 150 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 208
Query: 910 WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK 959
           W   +L          P   +++     L  ++      E C   ++ L   C   +P  
Sbjct: 209 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 268
Query: 960 RID------AKDTITRLLKIRDTLSKRIG 982
           R        A +T+ +   I D + K +G
Sbjct: 269 RPSFAEIHQAFETMFQESSISDEVEKELG 297

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 67/269 (24%), Positives = 120/269 (44%), Gaps = 25/269 (9%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    ++ E+M+ G+L D L   N   +N    L +   I+SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRD 141
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-- 909
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K   
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 910 WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK 959
           W   +L          P   +++     L  ++      E C   ++ L   C   +P  
Sbjct: 201 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 260
Query: 960 RID------AKDTITRLLKIRDTLSKRIG 982
           R        A +T+ +   I D + K +G
Sbjct: 261 RPSFAEIHQAFETMFQESSISDEVEKELG 289

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 67/269 (24%), Positives = 120/269 (44%), Gaps = 25/269 (9%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    ++ E+M+ G+L D L   N   +N    L +   I+SA+EYL        IH D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRD 138
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-- 909
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K   
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 910 WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK 959
           W   +L          P   +++     L  ++      E C   ++ L   C   +P  
Sbjct: 198 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 257
Query: 960 RID------AKDTITRLLKIRDTLSKRIG 982
           R        A +T+ +   I D + K +G
Sbjct: 258 RPSFAEIHQAFETMFQESSISDEVEKELG 286

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 67/269 (24%), Positives = 120/269 (44%), Gaps = 25/269 (9%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    ++ E+M+ G+L D L   N   +N    L +   I+SA+EYL        IH D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRD 138
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-- 909
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K   
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 910 WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK 959
           W   +L          P   +++     L  ++      E C   ++ L   C   +P  
Sbjct: 198 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 257
Query: 960 RID------AKDTITRLLKIRDTLSKRIG 982
           R        A +T+ +   I D + K +G
Sbjct: 258 RPSFAEIHQAFETMFQESSISDEVEKELG 286

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 9/203 (4%)
Query: 708 SSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTL 766
           S  P+   +  +E+ R   +    + +G G +G VY    +   + +A+K         +
Sbjct: 2   SMDPSSPNYDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-V 58
Query: 767 KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCR 825
           + F  E  V+K I+H NLV+++  C+ +    ++ E+M+ G+L D L   N   +N    
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 118
Query: 826 LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR 885
           L +   I+SA+EYL        IH DL   N L+ E+ +  ++DFG+++L++G D  T  
Sbjct: 119 LYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAH 174
Query: 886 TQTLATIGYMAPDEIFVGELSLK 908
                 I + AP+ +   + S+K
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIK 197

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 51/177 (28%), Positives = 90/177 (50%), Gaps = 7/177 (3%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    ++ E+M+ G+L D L   N   +N    L +   I+SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRD 141
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIK 197

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 4/167 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG+VY+ +    V + +          L++F+ E  V++  RH N++  +   + 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
               A+V ++    SL   LH       +   ++I    A  ++YLH   +  IIH DLK
Sbjct: 104 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 159
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            +N+ L ED+   + DFG+A + S    S    Q   +I +MAP+ I
Sbjct: 160 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 206

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 4/167 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG+VY+ +    V + +          L++F+ E  V++  RH N++  +   + 
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
               A+V ++    SL   LH       +   ++I    A  ++YLH   +  IIH DLK
Sbjct: 103 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 158
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            +N+ L ED+   + DFG+A + S    S    Q   +I +MAP+ I
Sbjct: 159 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 205

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 67/269 (24%), Positives = 120/269 (44%), Gaps = 25/269 (9%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    ++ E+M+ G+L D L   N   +N    L +   I+SA+EYL        IH D
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRD 137
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-- 909
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K   
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 910 WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK 959
           W   +L          P   +++     L  ++      E C   ++ L   C   +P  
Sbjct: 197 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 256
Query: 960 RID------AKDTITRLLKIRDTLSKRIG 982
           R        A +T+ +   I D + K +G
Sbjct: 257 RPSFAEIHQAFETMFQESSISDEVEKELG 285

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 67/269 (24%), Positives = 120/269 (44%), Gaps = 25/269 (9%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    ++ E+M+ G+L D L   N   +N    L +   I+SA+EYL        IH D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRD 138
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-- 909
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K   
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 910 WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK 959
           W   +L          P   +++     L  ++      E C   ++ L   C   +P  
Sbjct: 198 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 257
Query: 960 RID------AKDTITRLLKIRDTLSKRIG 982
           R        A +T+ +   I D + K +G
Sbjct: 258 RPSFAEIHQAFETMFQESSISDEVEKELG 286

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 68/275 (24%), Positives = 121/275 (44%), Gaps = 37/275 (13%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G FG VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    ++ E+M+ G+L D L   N   ++    L +   I+SA+EYL        IH D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRD 134
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-- 909
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K   
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 910 WVNDLL----------------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECT 953
           W   +L                P  + E+++K      +      E C   ++ L   C 
Sbjct: 194 WAFGVLLWEIATYGMSPYPGIDPSQVYELLEK------DYRMERPEGCPEKVYELMRACW 247
Query: 954 MESPEKRID------AKDTITRLLKIRDTLSKRIG 982
             +P  R        A +T+ +   I D + K +G
Sbjct: 248 QWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 282

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 4/167 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG+VY+ +    V + +          L++F+ E  V++  RH N++  +   + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
               A+V ++    SL   LH       +   ++I    A  ++YLH   +  IIH DLK
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 131
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            +N+ L ED+   + DFG+A + S    S    Q   +I +MAP+ I
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 4/167 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG+VY+ +    V + +          L++F+ E  V++  RH N++  +   + 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
               A+V ++    SL   LH       +   ++I    A  ++YLH   +  IIH DLK
Sbjct: 81  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 136
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            +N+ L ED+   + DFG+A + S    S    Q   +I +MAP+ I
Sbjct: 137 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 4/167 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG+VY+ +    V + +          L++F+ E  V++  RH N++  +   + 
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
               A+V ++    SL   LH       +   ++I    A  ++YLH   +  IIH DLK
Sbjct: 78  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 133
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            +N+ L ED+   + DFG+A + S    S    Q   +I +MAP+ I
Sbjct: 134 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 180

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 66/269 (24%), Positives = 121/269 (44%), Gaps = 25/269 (9%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    +++E+M+ G+L D L   N   ++    L +   I+SA+EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRD 136
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-- 909
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K   
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 910 WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK 959
           W   +L          P   +++     L  ++      E C   ++ L   C   +P  
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 960 RID------AKDTITRLLKIRDTLSKRIG 982
           R        A +T+ +   I D + K +G
Sbjct: 256 RPSFAEIHQAFETMFQESSISDEVEKELG 284

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 66/269 (24%), Positives = 121/269 (44%), Gaps = 25/269 (9%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    +++E+M+ G+L D L   N   ++    L +   I+SA+EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRD 136
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-- 909
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K   
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 910 WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK 959
           W   +L          P   +++     L  ++      E C   ++ L   C   +P  
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 960 RID------AKDTITRLLKIRDTLSKRIG 982
           R        A +T+ +   I D + K +G
Sbjct: 256 RPSFAEIHQAFETMFQESSISDEVEKELG 284

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 4/167 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG+VY+ +    V + +          L++F+ E  V++  RH N++  +   + 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
               A+V ++    SL   LH       +   ++I    A  ++YLH   +  IIH DLK
Sbjct: 81  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 136
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            +N+ L ED+   + DFG+A + S    S    Q   +I +MAP+ I
Sbjct: 137 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 51/177 (28%), Positives = 90/177 (50%), Gaps = 7/177 (3%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    ++ E+M+ G+L D L   N   +N    L +   I+SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRD 136
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIK 192

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 51/177 (28%), Positives = 90/177 (50%), Gaps = 7/177 (3%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    ++ E+M+ G+L D L   N   +N    L +   I+SA+EYL        IH D
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRD 140
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIK 196

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 51/177 (28%), Positives = 90/177 (50%), Gaps = 7/177 (3%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    ++ E+M+ G+L D L   N   +N    L +   I+SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRD 136
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIK 192

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 4/167 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG+VY+ +    V + +          L++F+ E  V++  RH N++  +   + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
               A+V ++    SL   LH       +   ++I    A  ++YLH   +  IIH DLK
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 131
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            +N+ L ED+   + DFG+A + S    S    Q   +I +MAP+ I
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 4/167 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG+VY+ +    V + +          L++F+ E  V++  RH N++  +   + 
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
               A+V ++    SL   LH+S     +   ++I    A  ++YLH   +  IIH DLK
Sbjct: 92  PQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLK 147
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            +N+ L ED    + DFG+A   S    S    Q   +I +MAP+ I
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 50/177 (28%), Positives = 91/177 (51%), Gaps = 7/177 (3%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    +++E+M+ G+L D L   N   ++    L +   I+SA+EYL        IH D
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRD 134
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIK 190

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 112/243 (46%), Gaps = 35/243 (14%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V+ A      ++A+K   P   S +++F AE  V+K ++H  LVK+ +  + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL-EYLHFGHSTPIIHCDL 852
           +    ++ E+M+ GSL D L S   +     +L   ID ++ + E + F      IH DL
Sbjct: 249 EPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKL---IDFSAQIAEGMAFIEQRNYIHRDL 304
Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR--W 910
           + +N+L+   +V  ++DFG+A           R      I + AP+ I  G  ++K   W
Sbjct: 305 RAANILVSASLVCKIADFGLA-----------RVGAKFPIKWTAPEAINFGSFTIKSDVW 353
Query: 911 VNDLLPVSLV-------------EVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESP 957
              +L + +V             EV+ ++L  G        E C   ++++ + C    P
Sbjct: 354 SFGILLMEIVTYGRIPYPGMSNPEVI-RALERG--YRMPRPENCPEELYNIMMRCWKNRP 410
Query: 958 EKR 960
           E+R
Sbjct: 411 EER 413

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/275 (21%), Positives = 121/275 (44%), Gaps = 35/275 (12%)
Query: 730 ENNIIGIGGFGSVYRARLEDG-----VEIAIKVFHPQCASTLK-SFEAECEVIKNIRHRN 783
              +IG G FG VY+  L+       V +AIK          +  F  E  ++    H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           ++++    S      ++ EYM NG+L+  L   +   ++   + ++  IA+ ++YL    
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA--- 164
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ-TLATIGYMAPDEIFV 902
           +   +H DL   N+L++ ++V  +SDFG++++L  + E+T  T      I + AP+ I  
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI-- 222
Query: 903 GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQ-----------------CLLSI 945
              S +++ +     S   V+ + +  GE  ++                      C  +I
Sbjct: 223 ---SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 279
Query: 946 FSLALECTMESPEKRIDAKDTIT---RLLKIRDTL 977
           + L ++C  +   +R    D ++   +L++  D+L
Sbjct: 280 YQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 4/167 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG+VY+ +    V + +          L++F+ E  V++  RH N++  +   + 
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
               A+V ++    SL   LH+S     +   ++I    A  ++YLH   +  IIH DLK
Sbjct: 92  PQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLK 147
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            +N+ L ED    + DFG+A   S    S    Q   +I +MAP+ I
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 66/269 (24%), Positives = 120/269 (44%), Gaps = 25/269 (9%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    ++ E+M+ G+L D L   N   ++    L +   I+SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRD 136
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-- 909
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K   
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 910 WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK 959
           W   +L          P   +++     L  ++      E C   ++ L   C   +P  
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 960 RID------AKDTITRLLKIRDTLSKRIG 982
           R        A +T+ +   I D + K +G
Sbjct: 256 RPSFAEIHQAFETMFQESSISDEVEKELG 284

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 66/269 (24%), Positives = 120/269 (44%), Gaps = 25/269 (9%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    ++ E+M+ G+L D L   N   ++    L +   I+SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRD 136
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-- 909
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K   
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 910 WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK 959
           W   +L          P   +++     L  ++      E C   ++ L   C   +P  
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 960 RID------AKDTITRLLKIRDTLSKRIG 982
           R        A +T+ +   I D + K +G
Sbjct: 256 RPSFAEIHQAFETMFQESSISDEVEKELG 284

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 66/269 (24%), Positives = 120/269 (44%), Gaps = 25/269 (9%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    ++ E+M+ G+L D L   N   ++    L +   I+SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRD 141
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-- 909
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K   
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 910 WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK 959
           W   +L          P   +++     L  ++      E C   ++ L   C   +P  
Sbjct: 201 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 260
Query: 960 RID------AKDTITRLLKIRDTLSKRIG 982
           R        A +T+ +   I D + K +G
Sbjct: 261 RPSFAEIHQAFETMFQESSISDEVEKELG 289

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 4/167 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG+VY+ +    V + +          L++F+ E  V++  RH N++  +   + 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
               A+V ++    SL   LH       +   ++I    A  ++YLH   +  IIH DLK
Sbjct: 104 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 159
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            +N+ L ED+   + DFG+A   S    S    Q   +I +MAP+ I
Sbjct: 160 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 206

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 4/167 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG+VY+ +    V + +          L++F+ E  V++  RH N++  +   + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
               A+V ++    SL   LH       +   ++I    A  ++YLH   +  IIH DLK
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 131
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            +N+ L ED+   + DFG+A   S    S    Q   +I +MAP+ I
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 178

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 90/182 (49%), Gaps = 27/182 (14%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTL--KSFEAEC---EVIKNIRHRNLVKI 787
           +G GGFG V R   +D G ++AIK    QC   L  K+ E  C   +++K + H N+V  
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 788 ------ISSCSNDDFKALVLEYMSNGSLEDCLHSSN--CALNIFCRLNIMIDIASALEYL 839
                 +   + +D   L +EY   G L   L+     C L       ++ DI+SAL YL
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 840 HFGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
           H      IIH DLKP N++L    + ++  + D G AK L   D+  + T+ + T+ Y+A
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLA 191
Query: 897 PD 898
           P+
Sbjct: 192 PE 193

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 90/182 (49%), Gaps = 27/182 (14%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTL--KSFEAEC---EVIKNIRHRNLVKI 787
           +G GGFG V R   +D G ++AIK    QC   L  K+ E  C   +++K + H N+V  
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 78
Query: 788 ------ISSCSNDDFKALVLEYMSNGSLEDCLHSSN--CALNIFCRLNIMIDIASALEYL 839
                 +   + +D   L +EY   G L   L+     C L       ++ DI+SAL YL
Sbjct: 79  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 138
Query: 840 HFGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
           H      IIH DLKP N++L    + ++  + D G AK L   D+  + T+ + T+ Y+A
Sbjct: 139 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLA 192
Query: 897 PD 898
           P+
Sbjct: 193 PE 194

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 4/167 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG+VY+ +    V + +          L++F+ E  V++  RH N++  +   + 
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
               A+V ++    SL   LH       +   ++I    A  ++YLH   +  IIH DLK
Sbjct: 96  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 151
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            +N+ L ED+   + DFG+A   S    S    Q   +I +MAP+ I
Sbjct: 152 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 198

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 67/275 (24%), Positives = 121/275 (44%), Gaps = 37/275 (13%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    ++ E+M+ G+L D L   N   ++    L +   I+SA+EYL        IH D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRD 134
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR-- 909
           L   N L+ E+ +  ++DFG+++L++G D  T        I + AP+ +   + S+K   
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTFTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 910 WVNDLL----------------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECT 953
           W   +L                P  + E+++K      +      E C   ++ L   C 
Sbjct: 194 WAFGVLLWEIATYGMSPYPGIDPSQVYELLEK------DYRMERPEGCPEKVYELMRACW 247
Query: 954 MESPEKRID------AKDTITRLLKIRDTLSKRIG 982
             +P  R        A +T+ +   I D + K +G
Sbjct: 248 QWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 282

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 24/188 (12%)
Query: 734 IGIGGFGSVYRAR------LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKI 787
           +G G FG V+ A        +D + +A+K       +  K F+ E E++ N++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHS---------------SNCALNIFCRLNIMIDI 832
              C + D   +V EYM +G L   L +               +   L +   L+I   I
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           AS + YL   H    +H DL   N L+  +++  + DFGM++ +   D   +   T+  I
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 893 GYMAPDEI 900
            +M P+ I
Sbjct: 200 RWMPPESI 207

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 711 PTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFH-PQCAST 765
           PT     + + L AT N + + ++G G FG V   RL+      + +AIK          
Sbjct: 31  PTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 766 LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR 825
            + F  E  ++    H N++++    +      +V EYM NGSL+  L   +    +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 149
Query: 826 LNIMIDIASALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
           + ++  IAS ++YL   G+    +H DL   N+L++ ++V  +SDFG+A++L  + E+  
Sbjct: 150 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAY 205
Query: 885 RTQ-TLATIGYMAPDEI 900
            T+     I + +P+ I
Sbjct: 206 TTRGGKIPIRWTSPEAI 222

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 26/294 (8%)
Query: 704 DIILSSQPTIRRFSYFELLRAT--DNFAENN-------IIGIGGFGSVYRARLE-DGVEI 753
           D +LS+Q  + + S   L RA   D +  N+        IG G FG V+  RL  D   +
Sbjct: 83  DHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLV 142
Query: 754 AIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDC 812
           A+K         LK+ F  E  ++K   H N+V++I  C+      +V+E +  G     
Sbjct: 143 AVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTF 202
Query: 813 LHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGM 872
           L +    L +   L ++ D A+ +EYL    S   IH DL   N L+ E  V  +SDFGM
Sbjct: 203 LRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRDLAARNCLVTEKNVLKISDFGM 259
Query: 873 AKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR--WVNDLL---PVSLVEVVDKSL 927
           ++  +    +         + + AP+ +  G  S +   W   +L     SL      +L
Sbjct: 260 SREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319
Query: 928 LSGEEKHFAAK-------EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR 974
            + + + F  K       E C  ++F L  +C    P +R         L  IR
Sbjct: 320 SNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 71/297 (23%), Positives = 126/297 (42%), Gaps = 43/297 (14%)
Query: 722 LRATDNFAENNI-----IGIGGFGSVYRAR---LED--GVEIAIKVFHPQCASTLKSFEA 771
           +R    F E ++     +G G FGSV   R   L+D  G  +A+K         L+ FE 
Sbjct: 1   MRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 772 ECEVIKNIRHRNLVKIISSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM 829
           E E++K+++H N+VK    C +   +   L++EY+  GSL D L      ++    L   
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 830 IDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQT 888
             I   +EYL    +   IH DL   N+L++ +    + DFG+ K+L  + E   ++   
Sbjct: 121 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 177
Query: 889 LATIGYMAPDEIFVGELSLKR--WVNDLLPVSLVEVVDKS--------LLSGEEKH---- 934
            + I + AP+ +   + S+    W   ++   L   ++KS         + G +K     
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237
Query: 935 -------------FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS 978
                            + C   I+ +  EC   +  +R   +D   R+ +IRD ++
Sbjct: 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 26/294 (8%)
Query: 704 DIILSSQPTIRRFSYFELLRAT--DNFAENN-------IIGIGGFGSVYRARLE-DGVEI 753
           D +LS+Q  + + S   L RA   D +  N+        IG G FG V+  RL  D   +
Sbjct: 83  DHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLV 142
Query: 754 AIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDC 812
           A+K         LK+ F  E  ++K   H N+V++I  C+      +V+E +  G     
Sbjct: 143 AVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTF 202
Query: 813 LHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGM 872
           L +    L +   L ++ D A+ +EYL    S   IH DL   N L+ E  V  +SDFGM
Sbjct: 203 LRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRDLAARNCLVTEKNVLKISDFGM 259
Query: 873 AKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR--WVNDLL---PVSLVEVVDKSL 927
           ++  +    +         + + AP+ +  G  S +   W   +L     SL      +L
Sbjct: 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319
Query: 928 LSGEEKHFAAK-------EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR 974
            + + + F  K       E C  ++F L  +C    P +R         L  IR
Sbjct: 320 SNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 75/167 (44%), Gaps = 18/167 (10%)
Query: 722 LRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIR 780
           LR   +F E  ++G G FG V +AR   D    AIK         L +  +E  ++ ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60
Query: 781 H-------------RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN 827
           H             RN VK +++        + +EY  NG+L D +HS N          
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 828 IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK 874
           +   I  AL Y+H   S  IIH DLKP N+ +DE     + DFG+AK
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 21/185 (11%)
Query: 734 IGIGGFGSVYRARL------EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKI 787
           +G G FG V+ A        +D + +A+K       +  K F  E E++ N++H ++VK 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSN------------CALNIFCRLNIMIDIASA 835
              C   D   +V EYM +G L   L +                L     L+I   IA+ 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYM 895
           + YL   H    +H DL   N L+ E+++  + DFGM++ +   D   +   T+  I +M
Sbjct: 141 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 896 APDEI 900
            P+ I
Sbjct: 198 PPESI 202

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 38/280 (13%)
Query: 734 IGIGGFGSVYRAR---LED--GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +G G FGSV   R   L+D  G  +A+K         L+ FE E E++K+++H N+VK  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 789 SSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
             C +   +   L++EY+  GSL D L      ++    L     I   +EYL    +  
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKR 141
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPDEIFVGEL 905
            IH DL   N+L++ +    + DFG+ K+L  + E   ++    + I + AP+ +   + 
Sbjct: 142 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 201
Query: 906 SLKR--WVNDLLPVSLVEVVDKS--------LLSGEEKH-----------------FAAK 938
           S+    W   ++   L   ++KS         + G +K                      
Sbjct: 202 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 261
Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS 978
           + C   I+ +  EC   +  +R   +D   R+ +IRD ++
Sbjct: 262 DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 301

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 38/280 (13%)
Query: 734 IGIGGFGSVYRAR---LED--GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +G G FGSV   R   L+D  G  +A+K         L+ FE E E++K+++H N+VK  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 789 SSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
             C +   +   L++EY+  GSL D L      ++    L     I   +EYL    +  
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKR 139
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPDEIFVGEL 905
            IH DL   N+L++ +    + DFG+ K+L  + E   ++    + I + AP+ +   + 
Sbjct: 140 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 199
Query: 906 SLKR--WVNDLLPVSLVEVVDKS--------LLSGEEKH-----------------FAAK 938
           S+    W   ++   L   ++KS         + G +K                      
Sbjct: 200 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 259
Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS 978
           + C   I+ +  EC   +  +R   +D   R+ +IRD ++
Sbjct: 260 DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 299

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 38/280 (13%)
Query: 734 IGIGGFGSVYRAR---LED--GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +G G FGSV   R   L+D  G  +A+K         L+ FE E E++K+++H N+VK  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 789 SSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
             C +   +   L++EY+  GSL D L      ++    L     I   +EYL    +  
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKR 140
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPDEIFVGEL 905
            IH DL   N+L++ +    + DFG+ K+L  + E   ++    + I + AP+ +   + 
Sbjct: 141 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 200
Query: 906 SLKR--WVNDLLPVSLVEVVDKS--------LLSGEEKH-----------------FAAK 938
           S+    W   ++   L   ++KS         + G +K                      
Sbjct: 201 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 260
Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS 978
           + C   I+ +  EC   +  +R   +D   R+ +IRD ++
Sbjct: 261 DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 300

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 38/280 (13%)
Query: 734 IGIGGFGSVYRAR---LED--GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +G G FGSV   R   L+D  G  +A+K         L+ FE E E++K+++H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 789 SSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
             C +   +   L++EY+  GSL D L      ++    L     I   +EYL    +  
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKR 137
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPDEIFVGEL 905
            IH DL   N+L++ +    + DFG+ K+L  + E   ++    + I + AP+ +   + 
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 197
Query: 906 SLKR--WVNDLLPVSLVEVVDKS--------LLSGEEKH-----------------FAAK 938
           S+    W   ++   L   ++KS         + G +K                      
Sbjct: 198 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 257
Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS 978
           + C   I+ +  EC   +  +R   +D   R+ +IRD ++
Sbjct: 258 DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 38/280 (13%)
Query: 734 IGIGGFGSVYRAR---LED--GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +G G FGSV   R   L+D  G  +A+K         L+ FE E E++K+++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 789 SSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
             C +   +   L++EY+  GSL D L      ++    L     I   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKR 134
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPDEIFVGEL 905
            IH DL   N+L++ +    + DFG+ K+L  + E   ++    + I + AP+ +   + 
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 194
Query: 906 SLKR--WVNDLLPVSLVEVVDKS--------LLSGEEKH-----------------FAAK 938
           S+    W   ++   L   ++KS         + G +K                      
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 254
Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS 978
           + C   I+ +  EC   +  +R   +D   R+ +IRD ++
Sbjct: 255 DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 38/280 (13%)
Query: 734 IGIGGFGSVYRAR---LED--GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +G G FGSV   R   L+D  G  +A+K         L+ FE E E++K+++H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 789 SSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
             C +   +   L++EY+  GSL D L      ++    L     I   +EYL    +  
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKR 152
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPDEIFVGEL 905
            IH DL   N+L++ +    + DFG+ K+L  + E   ++    + I + AP+ +   + 
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 212
Query: 906 SLKR--WVNDLLPVSLVEVVDKS--------LLSGEEKH-----------------FAAK 938
           S+    W   ++   L   ++KS         + G +K                      
Sbjct: 213 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 272
Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS 978
           + C   I+ +  EC   +  +R   +D   R+ +IRD ++
Sbjct: 273 DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 312

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 38/280 (13%)
Query: 734 IGIGGFGSVYRAR---LED--GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +G G FGSV   R   L+D  G  +A+K         L+ FE E E++K+++H N+VK  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 789 SSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
             C +   +   L++EY+  GSL D L      ++    L     I   +EYL    +  
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKR 138
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPDEIFVGEL 905
            IH DL   N+L++ +    + DFG+ K+L  + E   ++    + I + AP+ +   + 
Sbjct: 139 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 198
Query: 906 SLKR--WVNDLLPVSLVEVVDKS--------LLSGEEKH-----------------FAAK 938
           S+    W   ++   L   ++KS         + G +K                      
Sbjct: 199 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 258
Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS 978
           + C   I+ +  EC   +  +R   +D   R+ +IRD ++
Sbjct: 259 DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 298

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 68/280 (24%), Positives = 121/280 (43%), Gaps = 38/280 (13%)
Query: 734 IGIGGFGSVYRAR---LED--GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +G G FGSV   R   L+D  G  +A+K         L+ FE E E++K+++H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 789 SSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
             C +   +   L++EY+  GSL D L +    ++    L     I   +EYL    +  
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYL---GTKR 137
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPDEIFVGEL 905
            IH DL   N+L++ +    + DFG+ K+L  + E   ++    + I + AP+ +   + 
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 197
Query: 906 SLKR--WVNDLLPVSLVEVVDKS--------LLSGEEKH-----------------FAAK 938
           S+    W   ++   L   ++KS         + G +K                      
Sbjct: 198 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 257
Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS 978
           + C   I+ +  EC   +  +R   +D   R+ +IRD ++
Sbjct: 258 DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 38/280 (13%)
Query: 734 IGIGGFGSVYRAR---LED--GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +G G FGSV   R   L+D  G  +A+K         L+ FE E E++K+++H N+VK  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 789 SSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
             C +   +   L++EY+  GSL D L      ++    L     I   +EYL    +  
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKR 133
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPDEIFVGEL 905
            IH DL   N+L++ +    + DFG+ K+L  + E   ++    + I + AP+ +   + 
Sbjct: 134 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 193
Query: 906 SLKR--WVNDLLPVSLVEVVDKS--------LLSGEEKH-----------------FAAK 938
           S+    W   ++   L   ++KS         + G +K                      
Sbjct: 194 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 253
Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS 978
           + C   I+ +  EC   +  +R   +D   R+ +IRD ++
Sbjct: 254 DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 293

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 718 YFELLRATDNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTL--KSFEAECE 774
           YF+ +   +N     ++G G +G V + R +D G  +AIK F       +  K    E +
Sbjct: 20  YFQSMEKYENLG---LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIK 76
Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           ++K +RH NLV ++  C       LV E++ +  L+D     N  L+       +  I +
Sbjct: 77  LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN-GLDYQVVQKYLFQIIN 135
Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY 894
            +    F HS  IIH D+KP N+L+ +  V  L DFG A+ L+   E  +    +AT  Y
Sbjct: 136 GI---GFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWY 190
Query: 895 MAPDEIFVGELSLKRWVN 912
            AP E+ VG++   + V+
Sbjct: 191 RAP-ELLVGDVKYGKAVD 207

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 38/280 (13%)
Query: 734 IGIGGFGSVYRAR---LED--GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +G G FGSV   R   L+D  G  +A+K         L+ FE E E++K+++H N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 789 SSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
             C +   +   L++EY+  GSL D L      ++    L     I   +EYL    +  
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKR 165
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST-MRTQTLATIGYMAPDEIFVGEL 905
            IH DL   N+L++ +    + DFG+ K+L  + E   ++    + I + AP+ +   + 
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 225
Query: 906 SLKR--WVNDLLPVSLVEVVDKS--------LLSGEEKH-----------------FAAK 938
           S+    W   ++   L   ++KS         + G +K                      
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 285
Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS 978
           + C   I+ +  EC   +  +R   +D   R+ +IRD ++
Sbjct: 286 DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 38/280 (13%)
Query: 734 IGIGGFGSVYRAR---LED--GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +G G FGSV   R   L+D  G  +A+K         L+ FE E E++K+++H N+VK  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 789 SSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
             C +   +   L++EY+  GSL D L      ++    L     I   +EYL    +  
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKR 132
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPDEIFVGEL 905
            IH DL   N+L++ +    + DFG+ K+L  + E   ++    + I + AP+ +   + 
Sbjct: 133 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 192
Query: 906 SLKR--WVNDLLPVSLVEVVDKS--------LLSGEEKH-----------------FAAK 938
           S+    W   ++   L   ++KS         + G +K                      
Sbjct: 193 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 252
Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS 978
           + C   I+ +  EC   +  +R   +D   R+ +IRD ++
Sbjct: 253 DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 292

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 53/177 (29%), Positives = 87/177 (49%), Gaps = 7/177 (3%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNC-ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
            +    +V EYM  G+L D L   N   +     L +   I+SA+EYL        IH D
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYL---EKKNFIHRD 155
Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
           L   N L+ E+ V  ++DFG+++L++G D  T        I + AP+ +     S+K
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNTFSIK 211

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 119/279 (42%), Gaps = 38/279 (13%)
Query: 734 IGIGGFGSVYRAR---LED--GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +G G FGSV   R   L+D  G  +A+K         L+ FE E E++K+++H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 789 SSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
             C +   +   L++EY+  GSL D L      ++    L     I   +EYL    +  
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKR 152
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPDEIFVGEL 905
            IH DL   N+L++ +    + DFG+ K+L  + E   ++    + I + AP+ +   + 
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 212
Query: 906 SLKR--WVNDLLPVSLVEVVDKS--------LLSGEEKH-----------------FAAK 938
           S+    W   ++   L   ++KS         + G +K                      
Sbjct: 213 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 272
Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL 977
           + C   I+ +  EC   +  +R   +D   R+ +IRD +
Sbjct: 273 DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 311

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 93/196 (47%), Gaps = 10/196 (5%)
Query: 711 PTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFH-PQCAST 765
           PT     + + L AT N + + ++G G FG V   RL+      + +AIK          
Sbjct: 31  PTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 766 LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR 825
            + F  E  ++    H N++++    +      +V EYM NGSL+  L   +    +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 149
Query: 826 LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR 885
           + ++  IAS ++YL        +H DL   N+L++ ++V  +SDFG++++L  + E+   
Sbjct: 150 VGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 886 TQ-TLATIGYMAPDEI 900
           T+     I + +P+ I
Sbjct: 207 TRGGKIPIRWTSPEAI 222

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     IG G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EYM  G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 711 PTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFH-PQCAST 765
           PT     + + L AT N + + ++G G FG V   RL+      + +AIK          
Sbjct: 31  PTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 766 LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR 825
            + F  E  ++    H N++++    +      +V EYM NGSL+  L   +    +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 149
Query: 826 LNIMIDIASALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
           + ++  IAS ++YL   G+    +H DL   N+L++ ++V  +SDFG++++L  + E+  
Sbjct: 150 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 885 RTQ-TLATIGYMAPDEI 900
            T+     I + +P+ I
Sbjct: 206 TTRGGKIPIRWTSPEAI 222

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 38/280 (13%)
Query: 734 IGIGGFGSVYRAR---LED--GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +G G FGSV   R   L+D  G  +A+K         L+ FE E E++K+++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 789 SSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
             C +   +   L++EY+  GSL D L      ++    L     I   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKR 134
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPDEIFVGEL 905
            IH DL   N+L++ +    + DFG+ K+L  + E   ++    + I + AP+ +   + 
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 906 SLKR--WVNDLLPVSLVEVVDKS--------LLSGEEKH-----------------FAAK 938
           S+    W   ++   L   ++KS         + G +K                      
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 254
Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS 978
           + C   I+ +  EC   +  +R   +D   R+ +IRD ++
Sbjct: 255 DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 711 PTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFH-PQCAST 765
           PT     + + L AT N + + ++G G FG V   RL+      + +AIK          
Sbjct: 31  PTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 766 LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR 825
            + F  E  ++    H N++++    +      +V EYM NGSL+  L   +    +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 149
Query: 826 LNIMIDIASALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
           + ++  IAS ++YL   G+    +H DL   N+L++ ++V  +SDFG++++L  + E+  
Sbjct: 150 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 885 RTQ-TLATIGYMAPDEI 900
            T+     I + +P+ I
Sbjct: 206 TTRGGKIPIRWTSPEAI 222

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 711 PTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFH-PQCAST 765
           PT     + + L AT N + + ++G G FG V   RL+      + +AIK          
Sbjct: 31  PTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 766 LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR 825
            + F  E  ++    H N++++    +      +V EYM NGSL+  L   +    +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 149
Query: 826 LNIMIDIASALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
           + ++  IAS ++YL   G+    +H DL   N+L++ ++V  +SDFG++++L  + E+  
Sbjct: 150 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 885 RTQ-TLATIGYMAPDEI 900
            T+     I + +P+ I
Sbjct: 206 TTRGGKIPIRWTSPEAI 222

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 711 PTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFH-PQCAST 765
           PT     + + L AT N + + ++G G FG V   RL+      + +AIK          
Sbjct: 31  PTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 766 LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR 825
            + F  E  ++    H N++++    +      +V EYM NGSL+  L   +    +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 149
Query: 826 LNIMIDIASALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
           + ++  IAS ++YL   G+    +H DL   N+L++ ++V  +SDFG+ ++L  + E+  
Sbjct: 150 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAY 205
Query: 885 RTQ-TLATIGYMAPDEI 900
            T+     I + +P+ I
Sbjct: 206 TTRGGKIPIRWTSPEAI 222

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     IG G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EYM  G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 89/183 (48%), Gaps = 11/183 (6%)
Query: 711 PTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFH-PQCAST 765
           PT     + + L AT N + + ++G G FG V   RL+      + +AIK          
Sbjct: 31  PTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 766 LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR 825
            + F  E  ++    H N++++    +      +V EYM NGSL+  L   +    +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 149
Query: 826 LNIMIDIASALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
           + ++  IAS ++YL   G+    +H DL   N+L++ ++V  +SDFG++++L  + E+  
Sbjct: 150 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 885 RTQ 887
            T+
Sbjct: 206 TTR 208

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 115/266 (43%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 144
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT TL  T  Y+AP   
Sbjct: 145 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAP--- 193
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 194 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 247
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 248 SSDLKDLLRNLLQV--DLTKRFGNLK 271

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/275 (21%), Positives = 112/275 (40%), Gaps = 47/275 (17%)
Query: 734 IGIGGFGSVYRARL------EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKI 787
           +G G FG V+ A        +D + +A+K       S  + F+ E E++  ++H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHS--------------SNCALNIFCRLNIMIDIA 833
              C+      +V EYM +G L   L S              +   L +   L +   +A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
           + + YL   H    +H DL   N L+ + +V  + DFGM++ +   D   +  +T+  I 
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 894 YMAPDEIFVGELSLKRWVNDLLPVSLV------------------EVVDKSLLSGEEKHF 935
           +M P+ I   + + +   +D+    +V                  E +D  +  G E   
Sbjct: 226 WMPPESILYRKFTTE---SDVWSFGVVLWEIFTYGKQPWYQLSNTEAID-CITQGRE--L 279
Query: 936 AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRL 970
                C   ++++   C    P++R   KD   RL
Sbjct: 280 ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 89/183 (48%), Gaps = 11/183 (6%)
Query: 711 PTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFH-PQCAST 765
           PT     + + L AT N + + ++G G FG V   RL+      + +AIK          
Sbjct: 29  PTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 87
Query: 766 LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR 825
            + F  E  ++    H N++++    +      +V EYM NGSL+  L   +    +   
Sbjct: 88  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 147
Query: 826 LNIMIDIASALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
           + ++  IAS ++YL   G+    +H DL   N+L++ ++V  +SDFG++++L  + E+  
Sbjct: 148 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 203
Query: 885 RTQ 887
            T+
Sbjct: 204 TTR 206

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 115/266 (43%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT TL  T  Y+AP   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAP--- 208
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 209 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 262
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 263 SSDLKDLLRNLLQV--DLTKRFGNLK 286

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 91/185 (49%), Gaps = 13/185 (7%)
Query: 709 SQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFH-PQCA 763
           S  T+  F+  + L AT N + + ++G G FG V   RL+      + +AIK        
Sbjct: 19  STQTVHEFA--KELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 75
Query: 764 STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIF 823
              + F  E  ++    H N++++    +      +V EYM NGSL+  L   +    + 
Sbjct: 76  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 135
Query: 824 CRLNIMIDIASALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES 882
             + ++  IAS ++YL   G+    +H DL   N+L++ ++V  +SDFG++++L  + E+
Sbjct: 136 QLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 191
Query: 883 TMRTQ 887
              T+
Sbjct: 192 AYTTR 196

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 91/185 (49%), Gaps = 13/185 (7%)
Query: 709 SQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFH-PQCA 763
           S  T+  F+  + L AT N + + ++G G FG V   RL+      + +AIK        
Sbjct: 2   STQTVHEFA--KELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 58
Query: 764 STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIF 823
              + F  E  ++    H N++++    +      +V EYM NGSL+  L   +    + 
Sbjct: 59  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 118
Query: 824 CRLNIMIDIASALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES 882
             + ++  IAS ++YL   G+    +H DL   N+L++ ++V  +SDFG++++L  + E+
Sbjct: 119 QLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 174
Query: 883 TMRTQ 887
              T+
Sbjct: 175 AYTTR 179

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 45/174 (25%), Positives = 87/174 (50%), Gaps = 12/174 (6%)
Query: 734 IGIGGFGSVYRARLE-----DGVEIAIKVFHPQCAST-LKSFEAECEVIKNIRHRNLVKI 787
           +G G FG V   R +      G ++A+K   P+     +   + E E+++N+ H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 788 ISSCSNDDFKA--LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
              C+ D      L++E++ +GSL++ L  +   +N+  +L   + I   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---GSR 145
Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPD 898
             +H DL   NVL++ +    + DFG+ K +  + E  T++    + + + AP+
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE 199

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 45/174 (25%), Positives = 87/174 (50%), Gaps = 12/174 (6%)
Query: 734 IGIGGFGSVYRARLE-----DGVEIAIKVFHPQCAST-LKSFEAECEVIKNIRHRNLVKI 787
           +G G FG V   R +      G ++A+K   P+     +   + E E+++N+ H N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 788 ISSCSNDDFKA--LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
              C+ D      L++E++ +GSL++ L  +   +N+  +L   + I   ++YL    S 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---GSR 133
Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPD 898
             +H DL   NVL++ +    + DFG+ K +  + E  T++    + + + AP+
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE 187

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 67/280 (23%), Positives = 120/280 (42%), Gaps = 38/280 (13%)
Query: 734 IGIGGFGSVYRAR---LED--GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +G G FGSV   R   L+D  G  +A+K         L+ FE E E++K+++H N+VK  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 789 SSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
             C +   +   L++EY+  GSL D L      ++    L     I   +EYL    +  
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKR 135
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPDEIFVGEL 905
            IH +L   N+L++ +    + DFG+ K+L  + E   ++    + I + AP+ +   + 
Sbjct: 136 YIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 195
Query: 906 SLKR--WVNDLLPVSLVEVVDKS--------LLSGEEKH-----------------FAAK 938
           S+    W   ++   L   ++KS         + G +K                      
Sbjct: 196 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 255
Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS 978
           + C   I+ +  EC   +  +R   +D   R+ +IRD ++
Sbjct: 256 DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 295

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 208
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 209 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 262
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 263 SSDLKDLLRNLLQV--DLTKRFGNLK 286

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 115/266 (43%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA-TIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  LA T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLAGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     IG G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 115/266 (43%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 145
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+DE     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 146 --SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 194
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 195 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 248
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 249 SSDLKDLLRNLLQV--DLTKRFGNLK 272

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 6/168 (3%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG V+     +  ++AIK    + A + + F  E EV+  + H  LV++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
                LV E+M +G L D L +          L + +D+   + YL       +IH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEASVIHRDLA 130
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
             N L+ E+ V  +SDFGM + +  +D+ T  T T   + + +P E+F
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP-EVF 176

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 52/186 (27%), Positives = 90/186 (48%), Gaps = 17/186 (9%)
Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCA---STLKSFEAECEVIKNIR 780
           +D +    I+G GG   V+ AR L D  ++A+KV     A   S    F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 781 HRNLVKIISSCSNDD----FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL 836
           H  +V +  +   +        +V+EY+   +L D +H+      +  +  I + IA A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG--- 893
           + L+F H   IIH D+KP+N+++       + DFG+A+ ++  D     TQT A IG   
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 184
Query: 894 YMAPDE 899
           Y++P++
Sbjct: 185 YLSPEQ 190

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 52/186 (27%), Positives = 90/186 (48%), Gaps = 17/186 (9%)
Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCA---STLKSFEAECEVIKNIR 780
           +D +    I+G GG   V+ AR L D  ++A+KV     A   S    F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 781 HRNLVKIISSCSNDD----FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL 836
           H  +V +  +   +        +V+EY+   +L D +H+      +  +  I + IA A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG--- 893
           + L+F H   IIH D+KP+N+++       + DFG+A+ ++  D     TQT A IG   
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 184
Query: 894 YMAPDE 899
           Y++P++
Sbjct: 185 YLSPEQ 190

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 60/186 (32%), Positives = 92/186 (49%), Gaps = 8/186 (4%)
Query: 720 ELLRATDNFAENN---IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEV 775
           +LL     + EN    ++G G +G VY  R L + V IAIK    + +   +    E  +
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72
Query: 776 IKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASA 835
            K+++H+N+V+ + S S + F  + +E +  GSL   L S    L       I       
Sbjct: 73  HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKD-NEQTIGFYTKQI 131
Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           LE L + H   I+H D+K  NVL++    V  +SDFG +K L+G +  T  T T  T+ Y
Sbjct: 132 LEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT-ETFT-GTLQY 189
Query: 895 MAPDEI 900
           MAP+ I
Sbjct: 190 MAPEII 195

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 179
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 228
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 229 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 282
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 283 SSDLKDLLRNLLQV--DLTKRFGNLK 306

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 208
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 209 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 262
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 263 SSDLKDLLRNLLQV--DLTKRFGNLK 286

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 57/177 (32%), Positives = 88/177 (49%), Gaps = 5/177 (2%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
           D   +  ++G G +G VY  R L + V IAIK    + +   +    E  + K+++H+N+
Sbjct: 8   DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 67
Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           V+ + S S + F  + +E +  GSL   L S    L       I       LE L + H 
Sbjct: 68  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKD-NEQTIGFYTKQILEGLKYLHD 126
Query: 845 TPIIHCDLKPSNVLLDE-DMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
             I+H D+K  NVL++    V  +SDFG +K L+G +  T  T T  T+ YMAP+ I
Sbjct: 127 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT-ETFT-GTLQYMAPEII 181

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 86/173 (49%), Gaps = 15/173 (8%)
Query: 733 IIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAEC------EVIKNIRHRNLV 785
           +IG G FG V  AR + + V  A+KV   Q  + LK  E +        ++KN++H  LV
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVL--QKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
            +  S    D    VL+Y++ G L   L    C L    R     +IASAL YLH   S 
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SL 158
Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
            I++ DLKP N+LLD      L+DFG+ K  + E  ST  T    T  Y+AP+
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTST-FCGTPEYLAPE 209

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 12/183 (6%)
Query: 727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLK---SFEAECEVIKNIRHR 782
           ++   + +G+G FG V     +  G ++A+K+ + Q   +L      + E + +K  RH 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           +++K+    S      +V+EY+S G L D +        +  R  +   I SA++Y H  
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH-- 128
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV 902
               ++H DLKP NVLLD  M A ++DFG++ ++S  D   +RT +  +  Y AP E+  
Sbjct: 129 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRT-SCGSPNYAAP-EVIS 183
Query: 903 GEL 905
           G L
Sbjct: 184 GRL 186

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 66/280 (23%), Positives = 120/280 (42%), Gaps = 38/280 (13%)
Query: 734 IGIGGFGSVYRAR---LED--GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +G G FGSV   R   L+D  G  +A+K         L+ FE E E++K+++H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 789 SSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
             C +   +   L++E++  GSL + L      ++    L     I   +EYL    +  
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKR 137
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPDEIFVGEL 905
            IH DL   N+L++ +    + DFG+ K+L  + E   ++    + I + AP+ +   + 
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 197
Query: 906 SLKR--WVNDLLPVSLVEVVDKS--------LLSGEEKH-----------------FAAK 938
           S+    W   ++   L   ++KS         + G +K                      
Sbjct: 198 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 257
Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS 978
           + C   I+ +  EC   +  +R   +D   R+ +IRD ++
Sbjct: 258 DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 58/192 (30%), Positives = 93/192 (48%), Gaps = 17/192 (8%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNIRHRN 783
           D F     +G G FG V+       G+E  IK  +   +   ++  EAE EV+K++ H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNC---ALNIFCRLNIMIDIASALEYLH 840
           ++KI     +     +V+E    G L + + S+     AL+      +M  + +AL Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAH----LSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
             H   ++H DLKP N+L  +D   H    + DFG+A+L   ++ S   T    T  YMA
Sbjct: 142 SQH---VVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMA 194
Query: 897 PDEIFVGELSLK 908
           P E+F  +++ K
Sbjct: 195 P-EVFKRDVTFK 205

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 153
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 154 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 202
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 203 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 256
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 257 SSDLKDLLRNLLQV--DLTKRFGNLK 280

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 84/181 (46%), Gaps = 12/181 (6%)
Query: 727 NFAENNIIGIGGFGSVYRAR-LEDGVEIAIK---VFHPQCASTLKSFEAECEVIKNIRHR 782
           NF     IG G F  VYRA  L DGV +A+K   +F    A        E +++K + H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNI---MIDIASALEYL 839
           N++K  +S   D+   +VLE    G L   +        +     +    + + SALE++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
           H   S  ++H D+KP+NV +    V  L D G+ +  S   ++T     + T  YM+P+ 
Sbjct: 153 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPER 207
Query: 900 I 900
           I
Sbjct: 208 I 208

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 6/168 (3%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG V+     +  ++AIK    + A + + F  E EV+  + H  LV++   C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
                LV E+M +G L D L +          L + +D+   + YL       +IH DL 
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLA 128
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
             N L+ E+ V  +SDFGM + +  +D+ T  T T   + + +P E+F
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP-EVF 174

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 6/168 (3%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG V+     +  ++AIK    + A + + F  E EV+  + H  LV++   C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
                LV E+M +G L D L +          L + +D+   + YL       +IH DL 
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLA 133
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
             N L+ E+ V  +SDFGM + +  +D+ T  T T   + + +P E+F
Sbjct: 134 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP-EVF 179

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 6/168 (3%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG V+     +  ++AIK    + A + + F  E EV+  + H  LV++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
                LV E+M +G L D L +          L + +D+   + YL       +IH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLA 130
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
             N L+ E+ V  +SDFGM + +  +D+ T  T T   + + +P E+F
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP-EVF 176

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 57/185 (30%), Positives = 94/185 (50%), Gaps = 18/185 (9%)
Query: 737 GGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS----CS 792
           G FG V++A+L +   +A+K+F  Q   + ++ E E   +  ++H N+++ I +     S
Sbjct: 35  GRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF-------GHST 845
            D    L+  +   GSL D L ++  + N  C  +I   +A  L YLH        GH  
Sbjct: 93  VDVDLWLITAFHEKGSLSDFLKANVVSWNELC--HIAETMARGLAYLHEDIPGLKDGHKP 150
Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
            I H D+K  NVLL  ++ A ++DFG+A K  +G+       Q + T  YMAP E+  G 
Sbjct: 151 AISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ-VGTRRYMAP-EVLEGA 208
Query: 905 LSLKR 909
           ++ +R
Sbjct: 209 INFQR 213

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 151
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 200
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 201 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 254
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 255 SSDLKDLLRNLLQV--DLTKRFGNLK 278

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 88/183 (48%), Gaps = 11/183 (6%)
Query: 711 PTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFH-PQCAST 765
           PT     + + L AT N + + ++G G FG V   RL+      + +AIK          
Sbjct: 31  PTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 766 LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR 825
            + F  E  ++    H N++++    +      +V E M NGSL+  L   +    +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL 149
Query: 826 LNIMIDIASALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
           + ++  IAS ++YL   G+    +H DL   N+L++ ++V  +SDFG++++L  + E+  
Sbjct: 150 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 885 RTQ 887
            T+
Sbjct: 206 TTR 208

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY   G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+++D+     ++DFG+AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLXGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 52/186 (27%), Positives = 89/186 (47%), Gaps = 17/186 (9%)
Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCA---STLKSFEAECEVIKNIR 780
           +D +    I+G GG   V+ AR L D  ++A+KV     A   S    F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 781 HRNLVKIISSCSNDD----FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL 836
           H  +V +  +   +        +V+EY+   +L D +H+      +  +  I + IA A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG--- 893
           + L+F H   IIH D+KP+N+L+       + DFG+A+ ++  D      QT A IG   
Sbjct: 127 QALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIA--DSGNSVXQTAAVIGTAQ 184
Query: 894 YMAPDE 899
           Y++P++
Sbjct: 185 YLSPEQ 190

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 711 PTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFH-PQCAST 765
           PT     + + L AT N + + ++G G FG V   RL+      + +AIK          
Sbjct: 31  PTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 766 LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR 825
            + F  E  ++    H N++++    +      +V E M NGSL+  L   +    +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL 149
Query: 826 LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR 885
           + ++  IAS ++YL        +H DL   N+L++ ++V  +SDFG++++L  + E+   
Sbjct: 150 VGMLRGIASGMKYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 886 TQ-TLATIGYMAPDEI 900
           T+     I + +P+ I
Sbjct: 207 TRGGKIPIRWTSPEAI 222

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 90/178 (50%), Gaps = 12/178 (6%)
Query: 732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLK---SFEAECEVIKNIRHRNLVKI 787
           + +G+G FG V   + E  G ++A+K+ + Q   +L        E + +K  RH +++K+
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
               S      +V+EY+S G L D +   N  L+      +   I S ++Y H      +
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCH---RHMV 137
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGEL 905
           +H DLKP NVLLD  M A ++DFG++ ++S  D   +R  +  +  Y AP E+  G L
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRX-SCGSPNYAAP-EVISGRL 191

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 114/265 (43%), Gaps = 27/265 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNL 984
             D KD +  LL++   L+KR GNL
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNL 284

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY   G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+++D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 208
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 209 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 262
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 263 SSDLKDLLRNLLQV--DLTKRFGNLK 286

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 6/168 (3%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG V+     +  ++AIK    + A + + F  E EV+  + H  LV++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
                LV E+M +G L D L +          L + +D+   + YL       +IH DL 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLA 131
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
             N L+ E+ V  +SDFGM + +  +D+ T  T T   + + +P E+F
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP-EVF 177

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 228
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 229 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 282
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 283 SSDLKDLLRNLLQV--DLTKRFGNLK 306

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY   G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+++D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 56/175 (32%), Positives = 83/175 (47%), Gaps = 16/175 (9%)
Query: 733 IIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           ++G G FG V +A+     ++AIK    +  S  K+F  E   +  + H N+VK+  +C 
Sbjct: 16  VVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL 72
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM---IDIASALEYLHFGHSTPIIH 849
           N     LV+EY   GSL + LH +   L  +   + M   +  +  + YLH      +IH
Sbjct: 73  NP--VCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 129
Query: 850 CDLKPSNVLL-DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG 903
            DLKP N+LL     V  + DFG A      D  T  T    +  +MAP E+F G
Sbjct: 130 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAP-EVFEG 178

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 56/175 (32%), Positives = 83/175 (47%), Gaps = 16/175 (9%)
Query: 733 IIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           ++G G FG V +A+     ++AIK    +  S  K+F  E   +  + H N+VK+  +C 
Sbjct: 15  VVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM---IDIASALEYLHFGHSTPIIH 849
           N     LV+EY   GSL + LH +   L  +   + M   +  +  + YLH      +IH
Sbjct: 72  NP--VCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 850 CDLKPSNVLL-DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG 903
            DLKP N+LL     V  + DFG A      D  T  T    +  +MAP E+F G
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAP-EVFEG 177

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G       T TL  T  Y+AP   
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA------TWTLCGTPEYLAP--- 228
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 229 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 282
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 283 SSDLKDLLRNLLQV--DLTKRFGNLK 306

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 90/185 (48%), Gaps = 13/185 (7%)
Query: 709 SQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFH-PQCA 763
           S  T+  F+  + L AT N + + ++G G FG V   RL+      + +AIK        
Sbjct: 2   STQTVHEFA--KELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 58
Query: 764 STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIF 823
              + F  E  ++    H N++++    +      +V E M NGSL+  L   +    + 
Sbjct: 59  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI 118
Query: 824 CRLNIMIDIASALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES 882
             + ++  IAS ++YL   G+    +H DL   N+L++ ++V  +SDFG++++L  + E+
Sbjct: 119 QLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 174
Query: 883 TMRTQ 887
              T+
Sbjct: 175 AYTTR 179

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 151
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 200
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 201 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 254
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 255 SSDLKDLLRNLLQV--DLTKRFGNLK 278

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY   G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+++D+     ++DFG+AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 208
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 209 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 262
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 263 SSDLKDLLRNLLQV--DLTKRFGNLK 286

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 208
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 209 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 262
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 263 SSDLKDLLRNLLQV--DLTKRFGNLK 286

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY+  G +   L           R      I    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 208
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 209 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 262
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 263 SSDLKDLLRNLLQV--DLTKRFGNLK 286

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 58/186 (31%), Positives = 92/186 (49%), Gaps = 19/186 (10%)
Query: 737 GGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS---CSN 793
           G FG V++A+L +   +A+K+F  Q   + +S E E      ++H NL++ I++    SN
Sbjct: 26  GRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 794 DDFKA-LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF--------GHS 844
            + +  L+  +   GSL D L  +    N  C  ++   ++  L YLH         GH 
Sbjct: 84  LEVELWLITAFHDKGSLTDYLKGNIITWNELC--HVAETMSRGLSYLHEDVPWCRGEGHK 141
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDESTMRTQTLATIGYMAPDEIFVG 903
             I H D K  NVLL  D+ A L+DFG+A +   G+       Q + T  YMAP E+  G
Sbjct: 142 PSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQ-VGTRRYMAP-EVLEG 199
Query: 904 ELSLKR 909
            ++ +R
Sbjct: 200 AINFQR 205

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 469 ELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGP 528
           +LDL  NK+S   S     LT L+ L L  N+   +    F  LK++ +  ++ N L   
Sbjct: 41  KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-- 98
Query: 529 ISLAIGNLKAVVG---IDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMT 585
            +L IG    +V    + L RN L    P   + L  L  +SL YN L+      F  +T
Sbjct: 99  -ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157
Query: 586 SLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGG 629
           SL+ L L NN++      +F+KL+ LK L L  N+LK  +P G 
Sbjct: 158 SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGA 200

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY   G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+++D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 53/183 (28%), Positives = 92/183 (50%), Gaps = 12/183 (6%)
Query: 727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLK---SFEAECEVIKNIRHR 782
           ++   + +G+G FG V     +  G ++A+K+ + Q   +L      + E + +K  RH 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           +++K+    S      +V+EY+S G L D +        +  R  +   I SA++Y H  
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH-- 128
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV 902
               ++H DLKP NVLLD  M A ++DFG++ ++S  D   +R  +  +  Y AP E+  
Sbjct: 129 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLR-DSCGSPNYAAP-EVIS 183
Query: 903 GEL 905
           G L
Sbjct: 184 GRL 186

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 50/168 (29%), Positives = 77/168 (45%), Gaps = 6/168 (3%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG V+     +  ++AIK       S    F  E EV+  + H  LV++   C  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
                LV E+M +G L D L +          L + +D+   + YL       +IH DL 
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLA 150
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
             N L+ E+ V  +SDFGM + +  +D+ T  T T   + + +P E+F
Sbjct: 151 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP-EVF 196

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 5/175 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V   +     ++AIK+      S    F  E +V+ N+ H  LV++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
                ++ EYM+NG L + L            L +  D+  A+EYL    S   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 147
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
             N L+++  V  +SDFG+++ +  +DE T    +   + +  P+ +   + S K
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVL-DDEETSSVGSKFPVRWSPPEVLMYSKFSSK 201

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 43/274 (15%)
Query: 734 IGIGGFGSVYRARL------EDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVK 786
           +G   FG VY+  L      E    +AIK    +    L+  F  E  +   ++H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCL-----HSS----------NCALNIFCRLNIMID 831
           ++   + D   +++  Y S+G L + L     HS             AL     ++++  
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           IA+ +EYL   H   ++H DL   NVL+ + +   +SD G+ + +   D   +   +L  
Sbjct: 154 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 892 IGYMAPDEIFVGELSLKRWVNDLLP--VSLVEVVDKSL-------------LSGEEKHFA 936
           I +MAP+ I  G+ S+    +D+    V L EV    L             +    +   
Sbjct: 211 IRWMAPEAIMYGKFSID---SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP 267
Query: 937 AKEQCLLSIFSLALECTMESPEKRIDAKDTITRL 970
             + C   +++L +EC  E P +R   KD  +RL
Sbjct: 268 CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 43/274 (15%)
Query: 734 IGIGGFGSVYRARL------EDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVK 786
           +G   FG VY+  L      E    +AIK    +    L+  F  E  +   ++H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCL-----HSS----------NCALNIFCRLNIMID 831
           ++   + D   +++  Y S+G L + L     HS             AL     ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           IA+ +EYL   H   ++H DL   NVL+ + +   +SD G+ + +   D   +   +L  
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 892 IGYMAPDEIFVGELSLKRWVNDLLP--VSLVEVVDKSL-------------LSGEEKHFA 936
           I +MAP+ I  G+ S+    +D+    V L EV    L             +    +   
Sbjct: 194 IRWMAPEAIMYGKFSID---SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP 250
Query: 937 AKEQCLLSIFSLALECTMESPEKRIDAKDTITRL 970
             + C   +++L +EC  E P +R   KD  +RL
Sbjct: 251 CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 48/175 (27%), Positives = 83/175 (47%), Gaps = 11/175 (6%)
Query: 733 IIGIGGFGSVYRARL----EDGVEIAIKVFHP-QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IIG G  G V   RL    +  V +AIK           + F +E  ++    H N++++
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-FGHSTP 846
               +      +V EYM NGSL+  L + +    I   + ++  + + + YL   G+   
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY--- 172
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAPDEI 900
            +H DL   NVL+D ++V  +SDFG++++L  + D +   T     I + AP+ I
Sbjct: 173 -VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAI 226

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 60/272 (22%), Positives = 112/272 (41%), Gaps = 41/272 (15%)
Query: 734 IGIGGFGSVYRARL------EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKI 787
           +G G FG V+ A        +D + +A+K       S  + F+ E E++  ++H+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHS--------------SNCALNIFCRLNIMIDIA 833
              C+      +V EYM +G L   L S              +   L +   L +   +A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
           + + YL   H    +H DL   N L+ + +V  + DFGM++ +   D   +  +T+  I 
Sbjct: 146 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 894 YMAPDEIFVGELSLKR--WVNDLL-------------PVSLVEVVDKSLLSGEEKHFAAK 938
           +M P+ I   + + +   W   ++              +S  E +D  +  G E      
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID-CITQGRE--LERP 259
Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRL 970
             C   ++++   C    P++R   KD   RL
Sbjct: 260 RACPPEVYAIMRGCWQREPQQRHSIKDVHARL 291

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 60/272 (22%), Positives = 112/272 (41%), Gaps = 41/272 (15%)
Query: 734 IGIGGFGSVYRARL------EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKI 787
           +G G FG V+ A        +D + +A+K       S  + F+ E E++  ++H+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHS--------------SNCALNIFCRLNIMIDIA 833
              C+      +V EYM +G L   L S              +   L +   L +   +A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
           + + YL   H    +H DL   N L+ + +V  + DFGM++ +   D   +  +T+  I 
Sbjct: 140 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 894 YMAPDEIFVGELSLKR--WVNDLL-------------PVSLVEVVDKSLLSGEEKHFAAK 938
           +M P+ I   + + +   W   ++              +S  E +D  +  G E      
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID-CITQGRE--LERP 253
Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRL 970
             C   ++++   C    P++R   KD   RL
Sbjct: 254 RACPPEVYAIMRGCWQREPQQRHSIKDVHARL 285

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 120/284 (42%), Gaps = 56/284 (19%)
Query: 727 NFAENNI-----IGIGGFGSVYRAR------LEDGVEIAIKVFHPQCASTLKS-FEAECE 774
            +  NNI     IG G FG V++AR       E    +A+K+   + ++ +++ F+ E  
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSN----CALN--------- 821
           ++    + N+VK++  C+      L+ EYM+ G L + L S +    C+L+         
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 822 --------IFC--RLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFG 871
                   + C  +L I   +A+ + YL        +H DL   N L+ E+MV  ++DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFG 219
Query: 872 MAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR--WVNDLLPVSLVEVVDKSL-- 927
           +++ +   D           I +M P+ IF    + +   W      V L E+    L  
Sbjct: 220 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG---VVLWEIFSYGLQP 276
Query: 928 ---LSGEEKHF--------AAKEQCLLSIFSLALECTMESPEKR 960
              ++ EE  +        A  E C L +++L   C  + P  R
Sbjct: 277 YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 320

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 17/254 (6%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V   + +   ++A+K+      S  + F+ E + +  + H  LVK    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ-EAQTMMKLSHPKLVKFYGVCSK 74
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
           +    +V EY+SNG L + L S    L     L +  D+   + +L    S   IH DL 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLA 131
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR--WV 911
             N L+D D+   +SDFGM + +  +D+      T   + + AP+     + S K   W 
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 912 NDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
             +L          P  L    +  L   +            +I+ +   C  E PEKR 
Sbjct: 191 FGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRP 250
Query: 962 DAKDTITRLLKIRD 975
             +  ++ +  +R+
Sbjct: 251 TFQQLLSSIEPLRE 264

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 117/246 (47%), Gaps = 32/246 (13%)
Query: 732 NIIGIGGFGSVYRA-RLEDG----VEIAIKVFHPQCASTLKSFEAECE---VIKNIRHRN 783
            ++G G FG+V++   + +G    + + IKV   +  S  +SF+A  +    I ++ H +
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIGSLDHAH 94
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +V+++  C     + LV +Y+  GSL D +     AL     LN  + IA  + YL    
Sbjct: 95  IVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE--- 150
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG 903
              ++H +L   NVLL       ++DFG+A LL  +D+  + ++    I +MA + I  G
Sbjct: 151 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 210
Query: 904 ELSLKR--W-----VNDLLP--------VSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSL 948
           + + +   W     V +L+         + L EV D  LL   E+  A  + C + ++ +
Sbjct: 211 KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD--LLEKGER-LAQPQICTIDVYMV 267
Query: 949 ALECTM 954
            ++C M
Sbjct: 268 MVKCWM 273

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 112/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             L K+  S  ++    +V+EY   G +   L           R      I    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+++D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 208
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 209 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 262
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 263 SSDLKDLLRNLLQV--DLTKRFGNLK 286

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 45/176 (25%), Positives = 83/176 (47%), Gaps = 11/176 (6%)
Query: 733 IIGIGGFGSVYRARLEDGVE----IAIKVFHP-QCASTLKSFEAECEVIKNIRHRNLVKI 787
           +IG G FG V R RL+   +    +AIK           + F +E  ++    H N++++
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
               +N     ++ E+M NG+L+  L  ++    +   + ++  IAS + YL        
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL---AEMSY 139
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA---TIGYMAPDEI 900
           +H DL   N+L++ ++V  +SDFG+++ L         T +L     I + AP+ I
Sbjct: 140 VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 54/168 (32%), Positives = 80/168 (47%), Gaps = 8/168 (4%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G +GSVY+A   E G  +AIK       S L+    E  +++     ++VK   S  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIK--QVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
            +    +V+EY   GS+ D +   N  L       I+      LEYLHF      IH D+
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDI 151
Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           K  N+LL+ +  A L+DFG+A  L+  D    R   + T  +MAP+ I
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAPEVI 197

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 5/175 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V   +     ++AIK+      S    F  E +V+ N+ H  LV++   C+ 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
                ++ EYM+NG L + L            L +  D+  A+EYL    S   +H DL 
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 138
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
             N L+++  V  +SDFG+++ +  +DE T    +   + +  P+ +   + S K
Sbjct: 139 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 192

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 5/175 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V   +     ++AIK+      S    F  E +V+ N+ H  LV++   C+ 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
                ++ EYM+NG L + L            L +  D+  A+EYL    S   +H DL 
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 131
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
             N L+++  V  +SDFG+++ +  +DE T    +   + +  P+ +   + S K
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 185

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 5/175 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V   +     ++AIK+      S    F  E +V+ N+ H  LV++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
                ++ EYM+NG L + L            L +  D+  A+EYL    S   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 132
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
             N L+++  V  +SDFG+++ +  +DE T    +   + +  P+ +   + S K
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 186

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 5/175 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V   +     ++AIK+      S    F  E +V+ N+ H  LV++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
                ++ EYM+NG L + L            L +  D+  A+EYL    S   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 147
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
             N L+++  V  +SDFG+++ +  +DE T    +   + +  P+ +   + S K
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 5/175 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V   +     ++AIK+      S    F  E +V+ N+ H  LV++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
                ++ EYM+NG L + L            L +  D+  A+EYL    S   +H DL 
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 127
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
             N L+++  V  +SDFG+++ +  +DE T    +   + +  P+ +   + S K
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 50/168 (29%), Positives = 76/168 (45%), Gaps = 20/168 (11%)
Query: 722 LRATDNFAENNIIGIGGFGSVYRAR--LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI 779
           LR   +F E  ++G G FG V +AR  L+       K+ H +    L +  +E  ++ ++
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASL 59
Query: 780 RH-------------RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL 826
            H             RN VK +++        + +EY  N +L D +HS N         
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 827 NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK 874
            +   I  AL Y+H   S  IIH DLKP N+ +DE     + DFG+AK
Sbjct: 120 RLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 48/175 (27%), Positives = 83/175 (47%), Gaps = 11/175 (6%)
Query: 733 IIGIGGFGSVYRARL----EDGVEIAIKVFHP-QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IIG G  G V   RL    +  V +AIK           + F +E  ++    H N++++
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-FGHSTP 846
               +      +V EYM NGSL+  L + +    I   + ++  + + + YL   G+   
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY--- 172
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAPDEI 900
            +H DL   NVL+D ++V  +SDFG++++L  + D +   T     I + AP+ I
Sbjct: 173 -VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 9/174 (5%)
Query: 733 IIGIGGFGSVYRARLE--DGVEIAIKVFHPQCASTLKS---FEAECEVIKNIRHRNLVKI 787
           +IG+G FG V   RL+     EI + +   +   T K    F +E  ++    H N++ +
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
               +      ++ EYM NGSL+  L  ++    +   + ++  I S ++YL        
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSY 131
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ-TLATIGYMAPDEI 900
           +H DL   N+L++ ++V  +SDFGM+++L  + E+   T+     I + AP+ I
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 185

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 9/174 (5%)
Query: 733 IIGIGGFGSVYRARLE--DGVEIAIKVFHPQCASTLKS---FEAECEVIKNIRHRNLVKI 787
           +IG+G FG V   RL+     EI + +   +   T K    F +E  ++    H N++ +
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
               +      ++ EYM NGSL+  L  ++    +   + ++  I S ++YL        
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSY 137
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ-TLATIGYMAPDEI 900
           +H DL   N+L++ ++V  +SDFGM+++L  + E+   T+     I + AP+ I
Sbjct: 138 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 191

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 9/174 (5%)
Query: 733 IIGIGGFGSVYRARLE--DGVEIAIKVFHPQCASTLKS---FEAECEVIKNIRHRNLVKI 787
           +IG+G FG V   RL+     EI + +   +   T K    F +E  ++    H N++ +
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
               +      ++ EYM NGSL+  L  ++    +   + ++  I S ++YL        
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSA 152
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ-TLATIGYMAPDEI 900
           +H DL   N+L++ ++V  +SDFGM+++L  + E+   T+     I + AP+ I
Sbjct: 153 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 206

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 51/186 (27%), Positives = 90/186 (48%), Gaps = 17/186 (9%)
Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCA---STLKSFEAECEVIKNIR 780
           +D +    I+G GG   V+ AR L    ++A+KV     A   S    F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 781 HRNLVKIISSCSNDD----FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL 836
           H  +V + ++   +        +V+EY+   +L D +H+      +  +  I + IA A 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG--- 893
           + L+F H   IIH D+KP+N+++       + DFG+A+ ++  D     TQT A IG   
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 184
Query: 894 YMAPDE 899
           Y++P++
Sbjct: 185 YLSPEQ 190

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+++D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ + +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 21/178 (11%)
Query: 720 ELLRATDNFAENNIIGIGGFGSVYRARL--EDG--VEIAIKVFHPQ--CASTLKSFEAEC 773
           ++L     F    ++G G FGSV  A+L  EDG  V++A+K+       +S ++ F  E 
Sbjct: 17  DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 774 EVIKNIRHRNLVKIISSCSNDDFKA------LVLEYMSNGSLEDCLHSSNCALNIF---- 823
             +K   H ++ K++        K       ++L +M +G L   L +S    N F    
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 824 -CRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGE 879
              +  M+DIA  +EYL    S   IH DL   N +L EDM   ++DFG++ K+ SG+
Sbjct: 137 QTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 94/191 (49%), Gaps = 28/191 (14%)
Query: 716 FSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQ-CAS--TLKSFEA 771
           F +FE+LRA         IG G FG V   +  D  ++ A+K  + Q C     +++   
Sbjct: 14  FDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 772 ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSL----EDCLHSSNCALNIFCRLN 827
           E ++++ + H  LV +  S  +++   +V++ +  G L    +  +H     + +F    
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF---- 120
Query: 828 IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ 887
            + ++  AL+YL    +  IIH D+KP N+LLDE    H++DF +A +L  E   T  T 
Sbjct: 121 -ICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITT 173
Query: 888 TLATIGYMAPD 898
              T  YMAP+
Sbjct: 174 MAGTKPYMAPE 184

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 5/175 (2%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           +G G FG V   +     ++AIK+      S    F  E +V+ N+ H  LV++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
                ++ EYM+NG L + L            L +  D+  A+EYL    S   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 132
Query: 854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
             N L+++  V  +SDFG+++ +  +DE T    +   + +  P+ +   + S K
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSRGSKFPVRWSPPEVLMYSKFSSK 186

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 45/176 (25%), Positives = 83/176 (47%), Gaps = 11/176 (6%)
Query: 733 IIGIGGFGSVYRARLEDGVE----IAIKVFHP-QCASTLKSFEAECEVIKNIRHRNLVKI 787
           +IG G FG V R RL+   +    +AIK           + F +E  ++    H N++++
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
               +N     ++ E+M NG+L+  L  ++    +   + ++  IAS + YL        
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL---AEMSY 137
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA---TIGYMAPDEI 900
           +H DL   N+L++ ++V  +SDFG+++ L         T +L     I + AP+ I
Sbjct: 138 VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP  I
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAPAII 210
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
                 L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 211 ------LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 112/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             L K+  S  ++    +V+EY   G +   L           R      I    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+++D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 208
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 209 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 262
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 263 SSDLKDLLRNLLQV--DLTKRFGNLK 286

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 112/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   + +E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             L K+  S  ++    +V+EY   G +   L           R      I    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+++D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 208
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 209 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 262
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 263 SSDLKDLLRNLLQV--DLTKRFGNLK 286

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 17/186 (9%)
Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCA---STLKSFEAECEVIKNIR 780
           +D +    I+G GG   V+ AR L    ++A+KV     A   S    F  E +    + 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 781 HRNLVKIISSCSNDD----FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL 836
           H  +V +  +   +        +V+EY+   +L D +H+      +  +  I + IA A 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 143
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG--- 893
           + L+F H   IIH D+KP+N+++       + DFG+A+ ++  D     TQT A IG   
Sbjct: 144 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 201
Query: 894 YMAPDE 899
           Y++P++
Sbjct: 202 YLSPEQ 207

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 17/186 (9%)
Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCA---STLKSFEAECEVIKNIR 780
           +D +    I+G GG   V+ AR L    ++A+KV     A   S    F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 781 HRNLVKIISSCSNDD----FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL 836
           H  +V +  +   +        +V+EY+   +L D +H+      +  +  I + IA A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG--- 893
           + L+F H   IIH D+KP+N+++       + DFG+A+ ++  D     TQT A IG   
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 184
Query: 894 YMAPDE 899
           Y++P++
Sbjct: 185 YLSPEQ 190

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 112/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY   G +   L           R      I    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+++D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 208
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 209 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 262
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 263 SSDLKDLLRNLLQV--DLTKRFGNLK 286

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 111/266 (41%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  + + +  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +VLEY   G +   L           R      I    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG------RTWXLCGTPEYLAP--- 208
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 209 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 262
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 263 SSDLKDLLRNLLQV--DLTKRFGNLK 286

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 26/197 (13%)
Query: 728 FAENNI-----IGIGGFGSVYRARL-EDGVEIAIKVF-------HPQCASTLKSFEAECE 774
            A+N I     IG GGFG V++ RL +D   +AIK           +     + F+ E  
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           ++ N+ H N+VK+     N     +V+E++  G L   L      +    +L +M+DIA 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 835 ALEYLHFGHSTPIIHCDLKPSNVL---LDED--MVAHLSDFGMAKLLSGEDESTMRTQTL 889
            +EY+    + PI+H DL+  N+    LDE+  + A ++DFG++     +      +  L
Sbjct: 134 GIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSVSGLL 187
Query: 890 ATIGYMAPDEIFVGELS 906
               +MAP+ I   E S
Sbjct: 188 GNFQWMAPETIGAEEES 204

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 120/271 (44%), Gaps = 43/271 (15%)
Query: 727 NFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFH--------PQCASTLKSFEAECEVIK 777
            +   ++IG G    V R      G E A+K+           Q     ++   E  +++
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 778 NIR-HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL 836
            +  H +++ +I S  +  F  LV + M  G L D L +   AL+     +IM    S L
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIM---RSLL 210
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDESTMRTQTLATIGYM 895
           E + F H+  I+H DLKP N+LLD++M   LSDFG +  L  GE    +R +   T GY+
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLR-ELCGTPGYL 266
Query: 896 AP-------DEIFVG---ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSI 945
           AP       DE   G   E+ L  W           V+  +LL+G    F  + Q L+  
Sbjct: 267 APEILKCSMDETHPGYGKEVDL--WA--------CGVILFTLLAGSPP-FWHRRQILMLR 315
Query: 946 FSLALECTMESPE---KRIDAKDTITRLLKI 973
             +  +    SPE   +    KD I+RLL++
Sbjct: 316 MIMEGQYQFSSPEWDDRSSTVKDLISRLLQV 346

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 64/236 (27%), Positives = 108/236 (45%), Gaps = 32/236 (13%)
Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           IG G  G+VY A  +  G E+AI+  + Q     +    E  V++  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 793 NDDFKALVLEYMSNGSLED-----CLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
             D   +V+EY++ GSL D     C+     A    CR          L+ L F HS  +
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA--AVCR--------ECLQALEFLHSNQV 137
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSL 907
           IH D+K  N+LL  D    L+DFG    ++   E + R++ + T  +MAP+ +       
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSEMVGTPYWMAPEVVTRKAYGP 195
Query: 908 KR--WVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECT--MESPEK 959
           K   W   ++ + ++E        GE  +    E  L +++ +A   T  +++PEK
Sbjct: 196 KVDIWSLGIMAIEMIE--------GEPPYL--NENPLRALYLIATNGTPELQNPEK 241

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/267 (22%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 731 NNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
           N +IG G FG VY   L D     +  A+K  +       +  F  E  ++K+  H N++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 786 KIISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            ++  C   +   LV L YM +G L + + +      +   +   + +A  ++YL    S
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 170
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEIFV 902
              +H DL   N +LDE     ++DFG+A+ +  ++  ++  +T A   + +MA + +  
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 903 GELSLKR--WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            + + K   W   +L          P   V   D ++   + +     E C   ++ + L
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 290
Query: 951 ECTMESPEKRIDAKDTITRLLKIRDTL 977
           +C     E R    + ++R+  I  T 
Sbjct: 291 KCWHPKAEMRPSFSELVSRISAIFSTF 317

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 94/189 (49%), Gaps = 28/189 (14%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFE-AECEVIKNIRHRNL 784
           ++ +  +IG G FG VY+A+L D  E +AIK          K+F+  E ++++ + H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQGKAFKNRELQIMRKLDHCNI 75
Query: 785 VKI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASA 835
           V++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRS 134
Query: 836 LEYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAK-LLSGEDESTMRTQTLATI 892
           L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + + 
Sbjct: 135 LAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSR 186
Query: 893 GYMAPDEIF 901
            Y AP+ IF
Sbjct: 187 YYRAPELIF 195

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T  Y+AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEYLAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+K  GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKAFGNLK 285

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 91/178 (51%), Gaps = 11/178 (6%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRH 781
           ++F   N++G G F  VYRA  +  G+E+AIK+   +    A  ++  + E ++   ++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
            +++++ +   + ++  LVLE   NG +   L +     +     + M  I + + YLH 
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH- 129
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPD 898
             S  I+H DL  SN+LL  +M   ++DFG+A  L    E   +  TL  T  Y++P+
Sbjct: 130 --SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE---KHYTLCGTPNYISPE 182

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/267 (22%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 731 NNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
           N +IG G FG VY   L D     +  A+K  +       +  F  E  ++K+  H N++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 786 KIISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            ++  C   +   LV L YM +G L + + +      +   +   + +A  ++YL    S
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 169
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEIFV 902
              +H DL   N +LDE     ++DFG+A+ +  ++  ++  +T A   + +MA + +  
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 903 GELSLKR--WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            + + K   W   +L          P   V   D ++   + +     E C   ++ + L
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 289
Query: 951 ECTMESPEKRIDAKDTITRLLKIRDTL 977
           +C     E R    + ++R+  I  T 
Sbjct: 290 KCWHPKAEMRPSFSELVSRISAIFSTF 316

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/267 (22%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 731 NNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
           N +IG G FG VY   L D     +  A+K  +       +  F  E  ++K+  H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 786 KIISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            ++  C   +   LV L YM +G L + + +      +   +   + +A  ++YL    S
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 150
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEIFV 902
              +H DL   N +LDE     ++DFG+A+ +  ++  ++  +T A   + +MA + +  
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 903 GELSLKR--WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            + + K   W   +L          P   V   D ++   + +     E C   ++ + L
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 270
Query: 951 ECTMESPEKRIDAKDTITRLLKIRDTL 977
           +C     E R    + ++R+  I  T 
Sbjct: 271 KCWHPKAEMRPSFSELVSRISAIFSTF 297

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++ +  +IG G FG VY+A+L D  E +AIK    +     +    E ++++ + H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 76
Query: 786 KI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASAL 836
           ++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 135
Query: 837 EYLH-FGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAK-LLSGEDESTMRTQTLATIG 893
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + +  
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 187
Query: 894 YMAPDEIF 901
           Y AP+ IF
Sbjct: 188 YRAPELIF 195

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++ +  +IG G FG VY+A+L D  E +AIK    +     +    E ++++ + H N+V
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 89
Query: 786 KI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASAL 836
           ++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +L
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 148
Query: 837 EYLH-FGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAK-LLSGEDESTMRTQTLATIG 893
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + +  
Sbjct: 149 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 200
Query: 894 YMAPDEIF 901
           Y AP+ IF
Sbjct: 201 YRAPELIF 208

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++ +  +IG G FG VY+A+L D  E +AIK    +     +    E ++++ + H N+V
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 81
Query: 786 KI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASAL 836
           ++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +L
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 140
Query: 837 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAK-LLSGEDESTMRTQTLATIG 893
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + +  
Sbjct: 141 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 192
Query: 894 YMAPDEIF 901
           Y AP+ IF
Sbjct: 193 YRAPELIF 200

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++ +  +IG G FG VY+A+L D  E +AIK    +     +    E ++++ + H N+V
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 95
Query: 786 KI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASAL 836
           ++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +L
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 154
Query: 837 EYLH-FGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAK-LLSGEDESTMRTQTLATIG 893
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + +  
Sbjct: 155 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX----ICSRY 206
Query: 894 YMAPDEIF 901
           Y AP+ IF
Sbjct: 207 YRAPELIF 214

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++ +  +IG G FG VY+A+L D  E +AIK    +     +    E ++++ + H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 76
Query: 786 KI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASAL 836
           ++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 135
Query: 837 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAK-LLSGEDESTMRTQTLATIG 893
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + +  
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX----ICSRY 187
Query: 894 YMAPDEIF 901
           Y AP+ IF
Sbjct: 188 YRAPELIF 195

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++ +  +IG G FG VY+A+L D  E +AIK    +     +    E ++++ + H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 110
Query: 786 KI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASAL 836
           ++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 169
Query: 837 EYLH-FGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAK-LLSGEDESTMRTQTLATIG 893
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + +  
Sbjct: 170 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 221
Query: 894 YMAPDEIF 901
           Y AP+ IF
Sbjct: 222 YRAPELIF 229

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 94/189 (49%), Gaps = 28/189 (14%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFE-AECEVIKNIRHRNL 784
           ++ +  +IG G FG VY+A+L D  E +AIK          K+F+  E ++++ + H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQGKAFKNRELQIMRKLDHCNI 75
Query: 785 VKI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASA 835
           V++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRS 134
Query: 836 LEYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAK-LLSGEDESTMRTQTLATI 892
           L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + + 
Sbjct: 135 LAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSR 186
Query: 893 GYMAPDEIF 901
            Y AP+ IF
Sbjct: 187 YYRAPELIF 195

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++ +  +IG G FG VY+A+L D  E +AIK    +     +    E ++++ + H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 76
Query: 786 KI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASAL 836
           ++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +L
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 135
Query: 837 EYLH-FGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAK-LLSGEDESTMRTQTLATIG 893
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + +  
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX----ICSRY 187
Query: 894 YMAPDEIF 901
           Y AP+ IF
Sbjct: 188 YRAPELIF 195

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++ +  +IG G FG VY+A+L D  E +AIK    +     +    E ++++ + H N+V
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 155
Query: 786 KI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASAL 836
           ++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +L
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 214
Query: 837 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAK-LLSGEDESTMRTQTLATIG 893
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + +  
Sbjct: 215 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 266
Query: 894 YMAPDEIF 901
           Y AP+ IF
Sbjct: 267 YRAPELIF 274

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++ +  +IG G FG VY+A+L D  E +AIK    +     +    E ++++ + H N+V
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 77
Query: 786 KI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASAL 836
           ++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +L
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 136
Query: 837 EYLH-FGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAK-LLSGEDESTMRTQTLATIG 893
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + +  
Sbjct: 137 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX----ICSRY 188
Query: 894 YMAPDEIF 901
           Y AP+ IF
Sbjct: 189 YRAPELIF 196

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 120/406 (29%), Positives = 179/406 (44%), Gaps = 65/406 (16%)
Query: 201 LGYNNLSGAIPK-EIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVP 259
           LG  N++  + + ++  +T LQ   L    + G     + YL NL  +    N LT + P
Sbjct: 26  LGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP 80
Query: 260 ATIFNMSTLKEIFLYNNSLSGSLPSRIDLA-LPNLEFLNLGINSFSGTIPSSITNASKLI 318
             + N++ L +I + NN ++   P    LA L NL  L L  N  +   P  + N + L 
Sbjct: 81  --LKNLTKLVDILMNNNQIADITP----LANLTNLTGLTLFNNQITDIDP--LKNLTNLN 132
Query: 319 LLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGN 378
            LE+ SN+ S    SA+  L +L+  +   N +T   P       LAN   L  L +  N
Sbjct: 133 RLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLKP-------LANLTTLERLDISSN 183
Query: 379 PLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFG 438
            +     S +  L+ +LE L      IS   P  +G L+NL  LSL GN L      T  
Sbjct: 184 KVSDI--SVLAKLT-NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLA 236
Query: 439 GLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGS 498
            L  L  LDLA N+++   P  +  L++L EL L  N+IS    S L  LT+L  L L  
Sbjct: 237 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI--SPLAGLTALTNLELNE 292
Query: 499 NRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLE 558
           N+           L+DI            PIS    NLK +  + L  NN+S   P  + 
Sbjct: 293 NQ-----------LEDI-----------SPIS----NLKNLTYLTLYFNNISDISP--VS 324
Query: 559 GLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS 604
            L  LQ +    N++      S  N+T++  L   +N+IS   P++
Sbjct: 325 SLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTPLA 368

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 74/218 (33%), Positives = 111/218 (50%), Gaps = 18/218 (8%)
Query: 413 IGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDL 472
           + NL+ L+ + +  N ++   P     L  L GL L FN     I D +  L+ LN L+L
Sbjct: 81  LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL-FNNQITDI-DPLKNLTNLNRLEL 136
Query: 473 NGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLL-DGPISL 531
           + N IS    S L  LTSLQ LN  SN+ T + P    NL  +   DISSN + D  +  
Sbjct: 137 SSNTISDI--SALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSDISVLA 192
Query: 532 AIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLD 591
            + NL++++    + N +S   P  L  L +L  +SL  N+L+     +  ++T+L  LD
Sbjct: 193 KLTNLESLIA---TNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLD 245
Query: 592 LSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGG 629
           L+NN+IS   P+S   L+ L EL L  N++    P  G
Sbjct: 246 LANNQISNLAPLS--GLTKLTELKLGANQISNISPLAG 281

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++ +  +IG G FG VY+A+L D  E +AIK    +     +    E ++++ + H N+V
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 114
Query: 786 KI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASAL 836
           ++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +L
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 173
Query: 837 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAK-LLSGEDESTMRTQTLATIG 893
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + +  
Sbjct: 174 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 225
Query: 894 YMAPDEIF 901
           Y AP+ IF
Sbjct: 226 YRAPELIF 233

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++ +  +IG G FG VY+A+L D  E +AIK    +     +    E ++++ + H N+V
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 112
Query: 786 KI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASAL 836
           ++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +L
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 171
Query: 837 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAK-LLSGEDESTMRTQTLATIG 893
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + +  
Sbjct: 172 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 223
Query: 894 YMAPDEIF 901
           Y AP+ IF
Sbjct: 224 YRAPELIF 231

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++ +  +IG G FG VY+A+L D  E +AIK    +     +    E ++++ + H N+V
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 84
Query: 786 KI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASAL 836
           ++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +L
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 143
Query: 837 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAK-LLSGEDESTMRTQTLATIG 893
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + +  
Sbjct: 144 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX----ICSRY 195
Query: 894 YMAPDEIF 901
           Y AP+ IF
Sbjct: 196 YRAPELIF 203

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++ +  +IG G FG VY+A+L D  E +AIK    +     +    E ++++ + H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 88
Query: 786 KI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASAL 836
           ++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +L
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 147
Query: 837 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAK-LLSGEDESTMRTQTLATIG 893
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + +  
Sbjct: 148 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX----ICSRY 199
Query: 894 YMAPDEIF 901
           Y AP+ IF
Sbjct: 200 YRAPELIF 207

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++ +  +IG G FG VY+A+L D  E +AIK    +     +    E ++++ + H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 88
Query: 786 KI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASAL 836
           ++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +L
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 147
Query: 837 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAK-LLSGEDESTMRTQTLATIG 893
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + +  
Sbjct: 148 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX----ICSRY 199
Query: 894 YMAPDEIF 901
           Y AP+ IF
Sbjct: 200 YRAPELIF 207

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++ +  +IG G FG VY+A+L D  E +AIK    +     +    E ++++ + H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 76
Query: 786 KI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASAL 836
           ++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 135
Query: 837 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAK-LLSGEDESTMRTQTLATIG 893
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + +  
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX----ICSRY 187
Query: 894 YMAPDEIF 901
           Y AP+ IF
Sbjct: 188 YRAPELIF 195

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++ +  +IG G FG VY+A+L D  E +AIK    +     +    E ++++ + H N+V
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 80
Query: 786 KI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASAL 836
           ++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +L
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 139
Query: 837 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAK-LLSGEDESTMRTQTLATIG 893
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + +  
Sbjct: 140 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX----ICSRY 191
Query: 894 YMAPDEIF 901
           Y AP+ IF
Sbjct: 192 YRAPELIF 199

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 772 ECEVIKNIRHRNLVKIISSCS--NDDFKALVLEYMSNGSLEDCLH----SSNCALNIFCR 825
           E  ++K + H N+VK++      N+D   +V E ++ G + +       S + A   F  
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYF-- 143
Query: 826 LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR 885
                D+   +EYLH+     IIH D+KPSN+L+ ED    ++DFG++    G D   + 
Sbjct: 144 ----QDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALL 194
Query: 886 TQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLS- 944
           + T+ T  +MAP+ +     + K +    L V  + V     + G+      +  CL S 
Sbjct: 195 SNTVGTPAFMAPESL---SETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK 251
Query: 945 IFSLALECTMESPEKRIDAKDTITRLL 971
           I S ALE   + P+   D KD ITR+L
Sbjct: 252 IKSQALEFP-DQPDIAEDLKDLITRML 277

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++ +  +IG G FG VY+A+L D  E +AIK    +     +    E ++++ + H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 110
Query: 786 KI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASAL 836
           ++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 169
Query: 837 EYLH-FGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAK-LLSGEDESTMRTQTLATIG 893
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + +  
Sbjct: 170 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX----ICSRY 221
Query: 894 YMAPDEIF 901
           Y AP+ IF
Sbjct: 222 YRAPELIF 229

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 26/197 (13%)
Query: 728 FAENNI-----IGIGGFGSVYRARL-EDGVEIAIKVF-------HPQCASTLKSFEAECE 774
            A+N I     IG GGFG V++ RL +D   +AIK           +     + F+ E  
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           ++ N+ H N+VK+     N     +V+E++  G L   L      +    +L +M+DIA 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 835 ALEYLHFGHSTPIIHCDLKPSNVL---LDED--MVAHLSDFGMAKLLSGEDESTMRTQTL 889
            +EY+    + PI+H DL+  N+    LDE+  + A ++DFG     + +      +  L
Sbjct: 134 GIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG-----TSQQSVHSVSGLL 187
Query: 890 ATIGYMAPDEIFVGELS 906
               +MAP+ I   E S
Sbjct: 188 GNFQWMAPETIGAEEES 204

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 54/195 (27%), Positives = 88/195 (45%), Gaps = 21/195 (10%)
Query: 721 LLRATDNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI 779
           + R +D      ++G G FG   +    E G  + +K        T ++F  E +V++ +
Sbjct: 6   IFRPSD-LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
            H N++K I     D     + EY+  G+L   + S +       R++   DIAS + YL
Sbjct: 65  EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM-----------RTQT 888
              HS  IIH DL   N L+ E+    ++DFG+A+L+   DE T            R + 
Sbjct: 125 ---HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV--DEKTQPEGLRSLKKPDRKKR 179
Query: 889 LATIG---YMAPDEI 900
              +G   +MAP+ I
Sbjct: 180 YTVVGNPYWMAPEMI 194

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++ +  +IG G FG VY+A+L D  E +AIK    +     +    E ++++ + H N+V
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 104
Query: 786 KI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASAL 836
           ++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +L
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 163
Query: 837 EYLH-FGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAK-LLSGEDESTMRTQTLATIG 893
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + +  
Sbjct: 164 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 215
Query: 894 YMAPDEIF 901
           Y AP+ IF
Sbjct: 216 YRAPELIF 223

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 58/184 (31%), Positives = 86/184 (46%), Gaps = 17/184 (9%)
Query: 727 NFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRN 783
           N+     IG G F  V  AR +  G E+A+K+       +S+L+    E  ++K + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +VK+      +    LV+EY S G + D L +         R      I SA++Y H   
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH--- 130
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG---YMAPDEI 900
              I+H DLK  N+LLD DM   ++DFG +      +E T   +  A  G   Y AP E+
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDAFCGAPPYAAP-EL 183
Query: 901 FVGE 904
           F G+
Sbjct: 184 FQGK 187

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 120/406 (29%), Positives = 178/406 (43%), Gaps = 65/406 (16%)
Query: 201 LGYNNLSGAIPK-EIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVP 259
           LG  N++  + + ++  +T LQ   L    + G     + YL NL  +    N LT + P
Sbjct: 26  LGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP 80
Query: 260 ATIFNMSTLKEIFLYNNSLSGSLPSRIDLA-LPNLEFLNLGINSFSGTIPSSITNASKLI 318
             + N++ L +I + NN ++   P    LA L NL  L L  N  +   P  + N + L 
Sbjct: 81  --LKNLTKLVDILMNNNQIADITP----LANLTNLTGLTLFNNQITDIDP--LKNLTNLN 132
Query: 319 LLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGN 378
            LE+ SN+ S    SA+  L +L+      N +T   P       LAN   L  L +  N
Sbjct: 133 RLELSSNTISDI--SALSGLTSLQQLSFSSNQVTDLKP-------LANLTTLERLDISSN 183
Query: 379 PLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFG 438
            +     S +  L+ +LE L      IS   P  +G L+NL  LSL GN L      T  
Sbjct: 184 KVSDI--SVLAKLT-NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLA 236
Query: 439 GLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGS 498
            L  L  LDLA N+++   P  +  L++L EL L  N+IS    S L  LT+L  L L  
Sbjct: 237 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI--SPLAGLTALTNLELNE 292
Query: 499 NRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLE 558
           N+           L+DI            PIS    NLK +  + L  NN+S   P  + 
Sbjct: 293 NQ-----------LEDI-----------SPIS----NLKNLTYLTLYFNNISDISP--VS 324
Query: 559 GLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS 604
            L  LQ +    N++      S  N+T++  L   +N+IS   P++
Sbjct: 325 SLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTPLA 368

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 73/218 (33%), Positives = 111/218 (50%), Gaps = 18/218 (8%)
Query: 413 IGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDL 472
           + NL+ L+ + +  N ++   P     L  L GL L FN     I D +  L+ LN L+L
Sbjct: 81  LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL-FNNQITDI-DPLKNLTNLNRLEL 136
Query: 473 NGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLL-DGPISL 531
           + N IS    S L  LTSLQ L+  SN+ T + P    NL  +   DISSN + D  +  
Sbjct: 137 SSNTISDI--SALSGLTSLQQLSFSSNQVTDLKP--LANLTTLERLDISSNKVSDISVLA 192
Query: 532 AIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLD 591
            + NL++++    + N +S   P  L  L +L  +SL  N+L+     +  ++T+L  LD
Sbjct: 193 KLTNLESLIA---TNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLD 245
Query: 592 LSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGG 629
           L+NN+IS   P+S   L+ L EL L  N++    P  G
Sbjct: 246 LANNQISNLAPLS--GLTKLTELKLGANQISNISPLAG 281

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK  E    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L           R      I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEI 900
             S  +I+ DLKP N+L+D+     ++DFG AK + G      RT  L  T   +AP   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLCGTPEALAP--- 207
Query: 901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK- 959
              E+ L +  N  +    + V+   + +G    FA +    + I+   +   +  P   
Sbjct: 208 ---EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFPSHF 261
Query: 960 RIDAKDTITRLLKIRDTLSKRIGNLS 985
             D KD +  LL++   L+KR GNL 
Sbjct: 262 SSDLKDLLRNLLQV--DLTKRFGNLK 285

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 32/236 (13%)
Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           IG G  G+VY A  +  G E+AI+  + Q     +    E  V++  ++ N+V  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 793 NDDFKALVLEYMSNGSLED-----CLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
             D   +V+EY++ GSL D     C+     A    CR          L+ L F HS  +
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA--AVCR--------ECLQALEFLHSNQV 138
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSL 907
           IH D+K  N+LL  D    L+DFG    ++   E + R+  + T  +MAP+ +       
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSXMVGTPYWMAPEVVTRKAYGP 196
Query: 908 KR--WVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECT--MESPEK 959
           K   W   ++ + ++E        GE  +    E  L +++ +A   T  +++PEK
Sbjct: 197 KVDIWSLGIMAIEMIE--------GEPPYL--NENPLRALYLIATNGTPELQNPEK 242

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 32/236 (13%)
Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           IG G  G+VY A  +  G E+AI+  + Q     +    E  V++  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 793 NDDFKALVLEYMSNGSLED-----CLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
             D   +V+EY++ GSL D     C+     A    CR          L+ L F HS  +
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA--AVCR--------ECLQALEFLHSNQV 137
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSL 907
           IH D+K  N+LL  D    L+DFG    ++   E + R+  + T  +MAP+ +       
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSXMVGTPYWMAPEVVTRKAYGP 195
Query: 908 KR--WVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECT--MESPEK 959
           K   W   ++ + ++E        GE  +    E  L +++ +A   T  +++PEK
Sbjct: 196 KVDIWSLGIMAIEMIE--------GEPPYL--NENPLRALYLIATNGTPELQNPEK 241

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 91/181 (50%), Gaps = 12/181 (6%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVEIA----IKVFHPQCASTLKSFEA--ECEVIKNIR 780
            + + + +G G F +VY+AR ++  +I     IK+ H   A    +  A  E ++++ + 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N++ ++ +  +    +LV ++M    LE  +  ++  L        M+     LEYLH
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
                 I+H DLKP+N+LLDE+ V  L+DFG+AK     + +      + T  Y AP+ +
Sbjct: 130 ---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--XHQVVTRWYRAPELL 184
Query: 901 F 901
           F
Sbjct: 185 F 185

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 32/236 (13%)
Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           IG G  G+VY A  +  G E+AI+  + Q     +    E  V++  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 793 NDDFKALVLEYMSNGSLED-----CLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
             D   +V+EY++ GSL D     C+     A    CR          L+ L F HS  +
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA--AVCR--------ECLQALEFLHSNQV 137
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSL 907
           IH D+K  N+LL  D    L+DFG    ++   E + R+  + T  +MAP+ +       
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 908 KR--WVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECT--MESPEK 959
           K   W   ++ + ++E        GE  +    E  L +++ +A   T  +++PEK
Sbjct: 196 KVDIWSLGIMAIEMIE--------GEPPYL--NENPLRALYLIATNGTPELQNPEK 241

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 49/170 (28%), Positives = 84/170 (49%), Gaps = 10/170 (5%)
Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G FG VY+A+  E G   A KV   +    L+ +  E E++    H  +VK++ +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
           +D    +++E+   G+++  +   +  L       I +     LE L+F HS  IIH DL
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHSKRIIHRDL 135
Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM--RTQTLATIGYMAPDEI 900
           K  NVL+  +    L+DFG    +S ++  T+  R   + T  +MAP+ +
Sbjct: 136 KAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTPYWMAPEVV 181

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 49/170 (28%), Positives = 84/170 (49%), Gaps = 10/170 (5%)
Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G FG VY+A+  E G   A KV   +    L+ +  E E++    H  +VK++ +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
           +D    +++E+   G+++  +   +  L       I +     LE L+F HS  IIH DL
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHSKRIIHRDL 143
Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM--RTQTLATIGYMAPDEI 900
           K  NVL+  +    L+DFG    +S ++  T+  R   + T  +MAP+ +
Sbjct: 144 KAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTPYWMAPEVV 189

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSF 769
           +EL R  D       +G G FG V  A        +     ++A+K+         L   
Sbjct: 64  WELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 121
Query: 770 EAECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCL---------HSSNCA 819
            +E E++K I +H+N++ ++ +C+ D    +++EY S G+L + L         +S N +
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 820 LNIFCRLN------IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA 873
            N   +L+          +A  +EYL    S   IH DL   NVL+ ED V  ++DFG+A
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
Query: 874 KLLSGEDESTMRTQTLATIGYMAPDEIF 901
           + +   D     T     + +MAP+ +F
Sbjct: 239 RDIHHIDYYKKTTNGRLPVKWMAPEALF 266

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        + ++ V +A+K+         L    +E E++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNC---------------ALNIFCRLNI 828
           ++ ++ +C+ D    +++EY S G+L + L +                   +     ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ E+ V  ++DFG+A+ ++  D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 220 RLPVKWMAPEALF 232

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        + ++ V +A+K+         L    +E E++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNC---------------ALNIFCRLNI 828
           ++ ++ +C+ D    +++EY S G+L + L +                   +     ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ E+ V  ++DFG+A+ ++  D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 220 RLPVKWMAPEALF 232

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 94/189 (49%), Gaps = 28/189 (14%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLKSFE-AECEVIKNIRHRNL 784
           ++ +  +IG G FG VY+A+L D  E +AIK          K+F+  E ++++ + H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQGKAFKNRELQIMRKLDHCNI 75
Query: 785 VKI----ISSCSNDD--FKALVLEYMSNGSLEDCLHSSNCALN---IFCRLNIMIDIASA 835
           V++     SS    D  +  LVL+Y+         H S        I+ +L  M  +  +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL-YMYQLFRS 134
Query: 836 LEYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAK-LLSGEDESTMRTQTLATI 892
           L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+ GE   +     + + 
Sbjct: 135 LAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX----ICSR 186
Query: 893 GYMAPDEIF 901
            Y AP+ IF
Sbjct: 187 YYRAPELIF 195

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 29/202 (14%)
Query: 709 SQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE-----DGVEIAIKVFHPQCA 763
           S PT+    Y + +R          +G G FG V     +      G  +A+K     C 
Sbjct: 1   SDPTVFHKRYLKKIRD---------LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCG 51
Query: 764 STLKS-FEAECEVIKNIRHRNLVKIISSCSNDDFKA--LVLEYMSNGSLEDCL--HSSNC 818
             L+S ++ E E+++ + H ++VK    C +   K+  LV+EY+  GSL D L  H    
Sbjct: 52  PQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL 111
Query: 819 A-LNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL- 876
           A L +F +      I   + YLH  H    IH  L   NVLLD D +  + DFG+AK + 
Sbjct: 112 AQLLLFAQ-----QICEGMAYLHAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVP 163
Query: 877 SGEDESTMRTQTLATIGYMAPD 898
            G +   +R    + + + AP+
Sbjct: 164 EGHEYYRVREDGDSPVFWYAPE 185

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVF-------HPQCASTLKSFEAECEV 775
           A +       IG GGFG V++ RL +D   +AIK           +     + F+ E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 776 IKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASA 835
           + N+ H N+VK+     N     +V+E++  G L   L      +    +L +M+DIA  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 836 LEYLHFGHSTPIIHCDLKPSNVL---LDED--MVAHLSDFGMAKLLSGEDESTMRTQTLA 890
           +EY+    + PI+H DL+  N+    LDE+  + A ++DF ++     +      +  L 
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS-----QQSVHSVSGLLG 188
Query: 891 TIGYMAPDEIFVGELS 906
              +MAP+ I   E S
Sbjct: 189 NFQWMAPETIGAEEES 204

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 122/406 (30%), Positives = 180/406 (44%), Gaps = 66/406 (16%)
Query: 201 LGYNNLSGAIPK-EIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVP 259
           LG  N++  + + ++  +T LQ   L    + G     + YL NL  +    N LT + P
Sbjct: 30  LGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP 84
Query: 260 ATIFNMSTLKEIFLYNNSLSGSLPSRIDLA-LPNLEFLNLGINSFSGTIPSSITNASKLI 318
             + N++ L +I + NN ++   P    LA L NL  L L  N  +   P  + N + L 
Sbjct: 85  --LKNLTKLVDILMNNNQIADITP----LANLTNLTGLTLFNNQITDIDP--LKNLTNLN 136
Query: 319 LLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGN 378
            LE+ SN+ S    SA+  L +L+    F N +T   P       LAN   L  L +  N
Sbjct: 137 RLELSSNTISDI--SALSGLTSLQQLS-FGNQVTDLKP-------LANLTTLERLDISSN 186
Query: 379 PLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFG 438
            +     S +  L+ +LE L      IS   P  +G L+NL  LSL GN L      T  
Sbjct: 187 KVSDI--SVLAKLT-NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLA 239
Query: 439 GLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGS 498
            L  L  LDLA N+++   P  +  L++L EL L  N+IS    S L  LT+L  L L  
Sbjct: 240 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI--SPLAGLTALTNLELNE 295
Query: 499 NRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLE 558
           N+           L+DI            PIS    NLK +  + L  NN+S   P  + 
Sbjct: 296 NQ-----------LEDI-----------SPIS----NLKNLTYLTLYFNNISDISP--VS 327
Query: 559 GLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS 604
            L  LQ +  A N++      S  N+T++  L   +N+IS   P++
Sbjct: 328 SLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTPLA 371

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 73/216 (33%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 415 NLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNG 474
           NL+ L+ + +  N ++   P     L  L GL L FN     I D +  L+ LN L+L+ 
Sbjct: 87  NLTKLVDILMNNNQIADITP--LANLTNLTGLTL-FNNQITDI-DPLKNLTNLNRLELSS 142
Query: 475 NKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLL-DGPISLAI 533
           N IS    S L  LTSLQ L+ G N+ T + P    NL  +   DISSN + D  +   +
Sbjct: 143 NTISDI--SALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSDISVLAKL 197
Query: 534 GNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLS 593
            NL++++    + N +S   P  L  L +L  +SL  N+L+     +  ++T+L  LDL+
Sbjct: 198 TNLESLIA---TNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLA 250
Query: 594 NNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGG 629
           NN+IS   P+S   L+ L EL L  N++    P  G
Sbjct: 251 NNQISNLAPLS--GLTKLTELKLGANQISNISPLAG 284

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 44/174 (25%), Positives = 83/174 (47%), Gaps = 9/174 (5%)
Query: 733 IIGIGGFGSVYRARLE----DGVEIAIKVFH-PQCASTLKSFEAECEVIKNIRHRNLVKI 787
           +IG G FG V   RL+      + +AIK           + F  E  ++    H N++ +
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
               +      +V EYM NGSL+  L  ++    +   + ++  I++ ++YL        
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLS---DMGY 145
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ-TLATIGYMAPDEI 900
           +H DL   N+L++ ++V  +SDFG++++L  + E+   T+     I + AP+ I
Sbjct: 146 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 199

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 7/150 (4%)
Query: 727 NFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRN 783
           N+     IG G F  V  AR +  G E+A+K+       +S+L+    E  ++K + H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +VK+      +    LV+EY S G + D L +         R      I SA++Y H   
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCH--- 123
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMA 873
              I+H DLK  N+LLD DM   ++DFG +
Sbjct: 124 QKFIVHRDLKAENLLLDADMNIKIADFGFS 153

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 121/406 (29%), Positives = 180/406 (44%), Gaps = 66/406 (16%)
Query: 201 LGYNNLSGAIPK-EIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVP 259
           LG  N++  + + ++  +T LQ   L    + G     + YL NL  +    N LT + P
Sbjct: 26  LGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP 80
Query: 260 ATIFNMSTLKEIFLYNNSLSGSLPSRIDLA-LPNLEFLNLGINSFSGTIPSSITNASKLI 318
             + N++ L +I + NN ++   P    LA L NL  L L  N  +   P  + N + L 
Sbjct: 81  --LKNLTKLVDILMNNNQIADITP----LANLTNLTGLTLFNNQITDIDP--LKNLTNLN 132
Query: 319 LLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGN 378
            LE+ SN+ S    SA+  L +L+  + F N +T   P       LAN   L  L +  N
Sbjct: 133 RLELSSNTISDI--SALSGLTSLQQLN-FGNQVTDLKP-------LANLTTLERLDISSN 182
Query: 379 PLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFG 438
            +     S +  L+ +LE L      IS   P  +G L+NL  LSL GN L      T  
Sbjct: 183 KVSDI--SVLAKLT-NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLA 235
Query: 439 GLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGS 498
            L  L  LDLA N+++   P  +  L++L EL L  N+IS    S L  LT+L  L L  
Sbjct: 236 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI--SPLAGLTALTNLELNE 291
Query: 499 NRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLE 558
           N+           L+DI            PIS    NLK +  + L  NN+S   P  + 
Sbjct: 292 NQ-----------LEDI-----------SPIS----NLKNLTYLTLYFNNISDISP--VS 323
Query: 559 GLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS 604
            L  LQ +    N++      S  N+T++  L   +N+IS   P++
Sbjct: 324 SLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTPLA 367

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 75/218 (34%), Positives = 111/218 (50%), Gaps = 19/218 (8%)
Query: 413 IGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDL 472
           + NL+ L+ + +  N ++   P     L  L GL L FN     I D +  L+ LN L+L
Sbjct: 81  LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL-FNNQITDI-DPLKNLTNLNRLEL 136
Query: 473 NGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLA 532
           + N IS    S L  LTSLQ LN G N+ T + P    NL  +   DISSN +     LA
Sbjct: 137 SSNTISDI--SALSGLTSLQQLNFG-NQVTDLKP--LANLTTLERLDISSNKVSDISVLA 191
Query: 533 -IGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLD 591
            + NL++++    + N +S   P  L  L +L  +SL  N+L+     +  ++T+L  LD
Sbjct: 192 KLTNLESLIA---TNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLD 244
Query: 592 LSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGG 629
           L+NN+IS   P+S   L+ L EL L  N++    P  G
Sbjct: 245 LANNQISNLAPLS--GLTKLTELKLGANQISNISPLAG 280

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 51/147 (34%), Positives = 77/147 (52%), Gaps = 12/147 (8%)
Query: 770 EAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM 829
           E E E++K + H  ++KI +    +D+  +VLE M  G L D +  +       C+L   
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 120
Query: 830 IDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRT 886
             +  A++YLH      IIH DLKP NVLL   +ED +  ++DFG +K+L   + S MRT
Sbjct: 121 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRT 175
Query: 887 QTLATIGYMAPDEIF-VGELSLKRWVN 912
               T  Y+AP+ +  VG     R V+
Sbjct: 176 -LCGTPTYLAPEVLVSVGTAGYNRAVD 201

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 51/147 (34%), Positives = 77/147 (52%), Gaps = 12/147 (8%)
Query: 770 EAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM 829
           E E E++K + H  ++KI +    +D+  +VLE M  G L D +  +       C+L   
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 120
Query: 830 IDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRT 886
             +  A++YLH      IIH DLKP NVLL   +ED +  ++DFG +K+L   + S MRT
Sbjct: 121 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRT 175
Query: 887 QTLATIGYMAPDEIF-VGELSLKRWVN 912
               T  Y+AP+ +  VG     R V+
Sbjct: 176 -LCGTPTYLAPEVLVSVGTAGYNRAVD 201

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 51/147 (34%), Positives = 77/147 (52%), Gaps = 12/147 (8%)
Query: 770 EAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM 829
           E E E++K + H  ++KI +    +D+  +VLE M  G L D +  +       C+L   
Sbjct: 62  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 119
Query: 830 IDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRT 886
             +  A++YLH      IIH DLKP NVLL   +ED +  ++DFG +K+L   + S MRT
Sbjct: 120 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRT 174
Query: 887 QTLATIGYMAPDEIF-VGELSLKRWVN 912
               T  Y+AP+ +  VG     R V+
Sbjct: 175 -LCGTPTYLAPEVLVSVGTAGYNRAVD 200

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 51/147 (34%), Positives = 77/147 (52%), Gaps = 12/147 (8%)
Query: 770 EAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM 829
           E E E++K + H  ++KI +    +D+  +VLE M  G L D +  +       C+L   
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 120
Query: 830 IDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRT 886
             +  A++YLH      IIH DLKP NVLL   +ED +  ++DFG +K+L   + S MRT
Sbjct: 121 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRT 175
Query: 887 QTLATIGYMAPDEIF-VGELSLKRWVN 912
               T  Y+AP+ +  VG     R V+
Sbjct: 176 -LCGTPTYLAPEVLVSVGTAGYNRAVD 201

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 34/206 (16%)
Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKN--IRHRN 783
           DN     +IG G +G+VY+  L D   +A+KVF     +  ++F  E  + +   + H N
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVPLMEHDN 68
Query: 784 LVKIISSCSNDDFKA-------LVLEYMSNGSLED--CLHSSNCALNIFCRLNIMIDIAS 834
           + + I    ++   A       LV+EY  NGSL     LH+S+   +  CRL     +  
Sbjct: 69  IARFI--VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSS--CRL--AHSVTR 122
Query: 835 ALEYLHF-----GHSTPII-HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE------DES 882
            L YLH       H  P I H DL   NVL+  D    +SDFG++  L+G       +E 
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 883 TMRTQTLATIGYMAPDEIFVGELSLK 908
                 + TI YMAP E+  G ++L+
Sbjct: 183 NAAISEVGTIRYMAP-EVLEGAVNLR 207

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 7/150 (4%)
Query: 727 NFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRN 783
           N+     IG G F  V  AR +  G E+A+K+       +S+L+    E  ++K + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +VK+      +    LV+EY S G + D L +         R      I SA++Y H   
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH--- 130
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMA 873
              I+H DLK  N+LLD DM   ++DFG +
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 7/150 (4%)
Query: 727 NFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRN 783
           N+     IG G F  V  AR +  G E+A+K+       +S+L+    E  ++K + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +VK+      +    LV+EY S G + D L +         R      I SA++Y H   
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH--- 130
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMA 873
              I+H DLK  N+LLD DM   ++DFG +
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        +     ++A+K+         L    +E E++K I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCL---------------HSSNCALNIFCRLNI 828
           ++ ++ +C+ D    +++EY S G+L + L               H+    L+    ++ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ ED V  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 213 RLPVKWMAPEALF 225

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 15/156 (9%)
Query: 750 GVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKIISSCSNDDFKA--LVLEYMSN 806
           G  +A+K     C   L+S ++ E E+++ + H ++VK    C +   K+  LV+EY+  
Sbjct: 37  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 96
Query: 807 GSLEDCL--HSSNCA-LNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM 863
           GSL D L  H    A L +F +      I   + YLH  H    IH  L   NVLLD D 
Sbjct: 97  GSLRDYLPRHCVGLAQLLLFAQ-----QICEGMAYLHAQH---YIHRALAARNVLLDNDR 148
Query: 864 VAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAPD 898
           +  + DFG+AK +  G +   +R    + + + AP+
Sbjct: 149 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 184

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 29/203 (14%)
Query: 708 SSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE-----DGVEIAIKVFHPQC 762
           +S PT+    Y + +R          +G G FG V     +      G  +A+K     C
Sbjct: 5   ASDPTVFHKRYLKKIRD---------LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADC 55
Query: 763 ASTLKS-FEAECEVIKNIRHRNLVKIISSCSNDDFKAL--VLEYMSNGSLEDCL--HSSN 817
               +S ++ E ++++ + H +++K    C +   K+L  V+EY+  GSL D L  HS  
Sbjct: 56  GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIG 115
Query: 818 CA-LNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL 876
            A L +F +      I   + YLH  H    IH +L   NVLLD D +  + DFG+AK +
Sbjct: 116 LAQLLLFAQ-----QICEGMAYLHAQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAV 167
Query: 877 -SGEDESTMRTQTLATIGYMAPD 898
             G +   +R    + + + AP+
Sbjct: 168 PEGHEYYRVREDGDSPVFWYAPE 190

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 49/168 (29%), Positives = 74/168 (44%), Gaps = 20/168 (11%)
Query: 722 LRATDNFAENNIIGIGGFGSVYRAR--LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI 779
           LR   +F E  ++G G FG V +AR  L+       K+ H +    L +  +E  ++ ++
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVXLLASL 59
Query: 780 RH-------------RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL 826
            H             RN VK  ++        +  EY  N +L D +HS N         
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 827 NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK 874
            +   I  AL Y+H   S  IIH +LKP N+ +DE     + DFG+AK
Sbjct: 120 RLFRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 29/203 (14%)
Query: 708 SSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE-----DGVEIAIKVFHPQC 762
           +S PT+    Y + +R          +G G FG V     +      G  +A+K     C
Sbjct: 5   ASDPTVFHKRYLKKIRD---------LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADC 55
Query: 763 ASTLKS-FEAECEVIKNIRHRNLVKIISSCSNDDFKAL--VLEYMSNGSLEDCL--HSSN 817
               +S ++ E ++++ + H +++K    C +   K+L  V+EY+  GSL D L  HS  
Sbjct: 56  GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIG 115
Query: 818 CA-LNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL 876
            A L +F +      I   + YLH  H    IH +L   NVLLD D +  + DFG+AK +
Sbjct: 116 LAQLLLFAQ-----QICEGMAYLHSQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAV 167
Query: 877 -SGEDESTMRTQTLATIGYMAPD 898
             G +   +R    + + + AP+
Sbjct: 168 PEGHEYYRVREDGDSPVFWYAPE 190

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 15/181 (8%)
Query: 725 TDNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRH 781
           +DN+     +G G F  V R      G+E A K+ + +   A   +  E E  + + ++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSL-EDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
            N+V++  S   + F  LV + ++ G L ED +     A   +   +    I   LE + 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV-----AREFYSEADASHCIQQILESIA 142
Query: 841 FGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           + HS  I+H +LKP N+LL    +     L+DFG+A  +   ++S        T GY++P
Sbjct: 143 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLSP 199
Query: 898 D 898
           +
Sbjct: 200 E 200

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 59/267 (22%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 731 NNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
           N +IG G FG VY   L D     +  A+K  +       +  F  E  ++K+  H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 786 KIISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            ++  C   +   LV L YM +G L + + +      +   +   + +A  ++YL    S
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 146
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEIFV 902
              +H DL   N +LDE     ++DFG+A+ +  ++  ++  +T A   + +MA + +  
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 903 GELSLKR--WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            + + K   W   +L          P   V   D ++   + +     E C   ++ + L
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 266
Query: 951 ECTMESPEKRIDAKDTITRLLKIRDTL 977
           +C     E R    + ++R+  I  T 
Sbjct: 267 KCWHPKAEMRPSFSELVSRISAIFSTF 293

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/267 (22%), Positives = 115/267 (43%), Gaps = 23/267 (8%)
Query: 731 NNIIGIGGFGSVYRARL--EDGVEI--AIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
           N +IG G FG VY   L   DG +I  A+K  +       +  F  E  ++K+  H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 786 KIISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            ++  C   +   LV L YM +G L + + +      +   +   + +A  +++L    S
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 210
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEIFV 902
              +H DL   N +LDE     ++DFG+A+ +  ++  ++  +T A   + +MA + +  
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 903 GELSLKR--WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            + + K   W   +L          P   V   D ++   + +     E C   ++ + L
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 330
Query: 951 ECTMESPEKRIDAKDTITRLLKIRDTL 977
           +C     E R    + ++R+  I  T 
Sbjct: 331 KCWHPKAEMRPSFSELVSRISAIFSTF 357

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 59/267 (22%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 731 NNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
           N +IG G FG VY   L D     +  A+K  +       +  F  E  ++K+  H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 786 KIISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            ++  C   +   LV L YM +G L + + +      +   +   + +A  ++YL    S
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 149
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEIFV 902
              +H DL   N +LDE     ++DFG+A+ +  ++  ++  +T A   + +MA + +  
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 903 GELSLKR--WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            + + K   W   +L          P   V   D ++   + +     E C   ++ + L
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 269
Query: 951 ECTMESPEKRIDAKDTITRLLKIRDTL 977
           +C     E R    + ++R+  I  T 
Sbjct: 270 KCWHPKAEMRPSFSELVSRISAIFSTF 296

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 59/267 (22%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 731 NNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
           N +IG G FG VY   L D     +  A+K  +       +  F  E  ++K+  H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 786 KIISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            ++  C   +   LV L YM +G L + + +      +   +   + +A  ++YL    S
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 150
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEIFV 902
              +H DL   N +LDE     ++DFG+A+ +  ++  ++  +T A   + +MA + +  
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 903 GELSLKR--WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            + + K   W   +L          P   V   D ++   + +     E C   ++ + L
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 270
Query: 951 ECTMESPEKRIDAKDTITRLLKIRDTL 977
           +C     E R    + ++R+  I  T 
Sbjct: 271 KCWHPKAEMRPSFSELVSRISAIFSTF 297

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        + ++ V +A+K+         L    +E E++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA---------------LNIFCRLNI 828
           ++ ++ +C+ D    +++EY S G+L + L +                   +     ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ E+ V  ++DFG+A+ ++  D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 220 RLPVKWMAPEALF 232

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 50/189 (26%), Positives = 93/189 (49%), Gaps = 26/189 (13%)
Query: 732 NIIGIGGFGSVYRARLE-DGVEI--AIKVFHPQCAST-LKSFEAECEVIKNI-RHRNLVK 786
           ++IG G FG V +AR++ DG+ +  AIK      +    + F  E EV+  +  H N++ 
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCL---------------HSSNCALNIFCRLNIMID 831
           ++ +C +  +  L +EY  +G+L D L               +S+   L+    L+   D
Sbjct: 81  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           +A  ++YL        IH DL   N+L+ E+ VA ++DFG+++   G++    +T     
Sbjct: 141 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 194
Query: 892 IGYMAPDEI 900
           + +MA + +
Sbjct: 195 VRWMAIESL 203

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 50/189 (26%), Positives = 93/189 (49%), Gaps = 26/189 (13%)
Query: 732 NIIGIGGFGSVYRARLE-DGVEI--AIKVFHPQCAST-LKSFEAECEVIKNI-RHRNLVK 786
           ++IG G FG V +AR++ DG+ +  AIK      +    + F  E EV+  +  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCL---------------HSSNCALNIFCRLNIMID 831
           ++ +C +  +  L +EY  +G+L D L               +S+   L+    L+   D
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           +A  ++YL        IH DL   N+L+ E+ VA ++DFG+++   G++    +T     
Sbjct: 151 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 204
Query: 892 IGYMAPDEI 900
           + +MA + +
Sbjct: 205 VRWMAIESL 213

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 59/267 (22%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 731 NNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
           N +IG G FG VY   L D     +  A+K  +       +  F  E  ++K+  H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 786 KIISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            ++  C   +   LV L YM +G L + + +      +   +   + +A  ++YL    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 151
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEIFV 902
              +H DL   N +LDE     ++DFG+A+ +  ++  ++  +T A   + +MA + +  
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 903 GELSLKR--WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            + + K   W   +L          P   V   D ++   + +     E C   ++ + L
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 271
Query: 951 ECTMESPEKRIDAKDTITRLLKIRDTL 977
           +C     E R    + ++R+  I  T 
Sbjct: 272 KCWHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 64/245 (26%), Positives = 117/245 (47%), Gaps = 32/245 (13%)
Query: 733 IIGIGGFGSVYRAR-LEDG----VEIAIKVFHPQCASTLKSFEAECE---VIKNIRHRNL 784
           ++G G FG+V++   + +G    + + IKV   +  S  +SF+A  +    I ++ H ++
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           V+++  C     + LV +Y+  GSL D +     AL     LN  + IA  + YL     
Sbjct: 78  VRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---E 133
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
             ++H +L   NVLL       ++DFG+A LL  +D+  + ++    I +MA + I  G+
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 905 LSLKR--W-----VNDLLP--------VSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLA 949
            + +   W     V +L+         + L EV D  LL   E+  A  + C + ++ + 
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD--LLEKGER-LAQPQICTIDVYMVM 250
Query: 950 LECTM 954
           ++C M
Sbjct: 251 VKCWM 255

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 59/267 (22%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 731 NNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
           N +IG G FG VY   L D     +  A+K  +       +  F  E  ++K+  H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 786 KIISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            ++  C   +   LV L YM +G L + + +      +   +   + +A  ++YL    S
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 148
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEIFV 902
              +H DL   N +LDE     ++DFG+A+ +  ++  ++  +T A   + +MA + +  
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 903 GELSLKR--WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            + + K   W   +L          P   V   D ++   + +     E C   ++ + L
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 268
Query: 951 ECTMESPEKRIDAKDTITRLLKIRDTL 977
           +C     E R    + ++R+  I  T 
Sbjct: 269 KCWHPKAEMRPSFSELVSRISAIFSTF 295

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        + ++ V +A+K+         L    +E E++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA---------------LNIFCRLNI 828
           ++ ++ +C+ D    +++EY S G+L + L +                   +     ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ E+ V  ++DFG+A+ ++  D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 220 RLPVKWMAPEALF 232

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        + ++ V +A+K+         L    +E E++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA---------------LNIFCRLNI 828
           ++ ++ +C+ D    +++EY S G+L + L +                   +     ++ 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ E+ V  ++DFG+A+ ++  D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 220 RLPVKWMAPEALF 232

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        + ++ V +A+K+         L    +E E++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA---------------LNIFCRLNI 828
           ++ ++ +C+ D    +++EY S G+L + L +                   +     ++ 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ E+ V  ++DFG+A+ ++  D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 220 RLPVKWMAPEALF 232

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 59/267 (22%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 731 NNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
           N +IG G FG VY   L D     +  A+K  +       +  F  E  ++K+  H N++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 786 KIISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            ++  C   +   LV L YM +G L + + +      +   +   + +A  ++YL    S
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEIFV 902
              +H DL   N +LDE     ++DFG+A+ +  ++  ++  +T A   + +MA + +  
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 903 GELSLKR--WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            + + K   W   +L          P   V   D ++   + +     E C   ++ + L
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 263
Query: 951 ECTMESPEKRIDAKDTITRLLKIRDTL 977
           +C     E R    + ++R+  I  T 
Sbjct: 264 KCWHPKAEMRPSFSELVSRISAIFSTF 290

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 59/267 (22%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 731 NNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
           N +IG G FG VY   L D     +  A+K  +       +  F  E  ++K+  H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 786 KIISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            ++  C   +   LV L YM +G L + + +      +   +   + +A  ++YL    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 151
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEIFV 902
              +H DL   N +LDE     ++DFG+A+ +  ++  ++  +T A   + +MA + +  
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 903 GELSLKR--WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            + + K   W   +L          P   V   D ++   + +     E C   ++ + L
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 271
Query: 951 ECTMESPEKRIDAKDTITRLLKIRDTL 977
           +C     E R    + ++R+  I  T 
Sbjct: 272 KCWHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        + ++ V +A+K+         L    +E E++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA---------------LNIFCRLNI 828
           ++ ++ +C+ D    +++EY S G+L + L +                   +     ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ E+ V  ++DFG+A+ ++  D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 220 RLPVKWMAPEALF 232

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        + ++ V +A+K+         L    +E E++K I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA---------------LNIFCRLNI 828
           ++ ++ +C+ D    +++EY S G+L + L +                   +     ++ 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ E+ V  ++DFG+A+ ++  D     T  
Sbjct: 209 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 266 RLPVKWMAPEALF 278

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 9/172 (5%)
Query: 733 IIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +IG G FG VY  R    V I +          LK+F+ E    +  RH N+V  + +C 
Sbjct: 40  LIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
           +    A++       +L   +  +   L++     I  +I   + YL   H+  I+H DL
Sbjct: 100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGILHKDL 156
Query: 853 KPSNVLLDEDMVAHLSDFGM----AKLLSGEDESTMRTQTLATIGYMAPDEI 900
           K  NV  D   V  ++DFG+      L +G  E  +R Q    + ++AP+ I
Sbjct: 157 KSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQN-GWLCHLAPEII 206

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 49/193 (25%), Positives = 87/193 (45%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        +     ++A+K+         L    +E E++K I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR---------------LNI 828
           ++ ++ +C+ D    +++EY S G+L + L +       +C                ++ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ ED V  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 213 RLPVKWMAPEALF 225

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 49/193 (25%), Positives = 87/193 (45%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        +     ++A+K+         L    +E E++K I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR---------------LNI 828
           ++ ++ +C+ D    +++EY S G+L + L +       +C                ++ 
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ ED V  ++DFG+A+ +   D     T  
Sbjct: 141 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 198 RLPVKWMAPEALF 210

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 47/150 (31%), Positives = 72/150 (48%), Gaps = 7/150 (4%)
Query: 727 NFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRN 783
           N+     IG G F  V  AR +  G E+A+K+        ++L+    E  ++K + H N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +VK+      +    LV+EY S G + D L +         R      I SA++Y H  +
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKY 134
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMA 873
              I+H DLK  N+LLD DM   ++DFG +
Sbjct: 135 ---IVHRDLKAENLLLDGDMNIKIADFGFS 161

>pdb|2A0Z|A Chain A, The Molecular Structure Of Toll-like Receptor 3 Ligand Binding Domain Length = 705

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 165/633 (26%), Positives = 245/633 (38%), Gaps = 97/633 (15%)
Query: 75  VTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLS 134
           +T LNL+   L+          S L SLD+  N +S   P     +  LKVL L  N+LS
Sbjct: 32  ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 91
Query: 135 G-SLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKC 193
             S  +F F T ++ ++ L  N +                   ++ N F         K 
Sbjct: 92  QLSDKTFAFCT-NLTELHLMSNSIQK-----------------IKNNPFV--------KQ 125
Query: 194 KQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQN--LDVLQLGF 251
           K L  L L +N LS         L  LQ + L NNK+     +E+    N  L  L+L  
Sbjct: 126 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 185
Query: 252 NNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSI 311
           N +    P     +  L  +FL N  L  SL  ++ L L N    NL +++   +  S+ 
Sbjct: 186 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 245
Query: 312 T----NASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANC 367
           T      + L +L++  N+ +     +   L  L+ F + +NN+     +  F  SL   
Sbjct: 246 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI-----QHLFSHSLHGL 300
Query: 368 KKLRYLGLGGNPLDGFLPSSIGNLSLS------------LERLNIAFCNISGNIPKAIGN 415
             +RYL L       F   SI   SL             LE LN+   +I G        
Sbjct: 301 FNVRYLNLKR----SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTG 356
Query: 416 LSNLIVLSLGGN--NLSGSIPVTFGGLQK--LQGLDLAFNKLAGSIPDEICLLSRLNELD 471
           L NL  LSL  +  +L      TF  L    L  L+L  NK++    D    L  L  LD
Sbjct: 357 LINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLD 416
Query: 472 LN----GNKISGSISSCLGNLTSL-----QYLNLGSNRFTFV------------------ 504
           L     G +++G     L N+  +     +YL L  N F  V                  
Sbjct: 417 LGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 476
Query: 505 IPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLS--------GNIPTT 556
            PS F  L+++   D+S+N +       +  L+ +  +DL  NNL+        G     
Sbjct: 477 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYF 536
Query: 557 LEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS-FEKLSYLKELN 615
           L+GL  L  ++L  N  +    E F ++  L+ +DL  N +  ++P S F     LK LN
Sbjct: 537 LKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNL-NTLPASVFNNQVSLKSLN 595
Query: 616 LSFNKLKG-EIPRGGP-FANFTAESFMGNELLC 646
           L  N +   E    GP F N T      N   C
Sbjct: 596 LQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 628

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 47/150 (31%), Positives = 72/150 (48%), Gaps = 7/150 (4%)
Query: 727 NFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRN 783
           N+     IG G F  V  AR +  G E+A+++       +S+L+    E  ++K + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +VK+      +    LV+EY S G + D L +         R      I SA++Y H   
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH--- 130
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMA 873
              I+H DLK  N+LLD DM   ++DFG +
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 47/150 (31%), Positives = 72/150 (48%), Gaps = 7/150 (4%)
Query: 727 NFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRN 783
           N+     IG G F  V  AR +  G E+A+++       +S+L+    E  ++K + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +VK+      +    LV+EY S G + D L +         R      I SA++Y H   
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH--- 130
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMA 873
              I+H DLK  N+LLD DM   ++DFG +
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 56/187 (29%), Positives = 94/187 (50%), Gaps = 13/187 (6%)
Query: 722 LRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKN 778
           L + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K 
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           + H N+VK++     ++   LV E++S   L+D + +S  AL       I   +   L+ 
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDAS--ALTGIPLPLIKSYLFQLLQG 117
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMA 896
           L F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y A
Sbjct: 118 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRA 173
Query: 897 PDEIFVG 903
           P EI +G
Sbjct: 174 P-EILLG 179

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 57/184 (30%), Positives = 86/184 (46%), Gaps = 17/184 (9%)
Query: 727 NFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRN 783
           N+     IG G F  V  AR +  G E+AIK+        ++L+    E  ++K + H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +VK+      +    L++EY S G + D L +         R      I SA++Y H   
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH--- 131
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG---YMAPDEI 900
              I+H DLK  N+LLD DM   ++DFG +      +E T+  +  A  G   Y AP E+
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDAFCGAPPYAAP-EL 184
Query: 901 FVGE 904
           F G+
Sbjct: 185 FQGK 188

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 91/186 (48%), Gaps = 20/186 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIK----VFHPQCASTLKSFEAECEVIKNIR 780
           D +     IG G +G V  AR    G ++AIK     F     +  K    E +++K+ +
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFK 111
Query: 781 HRNLVKIIS----SCSNDDFKAL--VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           H N++ I      +    +FK++  VL+ M +  L   +HSS   L +      +  +  
Sbjct: 112 HDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQ-PLTLEHVRYFLYQLLR 169
Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL--SGEDESTMRTQTLATI 892
            L+Y+H   S  +IH DLKPSN+L++E+    + DFGMA+ L  S  +     T+ +AT 
Sbjct: 170 GLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 893 GYMAPD 898
            Y AP+
Sbjct: 227 WYRAPE 232

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        +     ++A+K+         L    +E E++K I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCL---------------HSSNCALNIFCRLNI 828
           ++ ++ +C+ D    +++EY S G+L + L               H+    L+    ++ 
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ ED V  ++DFG+A+ +   D     T  
Sbjct: 148 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 205 RLPVKWMAPEALF 217

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        +     ++A+K+         L    +E E++K I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCL---------------HSSNCALNIFCRLNI 828
           ++ ++ +C+ D    +++EY S G+L + L               H+    L+    ++ 
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ ED V  ++DFG+A+ +   D     T  
Sbjct: 145 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 202 RLPVKWMAPEALF 214

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        +     ++A+K+         L    +E E++K I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCL---------------HSSNCALNIFCRLNI 828
           ++ ++ +C+ D    +++EY S G+L + L               H+    L+    ++ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ ED V  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 213 RLPVKWMAPEALF 225

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        +     ++A+K+         L    +E E++K I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCL---------------HSSNCALNIFCRLNI 828
           ++ ++ +C+ D    +++EY S G+L + L               H+    L+    ++ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ ED V  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 213 RLPVKWMAPEALF 225

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        +     ++A+K+         L    +E E++K I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCL---------------HSSNCALNIFCRLNI 828
           ++ ++ +C+ D    +++EY S G+L + L               H+    L+    ++ 
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ ED V  ++DFG+A+ +   D     T  
Sbjct: 149 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 206 RLPVKWMAPEALF 218

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 32/236 (13%)
Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           IG G  G+VY A  +  G E+AI+  + Q     +    E  V++  ++ N+V  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 793 NDDFKALVLEYMSNGSLED-----CLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
             D   +V+EY++ GSL D     C+     A    CR          L+ L F HS  +
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA--AVCR--------ECLQALEFLHSNQV 138
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSL 907
           IH ++K  N+LL  D    L+DFG    ++   E + R+  + T  +MAP+ +       
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKAYGP 196
Query: 908 KR--WVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECT--MESPEK 959
           K   W   ++ + ++E        GE  +    E  L +++ +A   T  +++PEK
Sbjct: 197 KVDIWSLGIMAIEMIE--------GEPPYL--NENPLRALYLIATNGTPELQNPEK 242

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 107/228 (46%), Gaps = 33/228 (14%)
Query: 694 RGKRGTMLSNDIILSSQPTIRRFSYFEL-----------LRATDNFAENNIIGIGGFGSV 742
           +GKR  + +N  I  S    + F +F+L           LR  D +  +  +G G  G V
Sbjct: 108 KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALR--DEYIMSKTLGSGACGEV 165
Query: 743 YRA-RLEDGVEIAIKVFHPQC--------ASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
             A   +   ++AI++   +         A    + E E E++K + H  ++KI +    
Sbjct: 166 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 225
Query: 794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK 853
           +D+  +VLE M  G L D +  +       C+L     +  A++YLH      IIH DLK
Sbjct: 226 EDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAVQYLH---ENGIIHRDLK 280
Query: 854 PSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           P NVLL   +ED +  ++DFG +K+L   + S MRT    T  Y+AP+
Sbjct: 281 PENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRT-LCGTPTYLAPE 325

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 702 SNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVE----IAIKV 757
           S++  ++  P   R   FELLR         ++G GG+G V++ R   G       A+KV
Sbjct: 2   SSETSVNRGPEKIRPECFELLR---------VLGKGGYGKVFQVRKVTGANTGKIFAMKV 52
Query: 758 FHP----QCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCL 813
                  + A      +AE  +++ ++H  +V +I +        L+LEY+S G L   L
Sbjct: 53  LKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL 112
Query: 814 HSSNCAL-NIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGM 872
                 + +  C    + +I+ AL +LH      II+ DLKP N++L+      L+DFG+
Sbjct: 113 EREGIFMEDTACFY--LAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGL 167
Query: 873 AKLLSGEDESTMRTQTLATIGYMAPD 898
            K      + T+      TI YMAP+
Sbjct: 168 CK--ESIHDGTVTHXFCGTIEYMAPE 191

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 91/186 (48%), Gaps = 20/186 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIK----VFHPQCASTLKSFEAECEVIKNIR 780
           D +     IG G +G V  AR    G ++AIK     F     +  K    E +++K+ +
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFK 112
Query: 781 HRNLVKIIS----SCSNDDFKAL--VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           H N++ I      +    +FK++  VL+ M +  L   +HSS   L +      +  +  
Sbjct: 113 HDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQ-PLTLEHVRYFLYQLLR 170
Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL--SGEDESTMRTQTLATI 892
            L+Y+H   S  +IH DLKPSN+L++E+    + DFGMA+ L  S  +     T+ +AT 
Sbjct: 171 GLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 893 GYMAPD 898
            Y AP+
Sbjct: 228 WYRAPE 233

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 56/187 (29%), Positives = 94/187 (50%), Gaps = 13/187 (6%)
Query: 722 LRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKN 778
           L + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           + H N+VK++     ++   LV E++S   L+D + +S  AL       I   +   L+ 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDAS--ALTGIPLPLIKSYLFQLLQG 118
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMA 896
           L F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y A
Sbjct: 119 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRA 174
Query: 897 PDEIFVG 903
           P EI +G
Sbjct: 175 P-EILLG 180

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 702 SNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVE----IAIKV 757
           S++  ++  P   R   FELLR         ++G GG+G V++ R   G       A+KV
Sbjct: 2   SSETSVNRGPEKIRPECFELLR---------VLGKGGYGKVFQVRKVTGANTGKIFAMKV 52
Query: 758 FHP----QCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCL 813
                  + A      +AE  +++ ++H  +V +I +        L+LEY+S G L   L
Sbjct: 53  LKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL 112
Query: 814 HSSNCAL-NIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGM 872
                 + +  C    + +I+ AL +LH      II+ DLKP N++L+      L+DFG+
Sbjct: 113 EREGIFMEDTACFY--LAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGL 167
Query: 873 AKLLSGEDESTMRTQTLATIGYMAPD 898
            K      + T+      TI YMAP+
Sbjct: 168 CK--ESIHDGTVTHTFCGTIEYMAPE 191

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 688 VALALKRGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRA-R 746
           +AL+L R K    +  D+ +  Q       Y + LR  D +  +  +G G  G V  A  
Sbjct: 106 IALSLSRNK--VFVFFDLTVDDQSV-----YPKALR--DEYIMSKTLGSGACGEVKLAFE 156
Query: 747 LEDGVEIAIKVFHPQC--------ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA 798
            +   ++AI++   +         A    + E E E++K + H  ++KI +    +D+  
Sbjct: 157 RKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-Y 215
Query: 799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVL 858
           +VLE M  G L D +  +       C+L     +  A++YLH      IIH DLKP NVL
Sbjct: 216 IVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAVQYLH---ENGIIHRDLKPENVL 271
Query: 859 L---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           L   +ED +  ++DFG +K+L   + S MRT    T  Y+AP+
Sbjct: 272 LSSQEEDCLIKITDFGHSKILG--ETSLMRT-LCGTPTYLAPE 311

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 23/208 (11%)
Query: 718 YFELLRATDNFAENNIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQC--------ASTLKS 768
           Y + LR  D +  +  +G G  G V  A   +   ++AIK+   +         A    +
Sbjct: 10  YPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 67
Query: 769 FEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNI 828
            E E E++K + H  ++KI +    +D+  +VLE M  G L D +  +       C+L  
Sbjct: 68  VETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-Y 125
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMR 885
              +  A++YLH      IIH DLKP NVLL   +ED +  ++DFG +K+L   + S MR
Sbjct: 126 FYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMR 180
Query: 886 TQTLATIGYMAPDEIF-VGELSLKRWVN 912
           T    T  Y+AP+ +  VG     R V+
Sbjct: 181 T-LCGTPTYLAPEVLVSVGTAGYNRAVD 207

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 90/192 (46%), Gaps = 18/192 (9%)
Query: 718 YFELL----RATDNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQ--CASTLKSFE 770
           YF+ +    R TD++     +G G F  V R  +     E A K+ + +   A   +  E
Sbjct: 19  YFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLE 78
Query: 771 AECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSL-EDCLHSSNCALNIFCRLNIM 829
            E  + + ++H N+V++  S S + F  LV + ++ G L ED +     A   +   +  
Sbjct: 79  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV-----AREYYSEADAS 133
Query: 830 IDIASALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLSGEDESTMRT 886
             I   LE ++  H   I+H DLKP N+LL    +     L+DFG+A  + GE ++    
Sbjct: 134 HCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF-- 191
Query: 887 QTLATIGYMAPD 898
               T GY++P+
Sbjct: 192 GFAGTPGYLSPE 203

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 53/182 (29%), Positives = 89/182 (48%), Gaps = 16/182 (8%)
Query: 722 LRATDNFAENNIIGIGGFGSVY--RARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI 779
           +R T  F E  ++G G F  V+  + RL  G   A+K      A    S E E  V+K I
Sbjct: 7   IRKTFIFME--VLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKI 63
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           +H N+V +     +     LV++ +S G L D +            L ++  + SA++YL
Sbjct: 64  KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-VIQQVLSAVKYL 122
Query: 840 HFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
              H   I+H DLKP N+L    +E+    ++DFG++K+    +++ + +    T GY+A
Sbjct: 123 ---HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVA 175
Query: 897 PD 898
           P+
Sbjct: 176 PE 177

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 11/179 (6%)
Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G FG VY+A+  E  V  A KV   +    L+ +  E +++ +  H N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
            ++   +++E+ + G+++  +      L       I +     L+ L++ H   IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM--RTQTLATIGYMAPDEIFVGELSLKR 909
           K  N+L   D    L+DFG    +S ++  T+  R   + T  +MAP E+ + E S  R
Sbjct: 162 KAGNILFTLDGDIKLADFG----VSAKNTRTIQRRDSFIGTPYWMAP-EVVMCETSKDR 215

>pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 165/633 (26%), Positives = 246/633 (38%), Gaps = 97/633 (15%)
Query: 75  VTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLS 134
           +T LNL+   L+          S L SLD+  N +S   P     +  LKVL L  N+LS
Sbjct: 27  ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 135 G-SLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKC 193
             S  +F F T ++ ++ L  N +                   ++ N F         K 
Sbjct: 87  QLSDKTFAFCT-NLTELHLMSNSIQK-----------------IKNNPFV--------KQ 120
Query: 194 KQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQN--LDVLQLGF 251
           K L  L L +N LS         L  LQ + L NNK+     +E+    N  L  L+L  
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 252 NNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSI 311
           N +    P     +  L  +FL N  L  SL  ++ L L N    NL +++   +  S+ 
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 312 T----NASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANC 367
           T      + L +L++  N+ +     +   L  L+ F + +NN+     +  F  SL   
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI-----QHLFSHSLHGL 295
Query: 368 KKLRYLGLGGNPLDGFLPSSIGNLSLS------------LERLNIAFCNISGNIPKAIGN 415
             +RYL L       F   SI   SL             LE LN+   +I G        
Sbjct: 296 FNVRYLNLKR----SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTG 351
Query: 416 LSNLIVLSLGGN--NLSGSIPVTFGGLQK--LQGLDLAFNKLAGSIPDEICLLSRLNELD 471
           L NL  LSL  +  +L      TF  L    L  L+L  NK++    D    L  L  LD
Sbjct: 352 LINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLD 411
Query: 472 LN----GNKISGSISSCLGNLTSL-----QYLNLGSNRFTFV------------------ 504
           L     G +++G     L N+  +     +YL L  N F  V                  
Sbjct: 412 LGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 471
Query: 505 IPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLS--------GNIPTT 556
            PS F  L+++   D+S+N +       +  L+ +  +DL  NNL+        G     
Sbjct: 472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYF 531
Query: 557 LEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS-FEKLSYLKELN 615
           L+GL  L  ++L  N  +    E F ++  L+ +DL  N ++ ++P S F     LK LN
Sbjct: 532 LKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLN-TLPASVFNNQVSLKSLN 590
Query: 616 LSFNKLKG-EIPRGGP-FANFTAESFMGNELLC 646
           L  N +   E    GP F N T      N   C
Sbjct: 591 LQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 86/178 (48%), Gaps = 17/178 (9%)
Query: 732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIIS-S 790
            +IG G FG V++A+L +  E+AIK    +     +    E ++++ ++H N+V + +  
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIK----KVLQDKRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 791 CSNDD-----FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
            SN D     F  LVLEY+         H +         L I + +   L  L + HS 
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLK-QTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 846 PIIHCDLKPSNVLLDEDM-VAHLSDFGMAK-LLSGEDESTMRTQTLATIGYMAPDEIF 901
            I H D+KP N+LLD    V  L DFG AK L++GE   +     + +  Y AP+ IF
Sbjct: 161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS----XICSRYYRAPELIF 214

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 121/406 (29%), Positives = 179/406 (44%), Gaps = 66/406 (16%)
Query: 201 LGYNNLSGAIPK-EIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVP 259
           LG  N++  + + ++  +T LQ   L    + G     + YL NL  +    N LT + P
Sbjct: 31  LGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP 85
Query: 260 ATIFNMSTLKEIFLYNNSLSGSLPSRIDLA-LPNLEFLNLGINSFSGTIPSSITNASKLI 318
             + N++ L +I + NN ++   P    LA L NL  L L  N  +   P  + N + L 
Sbjct: 86  --LKNLTKLVDILMNNNQIADITP----LANLTNLTGLTLFNNQITDIDP--LKNLTNLN 137
Query: 319 LLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGN 378
            LE+ SN+ S    SA+  L +L+    F N +T   P       LAN   L  L +  N
Sbjct: 138 RLELSSNTISDI--SALSGLTSLQQLS-FGNQVTDLKP-------LANLTTLERLDISSN 187
Query: 379 PLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFG 438
            +     S +  L+ +LE L      IS   P  +G L+NL  LSL GN L      T  
Sbjct: 188 KVSDI--SVLAKLT-NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLA 240
Query: 439 GLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGS 498
            L  L  LDLA N+++   P  +  L++L EL L  N+IS    S L  LT+L  L L  
Sbjct: 241 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI--SPLAGLTALTNLELNE 296
Query: 499 NRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLE 558
           N+           L+DI            PIS    NLK +  + L  NN+S   P  + 
Sbjct: 297 NQ-----------LEDI-----------SPIS----NLKNLTYLTLYFNNISDISP--VS 328
Query: 559 GLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS 604
            L  LQ +    N++      S  N+T++  L   +N+IS   P++
Sbjct: 329 SLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTPLA 372

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 73/216 (33%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 415 NLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNG 474
           NL+ L+ + +  N ++   P     L  L GL L FN     I D +  L+ LN L+L+ 
Sbjct: 88  NLTKLVDILMNNNQIADITP--LANLTNLTGLTL-FNNQITDI-DPLKNLTNLNRLELSS 143
Query: 475 NKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLL-DGPISLAI 533
           N IS    S L  LTSLQ L+ G N+ T + P    NL  +   DISSN + D  +   +
Sbjct: 144 NTISDI--SALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSDISVLAKL 198
Query: 534 GNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLS 593
            NL++++    + N +S   P  L  L +L  +SL  N+L+     +  ++T+L  LDL+
Sbjct: 199 TNLESLIA---TNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLA 251
Query: 594 NNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGG 629
           NN+IS   P+S   L+ L EL L  N++    P  G
Sbjct: 252 NNQISNLAPLS--GLTKLTELKLGANQISNISPLAG 285

>pdb|3ULU|A Chain A, Structure Of Quaternary Complex Of Human Tlr3ecd With Three Fabs (Form1) Length = 694

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 165/633 (26%), Positives = 245/633 (38%), Gaps = 97/633 (15%)
Query: 75  VTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLS 134
           +T LNL+   L+          S L SLD+  N +S   P     +  LKVL L  N+LS
Sbjct: 37  ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 96
Query: 135 G-SLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKC 193
             S  +F F T ++ ++ L  N +                   ++ N F         K 
Sbjct: 97  QLSDKTFAFCT-NLTELHLMSNSIQK-----------------IKNNPFV--------KQ 130
Query: 194 KQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQN--LDVLQLGF 251
           K L  L L +N LS         L  LQ + L NNK+     +E+    N  L  L+L  
Sbjct: 131 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 190
Query: 252 NNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSI 311
           N +    P     +  L  +FL N  L  SL  ++ L L N    NL +++   +  S+ 
Sbjct: 191 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 250
Query: 312 T----NASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANC 367
           T      + L +L++  N+ +     +   L  L+ F + +NN+     +  F  SL   
Sbjct: 251 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI-----QHLFSHSLHGL 305
Query: 368 KKLRYLGLGGNPLDGFLPSSIGNLSLS------------LERLNIAFCNISGNIPKAIGN 415
             +RYL L       F   SI   SL             LE LN+   +I G        
Sbjct: 306 FNVRYLNLKR----SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTG 361
Query: 416 LSNLIVLSLGGN--NLSGSIPVTFGGLQK--LQGLDLAFNKLAGSIPDEICLLSRLNELD 471
           L NL  LSL  +  +L      TF  L    L  L+L  NK++    D    L  L  LD
Sbjct: 362 LINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLD 421
Query: 472 LN----GNKISGSISSCLGNLTSL-----QYLNLGSNRFTFV------------------ 504
           L     G +++G     L N+  +     +YL L  N F  V                  
Sbjct: 422 LGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 481
Query: 505 IPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLS--------GNIPTT 556
            PS F  L+++   D+S+N +       +  L+ +  +DL  NNL+        G     
Sbjct: 482 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYF 541
Query: 557 LEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS-FEKLSYLKELN 615
           L+GL  L  ++L  N  +    E F ++  L+ +DL  N +  ++P S F     LK LN
Sbjct: 542 LKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNL-NTLPASVFNNQVSLKSLN 600
Query: 616 LSFNKLKG-EIPRGGP-FANFTAESFMGNELLC 646
           L  N +   E    GP F N T      N   C
Sbjct: 601 LQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 633

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        + ++ V +A+K+         L    +E E++K I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA---------------LNIFCRLNI 828
           ++ ++ +C+ D    +++EY S G+L + L +                   +     ++ 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ E+ V  ++DFG+A+ ++  D     T  
Sbjct: 150 TYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 207 RLPVKWMAPEALF 219

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        + ++ V +A+K+         L    +E E++K I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA---------------LNIFCRLNI 828
           ++ ++ +C+ D    +++EY S G+L + L +                   +     ++ 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ E+ V  ++DFG+A+ ++  D     T  
Sbjct: 155 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 212 RLPVKWMAPEALF 224

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        + ++ V +A+K+         L    +E E++K I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA---------------LNIFCRLNI 828
           ++ ++ +C+ D    +++EY S G+L + L +                   +     ++ 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ E+ V  ++DFG+A+ ++  D     T  
Sbjct: 152 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 209 RLPVKWMAPEALF 221

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 15/181 (8%)
Query: 725 TDNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRH 781
           +DN+     +G G F  V R      G+E A K+ + +   A   +  E E  + + ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSL-EDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
            N+V++  S   + F  LV + ++ G L ED +     A   +   +    I   LE + 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV-----AREFYSEADASHCIQQILESIA 119
Query: 841 FGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           + HS  I+H +LKP N+LL    +     L+DFG+A  +   ++S        T GY++P
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLSP 176
Query: 898 D 898
           +
Sbjct: 177 E 177

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 15/181 (8%)
Query: 725 TDNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRH 781
           +DN+     +G G F  V R      G+E A K+ + +   A   +  E E  + + ++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSL-EDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
            N+V++  S   + F  LV + ++ G L ED +     A   +   +    I   LE + 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV-----AREFYSEADASHCIQQILESIA 118
Query: 841 FGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           + HS  I+H +LKP N+LL    +     L+DFG+A  +   ++S        T GY++P
Sbjct: 119 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLSP 175
Query: 898 D 898
           +
Sbjct: 176 E 176

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 15/181 (8%)
Query: 725 TDNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRH 781
           +DN+     +G G F  V R      G+E A K+ + +   A   +  E E  + + ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSL-EDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
            N+V++  S   + F  LV + ++ G L ED +     A   +   +    I   LE + 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV-----AREFYSEADASHCIQQILESIA 119
Query: 841 FGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           + HS  I+H +LKP N+LL    +     L+DFG+A  +   ++S        T GY++P
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLSP 176
Query: 898 D 898
           +
Sbjct: 177 E 177

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 47/150 (31%), Positives = 71/150 (47%), Gaps = 7/150 (4%)
Query: 727 NFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRN 783
           N+     IG G F  V  AR +  G E+AIK+        ++L+    E  ++K + H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +VK+      +    L++EY S G + D L +         R      I SA++Y H   
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH--- 128
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMA 873
              I+H DLK  N+LLD DM   ++DFG +
Sbjct: 129 QKRIVHRDLKAENLLLDADMNIKIADFGFS 158

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 58/267 (21%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 731 NNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
           N +IG G FG VY   L D     +  A+K  +       +  F  E  ++K+  H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 786 KIISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            ++  C   +   LV L YM +G L + + +      +   +   + +A  +++L    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 151
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEIFV 902
              +H DL   N +LDE     ++DFG+A+ +  ++  ++  +T A   + +MA + +  
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 903 GELSLKR--WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            + + K   W   +L          P   V   D ++   + +     E C   ++ + L
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 271
Query: 951 ECTMESPEKRIDAKDTITRLLKIRDTL 977
           +C     E R    + ++R+  I  T 
Sbjct: 272 KCWHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 89/183 (48%), Gaps = 13/183 (7%)
Query: 727 NFAENNIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHR 782
           N+     +G G FG V  A     G ++A+K+ + +    +      E E   ++ +RH 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           +++K+     + D   +V+EY  N   +  +     +     R      I SA+EY H  
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH-- 129
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV 902
               I+H DLKP N+LLDE +   ++DFG++ +++  D + ++T +  +  Y AP E+  
Sbjct: 130 -RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP-EVIS 184
Query: 903 GEL 905
           G+L
Sbjct: 185 GKL 187

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 58/267 (21%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 731 NNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
           N +IG G FG VY   L D     +  A+K  +       +  F  E  ++K+  H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 786 KIISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            ++  C   +   LV L YM +G L + + +      +   +   + +A  +++L    S
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 149
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEIFV 902
              +H DL   N +LDE     ++DFG+A+ +  ++  ++  +T A   + +MA + +  
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 903 GELSLKR--WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            + + K   W   +L          P   V   D ++   + +     E C   ++ + L
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 269
Query: 951 ECTMESPEKRIDAKDTITRLLKIRDTL 977
           +C     E R    + ++R+  I  T 
Sbjct: 270 KCWHPKAEMRPSFSELVSRISAIFSTF 296

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 58/267 (21%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 731 NNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
           N +IG G FG VY   L D     +  A+K  +       +  F  E  ++K+  H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 786 KIISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            ++  C   +   LV L YM +G L + + +      +   +   + +A  +++L    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 151
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEIFV 902
              +H DL   N +LDE     ++DFG+A+ +  ++  ++  +T A   + +MA + +  
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 903 GELSLKR--WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            + + K   W   +L          P   V   D ++   + +     E C   ++ + L
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 271
Query: 951 ECTMESPEKRIDAKDTITRLLKIRDTL 977
           +C     E R    + ++R+  I  T 
Sbjct: 272 KCWHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 45/178 (25%), Positives = 85/178 (47%), Gaps = 15/178 (8%)
Query: 733 IIGIGGFGSVYRARLE----DGVEIAIKVFHP-QCASTLKSFEAECEVIKNIRHRNLVKI 787
           +IG G FG V    L+      + +AIK           + F +E  ++    H N++ +
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 99
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
               +      ++ E+M NGSL+  L  ++    +   + ++  IA+ ++YL        
Sbjct: 100 EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNY 156
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA-----TIGYMAPDEI 900
           +H DL   N+L++ ++V  +SDFG+++ L  ED+++  T T A      I + AP+ I
Sbjct: 157 VHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSALGGKIPIRWTAPEAI 212

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 89/183 (48%), Gaps = 13/183 (7%)
Query: 727 NFAENNIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHR 782
           N+     +G G FG V  A     G ++A+K+ + +    +      E E   ++ +RH 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           +++K+     + D   +V+EY  N   +  +     +     R      I SA+EY H  
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH-- 130
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV 902
               I+H DLKP N+LLDE +   ++DFG++ +++  D + ++T +  +  Y AP E+  
Sbjct: 131 -RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP-EVIS 185
Query: 903 GEL 905
           G+L
Sbjct: 186 GKL 188

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 49/189 (25%), Positives = 93/189 (49%), Gaps = 26/189 (13%)
Query: 732 NIIGIGGFGSVYRARLE-DGVEI--AIKVFHPQCAST-LKSFEAECEVIKNI-RHRNLVK 786
           ++IG G FG V +AR++ DG+ +  AIK      +    + F  E EV+  +  H N++ 
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCL---------------HSSNCALNIFCRLNIMID 831
           ++ +C +  +  L +EY  +G+L D L               +S+   L+    L+   D
Sbjct: 88  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           +A  ++YL        IH +L   N+L+ E+ VA ++DFG+++   G++    +T     
Sbjct: 148 VARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 201
Query: 892 IGYMAPDEI 900
           + +MA + +
Sbjct: 202 VRWMAIESL 210

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 33/205 (16%)
Query: 727 NFAENNIIGIGGFGSVYRARL------EDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI 779
           N      +G G FG V +A             +A+K+     + S L+   +E  V+K +
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCL-----------------------HSS 816
            H +++K+  +CS D    L++EY   GSL   L                       H  
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 817 NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL 876
             AL +   ++    I+  ++YL       ++H DL   N+L+ E     +SDFG+++ +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 877 SGEDESTMRTQTLATIGYMAPDEIF 901
             ED    R+Q    + +MA + +F
Sbjct: 201 YEEDSXVKRSQGRIPVKWMAIESLF 225

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 58/267 (21%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 731 NNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
           N +IG G FG VY   L D     +  A+K  +       +  F  E  ++K+  H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 786 KIISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            ++  C   +   LV L YM +G L + + +      +   +   + +A  +++L    S
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 152
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEIFV 902
              +H DL   N +LDE     ++DFG+A+ +  ++  ++  +T A   + +MA + +  
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 903 GELSLKR--WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            + + K   W   +L          P   V   D ++   + +     E C   ++ + L
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 272
Query: 951 ECTMESPEKRIDAKDTITRLLKIRDTL 977
           +C     E R    + ++R+  I  T 
Sbjct: 273 KCWHPKAEMRPSFSELVSRISAIFSTF 299

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 58/267 (21%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 731 NNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
           N +IG G FG VY   L D     +  A+K  +       +  F  E  ++K+  H N++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 786 KIISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            ++  C   +   LV L YM +G L + + +      +   +   + +A  +++L    S
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 156
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEIFV 902
              +H DL   N +LDE     ++DFG+A+ +  ++  ++  +T A   + +MA + +  
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 903 GELSLKR--WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            + + K   W   +L          P   V   D ++   + +     E C   ++ + L
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 276
Query: 951 ECTMESPEKRIDAKDTITRLLKIRDTL 977
           +C     E R    + ++R+  I  T 
Sbjct: 277 KCWHPKAEMRPSFSELVSRISAIFSTF 303

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 33/205 (16%)
Query: 727 NFAENNIIGIGGFGSVYRARL------EDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI 779
           N      +G G FG V +A             +A+K+     + S L+   +E  V+K +
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCL-----------------------HSS 816
            H +++K+  +CS D    L++EY   GSL   L                       H  
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 817 NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL 876
             AL +   ++    I+  ++YL       ++H DL   N+L+ E     +SDFG+++ +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 877 SGEDESTMRTQTLATIGYMAPDEIF 901
             ED    R+Q    + +MA + +F
Sbjct: 201 YEEDSXVKRSQGRIPVKWMAIESLF 225

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 41/160 (25%), Positives = 77/160 (48%), Gaps = 10/160 (6%)
Query: 733 IIGIGGFGSVYRARLE----DGVEIAIKVFH-PQCASTLKSFEAECEVIKNIRHRNLVKI 787
           +IG G FG V   RL+      V +AIK           + F  E  ++    H N+V +
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL-HFGHSTP 846
               +      +V+E+M NG+L+  L   +    +   + ++  IA+ + YL   G+   
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGY--- 166
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
            +H DL   N+L++ ++V  +SDFG+++++  + E+   T
Sbjct: 167 -VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTT 205

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 89/189 (47%), Gaps = 16/189 (8%)
Query: 726 DNFAENNIIGIGGFGSVYRARL----EDGVEIAIKVFHP----QCASTLKSFEAECEVIK 777
           +NF    ++G G +G V+  R     + G   A+KV       Q A T +    E +V++
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 778 NIRHRNLVKIISSCSNDDFK-ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI-DIASA 835
           +IR    +  +      + K  L+L+Y++ G L    H S         + I + +I  A
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVLA 171
Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYM 895
           LE+LH      II+ D+K  N+LLD +    L+DFG++K     DE+        TI YM
Sbjct: 172 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYM 227
Query: 896 APDEIFVGE 904
           APD +  G+
Sbjct: 228 APDIVRGGD 236

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 14/181 (7%)
Query: 725 TDNFAENNIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRH 781
           TD +     +G G F  V R  ++  G E A K+ + +   A   +  E E  + + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSL-EDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
            N+V++  S S + F  LV + ++ G L ED +     A   +   +    I   LE ++
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV-----AREYYSEADASHCIQQILESVN 117
Query: 841 FGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
             H   I+H DLKP N+LL    +     L+DFG+A  + G+ ++        T GY++P
Sbjct: 118 HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSP 175
Query: 898 D 898
           +
Sbjct: 176 E 176

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 14/181 (7%)
Query: 725 TDNFAENNIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRH 781
           TD +     +G G F  V R  ++  G E A K+ + +   A   +  E E  + + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSL-EDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
            N+V++  S S + F  LV + ++ G L ED +     A   +   +    I   LE ++
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV-----AREYYSEADASHCIQQILESVN 117
Query: 841 FGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
             H   I+H DLKP N+LL    +     L+DFG+A  + G+ ++        T GY++P
Sbjct: 118 HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSP 175
Query: 898 D 898
           +
Sbjct: 176 E 176

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 58/267 (21%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 731 NNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
           N +IG G FG VY   L D     +  A+K  +       +  F  E  ++K+  H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 786 KIISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            ++  C   +   LV L YM +G L + + +      +   +   + +A  +++L    S
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 152
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEIFV 902
              +H DL   N +LDE     ++DFG+A+ +  ++  ++  +T A   + +MA + +  
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 903 GELSLKR--WVNDLL----------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            + + K   W   +L          P   V   D ++   + +     E C   ++ + L
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 272
Query: 951 ECTMESPEKRIDAKDTITRLLKIRDTL 977
           +C     E R    + ++R+  I  T 
Sbjct: 273 KCWHPKAEMRPSFSELVSRISAIFSTF 299

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 13/185 (7%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIR 780
           + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+VK++     ++   LV E++    L+D + +S  AL       I   +   L+ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDAS--ALTGIPLPLIKSYLFQLLQGLA 117
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMAPD 898
           F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y AP 
Sbjct: 118 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRAP- 172
Query: 899 EIFVG 903
           EI +G
Sbjct: 173 EILLG 177

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 33/205 (16%)
Query: 727 NFAENNIIGIGGFGSVYRARL------EDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI 779
           N      +G G FG V +A             +A+K+     + S L+   +E  V+K +
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCL-----------------------HSS 816
            H +++K+  +CS D    L++EY   GSL   L                       H  
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 817 NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL 876
             AL +   ++    I+  ++YL       ++H DL   N+L+ E     +SDFG+++ +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 877 SGEDESTMRTQTLATIGYMAPDEIF 901
             ED    R+Q    + +MA + +F
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLF 225

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 14/181 (7%)
Query: 725 TDNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRH 781
           TD +     IG G F  V R  +L  G E A K+ + +   A   +  E E  + + ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSL-EDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
            N+V++  S S + F  LV + ++ G L ED +     A   +   +    I   LE + 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV-----AREYYSEADASHCIQQILEAVL 117
Query: 841 FGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
             H   ++H DLKP N+LL    +     L+DFG+A  + G+ ++        T GY++P
Sbjct: 118 HCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSP 175
Query: 898 D 898
           +
Sbjct: 176 E 176

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 47/193 (24%), Positives = 88/193 (45%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        + ++ V +A+K+         L    +E E++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA---------------LNIFCRLNI 828
           ++ ++ +C+ D    +++ Y S G+L + L +                   +     ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ E+ V  ++DFG+A+ ++  D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 220 RLPVKWMAPEALF 232

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 7/177 (3%)
Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G FG VY+A+  E  V  A KV   +    L+ +  E +++ +  H N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
            ++   +++E+ + G+++  +      L       I +     L+ L++ H   IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
           K  N+L   D    L+DFG++           R   + T  +MAP E+ + E S  R
Sbjct: 162 KAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDSFIGTPYWMAP-EVVMCETSKDR 215

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 125/443 (28%), Positives = 184/443 (41%), Gaps = 93/443 (20%)
Query: 201 LGYNNLSGAIPK-EIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVP 259
           LG  N++  + + ++  +T LQ   L    + G     + YL NL  +    N LT + P
Sbjct: 26  LGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP 80
Query: 260 ATIFNMSTLKEIFLYNNSLSGSLPSRIDLA-LPNLEFLNLGINSFSGTIPSSITNASKLI 318
             + N++ L +I + NN ++   P    LA L NL  L L  N  +   P  + N + L 
Sbjct: 81  --LKNLTKLVDILMNNNQIADITP----LANLTNLTGLTLFNNQITDIDP--LKNLTNLN 132
Query: 319 LLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGN 378
            LE+ SN+ S    SA+  L +L+      N +T   P       LAN   L  L +  N
Sbjct: 133 RLELSSNTISDI--SALSGLTSLQQLSFSSNQVTDLKP-------LANLTTLERLDISSN 183
Query: 379 PLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFG 438
            +     S +  L+ +LE L      IS   P  +G L+NL  LSL GN L      T  
Sbjct: 184 KVSDI--SVLAKLT-NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLA 236
Query: 439 GLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGS 498
            L  L  LDLA N+++   P  +  L++L EL L  N+IS    S L  LT+L  L L  
Sbjct: 237 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI--SPLAGLTALTNLELNE 292
Query: 499 NRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLE 558
           N+           L+DI            PIS                            
Sbjct: 293 NQ-----------LEDI-----------SPIS---------------------------- 302
Query: 559 GLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSF 618
            LK+L  ++L +N +    P S  ++T L+ L  SNNK+S     S   L+ +  L+   
Sbjct: 303 NLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFSNNKVSDV--SSLANLTNINWLSAGH 358
Query: 619 NKLKGEIPRGGPFANFTAESFMG 641
           N    +I    P AN T  + +G
Sbjct: 359 N----QISDLTPLANLTRITQLG 377

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 697 RGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAI 755
           RG+ ++      + P + R   F++     N +    IG G +G V  A    + V +AI
Sbjct: 17  RGSHMAAAAAAGAGPEMVRGQVFDVGPRYTNLS---YIGEGAYGMVCSAYDNVNKVRVAI 73
Query: 756 KVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSN---- 806
           K   P      C  TL+    E +++   RH N++ I     ND  +A  +E M +    
Sbjct: 74  KKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI-----NDIIRAPTIEQMKDVYLV 124
Query: 807 -----GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE 861
                  L   L + + + +  C    +  I   L+Y+H   S  ++H DLKPSN+LL+ 
Sbjct: 125 THLMGADLYKLLKTQHLSNDHICYF--LYQILRGLKYIH---SANVLHRDLKPSNLLLNT 179
Query: 862 DMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAPD 898
                + DFG+A++   + D +   T+ +AT  Y AP+
Sbjct: 180 TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 7/177 (3%)
Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G FG VY+A+  E  V  A KV   +    L+ +  E +++ +  H N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
            ++   +++E+ + G+++  +      L       I +     L+ L++ H   IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
           K  N+L   D    L+DFG++           R   + T  +MAP E+ + E S  R
Sbjct: 162 KAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDXFIGTPYWMAP-EVVMCETSKDR 215

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 47/193 (24%), Positives = 88/193 (45%), Gaps = 28/193 (14%)
Query: 734 IGIGGFGSVYRA--------RLEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
           +G G FG V  A        + ++ V +A+K+         L    +E E++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA---------------LNIFCRLNI 828
           ++ ++ +C+ D    +++ Y S G+L + L +                   +     ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +A  +EYL    S   IH DL   NVL+ E+ V  ++DFG+A+ ++  D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 889 LATIGYMAPDEIF 901
              + +MAP+ +F
Sbjct: 220 RLPVKWMAPEALF 232

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 11/186 (5%)
Query: 718 YFELLRATDNFAENNIIGIGGFGSVYRARLEDGVE--IAIKVFH-PQCASTLKSFEAECE 774
           YF+ +   + F +   IG G FG V++  +++  +  +AIK+    +    ++  + E  
Sbjct: 19  YFQSMDPEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEIT 77
Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           V+       + K   S   D    +++EY+  GS  D L      L+      I+ +I  
Sbjct: 78  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILK 135
Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY 894
            L+YLH   S   IH D+K +NVLL E     L+DFG+A  L+  D    R   + T  +
Sbjct: 136 GLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFW 190
Query: 895 MAPDEI 900
           MAP+ I
Sbjct: 191 MAPEVI 196

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 84/184 (45%), Gaps = 36/184 (19%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 788 ISSCSNDDFKALVLEYMSN------------GSLEDCLHSSNCALNIFCRLNIMIDIASA 835
                ND  +A  +E M +              L  C H SN  +  F     +  I   
Sbjct: 91  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYF-----LYQILRG 140
Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGY 894
           L+Y+H   S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y
Sbjct: 141 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 895 MAPD 898
            AP+
Sbjct: 198 RAPE 201

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 49/183 (26%), Positives = 89/183 (48%), Gaps = 13/183 (7%)
Query: 727 NFAENNIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHR 782
           N+     +G G FG V  A     G ++A+K+ + +    +      E E   ++ +RH 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           +++K+     + D   +V+EY  N   +  +     +     R      I SA+EY H  
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH-- 120
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV 902
               I+H DLKP N+LLDE +   ++DFG++ +++  D + ++T +  +  Y AP E+  
Sbjct: 121 -RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP-EVIS 175
Query: 903 GEL 905
           G+L
Sbjct: 176 GKL 178

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 49/183 (26%), Positives = 89/183 (48%), Gaps = 13/183 (7%)
Query: 727 NFAENNIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHR 782
           N+     +G G FG V  A     G ++A+K+ + +    +      E E   ++ +RH 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           +++K+     + D   +V+EY  N   +  +     +     R      I SA+EY H  
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH-- 124
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV 902
               I+H DLKP N+LLDE +   ++DFG++ +++  D + ++T +  +  Y AP E+  
Sbjct: 125 -RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP-EVIS 179
Query: 903 GEL 905
           G+L
Sbjct: 180 GKL 182

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 18/178 (10%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVF-HPQCASTLKSFE-AECEVIKNIRHRNLVKIISS 790
           IG G +G V++ R  D G  +AIK F   +    +K     E  ++K ++H NLV ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR---LNIMIDIA-SALEYLHFGHSTP 846
                   LV EY        C H+    L+ + R    +++  I    L+ ++F H   
Sbjct: 71  FRRKRRLHLVFEY--------CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
            IH D+KP N+L+ +  V  L DFG A+LL+G   S      +AT  Y +P E+ VG+
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSDYYDDEVATRWYRSP-ELLVGD 177

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 57/184 (30%), Positives = 83/184 (45%), Gaps = 17/184 (9%)
Query: 727 NFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRN 783
           N+     IG G F  V  AR +  G E+A+K+       +S+L+    E  + K + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +VK+      +    LV EY S G + D L +         R      I SA++Y H   
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCH--- 130
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG---YMAPDEI 900
              I+H DLK  N+LLD D    ++DFG +      +E T   +  A  G   Y AP E+
Sbjct: 131 QKFIVHRDLKAENLLLDADXNIKIADFGFS------NEFTFGNKLDAFCGAPPYAAP-EL 183
Query: 901 FVGE 904
           F G+
Sbjct: 184 FQGK 187

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 99/352 (28%), Positives = 163/352 (46%), Gaps = 37/352 (10%)
Query: 290 LPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFN 349
           L NL  +N   N  +   P  + N +KL+ + M +N  +   P  + NL NL    +F N
Sbjct: 62  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 117
Query: 350 NLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNI 409
            +T   P       L N   L  L L  N +     S++  L+ SL++LN  F N   ++
Sbjct: 118 QITDIDP-------LKNLTNLNRLELSSNTISDI--SALSGLT-SLQQLN--FGNQVTDL 165
Query: 410 PKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNE 469
            K + NL+ L  L +  N +S  I V    L  L+ L    N+++   P  + +L+ L+E
Sbjct: 166 -KPLANLTTLERLDISSNKVS-DISV-LAKLTNLESLIATNNQISDITP--LGILTNLDE 220
Query: 470 LDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPI 529
           L LNGN++       L +LT+L  L+L +N+ + + P     L  +    + +N +    
Sbjct: 221 LSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS 276
Query: 530 SLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLES 589
            LA   L A+  ++L+ N L    P  +  LK+L  ++L +N +    P S  ++T L+ 
Sbjct: 277 PLA--GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQR 330
Query: 590 LDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMG 641
           L  SNNK+S     S   L+ +  L+   N    +I    P AN T  + +G
Sbjct: 331 LFFSNNKVSDV--SSLANLTNINWLSAGHN----QISDLTPLANLTRITQLG 376

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 13/187 (6%)
Query: 722 LRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKN 778
           L + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           + H N+VK++     ++   LV E++S   L+  + +S  AL       I   +   L+ 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQG 118
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMA 896
           L F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y A
Sbjct: 119 LAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRA 174
Query: 897 PDEIFVG 903
           P EI +G
Sbjct: 175 P-EILLG 180

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 52/189 (27%), Positives = 89/189 (47%), Gaps = 14/189 (7%)
Query: 715 RFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLK-SFEAE 772
           R+   E +R   +F   +++G G F  V  A  +   + +AIK    +     + S E E
Sbjct: 9   RWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+  I+H N+V +     +     L+++ +S G L D +         +   +    I
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLI 122
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVL---LDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
              L+ + + H   I+H DLKP N+L   LDED    +SDFG++K+   ED  ++ +   
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTAC 179
Query: 890 ATIGYMAPD 898
            T GY+AP+
Sbjct: 180 GTPGYVAPE 188

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 52/189 (27%), Positives = 89/189 (47%), Gaps = 14/189 (7%)
Query: 715 RFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLK-SFEAE 772
           R+   E +R   +F   +++G G F  V  A  +   + +AIK    +     + S E E
Sbjct: 9   RWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+  I+H N+V +     +     L+++ +S G L D +         +   +    I
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLI 122
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVL---LDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
              L+ + + H   I+H DLKP N+L   LDED    +SDFG++K+   ED  ++ +   
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTAC 179
Query: 890 ATIGYMAPD 898
            T GY+AP+
Sbjct: 180 GTPGYVAPE 188

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 52/189 (27%), Positives = 89/189 (47%), Gaps = 14/189 (7%)
Query: 715 RFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLK-SFEAE 772
           R+   E +R   +F   +++G G F  V  A  +   + +AIK    +     + S E E
Sbjct: 9   RWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+  I+H N+V +     +     L+++ +S G L D +         +   +    I
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLI 122
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVL---LDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
              L+ + + H   I+H DLKP N+L   LDED    +SDFG++K+   ED  ++ +   
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTAC 179
Query: 890 ATIGYMAPD 898
            T GY+AP+
Sbjct: 180 GTPGYVAPE 188

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 54/183 (29%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIRHR 782
           +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT--LATIGYMAPDEI 900
           HS  ++H DLKP N+L++ +    L+DFG+A+         +RT T  + T+ Y AP EI
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVVTLWYRAP-EI 174
Query: 901 FVG 903
            +G
Sbjct: 175 LLG 177

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 19/178 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI--RHRNLVKIISSC 791
           IG G FG V+R +   G E+A+K+F    +   +S+  E E+ + +  RH N++  I++ 
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 792 SNDDFKA----LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF----GH 843
           + D+       LV +Y  +GSL D L+     +    +L   +  AS L +LH       
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL--ALSTASGLAHLHMEIVGTQ 163
Query: 844 STPII-HCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDESTMR-TQTLATIGYMAPD 898
             P I H DLK  N+L+ ++    ++D G+A +  S  D   +     + T  YMAP+
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 82/181 (45%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 121
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ RT+   T+ Y+ P+ 
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTELCGTLDYLPPEM 177
Query: 900 I 900
           I
Sbjct: 178 I 178

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 51/183 (27%), Positives = 82/183 (44%), Gaps = 10/183 (5%)
Query: 718 YFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEA--ECEV 775
           YF+ L   + + +   +G G +G VY+A+   G  +A+K              A  E  +
Sbjct: 15  YFQGL--MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISL 72
Query: 776 IKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASA 835
           +K + H N+V +I    ++    LV E+M    L+  L  +   L       I I +   
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQ---DSQIKIYLYQL 128
Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYM 895
           L  +   H   I+H DLKP N+L++ D    L+DFG+A+       S   T  + T+ Y 
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYR 186
Query: 896 APD 898
           APD
Sbjct: 187 APD 189

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 51/183 (27%), Positives = 82/183 (44%), Gaps = 10/183 (5%)
Query: 718 YFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEA--ECEV 775
           YF+ L   + + +   +G G +G VY+A+   G  +A+K              A  E  +
Sbjct: 15  YFQGL--MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISL 72
Query: 776 IKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASA 835
           +K + H N+V +I    ++    LV E+M    L+  L  +   L       I I +   
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQ---DSQIKIYLYQL 128
Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYM 895
           L  +   H   I+H DLKP N+L++ D    L+DFG+A+       S   T  + T+ Y 
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYR 186
Query: 896 APD 898
           APD
Sbjct: 187 APD 189

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 13/185 (7%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIR 780
           + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLA 118
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT--LATIGYMAPD 898
           F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT T  + T+ Y AP 
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVVTLWYRAP- 173
Query: 899 EIFVG 903
           EI +G
Sbjct: 174 EILLG 178

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 80/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G +   L      L+ F        I      L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK----LSKFDEQRTATYITELANAL 126
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ RT    T+ Y+ P+ 
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEM 182
Query: 900 I 900
           I
Sbjct: 183 I 183

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 88/197 (44%), Gaps = 23/197 (11%)
Query: 728 FAENNI-----IGIGGFGSVYRARL-----EDGV-EIAIKVFHPQC-ASTLKSFEAECEV 775
           F  NN+     +G G FG V  A       ED V ++A+K+      A   ++  +E ++
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 776 IKNI-RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           + ++ +H N+V ++ +C++     ++ EY   G L + L   +  L       I    AS
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 835 ALEYLHFGH----------STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
             + LHF            S   IH D+   NVLL    VA + DFG+A+ +  +    +
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 885 RTQTLATIGYMAPDEIF 901
           +      + +MAP+ IF
Sbjct: 223 KGNARLPVKWMAPESIF 239

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 54/183 (29%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIRHR 782
           +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT--LATIGYMAPDEI 900
           HS  ++H DLKP N+L++ +    L+DFG+A+         +RT T  + T+ Y AP EI
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVVTLWYRAP-EI 174
Query: 901 FVG 903
            +G
Sbjct: 175 LLG 177

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 54/183 (29%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIRHR 782
           +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT--LATIGYMAPDEI 900
           HS  ++H DLKP N+L++ +    L+DFG+A+         +RT T  + T+ Y AP EI
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVVTLWYRAP-EI 174
Query: 901 FVG 903
            +G
Sbjct: 175 LLG 177

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 54/183 (29%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIRHR 782
           +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L F 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT--LATIGYMAPDEI 900
           HS  ++H DLKP N+L++ +    L+DFG+A+         +RT T  + T+ Y AP EI
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVVTLWYRAP-EI 178
Query: 901 FVG 903
            +G
Sbjct: 179 LLG 181

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 54/183 (29%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIRHR 782
           +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT--LATIGYMAPDEI 900
           HS  ++H DLKP N+L++ +    L+DFG+A+         +RT T  + T+ Y AP EI
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVVTLWYRAP-EI 173
Query: 901 FVG 903
            +G
Sbjct: 174 LLG 176

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 54/183 (29%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIRHR 782
           +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L F 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT--LATIGYMAPDEI 900
           HS  ++H DLKP N+L++ +    L+DFG+A+         +RT T  + T+ Y AP EI
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVVTLWYRAP-EI 181
Query: 901 FVG 903
            +G
Sbjct: 182 LLG 184

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 54/183 (29%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIRHR 782
           +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT--LATIGYMAPDEI 900
           HS  ++H DLKP N+L++ +    L+DFG+A+         +RT T  + T+ Y AP EI
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVVTLWYRAP-EI 174
Query: 901 FVG 903
            +G
Sbjct: 175 LLG 177

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 54/183 (29%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIRHR 782
           +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L F 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT--LATIGYMAPDEI 900
           HS  ++H DLKP N+L++ +    L+DFG+A+         +RT T  + T+ Y AP EI
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVVTLWYRAP-EI 181
Query: 901 FVG 903
            +G
Sbjct: 182 LLG 184

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 54/183 (29%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIRHR 782
           +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT--LATIGYMAPDEI 900
           HS  ++H DLKP N+L++ +    L+DFG+A+         +RT T  + T+ Y AP EI
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVVTLWYRAP-EI 173
Query: 901 FVG 903
            +G
Sbjct: 174 LLG 176

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 126
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ RT    T+ Y+ P+ 
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEX 182
Query: 900 I 900
           I
Sbjct: 183 I 183

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 89/189 (47%), Gaps = 14/189 (7%)
Query: 715 RFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTLK-SFEAE 772
           R+   E +R   +F   +++G G F  V  A  +   + +AIK    +     + S E E
Sbjct: 9   RWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 66
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+  I+H N+V +     +     L+++ +S G L D +         +   +    I
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLI 122
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVL---LDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
              L+ + + H   I+H DLKP N+L   LDED    +SDFG++K+   ED  ++ +   
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTAC 179
Query: 890 ATIGYMAPD 898
            T GY+AP+
Sbjct: 180 GTPGYVAPE 188

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 13/185 (7%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIR 780
           + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+VK++     ++   LV E++S   L+  + +S  AL       I   +   L+ L 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLA 118
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMAPD 898
           F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y AP 
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRAP- 173
Query: 899 EIFVG 903
           EI +G
Sbjct: 174 EILLG 178

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 71/274 (25%), Positives = 121/274 (44%), Gaps = 40/274 (14%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVY--RARLEDGVEIAIKVFHPQCASTLKSFEA---EC 773
           F++LR          +G G FG V+  R+R  +G   A+KV   +    LK  E    E 
Sbjct: 8   FQILRT---------LGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDER 57
Query: 774 EVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
            ++  + H  ++++  +  +     ++++Y+  G L   L  S    N   +     ++ 
Sbjct: 58  LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVC 116
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
            ALEYLH   S  II+ DLKP N+LLD++    ++DFG AK +       +      T  
Sbjct: 117 LALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYXLCGTPD 168
Query: 894 YMAPDEIFVGEL--SLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALE 951
           Y+AP+ +       S+  W   +L           +L+G    + +     +  +   L 
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIY--------EMLAGYTPFYDSNT---MKTYEKILN 217
Query: 952 CTMESPE-KRIDAKDTITRLLKIRDTLSKRIGNL 984
             +  P     D KD ++RL+  RD LS+R+GNL
Sbjct: 218 AELRFPPFFNEDVKDLLSRLIT-RD-LSQRLGNL 249

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 54/187 (28%), Positives = 92/187 (49%), Gaps = 13/187 (6%)
Query: 722 LRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKN 778
           L + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           + H N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQG 118
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMA 896
           L F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y A
Sbjct: 119 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRA 174
Query: 897 PDEIFVG 903
           P EI +G
Sbjct: 175 P-EILLG 180

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 33/196 (16%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSVYRARL----EDGVEIAIKVFHPQCASTLK----- 767
           S+FELL+         ++G G FG V+  R     + G   A+KV      +TLK     
Sbjct: 28  SHFELLK---------VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLK---KATLKVRDRV 75
Query: 768 SFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN 827
             + E +++ ++ H  +VK+  +   +    L+L+++  G L   L        +F   +
Sbjct: 76  RTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV----MFTEED 131
Query: 828 I---MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
           +   + ++A  L++LH   S  II+ DLKP N+LLDE+    L+DFG++K     D    
Sbjct: 132 VKFYLAELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKK 186
Query: 885 RTQTLATIGYMAPDEI 900
                 T+ YMAP+ +
Sbjct: 187 AYSFCGTVEYMAPEVV 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 54/187 (28%), Positives = 92/187 (49%), Gaps = 13/187 (6%)
Query: 722 LRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKN 778
           L + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K 
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           + H N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ 
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQG 119
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMA 896
           L F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y A
Sbjct: 120 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRA 175
Query: 897 PDEIFVG 903
           P EI +G
Sbjct: 176 P-EILLG 181

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 126
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ RT    T+ Y+ P+ 
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTDLCGTLDYLPPEM 182
Query: 900 I 900
           I
Sbjct: 183 I 183

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 121
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ RT    T+ Y+ P+ 
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTDLCGTLDYLPPEM 177
Query: 900 I 900
           I
Sbjct: 178 I 178

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 121
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ RT    T+ Y+ P+ 
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTDLCGTLDYLPPEM 177
Query: 900 I 900
           I
Sbjct: 178 I 178

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 122
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ RT    T+ Y+ P+ 
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTDLCGTLDYLPPEM 178
Query: 900 I 900
           I
Sbjct: 179 I 179

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 697 RGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAI 755
           RG+ ++      + P + R   F++     N +    IG G +G V  A    + V +AI
Sbjct: 17  RGSHMAAAAAAGAGPEMVRGQVFDVGPRYTNLS---YIGEGAYGMVCSAYDNVNKVRVAI 73
Query: 756 KVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSN---- 806
           K   P      C  TL+    E +++   RH N++ I     ND  +A  +E M +    
Sbjct: 74  KKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI-----NDIIRAPTIEQMKDVYIV 124
Query: 807 -----GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE 861
                  L   L + + + +  C    +  I   L+Y+H   S  ++H DLKPSN+LL+ 
Sbjct: 125 QDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKYIH---SANVLHRDLKPSNLLLNT 179
Query: 862 DMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAPD 898
                + DFG+A++   + D +   T+ +AT  Y AP+
Sbjct: 180 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 121
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ RT    T+ Y+ P+ 
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTXLCGTLDYLPPEM 177
Query: 900 I 900
           I
Sbjct: 178 I 178

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 125
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ RT    T+ Y+ P+ 
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEM 181
Query: 900 I 900
           I
Sbjct: 182 I 182

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 138
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ RT    T+ Y+ P+ 
Sbjct: 139 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEM 194
Query: 900 I 900
           I
Sbjct: 195 I 195

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 124
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ RT    T+ Y+ P+ 
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEM 180
Query: 900 I 900
           I
Sbjct: 181 I 181

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 120
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ RT    T+ Y+ P+ 
Sbjct: 121 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEM 176
Query: 900 I 900
           I
Sbjct: 177 I 177

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 126
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ RT    T+ Y+ P+ 
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEM 182
Query: 900 I 900
           I
Sbjct: 183 I 183

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 124
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ RT    T+ Y+ P+ 
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEM 180
Query: 900 I 900
           I
Sbjct: 181 I 181

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 147
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ RT    T+ Y+ P+ 
Sbjct: 148 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEM 203
Query: 900 I 900
           I
Sbjct: 204 I 204

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 121
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ RT    T+ Y+ P+ 
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEM 177
Query: 900 I 900
           I
Sbjct: 178 I 178

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 22/183 (12%)
Query: 728 FAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFH---PQCASTLKSFEAECEVIKNIRHRN 783
           F++   IG G FG+VY AR + +   +AIK       Q     +    E   ++ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS----ALEYL 839
            ++       +    LV+EY        CL S++  L +  +    ++IA+    AL+ L
Sbjct: 116 TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+K  N+LL E  +  L DFG A +++  +        + T  +MAP+ 
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEV 221
Query: 900 IFV 902
           I  
Sbjct: 222 ILA 224

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 15/156 (9%)
Query: 750 GVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKIISSCSNDDFKAL--VLEYMSN 806
           G  +A+K          +S ++ E ++++ + H +++K    C +    +L  V+EY+  
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 807 GSLEDCL--HSSNCA-LNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM 863
           GSL D L  HS   A L +F +      I   + YLH  H    IH DL   NVLLD D 
Sbjct: 120 GSLRDYLPRHSIGLAQLLLFAQ-----QICEGMAYLHAQH---YIHRDLAARNVLLDNDR 171
Query: 864 VAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAPD 898
           +  + DFG+AK +  G +   +R    + + + AP+
Sbjct: 172 LVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPE 207

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 10/182 (5%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCA-STLKSFEAECEVIKN 778
           A ++   N I+G G FG VY         + + +A+K     C     + F +E  ++KN
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           + H ++VK+I     +    +++E    G L   L  +  +L +   +   + I  A+ Y
Sbjct: 82  LDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 140
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           L    S   +H D+   N+L+       L DFG+++ +  ED        L  I +M+P+
Sbjct: 141 LE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPE 196
Query: 899 EI 900
            I
Sbjct: 197 SI 198

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 10/182 (5%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCA-STLKSFEAECEVIKN 778
           A ++   N I+G G FG VY         + + +A+K     C     + F +E  ++KN
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           + H ++VK+I     +    +++E    G L   L  +  +L +   +   + I  A+ Y
Sbjct: 66  LDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 124
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           L    S   +H D+   N+L+       L DFG+++ +  ED        L  I +M+P+
Sbjct: 125 LE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPE 180
Query: 899 EI 900
            I
Sbjct: 181 SI 182

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 10/182 (5%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCA-STLKSFEAECEVIKN 778
           A ++   N I+G G FG VY         + + +A+K     C     + F +E  ++KN
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           + H ++VK+I     +    +++E    G L   L  +  +L +   +   + I  A+ Y
Sbjct: 70  LDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           L    S   +H D+   N+L+       L DFG+++ +  ED        L  I +M+P+
Sbjct: 129 LE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPE 184
Query: 899 EI 900
            I
Sbjct: 185 SI 186

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 87  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 139
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 140 IH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 898 D 898
           +
Sbjct: 197 E 197

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 122
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ RT    T+ Y+ P+ 
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SCHAPSSRRTTLSGTLDYLPPEM 178
Query: 900 I 900
           I
Sbjct: 179 I 179

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR ++   I A+KV F  Q   A        E E+  ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 121
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ R     T+ Y+ P+ 
Sbjct: 122 SYCHSKKVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRAALCGTLDYLPPEM 177
Query: 900 I 900
           I
Sbjct: 178 I 178

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 89/185 (48%), Gaps = 12/185 (6%)
Query: 718 YFELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA--ECE 774
           YF+   + + +     IG G FG     +  EDG +  IK  +    S+ +  E+  E  
Sbjct: 19  YFQ---SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVA 75
Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR-LNIMIDIA 833
           V+ N++H N+V+   S   +    +V++Y   G L   +++    L    + L+  + I 
Sbjct: 76  VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
            AL+++H      I+H D+K  N+ L +D    L DFG+A++L+   E  +    + T  
Sbjct: 136 LALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPY 190
Query: 894 YMAPD 898
           Y++P+
Sbjct: 191 YLSPE 195

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 19/164 (11%)
Query: 733 IIGIGGFGSVYRARL--EDG--VEIAIKVFHPQCAST--LKSFEAECEVIKNIRHRNLVK 786
           I+G G FGSV    L  EDG  +++A+K      +S   ++ F +E   +K+  H N+++
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 787 IISSCSNDDFKAL-----VLEYMSNGSLEDCLHSSNCA-----LNIFCRLNIMIDIASAL 836
           ++  C     + +     +L +M  G L   L  S        + +   L  M+DIA  +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED 880
           EYL    +   +H DL   N +L +DM   ++DFG++K +   D
Sbjct: 161 EYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 11/175 (6%)
Query: 734 IGIGGFGSVYRARLE-----DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKI- 787
           +G G FGSV   R +      G  +A+K          + F+ E +++K +    +VK  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 788 -ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
            +S         LV+EY+ +G L D L      L+    L     I   +EYL    S  
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 131
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS-GEDESTMRTQTLATIGYMAPDEI 900
            +H DL   N+L++ +    ++DFG+AKLL   +D   +R    + I + AP+ +
Sbjct: 132 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESL 186

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 54/183 (29%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIRHR 782
           +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT--LATIGYMAPDEI 900
           HS  ++H DLKP N+L++ +    L+DFG+A+         +RT T  + T+ Y AP EI
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVVTLWYRAP-EI 173
Query: 901 FVG 903
            +G
Sbjct: 174 LLG 176

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 11/175 (6%)
Query: 734 IGIGGFGSVYRARLE-----DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKI- 787
           +G G FGSV   R +      G  +A+K          + F+ E +++K +    +VK  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 788 -ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
            +S         LV+EY+ +G L D L      L+    L     I   +EYL    S  
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 134
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS-GEDESTMRTQTLATIGYMAPDEI 900
            +H DL   N+L++ +    ++DFG+AKLL   +D   +R    + I + AP+ +
Sbjct: 135 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 189

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 11/175 (6%)
Query: 734 IGIGGFGSVYRARLE-----DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKI- 787
           +G G FGSV   R +      G  +A+K          + F+ E +++K +    +VK  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 788 -ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
            +S         LV+EY+ +G L D L      L+    L     I   +EYL    S  
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 135
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS-GEDESTMRTQTLATIGYMAPDEI 900
            +H DL   N+L++ +    ++DFG+AKLL   +D   +R    + I + AP+ +
Sbjct: 136 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 190

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 11/175 (6%)
Query: 734 IGIGGFGSVYRARLE-----DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKI- 787
           +G G FGSV   R +      G  +A+K          + F+ E +++K +    +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 788 -ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
            +S         LV+EY+ +G L D L      L+    L     I   +EYL    S  
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS-GEDESTMRTQTLATIGYMAPDEI 900
            +H DL   N+L++ +    ++DFG+AKLL   +D   +R    + I + AP+ +
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202

>pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 111/234 (47%), Gaps = 20/234 (8%)
Query: 398 LNIAFCNISGNIPKAI-----GNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLDLAFN 451
           +N  + N+  N  + I      +L +L +L L   NL   I V  F GL  L  L+L  N
Sbjct: 35  VNTRYLNLQENSIQVIRTDTFKHLRHLEILQLS-KNLVRKIEVGAFNGLPSLNTLELFDN 93
Query: 452 KLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGS-NRFTFVIPSTFW 510
           +L          LS+L EL L  N I    S     + SL+ L+LG   R  ++  + F 
Sbjct: 94  RLTTVPTQAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLRRLDLGELKRLEYISEAAFE 153
Query: 511 NLKDILSFDIS-SNLLDGPISLAIGNLKAVVGID---LSRNNLSGNIPTTLEGLKSLQNI 566
            L ++   ++   NL D P      NL A+V ++   LS N L    P + +GL SL+ +
Sbjct: 154 GLVNLRYLNLGMCNLKDIP------NLTALVRLEELELSGNRLDLIRPGSFQGLTSLRKL 207
Query: 567 SLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS-FEKLSYLKELNLSFN 619
            L + ++      +F ++ SLE L+LS+N +  S+P   F  L  L+ ++L+ N
Sbjct: 208 WLMHAQVATIERNAFDDLKSLEELNLSHNNLM-SLPHDLFTPLHRLERVHLNHN 260

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 13/185 (7%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIR 780
           + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLA 119
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMAPD 898
           F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y AP 
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRAP- 174
Query: 899 EIFVG 903
           EI +G
Sbjct: 175 EILLG 179

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 13/185 (7%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIR 780
           + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLA 119
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMAPD 898
           F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y AP 
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRAP- 174
Query: 899 EIFVG 903
           EI +G
Sbjct: 175 EILLG 179

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 13/185 (7%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIR 780
           + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLA 117
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMAPD 898
           F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y AP 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRAP- 172
Query: 899 EIFVG 903
           EI +G
Sbjct: 173 EILLG 177

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 13/185 (7%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIR 780
           + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLA 120
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMAPD 898
           F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y AP 
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRAP- 175
Query: 899 EIFVG 903
           EI +G
Sbjct: 176 EILLG 180

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 13/185 (7%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIR 780
           + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLA 117
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMAPD 898
           F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y AP 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRAP- 172
Query: 899 EIFVG 903
           EI +G
Sbjct: 173 EILLG 177

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 13/185 (7%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIR 780
           + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLA 117
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMAPD 898
           F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y AP 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRAP- 172
Query: 899 EIFVG 903
           EI +G
Sbjct: 173 EILLG 177

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 13/185 (7%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIR 780
           + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLA 118
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMAPD 898
           F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y AP 
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRAP- 173
Query: 899 EIFVG 903
           EI +G
Sbjct: 174 EILLG 178

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 13/185 (7%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIR 780
           + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLA 117
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMAPD 898
           F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y AP 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRAP- 172
Query: 899 EIFVG 903
           EI +G
Sbjct: 173 EILLG 177

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 13/185 (7%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIR 780
           + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLA 119
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMAPD 898
           F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y AP 
Sbjct: 120 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRAP- 174
Query: 899 EIFVG 903
           EI +G
Sbjct: 175 EILLG 179

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 13/185 (7%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIR 780
           + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLA 118
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMAPD 898
           F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y AP 
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRAP- 173
Query: 899 EIFVG 903
           EI +G
Sbjct: 174 EILLG 178

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 83/178 (46%), Gaps = 14/178 (7%)
Query: 727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ---CASTLKSFEAECEVIKNIRHR 782
           +F    ++G G FG V   R +  G   A+K+   +       +     E  V++N RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM-IDIASALEYLHF 841
            L  +  +    D    V+EY + G L    H S   +    R      +I SALEYLH 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH- 122
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG-EDESTMRTQTLATIGYMAPD 898
             S  +++ D+K  N++LD+D    ++DFG+ K   G  D +TM+T    T  Y+AP+
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKT-FCGTPEYLAPE 175

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 87  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 139
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 140 IH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 898 D 898
           +
Sbjct: 197 E 197

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 44/178 (24%), Positives = 84/178 (47%), Gaps = 15/178 (8%)
Query: 733 IIGIGGFGSVYRARLE----DGVEIAIKVFHP-QCASTLKSFEAECEVIKNIRHRNLVKI 787
           +IG G FG V    L+      + +AIK           + F +E  ++    H N++ +
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
               +      ++ E+M NGSL+  L  ++    +   + ++  IA+ ++YL        
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNY 130
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA-----TIGYMAPDEI 900
           +H  L   N+L++ ++V  +SDFG+++ L  ED+++  T T A      I + AP+ I
Sbjct: 131 VHRALAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSALGGKIPIRWTAPEAI 186

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 83/178 (46%), Gaps = 14/178 (7%)
Query: 727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ---CASTLKSFEAECEVIKNIRHR 782
           +F    ++G G FG V   R +  G   A+K+   +       +     E  V++N RH 
Sbjct: 9   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 68
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM-IDIASALEYLHF 841
            L  +  +    D    V+EY + G L    H S   +    R      +I SALEYLH 
Sbjct: 69  FLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH- 125
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG-EDESTMRTQTLATIGYMAPD 898
             S  +++ D+K  N++LD+D    ++DFG+ K   G  D +TM+T    T  Y+AP+
Sbjct: 126 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKT-FCGTPEYLAPE 178

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 13/185 (7%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIR 780
           + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDAS--ALTGIPLPLIKSYLFQLLQGLA 120
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMAPD 898
           F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y AP 
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRAP- 175
Query: 899 EIFVG 903
           EI +G
Sbjct: 176 EILLG 180

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 13/183 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR--LEDGVEIAIKV-FHPQCASTLKSFEAECEVIKNIRHR 782
           +NF +   IG G +G VY+AR  L   V    K+    +      +   E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT--LATIGYMAPDEI 900
           HS  ++H DLKP N+L++ +    L+DFG+A+         +RT T  + T+ Y AP EI
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVVTLWYRAP-EI 174
Query: 901 FVG 903
            +G
Sbjct: 175 LLG 177

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 13/183 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRAR--LEDGVEIAIKV-FHPQCASTLKSFEAECEVIKNIRHR 782
           +NF +   IG G +G VY+AR  L   V    K+    +      +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT--LATIGYMAPDEI 900
           HS  ++H DLKP N+L++ +    L+DFG+A+         +RT T  + T+ Y AP EI
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVVTLWYRAP-EI 173
Query: 901 FVG 903
            +G
Sbjct: 174 LLG 176

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 41/155 (26%), Positives = 78/155 (50%), Gaps = 10/155 (6%)
Query: 733 IIGIGGFGSVYRA-RLEDG----VEIAIKVFHPQCASTLK-SFEAECEVIKNIRHRNLVK 786
           ++G G FG+VY+   + +G    + +AIK+ +          F  E  ++ ++ H +LV+
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
           ++  C +   + LV + M +G L + +H     +     LN  + IA  + YL       
Sbjct: 105 LLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 160
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE 881
           ++H DL   NVL+       ++DFG+A+LL G+++
Sbjct: 161 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 195

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 41/155 (26%), Positives = 78/155 (50%), Gaps = 10/155 (6%)
Query: 733 IIGIGGFGSVYRA-RLEDG----VEIAIKVFHPQCASTLK-SFEAECEVIKNIRHRNLVK 786
           ++G G FG+VY+   + +G    + +AIK+ +          F  E  ++ ++ H +LV+
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
           ++  C +   + LV + M +G L + +H     +     LN  + IA  + YL       
Sbjct: 82  LLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 137
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE 881
           ++H DL   NVL+       ++DFG+A+LL G+++
Sbjct: 138 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 172

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/183 (28%), Positives = 90/183 (49%), Gaps = 13/183 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIRHR 782
           +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMAPDEI 900
           HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y AP EI
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRAP-EI 173
Query: 901 FVG 903
            +G
Sbjct: 174 LLG 176

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/183 (28%), Positives = 90/183 (49%), Gaps = 13/183 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIRHR 782
           +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMAPDEI 900
           HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y AP EI
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRAP-EI 173
Query: 901 FVG 903
            +G
Sbjct: 174 LLG 176

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/183 (28%), Positives = 90/183 (49%), Gaps = 13/183 (7%)
Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIRHR 782
           +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L F 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMAPDEI 900
           HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y AP EI
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRAP-EI 175
Query: 901 FVG 903
            +G
Sbjct: 176 LLG 178

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 91  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 143
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 144 IH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 898 D 898
           +
Sbjct: 201 E 201

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 43/206 (20%)
Query: 727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           +F E  +IG GGFG V++A+   DG    I+    +     +  E E + +  + H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIR----RVKYNNEKAEREVKALAKLDHVNIV 68
Query: 786 KIISSC----------SNDDFKA--------------------LVLEYMSNGSLEDCLHS 815
              + C          S+D  ++                    + +E+   G+LE  +  
Sbjct: 69  HY-NGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 816 SNC-ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK 874
                L+    L +   I   ++Y+H   S  +IH DLKPSN+ L +     + DFG+  
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 875 LLSGEDESTMRTQTLATIGYMAPDEI 900
            L  + +   RT++  T+ YM+P++I
Sbjct: 185 SLKNDGK---RTRSKGTLRYMSPEQI 207

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 12/179 (6%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKV-FHPQC--ASTLKSFEAECEVIKNIRH 781
           ++F     +G G FG+VY AR  +    +A+KV F  Q   A        E E+  ++RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
            N++++     +     L+LEY   G++   L      L+ F        I      L +
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSRFDEQRTATYITELANALSY 127
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            HS  +IH D+KP N+LL  +    ++DFG     S    S+ RT    T+ Y+ P+ I
Sbjct: 128 CHSKRVIHRDIKPENLLLGSNGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMI 182

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 87  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 139
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 140 IH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 898 D 898
           +
Sbjct: 197 E 197

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 118
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ RT    T+ Y+ P+ 
Sbjct: 119 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEM 174
Query: 900 I 900
           I
Sbjct: 175 I 175

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 52/186 (27%), Positives = 86/186 (46%), Gaps = 17/186 (9%)
Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFH-PQCASTLKSFEAECEVIKNIRHRN 783
           D++    +IG G    V  A      E +AIK  +  +C +++     E + +    H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCL--------HSSNCALNIFCRLNIMIDIASA 835
           +V   +S    D   LV++ +S GS+ D +        H S   L+      I+ ++   
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG-VLDESTIATILREVLEG 128
Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGED--ESTMRTQTLATI 892
           LEYLH       IH D+K  N+LL ED    ++DFG++  L +G D   + +R   + T 
Sbjct: 129 LEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 893 GYMAPD 898
            +MAP+
Sbjct: 186 CWMAPE 191

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 52/186 (27%), Positives = 86/186 (46%), Gaps = 17/186 (9%)
Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFH-PQCASTLKSFEAECEVIKNIRHRN 783
           D++    +IG G    V  A      E +AIK  +  +C +++     E + +    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCL--------HSSNCALNIFCRLNIMIDIASA 835
           +V   +S    D   LV++ +S GS+ D +        H S   L+      I+ ++   
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG-VLDESTIATILREVLEG 133
Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGED--ESTMRTQTLATI 892
           LEYLH       IH D+K  N+LL ED    ++DFG++  L +G D   + +R   + T 
Sbjct: 134 LEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 893 GYMAPD 898
            +MAP+
Sbjct: 191 CWMAPE 196

>pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 13/211 (6%)
Query: 415 NLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPD-EICLLSRLNELDLN 473
           +L +L +L L  N++       F GL  L  L+L  N+L  +IP+     LS+L EL L 
Sbjct: 86  HLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLR 144
Query: 474 GNKISGSISSCLGNLTSLQYLNLGS-NRFTFVIPSTFWNLKDILSFDIS-SNLLDGPISL 531
            N I    S     + SL+ L+LG   R +++    F  L ++   +++  NL + P   
Sbjct: 145 NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP--- 201
Query: 532 AIGNLKAVVG---IDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLE 588
              NL  ++    +DLS N+LS   P + +GL  LQ + +  ++++     +F N+ SL 
Sbjct: 202 ---NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLV 258
Query: 589 SLDLSNNKISGSIPVSFEKLSYLKELNLSFN 619
            ++L++N ++      F  L +L+ ++L  N
Sbjct: 259 EINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 88/181 (48%), Gaps = 25/181 (13%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI--RHRNLVKIISSC 791
           +G G +G V+R   + G  +A+K+F    +   KS+  E E+   +  RH N++  I+S 
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 792 SNDDFKA----LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH---FG-H 843
                 +    L+  Y   GSL D L  +   L+    L I++ IAS L +LH   FG  
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 844 STPII-HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT-----LATIGYMAP 897
             P I H DLK  N+L+ ++    ++D G+A + S   +ST +        + T  YMAP
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS---QSTNQLDVGNNPRVGTKRYMAP 215
Query: 898 D 898
           +
Sbjct: 216 E 216

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G +   L      L+ F        I      L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK----LSKFDEQRTATYITELANAL 126
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ R     T+ Y+ P+ 
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRXXLXGTLDYLPPEM 182
Query: 900 I 900
           I
Sbjct: 183 I 183

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 723 RATDNFAENNIIGIGGFGSVYRA--RLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI- 779
           R T  F E   IG G FGSV++   RL DG   AIK      A ++    A  EV  +  
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 780 --RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL---NIMIDIAS 834
             +H ++V+  S+ + DD   +  EY + GSL D +  +   ++ F      ++++ +  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLL 859
            L Y+H   S  ++H D+KPSN+ +
Sbjct: 127 GLRYIH---SMSLVHMDIKPSNIFI 148

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 723 RATDNFAENNIIGIGGFGSVYRA--RLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI- 779
           R T  F E   IG G FGSV++   RL DG   AIK      A ++    A  EV  +  
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 62
Query: 780 --RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL---NIMIDIAS 834
             +H ++V+  S+ + DD   +  EY + GSL D +  +   ++ F      ++++ +  
Sbjct: 63  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 122
Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLL 859
            L Y+H   S  ++H D+KPSN+ +
Sbjct: 123 GLRYIH---SMSLVHMDIKPSNIFI 144

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 723 RATDNFAENNIIGIGGFGSVYRA--RLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI- 779
           R T  F E   IG G FGSV++   RL DG   AIK      A ++    A  EV  +  
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 64
Query: 780 --RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL---NIMIDIAS 834
             +H ++V+  S+ + DD   +  EY + GSL D +  +   ++ F      ++++ +  
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLL 859
            L Y+H   S  ++H D+KPSN+ +
Sbjct: 125 GLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 723 RATDNFAENNIIGIGGFGSVYRA--RLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI- 779
           R T  F E   IG G FGSV++   RL DG   AIK      A ++    A  EV  +  
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 64
Query: 780 --RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL---NIMIDIAS 834
             +H ++V+  S+ + DD   +  EY + GSL D +  +   ++ F      ++++ +  
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLL 859
            L Y+H   S  ++H D+KPSN+ +
Sbjct: 125 GLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 28/192 (14%)
Query: 727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           +F E  +IG GGFG V++A+   DG    IK    +     +  E E + +  + H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIK----RVKYNNEKAEREVKALAKLDHVNIV 67
Query: 786 KIISSCSNDDFKA----------------LVLEYMSNGSLEDCLHSSNC-ALNIFCRLNI 828
                    D+                  + +E+   G+LE  +       L+    L +
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              I   ++Y+H   S  +I+ DLKPSN+ L +     + DFG+   L  + +   R ++
Sbjct: 128 FEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RXRS 181
Query: 889 LATIGYMAPDEI 900
             T+ YM+P++I
Sbjct: 182 KGTLRYMSPEQI 193

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 91
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 92  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 144
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 145 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 201
Query: 898 D 898
           +
Sbjct: 202 E 202

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 92
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 93  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 145
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 146 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 202
Query: 898 D 898
           +
Sbjct: 203 E 203

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 83
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 84  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 136
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 137 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 193
Query: 898 D 898
           +
Sbjct: 194 E 194

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 91  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 143
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 144 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 898 D 898
           +
Sbjct: 201 E 201

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 13/185 (7%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH--PQCASTLKSFEAECEVIKNIR 780
           + +NF +   IG G +G VY+AR +  G  +A+K      +      +   E  ++K + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+VK++     ++   LV E++    L+  + +S  AL       I   +   L+ L 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLA 120
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT--QTLATIGYMAPD 898
           F HS  ++H DLKP N+L++ +    L+DFG+A+         +RT    + T+ Y AP 
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYXHEVVTLWYRAP- 175
Query: 899 EIFVG 903
           EI +G
Sbjct: 176 EILLG 180

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 87  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 139
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 140 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 898 D 898
           +
Sbjct: 197 E 197

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 88
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 89  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 141
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 142 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 898 D 898
           +
Sbjct: 199 E 199

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 84
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 85  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 137
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 138 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 898 D 898
           +
Sbjct: 195 E 195

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 84
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 85  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 137
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 138 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 898 D 898
           +
Sbjct: 195 E 195

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 23/197 (11%)
Query: 728 FAENNI-----IGIGGFGSVYRARL-----EDGV-EIAIKVFHPQC-ASTLKSFEAECEV 775
           F  NN+     +G G FG V  A       ED V ++A+K+      A   ++  +E ++
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 776 IKNI-RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           + ++ +H N+V ++ +C++     ++ EY   G L + L   +  L       I     S
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLS 162
Query: 835 ALEYLHFGH----------STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
             + LHF            S   IH D+   NVLL    VA + DFG+A+ +  +    +
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 885 RTQTLATIGYMAPDEIF 901
           +      + +MAP+ IF
Sbjct: 223 KGNARLPVKWMAPESIF 239

>pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 111/234 (47%), Gaps = 20/234 (8%)
Query: 398 LNIAFCNISGNIPKAI-----GNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLDLAFN 451
           +N  + N+  N  + I      +L +L +L L   NL   I V  F GL  L  L+L  N
Sbjct: 35  VNTRYLNLQENSIQVIRTDTFKHLRHLEILQLS-KNLVRKIEVGAFNGLPSLNTLELFDN 93
Query: 452 KLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGS-NRFTFVIPSTFW 510
           +L          LS+L EL L  N I    S     + SL+ L+LG   R  ++  + F 
Sbjct: 94  RLTTVPTQAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLRRLDLGELKRLEYISEAAFE 153
Query: 511 NLKDILSFDIS-SNLLDGPISLAIGNLKAVVGID---LSRNNLSGNIPTTLEGLKSLQNI 566
            L ++   ++   NL D P      NL A+V ++   LS N L    P + +GL SL+ +
Sbjct: 154 GLVNLRYLNLGMCNLKDIP------NLTALVRLEELELSGNRLDLIRPGSFQGLTSLRKL 207
Query: 567 SLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS-FEKLSYLKELNLSFN 619
            L + ++      +F ++ SLE L+LS+N +  S+P   F  L  L+ ++L+ N
Sbjct: 208 WLMHAQVATIERNAFDDLKSLEELNLSHNNLM-SLPHDLFTPLHRLERVHLNHN 260

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 84/190 (44%), Gaps = 34/190 (17%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVE---IAIKVFHP-----QCASTLKSFEAECEVIKN 778
            + +   IG G +G V  A   D V    +AIK   P      C  TL+    E +++  
Sbjct: 44  RYTQLQYIGEGAYGMVSSAY--DHVRKTRVAIKKISPFEHQTYCQRTLR----EIQILLR 97
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIM 829
            RH N++ I      D  +A  LE M +           L   L S   + +  C    +
Sbjct: 98  FRHENVIGI-----RDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYF--L 150
Query: 830 IDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQT 888
             I   L+Y+H   S  ++H DLKPSN+L++      + DFG+A++   E D +   T+ 
Sbjct: 151 YQILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEX 207
Query: 889 LATIGYMAPD 898
           +AT  Y AP+
Sbjct: 208 VATRWYRAPE 217

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 94
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 95  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 147
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 148 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 204
Query: 898 D 898
           +
Sbjct: 205 E 205

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 87  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 139
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 140 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 898 D 898
           +
Sbjct: 197 E 197

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 87/186 (46%), Gaps = 17/186 (9%)
Query: 722 LRATDNFAENNIIGIGGFGSVYRA-RLEDGVEIAIK-VFHPQCASTLKSFEAECEVIKNI 779
           + ++  F +   +G G + +VY+      GV +A+K V       T  +   E  ++K +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA-------LNIFCRLNIMIDI 832
           +H N+V++      ++   LV E+M N  L+  + S           LN+       +  
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL-- 117
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
              L+ L F H   I+H DLKP N+L+++     L DFG+A+   G   +T  ++ + T+
Sbjct: 118 ---LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSE-VVTL 172
Query: 893 GYMAPD 898
            Y APD
Sbjct: 173 WYRAPD 178

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 33/196 (16%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI----AIKVFHPQCASTLK----- 767
           S FELL+         ++G G FG V+  +   G +     A+KV      +TLK     
Sbjct: 25  SQFELLK---------VLGQGSFGKVFLVKKISGSDARQLYAMKVLK---KATLKVRDRV 72
Query: 768 SFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN 827
             + E +++  + H  +VK+  +   +    L+L+++  G L   L        +F   +
Sbjct: 73  RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV----MFTEED 128
Query: 828 I---MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
           +   + ++A AL++LH   S  II+ DLKP N+LLDE+    L+DFG++K     D    
Sbjct: 129 VKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKK 183
Query: 885 RTQTLATIGYMAPDEI 900
                 T+ YMAP+ +
Sbjct: 184 AYSFCGTVEYMAPEVV 199

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 33/196 (16%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI----AIKVFHPQCASTLK----- 767
           S FELL+         ++G G FG V+  +   G +     A+KV      +TLK     
Sbjct: 24  SQFELLK---------VLGQGSFGKVFLVKKISGSDARQLYAMKVLK---KATLKVRDRV 71
Query: 768 SFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN 827
             + E +++  + H  +VK+  +   +    L+L+++  G L   L        +F   +
Sbjct: 72  RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV----MFTEED 127
Query: 828 I---MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
           +   + ++A AL++LH   S  II+ DLKP N+LLDE+    L+DFG++K     D    
Sbjct: 128 VKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKK 182
Query: 885 RTQTLATIGYMAPDEI 900
                 T+ YMAP+ +
Sbjct: 183 AYSFCGTVEYMAPEVV 198

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 33/196 (16%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI----AIKVFHPQCASTLK----- 767
           S FELL+         ++G G FG V+  +   G +     A+KV      +TLK     
Sbjct: 24  SQFELLK---------VLGQGSFGKVFLVKKISGSDARQLYAMKVLK---KATLKVRDRV 71
Query: 768 SFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN 827
             + E +++  + H  +VK+  +   +    L+L+++  G L   L        +F   +
Sbjct: 72  RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV----MFTEED 127
Query: 828 I---MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
           +   + ++A AL++LH   S  II+ DLKP N+LLDE+    L+DFG++K     D    
Sbjct: 128 VKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKK 182
Query: 885 RTQTLATIGYMAPDEI 900
                 T+ YMAP+ +
Sbjct: 183 AYSFCGTVEYMAPEVV 198

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 81/173 (46%), Gaps = 18/173 (10%)
Query: 734 IGIGGFGSV---YRARLEDGVEIAIKVFHP-QCASTLKSFEAECEVIKNIRHRNLVKIIS 789
           +G G +GSV   Y ARL   V +  K+  P Q     +    E  ++K+++H N++ ++ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVK-KLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLD 94
Query: 790 ----SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
               + S +DF  + L     G+  D  +   C        ++   +   L  L + HS 
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGA--DLNNIVKC--QALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
            IIH DLKPSNV ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRWYRAPE 198

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 14/177 (7%)
Query: 728 FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLK--SFEAECEVIKNIRHRNL 784
           F     +G G F  V  A  +  G   A+K   P+ A   K  S E E  V++ I+H N+
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCI-PKKALKGKESSIENEIAVLRKIKHENI 82
Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           V +     + +   LV++ +S G L D +         +   +    I   L+ +++ H 
Sbjct: 83  VALEDIYESPNHLYLVMQLVSGGELFDRI----VEKGFYTEKDASTLIRQVLDAVYYLHR 138
Query: 845 TPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             I+H DLKP N+L    DE+    +SDFG++K+   E +  + +    T GY+AP+
Sbjct: 139 MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTACGTPGYVAPE 192

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 123
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       +++FG     S    S+ RT    T+ Y+ P+ 
Sbjct: 124 SYCHSKRVIHRDIKPENLLLGSAGELKIANFGW----SVHAPSSRRTTLCGTLDYLPPEM 179
Query: 900 I 900
           I
Sbjct: 180 I 180

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 124
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       +++FG     S    S+ RT    T+ Y+ P+ 
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIANFGW----SVHAPSSRRTTLCGTLDYLPPEM 180
Query: 900 I 900
           I
Sbjct: 181 I 181

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFRHENIIGI 88
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 89  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 141
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 142 IH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 898 D 898
           +
Sbjct: 199 E 199

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFRHENIIGI 88
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 89  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 141
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 142 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 898 D 898
           +
Sbjct: 199 E 199

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 124
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ R     T+ Y+ P+ 
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRAALCGTLDYLPPEM 180
Query: 900 I 900
           I
Sbjct: 181 I 181

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 82/174 (47%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSV---YRARLEDGVEIAIKVFHP-QCASTLKSFEAECEVIKNIRHRNLVKIIS 789
           +G G +GSV   Y ARL   V +  K+  P Q     +    E  ++K+++H N++ ++ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVK-KLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLD 94
Query: 790 ----SCSNDDFKALVL-EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
               + S +DF  + L   +    L + + S   +       ++   +   L  L + HS
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDE-----HVQFLVYQLLRGLKYIHS 149
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSNV ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRWYRAPE 198

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 121
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ R     T+ Y+ P+ 
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRAALCGTLDYLPPEM 177
Query: 900 I 900
           I
Sbjct: 178 I 178

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 81/173 (46%), Gaps = 18/173 (10%)
Query: 734 IGIGGFGSV---YRARLEDGVEIAIKVFHP-QCASTLKSFEAECEVIKNIRHRNLVKIIS 789
           +G G +GSV   Y ARL   V +  K+  P Q     +    E  ++K+++H N++ ++ 
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVK-KLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLD 86
Query: 790 ----SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
               + S +DF  + L     G+  D  +   C        ++   +   L  L + HS 
Sbjct: 87  VFTPATSIEDFSEVYLVTTLMGA--DLNNIVKC--QALSDEHVQFLVYQLLRGLKYIHSA 142
Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
            IIH DLKPSNV ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 143 GIIHRDLKPSNVAVNEDCELRILDFGLARQADEE-----MTGYVATRWYRAPE 190

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 123
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ R     T+ Y+ P+ 
Sbjct: 124 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRXXLCGTLDYLPPEM 179
Query: 900 I 900
           I
Sbjct: 180 I 180

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AI+   P      C  TL+    E +++   RH N++ I
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 91  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 143
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 144 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 898 D 898
           +
Sbjct: 201 E 201

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 124
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ R     T+ Y+ P+ 
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRXXLCGTLDYLPPEM 180
Query: 900 I 900
           I
Sbjct: 181 I 181

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 121
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ R     T+ Y+ P+ 
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRXXLCGTLDYLPPEM 177
Query: 900 I 900
           I
Sbjct: 178 I 178

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 51/182 (28%), Positives = 85/182 (46%), Gaps = 22/182 (12%)
Query: 728 FAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFH---PQCASTLKSFEAECEVIKNIRHRN 783
           F++   IG G FG+VY AR + +   +AIK       Q     +    E   ++ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS----ALEYL 839
            ++       +    LV+EY        CL S++  L +  +    ++IA+    AL+ L
Sbjct: 77  TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+K  N+LL E  +  L DFG A +++  +        + T  +MAP+ 
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEV 182
Query: 900 IF 901
           I 
Sbjct: 183 IL 184

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 147
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ R     T+ Y+ P+ 
Sbjct: 148 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRDDLCGTLDYLPPEM 203
Query: 900 I 900
           I
Sbjct: 204 I 204

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 124
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ R     T+ Y+ P+ 
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRDDLCGTLDYLPPEM 180
Query: 900 I 900
           I
Sbjct: 181 I 181

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 12/181 (6%)
Query: 724 ATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV-FHPQC--ASTLKSFEAECEVIKNI 779
           A ++F     +G G FG+VY AR +    I A+KV F  Q   A        E E+  ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           RH N++++     +     L+LEY   G++   L      L+ F        I      L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 122
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
            + HS  +IH D+KP N+LL       ++DFG     S    S+ R     T+ Y+ P+ 
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRDTLCGTLDYLPPEM 178
Query: 900 I 900
           I
Sbjct: 179 I 179

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 177

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 96/253 (37%), Gaps = 35/253 (13%)
Query: 734 IGIGGFGSVYRARLE----DGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHRNLVK 786
           +G G FG V R   +      V +A+K   P   S    +  F  E   + ++ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCL--HSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           +         K +V E    GSL D L  H  +  L    R  + +  A  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGMGYLE---S 133
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAPDEIFVG 903
              IH DL   N+LL    +  + DFG+ + L   +D   M+        + AP+ +   
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 904 ELSL--KRWVNDLLPVSLVEVVDKSL--------------LSGEEKHFAAKEQCLLSIFS 947
             S     W   +  V+L E+                   +  E +     E C   I++
Sbjct: 194 TFSHASDTW---MFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 250
Query: 948 LALECTMESPEKR 960
           + ++C    PE R
Sbjct: 251 VMVQCWAHKPEDR 263

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 63/132 (47%), Gaps = 4/132 (3%)
Query: 533 IGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDL 592
            G L  +V ++L RN L+G  P   EG   +Q + L  N+++    + F  +  L++L+L
Sbjct: 50  FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109
Query: 593 SNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLP--- 649
            +N+IS  +P SFE L+ L  LNL+ N                 +S  G    CG P   
Sbjct: 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV 169
Query: 650 -NLQVPPCKHSQ 660
            ++Q+    HS+
Sbjct: 170 RDVQIKDLPHSE 181

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 55/181 (30%), Positives = 88/181 (48%), Gaps = 25/181 (13%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI--RHRNLVKIISSC 791
           +G G +G V+R   + G  +A+K+F    +   KS+  E E+   +  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 792 SNDDFKA----LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH---FG-H 843
                 +    L+  Y   GSL D L  +   L+    L I++ IAS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 844 STPII-HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT-----LATIGYMAP 897
             P I H DLK  N+L+ ++    ++D G+A + S   +ST +        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS---QSTNQLDVGNNPRVGTKRYMAP 186
Query: 898 D 898
           +
Sbjct: 187 E 187

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 55/181 (30%), Positives = 88/181 (48%), Gaps = 25/181 (13%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI--RHRNLVKIISSC 791
           +G G +G V+R   + G  +A+K+F    +   KS+  E E+   +  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 792 SNDDFKA----LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH---FG-H 843
                 +    L+  Y   GSL D L  +   L+    L I++ IAS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 844 STPII-HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT-----LATIGYMAP 897
             P I H DLK  N+L+ ++    ++D G+A + S   +ST +        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS---QSTNQLDVGNNPRVGTKRYMAP 186
Query: 898 D 898
           +
Sbjct: 187 E 187

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ---CASTLKSFEAECEVIKNIRHR 782
           +F    ++G G FG V   R +  G   A+K+   +       +     E  V++N RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM-IDIASALEYLHF 841
            L  +  +    D    V+EY + G L    H S   +    R      +I SALEYLH 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH- 122
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG-EDESTMRTQTLATIGYMAPD 898
             S  +++ D+K  N++LD+D    ++DFG+ K   G  D +TM+     T  Y+AP+
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKX-FCGTPEYLAPE 175

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ---CASTLKSFEAECEVIKNIRHR 782
           +F    ++G G FG V   R +  G   A+K+   +       +     E  V++N RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM-IDIASALEYLHF 841
            L  +  +    D    V+EY + G L    H S   +    R      +I SALEYLH 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH- 122
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG-EDESTMRTQTLATIGYMAPD 898
             S  +++ D+K  N++LD+D    ++DFG+ K   G  D +TM+     T  Y+AP+
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKX-FCGTPEYLAPE 175

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 19/178 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI--RHRNLVKIISSC 791
           IG G FG V+R +   G E+A+K+F    +   +S+  E E+ + +  RH N++  I++ 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 792 SNDDFKA----LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF----GH 843
           + D+       LV +Y  +GSL D L+     +    +L   +  AS L +LH       
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL--ALSTASGLAHLHMEIVGTQ 125
Query: 844 STPII-HCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDESTMR-TQTLATIGYMAPD 898
             P I H DLK  N+L+ ++    ++D G+A +  S  D   +     + T  YMAP+
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 183

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 19/178 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI--RHRNLVKIISSC 791
           IG G FG V+R +   G E+A+K+F    +   +S+  E E+ + +  RH N++  I++ 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 792 SNDDFKA----LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF----GH 843
           + D+       LV +Y  +GSL D L+     +    +L   +  AS L +LH       
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL--ALSTASGLAHLHMEIVGTQ 124
Query: 844 STPII-HCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDESTMR-TQTLATIGYMAPD 898
             P I H DLK  N+L+ ++    ++D G+A +  S  D   +     + T  YMAP+
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 19/178 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI--RHRNLVKIISSC 791
           IG G FG V+R +   G E+A+K+F    +   +S+  E E+ + +  RH N++  I++ 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 792 SNDDFKA----LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF----GH 843
           + D+       LV +Y  +GSL D L+     +    +L   +  AS L +LH       
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL--ALSTASGLAHLHMEIVGTQ 150
Query: 844 STPII-HCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDESTMR-TQTLATIGYMAPD 898
             P I H DLK  N+L+ ++    ++D G+A +  S  D   +     + T  YMAP+
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 208

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 19/178 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI--RHRNLVKIISSC 791
           IG G FG V+R +   G E+A+K+F    +   +S+  E E+ + +  RH N++  I++ 
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 792 SNDDFKA----LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF----GH 843
           + D+       LV +Y  +GSL D L+     +    +L   +  AS L +LH       
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL--ALSTASGLAHLHMEIVGTQ 130
Query: 844 STPII-HCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDESTMR-TQTLATIGYMAPD 898
             P I H DLK  N+L+ ++    ++D G+A +  S  D   +     + T  YMAP+
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 188

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 19/178 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI--RHRNLVKIISSC 791
           IG G FG V+R +   G E+A+K+F    +   +S+  E E+ + +  RH N++  I++ 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 792 SNDDFKA----LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF----GH 843
           + D+       LV +Y  +GSL D L+     +    +L   +  AS L +LH       
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL--ALSTASGLAHLHMEIVGTQ 127
Query: 844 STPII-HCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDESTMR-TQTLATIGYMAPD 898
             P I H DLK  N+L+ ++    ++D G+A +  S  D   +     + T  YMAP+
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 185

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 53/179 (29%), Positives = 80/179 (44%), Gaps = 12/179 (6%)
Query: 726 DNFAENNIIGIGGFGSVYRARLEDG-VEIAIKV-FHPQCAS--TLKSFEAECEVIKNIRH 781
           D+F     +G G FG+VY AR +     +A+KV F  Q            E E+  ++ H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
            N++++ +   +     L+LEY   G L   L  S C  +      IM ++A AL Y H 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKS-CTFDEQRTATIMEELADALMYCH- 140
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
                +IH D+KP N+LL       ++DFG     S    S  R     T+ Y+ P+ I
Sbjct: 141 --GKKVIHRDIKPENLLLGLKGELKIADFGW----SVHAPSLRRKTMCGTLDYLPPEMI 193

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ---CASTLKSFEAECEVIKNIRHR 782
           +F    ++G G FG V   R +  G   A+K+   +       +     E  V++N RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM-IDIASALEYLHF 841
            L  +  +    D    V+EY + G L    H S   +    R      +I SALEYLH 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH- 122
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG-EDESTMRTQTLATIGYMAPD 898
             S  +++ D+K  N++LD+D    ++DFG+ K   G  D +TM+     T  Y+AP+
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKX-FCGTPEYLAPE 175

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 87/180 (48%), Gaps = 20/180 (11%)
Query: 731 NNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRHRNLVK 786
           ++I+G G   +V+R R +  G   AIKVF+    S L+  +    E EV+K + H+N+VK
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFN--NISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 787 I--ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR--LNIMIDIASALEYLHFG 842
           +  I   +    K L++E+   GSL   L   + A  +     L ++ D+   + +L   
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL--- 128
Query: 843 HSTPIIHCDLKPSNVLL----DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
               I+H ++KP N++     D   V  L+DFG A+ L  ED+         T  Y+ PD
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQF-VSLYGTEEYLHPD 185

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 46/172 (26%), Positives = 81/172 (47%), Gaps = 14/172 (8%)
Query: 734 IGIGGFGSVYR-ARLEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G F  V R  ++  G E A K+ + +   A   +  E E  + + ++H N+V++  S
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 791 CSNDDFKALVLEYMSNGSL-EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
            S +    L+ + ++ G L ED +     A   +   +    I   LE +   H   ++H
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIV-----AREYYSEADASHCIQQILEAVLHCHQMGVVH 144
Query: 850 CDLKPSNVLLDEDM---VAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
            DLKP N+LL   +      L+DFG+A  + GE ++        T GY++P+
Sbjct: 145 RDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPE 194

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 90/179 (50%), Gaps = 14/179 (7%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIK-NIRHRNLV 785
           +F   +++G G  G++    + D  ++A+K   P+C S     + E ++++ +  H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVI 81
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
           +   +  +  F+ + +E +   +L++ +   + A      + ++    S L +LH   S 
Sbjct: 82  RYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SL 137
Query: 846 PIIHCDLKPSNVLL-----DEDMVAHLSDFGMAKLLS-GEDESTMRTQTLATIGYMAPD 898
            I+H DLKP N+L+        + A +SDFG+ K L+ G    + R+    T G++AP+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ---CASTLKSFEAECEVIKNIRHR 782
           +F    ++G G FG V   R +  G   A+K+   +       +     E  V++N RH 
Sbjct: 11  DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM-IDIASALEYLHF 841
            L  +  +    D    V+EY + G L    H S   +    R      +I SALEYLH 
Sbjct: 71  FLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH- 127
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG-EDESTMRTQTLATIGYMAPD 898
             S  +++ D+K  N++LD+D    ++DFG+ K   G  D +TM+     T  Y+AP+
Sbjct: 128 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKX-FCGTPEYLAPE 180

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 12/179 (6%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKV-FHPQC--ASTLKSFEAECEVIKNIRH 781
           ++F     +G G FG+VY AR  +    +A+KV F  Q   A        E E+  ++RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
            N++++     +     L+LEY   G++   L      L+ F        I      L +
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSRFDEQRTATYITELANALSY 127
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            HS  +IH D+KP N+LL  +    ++DFG     S    S+ R     T+ Y+ P+ I
Sbjct: 128 CHSKRVIHRDIKPENLLLGSNGELKIADFGW----SVHAPSSRRDTLCGTLDYLPPEMI 182

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 715 RFSYFELLRAT----DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSF 769
           RF  ++ L A     D F +  ++G GGFG V+  +++  G   A K  + +     K +
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 770 EA---ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLH---SSNCALNIF 823
           +    E +++  +  R +V +  +        LV+  M+ G +   ++     N      
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289
Query: 824 CRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDES 882
             +     I S LE+LH      II+ DLKP NVLLD+D    +SD G+A +L +G+   
Sbjct: 290 RAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--- 343
Query: 883 TMRTQTLATIGYMAPDEIFVGE 904
           T       T G+MAP E+ +GE
Sbjct: 344 TKTKGYAGTPGFMAP-ELLLGE 364

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 91  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 143
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +    + +AT  Y AP
Sbjct: 144 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 200
Query: 898 D 898
           +
Sbjct: 201 E 201

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 30/181 (16%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-----QCASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G V  A    + V +AIK   P      C  TL+    E +++   RH N++ I
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 91
Query: 788 ISSCSNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                ND  +A  +E M +           L   L + + + +  C    +  I   L+Y
Sbjct: 92  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKY 144
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAP 897
           +H   S  ++H DLKPSN+LL+      + DFG+A++   + D +    + +AT  Y AP
Sbjct: 145 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 201
Query: 898 D 898
           +
Sbjct: 202 E 202

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 83/177 (46%), Gaps = 22/177 (12%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHP-QCASTLKSFEAECEVIKNIRHRNLVKIISSC 791
           IG G +G V  A    + V +AIK   P +  +  +    E +++   RH N++ I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGI---- 90
Query: 792 SNDDFKALVLEYMSN---------GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
            ND  +A  +E M +           L   L + + + +  C    +  I   L+Y+H  
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF--LYQILRGLKYIH-- 145
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAPD 898
            S  ++H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y AP+
Sbjct: 146 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 715 RFSYFELLRAT----DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSF 769
           RF  ++ L A     D F +  ++G GGFG V+  +++  G   A K  + +     K +
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 770 EA---ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLH---SSNCALNIF 823
           +    E +++  +  R +V +  +        LV+  M+ G +   ++     N      
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289
Query: 824 CRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDES 882
             +     I S LE+LH      II+ DLKP NVLLD+D    +SD G+A +L +G+   
Sbjct: 290 RAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--- 343
Query: 883 TMRTQTLATIGYMAPDEIFVGE 904
           T       T G+MAP E+ +GE
Sbjct: 344 TKTKGYAGTPGFMAP-ELLLGE 364

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 49/196 (25%), Positives = 89/196 (45%), Gaps = 25/196 (12%)
Query: 728 FAENNI-----IGIGGFGSVYRARL-----EDGV-EIAIKVFHPQC-ASTLKSFEAECEV 775
           F  NN+     +G G FG V  A       ED V ++A+K+      A   ++  +E ++
Sbjct: 35  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 94
Query: 776 IKNI-RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA---------LNIFCR 825
           + ++ +H N+V ++ +C++     ++ EY   G L + L     A         L +   
Sbjct: 95  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 154
Query: 826 LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR 885
           L+    +A  + +L    S   IH D+   NVLL    VA + DFG+A+ +  +    ++
Sbjct: 155 LHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 211
Query: 886 TQTLATIGYMAPDEIF 901
                 + +MAP+ IF
Sbjct: 212 GNARLPVKWMAPESIF 227

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 715 RFSYFELLRAT----DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSF 769
           RF  ++ L A     D F +  ++G GGFG V+  +++  G   A K  + +     K +
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 770 EA---ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLH---SSNCALNIF 823
           +    E +++  +  R +V +  +        LV+  M+ G +   ++     N      
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289
Query: 824 CRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDES 882
             +     I S LE+LH      II+ DLKP NVLLD+D    +SD G+A +L +G+   
Sbjct: 290 RAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--- 343
Query: 883 TMRTQTLATIGYMAPDEIFVGE 904
           T       T G+MAP E+ +GE
Sbjct: 344 TKTKGYAGTPGFMAP-ELLLGE 364

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           IG G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 95  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 149 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPE 197

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 14/181 (7%)
Query: 725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIR 780
           +D +    ++G G FG V   + +  G E A+KV   +        E+   E +++K + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+ K+     +  +  LV E  + G L D + S       F  ++    I   L  + 
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGIT 140
Query: 841 FGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           + H   I+H DLKP N+LL+   +D    + DFG++        S      + T  Y+AP
Sbjct: 141 YXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKXKDKIGTAYYIAP 197
Query: 898 D 898
           +
Sbjct: 198 E 198

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 25/185 (13%)
Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++F+ + IIG GGFG VY  R  D      K++  +C    +    + E +  +  R ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIML 243
Query: 786 KIISS-------CSNDDFK-----ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
            ++S+       C +  F      + +L+ M+ G L    H       +F   ++    A
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFYAA 299
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
             +  L   H+  +++ DLKP+N+LLDE     +SD G+A   S +        ++ T G
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHG 355
Query: 894 YMAPD 898
           YMAP+
Sbjct: 356 YMAPE 360

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 25/185 (13%)
Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++F+ + IIG GGFG VY  R  D      K++  +C    +    + E +  +  R ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIML 243
Query: 786 KIISS-------CSNDDFK-----ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
            ++S+       C +  F      + +L+ M+ G L    H       +F   ++    A
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFYAA 299
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
             +  L   H+  +++ DLKP+N+LLDE     +SD G+A   S +        ++ T G
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHG 355
Query: 894 YMAPD 898
           YMAP+
Sbjct: 356 YMAPE 360

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 25/185 (13%)
Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++F+ + IIG GGFG VY  R  D      K++  +C    +    + E +  +  R ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIML 243
Query: 786 KIISS-------CSNDDFK-----ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
            ++S+       C +  F      + +L+ M+ G L    H       +F   ++    A
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFYAA 299
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
             +  L   H+  +++ DLKP+N+LLDE     +SD G+A   S +        ++ T G
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHG 355
Query: 894 YMAPD 898
           YMAP+
Sbjct: 356 YMAPE 360

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 25/185 (13%)
Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++F+ + IIG GGFG VY  R  D      K++  +C    +    + E +  +  R ++
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIML 242
Query: 786 KIISS-------CSNDDFK-----ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
            ++S+       C +  F      + +L+ M+ G L    H       +F   ++    A
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFYAA 298
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
             +  L   H+  +++ DLKP+N+LLDE     +SD G+A   S +        ++ T G
Sbjct: 299 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHG 354
Query: 894 YMAPD 898
           YMAP+
Sbjct: 355 YMAPE 359

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 715 RFSYFELLRAT----DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSF 769
           RF  ++ L A     D F +  ++G GGFG V+  +++  G   A K  + +     K +
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 770 EA---ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLH---SSNCALNIF 823
           +    E +++  +  R +V +  +        LV+  M+ G +   ++     N      
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289
Query: 824 CRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDES 882
             +     I S LE+LH      II+ DLKP NVLLD+D    +SD G+A +L +G+   
Sbjct: 290 RAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--- 343
Query: 883 TMRTQTLATIGYMAPDEIFVGE 904
           T       T G+MAP E+ +GE
Sbjct: 344 TKTKGYAGTPGFMAP-ELLLGE 364

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 89/183 (48%), Gaps = 13/183 (7%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHP--QCASTLKSFEAECEVIKNIRHRN 783
           +F   +++G G +G V  A  +   EI AIK   P  +    L++   E +++K+ +H N
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHEN 70
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           ++ I +    D F+     Y+    ++  LH    +  +    +I   I   L  +   H
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRV-ISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL--SGEDES------TMRTQTLATIGYM 895
            + +IH DLKPSN+L++ +    + DFG+A+++  S  D S      +  T+ +AT  Y 
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYR 189
Query: 896 APD 898
           AP+
Sbjct: 190 APE 192

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 89/183 (48%), Gaps = 13/183 (7%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHP--QCASTLKSFEAECEVIKNIRHRN 783
           +F   +++G G +G V  A  +   EI AIK   P  +    L++   E +++K+ +H N
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHEN 70
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           ++ I +    D F+     Y+    ++  LH    +  +    +I   I   L  +   H
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRV-ISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL--SGEDES------TMRTQTLATIGYM 895
            + +IH DLKPSN+L++ +    + DFG+A+++  S  D S      +  T+ +AT  Y 
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYR 189
Query: 896 APD 898
           AP+
Sbjct: 190 APE 192

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 101 FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 154
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 155 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPE 203

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 80/181 (44%), Gaps = 14/181 (7%)
Query: 725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIR 780
           +D +    ++G G FG V   + +  G E A+KV   +        E+   E +++K + 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N++K+     +  +  LV E  + G L D + S       F  ++    I   L  + 
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGIT 164
Query: 841 FGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           + H   I+H DLKP N+LL+   +D    + DFG++        S      + T  Y+AP
Sbjct: 165 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGTAYYIAP 221
Query: 898 D 898
           +
Sbjct: 222 E 222

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 70/273 (25%), Positives = 116/273 (42%), Gaps = 36/273 (13%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLK------SF 769
           S F      D++     +G G F  V + R +  G E A K    +  S+ +        
Sbjct: 3   STFRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEI 62
Query: 770 EAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM 829
           E E  +++ IRH N++ +     N     L+LE +S G L D L             ++ 
Sbjct: 63  EREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---------SLT 113
Query: 830 IDIASA-----LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH----LSDFGMAKLLSGED 880
            D A+      L+ +H+ HS  I H DLKP N++L +  V +    L DFG+A  +   +
Sbjct: 114 EDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 173
Query: 881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKE 939
           E         T  ++AP+ +    L L+    D+  + ++  +   LLSG        K+
Sbjct: 174 EF---KNIFGTPEFVAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGETKQ 224
Query: 940 QCLLSIFSLALECTMESPEKRID-AKDTITRLL 971
           + L +I ++  +   E      + AKD I RLL
Sbjct: 225 ETLTNISAVNYDFDEEYFSNTSELAKDFIRRLL 257

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 91/189 (48%), Gaps = 11/189 (5%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---E 772
             +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +    E
Sbjct: 13  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 71
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+ ++ + ++ +++  C     + L+++ M  G L D +      +     LN  + I
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 130
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 131 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 187
Query: 893 GYMAPDEIF 901
            +MA + I 
Sbjct: 188 KWMALESIL 196

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 731 NNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRHRNLVK 786
           ++I+G G   +V+R R +  G   AIKVF+    S L+  +    E EV+K + H+N+VK
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNN--ISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 787 I--ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNI----FCRLNIMIDIASALEYLH 840
           +  I   +    K L++E+   GSL   L   + A  +    F  L ++ D+   + +L 
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF--LIVLRDVVGGMNHL- 128
Query: 841 FGHSTPIIHCDLKPSNVLL----DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
                 I+H ++KP N++     D   V  L+DFG A+ L  ED+         T  Y+ 
Sbjct: 129 --RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQF-VXLYGTEEYLH 183
Query: 897 PD 898
           PD
Sbjct: 184 PD 185

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 80/181 (44%), Gaps = 14/181 (7%)
Query: 725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIR 780
           +D +    ++G G FG V   + +  G E A+KV   +        E+   E +++K + 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N++K+     +  +  LV E  + G L D + S       F  ++    I   L  + 
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGIT 163
Query: 841 FGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           + H   I+H DLKP N+LL+   +D    + DFG++        S      + T  Y+AP
Sbjct: 164 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGTAYYIAP 220
Query: 898 D 898
           +
Sbjct: 221 E 221

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 95  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 149 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPE 197

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 91/189 (48%), Gaps = 11/189 (5%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---E 772
             +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+ ++ + ++ +++  C     + L+++ M  G L D +      +     LN  + I
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 893 GYMAPDEIF 901
            +MA + I 
Sbjct: 186 KWMALESIL 194

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 91/189 (48%), Gaps = 11/189 (5%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---E 772
             +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+ ++ + ++ +++  C     + L+++ M  G L D +      +     LN  + I
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 893 GYMAPDEIF 901
            +MA + I 
Sbjct: 187 KWMALESIL 195

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 88/187 (47%), Gaps = 10/187 (5%)
Query: 694 RGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNF---AENNIIGIGGFGSVYR-ARLED 749
           + KR + L+ DI     P   R    +   A ++F   ++  I+G G FG V++      
Sbjct: 55  KSKRTSALAVDIPAPPAPFDHRIVTAKQ-GAVNSFYTVSKTEILGGGRFGQVHKCEETAT 113
Query: 750 GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSL 809
           G+++A K+   +     +  + E  V+  + H NL+++  +  + +   LV+EY+  G L
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173
Query: 810 EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVL-LDEDMVA-HL 867
            D +   +  L     +  M  I   + ++   H   I+H DLKP N+L ++ D     +
Sbjct: 174 FDRIIDESYNLTELDTILFMKQICEGIRHM---HQMYILHLDLKPENILCVNRDAKQIKI 230
Query: 868 SDFGMAK 874
            DFG+A+
Sbjct: 231 IDFGLAR 237

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 80/181 (44%), Gaps = 14/181 (7%)
Query: 725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIR 780
           +D +    ++G G FG V   + +  G E A+KV   +        E+   E +++K + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N++K+     +  +  LV E  + G L D + S       F  ++    I   L  + 
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGIT 140
Query: 841 FGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           + H   I+H DLKP N+LL+   +D    + DFG++        S      + T  Y+AP
Sbjct: 141 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGTAYYIAP 197
Query: 898 D 898
           +
Sbjct: 198 E 198

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 68/264 (25%), Positives = 114/264 (43%), Gaps = 36/264 (13%)
Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLK------SFEAECEVIKN 778
           D++     +G G F  V + R +  G E A K    +  S+ +        E E  +++ 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASA--- 835
           IRH N++ +     N     L+LE +S G L D L             ++  D A+    
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---------SLTEDEATQFLK 115
Query: 836 --LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH----LSDFGMAKLLSGEDESTMRTQTL 889
             L+ +H+ HS  I H DLKP N++L +  V +    L DFG+A  +   +E        
Sbjct: 116 QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIF 172
Query: 890 ATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIFSL 948
            T  ++AP+ +    L L+    D+  + ++  +   LLSG        K++ L +I ++
Sbjct: 173 GTPEFVAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGETKQETLTNISAV 226
Query: 949 ALECTMESPEKRID-AKDTITRLL 971
             +   E      + AKD I RLL
Sbjct: 227 NYDFDEEYFSNTSELAKDFIRRLL 250

>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 76/172 (44%)
Query: 446 LDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVI 505
           LDL  N++     DE      L EL+LN N +S        NL +L+ L L SNR   + 
Sbjct: 37  LDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIP 96
Query: 506 PSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQN 565
              F  L ++   DIS N +   +     +L  +  +++  N+L         GL SL+ 
Sbjct: 97  LGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQ 156
Query: 566 ISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLS 617
           ++L    L     E+  ++  L  L L +  I+     SF++L  LK L +S
Sbjct: 157 LTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEIS 208

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 90/189 (47%), Gaps = 11/189 (5%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---E 772
             +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +    E
Sbjct: 43  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDE 101
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  + I
Sbjct: 102 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 160
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 161 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 217
Query: 893 GYMAPDEIF 901
            +MA + I 
Sbjct: 218 KWMALESIL 226

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 12/178 (6%)
Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ---CASTLKSFEAECEVIKNIRH 781
           ++F    ++G G FG V   R +  G   A+K+   +       +     E  V++N RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             L  +  +    D    V+EY + G L   L           R     +I SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG-EDESTMRTQTLATIGYMAPD 898
             S  +++ D+K  N++LD+D    ++DFG+ K   G  D +TM+T    T  Y+AP+
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKT-FCGTPEYLAPE 175

>pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 5/160 (3%)
Query: 471 DLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPIS 530
           DL+ +KI   + S   + T L+ L L  N    +  + FW L  +L  ++S N L    S
Sbjct: 281 DLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDS 340
Query: 531 LAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESL 590
               NL  +  +DLS N++      +  GL +L+ ++L  N+L+      F  +TSL+ +
Sbjct: 341 RMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKI 400
Query: 591 DLSNNKISGSIPVSFEKLSYL-KELNLSFNKLKGEIPRGG 629
            L  N    S P    ++ YL + LN +  K +G     G
Sbjct: 401 WLHTNPWDCSCP----RIDYLSRWLNKNSQKEQGSAKCSG 436

>pdb|3O6N|A Chain A, Crystal Structure Of Apl1 Leucine-Rich Repeat Domain Length = 390

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 113/267 (42%), Gaps = 31/267 (11%)
Query: 384 LPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKL 443
           LP+++ +    +E LN+    I      A      +  L +G N +    P  F  +  L
Sbjct: 60  LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL 119
Query: 444 QGLDLAFNKLAGSIPDEICL-LSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFT 502
             L L  N L+ S+P  I     +L  L ++ N +           TSLQ L L SNR T
Sbjct: 120 TVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178
Query: 503 FV----IPSTF-----WNLKDILSFDI----------SSNLLDGPISLAIGNLKAVVGID 543
            V    IPS F     +NL   L+  I          S N++ GP+++ +  LK      
Sbjct: 179 HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILK------ 232
Query: 544 LSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPV 603
           L  NNL+      L     L  + L+YN LE  +   F  M  LE L +SNN++   + +
Sbjct: 233 LQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNL 289
Query: 604 SFEKLSYLKELNLSFNKLKGEIPRGGP 630
             + +  LK L+LS N L   + R  P
Sbjct: 290 YGQPIPTLKVLDLSHNHL-LHVERNQP 315

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 102 FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 155
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 204

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 12/138 (8%)
Query: 764 STLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNI 822
           +TLK    E ++++ +  H N++++  +   + F  LV + M  G L D L +    L+ 
Sbjct: 69  ATLK----EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSE 123
Query: 823 FCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES 882
                IM    + LE +   H   I+H DLKP N+LLD+DM   L+DFG +  L   D  
Sbjct: 124 KETRKIM---RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPG 177
Query: 883 TMRTQTLATIGYMAPDEI 900
               +   T  Y+AP+ I
Sbjct: 178 EKLREVCGTPSYLAPEII 195

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 12/138 (8%)
Query: 764 STLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNI 822
           +TLK    E ++++ +  H N++++  +   + F  LV + M  G L D L +    L+ 
Sbjct: 56  ATLK----EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSE 110
Query: 823 FCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES 882
                IM    + LE +   H   I+H DLKP N+LLD+DM   L+DFG +  L   D  
Sbjct: 111 KETRKIM---RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPG 164
Query: 883 TMRTQTLATIGYMAPDEI 900
               +   T  Y+AP+ I
Sbjct: 165 EKLREVCGTPSYLAPEII 182

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 92  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 146 ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPE 194

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 97  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+  + E      T  +AT  Y AP+
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPE 199

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 97  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+  + E      T  +AT  Y AP+
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPE 199

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 97  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+  + E      T  +AT  Y AP+
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPE 199

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 116/250 (46%), Gaps = 26/250 (10%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFE--AECEVIKNIRHRNLVKIISS 790
           +G G +G V   R +   VE AIK+      ST  + +   E  V+K + H N++K+   
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 791 CSNDDFKALVLEYMSNGSL-EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
             +     LV+E    G L ++ +H        F  ++  + I   L  + + H   I+H
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMK-----FNEVDAAVIIKQVLSGVTYLHKHNIVH 159
Query: 850 CDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELS 906
            DLKP N+LL   ++D +  + DFG++ +   E++  M+ + L T  Y+AP+        
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMK-ERLGTAYYIAPE-------V 209
Query: 907 LKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKR---IDA 963
           L++  ++   V  + V+   LL+G        +Q +L       + T +SPE +     A
Sbjct: 210 LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG-KYTFDSPEWKNVSEGA 268
Query: 964 KDTITRLLKI 973
           KD I ++L+ 
Sbjct: 269 KDLIKQMLQF 278

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRWYRAPE 192

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 27/182 (14%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI--RHRNLVKIISSC 791
           IG G +G V+  +   G ++A+KVF     +   S+  E E+ + +  RH N++  I++ 
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIAA- 99
Query: 792 SNDDFKA--------LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF-- 841
              D K         L+ +Y  NGSL D L S+   L+    L +     S L +LH   
Sbjct: 100 ---DIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 842 --GHSTPII-HCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDESTMRTQT-LATIGYMA 896
                 P I H DLK  N+L+ ++    ++D G+A K +S  +E  +   T + T  YM 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 897 PD 898
           P+
Sbjct: 215 PE 216

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 101 FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 154
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 155 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 203

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 96  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 150 ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPE 198

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 697 RGTMLSNDIILSSQPTIRRFSYFELLRATDNFAEN-NIIGIGGFGSVYRA-RLEDGVEIA 754
           RG+ +S +     +PT  R    + +       +N + +G G +GSV  A   + G+ +A
Sbjct: 17  RGSHMSQE-----RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVA 71
Query: 755 IKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDC 812
           +K       S +  K    E  ++K+++H N++ ++   +     A  LE  ++  L   
Sbjct: 72  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT----PARSLEEFNDVYL--V 125
Query: 813 LHSSNCALNIFCRLNIMID------IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH 866
            H     LN   +   + D      I   L  L + HS  IIH DLKPSN+ ++ED    
Sbjct: 126 THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK 185
Query: 867 LSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           + DFG+A+    E      T  +AT  Y AP+
Sbjct: 186 ILDFGLARHTDDE-----MTGYVATRWYRAPE 212

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 92  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 194

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 102 FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 155
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 204

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 102 FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 155
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 204

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 92  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 194

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 82/174 (47%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  +  ++ G++IA+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 119 FT----PATSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 172
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 173 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 221

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 86  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 188

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 88  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 141
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 142 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 190

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 697 RGTMLSNDIILSSQPTIRRFSYFELLRATDNFAEN-NIIGIGGFGSVYRA-RLEDGVEIA 754
           RG+ +S +     +PT  R    + +       +N + +G G +GSV  A   + G+ +A
Sbjct: 16  RGSHMSQE-----RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVA 70
Query: 755 IKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDC 812
           +K       S +  K    E  ++K+++H N++ ++   +     A  LE  ++  L   
Sbjct: 71  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT----PARSLEEFNDVYL--V 124
Query: 813 LHSSNCALNIFCRLNIMID------IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH 866
            H     LN   +   + D      I   L  L + HS  IIH DLKPSN+ ++ED    
Sbjct: 125 THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK 184
Query: 867 LSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           + DFG+A+    E      T  +AT  Y AP+
Sbjct: 185 ILDFGLARHTDDE-----MTGYVATRWYRAPE 211

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 113 FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 166
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 167 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 215

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 87  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 140
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 141 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 189

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 97  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 199

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 87  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 140
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 141 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 189

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 96  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 198

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 13/183 (7%)
Query: 727 NFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHP--QCASTLKSFEAECEVIKNIRHRN 783
           +F   +++G G +G V  A  +   EI AIK   P  +    L++   E +++K+ +H N
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHEN 70
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           ++ I +    D F+     Y+    ++  LH    +  +    +I   I   L  +   H
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRV-ISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL--SGEDESTMRTQT------LATIGYM 895
            + +IH DLKPSN+L++ +    + DFG+A+++  S  D S    Q       +AT  Y 
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189
Query: 896 APD 898
           AP+
Sbjct: 190 APE 192

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 92  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 194

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 95  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 149 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 197

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 95  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 149 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 197

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 89  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 142
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 143 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 191

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 90/189 (47%), Gaps = 11/189 (5%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---E 772
             +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+ ++ + ++ +++  C     + L+++ M  G L D +      +     LN  + I
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           A  + YL       ++H DL   NVL+       ++DFG AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 893 GYMAPDEIF 901
            +MA + I 
Sbjct: 186 KWMALESIL 194

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 90/189 (47%), Gaps = 11/189 (5%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---E 772
             +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+ ++ + ++ +++  C     + L+++ M  G L D +      +     LN  + I
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           A  + YL       ++H DL   NVL+       ++DFG AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 893 GYMAPDEIF 901
            +MA + I 
Sbjct: 186 KWMALESIL 194

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 99/229 (43%), Gaps = 38/229 (16%)
Query: 713 IRRFSY---FELLRATDNFAENNIIGIGGFGSVYRA------RLEDGVEIAIKVFHPQC- 762
            R + Y   +E  R  +N     ++G G FG V  A      +    +++A+K+   +  
Sbjct: 31  FREYEYDLKWEFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD 88
Query: 763 ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYMSNGSL------------ 809
           +S  ++  +E +++  +  H N+V ++ +C+      L+ EY   G L            
Sbjct: 89  SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFS 148
Query: 810 EDCLHSSNCA-------LNIFCRLNIM---IDIASALEYLHFGHSTPIIHCDLKPSNVLL 859
           ED +   N         LN+    +++     +A  +E+L F      +H DL   NVL+
Sbjct: 149 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLV 205
Query: 860 DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
               V  + DFG+A+ +  +    +R      + +MAP+ +F G  ++K
Sbjct: 206 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 254

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 90/189 (47%), Gaps = 11/189 (5%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---E 772
             +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +    E
Sbjct: 13  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 71
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+ ++ + ++ +++  C     + L+++ M  G L D +      +     LN  + I
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 130
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           A  + YL       ++H DL   NVL+       ++DFG AKLL  E++          I
Sbjct: 131 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 187
Query: 893 GYMAPDEIF 901
            +MA + I 
Sbjct: 188 KWMALESIL 196

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 24/178 (13%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRN--LVKIIS 789
           IG GG   V++   E     AIK  + + A   TL S+  E   +  ++  +  ++++  
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID-------IASALEYLHFG 842
               D +  +V+E         C    N  LN + +    ID         + LE +H  
Sbjct: 77  YEITDQYIYMVME---------C---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H DLKP+N L+ + M+  L DFG+A  +  +  S ++   + T+ YM P+ I
Sbjct: 125 HQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 60/256 (23%), Positives = 97/256 (37%), Gaps = 41/256 (16%)
Query: 734 IGIGGFGSVYRARLE----DGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHRNLVK 786
           +G G FG V R   +      V +A+K   P   S    +  F  E   + ++ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCL--HSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           +         K +V E    GSL D L  H  +  L    R    + +A  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 139
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAPDEIFVG 903
              IH DL   N+LL    +  + DFG+ + L   +D   M+        + AP+ +   
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 904 ELS-------------------LKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLS 944
             S                    + W+  L    ++  +DK     E +     E C   
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDK-----EGERLPRPEDCPQD 253
Query: 945 IFSLALECTMESPEKR 960
           I+++ ++C    PE R
Sbjct: 254 IYNVMVQCWAHKPEDR 269

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 42/171 (24%), Positives = 78/171 (45%), Gaps = 16/171 (9%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQ------CASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G VY+A+   G   A+K    +       ++T++    E  ++K ++H N+VK+
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKELKHSNIVKL 65
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
                      LV E++    L+  L      L      + ++ + + + Y H      +
Sbjct: 66  YDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           +H DLKP N+L++ +    ++DFG+A+           T  + T+ Y APD
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPD 170

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 12/138 (8%)
Query: 764 STLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNI 822
           +TLK    E ++++ +  H N++++  +   + F  LV + M  G L D L +    L+ 
Sbjct: 69  ATLK----EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSE 123
Query: 823 FCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES 882
                IM    + LE +   H   I+H DLKP N+LLD+DM   L+DFG +  L   D  
Sbjct: 124 KETRKIM---RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPG 177
Query: 883 TMRTQTLATIGYMAPDEI 900
                   T  Y+AP+ I
Sbjct: 178 EKLRSVCGTPSYLAPEII 195

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 90/189 (47%), Gaps = 11/189 (5%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---E 772
             +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +    E
Sbjct: 16  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  + I
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 893 GYMAPDEIF 901
            +MA + I 
Sbjct: 191 KWMALESIL 199

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 60/256 (23%), Positives = 97/256 (37%), Gaps = 41/256 (16%)
Query: 734 IGIGGFGSVYRARLE----DGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHRNLVK 786
           +G G FG V R   +      V +A+K   P   S    +  F  E   + ++ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCL--HSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           +         K +V E    GSL D L  H  +  L    R    + +A  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 129
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAPDEIFVG 903
              IH DL   N+LL    +  + DFG+ + L   +D   M+        + AP+ +   
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 904 ELS-------------------LKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLS 944
             S                    + W+  L    ++  +DK     E +     E C   
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDK-----EGERLPRPEDCPQD 243
Query: 945 IFSLALECTMESPEKR 960
           I+++ ++C    PE R
Sbjct: 244 IYNVMVQCWAHKPEDR 259

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 84/183 (45%), Gaps = 14/183 (7%)
Query: 723 RATDNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNI 779
           R T+ +     +G G F  V R  ++  G E A  + + +   A   +  E E  + + +
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSL-EDCLHSSNCALNIFCRLNIMIDIASALEY 838
           +H N+V++  S S +    L+ + ++ G L ED +     A   +   +    I   LE 
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV-----AREYYSEADASHCIQQILEA 122
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDM---VAHLSDFGMAKLLSGEDESTMRTQTLATIGYM 895
           +   H   ++H +LKP N+LL   +      L+DFG+A  + GE ++        T GY+
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--GFAGTPGYL 180
Query: 896 APD 898
           +P+
Sbjct: 181 SPE 183

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 90/189 (47%), Gaps = 11/189 (5%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---E 772
             +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  + I
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 893 GYMAPDEIF 901
            +MA + I 
Sbjct: 186 KWMALESIL 194

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 90/189 (47%), Gaps = 11/189 (5%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---E 772
             +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  + I
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 893 GYMAPDEIF 901
            +MA + I 
Sbjct: 187 KWMALESIL 195

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 90/189 (47%), Gaps = 11/189 (5%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---E 772
             +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +    E
Sbjct: 15  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 73
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  + I
Sbjct: 74  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 132
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 133 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 189
Query: 893 GYMAPDEIF 901
            +MA + I 
Sbjct: 190 KWMALESIL 198

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 25/197 (12%)
Query: 727 NFAENNI-----IGIGGFGSVYRARL-----EDGV-EIAIKVFHPQC-ASTLKSFEAECE 774
            F  NN+     +G G FG V  A       ED V ++A+K+      A   ++  +E +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 775 VIKNI-RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA---------LNIFC 824
           ++ ++ +H N+V ++ +C++     ++ EY   G L + L     A         L +  
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 161
Query: 825 RLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
            L+    +A  + +L    S   IH D+   NVLL    VA + DFG+A+ +  +    +
Sbjct: 162 LLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 218
Query: 885 RTQTLATIGYMAPDEIF 901
           +      + +MAP+ IF
Sbjct: 219 KGNARLPVKWMAPESIF 235

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 90/189 (47%), Gaps = 11/189 (5%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---E 772
             +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  + I
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 893 GYMAPDEIF 901
            +MA + I 
Sbjct: 187 KWMALESIL 195

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 69/272 (25%), Positives = 117/272 (43%), Gaps = 37/272 (13%)
Query: 718 YFELLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLK------SFE 770
           YF+ +   D++     +G G F  V + R +  G E A K    +   + +        E
Sbjct: 19  YFQSM-VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIE 77
Query: 771 AECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
            E  +++ IRH N++ +     N     L+LE +S G L D L             ++  
Sbjct: 78  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---------SLTE 128
Query: 831 DIASA-----LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH----LSDFGMAKLLSGEDE 881
           D A+      L+ +H+ HS  I H DLKP N++L +  V +    L DFG+A  +   +E
Sbjct: 129 DEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 188
Query: 882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQ 940
                    T  ++AP+ +    L L+    D+  + ++  +   LLSG        K++
Sbjct: 189 F---KNIFGTPEFVAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGETKQE 239
Query: 941 CLLSIFSLALECTMESPEKRID-AKDTITRLL 971
            L +I ++  +   E      + AKD I RLL
Sbjct: 240 TLTNISAVNYDFDEEYFSNTSELAKDFIRRLL 271

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 90/189 (47%), Gaps = 11/189 (5%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---E 772
             +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  + I
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 893 GYMAPDEIF 901
            +MA + I 
Sbjct: 187 KWMALESIL 195

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 90/187 (48%), Gaps = 11/187 (5%)
Query: 721 LLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---ECE 774
           +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +    E  
Sbjct: 36  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 94
Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  + IA 
Sbjct: 95  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 153
Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY 894
            + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I +
Sbjct: 154 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 210
Query: 895 MAPDEIF 901
           MA + I 
Sbjct: 211 MALESIL 217

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 88/189 (46%), Gaps = 17/189 (8%)
Query: 712 TIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEA 771
           T+  F Y +LL     F +  ++     G  Y  ++   ++  + V   + A TL     
Sbjct: 146 TMNEFEYLKLL-GKGTFGKVILVKEKATGRYYAMKI---LKKEVIVAKDEVAHTL----T 197
Query: 772 ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM-I 830
           E  V++N RH  L  +  S    D    V+EY + G L    H S   +    R      
Sbjct: 198 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 255
Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG-EDESTMRTQTL 889
           +I SAL+YLH      +++ DLK  N++LD+D    ++DFG+ K   G +D +TM+T   
Sbjct: 256 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKT-FC 310
Query: 890 ATIGYMAPD 898
            T  Y+AP+
Sbjct: 311 GTPEYLAPE 319

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 88/189 (46%), Gaps = 17/189 (8%)
Query: 712 TIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEA 771
           T+  F Y +LL     F +  ++     G  Y  ++   ++  + V   + A TL     
Sbjct: 149 TMNEFEYLKLL-GKGTFGKVILVKEKATGRYYAMKI---LKKEVIVAKDEVAHTL----T 200
Query: 772 ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM-I 830
           E  V++N RH  L  +  S    D    V+EY + G L    H S   +    R      
Sbjct: 201 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 258
Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG-EDESTMRTQTL 889
           +I SAL+YLH      +++ DLK  N++LD+D    ++DFG+ K   G +D +TM+T   
Sbjct: 259 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKT-FC 313
Query: 890 ATIGYMAPD 898
            T  Y+AP+
Sbjct: 314 GTPEYLAPE 322

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 37/139 (26%), Positives = 61/139 (43%), Gaps = 18/139 (12%)
Query: 767 KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL 826
           ++ + E  + K + H N+VK        + + L LEY S G L D +             
Sbjct: 49  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----------- 97
Query: 827 NIMIDIASALEYLH-------FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE 879
           +I +    A  + H       + H   I H D+KP N+LLDE     +SDFG+A +    
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 157
Query: 880 DESTMRTQTLATIGYMAPD 898
           +   +  +   T+ Y+AP+
Sbjct: 158 NRERLLNKMCGTLPYVAPE 176

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 42/171 (24%), Positives = 78/171 (45%), Gaps = 16/171 (9%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQ------CASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G VY+A+   G   A+K    +       ++T++    E  ++K ++H N+VK+
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKELKHSNIVKL 65
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
                      LV E++    L+  L      L      + ++ + + + Y H      +
Sbjct: 66  YDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           +H DLKP N+L++ +    ++DFG+A+           T  + T+ Y APD
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPD 170

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 42/171 (24%), Positives = 78/171 (45%), Gaps = 16/171 (9%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQ------CASTLKSFEAECEVIKNIRHRNLVKI 787
           IG G +G VY+A+   G   A+K    +       ++T++    E  ++K ++H N+VK+
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKELKHSNIVKL 65
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
                      LV E++    L+  L      L      + ++ + + + Y H      +
Sbjct: 66  YDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           +H DLKP N+L++ +    ++DFG+A+           T  + T+ Y APD
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPD 170

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 46/191 (24%), Positives = 92/191 (48%), Gaps = 11/191 (5%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDG--VEIAIKVFHPQCASTLKSFEA-- 771
           +   +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +   
Sbjct: 8   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 66
Query: 772 -ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
            E  V+ ++ + ++ +++  C     + L+++ M  G L D +      +     LN  +
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCV 125
Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            IA  + YL       ++H DL   NVL+       ++DFG+AKLL  E++         
Sbjct: 126 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182
Query: 891 TIGYMAPDEIF 901
            I +MA + I 
Sbjct: 183 PIKWMALESIL 193

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 90/189 (47%), Gaps = 11/189 (5%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---E 772
             +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +    E
Sbjct: 19  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 77
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  + I
Sbjct: 78  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 136
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 137 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 193
Query: 893 GYMAPDEIF 901
            +MA + I 
Sbjct: 194 KWMALESIL 202

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 12/190 (6%)
Query: 715 RFSYFELLRATDN-FAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEA-- 771
           ++ + E    T N F +  ++G GGFG V   ++    ++       +     +  EA  
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 772 --ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLE-DCLHSSNCALNIFCRLNI 828
             E ++++ +  R +V +  +    D   LVL  M+ G L+    H           +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
             +I   LE LH      I++ DLKP N+LLD+     +SD G+A  +    E       
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGR 345
Query: 889 LATIGYMAPD 898
           + T+GYMAP+
Sbjct: 346 VGTVGYMAPE 355

>pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 133/516 (25%), Positives = 217/516 (42%), Gaps = 86/516 (16%)
Query: 187 PSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDV 246
           P++ ++  QL  L  G+N++S   P+    L +L+ ++L +N+L     Q   +  NL  
Sbjct: 42  PTNFTRYSQLAILDAGFNSISKLEPELCQILPLLKVLNLQHNELSQISDQTFVFCTNLTE 101
Query: 247 LQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGS----------------LPSRIDLAL 290
           L L  N++  +      N   L ++ L +N LS +                  ++I LAL
Sbjct: 102 LDLMSNSIHKIKSNPFKNQKNLIKLDLSHNGLSSTKLGTGVQLENLQELLLAKNKI-LAL 160
Query: 291 PNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNN 350
            + E   LG               S L  L++ SN    F P     +   KLF +  NN
Sbjct: 161 RSEELEFLG--------------NSSLRKLDLSSNPLKEFSPGCFQTIG--KLFALLLNN 204
Query: 351 LTSSTPEL--GFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLS-LERLNIAFCNISG 407
                P L       L+N   ++ L L  N L     S+   L  + L +L++++ N+  
Sbjct: 205 -AQLNPHLTEKLCWELSNT-SIQNLSLANNQLLATSESTFSGLKWTNLTQLDLSYNNLHD 262
Query: 408 NIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDL--AFNKLAGSIPDE----- 460
               +   L +L  LSL  NN+    P +F GL  L+ L L  AF K + S+        
Sbjct: 263 VGNGSFSYLPSLRYLSLEYNNIQRLSPRSFYGLSNLRYLSLKRAFTKQSVSLASHPNIDD 322
Query: 461 --ICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFT---FVIPSTFWNLKD- 514
                L  L  L+++ N I  + S+    L SL+YL+L S  FT    +   TF +L   
Sbjct: 323 FSFQWLKYLEYLNMDDNNIPSTKSNTFTGLVSLKYLSL-SKTFTSLQTLTNETFVSLAHS 381
Query: 515 -ILSFDISSN----LLDGPISLAIGNLKAV-VGIDLSRNNLSGNIPTTLEGLKSLQNISL 568
            +L+ +++ N    + +G  S  +G L+ + +G++     LSG       GL+++  I L
Sbjct: 382 PLLTLNLTKNHISKIANGTFSW-LGQLRILDLGLNEIEQKLSGQ---EWRGLRNIFEIYL 437
Query: 569 AYNRLEGPIPESFGNMTSLESL-----DLSNNKISGSIPVSFEKLSYLKELNLSFNKLKG 623
           +YN+       SF  + SL+ L      L N  IS   P  F  L  L  L+LS N +  
Sbjct: 438 SYNKYLQLSTSSFALVPSLQRLMLRRVALKNVDIS---PSPFRPLRNLTILDLSNNNIAN 494
Query: 624 EIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKHS 659
                           +  +LL GL NL++   +H+
Sbjct: 495 ----------------INEDLLEGLENLEILDFQHN 514

>pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 115/293 (39%), Gaps = 67/293 (22%)
Query: 397 RLNIAFC------NISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAF 450
           R N+A C      +I  ++P      SN+ VL+L  N L    P  F    +L  LD  F
Sbjct: 5   RYNVADCSHLKLTHIPDDLP------SNITVLNLTHNQLRRLPPTNFTRYSQLAILDAGF 58
Query: 451 NKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFW 510
           N ++   P+   +L  L  L+L  N++S          T+L  L+L SN    +  + F 
Sbjct: 59  NSISKLEPELCQILPLLKVLNLQHNELSQISDQTFVFCTNLTELDLMSNSIHKIKSNPFK 118
Query: 511 NLKDILSFDISSNLLDGP---------------------ISLAIGNLK-----AVVGIDL 544
           N K+++  D+S N L                        ++L    L+     ++  +DL
Sbjct: 119 NQKNLIKLDLSHNGLSSTKLGTGVQLENLQELLLAKNKILALRSEELEFLGNSSLRKLDL 178
Query: 545 SRNNLSGNIPTTLEGL---------------------------KSLQNISLAYNRLEGPI 577
           S N L    P   + +                            S+QN+SLA N+L    
Sbjct: 179 SSNPLKEFSPGCFQTIGKLFALLLNNAQLNPHLTEKLCWELSNTSIQNLSLANNQLLATS 238
Query: 578 PESFGNM--TSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRG 628
             +F  +  T+L  LDLS N +      SF  L  L+ L+L +N ++   PR 
Sbjct: 239 ESTFSGLKWTNLTQLDLSYNNLHDVGNGSFSYLPSLRYLSLEYNNIQRLSPRS 291

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 46/191 (24%), Positives = 92/191 (48%), Gaps = 11/191 (5%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDG--VEIAIKVFHPQCASTLKSFEA-- 771
           +   +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +   
Sbjct: 8   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 66
Query: 772 -ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
            E  V+ ++ + ++ +++  C     + L+++ M  G L D +      +     LN  +
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV 125
Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            IA  + YL       ++H DL   NVL+       ++DFG+AKLL  E++         
Sbjct: 126 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182
Query: 891 TIGYMAPDEIF 901
            I +MA + I 
Sbjct: 183 PIKWMALESIL 193

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 46/191 (24%), Positives = 92/191 (48%), Gaps = 11/191 (5%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDG--VEIAIKVFHPQCASTLKSFEA-- 771
           +   +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +   
Sbjct: 7   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 772 -ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
            E  V+ ++ + ++ +++  C     + L+++ M  G L D +      +     LN  +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            IA  + YL       ++H DL   NVL+       ++DFG+AKLL  E++         
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 891 TIGYMAPDEIF 901
            I +MA + I 
Sbjct: 182 PIKWMALESIL 192

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 60/256 (23%), Positives = 97/256 (37%), Gaps = 41/256 (16%)
Query: 734 IGIGGFGSVYRARLE----DGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHRNLVK 786
           +G G FG V R   +      V +A+K   P   S    +  F  E   + ++ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCL--HSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           +         K +V E    GSL D L  H  +  L    R    + +A  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 133
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAPDEIFVG 903
              IH DL   N+LL    +  + DFG+ + L   +D   M+        + AP+ +   
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 904 ELS-------------------LKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLS 944
             S                    + W+  L    ++  +DK     E +     E C   
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDK-----EGERLPRPEDCPQD 247
Query: 945 IFSLALECTMESPEKR 960
           I+++ ++C    PE R
Sbjct: 248 IYNVMVQCWAHKPEDR 263

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 60/256 (23%), Positives = 97/256 (37%), Gaps = 41/256 (16%)
Query: 734 IGIGGFGSVYRARLE----DGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHRNLVK 786
           +G G FG V R   +      V +A+K   P   S    +  F  E   + ++ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCL--HSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           +         K +V E    GSL D L  H  +  L    R    + +A  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 129
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAPDEIFVG 903
              IH DL   N+LL    +  + DFG+ + L   +D   M+        + AP+ +   
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 904 ELS-------------------LKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLS 944
             S                    + W+  L    ++  +DK     E +     E C   
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDK-----EGERLPRPEDCPQD 243
Query: 945 IFSLALECTMESPEKR 960
           I+++ ++C    PE R
Sbjct: 244 IYNVMVQCWAHKPEDR 259

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 60/256 (23%), Positives = 97/256 (37%), Gaps = 41/256 (16%)
Query: 734 IGIGGFGSVYRARLE----DGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHRNLVK 786
           +G G FG V R   +      V +A+K   P   S    +  F  E   + ++ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCL--HSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           +         K +V E    GSL D L  H  +  L    R    + +A  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 139
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAPDEIFVG 903
              IH DL   N+LL    +  + DFG+ + L   +D   M+        + AP+ +   
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 904 ELS-------------------LKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLS 944
             S                    + W+  L    ++  +DK     E +     E C   
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDK-----EGERLPRPEDCPQD 253
Query: 945 IFSLALECTMESPEKR 960
           I+++ ++C    PE R
Sbjct: 254 IYNVMVQCWAHKPEDR 269

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 96  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 198

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 49/183 (26%), Positives = 88/183 (48%), Gaps = 12/183 (6%)
Query: 734 IGIGGFGSVYRARLEDGVEI-AIKV--FHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           IG G +G+V++A+  +  EI A+K             S   E  ++K ++H+N+V++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHC 850
             +D    LV E+  +  L+    S N  L+     + +  +   L+ L F HS  ++H 
Sbjct: 70  LHSDKKLTLVFEF-CDQDLKKYFDSCNGDLDPEIVKSFLFQL---LKGLGFCHSRNVLHR 125
Query: 851 DLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGEL---SL 907
           DLKP N+L++ +    L+DFG+A+           +  + T+ Y  PD +F  +L   S+
Sbjct: 126 DLKPQNLLINRNGELKLADFGLARAFG--IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 908 KRW 910
             W
Sbjct: 184 DMW 186

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 60/256 (23%), Positives = 97/256 (37%), Gaps = 41/256 (16%)
Query: 734 IGIGGFGSVYRARLE----DGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHRNLVK 786
           +G G FG V R   +      V +A+K   P   S    +  F  E   + ++ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCL--HSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           +         K +V E    GSL D L  H  +  L    R    + +A  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 129
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAPDEIFVG 903
              IH DL   N+LL    +  + DFG+ + L   +D   M+        + AP+ +   
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 904 ELS-------------------LKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLS 944
             S                    + W+  L    ++  +DK     E +     E C   
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDK-----EGERLPRPEDCPQD 243
Query: 945 IFSLALECTMESPEKR 960
           I+++ ++C    PE R
Sbjct: 244 IYNVMVQCWAHKPEDR 259

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 24/178 (13%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRN--LVKIIS 789
           IG GG   V++   E     AIK  + + A   TL S+  E   +  ++  +  ++++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID-------IASALEYLHFG 842
               D +  +V+E         C    N  LN + +    ID         + LE +H  
Sbjct: 124 YEITDQYIYMVME---------C---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H DLKP+N L+ + M+  L DFG+A  +  +  S ++   + T+ YM P+ I
Sbjct: 172 HQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 17/194 (8%)
Query: 707 LSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTL 766
           L S+ T+  F Y +LL     F +  ++     G  Y  ++   ++  + V   + A TL
Sbjct: 1   LGSRVTMNEFEYLKLL-GKGTFGKVILVKEKATGRYYAMKI---LKKEVIVAKDEVAHTL 56
Query: 767 KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL 826
                E  V++N RH  L  +  S    D    V+EY + G L    H S   +    R 
Sbjct: 57  ----TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRA 110
Query: 827 NIM-IDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG-EDESTM 884
                +I SAL+YLH      +++ DLK  N++LD+D    ++DFG+ K   G +D +TM
Sbjct: 111 RFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATM 166
Query: 885 RTQTLATIGYMAPD 898
           +     T  Y+AP+
Sbjct: 167 KX-FCGTPEYLAPE 179

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 81/186 (43%), Gaps = 16/186 (8%)
Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFEAECEVIKN------ 778
           ++F  + ++G G FG V+ A  +   +  AIK         L   + EC +++       
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV--VLMDDDVECTMVEKRVLSLA 75
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
             H  L  +  +    +    V+EY++ G L    H  +C      R       A  +  
Sbjct: 76  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYA--AEIILG 131
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           L F HS  I++ DLK  N+LLD+D    ++DFGM K     D  T   +   T  Y+AP 
Sbjct: 132 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NEFCGTPDYIAP- 188
Query: 899 EIFVGE 904
           EI +G+
Sbjct: 189 EILLGQ 194

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 51/176 (28%), Positives = 82/176 (46%), Gaps = 11/176 (6%)
Query: 728 FAENNIIGIGGFGSVYRARLEDGVE--IAIKVFH-PQCASTLKSFEAECEVIKNIRHRNL 784
           F +   IG G FG V++  +++  +  +AIK+    +    ++  + E  V+       +
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            K   S   D    +++EY+  GS  D L      L+      I+ +I   L+YLH   S
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---S 122
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
              IH D+K +NVLL E     L+DFG+A  L+  D    R   + T  +MAP+ I
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVI 176

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 51/176 (28%), Positives = 82/176 (46%), Gaps = 11/176 (6%)
Query: 728 FAENNIIGIGGFGSVYRARLEDGVE--IAIKVFH-PQCASTLKSFEAECEVIKNIRHRNL 784
           F +   IG G FG V++  +++  +  +AIK+    +    ++  + E  V+       +
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            K   S   D    +++EY+  GS  D L      L+      I+ +I   L+YLH   S
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---S 122
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
              IH D+K +NVLL E     L+DFG+A  L+  D    R   + T  +MAP+ I
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 176

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + D+G+A+    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTGYVATRWYRAPE 192

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 51/176 (28%), Positives = 82/176 (46%), Gaps = 11/176 (6%)
Query: 728 FAENNIIGIGGFGSVYRARLEDGVE--IAIKVFH-PQCASTLKSFEAECEVIKNIRHRNL 784
           F +   IG G FG V++  +++  +  +AIK+    +    ++  + E  V+       +
Sbjct: 24  FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            K   S   D    +++EY+  GS  D L      L+      I+ +I   L+YLH   S
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---S 137
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
              IH D+K +NVLL E     L+DFG+A  L+  D    R   + T  +MAP+ I
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVI 191

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 47/168 (27%), Positives = 79/168 (47%), Gaps = 8/168 (4%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           IG G  G V  A     G ++A+K    +     +    E  ++++  H N+V + SS  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
             D   +V+E++  G+L D +  ++  +N      + + +  AL YLH   +  +IH D+
Sbjct: 113 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDI 167
Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           K  ++LL  D    LSDFG    +S   E   R   + T  +MAP+ I
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVS--KEVPKRKXLVGTPYWMAPEVI 213

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 14/181 (7%)
Query: 725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIR 780
           +D +    ++G G FG V   + +  G E A+KV   +     +  +S   E +++K + 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N++K+     +  +  LV E  + G L D + S       F  ++    I   L  + 
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGIT 146
Query: 841 FGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           + H   I+H DLKP N+LL+   +D    + DFG++     E    M+ + + T  Y+AP
Sbjct: 147 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDK-IGTAYYIAP 203
Query: 898 D 898
           +
Sbjct: 204 E 204

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 22/175 (12%)
Query: 734 IGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G V  A     E+ V + I V   +     ++ + E  +   + H N+VK    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-------FGH 843
               + + L LEY S G L D +             +I +    A  + H       + H
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 12/190 (6%)
Query: 715 RFSYFELLRATDN-FAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEA-- 771
           ++ + E    T N F +  ++G GGFG V   ++    ++       +     +  EA  
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 772 --ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLE-DCLHSSNCALNIFCRLNI 828
             E ++++ +  R +V +  +    D   LVL  M+ G L+    H           +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
             +I   LE LH      I++ DLKP N+LLD+     +SD G+A  +    E       
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGR 345
Query: 889 LATIGYMAPD 898
           + T+GYMAP+
Sbjct: 346 VGTVGYMAPE 355

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 697 RGTMLSNDIILSSQPTIRRFSYFELLRATDNFAEN-NIIGIGGFGSVYRA-RLEDGVEIA 754
           RG+ +S +     +PT  R    + +       +N + +G G +GSV  A   + G  +A
Sbjct: 17  RGSHMSQE-----RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVA 71
Query: 755 IKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDC 812
           +K       S +  K    E  ++K+++H N++ ++   +     A  LE  ++  L   
Sbjct: 72  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT----PARSLEEFNDVYL--V 125
Query: 813 LHSSNCALNIFCRLNIMID------IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH 866
            H     LN   +   + D      I   L  L + HS  IIH DLKPSN+ ++ED    
Sbjct: 126 THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK 185
Query: 867 LSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           + DFG+A+    E      T  +AT  Y AP+
Sbjct: 186 ILDFGLARHTDDE-----MTGYVATRWYRAPE 212

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 697 RGTMLSNDIILSSQPTIRRFSYFELLRATDNFAEN-NIIGIGGFGSVYRA-RLEDGVEIA 754
           RG+ +S +     +PT  R    + +       +N + +G G +GSV  A   + G  +A
Sbjct: 16  RGSHMSQE-----RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVA 70
Query: 755 IKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDC 812
           +K       S +  K    E  ++K+++H N++ ++   +     A  LE  ++  L   
Sbjct: 71  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT----PARSLEEFNDVYL--V 124
Query: 813 LHSSNCALNIFCRLNIMID------IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH 866
            H     LN   +   + D      I   L  L + HS  IIH DLKPSN+ ++ED    
Sbjct: 125 THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK 184
Query: 867 LSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           + DFG+A+    E      T  +AT  Y AP+
Sbjct: 185 ILDFGLARHTDDE-----MTGYVATRWYRAPE 211

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 12/179 (6%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKV-FHPQCAS--TLKSFEAECEVIKNIRH 781
           D+F     +G G FG+VY AR  ++   +A+KV F  Q            E E+  ++RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
            N++++ +   +     L+LE+   G L   L       +       M ++A AL   H+
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADAL---HY 130
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            H   +IH D+KP N+L+       ++DFG     S    S  R     T+ Y+ P+ I
Sbjct: 131 CHERKVIHRDIKPENLLMGYKGELKIADFGW----SVHAPSLRRRXMCGTLDYLPPEMI 185

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 31/205 (15%)
Query: 723 RATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFH-PQCASTLKSFEAECEVIKNIR 780
           R   +F     +G GGFG V+ A+ + D    AIK    P      +    E + +  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 781 H------------RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR--- 825
           H            +N  + +   S   +  + ++     +L+D + +  C +    R   
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM-NGRCTIEERERSVC 120
Query: 826 LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTM 884
           L+I + IA A+E+LH   S  ++H DLKPSN+    D V  + DFG+   +   E+E T+
Sbjct: 121 LHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 885 ---------RTQTLATIGYMAPDEI 900
                     T  + T  YM+P++I
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQI 202

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 12/171 (7%)
Query: 733 IIGIGGFGSVYRARLEDGVEIAIKVFHPQC----ASTLKSFEAECEVIKNIRHRNLVKII 788
            +G GGF   +     D  E+      P+         +    E  + +++ H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
               ++DF  +VLE     SL + LH    AL        +  I    +YLH      +I
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 139
Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPD 898
           H DLK  N+ L+ED+   + DFG+A  +  + E   R +TL  T  Y+AP+
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKTLCGTPNYIAPE 187

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 12/171 (7%)
Query: 733 IIGIGGFGSVYRARLEDGVEIAIKVFHPQC----ASTLKSFEAECEVIKNIRHRNLVKII 788
            +G GGF   +     D  E+      P+         +    E  + +++ H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
               ++DF  +VLE     SL + LH    AL        +  I    +YLH      +I
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 139
Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPD 898
           H DLK  N+ L+ED+   + DFG+A  +  + E   R +TL  T  Y+AP+
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKTLCGTPNYIAPE 187

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 100/246 (40%), Gaps = 25/246 (10%)
Query: 694 RGKRGTMLSN------DIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYR-AR 746
           RGK GT+ SN      DI     P      +  +L   D++  +  +G G FG V+R   
Sbjct: 123 RGK-GTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTE 178
Query: 747 LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSN 806
              G   A K       S  ++   E + +  +RH  LV +  +  +D+   ++ E+MS 
Sbjct: 179 RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238
Query: 807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH 866
           G L + +   +  ++    +  M  +   L ++   H    +H DLKP N++        
Sbjct: 239 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNE 295
Query: 867 LS--DFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD 924
           L   DFG+   L   D       T  T  + AP+   V E     +  D+  V ++  + 
Sbjct: 296 LKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPE---VAEGKPVGYYTDMWSVGVLSYI- 348
Query: 925 KSLLSG 930
             LLSG
Sbjct: 349 --LLSG 352

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G  +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 86  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 188

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 12/171 (7%)
Query: 733 IIGIGGFGSVYRARLEDGVEIAIKVFHPQC----ASTLKSFEAECEVIKNIRHRNLVKII 788
            +G GGF   +     D  E+      P+         +    E  + +++ H+++V   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
               ++DF  +VLE     SL + LH    AL        +  I    +YLH      +I
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 143
Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPD 898
           H DLK  N+ L+ED+   + DFG+A  +  + E   R +TL  T  Y+AP+
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKTLCGTPNYIAPE 191

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 89/189 (47%), Gaps = 11/189 (5%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---E 772
             +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +    E
Sbjct: 16  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  + I
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           A  + YL       ++H DL   NVL+       ++DFG AKLL  E++          I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 190
Query: 893 GYMAPDEIF 901
            +MA + I 
Sbjct: 191 KWMALESIL 199

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G  +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 24/178 (13%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRN--LVKIIS 789
           IG GG   V++   E     AIK  + + A   TL S+  E   +  ++  +  ++++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID-------IASALEYLHFG 842
               D +  +V+E         C    N  LN + +    ID         + LE +H  
Sbjct: 124 YEITDQYIYMVME---------C---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H DLKP+N L+ + M+  L DFG+A  +  +  S ++   + T+ YM P+ I
Sbjct: 172 HQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 100/246 (40%), Gaps = 25/246 (10%)
Query: 694 RGKRGTMLSN------DIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYR-AR 746
           RGK GT+ SN      DI     P      +  +L   D++  +  +G G FG V+R   
Sbjct: 17  RGK-GTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTE 72
Query: 747 LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSN 806
              G   A K       S  ++   E + +  +RH  LV +  +  +D+   ++ E+MS 
Sbjct: 73  RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 132
Query: 807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH 866
           G L + +   +  ++    +  M  +   L ++   H    +H DLKP N++        
Sbjct: 133 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNE 189
Query: 867 LS--DFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD 924
           L   DFG+   L   D       T  T  + AP+   V E     +  D+  V ++  + 
Sbjct: 190 LKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPE---VAEGKPVGYYTDMWSVGVLSYI- 242
Query: 925 KSLLSG 930
             LLSG
Sbjct: 243 --LLSG 246

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 11/176 (6%)
Query: 728 FAENNIIGIGGFGSVYRARLEDGVE--IAIKVFH-PQCASTLKSFEAECEVIKNIRHRNL 784
           F +   IG G FG V++  +++  +  +AIK+    +    ++  + E  V+       +
Sbjct: 25  FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYV 83
Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            K   S        +++EY+  GS  D L +     + F    ++ +I   L+YLH   S
Sbjct: 84  TKYYGSYLKGSKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---S 138
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
              IH D+K +NVLL E     L+DFG+A  L+  D    R   + T  +MAP+ I
Sbjct: 139 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 192

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G  +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 100 FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 153
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 154 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 202

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 89/189 (47%), Gaps = 11/189 (5%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---E 772
             +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  + I
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           A  + YL       ++H DL   NVL+       ++DFG AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 893 GYMAPDEIF 901
            +MA + I 
Sbjct: 186 KWMALESIL 194

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/189 (23%), Positives = 89/189 (47%), Gaps = 24/189 (12%)
Query: 716 FSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVF----HPQCASTLKSFEA 771
           + Y+++L           +G G FG V+R   +    + +  F    +P    T+K+   
Sbjct: 50  YDYYDILEE---------LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN--- 97
Query: 772 ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID 831
           E  ++  + H  L+ +  +  +     L+LE++S G L D + + +  ++    +N M  
Sbjct: 98  EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 157
Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLS--DFGMAKLLSGEDESTMRTQTL 889
               L+++H  HS  I+H D+KP N++ +    + +   DFG+A  L+ ++   +   T 
Sbjct: 158 ACEGLKHMH-EHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTT 211
Query: 890 ATIGYMAPD 898
           AT  + AP+
Sbjct: 212 ATAEFAAPE 220

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 80/182 (43%), Gaps = 19/182 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNI----- 779
           DNF    ++G G FG V  AR+ E G   A+KV        L+  + EC + +       
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV--ILQDDDVECTMTEKRILSLA 80
Query: 780 -RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
             H  L ++       D    V+E+++ G L   +  S        R     +I SAL +
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMF 139
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK--LLSGEDESTMRTQTLATIGYMA 896
           LH      II+ DLK  NVLLD +    L+DFGM K  + +G   +T       T  Y+A
Sbjct: 140 LH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF----CGTPDYIA 192
Query: 897 PD 898
           P+
Sbjct: 193 PE 194

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 18/172 (10%)
Query: 734 IGIGGFGSVYR--ARLEDGVEI--AIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIIS 789
           +G G + +VY+  ++L D +     I++ H + A    +   E  ++K+++H N+V +  
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC--TAIREVSLLKDLKHANIVTLHD 67
Query: 790 SCSNDDFKALVLEYMSNG---SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
               +    LV EY+       L+DC        NI    N+ + +   L  L + H   
Sbjct: 68  IIHTEKSLTLVFEYLDKDLKQYLDDCG-------NIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           ++H DLKP N+L++E     L+DFG+A+  S   ++      + T+ Y  PD
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYRPPD 170

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 85/178 (47%), Gaps = 11/178 (6%)
Query: 726 DNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQCASTLK-SFEAECEVIKNIRHRN 783
           D+F + + +G G  G V++ +    G+ +A K+ H +    ++     E +V+       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFG 842
           +V    +  +D   ++ +E+M  GSL+  L  +      I  +++I +     L YL   
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 185
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H D+KPSN+L++      L DFG    +SG+   +M    + T  YM+P+ +
Sbjct: 186 HK--IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERL 237

>pdb|3OJA|B Chain B, Crystal Structure Of Lrim1APL1C COMPLEX Length = 597

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 114/272 (41%), Gaps = 41/272 (15%)
Query: 384 LPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKL 443
           LP+++ +    +E LN+    I      A      +  L +G N +    P  F  +  L
Sbjct: 66  LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL 125
Query: 444 QGLDLAFNKLAGSIPDEICL-LSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFT 502
             L L  N L+ S+P  I     +L  L ++ N +           TSLQ L L SNR T
Sbjct: 126 TVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 184
Query: 503 FV----IPSTF-----WNLKDILSFDISSNLLD----------GPISLAIGNLKAVVGID 543
            V    IPS F     +NL   L+  I+   LD          GP+++ +  LK      
Sbjct: 185 HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILK------ 238
Query: 544 LSRNNLSG-----NIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKIS 598
           L  NNL+      N P  +E       + L+YN LE  +   F  M  LE L +SNN++ 
Sbjct: 239 LQHNNLTDTAWLLNYPGLVE-------VDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
Query: 599 GSIPVSFEKLSYLKELNLSFNKLKGEIPRGGP 630
             + +  + +  LK L+LS N L   + R  P
Sbjct: 292 A-LNLYGQPIPTLKVLDLSHNHL-LHVERNQP 321

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 11/176 (6%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
           DNF +   IG G  G V  A +   G  +A+K    +     +    E  ++++ +H N+
Sbjct: 77  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           V++ +S    D   +V+E++  G+L D +  ++  +N      + + +  AL  LH   +
Sbjct: 134 VEMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---A 188
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
             +IH D+K  ++LL  D    LSDFG    +S   E   R   + T  +MAP+ I
Sbjct: 189 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--KEVPRRKXLVGTPYWMAPELI 242

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 113 FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 166
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E         +AT  Y AP+
Sbjct: 167 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGYVATRWYRAPE 215

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 90/189 (47%), Gaps = 11/189 (5%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---E 772
             +L+ T+ F +  ++  G FG+VY+   + +G  V+I + +   + A++ K+ +    E
Sbjct: 16  LRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+ ++ + ++ +++  C     + L+++ M  G L D +      +     LN  + I
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 893 GYMAPDEIF 901
            +MA + I 
Sbjct: 191 KWMALESIL 199

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 24/178 (13%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRN--LVKIIS 789
           IG GG   V++   E     AIK  + + A   TL S+  E   +  ++  +  ++++  
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID-------IASALEYLHFG 842
               D +  +V+E              N  LN + +    ID         + LE +H  
Sbjct: 76  YEITDQYIYMVME------------CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 123
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H DLKP+N L+ + M+  L DFG+A  +  +  S ++   + T+ YM P+ I
Sbjct: 124 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 180

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 31/202 (15%)
Query: 728 FAENNI-----IGIGGFGSVYRARL-----EDGV-EIAIKVFHPQC-ASTLKSFEAECEV 775
           F  NN+     +G G FG V  A       ED V ++A+K+      A   ++  +E ++
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 776 IKNI-RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCL---------------HSSNCA 819
           + ++ +H N+V ++ +C++     ++ EY   G L + L               H+    
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQ 162
Query: 820 LNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE 879
           L+    L+    +A  + +L    S   IH D+   NVLL    VA + DFG+A+ +  +
Sbjct: 163 LSSRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 219
Query: 880 DESTMRTQTLATIGYMAPDEIF 901
               ++      + +MAP+ IF
Sbjct: 220 SNYIVKGNARLPVKWMAPESIF 241

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 61/261 (23%), Positives = 117/261 (44%), Gaps = 37/261 (14%)
Query: 726 DNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRN 783
           D+F + + +G G  G V++ +    G+ +A K+ H +    +++    E +V+       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFG 842
           +V    +  +D   ++ +E+M  GSL+  L  +      I  +++I +     L YL   
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 126
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV 902
           H   I+H D+KPSN+L++      L DFG    +SG+    M  + + T  YM+P+ +  
Sbjct: 127 HK--IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDEMANEFVGTRSYMSPERLQG 180
Query: 903 GELSLKR--WVNDLL------------PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSL 948
              S++   W   L             P+++ E++D  +     K  +A       +FSL
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSA-------VFSL 233
Query: 949 ALE-----CTMESPEKRIDAK 964
             +     C +++P +R D K
Sbjct: 234 EFQDFVNKCLIKNPAERADLK 254

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 50/175 (28%), Positives = 77/175 (44%), Gaps = 9/175 (5%)
Query: 728 FAENNIIGIGGFGSVYRARLEDGVEI-AIKVFH-PQCASTLKSFEAECEVIKNIRHRNLV 785
           F + + IG G FG VY+       E+ AIK+    +    ++  + E  V+       + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
           +   S        +++EY+  GS  D L              I+ +I   L+YLH   S 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA--TILREILKGLDYLH---SE 135
Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
             IH D+K +NVLL E     L+DFG+A  L+  D    R   + T  +MAP+ I
Sbjct: 136 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVI 188

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 46/191 (24%), Positives = 91/191 (47%), Gaps = 11/191 (5%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDG--VEIAIKVFHPQCASTLKSFEA-- 771
           +   +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +   
Sbjct: 7   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 772 -ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
            E  V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCV 124
Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            IA  + YL       ++H DL   NVL+       ++DFG+AKLL  E++         
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 891 TIGYMAPDEIF 901
            I +MA + I 
Sbjct: 182 PIKWMALESIL 192

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 46/181 (25%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKV--FHPQCASTLKSFEAECEVIKNIRHRNLVK---- 786
           IG G +G   + R + DG  +  K   +     +  +   +E  +++ ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA---LNIFCRLNIMIDIASALEYLHF-- 841
           II   +   +  +V+EY   G L   +         L+    L +M  +  AL+  H   
Sbjct: 74  IIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 842 --GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
             GH+  ++H DLKP+NV LD      L DFG+A++L+ +++     + + T  YM+P++
Sbjct: 132 DGGHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED--FAKEFVGTPYYMSPEQ 187
Query: 900 I 900
           +
Sbjct: 188 M 188

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 11/178 (6%)
Query: 726 DNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRN 783
           D+F + + +G G  G V++ +    G+ +A K+ H +    +++    E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFG 842
           +V    +  +D   ++ +E+M  GSL+  L  +      I  +++I +     L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 123
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H D+KPSN+L++      L DFG    +SG+   +M    + T  YM+P+ +
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERL 175

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 11/178 (6%)
Query: 726 DNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRN 783
           D+F + + +G G  G V++ +    G+ +A K+ H +    +++    E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFG 842
           +V    +  +D   ++ +E+M  GSL+  L  +      I  +++I +     L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 123
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H D+KPSN+L++      L DFG    +SG+   +M    + T  YM+P+ +
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERL 175

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 85/178 (47%), Gaps = 11/178 (6%)
Query: 726 DNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQCASTLK-SFEAECEVIKNIRHRN 783
           D+F + + +G G  G V++ +    G+ +A K+ H +    ++     E +V+       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFG 842
           +V    +  +D   ++ +E+M  GSL+  L  +      I  +++I +     L YL   
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 150
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H D+KPSN+L++      L DFG    +SG+   +M    + T  YM+P+ +
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERL 202

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 24/178 (13%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRN--LVKIIS 789
           IG GG   V++   E     AIK  + + A   TL S+  E   +  ++  +  ++++  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID-------IASALEYLHFG 842
               D +  +V+E              N  LN + +    ID         + LE +H  
Sbjct: 96  YEITDQYIYMVME------------CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H DLKP+N L+ + M+  L DFG+A  +  +  S ++   + T+ YM P+ I
Sbjct: 144 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 85/178 (47%), Gaps = 11/178 (6%)
Query: 726 DNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQCASTLK-SFEAECEVIKNIRHRN 783
           D+F + + +G G  G V++ +    G+ +A K+ H +    ++     E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFG 842
           +V    +  +D   ++ +E+M  GSL+  L  +      I  +++I +     L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 123
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H D+KPSN+L++      L DFG    +SG+   +M    + T  YM+P+ +
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERL 175

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKV--FHPQCASTLKSFEAECEVIKNIRHRNLVK---- 786
           IG G +G   + R + DG  +  K   +     +  +   +E  +++ ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA---LNIFCRLNIMIDIASALEYLHF-- 841
           II   +   +  +V+EY   G L   +         L+    L +M  +  AL+  H   
Sbjct: 74  IIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 842 --GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
             GH+  ++H DLKP+NV LD      L DFG+A++L+  D S  +T  + T  YM+P++
Sbjct: 132 DGGHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKT-FVGTPYYMSPEQ 187
Query: 900 I 900
           +
Sbjct: 188 M 188

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 11/178 (6%)
Query: 726 DNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRN 783
           D+F + + +G G  G V++ +    G+ +A K+ H +    +++    E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFG 842
           +V    +  +D   ++ +E+M  GSL+  L  +      I  +++I +     L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 123
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H D+KPSN+L++      L DFG    +SG+   +M    + T  YM+P+ +
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERL 175

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 46/191 (24%), Positives = 91/191 (47%), Gaps = 11/191 (5%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDG--VEIAIKVFHPQCASTLKSFEA-- 771
           +   +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +   
Sbjct: 4   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 62
Query: 772 -ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
            E  V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  +
Sbjct: 63  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 121
Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            IA  + YL       ++H DL   NVL+       ++DFG+AKLL  E++         
Sbjct: 122 QIAEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 178
Query: 891 TIGYMAPDEIF 901
            I +MA + I 
Sbjct: 179 PIKWMALESIL 189

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 46/191 (24%), Positives = 91/191 (47%), Gaps = 11/191 (5%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDG--VEIAIKVFHPQCASTLKSFEA-- 771
           +   +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +   
Sbjct: 7   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 772 -ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
            E  V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            IA  + YL       ++H DL   NVL+       ++DFG+AKLL  E++         
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 891 TIGYMAPDEIF 901
            I +MA + I 
Sbjct: 182 PIKWMALESIL 192

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 46/191 (24%), Positives = 91/191 (47%), Gaps = 11/191 (5%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDG--VEIAIKVFHPQCASTLKSFEA-- 771
           +   +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +   
Sbjct: 1   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 59
Query: 772 -ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
            E  V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  +
Sbjct: 60  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 118
Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            IA  + YL       ++H DL   NVL+       ++DFG+AKLL  E++         
Sbjct: 119 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 891 TIGYMAPDEIF 901
            I +MA + I 
Sbjct: 176 PIKWMALESIL 186

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 46/191 (24%), Positives = 91/191 (47%), Gaps = 11/191 (5%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDG--VEIAIKVFHPQCASTLKSFEA-- 771
           +   +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +   
Sbjct: 7   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 772 -ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
            E  V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            IA  + YL       ++H DL   NVL+       ++DFG+AKLL  E++         
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 891 TIGYMAPDEIF 901
            I +MA + I 
Sbjct: 182 PIKWMALESIL 192

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 85/178 (47%), Gaps = 11/178 (6%)
Query: 726 DNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQCASTLK-SFEAECEVIKNIRHRN 783
           D+F + + +G G  G V++ +    G+ +A K+ H +    ++     E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFG 842
           +V    +  +D   ++ +E+M  GSL+  L  +      I  +++I +     L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 123
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H D+KPSN+L++      L DFG    +SG+   +M    + T  YM+P+ +
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERL 175

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 11/178 (6%)
Query: 726 DNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRN 783
           D+F + + +G G  G V++ +    G+ +A K+ H +    +++    E +V+       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFG 842
           +V    +  +D   ++ +E+M  GSL+  L  +      I  +++I +     L YL   
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 142
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H D+KPSN+L++      L DFG    +SG+   +M    + T  YM+P+ +
Sbjct: 143 HK--IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERL 194

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 24/178 (13%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRN--LVKIIS 789
           IG GG   V++   E     AIK  + + A   TL S+  E   +  ++  +  ++++  
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID-------IASALEYLHFG 842
               D +  +V+E              N  LN + +    ID         + LE +H  
Sbjct: 80  YEITDQYIYMVME------------CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 127
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H DLKP+N L+ + M+  L DFG+A  +  +  S ++   + T+ YM P+ I
Sbjct: 128 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 184

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+ +    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYVATRWYRAPE 192

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G  +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 96  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 198

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 12/179 (6%)
Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKV-FHPQCAS--TLKSFEAECEVIKNIRH 781
           D+F     +G G FG+VY AR  ++   +A+KV F  Q            E E+  ++RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
            N++++ +   +     L+LE+   G L   L       +       M ++A AL   H+
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADAL---HY 129
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            H   +IH D+KP N+L+       ++DFG     S    S  R     T+ Y+ P+ I
Sbjct: 130 CHERKVIHRDIKPENLLMGYKGELKIADFGW----SVHAPSLRRRXMCGTLDYLPPEMI 184

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 15/178 (8%)
Query: 732 NIIGIGGFGSVYRA-RLEDGVEIAIKV-----FHPQCASTLKSFEAECEVIKNIRHRNLV 785
            +IG G F  V R    E G + A+K+     F      + +  + E  +   ++H ++V
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID--IASALEYLHFGH 843
           +++ + S+D    +V E+M    L  C      A   F     +    +   LE L + H
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADL--CFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 844 STPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
              IIH D+KP NVLL   +      L DFG+A  L   +   +    + T  +MAP+
Sbjct: 148 DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG--ESGLVAGGRVGTPHFMAPE 203

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G  +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 86  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHS 139
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E      T  +AT  Y AP+
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 188

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 12/188 (6%)
Query: 720 ELLRATDNFAENNI-IGIGGFGSV----YRARLEDGVEIAIKVFHPQC-ASTLKSFEAEC 773
           +L    DN    +I +G G FGSV    YR R +  +++AIKV       +  +    E 
Sbjct: 3   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 774 EVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
           +++  + +  +V++I  C  +    LV+E    G L   L      + +     ++  ++
Sbjct: 62  QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATI 892
             ++YL        +H DL   NVLL     A +SDFG++K L  +D   T R+     +
Sbjct: 121 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 177
Query: 893 GYMAPDEI 900
            + AP+ I
Sbjct: 178 KWYAPECI 185

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           IG G  G V  AR +  G ++A+K+   +     +    E  ++++ +H N+V++  S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
             +   +++E++  G+L D +  S   LN      +   +  AL YLH   +  +IH D+
Sbjct: 113 VGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI----FVGELSLK 908
           K  ++LL  D    LSDFG    +S   +   R   + T  +MAP+ I    +  E+ + 
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQIS--KDVPKRKXLVGTPYWMAPEVISRSLYATEVDI- 224
Query: 909 RWVNDLLPVSLVEVVDKSLLSGEEKHFA 936
            W    L + ++E+VD     GE  +F+
Sbjct: 225 -WS---LGIMVIEMVD-----GEPPYFS 243

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 80/186 (43%), Gaps = 16/186 (8%)
Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFEAECEVIKN------ 778
           ++F  + ++G G FG V+ A  +   +  AIK         L   + EC +++       
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV--VLMDDDVECTMVEKRVLSLA 74
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
             H  L  +  +    +    V+EY++ G L    H  +C      R       A  +  
Sbjct: 75  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYA--AEIILG 130
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           L F HS  I++ DLK  N+LLD+D    ++DFGM K     D  T       T  Y+AP 
Sbjct: 131 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NXFCGTPDYIAP- 187
Query: 899 EIFVGE 904
           EI +G+
Sbjct: 188 EILLGQ 193

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 11/174 (6%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
           DNF +   IG G  G V  A +   G  +A+K    +     +    E  ++++ +H N+
Sbjct: 154 DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 210
Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           V++ +S    D   +V+E++  G+L D +  ++  +N      + + +  AL  LH   +
Sbjct: 211 VEMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---A 265
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             +IH D+K  ++LL  D    LSDFG    +S   E   R   + T  +MAP+
Sbjct: 266 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--KEVPRRKXLVGTPYWMAPE 317

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 82/171 (47%), Gaps = 12/171 (7%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIIS 789
           +G G FG V  A   +   ++A+K    Q    +      E E   +K +RH +++K+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
             +      +V+EY + G L D +           R      I  A+EY H      I+H
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH---RHKIVH 131
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            DLKP N+LLD+++   ++DFG++ +++  D + ++T +  +  Y AP+ I
Sbjct: 132 RDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEVI 179

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 48/181 (26%), Positives = 77/181 (42%), Gaps = 12/181 (6%)
Query: 723 RATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQC----ASTLKSFEAECEVIKN 778
           R    +     +G GGF   Y     D  E+      P+         +    E  + K+
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           + + ++V       +DDF  +VLE     SL + LH    A+        M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAP 897
           LH   +  +IH DLK  N+ L++DM   + DFG+A  +  + E   R +TL  T  Y+AP
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RKKTLCGTPNYIAP 211
Query: 898 D 898
           +
Sbjct: 212 E 212

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 734 IGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIIS--- 789
           +G GG G V+ A   D    +AIK        ++K    E ++I+ + H N+VK+     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 790 ---SCSNDDFKAL--------VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
              S   DD  +L        V EYM    L + L      L    RL  M  +   L+Y
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPL-LEEHARL-FMYQLLRGLKY 135
Query: 839 LHFGHSTPIIHCDLKPSNVLLD-EDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMA 896
           +H   S  ++H DLKP+N+ ++ ED+V  + DFG+A+++          ++ L T  Y +
Sbjct: 136 IH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRS 192
Query: 897 P 897
           P
Sbjct: 193 P 193

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 88/191 (46%), Gaps = 22/191 (11%)
Query: 718 YFELLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEA---EC 773
           YF+ L  +D +     +G G +G V   + +  G E AIK+      +T  +  A   E 
Sbjct: 15  YFQGL--SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEV 72
Query: 774 EVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN---IMI 830
            V+K + H N++K+     +     LV+E    G L D +         F  ++   IM 
Sbjct: 73  AVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI----ILRQKFSEVDAAVIMK 128
Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLSGEDESTMRTQ 887
            + S   YLH  H+  I+H DLKP N+LL+    D +  + DFG++     E    M+ +
Sbjct: 129 QVLSGTTYLH-KHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMK-E 182
Query: 888 TLATIGYMAPD 898
            L T  Y+AP+
Sbjct: 183 RLGTAYYIAPE 193

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 18/184 (9%)
Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA--ECEVIKNIRHRNLVKIISS 790
           IG G FG V++AR  + G ++A+K    +         A  E ++++ ++H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 791 CSNDDFKALVLEYMSNGSL----EDCLHSSNCAL-NIFCRLNIMIDIASALEYL----HF 841
           C     KA        GS+    + C H     L N+  +  +  +I   ++ L    ++
Sbjct: 86  CRT---KASPYN-RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS-EIKRVMQMLLNGLYY 140
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS-GEDESTMRTQTLATIGYMAPDEI 900
            H   I+H D+K +NVL+  D V  L+DFG+A+  S  ++    R        +  P E+
Sbjct: 141 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 901 FVGE 904
            +GE
Sbjct: 201 LLGE 204

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 21/184 (11%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLKSFE--AECEVIKNIRHRNLV 785
           +G G FG VY        + E    +AIK  + + AS  +  E   E  V+K     ++V
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASAL 836
           +++   S      +++E M+ G L+  L S      N  +     L+ MI    +IA  +
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
            YL+   +   +H DL   N ++ ED    + DFGM + +   D      + L  + +M+
Sbjct: 146 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 202
Query: 897 PDEI 900
           P+ +
Sbjct: 203 PESL 206

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 21/184 (11%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLKSFE--AECEVIKNIRHRNLV 785
           +G G FG VY        + E    +AIK  + + AS  +  E   E  V+K     ++V
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVV 76
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASAL 836
           +++   S      +++E M+ G L+  L S      N  +     L+ MI    +IA  +
Sbjct: 77  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 136
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
            YL+   +   +H DL   N ++ ED    + DFGM + +   D      + L  + +M+
Sbjct: 137 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 193
Query: 897 PDEI 900
           P+ +
Sbjct: 194 PESL 197

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 15/172 (8%)
Query: 732 NIIGIGGFGSVYRARLEDGVEI--AIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIIS 789
           N IG G +G V +  ++ G  I  A K         +  F+ E E++K++ H N++++  
Sbjct: 15  NTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 790 SCSNDDFKALVLEYMSNGSL-EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
           +  ++    LV+E  + G L E  +H      +   R  IM D+ SA+ Y    H   + 
Sbjct: 74  TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYC---HKLNVA 128
Query: 849 HCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           H DLKP N L      D    L DFG+A     +    MRT+ + T  Y++P
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTK-VGTPYYVSP 177

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 15/172 (8%)
Query: 732 NIIGIGGFGSVYRARLEDGVEI--AIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIIS 789
           N IG G +G V +  ++ G  I  A K         +  F+ E E++K++ H N++++  
Sbjct: 32  NTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 90
Query: 790 SCSNDDFKALVLEYMSNGSL-EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
           +  ++    LV+E  + G L E  +H      +   R  IM D+ SA+ Y    H   + 
Sbjct: 91  TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYC---HKLNVA 145
Query: 849 HCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           H DLKP N L      D    L DFG+A     +    MRT+ + T  Y++P
Sbjct: 146 HRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTK-VGTPYYVSP 194

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 83/178 (46%), Gaps = 11/178 (6%)
Query: 726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLK-SFEAECEVIKNIRHRN 783
           D+F   + +G G  G V + +    G+ +A K+ H +    ++     E +V+       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCL-HSSNCALNIFCRLNIMIDIASALEYLHFG 842
           +V    +  +D   ++ +E+M  GSL+  L  +      I  +++I +     L YL   
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAYLREK 133
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H D+KPSN+L++      L DFG    +SG+   +M    + T  YMAP+ +
Sbjct: 134 HQ--IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMAPERL 185

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 12/183 (6%)
Query: 734 IGIGGFGSVYRARLEDGVEI-AIKV--FHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           IG G +G+V++A+  +  EI A+K             S   E  ++K ++H+N+V++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHC 850
             +D    LV E+  +  L+    S N  L+     + +  +   L+ L F HS  ++H 
Sbjct: 70  LHSDKKLTLVFEF-CDQDLKKYFDSCNGDLDPEIVKSFLFQL---LKGLGFCHSRNVLHR 125
Query: 851 DLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGEL---SL 907
           DLKP N+L++ +    L++FG+A+           +  + T+ Y  PD +F  +L   S+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFG--IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 908 KRW 910
             W
Sbjct: 184 DMW 186

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 24/178 (13%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRN--LVKIIS 789
           IG GG   V++   E     AIK  + + A   TL S+  E   +  ++  +  ++++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID-------IASALEYLHFG 842
               D +  +V+E         C    N  LN + +    ID         + LE +H  
Sbjct: 124 YEITDQYIYMVME---------C---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H DLKP+N L+ + M+  L DFG+A  +  +  S ++   +  + YM P+ I
Sbjct: 172 HQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 21/182 (11%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLKSFEA--ECEVIKNIRHRNLV 785
           +G G FG VY        + E    +AIK  + + AS  +  E   E  V+K     ++V
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVV 113
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASAL 836
           +++   S      +++E M+ G L+  L S      N  +     L+ MI    +IA  +
Sbjct: 114 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 173
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
            YL+   +   +H DL   N ++ ED    + DFGM + +   D      + L  + +M+
Sbjct: 174 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 230
Query: 897 PD 898
           P+
Sbjct: 231 PE 232

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
           DNF +   IG G  G V  A +   G  +A+K    +     +    E  ++++ +H N+
Sbjct: 32  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN---IMIDIASALEYLHF 841
           V++ +S    D   +V+E++  G+L D +  +        R+N   I     + L+ L  
Sbjct: 89  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--------RMNEEQIAAVCLAVLQALSV 140
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            H+  +IH D+K  ++LL  D    LSDFG    +S   E   R   + T  +MAP+ I
Sbjct: 141 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--KEVPRRKXLVGTPYWMAPELI 197

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
           DNF +   IG G  G V  A +   G  +A+K    +     +    E  ++++ +H N+
Sbjct: 34  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN---IMIDIASALEYLHF 841
           V++ +S    D   +V+E++  G+L D +  +        R+N   I     + L+ L  
Sbjct: 91  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--------RMNEEQIAAVCLAVLQALSV 142
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            H+  +IH D+K  ++LL  D    LSDFG    +S   E   R   + T  +MAP+ I
Sbjct: 143 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--KEVPRRKXLVGTPYWMAPELI 199

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
           DNF +   IG G  G V  A +   G  +A+K    +     +    E  ++++ +H N+
Sbjct: 23  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN---IMIDIASALEYLHF 841
           V++ +S    D   +V+E++  G+L D +  +        R+N   I     + L+ L  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--------RMNEEQIAAVCLAVLQALSV 131
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            H+  +IH D+K  ++LL  D    LSDFG    +S   E   R   + T  +MAP+ I
Sbjct: 132 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--KEVPRRKXLVGTPYWMAPELI 188

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
           DNF +   IG G  G V  A +   G  +A+K    +     +    E  ++++ +H N+
Sbjct: 27  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN---IMIDIASALEYLHF 841
           V++ +S    D   +V+E++  G+L D +  +        R+N   I     + L+ L  
Sbjct: 84  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--------RMNEEQIAAVCLAVLQALSV 135
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
            H+  +IH D+K  ++LL  D    LSDFG    +S   E   R   + T  +MAP+ I
Sbjct: 136 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--KEVPRRKXLVGTPYWMAPELI 192

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 87/188 (46%), Gaps = 26/188 (13%)
Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA--ECEVIKNIRHRNLVKIISS 790
           IG G FG V++AR  + G ++A+K    +         A  E ++++ ++H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 791 CSN-----DDFKA---LVLEYMSNGSLEDCLHSSNCAL-NIFCRLNIMIDIASALEYL-- 839
           C       +  KA   LV ++        C H     L N+  +  +  +I   ++ L  
Sbjct: 86  CRTKASPYNRCKASIYLVFDF--------CEHDLAGLLSNVLVKFTLS-EIKRVMQMLLN 136
Query: 840 --HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS-GEDESTMRTQTLATIGYMA 896
             ++ H   I+H D+K +NVL+  D V  L+DFG+A+  S  ++    R        +  
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 897 PDEIFVGE 904
           P E+ +GE
Sbjct: 197 PPELLLGE 204

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 46/181 (25%), Positives = 86/181 (47%), Gaps = 20/181 (11%)
Query: 734 IGIGGFGSVYRARLE-DGVEIAIKV--FHPQCASTLKSFEAECEVIKNIRHRNLVK---- 786
           IG G +G   + R + DG  +  K   +     +  +   +E  +++ ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA---LNIFCRLNIMIDIASALEYLHF-- 841
           II   +   +  +V+EY   G L   +         L+    L +M  +  AL+  H   
Sbjct: 74  IIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 842 --GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
             GH+  ++H DLKP+NV LD      L DFG+A++L+   +++     + T  YM+P++
Sbjct: 132 DGGHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPYYMSPEQ 187
Query: 900 I 900
           +
Sbjct: 188 M 188

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 79/176 (44%), Gaps = 20/176 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +G+V  A     G ++AIK  +    S L  K    E  ++K++RH N++ ++  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 791 CSND----DFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
            + D    DF    LV+ +M    L   +       +      I   +   L+ L + H+
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGED-----RIQFLVYQMLKGLRYIHA 146
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
             IIH DLKP N+ ++ED    + DFG+A+    E         + T  Y AP+ I
Sbjct: 147 AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MXGXVVTRWYRAPEVI 197

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 26/212 (12%)
Query: 697 RGTMLSNDIILSSQPTIRRFSYFELLRATDNFAEN-NIIGIGGFGSVYRA-RLEDGVEIA 754
           RG+ +S +     +PT  R    + +       +N + +G G +GSV  A   + G  +A
Sbjct: 17  RGSHMSQE-----RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVA 71
Query: 755 IKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDC 812
           +K       S +  K    E  ++K+++H N++ ++   +     A  LE  ++  L   
Sbjct: 72  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT----PARSLEEFNDVYL--V 125
Query: 813 LHSSNCALNIFCRLNIMID------IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH 866
            H     LN   +   + D      I   L  L + HS  IIH DLKPSN+ ++ED    
Sbjct: 126 THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK 185
Query: 867 LSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           + DFG+A+    E         +AT  Y AP+
Sbjct: 186 ILDFGLARHTDDE-----MXGXVATRWYRAPE 212

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 18/184 (9%)
Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA--ECEVIKNIRHRNLVKIISS 790
           IG G FG V++AR  + G ++A+K    +         A  E ++++ ++H N+V +I  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 791 CSNDDFKALVLEYMSNGSL----EDCLHSSNCAL-NIFCRLNIMIDIASALEYL----HF 841
           C     KA        GS+    + C H     L N+  +  +  +I   ++ L    ++
Sbjct: 85  CRT---KASPYN-RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS-EIKRVMQMLLNGLYY 139
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS-GEDESTMRTQTLATIGYMAPDEI 900
            H   I+H D+K +NVL+  D V  L+DFG+A+  S  ++    R        +  P E+
Sbjct: 140 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 199
Query: 901 FVGE 904
            +GE
Sbjct: 200 LLGE 203

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 89/189 (47%), Gaps = 11/189 (5%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRA-RLEDG--VEIAIKVFHPQCASTLKSFEA---E 772
             +L+ T+ F +  ++  G FG+VY+   + +G  V+I + +   + A++ K+ +    E
Sbjct: 16  LRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  + I
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 893 GYMAPDEIF 901
            +MA + I 
Sbjct: 191 KWMALESIL 199

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 18/184 (9%)
Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA--ECEVIKNIRHRNLVKIISS 790
           IG G FG V++AR  + G ++A+K    +         A  E ++++ ++H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 791 CSNDDFKALVLEYMSNGSL----EDCLHSSNCAL-NIFCRLNIMIDIASALEYL----HF 841
           C     KA        GS+    + C H     L N+  +  +  +I   ++ L    ++
Sbjct: 86  CRT---KASPYN-RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS-EIKRVMQMLLNGLYY 140
Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS-GEDESTMRTQTLATIGYMAPDEI 900
            H   I+H D+K +NVL+  D V  L+DFG+A+  S  ++    R        +  P E+
Sbjct: 141 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 901 FVGE 904
            +GE
Sbjct: 201 LLGE 204

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 70/274 (25%), Positives = 121/274 (44%), Gaps = 37/274 (13%)
Query: 731 NNIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKII 788
           + ++G G +  V  A  L++G E A+K+   Q   +      E E +   + ++N++++I
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
               +D    LV E +  GS+   +       N      ++ D+A+AL++LH   +  I 
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQK-HFNEREASRVVRDVAAALDFLH---TKGIA 133
Query: 849 HCDLKPSNVLLDE-DMVA--HLSDFGMAKLLSGEDEST-MRTQTLAT----IGYMAPD-- 898
           H DLKP N+L +  + V+   + DF +   +   +  T + T  L T      YMAP+  
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 899 EIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK---HFAAK---------EQCLLSIF 946
           E+F  + +      DL  + +V  +   +LSG      H  A            C   +F
Sbjct: 194 EVFTDQATFYDKRCDLWSLGVVLYI---MLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 250
Query: 947 SLALECTMESPEK-----RIDAKDTITRLLKIRD 975
               E   E P+K       +AKD I++LL +RD
Sbjct: 251 ESIQEGKYEFPDKDWAHISSEAKDLISKLL-VRD 283

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 19/178 (10%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI--RHRNLVKIISS- 790
           +G G +G V+R  L  G  +A+K+F    +   +S+  E E+   +  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFS---SRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 791 --CSNDDFKA-LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH---FG-H 843
               N   +  L+  Y  +GSL D L       ++  RL   +  A  L +LH   FG  
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRL--AVSAACGLAHLHVEIFGTQ 129
Query: 844 STPII-HCDLKPSNVLLDEDMVAHLSDFGMAKLLS-GEDESTM-RTQTLATIGYMAPD 898
             P I H D K  NVL+  ++   ++D G+A + S G D   +     + T  YMAP+
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPE 187

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 12/171 (7%)
Query: 733 IIGIGGFGSVYRARLEDGVEIAIKVFHPQC----ASTLKSFEAECEVIKNIRHRNLVKII 788
            +G GGF   +     D  E+      P+         +    E  + +++ H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
               ++DF  +VLE     SL + LH    AL        +  I    +YLH      +I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 163
Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPD 898
           H DLK  N+ L+ED+   + DFG+A  +  + E   R + L  T  Y+AP+
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPE 211

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 707 LSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTL 766
           +  + T+  F Y +LL     F +  ++     G  Y  ++   ++  + V   + A TL
Sbjct: 3   MDPRVTMNEFEYLKLL-GKGTFGKVILVKEKATGRYYAMKI---LKKEVIVAKDEVAHTL 58
Query: 767 KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL 826
                E  V++N RH  L  +  S    D    V+EY + G L    H S   +    R 
Sbjct: 59  ----TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRA 112
Query: 827 NIM-IDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG-EDESTM 884
                +I SAL+YLH      +++ DLK  N++LD+D    ++DFG+ K   G +D +TM
Sbjct: 113 RFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATM 168
Query: 885 RTQTLATIGYMAPD 898
           +     T  Y+AP+
Sbjct: 169 KX-FCGTPEYLAPE 181

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 17/189 (8%)
Query: 712 TIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEA 771
           T+  F Y +LL     F +  ++     G  Y  ++   ++  + V   + A TL     
Sbjct: 7   TMNEFEYLKLL-GKGTFGKVILVKEKATGRYYAMKI---LKKEVIVAKDEVAHTL----T 58
Query: 772 ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM-I 830
           E  V++N RH  L  +  S    D    V+EY + G L    H S   +    R      
Sbjct: 59  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 116
Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG-EDESTMRTQTL 889
           +I SAL+YLH      +++ DLK  N++LD+D    ++DFG+ K   G +D +TM+    
Sbjct: 117 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKX-FC 171
Query: 890 ATIGYMAPD 898
            T  Y+AP+
Sbjct: 172 GTPEYLAPE 180

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    +  FG+A+    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----MTGYVATRWYRAPE 192

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 12/171 (7%)
Query: 733 IIGIGGFGSVYRARLEDGVEIAIKVFHPQC----ASTLKSFEAECEVIKNIRHRNLVKII 788
            +G GGF   +     D  E+      P+         +    E  + +++ H+++V   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
               ++DF  +VLE     SL + LH    AL        +  I    +YLH      +I
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 161
Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPD 898
           H DLK  N+ L+ED+   + DFG+A  +  + E   R + L  T  Y+AP+
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPE 209

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 38/209 (18%)
Query: 728 FAENNI-----IGIGGFGSVYRARL-----EDGV-EIAIKVFHPQC-ASTLKSFEAECEV 775
           F  NN+     +G G FG V  A       ED V ++A+K+      A   ++  +E ++
Sbjct: 28  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 87
Query: 776 IKNI-RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA--------------- 819
           + ++ +H N+V ++ +C++     ++ EY   G L + L     A               
Sbjct: 88  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGL 147
Query: 820 -------LNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGM 872
                  L +   L+    +A  + +L    S   IH D+   NVLL    VA + DFG+
Sbjct: 148 DKEDGRPLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGL 204
Query: 873 AKLLSGEDESTMRTQTLATIGYMAPDEIF 901
           A+ +  +    ++      + +MAP+ IF
Sbjct: 205 ARDIMNDSNYIVKGNARLPVKWMAPESIF 233

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 39/136 (28%), Positives = 70/136 (51%), Gaps = 11/136 (8%)
Query: 740 GSVYRARLEDGVEIAIKVFHPQCASTLKS--FEAECEVIKNIRHRNLVKIISSCSND--D 795
           G +++ R + G +I +KV   +  ST KS  F  EC  ++   H N++ ++ +C +    
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 796 FKALVLEYMSNGSLEDCLHS-SNCALNIFCRLNIMIDIASALEYLHFGHSTPII--HCDL 852
              L+  +M  GSL + LH  +N  ++    +   +D+A  + +LH     P+I  H  L
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHA-L 139
Query: 853 KPSNVLLDEDMVAHLS 868
              +V++DEDM A +S
Sbjct: 140 NSRSVMIDEDMTARIS 155

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + D G+A+    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----MTGYVATRWYRAPE 192

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 11/191 (5%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDG--VEIAIKVFHPQCASTLKSFEA-- 771
           +   +L+ T+ F +  ++G G FG+VY+   + +G  V+I + +   + A++ K+ +   
Sbjct: 7   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 772 -ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
            E  V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            IA  + YL       ++H DL   NVL+       ++DFG AKLL  E++         
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 181
Query: 891 TIGYMAPDEIF 901
            I +MA + I 
Sbjct: 182 PIKWMALESIL 192

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + D G+A+    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTGYVATRWYRAPE 192

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 43/184 (23%), Positives = 81/184 (44%), Gaps = 21/184 (11%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLKSFE--AECEVIKNIRHRNLV 785
           +G G FG VY        + E    +AIK  + + AS  +  E   E  V+K     ++V
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCAL---------NIFCRLNIMIDIASAL 836
           +++   S      +++E M+ G L+  L S   A+         ++   + +  +IA  +
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
            YL+   +   +H DL   N ++ ED    + DFGM + +   D      + L  + +M+
Sbjct: 152 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 897 PDEI 900
           P+ +
Sbjct: 209 PESL 212

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 43/184 (23%), Positives = 81/184 (44%), Gaps = 21/184 (11%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLKSFE--AECEVIKNIRHRNLV 785
           +G G FG VY        + E    +AIK  + + AS  +  E   E  V+K     ++V
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVV 81
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCAL---------NIFCRLNIMIDIASAL 836
           +++   S      +++E M+ G L+  L S   A+         ++   + +  +IA  +
Sbjct: 82  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
            YL+   +   +H DL   N ++ ED    + DFGM + +   D      + L  + +M+
Sbjct: 142 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 198
Query: 897 PDEI 900
           P+ +
Sbjct: 199 PESL 202

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 82/184 (44%), Gaps = 20/184 (10%)
Query: 725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIR 780
           +D +     +G G +G V   + +  G E AIK+      +T  +  A   E  V+K + 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN---IMIDIASALE 837
           H N++K+     +     LV+E    G L D +         F  ++   IM  + S   
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI----ILRQKFSEVDAAVIMKQVLSGTT 118
Query: 838 YLHFGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           YLH      I+H DLKP N+LL+    D +  + DFG++     E    M+ + L T  Y
Sbjct: 119 YLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMK-ERLGTAYY 172
Query: 895 MAPD 898
           +AP+
Sbjct: 173 IAPE 176

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 24/178 (13%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRN--LVKIIS 789
           IG GG   V++   E     AIK  + + A   TL S+  E   +  ++  +  ++++  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID-------IASALEYLHFG 842
               D +  +V+E              N  LN + +    ID         + LE +H  
Sbjct: 96  YEITDQYIYMVME------------CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   I+H DLKP+N L+ + M+  L DFG+A  +  +    ++   + T+ YM P+ I
Sbjct: 144 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAI 200

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 15/179 (8%)
Query: 725 TDNFAENNIIGIGGFGSVYRARLEDGVE--IAIKVFHPQCASTLKSFEAECEVIKNIRHR 782
           +D F   + +G G    VYR + + G +   A+KV         K    E  V+  + H 
Sbjct: 52  SDFFEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHP 108
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N++K+          +LVLE ++ G L D +         +   +    +   LE + + 
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYL 164
Query: 843 HSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           H   I+H DLKP N+L      D    ++DFG++K++  E +  M+T    T GY AP+
Sbjct: 165 HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKT-VCGTPGYCAPE 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G  +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E         +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPE 192

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 22/190 (11%)
Query: 718 YFELLRATDNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQCASTLKSFEAECEVI 776
           YF+ +  +D +     IG+G +    R       +E A+KV       + +    E E++
Sbjct: 19  YFQSMVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVID----KSKRDPSEEIEIL 74
Query: 777 -KNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN---IMIDI 832
            +  +H N++ +     +     LV E M  G L D +         F       ++  I
Sbjct: 75  LRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI----LRQKFFSEREASFVLHTI 130
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVL-LDED---MVAHLSDFGMAKLLSGEDESTMRTQT 888
              +EYLH   S  ++H DLKPSN+L +DE        + DFG AK L  E+   M    
Sbjct: 131 GKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLM--TP 185
Query: 889 LATIGYMAPD 898
             T  ++AP+
Sbjct: 186 CYTANFVAPE 195

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G  +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 86  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E         +AT  Y AP+
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPE 188

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 120/266 (45%), Gaps = 26/266 (9%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCAS------TLKSFEA 771
           F+  +  D +     +G G F  V + R +  G+E A K    + +       + +  E 
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 772 ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID 831
           E  +++ + H N++ +     N     L+LE +S G L D L     +L+     + +  
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQ 123
Query: 832 IASALEYLHFGHSTPIIHCDLKPSNV-LLDEDM-VAH--LSDFGMAKLLSGEDESTMRTQ 887
           I   + YL   H+  I H DLKP N+ LLD+++ + H  L DFG+A  +  ED    +  
Sbjct: 124 ILDGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFK-N 177
Query: 888 TLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIF 946
              T  ++AP+ +    L L+    D+  + ++  +   LLSG        K++ L +I 
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGDTKQETLANIT 231
Query: 947 SLALECTMESPEKRID-AKDTITRLL 971
           S++ +   E      + AKD I +LL
Sbjct: 232 SVSYDFDEEFFSHTSELAKDFIRKLL 257

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 53/187 (28%), Positives = 83/187 (44%), Gaps = 27/187 (14%)
Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISS 790
           ++G G +G VY+ R ++ G   AIKV         +  + E  ++K    HRN+     +
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 791 C------SNDDFKALVLEYMSNGSLEDCLHSSNCA------LNIFCRLNIMIDIASALEY 838
                    DD   LV+E+   GS+ D + ++         +   CR     +I   L +
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR-----EILRGLSH 144
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT-LATIGYMAP 897
           LH      +IH D+K  NVLL E+    L DFG++  L   D +  R  T + T  +MAP
Sbjct: 145 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAP 198
Query: 898 DEIFVGE 904
           + I   E
Sbjct: 199 EVIACDE 205

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G  +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DFG+A+    E         +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPE 192

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 34/266 (12%)
Query: 728 FAEN-NII---GIGGFGSVYRARLEDGV---EIAIKVFHPQCAST--LKSFEAECEVIKN 778
           FAE  NI+   G G FG V + +  D +   E A+KV +   A      +   E E++K 
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCK--DRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSL-EDCLHSSNCALNIFCRLNIMIDIASALE 837
           + H N++K+     +     +V E  + G L ++ +     + +   R  I+  + S + 
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGIT 135
Query: 838 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           Y+H  H+  I+H DLKP N+LL   ++D    + DFG++       ++T     + T  Y
Sbjct: 136 YMH-KHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYY 189
Query: 895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTM 954
           +AP E+  G    K    D+    ++  +   LLSG    +   E  +L       +   
Sbjct: 190 IAP-EVLRGTYDEK---CDVWSAGVILYI---LLSGTPPFYGKNEYDILKRVETG-KYAF 241
Query: 955 ESPEKRI---DAKDTITRLLKIRDTL 977
           + P+ R    DAKD I ++L    +L
Sbjct: 242 DLPQWRTISDDAKDLIRKMLTFHPSL 267

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 34/266 (12%)
Query: 728 FAEN-NII---GIGGFGSVYRARLEDGV---EIAIKVFHPQCAST--LKSFEAECEVIKN 778
           FAE  NI+   G G FG V + +  D +   E A+KV +   A      +   E E++K 
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCK--DRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSL-EDCLHSSNCALNIFCRLNIMIDIASALE 837
           + H N++K+     +     +V E  + G L ++ +     + +   R  I+  + S + 
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGIT 135
Query: 838 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           Y+H  H+  I+H DLKP N+LL   ++D    + DFG++       ++T     + T  Y
Sbjct: 136 YMH-KHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYY 189
Query: 895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTM 954
           +AP E+  G    K    D+    ++  +   LLSG    +   E  +L       +   
Sbjct: 190 IAP-EVLRGTYDEK---CDVWSAGVILYI---LLSGTPPFYGKNEYDILKRVETG-KYAF 241
Query: 955 ESPEKRI---DAKDTITRLLKIRDTL 977
           + P+ R    DAKD I ++L    +L
Sbjct: 242 DLPQWRTISDDAKDLIRKMLTFHPSL 267

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 78/290 (26%), Positives = 123/290 (42%), Gaps = 46/290 (15%)
Query: 724 ATDNFA---------ENNIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFEAEC 773
           +TD+F+         + +++G G    V     L    E A+K+   Q          E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 774 EVIKNIR-HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
           E++   + HRN++++I     +D   LV E M  GS+   +H      N      ++ D+
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDV 120
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVA--HLSDFGMAK--LLSGEDESTMRTQ 887
           ASAL++LH   +  I H DLKP N+L +  + V+   + DFG+     L+G+       +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPE 177
Query: 888 TLATIG---YMAPD--EIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------ 936
            L   G   YMAP+  E F  E S+     DL  + ++  +   LLSG            
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYI---LLSGYPPFVGRCGSDC 234
Query: 937 ------AKEQCLLSIFSLALECTMESPEK-----RIDAKDTITRLLKIRD 975
                 A   C   +F    E   E P+K        AKD I++LL +RD
Sbjct: 235 GWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLL-VRD 283

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G+ +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + D G+A+    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MTGYVATRWYRAPE 192

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 120/266 (45%), Gaps = 26/266 (9%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCAS------TLKSFEA 771
           F+  +  D +     +G G F  V + R +  G+E A K    + +       + +  E 
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 772 ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID 831
           E  +++ + H N++ +     N     L+LE +S G L D L     +L+     + +  
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQ 123
Query: 832 IASALEYLHFGHSTPIIHCDLKPSNV-LLDEDM-VAH--LSDFGMAKLLSGEDESTMRTQ 887
           I   + YL   H+  I H DLKP N+ LLD+++ + H  L DFG+A  +  ED    +  
Sbjct: 124 ILDGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFK-N 177
Query: 888 TLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIF 946
              T  ++AP+ +    L L+    D+  + ++  +   LLSG        K++ L +I 
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGDTKQETLANIT 231
Query: 947 SLALECTMESPEKRID-AKDTITRLL 971
           S++ +   E      + AKD I +LL
Sbjct: 232 SVSYDFDEEFFSHTSELAKDFIRKLL 257

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 13/159 (8%)
Query: 722 LRATDNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQCASTLK-SFEAECEVIKNI 779
           LR  + +     IG G FG +Y  A +  G E+AIK+   +C  T       E +  K +
Sbjct: 5   LRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKL---ECVKTKHPQLHIESKFYKMM 61
Query: 780 RHRNLVKIISSCSND-DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           +    +  I  C  + D+  +V+E +   SLED  +  +   ++   L +   + S +EY
Sbjct: 62  QGGVGIPSIKWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 839 LHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAK 874
           +H   S   IH D+KP N L+    +  + ++ DFG+AK
Sbjct: 121 IH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 52/103 (50%), Gaps = 21/103 (20%)
Query: 808 SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHL 867
           SLED  H         C L+I I IA A+E+LH   S  ++H DLKPSN+    D V  +
Sbjct: 157 SLEDREHG-------VC-LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKV 205
Query: 868 SDFGMAKLL-SGEDESTMRTQTLA---------TIGYMAPDEI 900
            DFG+   +   E+E T+ T   A         T  YM+P++I
Sbjct: 206 GDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQI 248

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 120/266 (45%), Gaps = 26/266 (9%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCAS------TLKSFEA 771
           F+  +  D +     +G G F  V + R +  G+E A K    + +       + +  E 
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 772 ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID 831
           E  +++ + H N++ +     N     L+LE +S G L D L     +L+     + +  
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQ 123
Query: 832 IASALEYLHFGHSTPIIHCDLKPSNV-LLDEDM-VAH--LSDFGMAKLLSGEDESTMRTQ 887
           I   + YL   H+  I H DLKP N+ LLD+++ + H  L DFG+A  +  ED    +  
Sbjct: 124 ILDGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFK-N 177
Query: 888 TLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIF 946
              T  ++AP+ +    L L+    D+  + ++  +   LLSG        K++ L +I 
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGDTKQETLANIT 231
Query: 947 SLALECTMESPEKRID-AKDTITRLL 971
           S++ +   E      + AKD I +LL
Sbjct: 232 SVSYDFDEEFFSHTSELAKDFIRKLL 257

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 67/266 (25%), Positives = 121/266 (45%), Gaps = 26/266 (9%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCAS------TLKSFEA 771
           F+  +  D +     +G G F  V + R +  G+E A K    + +       + +  E 
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 772 ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID 831
           E  +++ + H N++ +     N     L+LE +S G L D L     +L+     + +  
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQ 123
Query: 832 IASALEYLHFGHSTPIIHCDLKPSNV-LLDEDM-VAH--LSDFGMAKLLSGEDESTMRTQ 887
           I   + YL   H+  I H DLKP N+ LLD+++ + H  L DFG+A  +  ED    +  
Sbjct: 124 ILDGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFK-N 177
Query: 888 TLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIF 946
              T  ++AP+ +    L L+    D+  + ++  +   LLSG        K++ L +I 
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGDTKQETLANIT 231
Query: 947 SLALECTMESPEKRID-AKDTITRLL 971
           +++ +   E   +  + AKD I +LL
Sbjct: 232 AVSYDFDEEFFSQTSELAKDFIRKLL 257

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 34/266 (12%)
Query: 728 FAEN-NII---GIGGFGSVYRARLEDGV---EIAIKVFHPQCAS--TLKSFEAECEVIKN 778
           FAE  NI+   G G FG V + +  D +   E A+KV +   A      +   E E++K 
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCK--DRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSL-EDCLHSSNCALNIFCRLNIMIDIASALE 837
           + H N++K+     +     +V E  + G L ++ +     + +   R  I+  + S + 
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGIT 135
Query: 838 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           Y+H  H+  I+H DLKP N+LL   ++D    + DFG++       ++T     + T  Y
Sbjct: 136 YMH-KHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYY 189
Query: 895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTM 954
           +AP E+  G    K    D+    ++  +   LLSG    +   E  +L       +   
Sbjct: 190 IAP-EVLRGTYDEK---CDVWSAGVILYI---LLSGTPPFYGKNEYDILKRVETG-KYAF 241
Query: 955 ESPEKRI---DAKDTITRLLKIRDTL 977
           + P+ R    DAKD I ++L    +L
Sbjct: 242 DLPQWRTISDDAKDLIRKMLTFHPSL 267

>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 55/187 (29%), Positives = 79/187 (42%), Gaps = 2/187 (1%)
Query: 362 SSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIA-FCNISGNIPKAIGNLSNLI 420
           +S   C+ L  L L  N L     ++   L+L LE+L+++    +    P     L  L 
Sbjct: 50  ASFRACRNLTILWLHSNVLARIDAAAFTGLAL-LEQLDLSDNAQLRSVDPATFHGLGRLH 108
Query: 421 VLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGS 480
            L L    L    P  F GL  LQ L L  N L     D    L  L  L L+GN+IS  
Sbjct: 109 TLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168
Query: 481 ISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVV 540
                  L SL  L L  NR   V P  F +L  +++  + +N L    + A+  L+A+ 
Sbjct: 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228
Query: 541 GIDLSRN 547
            + L+ N
Sbjct: 229 YLRLNDN 235

>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 47/179 (26%), Positives = 75/179 (41%), Gaps = 1/179 (0%)
Query: 418 NLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSI-PDEICLLSRLNELDLNGNK 476
           NL +L L  N L+      F GL  L+ LDL+ N    S+ P     L RL+ L L+   
Sbjct: 57  NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116
Query: 477 ISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNL 536
           +          L +LQYL L  N    +   TF +L ++    +  N +      A   L
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176
Query: 537 KAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNN 595
            ++  + L +N ++   P     L  L  + L  N L     E+   + +L+ L L++N
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 55/187 (29%), Positives = 79/187 (42%), Gaps = 2/187 (1%)
Query: 362 SSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIA-FCNISGNIPKAIGNLSNLI 420
           +S   C+ L  L L  N L     ++   L+L LE+L+++    +    P     L  L 
Sbjct: 49  ASFRACRNLTILWLHSNVLARIDAAAFTGLAL-LEQLDLSDNAQLRSVDPATFHGLGRLH 107
Query: 421 VLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGS 480
            L L    L    P  F GL  LQ L L  N L     D    L  L  L L+GN+IS  
Sbjct: 108 TLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 167
Query: 481 ISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVV 540
                  L SL  L L  NR   V P  F +L  +++  + +N L    + A+  L+A+ 
Sbjct: 168 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 227
Query: 541 GIDLSRN 547
            + L+ N
Sbjct: 228 YLRLNDN 234

>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 47/179 (26%), Positives = 75/179 (41%), Gaps = 1/179 (0%)
Query: 418 NLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSI-PDEICLLSRLNELDLNGNK 476
           NL +L L  N L+      F GL  L+ LDL+ N    S+ P     L RL+ L L+   
Sbjct: 56  NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 115
Query: 477 ISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNL 536
           +          L +LQYL L  N    +   TF +L ++    +  N +      A   L
Sbjct: 116 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 175
Query: 537 KAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNN 595
            ++  + L +N ++   P     L  L  + L  N L     E+   + +L+ L L++N
Sbjct: 176 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 234

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 704 DIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQ- 761
           D +  ++P + R     L R  D+F    +IG G F  V   ++ + G   A+K+ +   
Sbjct: 41  DFLQWAEPIVVRLKEVRLQR--DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD 98
Query: 762 --CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA 819
                 +  F  E +V+ N   R + ++  +  ++++  LV+EY   G L   L      
Sbjct: 99  MLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER 158
Query: 820 LNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE 879
           +        + +I  A++ +H       +H D+KP N+LLD      L+DFG    L   
Sbjct: 159 IPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA- 214
Query: 880 DESTMRT-QTLATIGYMAPD 898
            + T+R+   + T  Y++P+
Sbjct: 215 -DGTVRSLVAVGTPDYLSPE 233

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 21/184 (11%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLKSFE--AECEVIKNIRHRNLV 785
           +G G FG VY        + E    +AIK  + + AS  +  E   E  V+K     ++V
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVV 82
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASAL 836
           +++   S      +++E M+ G L+  L S      N  +     L+ MI    +IA  +
Sbjct: 83  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 142
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
            YL+   +   +H DL   N ++ ED    + DFGM + +   D      + L  + +M+
Sbjct: 143 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 199
Query: 897 PDEI 900
           P+ +
Sbjct: 200 PESL 203

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 21/184 (11%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLKSFE--AECEVIKNIRHRNLV 785
           +G G FG VY        + E    +AIK  + + AS  +  E   E  V+K     ++V
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASAL 836
           +++   S      +++E M+ G L+  L S      N  +     L+ MI    +IA  +
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
            YL+   +   +H DL   N ++ ED    + DFGM + +   D      + L  + +M+
Sbjct: 139 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 195
Query: 897 PDEI 900
           P+ +
Sbjct: 196 PESL 199

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 21/184 (11%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLKSFE--AECEVIKNIRHRNLV 785
           +G G FG VY        + E    +AIK  + + AS  +  E   E  V+K     ++V
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASAL 836
           +++   S      +++E M+ G L+  L S      N  +     L+ MI    +IA  +
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
            YL+   +   +H DL   N ++ ED    + DFGM + +   D      + L  + +M+
Sbjct: 145 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 201
Query: 897 PDEI 900
           P+ +
Sbjct: 202 PESL 205

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 21/184 (11%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLKSFE--AECEVIKNIRHRNLV 785
           +G G FG VY        + E    +AIK  + + AS  +  E   E  V+K     ++V
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASAL 836
           +++   S      +++E M+ G L+  L S      N  +     L+ MI    +IA  +
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
            YL+   +   +H DL   N ++ ED    + DFGM + +   D      + L  + +M+
Sbjct: 145 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 201
Query: 897 PDEI 900
           P+ +
Sbjct: 202 PESL 205

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 21/184 (11%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLKSFE--AECEVIKNIRHRNLV 785
           +G G FG VY        + E    +AIK  + + AS  +  E   E  V+K     ++V
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASAL 836
           +++   S      +++E M+ G L+  L S      N  +     L+ MI    +IA  +
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 151
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
            YL+   +   +H DL   N ++ ED    + DFGM + +   D      + L  + +M+
Sbjct: 152 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 897 PDEI 900
           P+ +
Sbjct: 209 PESL 212

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 21/184 (11%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLKSFE--AECEVIKNIRHRNLV 785
           +G G FG VY        + E    +AIK  + + AS  +  E   E  V+K     ++V
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASAL 836
           +++   S      +++E M+ G L+  L S      N  +     L+ MI    +IA  +
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
            YL+   +   +H DL   N ++ ED    + DFGM + +   D      + L  + +M+
Sbjct: 146 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 202
Query: 897 PDEI 900
           P+ +
Sbjct: 203 PESL 206

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 67/266 (25%), Positives = 121/266 (45%), Gaps = 26/266 (9%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCAS------TLKSFEA 771
           F+  +  D +     +G G F  V + R +  G+E A K    + +       + +  E 
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 772 ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID 831
           E  +++ + H N++ +     N     L+LE +S G L D L     +L+     + +  
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQ 123
Query: 832 IASALEYLHFGHSTPIIHCDLKPSNV-LLDEDM-VAH--LSDFGMAKLLSGEDESTMRTQ 887
           I   + YL   H+  I H DLKP N+ LLD+++ + H  L DFG+A  +  ED    +  
Sbjct: 124 ILDGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFK-N 177
Query: 888 TLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIF 946
              T  ++AP+ +    L L+    D+  + ++  +   LLSG        K++ L +I 
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGDTKQETLANIT 231
Query: 947 SLALECTMESPEKRID-AKDTITRLL 971
           +++ +   E   +  + AKD I +LL
Sbjct: 232 AVSYDFDEEFFSQTSELAKDFIRKLL 257

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 13/159 (8%)
Query: 722 LRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLK-SFEAECEVIKNI 779
           LR  + +     IG G FG +Y    +  G E+AIK+   +C  T       E ++ K +
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMM 59
Query: 780 RHRNLVKIISSCSND-DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           +    +  I  C  + D+  +V+E +   SLED  +  +   ++   L +   + S +EY
Sbjct: 60  QGGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 839 LHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAK 874
           +H   S   IH D+KP N L+    +  + ++ DFG+AK
Sbjct: 119 IH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 13/159 (8%)
Query: 722 LRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLK-SFEAECEVIKNI 779
           LR  + +     IG G FG +Y    +  G E+AIK+   +C  T       E ++ K +
Sbjct: 5   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMM 61
Query: 780 RHRNLVKIISSCSND-DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           +    +  I  C  + D+  +V+E +   SLED  +  +   ++   L +   + S +EY
Sbjct: 62  QGGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 839 LHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAK 874
           +H   S   IH D+KP N L+    +  + ++ DFG+AK
Sbjct: 121 IH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 10/180 (5%)
Query: 723 RATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQC----ASTLKSFEAECEVIKN 778
           R    +     +G GGF   Y     D  E+      P+         +    E  + K+
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           + + ++V       +DDF  +VLE     SL + LH    A+        M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           LH   +  +IH DLK  N+ L++DM   + DFG+A  +  + E   +     T  Y+AP+
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPE 212

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 10/180 (5%)
Query: 723 RATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQC----ASTLKSFEAECEVIKN 778
           R    +     +G GGF   Y     D  E+      P+         +    E  + K+
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           + + ++V       +DDF  +VLE     SL + LH    A+        M      ++Y
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 141
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           LH   +  +IH DLK  N+ L++DM   + DFG+A  +  + E   +     T  Y+AP+
Sbjct: 142 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPE 196

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 87/184 (47%), Gaps = 12/184 (6%)
Query: 720 ELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV---FHPQCASTLKSFEAECEV 775
           +L    +++    +IG G FG V   R +   ++ A+K+   F     S    F  E ++
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 776 IKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASA 835
           +       +V++  +  +D +  +V+EYM  G L + + + +     + R     ++  A
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP-EKWARF-YTAEVVLA 180
Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT-LATIGY 894
           L+ +H   S   IH D+KP N+LLD+     L+DFG    ++   E  +R  T + T  Y
Sbjct: 181 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK--EGMVRCDTAVGTPDY 235
Query: 895 MAPD 898
           ++P+
Sbjct: 236 ISPE 239

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 45/191 (23%), Positives = 90/191 (47%), Gaps = 11/191 (5%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDG--VEIAIKVFHPQCASTLKSFEA-- 771
           +   +L+ T+ F +  ++  G FG+VY+   + +G  V+I + +   + A++ K+ +   
Sbjct: 7   ALLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 772 -ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
            E  V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            IA  + YL       ++H DL   NVL+       ++DFG+AKLL  E++         
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 891 TIGYMAPDEIF 901
            I +MA + I 
Sbjct: 182 PIKWMALESIL 192

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 87/184 (47%), Gaps = 12/184 (6%)
Query: 720 ELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV---FHPQCASTLKSFEAECEV 775
           +L    +++    +IG G FG V   R +   ++ A+K+   F     S    F  E ++
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 776 IKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASA 835
           +       +V++  +  +D +  +V+EYM  G L + + + +     + R     ++  A
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP-EKWARF-YTAEVVLA 185
Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT-LATIGY 894
           L+ +H   S   IH D+KP N+LLD+     L+DFG    ++   E  +R  T + T  Y
Sbjct: 186 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK--EGMVRCDTAVGTPDY 240
Query: 895 MAPD 898
           ++P+
Sbjct: 241 ISPE 244

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 734 IGIGGFGSV----YRARLEDGVEIAIKVFHPQCASTLKSFE--AECEVIKNIRHRNLVKI 787
           +G G FGSV    YR R +  +++AIKV   Q      + E   E +++  + +  +V++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQ-IDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
           I  C  +    LV+E    G L   L      + +     ++  ++  ++YL        
Sbjct: 402 IGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNF 457
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIGYMAPDEI 900
           +H +L   NVLL     A +SDFG++K L  +D   T R+     + + AP+ I
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 87/184 (47%), Gaps = 12/184 (6%)
Query: 720 ELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKV---FHPQCASTLKSFEAECEV 775
           +L    +++    +IG G FG V   R +   ++ A+K+   F     S    F  E ++
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 776 IKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASA 835
           +       +V++  +  +D +  +V+EYM  G L + + + +     + R     ++  A
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP-EKWARF-YTAEVVLA 185
Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT-LATIGY 894
           L+ +H   S   IH D+KP N+LLD+     L+DFG    ++   E  +R  T + T  Y
Sbjct: 186 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK--EGMVRCDTAVGTPDY 240
Query: 895 MAPD 898
           ++P+
Sbjct: 241 ISPE 244

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 20/174 (11%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTL--KSFEAECEVIKNIRHRNLVKIISS 790
           +G G +GSV  A   + G  +A+K       S +  K    E  ++K+++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID------IASALEYLHFGHS 844
            +     A  LE  ++  L    H     LN   +   + D      I   L  L + HS
Sbjct: 90  FT----PARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
             IIH DLKPSN+ ++ED    + DF +A+    E      T  +AT  Y AP+
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MTGYVATRWYRAPE 192

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 10/180 (5%)
Query: 723 RATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQC----ASTLKSFEAECEVIKN 778
           R    +     +G GGF   Y     D  E+      P+         +    E  + K+
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           + + ++V       +DDF  +VLE     SL + LH    A+        M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           LH   +  +IH DLK  N+ L++DM   + DFG+A  +  + E   +     T  Y+AP+
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPNYIAPE 212

>pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 86/180 (47%), Gaps = 9/180 (5%)
Query: 446 LDLAFNKLAGSIP----DEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRF 501
           L+L  NKL  S+P    D++  L++L+ L  NG    G  S      TSL+YL+L  N  
Sbjct: 33  LELESNKLQ-SLPHGVFDKLTQLTKLS-LSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG- 89
Query: 502 TFVIPSTFWNLKDILSFDIS-SNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGL 560
              + S F  L+ +   D   SNL          +L+ ++ +D+S  +          GL
Sbjct: 90  VITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 149
Query: 561 KSLQNISLAYNRL-EGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFN 619
            SL+ + +A N   E  +P+ F  + +L  LDLS  ++    P +F  LS L+ LN+S N
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 209

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 19/183 (10%)
Query: 734 IGIGGFGSVYRARLEDGVE------IAIKVFHPQCASTLK-SFEAECEVIKNIRHRNLVK 786
           +G G FG VY     D ++      +A+K  +   +   +  F  E  V+K     ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASALE 837
           ++   S      +V+E M++G L+  L S      N        L  MI    +IA  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           YL+   +   +H DL   N ++  D    + DFGM + +   D      + L  + +MAP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 898 DEI 900
           + +
Sbjct: 199 ESL 201

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 19/183 (10%)
Query: 734 IGIGGFGSVYRARLEDGVE------IAIKVFHPQCASTLK-SFEAECEVIKNIRHRNLVK 786
           +G G FG VY     D ++      +A+K  +   +   +  F  E  V+K     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASALE 837
           ++   S      +V+E M++G L+  L S      N        L  MI    +IA  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           YL+   +   +H DL   N ++  D    + DFGM + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 898 DEI 900
           + +
Sbjct: 202 ESL 204

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 19/183 (10%)
Query: 734 IGIGGFGSVYRARLEDGVE------IAIKVFHPQCASTLK-SFEAECEVIKNIRHRNLVK 786
           +G G FG VY     D ++      +A+K  +   +   +  F  E  V+K     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASALE 837
           ++   S      +V+E M++G L+  L S      N        L  MI    +IA  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           YL+   +   +H DL   N ++  D    + DFGM + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 898 DEI 900
           + +
Sbjct: 202 ESL 204

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 76/176 (43%), Gaps = 10/176 (5%)
Query: 732 NIIGIGGFGSVYRA-RLEDG----VEIAIKVFHPQCASTL-KSFEAECEVIKNIRHRNLV 785
            ++G G FG+VY+   + DG    + +AIKV     +    K    E  V+  +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
           +++  C     + LV + M  G L D +  +   L     LN  + IA  + YL      
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLE---DV 138
Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
            ++H DL   NVL+       ++DFG+A+LL  ++           I +MA + I 
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 74/179 (41%), Gaps = 16/179 (8%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQ-----CA---STLKSFEAECEVIKNIRHRNL 784
           +G G FG V+ A   E   E+ +K    +     C      L     E  ++  + H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           +K++    N  F  LV+E   +G         +  L+      I   + SA+ YL     
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD- 150
Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG 903
             IIH D+K  N+++ ED    L DFG A  L   +   +      TI Y AP E+ +G
Sbjct: 151 --IIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGTIEYCAP-EVLMG 203

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 77/290 (26%), Positives = 121/290 (41%), Gaps = 46/290 (15%)
Query: 724 ATDNFA---------ENNIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFEAEC 773
           +TD+F+         + +++G G    V     L    E A+K+   Q          E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 774 EVIKNIR-HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
           E++   + HRN++++I     +D   LV E M  GS+   +H      N      ++ D+
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDV 120
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHLS----DFGMAKLLSGEDESTMRTQ 887
           ASAL++LH   +  I H DLKP N+L +  + V+ +     D G    L+G+       +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 888 TLATIG---YMAPD--EIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------ 936
            L   G   YMAP+  E F  E S+     DL  + ++  +   LLSG            
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYI---LLSGYPPFVGRCGSDC 234
Query: 937 ------AKEQCLLSIFSLALECTMESPEK-----RIDAKDTITRLLKIRD 975
                 A   C   +F    E   E P+K        AKD I++LL +RD
Sbjct: 235 GWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLL-VRD 283

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 50/191 (26%), Positives = 86/191 (45%), Gaps = 20/191 (10%)
Query: 721 LLRATDNFAENNIIGIGGFGSVYRAR-LEDGVE-IAIKVFHPQCA------STLKSFEAE 772
           L RA   +     IG G +G V++AR L++G   +A+K    Q        ST++   A 
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AV 64
Query: 773 CEVIKNIRHRNLVKIISSC--SNDDFKA---LVLEYMSNGSLEDCLHSSNCALNIFCRLN 827
              ++   H N+V++   C  S  D +    LV E++               +      +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 828 IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ 887
           +M  +   L++LH   S  ++H DLKP N+L+       L+DFG+A++ S +      T 
Sbjct: 125 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTS 178
Query: 888 TLATIGYMAPD 898
            + T+ Y AP+
Sbjct: 179 VVVTLWYRAPE 189

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 50/191 (26%), Positives = 86/191 (45%), Gaps = 20/191 (10%)
Query: 721 LLRATDNFAENNIIGIGGFGSVYRAR-LEDGVE-IAIKVFHPQCA------STLKSFEAE 772
           L RA   +     IG G +G V++AR L++G   +A+K    Q        ST++   A 
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AV 64
Query: 773 CEVIKNIRHRNLVKIISSC--SNDDFKA---LVLEYMSNGSLEDCLHSSNCALNIFCRLN 827
              ++   H N+V++   C  S  D +    LV E++               +      +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 828 IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ 887
           +M  +   L++LH   S  ++H DLKP N+L+       L+DFG+A++ S +      T 
Sbjct: 125 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTS 178
Query: 888 TLATIGYMAPD 898
            + T+ Y AP+
Sbjct: 179 VVVTLWYRAPE 189

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 50/191 (26%), Positives = 86/191 (45%), Gaps = 20/191 (10%)
Query: 721 LLRATDNFAENNIIGIGGFGSVYRAR-LEDGVE-IAIKVFHPQCA------STLKSFEAE 772
           L RA   +     IG G +G V++AR L++G   +A+K    Q        ST++   A 
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AV 64
Query: 773 CEVIKNIRHRNLVKIISSC--SNDDFKA---LVLEYMSNGSLEDCLHSSNCALNIFCRLN 827
              ++   H N+V++   C  S  D +    LV E++               +      +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 828 IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ 887
           +M  +   L++LH   S  ++H DLKP N+L+       L+DFG+A++ S +      T 
Sbjct: 125 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTS 178
Query: 888 TLATIGYMAPD 898
            + T+ Y AP+
Sbjct: 179 VVVTLWYRAPE 189

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 50/190 (26%), Positives = 87/190 (45%), Gaps = 22/190 (11%)
Query: 724 ATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIK-VFHPQCA--------STLKSFEAEC 773
           AT  +     IG+G +G+VY+AR    G  +A+K V  P           ST++   A  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREV-ALL 65
Query: 774 EVIKNIRHRNLVKIISSC----SNDDFK-ALVLEYMSNGSLEDCLHSSNCALNIFCRLNI 828
             ++   H N+V+++  C    ++ + K  LV E++          +    L      ++
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
           M      L++L   H+  I+H DLKP N+L+       L+DFG+A++ S +      T  
Sbjct: 126 MRQFLRGLDFL---HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPV 179
Query: 889 LATIGYMAPD 898
           + T+ Y AP+
Sbjct: 180 VVTLWYRAPE 189

>pdb|3VQ1|A Chain A, Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLEX Length = 606

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 131/552 (23%), Positives = 235/552 (42%), Gaps = 61/552 (11%)
Query: 87  GTIPP--EIANLSSLKSLDLSHNKLSSNIPSSI----FTMSTLKVLYLMDNQLSGSLSSF 140
           G++ P  E+    + + +D   +K+  +IPSS      + + LK+L            S+
Sbjct: 2   GSLNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKIL-----------KSY 50
Query: 141 TF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQEL 199
           +F N S +  + LS+ ++   + +   + L +L +L L  N      P S S    L+ L
Sbjct: 51  SFSNFSELQWLDLSRCEIE-TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENL 109
Query: 200 HLGYNNLSGAIPKEIGNLTVLQRISLINNKLHG-EIPQEIGYLQNLDVLQLGFNNLTGVV 258
                 L+      IG L  L+++++ +N +H  ++P     L NL  + L +N +  + 
Sbjct: 110 VAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI- 168
Query: 259 PATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFS--GTIPSSITNASK 316
             T+ ++  L+E    N SL  SL + ID  + +  F  + ++  +  G   SS  N  K
Sbjct: 169 --TVNDLQFLRENPQVNLSLDMSL-NPIDF-IQDQAFQGIKLHELTLRGNFNSS--NIMK 222
Query: 317 LILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPEL--GFLSSLANCKKLRYLG 374
             L  +        I     + RNL++F+          P +  G      +  +L Y  
Sbjct: 223 TCLQNLAGLHVHRLILGEFKDERNLEIFE----------PSIMEGLCDVTIDEFRLTYTN 272
Query: 375 LGGNPLDGFLPSSIGNLS-LSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSI 433
              + +  F    + N+S +SL  ++I +     ++PK     S  I+        +  +
Sbjct: 273 DFSDDIVKF--HCLANVSAMSLAGVSIKYLE---DVPKHFKWQSLSIIRCQLKQFPTLDL 327
Query: 434 PVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNL--TSL 491
           P        L+ L L  NK  GSI  +   L  L+ LDL+ N +S S      +L   SL
Sbjct: 328 PF-------LKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSL 378
Query: 492 QYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISL-AIGNLKAVVGIDLSRNNLS 550
           ++L+L  N    ++ + F  L+++   D   + L       A  +L+ ++ +D+S  N  
Sbjct: 379 RHLDLSFNG-AIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 551 GNIPTTLEGLKSLQNISLAYNRL-EGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLS 609
            +      GL SL  + +A N   +  +   F N T+L  LDLS  ++       F+ L 
Sbjct: 438 IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH 497
Query: 610 YLKELNLSFNKL 621
            L+ LN+S N L
Sbjct: 498 RLQLLNMSHNNL 509

>pdb|3VQ1|A Chain A, Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLEX Length = 606

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 115/271 (42%), Gaps = 15/271 (5%)
Query: 373 LGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGS 432
           + L  NPL      S  N S  L+ L+++ C I     KA   L +L  L L GN +   
Sbjct: 37  IDLSFNPLKILKSYSFSNFS-ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSF 95
Query: 433 IPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKI-SGSISSCLGNLTSL 491
            P +F GL  L+ L     KLA      I  L  L +L++  N I S  + +   NLT+L
Sbjct: 96  SPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNL 155
Query: 492 QYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSG 551
            +++L  N    +  +    L++    ++S ++   PI       +A  GI L    L G
Sbjct: 156 VHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQD--QAFQGIKLHELTLRG 213
Query: 552 NIPTTLEGLKSLQNIS-LAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSY 610
           N  ++      LQN++ L  +RL   I   F +  +LE  + S  +    + +   +L+Y
Sbjct: 214 NFNSSNIMKTCLQNLAGLHVHRL---ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270
Query: 611 LKELNLSFNKLKGEIPRGGPFANFTAESFMG 641
                   N    +I +    AN +A S  G
Sbjct: 271 T-------NDFSDDIVKFHCLANVSAMSLAG 294

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 19/155 (12%)
Query: 731 NNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA----------STLKSFEAECEVIKNIR 780
           + +IG G FG VY     D  +  I     QCA            +++F  E  +++ + 
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRI-----QCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 781 HRNLVKIIS-SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
           H N++ +I      +    ++L YM +G L   + S      +   ++  + +A  +EYL
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK 874
                   +H DL   N +LDE     ++DFG+A+
Sbjct: 141 A---EQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|2Z64|A Chain A, Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Complex Length = 599

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 128/539 (23%), Positives = 229/539 (42%), Gaps = 59/539 (10%)
Query: 98  SLKSLDLSHNKLSSNIPSSI----FTMSTLKVLYLMDNQLSGSLSSFTF-NTSSILDIRL 152
           + + +D   +K+  +IPSS      + + LK+L            S++F N S +  + L
Sbjct: 10  TYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKIL-----------KSYSFSNFSELQWLDL 58
Query: 153 SKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPK 212
           S+ ++   + +   + L +L +L L  N      P S S    L+ L      L+     
Sbjct: 59  SRCEIE-TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESF 117
Query: 213 EIGNLTVLQRISLINNKLHG-EIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEI 271
            IG L  L+++++ +N +H  ++P     L NL  + L +N +  +   T+ ++  L+E 
Sbjct: 118 PIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI---TVNDLQFLREN 174
Query: 272 FLYNNSLSGSLPSRIDLALPNLEFLNLGINSFS--GTIPSSITNASKLILLEMGSNSFSG 329
              N SL  SL + ID  + +  F  + ++  +  G   SS  N  K  L  +       
Sbjct: 175 PQVNLSLDMSL-NPIDF-IQDQAFQGIKLHELTLRGNFNSS--NIMKTCLQNLAGLHVHR 230
Query: 330 FIPSAIGNLRNLKLFDIFFNNLTSSTPEL--GFLSSLANCKKLRYLGLGGNPLDGFLPSS 387
            I     + RNL++F+          P +  G      +  +L Y     + +  F    
Sbjct: 231 LILGEFKDERNLEIFE----------PSIMEGLCDVTIDEFRLTYTNDFSDDIVKF--HC 278
Query: 388 IGNLS-LSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGL 446
           + N+S +SL  ++I +     ++PK     S  I+        +  +P        L+ L
Sbjct: 279 LANVSAMSLAGVSIKYLE---DVPKHFKWQSLSIIRCQLKQFPTLDLPF-------LKSL 328
Query: 447 DLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNL--TSLQYLNLGSNRFTFV 504
            L  NK  GSI  +   L  L+ LDL+ N +S S      +L   SL++L+L  N    +
Sbjct: 329 TLTMNK--GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNG-AII 385
Query: 505 IPSTFWNLKDILSFDISSNLLDGPISL-AIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSL 563
           + + F  L+++   D   + L       A  +L+ ++ +D+S  N   +      GL SL
Sbjct: 386 MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 445
Query: 564 QNISLAYNRL-EGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKL 621
             + +A N   +  +   F N T+L  LDLS  ++       F+ L  L+ LN+S N L
Sbjct: 446 NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 504

>pdb|2Z64|A Chain A, Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Complex Length = 599

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 116/273 (42%), Gaps = 15/273 (5%)
Query: 371 RYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLS 430
           + + L  NPL      S  N S  L+ L+++ C I     KA   L +L  L L GN + 
Sbjct: 30  KNIDLSFNPLKILKSYSFSNFS-ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 88
Query: 431 GSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKI-SGSISSCLGNLT 489
              P +F GL  L+ L     KLA      I  L  L +L++  N I S  + +   NLT
Sbjct: 89  SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 148
Query: 490 SLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNL 549
           +L +++L  N    +  +    L++    ++S ++   PI       +A  GI L    L
Sbjct: 149 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQD--QAFQGIKLHELTL 206
Query: 550 SGNIPTTLEGLKSLQNIS-LAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKL 608
            GN  ++      LQN++ L  +RL   I   F +  +LE  + S  +    + +   +L
Sbjct: 207 RGNFNSSNIMKTCLQNLAGLHVHRL---ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 263
Query: 609 SYLKELNLSFNKLKGEIPRGGPFANFTAESFMG 641
           +Y        N    +I +    AN +A S  G
Sbjct: 264 TYT-------NDFSDDIVKFHCLANVSAMSLAG 289

>pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 54/297 (18%)
Query: 236 QEIGYLQNLDVLQLGFNNLTGVVP--------------------ATIFNMSTLKEIFLYN 275
           Q I YL NL+ L L  N +T + P                    + + N++ L+E++L  
Sbjct: 60  QGIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKITDISALQNLTNLRELYLNE 119
Query: 276 NSLSGSLPSRIDLALPNLE---FLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIP 332
           +++S   P      L NL     LNLG N     + S ++N + L  L +  +      P
Sbjct: 120 DNISDISP------LANLTKXYSLNLGANHNLSDL-SPLSNXTGLNYLTVTESKVKDVTP 172
Query: 333 SAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLS 392
             I NL +L    + +N +   +P       LA+   L Y     N +    P  + N +
Sbjct: 173 --IANLTDLYSLSLNYNQIEDISP-------LASLTSLHYFTAYVNQITDITP--VANXT 221
Query: 393 LSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNK 452
             L  L I    I+   P  + NLS L  L +G N +S    V    L KL+ L++  N+
Sbjct: 222 -RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAV--KDLTKLKXLNVGSNQ 276
Query: 453 LAGSIPDEICLL---SRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIP 506
           ++     +I +L   S+LN L LN N++       +G LT+L  L L  N  T + P
Sbjct: 277 IS-----DISVLNNLSQLNSLFLNNNQLGNEDXEVIGGLTNLTTLFLSQNHITDIRP 328

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 82/177 (46%), Gaps = 23/177 (12%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFEAECEVI--KNIRHRNLVKII-- 788
           +G G +GSV  A     G ++AIK       S + +  A  E++  K+++H N++ ++  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 789 ----SSCSN-DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
               SS  N  DF  LV+ +M    L+  +         F    I   +   L+ L + H
Sbjct: 110 FTPASSLRNFYDF-YLVMPFMQT-DLQKIMGME------FSEEKIQYLVYQMLKGLKYIH 161
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           S  ++H DLKP N+ ++ED    + DFG+A+    E      T  + T  Y AP+ I
Sbjct: 162 SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVI 213

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 46/184 (25%), Positives = 80/184 (43%), Gaps = 21/184 (11%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLKSFE--AECEVIKNIRHRNLV 785
           +G G FG VY        + E    +AIK  + + AS  +  E   E  V+K     ++V
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASAL 836
           +++   S      +++E M+ G L+  L S      N  +     L+ MI    +IA  +
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
            YL+   +   +H DL   N  + ED    + DFGM + +   D      + L  + +M+
Sbjct: 139 AYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 195
Query: 897 PDEI 900
           P+ +
Sbjct: 196 PESL 199

>pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 562

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 74/143 (51%), Gaps = 9/143 (6%)
Query: 368 KKLRYLGLGGNPLDGFLPSSI--GNLSLSLERLNIAFCNI-SGNIPKAIGNLSNLIVLSL 424
           K+L+ L L  N L  F   ++   N+S SLE L+++  ++ S    +      +++VL+L
Sbjct: 377 KRLQTLILQRNGLKNFFKVALMTKNMS-SLETLDVSLNSLNSHAYDRTCAWAESILVLNL 435
Query: 425 GGNNLSGSIPVTFGGLQ-KLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISS 483
             N L+GS+   F  L  K++ LDL  N++  SIP ++  L  L EL++  N++      
Sbjct: 436 SSNMLTGSV---FRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDG 491
Query: 484 CLGNLTSLQYLNLGSNRFTFVIP 506
               LTSLQY+ L  N +    P
Sbjct: 492 VFDRLTSLQYIWLHDNPWDCTCP 514

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 17/186 (9%)
Query: 724 ATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIK-VFHPQCASTLK-SFEAECEVIKNIR 780
           AT  +     IG+G +G+VY+AR    G  +A+K V  P     L  S   E  +++ + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 781 ---HRNLVKIISSC----SNDDFK-ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
              H N+V+++  C    ++ + K  LV E++          +    L      ++M   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
              L++LH   +  I+H DLKP N+L+       L+DFG+A++ S +         + T+
Sbjct: 122 LRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALAPVVVTL 175
Query: 893 GYMAPD 898
            Y AP+
Sbjct: 176 WYRAPE 181

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 82/177 (46%), Gaps = 23/177 (12%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFEAECEVI--KNIRHRNLVKII-- 788
           +G G +GSV  A     G ++AIK       S + +  A  E++  K+++H N++ ++  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 789 ----SSCSN-DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
               SS  N  DF  LV+ +M    L+  +         F    I   +   L+ L + H
Sbjct: 92  FTPASSLRNFYDF-YLVMPFMQT-DLQKIMGLK------FSEEKIQYLVYQMLKGLKYIH 143
Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           S  ++H DLKP N+ ++ED    + DFG+A+    E      T  + T  Y AP+ I
Sbjct: 144 SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVI 195

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 17/186 (9%)
Query: 724 ATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIK-VFHPQCASTLK-SFEAECEVIKNIR 780
           AT  +     IG+G +G+VY+AR    G  +A+K V  P     L  S   E  +++ + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 781 ---HRNLVKIISSC----SNDDFK-ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
              H N+V+++  C    ++ + K  LV E++          +    L      ++M   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
              L++LH   +  I+H DLKP N+L+       L+DFG+A++ S +         + T+
Sbjct: 122 LRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALDPVVVTL 175
Query: 893 GYMAPD 898
            Y AP+
Sbjct: 176 WYRAPE 181

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 19/183 (10%)
Query: 734 IGIGGFGSVYRARLEDGVE------IAIKVFHPQCASTLK-SFEAECEVIKNIRHRNLVK 786
           +G G FG VY     D ++      +A+K  +   +   +  F  E  V+K     ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASALE 837
           ++   S      +V+E M++G L+  L S      N        L  MI    +IA  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           YL+   +   +H DL   N ++  D    + DFGM + +   D      + L  + +MAP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 898 DEI 900
           + +
Sbjct: 201 ESL 203

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 19/183 (10%)
Query: 734 IGIGGFGSVYRARLEDGVE------IAIKVFHPQCASTLK-SFEAECEVIKNIRHRNLVK 786
           +G G FG VY     D ++      +A+K  +   +   +  F  E  V+K     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASALE 837
           ++   S      +V+E M++G L+  L S      N        L  MI    +IA  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           YL+   +   +H DL   N ++  D    + DFGM + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 898 DEI 900
           + +
Sbjct: 202 ESL 204

>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 5/152 (3%)
Query: 357 ELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAI-GN 415
           +L  +S+L     L YL L GN L   LP+ + +   +L+ L +   N   ++P  +   
Sbjct: 74  KLHDISALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKEL-VLVENQLQSLPDGVFDK 131
Query: 416 LSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEIC-LLSRLNELDLNG 474
           L+NL  L+L  N L       F  L  L  LDL++N+L  S+P+ +   L++L +L L  
Sbjct: 132 LTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQ 190
Query: 475 NKISGSISSCLGNLTSLQYLNLGSNRFTFVIP 506
           N++          LTSLQY+ L  N +    P
Sbjct: 191 NQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222

>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 85/195 (43%), Gaps = 31/195 (15%)
Query: 461 ICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDI 520
           I  L  +  L L GNK+     S L  LT+L YL L  N+   +    F    D L+   
Sbjct: 59  IQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVF----DKLT--- 109
Query: 521 SSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPES 580
                         NLK +V   L  N L        + L +L  ++LA+N+L+      
Sbjct: 110 --------------NLKELV---LVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGV 152
Query: 581 FGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFM 640
           F  +T+L  LDLS N++       F+KL+ LK+L L  N+LK  +P  G F   T+  ++
Sbjct: 153 FDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS-VP-DGVFDRLTSLQYI 210
Query: 641 ---GNELLCGLPNLQ 652
               N   C  P ++
Sbjct: 211 WLHDNPWDCTCPGIR 225

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 30/73 (41%), Positives = 42/73 (57%), Gaps = 5/73 (6%)
Query: 828 IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ 887
           + + I  AL YL   H   +IH D+KPSN+LLDE     L DFG++  L  +D++  R+ 
Sbjct: 129 MTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSA 185
Query: 888 TLATIGYMAPDEI 900
             A   YMAP+ I
Sbjct: 186 GCA--AYMAPERI 196

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCA---STLKSFEAECE 774
           F+LLR         +IG G +  V   RL+    I A++V   +       +   + E  
Sbjct: 54  FDLLR---------VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH 104
Query: 775 VIKNIRHRNLVKIISSCSNDDFK-ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
           V +   +   +  + SC   + +   V+EY++ G L   +           R     +I+
Sbjct: 105 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEIS 163
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK--LLSGEDESTMRTQTLAT 891
            AL YLH      II+ DLK  NVLLD +    L+D+GM K  L  G+  ST       T
Sbjct: 164 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF----CGT 216
Query: 892 IGYMAPDEIFVGE---LSLKRWV 911
             Y+AP EI  GE    S+  W 
Sbjct: 217 PNYIAP-EILRGEDYGFSVDWWA 238

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/267 (22%), Positives = 103/267 (38%), Gaps = 42/267 (15%)
Query: 721 LLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR 780
           ++  +D +     IG G FG     R +   E+    +  + A+  ++ + E    +++R
Sbjct: 15  IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR 74
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+V+           A+++EY S G     L+   C    F            L  + 
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGE----LYERICNAGRFSEDEARFFFQQLLSGVS 130
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLS--DFGMAKLLSGEDESTMRTQTLATIG---YM 895
           + HS  I H DLK  N LLD      L   DFG +K       S + +Q  +T+G   Y+
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYI 184
Query: 896 APDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALEC-TM 954
           AP+ +   E   K                           A    C ++++ + +     
Sbjct: 185 APEVLLRQEYDGK--------------------------IADVWSCGVTLYVMLVGAYPF 218
Query: 955 ESPEKRIDAKDTITRLLKIRDTLSKRI 981
           E PE+  D + TI R+L ++ ++   I
Sbjct: 219 EDPEEPRDYRKTIQRILSVKYSIPDDI 245

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 42/173 (24%), Positives = 81/173 (46%), Gaps = 12/173 (6%)
Query: 734 IGIGGFGSV----YRARLEDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKII 788
           IG G FG V    Y +     + +AIK      + +++  F  E   ++   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
              + +    +++E  + G L   L     +L++   +     +++AL YL    S   +
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR-TQTLATIGYMAPDEI 900
           H D+   NVL+  +    L DFG+++ +  ED +  + ++    I +MAP+ I
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTXXKASKGKLPIKWMAPESI 184

>pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 89/193 (46%), Gaps = 9/193 (4%)
Query: 431 GSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKIS--GSISSCLGNL 488
           G  P     L+ L+ L    NK  G+   E+ L S L  LDL+ N +S  G  S      
Sbjct: 317 GQFPTL--KLKSLKRLTFTSNK-GGNAFSEVDLPS-LEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 489 TSLQYLNLGSNRFTFVIPSTFWNLKDILSFDIS-SNLLDGPISLAIGNLKAVVGIDLSRN 547
           TSL+YL+L  N     + S F  L+ +   D   SNL          +L+ ++ +D+S  
Sbjct: 373 TSLKYLDLSFNG-VITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 548 NLSGNIPTTLEGLKSLQNISLAYNRL-EGPIPESFGNMTSLESLDLSNNKISGSIPVSFE 606
           +          GL SL+ + +A N   E  +P+ F  + +L  LDLS  ++    P +F 
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 607 KLSYLKELNLSFN 619
            LS L+ LN+S N
Sbjct: 492 SLSSLQVLNMSHN 504

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 12/170 (7%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQC----ASTLKSFEAECEVIKNIRHRNLVKIIS 789
           +G GGF   +     D  E+      P+         +    E  + +++ H+++V    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
              ++DF  +VLE     SL + LH    AL        +  I    +YLH      +IH
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIH 138
Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPD 898
            DLK  N+ L+ED+   + DFG+A  +  + E   R + L  T  Y+AP+
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPE 185

>pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex Length = 612

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 120/493 (24%), Positives = 196/493 (39%), Gaps = 79/493 (16%)
Query: 170 RYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNK 229
           ++LKHLFL +          +   + L+ LHLG N++S     E      L+ +   NN 
Sbjct: 104 KFLKHLFLTQTGISNLEFIPVHNLENLESLHLGSNHISSINLPENFPTQNLKVLDFQNNA 163
Query: 230 LHGEIPQEIGYLQNLDVLQLGFN--NLTGVVPATIFNM---------------------- 265
           +H    ++   L+    L L FN  ++ G+ P    +                       
Sbjct: 164 IHYISRKDTNSLEQATNLSLNFNGNDIKGIEPGAFISKIFQSLKFGGSLNLFIIFKGLQN 223
Query: 266 STLKEIFL--YNNSLSGSLPSRIDLALPNL--EFLNLGINSFSGTIPSSITNASKLILLE 321
           STL+ ++L  + ++    L S     L ++  E +NL  + FS    S+    +++  L+
Sbjct: 224 STLQSLWLGTFEDTDDQYLTSATFEGLCDMSVESINLQKHRFSDLSSSTFRCFTRVQELD 283
Query: 322 MGSNSFSGFIPSAIGNLRNLKL-------FDIFFNNLTSSTPELGFLSSLANCKKLRYLG 374
           + +   +G +PS I  + +LK        FD       +S P L  L    N   +R L 
Sbjct: 284 LTAAHLNG-LPSGIEGMNSLKKLVLNANSFDQLCQINAASFPSLRDLYIKGN---MRKLD 339
Query: 375 LGGNPLDGFLPSSIGNLSLSLERLNIA-FCNISGNIPKAIGNLSNLIVLSLGGNNLSGSI 433
           LG   L+     ++  L LS   +  +  CN+       + NL +L  L+L  N   G  
Sbjct: 340 LGTRCLEKL--ENLQKLDLSHSDIEASDCCNLQ------LKNLRHLQYLNLSYNEPLGLE 391
Query: 434 PVTFGGLQKLQGLDLAFNKLAGSIPDE-ICLLSRLNELDLNGNKISGSISSCLGNLTSLQ 492
              F    +L+ LD+AF  L    P      L  L  L+L+   +  S    L  L  L+
Sbjct: 392 DQAFKECPQLELLDVAFTHLHVKAPHSPFQNLHLLRVLNLSHCLLDTSNQHLLAGLQDLR 451
Query: 493 YLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVG----IDLSRNN 548
           +LNL  N F                        DG IS    NL  +VG    + LS  N
Sbjct: 452 HLNLQGNSFQ-----------------------DGSISKT--NLLQMVGSLEILILSSCN 486
Query: 549 LSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKL 608
           L         GL+++ ++ L++N L G   ++  ++  L  L++++N I    P     L
Sbjct: 487 LLSIDQQAFHGLRNVNHLDLSHNSLTGDSMDALSHLKGL-YLNMASNNIRIIPPHLLPAL 545
Query: 609 SYLKELNLSFNKL 621
           S    +NLS N L
Sbjct: 546 SQQSIINLSHNPL 558

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 24/182 (13%)
Query: 734 IGIGGFGSVYRARLEDG-VEIAIKVFHP------QCASTLKSFEA-------ECEVIKNI 779
           +G G +G V   + ++G  E AIKV         + +   K+ E        E  ++K++
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
            H N++K+     +  +  LV E+   G L + + + +   +     NIM  I S + YL
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYL 162
Query: 840 HFGHSTPIIHCDLKPSNVLLDED---MVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
           H      I+H D+KP N+LL+     +   + DFG++   S   +  +R + L T  Y+A
Sbjct: 163 H---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--DYKLRDR-LGTAYYIA 216
Query: 897 PD 898
           P+
Sbjct: 217 PE 218

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 46/190 (24%), Positives = 82/190 (43%), Gaps = 25/190 (13%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLV 785
           +G G FG V  A      +      +A+K+       S  ++  +E +++ +I  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 786 KIISSCSNDDFKALVL-EYMSNGSLEDCLHSSNCAL---------NIFCRLNIMI----D 831
            ++ +C+      +V+ E+   G+L   L S                F  L  +I     
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           +A  +E+L    S   IH DL   N+LL E  V  + DFG+A+ +  + +   +      
Sbjct: 157 VAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 892 IGYMAPDEIF 901
           + +MAP+ IF
Sbjct: 214 LKWMAPETIF 223

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 46/188 (24%), Positives = 82/188 (43%), Gaps = 23/188 (12%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLV 785
           +G G FG V  A      +      +A+K+       S  ++  +E +++ +I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 786 KIISSCSNDDFKALVL-EYMSNGSLEDCLHSSNCAL-------NIFCRLNIMI----DIA 833
            ++ +C+      +V+ E+   G+L   L S              F  L  +I     +A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
             +E+L    S   IH DL   N+LL E  V  + DFG+A+ +  + +   +      + 
Sbjct: 155 KGMEFLA---SRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 894 YMAPDEIF 901
           +MAP+ IF
Sbjct: 212 WMAPETIF 219

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 17/186 (9%)
Query: 724 ATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIK-VFHPQCASTLK-SFEAECEVIKNIR 780
           AT  +     IG+G +G+VY+AR    G  +A+K V  P     L  S   E  +++ + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 781 ---HRNLVKIISSC----SNDDFK-ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
              H N+V+++  C    ++ + K  LV E++          +    L      ++M   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
              L++LH   +  I+H DLKP N+L+       L+DFG+A++ S +         + T+
Sbjct: 122 LRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALFPVVVTL 175
Query: 893 GYMAPD 898
            Y AP+
Sbjct: 176 WYRAPE 181

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 46/188 (24%), Positives = 82/188 (43%), Gaps = 23/188 (12%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLV 785
           +G G FG V  A      +      +A+K+       S  ++  +E +++ +I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 786 KIISSCSNDDFKALVL-EYMSNGSLEDCLHSSNCAL-------NIFCRLNIMI----DIA 833
            ++ +C+      +V+ E+   G+L   L S              F  L  +I     +A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
             +E+L    S   IH DL   N+LL E  V  + DFG+A+ +  + +   +      + 
Sbjct: 155 KGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 894 YMAPDEIF 901
           +MAP+ IF
Sbjct: 212 WMAPETIF 219

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 42/173 (24%), Positives = 81/173 (46%), Gaps = 12/173 (6%)
Query: 734 IGIGGFGSV----YRARLEDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKII 788
           IG G FG V    Y +     + +AIK      + +++  F  E   ++   H ++VK+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
              + +    +++E  + G L   L     +L++   +     +++AL YL    S   +
Sbjct: 83  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR-TQTLATIGYMAPDEI 900
           H D+   NVL+  +    L DFG+++ +  ED +  + ++    I +MAP+ I
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESI 189

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 42/173 (24%), Positives = 81/173 (46%), Gaps = 12/173 (6%)
Query: 734 IGIGGFGSV----YRARLEDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKII 788
           IG G FG V    Y +     + +AIK      + +++  F  E   ++   H ++VK+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
              + +    +++E  + G L   L     +L++   +     +++AL YL    S   +
Sbjct: 106 GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 161
Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR-TQTLATIGYMAPDEI 900
           H D+   NVL+  +    L DFG+++ +  ED +  + ++    I +MAP+ I
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESI 212

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 42/173 (24%), Positives = 81/173 (46%), Gaps = 12/173 (6%)
Query: 734 IGIGGFGSV----YRARLEDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKII 788
           IG G FG V    Y +     + +AIK      + +++  F  E   ++   H ++VK+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
              + +    +++E  + G L   L     +L++   +     +++AL YL    S   +
Sbjct: 81  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 136
Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR-TQTLATIGYMAPDEI 900
           H D+   NVL+  +    L DFG+++ +  ED +  + ++    I +MAP+ I
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESI 187

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 42/173 (24%), Positives = 81/173 (46%), Gaps = 12/173 (6%)
Query: 734 IGIGGFGSV----YRARLEDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKII 788
           IG G FG V    Y +     + +AIK      + +++  F  E   ++   H ++VK+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
              + +    +++E  + G L   L     +L++   +     +++AL YL    S   +
Sbjct: 75  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR-TQTLATIGYMAPDEI 900
           H D+   NVL+  +    L DFG+++ +  ED +  + ++    I +MAP+ I
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESI 181

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 42/173 (24%), Positives = 81/173 (46%), Gaps = 12/173 (6%)
Query: 734 IGIGGFGSV----YRARLEDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKII 788
           IG G FG V    Y +     + +AIK      + +++  F  E   ++   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
              + +    +++E  + G L   L     +L++   +     +++AL YL    S   +
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR-TQTLATIGYMAPDEI 900
           H D+   NVL+  +    L DFG+++ +  ED +  + ++    I +MAP+ I
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESI 184

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 42/173 (24%), Positives = 81/173 (46%), Gaps = 12/173 (6%)
Query: 734 IGIGGFGSV----YRARLEDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKII 788
           IG G FG V    Y +     + +AIK      + +++  F  E   ++   H ++VK+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
              + +    +++E  + G L   L     +L++   +     +++AL YL    S   +
Sbjct: 80  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 135
Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR-TQTLATIGYMAPDEI 900
           H D+   NVL+  +    L DFG+++ +  ED +  + ++    I +MAP+ I
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESI 186

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 26/259 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLK------SFEAECEVIKN 778
           D +     +G G F  V + R +  G++ A K    +   + +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           I+H N++ +     N     L+LE ++ G L D L     +L        +  I + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           L   HS  I H DLKP N++L +  V      + DFG+A  +   +E         T  +
Sbjct: 130 L---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 183
Query: 895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIFSLALECT 953
           +AP+ +    L L+    D+  + ++  +   LLSG        K++ L ++ ++  E  
Sbjct: 184 VAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGDTKQETLANVSAVNYEFE 237
Query: 954 MES-PEKRIDAKDTITRLL 971
            E        AKD I RLL
Sbjct: 238 DEYFSNTSALAKDFIRRLL 256

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 42/173 (24%), Positives = 81/173 (46%), Gaps = 12/173 (6%)
Query: 734 IGIGGFGSV----YRARLEDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKII 788
           IG G FG V    Y +     + +AIK      + +++  F  E   ++   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
              + +    +++E  + G L   L     +L++   +     +++AL YL    S   +
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR-TQTLATIGYMAPDEI 900
           H D+   NVL+  +    L DFG+++ +  ED +  + ++    I +MAP+ I
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESI 184

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 81/172 (47%), Gaps = 14/172 (8%)
Query: 733 IIGIGGFGSVYRARLEDGVEI-AIKV---FHPQCASTLKSFEAECEVIKNIRHRNLVKII 788
           +IG G FG V   R +   ++ A+K+   F     S    F  E +++       +V++ 
Sbjct: 82  VIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 141
Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
            +  +D +  +V+EYM  G L + +  SN  +          ++  AL+ +H   S  +I
Sbjct: 142 CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIH---SMGLI 196
Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR--TQTLATIGYMAPD 898
           H D+KP N+LLD+     L+DFG    +   DE+ M      + T  Y++P+
Sbjct: 197 HRDVKPDNMLLDKHGHLKLADFGTCMKM---DETGMVHCDTAVGTPDYISPE 245

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 89/195 (45%), Gaps = 32/195 (16%)
Query: 734 IGIGGFGSVYRA--RLEDGVEIAIKVFHP-QCASTLKSFEAECEVIKNIR-HRNLVKIIS 789
           +G G +G V+++  R    V    K+F   Q ++  +    E  ++  +  H N+V +++
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 790 --SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
                ND    LV +YM     E  LH+   A NI   ++    +   ++ + + HS  +
Sbjct: 77  VLRADNDRDVYLVFDYM-----ETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGL 130
Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG-------------------EDESTMRTQT 888
           +H D+KPSN+LL+ +    ++DFG+++                       +D+  + T  
Sbjct: 131 LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDY 190
Query: 889 LATIGYMAPDEIFVG 903
           +AT  Y AP EI +G
Sbjct: 191 VATRWYRAP-EILLG 204

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 26/259 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLK------SFEAECEVIKN 778
           D +     +G G F  V + R +  G++ A K    +   + +        E E  ++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           I+H N++ +     N     L+LE ++ G L D L     +L        +  I + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 128
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           L   HS  I H DLKP N++L +  V      + DFG+A  +   +E         T  +
Sbjct: 129 L---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 182
Query: 895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIFSLALECT 953
           +AP+ +    L L+    D+  + ++  +   LLSG        K++ L ++ ++  E  
Sbjct: 183 VAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGDTKQETLANVSAVNYEFE 236
Query: 954 MES-PEKRIDAKDTITRLL 971
            E        AKD I RLL
Sbjct: 237 DEYFSNTSALAKDFIRRLL 255

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 26/259 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLK------SFEAECEVIKN 778
           D +     +G G F  V + R +  G++ A K    +   + +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           I+H N++ +     N     L+LE ++ G L D L     +L        +  I + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           L   HS  I H DLKP N++L +  V      + DFG+A  +   +E         T  +
Sbjct: 130 L---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 183
Query: 895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIFSLALECT 953
           +AP+ +    L L+    D+  + ++  +   LLSG        K++ L ++ ++  E  
Sbjct: 184 VAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGDTKQETLANVSAVNYEFE 237
Query: 954 MES-PEKRIDAKDTITRLL 971
            E        AKD I RLL
Sbjct: 238 DEYFSNTSALAKDFIRRLL 256

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 26/259 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLK------SFEAECEVIKN 778
           D +     +G G F  V + R +  G++ A K    +   + +        E E  ++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           I+H N++ +     N     L+LE ++ G L D L     +L        +  I + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 128
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           L   HS  I H DLKP N++L +  V      + DFG+A  +   +E         T  +
Sbjct: 129 L---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 182
Query: 895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIFSLALECT 953
           +AP+ +    L L+    D+  + ++  +   LLSG        K++ L ++ ++  E  
Sbjct: 183 VAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGDTKQETLANVSAVNYEFE 236
Query: 954 MES-PEKRIDAKDTITRLL 971
            E        AKD I RLL
Sbjct: 237 DEYFSNTSALAKDFIRRLL 255

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 26/259 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLK------SFEAECEVIKN 778
           D +     +G G F  V + R +  G++ A K    +   + +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           I+H N++ +     N     L+LE ++ G L D L     +L        +  I + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           L   HS  I H DLKP N++L +  V      + DFG+A  +   +E         T  +
Sbjct: 130 L---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 183
Query: 895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIFSLALECT 953
           +AP+ +    L L+    D+  + ++  +   LLSG        K++ L ++ ++  E  
Sbjct: 184 VAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGDTKQETLANVSAVNYEFE 237
Query: 954 MES-PEKRIDAKDTITRLL 971
            E        AKD I RLL
Sbjct: 238 DEYFSNTSALAKDFIRRLL 256

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 77/183 (42%), Gaps = 22/183 (12%)
Query: 725 TDNFAENNIIGIGGFGSVYR-ARLEDGVEIAIKVFHPQCASTLKSFEAECEVI-KNIRHR 782
           +D +     IG+G +    R       +E A+KV       + +    E E++ +  +H 
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVI----DKSKRDPSEEIEILLRYGQHP 81
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN---IMIDIASALEYL 839
           N++ +     +     LV E M  G L D +         F       ++  I   +EYL
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKI----LRQKFFSEREASFVLHTIGKTVEYL 137
Query: 840 HFGHSTPIIHCDLKPSNVL-LDED---MVAHLSDFGMAKLLSGEDESTMRTQTLATIGYM 895
           H   S  ++H DLKPSN+L +DE        + DFG AK L  E+   M      T  ++
Sbjct: 138 H---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLM--TPCYTANFV 192
Query: 896 APD 898
           AP+
Sbjct: 193 APE 195

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 26/259 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLK------SFEAECEVIKN 778
           D +     +G G F  V + R +  G++ A K    +   + +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           I+H N++ +     N     L+LE ++ G L D L     +L        +  I + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           L   HS  I H DLKP N++L +  V      + DFG+A  +   +E         T  +
Sbjct: 130 L---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 183
Query: 895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIFSLALECT 953
           +AP+ +    L L+    D+  + ++  +   LLSG        K++ L ++ ++  E  
Sbjct: 184 VAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGDTKQETLANVSAVNYEFE 237
Query: 954 MES-PEKRIDAKDTITRLL 971
            E        AKD I RLL
Sbjct: 238 DEYFSNTSALAKDFIRRLL 256

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 26/259 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLK------SFEAECEVIKN 778
           D +     +G G F  V + R +  G++ A K    +   + +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           I+H N++ +     N     L+LE ++ G L D L     +L        +  I + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           L   HS  I H DLKP N++L +  V      + DFG+A  +   +E         T  +
Sbjct: 130 L---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 183
Query: 895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIFSLALECT 953
           +AP+ +    L L+    D+  + ++  +   LLSG        K++ L ++ ++  E  
Sbjct: 184 VAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGDTKQETLANVSAVNYEFE 237
Query: 954 MES-PEKRIDAKDTITRLL 971
            E        AKD I RLL
Sbjct: 238 DEYFSNTSALAKDFIRRLL 256

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 26/259 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLK------SFEAECEVIKN 778
           D +     +G G F  V + R +  G++ A K    +   + +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           I+H N++ +     N     L+LE ++ G L D L     +L        +  I + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           L   HS  I H DLKP N++L +  V      + DFG+A  +   +E         T  +
Sbjct: 130 L---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 183
Query: 895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIFSLALECT 953
           +AP+ +    L L+    D+  + ++  +   LLSG        K++ L ++ ++  E  
Sbjct: 184 VAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGDTKQETLANVSAVNYEFE 237
Query: 954 MES-PEKRIDAKDTITRLL 971
            E        AKD I RLL
Sbjct: 238 DEYFSNTSALAKDFIRRLL 256

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 26/259 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLK------SFEAECEVIKN 778
           D +     +G G F  V + R +  G++ A K    +   + +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           I+H N++ +     N     L+LE ++ G L D L     +L        +  I + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           L   HS  I H DLKP N++L +  V      + DFG+A  +   +E         T  +
Sbjct: 130 L---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 183
Query: 895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIFSLALECT 953
           +AP+ +    L L+    D+  + ++  +   LLSG        K++ L ++ ++  E  
Sbjct: 184 VAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGDTKQETLANVSAVNYEFE 237
Query: 954 MES-PEKRIDAKDTITRLL 971
            E        AKD I RLL
Sbjct: 238 DEYFSNTSALAKDFIRRLL 256

>pdb|3T6Q|A Chain A, Crystal Structure Of Mouse Rp105MD-1 Complex Length = 606

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 127/465 (27%), Positives = 195/465 (41%), Gaps = 102/465 (21%)
Query: 241 LQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSG-SLPSRIDLA-LPNLEFLNL 298
           L++L  +Q G +++   +P  + N  TL+ ++L +N +S   LP       L  L+F N 
Sbjct: 107 LKHLFFIQTGISSI-DFIP--LHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 299 GINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAI----------GNLRNLKLFDIFF 348
            I+  S    SS+  A+ L L  +  N  +G  P A           G  +NL    + F
Sbjct: 164 AIHYLSKEDMSSLQQATNLSL-NLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLL---VIF 219
Query: 349 NNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSI--GNLSLSLERLNIA---FC 403
             L +ST     + SL       +LG   +  D  +  ++  G   +S+E +N+    F 
Sbjct: 220 KGLKNST-----IQSL-------WLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF 267
Query: 404 NISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKL-------AGS 456
           NIS N        S L  L L   +LS  +P    GL  L+ L L+ NK        A +
Sbjct: 268 NISSN---TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASN 323
Query: 457 IPD-------------EI---CL--LSRLNELDLNGNKISGSISSC---LGNLTSLQYLN 495
            P              E+   CL  L  L ELDL+ + I  S   C   L NL+ LQ LN
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS-DCCNLQLRNLSHLQSLN 382
Query: 496 LGSNR---------------------FTFV----IPSTFWNLKDILSFDISSNLLDGPIS 530
           L  N                      FT +      S F NL  +   ++S +LLD    
Sbjct: 383 LSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442
Query: 531 LAIGNLKAVVGIDLSRNNL-SGNIPTT--LEGLKSLQNISLAYNRLEGPIPESFGNMTSL 587
                L A+  ++L  N+   GNI  T  L+ L  L+ + L++  L      +F ++  +
Sbjct: 443 QLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM 502
Query: 588 ESLDLSNNKISGSIPVSFEKLSYLK--ELNLSFNKLKGEIPRGGP 630
             +DLS+N+++ S   S E LS+LK   LNL+ N +   +P   P
Sbjct: 503 NHVDLSHNRLTSS---SIEALSHLKGIYLNLASNHISIILPSLLP 544

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 46/191 (24%), Positives = 82/191 (42%), Gaps = 26/191 (13%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLV 785
           +G G FG V  A      +      +A+K+       S  ++  +E +++ +I  H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 786 KIISSCSNDDFKALVL-EYMSNGSLEDCLHSSNCAL----------NIFCRLNIMI---- 830
            ++ +C+      +V+ E+   G+L   L S                 F  L  +I    
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            +A  +E+L    S   IH DL   N+LL E  V  + DFG+A+ +  + +   +     
Sbjct: 156 QVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 891 TIGYMAPDEIF 901
            + +MAP+ IF
Sbjct: 213 PLKWMAPETIF 223

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 24/164 (14%)
Query: 723 RATDNFAENNI-IGIGGFGSVYRARLED---GVEIAIKVFHPQCASTLKSFEAE----CE 774
           R   ++A + + +G G FG V+R  +ED   G + A+K         L+ F AE    C 
Sbjct: 89  REEVHWATHQLRLGRGSFGEVHR--MEDKQTGFQCAVKKV------RLEVFRAEELMACA 140
Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
            + + R   +V +  +     +  + +E +  GSL   +    C          +  +  
Sbjct: 141 GLTSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC----LPEDRALYYLGQ 193
Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMV-AHLSDFGMAKLLS 877
           ALE L + HS  I+H D+K  NVLL  D   A L DFG A  L 
Sbjct: 194 ALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQ 237

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 26/259 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLK------SFEAECEVIKN 778
           D +     +G G F  V + R +  G++ A K    +   + +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           I+H N++ +     N     L+LE ++ G L D L     +L        +  I + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           L   HS  I H DLKP N++L +  V      + DFG+A  +   +E         T  +
Sbjct: 130 L---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 183
Query: 895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIFSLALECT 953
           +AP+ +    L L+    D+  + ++  +   LLSG        K++ L ++ ++  E  
Sbjct: 184 VAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGDTKQETLANVSAVNYEFE 237
Query: 954 MES-PEKRIDAKDTITRLL 971
            E        AKD I RLL
Sbjct: 238 DEYFSNTSALAKDFIRRLL 256

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 28/187 (14%)
Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFEAEC-----EVIKNI 779
           ++F    +IG G FG V   +L++  ++ A+K+ +      LK  E  C     +V+ N 
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW--EMLKRAETACFREERDVLVNG 131
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSL-------EDCLHSSNCALNIFCRLNIMIDI 832
             + +  +  +  +D+   LV++Y   G L       ED L     A      + I ID 
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRL-PEEMARFYLAEMVIAIDS 190
Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA-KLLSGEDESTMRTQTLAT 891
              L Y         +H D+KP N+L+D +    L+DFG   KL+  ED +   +  + T
Sbjct: 191 VHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGT 239
Query: 892 IGYMAPD 898
             Y++P+
Sbjct: 240 PDYISPE 246

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 24/164 (14%)
Query: 723 RATDNFAENNI-IGIGGFGSVYRARLED---GVEIAIKVFHPQCASTLKSFEAE----CE 774
           R   ++A + + +G G FG V+R  +ED   G + A+K         L+ F AE    C 
Sbjct: 70  REEVHWATHQLRLGRGSFGEVHR--MEDKQTGFQCAVKKV------RLEVFRAEELMACA 121
Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
            + + R   +V +  +     +  + +E +  GSL   +    C          +  +  
Sbjct: 122 GLTSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC----LPEDRALYYLGQ 174
Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMV-AHLSDFGMAKLLS 877
           ALE L + HS  I+H D+K  NVLL  D   A L DFG A  L 
Sbjct: 175 ALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQ 218

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 78/173 (45%), Gaps = 12/173 (6%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCA-----STLKSFEAECEVIKNIRHRNLVKII 788
           IG G FG V++         A+ V    C      S  + F  E   ++   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
              + +    +++E  + G L   L     +L++   +     +++AL YL    S   +
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR-TQTLATIGYMAPDEI 900
           H D+   NVL+  +    L DFG+++ +  ED +  + ++    I +MAP+ I
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESI 564

>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 66/240 (27%), Positives = 109/240 (45%), Gaps = 19/240 (7%)
Query: 71  NSHKVTTLNLSSFNLQG--TIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYL 128
           N  KVTT    S   QG   +P  I   +S + + L  N++S    +S  +   L +L+L
Sbjct: 9   NEPKVTT----SCPQQGLQAVPTGIP--ASSQRIFLHGNRISYVPAASFQSCRNLTILWL 62
Query: 129 MDNQLSGSLSSFTFNTSSILD-IRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIP 187
             N L+G + +  F   ++L+ + LS N     +       L +L  L L         P
Sbjct: 63  HSNALAG-IDAAAFTGLTLLEQLDLSDNAQLRVVDPTTFRGLGHLHTLHLDRCGLQELGP 121
Query: 188 SSLSKCKQLQELHLGYNNLSGAIP----KEIGNLTVLQRISLINNKLHGEIPQEIGYLQN 243
                   LQ L+L  NNL  A+P    +++GNLT    + L  N++          L +
Sbjct: 122 GLFRGLAALQYLYLQDNNLQ-ALPDNTFRDLGNLT---HLFLHGNRIPSVPEHAFRGLHS 177
Query: 244 LDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSF 303
           LD L L  N++  V P    ++  L  ++L+ N+LS  LP+ + + L +L++L L  N +
Sbjct: 178 LDRLLLHQNHVARVHPHAFRDLGRLMTLYLFANNLS-MLPAEVLVPLRSLQYLRLNDNPW 236

>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 1/179 (0%)
Query: 418 NLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFN-KLAGSIPDEICLLSRLNELDLNGNK 476
           NL +L L  N L+G     F GL  L+ LDL+ N +L    P     L  L+ L L+   
Sbjct: 56  NLTILWLHSNALAGIDAAAFTGLTLLEQLDLSDNAQLRVVDPTTFRGLGHLHTLHLDRCG 115
Query: 477 ISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNL 536
           +          L +LQYL L  N    +  +TF +L ++    +  N +      A   L
Sbjct: 116 LQELGPGLFRGLAALQYLYLQDNNLQALPDNTFRDLGNLTHLFLHGNRIPSVPEHAFRGL 175
Query: 537 KAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNN 595
            ++  + L +N+++   P     L  L  + L  N L     E    + SL+ L L++N
Sbjct: 176 HSLDRLLLHQNHVARVHPHAFRDLGRLMTLYLFANNLSMLPAEVLVPLRSLQYLRLNDN 234

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 85/203 (41%), Gaps = 28/203 (13%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCA---STLKSFEAECE 774
           F+LLR         +IG G +  V   RL+    I A+KV   +       +   + E  
Sbjct: 11  FDLLR---------VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 775 VIKNIRHRNLVKIISSCSNDDFK-ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
           V +   +   +  + SC   + +   V+EY++ G L   +           R     +I+
Sbjct: 62  VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEIS 120
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK--LLSGEDESTMRTQTLAT 891
            AL YLH      II+ DLK  NVLLD +    L+D+GM K  L  G+  S        T
Sbjct: 121 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF----CGT 173
Query: 892 IGYMAPDEIFVGE---LSLKRWV 911
             Y+AP EI  GE    S+  W 
Sbjct: 174 PNYIAP-EILRGEDYGFSVDWWA 195

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 26/259 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLK------SFEAECEVIKN 778
           D +     +G G F  V + R +  G++ A K    +   + +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           I+H N++ +     N     L+LE ++ G L D L     +L        +  I + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           L   HS  I H DLKP N++L +  V      + DFG+A  +   +E         T  +
Sbjct: 130 L---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 183
Query: 895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIFSLALECT 953
           +AP+ +    L L+    D+  + ++  +   LLSG        K++ L ++ ++  E  
Sbjct: 184 VAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGDTKQETLANVSAVNYEFE 237
Query: 954 MES-PEKRIDAKDTITRLL 971
            E        AKD I RLL
Sbjct: 238 DEYFSNTSALAKDFIRRLL 256

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 32/213 (15%)
Query: 697 RGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRA-RLEDGVEIAI 755
           RG+M  +D++                   D +    +IG G F  V R    E G + A+
Sbjct: 14  RGSMADDDVLFE-----------------DVYELCEVIGKGPFSVVRRCINRETGQQFAV 56
Query: 756 KV-----FHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLE 810
           K+     F      + +  + E  +   ++H ++V+++ + S+D    +V E+M    L 
Sbjct: 57  KIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL- 115
Query: 811 DCLHSSNCALNIFCRLNIMID--IASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVA 865
            C      A   F     +    +   LE L + H   IIH D+KP  VLL   +     
Sbjct: 116 -CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV 174
Query: 866 HLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
            L  FG+A  L   +   +    + T  +MAP+
Sbjct: 175 KLGGFGVAIQLG--ESGLVAGGRVGTPHFMAPE 205

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 36/116 (31%), Positives = 63/116 (54%), Gaps = 19/116 (16%)
Query: 770 EAECEVIKNIRHRNLVKIISSCSNDDFKAL--VLEYMSNGSLEDCLHSSN------C-AL 820
           + E ++++ +RH+N+++++    N++ + +  V+EY   G +++ L S        C A 
Sbjct: 54  KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAH 112
Query: 821 NIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL 876
             FC+L   ID    LEYLH   S  I+H D+KP N+LL       +S  G+A+ L
Sbjct: 113 GYFCQL---ID---GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 85/203 (41%), Gaps = 28/203 (13%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCA---STLKSFEAECE 774
           F+LLR         +IG G +  V   RL+    I A+KV   +       +   + E  
Sbjct: 7   FDLLR---------VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 57
Query: 775 VIKNIRHRNLVKIISSCSNDDFKAL-VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
           V +   +   +  + SC   + +   V+EY++ G L   +           R     +I+
Sbjct: 58  VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEIS 116
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK--LLSGEDESTMRTQTLAT 891
            AL YLH      II+ DLK  NVLLD +    L+D+GM K  L  G+  S        T
Sbjct: 117 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF----CGT 169
Query: 892 IGYMAPDEIFVGE---LSLKRWV 911
             Y+AP EI  GE    S+  W 
Sbjct: 170 PNYIAP-EILRGEDYGFSVDWWA 191

>pdb|3V44|A Chain A, Crystal Structure Of The N-Terminal Fragment Of Zebrafish Tlr5 Length = 407

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 39/255 (15%)
Query: 395 LERLNIAFCNISGNIPKA--IGNLSNLIVLSLGGNNLSGSIPVTFG-GLQKLQGLDLAFN 451
           LE L +  CN+ G +        L++L +L L  NN+    P +F   +++   LDL FN
Sbjct: 105 LEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164
Query: 452 KLAGSIPDEICL----------------LSRLNELDLNGNKISGSISSCLGNLTSLQYLN 495
           K+  SI +E  L                L  +NE  L   K      +     TS+  L+
Sbjct: 165 KVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN-----TSITTLD 218
Query: 496 LGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPT 555
           L  N F   +   F++   I    I S +L    ++         G      N       
Sbjct: 219 LSGNGFKESMAKRFFDA--IAGTKIQSLILSNSYNM---------GSSFGHTNFKDPDNF 267
Query: 556 TLEGLKS--LQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKE 613
           T +GL++  ++   L+ +++   +   F + T LE L L+ N+I+     +F  L++LKE
Sbjct: 268 TFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLKE 327
Query: 614 LNLSFNKLKGEIPRG 628
           L L  N+LK  +P G
Sbjct: 328 LALDTNQLKS-VPDG 341

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/187 (24%), Positives = 83/187 (44%), Gaps = 18/187 (9%)
Query: 726 DNFAENNIIGIGGFGSVYRA---RLEDGVEIA-IKVFHPQCASTLKSFEAECEVIKNIRH 781
           D +     +G G +G VY+A      + V I  I++ H +      +   E  ++K ++H
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQH 92
Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
           RN++++ S   ++    L+ EY  N   +    + + ++ +         +   +  ++F
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSF-----LYQLINGVNF 147
Query: 842 GHSTPIIHCDLKPSNVLL-----DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
            HS   +H DLKP N+LL      E  V  + DFG+A+           T  + T+ Y  
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEIITLWYRP 205
Query: 897 PDEIFVG 903
           P EI +G
Sbjct: 206 P-EILLG 211

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 46/192 (23%), Positives = 82/192 (42%), Gaps = 27/192 (14%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLV 785
           +G G FG V  A      +      +A+K+       S  ++  +E +++ +I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 786 KIISSCSNDDFKALVL-EYMSNGSLEDCLHSSNCAL-----------NIFCRLNIMI--- 830
            ++ +C+      +V+ E+   G+L   L S                  F  L  +I   
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 831 -DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
             +A  +E+L    S   IH DL   N+LL E  V  + DFG+A+ +  + +   +    
Sbjct: 146 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 890 ATIGYMAPDEIF 901
             + +MAP+ IF
Sbjct: 203 LPLKWMAPETIF 214

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 46/192 (23%), Positives = 82/192 (42%), Gaps = 27/192 (14%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLV 785
           +G G FG V  A      +      +A+K+       S  ++  +E +++ +I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 786 KIISSCSNDDFKALVL-EYMSNGSLEDCLHSSNCAL-----------NIFCRLNIMI--- 830
            ++ +C+      +V+ E+   G+L   L S                  F  L  +I   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 831 -DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
             +A  +E+L    S   IH DL   N+LL E  V  + DFG+A+ +  + +   +    
Sbjct: 146 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 890 ATIGYMAPDEIF 901
             + +MAP+ IF
Sbjct: 203 LPLKWMAPETIF 214

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 46/192 (23%), Positives = 82/192 (42%), Gaps = 27/192 (14%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLV 785
           +G G FG V  A      +      +A+K+       S  ++  +E +++ +I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 786 KIISSCSNDDFKALVL-EYMSNGSLEDCLHSSNCAL-----------NIFCRLNIMI--- 830
            ++ +C+      +V+ E+   G+L   L S                  F  L  +I   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 831 -DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
             +A  +E+L    S   IH DL   N+LL E  V  + DFG+A+ +  + +   +    
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 890 ATIGYMAPDEIF 901
             + +MAP+ IF
Sbjct: 212 LPLKWMAPETIF 223

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 126/274 (45%), Gaps = 27/274 (9%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLK------SFEA 771
           F+  +  D +     +G G F  V + R +  G+E A K    + +   +        E 
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIER 64
Query: 772 ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID 831
           E  +++ + H N++ +     N     L+LE +S G L D L +   +L+     + +  
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQ 123
Query: 832 IASALEYLHFGHSTPIIHCDLKPSNV-LLDEDM-VAHLS--DFGMAKLLSGEDESTMRTQ 887
           I   + YL   H+  I H DLKP N+ LLD+++ + H+   DFG+A  +  ED    +  
Sbjct: 124 ILDGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN- 177
Query: 888 TLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIF 946
              T  ++AP+ +    L L+    D+  + ++  +   LLSG        K++ L +I 
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLE---ADMWSIGVITYI---LLSGASPFLGDTKQETLANIT 231
Query: 947 SLALECTMESPEKRID-AKDTITRLLKIRDTLSK 979
           +++ +   E   +  + AKD I +LL +++T  +
Sbjct: 232 AVSYDFDEEFFSQTSELAKDFIRKLL-VKETRKR 264

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 85/203 (41%), Gaps = 28/203 (13%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCA---STLKSFEAECE 774
           F+LLR         +IG G +  V   RL+    I A+KV   +       +   + E  
Sbjct: 22  FDLLR---------VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 72
Query: 775 VIKNIRHRNLVKIISSCSNDDFK-ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
           V +   +   +  + SC   + +   V+EY++ G L   +           R     +I+
Sbjct: 73  VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEIS 131
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK--LLSGEDESTMRTQTLAT 891
            AL YLH      II+ DLK  NVLLD +    L+D+GM K  L  G+  S        T
Sbjct: 132 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF----CGT 184
Query: 892 IGYMAPDEIFVGE---LSLKRWV 911
             Y+AP EI  GE    S+  W 
Sbjct: 185 PNYIAP-EILRGEDYGFSVDWWA 206

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 18/167 (10%)
Query: 722 LRATDNFAENNIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR 780
           ++ TD +     IG+G +    R       +E A+K+         +  E    +++  +
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQ 74
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN---IMIDIASALE 837
           H N++ +     +  +  +V E M  G L D +         F       ++  I   +E
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKI----LRQKFFSEREASAVLFTITKTVE 130
Query: 838 YLHFGHSTPIIHCDLKPSNVL-LDED---MVAHLSDFGMAKLLSGED 880
           YLH   +  ++H DLKPSN+L +DE        + DFG AK L  E+
Sbjct: 131 YLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 47/177 (26%), Positives = 76/177 (42%), Gaps = 22/177 (12%)
Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRNLVKII-- 788
           IG G F +VY+    E  VE+A      +    S  + F+ E E +K ++H N+V+    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 789 --SSCSNDDFKALVLEYMSNGSLEDCLHSSNC----ALNIFCRLNIMIDIASALEYLHFG 842
             S+        LV E  ++G+L+  L          L  +CR      I   L++LH  
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCR-----QILKGLQFLH-T 147
Query: 843 HSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
            + PIIH DLK  N+ +        + D G+A L      ++     + T  + AP+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFXAPE 200

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 83/190 (43%), Gaps = 22/190 (11%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLK-SFEAECEVIKNI-RHRNLV 785
           +G G FG V  A      + +  + +A+K+  P    T + +  +E +V+  +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLH---------SSNCALNIFCRLNIMIDIASAL 836
            ++ +C+      ++ EY   G L + L           ++ A+     L + ++   + 
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 837 EY-----LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
            Y     + F  S   IH DL   N+LL    +  + DFG+A+ +  +    ++      
Sbjct: 174 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLP 233
Query: 892 IGYMAPDEIF 901
           + +MAP+ IF
Sbjct: 234 VKWMAPESIF 243

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 110/259 (42%), Gaps = 26/259 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLK------SFEAECEVIKN 778
           D +     +G G F  V + R +  G++ A K    +   + +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           I+H N++ +     N     L+LE ++ G L D L +   +L        +  I + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           L   HS  I H DLKP N++L +  V      + DFG+A  +   +E         T  +
Sbjct: 130 L---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPAF 183
Query: 895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIFSLALECT 953
           +AP+ +    L L+    D+  + ++  +   LLSG        K++ L ++ ++  E  
Sbjct: 184 VAPEIVNYEPLGLE---ADMWSIGVITYI---LLSGASPFLGDTKQETLANVSAVNYEFE 237
Query: 954 MES-PEKRIDAKDTITRLL 971
            E        AKD I RLL
Sbjct: 238 DEYFSNTSALAKDFIRRLL 256

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 43/183 (23%), Positives = 78/183 (42%), Gaps = 19/183 (10%)
Query: 734 IGIGGFGSVYRARLEDGVE------IAIKVFHPQCASTLK-SFEAECEVIKNIRHRNLVK 786
           +G G FG VY     D ++      +A+K  +   +   +  F  E  V+K     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASALE 837
           ++   S      +V+E M++G L+  L S      N        L  MI    +IA  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           YL+   +   +H +L   N ++  D    + DFGM + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 898 DEI 900
           + +
Sbjct: 202 ESL 204

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 43/183 (23%), Positives = 78/183 (42%), Gaps = 19/183 (10%)
Query: 734 IGIGGFGSVYRARLEDGVE------IAIKVFHPQCASTLK-SFEAECEVIKNIRHRNLVK 786
           +G G FG VY     D ++      +A+K  +   +   +  F  E  V+K     ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASALE 837
           ++   S      +V+E M++G L+  L S      N        L  MI    +IA  + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           YL+   +   +H +L   N ++  D    + DFGM + +   D      + L  + +MAP
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 898 DEI 900
           + +
Sbjct: 203 ESL 205

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 46/192 (23%), Positives = 82/192 (42%), Gaps = 27/192 (14%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLV 785
           +G G FG V  A      +      +A+K+       S  ++  +E +++ +I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 786 KIISSCSNDDFKALVL-EYMSNGSLEDCLHSSNCAL-----------NIFCRLNIMI--- 830
            ++ +C+      +V+ E+   G+L   L S                  F  L  +I   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 831 -DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
             +A  +E+L    S   IH DL   N+LL E  V  + DFG+A+ +  + +   +    
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 890 ATIGYMAPDEIF 901
             + +MAP+ IF
Sbjct: 212 LPLKWMAPETIF 223

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 42/173 (24%), Positives = 80/173 (46%), Gaps = 12/173 (6%)
Query: 734 IGIGGFGSV----YRARLEDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKII 788
           IG G FG V    Y +     + +AIK      + +++  F  E   ++   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
              + +    +++E  + G L   L     +L++   +     +++AL YL    S   +
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR-TQTLATIGYMAPDEI 900
           H D+   NVL+       L DFG+++ +  ED +  + ++    I +MAP+ I
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESI 184

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 83/190 (43%), Gaps = 22/190 (11%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLK-SFEAECEVIKNI-RHRNLV 785
           +G G FG V  A      + +  + +A+K+  P    T + +  +E +V+  +  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLH---------SSNCALNIFCRLNIMIDIASAL 836
            ++ +C+      ++ EY   G L + L           ++ A+     L + ++   + 
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 837 EY-----LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
            Y     + F  S   IH DL   N+LL    +  + DFG+A+ +  +    ++      
Sbjct: 167 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 226
Query: 892 IGYMAPDEIF 901
           + +MAP+ IF
Sbjct: 227 VKWMAPESIF 236

>pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 101/390 (25%), Positives = 159/390 (40%), Gaps = 63/390 (16%)
Query: 241 LQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLE-FLNLG 299
           L+NL+ L LG N+++ +     F    LK +   NN++     SR D+   +LE  +NL 
Sbjct: 125 LENLESLYLGSNHISSIKFPKDFPARNLKVLDFQNNAI--HYISREDMR--SLEQAINLS 180
Query: 300 INSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELG 359
           +N F+G     I         E+G+   + F     G   NL    + FN L +ST +  
Sbjct: 181 LN-FNGNNVKGI---------ELGAFDSTIFQSLNFGGTPNLS---VIFNGLQNSTTQSL 227
Query: 360 FLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNL 419
           +L +    + +    +    L G    S+ +L+L   R    F +IS    +    L   
Sbjct: 228 WLGTF---EDIDDEDISSAMLKGLCEMSVESLNLQEHR----FSDISSTTFQCFTQLQE- 279
Query: 420 IVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISG 479
             L L   +L G +P    GL  L+ L L+ N       D++C +S  N   L    I G
Sbjct: 280 --LDLTATHLKG-LPSGMKGLNLLKKLVLSVNHF-----DQLCQISAANFPSLTHLYIRG 331
Query: 480 SISS------CLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAI 533
           ++        CL  L +LQ L+L  N              DI + D          SL +
Sbjct: 332 NVKKLHLGVGCLEKLGNLQTLDLSHN--------------DIEASDC--------CSLQL 369
Query: 534 GNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPES-FGNMTSLESLDL 592
            NL  +  ++LS N   G      +    L+ + LA+ RL    P+S F N+  L+ L+L
Sbjct: 370 KNLSHLQTLNLSHNEPLGLQSQAFKECPQLELLDLAFTRLHINAPQSPFQNLHFLQVLNL 429
Query: 593 SNNKISGSIPVSFEKLSYLKELNLSFNKLK 622
           +   +  S       L  L+ LNL  N  +
Sbjct: 430 TYCFLDTSNQHLLAGLPVLRHLNLKGNHFQ 459

>pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 112/250 (44%), Gaps = 31/250 (12%)
Query: 404 NISGNIPKAI--GNLSNLIVLSLGGNNLSGS--IPVTFGGLQK--LQGL------DLAFN 451
           N +GN  K I  G   + I  SL   N  G+  + V F GLQ    Q L      D+   
Sbjct: 182 NFNGNNVKGIELGAFDSTIFQSL---NFGGTPNLSVIFNGLQNSTTQSLWLGTFEDIDDE 238
Query: 452 KLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWN 511
            ++ ++   +C +S +  L+L  ++ S   S+     T LQ L+L +      +PS    
Sbjct: 239 DISSAMLKGLCEMS-VESLNLQEHRFSDISSTTFQCFTQLQELDLTATHLK-GLPSGMKG 296
Query: 512 LKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPT------TLEGLKSLQN 565
           L  +    +S N  D    ++  N  ++  +      + GN+         LE L +LQ 
Sbjct: 297 LNLLKKLVLSVNHFDQLCQISAANFPSLTHL-----YIRGNVKKLHLGVGCLEKLGNLQT 351
Query: 566 ISLAYNRLEGP--IPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKG 623
           + L++N +E          N++ L++L+LS+N+  G    +F++   L+ L+L+F +L  
Sbjct: 352 LDLSHNDIEASDCCSLQLKNLSHLQTLNLSHNEPLGLQSQAFKECPQLELLDLAFTRLHI 411
Query: 624 EIPRGGPFAN 633
             P+  PF N
Sbjct: 412 NAPQ-SPFQN 420

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 83/190 (43%), Gaps = 22/190 (11%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLK-SFEAECEVIKNI-RHRNLV 785
           +G G FG V  A      + +  + +A+K+  P    T + +  +E +V+  +  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLH---------SSNCALNIFCRLNIMIDIASAL 836
            ++ +C+      ++ EY   G L + L           ++ A+     L + ++   + 
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 837 EY-----LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
            Y     + F  S   IH DL   N+LL    +  + DFG+A+ +  +    ++      
Sbjct: 169 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 228
Query: 892 IGYMAPDEIF 901
           + +MAP+ IF
Sbjct: 229 VKWMAPESIF 238

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 83/190 (43%), Gaps = 22/190 (11%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLK-SFEAECEVIKNI-RHRNLV 785
           +G G FG V  A      + +  + +A+K+  P    T + +  +E +V+  +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLH---------SSNCALNIFCRLNIMIDIASAL 836
            ++ +C+      ++ EY   G L + L           ++ A+     L + ++   + 
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 837 EY-----LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
            Y     + F  S   IH DL   N+LL    +  + DFG+A+ +  +    ++      
Sbjct: 174 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 233
Query: 892 IGYMAPDEIF 901
           + +MAP+ IF
Sbjct: 234 VKWMAPESIF 243

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 83/190 (43%), Gaps = 22/190 (11%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCASTLK-SFEAECEVIKNI-RHRNLV 785
           +G G FG V  A      + +  + +A+K+  P    T + +  +E +V+  +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLH---------SSNCALNIFCRLNIMIDIASAL 836
            ++ +C+      ++ EY   G L + L           ++ A+     L + ++   + 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 837 EY-----LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
            Y     + F  S   IH DL   N+LL    +  + DFG+A+ +  +    ++      
Sbjct: 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210
Query: 892 IGYMAPDEIF 901
           + +MAP+ IF
Sbjct: 211 VKWMAPESIF 220

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 74/173 (42%), Gaps = 12/173 (6%)
Query: 731 NNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKII 788
             ++  GGF  VY A+ +  G E A+K          ++   E   +K +  H N+V+  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 789 SSCS-----NDDFKA--LVLEYMSNGSLEDCLHSSNCALNIFCR--LNIMIDIASALEYL 839
           S+ S     +D  +A  L+L  +  G L + L        + C   L I      A++++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           H     PIIH DLK  N+LL       L DFG A  +S   + +   Q  A +
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 77/173 (44%), Gaps = 12/173 (6%)
Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCA-----STLKSFEAECEVIKNIRHRNLVKII 788
           IG G FG V++         A+ V    C      S  + F  E   ++   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
              + +    +++E  + G L   L     +L++   +     +++AL YL    S   +
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR-TQTLATIGYMAPDEI 900
           H D+   NVL+       L DFG+++ +  ED +  + ++    I +MAP+ I
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESI 564

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 25/197 (12%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSV---YRARLEDGVEIAIKVFHP-QCASTLKSFEAE 772
           S F +L+   N      IG G  G V   Y A L+  V I  K+  P Q  +  K    E
Sbjct: 18  STFTVLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRE 73
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN----- 827
             ++K + H+N++ +++  +        LE   +  L   L  +N    I   L+     
Sbjct: 74  LVLMKXVNHKNIISLLNVFTPQK----TLEEFQDVYLVMELMDANLXQVIQMELDHERMS 129
Query: 828 -IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
            ++  +   +++LH   S  IIH DLKPSN+++  D    + DFG+A+       S M T
Sbjct: 130 YLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMT 183
Query: 887 QTLATIGYMAPDEIFVG 903
             + T  Y AP E+ +G
Sbjct: 184 PYVVTRYYRAP-EVILG 199

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 66/142 (46%), Gaps = 13/142 (9%)
Query: 731 NNIIGIGGFGSVYRA-RLEDG-------VEIAIKVFHPQCASTLKSFEAECEVIKNIRHR 782
           N  +G G F  +++  R E G        E+ +KV      +  +SF     ++  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           +LV     C   D   LV E++  GSL+  L  +   +NI  +L +   +A+A   +HF 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA---MHFL 129
Query: 843 HSTPIIHCDLKPSNVLL--DED 862
               +IH ++   N+LL  +ED
Sbjct: 130 EENTLIHGNVCAKNILLIREED 151

>pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/136 (33%), Positives = 63/136 (46%), Gaps = 5/136 (3%)
Query: 102 LDLSHNKLSSNIPSSIF-TMSTLKVLYLMDNQLSGSLSSFTFNT-SSILDIRLSKNKLSG 159
           LDL  N L S +P+ +F  +++L  LYL  N+L  SL +  FN  +S+  + LS N+L  
Sbjct: 33  LDLETNSLKS-LPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 160 KLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTV 219
            LP  + + L  LK L L  N           K  QL++L L  N L          LT 
Sbjct: 90  SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS 149
Query: 220 LQRISLINNKLHGEIP 235
           LQ I L +N      P
Sbjct: 150 LQYIWLHDNPWDCTCP 165

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 46/192 (23%), Positives = 82/192 (42%), Gaps = 27/192 (14%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLV 785
           +G G FG V  A      +      +A+K+       S  ++  +E +++ +I  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 786 KIISSCSNDDFKALVL-EYMSNGSLEDCLHSSNCAL-----------NIFCRLNIMI--- 830
            ++ +C+      +V+ E+   G+L   L S                  F  L  +I   
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 831 -DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
             +A  +E+L    S   IH DL   N+LL E  V  + DFG+A+ +  + +   +    
Sbjct: 157 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 890 ATIGYMAPDEIF 901
             + +MAP+ IF
Sbjct: 214 LPLKWMAPETIF 225

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 46/192 (23%), Positives = 82/192 (42%), Gaps = 27/192 (14%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLV 785
           +G G FG V  A      +      +A+K+       S  ++  +E +++ +I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 786 KIISSCSNDDFKALVL-EYMSNGSLEDCLHSSNCAL-----------NIFCRLNIMI--- 830
            ++ +C+      +V+ E+   G+L   L S                  F  L  +I   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 831 -DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
             +A  +E+L    S   IH DL   N+LL E  V  + DFG+A+ +  + +   +    
Sbjct: 146 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 890 ATIGYMAPDEIF 901
             + +MAP+ IF
Sbjct: 203 LPLKWMAPETIF 214

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 46/192 (23%), Positives = 82/192 (42%), Gaps = 27/192 (14%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLV 785
           +G G FG V  A      +      +A+K+       S  ++  +E +++ +I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 786 KIISSCSNDDFKALVL-EYMSNGSLEDCLHSSNCAL-----------NIFCRLNIMI--- 830
            ++ +C+      +V+ E+   G+L   L S                  F  L  +I   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 831 -DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
             +A  +E+L    S   IH DL   N+LL E  V  + DFG+A+ +  + +   +    
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 890 ATIGYMAPDEIF 901
             + +MAP+ IF
Sbjct: 212 LPLKWMAPETIF 223

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 46/192 (23%), Positives = 82/192 (42%), Gaps = 27/192 (14%)
Query: 734 IGIGGFGSVYRA------RLEDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLV 785
           +G G FG V  A      +      +A+K+       S  ++  +E +++ +I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 786 KIISSCSNDDFKALVL-EYMSNGSLEDCLHSSNCAL-----------NIFCRLNIMI--- 830
            ++ +C+      +V+ E+   G+L   L S                  F  L  +I   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 831 -DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
             +A  +E+L    S   IH DL   N+LL E  V  + DFG+A+ +  + +   +    
Sbjct: 146 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 890 ATIGYMAPDEIF 901
             + +MAP+ IF
Sbjct: 203 LPLKWMAPETIF 214

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 70/151 (46%), Gaps = 14/151 (9%)
Query: 763 ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSL---EDCL----HS 815
            S    F+ E ++I +I++   +      +N D   ++ EYM N S+   ++       +
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 816 SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL 875
             C + I     I+  + ++  Y+H  +   I H D+KPSN+L+D++    LSDFG ++ 
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEY 201
Query: 876 LSGEDESTMRTQTLATIGYMAPDEIFVGELS 906
           +  +     R     T  +M P E F  E S
Sbjct: 202 MVDKKIKGSR----GTYEFMPP-EFFSNESS 227

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 27/140 (19%)
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA------LNIFCRLNIMIDIAS 834
           H N+++   S + D F  + LE + N +L+D + S N +         +  ++++  IAS
Sbjct: 68  HPNVIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLD-------------EDMVAHLSDFGMAKLLSGEDE 881
            + +LH   S  IIH DLKP N+L+              E++   +SDFG+ K L    +
Sbjct: 127 GVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS-GQ 182
Query: 882 STMRT---QTLATIGYMAPD 898
           S+ RT       T G+ AP+
Sbjct: 183 SSFRTNLNNPSGTSGWRAPE 202

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLK------SFEAECEVIKN 778
           D +     +G G F  V + R +  G++ A K    +   + +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           I+H N++ +     N     L+LE ++ G L D L +   +L        +  I + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HLSDFGMA 873
           L   HS  I H DLKP N++L +  V      + DFG+A
Sbjct: 130 L---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 81/174 (46%), Gaps = 17/174 (9%)
Query: 726 DNFAENNIIGIGGFGSVYRA-RLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
           D++     +G G +  V+ A  + +  ++ +K+  P   + +K    E ++++N+R    
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKR---EIKILENLRGGPN 93
Query: 785 VKIISSCSNDDFK---ALVLEYMSNGSLEDCLHS-SNCALNIFCRLNIMIDIASALEYLH 840
           +  ++    D      ALV E+++N   +    + ++  +  +     M +I  AL+Y H
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFY-----MYEILKALDYCH 148
Query: 841 FGHSTPIIHCDLKPSNVLLD-EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
              S  I+H D+KP NV++D E     L D+G+A+      E  +R  +    G
Sbjct: 149 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 199

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 26/71 (36%), Positives = 37/71 (52%), Gaps = 3/71 (4%)
Query: 830 IDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
           I +A+     H   +  IIH D+KPSN+LLD      L DFG++  L    +S  +T+  
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDA 186
Query: 890 ATIGYMAPDEI 900
               YMAP+ I
Sbjct: 187 GCRPYMAPERI 197

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 66/153 (43%), Gaps = 18/153 (11%)
Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           +A  +E+L    S   IH DL   N+LL E+ V  + DFG+A+ +    +   +  T   
Sbjct: 208 VARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 892 IGYMAPDEIFVGELSLKR--WVNDLL----------PVSLVEVVDKSLLS--GEEKHFAA 937
           + +MAP+ IF    S K   W   +L          P   V+ +D+   S   E     A
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQ-MDEDFCSRLREGMRMRA 323
Query: 938 KEQCLLSIFSLALECTMESPEKRIDAKDTITRL 970
            E     I+ + L+C    P++R    + + +L
Sbjct: 324 PEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 11/210 (5%)
Query: 415 NLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNG 474
           NL NL  L L  N +S   P  F  L KL+ L L+ N+L   +P++  +   L EL ++ 
Sbjct: 74  NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEK--MPKTLQELRVHE 130
Query: 475 NKISGSISSCLGNLTSLQYLNLGSN--RFTFVIPSTFWNLKDILSFDIS-SNLLDGPISL 531
           N+I+    S    L  +  + LG+N  + + +    F  +K +    I+ +N+   P  L
Sbjct: 131 NEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL 190
Query: 532 AIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLD 591
                 ++  + L  N ++     +L+GL +L  + L++N +      S  N   L  L 
Sbjct: 191 P----PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 246
Query: 592 LSNNKISGSIPVSFEKLSYLKELNLSFNKL 621
           L+NNK+   +P       Y++ + L  N +
Sbjct: 247 LNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275

>pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 86/184 (46%), Gaps = 7/184 (3%)
Query: 440 LQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKIS--GSISSCLGNLTSLQYLNLG 497
           L+ L+ L    NK  G+   E+ L S L  LDL+ N +S  G  S       SL+YL+L 
Sbjct: 348 LKSLKRLTFTSNK-GGNAFSEVDLPS-LEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLS 405
Query: 498 SNRFTFVIPSTFWNLKDILSFDIS-SNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTT 556
            N     + S F  L+ +   D   SNL          +L+ ++ +D+S  +        
Sbjct: 406 FNG-VITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 464
Query: 557 LEGLKSLQNISLAYNRL-EGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELN 615
             GL SL+ + +A N   E  +P+ F  + +L  LDLS  ++    P +F  LS L+ LN
Sbjct: 465 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 524
Query: 616 LSFN 619
           +S N
Sbjct: 525 MSHN 528

>pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 11/210 (5%)
Query: 415 NLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNG 474
           NL NL  L L  N +S   P  F  L KL+ L L+ N+L   +P++  +   L EL ++ 
Sbjct: 74  NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEK--MPKTLQELRVHE 130
Query: 475 NKISGSISSCLGNLTSLQYLNLGSN--RFTFVIPSTFWNLKDILSFDIS-SNLLDGPISL 531
           N+I+    S    L  +  + LG+N  + + +    F  +K +    I+ +N+   P  L
Sbjct: 131 NEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL 190
Query: 532 AIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLD 591
                 ++  + L  N ++     +L+GL +L  + L++N +      S  N   L  L 
Sbjct: 191 P----PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 246
Query: 592 LSNNKISGSIPVSFEKLSYLKELNLSFNKL 621
           L+NNK+   +P       Y++ + L  N +
Sbjct: 247 LNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 15/153 (9%)
Query: 728 FAENNIIGIGGFGSVY--RARLEDGVE--IAIKVFHPQCASTLKSFEAECEVIKNIRHRN 783
           F   + IG G F SVY   A+L+ G E  IA+K   P       + E +C  +   +  N
Sbjct: 23  FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQD-N 81
Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-FG 842
           ++ +      +D   + + Y+ + S  D L+S    L+       M+++  AL+ +H FG
Sbjct: 82  VMGVKYCFRKNDHVVIAMPYLEHESFLDILNS----LSFQEVREYMLNLFKALKRIHQFG 137
Query: 843 HSTPIIHCDLKPSNVLLDEDMVAH-LSDFGMAK 874
               I+H D+KPSN L +  +  + L DFG+A+
Sbjct: 138 ----IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166

>pdb|1M10|B Chain B, Crystal Structure Of The Complex Of Glycoprotein Ib Alpha And The Von Willebrand Factor A1 Domain Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 35/107 (32%), Positives = 55/107 (51%), Gaps = 2/107 (1%)
Query: 77  TLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGS 136
           TL+LS   LQ ++P     L +L  LD+S N+L+S    ++  +  L+ LYL  N+L   
Sbjct: 81  TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139
Query: 137 LSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFY 183
                  T  +  + L+ N+L+ +LP  + N L  L  L L+EN  Y
Sbjct: 140 PPGLLTPTPKLEKLSLANNQLT-ELPAGLLNGLENLDTLLLQENSLY 185

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 24/194 (12%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSV---YRARLEDGVEIAIKVFHP-QCASTLKSFEAE 772
           S F +L+   N      IG G  G V   Y A LE  V I  K+  P Q  +  K    E
Sbjct: 18  STFTVLKRYQNLKP---IGSGAQGIVVAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRE 73
Query: 773 CEVIKNIRHRNLVKIIS----SCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRL 826
             ++K + H+N++ +++      S ++F+   +V+E M + +L   +      L+     
Sbjct: 74  LVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVI---QMELDHERMS 129
Query: 827 NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
            ++  +   +++LH   S  IIH DLKPSN+++  D    + DFG+A+       S M T
Sbjct: 130 YLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMT 183
Query: 887 QTLATIGYMAPDEI 900
             + T  Y AP+ I
Sbjct: 184 PYVVTRYYRAPEVI 197

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 88/179 (49%), Gaps = 18/179 (10%)
Query: 718 YFELLR---ATDNFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFHPQCASTL--KSFEA 771
           YF+ ++     DN+   ++IG G +G VY A  ++  + +AIK  +      +  K    
Sbjct: 15  YFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR 74
Query: 772 ECEVIKNIRHRNLVKIISSCSNDD---FKAL--VLEYMSNGSLEDCLHSSNCALNIF-CR 825
           E  ++  ++   ++++      DD   F  L  VLE +++  L+    +      IF   
Sbjct: 75  EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTP-----IFLTE 128
Query: 826 LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
            +I   + + L   +F H + IIH DLKP+N LL++D    + DFG+A+ ++ E ++ +
Sbjct: 129 EHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187

>pdb|3ULA|A Chain A, Crystal Structure Of The Tv3 Mutant F63w-Md-2-Eritoran Complex Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 84/161 (52%), Gaps = 19/161 (11%)
Query: 444 QGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTF 503
           Q ++L F K    IPD +   ++   LDL+ N +    S    +   LQ L+L       
Sbjct: 15  QCMELNFYK----IPDNLPFSTK--NLDLSWNPLRHLGSYSFFSFPELQVLDLSRCEIQT 68
Query: 504 VIPSTFWNLKDILSFDISSNLLDGPISLAIG------NLKAVVGIDLSRNNLSGNIPTTL 557
           +    + +L  + +  ++ N +    SLA+G      +L+ +V ++ +  +L  N P  +
Sbjct: 69  IEDGAYQSLSHLSTLILTGNPIQ---SLALGAFSGLSSLQKLVAVETNLASLE-NFP--I 122
Query: 558 EGLKSLQNISLAYNRLEG-PIPESFGNMTSLESLDLSNNKI 597
             LK+L+ +++A+N ++   +PE F N+T+LE LDLS+NKI
Sbjct: 123 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 163

>pdb|3UL7|A Chain A, Crystal Structure Of The Tv3 Mutant F63w Length = 278

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 84/161 (52%), Gaps = 19/161 (11%)
Query: 444 QGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTF 503
           Q ++L F K    IPD +   ++   LDL+ N +    S    +   LQ L+L       
Sbjct: 14  QCMELNFYK----IPDNLPFSTK--NLDLSWNPLRHLGSYSFFSFPELQVLDLSRCEIQT 67
Query: 504 VIPSTFWNLKDILSFDISSNLLDGPISLAIG------NLKAVVGIDLSRNNLSGNIPTTL 557
           +    + +L  + +  ++ N +    SLA+G      +L+ +V ++ +  +L  N P  +
Sbjct: 68  IEDGAYQSLSHLSTLILTGNPIQ---SLALGAFSGLSSLQKLVAVETNLASLE-NFP--I 121
Query: 558 EGLKSLQNISLAYNRLEG-PIPESFGNMTSLESLDLSNNKI 597
             LK+L+ +++A+N ++   +PE F N+T+LE LDLS+NKI
Sbjct: 122 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 162

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 10/107 (9%)
Query: 783 NLVKIISSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           N++K+I +  +   K  ALV EY++N   +           I    +I   +   L+ L 
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLY-------QILTDFDIRFYMYELLKALD 151
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVA-HLSDFGMAKLLSGEDESTMRT 886
           + HS  I+H D+KP NV++D       L D+G+A+      E  +R 
Sbjct: 152 YCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRV 198

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 10/107 (9%)
Query: 783 NLVKIISSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           N++K+I +  +   K  ALV EY++N   +           I    +I   +   L+ L 
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLY-------QILTDFDIRFYMYELLKALD 146
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVA-HLSDFGMAKLLSGEDESTMRT 886
           + HS  I+H D+KP NV++D       L D+G+A+      E  +R 
Sbjct: 147 YCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRV 193

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 86/194 (44%), Gaps = 24/194 (12%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSV---YRARLEDGVEIAIKVFHP-QCASTLKSFEAE 772
           S F +L+   N      IG G  G V   Y A L+  V I  K+  P Q  +  K    E
Sbjct: 18  STFTVLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRE 73
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN----- 827
             ++K + H+N++ +++  +        LE   +  L   L  +N    I   L+     
Sbjct: 74  LVLMKXVNHKNIISLLNVFTPQK----TLEEFQDVYLVMELMDANLXQVIQMELDHERMS 129
Query: 828 -IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
            ++  +   +++LH   S  IIH DLKPSN+++  D    + DFG+A+       S M T
Sbjct: 130 YLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMT 183
Query: 887 QTLATIGYMAPDEI 900
             + T  Y AP+ I
Sbjct: 184 PYVVTRYYRAPEVI 197

>pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 84/347 (24%), Positives = 130/347 (37%), Gaps = 51/347 (14%)
Query: 290 LPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAI--GNLRNLKLF--- 344
           LPNL  L+LG +      P +      L  L +    F G   + +  G  RNLK     
Sbjct: 72  LPNLRILDLGSSKIYFLHPDAFQGLFHLFELRL---YFCGLSDAVLKDGYFRNLKALTRL 128
Query: 345 DIFFNNLTSST--PELGFLSSLANC--------------------KKLRYLGLGGNPLDG 382
           D+  N + S    P  G L+SL +                     K L +  L  N L  
Sbjct: 129 DLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYS 188
Query: 383 FLPSSIGNLSLSLERLNIAFCNISGN--IPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGL 440
            +    G        + +   ++SGN       GN SN I         S S   +    
Sbjct: 189 RVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAI---------SKSQAFSLILA 239
Query: 441 QKLQGLDLAFNKLAGSIPDEICLLSR--LNELDLNGNKISGSISSCLGNLTSLQYLNLGS 498
             + G    F+ +     +    L+R  +  LDL+   +    S     L  L+ LNL  
Sbjct: 240 HHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAY 299
Query: 499 NRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLE 558
           N+   +    F+ L ++   ++S NLL    S     L  V  IDL +N+++     T +
Sbjct: 300 NKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFK 359
Query: 559 GLKSLQNISLAYNRLEG-----PIPESF--GN-MTSLESLDLSNNKI 597
            L+ LQ + L  N L        IP+ F  GN + +L  ++L+ N I
Sbjct: 360 FLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLI 406

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 23/183 (12%)
Query: 708 SSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRA--RLEDGVEIAIK----VFHP- 760
           SS+PT          +  D +   ++IG G +G V  A  +LE  V +AIK    VF   
Sbjct: 35  SSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRV-VAIKKILRVFEDL 93
Query: 761 -QCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA-----LVLEYMSNGSLEDCLH 814
             C   L+    E  ++  + H ++VK++      D +      +VLE +++   +    
Sbjct: 94  IDCKRILR----EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE-IADSDFKKLFR 148
Query: 815 SSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK 874
           +          L+I   + + L  + + HS  I+H DLKP+N L+++D    + DFG+A+
Sbjct: 149 TPV----YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204
Query: 875 LLS 877
            + 
Sbjct: 205 TVD 207

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 43/183 (23%), Positives = 77/183 (42%), Gaps = 19/183 (10%)
Query: 734 IGIGGFGSVYRARLEDGVE------IAIKVFHPQCASTLK-SFEAECEVIKNIRHRNLVK 786
           +G G FG VY     D ++      +A+K  +   +   +  F  E  V+K     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMI----DIASALE 837
           ++   S      +V+E M++G L+  L S      N        L  MI    +IA  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           YL+   +   +H DL   N ++  D    + DFGM + +          + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 898 DEI 900
           + +
Sbjct: 202 ESL 204

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 86/194 (44%), Gaps = 24/194 (12%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSV---YRARLEDGVEIAIKVFHP-QCASTLKSFEAE 772
           S F +L+   N      IG G  G V   Y A L+  V I  K+  P Q  +  K    E
Sbjct: 18  STFTVLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRE 73
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN----- 827
             ++K + H+N++ +++  +        LE   +  L   L  +N    I   L+     
Sbjct: 74  LVLMKXVNHKNIISLLNVFTPQK----TLEEFQDVYLVMELMDANLCQVIQMELDHERMS 129
Query: 828 -IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
            ++  +   +++LH   S  IIH DLKPSN+++  D    + DFG+A+       S M T
Sbjct: 130 YLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMT 183
Query: 887 QTLATIGYMAPDEI 900
             + T  Y AP+ I
Sbjct: 184 PYVVTRYYRAPEVI 197

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 771 AECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
           AE  V++ + +  +V++I  C  + +  LV+E    G L   L   N  +     + ++ 
Sbjct: 419 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVH 476
Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            ++  ++YL     +  +H DL   NVLL     A +SDFG++K L   DE+  + QT  
Sbjct: 477 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHG 532
Query: 891 T--IGYMAPD 898
              + + AP+
Sbjct: 533 KWPVKWYAPE 542

>pdb|2Z62|A Chain A, Crystal Structure Of The Tv3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 84/163 (51%), Gaps = 19/163 (11%)
Query: 444 QGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTF 503
           Q ++L F K    IPD +   ++   LDL+ N +    S    +   LQ L+L       
Sbjct: 13  QCMELNFYK----IPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 504 VIPSTFWNLKDILSFDISSNLLDGPISLAIG------NLKAVVGIDLSRNNLSGNIPTTL 557
           +    + +L  + +  ++ N +    SLA+G      +L+ +V ++ +  +L  N P  +
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQ---SLALGAFSGLSSLQKLVAVETNLASLE-NFP--I 120
Query: 558 EGLKSLQNISLAYNRLEG-PIPESFGNMTSLESLDLSNNKISG 599
             LK+L+ +++A+N ++   +PE F N+T+LE LDLS+NKI  
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 771 AECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
           AE  V++ + +  +V++I  C  + +  LV+E    G L   L   N  +     + ++ 
Sbjct: 420 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVH 477
Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            ++  ++YL     +  +H DL   NVLL     A +SDFG++K L   DE+  + QT  
Sbjct: 478 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHG 533
Query: 891 T--IGYMAPD 898
              + + AP+
Sbjct: 534 KWPVKWYAPE 543

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 24/194 (12%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSV---YRARLEDGVEIAIKVFHP-QCASTLKSFEAE 772
           S F +L+   N      IG G  G V   Y A LE  V I  K+  P Q  +  K    E
Sbjct: 18  STFTVLKRYQNLKP---IGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRE 73
Query: 773 CEVIKNIRHRNLVKIIS----SCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRL 826
             ++K + H+N++ +++      S ++F+   +V+E M + +L   +      L+     
Sbjct: 74  LVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVI---QMELDHERMS 129
Query: 827 NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
            ++  +   +++LH   S  IIH DLKPSN+++  D    + DFG+A+       S M T
Sbjct: 130 YLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMT 183
Query: 887 QTLATIGYMAPDEI 900
             + T  Y AP+ I
Sbjct: 184 PYVVTRYYRAPEVI 197

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 83/198 (41%), Gaps = 25/198 (12%)
Query: 721 LLRATDNFAENNIIGIGGFGSVYRARLEDGVE-IAIKVFH--PQCASTLKSFEAECEVI- 776
           ++  +D +     IG G FG     R +   E +A+K      + A+ +K      E+I 
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKR-----EIIN 68
Query: 777 -KNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASA 835
            +++RH N+V+           A+V+EY S G L + +    C    F            
Sbjct: 69  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQL 124
Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLS--DFGMAKLLSGEDESTMRTQTLATIG 893
           +  + + H+  + H DLK  N LLD      L   DFG +K       S + +Q  +T+G
Sbjct: 125 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVG 178
Query: 894 ---YMAPDEIFVGELSLK 908
              Y+AP+ +   E   K
Sbjct: 179 TPAYIAPEVLLKKEYDGK 196

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 40/74 (54%), Gaps = 5/74 (6%)
Query: 827 NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
            I + I  ALE+LH   S  +IH D+KPSNVL++      + DFG++  L    +S  +T
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DSVAKT 211
Query: 887 QTLATIGYMAPDEI 900
                  YMAP+ I
Sbjct: 212 IDAGCKPYMAPERI 225

>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 101/441 (22%), Positives = 171/441 (38%), Gaps = 58/441 (13%)
Query: 194 KQLQELHLGYNNL-SGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFN 252
           K L+EL++ +N + S  +P+   NLT L+ + L +NK+      ++  L  + +L L   
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS-- 181
Query: 253 NLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSIT 312
               + P         KEI L+  +L  +  S        L  +   I   +G       
Sbjct: 182 LDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDS--------LNVMKTCIQGLAG------L 227
Query: 313 NASKLILLEM-GSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPE-LGFLSSLANCKKL 370
              +L+L E     +   F  SA+  L NL + +     L     + +   + L N    
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 371 RYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPK-AIGNLSNLIVLSLGGNNL 429
             + +    +  F      + +   + L +  C   G  P   + +L  L   S  G N 
Sbjct: 288 SLVSVTIERVKDF------SYNFGWQHLELVNCKF-GQFPTLKLKSLKRLTFTSNKGGNA 340
Query: 430 SGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLT 489
              +      L  L+ LDL+ N L+                        G  S      T
Sbjct: 341 FSEV-----DLPSLEFLDLSRNGLS----------------------FKGCCSQSDFGTT 373
Query: 490 SLQYLNLGSNRFTFVIPSTFWNLKDILSFDIS-SNLLDGPISLAIGNLKAVVGIDLSRNN 548
           SL+YL+L  N     + S F  L+ +   D   SNL          +L+ ++ +D+S  +
Sbjct: 374 SLKYLDLSFNG-VITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432
Query: 549 LSGNIPTTLEGLKSLQNISLAYNRL-EGPIPESFGNMTSLESLDLSNNKISGSIPVSFEK 607
                     GL SL+ + +A N   E  +P+ F  + +L  LDLS  ++    P +F  
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 608 LSYLKELNLSFNKLKGEIPRG 628
           LS L+ LN++ N+LK  +P G
Sbjct: 493 LSSLQVLNMASNQLKS-VPDG 512

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 87/209 (41%), Gaps = 29/209 (13%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSVYRA------RLEDGVEIAIKVFHPQCA-STLKSF 769
           S +E  R  D       +G G FG V  A      +      +A+K+       S  ++ 
Sbjct: 57  SKWEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 114
Query: 770 EAECEVIKNIRHR-NLVKIISSCSNDDFKALVL-EYMSNGSLEDCLHSSNCAL------- 820
            +E +++ +I H  N+V ++ +C+      +V+ E+   G+L   L S            
Sbjct: 115 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 174
Query: 821 ----NIFCRLNIMI----DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGM 872
                 F  L  +I     +A  +E+L    S   IH DL   N+LL E  V  + DFG+
Sbjct: 175 EDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGL 231
Query: 873 AKLLSGEDESTMRTQTLATIGYMAPDEIF 901
           A+ +  + +   +      + +MAP+ IF
Sbjct: 232 ARDIYKDPDYVRKGDARLPLKWMAPETIF 260

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 65/142 (45%), Gaps = 13/142 (9%)
Query: 731 NNIIGIGGFGSVYRA-RLEDG-------VEIAIKVFHPQCASTLKSFEAECEVIKNIRHR 782
           N  +G G F  +++  R E G        E+ +KV      +  +SF     ++  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           +LV     C   D   LV E++  GSL+  L  +   +NI  +L +   +A A   +HF 
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA---MHFL 129
Query: 843 HSTPIIHCDLKPSNVLL--DED 862
               +IH ++   N+LL  +ED
Sbjct: 130 EENTLIHGNVCAKNILLIREED 151

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 24/194 (12%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSV---YRARLEDGVEIAIKVFHP-QCASTLKSFEAE 772
           S F +L+   N      IG G  G V   Y A LE  V I  K+  P Q  +  K    E
Sbjct: 18  STFTVLKRYQNLKP---IGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRE 73
Query: 773 CEVIKNIRHRNLVKIIS----SCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRL 826
             ++K + H+N++ +++      S ++F+   +V+E M + +L   +      L+     
Sbjct: 74  LVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVI---QMELDHERMS 129
Query: 827 NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
            ++  +   +++LH   S  IIH DLKPSN+++  D    + DFG+A+       S M T
Sbjct: 130 YLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMT 183
Query: 887 QTLATIGYMAPDEI 900
             + T  Y AP+ I
Sbjct: 184 PYVVTRYYRAPEVI 197

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 65/161 (40%), Gaps = 19/161 (11%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAE----C 773
           +E             +G G FG V+R +  + G + A+K         L+ F  E    C
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVAC 104
Query: 774 EVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
             + + R   +V +  +     +  + +E +  GSL   +    C          +  + 
Sbjct: 105 AGLSSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC----LPEDRALYYLG 157
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMA 873
            ALE L + H+  I+H D+K  NVLL  D   A L DFG A
Sbjct: 158 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA 198

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 86/194 (44%), Gaps = 24/194 (12%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSV---YRARLEDGVEIAIKVFHP-QCASTLKSFEAE 772
           S F +L+   N      IG G  G V   Y A L+  V I  K+  P Q  +  K    E
Sbjct: 11  STFTVLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRE 66
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN----- 827
             ++K + H+N++ +++  +        LE   +  L   L  +N    I   L+     
Sbjct: 67  LVLMKCVNHKNIISLLNVFTPQK----TLEEFQDVYLVMELMDANLXQVIQMELDHERMS 122
Query: 828 -IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
            ++  +   +++LH   S  IIH DLKPSN+++  D    + DFG+A+       S M T
Sbjct: 123 YLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMT 176
Query: 887 QTLATIGYMAPDEI 900
             + T  Y AP+ I
Sbjct: 177 PYVVTRYYRAPEVI 190

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 43/189 (22%), Positives = 77/189 (40%), Gaps = 15/189 (7%)
Query: 721 LLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR 780
           ++  +D +     IG G FG     R +   E+    +  +     ++ + E    +++R
Sbjct: 14  IMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLR 73
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+V+           A+V+EY S G L + +    C    F            +  + 
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 129
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHL--SDFGMAKLLSGEDESTMRTQTLATIG---YM 895
           + H+  + H DLK  N LLD      L  +DFG +K       S + +Q  + +G   Y+
Sbjct: 130 YAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSK------ASVLHSQPKSAVGTPAYI 183
Query: 896 APDEIFVGE 904
           AP+ +   E
Sbjct: 184 APEVLLKKE 192

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 25/197 (12%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSV---YRARLEDGVEIAIKVFHP-QCASTLKSFEAE 772
           S F +L+   N      IG G  G V   Y A L+  V I  K+  P Q  +  K    E
Sbjct: 18  STFTVLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRE 73
Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN----- 827
             ++K + H+N++ +++  +        LE   +  L   L  +N    I   L+     
Sbjct: 74  LVLMKCVNHKNIISLLNVFTPQK----TLEEFQDVYLVMELMDANLXQVIQMELDHERMS 129
Query: 828 -IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
            ++  +   +++LH   S  IIH DLKPSN+++  D    + DFG+A+       S M T
Sbjct: 130 YLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMT 183
Query: 887 QTLATIGYMAPDEIFVG 903
             + T  Y AP E+ +G
Sbjct: 184 PYVVTRYYRAP-EVILG 199

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 77/184 (41%), Gaps = 15/184 (8%)
Query: 726 DNFAENNIIGIGGFGSVYRA-RLEDGVEIAIKV-----FHPQCASTLKSFEAECEVIKNI 779
           D +    +IG G F  V R    E G + A+K+     F      + +  + E  +   +
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID--IASALE 837
           +H ++V+++ + S+D    +V E+M    L  C      A   F     +    +   LE
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADL--CFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 838 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY 894
            L + H   IIH D+KP  VLL   +      L  FG+A  L   +   +    + T  +
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGRVGTPHF 199
Query: 895 MAPD 898
           MAP+
Sbjct: 200 MAPE 203

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 75/312 (24%), Positives = 133/312 (42%), Gaps = 45/312 (14%)
Query: 691 ALKRGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDG 750
           AL+R K       + +  ++P  +     +L R  ++F    +IG G FG V   ++++ 
Sbjct: 61  ALRRDK----YVAEFLEWAKPFTQLVKEMQLHR--EDFEIIKVIGRGAFGEVAVVKMKNT 114
Query: 751 VEI-AIKVFHPQCASTLKSFEAEC-----EVIKNIRHRNLVKIISSCSNDDFKALVLEYM 804
             I A+K+ +      LK  E  C     +V+ N   + +  +  +  +++   LV++Y 
Sbjct: 115 ERIYAMKILNKW--EMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYY 172
Query: 805 SNGSL-------EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNV 857
             G L       ED L   + A      + + ID    L Y         +H D+KP NV
Sbjct: 173 VGGDLLTLLSKFEDKL-PEDMARFYIGEMVLAIDSIHQLHY---------VHRDIKPDNV 222
Query: 858 LLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPV 917
           LLD +    L+DFG   L   +D +   +  + T  Y++P+ +   E  + ++  +    
Sbjct: 223 LLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWW 281
Query: 918 SLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL--ECTMESPEKRID----AKDTITRLL 971
           SL  V    +L GE   +A   + L+  +   +  E   + P    D    AKD I RL+
Sbjct: 282 SL-GVCMYEMLYGETPFYA---ESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLI 337
Query: 972 KIRDTLSKRIGN 983
             R+   +R+G 
Sbjct: 338 CSRE---RRLGQ 346

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 65/161 (40%), Gaps = 19/161 (11%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAE----C 773
           +E             +G G FG V+R +  + G + A+K         L+ F  E    C
Sbjct: 67  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVAC 120
Query: 774 EVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
             + + R   +V +  +     +  + +E +  GSL   +    C          +  + 
Sbjct: 121 AGLSSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC----LPEDRALYYLG 173
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMA 873
            ALE L + H+  I+H D+K  NVLL  D   A L DFG A
Sbjct: 174 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA 214

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 24/194 (12%)
Query: 717 SYFELLRATDNFAENNIIGIGGFGSV---YRARLEDGVEIAIKVFHP-QCASTLKSFEAE 772
           S F +L+   N      IG G  G V   Y A LE  V I  K+  P Q  +  K    E
Sbjct: 18  STFTVLKRYQNLKP---IGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRE 73
Query: 773 CEVIKNIRHRNLVKIIS----SCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRL 826
             ++K + H+N++ +++      S ++F+   +V+E M + +L   +      L+     
Sbjct: 74  LVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVI---QMELDHERMS 129
Query: 827 NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
            ++  +   +++LH   S  IIH DLKPSN+++  D    + DFG+A+       S M T
Sbjct: 130 YLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMT 183
Query: 887 QTLATIGYMAPDEI 900
             + T  Y AP+ I
Sbjct: 184 PYVVTRYYRAPEVI 197

>pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 30/86 (34%), Positives = 48/86 (55%), Gaps = 3/86 (3%)
Query: 544 LSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPES-FGNMTSLESLDLSNNKISGSIP 602
           L  N ++   P   + L +L+ + L  N+L G +P   F ++T L  LDL  N+++    
Sbjct: 47  LHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLTVLPS 105
Query: 603 VSFEKLSYLKELNLSFNKLKGEIPRG 628
             F++L +LKEL +  NKL  E+PRG
Sbjct: 106 AVFDRLVHLKELFMCCNKLT-ELPRG 130

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 75/312 (24%), Positives = 133/312 (42%), Gaps = 45/312 (14%)
Query: 691 ALKRGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDG 750
           AL+R K       + +  ++P  +     +L R  ++F    +IG G FG V   ++++ 
Sbjct: 45  ALRRDK----YVAEFLEWAKPFTQLVKEMQLHR--EDFEIIKVIGRGAFGEVAVVKMKNT 98
Query: 751 VEI-AIKVFHPQCASTLKSFEAEC-----EVIKNIRHRNLVKIISSCSNDDFKALVLEYM 804
             I A+K+ +      LK  E  C     +V+ N   + +  +  +  +++   LV++Y 
Sbjct: 99  ERIYAMKILNKW--EMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYY 156
Query: 805 SNGSL-------EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNV 857
             G L       ED L   + A      + + ID    L Y         +H D+KP NV
Sbjct: 157 VGGDLLTLLSKFEDKL-PEDMARFYIGEMVLAIDSIHQLHY---------VHRDIKPDNV 206
Query: 858 LLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPV 917
           LLD +    L+DFG   L   +D +   +  + T  Y++P+ +   E  + ++  +    
Sbjct: 207 LLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWW 265
Query: 918 SLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL--ECTMESPEKRID----AKDTITRLL 971
           SL  V    +L GE   +A   + L+  +   +  E   + P    D    AKD I RL+
Sbjct: 266 SL-GVCMYEMLYGETPFYA---ESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLI 321
Query: 972 KIRDTLSKRIGN 983
             R+   +R+G 
Sbjct: 322 CSRE---RRLGQ 330

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 63/259 (24%), Positives = 108/259 (41%), Gaps = 26/259 (10%)
Query: 726 DNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLK------SFEAECEVIKN 778
           D +     +G G F  V + R +  G++ A K    +   + +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           I+H N++ +     N     L+ E ++ G L D L     +L        +  I + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           LH   S  I H DLKP N++L +  V      + DFG+A  +   +E         T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 183
Query: 895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-AKEQCLLSIFSLALECT 953
           +AP+ +    L L+    D+  + ++  +   LLSG        K++ L ++ ++  E  
Sbjct: 184 VAPEIVNYEPLGLEA---DMWSIGVITYI---LLSGASPFLGDTKQETLANVSAVNYEFE 237
Query: 954 MES-PEKRIDAKDTITRLL 971
            E        AKD I RLL
Sbjct: 238 DEYFSNTSALAKDFIRRLL 256

>pdb|3UL8|A Chain A, Crystal Structure Of The Tv3 Mutant V134l Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 84/161 (52%), Gaps = 19/161 (11%)
Query: 444 QGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTF 503
           Q ++L F K    IPD +   ++   LDL+ N +    S    +   LQ L+L       
Sbjct: 15  QCMELNFYK----IPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 68
Query: 504 VIPSTFWNLKDILSFDISSNLLDGPISLAIG------NLKAVVGIDLSRNNLSGNIPTTL 557
           +    + +L  + +  ++ N +    SLA+G      +L+ +V ++ +  +L  N P  +
Sbjct: 69  IEDGAYQSLSHLSTLILTGNPIQ---SLALGAFSGLSSLQKLVALETNLASLE-NFP--I 122
Query: 558 EGLKSLQNISLAYNRLEG-PIPESFGNMTSLESLDLSNNKI 597
             LK+L+ +++A+N ++   +PE F N+T+LE LDLS+NKI
Sbjct: 123 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 163

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/193 (23%), Positives = 78/193 (40%), Gaps = 15/193 (7%)
Query: 721 LLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR 780
           ++  +D +     IG G FG     R +   E+    +  +     ++ + E    +++R
Sbjct: 13  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 72
Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N+V+           A+V+EY S G L + +    C    F            +  + 
Sbjct: 73  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 128
Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLS--DFGMAKLLSGEDESTMRTQTLATIG---YM 895
           + H+  + H DLK  N LLD      L   DFG +K       S + +Q  +T+G   Y+
Sbjct: 129 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYI 182
Query: 896 APDEIFVGELSLK 908
           AP+ +   E   K
Sbjct: 183 APEVLLKKEYDGK 195

>pdb|2FT3|A Chain A, Crystal Structure Of The Biglycan Dimer Core Protein Length = 332

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 116/260 (44%), Gaps = 17/260 (6%)
Query: 43  TYDPTNLLGTNWTSNASICSWIGI--ICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLK 100
           TY      G +       CS +G+  +    S   T L+L + ++      +   L  L 
Sbjct: 22  TYSAMCPFGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLY 81
Query: 101 SLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGK 160
           +L L +NK+S     +   +  L+ LY+  N L     +     SS++++R+  N++  K
Sbjct: 82  ALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLP---SSLVELRIHDNRIR-K 137
Query: 161 LPENICNHLRYLKHLFLRENMFY--GKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLT 218
           +P+ + + LR +  + +  N     G  P +    K L  L +    L+G IPK++    
Sbjct: 138 VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLTG-IPKDLPE-- 193
Query: 219 VLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSL 278
            L  + L +NK+     +++     L  L LG N +  +   ++  + TL+E+ L NN L
Sbjct: 194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL 253
Query: 279 SGSLPSRIDLALPNLEFLNL 298
                SR+   LP+L+ L +
Sbjct: 254 -----SRVPAGLPDLKLLQV 268

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 65/161 (40%), Gaps = 19/161 (11%)
Query: 719 FELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAE----C 773
           +E             +G G FG V+R +  + G + A+K         L+ F  E    C
Sbjct: 65  YEYREEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVAC 118
Query: 774 EVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
             + + R   +V +  +     +  + +E +  GSL   +    C          +  + 
Sbjct: 119 AGLSSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC----LPEDRALYYLG 171
Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMA 873
            ALE L + H+  I+H D+K  NVLL  D   A L DFG A
Sbjct: 172 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA 212

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	985
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	0.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-163
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-115
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-112
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-109
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-102
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-93
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-43
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-109
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-80
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-54
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-37
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-98
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-76
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-39
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-37
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-93
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-46
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-92
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-82
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-76
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-37
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-34
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-31
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-88
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-72
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-84
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-67
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-63
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-35
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-70
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-25
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-05
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-67
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	8e-65
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-61
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-60
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-51
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-50
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-24
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-59
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-58
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-47
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-45
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-35
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-28
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-23
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-12
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-56
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-55
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-55
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-51
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-48
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-47
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-44
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-23
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-18
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-51
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-43
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-41
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-41
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-28
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-48
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-47
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-47
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-45
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-42
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-42
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-35
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-30
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-05
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-45
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-45
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-44
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-43
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-43
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-43
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-43
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-42
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-40
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-38
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-38
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-27
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-43
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-42
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-41
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-39
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-38
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-11
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-41
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-41
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-40
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-40
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-34
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-40
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-36
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-19
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-39
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-38
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-38
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-26
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-10
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-37
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-36
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-33
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-33
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-28
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-34
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-33
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-26
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-36
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-34
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-26
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-17
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-14
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-36
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-35
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-31
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-22
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-35
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-32
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-30
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-30
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-13
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-09
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-27
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-10
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-33
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-31
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-28
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-26
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-24
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-13
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-08
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-32
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-29
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-27
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-20
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-31
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-27
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-31
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-30
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-27
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-31
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-30
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-29
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-30
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-24
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-30
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-30
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-30
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-30
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-30
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-24
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-30
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-30
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-30
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-30
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-30
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-29
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-29
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-29
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-29
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-29
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-29
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-29
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-29
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-29
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-29
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-28
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-28
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-28
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-28
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-28
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-28
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-28
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-28
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-28
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-28
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-28
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-27
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-27
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-25
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-22
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-21
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-27
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-27
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-27
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-27
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-27
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-27
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	9e-27
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-27
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-26
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-26
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-26
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-26
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-26
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-26
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-26
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-26
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-25
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-25
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-25
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-24
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-15
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-24
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-24
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-24
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-24
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-16
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-24
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-23
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-23
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-18
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-18
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-11
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-23
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-23
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-22
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-22
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-22
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-22
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	8e-22
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-17
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-22
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-22
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-22
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-22
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-22
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-22
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-22
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	9e-21
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-16
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-22
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-22
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-21
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-21
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-21
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-21
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-21
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-21
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-21
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	9e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-13
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-20
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-20
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-11
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-20
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-20
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-20
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-19
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-19
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-19
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-13
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-19
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-19
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-19
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-19
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-19
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	8e-14
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-18
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-18
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-17
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-17
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-17
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-17
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-17
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-17
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-06
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-17
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-05
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-11
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-16
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-15
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-15
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-15
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	8e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-06
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	7e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-09
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-14
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	5e-14
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-09
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	7e-07
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-06
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-14
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-14
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	8e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-13
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-13
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-08
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-08
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-06
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-08
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-13
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-13
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-12
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-11
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-11
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	8e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	9e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	7e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	8e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-04
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-04
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-04
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-09
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-08
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	8e-08
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	4e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	1e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	5e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	2e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	5e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	9e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	9e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	6e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	6e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	1e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	9e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-04
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	3e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  548 bits (1414), Expect = 0.0
 Identities = 186/611 (30%), Positives = 298/611 (48%), Gaps = 25/611 (4%)

Query: 66  IICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKV 125
            +      ++  L +S   + G +   ++   +L+ LD+S N  S+ IP  +   S L+ 
Sbjct: 171 WVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQH 227

Query: 126 LYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGK 185
           L +  N+LSG  S      + +  + +S N+  G +P      L+YL    L EN F G+
Sbjct: 228 LDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYL---SLAENKFTGE 284

Query: 186 IPSSLS-KCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQE-IGYLQN 243
           IP  LS  C  L  L L  N+  GA+P   G+ ++L+ ++L +N   GE+P + +  ++ 
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG 344

Query: 244 LDVLQLGFNNLTGVVPATIFNMST-LKEIFLYNNSLSGSLPSRI-DLALPNLEFLNLGIN 301
           L VL L FN  +G +P ++ N+S  L  + L +N+ SG +   +       L+ L L  N
Sbjct: 345 LKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNN 404

Query: 302 SFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFL 361
            F+G IP +++N S+L+ L +  N  SG IPS++G+L  L+   ++ N L    P     
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP----- 459

Query: 362 SSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIV 421
             L   K L  L L  N L G +PS + N + +L  ++++   ++G IPK IG L NL +
Sbjct: 460 QELMYVKTLETLILDFNDLTGEIPSGLSNCT-NLNWISLSNNRLTGEIPKWIGRLENLAI 518

Query: 422 LSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSI 481
           L L  N+ SG+IP   G  + L  LDL  N   G+IP  +   S      +  N I+G  
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKR 574

Query: 482 SSCLGNLTSLQYLNLGSN--RFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAV 539
              + N    +  +   N   F  +       L      +I+S +  G  S    N  ++
Sbjct: 575 YVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM 634

Query: 540 VGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISG 599
           + +D+S N LSG IP  +  +  L  ++L +N + G IP+  G++  L  LDLS+NK+ G
Sbjct: 635 MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDG 694

Query: 600 SIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKHS 659
            IP +   L+ L E++LS N L G IP  G F  F    F+ N  LCG P   +P C  S
Sbjct: 695 RIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPS 751

Query: 660 QPRAQHKSKKT 670
                   +++
Sbjct: 752 NADGYAHHQRS 762

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  498 bits (1284), Expect = e-163
 Identities = 171/616 (27%), Positives = 281/616 (45%), Gaps = 33/616 (5%)

Query: 24  AASNISTDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSF 83
            + ++  +   L++ KD +  D   L   +W+SN + C++ G+ C     KVT+++LSS 
Sbjct: 6   PSQSLYREIHQLISFKDVLP-DKNLL--PDWSSNKNPCTFDGVTCR--DDKVTSIDLSSK 60

Query: 84  NLQ---GTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSF 140
            L      +   + +L+ L+SL LS++ ++ ++       ++L  L L  N LSG +++ 
Sbjct: 61  PLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTL 119

Query: 141 T--FNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSL---SKCKQ 195
           T   + S +  + +S N L      +    L  L+ L L  N   G           C +
Sbjct: 120 TSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE 179

Query: 196 LQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLT 255
           L+ L +  N +SG +   +     L+ + + +N     IP  +G    L  L +  N L+
Sbjct: 180 LKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLS 236

Query: 256 GVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSIT-NA 314
           G     I   + LK + + +N   G +P      L +L++L+L  N F+G IP  ++   
Sbjct: 237 GDFSRAISTCTELKLLNISSNQFVGPIPPLP---LKSLQYLSLAENKFTGEIPDFLSGAC 293

Query: 315 SKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLG 374
             L  L++  N F G +P   G+   L+   +  NN +   P      +L   + L+ L 
Sbjct: 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM----DTLLKMRGLKVLD 349

Query: 375 LGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGN--LSNLIVLSLGGNNLSGS 432
           L  N   G LP S+ NLS SL  L+++  N SG I   +     + L  L L  N  +G 
Sbjct: 350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409

Query: 433 IPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQ 492
           IP T     +L  L L+FN L+G+IP  +  LS+L +L L  N + G I   L  + +L+
Sbjct: 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE 469

Query: 493 YLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGN 552
            L L  N  T  IPS   N  ++    +S+N L G I   IG L+ +  + LS N+ SGN
Sbjct: 470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGN 529

Query: 553 IPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLK 612
           IP  L   +SL  + L  N   G IP +        S  ++ N I+G   V  +     K
Sbjct: 530 IPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKK 585

Query: 613 ELNLSFN--KLKGEIP 626
           E + + N  + +G   
Sbjct: 586 ECHGAGNLLEFQGIRS 601

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  370 bits (951), Expect = e-115
 Identities = 134/445 (30%), Positives = 202/445 (45%), Gaps = 25/445 (5%)

Query: 196 LQELHLGYNNLS---GAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFN 252
           +  + L    L+    A+   + +LT L+ + L N+ ++G +        +L  L L  N
Sbjct: 52  VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRN 110

Query: 253 NLTGVVPA--TIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSS 310
           +L+G V    ++ + S LK + + +N+L         L L +LE L+L  NS SG     
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170

Query: 311 IT---NASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANC 367
                   +L  L +  N  SG +   +    NL+  D+  NN ++  P LG      +C
Sbjct: 171 WVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLG------DC 222

Query: 368 KKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGN 427
             L++L + GN L G    +I   +  L+ LNI+     G IP     L +L  LSL  N
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCT-ELKLLNISSNQFVGPIPPL--PLKSLQYLSLAEN 279

Query: 428 NLSGSIPVTFGG-LQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSI-SSCL 485
             +G IP    G    L GLDL+ N   G++P      S L  L L+ N  SG +    L
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339

Query: 486 GNLTSLQYLNLGSNRFTFVIPSTFWNLKDILS-FDISSNLLDGPISLAIGN--LKAVVGI 542
             +  L+ L+L  N F+  +P +  NL   L   D+SSN   GPI   +       +  +
Sbjct: 340 LKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL 399

Query: 543 DLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIP 602
            L  N  +G IP TL     L ++ L++N L G IP S G+++ L  L L  N + G IP
Sbjct: 400 YLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP 459

Query: 603 VSFEKLSYLKELNLSFNKLKGEIPR 627
                +  L+ L L FN L GEIP 
Sbjct: 460 QELMYVKTLETLILDFNDLTGEIPS 484

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  360 bits (926), Expect = e-112
 Identities = 133/604 (22%), Positives = 231/604 (38%), Gaps = 29/604 (4%)

Query: 75  VTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLS 134
           +T LNL+   L+          S L SLD+  N +S   P     +  LKVL L  N+LS
Sbjct: 27  ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86

Query: 135 GSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCK 194
                     +++ ++ L  N +   +  N     + L  L L  N        +  + +
Sbjct: 87  QLSDKTFAFCTNLTELHLMSNSIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 145

Query: 195 QLQELHLGYNNLSGAIPKEIG--NLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFN 252
            LQEL L  N +     +E+     + L+++ L +N++    P     +  L  L L   
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205

Query: 253 NLTGVVPATIF---NMSTLKEIFLYNNSLSGSLPSRID-LALPNLEFLNLGINSFSGTIP 308
            L   +   +      ++++ + L N+ LS +  +    L   NL  L+L  N+ +    
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265

Query: 309 SSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGF----LSSL 364
            S     +L    +  N+       ++  L N++  ++  +    S            S 
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325

Query: 365 ANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIG----NLSNLI 420
              K L +L +  N + G   +    L  +L+ L+++    S              S L 
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLI-NLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384

Query: 421 VLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIP-DEICLLSRLNELDLNGNKISG 479
           +L+L  N +S      F  L  L+ LDL  N++   +   E   L  + E+ L+ NK   
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444

Query: 480 SISSCLGNLTSLQYLNLGSNRFTFV--IPSTFWNLKDILSFDISSNLLDGPISLAIGNLK 537
              +    + SLQ L L       V   PS F  L+++   D+S+N +       +  L+
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504

Query: 538 AVVGIDLSRNNLS--------GNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLES 589
            +  +DL  NNL+        G     L+GL  L  ++L  N  +    E F ++  L+ 
Sbjct: 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564

Query: 590 LDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPR--GGPFANFTAESFMGNELLCG 647
           +DL  N ++      F     LK LNL  N +     +  G  F N T      N   C 
Sbjct: 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624

Query: 648 LPNL 651
             ++
Sbjct: 625 CESI 628

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  351 bits (903), Expect = e-109
 Identities = 133/601 (22%), Positives = 204/601 (33%), Gaps = 43/601 (7%)

Query: 73  HKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQ 132
             +  LNL    L        A  ++L  L L  N +     +       L  L L  N 
Sbjct: 73  PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132

Query: 133 LSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICN-HLRYLKHLFLRENMFYGKIPSSLS 191
           LS +         ++ ++ LS NK+     E +       LK L L  N      P    
Sbjct: 133 LSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFH 192

Query: 192 KCKQLQELHLGYNNLSGAIPKEIG---NLTVLQRISLINNKLHGEIPQEIGYLQ--NLDV 246
              +L  L L    L  ++ +++      T ++ +SL N++L          L+  NL +
Sbjct: 193 AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTM 252

Query: 247 LQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLG------- 299
           L L +NNL  V   +   +  L+  FL  N++       +   L N+ +LNL        
Sbjct: 253 LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHG-LFNVRYLNLKRSFTKQS 311

Query: 300 --INSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPE 357
             + S       S      L  L M  N   G   +    L NLK   +  +  +  T  
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371

Query: 358 LGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIP-KAIGNL 416
                SLA+   L  L L  N +      +   L   LE L++    I   +  +    L
Sbjct: 372 NETFVSLAH-SPLHILNLTKNKISKIESDAFSWLG-HLEVLDLGLNEIGQELTGQEWRGL 429

Query: 417 SNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAG--SIPDEICLLSRLNELDLNG 474
            N+  + L  N        +F  +  LQ L L    L    S P     L  L  LDL+ 
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489

Query: 475 NKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIG 534
           N I+      L  L  L+ L+L  N                    +  +   G     + 
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLA----------------RLWKHANPGGPIYFLK 533

Query: 535 NLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSN 594
            L  +  ++L  N          + L  L+ I L  N L       F N  SL+SL+L  
Sbjct: 534 GLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQK 593

Query: 595 NKISGSIPVSFEK-LSYLKELNLSFNKLKGEIPRGGPFANFTAES-----FMGNELLCGL 648
           N I+      F      L EL++ FN           F N+  E+      + +  LC  
Sbjct: 594 NLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNT 653

Query: 649 P 649
           P
Sbjct: 654 P 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  334 bits (859), Expect = e-102
 Identities = 124/572 (21%), Positives = 217/572 (37%), Gaps = 46/572 (8%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSG 135
              + S   L   +P ++   +++  L+L+HN+L     ++    S L  L +  N +S 
Sbjct: 7   EVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63

Query: 136 SLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQ 195
                      +  + L  N+LS  L +        L  L L  N       +   K K 
Sbjct: 64  LEPELCQKLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122

Query: 196 LQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQN--LDVLQLGFNN 253
           L  L L +N LS         L  LQ + L NNK+     +E+    N  L  L+L  N 
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182

Query: 254 LTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRI--DLALPNLEFLNLGINSFSGTIPSSI 311
           +    P     +  L  +FL N  L  SL  ++  +LA  ++  L+L  +  S T  ++ 
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242

Query: 312 TN--ASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKK 369
                + L +L++  N+ +     +   L  L+ F + +NN+           SL     
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFS-----HSLHGLFN 297

Query: 370 LRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNL 429
           +RYL L  +                  + +I+  ++      +   L  L  L++  N++
Sbjct: 298 VRYLNLKRS----------------FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDI 341

Query: 430 SGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICL----LSRLNELDLNGNKISGSISSCL 485
            G     F GL  L+ L L+ +  +              S L+ L+L  NKIS   S   
Sbjct: 342 PGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAF 401

Query: 486 GNLTSLQYLNLGSNRFTFVIP-STFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDL 544
             L  L+ L+LG N     +    +  L++I    +S N        +   + ++  + L
Sbjct: 402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLML 461

Query: 545 SRNNLSG--NIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKIS---- 598
            R  L    + P+  + L++L  + L+ N +     +    +  LE LDL +N ++    
Sbjct: 462 RRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWK 521

Query: 599 ----GSIPVSFEKLSYLKELNLSFNKLKGEIP 626
               G      + LS+L  LNL  N       
Sbjct: 522 HANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  310 bits (795), Expect = 2e-93
 Identities = 123/574 (21%), Positives = 199/574 (34%), Gaps = 88/574 (15%)

Query: 98  SLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKL 157
           S +  D SH KL+  +P  + T   + VL L  NQL                        
Sbjct: 5   SHEVADCSHLKLTQ-VPDDLPT--NITVLNLTHNQLRR---------------------- 39

Query: 158 SGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNL 217
              LP         L  L +  N      P    K   L+ L+L +N LS    K     
Sbjct: 40  ---LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFC 96

Query: 218 TVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNS 277
           T L  + L++N +           +NL  L L  N L+     T   +  L+E+ L NN 
Sbjct: 97  TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156

Query: 278 LSGSLPSRID-LALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIG 336
           +       +D  A  +L+ L L                         SN    F P    
Sbjct: 157 IQALKSEELDIFANSSLKKLEL------------------------SSNQIKEFSPGCFH 192

Query: 337 NLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSL-SL 395
            +  L    +    L  S  E   L        +R L L  + L     ++   L   +L
Sbjct: 193 AIGRLFGLFLNNVQLGPSLTEKLCLEL--ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNL 250

Query: 396 ERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLA------ 449
             L++++ N++     +   L  L    L  NN+      +  GL  ++ L+L       
Sbjct: 251 TMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQ 310

Query: 450 ---FNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTF--V 504
                 L          L  L  L++  N I G  S+    L +L+YL+L ++  +   +
Sbjct: 311 SISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370

Query: 505 IPSTFWNL--KDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIP-TTLEGLK 561
              TF +L    +   +++ N +    S A   L  +  +DL  N +   +      GL+
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE 430

Query: 562 SLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISG--SIPVSFEKLSYLKELNLSFN 619
           ++  I L+YN+       SF  + SL+ L L    +    S P  F+ L  L  L+LS N
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490

Query: 620 KLKGEIPRGGPFANFTAESFMGNELLCGLPNLQV 653
            +                     ++L GL  L++
Sbjct: 491 NIANIND----------------DMLEGLEKLEI 508

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  166 bits (422), Expect = 7e-43
 Identities = 73/349 (20%), Positives = 126/349 (36%), Gaps = 19/349 (5%)

Query: 73  HKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLS-SNIPSSIF---TMSTLKVLYL 128
             +  LN+   ++ G        L +LK L LS++  S   + +  F     S L +L L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388

Query: 129 MDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPS 188
             N++S   S        +  + L  N++  +L       L  +  ++L  N +     +
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRN 448

Query: 189 SLSKCKQLQELHLGYNNLSG--AIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDV 246
           S +    LQ L L    L    + P     L  L  + L NN +       +  L+ L++
Sbjct: 449 SFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEI 508

Query: 247 LQLGFNNLT--------GVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNL 298
           L L  NNL         G     +  +S L  + L +N     +P  +   L  L+ ++L
Sbjct: 509 LDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE-IPVEVFKDLFELKIIDL 567

Query: 299 GINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIG-NLRNLKLFDIFFNNLTSSTPE 357
           G+N+ +    S   N   L  L +  N  +       G   RNL   D+ FN    +   
Sbjct: 568 GLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627

Query: 358 LGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNIS 406
           + +  +  N        L  + L    P   G     +   + + C  S
Sbjct: 628 IAWFVNWINETHTNIPELSSHYLCNTPPHYHG---FPVRLFDTSSCKDS 673

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 70.0 bits (172), Expect = 2e-12
 Identities = 34/146 (23%), Positives = 50/146 (34%), Gaps = 8/146 (5%)

Query: 71  NSHKVTTLNLSSFNLQ--------GTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMST 122
              K+  L+L   NL         G     +  LS L  L+L  N            +  
Sbjct: 502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561

Query: 123 LKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMF 182
           LK++ L  N L+   +S   N  S+  + L KN ++    +      R L  L +R N F
Sbjct: 562 LKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621

Query: 183 YGKIPSSLSKCKQLQELHLGYNNLSG 208
                S       + E H     LS 
Sbjct: 622 DCTCESIAWFVNWINETHTNIPELSS 647

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  350 bits (900), Expect = e-109
 Identities = 88/611 (14%), Positives = 195/611 (31%), Gaps = 70/611 (11%)

Query: 44  YDPTNLLGTNWTSNASICSW---IGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLK 100
                  G NW  N  +  W    G+  + ++ +VT L+L  F   G +P  I  L+ L+
Sbjct: 50  QGFGTQPGANWNFNKELDMWGAQPGVSLN-SNGRVTGLSLEGFGASGRVPDAIGQLTELE 108

Query: 101 SLDLSHNKLSSN----IPSSIFTMSTLKVLYLMDNQLSGSLSSFTF--NTSSILDIRLSK 154
            L L  +    N     P  I    + +    M      +   +    + S ++   ++ 
Sbjct: 109 VLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINS 168

Query: 155 NKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEI 214
           +     + ++    L+    +    N     +  ++ +  +L++ ++G +        E 
Sbjct: 169 DPQQKSIKKSSRITLK-DTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEA 226

Query: 215 GNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLY 274
                    +    + +     +   L++L  +++        +P  +  +  ++ I + 
Sbjct: 227 WENE-----NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281

Query: 275 NNSLSGSLPSRIDL-------ALPNLEFLNLGINSF-SGTIPSSITNASKLILLEMGSNS 326
            N        + D            ++ + +G N+  +  + +S+    KL +LE   N 
Sbjct: 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQ 341

Query: 327 FSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPS 386
             G +P+  G+   L   ++ +N +T               +++  L    N L      
Sbjct: 342 LEGKLPA-FGSEIKLASLNLAYNQITEIPANF-----CGFTEQVENLSFAHNKLKYIPNI 395

Query: 387 -SIGNLSLSLERLNIAFCNISG-------NIPKAIGNLSNLIVLSLGGNNLSGSIPVTFG 438
               ++S  +  ++ ++  I          +        N+  ++L  N +S      F 
Sbjct: 396 FDAKSVS-VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454

Query: 439 GLQKLQGLDLAFNKLAG-------SIPDEICLLSRLNELDLNGNKISGSISS-CLGNLTS 490
               L  ++L  N L            +       L  +DL  NK++          L  
Sbjct: 455 TGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPY 514

Query: 491 LQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLS 550
           L  ++L  N F+   P+   N   +  F I +                    D   N   
Sbjct: 515 LVGIDLSYNSFS-KFPTQPLNSSTLKGFGIRNQR------------------DAQGNRTL 555

Query: 551 GNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSY 610
              P  +    SL  + +  N +   + E      ++  LD+ +N               
Sbjct: 556 REWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIE 612

Query: 611 LKELNLSFNKL 621
                L ++K 
Sbjct: 613 AGMYMLFYDKT 623

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  273 bits (699), Expect = 3e-80
 Identities = 67/512 (13%), Positives = 160/512 (31%), Gaps = 54/512 (10%)

Query: 47  TNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSH 106
            +             +++      +   +    ++S   Q +I            +    
Sbjct: 133 MSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLS 192

Query: 107 NKLSSNIPSSIFTMSTLKVLYLMDNQLS-------GSLSSFTFNT------------SSI 147
           N ++  +  ++  ++ L+  Y+ ++              +  +                +
Sbjct: 193 NNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDL 251

Query: 148 LDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMF--------YGKIPSSLSKCKQLQEL 199
            D+ +       KLP  +   L  ++ + +  N            +  +     +++Q +
Sbjct: 252 TDVEVYNCPNLTKLPTFLKA-LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310

Query: 200 HLGYNNL-SGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVV 258
           ++GYNNL +  +   +  +  L  +  + N+L G++P   G    L  L L +N +T + 
Sbjct: 311 YIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIP 369

Query: 259 PATIFNMSTLKEIFLYNNSLSGSLPSRIDLA-LPNLEFLNLGINSFSG-------TIPSS 310
                    ++ +   +N L   +P+  D   +  +  ++   N            +  +
Sbjct: 370 ANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428

Query: 311 ITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPEL--GFLSSLANCK 368
                 +  + + +N  S F          L   ++  N LT            +  N  
Sbjct: 429 PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTY 488

Query: 369 KLRYLGLGGNPLDGFLPSSIGNLSL-SLERLNIAFCNISGNIPKAIGNLSNLIVLSLG-- 425
            L  + L  N L   L       +L  L  +++++ + S   P    N S L    +   
Sbjct: 489 LLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546

Query: 426 ----GNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSI 481
               GN      P        L  L +  N +   + ++I     ++ LD+  N      
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI--TPNISVLDIKDNPNISID 603

Query: 482 SSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLK 513
            S +          L  ++   +      ++K
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQDIRGCDALDIK 635

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  199 bits (509), Expect = 2e-54
 Identities = 59/349 (16%), Positives = 120/349 (34%), Gaps = 19/349 (5%)

Query: 297 NLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTP 356
           N  ++ +      S+ +  ++  L +     SG +P AIG L  L++  +  +    +  
Sbjct: 63  NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122

Query: 357 ELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLS-LERLNIAFCNISGNIPKAIGN 415
            L     ++                            S L +  I       +I K+   
Sbjct: 123 -LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181

Query: 416 LSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGN 475
                 +    NN++  +      L KL+   +  +        E          +    
Sbjct: 182 TLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEA-----WENENSEYA 235

Query: 476 KISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLA--- 532
           +   +      NL  L  + + +      +P+    L ++   +++ N       L    
Sbjct: 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDW 295

Query: 533 -----IGNLKAVVGIDLSRNNL-SGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTS 586
                    + +  I +  NNL +  + T+L+ +K L  +   YN+LEG +P  FG+   
Sbjct: 296 QALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIK 354

Query: 587 LESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFT 635
           L SL+L+ N+I+            ++ L+ + NKLK  IP      + +
Sbjct: 355 LASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVS 402

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  147 bits (374), Expect = 5e-37
 Identities = 32/250 (12%), Positives = 70/250 (28%), Gaps = 12/250 (4%)

Query: 399 NIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAG--- 455
           N            ++ +   +  LSL G   SG +P   G L +L+ L L  +       
Sbjct: 63  NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122

Query: 456 -SIPDEICLLSRLNELDLNGNKISGSISSCLG--NLTSLQYLNLGSNRFTFVIPSTFWNL 512
              P  I       +          +        + + L    + S+     I  +    
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182

Query: 513 KDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNR 572
                    SN +   +S A+  L  +    +  +                +N +  Y +
Sbjct: 183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA-----WENENSEYAQ 236

Query: 573 LEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFA 632
                   + N+  L  +++ N      +P   + L  ++ +N++ N+          + 
Sbjct: 237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ 296

Query: 633 NFTAESFMGN 642
                     
Sbjct: 297 ALADAPVGEK 306

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  321 bits (825), Expect = 2e-98
 Identities = 122/570 (21%), Positives = 207/570 (36%), Gaps = 38/570 (6%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSG 135
            T      N    IP  +    S K+LDLS N L      S F+   L+VL L   ++  
Sbjct: 10  ITYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66

Query: 136 SLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQ 195
                  + S +  + L+ N +   L     + L  L+ L   E          +   K 
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125

Query: 196 LQELHLGYNNL-SGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDV----LQLG 250
           L+EL++ +N + S  +P+   NLT L+ + L +NK+      ++  L  + +    L L 
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185

Query: 251 FNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGT---- 306
            N +  + P   F    L ++ L NN  S ++       L  LE   L +  F       
Sbjct: 186 LNPMNFIQP-GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244

Query: 307 --IPSSITNASKLILLEMGSNSFSGF---IPSAIGNLRNLKLFDIFFNNLTSSTPELGFL 361
               S++     L + E        +   I      L N+  F +    +         +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-------V 297

Query: 362 SSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIV 421
              +     ++L L       F    + +L        + F +  G    +  +L +L  
Sbjct: 298 KDFSYNFGWQHLELVNCKFGQFPTLKLKSL------KRLTFTSNKGGNAFSEVDLPSLEF 351

Query: 422 LSLGGNNLS--GSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISG 479
           L L  N LS  G    +  G   L+ LDL+FN +   +      L +L  LD   + +  
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ 410

Query: 480 SIS-SCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSN-LLDGPISLAIGNLK 537
               S   +L +L YL++            F  L  +    ++ N   +  +      L+
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470

Query: 538 AVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKI 597
            +  +DLS+  L    PT    L SLQ +++++N         +  + SL+ LD S N I
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 530

Query: 598 SGSIPVSFEKL-SYLKELNLSFNKLKGEIP 626
             S     +   S L  LNL+ N       
Sbjct: 531 MTSKKQELQHFPSSLAFLNLTQNDFACTCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  262 bits (671), Expect = 1e-76
 Identities = 96/492 (19%), Positives = 178/492 (36%), Gaps = 33/492 (6%)

Query: 152 LSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIP 211
             +     K+P+N+       K+L L  N        S     +LQ L L    +     
Sbjct: 14  CMELNFY-KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69

Query: 212 KEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEI 271
               +L+ L  + L  N +          L +L  L     NL  +    I ++ TLKE+
Sbjct: 70  GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129

Query: 272 FLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKL----ILLEMGSNSF 327
            + +N +           L NLE L+L  N       + +    ++    + L++  N  
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189

Query: 328 SGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGL------GGNPLD 381
           +   P A   +  L    +  N  + +  +    + +     L    L          L+
Sbjct: 190 NFIQPGAFKEI-RLHKLTLRNNFDSLNVMK----TCIQGLAGLEVHRLVLGEFRNEGNLE 244

Query: 382 GFLPSSIGNL-SLSLERLNIAFCNISGN-IPKAIGNLSNLIVLSLGGNNLSGSIPVTFGG 439
            F  S++  L +L++E   +A+ +   + I      L+N+   SL    +      ++  
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY-- 302

Query: 440 LQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSN 499
               Q L+L   K           L  L  L    NK   + S    +L SL++L+L  N
Sbjct: 303 NFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRN 357

Query: 500 RFTF--VIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPT-T 556
             +F      + +    +   D+S N +   +S     L+ +  +D   +NL        
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416

Query: 557 LEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSI-PVSFEKLSYLKELN 615
              L++L  + +++          F  ++SLE L ++ N    +  P  F +L  L  L+
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476

Query: 616 LSFNKLKGEIPR 627
           LS  +L+   P 
Sbjct: 477 LSQCQLEQLSPT 488

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  154 bits (391), Expect = 2e-39
 Identities = 55/274 (20%), Positives = 97/274 (35%), Gaps = 9/274 (3%)

Query: 78  LNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLS--SNIPSSIFTMSTLKVLYLMDNQLSG 135
             L+  + +G       +L SL+ LDLS N LS       S F  ++LK L L  N +  
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387

Query: 136 SLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQ 195
             S+F      +  +    + L      ++   LR L +L +             +    
Sbjct: 388 MSSNF-LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446

Query: 196 LQELHLGYNNLSGAIPKEI-GNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNL 254
           L+ L +  N+       +I   L  L  + L   +L    P     L +L VL +  NN 
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 506

Query: 255 TGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSS--IT 312
             +       +++L+ +    N +  S    +     +L FLNL  N F+ T      + 
Sbjct: 507 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQ 566

Query: 313 NASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDI 346
                  L +         PS   + + + +  +
Sbjct: 567 WIKDQRQLLVEVERMECATPS---DKQGMPVLSL 597

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  146 bits (371), Expect = 7e-37
 Identities = 50/281 (17%), Positives = 97/281 (34%), Gaps = 8/281 (2%)

Query: 41  HITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLS--SFNLQGTIPPEIANLSS 98
                PT  L +      +         +V+   +  L+LS    + +G         +S
Sbjct: 315 KFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374

Query: 99  LKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTF-NTSSILDIRLSKNKL 157
           LK LDLS N + + + S+   +  L+ L    + L        F +  +++ + +S    
Sbjct: 375 LKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433

Query: 158 SGKLPENICNHLRYLKHLFLRENMFYGKI-PSSLSKCKQLQELHLGYNNLSGAIPKEIGN 216
                      L  L+ L +  N F     P   ++ + L  L L    L    P    +
Sbjct: 434 RVAFNGIFNG-LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492

Query: 217 LTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNM-STLKEIFLYN 275
           L+ LQ +++ +N            L +L VL    N++       + +  S+L  + L  
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 552

Query: 276 NSLSGSLPSRIDLA-LPNLEFLNLGINSFSGTIPSSITNAS 315
           N  + +   +  L  + +   L + +       PS      
Sbjct: 553 NDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 593

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  314 bits (806), Expect = 4e-93
 Identities = 94/662 (14%), Positives = 203/662 (30%), Gaps = 92/662 (13%)

Query: 30  TDQQALLALKDHITYDP---------TNLLGTNWTSNASICSWIGIICDV--NSHKVTTL 78
            D +AL A+ + +               +   NW  N  +  W         N+ +VT L
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL 328

Query: 79  NLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLS 138
           +L+ F  +G +P  I  L+ LK L    +  + +         T  +     +++     
Sbjct: 329 SLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYK 388

Query: 139 SFTF------NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSK 192
                     N S +L   +++N     + ++    L+    +    N     I  ++ +
Sbjct: 389 KMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT-QIGNLTNRI-TFISKAIQR 446

Query: 193 CKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFN 252
             +LQ ++   +  +             +  +    K +         L++L  ++L   
Sbjct: 447 LTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501

Query: 253 NLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSIT 312
                +P  ++++  L+ + +  N    +   + D                   +     
Sbjct: 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW----------------TRLADDED 545

Query: 313 NASKLILLEMGSNSFSGFIPSA-IGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLR 371
              K+ +  MG N+   F  SA +  +  L L D   N +         L +     KL 
Sbjct: 546 TGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-------LEAFGTNVKLT 598

Query: 372 YLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKA--IGNLSNLIVLSLGGNNL 429
            L L  N ++  +P      +  +E L  +   +   IP      ++  +  +    N +
Sbjct: 599 DLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKI 656

Query: 430 SGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLT 489
                     +   +                       + + L+ N+I    +      +
Sbjct: 657 GSEGRNISCSMDDYK-------------------GINASTVTLSYNEIQKFPTELFATGS 697

Query: 490 SLQYLNLGSNRFTFV-------IPSTFWNLKDILSFDISSNLLDG-PISLAIGNLKAVVG 541
            +  + L +N  T +           + N   + + D+  N L           L  +  
Sbjct: 698 PISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSN 757

Query: 542 IDLSRNNLSGNIPTTLEGLKSLQ------NISLAYNRLEGPIPESFGNMTSLESLDLSNN 595
           +D+S N  S   PT       L+            NR+    P       SL  L + +N
Sbjct: 758 MDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSN 816

Query: 596 KISGSIPVSFEKLSYLKELNLSFNKLK-GEIPRGGPFANFTAESFMGN--ELLCGLPNLQ 652
            I   +         L  L+++ N     ++    P+        + +  + + G   L 
Sbjct: 817 DIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALG 873

Query: 653 VP 654
           + 
Sbjct: 874 IE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  179 bits (455), Expect = 2e-46
 Identities = 69/400 (17%), Positives = 132/400 (33%), Gaps = 40/400 (10%)

Query: 71  NSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLS---------SNIPSSIFTMS 121
           N   +T + L +      +P  + +L  L+SL+++ N+           + +     T  
Sbjct: 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGP 548

Query: 122 TLKVLYLMDNQLSGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLREN 180
            +++ Y+  N L    +S +      +  +    NK+   L          L  L L  N
Sbjct: 549 KIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGT-NVKLTDLKLDYN 605

Query: 181 MFYGKIPSSL-SKCKQLQELHLGYNNLSGAIPK--EIGNLTVLQRISLINNKLHGEIPQ- 236
               +IP    +   Q++ L   +N L   IP      ++ V+  +    NK+  E    
Sbjct: 606 QI-EEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNI 663

Query: 237 ----EIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLA--- 289
               +     N   + L +N +           S +  I L NN ++ S+P         
Sbjct: 664 SCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDG 722

Query: 290 ----LPNLEFLNLGINSFSGTIPSSI--TNASKLILLEMGSNSFSGFIPSAIGNLRNLKL 343
                  L  ++L  N  + ++      T    L  +++  N FS   P+   N   LK 
Sbjct: 723 NYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKA 780

Query: 344 FDIFFNNLTSSTPELGFL-SSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAF 402
           F I           L    + +  C  L  L +G N +   +   +      L  L+IA 
Sbjct: 781 FGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTP---QLYILDIAD 836

Query: 403 CNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQK 442
                    ++       +  L  +           G+++
Sbjct: 837 NPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIER 876

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  305 bits (784), Expect = 1e-92
 Identities = 115/558 (20%), Positives = 207/558 (37%), Gaps = 27/558 (4%)

Query: 77  TLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGS 136
           T N  +  L   IP  +   +S + L+ S N L +   ++   +  L  L L   Q+   
Sbjct: 16  TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY-W 71

Query: 137 LSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQ 195
           +   TF +   +  + L+ N L   + E   +  + LKHLF  +          L   K 
Sbjct: 72  IHEDTFQSQHRLDTLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130

Query: 196 LQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFN-NL 254
           L+ L+LG N++S     +      L+ +   NN +H    +++  LQ    L L  N N 
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190

Query: 255 TGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLA----LPNLEFLNLGINSFSGTIPSS 310
              +    F+ +  + +          +   +  +    L    F ++     S  +   
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250

Query: 311 ITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKL 370
           +   S +  + +  + F     +       L+  D+   +L+         S L     L
Sbjct: 251 LCEMS-VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE------LPSGLVGLSTL 303

Query: 371 RYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNI-PKAIGNLSNLIVLSLGGNNL 429
           + L L  N  +     S  N   SL  L+I        +    + NL NL  L L  +++
Sbjct: 304 KKLVLSANKFENLCQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDI 362

Query: 430 --SGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSIS-SCLG 486
             S    +    L  LQ L+L++N+      +      +L  LDL   ++    + S   
Sbjct: 363 ETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422

Query: 487 NLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIG---NLKAVVGID 543
           NL  L+ LNL  +         F  L  +   ++  N               L  +  + 
Sbjct: 423 NLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILV 482

Query: 544 LSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPV 603
           LS  +LS         LK + ++ L++NRL     E+  ++  +  L+L++N IS  +P 
Sbjct: 483 LSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPS 541

Query: 604 SFEKLSYLKELNLSFNKL 621
               LS  + +NL  N L
Sbjct: 542 LLPILSQQRTINLRQNPL 559

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  276 bits (709), Expect = 6e-82
 Identities = 101/535 (18%), Positives = 181/535 (33%), Gaps = 40/535 (7%)

Query: 100 KSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSG 159
           K+ +  +  L+  IP ++   ++ + L    N L                          
Sbjct: 15  KTYNCENLGLNE-IPGTLP--NSTECLEFSFNVLPT------------------------ 47

Query: 160 KLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTV 219
            +     + L  L  L L     Y     +     +L  L L  N L       +     
Sbjct: 48  -IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKA 106

Query: 220 LQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLS 279
           L+ +  I   +       +   + L+ L LG N+++ +     F    LK +   NN++ 
Sbjct: 107 LKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH 166

Query: 280 GSLPSRIDLALPNLEFLNLGINS-FSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNL 338
             L      +L     L+L +N      I     +++    L  G       I   + N 
Sbjct: 167 -YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNS 225

Query: 339 RNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERL 398
               L+   F ++            L     +  + L  +       ++    S  L+ L
Sbjct: 226 TIQSLWLGTFEDMDDEDISPAVFEGLCEM-SVESINLQKHYFFNISSNTFHCFS-GLQEL 283

Query: 399 NIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIP 458
           ++   ++S  +P  +  LS L  L L  N       ++      L  L +  N     + 
Sbjct: 284 DLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342

Query: 459 DE-ICLLSRLNELDLNGNKI--SGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDI 515
              +  L  L ELDL+ + I  S   +  L NL+ LQ LNL  N    +    F     +
Sbjct: 343 TGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQL 402

Query: 516 LSFDISSNLLDGPISL-AIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLE 574
              D++   L    +     NL  +  ++LS + L  +     +GL +LQ+++L  N   
Sbjct: 403 ELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP 462

Query: 575 GPI---PESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIP 626
                   S   +  LE L LS   +S     +F  L  +  ++LS N+L     
Sbjct: 463 KGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  259 bits (665), Expect = 9e-76
 Identities = 125/561 (22%), Positives = 209/561 (37%), Gaps = 46/561 (8%)

Query: 71  NSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMD 130
           + H++ TL L++  L       ++   +LK L      +SS     +    TL+ LYL  
Sbjct: 79  SQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGS 138

Query: 131 NQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENM-FYGKIPSS 189
           N +S       F T  +  +    N +   L +   + L+   +L L  N      I   
Sbjct: 139 NHISSIKLPKGFPTEKLKVLDFQNNAIHY-LSKEDMSSLQQATNLSLNLNGNDIAGIEPG 197

Query: 190 LSKCKQLQELHLGYNNLSGAIPKEIGNLTV--LQRISLINNKLHGEIPQEIGYLQNLDV- 246
                  Q L+ G       I K + N T+  L   +  +       P     L  + V 
Sbjct: 198 AFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVE 257

Query: 247 -LQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSG 305
            + L  +    +   T    S L+E+ L    LS  LPS + + L  L+ L L  N F  
Sbjct: 258 SINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGL-VGLSTLKKLVLSANKFEN 315

Query: 306 TIPSSITNASKLILLEMGSNSFSGFIPS-AIGNLRNLKLFDIFFNNLTSSTPELGFLSSL 364
               S +N   L  L +  N+    + +  + NL NL+  D+  +++ +S      L +L
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL 375

Query: 365 ANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPK-AIGNLSNLIVLS 423
           ++   L+ L L  N        +       LE L++AF  +     +    NL  L VL+
Sbjct: 376 SH---LQSLNLSYNEPLSLKTEAFKECP-QLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431

Query: 424 LGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSI---PDEICLLSRLNELDLNGNKISGS 480
           L  + L  S    F GL  LQ L+L  N          + +  L RL  L L+   +S  
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491

Query: 481 ISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVV 540
                 +L  + +++L  NR T        +LK I                         
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY------------------------ 527

Query: 541 GIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGS 600
            ++L+ N++S  +P+ L  L   + I+L  N L+     +  N+  LE    +  K+  +
Sbjct: 528 -LNLASNHISIILPSLLPILSQQRTINLRQNPLDC----TCSNIYFLEWYKENMQKLEDT 582

Query: 601 IPVSFEKLSYLKELNLSFNKL 621
                E    L+ + LS   L
Sbjct: 583 EDTLCENPPLLRGVRLSDVTL 603

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  149 bits (377), Expect = 1e-37
 Identities = 49/253 (19%), Positives = 85/253 (33%), Gaps = 9/253 (3%)

Query: 389 GNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDL 448
           G L  S E L  +F  +          L NL  L L    +      TF    +L  L L
Sbjct: 29  GTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVL 88

Query: 449 AFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPST 508
             N L       +     L  L      IS      L N  +L+ L LGSN  + +    
Sbjct: 89  TANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK 148

Query: 509 FWNLKDILSFDISSNLLDGPISLAIGNLKA--VVGIDLSRNNLSGNIPTTLEGLKSLQNI 566
            +  + +   D  +N +       + +L+    + ++L+ N+++G I          Q++
Sbjct: 149 GFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSL 207

Query: 567 SLAYNRLEGPIPE--SFGNMTSLESLDLSNNKISGSIPVSFEKLS--YLKELNLSFNKLK 622
           +    +    I +      + SL      +       P  FE L    ++ +NL  +   
Sbjct: 208 NFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF 267

Query: 623 GEIPRGGPFANFT 635
                   F  F+
Sbjct: 268 NISS--NTFHCFS 278

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  137 bits (348), Expect = 7e-34
 Identities = 38/217 (17%), Positives = 70/217 (32%), Gaps = 6/217 (2%)

Query: 421 VLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGS 480
             +     L+  IP T       + L+ +FN L          L  L  LDL   +I   
Sbjct: 16  TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 481 ISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVV 540
                 +   L  L L +N   F+  +     K +         +     + + N K + 
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132

Query: 541 GIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLE--SLDLSNNKIS 598
            + L  N++S          + L+ +    N +     E   ++      SL+L+ N I+
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192

Query: 599 GSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFT 635
             I       +  + LN    +    I +G   +   
Sbjct: 193 -GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQ 228

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  130 bits (328), Expect = 2e-31
 Identities = 41/207 (19%), Positives = 77/207 (37%), Gaps = 5/207 (2%)

Query: 446 LDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVI 505
            +     L   IP    L +    L+ + N +    ++    L +L +L+L   +  ++ 
Sbjct: 17  YNCENLGLN-EIPGT--LPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 506 PSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQN 565
             TF +   + +  +++N L      A+   KA+  +   +  +S      L   K+L++
Sbjct: 74  EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133

Query: 566 ISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLK--ELNLSFNKLKG 623
           + L  N +             L+ LD  NN I          L       LNL+ N + G
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193

Query: 624 EIPRGGPFANFTAESFMGNELLCGLPN 650
             P     A F + +F G + L  +  
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFK 220

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  282 bits (725), Expect = 9e-88
 Identities = 99/299 (33%), Positives = 141/299 (47%), Gaps = 34/299 (11%)

Query: 362 SSLANCKKLRYLGLGGNPLDG--FLPSSIGNLSLSLERLNIAFCN-ISGNIPKAIGNLSN 418
            +     ++  L L G  L     +PSS+ NL   L  L I   N + G IP AI  L+ 
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQ 102

Query: 419 LIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKIS 478
           L  L +   N+SG+IP     ++ L  LD ++N L+G++P  I  L  L  +  +GN+IS
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162

Query: 479 GSISSCLGNLTSL-QYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLK 537
           G+I    G+ + L   + +  NR T  IP TF NL                         
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN------------------------ 198

Query: 538 AVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKI 597
            +  +DLSRN L G+        K+ Q I LA N L   +    G   +L  LDL NN+I
Sbjct: 199 -LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRI 256

Query: 598 SGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPC 656
            G++P    +L +L  LN+SFN L GEIP+GG    F   ++  N+ LCG P   +P C
Sbjct: 257 YGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  239 bits (612), Expect = 9e-72
 Identities = 86/332 (25%), Positives = 137/332 (41%), Gaps = 32/332 (9%)

Query: 29  STDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGT 88
             D+QALL +K  +  +PT L     T++    +W+G++CD                   
Sbjct: 5   PQDKQALLQIKKDLG-NPTTLSSWLPTTDCCNRTWLGVLCD------------------- 44

Query: 89  IPPEIANLSSLKSLDLSHNKLS--SNIPSSIFTMSTLKVLYLMD-NQLSGSLSSFTFNTS 145
                     + +LDLS   L     IPSS+  +  L  LY+   N L G +       +
Sbjct: 45  ---TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLT 101

Query: 146 SILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNN 205
            +  + ++   +SG +P+ +   ++ L  L    N   G +P S+S    L  +    N 
Sbjct: 102 QLHYLYITHTNVSGAIPDFLSQ-IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160

Query: 206 LSGAIPKEIGNLTVLQR-ISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFN 264
           +SGAIP   G+ + L   +++  N+L G+IP     L NL  + L  N L G       +
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGS 219

Query: 265 MSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGS 324
               ++I L  NSL+  L         NL  L+L  N   GT+P  +T    L  L +  
Sbjct: 220 DKNTQKIHLAKNSLAFDLGKVGL--SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277

Query: 325 NSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTP 356
           N+  G IP   GNL+   +     N     +P
Sbjct: 278 NNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  283 bits (726), Expect = 3e-84
 Identities = 110/564 (19%), Positives = 195/564 (34%), Gaps = 38/564 (6%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSG 135
            T       L   +P +I   SS K++DLS N L      S    S L+ L L   ++  
Sbjct: 14  ITYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE- 69

Query: 136 SLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCK 194
           ++    +     + ++ L+ N +         + L  L++L   E          + +  
Sbjct: 70  TIEDKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQLI 128

Query: 195 QLQELHLGYNNLSGA-IPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLD----VLQL 249
            L++L++ +N +    +P    NLT L  + L  N +      ++ +L+        L +
Sbjct: 129 TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188

Query: 250 GFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPS 309
             N +  +     F    L E+ L  N  S ++       L  L    L +  F      
Sbjct: 189 SLNPIDFI-QDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL 247

Query: 310 SITNAS--------KLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFL 361
            I   S         +    +   +           L N+    +   ++         L
Sbjct: 248 EIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-------L 300

Query: 362 SSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIV 421
             +    K + L +    L  F    +  L    + L +     S  I      L +L  
Sbjct: 301 EDVPKHFKWQSLSIIRCQLKQFPTLDLPFL----KSLTLTMNKGS--ISFKKVALPSLSY 354

Query: 422 LSLGGNNLSGSIPVTF--GGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISG 479
           L L  N LS S   ++   G   L+ LDL+FN     +      L  L  LD   + +  
Sbjct: 355 LDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA-IIMSANFMGLEELQHLDFQHSTLKR 413

Query: 480 SIS-SCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSN-LLDGPISLAIGNLK 537
               S   +L  L YL++            F  L  + +  ++ N   D  +S    N  
Sbjct: 414 VTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTT 473

Query: 538 AVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKI 597
            +  +DLS+  L        + L  LQ +++++N L       +  + SL +LD S N+I
Sbjct: 474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533

Query: 598 SGSIPVSFEKLSYLKELNLSFNKL 621
             S  +       L   NL+ N +
Sbjct: 534 ETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  237 bits (606), Expect = 1e-67
 Identities = 99/494 (20%), Positives = 177/494 (35%), Gaps = 24/494 (4%)

Query: 144 TSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGY 203
               +  +    KLS K+P++I       K++ L  N        S S   +LQ L L  
Sbjct: 10  VVPNITYQCMDQKLS-KVPDDI---PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSR 65

Query: 204 NNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIF 263
             +     K    L  L  + L  N +    P     L +L+ L      L  +    I 
Sbjct: 66  CEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIG 125

Query: 264 NMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLIL---- 319
            + TLK++ + +N +           L NL  ++L  N       + +    +       
Sbjct: 126 QLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLS 185

Query: 320 LEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGF--LSSLANCKKLRYLGLGG 377
           L+M  N        A   +  L    +  N  +S+  +     L+ L   + +       
Sbjct: 186 LDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE 244

Query: 378 NPLDGFLPSSIGNL-SLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVT 436
             L+ F PS +  L  ++++   + + N   +       L+N+  +SL G ++     V 
Sbjct: 245 RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVP 304

Query: 437 FGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNL 496
                K Q L +   +L      +   L  L  L L  NK S S       L SL YL+L
Sbjct: 305 K--HFKWQSLSIIRCQLKQFPTLD---LPFLKSLTLTMNKGSISFK--KVALPSLSYLDL 357

Query: 497 GSNRFTFVIPSTFWNLK--DILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIP 554
             N  +F    ++ +L    +   D+S N     +S     L+ +  +D   + L     
Sbjct: 358 SRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTE 416

Query: 555 T-TLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS-FEKLSYLK 612
                 L+ L  + ++Y   +      F  +TSL +L ++ N    +   + F   + L 
Sbjct: 417 FSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLT 476

Query: 613 ELNLSFNKLKGEIP 626
            L+LS  +L+    
Sbjct: 477 FLDLSKCQLEQISW 490

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  225 bits (576), Expect = 1e-63
 Identities = 99/488 (20%), Positives = 171/488 (35%), Gaps = 39/488 (7%)

Query: 71  NSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMD 130
             H ++ L L+   +Q   P   + L+SL++L     KL+S     I  + TLK L +  
Sbjct: 78  GLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAH 137

Query: 131 NQLSGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFY---GKI 186
           N +        F N ++++ + LS N +   +  N    LR    + L  +M       I
Sbjct: 138 NFIHSCKLPAYFSNLTNLVHVDLSYNYIQT-ITVNDLQFLRENPQVNLSLDMSLNPIDFI 196

Query: 187 PSSLSKCKQLQELHLGYNNLSGAIPKE-IGNLTVLQRISLINNKLHGEIPQEI---GYLQ 242
                +  +L EL L  N  S  I K  + NL  L    LI  +   E   EI     ++
Sbjct: 197 QDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIME 256

Query: 243 NLDVLQ-----LGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLN 297
            L  +      L + N           ++ +  + L   S+             +L  + 
Sbjct: 257 GLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIR 316

Query: 298 LGINSFS----------------GTIPSSITNASKLILLEMGSNSFSGFIPSAIGNL--R 339
             +  F                 G+I         L  L++  N+ S     +  +L   
Sbjct: 317 CQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTN 376

Query: 340 NLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLN 399
           +L+  D+ FN     +     L  L      ++L    + L      S       L  L+
Sbjct: 377 SLRHLDLSFNGAIIMSANFMGLEEL------QHLDFQHSTLKRVTEFSAFLSLEKLLYLD 430

Query: 400 IAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLDLAFNKLAGSIP 458
           I++ N   +       L++L  L + GN+   +     F     L  LDL+  +L     
Sbjct: 431 ISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW 490

Query: 459 DEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSF 518
                L RL  L+++ N +    SS    L SL  L+   NR            K +  F
Sbjct: 491 GVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFF 550

Query: 519 DISSNLLD 526
           ++++N + 
Sbjct: 551 NLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  141 bits (357), Expect = 5e-35
 Identities = 47/258 (18%), Positives = 88/258 (34%), Gaps = 13/258 (5%)

Query: 390 NLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLA 449
           ++  S + ++++F  +      +  N S L  L L    +       + GL  L  L L 
Sbjct: 29  DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILT 88

Query: 450 FNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFV-IPST 508
            N +    P     L+ L  L     K++   S  +G L +L+ LN+  N      +P+ 
Sbjct: 89  GNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY 148

Query: 509 FWNLKDILSFDISSNLLDGPISLAIGNLK----AVVGIDLSRNNLSGNIPTTLEGLKSLQ 564
           F NL +++  D+S N +       +  L+      + +D+S N +        +G+  L 
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLH 207

Query: 565 NISLAYNRLEGPIPE-SFGNMTSLESLDLSNNKISGSIPVS------FEKLSYLKELNLS 617
            ++L  N     I +    N+  L    L   +      +        E L  +      
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267

Query: 618 FNKLKGEIPRGGPFANFT 635
                        F    
Sbjct: 268 LTYTNDFSDDIVKFHCLA 285

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  242 bits (619), Expect = 9e-70
 Identities = 118/569 (20%), Positives = 221/569 (38%), Gaps = 45/569 (7%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSG 135
            T      N    IP  +    S K+LDLS N L      S F+   L+VL L   ++  
Sbjct: 10  ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ- 65

Query: 136 SLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCK 194
           ++    + + S +  + L+ N +   L     + L  L+ L   E          +   K
Sbjct: 66  TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124

Query: 195 QLQELHLGYNNL-SGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDV----LQL 249
            L+EL++ +N + S  +P+   NLT L+ + L +NK+      ++  L  + +    L L
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184

Query: 250 GFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPS 309
             N +  +     F    L ++ L NN  S ++       L  LE   L +  F      
Sbjct: 185 SLNPMNFI-QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN---- 239

Query: 310 SITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKK 369
                           +   F  SA+  L NL + +     L     ++  L +      
Sbjct: 240 --------------EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN--CLTN 283

Query: 370 LRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNL 429
           +    L    ++     S       LE +N  F             L +L  L+   N  
Sbjct: 284 VSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTL------KLKSLKRLTFTSNKG 337

Query: 430 SGSIPVTFGGLQKLQGLDLAFNKLA--GSIPDEICLLSRLNELDLNGNKISGSISSCLGN 487
             +   +   L  L+ LDL+ N L+  G         + L  LDL+ N +  ++SS    
Sbjct: 338 GNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG 394

Query: 488 LTSLQYLNLGSNRFTFVIP-STFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSR 546
           L  L++L+   +    +   S F +L++++  DIS        +     L ++  + ++ 
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454

Query: 547 NNLSGNIPT-TLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSF 605
           N+   N        L++L  + L+  +LE   P +F +++SL+ L++++N++       F
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIF 514

Query: 606 EKLSYLKELNLSFNKLKGEIPRGGPFANF 634
           ++L+ L+++ L  N      PR    + +
Sbjct: 515 DRLTSLQKIWLHTNPWDCSCPRIDYLSRW 543

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  110 bits (278), Expect = 2e-25
 Identities = 55/296 (18%), Positives = 102/296 (34%), Gaps = 13/296 (4%)

Query: 75  VTTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQL 133
           +    L+  +       ++   L+++ S  L    +   +    +     + L L++ + 
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFG-WQHLELVNCKF 316

Query: 134 SGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENM--FYGKIPSSLS 191
                +    +   L    + NK      E     L  L+ L L  N   F G    S  
Sbjct: 317 G-QFPTLKLKSLKRLT--FTSNKGGNAFSEV---DLPSLEFLDLSRNGLSFKGCCSQSDF 370

Query: 192 KCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEI-GYLQNLDVLQLG 250
               L+ L L +N +   +      L  L+ +   ++ L       +   L+NL  L + 
Sbjct: 371 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429

Query: 251 FNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSS 310
             +           +S+L+ + +  NS   +    I   L NL FL+L         P++
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489

Query: 311 ITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLAN 366
             + S L +L M SN            L +L+   +  N    S P + +LS   N
Sbjct: 490 FNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLN 545

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 69.7 bits (171), Expect = 2e-12
 Identities = 20/93 (21%), Positives = 36/93 (38%), Gaps = 2/93 (2%)

Query: 543 DLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIP 602
           DLS N L      +      LQ + L+   ++     ++ +++ L +L L+ N I     
Sbjct: 34  DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLAL 93

Query: 603 VSFEKLSYLKELNLSFNKLKGEIPRGGPFANFT 635
            +F  LS L++L      L        P  +  
Sbjct: 94  GAFSGLSSLQKLVAVETNLASLEN--FPIGHLK 124

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 65.9 bits (161), Expect = 3e-11
 Identities = 31/115 (26%), Positives = 54/115 (46%), Gaps = 6/115 (5%)

Query: 71  NSHKVTTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYL 128
           +   +  L++S  + +      I   LSSL+ L ++ N    N    IFT +  L  L L
Sbjct: 419 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477

Query: 129 MDNQLSGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMF 182
              QL   LS   F + SS+  + ++ N+L   +P+ I + L  L+ ++L  N +
Sbjct: 478 SQCQLE-QLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 45.9 bits (109), Expect = 6e-05
 Identities = 21/68 (30%), Positives = 38/68 (55%), Gaps = 4/68 (5%)

Query: 74  KVTTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDN 131
            +T L+LS   L+  + P    +LSSL+ L+++ N+L S +P  IF  +++L+ ++L  N
Sbjct: 471 NLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKS-VPDGIFDRLTSLQKIWLHTN 528

Query: 132 QLSGSLSS 139
               S   
Sbjct: 529 PWDCSCPR 536

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  228 bits (583), Expect = 1e-67
 Identities = 93/287 (32%), Positives = 137/287 (47%), Gaps = 46/287 (16%)

Query: 713 IRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKS-FEA 771
           ++RFS  EL  A+DNF+  NI+G GGFG VY+ RL DG  +A+K    +     +  F+ 
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 772 ECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLH---SSNCALNIFCRLNI 828
           E E+I    HRNL+++   C     + LV  YM+NGS+  CL     S   L+   R  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
            +  A  L YLH      IIH D+K +N+LLDE+  A + DFG+AKL+    ++ + T  
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAV 195

Query: 889 LATIGYMAPDEIFVGELSLK----------------------------------RWVNDL 914
             TIG++AP+ +  G+ S K                                   WV  L
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255

Query: 915 LPV-SLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKR 960
           L    L  +VD  L    + ++  +E  +  +  +AL CT  SP +R
Sbjct: 256 LKEKKLEALVDVDL----QGNYKDEE--VEQLIQVALLCTQSSPMER 296

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  220 bits (563), Expect = 8e-65
 Identities = 80/304 (26%), Positives = 131/304 (43%), Gaps = 45/304 (14%)

Query: 693 KRGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVE 752
            +       +            R    +L  AT+NF    +IG G FG VY+  L DG +
Sbjct: 6   SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65

Query: 753 IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDC 812
           +A+K   P+ +  ++ FE E E +   RH +LV +I  C   +   L+ +YM NG+L+  
Sbjct: 66  VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125

Query: 813 LHSSN---CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSD 869
           L+ S+    +++   RL I I  A  L YLH      IIH D+K  N+LLDE+ V  ++D
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITD 182

Query: 870 FGMAKLLSGEDESTMRTQTLATIGYMAPD---------------------EIFVG----- 903
           FG++K  +  D++ + T    T+GY+ P+                     E+        
Sbjct: 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242

Query: 904 ------ELSLKRWVNDLLPVS-LVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMES 956
                  ++L  W  +      L ++VD +L          + + L      A++C   S
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNL----ADKI--RPESLRKFGDTAVKCLALS 296

Query: 957 PEKR 960
            E R
Sbjct: 297 SEDR 300

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  222 bits (568), Expect = 7e-61
 Identities = 120/596 (20%), Positives = 212/596 (35%), Gaps = 74/596 (12%)

Query: 61  CSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT- 119
           CS+ G I           NL+       +P     L++ + L LS N + + + +S F  
Sbjct: 2   CSFDGRIAF-YRF----CNLTQ------VPQ---VLNTTERLLLSFNYIRT-VTASSFPF 46

Query: 120 MSTLKVLYLMDNQLSGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLR 178
           +  L++L L       ++    F N  ++  + L  +K+   L  +    L +L  L L 
Sbjct: 47  LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLY 105

Query: 179 ENMFYGKI--PSSLSKCKQLQELHLGYNNLSG-AIPKEIGNLTVLQRISLINNKLHGEIP 235
                  +         K L  L L  N +    +    G L  L+ I   +N++     
Sbjct: 106 FCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCE 165

Query: 236 QEIGYLQ--NLDVLQLGFNNLTGVVPATIFN-MSTLKEIFLYNNSLSGSLPSRIDLALPN 292
            E+  LQ   L    L  N+L   V       M+  + + L    +SG+  +        
Sbjct: 166 HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWT-------- 217

Query: 293 LEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLR--NLKLFDIFFNN 350
           ++      N+ S +   S+  A  ++    G ++      +    L   +++  D+    
Sbjct: 218 VDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGF 277

Query: 351 LTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIP 410
           + S              K L+ L L  N ++     +   L  +L+ LN+++  +     
Sbjct: 278 VFSLNS-----RVFETLKDLKVLNLAYNKINKIADEAFYGLD-NLQVLNLSYNLLGELYS 331

Query: 411 KAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNEL 470
                L  +  + L  N+++     TF  L+KLQ LDL  N L       I  +  + ++
Sbjct: 332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDI 386

Query: 471 DLNGNKISG---------------------SISSCLGNLTSLQYLNLGSNRFTFVIPS-T 508
            L+GNK+                        I   L  +  LQ L L  NRF+      T
Sbjct: 387 FLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQT 446

Query: 509 FWNLKDILSFDISSNLLDGPISLAI-----GNLKAVVGIDLSRNNLSGNIPTTLEGLKSL 563
                 +    +  N+L       +       L  +  + L+ N L+   P     L +L
Sbjct: 447 PSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL 506

Query: 564 QNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFN 619
           + +SL  NRL            +LE LD+S N++    P  F  LS L   +  F 
Sbjct: 507 RGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFI 560

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  219 bits (560), Expect = 6e-60
 Identities = 113/539 (20%), Positives = 203/539 (37%), Gaps = 38/539 (7%)

Query: 97  SSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTF-NTSSILDIRLSKN 155
              +        L+  +P  +   +T + L L  N +  ++++ +F     +  + L   
Sbjct: 4   FDGRIAFYRFCNLTQ-VPQVL---NTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQ 58

Query: 156 KLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAI--PKE 213
                + +    +L  L+ L L  +  Y   P +      L EL L +  LS A+     
Sbjct: 59  YTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGY 118

Query: 214 IGNLTVLQRISLINNKLHG-EIPQEIGYLQNLDVLQLGFNNLTGVVPATI--FNMSTLKE 270
             NL  L R+ L  N++    +    G L +L  +    N +  V    +      TL  
Sbjct: 119 FRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSF 178

Query: 271 IFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGF 330
             L  NSL   +       +     + L I   SG       N   + +    SN+ S  
Sbjct: 179 FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG-------NGWTVDITGNFSNAISKS 231

Query: 331 IPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGN 390
              ++    ++      F+N+    P+    + LA    +R+L L    +          
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIK--DPDQNTFAGLARSS-VRHLDLSHGFVFSLNSRVFET 288

Query: 391 LSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAF 450
           L   L+ LN+A+  I+    +A   L NL VL+L  N L       F GL K+  +DL  
Sbjct: 289 LK-DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347

Query: 451 NKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFW 510
           N +A         L +L  LDL  N ++      +  + S+  + L  N+    +P    
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINL 401

Query: 511 NLKDILSFDISSNLLDG-PISLAIGNLKAVVGIDLSRNNLSG-NIPTTLEGLKSLQNISL 568
                    +S N L+   I   +  +  +  + L++N  S  +   T     SL+ + L
Sbjct: 402 TAN---LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFL 458

Query: 569 AYNRLEGPI-----PESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLK 622
             N L+         + F  ++ L+ L L++N ++   P  F  L+ L+ L+L+ N+L 
Sbjct: 459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  194 bits (495), Expect = 1e-51
 Identities = 109/491 (22%), Positives = 178/491 (36%), Gaps = 46/491 (9%)

Query: 185 KIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEI-GYLQN 243
           ++P  L+     + L L +N +          L  LQ + L +      I +E    L N
Sbjct: 18  QVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74

Query: 244 LDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLS-GSLPSRIDLALPNLEFLNLGINS 302
           L +L LG + +  + P     +  L E+ LY   LS   L       L  L  L+L  N 
Sbjct: 75  LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ 134

Query: 303 FSG-TIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKL--FDIFFNNLTSSTPELG 359
                +  S    + L  ++  SN         +  L+   L  F +  N+L S    + 
Sbjct: 135 IRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSR-VSVD 193

Query: 360 FLSSLANCK--KLRYLGLGGNPLDGFLPSSIGN-----------LSLSLERLNIAFCNIS 406
           +   +   +   L  L + GN     +  +  N           L+  +      F NI 
Sbjct: 194 WGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253

Query: 407 GNIPKAIGNL--SNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLL 464
                    L  S++  L L    +       F  L+ L+ L+LA+NK+     +    L
Sbjct: 254 DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGL 313

Query: 465 SRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNL 524
             L  L+L+ N +    SS    L  + Y++L  N    +   TF  L+ + + D+  N 
Sbjct: 314 DNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNA 373

Query: 525 LDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEG-PIPESFGN 583
           L       I  + ++  I LS N L       L    +   I L+ NRLE   I      
Sbjct: 374 LT-----TIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLDILYFLLR 424

Query: 584 MTSLESLDLSNNKISG-SIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGN 642
           +  L+ L L+ N+ S  S   +  +   L++L L  N L+        +  F        
Sbjct: 425 VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFE------- 477

Query: 643 ELLCGLPNLQV 653
               GL +LQV
Sbjct: 478 ----GLSHLQV 484

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  189 bits (482), Expect = 7e-50
 Identities = 114/526 (21%), Positives = 194/526 (36%), Gaps = 59/526 (11%)

Query: 76  TTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQL 133
             L L S     TI  E   NL +L+ LDL  +K+   +    F  +  L  L L    L
Sbjct: 51  QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYF-LHPDAFQGLFHLFELRLYFCGL 109

Query: 134 S-GSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLS 191
           S   L    F N  ++  + LSKN++           L  LK +    N  +      L 
Sbjct: 110 SDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELE 169

Query: 192 --KCKQLQELHLGYNNLSGAIPKEIGNL------TVLQRISLINNKLHGEIP-------- 235
             + K L    L  N+L   +  + G         VL+ + +  N    +I         
Sbjct: 170 PLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAIS 229

Query: 236 ----QEIGYLQNLDVLQLGFNNLTGVVPATIFNM--STLKEIFLYNNSLSGSLPSRIDLA 289
                 +    ++     GF+N+      T   +  S+++ + L +  +  SL SR+   
Sbjct: 230 KSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFET 288

Query: 290 LPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFN 349
           L +L+ LNL  N  +     +      L +L +  N       S    L  +   D+  N
Sbjct: 289 LKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348

Query: 350 NLTSSTPELGFLSSLANCKKLRYLGLGGNPL--DGFLPS------------SIGNLSLSL 395
           ++           +    +KL+ L L  N L    F+PS            ++  ++L+ 
Sbjct: 349 HIAIIQD-----QTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTA 403

Query: 396 ERLNIAFCNISG-NIPKAIGNLSNLIVLSLGGNNLSG-SIPVTFGGLQKLQGLDLAFNKL 453
             ++++   +   +I   +  + +L +L L  N  S  S   T      L+ L L  N L
Sbjct: 404 NLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENML 463

Query: 454 AGSIPDEICL-----LSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPST 508
             +   E+C      LS L  L LN N ++        +LT+L+ L+L SNR T +  + 
Sbjct: 464 QLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHND 523

Query: 509 FWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIP 554
                ++   DIS N L  P      +L     +D++ N       
Sbjct: 524 L--PANLEILDISRNQLLAPNPDVFVSLSV---LDITHNKFICECE 564

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  108 bits (271), Expect = 4e-24
 Identities = 68/361 (18%), Positives = 128/361 (35%), Gaps = 27/361 (7%)

Query: 71  NSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMD 130
               +  LNL+   +          L +L+ L+LS+N L     S+ + +  +  + L  
Sbjct: 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347

Query: 131 NQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSL 190
           N ++            +  + L  N L+        + +  +  +FL  N    K+ +  
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALTT------IHFIPSIPDIFLSGN----KLVTLP 397

Query: 191 SKCKQLQELHLGYNNLSG-AIPKEIGNLTVLQRISLINNKLHG-EIPQEIGYLQNLDVLQ 248
                   +HL  N L    I   +  +  LQ + L  N+       Q      +L+ L 
Sbjct: 398 KINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLF 457

Query: 249 LGFNNLTGVVPATI-----FNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSF 303
           LG N L       +       +S L+ ++L +N L+ SLP  +   L  L  L+L  N  
Sbjct: 458 LGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRL 516

Query: 304 SGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSS 363
           +  +  +    + L +L++  N      P       +L + DI  N          F+ +
Sbjct: 517 T-VLSHN-DLPANLEILDISRNQLLAPNPDV---FVSLSVLDITHNKFICECELSTFI-N 570

Query: 364 LANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLS 423
             N   +   G   +    +  S  G    SL  L+   C+    +     +L  +  ++
Sbjct: 571 WLNHTNVTIAGPPADIYCVYPDSFSGV---SLFSLSTEGCDEEEVLKSLKFSLFIVCTVT 627

Query: 424 L 424
           L
Sbjct: 628 L 628

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  204 bits (522), Expect = 3e-59
 Identities = 79/302 (26%), Positives = 129/302 (42%), Gaps = 56/302 (18%)

Query: 703 NDIILSSQPTIRRFSYFELLRATDNFAE------NNIIGIGGFGSVYRARLEDGVEIAIK 756
           N  +  S      FS++EL   T+NF E       N +G GGFG VY+  + +   +A+K
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60

Query: 757 VFHPQCAST----LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDC 812
                   T     + F+ E +V+   +H NLV+++   S+ D   LV  YM NGSL D 
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120

Query: 813 LH--SSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDF 870
           L        L+   R  I    A+ + +LH       IH D+K +N+LLDE   A +SDF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDF 177

Query: 871 GMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK---------------------- 908
           G+A+      ++ M ++ + T  YMAP E   GE++ K                      
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAP-EALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

Query: 909 --------RWVNDLL--PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPE 958
                       ++     ++ + +DK +         +    + +++S+A +C  E   
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYIDKKM-----NDADSTS--VEAMYSVASQCLHEKKN 289

Query: 959 KR 960
           KR
Sbjct: 290 KR 291

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  210 bits (536), Expect = 1e-58
 Identities = 91/537 (16%), Positives = 196/537 (36%), Gaps = 40/537 (7%)

Query: 95  NLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTF-NTSSILDIRLS 153
           +  +    D      +S IPS +     +K L L  N+++  +        +++  + L 
Sbjct: 3   SCDASGVCDGRSRSFTS-IPSGLTA--AMKSLDLSFNKIT-YIGHGDLRACANLQVLILK 58

Query: 154 KNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSG-AIPK 212
            ++++  +  +    L  L+HL L +N       S       L+ L+L  N      +  
Sbjct: 59  SSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117

Query: 213 EIGNLTVLQRISLINNKLHGEIPQE-IGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEI 271
              NLT LQ + + N +   EI +     L +L+ L++   +L      ++ ++  +  +
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177

Query: 272 FLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFI 331
            L+ +  +  L       L ++ +L L   + +    S +        ++  +       
Sbjct: 178 TLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF------ 230

Query: 332 PSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLA--NCKKLRYLGLGGNPLDGFLPSSIG 389
                  R   L D  FN L      +  LS +   +C          +  D        
Sbjct: 231 -------RGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV 283

Query: 390 NLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLA 449
              +++ RL+I    +  ++      L  +  +++  + +          L+ L+ LDL+
Sbjct: 284 ET-VTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLS 342

Query: 450 FNKLAGSIPDE---ICLLSRLNELDLNGNKIS--GSISSCLGNLTSLQYLNLGSNRFTFV 504
            N +                L  L L+ N +         L  L +L  L++  N F   
Sbjct: 343 ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP- 401

Query: 505 IPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQ 564
           +P +    + +   ++SS  +     +     + +  +D+S NNL  +       L  LQ
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGIR---VVKTCIPQTLEVLDVSNNNLD-SFSL---FLPRLQ 454

Query: 565 NISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKL 621
            + ++ N+L+     S      L  + +S N++       F++L+ L+++ L  N  
Sbjct: 455 ELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  178 bits (453), Expect = 1e-47
 Identities = 84/488 (17%), Positives = 167/488 (34%), Gaps = 31/488 (6%)

Query: 152 LSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIP 211
                 +  +P  +   +   K L L  N         L  C  LQ L L  + ++    
Sbjct: 12  GRSRSFT-SIPSGLTAAM---KSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG 67

Query: 212 KEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIF-NMSTLKE 270
               +L  L+ + L +N L        G L +L  L L  N    +   ++F N++ L+ 
Sbjct: 68  DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127

Query: 271 IFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGF 330
           + + N      +       L +L  L +   S       S+ +   +  L +  +  +  
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187

Query: 331 IPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGN 390
           +      L +++  ++   NL     +   L        ++ L   G+ L          
Sbjct: 188 LEIFADILSSVRYLELRDTNLARF--QFSPLPVDEVSSPMKKLAFRGSVL---------- 235

Query: 391 LSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAF 450
              S   L      I         + +   +     +       +       ++ L +  
Sbjct: 236 TDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQ 295

Query: 451 NKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPST-- 508
             L   +     LL ++  + +  +K+     S   +L SL++L+L  N           
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSA 355

Query: 509 -FWNLKDILSFDISSNLLD--GPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQN 565
                  + +  +S N L         +  LK +  +D+SRN     +P + +  + ++ 
Sbjct: 356 CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRF 414

Query: 566 ISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEI 625
           ++L+   +   +        +LE LD+SNN +  S  +    L  L+EL +S NKLK  +
Sbjct: 415 LNLSSTGIRV-VK--TCIPQTLEVLDVSNNNLD-SFSLF---LPRLQELYISRNKLK-TL 466

Query: 626 PRGGPFAN 633
           P    F  
Sbjct: 467 PDASLFPV 474

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  171 bits (436), Expect = 2e-45
 Identities = 82/473 (17%), Positives = 165/473 (34%), Gaps = 37/473 (7%)

Query: 76  TTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQL 133
             L L S +   TI  +   +L SL+ LDLS N LSS + SS F  +S+LK L LM N  
Sbjct: 53  QVLILKS-SRINTIEGDAFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGNPY 110

Query: 134 SGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSK 192
                +  F N +++  +R+   +   ++       L  L  L ++          SL  
Sbjct: 111 QTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS 170

Query: 193 CKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFN 252
            + +  L L  +  +  +      L+ ++ + L +  L       +   +    ++    
Sbjct: 171 IRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF 230

Query: 253 NLTGVVPATIFNMSTLKEIFLYNNSLS-----------------GSLPSRIDLALPNLEF 295
             + +   +   +  L    L  + +                    +     +    +  
Sbjct: 231 RGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRR 290

Query: 296 LNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSST 355
           L++        + +  +   K+  + + ++       S   +L++L+  D+  N +    
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEY 350

Query: 356 PELGFLSSLANCKKLRYLGLGGNPLD--GFLPSSIGNLSLSLERLNIAFCNISGNIPKAI 413
            +    +       L+ L L  N L         +  L  +L  L+I+       +P + 
Sbjct: 351 LKNS--ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK-NLTSLDISRNTFH-PMPDSC 406

Query: 414 GNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLN 473
                +  L+L    +     V     Q L+ LD++ N L  S       L RL EL ++
Sbjct: 407 QWPEKMRFLNLSSTGIRV---VKTCIPQTLEVLDVSNNNLD-SFSLF---LPRLQELYIS 459

Query: 474 GNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLD 526
            NK+  ++         L  + +  N+   V    F  L  +    + +N  D
Sbjct: 460 RNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  142 bits (359), Expect = 1e-35
 Identities = 81/434 (18%), Positives = 154/434 (35%), Gaps = 48/434 (11%)

Query: 71  NSHKVTTLNLSSFNLQGTIPPE-IANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLM 129
           N   + TL + +      I     A L+SL  L++    L +    S+ ++  +  L L 
Sbjct: 121 NLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180

Query: 130 DNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSS 189
            ++ +  L  F    SS+  + L    L+ +   +          +             S
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239

Query: 190 LSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQ--NLDVL 247
            ++  +L    L  + +         + T+        ++   ++  E+G ++   +  L
Sbjct: 240 FNELLKLLRYILELSEVE------FDDCTLNGLGDFNPSES--DVVSELGKVETVTIRRL 291

Query: 248 QLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTI 307
            +    L   +      +  +K I + N+ +   +P      L +LEFL+L  N      
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEY 350

Query: 308 PSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANC 367
             +                      +  G   +L+   +  N+L S       L +L   
Sbjct: 351 LKN---------------------SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL--- 386

Query: 368 KKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGN 427
           K L  L +  N     +P S       +  LN++   I   +   I     L VL +  N
Sbjct: 387 KNLTSLDISRNTF-HPMPDSCQWPE-KMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNN 441

Query: 428 NLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGN 487
           NL  S  +    L +LQ L ++ NKL  ++PD   L   L  + ++ N++          
Sbjct: 442 NLD-SFSL---FLPRLQELYISRNKLK-TLPDAS-LFPVLLVMKISRNQLKSVPDGIFDR 495

Query: 488 LTSLQYLNLGSNRF 501
           LTSLQ + L +N +
Sbjct: 496 LTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  118 bits (298), Expect = 7e-28
 Identities = 41/211 (19%), Positives = 82/211 (38%), Gaps = 5/211 (2%)

Query: 415 NLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNG 474
           +     V      + + SIP   G    ++ LDL+FNK+      ++   + L  L L  
Sbjct: 3   SCDASGVCDGRSRSFT-SIPS--GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59

Query: 475 NKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDG-PISLAI 533
           ++I+        +L SL++L+L  N  + +  S F  L  +   ++  N      ++   
Sbjct: 60  SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119

Query: 534 GNLKAVVGIDLSRNNLSGNIP-TTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDL 592
            NL  +  + +        I      GL SL  + +    L     +S  ++  +  L L
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179

Query: 593 SNNKISGSIPVSFEKLSYLKELNLSFNKLKG 623
             ++ +  + +  + LS ++ L L    L  
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLAR 210

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  105 bits (264), Expect = 1e-23
 Identities = 70/310 (22%), Positives = 122/310 (39%), Gaps = 27/310 (8%)

Query: 71  NSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMS--------T 122
            + + + L   SFN    +   I  LS ++  D + N L    PS    +S        T
Sbjct: 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287

Query: 123 LKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMF 182
           ++ L++    L   LS+       +  I +  +K+   +P +   HL+ L+ L L EN+ 
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLM 346

Query: 183 ---YGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIG---NLTVLQRISLINNKLHGEIPQ 236
              Y K  +       LQ L L  N+L  ++ K       L  L  + +  N  H  +P 
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPD 404

Query: 237 EIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFL 296
              + + +  L L    +  VV   I    TL+ + + NN+L         L LP L+ L
Sbjct: 405 SCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLD-----SFSLFLPRLQEL 456

Query: 297 NLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTP 356
            +  N    T+P + +    L+++++  N            L +L+   +  N    S P
Sbjct: 457 YISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514

Query: 357 ELGFLSSLAN 366
            + +LS   N
Sbjct: 515 RIDYLSRWLN 524

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 68.6 bits (168), Expect = 5e-12
 Identities = 31/94 (32%), Positives = 46/94 (48%), Gaps = 1/94 (1%)

Query: 542 IDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSI 601
           +DLS N ++      L    +LQ + L  +R+     ++F ++ SLE LDLS+N +S   
Sbjct: 31  LDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLS 90

Query: 602 PVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFT 635
              F  LS LK LNL  N  +  +     F N T
Sbjct: 91  SSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLT 123

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  199 bits (509), Expect = 8e-56
 Identities = 108/484 (22%), Positives = 184/484 (38%), Gaps = 44/484 (9%)

Query: 143 NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLG 202
             +  +   L K  ++  + +     L  +  L         K    +     L +++  
Sbjct: 22  ALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRL--GIKSIDGVEYLNNLTQINFS 76

Query: 203 YNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATI 262
            N L+   P  + NLT L  I + NN++    P  +  L NL  L L  N +T + P  +
Sbjct: 77  NNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--L 130

Query: 263 FNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEM 322
            N++ L  + L +N++S  + +   L   +L+ L+ G      T    + N + L  L++
Sbjct: 131 KNLTNLNRLELSSNTIS-DISALSGL--TSLQQLSFGNQV---TDLKPLANLTTLERLDI 184

Query: 323 GSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDG 382
            SN  S    S +  L NL+      N ++        ++ L     L  L L GN L  
Sbjct: 185 SSNKVSD--ISVLAKLTNLESLIATNNQISD-------ITPLGILTNLDELSLNGNQLKD 235

Query: 383 FLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQK 442
               ++ +L+ +L  L++A   IS   P  +  L+ L  L LG N +S   P    GL  
Sbjct: 236 --IGTLASLT-NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTA 288

Query: 443 LQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFT 502
           L  L+L  N+L    P  I  L  L  L L  N IS      + +LT LQ L   +N+ +
Sbjct: 289 LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS 344

Query: 503 FVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKS 562
               S+  NL +I       N +       + NL  +  + L+    +         +  
Sbjct: 345 --DVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSI 400

Query: 563 LQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLK 622
              +      L    P +  +  S    D++ N  S +  VS+   S    +        
Sbjct: 401 PNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYTNEVSYT-FSQPVTIGKGTTTFS 457

Query: 623 GEIP 626
           G + 
Sbjct: 458 GTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  198 bits (505), Expect = 3e-55
 Identities = 102/494 (20%), Positives = 187/494 (37%), Gaps = 44/494 (8%)

Query: 66  IICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKV 125
           I  D    +     L   N+  T+     +L  + +L      + S     +  ++ L  
Sbjct: 17  IFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQ 72

Query: 126 LYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGK 185
           +   +NQL+  ++    N + ++DI ++ N+++      + N L  L  L L  N     
Sbjct: 73  INFSNNQLT-DITPLK-NLTKLVDILMNNNQIAD--ITPLAN-LTNLTGLTLFNNQI--T 125

Query: 186 IPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLD 245
               L     L  L L  N +S      +  LT LQ++S  N        + +  L  L+
Sbjct: 126 DIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLE 180

Query: 246 VLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSG 305
            L +  N ++ +    +  ++ L+ +   NN +S   P      L NL+ L+L  N    
Sbjct: 181 RLDISSNKVSDISV--LAKLTNLESLIATNNQISDITP---LGILTNLDELSLNGNQLKD 235

Query: 306 TIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLA 365
               ++ + + L  L++ +N  S   P  +  L  L    +  N +++       +S LA
Sbjct: 236 --IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-------ISPLA 284

Query: 366 NCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLG 425
               L  L L  N L+    S I NL  +L  L + F NIS   P  + +L+ L  L   
Sbjct: 285 GLTALTNLELNENQLEDI--SPISNLK-NLTYLTLYFNNISDISP--VSSLTKLQRLFFY 339

Query: 426 GNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCL 485
            N +S         L  +  L    N+++   P  +  L+R+ +L LN    + +  +  
Sbjct: 340 NNKVSDVSS--LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYK 395

Query: 486 GNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLS 545
            N++    +   +     + P+T  +       DI+ NL      +        V I   
Sbjct: 396 ANVSIPNTVKNVTG--ALIAPATISDGGSYTEPDITWNLPSYTNEV-SYTFSQPVTIGKG 452

Query: 546 RNNLSGNIPTTLEG 559
               SG +   L+ 
Sbjct: 453 TTTFSGTVTQPLKA 466

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  197 bits (504), Expect = 3e-55
 Identities = 106/434 (24%), Positives = 179/434 (41%), Gaps = 40/434 (9%)

Query: 188 SSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVL 247
            + +   +  +  LG  N++  +     +L  +  +      +  +    + YL NL  +
Sbjct: 18  FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 73

Query: 248 QLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTI 307
               N LT + P  + N++ L +I + NN ++   P      L NL  L L  N  +   
Sbjct: 74  NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA---NLTNLTGLTLFNNQITDID 128

Query: 308 PSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANC 367
           P  + N + L  LE+ SN+ S    SA+  L +L+      N +T        L  LAN 
Sbjct: 129 P--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTD-------LKPLANL 176

Query: 368 KKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGN 427
             L  L +  N +     S +  L+ +LE L      IS   P  +G L+NL  LSL GN
Sbjct: 177 TTLERLDISSNKVSD--ISVLAKLT-NLESLIATNNQISDITP--LGILTNLDELSLNGN 231

Query: 428 NLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGN 487
            L      T   L  L  LDLA N+++   P  +  L++L EL L  N+IS      L  
Sbjct: 232 QLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAG 285

Query: 488 LTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRN 547
           LT+L  L L  N+   + P    NLK++    +  N +       + +L  +  +    N
Sbjct: 286 LTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFYNN 341

Query: 548 NLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEK 607
            +S    ++L  L ++  +S  +N++    P    N+T +  L L++   + +       
Sbjct: 342 KVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKAN 397

Query: 608 LSYLKELNLSFNKL 621
           +S    +      L
Sbjct: 398 VSIPNTVKNVTGAL 411

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  184 bits (469), Expect = 1e-51
 Identities = 79/382 (20%), Positives = 149/382 (39%), Gaps = 37/382 (9%)

Query: 241 LQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGI 300
              L  L    N +         +++      L   S++  +       L ++  L +  
Sbjct: 2   AATLATLPAPINQIF-----PDADLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAG 53

Query: 301 NSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGF 360
                     I   + L  L +  N  +   P  + NL  L    I  N +T        
Sbjct: 54  EKV--ASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD------- 102

Query: 361 LSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLI 420
           +S+L N   LR L L  + +     S + NL+  +  LN+   +   ++   + N++ L 
Sbjct: 103 ISALQNLTNLRELYLNEDNISDI--SPLANLT-KMYSLNLGANHNLSDL-SPLSNMTGLN 158

Query: 421 VLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGS 480
            L++  + +    P     L  L  L L +N++    P  +  L+ L+      N+I+  
Sbjct: 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI 214

Query: 481 ISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVV 540
               + N+T L  L +G+N+ T + P    NL  +   +I +N +      A+ +L  + 
Sbjct: 215 TP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDIN--AVKDLTKLK 268

Query: 541 GIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGS 600
            +++  N +S    + L  L  L ++ L  N+L     E  G +T+L +L LS N I+  
Sbjct: 269 MLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326

Query: 601 IPVSFEKLSYLKELNLSFNKLK 622
            P     LS +   + +   +K
Sbjct: 327 RP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  175 bits (446), Expect = 1e-48
 Identities = 81/359 (22%), Positives = 141/359 (39%), Gaps = 32/359 (8%)

Query: 268 LKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSF 327
              +      ++   P   D  L       L   S +  +         +  L +     
Sbjct: 2   AATLATLPAPINQIFP---DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV 56

Query: 328 SGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSS 387
           +      I  L NL+  ++  N +T        +S L+N  KL  L +G N +     S+
Sbjct: 57  ASI--QGIEYLTNLEYLNLNGNQITD-------ISPLSNLVKLTNLYIGTNKITD--ISA 105

Query: 388 IGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLD 447
           + NL+ +L  L +   NIS      + NL+ +  L+LG N+    +      +  L  L 
Sbjct: 106 LQNLT-NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLT 161

Query: 448 LAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPS 507
           +  +K+    P  I  L+ L  L LN N+I       L +LTSL Y     N+ T + P 
Sbjct: 162 VTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP- 216

Query: 508 TFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNIS 567
              N+  + S  I +N +     L   NL  +  +++  N +S      ++ L  L+ ++
Sbjct: 217 -VANMTRLNSLKIGNNKITDLSPL--ANLSQLTWLEIGTNQISD--INAVKDLTKLKMLN 271

Query: 568 LAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIP 626
           +  N++         N++ L SL L+NN++          L+ L  L LS N +    P
Sbjct: 272 VGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  170 bits (433), Expect = 9e-47
 Identities = 78/404 (19%), Positives = 146/404 (36%), Gaps = 59/404 (14%)

Query: 99  LKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLS 158
             +L      ++   P +   ++      L    ++  ++                    
Sbjct: 2   AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVT-------------------- 39

Query: 159 GKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLT 218
                     L  +  L +            +     L+ L+L  N ++   P  + NL 
Sbjct: 40  -------QEELESITKLVVAGEKV--ASIQGIEYLTNLEYLNLNGNQITDISP--LSNLV 88

Query: 219 VLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSL 278
            L  + +  NK+       +  L NL  L L  +N++ + P  + N++ +  + L  N  
Sbjct: 89  KLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHN 144

Query: 279 SGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNL 338
             S  S +   +  L +L +  +      P  I N + L  L +  N      P  + +L
Sbjct: 145 L-SDLSPLS-NMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASL 198

Query: 339 RNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERL 398
            +L  F  + N +T        ++ +AN  +L  L +G N +     S + NLS  L  L
Sbjct: 199 TSLHYFTAYVNQITD-------ITPVANMTRLNSLKIGNNKITDL--SPLANLS-QLTWL 248

Query: 399 NIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIP 458
            I    IS     A+ +L+ L +L++G N +S         L +L  L L  N+L     
Sbjct: 249 EIGTNQISD--INAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDM 304

Query: 459 DEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFT 502
           + I  L+ L  L L+ N I+      L +L+ +   +  +    
Sbjct: 305 EVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  164 bits (417), Expect = 1e-44
 Identities = 82/388 (21%), Positives = 158/388 (40%), Gaps = 57/388 (14%)

Query: 66  IICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKV 125
           I  D +  +     L   ++   +      L S+  L ++  K++S     I  ++ L+ 
Sbjct: 15  IFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEY 70

Query: 126 LYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGK 185
           L L  NQ++  +S  +                          +L  L +L++  N     
Sbjct: 71  LNLNGNQIT-DISPLS--------------------------NLVKLTNLYIGTNKI--T 101

Query: 186 IPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLD 245
             S+L     L+EL+L  +N+S   P  + NLT +  ++L  N    ++   +  +  L+
Sbjct: 102 DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLN 158

Query: 246 VLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSG 305
            L +  + +  V P  I N++ L  + L  N +    P     +L +L +    +N  + 
Sbjct: 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLA---SLTSLHYFTAYVNQITD 213

Query: 306 TIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLA 365
             P  + N ++L  L++G+N  +   P  + NL  L   +I  N ++        ++++ 
Sbjct: 214 ITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-------INAVK 262

Query: 366 NCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLG 425
           +  KL+ L +G N +     S + NLS  L  L +    +     + IG L+NL  L L 
Sbjct: 263 DLTKLKMLNVGSNQISDI--SVLNNLS-QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLS 319

Query: 426 GNNLSGSIPVTFGGLQKLQGLDLAFNKL 453
            N+++   P     L K+   D A   +
Sbjct: 320 QNHITDIRP--LASLSKMDSADFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =   99 bits (250), Expect = 9e-23
 Identities = 47/204 (23%), Positives = 94/204 (46%), Gaps = 15/204 (7%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSG 135
             L ++   +       IANL+ L SL L++N++    P  + ++++L       NQ++ 
Sbjct: 158 NYLTVTESKV--KDVTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQIT- 212

Query: 136 SLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQ 195
            ++    N + +  +++  NK++      + N L  L  L +  N       +++    +
Sbjct: 213 DITPVA-NMTRLNSLKIGNNKITD--LSPLAN-LSQLTWLEIGTNQI--SDINAVKDLTK 266

Query: 196 LQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLT 255
           L+ L++G N +S      + NL+ L  + L NN+L  E  + IG L NL  L L  N++T
Sbjct: 267 LKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324

Query: 256 GVVPATIFNMSTLKEIFLYNNSLS 279
            + P  + ++S +      N  + 
Sbjct: 325 DIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 86.1 bits (214), Expect = 4e-18
 Identities = 42/186 (22%), Positives = 77/186 (41%), Gaps = 15/186 (8%)

Query: 71  NSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMD 130
           N   + +L+L+   ++   P  +A+L+SL       N+++   P  +  M+ L  L + +
Sbjct: 175 NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGN 230

Query: 131 NQLSGSLSSFTFNTS-SILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSS 189
           N+++  LS     +  + L+  +  N++S      + + L  LK L +  N       S 
Sbjct: 231 NKIT-DLSPLANLSQLTWLE--IGTNQISD--INAVKD-LTKLKMLNVGSNQI--SDISV 282

Query: 190 LSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQL 249
           L+   QL  L L  N L     + IG LT L  + L  N +    P  +  L  +D    
Sbjct: 283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADF 340

Query: 250 GFNNLT 255
               + 
Sbjct: 341 ANQVIK 346

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  186 bits (474), Expect = 3e-51
 Identities = 103/533 (19%), Positives = 180/533 (33%), Gaps = 83/533 (15%)

Query: 89  IPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSIL 148
           I P   + + L+      + L+  +P     + +    Y   ++   +          + 
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 149 DIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSG 208
             RL                      L L        +P        L+ L    N+L+ 
Sbjct: 62  VSRLRDCLDRQ------------AHELELNNLGL-SSLPELPP---HLESLVASCNSLT- 104

Query: 209 AIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTL 268
            +P+   +L  L   +     L    P        L+ L +  N L  +    + N S L
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEKL--PELQNSSFL 155

Query: 269 KEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFS 328
           K I + NNSL   LP       P+LEF+  G N         + N   L  +   +NS  
Sbjct: 156 KIIDVDNNSLK-KLPD----LPPSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK 208

Query: 329 GFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSI 388
             +P    +L ++       N L         L  L N   L  +    N L   LP   
Sbjct: 209 -KLPDLPLSLESI---VAGNNILEE-------LPELQNLPFLTTIYADNNLLKT-LPDLP 256

Query: 389 GNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDL 448
            +    LE LN+    ++ ++P+   +L+ L V     + LS   P        L  L+ 
Sbjct: 257 PS----LEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNA 304

Query: 449 AFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPST 508
           + N++  S+ D   L   L EL+++ NK+   + +       L+ L    N     +P  
Sbjct: 305 SSNEIR-SLCD---LPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPEL 355

Query: 509 FWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISL 568
             NLK      +  N L         +++     DL  N+    +P   + LK L    +
Sbjct: 356 PQNLK---QLHVEYNPLRE-FPDIPESVE-----DLRMNSHLAEVPELPQNLKQL---HV 403

Query: 569 AYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKL 621
             N L    P+      S+E L +++ ++      + E    L++     +  
Sbjct: 404 ETNPLRE-FPDI---PESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  162 bits (412), Expect = 5e-43
 Identities = 92/436 (21%), Positives = 161/436 (36%), Gaps = 70/436 (16%)

Query: 187 PSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDV 246
           P ++S    LQE     +NL+  +P E  N+          ++     P   G  + + V
Sbjct: 5   PRNVSNT-FLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 247 LQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGT 306
            +L                    E+ L N  LS SLP       P+LE L    NS +  
Sbjct: 63  SRLRDCLDRQ-----------AHELELNNLGLS-SLPELP----PHLESLVASCNSLT-E 105

Query: 307 IPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLAN 366
           +P    +   L++      + S   P        L+   +  N L         L  L N
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEK-------LPELQN 151

Query: 367 CKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGG 426
              L+ + +  N L   LP    +    LE +      +   +P+ + NL  L  +    
Sbjct: 152 SSFLKIIDVDNNSLK-KLPDLPPS----LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADN 204

Query: 427 NNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLG 486
           N+L   +P        L+ +    N L      E+  L  L  +  + N +  ++     
Sbjct: 205 NSLK-KLP---DLPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPP 257

Query: 487 NLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSR 546
           +L +   LN+  N  T  +P    +L  +   D+S N+  G +S    NL     ++ S 
Sbjct: 258 SLEA---LNVRDNYLTD-LPELPQSLTFL---DVSENIFSG-LSELPPNLYY---LNASS 306

Query: 547 NNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFE 606
           N +  ++      L+ L   +++ N+L   +P        LE L  S N ++  +P   E
Sbjct: 307 NEIR-SLCDLPPSLEEL---NVSNNKLIE-LPALPPR---LERLIASFNHLA-EVP---E 354

Query: 607 KLSYLKELNLSFNKLK 622
               LK+L++ +N L+
Sbjct: 355 LPQNLKQLHVEYNPLR 370

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  158 bits (401), Expect = 1e-41
 Identities = 92/474 (19%), Positives = 172/474 (36%), Gaps = 82/474 (17%)

Query: 162 PENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTV-- 219
           P N+ N   +L+      +    ++P      K   E +  ++      P   G      
Sbjct: 5   PRNVSN--TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 220 -----------LQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTL 268
                         + L N  L   +P+   +L++L       N+LT  +P    ++ +L
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSL 116

Query: 269 KEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFS 328
                   +LS  LP       P LE+L +  N     +P  + N+S L ++++ +NS  
Sbjct: 117 LVDNNNLKALS-DLP-------PLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK 166

Query: 329 GFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSI 388
             +P    +L  +       N L         L  L N   L  +    N L   LP   
Sbjct: 167 -KLPDLPPSLEFI---AAGNNQLEE-------LPELQNLPFLTAIYADNNSLK-KLPDLP 214

Query: 389 GNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDL 448
            +L    E +      +       + NL  L  +    N L  ++P     L+ L   D 
Sbjct: 215 LSL----ESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDN 267

Query: 449 AFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPST 508
                   +P+    L+ L+  +   + +S           +L YLN  SN     +   
Sbjct: 268 YLT----DLPELPQSLTFLDVSENIFSGLSELP-------PNLYYLNASSNEIR-SLCDL 315

Query: 509 FWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISL 568
             +L+     ++S+N L   +      L+    +  S N+L+  +P   E  ++L+ + +
Sbjct: 316 PPSLE---ELNVSNNKLIE-LPALPPRLER---LIASFNHLA-EVP---ELPQNLKQLHV 364

Query: 569 AYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLK 622
            YN L    P+   +   +E L ++++     +P   E    LK+L++  N L+
Sbjct: 365 EYNPLRE-FPDIPES---VEDLRMNSH--LAEVP---ELPQNLKQLHVETNPLR 409

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  156 bits (396), Expect = 7e-41
 Identities = 93/447 (20%), Positives = 161/447 (36%), Gaps = 69/447 (15%)

Query: 67  ICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVL 126
           + D    +   L L++  L  ++P    +   L+SL  S N L+  +P    ++ +L V 
Sbjct: 65  LRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLTE-LPELPQSLKSLLVD 119

Query: 127 YLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKI 186
                 LS       +       + +S N+L  KLPE    +  +LK + +  N    K+
Sbjct: 120 NNNLKALSDLPPLLEY-------LGVSNNQLE-KLPEL--QNSSFLKIIDVDNNSL-KKL 168

Query: 187 PSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDV 246
           P        L+ +  G N L   +P E+ NL  L  I   NN L  ++P     L+++  
Sbjct: 169 PDLPP---SLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESIV- 221

Query: 247 LQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGT 306
              G N L       + N+  L  I+  NN L  +LP       P+LE LN+  N  +  
Sbjct: 222 --AGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLP----PSLEALNVRDNYLT-D 271

Query: 307 IPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSL-- 364
           +P    + + L + E   +     +     NL  L       N + S       L  L  
Sbjct: 272 LPELPQSLTFLDVSENIFSG----LSELPPNLYYLNASS---NEIRSLCDLPPSLEELNV 324

Query: 365 ---------ANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGN 415
                    A   +L  L    N L   +P    N    L++L++ +  +    P    +
Sbjct: 325 SNNKLIELPALPPRLERLIASFNHL-AEVPELPQN----LKQLHVEYNPLR-EFPDIPES 378

Query: 416 LSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGN 475
           + +L +     N+    +P      Q L+ L +  N L    PD       + +L +N  
Sbjct: 379 VEDLRM-----NSHLAEVPEL---PQNLKQLHVETNPLR-EFPDIP---ESVEDLRMNSE 426

Query: 476 KISGSISSCLGNLTSLQYLNLGSNRFT 502
           ++             L+      +   
Sbjct: 427 RVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  118 bits (298), Expect = 3e-28
 Identities = 55/309 (17%), Positives = 103/309 (33%), Gaps = 45/309 (14%)

Query: 330 FIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIG 389
           FI     +   L+      +NLT    E        N K         +  +   P   G
Sbjct: 2   FINPRNVSNTFLQEPLRHSSNLTEMPVEAE------NVKSKTEYYNAWSEWERNAPPGNG 55

Query: 390 NLS------------LSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTF 437
                               L +    +S ++P+   +L +   L    N+L+  +P   
Sbjct: 56  EQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELP 110

Query: 438 GGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLG 497
             L+ L   +     L+        L   L  L ++ N++   +   L N + L+ +++ 
Sbjct: 111 QSLKSLLVDNNNLKALSD-------LPPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVD 161

Query: 498 SNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTL 557
           +N     +P    +L+ I      +N L+      + NL  +  I    N+L   +P   
Sbjct: 162 NNSLKK-LPDLPPSLEFI---AAGNNQLEELPE--LQNLPFLTAIYADNNSLK-KLP--- 211

Query: 558 EGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLS 617
           +   SL++I    N LE        N+  L ++   NN +  ++P     L  L   +  
Sbjct: 212 DLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNY 268

Query: 618 FNKLKGEIP 626
              L     
Sbjct: 269 LTDLPELPQ 277

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  174 bits (444), Expect = 1e-48
 Identities = 64/319 (20%), Positives = 114/319 (35%), Gaps = 61/319 (19%)

Query: 708 SSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLK 767
               +        L   +       +   G FG V++A+L     +A+K+F  Q     +
Sbjct: 6   HHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK---Q 61

Query: 768 SFEAECEV--IKNIRHRNLVKIISSCSNDDFKA----LVLEYMSNGSLEDCLHSSNCALN 821
           S++ E EV  +  ++H N+++ I +            L+  +   GSL D L ++   ++
Sbjct: 62  SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVS 119

Query: 822 IFCRLNIMIDIASALEYLH------FGHSTP-IIHCDLKPSNVLLDEDMVAHLSDFGMAK 874
                +I   +A  L YLH           P I H D+K  NVLL  ++ A ++DFG+A 
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179

Query: 875 LL-SGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVN--------------------- 912
              +G+       Q   T  YMAP E+  G ++ +R                        
Sbjct: 180 KFEAGKSAGDTHGQV-GTRRYMAP-EVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237

Query: 913 -------------DLLPV-----SLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTM 954
                        + +        + EVV         + +  K   +  +     EC  
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297

Query: 955 ESPEKRIDAKDTITRLLKI 973
              E R+ A     R+ ++
Sbjct: 298 HDAEARLSAGCVGERITQM 316

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  170 bits (434), Expect = 2e-47
 Identities = 56/177 (31%), Positives = 91/177 (51%), Gaps = 9/177 (5%)

Query: 732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIIS 789
             IG G FG+V+RA    G ++A+K+   Q   A  +  F  E  ++K +RH N+V  + 
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCA--LNIFCRLNIMIDIASALEYLHFGHSTPI 847
           + +     ++V EY+S GSL   LH S     L+   RL++  D+A  + YLH   + PI
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPI 160

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
           +H +LK  N+L+D+     + DFG+++L +             T  +MAP E+   E
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAP-EVLRDE 214

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  170 bits (431), Expect = 8e-47
 Identities = 68/327 (20%), Positives = 113/327 (34%), Gaps = 70/327 (21%)

Query: 716 FSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEV 775
            +  E     DN     +IG G +G+VY+  L D   +A+KVF        ++F  E  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNI 58

Query: 776 --IKNIRHRNLVKIISSCSNDDFKA-----LVLEYMSNGSLEDCLHSSNCALNIFCRLNI 828
             +  + H N+ + I               LV+EY  NGSL   L       +      +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRL 116

Query: 829 MIDIASALEYLH-----FGHSTP-IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES 882
              +   L YLH       H  P I H DL   NVL+  D    +SDFG++  L+G    
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 883 TMRTQTLA------TIGYMAPDEIFVGELSLKRWVN-----DLLPVSLV----------- 920
               +  A      TI YMAP E+  G ++L+   +     D+  + L+           
Sbjct: 177 RPGEEDNAAISEVGTIRYMAP-EVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

Query: 921 ----------------------------EVVDKSLLSGEEKHFAAKEQCLLSIFSLALEC 952
                                        V  +       + +      + S+     +C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295

Query: 953 TMESPEKRIDAKDTITRLLKIRDTLSK 979
             +  E R+ A+    R+ ++     +
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWER 322

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  165 bits (420), Expect = 3e-45
 Identities = 58/334 (17%), Positives = 108/334 (32%), Gaps = 31/334 (9%)

Query: 290 LPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFN 349
               E L    ++        ++   +    +               N  N ++      
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGR 66

Query: 350 NLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNI 409
            L ++   L   +          L L   PL    P     LS  L+ + I    +   +
Sbjct: 67  ALKATADLLEDATQP----GRVALELRSVPLP-QFPDQAFRLS-HLQHMTIDAAGLM-EL 119

Query: 410 PKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNE 469
           P  +   + L  L+L  N L  ++P +   L +L+ L +        +P+ +       E
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178

Query: 470 LDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPI 529
                             L +LQ L L        +P++  NL+++ S  I ++ L   +
Sbjct: 179 H---------------QGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA-L 221

Query: 530 SLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLA-YNRLEGPIPESFGNMTSLE 588
             AI +L  +  +DL       N P    G   L+ + L   + L   +P     +T LE
Sbjct: 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLE 280

Query: 589 SLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLK 622
            LDL        +P    +L     + +  +   
Sbjct: 281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  157 bits (399), Expect = 1e-42
 Identities = 64/406 (15%), Positives = 115/406 (28%), Gaps = 81/406 (19%)

Query: 87  GTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSS 146
           G+      + S  ++L    +         +   S  +  Y  D     S        S+
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVL---SQWQRHYNADRNRWHSAWRQA--NSN 56

Query: 147 ILDIRLSKNKLSGKLPENICN-HLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNN 205
              I     +      + + +        L LR      + P    +   LQ + +    
Sbjct: 57  NPQIETRTGRALKATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAG 115

Query: 206 LSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNM 265
           L   +P  +     L+ ++L  N L   +P  I  L  L  L +        +P  + + 
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173

Query: 266 STLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSN 325
               E                   L NL+ L L                           
Sbjct: 174 DASGEHQ----------------GLVNLQSLRLEWTGIR--------------------- 196

Query: 326 SFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLP 385
                +P++I NL+NLK   I  + L++                              L 
Sbjct: 197 ----SLPASIANLQNLKSLKIRNSPLSA------------------------------LG 222

Query: 386 SSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQG 445
            +I +L   LE L++  C    N P   G  + L  L L   +   ++P+    L +L+ 
Sbjct: 223 PAIHHLP-KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEK 281

Query: 446 LDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSL 491
           LDL        +P  I  L     + +  +  +           + 
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  155 bits (393), Expect = 8e-42
 Identities = 54/328 (16%), Positives = 104/328 (31%), Gaps = 24/328 (7%)

Query: 208 GAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMST 267
           G+      + +  + +    +         +   Q          +          N + 
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57

Query: 268 LKEIFLYNNSLSGSLPSRI-DLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNS 326
            +       +L  +    + D   P    L L         P      S L  + + +  
Sbjct: 58  PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115

Query: 327 FSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPS 386
               +P  +     L+   +  N L +        +S+A+  +LR L +   P    LP 
Sbjct: 116 LME-LPDTMQQFAGLETLTLARNPLRA------LPASIASLNRLRELSIRACPELTELPE 168

Query: 387 SIGNLSL--------SLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFG 438
            + +           +L+ L + +  I  ++P +I NL NL  L +  + LS ++     
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIH 226

Query: 439 GLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGS 498
            L KL+ LDL       + P      + L  L L       ++   +  LT L+ L+L  
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRG 286

Query: 499 NRFTFVIPSTFWNLKDILSFDISSNLLD 526
                 +PS    L       +  +L  
Sbjct: 287 CVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  136 bits (344), Expect = 3e-35
 Identities = 53/278 (19%), Positives = 100/278 (35%), Gaps = 22/278 (7%)

Query: 48  NLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHN 107
           N       +  ++ +   ++ D        L L S  L    P +   LS L+ + +   
Sbjct: 56  NNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114

Query: 108 KLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICN 167
            L   +P ++   + L+ L L  N L  +L +   + + + ++ +       +LPE + +
Sbjct: 115 GLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172

Query: 168 HLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLIN 227
                                       LQ L L +  +  ++P  I NL  L+ + + N
Sbjct: 173 ----------------TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRN 215

Query: 228 NKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRID 287
           + L   +   I +L  L+ L L         P      + LK + L + S   +LP  I 
Sbjct: 216 SPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH 274

Query: 288 LALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSN 325
             L  LE L+L        +PS I       ++ +  +
Sbjct: 275 -RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  122 bits (308), Expect = 2e-30
 Identities = 48/225 (21%), Positives = 91/225 (40%), Gaps = 15/225 (6%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMD-NQL- 133
             + + +  L   +P  +   + L++L L+ N L + +P+SI +++ L+ L +    +L 
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELT 164

Query: 134 -------SGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKI 186
                  S   S       ++  +RL    +   LP +I N L+ LK L +R +     +
Sbjct: 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIAN-LQNLKSLKIRNSPL-SAL 221

Query: 187 PSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDV 246
             ++    +L+EL L         P   G    L+R+ L +      +P +I  L  L+ 
Sbjct: 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEK 281

Query: 247 LQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALP 291
           L L        +P+ I  +     I +  + L   L     +A P
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPH-LQAQLDQHRPVARP 325

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 44.6 bits (106), Expect = 9e-05
 Identities = 12/115 (10%), Positives = 26/115 (22%), Gaps = 23/115 (20%)

Query: 533 IGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPES------------ 580
             +      +    +         L   +   N              S            
Sbjct: 8   HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRA 67

Query: 581 ---------FGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIP 626
                            +L+L +  +    P    +LS+L+ + +    L  E+P
Sbjct: 68  LKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELP 120

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  164 bits (416), Expect = 3e-45
 Identities = 52/177 (29%), Positives = 86/177 (48%), Gaps = 9/177 (5%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSC 791
           IG G FG+VY+ +    V  A+K+ +    +   L++F+ E  V++  RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
           +     A+V ++    SL   LH+S     +   ++I    A  ++YLH   +  IIH D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145

Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
           LK +N+ L ED    + DFG+A   S    S    Q   +I +MAP E+   + S  
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP-EVIRMQDSNP 201

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  162 bits (413), Expect = 8e-45
 Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 22/186 (11%)

Query: 732 NIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQC-------ASTLKSFEAECEVIKNIRHRN 783
             IG GGFG V++ R ++D   +AIK                 + F+ E  ++ N+ H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +VK+     N     +V+E++  G L   L      +    +L +M+DIA  +EY+    
Sbjct: 85  IVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQ 141

Query: 844 STPIIHCDLKPSNVLLDE-----DMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           + PI+H DL+  N+ L        + A ++DFG+++    +   ++ +  L    +MAP 
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSV-SGLLGNFQWMAP- 195

Query: 899 EIFVGE 904
           E    E
Sbjct: 196 ETIGAE 201

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  160 bits (408), Expect = 5e-44
 Identities = 54/176 (30%), Positives = 81/176 (46%), Gaps = 14/176 (7%)

Query: 732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSC 791
            ++G G FG V +A+     ++AIK    +  S  K+F  E   +  + H N+VK+  +C
Sbjct: 14  EVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSN--CALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
            N     LV+EY   GSL + LH +           ++  +  +  + YLH      +IH
Sbjct: 71  LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128

Query: 850 CDLKPSNVLLDEDM-VAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
            DLKP N+LL     V  + DFG A      D  T  T    +  +MAP E+F G 
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAP-EVFEGS 178

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  158 bits (402), Expect = 1e-43
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 20/185 (10%)

Query: 732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQC----ASTLKSFEAECEVIKNIRHRNLVKI 787
            IIGIGGFG VYRA    G E+A+K          + T+++   E ++   ++H N++ +
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
              C  +    LV+E+   G L   L      +     +N  + IA  + YLH     PI
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 848 IHCDLKPSNVLLDEDMVAH--------LSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
           IH DLK SN+L+ + +           ++DFG+A+       +T  +       +MAP E
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSAA-GAYAWMAP-E 184

Query: 900 IFVGE 904
           +    
Sbjct: 185 VIRAS 189

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  157 bits (400), Expect = 3e-43
 Identities = 37/178 (20%), Positives = 72/178 (40%), Gaps = 15/178 (8%)

Query: 732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIIS 789
             +     G +++ R   G +I +KV   +  S    + F  EC  ++   H N++ ++ 
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 790 SCSN--DDFKALVLEYMSNGSLEDCLHSSNC-ALNIFCRLNIMIDIASALEYLHFGHSTP 846
           +C +       L+  +M  GSL + LH      ++    +   +D+A  + +LH      
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPL 133

Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
           I    L   +V++DEDM A +S   +         S      +    ++AP E    +
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAP-EALQKK 183

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  163 bits (415), Expect = 3e-43
 Identities = 63/417 (15%), Positives = 129/417 (30%), Gaps = 25/417 (5%)

Query: 209 AIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTL 268
           AI +   N    +   + ++ L   +        N+  L L  N L+ +  A +   + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 269 KEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFS 328
           + + L +N L  +L      +L  L  L+L  N         +     +  L   +N+ S
Sbjct: 61  ELLNLSSNVLYETLDLE---SLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112

Query: 329 GFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSI 388
               S     +N+ L +   N +T                +++YL L  N +D    + +
Sbjct: 113 RVSCSRGQGKKNIYLAN---NKITMLRDL-----DEGCRSRVQYLDLKLNEIDTVNFAEL 164

Query: 389 GNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDL 448
              S +LE LN+ +  I  ++   +   + L  L L  N L+  +   F     +  + L
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221

Query: 449 AFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPST 508
             NKL   I   +     L   DL GN      +       + +   +       +    
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279

Query: 509 FWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGN----IPTTLEGLKSLQ 564
                        +   +   +     L A+   + +  +  G+    +    E     +
Sbjct: 280 EEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQR 339

Query: 565 NISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKL 621
            I     +    I +      +  +L+     +   +       + L          
Sbjct: 340 EIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ 396

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  161 bits (410), Expect = 1e-42
 Identities = 60/459 (13%), Positives = 133/459 (28%), Gaps = 46/459 (10%)

Query: 165 ICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRIS 224
           I  +    K   + ++     + S       ++EL L  N LS     ++   T L+ ++
Sbjct: 5   IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64

Query: 225 LINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPS 284
           L +N L+     ++  L  L  L L  N +       +    +++ +   NN++S  +  
Sbjct: 65  LSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSC 116

Query: 285 RIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSA-IGNLRNLKL 343
                    + + L  N  +          S++  L++  N       +    +   L+ 
Sbjct: 117 SR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173

Query: 344 FDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFC 403
            ++ +N +         +       KL+ L L  N L  F+     + +  +  +++   
Sbjct: 174 LNLQYNFIYD-------VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAA-GVTWISLRNN 224

Query: 404 NISGNIPKAIGNLSNLIVLSLGGNNLS-GSIPVTFGGLQKLQGLDLAFNKLAGSIPDEIC 462
            +   I KA+    NL    L GN    G++   F   Q++Q +      +         
Sbjct: 225 KLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEE 281

Query: 463 LLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISS 522
             +                +     L +L+                              
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER-------------- 327

Query: 523 NLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFG 582
                 +     N      ID  +      I       ++   +      L+  +     
Sbjct: 328 ------LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRR 381

Query: 583 NMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKL 621
               L+            +  + E+ S L+ L     + 
Sbjct: 382 AHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIVKRY 419

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  155 bits (393), Expect = 2e-40
 Identities = 77/522 (14%), Positives = 155/522 (29%), Gaps = 48/522 (9%)

Query: 71  NSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMD 130
           N ++     ++  +L+  +     +  ++K LDLS N LS    + +   + L++L L  
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 131 NQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSL 190
           N L                                   L  L+ L L  N         L
Sbjct: 68  NVLY-ETLDLE--------------------------SLSTLRTLDLNNNYV-----QEL 95

Query: 191 SKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLG 250
                ++ LH   NN+S  +    G     + I L NNK+      + G    +  L L 
Sbjct: 96  LVGPSIETLHAANNNIS-RVSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152

Query: 251 FNNLTGVVPATIF-NMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPS 309
            N +  V  A +  +  TL+ + L  N +   +     +    L+ L+L  N  +  +  
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG--QVVFAKLKTLDLSSNKLA-FMGP 208

Query: 310 SITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKK 369
              +A+ +  + + +N     I  A+   +NL+ FD+  N     T    F  +     +
Sbjct: 209 EFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ----R 263

Query: 370 LRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNL--SNLIVLSLGGN 427
           ++ +                 +            ++       +  L      +LS  G+
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGS 323

Query: 428 NLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGN 487
                +        + + +D    +    I            L+     +   +S+    
Sbjct: 324 ETE-RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRA 382

Query: 488 LTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRN 547
              L      +     +  +T       L   I     +  +        A+   D+ ++
Sbjct: 383 HAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQH 442

Query: 548 NLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLES 589
             +          K      LA       + E      +L S
Sbjct: 443 KETQLAEENARLKKLNGEADLALASANATLQELVVREQNLAS 484

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  149 bits (378), Expect = 2e-38
 Identities = 56/372 (15%), Positives = 126/372 (33%), Gaps = 28/372 (7%)

Query: 262 IFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLE 321
             N +  K   + ++SL     + +  +  N++ L+L  N  S    + +   +KL LL 
Sbjct: 6   KQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64

Query: 322 MGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLD 381
           + SN         + +L  L+  D+  N +            L     +  L    N + 
Sbjct: 65  LSSNVLYET--LDLESLSTLRTLDLNNNYVQE----------LLVGPSIETLHAANNNI- 111

Query: 382 GFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSG-SIPVTFGGL 440
             +  S G      + + +A   I+       G  S +  L L  N +   +        
Sbjct: 112 SRVSCSRGQ---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168

Query: 441 QKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNR 500
             L+ L+L +N +   +  ++   ++L  LDL+ NK++  +     +   + +++L +N+
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225

Query: 501 FTFVIPSTFWNLKDILSFDISSNLLD-GPISLAIGNLKAVVGIDLSRN-NLSGNIPTTLE 558
               I       +++  FD+  N    G +       + V  +       L+G       
Sbjct: 226 LVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284

Query: 559 GLKSLQNISLAYNRLEGPIPESFGNMTS--LESLDLSNNKISGSIPVSFEKLSYLKELNL 616
                   +     L  P  +    +       L    ++    +    E  +  +E++ 
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE-RLECERENQARQREIDA 343

Query: 617 SFNKLKGEIPRG 628
              + +  +   
Sbjct: 344 LKEQYR-TVIDQ 354

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  148 bits (375), Expect = 5e-38
 Identities = 48/296 (16%), Positives = 105/296 (35%), Gaps = 17/296 (5%)

Query: 366 NCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLG 425
           N  + +   +  + L   L S   +   +++ L+++   +S      +   + L +L+L 
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAW-NVKELDLSGNPLSQISAADLAPFTKLELLNLS 66

Query: 426 GNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCL 485
            N L  ++      L  L+ LDL  N +      E+ +   +  L    N IS  +S   
Sbjct: 67  SNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSC-- 116

Query: 486 GNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDG-PISLAIGNLKAVVGIDL 544
                 + + L +N+ T +          +   D+  N +D    +    +   +  ++L
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176

Query: 545 SRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS 604
             N +  ++   +     L+ + L+ N+L   +   F +   +  + L NNK+   I  +
Sbjct: 177 QYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKA 232

Query: 605 FEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKHSQ 660
                 L+  +L  N       R   F+       +  + +  L       C    
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  114 bits (287), Expect = 7e-27
 Identities = 43/229 (18%), Positives = 87/229 (37%), Gaps = 18/229 (7%)

Query: 432 SIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSL 491
           +I        + +   +  + L  ++         + ELDL+GN +S   ++ L   T L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 492 QYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSG 551
           + LNL SN     +     +L  + + D+++N +       +    ++  +  + NN+S 
Sbjct: 61  ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 552 NIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISG-SIPVSFEKLSY 610
            +       +  +NI LA N++        G  + ++ LDL  N+I   +          
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 611 LKELNLSFNKLKGEIPRGGPFANFTAESFMGNEL------LCGLPNLQV 653
           L+ LNL +N +  ++     FA         N+L            +  
Sbjct: 171 LEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTW 218

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  159 bits (403), Expect = 3e-43
 Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 12/175 (6%)

Query: 732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRNLVKIIS 789
            +IG G FG VY  R     E+AI++   +      LK+F+ E    +  RH N+V  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
           +C +    A++       +L   +  +   L++     I  +I   + YL   H+  I+H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGILH 153

Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA---TIGYMAPDEIF 901
            DLK  NV  D   V  ++DFG+  +           +       + ++AP EI 
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP-EII 206

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  155 bits (395), Expect = 4e-42
 Identities = 61/260 (23%), Positives = 101/260 (38%), Gaps = 39/260 (15%)

Query: 732 NIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
            ++G G FG   +    E G  + +K        T ++F  E +V++ + H N++K I  
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHC 850
              D     + EY+  G+L   + S +       R++   DIAS + YL   HS  IIH 
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL---HSMNIIHR 132

Query: 851 DLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST------------MRTQTLATIGYMAPD 898
           DL   N L+ E+    ++DFG+A+L+  E                 R   +    +MAP 
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP- 191

Query: 899 EIFVGE------------------LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQ 940
           E+  G                   +       D LP +       ++    +++      
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT--MDFGLNVRGFLDRY--CPPN 247

Query: 941 CLLSIFSLALECTMESPEKR 960
           C  S F + + C    PEKR
Sbjct: 248 CPPSFFPITVRCCDLDPEKR 267

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  156 bits (397), Expect = 1e-41
 Identities = 67/440 (15%), Positives = 132/440 (30%), Gaps = 74/440 (16%)

Query: 210 IPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLK 269
           I   +    V   + +           E   L N  ++    + +  +  A + +   ++
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 270 EIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSG 329
            + L +  +   + +        ++ L +G N+     P    N   L +L +  N  S 
Sbjct: 73  LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131

Query: 330 FIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIG 389
                  N   L    +  NNL     +            L+ L L  N L         
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDT-----FQATTSLQNLQLSSNRLTHV------ 180

Query: 390 NLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLA 449
                                  +  + +L   ++  N LS     T      ++ LD +
Sbjct: 181 ----------------------DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDAS 213

Query: 450 FNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTF 509
            N +   +     +   L  L L  N ++   +  L N   L  ++L  N    ++   F
Sbjct: 214 HNSIN-VVRGP--VNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPF 268

Query: 510 WNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLA 569
             ++                      L+    + +S N L   +    + + +L+ + L+
Sbjct: 269 VKMQ---------------------RLE---RLYISNNRLV-ALNLYGQPIPTLKVLDLS 303

Query: 570 YNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGG 629
           +N L   +  +      LE+L L +N I     +       LK L LS N          
Sbjct: 304 HNHLLH-VERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWD-CNSLRA 358

Query: 630 PFANFTAESFMGNELLCGLP 649
            F N    +    +  C + 
Sbjct: 359 LFRNVARPAVDDADQHCKID 378

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  148 bits (376), Expect = 6e-39
 Identities = 64/362 (17%), Positives = 133/362 (36%), Gaps = 27/362 (7%)

Query: 166 CNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISL 225
             +      + +                   + +    + +       + +   ++ ++L
Sbjct: 17  LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL 76

Query: 226 INNKLHGEIPQEI-GYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPS 284
            + ++  EI      Y   +  L +GFN +  + P    N+  L  + L  N LS SLP 
Sbjct: 77  NDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPR 134

Query: 285 RIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLF 344
            I    P L  L++  N+       +    + L  L++ SN  +      +  + +L   
Sbjct: 135 GIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHA 191

Query: 345 DIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCN 404
           ++ +N L+          +LA    +  L    N ++         +++ L  L +   N
Sbjct: 192 NVSYNLLS----------TLAIPIAVEELDASHNSINVVRG----PVNVELTILKLQHNN 237

Query: 405 ISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLL 464
           ++ +    + N   L+ + L  N L   +   F  +Q+L+ L ++ N+L  ++      +
Sbjct: 238 LT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 294

Query: 465 SRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNL 524
             L  LDL+ N +   +         L+ L L  N    +  ST   LK++    +S N 
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL---TLSHND 350

Query: 525 LD 526
            D
Sbjct: 351 WD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  146 bits (370), Expect = 3e-38
 Identities = 74/412 (17%), Positives = 142/412 (34%), Gaps = 55/412 (13%)

Query: 88  TIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSI 147
            I   +        + +              T++  K++   ++ +              
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR------------- 58

Query: 148 LDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLS 207
                       KLP  + +  R ++ L L +         + +    +Q+L++G+N + 
Sbjct: 59  ------------KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 106

Query: 208 GAIPKEI-GNLTVLQRISLINNKLHGEIPQEI-GYLQNLDVLQLGFNNLTGVVPATIFNM 265
             +P  +  N+ +L  + L  N L   +P+ I      L  L +  NNL  +   T    
Sbjct: 107 -YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT 164

Query: 266 STLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSN 325
           ++L+ + L +N L+  +       +P+L   N+  N       S++     +  L+   N
Sbjct: 165 TSLQNLQLSSNRLT-HVDLS---LIPSLFHANVSYNLL-----STLAIPIAVEELDASHN 215

Query: 326 SFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLP 385
           S +         L  LKL     NNLT         + L N   L  + L  N L+  + 
Sbjct: 216 SINVVRGPVNVELTILKLQH---NNLTD-------TAWLLNYPGLVEVDLSYNELEKIMY 265

Query: 386 SSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQG 445
                +   LERL I+   +   +      +  L VL L  N+L   +        +L+ 
Sbjct: 266 HPFVKMQ-RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 322

Query: 446 LDLAFNKLAGSIPDEICLLSRLNELDLNGNKISG-SISSCLGNLTSLQYLNL 496
           L L  N +  ++         L  L L+ N     S+ +   N+      + 
Sbjct: 323 LYLDHNSIV-TLKLST--HHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDA 371

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 69.3 bits (170), Expect = 2e-12
 Identities = 22/131 (16%), Positives = 41/131 (31%), Gaps = 1/131 (0%)

Query: 498 SNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTL 557
                  I S            I     D         L     +    + +       L
Sbjct: 6   RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65

Query: 558 EGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLS 617
           +  + ++ ++L   ++E     +F    +++ L +  N I    P  F+ +  L  L L 
Sbjct: 66  DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125

Query: 618 FNKLKGEIPRG 628
            N L   +PRG
Sbjct: 126 RNDLS-SLPRG 135

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 65.1 bits (159), Expect = 4e-11
 Identities = 39/165 (23%), Positives = 70/165 (42%), Gaps = 12/165 (7%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQLS 134
           T L L   NL  T    + N   L  +DLS+N+L   I    F  M  L+ LY+ +N+L 
Sbjct: 229 TILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYISNNRLV 285

Query: 135 GSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCK 194
            +L+ +     ++  + LS N L   +  N       L++L+L  N     +  S     
Sbjct: 286 -ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ-FDRLENLYLDHNSI-VTLKLST--HH 339

Query: 195 QLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIG 239
            L+ L L +N+      + +     + R ++ +   H +I  ++ 
Sbjct: 340 TLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLE 382

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  152 bits (386), Expect = 4e-41
 Identities = 51/189 (26%), Positives = 82/189 (43%), Gaps = 20/189 (10%)

Query: 732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIK--NIRHRNLVKIIS 789
             +G G +G V+R     G  +A+K+F  +     KS+  E E+     +RH N++  I+
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIA 69

Query: 790 SCSNDDFKA----LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH----- 840
           S       +    L+  Y   GSL D L  +   L+    L I++ IAS L +LH     
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA--TIGYMAPD 898
                 I H DLK  N+L+ ++    ++D G+A + S               T  YMAP 
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP- 186

Query: 899 EIFVGELSL 907
           E+    + +
Sbjct: 187 EVLDETIQV 195

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  150 bits (381), Expect = 5e-40
 Identities = 48/192 (25%), Positives = 78/192 (40%), Gaps = 20/192 (10%)

Query: 732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEV--IKNIRHRNLVKIIS 789
             IG G +G V+  +   G ++A+KVF         S+  E E+     +RH N++  I+
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98

Query: 790 SCSNDDFK----ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH----- 840
           +            L+ +Y  NGSL D L S+   L+    L +     S L +LH     
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA--TIGYMAPD 898
                 I H DLK  N+L+ ++    ++D G+A     +             T  YM P 
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP- 215

Query: 899 EIFVGELSLKRW 910
           E+    L+   +
Sbjct: 216 EVLDESLNRNHF 227

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  154 bits (390), Expect = 5e-40
 Identities = 65/320 (20%), Positives = 118/320 (36%), Gaps = 15/320 (4%)

Query: 331 IPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGN 390
           +P  I      +L D+  N + +           A+   L  L L  N +    P +  N
Sbjct: 26  VPEGI--PTETRLLDLGKNRIKTLNQ-----DEFASFPHLEELELNENIVSAVEPGAFNN 78

Query: 391 LSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAF 450
           L  +L  L +    +          LSNL  L +  N +   +   F  L  L+ L++  
Sbjct: 79  LF-NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD 137

Query: 451 NKLAGSIPDEI-CLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTF 509
           N L   I       L+ L +L L    ++   +  L +L  L  L L       +   +F
Sbjct: 138 NDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSF 196

Query: 510 WNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPT-TLEGLKSLQNISL 568
             L  +   +IS       ++        +  + ++  NL+  +P   +  L  L+ ++L
Sbjct: 197 KRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNL 255

Query: 569 AYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRG 628
           +YN +          +  L+ + L   +++   P +F  L+YL+ LN+S N+L   +   
Sbjct: 256 SYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEES 314

Query: 629 --GPFANFTAESFMGNELLC 646
                 N        N L C
Sbjct: 315 VFHSVGNLETLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  137 bits (347), Expect = 2e-34
 Identities = 66/361 (18%), Positives = 135/361 (37%), Gaps = 39/361 (10%)

Query: 72  SHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMD 130
           S +   +          +P  I   +  + LDL  N++ + +    F     L+ L L +
Sbjct: 10  SAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKT-LNQDEFASFPHLEELELNE 65

Query: 131 NQLSGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSS 189
           N +S ++    F N  ++  + L  N+L   +P  +   L  L  L + EN     +   
Sbjct: 66  NIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYM 123

Query: 190 LSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQL 249
                 L+ L +G N+L                  + +    G        L +L+ L L
Sbjct: 124 FQDLYNLKSLEVGDNDLV----------------YISHRAFSG--------LNSLEQLTL 159

Query: 250 GFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPS 309
              NLT +    + ++  L  + L + +++ ++       L  L+ L +    +  T+  
Sbjct: 160 EKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTP 218

Query: 310 SITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKK 369
           +      L  L +   + +     A+ +L  L+  ++ +N +++        S L    +
Sbjct: 219 NCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEG-----SMLHELLR 273

Query: 370 LRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNL 429
           L+ + L G  L    P +   L+  L  LN++   ++        ++ NL  L L  N L
Sbjct: 274 LQEIQLVGGQLAVVEPYAFRGLN-YLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332

Query: 430 S 430
           +
Sbjct: 333 A 333

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  154 bits (391), Expect = 7e-40
 Identities = 102/564 (18%), Positives = 187/564 (33%), Gaps = 102/564 (18%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSG 135
             ++ S   L   +P +++       L++S N +S    S I ++S L++L +  N++  
Sbjct: 3   FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ- 58

Query: 136 SLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQ 195
                                    L  ++    + L++L L  N    KI         
Sbjct: 59  ------------------------YLDISVFKFNQELEYLDLSHNKL-VKISCH--PTVN 91

Query: 196 LQELHLGYNNL-SGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNL 254
           L+ L L +N   +  I KE GN++ L+ + L    L       I +L    VL +     
Sbjct: 92  LKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY 151

Query: 255 TGVVPATIFNMSTLKE--IFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSIT 312
                         +   I    N     +       + NLE  N+            ++
Sbjct: 152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS 211

Query: 313 NASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRY 372
             +KL                      N KL ++  NN+ ++      +  L     + Y
Sbjct: 212 ILAKL--------------------QTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251

Query: 373 LGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGS 432
             +    L G L     + S +                    +L  L +  +  +     
Sbjct: 252 FSISNVKLQGQLDFRDFDYSGT--------------------SLKALSIHQVVSDVFGFP 291

Query: 433 IPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQ 492
               +     +   +   +            +S    LD + N ++ ++    G+LT L+
Sbjct: 292 QSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELE 351

Query: 493 YLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGN 552
            L L  N+                     + +     SL          +D+S+N++S +
Sbjct: 352 TLILQMNQLK--------------ELSKIAEMTTQMKSLQQ--------LDISQNSVSYD 389

Query: 553 IPT-TLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYL 611
                    KSL +++++ N L   I         ++ LDL +NKI  SIP    KL  L
Sbjct: 390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEAL 446

Query: 612 KELNLSFNKLKGEIPRGGPFANFT 635
           +ELN++ N+LK  +P  G F   T
Sbjct: 447 QELNVASNQLK-SVPD-GIFDRLT 468

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  144 bits (364), Expect = 2e-36
 Identities = 101/531 (19%), Positives = 182/531 (34%), Gaps = 85/531 (16%)

Query: 75  VTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQL 133
            T LN+S   +      +I +LS L+ L +SHN++   +  S+F     L+ L L  N+L
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSHNKL 81

Query: 134 SGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYG-KIPSSLSK 192
                                     K+    C+    LKHL L  N F    I      
Sbjct: 82  V-------------------------KIS---CHPTVNLKHLDLSFNAFDALPICKEFGN 113

Query: 193 CKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFN 252
             QL+ L L   +L  +    I +L + + + ++      +   +   LQ+ +   L   
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIV 171

Query: 253 NLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSIT 312
                                  N     +       + NLE  N+            ++
Sbjct: 172 FP--------------------TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS 211

Query: 313 NASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRY 372
             +KL                      N KL ++  NN+ ++      +  L     + Y
Sbjct: 212 ILAKL--------------------QTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251

Query: 373 LGLGGNPLDGFLPSSIGNLSL----SLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNN 428
             +    L G L     + S     +L    +                SN+ + +   + 
Sbjct: 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG 311

Query: 429 LSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKIS--GSISSCLG 486
                 +    +     LD + N L  ++ +    L+ L  L L  N++     I+    
Sbjct: 312 TRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTT 371

Query: 487 NLTSLQYLNLGSNRFTFVIPS-TFWNLKDILSFDISSN-LLDGPISLAIGNLKAVVGIDL 544
            + SLQ L++  N  ++          K +LS ++SSN L D         +K    +DL
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKV---LDL 428

Query: 545 SRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNN 595
             N +  +IP  +  L++LQ +++A N+L+      F  +TSL+ + L  N
Sbjct: 429 HSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 90.7 bits (225), Expect = 5e-19
 Identities = 40/187 (21%), Positives = 82/187 (43%), Gaps = 11/187 (5%)

Query: 73  HKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQ 132
             +   N +    +       + +S    LD S+N L+  +  +   ++ L+ L L  NQ
Sbjct: 300 SNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ 359

Query: 133 LS--GSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSL 190
           L     ++  T    S+  + +S+N +S    +  C+  + L  L +  N     +  ++
Sbjct: 360 LKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSN----ILTDTI 415

Query: 191 SKC--KQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEI-GYLQNLDVL 247
            +C   +++ L L  N +  +IPK++  L  LQ +++ +N+L   +P  I   L +L  +
Sbjct: 416 FRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKI 473

Query: 248 QLGFNNL 254
            L  N  
Sbjct: 474 WLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 90.3 bits (224), Expect = 7e-19
 Identities = 53/297 (17%), Positives = 109/297 (36%), Gaps = 16/297 (5%)

Query: 77  TLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTM---STLKVLYLMDNQL 133
            L  +  +   +I  ++     L +L L++ + + N    I  +   +T+    + + +L
Sbjct: 200 VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKL 259

Query: 134 SGSLSSFTFNTSS----ILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSS 189
            G L    F+ S      L I    + + G     I      +       +         
Sbjct: 260 QGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLC 319

Query: 190 LSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGY---LQNLDV 246
            SK      L    N L+  + +  G+LT L+ + L  N+L  E+ +       +++L  
Sbjct: 320 PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQ 378

Query: 247 LQLGFNNLTGVVPATIF-NMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSG 305
           L +  N+++            +L  + + +N L+ ++   +    P ++ L+L  N    
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL---PPRIKVLDLHSNKIK- 434

Query: 306 TIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLS 362
           +IP  +     L  L + SN            L +L+   +  N    S P + +LS
Sbjct: 435 SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 491

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  149 bits (377), Expect = 2e-39
 Identities = 50/192 (26%), Positives = 89/192 (46%), Gaps = 20/192 (10%)

Query: 732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEV--IKNIRHRNLVKIIS 789
             IG G FG V+R +   G E+A+K+F  +     +S+  E E+     +RH N++  I+
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIA 103

Query: 790 SCSNDDFKA----LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH----- 840
           + + D+       LV +Y  +GSL D L+     + +   + + +  AS L +LH     
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA--TIGYMAPD 898
                 I H DLK  N+L+ ++    ++D G+A       ++          T  YMAP 
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP- 220

Query: 899 EIFVGELSLKRW 910
           E+    +++K +
Sbjct: 221 EVLDDSINMKHF 232

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  150 bits (380), Expect = 4e-38
 Identities = 67/440 (15%), Positives = 132/440 (30%), Gaps = 74/440 (16%)

Query: 210 IPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLK 269
           I   +    V   + +           E   L N  ++    + +  +  A + +   ++
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78

Query: 270 EIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSG 329
            + L +  +   + +        ++ L +G N+     P    N   L +L +  N  S 
Sbjct: 79  LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 137

Query: 330 FIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIG 389
                  N   L    +  NNL     +            L+ L L  N L         
Sbjct: 138 LPRGIFHNTPKLTTLSMSNNNLERIEDDT-----FQATTSLQNLQLSSNRLTHV------ 186

Query: 390 NLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLA 449
                                  +  + +L   ++  N LS     T      ++ LD +
Sbjct: 187 ----------------------DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDAS 219

Query: 450 FNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTF 509
            N +   +   +     L  L L  N ++   +  L N   L  ++L  N    ++   F
Sbjct: 220 HNSIN-VVRGPVN--VELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPF 274

Query: 510 WNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLA 569
             ++                      L+    + +S N L   +    + + +L+ + L+
Sbjct: 275 VKMQ---------------------RLE---RLYISNNRLV-ALNLYGQPIPTLKVLDLS 309

Query: 570 YNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGG 629
           +N L   +  +      LE+L L +N I     +       LK L LS N          
Sbjct: 310 HNHLLH-VERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWD-CNSLRA 364

Query: 630 PFANFTAESFMGNELLCGLP 649
            F N    +    +  C + 
Sbjct: 365 LFRNVARPAVDDADQHCKID 384

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  149 bits (378), Expect = 7e-38
 Identities = 88/541 (16%), Positives = 174/541 (32%), Gaps = 66/541 (12%)

Query: 88  TIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSI 147
            I   +        + +              T++  K++   ++ +              
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR------------- 64

Query: 148 LDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLS 207
                       KLP  + +  R ++ L L +         + +    +Q+L++G+N + 
Sbjct: 65  ------------KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 112

Query: 208 GAIPKEI-GNLTVLQRISLINNKLHGEIPQEI-GYLQNLDVLQLGFNNLTGVVPATIFNM 265
             +P  +  N+ +L  + L  N L   +P+ I      L  L +  NNL  +   T    
Sbjct: 113 -YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT 170

Query: 266 STLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSN 325
           ++L+ + L +N L+  +       +P+L   N+  N       S++     +  L+   N
Sbjct: 171 TSLQNLQLSSNRLT-HVDLS---LIPSLFHANVSYNLL-----STLAIPIAVEELDASHN 221

Query: 326 SFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLP 385
           S +         L  LKL     NNLT         + L N   L  + L  N L+  + 
Sbjct: 222 SINVVRGPVNVELTILKLQH---NNLTD-------TAWLLNYPGLVEVDLSYNELEKIMY 271

Query: 386 SSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQG 445
                +   LERL I+   +   +      +  L VL L  N+L   +        +L+ 
Sbjct: 272 HPFVKMQ-RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 328

Query: 446 LDLAFNKLAGSIPDEICLLSRLNELDLNGNKISG-SISSCLGNLTSLQYLNLGSN----- 499
           L L  N +  ++         L  L L+ N     S+ +   N+      +   +     
Sbjct: 329 LYLDHNSIV-TLKLST--HHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDY 385

Query: 500 --RFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTL 557
                     +     D L   I+   +   +  A G   A   I+  ++          
Sbjct: 386 QLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGG 445

Query: 558 EGLKSLQNISLAYNRLEGPI----PESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKE 613
             L+  + +    N L   +     E       L+ L    +       +  + L+   +
Sbjct: 446 VPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSD 505

Query: 614 L 614
            
Sbjct: 506 N 506

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  113 bits (283), Expect = 5e-26
 Identities = 43/279 (15%), Positives = 95/279 (34%), Gaps = 32/279 (11%)

Query: 375 LGGNPLDGFLPSSIG------NLSLSLERLNIAFCNISGNIPKAI--GNLSNLIVLSLGG 426
           +GG       P          NL       ++     + ++        L+N  +++   
Sbjct: 1   VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60

Query: 427 NNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEI-CLLSRLNELDLNGNKISGSISSCL 485
           + +           ++++ L+L   ++   I          + +L +  N I        
Sbjct: 61  STMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF 119

Query: 486 GNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLS 545
            N+  L  L L  N  + +    F N   + +  +S+N L+           ++  + LS
Sbjct: 120 QNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS 179

Query: 546 RN----------------NLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLES 589
            N                N+S N+ +TL    +++ +  ++N +             L  
Sbjct: 180 SNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVN---VELTI 236

Query: 590 LDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRG 628
           L L +N ++            L E++LS+N+L+ +I   
Sbjct: 237 LKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYH 272

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 64.6 bits (157), Expect = 1e-10
 Identities = 50/409 (12%), Positives = 121/409 (29%), Gaps = 54/409 (13%)

Query: 74  KVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQ 132
           ++T L L   NL  T    + N   L  +DLS+N+L   I    F  M  L+ LY+ +N+
Sbjct: 233 ELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYISNNR 289

Query: 133 LSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSK 192
           L  +L+ +     ++  + LS N L                            +  +  +
Sbjct: 290 LV-ALNLYGQPIPTLKVLDLSHNHLL--------------------------HVERNQPQ 322

Query: 193 CKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFN 252
             +L+ L+L +N++   +   +     L+ ++L +N       + +   +N+    +   
Sbjct: 323 FDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDA 377

Query: 253 NLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSIT 312
           +    +   + +        L           R+   +     +     +      +   
Sbjct: 378 DQHCKIDYQLEH-------GLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTI 430

Query: 313 NASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRY 372
           N+ + +   +          +        +L       +   T E   +      + L  
Sbjct: 431 NSVQSLSHYITQQGGVPLQGNEQLEAEVNEL----RAEVQQLTNEQ--IQQEQLLQGLHA 484

Query: 373 LGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGS 432
                          +   S +L ++            +A          +        +
Sbjct: 485 EIDTNLRRYRLPKDGLARSSDNLNKVFTHLKE-----RQAFKLRETQARRTEADAKQKET 539

Query: 433 IPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSI 481
             +    +   + LD    K A    +      ++ +L+   N+   + 
Sbjct: 540 EDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQLEAKKNRNPDTR 588

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  149 bits (377), Expect = 1e-37
 Identities = 77/418 (18%), Positives = 137/418 (32%), Gaps = 83/418 (19%)

Query: 92  EIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIR 151
                +    L++  + L++ +P  +     +  L + DN L+                 
Sbjct: 35  RACLNNGNAVLNVGESGLTT-LPDCLPA--HITTLVIPDNNLT----------------- 74

Query: 152 LSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIP 211
                    LP         L+ L +  N     +P       +L        +L    P
Sbjct: 75  --------SLPALPPE----LRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL----P 117

Query: 212 KEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEI 271
                L  L    +  N+L   +P     LQ L    +  N L   +PA    +  L   
Sbjct: 118 ALPSGLCKL---WIFGNQLT-SLPVLPPGLQELS---VSDNQLA-SLPALPSELCKLW-- 167

Query: 272 FLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFI 331
             YNN L+ SLP         L+ L++  N  + ++P+  +    L  L   +N  +  +
Sbjct: 168 -AYNNQLT-SLPMLP----SGLQELSVSDNQLA-SLPTLPSE---LYKLWAYNNRLT-SL 216

Query: 332 PSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNL 391
           P+    L+ L +     N LTS               +L+ L + GN L   LP      
Sbjct: 217 PALPSGLKELIVSG---NRLTSLPVLPS---------ELKELMVSGNRLTS-LPMLPSG- 262

Query: 392 SLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLD---L 448
              L  L++    ++  +P+++ +LS+   ++L GN LS         +    G     +
Sbjct: 263 ---LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPII 318

Query: 449 AFNKLAGSIPDEICLLSRLNELDLNGNKISGSIS----SCLGNLTSLQYLNLGSNRFT 502
            F+    S P E   L       L   +             G   +    +L  +R +
Sbjct: 319 RFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  146 bits (369), Expect = 2e-36
 Identities = 74/359 (20%), Positives = 134/359 (37%), Gaps = 54/359 (15%)

Query: 153 SKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPK 212
            +  +  K+   + N    L    + E+     +P  L     +  L +  NNL+ ++P 
Sbjct: 26  GRAAVVQKMRACLNNGNAVLN---VGESGL-TTLPDCL--PAHITTLVIPDNNLT-SLPA 78

Query: 213 EIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIF 272
               L  L    +  N+L   +P     L  L +      +L  +          L +++
Sbjct: 79  LPPELRTL---EVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLW 127

Query: 273 LYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIP 332
           ++ N L+ SLP       P L+ L++  N  + ++P+  +    L  L   +N  +  +P
Sbjct: 128 IFGNQLT-SLPVLP----PGLQELSVSDNQLA-SLPALPSE---LCKLWAYNNQLT-SLP 177

Query: 333 SAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLS 392
                L+ L + D   N L S               +L  L    N L   LP+    L 
Sbjct: 178 MLPSGLQELSVSD---NQLASLPTLPS---------ELYKLWAYNNRLT-SLPALPSGL- 223

Query: 393 LSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNK 452
              + L ++   ++ ++P     L  L    + GN L+ S+P+   GL  L    +  N+
Sbjct: 224 ---KELIVSGNRLT-SLPVLPSELKEL---MVSGNRLT-SLPMLPSGLLSL---SVYRNQ 272

Query: 453 LAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWN 511
           L   +P+ +  LS    ++L GN +S      L  +TS    +    RF     S    
Sbjct: 273 LT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRE 330

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  136 bits (343), Expect = 3e-33
 Identities = 71/368 (19%), Positives = 132/368 (35%), Gaps = 60/368 (16%)

Query: 74  KVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQL 133
            +TTL +   NL  ++P     L   ++L++S N+L+S +P     +  L +       L
Sbjct: 62  HITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQLTS-LPVLPPGLLELSIFSNPLTHL 116

Query: 134 SGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKC 193
               S           + +  N+L+  LP         L+ L + +N     +P+  S  
Sbjct: 117 PALPSGLC-------KLWIFGNQLT-SLPVLPPG----LQELSVSDNQL-ASLPALPS-- 161

Query: 194 KQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNN 253
            +L +L    N L+ ++P     L  L   S+ +N+L   +P     L  L        +
Sbjct: 162 -ELCKLWAYNNQLT-SLPMLPSGLQEL---SVSDNQLA-SLPTLPSELYKLWAYNNRLTS 215

Query: 254 LTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITN 313
           L    PA       LKE+ +  N L+ SLP         L+ L +  N  + ++P   + 
Sbjct: 216 L----PALPSG---LKELIVSGNRLT-SLPV----LPSELKELMVSGNRLT-SLPMLPSG 262

Query: 314 ASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYL 373
              L+ L +  N  +  +P ++ +L +    ++  N L+  T +          +++   
Sbjct: 263 ---LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ--------ALREITSA 310

Query: 374 GLGGNPL------DGFLPSSIGNLSLSLERL---NIAFCNISGNIPKAIGNLSNLIVLSL 424
                P+          P     L L+                +     G   N    SL
Sbjct: 311 PGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSL 370

Query: 425 GGNNLSGS 432
             + LS +
Sbjct: 371 FLDRLSET 378

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  135 bits (340), Expect = 7e-33
 Identities = 76/342 (22%), Positives = 137/342 (40%), Gaps = 51/342 (14%)

Query: 280 GSLPSRIDLALP-NLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNL 338
            ++  ++   L      LN+G +  + T+P  +     +  L +  N+ +  +P+    L
Sbjct: 28  AAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPEL 83

Query: 339 RNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERL 398
           R L   ++  N LTS               +L         L   LPS +  L +   +L
Sbjct: 84  RTL---EVSGNQLTSLPVLPP------GLLELSIFSNPLTHLPA-LPSGLCKLWIFGNQL 133

Query: 399 NIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIP 458
                    ++P     L  L   S+  N L+ S+P     L KL       N+L  S+P
Sbjct: 134 T--------SLPVLPPGLQEL---SVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLP 177

Query: 459 DEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSF 518
                 S L EL ++ N+++ S+ +    L  L   N   NR T  +P+    LK     
Sbjct: 178 MLP---SGLQELSVSDNQLA-SLPTLPSELYKLWAYN---NRLT-SLPALPSGLK---EL 226

Query: 519 DISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIP 578
            +S N L   + +    LK    + +S N L+ ++P    GL SL   S+  N+L   +P
Sbjct: 227 IVSGNRLTS-LPVLPSELKE---LMVSGNRLT-SLPMLPSGLLSL---SVYRNQLTR-LP 277

Query: 579 ESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNK 620
           ES  +++S  +++L  N +S     +  +++     +    +
Sbjct: 278 ESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIR 319

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  131 bits (330), Expect = 9e-32
 Identities = 67/351 (19%), Positives = 130/351 (37%), Gaps = 51/351 (14%)

Query: 266 STLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSN 325
           +    + +  + L+ +LP  +     ++  L +  N+ + ++P+       L  LE+  N
Sbjct: 40  NGNAVLNVGESGLT-TLPDCL---PAHITTLVIPDNNLT-SLPALPPE---LRTLEVSGN 91

Query: 326 SFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLP 385
             +  +P     L  L +F     +L +                L  L + GN L   LP
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPAL------------PSGLCKLWIFGNQL-TSLP 137

Query: 386 SSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQG 445
                L    + L+++   ++ ++P     L  L       N L+ S+P+   GLQ+L  
Sbjct: 138 VLPPGL----QELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPMLPSGLQEL-- 186

Query: 446 LDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVI 505
             ++ N+LA S+P     L +L   +     +           + L+ L +  NR T  +
Sbjct: 187 -SVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALP-------SGLKELIVSGNRLT-SL 236

Query: 506 PSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQN 565
           P     LK      +S N L   + +    L +   + + RN L+  +P +L  L S   
Sbjct: 237 PVLPSELK---ELMVSGNRLTS-LPMLPSGLLS---LSVYRNQLT-RLPESLIHLSSETT 288

Query: 566 ISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNL 616
           ++L  N L     ++   +TS         +   +   +  +   L     
Sbjct: 289 VNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA 339

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  119 bits (299), Expect = 7e-28
 Identities = 63/263 (23%), Positives = 106/263 (40%), Gaps = 41/263 (15%)

Query: 365 ANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSL 424
                   L +G + L   LP  +      +  L I   N++ ++P     L  L    +
Sbjct: 37  CLNNGNAVLNVGESGL-TTLPDCLPA---HITTLVIPDNNLT-SLPALPPELRTL---EV 88

Query: 425 GGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSC 484
            GN L+ S+PV   GL +L         L         L S L +L + GN+++ S+   
Sbjct: 89  SGNQLT-SLPVLPPGLLELSIFSNPLTHLPA-------LPSGLCKLWIFGNQLT-SLPVL 139

Query: 485 LGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDL 544
              L  L   ++  N+    +P+    L         +N L   + +    L+    + +
Sbjct: 140 PPGLQEL---SVSDNQLA-SLPALPSELC---KLWAYNNQLTS-LPMLPSGLQE---LSV 188

Query: 545 SRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS 604
           S N L+ ++PT    L  L       NRL   +P      + L+ L +S N+++ S+PV 
Sbjct: 189 SDNQLA-SLPTLPSELYKL---WAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLPVL 239

Query: 605 FEKLSYLKELNLSFNKLKGEIPR 627
               S LKEL +S N+L   +P 
Sbjct: 240 ---PSELKELMVSGNRLT-SLPM 258

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  140 bits (355), Expect = 7e-37
 Identities = 55/239 (23%), Positives = 99/239 (41%), Gaps = 15/239 (6%)

Query: 384 LPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKL 443
           +     N +   +   +   ++   +     +  N+  L L GN LS           KL
Sbjct: 2   IHEIKQNGN-RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 444 QGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTF 503
           + L+L+ N L     D +  LS L  LDLN N +       L    S++ L+  +N  + 
Sbjct: 61  ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113

Query: 504 VIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSG-NIPTTLEGLKS 562
           V  S     K+I    +++N +     L  G    V  +DL  N +   N         +
Sbjct: 114 VSCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 563 LQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKL 621
           L++++L YN +   +         L++LDLS+NK++  +   F+  + +  ++L  NKL
Sbjct: 171 LEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  140 bits (355), Expect = 9e-37
 Identities = 58/323 (17%), Positives = 106/323 (32%), Gaps = 24/323 (7%)

Query: 331 IPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGN 390
           I     N    K+  +  ++L  +   L       +   ++ L L GNPL     + +  
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASL-----RQSAWNVKELDLSGNPLSQISAADLAP 56

Query: 391 LSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAF 450
            +  LE LN++   +       + +LS L  L L  N +             ++ L  A 
Sbjct: 57  FT-KLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAAN 108

Query: 451 NKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFV-IPSTF 509
           N ++  +            + L  NKI+       G  + +QYL+L  N    V      
Sbjct: 109 NNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165

Query: 510 WNLKDILSFDISSNLLDG-PISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISL 568
            +   +   ++  N +      +    LK    +DLS N L+  +    +    +  ISL
Sbjct: 166 ASSDTLEHLNLQYNFIYDVKGQVVFAKLKT---LDLSSNKLA-FMGPEFQSAAGVTWISL 221

Query: 569 AYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRG 628
             N+L   I ++     +LE  DL  N       +        +   ++   +K    + 
Sbjct: 222 RNNKLVL-IEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279

Query: 629 GPFANFTAESFMGNELLCGLPNL 651
                       G      LP  
Sbjct: 280 EEECTVPTLGHYGAYCCEDLPAP 302

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  132 bits (333), Expect = 6e-34
 Identities = 57/311 (18%), Positives = 109/311 (35%), Gaps = 21/311 (6%)

Query: 209 AIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTL 268
           AI +   N    +   + ++ L   +        N+  L L  N L+ +  A +   + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 269 KEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFS 328
           + + L +N L  +L      +L  L  L+L  N         +     +  L   +N+ S
Sbjct: 61  ELLNLSSNVLYETLDLE---SLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112

Query: 329 GFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSI 388
               S     +N+ L +   N +T                +++YL L  N +D    + +
Sbjct: 113 RVSCSRGQGKKNIYLAN---NKITMLRDL-----DEGCRSRVQYLDLKLNEIDTVNFAEL 164

Query: 389 GNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDL 448
              S +LE LN+ +  I  ++   +   + L  L L  N L+  +   F     +  + L
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221

Query: 449 AFNKLAGSIPDEICLLSRLNELDLNGNKIS-GSISSCLGNLTSLQYLNLGSNRFTFVIPS 507
             NKL   I   +     L   DL GN    G++         +Q +   + +       
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280

Query: 508 TFWNLKDILSF 518
               +  +  +
Sbjct: 281 EECTVPTLGHY 291

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  128 bits (325), Expect = 7e-33
 Identities = 58/278 (20%), Positives = 104/278 (37%), Gaps = 19/278 (6%)

Query: 89  IPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTF-NTSSI 147
           I     N +  K   ++ + L   + S   +   +K L L  N LS  +S+      + +
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKL 60

Query: 148 LDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLS 207
             + LS N L  +  +     L  L+ L L  N         L     ++ LH   NN+S
Sbjct: 61  ELLNLSSNVLY-ETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112

Query: 208 GAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIF-NMS 266
             +    G     + I L NNK+      + G    +  L L  N +  V  A +  +  
Sbjct: 113 -RVSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 267 TLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNS 326
           TL+ + L  N +   +     +    L+ L+L  N  +  +     +A+ +  + + +N 
Sbjct: 170 TLEHLNLQYNFIY-DVKG--QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225

Query: 327 FSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSL 364
               I  A+   +NL+ FD+  N     T    F  + 
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  127 bits (321), Expect = 2e-32
 Identities = 52/342 (15%), Positives = 112/342 (32%), Gaps = 51/342 (14%)

Query: 136 SLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQ 195
           ++     N +     +++ + L  +                           S       
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLK-QAL------------------------ASLRQSAWN 35

Query: 196 LQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLT 255
           ++EL L  N LS     ++   T L+ ++L +N L+ E   ++  L  L  L L  N + 
Sbjct: 36  VKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ 93

Query: 256 GVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNAS 315
                 +    +++ +   NN++S  +           + + L  N  +          S
Sbjct: 94  -----ELLVGPSIETLHAANNNIS-RVSCSR---GQGKKNIYLANNKITMLRDLDEGCRS 144

Query: 316 KLILLEMGSNSFSGF-IPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLG 374
           ++  L++  N            +   L+  ++ +N +         +       KL+ L 
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-------VKGQVVFAKLKTLD 197

Query: 375 LGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLS-GSI 433
           L  N L  F+     + +  +  +++    +   I KA+    NL    L GN    G++
Sbjct: 198 LSSNKLA-FMGPEFQSAA-GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTL 254

Query: 434 PVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGN 475
              F   Q++Q +     K    +  +      +  L   G 
Sbjct: 255 RDFFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYGA 293

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  110 bits (276), Expect = 2e-26
 Identities = 29/180 (16%), Positives = 74/180 (41%), Gaps = 11/180 (6%)

Query: 456 SIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDI 515
           +I +     +R     +  + +  +++S   +  +++ L+L  N  + +  +       +
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 516 LSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEG 575
              ++SSN+L     L + +L  +  +DL+ N +       L    S++ +  A N +  
Sbjct: 61  ELLNLSSNVLYET--LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113

Query: 576 PIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFT 635
            +          +++ L+NNKI+    +     S ++ L+L  N++   +      A+  
Sbjct: 114 -VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSD 169

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  144 bits (365), Expect = 2e-36
 Identities = 100/547 (18%), Positives = 181/547 (33%), Gaps = 88/547 (16%)

Query: 97  SSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNK 156
                +D S+  L+  +P  +      K L L  N +S                      
Sbjct: 31  ELESMVDYSNRNLTH-VPKDLPP--RTKALSLSQNSIS---------------------- 65

Query: 157 LSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEI-G 215
              +L                            +S   +L+ L L +N +  ++   +  
Sbjct: 66  ---ELR------------------------MPDISFLSELRVLRLSHNRIR-SLDFHVFL 97

Query: 216 NLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIF-NMSTLKEIFLY 274
               L+ + + +N+L   I      + +L  L L FN+   +     F N++ L  + L 
Sbjct: 98  FNQDLEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLS 154

Query: 275 NNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSIT--NASKLILLEMGSNSFSGFIP 332
                      +     +   L+L      G    S+   N + L L+   ++ FS  + 
Sbjct: 155 AAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVN 214

Query: 333 SAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLS 392
            ++  L +L+L +I  N+                   L                      
Sbjct: 215 MSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFW 274

Query: 393 LS-LERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFN 451
              +E LNI    I+  I +     S                      L+ L    +   
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYSETA-------------------LKSLMIEHVKNQ 315

Query: 452 KLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWN 511
               S      + + +N   L+ +        C  + +S  +LN   N FT  +      
Sbjct: 316 VFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCST 375

Query: 512 LKDILSFDISSNLLD--GPISLAIGNLKAVVGIDLSRNNL-SGNIPTTLEGLKSLQNISL 568
           LK + +  +  N L     ++L   N+ ++  +D+S N+L S     T    +S+  ++L
Sbjct: 376 LKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNL 435

Query: 569 AYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRG 628
           + N L G +         ++ LDL NN+I  SIP     L  L+ELN++ N+LK  +P  
Sbjct: 436 SSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPD- 490

Query: 629 GPFANFT 635
           G F   T
Sbjct: 491 GVFDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  138 bits (350), Expect = 2e-34
 Identities = 95/548 (17%), Positives = 192/548 (35%), Gaps = 68/548 (12%)

Query: 59  SICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIF 118
           ++   +G +   ++   + ++ S+ NL   +P ++      K+L LS N +S      I 
Sbjct: 17  ALALIVGSMTPFSNELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDIS 73

Query: 119 TMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLR 178
            +S L+VL L  N++                           L  ++    + L++L + 
Sbjct: 74  FLSELRVLRLSHNRIR-------------------------SLDFHVFLFNQDLEYLDVS 108

Query: 179 ENMFYGKIPSSLSKCKQLQELHLGYNNL-SGAIPKEIGNLTVLQRISLINNKLHGEIPQE 237
            N     I         L+ L L +N+     + KE GNLT L  + L   K        
Sbjct: 109 HNRL-QNISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLP 165

Query: 238 IGYLQ-NLDVLQLGFNNLTGVVPATIFNMSTLK-EIFLYNNSLSGSLPSRIDLALPNLEF 295
           + +L  +  +L L   ++ G    ++   +T    +  + NSL     +    AL +L+ 
Sbjct: 166 VAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQL 225

Query: 296 LNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSST 355
            N+ +N                        +    +       R   L ++   ++ ++ 
Sbjct: 226 SNIKLN----------------------DENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263

Query: 356 PELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSL----SLERLNIAFCNISGNIPK 411
                L      + + YL +    +   +       S     SL   ++       +   
Sbjct: 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEA 323

Query: 412 AIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELD 471
                + + +  L  ++      V          L+   N    S+      L RL  L 
Sbjct: 324 LYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLI 383

Query: 472 LNGNKIS--GSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSF-DISSN-LLDG 527
           L  N +     ++    N++SL+ L++  N              + +   ++SSN L   
Sbjct: 384 LQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443

Query: 528 PISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSL 587
                   +K    +DL  N +  +IP  +  L++LQ +++A N+L+      F  +TSL
Sbjct: 444 VFRCLPPKVKV---LDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSL 499

Query: 588 ESLDLSNN 595
           + + L +N
Sbjct: 500 QYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  114 bits (286), Expect = 2e-26
 Identities = 78/440 (17%), Positives = 139/440 (31%), Gaps = 47/440 (10%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQL- 133
             L++S   LQ  I      ++SL+ LDLS N          F  ++ L  L L   +  
Sbjct: 103 EYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR 159

Query: 134 SGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPS---SL 190
              L        S + + L    + G   E++      + HL    N  +    +   + 
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNA 219

Query: 191 SKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDV---- 246
               QL  + L   N    +            +++    +       +   Q        
Sbjct: 220 LGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279

Query: 247 -LQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSG----SLPSRIDLALPNLEFLNLGIN 301
            L +    +T  +    F  S      L    +           +      +    L I+
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339

Query: 302 SFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFL 361
                      + S    L    N F+  +      L+ L+   +  N L +        
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMT 399

Query: 362 SSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIV 421
            ++     L  L +  N L+          + S+  LN++   ++G++ + +     + V
Sbjct: 400 KNM---SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKV 454

Query: 422 LSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSI 481
           L L  N +  SIP     LQ LQ L++A N+L  S+PD +                    
Sbjct: 455 LDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGV-------------------- 492

Query: 482 SSCLGNLTSLQYLNLGSNRF 501
                 LTSLQY+ L  N +
Sbjct: 493 ---FDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 97.2 bits (242), Expect = 5e-21
 Identities = 66/407 (16%), Positives = 129/407 (31%), Gaps = 52/407 (12%)

Query: 243 NLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINS 302
               L L  N+++ +    I  +S L+ + L +N +  SL   + L   +LE+L++  N 
Sbjct: 53  RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNR 111

Query: 303 FSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLS 362
               I                              + +L+  D+ FN+       L    
Sbjct: 112 LQ-NISC--------------------------CPMASLRHLDLSFNDFDV----LPVCK 140

Query: 363 SLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVL 422
              N  KL +LGL            + +L LS   L++   +I G   +++    N  VL
Sbjct: 141 EFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVL 199

Query: 423 SLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSIS 482
            L  +  S         +  L  L L+  KL              N+ +        S  
Sbjct: 200 HLVFHPNSLFSVQVNMSVNALGHLQLSNIKL--------------NDENCQRLMTFLSEL 245

Query: 483 SCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGN-----LK 537
           +    L ++   ++ +     V    F+  + +   +I +  +   I           LK
Sbjct: 246 TRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALK 305

Query: 538 AVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKI 597
           +++   +       +          +    L+ +           + +S   L+ + N  
Sbjct: 306 SLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF 365

Query: 598 SGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNEL 644
           + S+      L  L+ L L  N LK          N ++   +   L
Sbjct: 366 TDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSL 412

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 84.2 bits (208), Expect = 8e-17
 Identities = 50/326 (15%), Positives = 108/326 (33%), Gaps = 28/326 (8%)

Query: 74  KVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQL 133
             T L+L              ++++L  L LS+ KL+      + T  +          +
Sbjct: 195 NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNV 254

Query: 134 SGSLSSFTFN----------TSSILDIRLSKNKLSGKLPENICNH----LRYLKHLFLRE 179
           +      T+              +  + +    ++ ++      +    L+ L    ++ 
Sbjct: 255 TLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKN 314

Query: 180 NMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIG 239
            +F     +  S   ++    L  ++          + +    ++   N     + Q   
Sbjct: 315 QVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCS 374

Query: 240 YLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLAL----PNLEF 295
            L+ L  L L  N L             +  +   + SL+ SL S           ++  
Sbjct: 375 TLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLN-SLNSHAYDRTCAWAESILV 432

Query: 296 LNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSST 355
           LNL  N  +G++   +    K+ +L++ +N     IP  + +L+ L+  ++  N L S  
Sbjct: 433 LNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVP 489

Query: 356 PELGFLSSLANCKKLRYLGLGGNPLD 381
                         L+Y+ L  NP D
Sbjct: 490 D-----GVFDRLTSLQYIWLHDNPWD 510

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 76.1 bits (187), Expect = 3e-14
 Identities = 50/300 (16%), Positives = 105/300 (35%), Gaps = 16/300 (5%)

Query: 78  LNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT---MSTLKVLYLMDNQLS 134
           LN  +     T   E+    +L ++ L H + +      +F       ++ L + +  ++
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT 289

Query: 135 GSLS----SFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSL 190
             +     +++      L I   KN++     E + +    +    L  +          
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349

Query: 191 SKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLG 250
                   L+   N  + ++ +    L  LQ + L  N L     +     +N+  L+  
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETL 408

Query: 251 FNNLT----GVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGT 306
             +L          T     ++  + L +N L+GS+   +    P ++ L+L  N    +
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL---PPKVKVLDLHNNRIM-S 464

Query: 307 IPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLAN 366
           IP  +T+   L  L + SN            L +L+   +  N    + P + +LS   N
Sbjct: 465 IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLSEWIN 524

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  141 bits (357), Expect = 7e-36
 Identities = 82/400 (20%), Positives = 147/400 (36%), Gaps = 39/400 (9%)

Query: 145 SSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPS-SLSKCKQLQELHLGY 203
           + +  + LS N ++ +L E   + L+ L+ L + +      I + +      L  L L Y
Sbjct: 30  AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88

Query: 204 NNLSGAIPKEI-GNLTVLQRISLINNKLHG-EIPQEI-GYLQNLDVLQLGFNNLTGVVPA 260
           N     +       L  L+ ++L    L G  +       L +L++L L  NN+  + PA
Sbjct: 89  NQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA 147

Query: 261 TIF-NMSTLKEIFLYNNSLSGSLPSRI--DLALPNLEFLNLGINSFSGTIPSSITNASKL 317
           + F NM     + L  N +  S+      +    +   L L   +               
Sbjct: 148 SFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSIT--------------- 191

Query: 318 ILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGG 377
            L +M                 ++   D+  N    S  +  F +      +   L    
Sbjct: 192 -LQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250

Query: 378 NPLDGFLPSSIGNLS----LSLERLNIAFCNISGN----IPKAI-GNLSNLIVLSLGGNN 428
           N    F  ++  +        LE   +  C++S +    + K++  + ++L  L+L  N 
Sbjct: 251 NMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNE 310

Query: 429 LSGSIPV-TFGGLQKLQGLDLAFNKLAGSIPDEICL-LSRLNELDLNGNKISGSISSCLG 486
           ++  I    F GL  L  L+L+ N L GSI   +   L +L  LDL+ N I         
Sbjct: 311 IN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFL 368

Query: 487 NLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLD 526
            L +L+ L L +N+   V    F  L  +    + +N  D
Sbjct: 369 GLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  138 bits (349), Expect = 7e-35
 Identities = 62/397 (15%), Positives = 144/397 (36%), Gaps = 42/397 (10%)

Query: 243 NLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINS 302
           +++ + L  N++  +   +   +  L+ + +   +    + +     L +L  L L  N 
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 303 FSGTIPSSI-TNASKLILLEMGSNSF-SGFIPSAI-GNLRNLKLFDIFFNNLTSSTPELG 359
           F   + +      + L +L +   +     +       L +L++  +  NN+    P   
Sbjct: 91  FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA-S 148

Query: 360 FLSSLANCKKLRYLGLGGNPLDGFLPSSIGNL-SLSLERLNIAFCNISGNIPKAIGNLSN 418
           F  ++   ++   L L  N +       + N        L                 LS+
Sbjct: 149 FFLNM---RRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR----------------LSS 189

Query: 419 LIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNEL-----DLN 473
           + +  +    L             +  LDL+ N    S+           ++       +
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249

Query: 474 GNKISGSISSCLGNL----------TSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSN 523
            N  S    +   +           + ++  +L  ++   ++ S F +  D+    ++ N
Sbjct: 250 YNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQN 309

Query: 524 LLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGN 583
            ++     A   L  ++ ++LS+N L        E L  L+ + L+YN +     +SF  
Sbjct: 310 EINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLG 369

Query: 584 MTSLESLDLSNNKISGSIPVS-FEKLSYLKELNLSFN 619
           + +L+ L L  N++  S+P   F++L+ L+++ L  N
Sbjct: 370 LPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  127 bits (321), Expect = 3e-31
 Identities = 73/353 (20%), Positives = 131/353 (37%), Gaps = 44/353 (12%)

Query: 306 TIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLA 365
            +P+ +        +++  NS +    ++   L++L+   +             F     
Sbjct: 27  ELPAHVNY------VDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTF----R 76

Query: 366 NCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNI-SGNIPKAI-GNLSNLIVLS 423
               L  L L  N        +   L+ +LE L +  CN+    +       L++L +L 
Sbjct: 77  GLSSLIILKLDYNQFLQLETGAFNGLA-NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLV 135

Query: 424 LGGNNLSGSIPVT-FGGLQKLQGLDLAFNKLAGSIPDEICL-----------LSRLNELD 471
           L  NN+    P + F  +++   LDL FNK+  SI +E  L           LS +   D
Sbjct: 136 LRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQD 194

Query: 472 LNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSF------------- 518
           +N   +           TS+  L+L  N F   +   F++                    
Sbjct: 195 MNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS 254

Query: 519 DISSNLLDGPISLAIGNLKA--VVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGP 576
                    P +     L+A  V   DLS++ +   + +       L+ ++LA N +   
Sbjct: 255 SFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKI 314

Query: 577 IPESFGNMTSLESLDLSNNKISGSIPV-SFEKLSYLKELNLSFNKLKGEIPRG 628
              +F  +T L  L+LS N +  SI    FE L  L+ L+LS+N ++  +   
Sbjct: 315 DDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQ 365

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  100 bits (251), Expect = 2e-22
 Identities = 53/264 (20%), Positives = 95/264 (35%), Gaps = 23/264 (8%)

Query: 386 SSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQ 444
             +  L   +  ++++  +I+     +   L +L  L +        I   TF GL  L 
Sbjct: 23  HQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82

Query: 445 GLDLAFNKLAGSIPDEICL-LSRLNELDLNGNKISGSI--SSCLGNLTSLQYLNLGSNRF 501
            L L +N+    +       L+ L  L L    + G++   +    LTSL+ L L  N  
Sbjct: 83  ILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141

Query: 502 TFVIPST-FWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGL 560
             + P++ F N++     D++ N +    S+   +L    G   +   LS          
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKVK---SICEEDLLNFQGKHFTLLRLSSI-------- 190

Query: 561 KSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKL---SYLKELNLS 617
                  +    L      +    TS+ +LDLS N    S+   F      + ++ L LS
Sbjct: 191 ---TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS 247

Query: 618 FNKLKGEIPRGGPFANFTAESFMG 641
            +   G       F +    +F G
Sbjct: 248 NSYNMGSSFGHTNFKDPDNFTFKG 271

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  135 bits (341), Expect = 7e-35
 Identities = 75/364 (20%), Positives = 125/364 (34%), Gaps = 77/364 (21%)

Query: 268 LKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSF 327
           L+ +   +  L   +P  +    P+   L+L  N  +        N   L  L + +N  
Sbjct: 33  LRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 328 SGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSS 387
           S   P A   L  L+   +  N L                            L   +P  
Sbjct: 89  SKISPGAFAPLVKLERLYLSKNQLKE--------------------------LPEKMPK- 121

Query: 388 IGNLSLSLERLNIAFCNISGNIPKAI-GNLSNLIVLSLGGNNL-SGSIPV-TFGGLQKLQ 444
                 +L+ L +    I+  + K++   L+ +IV+ LG N L S  I    F G++KL 
Sbjct: 122 ------TLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS 174

Query: 445 GLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFV 504
            + +A   +  +IP    L   L EL L+GNKI+   ++ L  L +L  L L  N  + V
Sbjct: 175 YIRIADTNIT-TIPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 231

Query: 505 IPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQ 564
              +  N           +L +               + L+ N L   +P  L   K +Q
Sbjct: 232 DNGSLANT---------PHLRE---------------LHLNNNKLV-KVPGGLADHKYIQ 266

Query: 565 NISLAYNRLEG------PIPESFGNMTSLESLDLSNNKISGSI--PVSFEKLSYLKELNL 616
            + L  N +          P       S   + L +N +      P +F  +     + L
Sbjct: 267 VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 326

Query: 617 SFNK 620
              K
Sbjct: 327 GNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  126 bits (319), Expect = 6e-32
 Identities = 53/270 (19%), Positives = 100/270 (37%), Gaps = 21/270 (7%)

Query: 370 LRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNL 429
              L L  N +         NL  +L  L +    IS   P A   L  L  L L  N L
Sbjct: 54  TALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112

Query: 430 SGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEI-CLLSRLNELDLNGNKISGSI--SSCLG 486
              +P      + LQ L +  N++   +   +   L+++  ++L  N +  S   +    
Sbjct: 113 K-ELP--EKMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168

Query: 487 NLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSR 546
            +  L Y+ +     T +      +L       +  N +    + ++  L  +  + LS 
Sbjct: 169 GMKKLSYIRIADTNITTIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNNLAKLGLSF 225

Query: 547 NNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS-- 604
           N++S     +L     L+ + L  N+L   +P    +   ++ + L NN IS +I  +  
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS-AIGSNDF 283

Query: 605 -----FEKLSYLKELNLSFNKLK-GEIPRG 628
                  K +    ++L  N ++  EI   
Sbjct: 284 CPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  121 bits (306), Expect = 3e-30
 Identities = 63/278 (22%), Positives = 103/278 (37%), Gaps = 43/278 (15%)

Query: 390 NLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLA 449
           +L      L++    I+        NL NL  L L  N +S   P  F  L KL+ L L+
Sbjct: 49  DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108

Query: 450 FNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTF 509
            N+L   +P++  +   L EL ++ N+I+    S    L  +  + LG+N          
Sbjct: 109 KNQLK-ELPEK--MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK------- 158

Query: 510 WNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLA 569
                  S  I +    G        +K +  I ++  N++  IP  L    SL  + L 
Sbjct: 159 -------SSGIENGAFQG--------MKKLSYIRIADTNIT-TIPQGL--PPSLTELHLD 200

Query: 570 YNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRG- 628
            N++      S   + +L  L LS N IS     S     +L+EL+L+ NKL  ++P G 
Sbjct: 201 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259

Query: 629 -------------GPFANFTAESFMGNELLCGLPNLQV 653
                           +   +  F          +   
Sbjct: 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 297

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  120 bits (303), Expect = 8e-30
 Identities = 72/380 (18%), Positives = 127/380 (33%), Gaps = 85/380 (22%)

Query: 220 LQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLS 279
           L+ +   +  L  ++P+++    +  +L L  N +T +      N+  L  + L NN +S
Sbjct: 33  LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89

Query: 280 GSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLR 339
             +       L  LE L L  N     +P  +     L  L +  N  +    S    L 
Sbjct: 90  -KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLN 145

Query: 340 NLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLN 399
            + + ++  N L SS  E G   +    KKL Y+ +    +                   
Sbjct: 146 QMIVVELGTNPLKSSGIENG---AFQGMKKLSYIRIADTNIT------------------ 184

Query: 400 IAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPD 459
                    IP+  G   +L  L L GN ++     +  GL  L  L L+FN ++ ++ +
Sbjct: 185 --------TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDN 233

Query: 460 EICL-LSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSF 518
                   L EL LN NK+   +   L +   +Q + L +N  + +  + F         
Sbjct: 234 GSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP------- 285

Query: 519 DISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPI- 577
                                              P       S   +SL  N ++    
Sbjct: 286 -----------------------------------PGYNTKKASYSGVSLFSNPVQYWEI 310

Query: 578 -PESFGNMTSLESLDLSNNK 596
            P +F  +    ++ L N K
Sbjct: 311 QPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  113 bits (286), Expect = 1e-27
 Identities = 66/309 (21%), Positives = 121/309 (39%), Gaps = 38/309 (12%)

Query: 75  VTTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQ 132
              L+L +  +   I      NL +L +L L +NK+S  I    F  +  L+ LYL  NQ
Sbjct: 54  TALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLSKNQ 111

Query: 133 LSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKI--PSSL 190
           L   L        ++ ++R+ +N+++ K+ +++ N L  +  + L  N          + 
Sbjct: 112 LK-ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167

Query: 191 SKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEI-GYLQNLDVLQL 249
              K+L  + +   N++  IP+  G    L  + L  NK+  ++       L NL  L L
Sbjct: 168 QGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGL 223

Query: 250 GFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPS 309
            FN+++ V   ++ N   L+E+ L NN L   +P  +      ++ + L  N+ S     
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA-DHKYIQVVYLHNNNIS----- 276

Query: 310 SITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKK 369
                       +GSN F    P       +     +F N +     +      +     
Sbjct: 277 -----------AIGSNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV---YV 320

Query: 370 LRYLGLGGN 378
              + LG  
Sbjct: 321 RAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 36/169 (21%), Positives = 71/169 (42%), Gaps = 17/169 (10%)

Query: 71  NSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLM 129
              K++ + ++  N+  TIP  +    SL  L L  NK++  + ++    ++ L  L L 
Sbjct: 169 GMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLS 224

Query: 130 DNQLSGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYG---- 184
            N +S ++ + +  NT  + ++ L+ NKL  K+P  +    +Y++ ++L  N        
Sbjct: 225 FNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGL-ADHKYIQVVYLHNNNISAIGSN 281

Query: 185 --KIPSSLSKCKQLQELHLGYNNLS-GAIPKEI-GNLTVLQRISLINNK 229
               P   +K      + L  N +    I       + V   + L N K
Sbjct: 282 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 29/89 (32%), Positives = 41/89 (46%), Gaps = 4/89 (4%)

Query: 542 IDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSI 601
           +  S   L   +P  L        + L  N++       F N+ +L +L L NNKIS   
Sbjct: 36  VQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 92

Query: 602 PVSFEKLSYLKELNLSFNKLKGEIPRGGP 630
           P +F  L  L+ L LS N+LK E+P   P
Sbjct: 93  PGAFAPLVKLERLYLSKNQLK-ELPEKMP 120

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  129 bits (326), Expect = 7e-33
 Identities = 58/266 (21%), Positives = 91/266 (34%), Gaps = 22/266 (8%)

Query: 390 NLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLA 449
            +S     L++   +IS         L +L  L L  N +S      F  L+KLQ L ++
Sbjct: 51  EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110

Query: 450 FNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVI--PS 507
            N L   IP    L S L EL ++ N+I          L ++  + +G N        P 
Sbjct: 111 KNHLV-EIPPN--LPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167

Query: 508 TFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPT-TLEGLKSLQNI 566
            F  LK +    IS   L     +     + +  + L  N +   I    L     L  +
Sbjct: 168 AFDGLK-LNYLRISEAKLT---GIPKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRL 222

Query: 567 SLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIP 626
            L +N++      S   + +L  L L NNK+S  +P     L  L+ + L  N +     
Sbjct: 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT---- 277

Query: 627 RGGPFANFTAESFMGNELLCGLPNLQ 652
                       F             
Sbjct: 278 ------KVGVNDFCPVGFGVKRAYYN 297

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  125 bits (317), Expect = 1e-31
 Identities = 80/363 (22%), Positives = 117/363 (32%), Gaps = 76/363 (20%)

Query: 268 LKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSF 327
           L+ +   +  L  ++P  I    P+   L+L  N  S            L  L + +N  
Sbjct: 35  LRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 328 SGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSS 387
           S     A   LR L+   I  N+L    P L           L  L +  N +       
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHLVEIPPNL-P-------SSLVELRIHDNRI-----RK 137

Query: 388 IGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSI--PVTFGGLQKLQG 445
           +     S                     L N+  + +GGN L  S   P  F GL KL  
Sbjct: 138 VPKGVFS--------------------GLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNY 176

Query: 446 LDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVI 505
           L ++  KL   IP +  L   LNEL L+ NKI       L   + L  L LG N+   + 
Sbjct: 177 LRISEAKLT-GIPKD--LPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIE 233

Query: 506 PSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQN 565
             +   L           L +               + L  N LS  +P  L  LK LQ 
Sbjct: 234 NGSLSFL---------PTLRE---------------LHLDNNKLS-RVPAGLPDLKLLQV 268

Query: 566 ISLAYNRLEGPIPESFGNM------TSLESLDLSNNKISGSI--PVSFEKLSYLKELNLS 617
           + L  N +       F  +           + L NN +      P +F  ++    +   
Sbjct: 269 VYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG 328

Query: 618 FNK 620
             K
Sbjct: 329 NYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  115 bits (290), Expect = 4e-28
 Identities = 50/269 (18%), Positives = 95/269 (35%), Gaps = 20/269 (7%)

Query: 370 LRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNL 429
              L L  N +          L   L  L +    IS    KA   L  L  L +  N+L
Sbjct: 56  TTLLDLQNNDISELRKDDFKGLQ-HLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114

Query: 430 SGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICL-LSRLNELDLNGNKI-SGSISSCLGN 487
              IP        L  L +  N++   +P  +   L  +N +++ GN + +        +
Sbjct: 115 V-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170

Query: 488 LTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRN 547
              L YL +   + T +       L ++    +  N +       +     +  + L  N
Sbjct: 171 GLKLNYLRISEAKLTGIPKDLPETLNEL---HLDHNKIQAIELEDLLRYSKLYRLGLGHN 227

Query: 548 NLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS--- 604
            +      +L  L +L+ + L  N+L   +P    ++  L+ + L  N I+  + V+   
Sbjct: 228 QIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFC 285

Query: 605 ----FEKLSYLKELNLSFNKLK-GEIPRG 628
                 K +Y   ++L  N +   E+   
Sbjct: 286 PVGFGVKRAYYNGISLFNNPVPYWEVQPA 314

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  108 bits (272), Expect = 9e-26
 Identities = 58/281 (20%), Positives = 117/281 (41%), Gaps = 26/281 (9%)

Query: 75  VTTLNLSSFNLQGTIPPE-IANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQ 132
            T L+L + ++   +  +    L  L +L L +NK+S  I    F+ +  L+ LY+  N 
Sbjct: 56  TTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKNH 113

Query: 133 LSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLREN-MFYGKIPSSLS 191
           L   +       SS++++R+  N++  K+P+ + + LR +  + +  N +          
Sbjct: 114 LV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF 169

Query: 192 KCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEI-GYLQNLDVLQLG 250
              +L  L +    L+  IPK       L  + L +NK+   I  E       L  L LG
Sbjct: 170 DGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLG 225

Query: 251 FNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSS 310
            N +  +   ++  + TL+E+ L NN LS  +P+ +   L  L+ + L  N+ +  +  +
Sbjct: 226 HNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLP-DLKLLQVVYLHTNNIT-KVGVN 282

Query: 311 I-------TNASKLILLEMGSN--SFSGFIPSAIGNLRNLK 342
                      +    + + +N   +    P+    + +  
Sbjct: 283 DFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRL 323

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  105 bits (264), Expect = 1e-24
 Identities = 56/312 (17%), Positives = 116/312 (37%), Gaps = 26/312 (8%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQLS 134
             +  S   L+  +P EI+       LDL +N +S  +    F  +  L  L L++N++S
Sbjct: 36  RVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNKIS 91

Query: 135 GSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKC 193
             +    F     +  + +SKN L  ++P N+      L  L + +N          S  
Sbjct: 92  -KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL---PSSLVELRIHDNRIRKVPKGVFSGL 146

Query: 194 KQLQELHLGYNNL-SGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFN 252
           + +  + +G N L +        +   L  + +   KL   IP+++   + L+ L L  N
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHN 203

Query: 253 NLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSIT 312
            +  +    +   S L  + L +N +   + +     LP L  L+L  N  S  +P+ + 
Sbjct: 204 KIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLP 261

Query: 313 NASKLILLEMGSNSFSGFIPSAIGNLR------NLKLFDIFFNNLTSSTPELGFLSSLAN 366
           +   L ++ + +N+ +    +    +             +F N +     +      +  
Sbjct: 262 DLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCV-- 319

Query: 367 CKKLRYLGLGGN 378
                 +  G  
Sbjct: 320 -TDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 37/167 (22%), Positives = 65/167 (38%), Gaps = 19/167 (11%)

Query: 74  KVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQ 132
           K+  L +S   L   IP ++    +L  L L HNK+ + I        S L  L L  NQ
Sbjct: 173 KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQ 228

Query: 133 LSGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSS-- 189
           +   + + +     ++ ++ L  NKLS ++P  +   L+ L+ ++L  N    K+  +  
Sbjct: 229 IR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGL-PDLKLLQVVYLHTNNI-TKVGVNDF 284

Query: 190 -----LSKCKQLQELHLGYNNLS-GAIPKEI-GNLTVLQRISLINNK 229
                  K      + L  N +    +       +T    I   N K
Sbjct: 285 CPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 25/89 (28%), Positives = 37/89 (41%), Gaps = 4/89 (4%)

Query: 542 IDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSI 601
           +  S   L   +P  +        + L  N +     + F  +  L +L L NNKIS   
Sbjct: 38  VQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIH 94

Query: 602 PVSFEKLSYLKELNLSFNKLKGEIPRGGP 630
             +F  L  L++L +S N L  EIP   P
Sbjct: 95  EKAFSPLRKLQKLYISKNHLV-EIPPNLP 122

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  126 bits (319), Expect = 3e-32
 Identities = 57/238 (23%), Positives = 94/238 (39%), Gaps = 8/238 (3%)

Query: 390 NLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLS--GSIPVTFGGLQKLQGLD 447
            +  S  RL +    +          L+ L  LSL  N LS  G    +  G   L+ LD
Sbjct: 25  GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84

Query: 448 LAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSC--LGNLTSLQYLNLGSNRFTFVI 505
           L+FN +  ++      L +L  LD   + +   +S      +L +L YL++         
Sbjct: 85  LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAF 142

Query: 506 PSTFWNLKDILSFDISSN-LLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQ 564
              F  L  +    ++ N   +  +      L+ +  +DLS+  L    PT    L SLQ
Sbjct: 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 202

Query: 565 NISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKL-SYLKELNLSFNKL 621
            +++++N         +  + SL+ LD S N I  S     +   S L  LNL+ N  
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  119 bits (300), Expect = 1e-29
 Identities = 51/235 (21%), Positives = 99/235 (42%), Gaps = 9/235 (3%)

Query: 370 LRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNIS--GNIPKAIGNLSNLIVLSLGGN 427
              L L  N L          L+  L +L+++   +S  G   ++    ++L  L L  N
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLT-QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88

Query: 428 NLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICL--LSRLNELDLNGNKISGSISSCL 485
            +  ++   F GL++L+ LD   + L   + +      L  L  LD++      + +   
Sbjct: 89  GVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 146

Query: 486 GNLTSLQYLNLGSNRF-TFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDL 544
             L+SL+ L +  N F    +P  F  L+++   D+S   L+     A  +L ++  +++
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 206

Query: 545 SRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNM-TSLESLDLSNNKIS 598
           S NN         + L SLQ +  + N +     +   +  +SL  L+L+ N  +
Sbjct: 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  113 bits (284), Expect = 1e-27
 Identities = 64/279 (22%), Positives = 103/279 (36%), Gaps = 38/279 (13%)

Query: 252 NNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSI 311
             LT  VP  I   S+   + L +N L  SLP  +   L  L  L+L  N          
Sbjct: 17  KGLT-SVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSN---------- 62

Query: 312 TNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLR 371
                L      S S  G          +LK  D+ FN + + +      S+    ++L 
Sbjct: 63  ----GLSFKGCCSQSDFG--------TTSLKYLDLSFNGVITMS------SNFLGLEQLE 104

Query: 372 YLGLGGNPLDGFLPSSI-GNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLS 430
           +L    + L      S+  +L  +L  L+I+  +           LS+L VL + GN+  
Sbjct: 105 HLDFQHSNLKQMSEFSVFLSLR-NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163

Query: 431 GSI-PVTFGGLQKLQGLDLAFNKLAGSIPDEI-CLLSRLNELDLNGNKISGSISSCLGNL 488
            +  P  F  L+ L  LDL+  +L   +       LS L  L+++ N      +     L
Sbjct: 164 ENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 222

Query: 489 TSLQYLNLGSNRFTFVIPSTFWNLKDILSF-DISSNLLD 526
            SLQ L+   N           +    L+F +++ N   
Sbjct: 223 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  108 bits (273), Expect = 3e-26
 Identities = 62/261 (23%), Positives = 107/261 (40%), Gaps = 17/261 (6%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQLS 134
           T +  +S  L  ++P  I   SS   L+L  NKL S +P  +F  ++ L  L L  N LS
Sbjct: 10  TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSSNGLS 65

Query: 135 -GSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSL-S 191
                S +   T+S+  + LS N +   +  N    L  L+HL  + +        S+  
Sbjct: 66  FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNF-LGLEQLEHLDFQHSNLKQMSEFSVFL 123

Query: 192 KCKQLQELHLGYNNLSGAIPKEI-GNLTVLQRISLINNKLHGEIPQEI-GYLQNLDVLQL 249
             + L  L + + +        I   L+ L+ + +  N        +I   L+NL  L L
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182

Query: 250 GFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPS 309
               L  + P    ++S+L+ + + +N+   SL +     L +L+ L+  +N    T   
Sbjct: 183 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKK 240

Query: 310 SI--TNASKLILLEMGSNSFS 328
                  S L  L +  N F+
Sbjct: 241 QELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  108 bits (273), Expect = 4e-26
 Identities = 58/287 (20%), Positives = 99/287 (34%), Gaps = 36/287 (12%)

Query: 98  SLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKL 157
           S   +  +   L+S +P+ I +  +   L L  N+L  SL    F+              
Sbjct: 8   SGTEIRCNSKGLTS-VPTGIPS--SATRLELESNKLQ-SLPHGVFD-------------- 49

Query: 158 SGKLPENICNHLRYLKHLFLRENMFYGK--IPSSLSKCKQLQELHLGYNNLSGAIPKEIG 215
                      L  L  L L  N    K     S      L+ L L +N +   +     
Sbjct: 50  ----------KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFL 98

Query: 216 NLTVLQRISLINNKLHGEIPQEI-GYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLY 274
            L  L+ +   ++ L       +   L+NL  L +   +           +S+L+ + + 
Sbjct: 99  GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 158

Query: 275 NNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSA 334
            NS   +    I   L NL FL+L         P++  + S L +L M  N+F       
Sbjct: 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 218

Query: 335 IGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLD 381
              L +L++ D   N++ +S  +   L        L +L L  N   
Sbjct: 219 YKCLNSLQVLDYSLNHIMTSKKQE--LQHFP--SSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 90.1 bits (224), Expect = 9e-20
 Identities = 37/213 (17%), Positives = 67/213 (31%), Gaps = 31/213 (14%)

Query: 71  NSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLM 129
            +  +  L+LS   +  T+      L  L+ LD  H+ L      S+F  +  L  L + 
Sbjct: 76  GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 134

Query: 130 DNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPS- 188
                                              I N L  L+ L +  N F       
Sbjct: 135 HTHTR-------------------------VAFNGIFNGLSSLEVLKMAGNSFQENFLPD 169

Query: 189 SLSKCKQLQELHLGYNNLSGAIPKEI-GNLTVLQRISLINNKLHGEIPQEIGYLQNLDVL 247
             ++ + L  L L    L   +      +L+ LQ +++ +N            L +L VL
Sbjct: 170 IFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 228

Query: 248 QLGFNNLTGVVPATIFNMST-LKEIFLYNNSLS 279
               N++       + +  + L  + L  N  +
Sbjct: 229 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  126 bits (319), Expect = 5e-31
 Identities = 62/243 (25%), Positives = 103/243 (42%), Gaps = 12/243 (4%)

Query: 409 IPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEI-CLLSRL 467
           +P+ I   SN   L+L  NN+      TF  L  L+ L L  N +   I       L+ L
Sbjct: 69  VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASL 125

Query: 468 NELDLNGNKISGSISS-CLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISS-NLL 525
           N L+L  N ++  I S     L+ L+ L L +N    +    F  +  ++  D+     L
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKL 184

Query: 526 DGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMT 585
           +     A   L  +  ++L   N+  ++P  L  L  L+ + ++ N      P SF  ++
Sbjct: 185 EYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLS 242

Query: 586 SLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRG--GPFANFTAESFMGNE 643
           SL+ L + N+++S     +F+ L+ L ELNL+ N L   +P     P           N 
Sbjct: 243 SLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNP 301

Query: 644 LLC 646
             C
Sbjct: 302 WNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  115 bits (291), Expect = 2e-27
 Identities = 61/261 (23%), Positives = 118/261 (45%), Gaps = 16/261 (6%)

Query: 72  SHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMD 130
           S++ + +  +   L   +P  I   S+ + L+L  N +   I +  F  +  L+VL L  
Sbjct: 53  SNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQM-IQADTFRHLHHLEVLQLGR 108

Query: 131 NQLSGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPS- 188
           N +   +    F   +S+  + L  N L+  +P     +L  L+ L+LR N     IPS 
Sbjct: 109 NSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI-ESIPSY 165

Query: 189 SLSKCKQLQELHLGYNNLSGAIPKEI-GNLTVLQRISLINNKLHGEIPQEIGYLQNLDVL 247
           + ++   L  L LG       I +     L  L+ ++L    +  ++P  +  L  L+ L
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEEL 223

Query: 248 QLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTI 307
           ++  N+   + P +   +S+LK++++ N+ +S  +       L +L  LNL  N+ S ++
Sbjct: 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SL 281

Query: 308 PSSI-TNASKLILLEMGSNSF 327
           P  + T    L+ L +  N +
Sbjct: 282 PHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  104 bits (262), Expect = 7e-24
 Identities = 66/292 (22%), Positives = 106/292 (36%), Gaps = 62/292 (21%)

Query: 186 IPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEI-GYLQNL 244
           +P  +      + L+L  NN+         +L  L+ + L  N +  +I       L +L
Sbjct: 69  VPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASL 125

Query: 245 DVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFS 304
           + L+L  N LT +       +S L+E++L NN +  S+PS     +P+L  L+LG     
Sbjct: 126 NTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLG----- 179

Query: 305 GTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSL 364
                                        A   L NLK  ++   N+         + +L
Sbjct: 180 ------------------ELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-------MPNL 214

Query: 365 ANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSL 424
                L  L + GN         I                     P +   LS+L  L +
Sbjct: 215 TPLVGLEELEMSGNHF-----PEIR--------------------PGSFHGLSSLKKLWV 249

Query: 425 GGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEIC-LLSRLNELDLNGN 475
             + +S      F GL  L  L+LA N L+ S+P ++   L  L EL L+ N
Sbjct: 250 MNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 99.1 bits (247), Expect = 7e-22
 Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 8/211 (3%)

Query: 71  NSHKVTTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYL 128
           + H +  L L   +++  I       L+SL +L+L  N L+  IPS  F  +S L+ L+L
Sbjct: 97  HLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWL 154

Query: 129 MDNQLSGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIP 187
            +N +  S+ S+ F    S++ + L + K    + E     L  LK+L L        +P
Sbjct: 155 RNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP 212

Query: 188 SSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVL 247
           + L+    L+EL +  N+     P     L+ L+++ ++N+++          L +L  L
Sbjct: 213 N-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL 271

Query: 248 QLGFNNLTGVVPATIFNMSTLKEIFLYNNSL 278
            L  NNL+ +       +  L E+ L++N  
Sbjct: 272 NLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  126 bits (318), Expect = 6e-31
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 7/233 (3%)

Query: 390 NLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLA 449
            +S +   LN+    I      +  +L +L +L L  N++       F GL  L  L+L 
Sbjct: 61  GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120

Query: 450 FNKLAGSIPDEICL-LSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGS-NRFTFVIPS 507
            N+L  +IP+   + LS+L EL L  N I    S     + SL+ L+LG   R +++   
Sbjct: 121 DNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEG 179

Query: 508 TFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNIS 567
            F  L ++   +++   L    +L    L  +  +DLS N+LS   P + +GL  LQ + 
Sbjct: 180 AFEGLSNLRYLNLAMCNLREIPNLT--PLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237

Query: 568 LAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS-FEKLSYLKELNLSFN 619
           +  ++++     +F N+ SL  ++L++N ++  +P   F  L +L+ ++L  N
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  124 bits (314), Expect = 2e-30
 Identities = 58/242 (23%), Positives = 99/242 (40%), Gaps = 10/242 (4%)

Query: 409 IPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEI-CLLSRL 467
           +P  I   +N  +L+L  N +      +F  L+ L+ L L+ N +  +I       L+ L
Sbjct: 58  VPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANL 114

Query: 468 NELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISS-NLLD 526
           N L+L  N+++   +     L+ L+ L L +N    +    F  +  +   D+     L 
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS 174

Query: 527 GPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTS 586
                A   L  +  ++L+  NL   IP  L  L  L  + L+ N L    P SF  +  
Sbjct: 175 YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMH 232

Query: 587 LESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRG--GPFANFTAESFMGNEL 644
           L+ L +  ++I      +F+ L  L E+NL+ N L   +P     P  +        N  
Sbjct: 233 LQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291

Query: 645 LC 646
            C
Sbjct: 292 NC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  114 bits (288), Expect = 4e-27
 Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 11/232 (4%)

Query: 76  TTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQL 133
             LNL    +Q  I      +L  L+ L LS N + + I    F  ++ L  L L DN+L
Sbjct: 67  RLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRT-IEIGAFNGLANLNTLELFDNRL 124

Query: 134 SGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPS-SLS 191
           + ++ +  F   S + ++ L  N +   +P    N +  L+ L L E      I   +  
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182

Query: 192 KCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGF 251
               L+ L+L   NL   IP  +  L  L  + L  N L    P     L +L  L +  
Sbjct: 183 GLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240

Query: 252 NNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSF 303
           + +  +      N+ +L EI L +N+L+  LP  +   L +LE ++L  N +
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  109 bits (273), Expect = 3e-25
 Identities = 64/288 (22%), Positives = 101/288 (35%), Gaps = 41/288 (14%)

Query: 97  SSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNK 156
           +    +      L   +P  I T    ++L L +NQ+                       
Sbjct: 43  NQFSKVICVRKNLRE-VPDGIST--NTRLLNLHENQIQ---------------------- 77

Query: 157 LSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEI-G 215
               +  N   HLR+L+ L L  N        + +    L  L L  N L+  IP     
Sbjct: 78  ---IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFV 133

Query: 216 NLTVLQRISLINNKLHGEIPQEI-GYLQNLDVLQLGFNNLTGVVPATIF-NMSTLKEIFL 273
            L+ L+ + L NN +   IP      + +L  L LG       +    F  +S L+ + L
Sbjct: 134 YLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNL 192

Query: 274 YNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPS 333
              +L   +P+     L  L+ L+L  N  S   P S      L  L M  +       +
Sbjct: 193 AMCNLR-EIPN--LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERN 249

Query: 334 AIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLD 381
           A  NL++L   ++  NNLT    +L           L  + L  NP +
Sbjct: 250 AFDNLQSLVEINLAHNNLTLLPHDL-----FTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  100 bits (252), Expect = 1e-22
 Identities = 59/246 (23%), Positives = 98/246 (39%), Gaps = 14/246 (5%)

Query: 186 IPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEI-GYLQNL 244
           +P  +S     + L+L  N +         +L  L+ + L  N +   I       L NL
Sbjct: 58  VPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANL 114

Query: 245 DVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFS 304
           + L+L  N LT +       +S LKE++L NN +  S+PS     +P+L  L+LG     
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRL 173

Query: 305 GTIPSSI-TNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSS 363
             I        S L  L +   +    IP  +  L  L   D+  N+L++  P      S
Sbjct: 174 SYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPG-----S 226

Query: 364 LANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLS 423
                 L+ L +  + +     ++  NL  SL  +N+A  N++         L +L  + 
Sbjct: 227 FQGLMHLQKLWMIQSQIQVIERNAFDNLQ-SLVEINLAHNNLTLLPHDLFTPLHHLERIH 285

Query: 424 LGGNNL 429
           L  N  
Sbjct: 286 LHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 33/112 (29%), Positives = 56/112 (50%), Gaps = 7/112 (6%)

Query: 73  HKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDN 131
             +  LNL+  NL     P +  L  L  LDLS N LS+ I    F  +  L+ L+++ +
Sbjct: 185 SNLRYLNLAMCNL--REIPNLTPLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQS 241

Query: 132 QLSGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMF 182
           Q+   +    F N  S+++I L+ N L+  LP ++   L +L+ + L  N +
Sbjct: 242 QIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  125 bits (317), Expect = 8e-31
 Identities = 84/497 (16%), Positives = 161/497 (32%), Gaps = 84/497 (16%)

Query: 77  TLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSG- 135
           +   ++F +Q T       L++L SLD  ++ ++    + I  ++ L  L    N ++  
Sbjct: 22  SEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNITTL 79

Query: 136 SLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQ 195
            LS  T    ++  +    NKL+  L       L  L +L    N         +S+   
Sbjct: 80  DLSQNT----NLTYLACDSNKLT-NLD---VTPLTKLTYLNCDTNKL---TKLDVSQNPL 128

Query: 196 LQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLT 255
           L  L+   N L+     ++ + T L  +    NK   ++   +     L  L   FN +T
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183

Query: 256 GVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLA-LPNLEFLNLGINSFSGTIPSSITNA 314
            +    +     L  +    N++     +++DL     L FL+   N  +  I   +T  
Sbjct: 184 EL---DVSQNKLLNRLNCDTNNI-----TKLDLNQNIQLTFLDCSSNKLT-EID--VTPL 232

Query: 315 SKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLG 374
           ++L   +   N  +    S +  L  L        +L            L +  +L Y  
Sbjct: 233 TQLTYFDCSVNPLTELDVSTLSKLTTLHCIQ---TDLLE--------IDLTHNTQLIYFQ 281

Query: 375 LGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIP 434
             G      L                            + + + L +L      ++  + 
Sbjct: 282 AEGCRKIKELD---------------------------VTHNTQLYLLDCQAAGIT-ELD 313

Query: 435 VTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYL 494
                  KL  L L   +L   +   +   ++L  L      I    SS +G + +L   
Sbjct: 314 --LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNN 366

Query: 495 NLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIP 554
                +   +   T  N    L+  +S +LLD       GN   +   D    + + N  
Sbjct: 367 FEAEGQTITMPKETLTNNS--LTIAVSPDLLD-----QFGNPMNIEPGDGGVYDQATNTI 419

Query: 555 TTLEGLKSLQNISLAYN 571
           T          ++  + 
Sbjct: 420 TWENLSTDNPAVTYTFT 436

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  124 bits (314), Expect = 2e-30
 Identities = 58/381 (15%), Positives = 122/381 (32%), Gaps = 46/381 (12%)

Query: 242 QNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGIN 301
            N          +      +   ++TL  +  +N+S++  +   I+  L  L  L    N
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IE-KLTGLTKLICTSN 74

Query: 302 SFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFL 361
           + + T+   ++  + L  L   SN  +      +  L  L   +   N LT         
Sbjct: 75  NIT-TLD--LSQNTNLTYLACDSNKLTNLD---VTPLTKLTYLNCDTNKLTK-------- 120

Query: 362 SSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIV 421
             ++    L YL    N L       + + +  L  L+         +   +   + L  
Sbjct: 121 LDVSQNPLLTYLNCARNTLTEI---DVSHNT-QLTELDCHLNKKITKLD--VTPQTQLTT 174

Query: 422 LSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSI 481
           L    N ++    +     + L  L+   N +   +   +    +L  LD + NK++   
Sbjct: 175 LDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT--- 225

Query: 482 SSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVG 541
              +  LT L Y +   N  T +  ST   L  +         L   + + + +   ++ 
Sbjct: 226 EIDVTPLTQLTYFDCSVNPLTELDVSTLSKLTTL---HCIQTDL---LEIDLTHNTQLIY 279

Query: 542 IDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSI 601
                      +   +     L  +      +             L  L L+N +++  +
Sbjct: 280 FQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-EL 333

Query: 602 PVSFEKLSYLKELNLSFNKLK 622
            VS    + LK L+     ++
Sbjct: 334 DVS--HNTKLKSLSCVNAHIQ 352

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  119 bits (301), Expect = 9e-29
 Identities = 65/429 (15%), Positives = 129/429 (30%), Gaps = 50/429 (11%)

Query: 196 LQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLT 255
                     +          L  L  +   N+ +  ++   I  L  L  L    NN+T
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77

Query: 256 GVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLA-LPNLEFLNLGINSFSGTIPSSITNA 314
            +    +   + L  +   +N L+      +D+  L  L +LN   N  +      ++  
Sbjct: 78  TL---DLSQNTNLTYLACDSNKLT-----NLDVTPLTKLTYLNCDTNKLT---KLDVSQN 126

Query: 315 SKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLG 374
             L  L    N+ +      + +   L   D   N   +          +    +L  L 
Sbjct: 127 PLLTYLNCARNTLTEID---VSHNTQLTELDCHLNKKITKLD-------VTPQTQLTTLD 176

Query: 375 LGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIP 434
              N +       +      L RLN    NI+  +   +     L  L    N L+  I 
Sbjct: 177 CSFNKITEL---DVSQNK-LLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID 228

Query: 435 VTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYL 494
                L +L   D + N L   +   +  LS+L  L      +   I   L + T L Y 
Sbjct: 229 --VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYF 280

Query: 495 NLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIP 554
                R    +     +   +   D  +  +     L +     +V + L+   L+  + 
Sbjct: 281 QAEGCRKIKELD--VTHNTQLYLLDCQAAGI---TELDLSQNPKLVYLYLNNTELT-ELD 334

Query: 555 TTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKEL 614
             +     L+++S     ++       G + +L +   +  +       +    S    +
Sbjct: 335 --VSHNTKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAV 390

Query: 615 NLSFNKLKG 623
           +       G
Sbjct: 391 SPDLLDQFG 399

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  126 bits (317), Expect = 3e-30
 Identities = 76/443 (17%), Positives = 137/443 (30%), Gaps = 47/443 (10%)

Query: 210 IPKEIGNLTVLQRISLINN--KLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMST 267
           I   I N   L + S  N     + +        +   +     N    ++   + N   
Sbjct: 3   IMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN--Q 60

Query: 268 LKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSF 327
             E+ L   +LS SLP  +    P +  L +  N+   ++P    +   L  L+   N  
Sbjct: 61  FSELQLNRLNLS-SLPDNL---PPQITVLEITQNALI-SLPELPAS---LEYLDACDNRL 112

Query: 328 SGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSS 387
           S  +P    +L++L + +   N LT                 L Y+    N L   LP  
Sbjct: 113 S-TLPELPASLKHLDVDN---NQLTMLPELPA---------LLEYINADNNQL-TMLPEL 158

Query: 388 IGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQ--- 444
             +L    E L++    ++  +P+   +L     L +  N L  S+P         +   
Sbjct: 159 PTSL----EVLSVRNNQLTF-LPELPESLE---ALDVSTNLLE-SLPAVPVRNHHSEETE 209

Query: 445 -GLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTF 503
                  N++   IP+ I  L     + L  N +S  I   L   T+    +     F+ 
Sbjct: 210 IFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSM 268

Query: 504 VIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSL 563
                  N       D  +          +  +      +   N  S      L    S 
Sbjct: 269 SDG--QQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSA 325

Query: 564 QNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKG 623
           +N S    +    +      +++   L   +  ++     S E    L   NL    L  
Sbjct: 326 RNTSGFREQ----VAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVH 381

Query: 624 EIPRGGPFANFTAESFMGNELLC 646
           +   G    +  A   +G E+  
Sbjct: 382 QASEGLFDNDTGALLSLGREMFR 404

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  106 bits (265), Expect = 7e-24
 Identities = 60/287 (20%), Positives = 102/287 (35%), Gaps = 34/287 (11%)

Query: 76  TTLNLSSFNL-QGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLS 134
               L   N  +     +   ++    L L+   LSS +P ++     + VL +  N L 
Sbjct: 37  EKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI 93

Query: 135 GSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCK 194
                      S+  +    N+LS  LPE   +    LKHL +  N     +P   +   
Sbjct: 94  SLPELPA----SLEYLDACDNRLS-TLPELPAS----LKHLDVDNNQL-TMLPELPA--- 140

Query: 195 QLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNL 254
            L+ ++   N L+  +P+   +L VL   S+ NN+L   +P+    L+ LD   +  N L
Sbjct: 141 LLEYINADNNQLT-MLPELPTSLEVL---SVRNNQL-TFLPELPESLEALD---VSTNLL 192

Query: 255 TGVVPATIFNMSTLKE----IFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSS 310
              +PA        +E         N ++  +P  I L+L     + L  N  S  I  S
Sbjct: 193 ES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENI-LSLDPTCTIILEDNPLSSRIRES 249

Query: 311 ITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPE 357
           ++  +           FS        N  +  L D        +   
Sbjct: 250 LSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQS 294

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  124 bits (313), Expect = 3e-30
 Identities = 66/245 (26%), Positives = 114/245 (46%), Gaps = 25/245 (10%)

Query: 732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSC 791
             +G G FG V+         +AIK   P    + ++F  E +V+K +RH  LV++ +  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHC 850
           S +    +V EYMS GSL D L       L +   +++   IAS + Y+        +H 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304

Query: 851 DLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRW 910
           DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G  ++K  
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363

Query: 911 V------------NDLLP---VSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTME 955
           V               +P   +   EV+D+ +  G         +C  S+  L  +C  +
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGY--RMPCPPECPESLHDLMCQCWRK 420

Query: 956 SPEKR 960
            PE+R
Sbjct: 421 EPEER 425

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  120 bits (303), Expect = 3e-30
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 9/169 (5%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSC 791
           ++G G +G VY  R L + V IAIK    + +   +    E  + K+++H+N+V+ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL--NIMIDIASALEYLHFGHSTPIIH 849
           S + F  + +E +  GSL   L S    L    +        I   L+YL   H   I+H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL---HDNQIVH 145

Query: 850 CDLKPSNVLLDEDM-VAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            D+K  NVL++    V  +SDFG +K L+    +        T+ YMAP
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLA--GINPCTETFTGTLQYMAP 192

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  124 bits (314), Expect = 3e-30
 Identities = 48/179 (26%), Positives = 90/179 (50%), Gaps = 7/179 (3%)

Query: 732 NIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           + +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
           C+ +    ++ E+M+ G+L D L   N   ++    L +   I+SA+EYL        IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 341

Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
            +L   N L+ E+ +  ++DFG+++L++  D  T        I + AP+ +   + S+K
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  119 bits (301), Expect = 3e-30
 Identities = 50/180 (27%), Positives = 78/180 (43%), Gaps = 11/180 (6%)

Query: 732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSC 791
             IG G FG V+     +  ++AIK      A + + F  E EV+  + H  LV++   C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL---HFGHSTPII 848
                  LV E+M +G L D L +          L + +D+   + YL           I
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------I 126

Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
           H DL   N L+ E+ V  +SDFGM + +  +D+ T  T T   + + +P+       S K
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  120 bits (302), Expect = 4e-30
 Identities = 59/233 (25%), Positives = 90/233 (38%), Gaps = 29/233 (12%)

Query: 390 NLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLA 449
            +  + +R+ +    IS     +     NL +L L  N L+      F GL  L+ LDL+
Sbjct: 29  GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88

Query: 450 FNKLAGSIPDEI-CLLSRLNELDLNGNKISGSISS-CLGNLTSLQYLNLGSNRFTFVIPS 507
            N    S+       L RL+ L L+   +   +       L +LQYL L  N    +   
Sbjct: 89  DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDD 147

Query: 508 TFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNIS 567
           TF +L                     GNL     + L  N +S        GL SL  + 
Sbjct: 148 TFRDL---------------------GNLTH---LFLHGNRISSVPERAFRGLHSLDRLL 183

Query: 568 LAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS-FEKLSYLKELNLSFN 619
           L  NR+    P +F ++  L +L L  N +S ++P      L  L+ L L+ N
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  103 bits (258), Expect = 2e-24
 Identities = 57/241 (23%), Positives = 103/241 (42%), Gaps = 14/241 (5%)

Query: 68  CDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVL 126
           C   +    T +     LQ  +P  I   ++ + + L  N++S  +P++ F     L +L
Sbjct: 6   CVCYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISH-VPAASFRACRNLTIL 61

Query: 127 YLMDNQLSGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGK 185
           +L  N L+  + +  F   + +  + LS N     +     + L  L  L L       +
Sbjct: 62  WLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QE 119

Query: 186 IPS-SLSKCKQLQELHLGYNNLSGAIPKEI-GNLTVLQRISLINNKLHGEIPQEI-GYLQ 242
           +          LQ L+L  N L  A+P +   +L  L  + L  N++   +P+     L 
Sbjct: 120 LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLH 177

Query: 243 NLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINS 302
           +LD L L  N +  V P    ++  L  ++L+ N+LS +LP+     L  L++L L  N 
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNP 236

Query: 303 F 303
           +
Sbjct: 237 W 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  100 bits (250), Expect = 3e-23
 Identities = 48/234 (20%), Positives = 86/234 (36%), Gaps = 19/234 (8%)

Query: 297 NLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTP 356
             G+ +    IP++         + +  N  S    ++    RNL +  +  N L     
Sbjct: 20  QQGLQAVPVGIPAASQR------IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73

Query: 357 ELGFLSSLANCKKLRYLGLGGNPLDGFLPSSI-GNLSLSLERLNIAFCNISGNIPK-AIG 414
                + LA    L  L L  N     +  +    L   L  L++  C +   +      
Sbjct: 74  --AAFTGLAL---LEQLDLSDNAQLRSVDPATFHGLG-RLHTLHLDRCGLQ-ELGPGLFR 126

Query: 415 NLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLDLAFNKLAGSIPDEI-CLLSRLNELDL 472
            L+ L  L L  N L  ++P  TF  L  L  L L  N+++ S+P+     L  L+ L L
Sbjct: 127 GLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLL 184

Query: 473 NGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLD 526
           + N+++        +L  L  L L +N  + +       L+ +    ++ N   
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 58/289 (20%), Positives = 100/289 (34%), Gaps = 65/289 (22%)

Query: 97  SSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTF-NTSSILDIRLSKN 155
               +       L + +P  I      + ++L  N++S  + + +F    ++  + L  N
Sbjct: 11  EPKVTTSCPQQGLQA-VPVGIPA--ASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSN 66

Query: 156 KLSGKLPENICNHLRYLKHLFLRENMFYGKIPSS-LSKCKQLQELHLGYNNLSGAIPKEI 214
            L+ ++       L  L+ L L +N     +  +      +L  LHL    L        
Sbjct: 67  VLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ------- 118

Query: 215 GNLTVLQRISLINNKLHGEIPQEI-GYLQNLDVLQLGFNNLTGVVPATIF-NMSTLKEIF 272
                             E+   +   L  L  L L  N L   +P   F ++  L  +F
Sbjct: 119 ------------------ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLF 159

Query: 273 LYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIP 332
           L+ N +S S+P R    L +L+ L L  N  +  +                 ++F     
Sbjct: 160 LHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVH---------------PHAFRD--- 199

Query: 333 SAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLD 381
                L  L    +F NNL++   E      LA  + L+YL L  NP  
Sbjct: 200 -----LGRLMTLYLFANNLSALPTEA-----LAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 60/274 (21%), Positives = 91/274 (33%), Gaps = 59/274 (21%)

Query: 203 YNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATI 262
              L  A+P  I      QRI L  N++           +NL +L L  N L  +  A  
Sbjct: 20  QQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76

Query: 263 FNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEM 322
             ++ L+++ L +N+   S+       L  L  L+L        +               
Sbjct: 77  TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELG-------------- 121

Query: 323 GSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDG 382
               F G        L+ L L D   N L +   +        +   L +L L GN +  
Sbjct: 122 -PGLFRGL-----AALQYLYLQD---NALQALPDDT-----FRDLGNLTHLFLHGNRIS- 166

Query: 383 FLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQK 442
            +P                         +A   L +L  L L  N ++   P  F  L +
Sbjct: 167 SVP------------------------ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202

Query: 443 LQGLDLAFNKLAGSIPDEI-CLLSRLNELDLNGN 475
           L  L L  N L+ ++P E    L  L  L LN N
Sbjct: 203 LMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  119 bits (301), Expect = 5e-30
 Identities = 46/193 (23%), Positives = 82/193 (42%), Gaps = 11/193 (5%)

Query: 708 SSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLK 767
            + P+     Y        +      +G G FG V   +     ++AIK+     + +  
Sbjct: 6   KNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSED 64

Query: 768 SFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN 827
            F  E +V+ N+ H  LV++   C+      ++ EYM+NG L + L            L 
Sbjct: 65  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 124

Query: 828 IMIDIASALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
           +  D+  A+EYL    F      +H DL   N L+++  V  +SDFG+++ +  +DE T 
Sbjct: 125 MCKDVCEAMEYLESKQF------LHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTS 177

Query: 885 RTQTLATIGYMAP 897
              +   + +  P
Sbjct: 178 SVGSKFPVRWSPP 190

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  121 bits (307), Expect = 6e-30
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 5/177 (2%)

Query: 734 IGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKIISSC 791
           IG G FG V+  RL  D   +A+K         LK+ F  E  ++K   H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
           +      +V+E +  G     L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRD 238

Query: 852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
           L   N L+ E  V  +SDFGM++  +    +         + + AP+ +  G  S +
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  119 bits (300), Expect = 7e-30
 Identities = 49/179 (27%), Positives = 76/179 (42%), Gaps = 22/179 (12%)

Query: 731 NNIIGIGGFGSVYRAR-LEDGVEIAIKVF--HPQCASTLKSFEAECEVIKNIRHRNLVKI 787
           +  IG G F +VY+    E  VE+A           S  + F+ E E++K ++H N+V+ 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 788 ISSCSNDDFKA----LVLEYMSNGSLEDCLHSSNC----ALNIFCRLNIMIDIASALEYL 839
             S  +         LV E M++G+L+  L          L  +CR      I   L++L
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR-----QILKGLQFL 145

Query: 840 HFGHSTPIIHCDLKPSNVLLD-EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           H   + PIIH DLK  N+ +        + D G+A L        +      T  +MAP
Sbjct: 146 H-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAP 199

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  120 bits (302), Expect = 7e-30
 Identities = 44/191 (23%), Positives = 79/191 (41%), Gaps = 11/191 (5%)

Query: 732 NIIGIGGFGSVYRARLEDGVEIAIKV--FHPQCASTLKSFEAECEVIKNIRHRNL--VKI 787
             IG GG   V++   E     AIK          TL S+  E   +  ++  +   +++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
                 D +  +V+E   N  L   L      ++ + R +   ++  A+  +H      I
Sbjct: 94  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 148

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSL 907
           +H DLKP+N L+ + M+  L DFG+A  +  +  S ++   + T+ YM P E      S 
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP-EAIKDMSSS 206

Query: 908 KRWVNDLLPVS 918
           +        +S
Sbjct: 207 RENGKSKSKIS 217

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  124 bits (312), Expect = 8e-30
 Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 7/202 (3%)

Query: 708 SSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLK 767
           +S+P  +  +        ++      +G G FG V+         +AIK   P    + +
Sbjct: 249 TSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPE 307

Query: 768 SFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRL 826
           +F  E +V+K +RH  LV++ +  S +    +V EYMS GSL D L       L +   +
Sbjct: 308 AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLV 366

Query: 827 NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
           ++   IAS + Y+        +H DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R 
Sbjct: 367 DMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQ 422

Query: 887 QTLATIGYMAPDEIFVGELSLK 908
                I + AP+    G  ++K
Sbjct: 423 GAKFPIKWTAPEAALYGRFTIK 444

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  117 bits (296), Expect = 2e-29
 Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 11/168 (6%)

Query: 733 IIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
            +G G FG V   + +   ++A+K+     + +   F  E + +  + H  LVK    CS
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL---HFGHSTPIIH 849
            +    +V EY+SNG L + L S    L     L +  D+   + +L    F      IH
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------IH 127

Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            DL   N L+D D+   +SDFGM + +  +D+      T   + + AP
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAP 174

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  122 bits (307), Expect = 2e-29
 Identities = 48/178 (26%), Positives = 92/178 (51%), Gaps = 7/178 (3%)

Query: 732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSC 791
             +G G FG V+ A      ++A+K   P  + ++++F AE  V+K ++H  LVK+ +  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHC 850
           + +    ++ E+M+ GSL D L S       +   ++    IA  + ++        IH 
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308

Query: 851 DLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
           DL+ +N+L+   +V  ++DFG+A+++  ++E T R      I + AP+ I  G  ++K
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIK 365

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  119 bits (299), Expect = 2e-29
 Identities = 49/185 (26%), Positives = 86/185 (46%), Gaps = 11/185 (5%)

Query: 732 NIIGIGGFGSVYRARLE-----DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVK 786
             +G G FGSV   R +      G  +A+K         L+ FE E E++K+++H N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 787 IISSCSNDDFKA--LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
               C +   +   L++EY+  GSL D L      ++    L     I   +EYL    +
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 163

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAPDEIFVG 903
              IH DL   N+L++ +    + DFG+ K+L   ++   ++    + I + AP+ +   
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223

Query: 904 ELSLK 908
           + S+ 
Sbjct: 224 KFSVA 228

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  119 bits (300), Expect = 2e-29
 Identities = 44/191 (23%), Positives = 79/191 (41%), Gaps = 11/191 (5%)

Query: 732 NIIGIGGFGSVYRARLEDGVEIAIKV--FHPQCASTLKSFEAECEVIKNIRHRNL--VKI 787
             IG GG   V++   E     AIK          TL S+  E   +  ++  +   +++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
                 D +  +V+E   N  L   L      ++ + R +   ++  A+  +H      I
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 129

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSL 907
           +H DLKP+N L+ + M+  L DFG+A  +  +  S ++   + T+ YM P E      S 
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP-EAIKDMSSS 187

Query: 908 KRWVNDLLPVS 918
           +        +S
Sbjct: 188 RENGKSKSKIS 198

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  118 bits (297), Expect = 2e-29
 Identities = 49/185 (26%), Positives = 86/185 (46%), Gaps = 11/185 (5%)

Query: 732 NIIGIGGFGSVYRARLE-----DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVK 786
             +G G FGSV   R +      G  +A+K         L+ FE E E++K+++H N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 787 IISSCSNDDFKA--LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
               C +   +   L++EY+  GSL D L      ++    L     I   +EYL    +
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---T 132

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAPDEIFVG 903
              IH DL   N+L++ +    + DFG+ K+L   ++   ++    + I + AP+ +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192

Query: 904 ELSLK 908
           + S+ 
Sbjct: 193 KFSVA 197

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  120 bits (302), Expect = 3e-29
 Identities = 43/191 (22%), Positives = 78/191 (40%), Gaps = 11/191 (5%)

Query: 732 NIIGIGGFGSVYRARLEDGVEIAIKV--FHPQCASTLKSFEAECEVIKNIRHRNL--VKI 787
             IG GG   V++   E     AIK          TL S+  E   +  ++  +   +++
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
                 D +  +V+E   N  L   L      ++ + R +   ++  A+  +H      I
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 176

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSL 907
           +H DLKP+N L+ + M+  L DFG+A  +  +  S ++   +  + YM P E      S 
Sbjct: 177 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP-EAIKDMSSS 234

Query: 908 KRWVNDLLPVS 918
           +        +S
Sbjct: 235 RENGKSKSKIS 245

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  118 bits (299), Expect = 3e-29
 Identities = 53/255 (20%), Positives = 95/255 (37%), Gaps = 38/255 (14%)

Query: 732 NIIGIGGFGSVYRARLEDG-----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
            ++G G FG+VY+           + +AIK           K    E  V+ ++ + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL---HFG 842
           +++  C     + L+ + M  G L D +      +     LN  + IA  + YL      
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL- 138

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV 902
                +H DL   NVL+       ++DFG+AKLL  E++          I +MA + I  
Sbjct: 139 -----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193

Query: 903 GELSLKR--W---VNDLL---------P---VSLVEVVDKSLLSGEEKHFAAKEQCLLSI 945
              + +   W   V   +         P   +   E+    L  GE         C + +
Sbjct: 194 RIYTHQSDVWSYGV--TVWELMTFGSKPYDGIPASEISSI-LEKGE--RLPQPPICTIDV 248

Query: 946 FSLALECTMESPEKR 960
           + +  +C M   + R
Sbjct: 249 YMIMRKCWMIDADSR 263

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  121 bits (304), Expect = 3e-29
 Identities = 56/258 (21%), Positives = 111/258 (43%), Gaps = 27/258 (10%)

Query: 727 NFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLV 785
           +F   +++G G  G++    + D  ++A+K   P+C       + E ++++    H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
           +   +  +  F+ + +E  +  +L++ +   + A      + ++    S L +L   HS 
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL---HSL 137

Query: 846 PIIHCDLKPSNVLLDE-----DMVAHLSDFGMAKLLSGEDESTMRTQTLA-TIGYMAPDE 899
            I+H DLKP N+L+        + A +SDFG+ K L+    S  R   +  T G++AP E
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP-E 196

Query: 900 IFVGELSLK--RWVNDL--LPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTME 955
           +   +        V D+              ++S     F    Q   +I   A      
Sbjct: 197 MLSEDCKENPTYTV-DIFSAGCVFYY-----VISEGSHPFGKSLQRQANILLGACSLDCL 250

Query: 956 SPEKRID--AKDTITRLL 971
            PEK  D  A++ I +++
Sbjct: 251 HPEKHEDVIARELIEKMI 268

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  116 bits (293), Expect = 5e-29
 Identities = 48/178 (26%), Positives = 92/178 (51%), Gaps = 7/178 (3%)

Query: 732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSC 791
             +G G FG V+        ++A+K      + +  +F AE  ++K ++H+ LV++ +  
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHC 850
           + +    ++ EYM NGSL D L + +   L I   L++   IA  + ++        IH 
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133

Query: 851 DLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
           DL+ +N+L+ + +   ++DFG+A+L+  ++E T R      I + AP+ I  G  ++K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIK 190

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  119 bits (299), Expect = 6e-29
 Identities = 72/367 (19%), Positives = 136/367 (37%), Gaps = 51/367 (13%)

Query: 653 VPPCKHSQPRAQHKSKKTILLLVIFLPLSTTLVIAVALALKRGKRGTMLSNDIILSSQPT 712
           + P  H       +       +++         I     L         S ++      T
Sbjct: 4   IDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANT 63

Query: 713 IR-RFSYF--ELLRATDNFAE---------NNIIGIGGFGSVYRARLEDG----VEIAIK 756
           +    S    EL++A  +            N +IG G FG VY   L D     +  A+K
Sbjct: 64  VHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 123

Query: 757 VFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL-VLEYMSNGSLEDCLH 814
             +       +  F  E  ++K+  H N++ ++  C   +   L VL YM +G L + + 
Sbjct: 124 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 183

Query: 815 SSNCALNIFCRLNIMIDIASALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFG 871
           +      +   +   + +A  +++L    F      +H DL   N +LDE     ++DFG
Sbjct: 184 NETHNPTVKDLIGFGLQVAKGMKFLASKKF------VHRDLAARNCMLDEKFTVKVADFG 237

Query: 872 MAKLLSGEDESTMRTQTLAT--IGYMAPDEIFVGELSLKR--W---VNDLL--------- 915
           +A+ +  ++  ++  +T A   + +MA + +   + + K   W   V  LL         
Sbjct: 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV--LLWELMTRGAP 295

Query: 916 P---VSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLK 972
           P   V+  ++    LL G        E C   ++ + L+C     E R    + ++R+  
Sbjct: 296 PYPDVNTFDITVY-LLQGR--RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352

Query: 973 IRDTLSK 979
           I  T   
Sbjct: 353 IFSTFIG 359

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  116 bits (292), Expect = 9e-29
 Identities = 58/256 (22%), Positives = 95/256 (37%), Gaps = 39/256 (15%)

Query: 733 IIGIGGFGSVYRARL----EDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRHRNLV 785
            +G G FG V R          V +A+K   P   S  ++ +    E   + ++ HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL---HFG 842
           ++         K +V E    GSL D L        +       + +A  + YL    F 
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF- 142

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAPDEIF 901
                IH DL   N+LL    +  + DFG+ + L   +D   M+        + AP+ + 
Sbjct: 143 -----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197

Query: 902 VGELSLKR--W---VNDLL---------P---VSLVEVVDKSLLSGEEKHFAAKEQCLLS 944
               S     W   V   L         P   ++  +++ K    GE       E C   
Sbjct: 198 TRTFSHASDTWMFGV--TLWEMFTYGQEPWIGLNGSQILHKIDKEGE--RLPRPEDCPQD 253

Query: 945 IFSLALECTMESPEKR 960
           I+++ ++C    PE R
Sbjct: 254 IYNVMVQCWAHKPEDR 269

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  117 bits (294), Expect = 9e-29
 Identities = 48/185 (25%), Positives = 81/185 (43%), Gaps = 11/185 (5%)

Query: 732 NIIGIGGFGSVYRARL-----EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVK 786
           + +G G FGSV   R        G  +A+K          + F+ E +++K +    +VK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 787 IISSCSNDDFKA--LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
                     ++  LV+EY+ +G L D L      L+    L     I   +EYL    S
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---S 145

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAPDEIFVG 903
              +H DL   N+L++ +    ++DFG+AKLL   +D   +R    + I + AP+ +   
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205

Query: 904 ELSLK 908
             S +
Sbjct: 206 IFSRQ 210

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  116 bits (293), Expect = 1e-28
 Identities = 63/284 (22%), Positives = 113/284 (39%), Gaps = 47/284 (16%)

Query: 731 NNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQCAST--LKSFEAECEVIKNIRHRNL 784
             I+G G FGSV    L+      +++A+K      +S   ++ F +E   +K+  H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 785 VKIISSCSNDDFKA-----LVLEYMSNGSLEDCL-----HSSNCALNIFCRLNIMIDIAS 834
           ++++  C     +      ++L +M  G L   L      +    + +   L  M+DIA 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 835 ALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
            +EYL   +F      +H DL   N +L +DM   ++DFG++K +   D           
Sbjct: 159 GMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212

Query: 892 IGYMAPDEIFVGELSLKR--W---VNDLL---------P---VSLVEVVDKSLLSGEEKH 934
           + ++A + +     + K   W   V   +         P   V   E+ D  LL G    
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGV--TMWEIATRGMTPYPGVQNHEMYDY-LLHGH--R 267

Query: 935 FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS 978
               E CL  ++ +   C    P  R        +L K+ ++L 
Sbjct: 268 LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  116 bits (293), Expect = 1e-28
 Identities = 45/183 (24%), Positives = 76/183 (41%), Gaps = 19/183 (10%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G GGF  V     L DG   A+K          +  + E ++ +   H N++++++ C 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96

Query: 793 NDDFKA----LVLEYMSNGSLEDCLHSSNCALNIFCR---LNIMIDIASALEYLHFGHST 845
            +        L+L +   G+L + +       N       L +++ I   LE +H   + 
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AK 153

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA-------TIGYMAPD 898
              H DLKP+N+LL ++    L D G         E + +  TL        TI Y AP 
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP- 212

Query: 899 EIF 901
           E+F
Sbjct: 213 ELF 215

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  115 bits (290), Expect = 1e-28
 Identities = 41/172 (23%), Positives = 74/172 (43%), Gaps = 15/172 (8%)

Query: 734 IGIGGFGSVYRARLEDG---VEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKIIS 789
           +G G FGSV +         +++AIKV               E +++  + +  +V++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL---HFGHSTP 846
            C  +    LV+E    G L   L      + +     ++  ++  ++YL   +F     
Sbjct: 78  VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 131

Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAP 897
            +H DL   NVLL     A +SDFG++K L + +   T R+     + + AP
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  115 bits (290), Expect = 2e-28
 Identities = 63/248 (25%), Positives = 110/248 (44%), Gaps = 29/248 (11%)

Query: 732 NIIGIGGFGSVYRARLEDG-VEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
           + +G G +G VY    +   + +A+K         ++ F  E  V+K I+H NLV+++  
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
           C+ +    ++ E+M+ G+L D L   N   ++    L +   I+SA+EYL        IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 134

Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
            DL   N L+ E+ +  ++DFG+++L++  D  T        I + AP+ +   + S+K 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193

Query: 910 --W---VNDLL---------P---VSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALEC 952
             W   V  LL         P   + L +V +  L           E C   ++ L   C
Sbjct: 194 DVWAFGV--LLWEIATYGMSPYPGIDLSQVYEL-LEKDY--RMERPEGCPEKVYELMRAC 248

Query: 953 TMESPEKR 960
              +P  R
Sbjct: 249 WQWNPSDR 256

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  115 bits (289), Expect = 3e-28
 Identities = 44/179 (24%), Positives = 90/179 (50%), Gaps = 12/179 (6%)

Query: 732 NIIGIGGFGSVYRARLE-----DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
             +G G FG V   R +      G ++A+K   P+   + +   + E E+++N+ H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 786 KIISSCSNDDFKA--LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           K    C+ D      L++E++ +GSL++ L  +   +N+  +L   + I   ++YL    
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG--- 143

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAPDEIF 901
           S   +H DL   NVL++ +    + DFG+ K + + ++  T++    + + + AP+ + 
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  114 bits (288), Expect = 4e-28
 Identities = 54/280 (19%), Positives = 104/280 (37%), Gaps = 39/280 (13%)

Query: 709 SQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQC-A 763
               +       +         + +IG G FG VY     D     ++ AIK        
Sbjct: 4   DSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM 63

Query: 764 STLKSFEAECEVIKNIRHRNLVKIISSCSNDD-FKALVLEYMSNGSLEDCLHSSNCALNI 822
             +++F  E  +++ + H N++ +I      +    ++L YM +G L   + S      +
Sbjct: 64  QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV 123

Query: 823 FCRLNIMIDIASALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE 879
              ++  + +A  +EYL    F      +H DL   N +LDE     ++DFG+A+ +   
Sbjct: 124 KDLISFGLQVARGMEYLAEQKF------VHRDLAARNCMLDESFTVKVADFGLARDILDR 177

Query: 880 DESTMRTQTLAT--IGYMAPDEIFVGELSLKR--W---VNDLL---------P---VSLV 920
           +  +++    A   + + A + +     + K   W   V  LL         P   +   
Sbjct: 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGV--LLWELLTRGAPPYRHIDPF 235

Query: 921 EVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKR 960
           ++    L  G        E C  S++ +  +C    P  R
Sbjct: 236 DLTHF-LAQGR--RLPQPEYCPDSLYQVMQQCWEADPAVR 272

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  114 bits (288), Expect = 4e-28
 Identities = 62/276 (22%), Positives = 114/276 (41%), Gaps = 39/276 (14%)

Query: 732 NIIGIGGFGSVYRARLEDG----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVK 786
            +IG G FG VY   L D     +  A+K  +       +  F  E  ++K+  H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 787 IISSCSNDDFKAL-VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL---HFG 842
           ++  C   +   L VL YM +G L + + +      +   +   + +A  ++YL    F 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT--IGYMAPDEI 900
                +H DL   N +LDE     ++DFG+A+ +  ++  ++  +T A   + +MA + +
Sbjct: 150 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 901 FVGELSLKR--W---VNDLL---------P---VSLVEVVDKSLLSGEEKHFAAKEQCLL 943
              + + K   W   V  LL         P   V+  ++    LL G        E C  
Sbjct: 205 QTQKFTTKSDVWSFGV--LLWELMTRGAPPYPDVNTFDITVY-LLQGR--RLLQPEYCPD 259

Query: 944 SIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK 979
            ++ + L+C     E R    + ++R+  I  T   
Sbjct: 260 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  115 bits (289), Expect = 5e-28
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 14/164 (8%)

Query: 732 NIIGIGGFGSVYRARL----EDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVK 786
            IIG G  G V   RL    +  V +AIK          +  F +E  ++    H N+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL---HFGH 843
           +    +      +V EYM NGSL+  L + +    I   + ++  + + + YL    +  
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY-- 172

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ 887
               +H DL   NVL+D ++V  +SDFG++++L  + ++   T 
Sbjct: 173 ----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  115 bits (289), Expect = 5e-28
 Identities = 60/252 (23%), Positives = 109/252 (43%), Gaps = 32/252 (12%)

Query: 732 NIIGIGGFGSVYRARLEDG-----VEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLV 785
            ++G G FG+V++           + + IKV   +    + ++       I ++ H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
           +++  C     + LV +Y+  GSL D +     AL     LN  + IA  + YL      
Sbjct: 79  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EH 134

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGEL 905
            ++H +L   NVLL       ++DFG+A LL  +D+  + ++    I +MA + I  G+ 
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194

Query: 906 SLKR--W---VNDLL---------P---VSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSL 948
           + +   W   V   +         P   + L EV D  L  GE    A  + C + ++ +
Sbjct: 195 THQSDVWSYGV--TVWELMTFGAEPYAGLRLAEVPDL-LEKGE--RLAQPQICTIDVYMV 249

Query: 949 ALECTMESPEKR 960
            ++C M     R
Sbjct: 250 MVKCWMIDENIR 261

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  114 bits (288), Expect = 5e-28
 Identities = 50/194 (25%), Positives = 88/194 (45%), Gaps = 17/194 (8%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFH-PQCASTLKSFEAECEVIKNIRHRN 783
             +  ++I+G G   +V+R R  + G   AIKVF+       +     E EV+K + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 784 LVKI--ISSCSNDDFKALVLEYMSNGSLEDCL--HSSNCALNIFCRLNIMIDIASALEYL 839
           +VK+  I   +    K L++E+   GSL   L   S+   L     L ++ D+   + +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 840 HFGHSTPIIHCDLKPSNVLL----DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYM 895
                  I+H ++KP N++     D   V  L+DFG A+ L   ++         T  Y+
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGTEEYL 182

Query: 896 APDEIFVGELSLKR 909
            P +++   +  K 
Sbjct: 183 HP-DMYERAVLRKD 195

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  114 bits (287), Expect = 8e-28
 Identities = 61/285 (21%), Positives = 115/285 (40%), Gaps = 48/285 (16%)

Query: 731 NNIIGIGGFGSVYRARLEDG----VEIAIKVFHPQCAST--LKSFEAECEVIKNIRHRNL 784
             ++G G FGSV  A+L+      V++A+K+      ++  ++ F  E   +K   H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 785 VKIISSCSNDDFKA------LVLEYMSNGSLEDCLHSS-----NCALNIFCRLNIMIDIA 833
            K++        K       ++L +M +G L   L +S        L +   +  M+DIA
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 834 SALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
             +EYL   +F      IH DL   N +L EDM   ++DFG+++ +   D       +  
Sbjct: 148 CGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201

Query: 891 TIGYMAPDEIFVGELSLKR--W---VNDLL---------P---VSLVEVVDKSLLSGEEK 933
            + ++A + +     ++    W   V   +         P   +   E+ +  L+ G   
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGV--TMWEIMTRGQTPYAGIENAEIYNY-LIGGN-- 256

Query: 934 HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS 978
                 +C+  ++ L  +C    P++R         L  I   LS
Sbjct: 257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  113 bits (285), Expect = 1e-27
 Identities = 56/208 (26%), Positives = 85/208 (40%), Gaps = 31/208 (14%)

Query: 722 LRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR 780
           LR   +F E  ++G G FG V +AR   D    AIK         L +  +E  ++ ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLN 60

Query: 781 HRNLVKIISSCSNDDFKA-------------LVLEYMSNGSLEDCLHSSNCALNIFCRLN 827
           H+ +V+  ++                     + +EY  NG+L D +HS N          
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 828 IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS---------- 877
           +   I  AL Y+H   S  IIH DLKP N+ +DE     + DFG+AK +           
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 878 --GEDESTMRTQTLATIGYMAPDEIFVG 903
                 S   T  + T  Y+A  E+  G
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVAT-EVLDG 204

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  114 bits (286), Expect = 1e-27
 Identities = 43/171 (25%), Positives = 65/171 (38%), Gaps = 14/171 (8%)

Query: 732 NIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISS 790
             +G G FG V+R +  + G + A+K    +          E      +    +V +  +
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118

Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHC 850
                +  + +E +  GSL   +    C L     L  +      LEYL   H+  I+H 
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYL---HTRRILHG 174

Query: 851 DLKPSNVLLDED-MVAHLSDFGMAKLLSGEDESTMRTQTLATIG---YMAP 897
           D+K  NVLL  D   A L DFG A  L  +             G   +MAP
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  114 bits (286), Expect = 2e-27
 Identities = 46/265 (17%), Positives = 104/265 (39%), Gaps = 18/265 (6%)

Query: 370 LRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNL 429
           ++ L L  N +     S +     +L+ L +    I+     +  +L +L  L L  N L
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCV-NLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112

Query: 430 SGSIPV-TFGGLQKLQGLDLAFNKLAGSIPDEICL--LSRLNELDLNGNKISGSISS-CL 485
           S ++    F  L  L  L+L  N    ++ +      L++L  L +        I     
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170

Query: 486 GNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLS 545
             LT L+ L + ++      P +  +++++    +        + + +    +V  ++L 
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELR 230

Query: 546 RNNLSGNIPT--------TLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKI 597
             +L     +        +L    + +N+ +    L   + +    ++ L  L+ S N++
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289

Query: 598 SGSIPVS-FEKLSYLKELNLSFNKL 621
             S+P   F++L+ L+++ L  N  
Sbjct: 290 K-SVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  106 bits (266), Expect = 6e-25
 Identities = 53/251 (21%), Positives = 107/251 (42%), Gaps = 16/251 (6%)

Query: 390 NLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLDL 448
            L+ +++ L+++   I+      +    NL  L L  N ++ +I   +F  L  L+ LDL
Sbjct: 49  GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDL 107

Query: 449 AFNKLAGSIPDEICL-LSRLNELDLNGNKISG-SISSCLGNLTSLQYLNLGSN-RFTFVI 505
           ++N L+ ++       LS L  L+L GN       +S   +LT LQ L +G+   FT + 
Sbjct: 108 SYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ 166

Query: 506 PSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQN 565
              F  L  +   +I ++ L      ++ +++ V  + L        +   ++   S++ 
Sbjct: 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVEC 226

Query: 566 ISLAYNRLEGP--------IPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLS 617
           + L    L+             S     +  ++ +++  +   +     ++S L EL  S
Sbjct: 227 LELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFS 285

Query: 618 FNKLKGEIPRG 628
            N+LK  +P G
Sbjct: 286 RNQLKS-VPDG 295

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  102 bits (256), Expect = 1e-23
 Identities = 49/285 (17%), Positives = 98/285 (34%), Gaps = 21/285 (7%)

Query: 252 NNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSI 311
            +L   +P+ +     +K + L NN ++  + +       NL+ L L  N  + TI    
Sbjct: 41  GSLN-SIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDS 95

Query: 312 -TNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKL 370
            ++   L  L++  N  S    S    L +L   ++  N   +      F    ++  KL
Sbjct: 96  FSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLF----SHLTKL 151

Query: 371 RYLGLGGNPLDGFLPSSI-GNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNL 429
           + L +G       +       L+  LE L I   ++    PK++ ++ N+  L L     
Sbjct: 152 QILRVGNMDTFTKIQRKDFAGLT-FLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210

Query: 430 SGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEIC--------LLSRLNELDLNGNKISGSI 481
              + +       ++ L+L    L      E+                + +    +   +
Sbjct: 211 ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QV 269

Query: 482 SSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLD 526
              L  ++ L  L    N+   V    F  L  +    + +N  D
Sbjct: 270 MKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  100 bits (251), Expect = 7e-23
 Identities = 72/324 (22%), Positives = 130/324 (40%), Gaps = 27/324 (8%)

Query: 50  LGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKL 109
           L    +SN +  S     CD N         SS +L  +IP  +    ++KSLDLS+N++
Sbjct: 17  LSKEESSNQASLS-----CDRN----GICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRI 64

Query: 110 SSNIPSSIFT-MSTLKVLYLMDNQLSGSLSSFTFNT-SSILDIRLSKNKLSGKLPENICN 167
           +  I +S       L+ L L  N ++ ++   +F++  S+  + LS N LS  L  +   
Sbjct: 65  TY-ISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFK 121

Query: 168 HLRYLKHLFLRENMFYGKIPSSL-SKCKQLQELHLGYNNLSGAIPKEI-GNLTVLQRISL 225
            L  L  L L  N +     +SL S   +LQ L +G  +    I ++    LT L+ + +
Sbjct: 122 PLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEI 181

Query: 226 INNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSR 285
             + L    P+ +  +QN+  L L       ++   +   S+++ + L +  L     S 
Sbjct: 182 DASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSE 241

Query: 286 ID-------LALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNL 338
           +        +       + +   S    +   +   S L+ LE   N            L
Sbjct: 242 LSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRL 300

Query: 339 RNLKLFDIFFNNLTSSTPELGFLS 362
            +L+   +  N    S P + +LS
Sbjct: 301 TSLQKIWLHTNPWDCSCPRIDYLS 324

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 97.9 bits (244), Expect = 5e-22
 Identities = 55/357 (15%), Positives = 117/357 (32%), Gaps = 64/357 (17%)

Query: 80  LSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSS 139
           + S + + +      +         S   L+S IPS +     +K L L +N+++     
Sbjct: 14  IISLSKEESSNQASLSCDRNGICKGSSGSLNS-IPSGLTE--AVKSLDLSNNRIT----- 65

Query: 140 FTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQEL 199
                                +                          S L +C  LQ L
Sbjct: 66  --------------------YIS------------------------NSDLQRCVNLQAL 81

Query: 200 HLGYNNLSGAIPKEI-GNLTVLQRISLINNKLHGEIPQEI-GYLQNLDVLQLGFNNLTGV 257
            L  N ++  I ++   +L  L+ + L  N L   +       L +L  L L  N    +
Sbjct: 82  VLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTL 139

Query: 258 VPATIF-NMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASK 316
              ++F +++ L+ + + N      +  +    L  LE L +  +      P S+ +   
Sbjct: 140 GETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQN 199

Query: 317 LILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTS---STPELGFLSSLANCKKLRYL 373
           +  L +        +   +    +++  ++   +L +   S    G  +SL      R +
Sbjct: 200 VSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNV 259

Query: 374 GLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPK-AIGNLSNLIVLSLGGNNL 429
            +    L   +   +  +S  L  L  +   +  ++P      L++L  + L  N  
Sbjct: 260 KITDESLFQ-VMKLLNQIS-GLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 96.3 bits (240), Expect = 1e-21
 Identities = 43/226 (19%), Positives = 82/226 (36%), Gaps = 32/226 (14%)

Query: 402 FCNISGN----IPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSI 457
            C  S      IP  +     +  L L  N ++            LQ L L  N +  +I
Sbjct: 35  ICKGSSGSLNSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TI 91

Query: 458 PDEICL-LSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDIL 516
            ++    L  L  LDL+ N +S   SS    L+SL +LNL  N +  +  ++ ++     
Sbjct: 92  EEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFS----- 146

Query: 517 SFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPT-TLEGLKSLQNISLAYNRLEG 575
                             +L  +  + +   +    I      GL  L+ + +  + L+ 
Sbjct: 147 ------------------HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS 188

Query: 576 PIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKL 621
             P+S  ++ ++  L L   +    + +  +  S ++ L L    L
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDL 234

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  112 bits (283), Expect = 2e-27
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 14/175 (8%)

Query: 732 NIIGIGGFGSVYRARLED-----GVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
             +G G FG V     +      G  +A+K             ++ E ++++ + H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 786 KIISSCSNDDFKA--LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           K    C +    +  LV+EY+  GSL D L   +  L     L     I   + YLH   
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL--LLFAQQICEGMAYLH--- 151

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAP 897
           +   IH DL   NVLLD D +  + DFG+AK +  G +   +R    + + + AP
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  111 bits (281), Expect = 3e-27
 Identities = 59/257 (22%), Positives = 102/257 (39%), Gaps = 39/257 (15%)

Query: 730 ENNIIGIGGFGSVYRARLEDG---VEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNL 784
           E+  +G G FG+V +   +       +A+K+   +           AE  V++ + +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL---HF 841
           V++I  C  + +  LV+E    G L   L   N  +     + ++  ++  ++YL   +F
Sbjct: 81  VRMIGICEAESWM-LVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNF 138

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAPDEI 900
                 +H DL   NVLL     A +SDFG++K L + E+    +T     + + AP+ I
Sbjct: 139 ------VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192

Query: 901 FVGELSLKR--W---VNDLL---------P---VSLVEVVDKSLLSGEEKHFAAKEQCLL 943
              + S K   W   V  L+         P   +   EV    L  GE         C  
Sbjct: 193 NYYKFSSKSDVWSFGV--LMWEAFSYGQKPYRGMKGSEVTAM-LEKGE--RMGCPAGCPR 247

Query: 944 SIFSLALECTMESPEKR 960
            ++ L   C     E R
Sbjct: 248 EMYDLMNLCWTYDVENR 264

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  114 bits (286), Expect = 4e-27
 Identities = 50/194 (25%), Positives = 88/194 (45%), Gaps = 17/194 (8%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFH-PQCASTLKSFEAECEVIKNIRHRN 783
             +  ++I+G G   +V+R R  + G   AIKVF+       +     E EV+K + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 784 LVKI--ISSCSNDDFKALVLEYMSNGSLEDCL--HSSNCALNIFCRLNIMIDIASALEYL 839
           +VK+  I   +    K L++E+   GSL   L   S+   L     L ++ D+   + +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 840 HFGHSTPIIHCDLKPSNVLL----DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYM 895
                  I+H ++KP N++     D   V  L+DFG A+ L   ++         T  Y+
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGTEEYL 182

Query: 896 APDEIFVGELSLKR 909
            P +++   +  K 
Sbjct: 183 HP-DMYERAVLRKD 195

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  112 bits (281), Expect = 5e-27
 Identities = 53/255 (20%), Positives = 96/255 (37%), Gaps = 38/255 (14%)

Query: 732 NIIGIGGFGSVYRARLEDG-----VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV 785
            ++G G FG+VY+           + +AIK           K    E  V+ ++ + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL---HFG 842
           +++  C     + L+ + M  G L D +      +     LN  + IA  + YL      
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL- 138

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV 902
                +H DL   NVL+       ++DFG+AKLL  E++          I +MA + I  
Sbjct: 139 -----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193

Query: 903 GELSLKR--W---VNDLL---------P---VSLVEVVDKSLLSGEEKHFAAKEQCLLSI 945
              + +   W   V   +         P   +   E+    L  GE         C + +
Sbjct: 194 RIYTHQSDVWSYGV--TVWELMTFGSKPYDGIPASEISSI-LEKGE--RLPQPPICTIDV 248

Query: 946 FSLALECTMESPEKR 960
           + + ++C M   + R
Sbjct: 249 YMIMVKCWMIDADSR 263

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  111 bits (279), Expect = 5e-27
 Identities = 55/173 (31%), Positives = 85/173 (49%), Gaps = 19/173 (10%)

Query: 734 IGIGGFGSVYRA---RLEDGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKI 787
           +G GG  +VY A    L   V  AIK           TLK FE E      + H+N+V +
Sbjct: 19  LGGGGMSTVYLAEDTILNIKV--AIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
           I     DD   LV+EY+   +L + + S +  L++   +N    I   +++ H      I
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMR---I 132

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG---YMAP 897
           +H D+KP N+L+D +    + DFG+AK LS   E+++ TQT   +G   Y +P
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALS---ETSL-TQTNHVLGTVQYFSP 181

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  116 bits (291), Expect = 7e-27
 Identities = 46/201 (22%), Positives = 83/201 (41%), Gaps = 16/201 (7%)

Query: 708 SSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDG---VEIAIKVFHPQCAS 764
            S P   +     L R     A+   +G G FGSV +         +++AIKV       
Sbjct: 319 FSDPEELKDKKLFLKRDNLLIADI-ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK 377

Query: 765 TLKS-FEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIF 823
                   E +++  + +  +V++I  C  +    LV+E    G L   L      + + 
Sbjct: 378 ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVS 436

Query: 824 CRLNIMIDIASALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGE 879
               ++  ++  ++YL   +F      +H +L   NVLL     A +SDFG++K L + +
Sbjct: 437 NVAELLHQVSMGMKYLEEKNF------VHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490

Query: 880 DESTMRTQTLATIGYMAPDEI 900
              T R+     + + AP+ I
Sbjct: 491 SYYTARSAGKWPLKWYAPECI 511

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  112 bits (282), Expect = 9e-27
 Identities = 43/178 (24%), Positives = 81/178 (45%), Gaps = 15/178 (8%)

Query: 732 NIIGIGGFGSVYRARL----EDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVK 786
            ++G G FG V   RL    +  + +AIK          +  F  E  ++    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL---HFGH 843
           +    +      +V EYM NGSL+  L   +    +   + ++  IAS ++YL    +  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-- 168

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST-MRTQTLATIGYMAPDEI 900
               +H DL   N+L++ ++V  +SDFG+ ++L  + E+          I + +P+ I
Sbjct: 169 ----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  111 bits (280), Expect = 9e-27
 Identities = 45/175 (25%), Positives = 85/175 (48%), Gaps = 16/175 (9%)

Query: 733 IIGIGGFGSVYRARL-----EDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVK 786
           +IG G FG VY+  L     +  V +AIK          +  F  E  ++    H N+++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL---HFGH 843
           +    S      ++ EYM NG+L+  L   +   ++   + ++  IA+ ++YL   ++  
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY-- 168

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ-TLATIGYMAP 897
               +H DL   N+L++ ++V  +SDFG++++L  + E+T  T      I + AP
Sbjct: 169 ----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  113 bits (286), Expect = 9e-27
 Identities = 57/179 (31%), Positives = 86/179 (48%), Gaps = 13/179 (7%)

Query: 732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSC 791
             IG G FG V       G ++A+K       +T ++F AE  V+  +RH NLV+++   
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 792 SNDDFKA-LVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
             +     +V EYM+ GSL D L S     L   C L   +D+  A+EYL        +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 312

Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
            DL   NVL+ ED VA +SDFG+ K     + S+ +      + + AP+ +   + S K
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTK 366

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  110 bits (277), Expect = 1e-26
 Identities = 47/180 (26%), Positives = 71/180 (39%), Gaps = 20/180 (11%)

Query: 734 IGIGGFGSVYRA---RLEDGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKI 787
           +G GG G VY A     E  V  A+K+     +         + E      ++  ++V I
Sbjct: 42  VGRGGMGDVYEAEDTVRERIV--ALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
                 D    + +  ++   L   L      L     + I+  I SAL+  H       
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAG---A 155

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG---YMAPDEIFVGE 904
            H D+KP N+L+  D  A+L DFG+A       +  + TQ   T+G   YMAP E F   
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASAT---TDEKL-TQLGNTVGTLYYMAP-ERFSES 210

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  115 bits (289), Expect = 1e-26
 Identities = 52/195 (26%), Positives = 85/195 (43%), Gaps = 20/195 (10%)

Query: 723 RATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQ-CASTLKSFEAECEVIKNIR 780
           +    +     +G GGFG V R    + G ++AIK    +      + +  E +++K + 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70

Query: 781 HRNLVKII------SSCSNDDFKALVLEYMSNGSLEDCL--HSSNCALNIFCRLNIMIDI 832
           H N+V            + +D   L +EY   G L   L    + C L       ++ DI
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130

Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
           +SAL YLH      IIH DLKP N++L    + ++  + D G AK L  +         +
Sbjct: 131 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-V 184

Query: 890 ATIGYMAPDEIFVGE 904
            T+ Y+AP E+   +
Sbjct: 185 GTLQYLAP-ELLEQK 198

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  109 bits (275), Expect = 1e-26
 Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 15/190 (7%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKV--FHPQCASTLKSFEAECEVIKNIRHR 782
           +++     IG G +G   + R   DG  +  K   +     +  +   +E  +++ ++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 783 NLVKIISSCSNDDFKAL--VLEYMSNGSLEDCLHSSNCALNIF---CRLNIMIDIASALE 837
           N+V+      +     L  V+EY   G L   +               L +M  +  AL+
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 838 YLHFGHSTP--IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA-TIGY 894
             H        ++H DLKP+NV LD      L DFG+A++L+     T   +T   T  Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN---HDTSFAKTFVGTPYY 182

Query: 895 MAPDEIFVGE 904
           M+P E     
Sbjct: 183 MSP-EQMNRM 191

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  109 bits (275), Expect = 1e-26
 Identities = 59/205 (28%), Positives = 89/205 (43%), Gaps = 13/205 (6%)

Query: 706 ILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAST 765
           +  S      F                 IG G FG V       G ++A+K       +T
Sbjct: 1   MGGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--AT 57

Query: 766 LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA-LVLEYMSNGSLEDCLHSSN-CALNIF 823
            ++F AE  V+  +RH NLV+++     +     +V EYM+ GSL D L S     L   
Sbjct: 58  AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 117

Query: 824 CRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST 883
           C L   +D+  A+EYL        +H DL   NVL+ ED VA +SDFG+ K     + S+
Sbjct: 118 CLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASS 169

Query: 884 MRTQTLATIGYMAPDEIFVGELSLK 908
            +      + + AP+ +   + S K
Sbjct: 170 TQDTGKLPVKWTAPEALREKKFSTK 194

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  111 bits (279), Expect = 1e-26
 Identities = 46/183 (25%), Positives = 81/183 (44%), Gaps = 18/183 (9%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKV--FHPQCASTLKSFEAECEVIKNIRHR 782
           + +     IG G FG     +  EDG +  IK        +   +    E  V+ N++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCAL----NIFCRLNIMIDIASALEY 838
           N+V+   S   +    +V++Y   G L   +++    L     I   L+  + I  AL++
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI---LDWFVQICLALKH 140

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA-TIGYMAP 897
           +H      I+H D+K  N+ L +D    L DFG+A++L+    +    +    T  Y++P
Sbjct: 141 VH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN---STVELARACIGTPYYLSP 194

Query: 898 DEI 900
            EI
Sbjct: 195 -EI 196

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  109 bits (275), Expect = 2e-26
 Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 16/173 (9%)

Query: 733 IIGIGGFGSVYRARL----EDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKI 787
           I+G G FG VY         + + +A+K     C    K  F +E  ++KN+ H ++VK+
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL---HFGHS 844
           I     +    +++E    G L   L  +  +L +   +   + I  A+ YL   +    
Sbjct: 79  IGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC--- 134

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
              +H D+   N+L+       L DFG+++ +  ED     + T   I +M+P
Sbjct: 135 ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSP 183

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  109 bits (274), Expect = 2e-26
 Identities = 49/200 (24%), Positives = 83/200 (41%), Gaps = 29/200 (14%)

Query: 723 RATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRH 781
           R   +F E  +IG GGFG V++A+   DG    IK          +    E + +  + H
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDH 63

Query: 782 RNLVKIISSCSNDDFKA----------------LVLEYMSNGSLEDCLHSSNCA-LNIFC 824
            N+V         D+                  + +E+   G+LE  +       L+   
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 825 RLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
            L +   I   ++Y+H   S  +I+ DLKPSN+ L +     + DFG+   L  + +   
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--- 177

Query: 885 RTQTLATIGYMAPDEIFVGE 904
           RT++  T+ YM+P E    +
Sbjct: 178 RTRSKGTLRYMSP-EQISSQ 196

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  109 bits (275), Expect = 2e-26
 Identities = 52/182 (28%), Positives = 80/182 (43%), Gaps = 13/182 (7%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIK---VFHPQCASTLKSFEAECEVIKNIRH 781
            NF     IG G F  VYRA  L DGV +A+K   +F    A        E +++K + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR---LNIMIDIASALEY 838
            N++K  +S   D+   +VLE    G L   +        +          + + SALE+
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           +H   S  ++H D+KP+NV +    V  L D G+ +  S +         + T  YM+P 
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSP- 205

Query: 899 EI 900
           E 
Sbjct: 206 ER 207

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  108 bits (272), Expect = 3e-26
 Identities = 38/173 (21%), Positives = 76/173 (43%), Gaps = 16/173 (9%)

Query: 733 IIGIGGFGSVYRARLEDG----VEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKI 787
            IG G FG V++          + +AIK      + +++  F  E   ++   H ++VK+
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL---HFGHS 844
           I   + +    +++E  + G L   L     +L++   +     +++AL YL    F   
Sbjct: 82  IGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF--- 137

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
              +H D+   NVL+  +    L DFG+++ +  +      ++    I +MAP
Sbjct: 138 ---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAP 186

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  108 bits (273), Expect = 4e-26
 Identities = 47/204 (23%), Positives = 75/204 (36%), Gaps = 19/204 (9%)

Query: 702 SNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHP 760
           S  +        R  S+F+      +F   + +G G +G V++ R  EDG   A+K    
Sbjct: 38  SETLQSPGYDPSRPESFFQ-----QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMS 92

Query: 761 QCASTLKSFEAECEVI---KNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSN 817
                        EV    K  +H   V++  +        L  E     SL+    +  
Sbjct: 93  PFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWG 151

Query: 818 CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS 877
            +L        + D   AL +LH   S  ++H D+KP+N+ L       L DFG+   L 
Sbjct: 152 ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208

Query: 878 GEDESTMRTQTLA-TIGYMAPDEI 900
               +    +       YMAP E+
Sbjct: 209 ----TAGAGEVQEGDPRYMAP-EL 227

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  113 bits (284), Expect = 7e-26
 Identities = 44/183 (24%), Positives = 75/183 (40%), Gaps = 30/183 (16%)

Query: 734 IGIGGFGSVYRA---RLEDGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIIS 789
           I  GG G +Y A    + +G  + +K       A       AE + +  + H ++V+I +
Sbjct: 88  IAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 790 SCSNDDFKA-----LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
              + D        +V+EY+   SL+         L +   +  +++I  AL YLH   S
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---S 200

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT---LATIGYMAPDEIF 901
             +++ DLKP N++L E+ +  L D G    +                 T G+ AP EI 
Sbjct: 201 IGLVYNDLKPENIMLTEEQLK-LIDLGAVSRI---------NSFGYLYGTPGFQAP-EIV 249

Query: 902 VGE 904
              
Sbjct: 250 RTG 252

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  110 bits (277), Expect = 8e-26
 Identities = 61/275 (22%), Positives = 110/275 (40%), Gaps = 38/275 (13%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEV-IKNIRHRNL 784
           +      I+G G  G+V       G  +A+K               E ++  ++  H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNV 71

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL------NIMIDIASALEY 838
           ++   S + D F  + LE   N +L+D + S N +             +++  IAS + +
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 839 LHFGHSTPIIHCDLKPSNVLLD-------------EDMVAHLSDFGMAKLLSGEDES-TM 884
           L   HS  IIH DLKP N+L+              E++   +SDFG+ K L     S   
Sbjct: 131 L---HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 885 RTQTLA-TIGYMAPDEIFVGELSLKRWVNDLLPV---SLVEVVDKSLLSGEEKHFAAKEQ 940
                + T G+ AP E+     +L+        +   S+   V   +LS  +  F  K  
Sbjct: 188 NLNNPSGTSGWRAP-ELLEESNNLQTKRRLTRSIDIFSM-GCVFYYILSKGKHPFGDKYS 245

Query: 941 CLLSIFS--LALECTMESPEKRI--DAKDTITRLL 971
              +I     +L+      ++ +  +A D I++++
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMI 280

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  107 bits (269), Expect = 9e-26
 Identities = 39/184 (21%), Positives = 72/184 (39%), Gaps = 31/184 (16%)

Query: 733 IIGIGGFGSVYRARL--------EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
            +G G F  +++               E+ +KV      +  +SF     ++  + H++L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL---HF 841
           V     C   D   LV E++  GSL+  L  +   +NI  +L +   +A+A+ +L     
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL 134

Query: 842 GHSTPIIHCDLKPSNVLLD--------EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
                 IH ++   N+LL               LSD G++  +  +D    R      I 
Sbjct: 135 ------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER------IP 182

Query: 894 YMAP 897
           ++ P
Sbjct: 183 WVPP 186

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  107 bits (269), Expect = 1e-25
 Identities = 46/208 (22%), Positives = 81/208 (38%), Gaps = 30/208 (14%)

Query: 723 RATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIK-VFHPQCASTLKSFEAECEVIKNIR 780
           R   +F     +G GGFG V+ A+   D    AIK +  P      +    E + +  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 781 HRNLVKIISSCSNDDFKA------------LVLEYMSNGSLEDCLHSSNCALNIFCR--L 826
           H  +V+  ++    +               + ++     +L+D ++             L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 827 NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
           +I + IA A+E+LH   S  ++H DLKPSN+    D V  + DFG+   +  ++E     
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 887 QTLATIG----------YMAPDEIFVGE 904
             +              YM+P E   G 
Sbjct: 179 TPMPAYARHTGQVGTKLYMSP-EQIHGN 205

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  107 bits (270), Expect = 2e-25
 Identities = 52/193 (26%), Positives = 75/193 (38%), Gaps = 31/193 (16%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKIISSC 791
           +  GGF  VY A+ +  G E A+K          ++   E   +K +  H N+V+  S+ 
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95

Query: 792 S-------NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR--LNIMIDIASALEYLHFG 842
           S           + L+L  +  G L + L        + C   L I      A++++H  
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-R 154

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG--------------EDESTMRTQT 888
              PIIH DLK  N+LL       L DFG A  +S               E+E T  T  
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT-- 212

Query: 889 LATIGYMAPDEIF 901
             T  Y  P EI 
Sbjct: 213 --TPMYRTP-EII 222

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  109 bits (273), Expect = 2e-25
 Identities = 66/240 (27%), Positives = 105/240 (43%), Gaps = 42/240 (17%)

Query: 692 LKRGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNI---------IGIGGFGSV 742
           + +GKR  + +N  I  S    + F +F+L     +     +         +G G  G V
Sbjct: 92  VGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEV 151

Query: 743 YRAR-LEDGVEIAIKVFH--------PQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
             A   +   ++AI++           + A    + E E E++K + H  ++KI +    
Sbjct: 152 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211

Query: 794 DDFKALVLEYMSNGSLED------CLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
           +D+  +VLE M  G L D       L  + C             +  A++YLH      I
Sbjct: 212 EDY-YIVLELMEGGELFDKVVGNKRLKEATCK-------LYFYQMLLAVQYLH---ENGI 260

Query: 848 IHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
           IH DLKP NVLL   +ED +  ++DFG +K+L   + S MRT    T  Y+AP E+ V  
Sbjct: 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT-LCGTPTYLAP-EVLVSV 316

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  106 bits (266), Expect = 5e-25
 Identities = 55/276 (19%), Positives = 109/276 (39%), Gaps = 41/276 (14%)

Query: 731 NNIIGIGGFGSVYRARLEDGVE------IAIKVFHPQCASTLKS-FEAECEVIKNIRHRN 783
           +  +G G FG VY    +  V+      +AIK  +   +   +  F  E  V+K     +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSS---------NCALNIFCRLNIMIDIAS 834
           +V+++   S      +++E M+ G L+  L S              ++   + +  +IA 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY 894
            + YL   ++   +H DL   N ++ ED    + DFGM + +   D      + L  + +
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206

Query: 895 MAPDEIFVGELSLKR--W---VNDLL---------P---VSLVEVVDKSLLSGEEKHFAA 937
           M+P+ +  G  +     W   V  +L         P   +S  +V+   ++ G       
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGV--VLWEIATLAEQPYQGLSNEQVLRF-VMEG--GLLDK 261

Query: 938 KEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI 973
            + C   +F L   C   +P+ R    + I+ + + 
Sbjct: 262 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  104 bits (262), Expect = 1e-24
 Identities = 54/301 (17%), Positives = 102/301 (33%), Gaps = 43/301 (14%)

Query: 336 GNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPL-DGFLPSSIGNLSLS 394
           G  R+L+      +           + SL     L+ L +    +    L  ++  L +S
Sbjct: 40  GGGRSLEYLLKRVDTEADLGQFTDIIKSL----SLKRLTVRAARIPSRILFGALRVLGIS 95

Query: 395 -LERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGG------LQKLQGLD 447
            L+ L +    ++G  P  +   +   +  L   N+S +    +           L+ L 
Sbjct: 96  GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155

Query: 448 LAFNKLAGSIPDEICLLSRLNELDLNGNKISGSI----SSCLGNLTSLQYLNLGSNRFTF 503
           +A         +++ +   L+ LDL+ N   G      + C     +LQ L L +     
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM-- 213

Query: 504 VIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIP-TTLEGLKS 562
                                  G  S        + G+DLS N+L       + +    
Sbjct: 214 -------------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254

Query: 563 LQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLK 622
           L +++L++  L+            L  LDLS N++    P S ++L  +  L+L  N   
Sbjct: 255 LNSLNLSFTGLKQVPKGLP---AKLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPFL 309

Query: 623 G 623
            
Sbjct: 310 D 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 90.7 bits (225), Expect = 7e-20
 Identities = 53/298 (17%), Positives = 81/298 (27%), Gaps = 61/298 (20%)

Query: 287 DLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDI 346
            L+L  L      I S        +   S L  L + +   +G  P  +       L  +
Sbjct: 67  SLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126

Query: 347 FFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNIS 406
              N++ +T                         D +L      L   L+ L+IA  +  
Sbjct: 127 NLRNVSWAT------------------------RDAWLAELQQWLKPGLKVLSIAQAHSL 162

Query: 407 GNIPKAIGNLSNLIVLSLGGNNLSGSIPVT----FGGLQKLQGLDLAFNKLA---GSIPD 459
               + +     L  L L  N   G   +           LQ L L    +    G    
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSA 222

Query: 460 EICLLSRLNELDLNGNKISGSI-SSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSF 518
                 +L  LDL+ N +  +  +      + L  LNL       V       L      
Sbjct: 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSV---- 278

Query: 519 DISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGP 576
                                  +DLS N L    P+  E L  + N+SL  N     
Sbjct: 279 -----------------------LDLSYNRLDR-NPSPDE-LPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 86.9 bits (215), Expect = 1e-18
 Identities = 49/232 (21%), Positives = 81/232 (34%), Gaps = 18/232 (7%)

Query: 414 GNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPD---EICLLSRLNEL 470
           G  S   +L                    L+ L +   ++   I      +  +S L EL
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 471 DLNGNKISGSISSCLGNLT--SLQYLNLGSNRFT----FVIPSTFWNLKDILSFDISSNL 524
            L   +++G+    L   T   L  LNL +  +     ++     W    +    I+   
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160

Query: 525 LDGPISLAIGNLKAVVGIDLSRNNLSGNIP----TTLEGLKSLQNISLAYNRLE---GPI 577
                   +    A+  +DLS N   G              +LQ ++L    +E   G  
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220

Query: 578 PESFGNMTSLESLDLSNNKISGSIPV-SFEKLSYLKELNLSFNKLKGEIPRG 628
                    L+ LDLS+N +  +    S +  S L  LNLSF  LK ++P+G
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 85.3 bits (211), Expect = 5e-18
 Identities = 49/285 (17%), Positives = 85/285 (29%), Gaps = 30/285 (10%)

Query: 78  LNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSS---IFTMSTLKVLYLMDNQLS 134
           L             +I    SLK L +   ++ S I      +  +S L+ L L + +++
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108

Query: 135 GS--LSSFTFNTSSILDIRLSKNKLSG---KLPENICNHLRYLKHLFLRENMFYGKIPSS 189
           G+            +  + L     +     L E        LK L + +          
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168

Query: 190 LSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQL 249
           +     L  L L  N   G                     +    P +   LQ L +   
Sbjct: 169 VRVFPALSTLDLSDNPELGERGL-----------------ISALCPLKFPTLQVLALRNA 211

Query: 250 GFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPS 309
           G    +GV  A       L+ + L +NSL  +  +        L  LNL        +P 
Sbjct: 212 GMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK 270

Query: 310 SITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSS 354
            +   +KL +L++  N        +   L  +    +  N    S
Sbjct: 271 GL--PAKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 79.9 bits (197), Expect = 3e-16
 Identities = 45/221 (20%), Positives = 75/221 (33%), Gaps = 18/221 (8%)

Query: 74  KVTTLNLSSFNLQGTIPPEIANL--SSLKSLDLSHNKLSSNIPS----SIFTMSTLKVLY 127
            +  L L +  + GT PP +       L  L+L +   ++          +    LKVL 
Sbjct: 96  GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155

Query: 128 LMDNQLSGSLSSFTFNTSSILDIRLSKNKLSG--KLPENICNH-LRYLKHLFLRENMF-- 182
           +                 ++  + LS N   G   L   +C      L+ L LR      
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215

Query: 183 -YGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTV-LQRISLINNKLHGEIPQEIGY 240
             G   +  +   QLQ L L +N+L  A      +    L  ++L    L  ++P+ +  
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL-- 272

Query: 241 LQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGS 281
              L VL L +N L          +  +  + L  N    S
Sbjct: 273 PAKLSVLDLSYNRLDRNPS--PDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 75.7 bits (186), Expect = 7e-15
 Identities = 39/184 (21%), Positives = 63/184 (34%), Gaps = 12/184 (6%)

Query: 56  SNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPS 115
           S A+  +W+  +       +  L+++  +       ++    +L +LDLS N        
Sbjct: 132 SWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191

Query: 116 SI----FTMSTLKVLYLMDNQ---LSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNH 168
                     TL+VL L +      SG  S+       +  + LS N L        C+ 
Sbjct: 192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251

Query: 169 LRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINN 228
              L  L L       ++P  L    +L  L L YN L    P     L  +  +SL  N
Sbjct: 252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGN 306

Query: 229 KLHG 232
               
Sbjct: 307 PFLD 310

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  104 bits (262), Expect = 1e-24
 Identities = 66/284 (23%), Positives = 118/284 (41%), Gaps = 52/284 (18%)

Query: 734 IGIGGFGSVYRARL------EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKI 787
           +G G FG V+ A        +D + +A+K       +  K F+ E E++ N++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCL---------------HSSNCALNIFCRLNIMIDI 832
              C + D   +V EYM +G L   L                 +   L +   L+I   I
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 833 ASALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
           AS + YL   HF      +H DL   N L+  +++  + DFGM++ +   D   +   T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 890 ATIGYMAPDEIFVGELSLKR--W---VNDLL---------P---VSLVEVVDKSLLSGEE 932
             I +M P+ I   + + +   W   V  +L         P   +S  EV++  +  G  
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGV--ILWEIFTYGKQPWFQLSNTEVIEC-ITQG-- 251

Query: 933 KHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDT 976
           +       C   ++ + L C    P++R++ K+    L  +   
Sbjct: 252 RVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  103 bits (260), Expect = 2e-24
 Identities = 45/177 (25%), Positives = 81/177 (45%), Gaps = 21/177 (11%)

Query: 734 IGIGGFGSVYRA---RLEDGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKI 787
           +G GG   V+ A   R    V  A+KV     A   S    F  E +    + H  +V +
Sbjct: 20  LGFGGMSEVHLARDLRDHRDV--AVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 788 ISSCSNDDFKA----LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
             +   +        +V+EY+   +L D +H+    +     + ++ D   AL + H   
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNG 136

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG---YMAP 897
              IIH D+KP+N+++       + DFG+A+ ++ +  +++ TQT A IG   Y++P
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSV-TQTAAVIGTAQYLSP 188

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  104 bits (262), Expect = 2e-24
 Identities = 48/232 (20%), Positives = 88/232 (37%), Gaps = 45/232 (19%)

Query: 702 SNDIILSSQPTIRRFSY--FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFH 759
           SN I L+     +      + ++R          +  G F  +     +D    A+K + 
Sbjct: 14  SNLIYLNKYVKEKDKYINDYRIIR---------TLNQGKFNKIILCE-KDNKFYALKKYE 63

Query: 760 -----------------PQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE 802
                                S    F+ E ++I +I++   +      +N D   ++ E
Sbjct: 64  KSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYE 123

Query: 803 YMSNGSLEDCLHSSN-CALNIFCRL------NIMIDIASALEYLHFGHSTPIIHCDLKPS 855
           YM N S+            N  C +       I+  + ++  Y+H   +  I H D+KPS
Sbjct: 124 YMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPS 181

Query: 856 NVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA-TIGYMAPDEIFVGELS 906
           N+L+D++    LSDFG ++ +  +     + +    T  +M P E F  E S
Sbjct: 182 NILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPP-EFFSNESS 227

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  108 bits (270), Expect = 3e-24
 Identities = 39/184 (21%), Positives = 78/184 (42%), Gaps = 16/184 (8%)

Query: 733 IIGIGGFGSVYRARLEDG----VEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNLVKI 787
            IG G FG V++          + +AIK      + +++  F  E   ++   H ++VK+
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL---HFGHS 844
           I   + +    +++E  + G L   L     +L++   +     +++AL YL    F   
Sbjct: 457 IGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF--- 512

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
              +H D+   NVL+  +    L DFG+++ +         ++    I +MAP+ I    
Sbjct: 513 ---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRR 568

Query: 905 LSLK 908
            +  
Sbjct: 569 FTSA 572

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  103 bits (260), Expect = 4e-24
 Identities = 45/195 (23%), Positives = 83/195 (42%), Gaps = 29/195 (14%)

Query: 732 NIIGIGGFGSVYRARLEDGVE------IAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
             +G G FG V+ A   + +       +A+K       S  + F+ E E++  ++H+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCL--------------HSSNCALNIFCRLNIMID 831
           +    C+      +V EYM +G L   L                +   L +   L +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 832 IASALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
           +A+ + YL   HF      +H DL   N L+ + +V  + DFGM++ +   D   +  +T
Sbjct: 167 VAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220

Query: 889 LATIGYMAPDEIFVG 903
           +  I +M P+ I   
Sbjct: 221 MLPIRWMPPESILYR 235

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  104 bits (260), Expect = 4e-24
 Identities = 41/218 (18%), Positives = 79/218 (36%), Gaps = 27/218 (12%)

Query: 708 SSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRAR------LEDGVEIAIKVFHPQ 761
              P I+  + F+L   +     ++++G G F  VY A        ++  +  +KV  P 
Sbjct: 49  CKLPAIKPKTEFQL--GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA 106

Query: 762 CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCL----HSSN 817
                       E +K       +K  S+    +   LV E  S G+L + +    ++  
Sbjct: 107 NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE 166

Query: 818 CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH----------- 866
             +     ++  + +   +E +   H   IIH D+KP N +L    +             
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQV---HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223

Query: 867 LSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
           L D G +  +    + T+ T    T G+    E+   +
Sbjct: 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCV-EMLSNK 260

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  104 bits (261), Expect = 6e-24
 Identities = 27/201 (13%), Positives = 63/201 (31%), Gaps = 40/201 (19%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVF----------------------------HPQCA 763
           ++G     +   A   E G    + V                             + + A
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 764 STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMS-NGSLEDCLH------SS 816
                F    +++K+ + + ++++     +    +    Y     +L+          S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 817 NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL 876
           + +L    RL + + +   L  LH      ++H  L+P +++LD+     L+ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 877 SGEDESTMRTQTLATIGYMAP 897
            G    +   +  A     A 
Sbjct: 262 -GASAVSPIGRGFAPPETTAE 281

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  102 bits (256), Expect = 7e-24
 Identities = 51/261 (19%), Positives = 97/261 (37%), Gaps = 19/261 (7%)

Query: 361 LSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLI 420
           +           +  G + +      +  +L   +  L+     ++  I   +  L+NLI
Sbjct: 12  IFPDPALANAIKIAAGKSNVTD--TVTQADLD-GITTLSAFGTGVT-TIE-GVQYLNNLI 66

Query: 421 VLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGS 480
            L L  N ++   P     L K+  L+L+ N L       I  L  +  LDL   +I+  
Sbjct: 67  GLELKDNQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDV 122

Query: 481 ISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVV 540
             + L  L++LQ L L  N+ T + P     L ++    I +  +   ++  + NL  + 
Sbjct: 123 --TPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LT-PLANLSKLT 176

Query: 541 GIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGS 600
            +    N +S +I   L  L +L  + L  N++         N ++L  + L+N  I+  
Sbjct: 177 TLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQ 232

Query: 601 IPVSFEKLSYLKELNLSFNKL 621
                  L     +       
Sbjct: 233 PVFYNNNLVVPNVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 51/323 (15%), Positives = 114/323 (35%), Gaps = 37/323 (11%)

Query: 309 SSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCK 368
                 +  I +  G ++ +  +     +L  +     F   +T+       +  +    
Sbjct: 13  FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-------IEGVQYLN 63

Query: 369 KLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNN 428
            L  L L  N +     + + NL+  +  L ++   +      AI  L ++  L L    
Sbjct: 64  NLIGLELKDNQITDL--APLKNLT-KITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQ 118

Query: 429 LSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNL 488
           ++   P    GL  LQ L L  N++  +    +  L+ L  L +   ++S  ++  L NL
Sbjct: 119 ITDVTP--LAGLSNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVS-DLTP-LANL 172

Query: 489 TSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNN 548
           + L  L    N+ + +  S   +L +++   + +N +     LA  N   +  + L+   
Sbjct: 173 SKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQT 228

Query: 549 LSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKL 608
           ++         L     +                    +    +S+N    S  +++   
Sbjct: 229 ITNQPVFYNNNLVVPNVVKGPSG-------------APIAPATISDNGTYASPNLTWNLT 275

Query: 609 SYLKELNLSFNKLKGEIPRGGPF 631
           S++  ++ +FN+         PF
Sbjct: 276 SFINNVSYTFNQSVTFKNTTVPF 298

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 60/289 (20%), Positives = 112/289 (38%), Gaps = 22/289 (7%)

Query: 66  IICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKV 125
           I  D        +     N+  T+    A+L  + +L      +++     +  ++ L  
Sbjct: 12  IFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIG 67

Query: 126 LYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGK 185
           L L DNQ++  L+    N + I ++ LS N L       I   L+ +K L L        
Sbjct: 68  LELKDNQIT-DLAPLK-NLTKITELELSGNPLKN--VSAIAG-LQSIKTLDLTSTQITDV 122

Query: 186 IPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLD 245
            P  L+    LQ L+L  N ++   P  +  LT LQ +S+ N ++    P  +  L  L 
Sbjct: 123 TP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLT 176

Query: 246 VLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSG 305
            L+   N ++ + P  + ++  L E+ L NN +S   P        NL  + L   + + 
Sbjct: 177 TLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA---NTSNLFIVTLTNQTITN 231

Query: 306 TIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSS 354
                  N   ++   +   S +   P+ I +       ++ +N  +  
Sbjct: 232 QPVFYNNN--LVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFI 278

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 61/292 (20%), Positives = 108/292 (36%), Gaps = 28/292 (9%)

Query: 146 SILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNN 205
           + + I   K+ ++  + +     L  +  L              +     L  L L  N 
Sbjct: 20  NAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQ 74

Query: 206 LSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNM 265
           ++   P  + NLT +  + L  N L  +    I  LQ++  L L    +T V P  +  +
Sbjct: 75  ITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LAGL 128

Query: 266 STLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSN 325
           S L+ ++L  N ++   P      L NL++L++G    S    + + N SKL  L+   N
Sbjct: 129 SNLQVLYLDLNQITNISPLA---GLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDN 183

Query: 326 SFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLP 385
             S    S + +L NL    +  N ++        +S LAN   L  + L    +     
Sbjct: 184 KISDI--SPLASLPNLIEVHLKNNQISD-------VSPLANTSNLFIVTLTNQTITNQPV 234

Query: 386 SSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTF 437
               NL +       +   I+   P  I +       +L  N  S    V++
Sbjct: 235 FYNNNLVVPNVVKGPSGAPIA---PATISDNGTYASPNLTWNLTSFINNVSY 283

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  101 bits (255), Expect = 7e-24
 Identities = 51/195 (26%), Positives = 91/195 (46%), Gaps = 21/195 (10%)

Query: 714 RRFSYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHP---QCASTLKSF 769
            +   F++           ++G G F  VYRA  +  G+E+AIK+        A  ++  
Sbjct: 8   EKIEDFKVGN---------LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRV 58

Query: 770 EAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM 829
           + E ++   ++H +++++ +   + ++  LVLE   NG +   L +     +     + M
Sbjct: 59  QNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM 118

Query: 830 IDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
             I + + YLH   S  I+H DL  SN+LL  +M   ++DFG+A  L    E   +  TL
Sbjct: 119 HQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE---KHYTL 172

Query: 890 -ATIGYMAPDEIFVG 903
             T  Y++P EI   
Sbjct: 173 CGTPNYISP-EIATR 186

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  102 bits (257), Expect = 8e-24
 Identities = 45/185 (24%), Positives = 75/185 (40%), Gaps = 25/185 (13%)

Query: 732 NIIGIGGFGSVYRARL------EDGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNL 784
             +G G FG VY  ++         +++A+K     C       F  E  +I    H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSS------NCALNIFCRLNIMIDIASALEY 838
           V+ I        + +++E M+ G L+  L  +        +L +   L++  DIA   +Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 839 L---HFGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           L   HF      IH D+   N LL       VA + DFGMA+ +            +  +
Sbjct: 156 LEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209

Query: 893 GYMAP 897
            +M P
Sbjct: 210 KWMPP 214

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  101 bits (254), Expect = 1e-23
 Identities = 47/197 (23%), Positives = 82/197 (41%), Gaps = 31/197 (15%)

Query: 732 NIIGIGGFGSVYRARL------EDGVEIAIKVFHPQCASTLKS-FEAECEVIKNIRHRNL 784
             +G   FG VY+  L      E    +AIK    +    L+  F  E  +   ++H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSS---------------NCALNIFCRLNIM 829
           V ++   + D   +++  Y S+G L + L                    AL     ++++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 830 IDIASALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
             IA+ +EYL   H       +H DL   NVL+ + +   +SD G+ + +   D   +  
Sbjct: 135 AQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188

Query: 887 QTLATIGYMAPDEIFVG 903
            +L  I +MAP+ I  G
Sbjct: 189 NSLLPIRWMAPEAIMYG 205

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score =  103 bits (260), Expect = 2e-23
 Identities = 82/459 (17%), Positives = 155/459 (33%), Gaps = 74/459 (16%)

Query: 97  SSLKSLDLSHNKLS-SNIPSSIFTMSTLKVLYLMDNQLS----GSLSSFTFNTSSILDIR 151
             ++SLD+   +LS +     +  +   +V+ L D  L+      +SS      ++ ++ 
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 152 LSKNKLSGKLPENICNHLRY----LKHLFLRENMF----YGKIPSSLSKCKQLQELHLGY 203
           L  N+L       +   L+     ++ L L+         G + S+L     LQELHL  
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 204 NNLSGAIPKEIG-----NLTVLQRISLINNKLHGEIPQEIGYL----QNLDVLQLGFNNL 254
           N L  A  + +          L+++ L    L     + +  +     +   L +  N++
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182

Query: 255 --TGV---VPATIFNMSTLKEIFLYNNSLSGSLPSRIDLAL---PNLEFLNLGINSFSGT 306
              GV         +   L+ + L +  ++      +   +    +L  L LG N     
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL--- 239

Query: 307 IPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTS-STPELGFLSSLA 365
                           G    +   P  +     L+   I+   +T+    +L     L 
Sbjct: 240 ----------------GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC--RVLR 281

Query: 366 NCKKLRYLGLGGNPLDG----FLPSSIGNLSLSLERLNIAFCNISG----NIPKAIGNLS 417
             + L+ L L GN L       L  ++      LE L +  C+ +     +    +    
Sbjct: 282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNR 341

Query: 418 NLIVLSLGGNNLSGSIPVTFG-GLQ----KLQGLDLAFNKL----AGSIPDEICLLSRLN 468
            L+ L +  N L  +       GL      L+ L LA   +      S+   +     L 
Sbjct: 342 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 401

Query: 469 ELDLNGNKISGSISSCLG-----NLTSLQYLNLGSNRFT 502
           ELDL+ N +  +    L          L+ L L    ++
Sbjct: 402 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 88.5 bits (220), Expect = 2e-18
 Identities = 78/481 (16%), Positives = 149/481 (30%), Gaps = 92/481 (19%)

Query: 66  IICDVNSHKVTTLNLSSFNLQGT----IPPEIANLSSLKSLDLSHNKLSSNIPSSIFTM- 120
            +  +       + L    L       I   +    +L  L+L  N+L       +    
Sbjct: 22  ELLPLLQQ-CQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGL 80

Query: 121 ----STLKVLYLMDNQLS----GSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRY- 171
                 ++ L L +  L+    G LSS      ++ ++ LS N L     + +C  L   
Sbjct: 81  QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDP 140

Query: 172 ---LKHLFLRENMFYGK----IPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRIS 224
              L+ L L            + S L      +EL +  N+++ A  + +          
Sbjct: 141 QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQ-------G 193

Query: 225 LINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNM----STLKEIFLYNNSLSG 280
           L ++               L+ L+L    +T      +  +    ++L+E+ L +N L  
Sbjct: 194 LKDSPC------------QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241

Query: 281 S----LPSRIDLALPNLEFLNLGINSFS----GTIPSSITNASKLILLEMGSNSFS---- 328
                L   +      L  L +     +    G +   +     L  L +  N       
Sbjct: 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 301

Query: 329 -GFIPSAIGNLRNLKLFDIFFNNLTS-STPELGFLSSLANCKKLRYLGLGGNPLDG---- 382
                + +     L+   +   + T+         S LA  + L  L +  N L+     
Sbjct: 302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFS--SVLAQNRFLLELQISNNRLEDAGVR 359

Query: 383 FLPSSIGNLSLSLERLNIAFCNIS----GNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFG 438
            L   +G     L  L +A C++S     ++   +    +L  L L  N L         
Sbjct: 360 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG-------- 411

Query: 439 GLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKIS----GSISSCLGNLTSLQYL 494
                   D    +L  S+    C    L +L L     S      + +   +  SL+ +
Sbjct: 412 --------DAGILQLVESVRQPGC---LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 460

Query: 495 N 495
           +
Sbjct: 461 S 461

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 87.3 bits (217), Expect = 4e-18
 Identities = 97/521 (18%), Positives = 158/521 (30%), Gaps = 122/521 (23%)

Query: 145 SSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGK----IPSSLSKCKQLQELH 200
             I  + +   +LS      +   L+  + + L +          I S+L     L EL+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 201 LGYNNLSGAIPKEIGNL-----TVLQRISLINNKLHGE----IPQEIGYLQNLDVLQLGF 251
           L  N L       +          +Q++SL N  L G     +   +  L  L  L L  
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 252 NNLTGVVPATIFNM-----STLKEIFLYNNSLSGSLPSRIDLAL---PNLEFLNLGINSF 303
           N L       +          L+++ L   SLS +    +   L   P+ + L +  N  
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182

Query: 304 SGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSS 363
           +                E G       +  +   L  LKL       +TS          
Sbjct: 183 N----------------EAGVRVLCQGLKDSPCQLEALKLES---CGVTSDNCR-DLCGI 222

Query: 364 LANCKKLRYLGLGGNPLDG----FLPSSIGNLSLSLERLNIAFCNIS----GNIPKAIGN 415
           +A+   LR L LG N L       L   + + S  L  L I  C I+    G++ + +  
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282

Query: 416 LSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGN 475
             +L  LSL GN L                 D     L  ++ +  C   +L  L +   
Sbjct: 283 KESLKELSLAGNELG----------------DEGARLLCETLLEPGC---QLESLWVKSC 323

Query: 476 KISG----SISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISL 531
             +       SS L     L  L + +N            L+D            G   L
Sbjct: 324 SFTAACCSHFSSVLAQNRFLLELQISNN-----------RLED-----------AGVREL 361

Query: 532 AIG---NLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLE 588
             G       +  + L+  ++      +     SL                +     SL 
Sbjct: 362 CQGLGQPGSVLRVLWLADCDV------SDSSCSSLA--------------ATLLANHSLR 401

Query: 589 SLDLSNNKISGSIPVSFEKL-----SYLKELNLSFNKLKGE 624
            LDLSNN +  +  +   +        L++L L       E
Sbjct: 402 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 64.6 bits (158), Expect = 7e-11
 Identities = 49/261 (18%), Positives = 90/261 (34%), Gaps = 46/261 (17%)

Query: 391 LSLSLERLNIAFCNISGN-IPKAIGNLSNLIVLSLGGNNLS----GSIPVTFGGLQKLQG 445
           +SL ++ L+I    +S     + +  L    V+ L    L+      I         L  
Sbjct: 1   MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60

Query: 446 LDLAFNKLAGSIPDEICLL-----SRLNELDLNGNKIS----GSISSCLGNLTSLQYLNL 496
           L+L  N+L       +         ++ +L L    ++    G +SS L  L +LQ L+L
Sbjct: 61  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120

Query: 497 GSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLS----GN 552
             N            L D     +   LLD    L          + L   +LS      
Sbjct: 121 SDN-----------LLGDAGLQLLCEGLLDPQCRLEK--------LQLEYCSLSAASCEP 161

Query: 553 IPTTLEGLKSLQNISLAYNRLEGP----IPESFG-NMTSLESLDLSNNKIS----GSIPV 603
           + + L      + ++++ N +       + +    +   LE+L L +  ++      +  
Sbjct: 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221

Query: 604 SFEKLSYLKELNLSFNKLKGE 624
                + L+EL L  NKL   
Sbjct: 222 IVASKASLRELALGSNKLGDV 242

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  102 bits (256), Expect = 2e-23
 Identities = 46/185 (24%), Positives = 75/185 (40%), Gaps = 25/185 (13%)

Query: 732 NIIGIGGFGSVYRARL------EDGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNL 784
             +G G FG VY  ++         +++A+K     C       F  E  +I    H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSS------NCALNIFCRLNIMIDIASALEY 838
           V+ I        + ++LE M+ G L+  L  +        +L +   L++  DIA   +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 839 L---HFGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
           L   HF      IH D+   N LL       VA + DFGMA+ +            +  +
Sbjct: 197 LEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250

Query: 893 GYMAP 897
            +M P
Sbjct: 251 KWMPP 255

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  101 bits (253), Expect = 3e-23
 Identities = 29/207 (14%), Positives = 52/207 (25%), Gaps = 44/207 (21%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHP---QCASTLKSFEAECEVIKNIRHRNLVKII 788
            + +G    V+  R +E   + A+KVF        S L+           +   +  +  
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 789 SSC----------------------SNDDFKA----LVLEYMS-----NGSLEDCLHSSN 817
                                      DD+      L++   S       S  D ++   
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 818 CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS 877
               I     +   +      L    S  ++H    P N+ +  D    L D        
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242

Query: 878 GEDESTMRTQTLATIGYMAPDEIFVGE 904
              +   R    +     AP E     
Sbjct: 243 ---KVGTRGPASSVPVTYAPREFLNAS 266

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 99.6 bits (249), Expect = 5e-23
 Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 47/214 (21%)

Query: 723 RATDNFAEN----NIIGIGGFGSVYRAR-LEDGVEIAIKVF---------HPQCASTLKS 768
            +T  F EN     I+G G    V R        E A+K+            +     ++
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 769 FEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL- 826
              E ++++ +  H N++++  +   + F  LV + M  G L             F  L 
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLT 116

Query: 827 -----------NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL 875
                       IM  +   +  LH  +   I+H DLKP N+LLD+DM   L+DFG +  
Sbjct: 117 EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173

Query: 876 LSGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
           L  +    +R     T  Y+AP EI    ++   
Sbjct: 174 L--DPGEKLRE-VCGTPSYLAP-EIIECSMNDNH 203

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 98.8 bits (247), Expect = 6e-23
 Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 24/200 (12%)

Query: 709 SQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLK 767
           S+        FE+ R          +G G FG+VY AR  +    +A+KV          
Sbjct: 1   SKKRQWALEDFEIGR---------PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG 51

Query: 768 SFE---AECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFC 824
                  E E+  ++RH N++++     +     L+LEY   G++   L   +       
Sbjct: 52  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 111

Query: 825 RLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
               + ++A+AL Y H   S  +IH D+KP N+LL       ++DFG +           
Sbjct: 112 A-TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----- 162

Query: 885 RTQTL-ATIGYMAPDEIFVG 903
           R   L  T+ Y+ P E+  G
Sbjct: 163 RRTDLCGTLDYLPP-EMIEG 181

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 43/202 (21%), Positives = 83/202 (41%), Gaps = 28/202 (13%)

Query: 732 NIIGIGGFGSVYRARL------EDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-RHRN 783
             +G G FG V  A        +  + +A+K+  P    T  ++  +E +V+  +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCL-----------------HSSNCALNIFCRL 826
           +V ++ +C+      ++ EY   G L + L                      AL++   L
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 827 NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
           +    +A  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +    ++ 
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 887 QTLATIGYMAPDEIFVGELSLK 908
                + +MAP+ IF    + +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFE 227

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 98.8 bits (247), Expect = 1e-22
 Identities = 46/200 (23%), Positives = 82/200 (41%), Gaps = 33/200 (16%)

Query: 732 NIIGIGGFGSVYRARL------EDGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNL 784
             +G G FG V +A             +A+K+       S L+   +E  V+K + H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR------------------- 825
           +K+  +CS D    L++EY   GSL   L  S      +                     
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 826 ----LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE 881
               ++    I+  ++YL       ++H DL   N+L+ E     +SDFG+++ +  ED 
Sbjct: 149 MGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

Query: 882 STMRTQTLATIGYMAPDEIF 901
              R+Q    + +MA + +F
Sbjct: 206 YVKRSQGRIPVKWMAIESLF 225

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 98.0 bits (245), Expect = 1e-22
 Identities = 42/175 (24%), Positives = 70/175 (40%), Gaps = 13/175 (7%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKS---FEAECEVIKNIRHRNLVKIIS 789
           +G GGF   +     +     A K+                 E  + +++ H+++V    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
              ++DF  +VLE     SL +             R   +  I    +YLH      +IH
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVIH 138

Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEIFVG 903
            DLK  N+ L+ED+   + DFG+A  +  + E   R + L  T  Y+AP E+   
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAP-EVLSK 189

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  102 bits (254), Expect = 2e-22
 Identities = 48/238 (20%), Positives = 93/238 (39%), Gaps = 18/238 (7%)

Query: 386 SSIGNLS--LSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKL 443
             I          + N+   +++  +      L+++  +    +++  S+      L  +
Sbjct: 12  KQIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNV 67

Query: 444 QGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTF 503
             L L  NKL   I   +  L  L  L L+ NKI   +SS L +L  L+ L+L  N  + 
Sbjct: 68  TKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISD 123

Query: 504 VIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSL 563
           +      +L  + S  + +N +     L+   L  +  + L  N +S +I   L GL  L
Sbjct: 124 ING--LVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIVP-LAGLTKL 177

Query: 564 QNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKL 621
           QN+ L+ N +      +   + +L+ L+L + +           L     +  +   L
Sbjct: 178 QNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  100 bits (249), Expect = 8e-22
 Identities = 65/356 (18%), Positives = 109/356 (30%), Gaps = 80/356 (22%)

Query: 268 LKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSF 327
           + E    +  +    P   D A       NL   S +  +       + +  +   ++  
Sbjct: 1   MGETITVSTPIKQIFP---DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI 55

Query: 328 SGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSS 387
                  I  L N+    +  N LT        +  L N K L +L L  N +       
Sbjct: 56  KSV--QGIQYLPNVTKLFLNGNKLTD-------IKPLTNLKNLGWLFLDENKI-----KD 101

Query: 388 IGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLD 447
           + +L                       +L  L  LSL  N +S  I      L +L+ L 
Sbjct: 102 LSSLK----------------------DLKKLKSLSLEHNGIS-DING-LVHLPQLESLY 137

Query: 448 LAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPS 507
           L  NK+  +    +  L++L+ L L  N+IS  I   L  LT LQ L L  N  +     
Sbjct: 138 LGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS----- 188

Query: 508 TFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNIS 567
                      D+           A+  LK +  ++L               L     + 
Sbjct: 189 -----------DLR----------ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 227

Query: 568 LAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKG 623
                L  P   S       +  D     +   +P    ++S++    ++  K K 
Sbjct: 228 NTDGSLVTPEIIS-------DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 84.8 bits (209), Expect = 5e-17
 Identities = 59/294 (20%), Positives = 110/294 (37%), Gaps = 56/294 (19%)

Query: 66  IICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKV 125
           I  D    +    NL   ++   +      L+S+  +  +++ + S     I  +  +  
Sbjct: 14  IFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--VQGIQYLPNVTK 69

Query: 126 LYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGK 185
           L+L  N+L+  +                              +L+ L  LFL EN    K
Sbjct: 70  LFLNGNKLT-DIKPL--------------------------TNLKNLGWLFLDEN----K 98

Query: 186 IP--SSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQN 243
           I   SSL   K+L+ L L +N +S      + +L  L+ + L NNK+       +  L  
Sbjct: 99  IKDLSSLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKI--TDITVLSRLTK 154

Query: 244 LDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDL----ALPNLEFLNLG 299
           LD L L  N ++ +VP  +  ++ L+ ++L  N +S       DL     L NL+ L L 
Sbjct: 155 LDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-------DLRALAGLKNLDVLELF 205

Query: 300 INSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTS 353
                    +  +N      ++    S     P  I +  + +  ++ ++    
Sbjct: 206 SQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEF 257

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 98.9 bits (247), Expect = 2e-22
 Identities = 42/181 (23%), Positives = 70/181 (38%), Gaps = 25/181 (13%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKS---FEAECEVIKNIRHRNLVKIIS 789
           +G GGF   +     +     A K+                 E  + +++ H+++V    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN------IMIDIASALEYLHFGH 843
              ++DF  +VLE     SL +              L        +  I    +YLH   
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRK-------ALTEPEARYYLRQIVLGCQYLH--- 158

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIGYMAPDEIFV 902
              +IH DLK  N+ L+ED+   + DFG+A  +  + E   R + L  T  Y+AP E+  
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAP-EVLS 214

Query: 903 G 903
            
Sbjct: 215 K 215

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 99.7 bits (248), Expect = 2e-22
 Identities = 27/202 (13%), Positives = 65/202 (32%), Gaps = 45/202 (22%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVF----------------------------HPQCA 763
           ++G     +   A   E G    + V                             + + A
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 764 STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM-SNGSLEDCLH------SS 816
                F    +++K+ + + ++++     +    +    Y     +L+          S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 817 NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL 876
           + +L    RL + + +   L  LH      ++H  L+P +++LD+     L+ F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 877 SGEDESTMRTQTLATIGYMAPD 898
                   R  +  + G+  P+
Sbjct: 255 ----RDGARVVSSVSRGFEPPE 272

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 98.5 bits (246), Expect = 2e-22
 Identities = 40/191 (20%), Positives = 83/191 (43%), Gaps = 24/191 (12%)

Query: 732 NIIGIGGFGSVYRARL------EDGVEIAIKVFHPQC-ASTLKSFEAECEVIKNI-RHRN 783
             +G G FG V  A        +  +++A+K+      A   ++  +E +++ ++ +H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSL-------------EDCLHSSNCALNIFCRLNIMI 830
           +V ++ +C++     ++ EY   G L             +     +N   +    L+   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            +A  + +L   +    IH D+   NVLL    VA + DFG+A+ +  +    ++     
Sbjct: 172 QVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228

Query: 891 TIGYMAPDEIF 901
            + +MAP+ IF
Sbjct: 229 PVKWMAPESIF 239

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 57/187 (30%), Positives = 82/187 (43%), Gaps = 20/187 (10%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFE---AECE 774
           F+  +         I+G G F +V  AR        AIK+   +             E +
Sbjct: 32  FKFGK---------ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 82

Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           V+  + H   VK+  +  +D+     L Y  NG L   +           R     +I S
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVS 141

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIG 893
           ALEYLH      IIH DLKP N+LL+EDM   ++DFG AK+LS E +   R  +   T  
Sbjct: 142 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQ 197

Query: 894 YMAPDEI 900
           Y++P E+
Sbjct: 198 YVSP-EL 203

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 98.1 bits (245), Expect = 3e-22
 Identities = 47/185 (25%), Positives = 76/185 (41%), Gaps = 20/185 (10%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKV-----FHPQCASTLKSFEAECEVIKNIRHRNLVK 786
           +IG G F  V R    E G + A+K+     F      + +  + E  +   ++H ++V+
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 787 IISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIF----CRLNIMIDIASALEYLHFG 842
           ++ + S+D    +V E+M    L   +     A  ++       + M  I  AL Y    
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS-HYMRQILEALRYC--- 146

Query: 843 HSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
           H   IIH D+KP  VLL   +      L  FG+A  L            + T  +MAP E
Sbjct: 147 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL-VAGG-RVGTPHFMAP-E 203

Query: 900 IFVGE 904
           +   E
Sbjct: 204 VVKRE 208

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 98.6 bits (246), Expect = 3e-22
 Identities = 62/289 (21%), Positives = 114/289 (39%), Gaps = 60/289 (20%)

Query: 732 NIIGIGGFGSVYRARL--------EDGVEIAIKVFHPQC-ASTLKSFEAECEVIKNI-RH 781
             +G G FG V  A          ++ V +A+K+         L    +E E++K I +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSL---------------EDCLHSSNCALNIFCRL 826
           +N++ ++ +C+ D    +++EY S G+L                D        +     +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 827 NIMIDIASALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST 883
           +    +A  +EYL           IH DL   NVL+ E+ V  ++DFG+A+ ++  D   
Sbjct: 207 SCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260

Query: 884 MRTQTLATIGYMAPDEIFVGELSLKR--W---VNDLL---------P---VSLVEVVDKS 926
             T     + +MAP+ +F    + +   W   V  L+         P   + + E+    
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV--LMWEIFTLGGSPYPGIPVEELFKL- 317

Query: 927 LLSGE--EKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI 973
           L  G   +K       C   ++ +  +C    P +R   K  +  L +I
Sbjct: 318 LKEGHRMDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 97.3 bits (243), Expect = 4e-22
 Identities = 41/201 (20%), Positives = 80/201 (39%), Gaps = 27/201 (13%)

Query: 732 NIIGIGGFGSVYRARL------EDGVEIAIKVFHPQC-ASTLKSFEAECEVIKNI-RHRN 783
             +G G FG V  A             +A+K+       S  ++  +E +++ +I  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 784 LVKIISSCSNDDFKALV-LEYMSNGSL---------------EDCLHSSNCALNIFCRLN 827
           +V ++ +C+      +V +E+   G+L                         L +   + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 828 IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ 887
               +A  +E+L        IH DL   N+LL E  V  + DFG+A+ +  + +   +  
Sbjct: 153 YSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209

Query: 888 TLATIGYMAPDEIFVGELSLK 908
               + +MAP+ IF    +++
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQ 230

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 97.8 bits (244), Expect = 5e-22
 Identities = 45/199 (22%), Positives = 82/199 (41%), Gaps = 39/199 (19%)

Query: 732 NIIGIGGFGSVYRARLEDGVE------IAIKVFHPQCASTLKS-FEAECEVIKNIRHRNL 784
             IG G FG V++AR    +       +A+K+   + ++ +++ F+ E  ++    + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR------------------- 825
           VK++  C+      L+ EYM+ G L + L S +                           
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 826 ----LNIMIDIASALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG 878
               L I   +A+ + YL    F      +H DL   N L+ E+MV  ++DFG+++ +  
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYS 226

Query: 879 EDESTMRTQTLATIGYMAP 897
            D           I +M P
Sbjct: 227 ADYYKADGNDAIPIRWMPP 245

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 97.4 bits (243), Expect = 5e-22
 Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 34/225 (15%)

Query: 708 SSQPTIRRFSYFELLRATD-NFAENNI-----IGIGGFGSVYRARL--------EDGVEI 753
           S  P +   S +EL       F  + +     +G G FG V  A          ++ V +
Sbjct: 11  SQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTV 70

Query: 754 AIKVFHPQCAST-LKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYMSNGSL-- 809
           A+K+         L    +E E++K I +H+N++ ++ +C+ D    +++EY S G+L  
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130

Query: 810 -------------EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSN 856
                         D        +     ++    +A  +EYL        IH DL   N
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187

Query: 857 VLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
           VL+ E+ V  ++DFG+A+ ++  D     T     + +MAP+ +F
Sbjct: 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF 232

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 96.6 bits (241), Expect = 5e-22
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 18/179 (10%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRN 783
              +     IG G  G+VY A  +  G E+AI+  + Q     +    E  V++  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALN-----IFCRLNIMIDIASALEY 838
           +V  + S    D   +V+EY++ GSL D +      ++       CR     +   ALE+
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCR-----ECLQALEF 131

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           LH   S  +IH D+K  N+LL  D    L+DFG    ++   E + R+  + T  +MAP
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAP 185

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 96.2 bits (240), Expect = 6e-22
 Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 40/240 (16%)

Query: 390 NLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLDL 448
           NL  S + L+++F  +      +  +   L VL L    +  +I    +  L  L  L L
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLIL 83

Query: 449 AFNKLAGSIPDEICL-LSRLNELDLNGNKISGSISSCL-GNLTSLQYLNLGSNRFTFVI- 505
             N +  S+       LS L +L      ++ S+ +   G+L +L+ LN+  N       
Sbjct: 84  TGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKL 141

Query: 506 PSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPT-TLEGLKSLQ 564
           P  F NL                      NL+    +DLS N +  +I    L  L  + 
Sbjct: 142 PEYFSNL---------------------TNLEH---LDLSSNKIQ-SIYCTDLRVLHQMP 176

Query: 565 ----NISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPV-SFEKLSYLKELNLSFN 619
               ++ L+ N +    P +F  +  L+ L L  N++  S+P   F++L+ L+++ L  N
Sbjct: 177 LLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 92.3 bits (230), Expect = 9e-21
 Identities = 59/235 (25%), Positives = 93/235 (39%), Gaps = 19/235 (8%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQLS 134
            T      N    IP  +    S K+LDLS N L   + S  F     L+VL L   ++ 
Sbjct: 10  ITYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQ 65

Query: 135 GSLSSFTFNTSSILDI-RLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSL-SK 192
            ++    + + S L    L+ N +   L     + L  L+ L   E      + +     
Sbjct: 66  -TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNL-ASLENFPIGH 122

Query: 193 CKQLQELHLGYNNLSGAIPKEI-GNLTVLQRISLINNKLHGEIPQEI-GYLQNLDV---- 246
            K L+EL++ +N +      E   NLT L+ + L +NK+   I       L  + +    
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLS 181

Query: 247 LQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGIN 301
           L L  N +   +    F    LKE+ L  N L  S+P  I   L +L+ + L  N
Sbjct: 182 LDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 53/228 (23%), Positives = 91/228 (39%), Gaps = 41/228 (17%)

Query: 408 NIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICL-LSR 466
           N+P       +   L L  N L      +F    +LQ LDL+  ++  +I D     LS 
Sbjct: 25  NLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 467 LNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLD 526
           L+ L L GN I          L+SLQ L                         + +  + 
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA----------------SLENFPIG 121

Query: 527 GPISLAIGNLKAVVGIDLSRNNL-SGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMT 585
              +L          ++++ N + S  +P     L +L+++ L+ N+++         + 
Sbjct: 122 HLKTLKE--------LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH 173

Query: 586 SLE----SLDLSNNKISGSIPV-SFEKLSYLKELNLSFNKLKGEIPRG 628
            +     SLDLS N ++  I   +F+++  LKEL L  N+LK  +P G
Sbjct: 174 QMPLLNLSLDLSLNPMN-FIQPGAFKEIR-LKELALDTNQLK-SVPDG 218

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 52/227 (22%), Positives = 88/227 (38%), Gaps = 22/227 (9%)

Query: 307 IPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLAN 366
           +P S  N      L++  N        +  +   L++ D+    + +     G   SL++
Sbjct: 26  LPFSTKN------LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED--GAYQSLSH 77

Query: 367 CKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGG 426
              L  L L GNP+   L     +   SL++L     N++      IG+L  L  L++  
Sbjct: 78  ---LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133

Query: 427 NNLSGSIPV--TFGGLQKLQGLDLAFNKLAGSIPDEI-----CLLSRLNELDLNGNKISG 479
           N +  S  +   F  L  L+ LDL+ NK+  SI          +      LDL+ N ++ 
Sbjct: 134 NLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN- 190

Query: 480 SISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLD 526
            I         L+ L L +N+   V    F  L  +    + +N  D
Sbjct: 191 FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 58/248 (23%), Positives = 88/248 (35%), Gaps = 41/248 (16%)

Query: 258 VPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKL 317
           +P  +    + K + L  N L   L S    + P L+ L+L       TI          
Sbjct: 22  IPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGA------ 71

Query: 318 ILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGG 377
                    +          L +L    +  N + S           +    L+ L    
Sbjct: 72  ---------YQS--------LSHLSTLILTGNPIQSLALGA-----FSGLSSLQKLVAVE 109

Query: 378 NPLDGFLPSSIGNLSLSLERLNIAFCNI-SGNIPKAIGNLSNLIVLSLGGNNLSGSIPV- 435
             L       IG+L  +L+ LN+A   I S  +P+   NL+NL  L L  N +  SI   
Sbjct: 110 TNLASLENFPIGHLK-TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCT 167

Query: 436 TFGGLQKLQG----LDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSL 491
               L ++      LDL+ N +   I        RL EL L+ N++          LTSL
Sbjct: 168 DLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSL 226

Query: 492 QYLNLGSN 499
           Q + L +N
Sbjct: 227 QKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 78.1 bits (193), Expect = 7e-16
 Identities = 48/271 (17%), Positives = 92/271 (33%), Gaps = 41/271 (15%)

Query: 100 KSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDI-RLSKNKLS 158
            +           IP ++    + K L L  N L   L S++F +   L +  LS+ ++ 
Sbjct: 10  ITYQCMELNFYK-IPDNLPF--STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ 65

Query: 159 GKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEI-GNL 217
             + +     L                          L  L L  N +  ++       L
Sbjct: 66  -TIEDGAYQSL------------------------SHLSTLILTGNPIQ-SLALGAFSGL 99

Query: 218 TVLQRISLINNKLHGEIPQEI-GYLQNLDVLQLGFNNLTGVVPATIF-NMSTLKEIFLYN 275
           + LQ++  +   L   +     G+L+ L  L +  N +        F N++ L+ + L +
Sbjct: 100 SSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158

Query: 276 NSLSGSLPSRIDLALPNLEF----LNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFI 331
           N +  S+       L  +      L+L +N  +  I        +L  L + +N      
Sbjct: 159 NKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVP 216

Query: 332 PSAIGNLRNLKLFDIFFNNLTSSTPELGFLS 362
                 L +L+   +  N    S P + +LS
Sbjct: 217 DGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 247

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 96.5 bits (241), Expect = 6e-22
 Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 37/188 (19%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSC 791
           ++G G F  V+  +    G   A+K      A    S E E  V+K I+H N+V +    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL------------NIMIDIASALEYL 839
            +     LV++ +S G L             F R+             ++  + SA++YL
Sbjct: 76  ESTTHYYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQVLSAVKYL 122

Query: 840 HFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
           H      I+H DLKP N+L    +E+    ++DFG++K+   E    M T    T GY+A
Sbjct: 123 H---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMST-ACGTPGYVA 175

Query: 897 PDEIFVGE 904
           P E+   +
Sbjct: 176 P-EVLAQK 182

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 96.6 bits (241), Expect = 7e-22
 Identities = 44/177 (24%), Positives = 81/177 (45%), Gaps = 12/177 (6%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRN 783
            + +     +G G FG VY+A+  E G   A KV   +    L+ +  E E++    H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +VK++ +  +D    +++E+   G+++  +   +  L       +   +  AL +LH   
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG---YMAP 897
              IIH DLK  NVL+  +    L+DFG++       ++  +  +   IG   +MAP
Sbjct: 138 ---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL---KTLQKRDSF--IGTPYWMAP 186

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 96.3 bits (240), Expect = 1e-21
 Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 18/179 (10%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRN 783
                    IG G  G V  AR    G ++A+K+   +     +    E  ++++ +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALN-----IFCRLNIMIDIASALEY 838
           +V++  S    +   +++E++  G+L D +      LN       C       +  AL Y
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCE-----AVLQALAY 156

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           LH   +  +IH D+K  ++LL  D    LSDFG    +S   +   R   + T  +MAP
Sbjct: 157 LH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS--KDVPKRKSLVGTPYWMAP 210

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 97.4 bits (243), Expect = 1e-21
 Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 28/196 (14%)

Query: 731 NNIIGIGGFGSVYRARL--------EDGVEIAIKVFHPQCAST-LKSFEAECEVIKNI-R 780
              +G G FG V  A              ++A+K+         L    +E E++K I +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCL---------------HSSNCALNIFCR 825
           H+N++ ++ +C+ D    +++EY S G+L + L               H+    L+    
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 826 LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR 885
           ++    +A  +EYL        IH DL   NVL+ ED V  ++DFG+A+ +   D     
Sbjct: 194 VSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

Query: 886 TQTLATIGYMAPDEIF 901
           T     + +MAP+ +F
Sbjct: 251 TNGRLPVKWMAPEALF 266

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 95.8 bits (239), Expect = 2e-21
 Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 48/201 (23%)

Query: 732 NIIGIGGFGSVYRARLEDG---VEIAIKVFHPQCASTLKS---------FEAECEVIKNI 779
           ++IG G FG V +AR++     ++ AIK         +K          F  E EV+  +
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIK--------RMKEYASKDDHRDFAGELEVLCKL 82

Query: 780 -RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR------------- 825
             H N++ ++ +C +  +  L +EY  +G+L D L  S                      
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 826 --LNIMIDIASALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED 880
             L+   D+A  ++YL    F      IH DL   N+L+ E+ VA ++DFG+++   G++
Sbjct: 143 QLLHFAADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSR---GQE 193

Query: 881 ESTMRTQTLATIGYMAPDEIF 901
               +T     + +MA + + 
Sbjct: 194 VYVKKTMGRLPVRWMAIESLN 214

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 95.8 bits (239), Expect = 2e-21
 Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 33/199 (16%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFH--------PQCASTLKSFEAECEV 775
            D +  +  +G G  G V  A   +   ++AIK+           + A    + E E E+
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 776 IKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLED------CLHSSNCALNIFCRLNIM 829
           +K + H  ++KI +    +D+  +VLE M  G L D       L  + C           
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK-------LYF 120

Query: 830 IDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRT 886
             +  A++YLH      IIH DLKP NVLL   +ED +  ++DFG +K+L   + S MRT
Sbjct: 121 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT 175

Query: 887 QTLATIGYMAPDEIFVGEL 905
               T  Y+AP E+ V   
Sbjct: 176 -LCGTPTYLAP-EVLVSVG 192

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 46/198 (23%), Positives = 83/198 (41%), Gaps = 24/198 (12%)

Query: 723 RATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVI---KN 778
           R T  F E   IG G FGSV++     DG   AIK      A ++    A  EV      
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR---LNIMIDIASA 835
            +H ++V+  S+ + DD   +  EY + GSL D +  +   ++ F      ++++ +   
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE----------STMR 885
           L Y+H   S  ++H D+KPSN+ +    + + +     +     ++           T  
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 886 TQTLATIG---YMAPDEI 900
           +      G   ++A  E+
Sbjct: 185 SSPQVEEGDSRFLAN-EV 201

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 47/190 (24%), Positives = 81/190 (42%), Gaps = 24/190 (12%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAECE 774
           F++ R          +G G FG+VY AR  ++   +A+KV      +          E E
Sbjct: 16  FDIGR---------PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE 66

Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           +  ++RH N++++ +   +     L+LE+   G L   L               M ++A 
Sbjct: 67  IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELAD 125

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIG 893
           AL Y H      +IH D+KP N+L+       ++DFG +           R +T+  T+ 
Sbjct: 126 ALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTLD 177

Query: 894 YMAPDEIFVG 903
           Y+ P E+  G
Sbjct: 178 YLPP-EMIEG 186

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 64/294 (21%), Positives = 110/294 (37%), Gaps = 46/294 (15%)

Query: 708 SSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFH-PQCAST 765
               +  R + +      D F     +G G FG V+       G+E  IK  +  +    
Sbjct: 4   HHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP 63

Query: 766 LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR 825
           ++  EAE EV+K++ H N++KI     +     +V+E    G L + + S+         
Sbjct: 64  MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123

Query: 826 L---NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGE 879
                +M  + +AL Y H  H   ++H DLKP N+L           + DFG+A+L   +
Sbjct: 124 GYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--K 178

Query: 880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDK-S-------LLSGE 931
            +         T  YMAP E+F  +++ K               D  S       LL+G 
Sbjct: 179 SDEHSTN-AAGTALYMAP-EVFKRDVTFK--------------CDIWSAGVVMYFLLTGC 222

Query: 932 EKHFAAKEQCLLSIFSLALEC--TMESPEKRI--DAKDTITRLLKIRDTLSKRI 981
                   +    +   A           + +   A D + ++L  +D   +R 
Sbjct: 223 LPFTGTSLE---EVQQKATYKEPNYAVECRPLTPQAVDLLKQML-TKDP-ERRP 271

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 94.4 bits (235), Expect = 4e-21
 Identities = 52/179 (29%), Positives = 79/179 (44%), Gaps = 18/179 (10%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRN 783
            + F     +G G +GSVY+A   E G  +AIK    +  S L+    E  +++     +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALN-----IFCRLNIMIDIASALEY 838
           +VK   S   +    +V+EY   GS+ D +   N  L         +          LEY
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ-----STLKGLEY 140

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           LH       IH D+K  N+LL+ +  A L+DFG+A  L+  D    R   + T  +MAP
Sbjct: 141 LH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT--DTMAKRNTVIGTPFWMAP 194

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 95.1 bits (237), Expect = 4e-21
 Identities = 42/200 (21%), Positives = 80/200 (40%), Gaps = 33/200 (16%)

Query: 732 NIIGIGGFGSVYRARL------EDGVEIAIKVFHPQC-ASTLKSFEAECEVIKNI-RHRN 783
            ++G G FG V  A           +++A+K+   +  +S  ++  +E +++  +  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCL----------------------HSSNCALN 821
           +V ++ +C+      L+ EY   G L + L                            L 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 822 IFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE 881
               L     +A  +E+L F      +H DL   NVL+    V  + DFG+A+ +  +  
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227

Query: 882 STMRTQTLATIGYMAPDEIF 901
             +R      + +MAP+ +F
Sbjct: 228 YVVRGNARLPVKWMAPESLF 247

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 95.2 bits (237), Expect = 5e-21
 Identities = 55/213 (25%), Positives = 85/213 (39%), Gaps = 46/213 (21%)

Query: 723 RATDNFAEN----NIIGIGGFGSVYRAR-LEDGVEIAIKVF--------HPQCASTLKSF 769
            A   F +     ++IG G    V R      G E A+K+           Q     ++ 
Sbjct: 87  AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146

Query: 770 EAECEVIKNIR-HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL-- 826
             E  +++ +  H +++ +I S  +  F  LV + M  G L             F  L  
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL-------------FDYLTE 193

Query: 827 ----------NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL 876
                     +IM  +  A+ +LH  +   I+H DLKP N+LLD++M   LSDFG +  L
Sbjct: 194 KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHL 250

Query: 877 SGEDESTMRTQTLATIGYMAPDEIFVGELSLKR 909
             E    +R     T GY+AP EI    +    
Sbjct: 251 --EPGEKLRE-LCGTPGYLAP-EILKCSMDETH 279

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 93.9 bits (234), Expect = 6e-21
 Identities = 69/294 (23%), Positives = 108/294 (36%), Gaps = 70/294 (23%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKIISS 790
           ++G G    V     L    E A+K+   Q          E E++   + HRN++++I  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNC------ALNIFCRLNIMIDIASALEYLHFGHS 844
              +D   LV E M  GS+   +H          +        ++ D+ASAL++LH   +
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS-------VVVQDVASALDFLH---N 129

Query: 845 TPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLS-GEDESTMRTQTLATI----GYMA 896
             I H DLKP N+L    ++     + DF +   +    D S + T  L T      YMA
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189

Query: 897 PDEIFVGELSLKRWVNDLLPVSLVEVVDKS------------LLSG------------EE 932
           P E+      ++ +  +          DK             LLSG              
Sbjct: 190 P-EV------VEAFSEEASI------YDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236

Query: 933 KHFAAKEQCLLSIFSLALEC--TMESPE-KRI--DAKDTITRLLKIRDTLSKRI 981
               A   C   +F    E        +   I   AKD I++LL  RD   +R+
Sbjct: 237 DRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLV-RDA-KQRL 288

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 95.1 bits (237), Expect = 6e-21
 Identities = 56/188 (29%), Positives = 90/188 (47%), Gaps = 23/188 (12%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFE---AECE 774
           FE+LRA         IG G FG V   +  D  ++ A+K  + Q             E +
Sbjct: 17  FEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67

Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           +++ + H  LV +  S  +++   +V++ +  G L   L  +        +L I  ++  
Sbjct: 68  IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVM 126

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA-TIG 893
           AL+YL    +  IIH D+KP N+LLDE    H++DF +A +L  E     +  T+A T  
Sbjct: 127 ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET----QITTMAGTKP 179

Query: 894 YMAPDEIF 901
           YMAP E+F
Sbjct: 180 YMAP-EMF 186

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 94.1 bits (234), Expect = 8e-21
 Identities = 39/234 (16%), Positives = 71/234 (30%), Gaps = 8/234 (3%)

Query: 390 NLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLDL 448
           +L  +   L      +      A     +L  + +  N++   I    F  L KL  + +
Sbjct: 27  DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86

Query: 449 AFNKLAGSIPDEICL-LSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPS 507
                   I  E    L  L  L ++   I         +      L++  N     I  
Sbjct: 87  EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER 146

Query: 508 -TFWNLKDIL-SFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQN 565
            +F  L        ++ N +    + A    +         NNL         G      
Sbjct: 147 NSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI 206

Query: 566 ISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFN 619
           + ++  R+         N+  L +    N K    +P + EKL  L E +L++ 
Sbjct: 207 LDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 89.1 bits (221), Expect = 4e-19
 Identities = 41/235 (17%), Positives = 84/235 (35%), Gaps = 16/235 (6%)

Query: 75  VTTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMD-N 131
              L      L+  I     +    L+ +++S N +   I + +F+ +  L  + +   N
Sbjct: 32  AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90

Query: 132 QLSGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSL 190
            L   ++   F N  ++  + +S   +   LP+    H      L +++N+    I  + 
Sbjct: 91  NLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148

Query: 191 SK--CKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEI-GYLQNLDVL 247
                 +   L L  N +   I     N T L  ++L +N    E+P ++        +L
Sbjct: 149 FVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL 207

Query: 248 QLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINS 302
            +    +  +    + N+  L+    YN     +L       L  L   +L   S
Sbjct: 208 DISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTLEK-----LVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 88.7 bits (220), Expect = 6e-19
 Identities = 51/281 (18%), Positives = 92/281 (32%), Gaps = 40/281 (14%)

Query: 223 ISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSL 282
                +K+  EIP ++   +N   L+     L  +          L++I +  N +   +
Sbjct: 14  FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70

Query: 283 PSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLK 342
            + +   LP L  + +                         +N+     P A  NL NL+
Sbjct: 71  EADVFSNLPKLHEIRIE-----------------------KANNLLYINPEAFQNLPNLQ 107

Query: 343 LFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPS-SIGNLSLSLERLNIA 401
              I    +    P++  + SL    +   L +  N     +   S   LS     L + 
Sbjct: 108 YLLISNTGIKHL-PDVHKIHSL----QKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 162

Query: 402 FCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLDLAFNKLAGSIPDE 460
              I   I  +  N + L  L+L  NN    +P   F G      LD++  ++  S+P  
Sbjct: 163 KNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSY 220

Query: 461 ICL-LSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNR 500
               L +L        K   ++      L +L   +L    
Sbjct: 221 GLENLKKLRARSTYNLKKLPTLE----KLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 88.0 bits (218), Expect = 9e-19
 Identities = 43/258 (16%), Positives = 80/258 (31%), Gaps = 19/258 (7%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQLS 134
                    +   IP ++    +   L     KL   I    F+    L+ + +  N + 
Sbjct: 12  RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVL 67

Query: 135 GSLSSFTF-NTSSILDIRLSK-NKLSGKLPENICNHLRYLKHLFLRENMFYGKIPS-SLS 191
             + +  F N   + +IR+ K N L   +      +L  L++L +        +P     
Sbjct: 68  EVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGI-KHLPDVHKI 125

Query: 192 KCKQLQELHLGYNNLSGAIPKE-IGNLTV-LQRISLINNKLHGEIPQEI-GYLQNLDVLQ 248
              Q   L +  N     I +     L+     + L  N +  EI        Q  ++  
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNL 184

Query: 249 LGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIP 308
              NNL  +        S    + +    +  SLPS     L  L   +         +P
Sbjct: 185 SDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLP 240

Query: 309 SSITNASKLILLEMGSNS 326
            ++     L+   +   S
Sbjct: 241 -TLEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 86.0 bits (213), Expect = 5e-18
 Identities = 47/270 (17%), Positives = 79/270 (29%), Gaps = 42/270 (15%)

Query: 331 IPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSI-G 389
           IPS +   RN          L           + +    L  + +  N +   + + +  
Sbjct: 24  IPSDL--PRNAIELRFVLTKLRVIQK-----GAFSGFGDLEKIEISQNDVLEVIEADVFS 76

Query: 390 NLSLSLERLNIAFCNISGNIP-KAIGNLSNLIVLSLGGNNLSGSIP-VTFGGLQKLQGLD 447
           NL   L  + I   N    I  +A  NL NL  L +    +   +P V      +   LD
Sbjct: 77  NLP-KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLD 134

Query: 448 LAFNKLAGSIPDEI--CLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVI 505
           +  N    +I       L      L LN N I    +S        +     +N    + 
Sbjct: 135 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELP 194

Query: 506 PSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQN 565
              F      +                         +D+SR  +       LE LK L+ 
Sbjct: 195 NDVFHGASGPVI------------------------LDISRTRIHSLPSYGLENLKKLRA 230

Query: 566 ISLAYNRLEGPIPESFGNMTSLESLDLSNN 595
            S    +    +P +   + +L    L+  
Sbjct: 231 RSTYNLKK---LP-TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 83.3 bits (206), Expect = 3e-17
 Identities = 44/247 (17%), Positives = 77/247 (31%), Gaps = 30/247 (12%)

Query: 409 IPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEI-CLLSRL 467
           IP  +    N I L      L       F G   L+ ++++ N +   I  ++   L +L
Sbjct: 24  IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81

Query: 468 NELDL-NGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLD 526
           +E+ +   N +         NL +LQYL + +     +      +    +  DI  N   
Sbjct: 82  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN--- 138

Query: 527 GPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKS-LQNISLAYNRLEGPIPESFGNMT 585
                                N+      +  GL      + L  N ++     +F    
Sbjct: 139 --------------------INIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQ 178

Query: 586 SLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELL 645
             E     NN +       F   S    L++S  ++   +P  G   N           L
Sbjct: 179 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG-LENLKKLRARSTYNL 236

Query: 646 CGLPNLQ 652
             LP L+
Sbjct: 237 KKLPTLE 243

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 71.0 bits (174), Expect = 4e-13
 Identities = 38/188 (20%), Positives = 74/188 (39%), Gaps = 14/188 (7%)

Query: 71  NSHKVTTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIFTMST-LKVLYL 128
           N  K+  + +   N    I PE   NL +L+ L +S+  +   +P      S    +L +
Sbjct: 77  NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIHSLQKVLLDI 135

Query: 129 MDNQLSGSLSSFTFN--TSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKI 186
            DN    ++   +F   +   + + L+KN +  ++  +  N  + L  L L +N    ++
Sbjct: 136 QDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQ-LDELNLSDNNNLEEL 193

Query: 187 PS-SLSKCKQLQELHLGYNNLSGAIPKEI-GNLTVLQRISLINNKLHGEIPQEIGYLQNL 244
           P+           L +    +  ++P     NL  L+  S  N K   ++P  +  L  L
Sbjct: 194 PNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVAL 248

Query: 245 DVLQLGFN 252
               L + 
Sbjct: 249 MEASLTYP 256

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 92.6 bits (231), Expect = 1e-20
 Identities = 47/202 (23%), Positives = 82/202 (40%), Gaps = 42/202 (20%)

Query: 725 TDNFAEN----NIIGIGGFGSVYRAR-LEDGVEIAIKVFH--PQCASTLKSFEAECEVIK 777
           +  F++N      +G G F  V R      G+E A K+ +     A   +  E E  + +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 778 NIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL----------- 826
            ++H N+V++  S   + F  LV + ++ G L             F  +           
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-------------FEDIVAREFYSEADA 107

Query: 827 -NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDES 882
            + +  I  ++ Y    HS  I+H +LKP N+LL    +     L+DFG+A  +   D  
Sbjct: 108 SHCIQQILESIAYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSE 162

Query: 883 TMRTQTLATIGYMAPDEIFVGE 904
                   T GY++P E+   +
Sbjct: 163 AWHG-FAGTPGYLSP-EVLKKD 182

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 49/194 (25%), Positives = 75/194 (38%), Gaps = 9/194 (4%)

Query: 436 TFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLN 495
               +     ++     L  ++P ++        L L+ N +     + L   T L  LN
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 496 LGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPT 555
           L     T +       L  + + D+S N L   + L    L A+  +D+S N L+     
Sbjct: 62  LDRAELTKL--QVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLG 118

Query: 556 TLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS-FEKLSYLKEL 614
            L GL  LQ + L  N L+   P        LE L L+NN ++  +P      L  L  L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTL 177

Query: 615 NLSFNKLKGEIPRG 628
            L  N L   IP+G
Sbjct: 178 LLQENSLYT-IPKG 190

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 57/205 (27%), Positives = 83/205 (40%), Gaps = 16/205 (7%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMST-LKVLYLMDNQLS 134
             +N    NL   +PP++        L LS N L +    +     T L  L L   +L+
Sbjct: 13  LEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELT 68

Query: 135 GSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSL-SKC 193
             L         +  + LS N+L   LP      L  L  L +  N     +P       
Sbjct: 69  -KLQVDG-TLPVLGTLDLSHNQLQ-SLPLLG-QTLPALTVLDVSFNRL-TSLPLGALRGL 123

Query: 194 KQLQELHLGYNNLSGAIPKEI-GNLTVLQRISLINNKLHGEIPQEI-GYLQNLDVLQLGF 251
            +LQEL+L  N L   +P  +      L+++SL NN L  E+P  +   L+NLD L L  
Sbjct: 124 GELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQE 181

Query: 252 NNLTGVVPATIFNMSTLKEIFLYNN 276
           N+L   +P   F    L   FL+ N
Sbjct: 182 NSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 47/216 (21%), Positives = 75/216 (34%), Gaps = 36/216 (16%)

Query: 405 ISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLL 464
           +  ++P       +  +L L  N L      T     +L  L+L   +L   +      L
Sbjct: 25  LPPDLP------KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTL 76

Query: 465 SRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNL 524
             L  LDL+ N++  S+      L +L  L++  NR T +       L            
Sbjct: 77  PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL------------ 123

Query: 525 LDGPISLAIGNLKAVVGIDLSRNNLSGNIPT-TLEGLKSLQNISLAYNRLEGPIPESFGN 583
                    G L+    + L  N L   +P   L     L+ +SLA N L          
Sbjct: 124 ---------GELQE---LYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG 170

Query: 584 MTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFN 619
           + +L++L L  N +  +IP  F     L    L  N
Sbjct: 171 LENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 17/211 (8%)

Query: 95  NLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDI-RLS 153
            ++S   ++     L++ +P  +       +L+L +N L  + S  T    + L    L 
Sbjct: 8   KVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLY-TFSLATLMPYTRLTQLNLD 63

Query: 154 KNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKE 213
           + +L+ KL   +   L  L  L L  N     +P        L  L + +N L+ ++P  
Sbjct: 64  RAELT-KLQ--VDGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLPLG 118

Query: 214 I-GNLTVLQRISLINNKLHGEIPQEI-GYLQNLDVLQLGFNNLTGVVPATIF-NMSTLKE 270
               L  LQ + L  N+L   +P  +      L+ L L  NNLT  +PA +   +  L  
Sbjct: 119 ALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDT 176

Query: 271 IFLYNNSLSGSLPSRIDLALPNLEFLNLGIN 301
           + L  NSL  ++P         L F  L  N
Sbjct: 177 LLLQENSLY-TIPKGF-FGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 69.4 bits (170), Expect = 7e-13
 Identities = 55/261 (21%), Positives = 86/261 (32%), Gaps = 64/261 (24%)

Query: 216 NLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYN 275
            +     ++     L   +P ++   ++  +L L  N L     AT+   + L ++ L  
Sbjct: 8   KVASHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 276 NSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAI 335
             L+  L   +D  LP L  L+L  N    ++P        L +L++  N  +  +P   
Sbjct: 65  AELT-KLQ--VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGA 119

Query: 336 GNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSL 395
                          L                 +L+ L L GN L   LP          
Sbjct: 120 ------------LRGLG----------------ELQELYLKGNELK-TLP---------- 140

Query: 396 ERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLDLAFNKLA 454
                         P  +     L  LSL  NNL+  +P     GL+ L  L L  N L 
Sbjct: 141 --------------PGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185

Query: 455 GSIPDEICLLSRLNELDLNGN 475
            +IP        L    L+GN
Sbjct: 186 -TIPKGFFGSHLLPFAFLHGN 205

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 93.4 bits (232), Expect = 3e-20
 Identities = 32/172 (18%), Positives = 69/172 (40%), Gaps = 12/172 (6%)

Query: 735 GIGGFGSVYRAR-LEDGVEIAIKVFHPQCAST--LKSFEAECEVIKNIRHRNLVKIISSC 791
           G     +V  AR    G  + ++  + +  S   +   + E  V K   H N+V   ++ 
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHC 850
             D+   +V  +M+ GS +D + +     +N      I+  +  AL+Y+H       +H 
Sbjct: 96  IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHR 152

Query: 851 DLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE--STMRTQTLATIG---YMAP 897
            +K S++L+  D   +LS       +    +    +      ++    +++P
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 92.8 bits (231), Expect = 3e-20
 Identities = 49/217 (22%), Positives = 94/217 (43%), Gaps = 14/217 (6%)

Query: 694 RGKRGTMLSNDIILSSQPTIRRFSYFELLRATD--NFAENNIIGIGGFGSVYRAR-LEDG 750
           + KR + L+ DI     P   R    +          ++  I+G G FG V++      G
Sbjct: 55  KSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATG 114

Query: 751 VEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLE 810
           +++A K+   +     +  + E  V+  + H NL+++  +  + +   LV+EY+  G L 
Sbjct: 115 LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174

Query: 811 DCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHL 867
           D +   +  L     +  M  I   + ++   H   I+H DLKP N+L    D   +  +
Sbjct: 175 DRIIDESYNLTELDTILFMKQICEGIRHM---HQMYILHLDLKPENILCVNRDAKQIK-I 230

Query: 868 SDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
            DFG+A+    +    ++     T  ++AP E+   +
Sbjct: 231 IDFGLARRY--KPREKLKV-NFGTPEFLAP-EVVNYD 263

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 92.2 bits (229), Expect = 3e-20
 Identities = 48/241 (19%), Positives = 78/241 (32%), Gaps = 57/241 (23%)

Query: 717 SYFELLRATDNFAEN----NIIGIGGFGSVYRAR-LEDGVEIAIKVF-----HPQCASTL 766
           + +    +     +       IG G +G V  A   +     AIK+             +
Sbjct: 13  NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV 72

Query: 767 KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL 826
           +  + E  ++K + H N+ ++     ++ +  LV+E    G L D L+         C +
Sbjct: 73  ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132

Query: 827 ---------------------------------------NIMIDIASALEYLHFGHSTPI 847
                                                  NIM  I SAL YLH      I
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---I 189

Query: 848 IHCDLKPSNVLLDEDMVAHL--SDFGMAKLLSG--EDESTMRTQTLATIGYMAPDEIFVG 903
            H D+KP N L   +    +   DFG++K        E    T    T  ++AP E+   
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP-EVLNT 248

Query: 904 E 904
            
Sbjct: 249 T 249

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 88.5 bits (220), Expect = 3e-20
 Identities = 35/221 (15%), Positives = 74/221 (33%), Gaps = 36/221 (16%)

Query: 404 NISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICL 463
             + NIP +       +   LG ++ +    +T   +  L  + LA   +   +   I  
Sbjct: 12  QDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEY 64

Query: 464 LSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSN 523
              + +L +N    +    + +  L++L+ L +     T         L           
Sbjct: 65  AHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLT---------- 112

Query: 524 LLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGN 583
                      +L     +D+S +    +I T +  L  + +I L+YN     I      
Sbjct: 113 -----------SLTL---LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKT 157

Query: 584 MTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGE 624
           +  L+SL++  + +        E    L +L      + G+
Sbjct: 158 LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 34/206 (16%), Positives = 69/206 (33%), Gaps = 31/206 (15%)

Query: 394 SLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKL 453
           + +         S         +++L  ++L   N++            L G++      
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-----------DLTGIE------ 63

Query: 454 AGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLK 513
                        + +L +N    +    + +  L++L+ L +     T         L 
Sbjct: 64  ---------YAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLT 112

Query: 514 DILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRL 573
            +   DIS +  D  I   I  L  V  IDLS N    +I   L+ L  L+++++ ++ +
Sbjct: 113 SLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGV 171

Query: 574 EGPIPESFGNMTSLESLDLSNNKISG 599
                    +   L  L   +  I G
Sbjct: 172 HDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 34/161 (21%), Positives = 60/161 (37%), Gaps = 8/161 (4%)

Query: 363 SLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVL 422
           + A    L Y+ L    +     + I     +++ L I   + +      I  LSNL  L
Sbjct: 39  TEAQMNSLTYITLANINVTDL--TGIEYAH-NIKDLTINNIHATN--YNPISGLSNLERL 93

Query: 423 SLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSIS 482
            + G +++        GL  L  LD++ +    SI  +I  L ++N +DL+ N     I 
Sbjct: 94  RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM 153

Query: 483 SCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSN 523
             L  L  L+ LN+  +           +   +      S 
Sbjct: 154 P-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 70.8 bits (174), Expect = 5e-14
 Identities = 29/192 (15%), Positives = 69/192 (35%), Gaps = 11/192 (5%)

Query: 66  IICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKV 125
            I D          L       T     A ++SL  + L++  ++    + I     +K 
Sbjct: 16  NIPDSTFKAYLNGLL---GQSSTANITEAQMNSLTYITLANINVTD--LTGIEYAHNIKD 70

Query: 126 LYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGK 185
           L + +   + + +  +   S++  +R+    ++     N+ + L  L  L +  +     
Sbjct: 71  LTINNIHAT-NYNPIS-GLSNLERLRIMGKDVTSDKIPNL-SGLTSLTLLDISHSAHDDS 127

Query: 186 IPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLD 245
           I + ++   ++  + L YN     I   +  L  L+ +++  + +H      I     L+
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLN 184

Query: 246 VLQLGFNNLTGV 257
            L      + G 
Sbjct: 185 QLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 68.1 bits (167), Expect = 4e-13
 Identities = 30/193 (15%), Positives = 68/193 (35%), Gaps = 19/193 (9%)

Query: 216 NLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYN 275
                    L  +        ++  L  + +  +   +LTG     I     +K++ + N
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75

Query: 276 NSLSGSLPSRIDLA-LPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSA 334
              +   P    ++ L NLE L +     +     +++  + L LL++  ++    I + 
Sbjct: 76  IHATNYNP----ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

Query: 335 IGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLS 394
           I  L  +   D+ +N   +       +  L    +L+ L +  + +  +    I +    
Sbjct: 132 INTLPKVNSIDLSYNGAITD------IMPLKTLPELKSLNIQFDGVHDY--RGIEDFP-K 182

Query: 395 LERLNIAFCNISG 407
           L +L      I G
Sbjct: 183 LNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 24/213 (11%), Positives = 67/213 (31%), Gaps = 38/213 (17%)

Query: 94  ANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLS 153
           +   +  +  L  +  ++   +    M++L  + L +  ++  L+               
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQ---MNSLTYITLANINVT-DLTGI------------- 62

Query: 154 KNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKE 213
                         +   +K L +          + +S    L+ L +   +++      
Sbjct: 63  -------------EYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPN 107

Query: 214 IGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFL 273
           +  LT L  + + ++     I  +I  L  ++ + L +N     +   +  +  LK + +
Sbjct: 108 LSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNI 166

Query: 274 YNNSLSGSLPSRIDLA-LPNLEFLNLGINSFSG 305
             + +         +   P L  L     +  G
Sbjct: 167 QFDGVHDYRG----IEDFPKLNQLYAFSQTIGG 195

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 94.5 bits (235), Expect = 3e-20
 Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 34/199 (17%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVF-------HPQCASTLKSFE 770
           F   R         ++G GGFG V+  +++   ++ A K                +    
Sbjct: 187 FLDFR---------VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---- 233

Query: 771 AECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
            E +++  +  R +V +  +        LV+  M+ G +   +++ +     F +    I
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF-QEPRAI 292

Query: 831 ----DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
                I S LE+LH      II+ DLKP NVLLD+D    +SD G+A  L        +T
Sbjct: 293 FYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT---KT 346

Query: 887 QTLA-TIGYMAPDEIFVGE 904
           +  A T G+MAP E+ +GE
Sbjct: 347 KGYAGTPGFMAP-ELLLGE 364

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 91.6 bits (228), Expect = 4e-20
 Identities = 39/180 (21%), Positives = 76/180 (42%), Gaps = 27/180 (15%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKIISS 790
            +G G F    +    +     A+K+          + + E   +K    H N+VK+   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEV 74

Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNC------ALNIFCRLNIMIDIASALEYLHFGHS 844
             +     LV+E ++ G L + +           +        IM  + SA+ ++H    
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS-------YIMRKLVSAVSHMH---D 124

Query: 845 TPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
             ++H DLKP N+L    ++++   + DFG A+L   +++  ++T    T+ Y AP E+ 
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKT-PCFTLHYAAP-ELL 181

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 91.2 bits (227), Expect = 4e-20
 Identities = 48/187 (25%), Positives = 84/187 (44%), Gaps = 15/187 (8%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFH-PQCASTLKSFEAECEVIKNIRHRN 783
           D++    +IG G    V  A       ++AIK  +  +C +++     E + +    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCL-HSSNCALNIFCRLN------IMIDIASAL 836
           +V   +S    D   LV++ +S GS+ D + H      +    L+      I+ ++   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG--- 893
           EYLH       IH D+K  N+LL ED    ++DFG++  L+   + T        +G   
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 894 YMAPDEI 900
           +MAP+ +
Sbjct: 192 WMAPEVM 198

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 90.3 bits (225), Expect = 5e-20
 Identities = 48/181 (26%), Positives = 78/181 (43%), Gaps = 24/181 (13%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSC 791
            IG G +G V  A      +  A K         +  F+ E E++K++ H N++++  + 
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 792 SNDDFKALVLEYMSNGSLED------CLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
            ++    LV+E  + G L +          S+ A        IM D+ SA+ Y H  +  
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-------RIMKDVLSAVAYCHKLN-- 126

Query: 846 PIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV 902
            + H DLKP N L      D    L DFG+A     +    MRT  + T  Y++P ++  
Sbjct: 127 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRT-KVGTPYYVSP-QVLE 181

Query: 903 G 903
           G
Sbjct: 182 G 182

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 92.0 bits (229), Expect = 5e-20
 Identities = 48/206 (23%), Positives = 85/206 (41%), Gaps = 42/206 (20%)

Query: 721 LLRATDNFAEN----NIIGIGGFGSVYRAR-LEDGVEIAIKVFH--PQCASTLKSFEAEC 773
           ++ A+  F++N      +G G F  V R      G+E A K+ +     A   +  E E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79

Query: 774 EVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL------- 826
            + + ++H N+V++  S   + F  LV + ++ G L             F  +       
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-------------FEDIVAREFYS 126

Query: 827 -----NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSG 878
                + +  I  ++ Y    HS  I+H +LKP N+LL    +     L+DFG+A  +  
Sbjct: 127 EADASHCIQQILESIAYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-- 181

Query: 879 EDESTMRTQTLATIGYMAPDEIFVGE 904
            D          T GY++P E+   +
Sbjct: 182 NDSEAWHG-FAGTPGYLSP-EVLKKD 205

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 93.7 bits (233), Expect = 8e-20
 Identities = 50/199 (25%), Positives = 79/199 (39%), Gaps = 37/199 (18%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVF-------HPQCASTLKSFE 770
           F   R         ++G GGFG V   ++    ++ A K             A  L    
Sbjct: 186 FRQYR---------VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL---- 232

Query: 771 AECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
            E ++++ +  R +V +  +    D   LVL  M+ G L+   H  +     F      +
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK--FHIYHMGQAGF-PEARAV 289

Query: 831 ----DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRT 886
               +I   LE LH      I++ DLKP N+LLD+     +SD G+A  +          
Sbjct: 290 FYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TI 342

Query: 887 QTLA-TIGYMAPDEIFVGE 904
           +    T+GYMAP E+   E
Sbjct: 343 KGRVGTVGYMAP-EVVKNE 360

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 91.7 bits (228), Expect = 9e-20
 Identities = 46/219 (21%), Positives = 89/219 (40%), Gaps = 14/219 (6%)

Query: 693 KRGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNFAEN----NIIGIGGFGSVYRAR-L 747
            RGK      ND     +   +++    +     +  +       +G G FG V+R    
Sbjct: 14  VRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEK 73

Query: 748 EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNG 807
             G     K  +        + + E  ++  + H  L+ +  +  +     L+LE++S G
Sbjct: 74  ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133

Query: 808 SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHL 867
            L D + + +  ++    +N M      L+++H      I+H D+KP N++ +    + +
Sbjct: 134 ELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSV 190

Query: 868 --SDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
              DFG+A  L    +  ++  T AT  + AP EI   E
Sbjct: 191 KIIDFGLATKL--NPDEIVKV-TTATAEFAAP-EIVDRE 225

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 89.6 bits (223), Expect = 1e-19
 Identities = 45/181 (24%), Positives = 79/181 (43%), Gaps = 26/181 (14%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAST--LKSFEAECEVIKNIRHRNLVKIIS 789
           ++G G FG V + +      E A+KV +   A      +   E E++K + H N++K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 790 SCSNDDFKALVLEYMSNGSLED------CLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
              +     +V E  + G L D           + A        I+  + S + Y+   H
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGITYM---H 138

Query: 844 STPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
              I+H DLKP N+LL   ++D    + DFG++     +  + M+   + T  Y+AP E+
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKD-RIGTAYYIAP-EV 194

Query: 901 F 901
            
Sbjct: 195 L 195

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 68/208 (32%), Positives = 102/208 (49%), Gaps = 15/208 (7%)

Query: 99  LKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSIL-DIRLSKNKL 157
             S+D S  KL++ IPS+I      K L L  N+LS SL S  F+  + L  + L+ NKL
Sbjct: 18  KNSVDCSSKKLTA-IPSNIPA--DTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKL 73

Query: 158 SGKLPENICNHLRYLKHLFLRENMFYGKIPSSL-SKCKQLQELHLGYNNLSGAIPKEI-G 215
              LP  I   L+ L+ L++ +N     +P  +  +   L EL L  N L  ++P  +  
Sbjct: 74  Q-TLPAGIFKELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFD 130

Query: 216 NLTVLQRISLINNKLHGEIPQEI-GYLQNLDVLQLGFNNLTGVVPATIF-NMSTLKEIFL 273
           +LT L  +SL  N+L   +P+ +   L +L  L+L  N L   VP   F  ++ LK + L
Sbjct: 131 SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKL 188

Query: 274 YNNSLSGSLPSRIDLALPNLEFLNLGIN 301
            NN L   +P     +L  L+ L L  N
Sbjct: 189 DNNQLK-RVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 73/225 (32%), Positives = 110/225 (48%), Gaps = 15/225 (6%)

Query: 57  NASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSS 116
           N ++C   G +C  N++K  +++ SS  L   IP  I   +  K LDL  NKLSS +PS 
Sbjct: 1   NEALCKKDGGVCSCNNNK-NSVDCSSKKLT-AIPSNI--PADTKKLDLQSNKLSS-LPSK 55

Query: 117 IFT-MSTLKVLYLMDNQLSGSLSSFTFNTSSIL-DIRLSKNKLSGKLPENICNHLRYLKH 174
            F  ++ L++LYL DN+L  +L +  F     L  + ++ NKL   LP  + + L  L  
Sbjct: 56  AFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAE 113

Query: 175 LFLRENMFYGKIPSSL-SKCKQLQELHLGYNNLSGAIPKEI-GNLTVLQRISLINNKLHG 232
           L L  N     +P  +     +L  L LGYN L  ++PK +   LT L+ + L NN+L  
Sbjct: 114 LRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK- 170

Query: 233 EIPQEI-GYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNN 276
            +P+     L  L  L+L  N L  V      ++  LK + L  N
Sbjct: 171 RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 36/215 (16%)

Query: 408 NIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICL-LSR 466
           NIP      ++   L L  N LS      F  L KL+ L L  NKL  ++P  I   L  
Sbjct: 34  NIP------ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86

Query: 467 LNELDLNGNKISGSISSCL-GNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLL 525
           L  L +  NK+  ++   +   L +L  L L  N+   + P  F +L             
Sbjct: 87  LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSL------------- 132

Query: 526 DGPISLAIGNLKAVVGIDLSRNNLSGNIPTTL-EGLKSLQNISLAYNRLEGPIPESFGNM 584
                     L     + L  N L  ++P  + + L SL+ + L  N+L+     +F  +
Sbjct: 133 --------TKLTY---LSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKL 180

Query: 585 TSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFN 619
           T L++L L NN++      +F+ L  LK L L  N
Sbjct: 181 TELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 57/235 (24%), Positives = 86/235 (36%), Gaps = 38/235 (16%)

Query: 267 TLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNS 326
               +   +  L+ ++PS I     + + L+L  N  S     +    +KL LL +  N 
Sbjct: 17  NKNSVDCSSKKLT-AIPSNI---PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNK 72

Query: 327 FSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPS 386
                      L+NL+   +  N L +     G    L N   L  L L  N L      
Sbjct: 73  LQTLPAGIFKELKNLETLWVTDNKLQALPI--GVFDQLVN---LAELRLDRNQLK----- 122

Query: 387 SIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQG 445
                  SL              P+   +L+ L  LSLG N L  S+P   F  L  L+ 
Sbjct: 123 -------SLP-------------PRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKE 161

Query: 446 LDLAFNKLAGSIPDEIC-LLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSN 499
           L L  N+L   +P+     L+ L  L L+ N++         +L  L+ L L  N
Sbjct: 162 LRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 58/199 (29%), Positives = 80/199 (40%), Gaps = 14/199 (7%)

Query: 331 IPSAI-GNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIG 389
           IPS I  + + L L     N L+S          L     LR L L  N L   LP+ I 
Sbjct: 31  IPSNIPADTKKLDLQS---NKLSSLPS--KAFHRLTK---LRLLYLNDNKLQ-TLPAGIF 81

Query: 390 NLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLDL 448
               +LE L +    +          L NL  L L  N L  S+P   F  L KL  L L
Sbjct: 82  KELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSL 140

Query: 449 AFNKLAGSIPDEIC-LLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPS 507
            +N+L  S+P  +   L+ L EL L  N++          LT L+ L L +N+   V   
Sbjct: 141 GYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEG 199

Query: 508 TFWNLKDILSFDISSNLLD 526
            F +L+ +    +  N  D
Sbjct: 200 AFDSLEKLKMLQLQENPWD 218

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 91.1 bits (226), Expect = 1e-19
 Identities = 44/177 (24%), Positives = 80/177 (45%), Gaps = 9/177 (5%)

Query: 726 DNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHP-QCASTLKSFEAECEVIKNIRHRN 783
           D+F + + +G G  G V++      G+ +A K+ H     +       E +V+       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +V    +  +D   ++ +E+M  GSL+  L  +   +       + I +   L YL   H
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKH 151

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
              I+H D+KPSN+L++      L DFG+    SG+   +M    + T  YM+P+ +
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERL 202

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 91.6 bits (228), Expect = 1e-19
 Identities = 43/191 (22%), Positives = 77/191 (40%), Gaps = 39/191 (20%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVF--HPQCASTLKSFEAECEVIKNIRHRNLVKIIS 789
            +G G F  V R   +  G E A  +       A   +  E E  + + ++H N+V++  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL------------NIMIDIASALE 837
           S S +    L+ + ++ G L             F  +            + +  I  A+ 
Sbjct: 78  SISEEGHHYLIFDLVTGGEL-------------FEDIVAREYYSEADASHCIQQILEAVL 124

Query: 838 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLA-TIG 893
           +    H   ++H +LKP N+LL    +     L+DFG+A  + GE +        A T G
Sbjct: 125 HC---HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ---AWFGFAGTPG 178

Query: 894 YMAPDEIFVGE 904
           Y++P E+   +
Sbjct: 179 YLSP-EVLRKD 188

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 89.2 bits (222), Expect = 2e-19
 Identities = 52/204 (25%), Positives = 82/204 (40%), Gaps = 45/204 (22%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVF--------------------------HPQCASTL 766
           IG G +G V  A    D    A+KV                             Q    +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 767 KSFEAECEVIKNIRHRNLVKIIS--SCSNDDFKALVLEYMSNGSLEDCLH----SSNCAL 820
           +    E  ++K + H N+VK++      N+D   +V E ++ G + +       S + A 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140

Query: 821 NIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED 880
             F       D+   +EYLH      IIH D+KPSN+L+ ED    ++DFG++    G D
Sbjct: 141 FYFQ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191

Query: 881 ESTMRTQTLATIGYMAPDEIFVGE 904
            + +   T+ T  +MAP E     
Sbjct: 192 -ALLSN-TVGTPAFMAP-ESLSET 212

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 91.7 bits (228), Expect = 2e-19
 Identities = 71/289 (24%), Positives = 117/289 (40%), Gaps = 60/289 (20%)

Query: 721 LLRATDNFAEN----NIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAST--LKSFEAEC 773
           +     + +E       +G G +G V   R     VE AIK+      ST        E 
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 774 EVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL------- 826
            V+K + H N++K+     +     LV+E    G L             F  +       
Sbjct: 88  AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL-------------FDEIIHRMKFN 134

Query: 827 -----NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSG 878
                 I+  + S + YLH  +   I+H DLKP N+LL   ++D +  + DFG++ +   
Sbjct: 135 EVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-- 189

Query: 879 EDESTMRTQTLATIGYMAPDEIFVGELSLK--RWVNDLLPVSLVEVVDKSLLSGEEKHFA 936
            +      + L T  Y+AP E+   +   K   W       S+  V+   LL+G      
Sbjct: 190 -ENQKKMKERLGTAYYIAP-EVLRKKYDEKCDVW-------SI-GVILFILLAGYPPFGG 239

Query: 937 AKEQCLL-SIFSLALECTMESPE-KRI--DAKDTITRLLKIRDTLSKRI 981
             +Q +L  +     + T +SPE K +   AKD I ++L+  D+  +RI
Sbjct: 240 QTDQEILRKV--EKGKYTFDSPEWKNVSEGAKDLIKQMLQ-FDS-QRRI 284

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 91.7 bits (228), Expect = 2e-19
 Identities = 71/290 (24%), Positives = 116/290 (40%), Gaps = 61/290 (21%)

Query: 721 LLRATDNFAEN----NIIGIGGFGSVYRAR-LEDGVEIAIKVF---HPQCASTLKSFEAE 772
           +  +T  F++      ++G G FG V   +    G E A+KV      +  +  +S   E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL------ 826
            +++K + H N++K+     +  +  LV E  + G L             F  +      
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL-------------FDEIISRKRF 123

Query: 827 ------NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLS 877
                  I+  + S + Y+H      I+H DLKP N+LL    +D    + DFG++    
Sbjct: 124 SEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF- 179

Query: 878 GEDESTMRTQTLATIGYMAPDEIFVGELSLK--RWVNDLLPVSLVEVVDKSLLSGEEKHF 935
             + S      + T  Y+AP E+  G    K   W       S   V+   LLSG     
Sbjct: 180 --EASKKMKDKIGTAYYIAP-EVLHGTYDEKCDVW-------ST-GVILYILLSGCPPFN 228

Query: 936 AAKEQCLL-SIFSLALECTMESPE-KRI--DAKDTITRLLKIRDTLSKRI 981
            A E  +L  +     + T E P+ K++   AKD I ++L      S RI
Sbjct: 229 GANEYDILKKV--EKGKYTFELPQWKKVSESAKDLIRKMLT-YVP-SMRI 274

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 50/175 (28%), Positives = 77/175 (44%), Gaps = 9/175 (5%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFH-PQCASTLKSFEAECEVIKNIRHR 782
            + F +   IG G FG V++         +AIK+    +    ++  + E  V+      
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
            + K   S   D    +++EY+  GS  D L      L+      I+ +I   L+YLH  
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLH-- 136

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            S   IH D+K +NVLL E     L+DFG+A  L+  D    R   + T  +MAP
Sbjct: 137 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 188

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 92.3 bits (229), Expect = 3e-19
 Identities = 65/280 (23%), Positives = 108/280 (38%), Gaps = 42/280 (15%)

Query: 717 SYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFEAEC-- 773
           + F + R         IIG GGFG VY  R  D  ++ A+K                   
Sbjct: 189 NDFSVHR---------IIGRGGFGEVYGCRKADTGKMYAMKCL--DKKRIKMKQGETLAL 237

Query: 774 ------EVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN 827
                  ++       +V +  +    D  + +L+ M+ G L   L           R  
Sbjct: 238 NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY 297

Query: 828 IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ 887
              +I   LE++H   +  +++ DLKP+N+LLDE     +SD G+A   S +     +  
Sbjct: 298 AA-EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPH 348

Query: 888 TLA-TIGYMAPDEIFVGELSLKRWVND--LLPVSLVEVVDKSLLSGEEKHFAAKEQCLLS 944
               T GYMAP E+    ++      D   L   L +     LL G       K +    
Sbjct: 349 ASVGTHGYMAP-EVLQKGVAYDSSA-DWFSLGCMLFK-----LLRGHSPFRQHKTKDKHE 401

Query: 945 IFSLALECTMESPEK-RIDAKDTITRLLKIRDTLSKRIGN 983
           I  + L   +E P+    + +  +  LL+ RD +++R+G 
Sbjct: 402 IDRMTLTMAVELPDSFSPELRSLLEGLLQ-RD-VNRRLGC 439

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 44/206 (21%), Positives = 81/206 (39%), Gaps = 19/206 (9%)

Query: 705 IILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCA 763
           + + S   ++           ++  +   IG G +GSV +      G  +A+K       
Sbjct: 1   MSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD 60

Query: 764 ST-LKSFEAECEVI-KNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALN 821
               K    + +V+ ++     +V+   +   +    + +E M + S +         L+
Sbjct: 61  EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLD 119

Query: 822 IFCRLN------IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL 875
               +       I +    AL +L       IIH D+KPSN+LLD      L DFG    
Sbjct: 120 D--VIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFG---- 171

Query: 876 LSGEDESTM-RTQTLATIGYMAPDEI 900
           +SG+   ++ +T+      YMAP+ I
Sbjct: 172 ISGQLVDSIAKTRDAGCRPYMAPERI 197

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 89.3 bits (222), Expect = 4e-19
 Identities = 45/201 (22%), Positives = 81/201 (40%), Gaps = 33/201 (16%)

Query: 720 ELLRATDNFAEN----NIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECE 774
           +L R +  F +       IG+G +    R       +E A+K+       + +    E E
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEIE 67

Query: 775 VI-KNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNC------ALNIFCRLN 827
           ++ +  +H N++ +     +  +  +V E M  G L D +           +        
Sbjct: 68  ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS-------A 120

Query: 828 IMIDIASALEYLHFGHSTPIIHCDLKPSNVLL----DEDMVAHLSDFGMAKLLSGEDEST 883
           ++  I   +EYLH   +  ++H DLKPSN+L            + DFG AK L  E+   
Sbjct: 121 VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG-L 176

Query: 884 MRTQTLATIGYMAPDEIFVGE 904
           + T    T  ++AP E+   +
Sbjct: 177 LMT-PCYTANFVAP-EVLERQ 195

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 88.6 bits (220), Expect = 5e-19
 Identities = 51/187 (27%), Positives = 74/187 (39%), Gaps = 28/187 (14%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKV--------FHPQCASTLKSFEAECEVIKNIRHRNL 784
           +G G FG V+ A   E   E+ +K                 L     E  ++  + H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 785 VKIISSCSNDDFKALVLEYMSNGS-LEDCLHSSNC-----ALNIFCRLNIMIDIASALEY 838
           +K++    N  F  LV+E   +G  L   +          A  IF +      + SA+ Y
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ------LVSAVGY 145

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           L       IIH D+K  N+++ ED    L DFG A  L  E      T    TI Y AP 
Sbjct: 146 LRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIEYCAP- 198

Query: 899 EIFVGEL 905
           E+ +G  
Sbjct: 199 EVLMGNP 205

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 88.1 bits (219), Expect = 5e-19
 Identities = 44/185 (23%), Positives = 77/185 (41%), Gaps = 25/185 (13%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA----ECEVIKNIRHRNLVK-- 786
           +G G +G V      E     A+K+   +    + + EA    E ++++ +RH+N+++  
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 787 -IISSCSNDDFKALVLEYMSNGSLE--DCLH----SSNCALNIFCRLNIMIDIASALEYL 839
            ++ +        +V+EY   G  E  D +         A   FC+      +   LEYL
Sbjct: 73  DVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQ------LIDGLEYL 125

Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDE 899
           H   S  I+H D+KP N+LL       +S  G+A+ L           +  +  +  P E
Sbjct: 126 H---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP-E 181

Query: 900 IFVGE 904
           I  G 
Sbjct: 182 IANGL 186

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 87.5 bits (217), Expect = 6e-19
 Identities = 22/146 (15%), Positives = 49/146 (33%), Gaps = 14/146 (9%)

Query: 734 IGIGGFGSVYRARLEDGV---EIAIKVFHPQCAST---LKSFEAECEVIKNIRHRNLVKI 787
            G       ++A   D     ++A+    PQ       L+   +    +  I    + ++
Sbjct: 39  HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 788 ISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPI 847
           +          +V E++  GSL++   +   + +    +  M  +A+A +  H      +
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAH---RAGV 150

Query: 848 IHCDLKPSNVLLDEDMVAHLSDFGMA 873
                 PS V +  D    L+     
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPATM 176

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 90.1 bits (224), Expect = 7e-19
 Identities = 44/188 (23%), Positives = 78/188 (41%), Gaps = 38/188 (20%)

Query: 732 NIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAST--LKSFEAECEVIKNIRHRNLVKII 788
            ++G G FG V + +      E A+KV +   A      +   E E++K + H N++K+ 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL------------NIMIDIASAL 836
               +     +V E  + G L             F  +             I+  + S +
Sbjct: 88  EILEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGI 134

Query: 837 EYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
            Y+H  +   I+H DLKP N+LL   ++D    + DFG++       ++T     + T  
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAY 188

Query: 894 YMAPDEIF 901
           Y+AP E+ 
Sbjct: 189 YIAP-EVL 195

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 87.0 bits (216), Expect = 7e-19
 Identities = 46/227 (20%), Positives = 92/227 (40%), Gaps = 16/227 (7%)

Query: 395 LERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLA 454
             + N+   +++  +      L+++  +    +++  S+      L  +  L L  NKL 
Sbjct: 26  TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT 81

Query: 455 GSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKD 514
             I   +  L  L  L L+ NK+   +SS L +L  L+ L+L  N  + +      +L  
Sbjct: 82  -DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISDING--LVHLPQ 135

Query: 515 ILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLE 574
           + S  + +N +     L+   L  +  + L  N +S +I   L GL  LQN+ L+ N + 
Sbjct: 136 LESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS 191

Query: 575 GPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKL 621
                +   + +L+ L+L + +           L     +  +   L
Sbjct: 192 DL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 55/313 (17%), Positives = 104/313 (33%), Gaps = 50/313 (15%)

Query: 309 SSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCK 368
            S    ++ I   +   S +  +      L ++       +++ S       +  +    
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-------VQGIQYLP 68

Query: 369 KLRYLGLGGNPLDGFLPSSIGNLS--LSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGG 426
            +  L L GN L     + I  L+   +L  L +    +  ++  ++ +L  L  LSL  
Sbjct: 69  NVTKLFLNGNKL-----TDIKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEH 121

Query: 427 NNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLG 486
           N +S  I      L +L+ L L  NK+  +    +  L++L+ L L  N+IS  I   L 
Sbjct: 122 NGIS-DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LA 175

Query: 487 NLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSR 546
            LT LQ L L  N  +                D+           A+  LK +  ++L  
Sbjct: 176 GLTKLQNLYLSKNHIS----------------DLR----------ALAGLKNLDVLELFS 209

Query: 547 NNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFE 606
                        L     +      L  P   S        ++     + +  +   F 
Sbjct: 210 QECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFY 269

Query: 607 KLSYLKELNLSFN 619
           +   + +    F+
Sbjct: 270 QPVTIGKAKARFH 282

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 72.4 bits (178), Expect = 8e-14
 Identities = 56/291 (19%), Positives = 109/291 (37%), Gaps = 48/291 (16%)

Query: 66  IICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKV 125
           I  D    +    NL   ++   +      L+S+  +  +++ + S     I  +  +  
Sbjct: 17  IFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTK 72

Query: 126 LYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGK 185
           L+L  N+L+  +                              +L+ L  LFL EN    K
Sbjct: 73  LFLNGNKLT-DIKPL--------------------------ANLKNLGWLFLDEN----K 101

Query: 186 IP--SSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQN 243
           +   SSL   K+L+ L L +N +S      + +L  L+ + L NNK+       +  L  
Sbjct: 102 VKDLSSLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKI--TDITVLSRLTK 157

Query: 244 LDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSF 303
           LD L L  N ++ +VP  +  ++ L+ ++L  N +S          L NL+ L L     
Sbjct: 158 LDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRALA---GLKNLDVLELFSQEC 212

Query: 304 SGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSS 354
                +  +N      ++    S     P  I +  + +  ++ ++    +
Sbjct: 213 LNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFT 261

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 90.3 bits (224), Expect = 8e-19
 Identities = 60/271 (22%), Positives = 108/271 (39%), Gaps = 37/271 (13%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRN 783
            D++  +  +G G FG V+R      G   A K       S  ++   E + +  +RH  
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           LV +  +  +D+   ++ E+MS G L + +   +  ++    +  M  +   L ++H  +
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275

Query: 844 STPIIHCDLKPSNVLLDEDMVAHL--SDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
               +H DLKP N++        L   DFG+   L  + + +++  T  T  + AP E+ 
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKV-TTGTAEFAAP-EVA 328

Query: 902 VGELSLKRWVNDLLPVSL------VEVVDKSLLSGEEKHFAAKEQCLLSIFS--LALECT 953
            G+           PV        V V+   LLSG        +           + +  
Sbjct: 329 EGK-----------PVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKSCDWN 374

Query: 954 MESPE-KRI--DAKDTITRLLKIRDTLSKRI 981
           M+      I  D KD I +LL + D  + R+
Sbjct: 375 MDDSAFSGISEDGKDFIRKLL-LADP-NTRM 403

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 88.2 bits (219), Expect = 8e-19
 Identities = 46/188 (24%), Positives = 72/188 (38%), Gaps = 31/188 (16%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFH------PQCASTLKSFEAECEVIKNIRHRNLVK 786
           +G G F  V + R    G+E A K          +     +  E E  +++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 787 IISSCSNDDFKALVLEYMSNGSL------EDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           +     N     L+LE +S G L      ++ L             + +  I   + YLH
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQILDGVNYLH 132

Query: 841 FGHSTPIIHCDLKPSNVLL----DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
                 I H DLKP N++L           L DFG+A  +  ED    +     T  ++A
Sbjct: 133 TKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN-IFGTPEFVA 186

Query: 897 PDEIFVGE 904
           P EI   E
Sbjct: 187 P-EIVNYE 193

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 86.8 bits (216), Expect = 9e-19
 Identities = 47/188 (25%), Positives = 73/188 (38%), Gaps = 31/188 (16%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFH------PQCASTLKSFEAECEVIKNIRHRNLVK 786
           +G G F  V + R    G E A K          +   + +  E E  +++ IRH N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 787 IISSCSNDDFKALVLEYMSNGSL------EDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           +     N     L+LE +S G L      ++ L               +  I   + YLH
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-------QFLKQILDGVHYLH 125

Query: 841 FGHSTPIIHCDLKPSNVLL----DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
                 I H DLKP N++L      +    L DFG+A  +  E  +  +     T  ++A
Sbjct: 126 SKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKN-IFGTPEFVA 179

Query: 897 PDEIFVGE 904
           P EI   E
Sbjct: 180 P-EIVNYE 186

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 87.9 bits (218), Expect = 9e-19
 Identities = 49/180 (27%), Positives = 74/180 (41%), Gaps = 20/180 (11%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKV---FHPQCASTLKSFEAECEVIKNIR 780
              F++   IG G FG+VY AR + +   +AIK       Q     +    E   ++ +R
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N ++       +    LV+EY   GS  D L      L       +       L YLH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG---YMAP 897
              S  +IH D+K  N+LL E  +  L DFG A +++          +   +G   +MAP
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-------PANSF--VGTPYWMAP 219

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 87.3 bits (217), Expect = 1e-18
 Identities = 46/189 (24%), Positives = 73/189 (38%), Gaps = 31/189 (16%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFH------PQCASTLKSFEAECEVIKNIRHRNLV 785
            +G G F  V + R    G+E A K          +   + +  E E  +++ + H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 786 KIISSCSNDDFKALVLEYMSNGSL------EDCLHSSNCALNIFCRLNIMIDIASALEYL 839
            +     N     L+LE +S G L      ++ L             + +  I   + YL
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQILDGVNYL 131

Query: 840 HFGHSTPIIHCDLKPSNVLL----DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYM 895
           H      I H DLKP N++L           L DFG+A  +  ED    +     T  ++
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN-IFGTPEFV 185

Query: 896 APDEIFVGE 904
           AP EI   E
Sbjct: 186 AP-EIVNYE 193

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 87.0 bits (216), Expect = 2e-18
 Identities = 53/217 (24%), Positives = 83/217 (38%), Gaps = 42/217 (19%)

Query: 708 SSQPTIRRFSYFELLRATDNFAEN----NIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQC 762
           +         Y+      D  ++     + +G G    VYR +        A+KV     
Sbjct: 31  APGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-- 88

Query: 763 ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNI 822
               K    E  V+  + H N++K+          +LVLE ++ G L             
Sbjct: 89  TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL------------- 135

Query: 823 FCRL------------NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHL 867
           F R+            + +  I  A+ YLH      I+H DLKP N+L      D    +
Sbjct: 136 FDRIVEKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKI 192

Query: 868 SDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
           +DFG++K++  E +  M+T    T GY AP EI  G 
Sbjct: 193 ADFGLSKIV--EHQVLMKT-VCGTPGYCAP-EILRGC 225

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 86.3 bits (214), Expect = 3e-18
 Identities = 56/211 (26%), Positives = 86/211 (40%), Gaps = 34/211 (16%)

Query: 707 LSSQPTIRRFSYFELLRATD---NFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQC 762
           ++S    R     +L    D    F    ++G G +G VY+ R ++ G   AIKV     
Sbjct: 2   MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT- 60

Query: 763 ASTLKSFEAECEVIKNI-RHRNLVKIISS------CSNDDFKALVLEYMSNGSLEDCLHS 815
               +  + E  ++K    HRN+     +         DD   LV+E+   GS+ D + +
Sbjct: 61  GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120

Query: 816 SNCALNIFCRLN------IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSD 869
           +         L       I  +I   L +LH      +IH D+K  NVLL E+    L D
Sbjct: 121 TKGN-----TLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVD 172

Query: 870 FGMAKLLSGEDESTMRTQTLATIG---YMAP 897
           FG++  L     +  R  T   IG   +MAP
Sbjct: 173 FGVSAQLD---RTVGRRNTF--IGTPYWMAP 198

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 85.8 bits (213), Expect = 4e-18
 Identities = 36/174 (20%), Positives = 74/174 (42%), Gaps = 11/174 (6%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G FG V+R            K    +  +     + E  ++   RHRN++ +  S  
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
           + +   ++ E++S   + + +++S   LN    ++ +  +  AL++LH  +   I H D+
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDI 128

Query: 853 KPSNVLL--DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
           +P N++          + +FG A+ L  +     R        Y AP E+   +
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRL-LFTAPEYYAP-EVHQHD 178

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 87.8 bits (218), Expect = 4e-18
 Identities = 46/217 (21%), Positives = 80/217 (36%), Gaps = 53/217 (24%)

Query: 721 LLRATDNFAEN----NIIGIGGFGSVYRAR-LEDGVEIAIKV-------------FHPQC 762
           + +      E+      +G G +G V   +      E AIKV              +   
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 763 ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNI 822
               +    E  ++K++ H N++K+     +  +  LV E+   G L             
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL------------- 133

Query: 823 FCRL------------NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHL 867
           F ++            NIM  I S + YLH  +   I+H D+KP N+LL   +  +   +
Sbjct: 134 FEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKI 190

Query: 868 SDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
            DFG++       +       L T  Y+AP E+   +
Sbjct: 191 VDFGLSSFF---SKDYKLRDRLGTAYYIAP-EVLKKK 223

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 85.3 bits (211), Expect = 6e-18
 Identities = 48/246 (19%), Positives = 79/246 (32%), Gaps = 74/246 (30%)

Query: 723 RATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVF----------------------- 758
           R   +F     +G GGFG V+ A+   D    AIK                         
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 759 HPQCASTLKSFEA-----------------------------------ECEVIKNIRHRN 783
           HP       ++                                     +   +     +N
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCA--LNIFCRLNIMIDIASALEYLHF 841
            V  +   S   +  + ++     +L+D ++             L+I I IA A+E+LH 
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH- 181

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE----------STMRTQTLAT 891
             S  ++H DLKPSN+    D V  + DFG+   +  ++E              T  + T
Sbjct: 182 --SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

Query: 892 IGYMAP 897
             YM+P
Sbjct: 240 KLYMSP 245

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 85.4 bits (212), Expect = 7e-18
 Identities = 73/275 (26%), Positives = 117/275 (42%), Gaps = 42/275 (15%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFE---AECE 774
           F+ ++          +G G FG V   + ++     A+K+   Q    LK  E    E  
Sbjct: 43  FDRIK---------TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93

Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           +++ +    LVK+  S  ++    +V+EY++ G +   L           R      I  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVL 152

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL-ATIG 893
             EYLH   S  +I+ DLKP N+L+D+     ++DFG AK + G      RT TL  T  
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPE 203

Query: 894 YMAPDEIFVGE---LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            +AP EI + +    ++  W    L V + E     + +G    FA +      I+   +
Sbjct: 204 ALAP-EIILSKGYNKAVDWWA---LGVLIYE-----MAAGYPPFFADQPI---QIYEKIV 251

Query: 951 ECTMESPEK-RIDAKDTITRLLKIRDTLSKRIGNL 984
              +  P     D KD +  LL+  D L+KR GNL
Sbjct: 252 SGKVRFPSHFSSDLKDLLRNLLQ-VD-LTKRFGNL 284

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 84.6 bits (210), Expect = 9e-18
 Identities = 43/188 (22%), Positives = 74/188 (39%), Gaps = 31/188 (16%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFH------PQCASTLKSFEAECEVIKNIRHRNLVK 786
           +G G F  V + R    G++ A K          +   + +  E E  ++K I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 787 IISSCSNDDFKALVLEYMSNGSL------EDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           +     N     L+LE ++ G L      ++ L               +  I + + YLH
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQILNGVYYLH 131

Query: 841 FGHSTPIIHCDLKPSNVLL----DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
                 I H DLKP N++L           + DFG+A  +  +  +  +     T  ++A
Sbjct: 132 SLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN-IFGTPEFVA 185

Query: 897 PDEIFVGE 904
           P EI   E
Sbjct: 186 P-EIVNYE 192

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 53/182 (29%), Positives = 81/182 (44%), Gaps = 25/182 (13%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISS 790
           IG G F  V  AR +  G E+AIK+        ++L+    E  ++K + H N+VK+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNC-----ALNIFCRLNIMIDIASALEYLHFGHST 845
              +    L++EY S G + D L +        A + F        I SA++Y H     
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR------QIVSAVQYCH---QK 133

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ--TLATIGYMAPDEIFVG 903
            I+H DLK  N+LLD DM   ++DFG +   +      +           Y AP E+F G
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFT--VGGKLDAFCGAPP---YAAP-ELFQG 187

Query: 904 EL 905
           + 
Sbjct: 188 KK 189

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 17/179 (9%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFH-PQCASTLKSFEAECEVIKNIRHRNLVKIISSC 791
           +G G +G V  A        +A+K+    +     ++ + E  + K + H N+VK     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 792 SNDDFKALVLEYMSNGSLED--CLH---SSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
              + + L LEY S G L D            A   F +      + + + YLH      
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLH---GIG 125

Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGEL 905
           I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP E+     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP-ELLKRRE 183

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 84.1 bits (209), Expect = 1e-17
 Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 29/189 (15%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFE---AECE 774
           F++LR          +G G FG V+  R        A+KV   +    LK  E    E  
Sbjct: 8   FQILR---------TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL 58

Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           ++  + H  ++++  +  +     ++++Y+  G L   L  S    N   +     ++  
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCL 117

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH--LSDFGMAKLLSGEDESTMRTQTL-AT 891
           ALEYLH   S  II+ DLKP N+LLD++   H  ++DFG AK           T TL  T
Sbjct: 118 ALEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAK------YVPDVTYTLCGT 166

Query: 892 IGYMAPDEI 900
             Y+AP E+
Sbjct: 167 PDYIAP-EV 174

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 44/182 (24%), Positives = 73/182 (40%), Gaps = 14/182 (7%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAST-LKSFEAECEVI-KNIRHR 782
           D+      +G G +G V + R +  G  +A+K       S   K    + ++  + +   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCL---HSSNCALNIFCRLNIMIDIASALEYL 839
             V    +   +    + +E M + SL+            +       I + I  ALE+L
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA-TIGYMAPD 898
           H   S  +IH D+KPSNVL++      + DFG    +SG     +     A    YMAP+
Sbjct: 126 HSKLS--VIHRDVKPSNVLINALGQVKMCDFG----ISGYLVDDVAKDIDAGCKPYMAPE 179

Query: 899 EI 900
            I
Sbjct: 180 RI 181

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 84.8 bits (210), Expect = 3e-17
 Identities = 52/195 (26%), Positives = 81/195 (41%), Gaps = 29/195 (14%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVF-------HPQCASTLKSFE 770
           FE L+         ++G G FG V   + +      A+K+          + A TL    
Sbjct: 150 FEYLK---------LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL---- 196

Query: 771 AECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
            E  V++N RH  L  +  S    D    V+EY + G L   L           R     
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA- 255

Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL- 889
           +I SAL+YLH   +  +++ DLK  N++LD+D    ++DFG+ K    +       +T  
Sbjct: 256 EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTFC 310

Query: 890 ATIGYMAPDEIFVGE 904
            T  Y+AP E+    
Sbjct: 311 GTPEYLAP-EVLEDN 324

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 17/179 (9%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFH-PQCASTLKSFEAECEVIKNIRHRNLVKIISSC 791
           +G G +G V  A        +A+K+    +     ++ + E  + K + H N+VK     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 792 SNDDFKALVLEYMSNGSLED--CLH---SSNCALNIFCRLNIMIDIASALEYLHFGHSTP 846
              + + L LEY S G L D            A   F +      + + + YLH      
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLH---GIG 125

Query: 847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGEL 905
           I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP E+     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP-ELLKRRE 183

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 41/209 (19%), Positives = 80/209 (38%), Gaps = 15/209 (7%)

Query: 413 IGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDL 472
              L+N +  +LG  +++    V+   L  +Q  +   + +       +   + L EL L
Sbjct: 15  DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHL 70

Query: 473 NGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLA 532
           + N+IS  +S  L +LT L+ L++  NR   +       L  +    + +N L    SL 
Sbjct: 71  SHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRL---FLDNNELRDTDSLI 125

Query: 533 IGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDL 592
             +LK +  + +  N L  +I   L  L  L+ + L  N +          +  +  +DL
Sbjct: 126 --HLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDL 179

Query: 593 SNNKISGSIPVSFEKLSYLKELNLSFNKL 621
           +  K          +L     +     + 
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRW 208

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 49/273 (17%), Positives = 87/273 (31%), Gaps = 33/273 (12%)

Query: 361 LSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLI 420
           +             LG   +      S   LS  ++  N    NI  ++   +   +NL 
Sbjct: 12  VFPDPGLANAVKQNLGKQSVTDL--VSQKELS-GVQNFNGDNSNIQ-SL-AGMQFFTNLK 66

Query: 421 VLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLN--ELDLNGNKIS 478
            L L  N +S  +      L KL+ L +  N+L       +  +       L L+ N++ 
Sbjct: 67  ELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELR 119

Query: 479 GSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKA 538
               S L +L +L+ L++ +N+   +       L  +   D+  N +     L    LK 
Sbjct: 120 -DTDS-LIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITNTGGLT--RLKK 173

Query: 539 VVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKIS 598
           V  IDL+              L     +     R              +    +SN    
Sbjct: 174 VNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW-------------ISPYYISNGGSY 220

Query: 599 GSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPF 631
               V +E   Y  E++  F++          F
Sbjct: 221 VDGCVLWELPVYTDEVSYKFSEYINVGETEAIF 253

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 42/250 (16%), Positives = 90/250 (36%), Gaps = 24/250 (9%)

Query: 188 SSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVL 247
                     + +LG  +++  +      L+ +Q  +  N+ +  +    + +  NL  L
Sbjct: 13  FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKEL 68

Query: 248 QLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTI 307
            L  N ++ + P  + +++ L+E+ +  N L         +    L  L L  N    T 
Sbjct: 69  HLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNG----IPSACLSRLFLDNNELRDT- 121

Query: 308 PSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANC 367
             S+ +   L +L + +N         +G L  L++ D+  N +T+          L   
Sbjct: 122 -DSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITN-------TGGLTRL 171

Query: 368 KKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGN 427
           KK+ ++ L G             L ++    +     IS   P  I N  + +   +   
Sbjct: 172 KKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS---PYYISNGGSYVDGCVLWE 228

Query: 428 NLSGSIPVTF 437
               +  V++
Sbjct: 229 LPVYTDEVSY 238

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 37/190 (19%), Positives = 76/190 (40%), Gaps = 16/190 (8%)

Query: 66  IICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKV 125
           +  D         NL   ++  T       LS +++ +  ++ + S   + +   + LK 
Sbjct: 12  VFPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQS--LAGMQFFTNLKE 67

Query: 126 LYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGK 185
           L+L  NQ+S  LS    + + + ++ +++N+L              L  LFL  N    +
Sbjct: 68  LHLSHNQIS-DLSPLK-DLTKLEELSVNRNRLKNLNGIPSAC----LSRLFLDNNEL--R 119

Query: 186 IPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLD 245
              SL   K L+ L +  N L   +   +G L+ L+ + L  N++       +  L+ ++
Sbjct: 120 DTDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEI--TNTGGLTRLKKVN 175

Query: 246 VLQLGFNNLT 255
            + L      
Sbjct: 176 WIDLTGQKCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 25/154 (16%), Positives = 54/154 (35%), Gaps = 35/154 (22%)

Query: 469 ELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGP 528
           E       I+  +      L +    NLG    T                D+ S      
Sbjct: 1   ESIQRPTPIN-QVF-PDPGLANAVKQNLGKQSVT----------------DLVS------ 36

Query: 529 ISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLE 588
                  L  V   +   +N+  ++   ++   +L+ + L++N++         ++T LE
Sbjct: 37  ----QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQISDL--SPLKDLTKLE 88

Query: 589 SLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLK 622
            L ++ N++     ++    + L  L L  N+L+
Sbjct: 89  ELSVNRNRLKN---LNGIPSACLSRLFLDNNELR 119

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 47.7 bits (114), Expect = 6e-06
 Identities = 33/163 (20%), Positives = 63/163 (38%), Gaps = 22/163 (13%)

Query: 73  HKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQ 132
             +  L+LS  N    + P + +L+ L+ L ++ N+L +    +    + L  L+L +N+
Sbjct: 63  TNLKELHLSH-NQISDLSP-LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNE 117

Query: 133 LSGSLSSFTFNTS-SILDIRLSKNKLSGKLPENICN--HLRYLKHLFLRENMFYGKIP-- 187
           L     S     +  IL   +  NKL      +I     L  L+ L L  N    +I   
Sbjct: 118 LR-DTDSLIHLKNLEILS--IRNNKLK-----SIVMLGFLSKLEVLDLHGN----EITNT 165

Query: 188 SSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKL 230
             L++ K++  + L          K    L +   +   + + 
Sbjct: 166 GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 43/178 (24%), Positives = 73/178 (41%), Gaps = 9/178 (5%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHP-QCASTLKSFEAECEVI-KNIRHR 782
           ++      +G G  G V++ R  + G  IA+K           K    + +V+ K+    
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
            +V+   +   +    + +E M     E         +       + + I  AL YL   
Sbjct: 85  YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           H   +IH D+KPSN+LLDE     L DFG++  L    +   + ++     YMAP+ I
Sbjct: 144 HG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAPERI 196

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 83.6 bits (207), Expect = 5e-17
 Identities = 46/201 (22%), Positives = 85/201 (42%), Gaps = 42/201 (20%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKS---FEAECE 774
           +E+++         +IG G FG V   R +   ++ A+K+              F  E +
Sbjct: 71  YEVVK---------VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121

Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID--- 831
           ++       +V++  +  +D +  +V+EYM  G L          +N+    ++      
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWAR 171

Query: 832 -----IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH--LSDFGMAKLLSGEDESTM 884
                +  AL+ +   HS   IH D+KP N+LLD+    H  L+DFG    ++ E    +
Sbjct: 172 FYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEG--MV 224

Query: 885 RTQTL-ATIGYMAPDEIFVGE 904
           R  T   T  Y++P E+   +
Sbjct: 225 RCDTAVGTPDYISP-EVLKSQ 244

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 81.9 bits (203), Expect = 8e-17
 Identities = 44/220 (20%), Positives = 81/220 (36%), Gaps = 25/220 (11%)

Query: 693 KRGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDGV 751
                  + + ++   S       +++ L         +  +G G F  V +      G 
Sbjct: 6   HHSSGVDLGTENLYFQSMENFN--NFYIL--------TSKELGRGKFAVVRQCISKSTGQ 55

Query: 752 EIAIKVFH--PQCASTLKSFEAECEVIKNIRHR-NLVKIISSCSNDDFKALVLEYMSNGS 808
           E A K      +          E  V++  +    ++ +     N     L+LEY + G 
Sbjct: 56  EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE 115

Query: 809 L-EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMV 864
           +   CL      ++    + ++  I   + YLH  +   I+H DLKP N+LL        
Sbjct: 116 IFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172

Query: 865 AHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
             + DFGM++ +       +R   + T  Y+AP EI   +
Sbjct: 173 IKIVDFGMSRKI--GHACELRE-IMGTPEYLAP-EILNYD 208

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 82.2 bits (203), Expect = 1e-16
 Identities = 49/190 (25%), Positives = 77/190 (40%), Gaps = 38/190 (20%)

Query: 446 LDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISS--CLGNLTSLQYLNLGSNRFTF 503
           L  +  +L  ++P  +   S    LDL+ N +S  + +      LT+L  L L  N   F
Sbjct: 23  LSCSKQQLP-NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF 78

Query: 504 VIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPT-TLEGLKS 562
           +    F  +                      NL+    +DLS N+L   +       L++
Sbjct: 79  ISSEAFVPVP---------------------NLRY---LDLSSNHLH-TLDEFLFSDLQA 113

Query: 563 LQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIP----VSFEKLSYLKELNLSF 618
           L+ + L  N +      +F +M  L+ L LS N+IS   P        KL  L  L+LS 
Sbjct: 114 LEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSS 172

Query: 619 NKLKGEIPRG 628
           NKLK ++P  
Sbjct: 173 NKLK-KLPLT 181

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 80.3 bits (198), Expect = 4e-16
 Identities = 39/211 (18%), Positives = 67/211 (31%), Gaps = 52/211 (24%)

Query: 390 NLSLSLERLNIAFCNISGNIPK-AIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLD 447
           +L      L+++  N+S    +     L+NL  L L  N+L+  I    F  +  L+ LD
Sbjct: 36  SLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLD 94

Query: 448 LAFNKLAGSIPDEICL-LSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIP 506
           L+ N L  ++ + +   L  L  L L  N I     +   ++  LQ L L  N+ +    
Sbjct: 95  LSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPV 153

Query: 507 STFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNI 566
               +                                                L  L  +
Sbjct: 154 ELIKDG---------------------------------------------NKLPKLMLL 168

Query: 567 SLAYNRLEGPIPESFGNMTSL--ESLDLSNN 595
            L+ N+L+         + +     L L NN
Sbjct: 169 DLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 79.1 bits (195), Expect = 1e-15
 Identities = 53/188 (28%), Positives = 76/188 (40%), Gaps = 20/188 (10%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQLS 134
             L+ S   L   +P  +   S    LDLSHN LS        T ++ L  L L  N L+
Sbjct: 21  NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN 77

Query: 135 GSLSSFTFNTSSILD-IRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKI----PSS 189
             +SS  F     L  + LS N L   L E + + L+ L+ L L  N     I     ++
Sbjct: 78  -FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNN----HIVVVDRNA 131

Query: 190 LSKCKQLQELHLGYNNLSGAIPKEI----GNLTVLQRISLINNKLHGEIPQEIGYLQNLD 245
                QLQ+L+L  N +S   P E+      L  L  + L +NKL      ++  L    
Sbjct: 132 FEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWV 190

Query: 246 VLQLGFNN 253
              L  +N
Sbjct: 191 KNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 76.4 bits (188), Expect = 7e-15
 Identities = 45/167 (26%), Positives = 70/167 (41%), Gaps = 15/167 (8%)

Query: 75  VTTLNLSSFNLQGTIPPEIA--NLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDN 131
              L+LS  NL   +  E     L++L SL LSHN L+  I S  F  +  L+ L L  N
Sbjct: 41  TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSN 98

Query: 132 QLSGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIP--- 187
            L  +L  F F +  ++  + L  N +   +  N    +  L+ L+L +N    + P   
Sbjct: 99  HLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155

Query: 188 -SSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQR--ISLINNKLH 231
               +K  +L  L L  N L      ++  L    +  + L NN L 
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 76.4 bits (188), Expect = 7e-15
 Identities = 33/158 (20%), Positives = 59/158 (37%), Gaps = 9/158 (5%)

Query: 370 LRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNL 429
              L L  N L             +L  L ++  +++    +A   + NL  L L  N+L
Sbjct: 41  TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL 100

Query: 430 SGSIPV-TFGGLQKLQGLDLAFNKLAGSIPDEI-CLLSRLNELDLNGNKISGSIS----S 483
             ++    F  LQ L+ L L  N +   +       +++L +L L+ N+IS         
Sbjct: 101 H-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK 157

Query: 484 CLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDIS 521
               L  L  L+L SN+   +  +    L   +   + 
Sbjct: 158 DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 42/171 (24%), Positives = 67/171 (39%), Gaps = 11/171 (6%)

Query: 186 IPSSLSKCKQLQELHLGYNNLSGAIPKEI--GNLTVLQRISLINNKLHGEIPQEI-GYLQ 242
           +P SL        L L +NNLS  +  E     LT L  + L +N L+  I  E    + 
Sbjct: 33  VPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88

Query: 243 NLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINS 302
           NL  L L  N+L  +      ++  L+ + LYNN +   +       +  L+ L L  N 
Sbjct: 89  NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQ 147

Query: 303 FSGTIPSSITNASKLILLE---MGSNSFSGFIPSAIGNLRNLKLFDIFFNN 350
            S      I + +KL  L    + SN       + +  L       ++ +N
Sbjct: 148 ISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 21/117 (17%), Positives = 40/117 (34%), Gaps = 19/117 (16%)

Query: 74  KVTTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIFT----MSTLKVLYL 128
            +  L L + ++   +      +++ L+ L LS N++S   P  +      +  L +L L
Sbjct: 113 ALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDL 170

Query: 129 MDNQLSGSLSSFTFNTSSIL---DIRLSKNKLSGKLPENICN-HLRYLKHLFLRENM 181
             N+L   L               + L  N L        C+  L  L   +    +
Sbjct: 171 SSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPLE-------CDCKLYQLFSHWQYRQL 219

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 80.3 bits (199), Expect = 1e-16
 Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 22/181 (12%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRHRNLVKIIS 789
           +G+G FG V        G ++A+K+ + Q   +L        E + +K  RH +++K+  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 790 SCSNDDFKALVLEYMSNGSLEDCL-----HSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
             S      +V+EY+S G L D +          A  +F +      I SA++Y H    
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ------ILSAVDYCH---R 129

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
             ++H DLKP NVLLD  M A ++DFG++ ++   D   +RT +  +  Y AP E+  G 
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRT-SCGSPNYAAP-EVISGR 185

Query: 905 L 905
           L
Sbjct: 186 L 186

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 82.5 bits (204), Expect = 1e-16
 Identities = 44/203 (21%), Positives = 85/203 (41%), Gaps = 44/203 (21%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKS---FEAECE 774
           FE+L+         +IG G FG V   +L++  ++ A+K+ +            F  E +
Sbjct: 76  FEILK---------VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126

Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMID--- 831
           V+ N   + +  +  +  +D+   LV++Y   G L          L +  +    +    
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL----------LTLLSKFEDRLPEEM 176

Query: 832 -------IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH--LSDFGMAKLLSGEDES 882
                  +  A++ +   H    +H D+KP N+L+D +   H  L+DFG    L   ++ 
Sbjct: 177 ARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLM--EDG 229

Query: 883 TMRTQTL-ATIGYMAPDEIFVGE 904
           T+++     T  Y++P EI    
Sbjct: 230 TVQSSVAVGTPDYISP-EILQAM 251

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 49/193 (25%), Positives = 81/193 (41%), Gaps = 45/193 (23%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEV---IKNIRHRNLVKII 788
           ++G+G  G V        G + A+K+ +        S +A  EV    +     ++V I+
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88

Query: 789 ----SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN----------IMIDIAS 834
               +         +++E M  G L            I  R +          IM DI +
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGELFS---------RIQERGDQAFTEREAAEIMRDIGT 139

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           A+++LH   S  I H D+KP N+L    ++D V  L+DFG AK      ++ ++T    T
Sbjct: 140 AIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET---TQNALQT-PCYT 192

Query: 892 IGYMAPDEIFVGE 904
             Y+AP E+   E
Sbjct: 193 PYYVAP-EVLGPE 204

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 82.1 bits (203), Expect = 2e-16
 Identities = 54/184 (29%), Positives = 89/184 (48%), Gaps = 28/184 (15%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRHRNLVKIIS 789
           +G+G FG V   +    G ++A+K+ + Q   +L        E + +K  RH +++K+  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 790 SCSNDDFKALVLEYMSNGSLED--CLH---SSNCALNIFCRLNIMIDIASALEYLHFGHS 844
             S      +V+EY+S G L D  C +       +  +F +      I S ++Y H    
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ------ILSGVDYCH---R 134

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG---YMAPDEIF 901
             ++H DLKP NVLLD  M A ++DFG++ ++   D   +RT    + G   Y AP E+ 
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRT----SCGSPNYAAP-EVI 187

Query: 902 VGEL 905
            G L
Sbjct: 188 SGRL 191

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 40/240 (16%), Positives = 80/240 (33%), Gaps = 36/240 (15%)

Query: 386 SSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQ 444
             I +L  S + L +   ++      A  NL N+  + +  +     +   +F  L K+ 
Sbjct: 24  QRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVT 83

Query: 445 GLDLAFNKLAGSIPDEICL-LSRLNELDLNGNKISGSIS--SCLGNLTSLQYLNLGSN-R 500
            +++   +    I  +    L  L  L +    +       + + +      L +  N  
Sbjct: 84  HIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPY 142

Query: 501 FTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPT-TLEG 559
            T +  + F  L          N                + + L  N  + ++      G
Sbjct: 143 MTSIPVNAFQGL---------CNET--------------LTLKLYNNGFT-SVQGYAFNG 178

Query: 560 LKSLQNISLAYNRLEGPIPE-SFGNMTS-LESLDLSNNKISGSIPV-SFEKLSYLKELNL 616
            K L  + L  N+    I + +FG + S    LD+S   ++ ++P    E L  L   N 
Sbjct: 179 TK-LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 43/231 (18%), Positives = 78/231 (33%), Gaps = 16/231 (6%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQLS 134
               ++  ++     P +    S ++L L    L + IPS  F+ +  +  +Y+  +   
Sbjct: 14  EDFRVTCKDI--QRIPSL--PPSTQTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDVTL 68

Query: 135 GSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIP--SSLS 191
             L S +F N S +  I +   +    +  +    L  LK L +         P  + + 
Sbjct: 69  QQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVY 127

Query: 192 KCKQLQELHLGYNNLSGAIPKEI--GNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQL 249
                  L +  N    +IP     G       + L NN     +         LD + L
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYL 186

Query: 250 GFNNLTGVVPATIFN--MSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNL 298
             N    V+    F    S    + +   S++ +LPS+    L  L   N 
Sbjct: 187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 35/221 (15%), Positives = 75/221 (33%), Gaps = 33/221 (14%)

Query: 416 LSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLDLAFNKLAGSIPDEI-CLLSRLNELDLN 473
             +   L L   +L  +IP   F  L  +  + ++ +     +       LS++  +++ 
Sbjct: 30  PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88

Query: 474 GNKISGSISS-CLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLA 532
             +    I    L  L  L++L + +                             P    
Sbjct: 89  NTRNLTYIDPDALKELPLLKFLGIFNTGLKMF-----------------------PDLTK 125

Query: 533 IGNLKAVVGIDLSRNNLSGNIPT-TLEGLKS-LQNISLAYNRLEGPIPESFGNMTSLESL 590
           + +      ++++ N    +IP    +GL +    + L  N     +     N T L+++
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAV 184

Query: 591 DLSNNKISGSIPV-SFEKL-SYLKELNLSFNKLKGEIPRGG 629
            L+ NK    I   +F  + S    L++S   +   +P  G
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 34/209 (16%), Positives = 73/209 (34%), Gaps = 11/209 (5%)

Query: 75  VTTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQ 132
             TL L   +L+ TIP    +NL ++  + +S +     + S  F  +S +  + + + +
Sbjct: 33  TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 133 LSGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSL- 190
               +          +  + +    L                 L + +N +   IP +  
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151

Query: 191 -SKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEI--GYLQNLDVL 247
              C +   L L  N  + ++     N T L  + L  NK    I ++   G      +L
Sbjct: 152 QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210

Query: 248 QLGFNNLTGVVPATIF-NMSTLKEIFLYN 275
            +   ++T  +P+    ++  L     + 
Sbjct: 211 DVSQTSVT-ALPSKGLEHLKELIARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 42/215 (19%), Positives = 68/215 (31%), Gaps = 17/215 (7%)

Query: 306 TIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLA 365
            IPS   +   L L              A  NL N+    +  +          F     
Sbjct: 25  RIPSLPPSTQTLKL---IETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSF----Y 77

Query: 366 NCKKLRYLGLGGNPLDGFLPSSI-GNLSLSLERLNIAFCNISGNIP--KAIGNLSNLIVL 422
           N  K+ ++ +       ++       L   L+ L I    +    P    + +     +L
Sbjct: 78  NLSKVTHIEIRNTRNLTYIDPDALKELP-LLKFLGIFNTGLK-MFPDLTKVYSTDIFFIL 135

Query: 423 SLGGNNLSGSIPV-TFGGLQK-LQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGS 480
            +  N    SIPV  F GL      L L  N    S+       ++L+ + LN NK    
Sbjct: 136 EITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTV 194

Query: 481 ISS-CLGNLTS-LQYLNLGSNRFTFVIPSTFWNLK 513
           I     G + S    L++     T +      +LK
Sbjct: 195 IDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLK 229

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 43/238 (18%), Positives = 82/238 (34%), Gaps = 17/238 (7%)

Query: 193 CKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFN 252
           C Q ++  +   ++   IP         Q + LI   L          L N+  + +  +
Sbjct: 10  CHQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSID 65

Query: 253 NLTGVVPATIF-NMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIP--S 309
                + +  F N+S +  I + N      +       LP L+FL +         P  +
Sbjct: 66  VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLT 124

Query: 310 SITNASKLILLEMGSNSFSGFIPS-AIGNLRNLKLF-DIFFNNLTSSTPELGFLSSLANC 367
            + +     +LE+  N +   IP  A   L N  L   ++ N  TS        +     
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQG--YAFNGT--- 179

Query: 368 KKLRYLGLGGNPLDGFLPSSI-GNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSL 424
            KL  + L  N     +     G +      L+++  +++    K + +L  LI  + 
Sbjct: 180 -KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 62.7 bits (153), Expect = 6e-11
 Identities = 35/174 (20%), Positives = 61/174 (35%), Gaps = 10/174 (5%)

Query: 460 EICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFD 519
             C   +  +  +    I   I S      S Q L L       +    F NL +I    
Sbjct: 6   PPCECHQEEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIY 61

Query: 520 ISSNLLDGPI-SLAIGNLKAVVGIDLSRNNLSGNIPT-TLEGLKSLQNISLAYNRLEG-P 576
           +S ++    + S +  NL  V  I++        I    L+ L  L+ + +    L+  P
Sbjct: 62  VSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFP 121

Query: 577 IPESFGNMTSLESLDLSNNKISGSIPV-SFEKL-SYLKELNLSFNKLKGEIPRG 628
                 +      L++++N    SIPV +F+ L +    L L  N     +   
Sbjct: 122 DLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY 174

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.8 bits (200), Expect = 3e-16
 Identities = 39/185 (21%), Positives = 65/185 (35%), Gaps = 26/185 (14%)

Query: 733 IIGIGGFGSVYRARLEDGVEIAIK--VFHPQCASTLKSFEA---------ECEVIKNIRH 781
            I  G +G+V      +G+ +AIK          T+              E  ++ +  H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 782 RNLVK---IISSCSNDDFKA--LVLEYMSNGSLEDCLHSSNCAL-NIFCRLNIMIDIASA 835
            N++    I             LV E M    L   +H     +     +   M  I   
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY-FMYHILLG 146

Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYM 895
           L  LH      ++H DL P N+LL ++    + DF +A+  + +      T  +    Y 
Sbjct: 147 LHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK---THYVTHRWYR 200

Query: 896 APDEI 900
           AP E+
Sbjct: 201 AP-EL 204

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 80.5 bits (199), Expect = 3e-16
 Identities = 50/206 (24%), Positives = 80/206 (38%), Gaps = 31/206 (15%)

Query: 708 SSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTL 766
              P +     ++ ++          IG G FG     R       +A+K      A   
Sbjct: 11  LDMPIMHDSDRYDFVK---------DIGSGNFGVARLMRDKLTKELVAVKYIERGAAID- 60

Query: 767 KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLED--CLH---SSNCALN 821
           ++ + E    +++RH N+V+           A+++EY S G L +  C     S + A  
Sbjct: 61  ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARF 120

Query: 822 IFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHL--SDFGMAKLLSGE 879
            F        + S + Y H   S  I H DLK  N LLD      L   DFG +K     
Sbjct: 121 FF------QQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS--V 169

Query: 880 DESTMRTQTLATIGYMAPDEIFVGEL 905
             S  ++ T+ T  Y+AP E+ + + 
Sbjct: 170 LHSQPKS-TVGTPAYIAP-EVLLRQE 193

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 79.2 bits (196), Expect = 7e-16
 Identities = 54/201 (26%), Positives = 85/201 (42%), Gaps = 42/201 (20%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVF-------HPQCASTLKSFE 770
           F+ L+         ++G G FG V   R +      A+K+          + A T+    
Sbjct: 7   FDYLK---------LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV---- 53

Query: 771 AECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIF----CRL 826
            E  V++N RH  L  +  +    D    V+EY + G L    H S     +F     R 
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFTEERARF 109

Query: 827 NIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH--LSDFGMAKLLSGEDESTM 884
               +I SALEYLH   S  +++ D+K  N++LD+D   H  ++DFG+ K    +     
Sbjct: 110 YGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGA--- 160

Query: 885 RTQTL-ATIGYMAPDEIFVGE 904
             +T   T  Y+AP E+    
Sbjct: 161 TMKTFCGTPEYLAP-EVLEDN 180

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 79.4 bits (196), Expect = 1e-15
 Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 32/197 (16%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQC---ASTLKSFEAECE 774
           FE+L+         +IG G F  V   +++   ++ A+K+ +         +  F  E +
Sbjct: 63  FEILK---------VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113

Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIF----CRLNIMI 830
           V+ N   R + ++  +  ++++  LV+EY   G   D L   +           R  +  
Sbjct: 114 VLVNGDRRWITQLHFAFQDENYLYLVMEYYVGG---DLLTLLSKFGERIPAEMARFYLA- 169

Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH--LSDFGMAKLLSGEDESTMRTQT 888
           +I  A++ +H       +H D+KP N+LLD     H  L+DFG    L  +   T+R+  
Sbjct: 170 EIVMAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADG--TVRSLV 222

Query: 889 L-ATIGYMAPDEIFVGE 904
              T  Y++P EI    
Sbjct: 223 AVGTPDYLSP-EILQAV 238

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 43/185 (23%), Positives = 71/185 (38%), Gaps = 22/185 (11%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIK------VFHPQCASTLKSFEAECEVIKNIR----HR 782
           +G GGFG+V+    L D +++AIK      V      S   +   E  ++  +     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGS-LEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
            +++++      +   LVLE       L D +           R      + +A+++ H 
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH- 156

Query: 842 GHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
             S  ++H D+K  N+L+D     A L DFG   LL  E  +        T  Y  P E 
Sbjct: 157 --SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD----FDGTRVYSPP-EW 209

Query: 901 FVGEL 905
                
Sbjct: 210 ISRHQ 214

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 39/183 (21%), Positives = 66/183 (36%), Gaps = 20/183 (10%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIK------VFHPQCASTLKSFEAECEVIKNIRHR--NL 784
           +G GGFGSVY    + D + +AIK      +              E  ++K +      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 785 VKIISSCSNDDFKALVLEYMSN-GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           ++++      D   L+LE       L D +           R +    +  A+ + H   
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH--- 166

Query: 844 STPIIHCDLKPSNVLLDED-MVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV 902
           +  ++H D+K  N+L+D +     L DFG   LL     +        T  Y  P E   
Sbjct: 167 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYSPP-EWIR 221

Query: 903 GEL 905
              
Sbjct: 222 YHR 224

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 78.9 bits (195), Expect = 2e-15
 Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 28/174 (16%)

Query: 725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
              +    +IG G FG V++A+L +  E+AIK          +    E ++++ ++H N+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNV 94

Query: 785 VK----IISSCSNDDFKA--LVLEYMSNGSLEDCLH-------SSNCAL-NIFCRLNIMI 830
           V       S+    D     LVLEY+      + ++            +  +  +L  M 
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLKQTMPMLLIKL-YMY 148

Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAKLLSGEDEST 883
            +  +L Y+H   S  I H D+KP N+LLD    V  L DFG AK+L   + + 
Sbjct: 149 QLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV 199

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 78.5 bits (194), Expect = 2e-15
 Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 34/197 (17%)

Query: 725 TDNFAENNIIGIGGFGSVYRARL-EDGVEIAIK-VF-HPQCAS-TLKSFEAECEVIKNIR 780
            D F    + G G FG+V   +    G+ +AIK V   P+  +  L+      + +  + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ----IMQDLAVLH 77

Query: 781 HRNLVK---IISSCSNDDFK----ALVLEYMSNGSLEDCLH-------SSNCAL-NIFCR 825
           H N+V+      +    D +     +V+EY+      D LH           A   I  +
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPPILIK 132

Query: 826 LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHLSDFGMAKLLSGEDESTM 884
           +  +  +  ++  LH   S  + H D+KP NVL++  D    L DFG AK LS  + +  
Sbjct: 133 V-FLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-- 188

Query: 885 RTQTLATIGYMAPDEIF 901
               + +  Y AP+ IF
Sbjct: 189 -VAYICSRYYRAPELIF 204

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 77.6 bits (192), Expect = 2e-15
 Identities = 50/194 (25%), Positives = 86/194 (44%), Gaps = 28/194 (14%)

Query: 723 RATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVI----- 776
           ++ + +    ++G G +G V + R  + G  +AIK F             + +++     
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL---------ESDDDKMVKKIAM 72

Query: 777 ------KNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
                 K +RH NLV ++  C       LV E++ + ++ D L      L+       + 
Sbjct: 73  REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLF 131

Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            I + + + H   S  IIH D+KP N+L+ +  V  L DFG A+ L+   E       +A
Sbjct: 132 QIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVA 186

Query: 891 TIGYMAPDEIFVGE 904
           T  Y AP E+ VG+
Sbjct: 187 TRWYRAP-ELLVGD 199

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 42/184 (22%), Positives = 72/184 (39%), Gaps = 39/184 (21%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKII-- 788
           ++G+G  G V +        + A+K+              E E+     +  ++V+I+  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 123

Query: 789 --SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN----------IMIDIASAL 836
             +  +      +V+E +  G L            I  R +          IM  I  A+
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFS---------RIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 837 EYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
           +YL   HS  I H D+KP N+L      + +  L+DFG AK       +++ T    T  
Sbjct: 175 QYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTT-PCYTPY 228

Query: 894 YMAP 897
           Y+AP
Sbjct: 229 YVAP 232

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 77.2 bits (191), Expect = 2e-15
 Identities = 45/204 (22%), Positives = 79/204 (38%), Gaps = 26/204 (12%)

Query: 706 ILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAST 765
           +                   + + +   +G G +G VY+A+   G  +A+K         
Sbjct: 1   MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------ 54

Query: 766 LKSFEAECE-----------VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLH 814
               +AE E           ++K + H N+V +I    ++    LV E+M    L+  L 
Sbjct: 55  ---LDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLD 110

Query: 815 SSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK 874
            +   L        +  +   + + H      I+H DLKP N+L++ D    L+DFG+A+
Sbjct: 111 ENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167

Query: 875 LLSGEDESTMRTQTLATIGYMAPD 898
                      T  + T+ Y APD
Sbjct: 168 AFG--IPVRSYTHEVVTLWYRAPD 189

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 77.7 bits (192), Expect = 3e-15
 Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 32/201 (15%)

Query: 715 RFSYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHP-----QCASTLKS 768
           R   F++      +   + IG G +G V  A    + V +AIK   P      C  TL+ 
Sbjct: 19  RGQVFDV---GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR- 74

Query: 769 FEAECEVIKNIRHRNLVK---IISSCSNDDFKA--LVLEYMSNGSLEDCLH---SSNCAL 820
              E +++   RH N++    II + + +  K   +V + M     E  L+    +    
Sbjct: 75  ---EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLS 126

Query: 821 NIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE- 879
           N       +  I   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A++   + 
Sbjct: 127 NDHICY-FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

Query: 880 DESTMRTQTLATIGYMAPDEI 900
           D +   T+ +AT  Y AP EI
Sbjct: 183 DHTGFLTEYVATRWYRAP-EI 202

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 77.8 bits (192), Expect = 4e-15
 Identities = 49/177 (27%), Positives = 85/177 (48%), Gaps = 33/177 (18%)

Query: 725 TDNFAENNIIGIGGFGSVYRARL-EDGVEIAIK-VFHPQCASTLKSFEA-ECEVIKNIRH 781
             ++ +  +IG G FG VY+A+L + G  +AIK V   +       F+  E ++++ + H
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDH 106

Query: 782 RNLVKII------SSCSNDDFKALVLEYMSNGSLEDCLH-------SSNCAL-NIFCRLN 827
            N+V++           ++ +  LVL+Y+      + ++        +   L  I+ +L 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKL- 160

Query: 828 IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAKLLSGEDEST 883
            M  +  +L Y+H   S  I H D+KP N+LLD D  V  L DFG AK L   + + 
Sbjct: 161 YMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 214

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 76.9 bits (190), Expect = 4e-15
 Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 13/176 (7%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIRHRNLVKIIS 789
           +G G FG V  A   +   ++A+K    Q             E   +K +RH +++K+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIH 849
             +      +V+EY + G L D +      +           I  A+EY H      I+H
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYI-VEKKRMTEDEGRRFFQQIICAIEYCH---RHKIVH 131

Query: 850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGEL 905
            DLKP N+LLD+++   ++DFG++ ++   D + ++T +  +  Y AP E+  G+L
Sbjct: 132 RDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKT-SCGSPNYAAP-EVINGKL 183

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 76.0 bits (188), Expect = 4e-15
 Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 26/184 (14%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECE----------- 774
           + +     IG G +G VY+A+   G   A+K             E E E           
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR---------LEKEDEGIPSTTIREIS 52

Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           ++K ++H N+VK+           LV E++    L+  L      L      + ++ + +
Sbjct: 53  ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLN 111

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY 894
            + Y H      ++H DLKP N+L++ +    ++DFG+A+           T  + T+ Y
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEIVTLWY 166

Query: 895 MAPD 898
            APD
Sbjct: 167 RAPD 170

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 76.1 bits (188), Expect = 5e-15
 Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 28/190 (14%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVI-------- 776
           + + +   IG G +G V++ R  + G  +AIK F             +  VI        
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL---------ESEDDPVIKKIALREI 53

Query: 777 ---KNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
              K ++H NLV ++          LV EY  + ++   L      +      +I     
Sbjct: 54  RMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL 112

Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
            A+ + H       IH D+KP N+L+ +  V  L DFG A+LL+G  +       +AT  
Sbjct: 113 QAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRW 167

Query: 894 YMAPDEIFVG 903
           Y +P E+ VG
Sbjct: 168 YRSP-ELLVG 176

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 75.6 bits (187), Expect = 5e-15
 Identities = 40/185 (21%), Positives = 80/185 (43%), Gaps = 27/185 (14%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECE---------- 774
             + +   IG G +G+V++A+  E    +A+K             + + E          
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR---------LDDDDEGVPSSALREI 52

Query: 775 -VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
            ++K ++H+N+V++     +D    LV E+     L+    S N  L+     + +  + 
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL 111

Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
             L + H   S  ++H DLKP N+L++ +    L++FG+A+           +  + T+ 
Sbjct: 112 KGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFG--IPVRCYSAEVVTLW 166

Query: 894 YMAPD 898
           Y  PD
Sbjct: 167 YRPPD 171

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 76.3 bits (188), Expect = 6e-15
 Identities = 40/148 (27%), Positives = 64/148 (43%), Gaps = 13/148 (8%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRH-RNLVKIISSC 791
           IG G FG +   + L     +AIK+   +  S       E    K +     + ++    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMK--SRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
               + A+VLE +   SLED     +   ++   L I I + S +EY+H   S  +I+ D
Sbjct: 75  PCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRD 130

Query: 852 LKPSNVLL-----DEDMVAHLSDFGMAK 874
           +KP N L+         V H+ DF +AK
Sbjct: 131 VKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 75.7 bits (187), Expect = 8e-15
 Identities = 60/213 (28%), Positives = 89/213 (41%), Gaps = 62/213 (29%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI----AIKVF--------HPQCASTL 766
           FELLR         ++G GG+G V++ R   G       A+KV             A T 
Sbjct: 19  FELLR---------VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK 69

Query: 767 KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRL 826
               AE  +++ ++H  +V +I +        L+LEY+S G L             F +L
Sbjct: 70  ----AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL-------------FMQL 112

Query: 827 NI------------MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH--LSDFGM 872
                         + +I+ AL +LH      II+ DLKP N++L+     H  L+DFG+
Sbjct: 113 EREGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGL 167

Query: 873 AKLLSGEDESTMRTQTLA-TIGYMAPDEIFVGE 904
            K    +      T T   TI YMAP EI +  
Sbjct: 168 CKESIHDGT---VTHTFCGTIEYMAP-EILMRS 196

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 77.5 bits (190), Expect = 8e-15
 Identities = 38/218 (17%), Positives = 70/218 (32%), Gaps = 20/218 (9%)

Query: 410 PKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNE 469
            +       L    L     +  +       ++LQ L+        +    + ++  +  
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPE------NKWCLLTIILLMRA 394

Query: 470 LDLNGNKISGSISSCLGNLTSLQYLNLG-----SNRFTFVIPSTFWNLKDILSFDISSNL 524
           LD    +           L ++  +         ++F            D+    ++   
Sbjct: 395 LDPLLYEKE--TLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452

Query: 525 LDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNM 584
           L     L    L  V  +DLS N L   +P  L  L+ L+ +  + N LE    +   N+
Sbjct: 453 LTVLCHL--EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE--NVDGVANL 507

Query: 585 TSLESLDLSNNKISG-SIPVSFEKLSYLKELNLSFNKL 621
             L+ L L NN++   +          L  LNL  N L
Sbjct: 508 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 77.1 bits (189), Expect = 1e-14
 Identities = 41/220 (18%), Positives = 77/220 (35%), Gaps = 24/220 (10%)

Query: 434 PVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQY 493
                  ++L   +L+  K    +  E+     L EL+        +I   +  L  L Y
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 494 LNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNI 553
                  F+ +          +     S  LL+  +         V+   L+  +L+  +
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDDL-RSKFLLENSVLKMEYADVRVL--HLAHKDLT-VL 456

Query: 554 PTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKE 613
              LE L  + ++ L++NRL   +P +   +  LE L  S+N +  ++      L  L+E
Sbjct: 457 CH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQE 512

Query: 614 LNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQV 653
           L L  N+L               +     + L   P L +
Sbjct: 513 LLLCNNRL---------------QQSAAIQPLVSCPRLVL 537

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 69.4 bits (169), Expect = 3e-12
 Identities = 49/327 (14%), Positives = 87/327 (26%), Gaps = 39/327 (11%)

Query: 275 NNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSA 334
             S+  S P  +   +  L  +                N    + L     +        
Sbjct: 256 CLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQ 315

Query: 335 IGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLS-- 392
                     D     +        +    A  ++L    L        L S + +    
Sbjct: 316 HTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKEL 374

Query: 393 LSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNK 452
             LE  N         + +A+  L          + L    P+    L  L+   L  N 
Sbjct: 375 QELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLEN- 433

Query: 453 LAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNL 512
                       + +  L L    ++  +   L  L  + +L+L  NR    +P     L
Sbjct: 434 -----SVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAAL 485

Query: 513 KDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNR 572
           + +     S N L+                     N+ G     +  L  LQ + L  NR
Sbjct: 486 RCLEVLQASDNALE---------------------NVDG-----VANLPRLQELLLCNNR 519

Query: 573 LEG-PIPESFGNMTSLESLDLSNNKIS 598
           L+     +   +   L  L+L  N + 
Sbjct: 520 LQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 62.9 bits (152), Expect = 3e-10
 Identities = 51/350 (14%), Positives = 101/350 (28%), Gaps = 54/350 (15%)

Query: 92  EIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIR 151
           E  ++     +      LS      +   S +  L LM ++   S+   T +  +     
Sbjct: 240 EPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHV 299

Query: 152 LSKNKLSGKLPENICNHLRYLKHLFLRENM-------FYGKIPSSLSKCKQLQELHLGYN 204
              +  +  L + +  H   +                         +  +QL    L   
Sbjct: 300 WLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVE 359

Query: 205 NLSGAIPKEIGNLTVLQRISLINNKLHGEI---PQEIGYLQNLDVLQLGFNNLTGVVPAT 261
             +  +  E+ +   LQ +   N      I    + +  L         F+ L  V P  
Sbjct: 360 KST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMR 418

Query: 262 IFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLE 321
              +  L+  FL  NS+             ++  L+L     +  +              
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEY-------ADVRVLHLAHKDLT-VLCH------------ 458

Query: 322 MGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLD 381
                        +  L  +   D+  N L +  P L         + L  L    N L+
Sbjct: 459 -------------LEQLLLVTHLDLSHNRLRALPPALA------ALRCLEVLQASDNALE 499

Query: 382 GFLPSSIGNLSLSLERLNIAFCNISG-NIPKAIGNLSNLIVLSLGGNNLS 430
                 + NL   L+ L +    +      + + +   L++L+L GN+L 
Sbjct: 500 NV--DGVANLP-RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 62.1 bits (150), Expect = 5e-10
 Identities = 36/201 (17%), Positives = 65/201 (32%), Gaps = 58/201 (28%)

Query: 45  DPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDL 104
           DP      +   +  +      +  +    V  L+L+  +L  T+   +  L  +  LDL
Sbjct: 415 DPMRAAYLDDLRSKFLLENS--VLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDL 470

Query: 105 SHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPEN 164
           SHN+L + +P ++  +  L+VL   DN L                       + G     
Sbjct: 471 SHNRLRA-LPPALAALRCLEVLQASDNALE---------------------NVDG----- 503

Query: 165 ICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSG-AIPKEIGNLTVLQRI 223
                                    ++   +LQEL L  N L   A  + + +   L  +
Sbjct: 504 -------------------------VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538

Query: 224 SLINNKLHGEIPQEIGYLQNL 244
           +L  N L  +       L  +
Sbjct: 539 NLQGNSLC-QEEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 58.6 bits (141), Expect = 7e-09
 Identities = 49/363 (13%), Positives = 110/363 (30%), Gaps = 77/363 (21%)

Query: 10  RSVIHCLLCLVITVAASNISTDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICD 69
            +V   +  L++ V  + +S + +              +L   +        ++  I   
Sbjct: 265 LTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTG 324

Query: 70  VNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLM 129
            +S K     L     +     + A    L   +LS  K +  + S + +   L+ L   
Sbjct: 325 SDSQK--ECVLLKDRPE-CWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPE 380

Query: 130 DNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHL--------FLRENM 181
           +     ++            I L +        +    +   LK +            + 
Sbjct: 381 NKWCLLTI------------ILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSK 428

Query: 182 FYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYL 241
           F  +      +   ++ LHL + +L+  +   +  L ++  + L +N+L   +P  +  L
Sbjct: 429 FLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAAL 485

Query: 242 QNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGIN 301
           + L+VLQ   N L             +  +                  LP L+ L L  N
Sbjct: 486 RCLEVLQASDNALE-----------NVDGV----------------ANLPRLQELLLCNN 518

Query: 302 SFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFL 361
                    +  ++ +                 + +   L L ++  N+L         L
Sbjct: 519 R--------LQQSAAI---------------QPLVSCPRLVLLNLQGNSLCQEEGIQERL 555

Query: 362 SSL 364
           + +
Sbjct: 556 AEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 50.1 bits (119), Expect = 3e-06
 Identities = 25/107 (23%), Positives = 47/107 (43%), Gaps = 8/107 (7%)

Query: 74  KVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQL 133
            VT L+LS   L+  +PP +A L  L+ L  S N L +     +  +  L+ L L +N+L
Sbjct: 464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN--VDGVANLPRLQELLLCNNRL 520

Query: 134 SGSLSSFT--FNTSSILDIRLSKNKLSGK--LPENICNHLRYLKHLF 176
               ++     +   ++ + L  N L  +  + E +   L  +  + 
Sbjct: 521 Q-QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 39/267 (14%), Positives = 86/267 (32%), Gaps = 46/267 (17%)

Query: 393 LSLERLNIAFCNISG----NIPKAIGNLSNLIVLSLGGNNLSG----SIPVTFGGLQKLQ 444
            S+E  ++    I+     ++   +    ++  + L GN +       +       + L+
Sbjct: 4   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63

Query: 445 GLDLAFNKL----------AGSIPDEICLLSRLNELDLNGNKISG----SISSCLGNLTS 490
             + +                 +   +    +L+ + L+ N         +   L   T 
Sbjct: 64  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123

Query: 491 LQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLS 550
           L++L L +N            L       I+  L +  ++    N   +  I   RN L 
Sbjct: 124 LEHLYLHNN-----------GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172

Query: 551 GN----IPTTLEGLKSLQNISLAYNRL-----EGPIPESFGNMTSLESLDLSNNKISG-- 599
                    T +  + L  + +  N +     E  + E       L+ LDL +N  +   
Sbjct: 173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG 232

Query: 600 --SIPVSFEKLSYLKELNLSFNKLKGE 624
             ++ ++ +    L+EL L+   L   
Sbjct: 233 SSALAIALKSWPNLRELGLNDCLLSAR 259

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 68.2 bits (167), Expect = 4e-12
 Identities = 63/362 (17%), Positives = 118/362 (32%), Gaps = 82/362 (22%)

Query: 172 LKHLFLRENMFYGK----IPSSLSKCKQLQELHLGYNNLSG----AIPKEIGNLTVLQRI 223
           ++   L+ +    +    + + L +   ++E+ L  N +       + + I +   L+  
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 224 SLINN---KLHGEIPQEIGYL-------QNLDVLQLGFNNLT--GVVP--ATIFNMSTLK 269
              +    ++  EIP+ +  L         L  ++L  N        P    +   + L+
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125

Query: 270 EIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSG 329
            ++L+NN L     ++I  AL  L             +     NA  L  +  G N    
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQEL------------AVNKKAKNAPPLRSIICGRNRLEN 173

Query: 330 ----FIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLP 385
                      + R L    +  N +     E   L  LA C++L+ L L  N       
Sbjct: 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF----- 228

Query: 386 SSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQG 445
           + +G+ +L+                 A+ +  NL  L L    LS       G    +  
Sbjct: 229 THLGSSALA----------------IALKSWPNLRELGLNDCLLSAR-----GAAAVVDA 267

Query: 446 LDLAFNKLAGSIPDEICLLSRLNELDLNGNKISG----SISSCLG-NLTSLQYLNLGSNR 500
                N               L  L L  N+I      ++ + +   +  L +L L  NR
Sbjct: 268 FSKLENI-------------GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314

Query: 501 FT 502
           F+
Sbjct: 315 FS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 66.3 bits (162), Expect = 2e-11
 Identities = 60/365 (16%), Positives = 114/365 (31%), Gaps = 76/365 (20%)

Query: 93  IANLSSLKSLDLSHNKLSS----NIPSSIFTMSTLKVLYLMDNQLSG----SLSSFTFNT 144
           +A  S ++   L  + +++    ++ + +    ++K + L  N +       LS    + 
Sbjct: 1   MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59

Query: 145 SSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYN 204
             +     S     G++ + I   LR L                +L KC +L  + L  N
Sbjct: 60  KDLEIAEFSDIFT-GRVKDEIPEALRLL--------------LQALLKCPKLHTVRLSDN 104

Query: 205 NLSG----AIPKEIGNLTVLQRISLINNKLHGEIPQEIG-YLQNLDVLQLGFNNLTGVVP 259
                    +   +   T L+ + L NN L  +   +I   LQ L V +   N       
Sbjct: 105 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNA------ 158

Query: 260 ATIFNMSTLKEIFLYNNSLSGSLPSRIDLAL---PNLEFLNLGINSFSGTIPSSITNASK 316
                   L+ I    N L                 L  + +  N               
Sbjct: 159 ------PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGI------------- 199

Query: 317 LILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSS-TPELGFLSSLANCKKLRYLGL 375
                         +   +   + LK+ D+  N  T   +  L    +L +   LR LGL
Sbjct: 200 ------RPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA--IALKSWPNLRELGL 251

Query: 376 GGNPLD-----GFLPSSIGNLSLSLERLNIAFCNISGNIPKAIG-----NLSNLIVLSLG 425
               L        + +     ++ L+ L + +  I  +  + +       + +L+ L L 
Sbjct: 252 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELN 311

Query: 426 GNNLS 430
           GN  S
Sbjct: 312 GNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 64.3 bits (157), Expect = 7e-11
 Identities = 57/363 (15%), Positives = 105/363 (28%), Gaps = 87/363 (23%)

Query: 293 LEFLNLGINSFSG----TIPSSITNASKLILLEMGSNSFSGFIPSAIG-------NLRNL 341
           +E  +L +++ +     ++ + +     +  + +  N+        +        +L   
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 342 KLFDIFFNNLTSSTPE--LGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNL---SLSLE 396
           +  DIF   +    PE     L +L  C KL  + L  N         + +       LE
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125

Query: 397 RLNIAFCNISGNIPKAIGN-LSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKL-- 453
            L +    +       I   L  L V     N               L+ +    N+L  
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPP------------LRSIICGRNRLEN 173

Query: 454 --AGSIPDEICLLSRLNELDLNGNKI-----SGSISSCLGNLTSLQYLNLGSNRFTFVIP 506
                          L+ + +  N I        +   L     L+ L+L  N FT    
Sbjct: 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT---- 229

Query: 507 STFWNLKDILSFDISSNLLDGPISLA--IGNLKAVVGIDLSRNNLSGNIPTTLEGLKSL- 563
                               G  +LA  + +   +  + L+   LS        G  ++ 
Sbjct: 230 ------------------HLGSSALAIALKSWPNLRELGLNDCLLSA------RGAAAVV 265

Query: 564 QNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSF-----EKLSYLKELNLSF 618
              S   N               L++L L  N+I      +      EK+  L  L L+ 
Sbjct: 266 DAFSKLEN-------------IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 312

Query: 619 NKL 621
           N+ 
Sbjct: 313 NRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 41/260 (15%), Positives = 82/260 (31%), Gaps = 52/260 (20%)

Query: 71  NSHKVTTLNLSSFNLQGTIPPEIA-----------NLSSLKSLDLSHNKLSSN----IPS 115
           +   +     S     G +  EI                L ++ LS N         +  
Sbjct: 58  SKKDLEIAEFSD-IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLID 116

Query: 116 SIFTMSTLKVLYLMDNQLS-------------GSLSSFTFNTSSILDIRLSKNKLSGKLP 162
            +   + L+ LYL +N L               +++    N   +  I   +N+L     
Sbjct: 117 FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSM 176

Query: 163 ENICNHLRY---LKHLFLRENMFYGK-----IPSSLSKCKQLQELHLGYNNLSG----AI 210
           +      +    L  + + +N    +     +   L+ C++L+ L L  N  +     A+
Sbjct: 177 KEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 236

Query: 211 PKEIGNLTVLQRISLINNKLHGE----IPQEIGYLQN--LDVLQLGFNNLT-----GVVP 259
              + +   L+ + L +  L       +      L+N  L  L+L +N +       +  
Sbjct: 237 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT 296

Query: 260 ATIFNMSTLKEIFLYNNSLS 279
                M  L  + L  N  S
Sbjct: 297 VIDEKMPDLLFLELNGNRFS 316

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 74.1 bits (183), Expect = 2e-14
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 56/205 (27%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI----AIKVFHPQCASTLKSFEAEC- 773
           FELL+         ++G G FG V+  +   G +     A+KV     A+          
Sbjct: 26  FELLK---------VLGQGSFGKVFLVKKISGSDARQLYAMKVLKK--ATLKVRDRVRTK 74

Query: 774 ---EVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNI-- 828
              +++  + H  +VK+  +   +    L+L+++  G L             F RL+   
Sbjct: 75  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-------------FTRLSKEV 121

Query: 829 ----------MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH--LSDFGMAKLL 876
                     + ++A AL++LH   S  II+ DLKP N+LLDE+   H  L+DFG++K  
Sbjct: 122 MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKES 176

Query: 877 SGEDESTMRTQTL-ATIGYMAPDEI 900
              ++   +  +   T+ YMAP E+
Sbjct: 177 IDHEK---KAYSFCGTVEYMAP-EV 197

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 74.6 bits (184), Expect = 3e-14
 Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 36/208 (17%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECE--- 774
                    + +   IG G FG V++AR  + G ++A+K             E E E   
Sbjct: 10  CPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---------MENEKEGFP 60

Query: 775 --------VIKNIRHRNLVK---IISSCSNDDFKA-----LVLEYMSNGSLEDCLHSSNC 818
                   +++ ++H N+V    I  + ++   +      LV ++  +  L   L +   
Sbjct: 61  ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV 119

Query: 819 ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG 878
              +     +M  + + L Y+H      I+H D+K +NVL+  D V  L+DFG+A+  S 
Sbjct: 120 KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 176

Query: 879 EDESTMR--TQTLATIGYMAPDEIFVGE 904
              S     T  + T+ Y  P E+ +GE
Sbjct: 177 AKNSQPNRYTNRVVTLWYRPP-ELLLGE 203

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 74.6 bits (184), Expect = 3e-14
 Identities = 60/210 (28%), Positives = 84/210 (40%), Gaps = 59/210 (28%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVF-------HPQCASTLKSFE 770
           F  L+         +IG G FG V  AR +      A+KV          +    +    
Sbjct: 40  FHFLK---------VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM---- 86

Query: 771 AECEV-IKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM 829
           +E  V +KN++H  LV +  S    D    VL+Y++ G L             F  L   
Sbjct: 87  SERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL-------------FYHLQRE 133

Query: 830 I------------DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH--LSDFGMAKL 875
                        +IASAL YLH   S  I++ DLKP N+LLD     H  L+DFG+ K 
Sbjct: 134 RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKE 188

Query: 876 LSGEDESTMRTQTL-ATIGYMAPDEIFVGE 904
               +     T T   T  Y+AP E+   +
Sbjct: 189 NIEHNS---TTSTFCGTPEYLAP-EVLHKQ 214

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 75.2 bits (185), Expect = 3e-14
 Identities = 43/223 (19%), Positives = 87/223 (39%), Gaps = 32/223 (14%)

Query: 708 SSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIK----VF-HPQ 761
            +    R  S +++    D +   ++IG G +G V  A    +   +AIK    VF    
Sbjct: 38  PTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI 94

Query: 762 CAS-TLKSFEAECEVIKNIRHRNLVK---IISSCSNDDFKA--LVLEYMSNGSLEDCLHS 815
                L+    E  ++  + H ++VK   I+     + F    +VLE   +   +    +
Sbjct: 95  DCKRILR----EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRT 149

Query: 816 SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL 875
                 +  +  ++ ++   ++Y+H   S  I+H DLKP+N L+++D    + DFG+A+ 
Sbjct: 150 PVYLTELHIKT-LLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLART 205

Query: 876 LSGEDESTMRTQTLATIGYMAPDEIFVGELSLK--------RW 910
           +   +    +         M        +   +        RW
Sbjct: 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRW 248

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 75.3 bits (185), Expect = 5e-14
 Identities = 79/448 (17%), Positives = 154/448 (34%), Gaps = 40/448 (8%)

Query: 36  LALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIA- 94
           + LK    +   NL+   W     +  WI  +   +   +  + L    +       IA 
Sbjct: 71  VELKGKPHFADFNLVPDGWG--GYVYPWIEAMSS-SYTWLEEIRLKRMVVTDDCLELIAK 127

Query: 95  NLSSLKSLDLSH-NKLSSNIPSSIFTM-STLKVLYLMDNQLSG----SLSSFTFNTSSIL 148
           +  + K L LS     S++  ++I      LK L L ++ +       LS F    +S++
Sbjct: 128 SFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187

Query: 149 DIRLS--KNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGY--- 203
            + +S   +++S    E +      LK L L   +   K+ + L +  QL+EL  G    
Sbjct: 188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTA 247

Query: 204 ---NNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGV-VP 259
               ++   +   +     L+ +S   + +   +P        L  L L +  +    + 
Sbjct: 248 EVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLV 307

Query: 260 ATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNL-GINSFSGTIPSSITNAS--- 315
             +     L+ +++ +      L   +     +L  L +     F      ++T      
Sbjct: 308 KLLCQCPKLQRLWVLDYIEDAGLEV-LASTCKDLRELRVFPSEPFVMEPNVALTEQGLVS 366

Query: 316 ------KLILLEMGSNSFSGFIPSAIG----NLRNLKLFDIFFNNLTSSTPEL---GFLS 362
                 KL  +       +      I     N+   +L  I        T E    GF +
Sbjct: 367 VSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGA 426

Query: 363 SLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIG-NLSNLIV 421
            + +CK LR L L G   D      IG  +  +E L++AF   S      +     +L  
Sbjct: 427 IVEHCKDLRRLSLSGLLTDKVF-EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRK 485

Query: 422 LSLGGNNLSG-SIPVTFGGLQKLQGLDL 448
           L +        ++      L+ ++ L +
Sbjct: 486 LEIRDCPFGDKALLANASKLETMRSLWM 513

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 59.9 bits (145), Expect = 3e-09
 Identities = 67/487 (13%), Positives = 155/487 (31%), Gaps = 53/487 (10%)

Query: 151 RLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAI 210
           ++         P  +      ++ +              L       + +L  +   G +
Sbjct: 47  KVFIGNCYAVSPATVIRRFPKVRSV-------------ELKGKPHFADFNLVPDGWGGYV 93

Query: 211 PKEIGNLTV----LQRISLINNKLHGEIPQEIG-YLQNLDVLQL-GFNNLTGVVPATIF- 263
              I  ++     L+ I L    +  +  + I    +N  VL L      +    A I  
Sbjct: 94  YPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAA 153

Query: 264 NMSTLKEIFLYNNS---LSGSLPSRIDLALPNLEFLNLGINSFSGT---IPSSITNASKL 317
               LKE+ L  +    +SG   S       +L  LN+   +   +   +   +T    L
Sbjct: 154 TCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNL 213

Query: 318 ILLEMGSNSFSGFIPSAIGNLRNLKLFDI-FFNNLTSSTPELGFLSSLANCKKLRYLGLG 376
             L++        + + +     L+      +          G   +L+ CK+LR L   
Sbjct: 214 KSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGF 273

Query: 377 GNPLDGFLPSSIGNLSLSLERLNIAFCNISGN-IPKAIGNLSNLIVLSLGGNNLSGSIPV 435
            + +  +LP+ + ++   L  LN+++  +    + K +     L  L +        + V
Sbjct: 274 WDAVPAYLPA-VYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEV 332

Query: 436 TFGGLQKLQGLDLAFNKLAGSIPDE----------ICLLSRLNELDLNGNKISG-SISSC 484
                + L+ L +  ++     P+                +L  +     +++  ++ + 
Sbjct: 333 LASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITI 392

Query: 485 LGNLTSLQYLNLGSNRFTFVIPSTFW-----------NLKDILSFDISSNLLDGPISLAI 533
             N  ++    L           T             + KD+    +S  L D       
Sbjct: 393 ARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIG 452

Query: 534 GNLKAVVGIDLSRNNLSGN-IPTTLEGLKSLQNISLAYNRL-EGPIPESFGNMTSLESLD 591
              K +  + ++    S   +   L G  SL+ + +      +  +  +   + ++ SL 
Sbjct: 453 TYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLW 512

Query: 592 LSNNKIS 598
           +S+  +S
Sbjct: 513 MSSCSVS 519

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 52.2 bits (125), Expect = 7e-07
 Identities = 40/300 (13%), Positives = 93/300 (31%), Gaps = 43/300 (14%)

Query: 337 NLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLS---L 393
            +     + +    +    P++  +  L          L  +   G++   I  +S    
Sbjct: 47  KVFIGNCYAVSPATVIRRFPKVRSVE-LKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYT 105

Query: 394 SLERLNIAFCNISGNIPKAIG-NLSNLIVLSLGG-NNLSGSIPVTFGGLQKLQGLDLAFN 451
            LE + +    ++ +  + I  +  N  VL L      S                     
Sbjct: 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFS----------------TDGLA 149

Query: 452 KLAGSIPDEICLLSRLNELDLNGNKISG----SISSCLGNLTSLQYLNLGSNRFTF---V 504
            +A +          L ELDL  + +       +S      TSL  LN+           
Sbjct: 150 AIAAT-------CRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSA 202

Query: 505 IPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLS------RNNLSGNIPTTLE 558
           +        ++ S  ++  +    ++  +     +  +         R ++   +   L 
Sbjct: 203 LERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALS 262

Query: 559 GLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISG-SIPVSFEKLSYLKELNLS 617
           G K L+ +S  ++ +   +P  +   + L +L+LS   +    +     +   L+ L + 
Sbjct: 263 GCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL 322

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 50.3 bits (120), Expect = 3e-06
 Identities = 58/416 (13%), Positives = 125/416 (30%), Gaps = 41/416 (9%)

Query: 240 YLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLG 299
           Y  +   +   F  +  V      + +    +              +  +   LE + L 
Sbjct: 54  YAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLK 113

Query: 300 INSFS----GTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSST 355
               +      I  S  N   L+L      S  G + +     RNLK  D+  +++   +
Sbjct: 114 RMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDG-LAAIAATCRNLKELDLRESDVDDVS 172

Query: 356 PELGFLSSLANCKKLRYLGLGGNPL---DGFLPSSIGNLSLSLERLNIAFCNISGNIPKA 412
                         L  L +           L   +     +L+ L +        +   
Sbjct: 173 GH-WLSHFPDTYTSLVSLNISCLASEVSFSAL-ERLVTRCPNLKSLKLNRAVPLEKLATL 230

Query: 413 IGNLSNLIVLSLGG------NNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSR 466
           +     L  L  GG       ++   + V   G ++L+ L   ++ +   +P    + SR
Sbjct: 231 LQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSR 290

Query: 467 LNELDLNGNKISG-SISSCLGNLTSLQYLNLGSNRFT----FVIPSTFWNLKDILSFDIS 521
           L  L+L+   +    +   L     LQ L +  +        V+ ST  +L+++  F   
Sbjct: 291 LTTLNLSYATVQSYDLVKLLCQCPKLQRLWV-LDYIEDAGLEVLASTCKDLRELRVFPSE 349

Query: 522 SNLLDGPISLAIGNLKAVVG-------IDLSRNNLSGNIPTTL-EGLKSLQNISLAYNRL 573
             +++  ++L    L +V         +      ++     T+     ++    L     
Sbjct: 350 PFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEP 409

Query: 574 EGPIPESFG-----------NMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSF 618
           + P   +             +   L  L LS                 ++ L+++F
Sbjct: 410 KAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAF 465

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 72.9 bits (180), Expect = 5e-14
 Identities = 44/188 (23%), Positives = 79/188 (42%), Gaps = 32/188 (17%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECE---------- 774
           +NF +   IG G +G VY+AR    G  +A+K             + E E          
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR---------LDTETEGVPSTAIREI 53

Query: 775 -VIKNIRHRNLVKIISSCSNDDFKALVLEYMSN---GSLEDCLHSSNCALNIFCRLNIMI 830
            ++K + H N+VK++     ++   LV E++       ++    +      I      + 
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS---YLF 110

Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            +   L + H   S  ++H DLKP N+L++ +    L+DFG+A+           T  + 
Sbjct: 111 QLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVV 165

Query: 891 TIGYMAPD 898
           T+ Y AP+
Sbjct: 166 TLWYRAPE 173

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 75.1 bits (184), Expect = 5e-14
 Identities = 50/197 (25%), Positives = 80/197 (40%), Gaps = 33/197 (16%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFEAECEVI- 776
           F  L          ++G G FG V  +  +   E+ A+K+        ++  + EC ++ 
Sbjct: 343 FNFLM---------VLGKGSFGKVMLSERKGTDELYAVKILKK--DVVIQDDDVECTMVE 391

Query: 777 KNI-----RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFC--RLNIM 829
           K +     +   L ++ S     D    V+EY++ G L    H        F        
Sbjct: 392 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQV--GRFKEPHAVFY 447

Query: 830 I-DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
             +IA  L +L    S  II+ DLK  NV+LD +    ++DFGM K    +      T+T
Sbjct: 448 AAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKT 501

Query: 889 LA-TIGYMAPDEIFVGE 904
              T  Y+AP EI   +
Sbjct: 502 FCGTPDYIAP-EIIAYQ 517

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 74.1 bits (182), Expect = 6e-14
 Identities = 41/197 (20%), Positives = 80/197 (40%), Gaps = 29/197 (14%)

Query: 723 RATDNFA-ENNIIGIGGFGSVYRAR---LEDGVEIAIKVFHPQCASTLKSFEAECEVI-- 776
           R  D F  E   +G G +G VY+A+    +D  + A+K       S      A  E+   
Sbjct: 17  RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALL 72

Query: 777 KNIRHRNLVK---IISSCSNDDFKALVLEYMSN---GSLEDCLHSSNCALNIFCRLN--- 827
           + ++H N++    +  S ++     L+ +Y  +     ++    S      +        
Sbjct: 73  RELKHPNVISLQKVFLSHADRKV-WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131

Query: 828 -IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH----LSDFGMAKLLSGEDES 882
            ++  I   + YLH   +  ++H DLKP+N+L+  +        ++D G A+L +   + 
Sbjct: 132 SLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188

Query: 883 -TMRTQTLATIGYMAPD 898
                  + T  Y AP+
Sbjct: 189 LADLDPVVVTFWYRAPE 205

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 74.0 bits (182), Expect = 6e-14
 Identities = 39/185 (21%), Positives = 77/185 (41%), Gaps = 21/185 (11%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIK----VFHPQ--CASTLKSFEAECEVIKNIRHRNLV 785
           +IG G +G VY A        +AIK    +F     C   L+    E  ++  ++   ++
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYII 88

Query: 786 K---IISSCSNDDFKA--LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           +   +I       F    +VLE   +  L+    +         +  I+ ++     ++H
Sbjct: 89  RLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNLLLGENFIH 146

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
               + IIH DLKP+N LL++D    + DFG+A+ ++ E ++ +             ++ 
Sbjct: 147 ---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203

Query: 901 FVGEL 905
              +L
Sbjct: 204 LKKQL 208

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 72.8 bits (179), Expect = 6e-14
 Identities = 39/146 (26%), Positives = 69/146 (47%), Gaps = 11/146 (7%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRH-RNLVKIISSC 791
           IG G FG +Y    +  G E+AIK+   +          E ++ K ++    +  I    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
           +  D+  +V+E +   SLED  +  +   ++   L +   + S +EY+H   S   IH D
Sbjct: 75  AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 130

Query: 852 LKPSNVLL---DEDMVAHLSDFGMAK 874
           +KP N L+    +  + ++ DFG+AK
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 73.4 bits (181), Expect = 6e-14
 Identities = 52/202 (25%), Positives = 76/202 (37%), Gaps = 43/202 (21%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVF-------HPQCASTLKSFE 770
           FE +R         ++G G FG V  AR+++  ++ A+KV              T+    
Sbjct: 25  FEFIR---------VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM---- 71

Query: 771 AECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYMSNGSL------EDCLHSSNCALNIF 823
            E  ++     H  L ++       D    V+E+++ G L            +       
Sbjct: 72  TEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA 131

Query: 824 CRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST 883
                   I SAL +LH      II+ DLK  NVLLD +    L+DFGM K         
Sbjct: 132 E-------IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV-- 179

Query: 884 MRTQTL-ATIGYMAPDEIFVGE 904
             T T   T  Y+AP EI    
Sbjct: 180 -TTATFCGTPDYIAP-EILQEM 199

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 72.6 bits (179), Expect = 7e-14
 Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 41/206 (19%)

Query: 723 RATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFH-----------PQCA----STL 766
            AT  +     IG+G +G+VY+AR    G  +A+K              P       + L
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 767 KSFEAECEVIKNIRHRNLVK---IISSCSNDDFKA--LVLEYMSN---GSLEDCLHSSNC 818
           +        ++   H N+V+   + ++   D      LV E++       L+        
Sbjct: 66  RR-------LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLP 118

Query: 819 ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG 878
           A  I     +M      L++LH   +  I+H DLKP N+L+       L+DFG+A++ S 
Sbjct: 119 AETIKD---LMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYS- 171

Query: 879 EDESTMRTQTLATIGYMAPDEIFVGE 904
             +  + T  + T+ Y AP E+ +  
Sbjct: 172 -YQMAL-TPVVVTLWYRAP-EVLLQS 194

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.0 bits (180), Expect = 8e-14
 Identities = 46/191 (24%), Positives = 82/191 (42%), Gaps = 38/191 (19%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIK---VFHPQ--CASTLKSFEAECEVIKNIRHRNLVK 786
           ++G G +G V  A     G  +AIK    F        TL+    E +++K+ +H N++ 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIIT 73

Query: 787 ---IISSCSNDDFKA--LVLEYMSNGSLEDC-LH---SSNCALNIFCRLNIMIDIASALE 837
              I    S ++F    ++ E M         LH   S+    +   +   +     A++
Sbjct: 74  IFNIQRPDSFENFNEVYIIQELM------QTDLHRVISTQMLSDDHIQY-FIYQTLRAVK 126

Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR--------TQTL 889
            LH    + +IH DLKPSN+L++ +    + DFG+A+++                  + +
Sbjct: 127 VLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183

Query: 890 ATIGYMAPDEI 900
           AT  Y AP E+
Sbjct: 184 ATRWYRAP-EV 193

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 73.0 bits (180), Expect = 8e-14
 Identities = 50/194 (25%), Positives = 87/194 (44%), Gaps = 30/194 (15%)

Query: 720 ELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECE---- 774
           ++      + + + +G G F +VY+AR       +AIK         L       +    
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK------LGHRSEAKDGINR 57

Query: 775 -------VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCAL---NIFC 824
                  +++ + H N++ ++ +  +    +LV ++M    LE  +  ++  L   +I  
Sbjct: 58  TALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKA 116

Query: 825 RLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM 884
               M+     LEYLH  H   I+H DLKP+N+LLDE+ V  L+DFG+AK     +    
Sbjct: 117 ---YMLMTLQGLEYLH-QHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AY 169

Query: 885 RTQTLATIGYMAPD 898
            T  + T  Y AP+
Sbjct: 170 -THQVVTRWYRAPE 182

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 72.6 bits (179), Expect = 1e-13
 Identities = 57/202 (28%), Positives = 77/202 (38%), Gaps = 43/202 (21%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVF-------HPQCASTLKSFE 770
           F+LLR         +IG G +  V   RL+    I A+KV                    
Sbjct: 11  FDLLR---------VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ---- 57

Query: 771 AECEV-IKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSL------EDCLHSSNCALNIF 823
            E  V  +   H  LV + S    +     V+EY++ G L      +  L   +      
Sbjct: 58  TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA 117

Query: 824 CRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST 883
                   I+ AL YLH      II+ DLK  NVLLD +    L+D+GM K      +  
Sbjct: 118 E-------ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-- 165

Query: 884 MRTQTL-ATIGYMAPDEIFVGE 904
             T T   T  Y+AP EI  GE
Sbjct: 166 -TTSTFCGTPNYIAP-EILRGE 185

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 55/214 (25%), Positives = 87/214 (40%), Gaps = 62/214 (28%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI----AIKVF--------HPQCASTL 766
           FELL+         ++G G +G V+  R   G +     A+KV               T 
Sbjct: 56  FELLK---------VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 106

Query: 767 KSFEAECEVIKNIRHRN-LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR 825
                E +V+++IR    LV +  +   +    L+L+Y++ G L             F  
Sbjct: 107 ----TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL-------------FTH 149

Query: 826 LNI------------MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH--LSDFG 871
           L+             + +I  ALE+LH      II+ D+K  N+LLD +   H  L+DFG
Sbjct: 150 LSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFG 204

Query: 872 MAKLLSGEDESTMRTQTLA-TIGYMAPDEIFVGE 904
           ++K    ++           TI YMAP +I  G 
Sbjct: 205 LSKEFVADETER--AYDFCGTIEYMAP-DIVRGG 235

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 35/212 (16%)

Query: 68  CDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLY 127
           C  N  K   ++    +L  ++P  I   +  + LDL    L++   ++   ++ L  L 
Sbjct: 10  CTCNEGK-KEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLN 65

Query: 128 LMDNQLSGSLSSFTFNTSSILD-IRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKI 186
           L  NQL  +LS+  F+  + L  + L+ N+L+  LP  + +HL  L  L+L  N      
Sbjct: 66  LDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGN------ 117

Query: 187 PSSLSKCKQLQELHLGYNNLSGAIPKEI-GNLTVLQRISLINNKLHGEIPQEI-GYLQNL 244
                   QL+           ++P  +   LT L+ + L  N+L   IP      L NL
Sbjct: 118 --------QLK-----------SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNL 157

Query: 245 DVLQLGFNNLTGVVPATIFNMSTLKEIFLYNN 276
             L L  N L  V       +  L+ I L+ N
Sbjct: 158 QTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 65.5 bits (160), Expect = 8e-12
 Identities = 42/162 (25%), Positives = 70/162 (43%), Gaps = 29/162 (17%)

Query: 469 ELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGP 528
           +LDL    ++    +    LT L +LNL  N+   +    F +L                
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLT--------------- 83

Query: 529 ISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPES-FGNMTSL 587
                  L  +    L+ N L+       + L  L  + L  N+L+  +P   F  +T L
Sbjct: 84  ------ELGTL---GLANNQLASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKL 133

Query: 588 ESLDLSNNKISGSIPVS-FEKLSYLKELNLSFNKLKGEIPRG 628
           + L L+ N++  SIP   F+KL+ L+ L+LS N+L+  +P G
Sbjct: 134 KELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQS-VPHG 173

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 48/175 (27%), Positives = 74/175 (42%), Gaps = 12/175 (6%)

Query: 209 AIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFN-MST 267
           ++P  I   T  +++ L +  L          L  L  L L +N L   + A +F+ ++ 
Sbjct: 28  SVPSGIPADT--EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84

Query: 268 LKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSI-TNASKLILLEMGSNS 326
           L  + L NN L+ SLP  +   L  L+ L LG N    ++PS +    +KL  L + +N 
Sbjct: 85  LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQ 142

Query: 327 FSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLD 381
                  A   L NL+   +  N L  S P   F        KL+ + L GN  D
Sbjct: 143 LQSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAF----DRLGKLQTITLFGNQFD 192

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 4/154 (2%)

Query: 396 ERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLDLAFNKLA 454
           E+L++    ++         L+ L  L+L  N L  ++    F  L +L  L LA N+LA
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96

Query: 455 GSIPDEI-CLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLK 513
            S+P  +   L++L++L L GN++    S     LT L+ L L +N+   +    F  L 
Sbjct: 97  -SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT 155

Query: 514 DILSFDISSNLLDGPISLAIGNLKAVVGIDLSRN 547
           ++ +  +S+N L      A   L  +  I L  N
Sbjct: 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 45/176 (25%), Positives = 73/176 (41%), Gaps = 28/176 (15%)

Query: 422 LSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEI-CLLSRLNELDLNGNKISGS 480
           L L    L+     TF GL KL  L+L +N+L  ++   +   L+ L  L L  N+++  
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASL 98

Query: 481 ISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVV 540
                 +LT L  L LG N+   +    F  L                       LK   
Sbjct: 99  PLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRL---------------------TKLKE-- 135

Query: 541 GIDLSRNNLSGNIPT-TLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNN 595
            + L+ N L  +IP    + L +LQ +SL+ N+L+     +F  +  L+++ L  N
Sbjct: 136 -LRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 49/199 (24%), Positives = 80/199 (40%), Gaps = 38/199 (19%)

Query: 331 IPSAI-GNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIG 389
           +PS I  +   L L       L + +      ++     KL +L L  N L   L + + 
Sbjct: 29  VPSGIPADTEKLDLQ---STGLATLSD-----ATFRGLTKLTWLNLDYNQL-QTLSAGVF 79

Query: 390 NLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLDL 448
           +                        +L+ L  L L  N L+ S+P+  F  L +L  L L
Sbjct: 80  D------------------------DLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYL 114

Query: 449 AFNKLAGSIPDEIC-LLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPS 507
             N+L  S+P  +   L++L EL LN N++    +     LT+LQ L+L +N+   V   
Sbjct: 115 GGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHG 173

Query: 508 TFWNLKDILSFDISSNLLD 526
            F  L  + +  +  N  D
Sbjct: 174 AFDRLGKLQTITLFGNQFD 192

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 19/72 (26%), Positives = 30/72 (41%), Gaps = 8/72 (11%)

Query: 552 NIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS-FEKLSY 610
            IP   E L       L    L      +F  +T L  L+L  N++  ++    F+ L+ 
Sbjct: 32  GIPADTEKLD------LQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84

Query: 611 LKELNLSFNKLK 622
           L  L L+ N+L 
Sbjct: 85  LGTLGLANNQLA 96

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 34/165 (20%), Positives = 67/165 (40%), Gaps = 29/165 (17%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVF---------HPQCASTLKSFE--AECEVIKNIRHR 782
           IG GGFG +Y A +     +              +    + LK ++  A+ E I+     
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 783 NLVKII----------SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDI 832
             +K +             +   ++ ++++   +  L+    ++    +    L + + I
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKTVLQLSLRI 161

Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAK 874
              LEY+   H    +H D+K SN+LL   + D V +L D+G+A 
Sbjct: 162 LDILEYI---HEHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 52/216 (24%), Positives = 85/216 (39%), Gaps = 49/216 (22%)

Query: 422 LSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSI 481
            +L   +++     T   L  +  +    + +  S+   I  L  +  L L GNK+    
Sbjct: 24  ANLKKKSVT-DAV-TQNELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLHD-- 77

Query: 482 SSCLG---NLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKA 538
              +     LT+L YL L  N+   +    F  L                          
Sbjct: 78  ---ISALKELTNLTYLILTGNQLQSLPNGVFDKLT------------------------- 109

Query: 539 VVGIDLSRNNLSGNIPTTLEG-----LKSLQNISLAYNRLEGPIPESFGNMTSLESLDLS 593
               +L    L  N   +L       L +L  ++LA+N+L+      F  +T+L  LDLS
Sbjct: 110 ----NLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLS 165

Query: 594 NNKISGSIPVS-FEKLSYLKELNLSFNKLKGEIPRG 628
            N++  S+P   F+KL+ LK+L L  N+LK  +P G
Sbjct: 166 YNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDG 199

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 43/210 (20%)

Query: 74  KVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIF-TMSTLKVLYLMDNQ 132
            +  +  ++ +++      I  L +++ L L  NKL      S    ++ L  L L  NQ
Sbjct: 42  SIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHD---ISALKELTNLTYLILTGNQ 96

Query: 133 LSGSLSSFTFNTSSIL-DIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPS--- 188
           L  SL +  F+  + L ++ L +N+L   LP+ + + L  L +L L  N     +P    
Sbjct: 97  LQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQL-QSLPKGVF 153

Query: 189 -SLSKCKQLQELHLGYNNLSGAIPKEI-GNLTVLQRISLINNKLHGEIPQEIGYLQNLDV 246
             L+    L EL L YN L  ++P+ +   LT L+ + L  N+L   +P  +        
Sbjct: 154 DKLTN---LTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGV-------- 200

Query: 247 LQLGFNNLTGVVPATIFNMSTLKEIFLYNN 276
               F+ LT           +L+ I+L++N
Sbjct: 201 ----FDRLT-----------SLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 36/215 (16%)

Query: 384 LPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKL 443
             +     S+     N    +   ++   I  L N+  L+LGGN L   I      L  L
Sbjct: 34  AVTQNELNSIDQIIAN---NSDIKSVQ-GIQYLPNVRYLALGGNKLH-DISA-LKELTNL 87

Query: 444 QGLDLAFNKLAGSIPDEI-CLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFT 502
             L L  N+L  S+P+ +   L+ L EL L  N++          LT+L YLNL  N+  
Sbjct: 88  TYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ 146

Query: 503 FVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPT-TLEGLK 561
            +    F    D L+                 NL     +DLS N L  ++P    + L 
Sbjct: 147 SLPKGVF----DKLT-----------------NLTE---LDLSYNQLQ-SLPEGVFDKLT 181

Query: 562 SLQNISLAYNRLEGPIPE-SFGNMTSLESLDLSNN 595
            L+++ L  N+L+  +P+  F  +TSL+ + L +N
Sbjct: 182 QLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 50/192 (26%), Positives = 81/192 (42%), Gaps = 20/192 (10%)

Query: 195 QLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIG---YLQNLDVLQLGF 251
            + ++    +++       I  L  ++ ++L  NKL      +I     L NL  L L  
Sbjct: 42  SIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKL-----HDISALKELTNLTYLILTG 94

Query: 252 NNLTGVVPATIFN-MSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSS 310
           N L  + P  +F+ ++ LKE+ L  N L  SLP  +   L NL +LNL  N    ++P  
Sbjct: 95  NQLQSL-PNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKG 151

Query: 311 ITNA-SKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKK 369
           + +  + L  L++  N            L  LK   ++ N L  S P+  F         
Sbjct: 152 VFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVF----DRLTS 206

Query: 370 LRYLGLGGNPLD 381
           L+Y+ L  NP D
Sbjct: 207 LQYIWLHDNPWD 218

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 19/221 (8%)

Query: 281 SLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRN 340
             P             NL   S +    +     + +  +   ++         I  L N
Sbjct: 12  IFPDDA---FAETIKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIKSV--QGIQYLPN 64

Query: 341 LKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNI 400
           ++   +  N L      +  L  L N   L YL L GN L   LP+ + +   +L+ L +
Sbjct: 65  VRYLALGGNKLHD----ISALKELTN---LTYLILTGNQLQS-LPNGVFDKLTNLKELVL 116

Query: 401 AFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLDLAFNKLAGSIPD 459
               +          L+NL  L+L  N L  S+P   F  L  L  LDL++N+L  S+P+
Sbjct: 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPE 174

Query: 460 EIC-LLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSN 499
            +   L++L +L L  N++          LTSLQY+ L  N
Sbjct: 175 GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 71.9 bits (177), Expect = 2e-13
 Identities = 46/198 (23%), Positives = 80/198 (40%), Gaps = 38/198 (19%)

Query: 723 RATDNFAENNIIGIGGFGSVYRAR--LEDGVEIAIKVFH--------PQCA----STLKS 768
           RA   +     IG G +G V++AR     G  +A+K           P       + L+ 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67

Query: 769 FEAECEVIKNIRHRNLVK---IISSCSNDDFKA--LVLEYMSN---GSLEDCLHSSNCAL 820
                  ++   H N+V+   + +    D      LV E++       L+          
Sbjct: 68  -------LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 120

Query: 821 NIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED 880
            I     +M  +   L++LH   S  ++H DLKP N+L+       L+DFG+A++ S   
Sbjct: 121 TIKD---MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--F 172

Query: 881 ESTMRTQTLATIGYMAPD 898
           +  + T  + T+ Y AP+
Sbjct: 173 QMAL-TSVVVTLWYRAPE 189

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 72.4 bits (178), Expect = 2e-13
 Identities = 55/200 (27%), Positives = 80/200 (40%), Gaps = 39/200 (19%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFEAECEVI- 776
           F+LLR         +IG G +  V   RL+    I A++V   +        + +     
Sbjct: 54  FDLLR---------VIGRGSYAKVLLVRLKKTDRIYAMRVV--KKELVNDDEDIDWVQTE 102

Query: 777 KNI-----RHRNLVKIISSCSNDDFKALVLEYMSNGSL------EDCLHSSNCALNIFCR 825
           K++      H  LV + S    +     V+EY++ G L      +  L   +        
Sbjct: 103 KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE- 161

Query: 826 LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR 885
                 I+ AL YLH      II+ DLK  NVLLD +    L+D+GM K      +    
Sbjct: 162 ------ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---T 209

Query: 886 TQTL-ATIGYMAPDEIFVGE 904
           T T   T  Y+AP EI  GE
Sbjct: 210 TSTFCGTPNYIAP-EILRGE 228

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 37/161 (22%), Positives = 63/161 (39%), Gaps = 36/161 (22%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKII-- 788
           ++G+G  G V +        + A+K+              E E+     +  ++V+I+  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 79

Query: 789 --SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLN----------IMIDIASAL 836
             +  +      +V+E +  G L            I  R +          IM  I  A+
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFS---------RIQDRGDQAFTEREASEIMKSIGEAI 130

Query: 837 EYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAK 874
           +YLH   S  I H D+KP N+L      + +  L+DFG AK
Sbjct: 131 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 30/149 (20%), Positives = 60/149 (40%), Gaps = 15/149 (10%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRH-RNLVKIISSC 791
           IG G FG ++    L +  ++AIK    +  +       E    K +     +  +    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 792 SNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD 851
                  LV++ +   SLED L       ++         + + ++ +H      +++ D
Sbjct: 76  QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 131

Query: 852 LKPSNVLL------DEDMVAHLSDFGMAK 874
           +KP N L+      + +M+ ++ DFGM K
Sbjct: 132 IKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.1 bits (175), Expect = 3e-13
 Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 38/195 (19%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIK--VFHPQ--CASTLKSFEAECEVIKNIRHRNLVKI 787
            +G GG G V+ A   +    +AIK  V          L+    E ++I+ + H N+VK+
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKV 73

Query: 788 I------------SSCSNDDFKA--LVLEYMSNGSLEDCLH---SSNCALNIFCRLNIMI 830
                           S  +  +  +V EYM     E  L         L    RL  M 
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARL-FMY 127

Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHLSDFGMAKLLSGE-DESTMRTQT 888
            +   L+Y+H   S  ++H DLKP+N+ ++ ED+V  + DFG+A+++          ++ 
Sbjct: 128 QLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 889 LATIGYMAPDEIFVG 903
           L T  Y +P  + + 
Sbjct: 185 LVTKWYRSP-RLLLS 198

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 71.5 bits (176), Expect = 3e-13
 Identities = 51/200 (25%), Positives = 81/200 (40%), Gaps = 39/200 (19%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVFHPQCASTLKSFEAECEVI- 776
           F  L          ++G G FG V  +  +   E+ A+K+        ++  + EC ++ 
Sbjct: 22  FNFLM---------VLGKGSFGKVMLSERKGTDELYAVKILKK--DVVIQDDDVECTMVE 70

Query: 777 KNI-----RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIF----CRLN 827
           K +     +   L ++ S     D    V+EY++ G L    H        F        
Sbjct: 71  KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQV--GRFKEPHAVFY 126

Query: 828 IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH--LSDFGMAKLLSGEDESTMR 885
              +IA  L +L    S  II+ DLK  NV+LD +   H  ++DFGM K    +      
Sbjct: 127 AA-EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGV---T 177

Query: 886 TQTL-ATIGYMAPDEIFVGE 904
           T+T   T  Y+AP EI   +
Sbjct: 178 TKTFCGTPDYIAP-EIIAYQ 196

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 71.1 bits (175), Expect = 3e-13
 Identities = 52/198 (26%), Positives = 80/198 (40%), Gaps = 35/198 (17%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI-AIKVF-------HPQCASTLKSFE 770
           F L +         ++G G FG V+ A  +   +  AIK               T+    
Sbjct: 19  FILHK---------MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM---- 65

Query: 771 AECEV-IKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIM 829
            E  V      H  L  +  +    +    V+EY++ G L   + S +            
Sbjct: 66  VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA 125

Query: 830 IDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH--LSDFGMAKLLSGEDESTMRTQ 887
            +I   L++LH   S  I++ DLK  N+LLD+D   H  ++DFGM K     D    +T 
Sbjct: 126 -EIILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDA---KTN 176

Query: 888 TL-ATIGYMAPDEIFVGE 904
           T   T  Y+AP EI +G+
Sbjct: 177 TFCGTPDYIAP-EILLGQ 193

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 36/139 (25%), Positives = 57/139 (41%), Gaps = 4/139 (2%)

Query: 390 NLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLDL 448
           NL  ++  + +    I    P A      L  + L  N +S  +    F GL+ L  L L
Sbjct: 29  NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVL 87

Query: 449 AFNKLAGSIPDEI-CLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPS 507
             NK+   +P  +   L  L  L LN NKI+        +L +L  L+L  N+   +   
Sbjct: 88  YGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKG 146

Query: 508 TFWNLKDILSFDISSNLLD 526
           TF  L+ I +  ++ N   
Sbjct: 147 TFSPLRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 37/175 (21%), Positives = 67/175 (38%), Gaps = 34/175 (19%)

Query: 105 SHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILD-IRLSKNKLSGKLPE 163
               L+  IP+++    T+  + L  N +   +    F+    L  I LS N++S +L  
Sbjct: 19  RGKGLTE-IPTNLPE--TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAP 73

Query: 164 NICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEI-GNLTVLQR 222
           +    L                        + L  L L  N ++  +PK +   L  LQ 
Sbjct: 74  DAFQGL------------------------RSLNSLVLYGNKIT-ELPKSLFEGLFSLQL 108

Query: 223 ISLINNKLHGEIPQEI-GYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNN 276
           + L  NK++  +  +    L NL++L L  N L  +   T   +  ++ + L  N
Sbjct: 109 LLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 31/151 (20%), Positives = 62/151 (41%), Gaps = 24/151 (15%)

Query: 469 ELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGP 528
           E+ L  N I             L+ ++L +N+ + + P  F  L+               
Sbjct: 36  EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLR--------------- 80

Query: 529 ISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLE 588
                 +L +   + L  N ++    +  EGL SLQ + L  N++     ++F ++ +L 
Sbjct: 81  ------SLNS---LVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLN 131

Query: 589 SLDLSNNKISGSIPVSFEKLSYLKELNLSFN 619
            L L +NK+      +F  L  ++ ++L+ N
Sbjct: 132 LLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 33/134 (24%), Positives = 60/134 (44%), Gaps = 8/134 (5%)

Query: 75  VTTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQ 132
           +T + L    ++  IPP   +    L+ +DLS+N++S  +    F  + +L  L L  N+
Sbjct: 34  ITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNK 91

Query: 133 LSGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLS 191
           ++  L    F    S+  + L+ NK++  L  +    L  L  L L +N        + S
Sbjct: 92  IT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149

Query: 192 KCKQLQELHLGYNN 205
             + +Q +HL   N
Sbjct: 150 PLRAIQTMHL-AQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 62.7 bits (153), Expect = 5e-11
 Identities = 29/110 (26%), Positives = 57/110 (51%), Gaps = 7/110 (6%)

Query: 74  KVTTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDN 131
           K+  ++LS+  +   + P+    L SL SL L  NK++  +P S+F  + +L++L L  N
Sbjct: 57  KLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNAN 114

Query: 132 QLSGSLSSFTFNT-SSILDIRLSKNKLSGKLPENICNHLRYLKHLFLREN 180
           +++  L    F    ++  + L  NKL   + +   + LR ++ + L +N
Sbjct: 115 KIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 38/141 (26%), Positives = 60/141 (42%), Gaps = 27/141 (19%)

Query: 489 TSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNN 548
            ++  + L  N    + P  F   K                      L+    IDLS N 
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYK---------------------KLRR---IDLSNNQ 67

Query: 549 LSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPV-SFEK 607
           +S   P   +GL+SL ++ L  N++       F  + SL+ L L+ NKI+  + V +F+ 
Sbjct: 68  ISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQD 126

Query: 608 LSYLKELNLSFNKLKGEIPRG 628
           L  L  L+L  NKL+  I +G
Sbjct: 127 LHNLNLLSLYDNKLQ-TIAKG 146

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 41/172 (23%), Positives = 63/172 (36%), Gaps = 38/172 (22%)

Query: 331 IPSAI-GNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIG 389
           IP+ +   +  ++L     N +    P      + +  KKLR + L  N +   L     
Sbjct: 26  IPTNLPETITEIRLE---QNTIKVIPP-----GAFSPYKKLRRIDLSNNQIS-ELA---- 72

Query: 390 NLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLDL 448
                               P A   L +L  L L GN ++  +P   F GL  LQ L L
Sbjct: 73  --------------------PDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLL 111

Query: 449 AFNKLAGSIPDEI-CLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSN 499
             NK+   +  +    L  LN L L  NK+          L ++Q ++L  N
Sbjct: 112 NANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 36/141 (25%), Positives = 58/141 (41%), Gaps = 10/141 (7%)

Query: 243 NLDVLQLGFNNLTGVVPATIF-NMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGIN 301
            +  ++L  N +  V+P   F     L+ I L NN +S  L       L +L  L L  N
Sbjct: 33  TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90

Query: 302 SFSGTIPSSI-TNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGF 360
             +  +P S+      L LL + +N  +     A  +L NL L  ++ N L +     G 
Sbjct: 91  KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAK--GT 147

Query: 361 LSSLANCKKLRYLGLGGNPLD 381
            S L   + ++ + L  NP  
Sbjct: 148 FSPL---RAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 52.7 bits (127), Expect = 9e-08
 Identities = 25/78 (32%), Positives = 38/78 (48%), Gaps = 9/78 (11%)

Query: 552 NIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPV-SFEKLSY 610
           N+P T+        I L  N ++   P +F     L  +DLSNN+IS  +   +F+ L  
Sbjct: 29  NLPETI------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81

Query: 611 LKELNLSFNKLKGEIPRG 628
           L  L L  NK+  E+P+ 
Sbjct: 82  LNSLVLYGNKIT-ELPKS 98

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 71.2 bits (175), Expect = 3e-13
 Identities = 51/195 (26%), Positives = 88/195 (45%), Gaps = 35/195 (17%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIK----VFHPQ--CASTLKSFEAECEVIK 777
            + +   + +G G +GSV  A   + G+ +A+K     F        T +    E  ++K
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLK 83

Query: 778 NIRHRNLVKI----ISSCSNDDFKA--LVLEYMSNGSLEDCLH---SSNCALNIFCRLNI 828
           +++H N++ +      + S ++F    LV   M        L+         +   +  +
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQF-L 137

Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
           +  I   L+Y+H   S  IIH DLKPSN+ ++ED    + DFG+A+  + E    M T  
Sbjct: 138 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----M-TGY 189

Query: 889 LATIGYMAPDEIFVG 903
           +AT  Y AP EI + 
Sbjct: 190 VATRWYRAP-EIMLN 203

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 70.3 bits (173), Expect = 5e-13
 Identities = 42/181 (23%), Positives = 79/181 (43%), Gaps = 20/181 (11%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA-------ECEVIK 777
           + + + + +G G + +VY+ +       +A+K         L+  E        E  ++K
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR------LEHEEGAPCTAIREVSLLK 55

Query: 778 NIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALE 837
           +++H N+V +      +    LV EY+    L+  L      +N+      +  +   L 
Sbjct: 56  DLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114

Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           Y H      ++H DLKP N+L++E     L+DFG+A+  S   + T     + T+ Y  P
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TY-DNEVVTLWYRPP 169

Query: 898 D 898
           D
Sbjct: 170 D 170

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 70.9 bits (174), Expect = 5e-13
 Identities = 51/213 (23%), Positives = 86/213 (40%), Gaps = 32/213 (15%)

Query: 708 SSQPTIRRFSYFELLRAT----DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIK----VF 758
           S       F   E+  +T      +     IG G  G V  A        +AIK     F
Sbjct: 3   SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF 62

Query: 759 HPQ--CASTLKSFEAECEVIKNIRHRNLVKI----ISSCSNDDFKA--LVLEYMSNGSLE 810
             Q       +    E  ++K + H+N++ +        S ++F+   +V+E M   +L 
Sbjct: 63  QNQTHAKRAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLC 117

Query: 811 DCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDF 870
             +       +      ++  +   +++LH   S  IIH DLKPSN+++  D    + DF
Sbjct: 118 QVIQME--LDHERMSY-LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 171

Query: 871 GMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG 903
           G+A+       S M T  + T  Y AP E+ +G
Sbjct: 172 GLAR---TAGTSFMMTPYVVTRYYRAP-EVILG 200

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 69.9 bits (172), Expect = 6e-13
 Identities = 42/190 (22%), Positives = 81/190 (42%), Gaps = 25/190 (13%)

Query: 722 LRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFH-------PQCASTLKSFEAEC 773
           + ++  F +   +G G + +VY+      GV +A+K          P  ++ ++    E 
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP--STAIR----EI 54

Query: 774 EVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCAL--NIFCRLNI--- 828
            ++K ++H N+V++      ++   LV E+M N  L+  + S              +   
Sbjct: 55  SLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYF 113

Query: 829 MIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
              +   L + H      I+H DLKP N+L+++     L DFG+A+           +  
Sbjct: 114 QWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG--IPVNTFSSE 168

Query: 889 LATIGYMAPD 898
           + T+ Y APD
Sbjct: 169 VVTLWYRAPD 178

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 70.6 bits (173), Expect = 9e-13
 Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 32/211 (15%)

Query: 707 LSSQPTIRRFSYFELLRAT----DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIK----V 757
           +S      +F   E+  +T      +     IG G  G V  A        +AIK     
Sbjct: 39  MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 98

Query: 758 FHPQ--CASTLKSFEAECEVIKNIRHRNLVKII----SSCSNDDFKA--LVLEYMSNGSL 809
           F  Q       +    E  ++K + H+N++ ++       + ++F+   LV+E M + +L
Sbjct: 99  FQNQTHAKRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 153

Query: 810 EDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSD 869
              +       +      ++  +   +++LH   S  IIH DLKPSN+++  D    + D
Sbjct: 154 CQVIQME--LDHERMSY-LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 207

Query: 870 FGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           FG+A+       S M T  + T  Y AP E+
Sbjct: 208 FGLAR---TAGTSFMMTPYVVTRYYRAP-EV 234

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 70.0 bits (171), Expect = 2e-12
 Identities = 35/147 (23%), Positives = 69/147 (46%), Gaps = 13/147 (8%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLV-KIISS 790
           IG G FG +Y    ++   E+AIK+ + +     L     E ++ + ++    +  +   
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY---ESKIYRILQGGTGIPNVRWF 71

Query: 791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHC 850
               D+  LV++ +   SLED  +  +  L++   L +   + + +E++H       +H 
Sbjct: 72  GVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHR 127

Query: 851 DLKPSNVLLDEDMVAH---LSDFGMAK 874
           D+KP N L+     A+   + DFG+AK
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 27/165 (16%), Positives = 57/165 (34%), Gaps = 29/165 (17%)

Query: 734 IGIGGFGSVYRAR---------LEDGVEIAIKV--FHPQCASTLKSFEAECEV------- 775
                 G +Y A               + ++K+     +  +    F+   +        
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 776 -IKNIRHRNLVKIISSCSN-DDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDI 832
            + +     +   +    + D ++ LVL  +   SL+  L  S    L+    L +   +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACRL 168

Query: 833 ASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAK 874
             ALE+LH       +H ++   N+ +   D+  V  L+ +G A 
Sbjct: 169 LDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 47/212 (22%), Positives = 89/212 (41%), Gaps = 34/212 (16%)

Query: 709 SQPTIRRFSYFELLRA----TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIK----VFH 759
           S    + F   ++ +        +     +G G +GSV  A     G ++AIK     F 
Sbjct: 3   SLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ 62

Query: 760 PQ--CASTLKSFEAECEVIKNIRHRNLVKI----ISSCSNDDFKA--LVLEYMSNGSLED 811
            +       +    E  ++K+++H N++ +      + S  +F    LV+ +M    L+ 
Sbjct: 63  SEIFAKRAYR----ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQK 117

Query: 812 CLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFG 871
            +           +  ++  +   L+Y+H   S  ++H DLKP N+ ++ED    + DFG
Sbjct: 118 IMGLK--FSEEKIQY-LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFG 171

Query: 872 MAKLLSGEDESTMRTQTLATIGYMAPDEIFVG 903
           +A+    E    M T  + T  Y AP E+ + 
Sbjct: 172 LARHADAE----M-TGYVVTRWYRAP-EVILS 197

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 43/208 (20%), Positives = 82/208 (39%), Gaps = 33/208 (15%)

Query: 708 SSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTL 766
           +  P     S      + D +     +G G +G VY+A        +AIK          
Sbjct: 16  TQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------- 68

Query: 767 KSFEAECE-----------VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHS 815
              E E E           ++K ++HRN++++ S   ++    L+ EY  N  L+  +  
Sbjct: 69  --LEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDK 125

Query: 816 SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH-----LSDF 870
           +   +++    + +  + + + + H   S   +H DLKP N+LL     +      + DF
Sbjct: 126 NP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181

Query: 871 GMAKLLSGEDESTMRTQTLATIGYMAPD 898
           G+A+           T  + T+ Y  P+
Sbjct: 182 GLARAFG--IPIRQFTHEIITLWYRPPE 207

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 68.6 bits (168), Expect = 3e-12
 Identities = 43/225 (19%), Positives = 81/225 (36%), Gaps = 64/225 (28%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRN 783
           +  ++    +G G FG V     +E G   A+K          +    E +++K + H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61

Query: 784 LVKII------------------------------------SSCSNDDFKA--LVLEYMS 805
           ++K++                                       +    K   +++EY+ 
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV- 120

Query: 806 NGSLEDCLH-------SSNCAL-NIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNV 857
                D LH        S  ++      +  +  +  A+ ++   HS  I H D+KP N+
Sbjct: 121 ----PDTLHKVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFI---HSLGICHRDIKPQNL 172

Query: 858 LLD-EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
           L++ +D    L DFG AK L   + S      + +  Y AP+ + 
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELML 214

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 68.5 bits (168), Expect = 3e-12
 Identities = 53/214 (24%), Positives = 89/214 (41%), Gaps = 40/214 (18%)

Query: 708 SSQPTIRR-FSYFELLRA----TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIK----V 757
           SS P  R  F   E+ +        + +   +G G +G+V  A     G ++AIK     
Sbjct: 2   SSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP 61

Query: 758 FHPQ--CASTLKSFEAECEVIKNIRHRNLVKII----SSCSNDDFKA--LVLEYMSNGSL 809
           F  +       +    E  ++K++RH N++ ++       + DDF    LV+ +M     
Sbjct: 62  FQSELFAKRAYR----ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM----- 112

Query: 810 EDCLH---SSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH 866
              L              +  ++  +   L Y+H   +  IIH DLKP N+ ++ED    
Sbjct: 113 GTDLGKLMKHEKLGEDRIQF-LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELK 168

Query: 867 LSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
           + DFG+A+    E    M T  + T  Y AP E+
Sbjct: 169 ILDFGLARQADSE----M-TGYVVTRWYRAP-EV 196

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 28/140 (20%), Positives = 57/140 (40%), Gaps = 5/140 (3%)

Query: 390 NLSLSLERLNIAFCNISGNIPKAI-GNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLD 447
           ++      L +     +      I   L  L  ++   N ++  I    F G   +  + 
Sbjct: 29  HIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEIL 87

Query: 448 LAFNKLAGSIPDEICL-LSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIP 506
           L  N+L  ++  ++   L  L  L L  N+I+   +     L+S++ L+L  N+ T V P
Sbjct: 88  LTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAP 146

Query: 507 STFWNLKDILSFDISSNLLD 526
             F  L  + + ++ +N  +
Sbjct: 147 GAFDTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 65.4 bits (160), Expect = 5e-12
 Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 3/95 (3%)

Query: 535 NLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSN 594
            L  +  I+ S N ++       EG   +  I L  NRLE    + F  + SL++L L +
Sbjct: 55  KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS 114

Query: 595 NKISGSIPV-SFEKLSYLKELNLSFNKLKGEIPRG 628
           N+I+  +   SF  LS ++ L+L  N++   +  G
Sbjct: 115 NRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPG 147

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 35/156 (22%), Positives = 65/156 (41%), Gaps = 9/156 (5%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQLS 134
           TT++ S+  L   IP  I        L L++N+ +    + IF  +  L+ +   +N+++
Sbjct: 14  TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70

Query: 135 GSLSSFTFN-TSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKC 193
             +    F   S + +I L+ N+L   +   +   L  LK L LR N        S    
Sbjct: 71  -DIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGL 128

Query: 194 KQLQELHLGYNNLSGAIPKEI-GNLTVLQRISLINN 228
             ++ L L  N ++  +       L  L  ++L+ N
Sbjct: 129 SSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 35/180 (19%), Positives = 66/180 (36%), Gaps = 33/180 (18%)

Query: 100 KSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILD-IRLSKNKLS 158
            ++D S+ KL+  IP  I        L L +N+ +   ++  F     L  I  S NK++
Sbjct: 14  TTVDCSNQKLNK-IPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70

Query: 159 GKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEI-GNL 217
             + E                                + E+ L  N L   +  ++   L
Sbjct: 71  -DIEEGAFEGA------------------------SGVNEILLTSNRLE-NVQHKMFKGL 104

Query: 218 TVLQRISLINNKLHGEIPQEI-GYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNN 276
             L+ + L +N++   +  +    L ++ +L L  N +T V P     + +L  + L  N
Sbjct: 105 ESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 22/110 (20%), Positives = 49/110 (44%), Gaps = 7/110 (6%)

Query: 74  KVTTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDN 131
           ++  +N S+  +   I        S +  + L+ N+L + +   +F  + +LK L L  N
Sbjct: 58  QLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSN 115

Query: 132 QLSGSLSSFTFNTSSILDI-RLSKNKLSGKLPENICNHLRYLKHLFLREN 180
           +++  + + +F   S + +  L  N+++  +     + L  L  L L  N
Sbjct: 116 RIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 32/129 (24%), Positives = 53/129 (41%), Gaps = 4/129 (3%)

Query: 373 LGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGS 432
           L L  N       + I      L ++N +   I+     A    S +  + L  N L  +
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-N 95

Query: 433 IPV-TFGGLQKLQGLDLAFNKLAGSIPDEICL-LSRLNELDLNGNKISGSISSCLGNLTS 490
           +    F GL+ L+ L L  N++   + ++  + LS +  L L  N+I+         L S
Sbjct: 96  VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS 154

Query: 491 LQYLNLGSN 499
           L  LNL +N
Sbjct: 155 LSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 30/131 (22%), Positives = 60/131 (45%), Gaps = 7/131 (5%)

Query: 469 ELDLNGNKISG-SISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDG 527
           EL LN N+ +    +     L  L+ +N  +N+ T +    F     +    ++SN L+ 
Sbjct: 36  ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE- 94

Query: 528 PISLAIG---NLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNM 584
             ++       L+++  + L  N ++     +  GL S++ +SL  N++    P +F  +
Sbjct: 95  --NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTL 152

Query: 585 TSLESLDLSNN 595
            SL +L+L  N
Sbjct: 153 HSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 33/156 (21%), Positives = 60/156 (38%), Gaps = 11/156 (7%)

Query: 228 NKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIF-NMSTLKEIFLYNNSLSGSLPSRI 286
           N+   +IP+ I   Q    L+L  N  T +    IF  +  L++I   NN ++  +    
Sbjct: 20  NQKLNKIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGA 76

Query: 287 DLALPNLEFLNLGINSFSGTIPSSI-TNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFD 345
                 +  + L  N     +   +      L  L + SN  +     +   L +++L  
Sbjct: 77  FEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135

Query: 346 IFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLD 381
           ++ N +T+  P  G   +L     L  L L  NP +
Sbjct: 136 LYDNQITTVAP--GAFDTL---HSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 30/135 (22%), Positives = 57/135 (42%), Gaps = 8/135 (5%)

Query: 197 QELHLGYNNLSGAIPKEI-GNLTVLQRISLINNKLHGEIPQEI-GYLQNLDVLQLGFNNL 254
            EL L  N  +      I   L  L++I+  NNK+  +I +        ++ + L  N L
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93

Query: 255 TGVVPATIF-NMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSI-T 312
             V    +F  + +LK + L +N ++  + +   + L ++  L+L  N  + T+      
Sbjct: 94  ENV-QHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFD 150

Query: 313 NASKLILLEMGSNSF 327
               L  L + +N F
Sbjct: 151 TLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 29/111 (26%), Positives = 58/111 (52%), Gaps = 15/111 (13%)

Query: 74  KVTTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDN 131
            V  + L+S  L+  +  ++   L SLK+L L  N+++  + +  F  +S++++L L DN
Sbjct: 82  GVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDN 139

Query: 132 QLSGSLSSFTFNT-SSILDIRLSKNKLSGKLPENICN-HLRYLKHLFLREN 180
           Q++ +++   F+T  S+  + L  N          CN +L +L   +LR+ 
Sbjct: 140 QIT-TVAPGAFDTLHSLSTLNLLANPF-------NCNCYLAWLGE-WLRKK 181

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 38/163 (23%), Positives = 68/163 (41%), Gaps = 28/163 (17%)

Query: 734 IGIGGFGSVYRA-RLEDGVEIAIKVF------HPQCASTLKSFE--AECEVIKNIRHRNL 784
           IG GGFG +Y A       + A  V       +    S LK ++  A+ + IK    R  
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 785 VKII----------SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           +  +          +      ++ +V+E +    L+  +   N        L + I +  
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQK-ISGQNGTFKKSTVLQLGIRMLD 162

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAK 874
            LEY+H       +H D+K +N+LL   + D V +L+D+G++ 
Sbjct: 163 VLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 58/337 (17%), Positives = 105/337 (31%), Gaps = 49/337 (14%)

Query: 93  IANLSSLKSLDLSHNKLSSNIPSSIFTM-----STLKVLYLMDNQLSGS-----LSSFTF 142
            +    + SLDLS N L S     +        +++  L L  N L        +     
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 143 NTSSILDIRLSKNKLSGKLPENICNHLRY----LKHLFLRENMFYGK----IPSSLSKC- 193
             +++  + LS N LS K  + +   L      +  L L  N F  K       + S   
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 194 KQLQELHLGYNNLSGAIPKEIGNL-----TVLQRISLINNKLHGEIPQEIGYL-----QN 243
             +  L+L  N+L      E+  +       +  ++L  N L  +   E+         +
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197

Query: 244 LDVLQLGFNNLT-----GVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLAL---PNLEF 295
           +  L L  N L       +        + +  + L  N L G     + L      +L+ 
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257

Query: 296 LNLGINSFSGT-------IPSSITNASKLILLEMGSNSFSGFIPSAIGNL-----RNLKL 343
           + L  +            + ++  N  K+IL++             I NL         +
Sbjct: 258 VYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADV 317

Query: 344 FDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPL 380
             +    L  +      +  L    +LR       PL
Sbjct: 318 PSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 64.0 bits (156), Expect = 8e-11
 Identities = 57/299 (19%), Positives = 101/299 (33%), Gaps = 51/299 (17%)

Query: 348 FNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDG----FLPSSIGNLSLSLERLNIAFC 403
              LT            +    +  L L  N L       L  +  N   S+  LN++  
Sbjct: 2   NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGN 61

Query: 404 NISGNIPKAIG-----NLSNLIVLSLGGNNLSGSIPVTFGGL-----QKLQGLDLAFNKL 453
           ++       +        +N+  L+L GN LS                 +  LDL +N  
Sbjct: 62  SLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF 121

Query: 454 AGSIPDEICLL-----SRLNELDLNGNKISG----SISSCLGNL-TSLQYLNLGSNRFT- 502
           +     E         + +  L+L GN +       +   L  +  ++  LNL  N    
Sbjct: 122 SSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181

Query: 503 -------FVIPSTFWNLKDILSFDISSNLL--DGPISLAIG---NLKAVVGIDLSRNNLS 550
                    + S   ++  +   D+S+NLL       LA         VV ++L  N L 
Sbjct: 182 KNCAELAKFLASIPASVTSL---DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238

Query: 551 G----NIPTTLEGLKSLQNISLAYNRLEGP-------IPESFGNMTSLESLDLSNNKIS 598
           G    N+    + LK LQ + L Y+ ++         +  +F N+  +  +D +  +I 
Sbjct: 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 62.3 bits (152), Expect = 4e-11
 Identities = 30/87 (34%), Positives = 44/87 (50%), Gaps = 4/87 (4%)

Query: 543 DLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIP 602
            L  N  +  +P  L   K L  I L+ NR+     +SF NMT L +L LS N++   IP
Sbjct: 37  YLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIP 94

Query: 603 V-SFEKLSYLKELNLSFNKLKGEIPRG 628
             +F+ L  L+ L+L  N +   +P G
Sbjct: 95  PRTFDGLKSLRLLSLHGNDIS-VVPEG 120

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 52.3 bits (126), Expect = 9e-08
 Identities = 28/93 (30%), Positives = 49/93 (52%), Gaps = 4/93 (4%)

Query: 409 IPKAIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLDLAFNKLAGSIPDEIC-LLSR 466
           +PK + N  +L ++ L  N +S ++   +F  + +L  L L++N+L   IP      L  
Sbjct: 46  VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKS 103

Query: 467 LNELDLNGNKISGSISSCLGNLTSLQYLNLGSN 499
           L  L L+GN IS        +L++L +L +G+N
Sbjct: 104 LRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 35/111 (31%), Positives = 54/111 (48%), Gaps = 6/111 (5%)

Query: 75  VTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIF-TMSTLKVLYLMDNQL 133
           VT L L        +P E++N   L  +DLS+N++S+ + +  F  M+ L  L L  N+L
Sbjct: 33  VTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNRL 90

Query: 134 SGSLSSFTFNT-SSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFY 183
              +   TF+   S+  + L  N +S  +PE   N L  L HL +  N  Y
Sbjct: 91  R-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLY 139

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 25/78 (32%), Positives = 38/78 (48%), Gaps = 10/78 (12%)

Query: 552 NIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPV-SFEKLSY 610
            IP  +  L       L  N+    +P+   N   L  +DLSNN+IS ++   SF  ++ 
Sbjct: 28  GIPRDVTELY------LDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79

Query: 611 LKELNLSFNKLKGEIPRG 628
           L  L LS+N+L+  IP  
Sbjct: 80  LLTLILSYNRLR-CIPPR 96

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 25/107 (23%), Positives = 49/107 (45%), Gaps = 3/107 (2%)

Query: 421 VLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEIC-LLSRLNELDLNGNKISG 479
            L L GN  +  +P      + L  +DL+ N+++ ++ ++    +++L  L L+ N++  
Sbjct: 35  ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRC 92

Query: 480 SISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLD 526
                   L SL+ L+L  N  + V    F +L  +    I +N L 
Sbjct: 93  IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 34/128 (26%), Positives = 57/128 (44%), Gaps = 27/128 (21%)

Query: 469 ELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGP 528
           EL L+GN+ +  +   L N   L  ++L +NR + +   +F N+                
Sbjct: 35  ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMT--------------- 78

Query: 529 ISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPE-SFGNMTSL 587
                  L     + LS N L    P T +GLKSL+ +SL  N +   +PE +F ++++L
Sbjct: 79  ------QLLT---LILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSAL 128

Query: 588 ESLDLSNN 595
             L +  N
Sbjct: 129 SHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 5/104 (4%)

Query: 175 LFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEI 234
           L+L  N F   +P  LS  K L  + L  N +S    +   N+T L  + L  N+L   I
Sbjct: 36  LYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93

Query: 235 PQEI-GYLQNLDVLQLGFNNLTGVVPATIF-NMSTLKEIFLYNN 276
           P      L++L +L L  N+++ VVP   F ++S L  + +  N
Sbjct: 94  PPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 43.4 bits (103), Expect = 8e-05
 Identities = 30/124 (24%), Positives = 54/124 (43%), Gaps = 9/124 (7%)

Query: 258 VPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKL 317
           +P  I     + E++L  N  +  +P  +     +L  ++L  N  S     S +N ++L
Sbjct: 25  LPKGIP--RDVTELYLDGNQFT-LVPKELS-NYKHLTLIDLSNNRISTLSNQSFSNMTQL 80

Query: 318 ILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGG 377
           + L +  N      P     L++L+L  +  N++ S  PE  F     +   L +L +G 
Sbjct: 81  LTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDI-SVVPEGAF----NDLSALSHLAIGA 135

Query: 378 NPLD 381
           NPL 
Sbjct: 136 NPLY 139

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 35/131 (26%), Positives = 50/131 (38%), Gaps = 30/131 (22%)

Query: 197 QELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTG 256
            EL+L  N  +  +PKE+ N   L  I L NN++             L            
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRI-----------STL------------ 69

Query: 257 VVPATIF-NMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSI-TNA 314
                 F NM+ L  + L  N L   +P R    L +L  L+L  N  S  +P     + 
Sbjct: 70  --SNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDL 125

Query: 315 SKLILLEMGSN 325
           S L  L +G+N
Sbjct: 126 SALSHLAIGAN 136

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 65.1 bits (159), Expect = 4e-11
 Identities = 38/182 (20%), Positives = 77/182 (42%), Gaps = 28/182 (15%)

Query: 732 NIIGIGGFGSVYRAR-LEDGVEIAIK----VFHPQ--CASTLKSFEAECEVIKNIR-HRN 783
             +G G +G V+++     G  +A+K     F        T +    E  ++  +  H N
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILTELSGHEN 70

Query: 784 LVKIISSCSNDDFKA--LVLEYMSNGSLEDC-LH---SSNCALNIFCRLNIMIDIASALE 837
           +V +++    D+ +   LV +YM      +  LH    +N    +  +  ++  +   ++
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYM------ETDLHAVIRANILEPVHKQY-VVYQLIKVIK 123

Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           YLH   S  ++H D+KPSN+LL+ +    ++DFG+++        T              
Sbjct: 124 YLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180

Query: 898 DE 899
           D+
Sbjct: 181 DD 182

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 64.0 bits (155), Expect = 8e-11
 Identities = 20/111 (18%), Positives = 42/111 (37%), Gaps = 8/111 (7%)

Query: 540 VGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIP-ESFGNMTSLESLDLSNNKIS 598
            G+  +R+    +    L G ++L  + +   +    +       +  L +L +  + + 
Sbjct: 11  SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69

Query: 599 GSIPV-SFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFM--GNELLC 646
             +   +F     L  LNLSFN L+  +         + +  +  GN L C
Sbjct: 70  -FVAPDAFHFTPRLSRLNLSFNALE-SLSW-KTVQGLSLQELVLSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 62.1 bits (150), Expect = 3e-10
 Identities = 25/103 (24%), Positives = 43/103 (41%), Gaps = 4/103 (3%)

Query: 520 ISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPT-TLEGLKSLQNISLAYNRLEGPIP 578
                LD    L     + +  + +       ++    L GL  L+N+++  + L    P
Sbjct: 16  TRDGALDSLHHLP--GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73

Query: 579 ESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKL 621
           ++F     L  L+LS N +      + + LS L+EL LS N L
Sbjct: 74  DAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 60.9 bits (147), Expect = 8e-10
 Identities = 21/97 (21%), Positives = 36/97 (37%), Gaps = 4/97 (4%)

Query: 408 NIPKAIGNLSNLIVLSLGGNNLSGSIP-VTFGGLQKLQGLDLAFNKLAGSIPDEI-CLLS 465
           +    +    NL  L +        +      GL +L+ L +  + L   +  +      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 466 RLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFT 502
           RL+ L+L+ N +  S+S       SLQ L L  N   
Sbjct: 81  RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 60.1 bits (145), Expect = 1e-09
 Identities = 18/95 (18%), Positives = 36/95 (37%), Gaps = 4/95 (4%)

Query: 186 IPSSLSKCKQLQELHLGYNNLSGAIPKE-IGNLTVLQRISLINNKLHGEIPQEI-GYLQN 243
               L   + L EL++        +    +  L  L+ ++++ + L   +  +   +   
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81

Query: 244 LDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSL 278
           L  L L FN L   +        +L+E+ L  N L
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.0 bits (142), Expect = 3e-09
 Identities = 18/112 (16%), Positives = 38/112 (33%), Gaps = 9/112 (8%)

Query: 71  NSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLM 129
            S  +      + +        +    +L  L + + +   ++       +  L+ L ++
Sbjct: 9   GSSGLRCTRDGALD----SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64

Query: 130 DNQLSGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLREN 180
            + L   ++   F  T  +  + LS N L   L       L  L+ L L  N
Sbjct: 65  KSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLS-LQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 56.3 bits (135), Expect = 2e-08
 Identities = 13/88 (14%), Positives = 24/88 (27%), Gaps = 1/88 (1%)

Query: 427 NNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDE-ICLLSRLNELDLNGNKISGSISSCL 485
            + +        G + L  L +   +    +    +  L  L  L +  + +        
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 486 GNLTSLQYLNLGSNRFTFVIPSTFWNLK 513
                L  LNL  N    +   T   L 
Sbjct: 77  HFTPRLSRLNLSFNALESLSWKTVQGLS 104

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 55.1 bits (132), Expect = 5e-08
 Identities = 15/76 (19%), Positives = 25/76 (32%), Gaps = 1/76 (1%)

Query: 451 NKLAGSIPDEICLLSRLNELDLNGNKISGSI-SSCLGNLTSLQYLNLGSNRFTFVIPSTF 509
              A      +     L EL +   +    +    L  L  L+ L +  +   FV P  F
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 510 WNLKDILSFDISSNLL 525
                +   ++S N L
Sbjct: 77  HFTPRLSRLNLSFNAL 92

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.0 bits (129), Expect = 1e-07
 Identities = 25/129 (19%), Positives = 41/129 (31%), Gaps = 10/129 (7%)

Query: 385 PSSIGNLSLSLERLNIAFCNISGNIPK-AIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQK 442
              +     +L  L I       ++    +  L  L  L++  + L   +    F    +
Sbjct: 24  LHHLPGAE-NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81

Query: 443 LQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFT 502
           L  L+L+FN L  S+  +      L EL L+GN +      C   L  LQ          
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL-----HCSCALRWLQRWEEEGLGGV 135

Query: 503 FVIPSTFWN 511
                    
Sbjct: 136 PEQKLQCHG 144

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 19/112 (16%), Positives = 34/112 (30%), Gaps = 4/112 (3%)

Query: 193 CKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQE-IGYLQNLDVLQLGF 251
                 L    +         +     L  + + N +    +    +  L  L  L +  
Sbjct: 7   PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 252 NNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSF 303
           + L  V P        L  + L  N+L  SL  +  +   +L+ L L  N  
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKT-VQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.0 bits (98), Expect = 6e-04
 Identities = 16/90 (17%), Positives = 29/90 (32%), Gaps = 6/90 (6%)

Query: 306 TIPSSITNASKLILLEMGSNSFSGFIPS-AIGNLRNLKLFDIFFNNLTSSTPELGFLSSL 364
                +  A  L  L + +      +    +  L  L+   I  + L    P+     + 
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD-----AF 76

Query: 365 ANCKKLRYLGLGGNPLDGFLPSSIGNLSLS 394
               +L  L L  N L+     ++  LSL 
Sbjct: 77  HFTPRLSRLNLSFNALESLSWKTVQGLSLQ 106

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 63.4 bits (155), Expect = 9e-11
 Identities = 45/186 (24%), Positives = 85/186 (45%), Gaps = 23/186 (12%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HR 782
            D++     +G G +  V+ A  + +  ++ +K+  P      K  + E ++++N+R   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGP 91

Query: 783 NLVKII----SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           N++ +        S     ALV E+++N   +    +     +   R   M +I  AL+Y
Sbjct: 92  NIITLADIVKDPVSRTP--ALVFEHVNNTDFKQLYQTLT---DYDIRF-YMYEILKALDY 145

Query: 839 LHFGHSTPIIHCDLKPSNVLLD-EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
            H   S  I+H D+KP NV++D E     L D+G+A+      E  +R   +A+  +  P
Sbjct: 146 CH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKGP 199

Query: 898 DEIFVG 903
            E+ V 
Sbjct: 200 -ELLVD 204

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 49/183 (26%), Positives = 80/183 (43%), Gaps = 35/183 (19%)

Query: 97  SSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSIL-DIRLSKN 155
            S  ++D    + +S +P+ I T    ++LYL DNQ++  L    F++   L ++ L  N
Sbjct: 19  CSGTTVDCRSKRHAS-VPAGIPT--NAQILYLHDNQIT-KLEPGVFDSLINLKELYLGSN 74

Query: 156 KLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEI- 214
           +L   LP  + + L                         QL  L LG N L+  +P  + 
Sbjct: 75  QLG-ALPVGVFDSL------------------------TQLTVLDLGTNQLT-VLPSAVF 108

Query: 215 GNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIF-NMSTLKEIFL 273
             L  L+ + +  NKL  E+P+ I  L +L  L L  N L  + P   F  +S+L   +L
Sbjct: 109 DRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSI-PHGAFDRLSSLTHAYL 166

Query: 274 YNN 276
           + N
Sbjct: 167 FGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 37/154 (24%), Positives = 57/154 (37%), Gaps = 28/154 (18%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIF-TMSTLKVLYLMDNQLS 134
             L L    +    P    +L +LK L L  N+L + +P  +F +++ L VL L  NQL+
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT 101

Query: 135 GSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCK 194
                                     LP  + + L +LK LF+  N    ++P  + +  
Sbjct: 102 -------------------------VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLT 135

Query: 195 QLQELHLGYNNLSGAIPKEIGNLTVLQRISLINN 228
            L  L L  N L          L+ L    L  N
Sbjct: 136 HLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 53.2 bits (128), Expect = 8e-08
 Identities = 33/131 (25%), Positives = 53/131 (40%), Gaps = 9/131 (6%)

Query: 421 VLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKL----AGSIPDEICLLSRLNELDLNGNK 476
           +L L  N ++   P  F  L  L+ L L  N+L     G + D    L++L  LDL  N+
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG-VFDS---LTQLTVLDLGTNQ 99

Query: 477 ISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNL 536
           ++   S+    L  L+ L +  N+ T  +P     L  +    +  N L      A   L
Sbjct: 100 LTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRL 158

Query: 537 KAVVGIDLSRN 547
            ++    L  N
Sbjct: 159 SSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 34/160 (21%), Positives = 55/160 (34%), Gaps = 50/160 (31%)

Query: 469 ELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGP 528
            L L+ N+I+        +L +L+ L LGSN+   +    F                   
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVF------------------- 84

Query: 529 ISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLE 588
                                        + L  L  + L  N+L       F  +  L+
Sbjct: 85  -----------------------------DSLTQLTVLDLGTNQLTVLPSAVFDRLVHLK 115

Query: 589 SLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRG 628
            L +  NK++  +P   E+L++L  L L  N+LK  IP G
Sbjct: 116 ELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS-IPHG 153

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 37/144 (25%), Positives = 60/144 (41%), Gaps = 9/144 (6%)

Query: 209 AIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFN-MST 267
           ++P  I      Q + L +N++    P     L NL  L LG N L   +P  +F+ ++ 
Sbjct: 33  SVPAGIPTNA--QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89

Query: 268 LKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSF 327
           L  + L  N L+  LPS +   L +L+ L +  N  +  +P  I   + L  L +  N  
Sbjct: 90  LTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147

Query: 328 SGFIPSAIGNLRNLKLFDIF-FNN 350
                 A   L +L     + F N
Sbjct: 148 KSIPHGAFDRLSSLT--HAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 44.7 bits (106), Expect = 5e-05
 Identities = 37/152 (24%), Positives = 61/152 (40%), Gaps = 25/152 (16%)

Query: 444 QGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTF 503
           Q L L  N++    P     L  L EL L  N++         +LT L  L+LG+N+ T 
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV 102

Query: 504 VIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSL 563
           +  + F  L                      +LK    + +  N L+  +P  +E L  L
Sbjct: 103 LPSAVFDRL---------------------VHLKE---LFMCCNKLT-ELPRGIERLTHL 137

Query: 564 QNISLAYNRLEGPIPESFGNMTSLESLDLSNN 595
            +++L  N+L+     +F  ++SL    L  N
Sbjct: 138 THLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 21/72 (29%), Positives = 37/72 (51%), Gaps = 8/72 (11%)

Query: 552 NIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS-FEKLSY 610
            IPT  + L       L  N++    P  F ++ +L+ L L +N++  ++PV  F+ L+ 
Sbjct: 37  GIPTNAQILY------LHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89

Query: 611 LKELNLSFNKLK 622
           L  L+L  N+L 
Sbjct: 90  LTVLDLGTNQLT 101

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 61.8 bits (149), Expect = 3e-10
 Identities = 44/262 (16%), Positives = 76/262 (29%), Gaps = 67/262 (25%)

Query: 707 LSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKV--------F 758
             SQ     FS+      T+       IG G FG V++    D   +AIK+         
Sbjct: 4   ECSQKGPVPFSHC---LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLV 59

Query: 759 HPQCASTLKSFEAECEVIKNI---------RHRNLVKIISSC------------------ 791
           +     T +    E  + K +         R    + + S                    
Sbjct: 60  NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119

Query: 792 ------------SNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
                         DD   +VLE+   G   D         ++    +I+  + ++L   
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVA 177

Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL----LSG-----EDESTMRTQTLA 890
               S    H DL   NVLL +  +  L      K       G      D +  R +   
Sbjct: 178 E--ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG 235

Query: 891 TIGYM---APDEIFVGELSLKR 909
            + +      +++F G+   + 
Sbjct: 236 IVVFCDVSMDEDLFTGDGDYQF 257

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 37/190 (19%), Positives = 71/190 (37%), Gaps = 45/190 (23%)

Query: 469 ELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGP 528
           EL      I   + + L  L + ++L L +N                    ISS      
Sbjct: 29  ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE----------------KISS------ 65

Query: 529 ISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGL----KSLQNISLAYNRLEGPIPESFGNM 584
               +  ++ +  + L RN +       +E L     +L+ + ++YN++          +
Sbjct: 66  ----LSGMENLRILSLGRNLI-----KKIENLDAVADTLEELWISYNQIA--SLSGIEKL 114

Query: 585 TSLESLDLSNNKISGSIPVSF-EKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNE 643
            +L  L +SNNKI+    +     L  L++L L+ N L  +       + +        E
Sbjct: 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYR------IE 168

Query: 644 LLCGLPNLQV 653
           ++  LPNL+ 
Sbjct: 169 VVKRLPNLKK 178

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 25/110 (22%), Positives = 48/110 (43%), Gaps = 6/110 (5%)

Query: 391 LSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAF 450
                  L+     I   +   +  L     L+L  NN+   I  +  G++ L+ L L  
Sbjct: 23  TEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGR 79

Query: 451 NKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNR 500
           N +   I +   +   L EL ++ N+I+ S+S  +  L +L+ L + +N+
Sbjct: 80  NLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNK 126

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 32/139 (23%), Positives = 53/139 (38%), Gaps = 31/139 (22%)

Query: 362 SSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIV 421
           ++L+  K  ++L L  N +       I +LS                       + NL +
Sbjct: 42  ATLSTLKACKHLALSTNNI-----EKISSLS----------------------GMENLRI 74

Query: 422 LSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISG-S 480
           LSLG N +   I         L+ L +++N++  +    I  L  L  L ++ NKI+   
Sbjct: 75  LSLGRNLIK-KIENLDAVADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKITNWG 131

Query: 481 ISSCLGNLTSLQYLNLGSN 499
               L  L  L+ L L  N
Sbjct: 132 EIDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 38/165 (23%), Positives = 63/165 (38%), Gaps = 20/165 (12%)

Query: 218 TVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNS 277
           T+   I +   +      +     + ++ L      +  +  AT+  +   K + L  N+
Sbjct: 6   TIKDAIRIFEERKSVVATE----AEKVE-LHGMIPPIEKM-DATLSTLKACKHLALSTNN 59

Query: 278 LSGSLPSRID--LALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAI 335
           +      +I     + NL  L+LG N     I +    A  L  L +  N  +    S I
Sbjct: 60  IE-----KISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGI 111

Query: 336 GNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPL 380
             L NL++  +  N +T      G +  LA   KL  L L GNPL
Sbjct: 112 EKLVNLRVLYMSNNKIT----NWGEIDKLAALDKLEDLLLAGNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.4 bits (113), Expect = 5e-06
 Identities = 33/150 (22%), Positives = 62/150 (41%), Gaps = 19/150 (12%)

Query: 64  IGIICDVNSHKVTTLNLSSFNLQGT----IPPEIANLSSLKSLDLSHNKLSSNIPSSIFT 119
           I I  +  S   T       +        +   ++ L + K L LS N +   I SS+  
Sbjct: 11  IRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-I-SSLSG 68

Query: 120 MSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRE 179
           M  L++L L  N +   + +      ++ ++ +S N+++  L   I   L  L+ L++  
Sbjct: 69  MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGI-EKLVNLRVLYMSN 124

Query: 180 NMFYGKIPS-----SLSKCKQLQELHLGYN 204
           N    KI +      L+   +L++L L  N
Sbjct: 125 N----KITNWGEIDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 15/75 (20%), Positives = 29/75 (38%), Gaps = 7/75 (9%)

Query: 548 NLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEK 607
                + T  E ++    +      +E  +  +   + + + L LS N I   I  S   
Sbjct: 16  ERKSVVATEAEKVE----LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSG 68

Query: 608 LSYLKELNLSFNKLK 622
           +  L+ L+L  N +K
Sbjct: 69  MENLRILSLGRNLIK 83

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 40.8 bits (96), Expect = 9e-04
 Identities = 29/118 (24%), Positives = 53/118 (44%), Gaps = 7/118 (5%)

Query: 185 KIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNL 244
           K+ ++LS  K  + L L  NN+   I   +  +  L+ +SL  N +  +I         L
Sbjct: 39  KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTL 95

Query: 245 DVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLA-LPNLEFLNLGIN 301
           + L + +N +  +    I  +  L+ +++ NN ++ +      LA L  LE L L  N
Sbjct: 96  EELWISYNQIASLSG--IEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGN 150

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 61.5 bits (149), Expect = 1e-09
 Identities = 69/483 (14%), Positives = 143/483 (29%), Gaps = 86/483 (17%)

Query: 163 ENICNHLRYLKHLFLRENMFY--GKIPSSLSKCKQLQELHLGY-NNLSGAIPKEIG-NLT 218
             I N+LR LK +  R  +         + ++   L+ L L   +  +      I  +  
Sbjct: 105 TEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCR 164

Query: 219 VLQRISLINNKLHGEIPQEIGYL----QNLDVLQLGFNNLTGVVPATIF----NMSTLKE 270
            ++ + +  +    +  + +  L     +L+VL         + P  +     N  +L  
Sbjct: 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVS 224

Query: 271 IFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSG- 329
           + + +  +          A  NLE    G  +    +P    N      L     S+ G 
Sbjct: 225 VKVGDFEILEL--VGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP 282

Query: 330 -FIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSI 388
             +P        ++  D+ +  L +        + +  C  L  L       D  L   +
Sbjct: 283 NEMPILFPFAAQIRKLDLLYALLETE----DHCTLIQKCPNLEVLETRNVIGDRGL-EVL 337

Query: 389 GNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDL 448
                 L+RL I        +    G +S   +++L                        
Sbjct: 338 AQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG--------------------- 376

Query: 449 AFNKLAGSIPDEICLLSRLNELDLNGNKIS----GSISSCLGNLTSLQYLNLGSNRFTFV 504
                             L  + +  + I+     SI + L NL   + + L        
Sbjct: 377 ---------------CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREE---- 417

Query: 505 IPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRN--NLSGNIPTTL-EGLK 561
                          I+   LD  +   +   K +           L+    + + +   
Sbjct: 418 --------------RITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSP 463

Query: 562 SLQNISLAYNRL--EGPIPESFGNMTSLESLDLSNNKIS-GSIPVSFEKLSYLKELNLSF 618
           +++ + L Y     EG + E      +L+ L++     S  +I  +  KL  L+ L +  
Sbjct: 464 NVRWMLLGYVGESDEG-LMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQG 522

Query: 619 NKL 621
            + 
Sbjct: 523 YRA 525

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 82/526 (15%), Positives = 155/526 (29%), Gaps = 88/526 (16%)

Query: 93  IANLSSLKSLDLSHNKLSS--NIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDI 150
                +L+SL L     ++  N+    +       +  + N L   L S  F    + D+
Sbjct: 69  SRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLR-QLKSVHFRRMIVSDL 127

Query: 151 RLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAI 210
            L +      L +   + L  LK L          + S ++ C++++ L +  ++ S   
Sbjct: 128 DLDR------LAKARADDLETLK-LDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKD 180

Query: 211 PKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIF-NMSTLK 269
            K +                  E+ Q    L+ L+     F  ++     TI  N  +L 
Sbjct: 181 GKWL-----------------HELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV 223

Query: 270 EIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSG 329
            + + +  +          A  NLE    G  +    +P    N      L     S+ G
Sbjct: 224 SVKVGDFEILEL--VGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG 281

Query: 330 --FIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSS 387
              +P        ++  D+ +  L +        + +  C  L  L       D  L   
Sbjct: 282 PNEMPILFPFAAQIRKLDLLYALLETE----DHCTLIQKCPNLEVLETRNVIGDRGL-EV 336

Query: 388 IGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLD 447
           +      L+RL I        +    G +S   +++L                       
Sbjct: 337 LAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG-------------------- 376

Query: 448 LAFNKLAGSIPDEICLLSRLNELDLNGNKIS----GSISSCLGNLTSLQYLNL-GSNRFT 502
                              L  + +  + I+     SI + L NL   + + L    R T
Sbjct: 377 ----------------CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERIT 420

Query: 503 FV--------IPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGN-I 553
            +        +      L+    +     L D  +S        V  + L     S   +
Sbjct: 421 DLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGL 480

Query: 554 PTTLEGLKSLQNISLAYNRL-EGPIPESFGNMTSLESLDLSNNKIS 598
                G  +LQ + +      E  I  +   + SL  L +   + S
Sbjct: 481 MEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 55.3 bits (133), Expect = 8e-08
 Identities = 77/457 (16%), Positives = 147/457 (32%), Gaps = 63/457 (13%)

Query: 94  ANLSSLKSLDLSHNKLSSNIPSSIFTMS----TLKVLYLMDNQLSG----SLSSFTFNTS 145
            +   +K+L +  +  S      +  ++    +L+VL     + +      L +   N  
Sbjct: 161 THCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCR 220

Query: 146 SILDIRLSK-NKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYN 204
           S++ +++     L          +L       L E++   +   +L   ++L    LG +
Sbjct: 221 SLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKL--CRLGLS 278

Query: 205 NLS-GAIPKEIGNLTVLQRISLINNKLHGE-IPQEIGYLQNLDVLQLGFNNLTGV-VPAT 261
            +    +P        ++++ L+   L  E     I    NL+VL+   N +    +   
Sbjct: 279 YMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVL 337

Query: 262 IFNMSTLKEIFLYNNSLSGSLPSRI----DLAL-------PNLEFLNLGINSFSGTIPSS 310
                 LK + +   +    +           L         LE++ +          S 
Sbjct: 338 AQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVY--------VSD 389

Query: 311 ITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDI-FFNNLTSSTPELGFLSSLANCKK 369
           ITN S   L  +G+            NL + +L  +     +T    + G  S L  CKK
Sbjct: 390 ITNES---LESIGTYL---------KNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKK 437

Query: 370 LRYLGLGGNP--LDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIG-NLSNLIVLSLGG 426
           LR          L     S IG  S ++  + + +   S            NL  L + G
Sbjct: 438 LRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRG 497

Query: 427 NNLS-GSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICL--------LSRLNELDLNGNKI 477
              S  +I      L  L+ L +   +   S+  +  +        +  +    +     
Sbjct: 498 CCFSERAIAAAVTKLPSLRYLWVQGYRA--SMTGQDLMQMARPYWNIELIPSRRVPEVNQ 555

Query: 478 SGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKD 514
            G I         L Y +L   R     P+T   LK+
Sbjct: 556 QGEIREMEHPAHILAYYSLAGQRTDC--PTTVRVLKE 590

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 43.0 bits (101), Expect = 4e-04
 Identities = 49/358 (13%), Positives = 111/358 (31%), Gaps = 35/358 (9%)

Query: 276 NSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLIL--LEMGSNSFSGFIPS 333
            SL      R  +     E     +  +   I +++     +    + +          +
Sbjct: 76  RSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKA 135

Query: 334 AIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPL---DGFLPSSIGN 390
              +L  LKL     +  T+     G LS + +C+K++ L +  +     DG     +  
Sbjct: 136 RADDLETLKLDKC--SGFTTD----GLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189

Query: 391 LSLSLERLNIAFCNISG----NIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGL 446
            + SLE LN      +     ++     N  +L+ + +G   +   +   F     L+  
Sbjct: 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGF-FKAAANLEEF 248

Query: 447 DLAFNKLAGSIPDEICLLSRLNELDLNGNKISG--SISSCLGNLTSLQYLNL-GSNRFTF 503
                     +P++   L    +L   G    G   +         ++ L+L  +   T 
Sbjct: 249 CGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETE 308

Query: 504 VIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSL 563
              +      ++   +  + + D  + +     K +  + + R      +      +   
Sbjct: 309 DHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQR 368

Query: 564 QNISLAYNRLEGPIPESFGNMTSLESLDLSNNKIS----GSIPVSFEKLSYLKELNLS 617
             I+LA                 LE + +  + I+     SI    + L   + + L 
Sbjct: 369 GLIALAQ------------GCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLD 414

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 26/120 (21%), Positives = 45/120 (37%), Gaps = 3/120 (2%)

Query: 789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPII 848
           S  S                 E         L +   +     +A  +E+L    S   I
Sbjct: 159 SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCI 215

Query: 849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK 908
           H DL   N+LL E  V  + DFG+A+ +  + +   +      + +MAP+ IF    +++
Sbjct: 216 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 275

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.9 bits (132), Expect = 7e-08
 Identities = 32/166 (19%), Positives = 58/166 (34%), Gaps = 17/166 (10%)

Query: 732 NIIGIGGFGSVYRARL------EDGVEIAIKVFHPQ-CASTLKSFEAECEVIKNI-RHRN 783
             +G G FG V  A             +A+K+       S  ++  +E +++ +I  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 784 LVKIISSCSNDDFKALV-LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           +V ++ +C+      +V +E+   G+L   L S       +             +Y+   
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKG--ARFRQGKDYVG-- 143

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQT 888
                I  DLK     +     +  S F   K LS  +E       
Sbjct: 144 ----AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDL 185

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 50/156 (32%), Positives = 71/156 (45%), Gaps = 10/156 (6%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSG 135
           TT+   S     ++P  I   +    LDL  N L S        +++L  LYL  N+L  
Sbjct: 10  TTVECYSQGRT-SVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ- 65

Query: 136 SLSSFTFNTSSILDI-RLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSL-SKC 193
           SL +  FN  + L    LS N+L   LP  + + L  LK L L  N     +P  +  K 
Sbjct: 66  SLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKL 123

Query: 194 KQLQELHLGYNNLSGAIPKEI-GNLTVLQRISLINN 228
            QL++L L  N L  ++P  +   LT LQ I L +N
Sbjct: 124 TQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 47/186 (25%), Positives = 77/186 (41%), Gaps = 40/186 (21%)

Query: 97  SSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDI-RLSKN 155
            S  +++      +S +P+ I        L L  N L  SL +  F+  + L    L  N
Sbjct: 7   CSGTTVECYSQGRTS-VPTGIPA--QTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGN 62

Query: 156 KLSGKLPENICNHLRYLKHLFLRENMFYGKIPS----SLSKCKQLQELHLGYNNLSGAIP 211
           KL   LP  + N L  L +L L  N     +P+     L++   L+EL L  N L  ++P
Sbjct: 63  KLQ-SLPNGVFNKLTSLTYLNLSTNQL-QSLPNGVFDKLTQ---LKELALNTNQLQ-SLP 116

Query: 212 KEI-GNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKE 270
             +   LT L+ + L  N+L   +P  +            F+ LT           +L+ 
Sbjct: 117 DGVFDKLTQLKDLRLYQNQLKS-VPDGV------------FDRLT-----------SLQY 152

Query: 271 IFLYNN 276
           I+L++N
Sbjct: 153 IWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 36/125 (28%), Positives = 59/125 (47%), Gaps = 9/125 (7%)

Query: 505 IPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQ 564
           IP+    L      D+ +N L    +     L ++  + L  N L          L SL 
Sbjct: 26  IPAQTTYL------DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT 79

Query: 565 NISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPV-SFEKLSYLKELNLSFNKLKG 623
            ++L+ N+L+      F  +T L+ L L+ N++  S+P   F+KL+ LK+L L  N+LK 
Sbjct: 80  YLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS 138

Query: 624 EIPRG 628
            +P G
Sbjct: 139 -VPDG 142

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 37/132 (28%), Positives = 57/132 (43%), Gaps = 4/132 (3%)

Query: 384 LPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPV-TFGGLQK 442
             S    +      L++   ++          L++L  L LGGN L  S+P   F  L  
Sbjct: 19  RTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77

Query: 443 LQGLDLAFNKLAGSIPDEIC-LLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRF 501
           L  L+L+ N+L  S+P+ +   L++L EL LN N++          LT L+ L L  N+ 
Sbjct: 78  LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL 136

Query: 502 TFVIPSTFWNLK 513
             V    F  L 
Sbjct: 137 KSVPDGVFDRLT 148

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 34/106 (32%), Positives = 44/106 (41%), Gaps = 3/106 (2%)

Query: 197 QELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTG 256
             L L  N+L          LT L ++ L  NKL          L +L  L L  N L  
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ- 89

Query: 257 VVPATIFNMST-LKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGIN 301
            +P  +F+  T LKE+ L  N L  SLP  +   L  L+ L L  N
Sbjct: 90  SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQN 134

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 33/128 (25%), Positives = 51/128 (39%), Gaps = 2/128 (1%)

Query: 421 VLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEIC-LLSRLNELDLNGNKISG 479
            L L  N+L       F  L  L  L L  NKL  S+P+ +   L+ L  L+L+ N++  
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQS 90

Query: 480 SISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAV 539
             +     LT L+ L L +N+   +    F  L  +    +  N L          L ++
Sbjct: 91  LPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSL 150

Query: 540 VGIDLSRN 547
             I L  N
Sbjct: 151 QYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 28/94 (29%), Positives = 41/94 (43%), Gaps = 5/94 (5%)

Query: 209 AIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFN-MST 267
           ++P  I   T    + L  N L          L +L  L LG N L   +P  +FN +++
Sbjct: 21  SVPTGIPAQT--TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77

Query: 268 LKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGIN 301
           L  + L  N L  SLP+ +   L  L+ L L  N
Sbjct: 78  LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTN 110

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 42/194 (21%), Positives = 79/194 (40%), Gaps = 33/194 (17%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSC 791
            +G G F +V+ A+ + +   +A+K+       T ++ E E ++++ +   +  K  S  
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 792 SN------DDFKA---------LVLEYMSNGSLEDCLHSSNCA-LNIFCRLNIMIDIASA 835
           +N      D F           +V E +   +L   +       + +     I   +   
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLG 143

Query: 836 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH------LSDFGMAKLLSGEDESTMRTQTL 889
           L+Y+H      IIH D+KP NVL++            ++D G A      DE    T ++
Sbjct: 144 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDE--HYTNSI 196

Query: 890 ATIGYMAPDEIFVG 903
            T  Y +P E+ +G
Sbjct: 197 QTREYRSP-EVLLG 209

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.9 bits (139), Expect = 1e-08
 Identities = 103/716 (14%), Positives = 186/716 (25%), Gaps = 238/716 (33%)

Query: 308 PSSITNASKL--ILLEMGSNSFS-----------GFIPSAI-----GNLRNLKLFDIFFN 349
             +++   +L   LL                    F+ S I           +++    +
Sbjct: 58  KDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRD 117

Query: 350 NLTSSTPEL--GFLSSLANCKKLR----------YLGLGGNPLDGFLPSSIGNLSLSLER 397
            L +         +S L    KLR           + + G  + G      G   ++L+ 
Sbjct: 118 RLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG--VLGS-----GKTWVALDV 170

Query: 398 L-NIAF-CNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAG 455
             +    C +   I            L+L   N   ++      L+ LQ L    +    
Sbjct: 171 CLSYKVQCKMDFKI----------FWLNLKNCNSPETV------LEMLQKLLYQIDPNWT 214

Query: 456 SIPDEICLLS-RLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKD 514
           S  D    +  R++ +     ++          L S  Y N        ++     N K 
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRL----------LKSKPYEN------CLLVLLNVQNAKA 258

Query: 515 ILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLE 574
             +F++S  +L              +    +R              K + +   A     
Sbjct: 259 WNAFNLSCKIL--------------L---TTRF-------------KQVTDFLSAATTTH 288

Query: 575 GPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFA-N 633
             +      +T  E   L                  LK L+     L  E+    P   +
Sbjct: 289 ISLDHHSMTLTPDEVKSL-----------------LLKYLDCRPQDLPREVLTTNPRRLS 331

Query: 634 FTAESFMGNELLCGLPNLQVPPCKHSQPRAQHKSKKTILLLVIFLPLSTTLVIAVALALK 693
             AES            ++                K          L+T +  ++   L+
Sbjct: 332 IIAES------------IRDGLA-TWDNWKHVNCDK----------LTTIIESSLN-VLE 367

Query: 694 RGKRGTMLSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEI 753
                            P   R   F+ L             +                I
Sbjct: 368 -----------------PAEYR-KMFDRL------------SV----------FPPSAHI 387

Query: 754 AIKVFHPQCASTL--KSFEAECEVIKN-IRHRNLVKIISSCSNDDFK----ALVLEYMSN 806
              +      S +     +++  V+ N +   +LV+        +      ++ LE    
Sbjct: 388 PTILL-----SLIWFDVIKSDVMVVVNKLHKYSLVE----KQPKESTISIPSIYLELKVK 438

Query: 807 GSLEDCLHSS--NC--ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED 862
              E  LH S  +       F   +++        Y H GH     H  LK         
Sbjct: 439 LENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-----H--LKNIEHPERMT 491

Query: 863 MVAHL-SDFGM--AKLLSGEDESTMRTQTLATIG----YMAPDEIFVGELSLKRWVNDLL 915
           +   +  DF     K+             L T+     Y     I   +   +R VN +L
Sbjct: 492 LFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYK--PYICDNDPKYERLVNAIL 549

Query: 916 PVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI--DAKDTITR 969
                      L   EE    +K   LL I   AL     + ++ I  +A   + R
Sbjct: 550 ---------DFLPKIEENLICSKYTDLLRI---AL----MAEDEAIFEEAHKQVQR 589

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 26/89 (29%), Positives = 37/89 (41%), Gaps = 4/89 (4%)

Query: 542 IDLSRNNLSGNIPT-TLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGS 600
           + L+ N L           L  L  + L  N+L G  P +F   + ++ L L  NKI   
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-E 92

Query: 601 IPV-SFEKLSYLKELNLSFNKLKGEIPRG 628
           I    F  L  LK LNL  N++   +  G
Sbjct: 93  ISNKMFLGLHQLKTLNLYDNQISC-VMPG 120

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 10/90 (11%)

Query: 415 NLSNLIVLSLGGNNLSGSIPV-TFGGLQKLQGLDLAFNKLAGSIPDEICL-LSRLNELDL 472
            L +L+ L L  N L+  I    F G   +Q L L  NK+   I +++ L L +L  L+L
Sbjct: 52  RLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNL 109

Query: 473 NGNKISGSISSCLG---NLTSLQYLNLGSN 499
             N+IS  +    G   +L SL  LNL SN
Sbjct: 110 YDNQIS-CVMP--GSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 34/109 (31%), Positives = 49/109 (44%), Gaps = 5/109 (4%)

Query: 421 VLSLGGNNLSGSIPVT--FGGLQKLQGLDLAFNKLAGSIPDEIC-LLSRLNELDLNGNKI 477
            L L  N L   I     FG L  L  L+L  N+L   I        S + EL L  NKI
Sbjct: 33  ELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90

Query: 478 SGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLD 526
               +     L  L+ LNL  N+ + V+P +F +L  + S +++SN  +
Sbjct: 91  KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 30/111 (27%), Positives = 48/111 (43%), Gaps = 15/111 (13%)

Query: 74  KVTTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDN 131
            +  L L    L   I P      S ++ L L  NK+   I + +F  +  LK L L DN
Sbjct: 55  HLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDN 112

Query: 132 QLSGSLSSFTFNT-SSILDIRLSKNKLSGKLPENICN-HLRYLKHLFLREN 180
           Q+S  +   +F   +S+  + L+ N  +       CN HL +    +LR+ 
Sbjct: 113 QIS-CVMPGSFEHLNSLTSLNLASNPFN-------CNCHLAWFAE-WLRKK 154

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 33/179 (18%), Positives = 57/179 (31%), Gaps = 55/179 (30%)

Query: 100 KSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILD-IRLSKNKLS 158
            ++D +   L   IP  I        L L DN+L    S   F     L  + L +N+L+
Sbjct: 11  TTVDCTGRGLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 159 GKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEI-GNL 217
             +  N                               +QEL LG N +   I  ++   L
Sbjct: 68  -GIEPNAFEGA------------------------SHIQELQLGENKIK-EISNKMFLGL 101

Query: 218 TVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNN 276
             L+ ++L +N++   +                F +L            +L  + L +N
Sbjct: 102 HQLKTLNLYDNQISC-VMPGS------------FEHLN-----------SLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 29/109 (26%), Positives = 47/109 (43%), Gaps = 8/109 (7%)

Query: 76  TTLNLSSFNLQGTIPPEIA--NLSSLKSLDLSHNKLSSNIPSSIF-TMSTLKVLYLMDNQ 132
           T L L+  N  G I  +     L  L  L+L  N+L+  I  + F   S ++ L L +N+
Sbjct: 32  TELLLND-NELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENK 89

Query: 133 LSGSLSSFTFNT-SSILDIRLSKNKLSGKLPENICNHLRYLKHLFLREN 180
           +   +S+  F     +  + L  N++S  +      HL  L  L L  N
Sbjct: 90  IK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 2/86 (2%)

Query: 535 NLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSN 594
            L  +V ++L RN L+G  P   EG   +Q + L  N+++    + F  +  L++L+L +
Sbjct: 52  RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYD 111

Query: 595 NKISGSIPV-SFEKLSYLKELNLSFN 619
           N+IS  +   SFE L+ L  LNL+ N
Sbjct: 112 NQIS-CVMPGSFEHLNSLTSLNLASN 136

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 51.5 bits (124), Expect = 1e-07
 Identities = 30/78 (38%), Positives = 44/78 (56%), Gaps = 9/78 (11%)

Query: 552 NIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS-FEKLSY 610
            IPTT       Q + L  N++    P  F  +T L  LDL NN+++  +P   F+KL+ 
Sbjct: 27  GIPTTT------QVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79

Query: 611 LKELNLSFNKLKGEIPRG 628
           L +L+L+ N+LK  IPRG
Sbjct: 80  LTQLSLNDNQLKS-IPRG 96

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 28/107 (26%), Positives = 57/107 (53%), Gaps = 8/107 (7%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIF-TMSTLKVLYLMDNQLS 134
           TT++ S  +L  ++P  I   ++ + L L  N+++  +   +F  ++ L  L L +NQL+
Sbjct: 12  TTVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITK-LEPGVFDRLTQLTRLDLDNNQLT 67

Query: 135 GSLSSFTFNTSSIL-DIRLSKNKLSGKLPENICNHLRYLKHLFLREN 180
             L +  F+  + L  + L+ N+L   +P    ++L+ L H++L  N
Sbjct: 68  -VLPAGVFDKLTQLTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 9/78 (11%)

Query: 552 NIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS-FEKLSY 610
            IPT        Q + L  N++    P  F ++ +L+ L  ++NK++ +IP   F+KL+ 
Sbjct: 30  GIPTDK------QRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82

Query: 611 LKELNLSFNKLKGEIPRG 628
           L +L+L+ N LK  IPRG
Sbjct: 83  LTQLDLNDNHLKS-IPRG 99

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 25/107 (23%), Positives = 55/107 (51%), Gaps = 8/107 (7%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIF-TMSTLKVLYLMDNQLS 134
           T +N  +  L  ++P  I   +  + L L++N+++  +   +F  +  L+ LY   N+L+
Sbjct: 15  TLVNCQNIRLA-SVPAGI--PTDKQRLWLNNNQITK-LEPGVFDHLVNLQQLYFNSNKLT 70

Query: 135 GSLSSFTFNTSSIL-DIRLSKNKLSGKLPENICNHLRYLKHLFLREN 180
            ++ +  F+  + L  + L+ N L   +P    ++L+ L H++L  N
Sbjct: 71  -AIPTGVFDKLTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 27/157 (17%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKV------FHPQCASTLKSFEAECEVIKNIRHR--- 782
           +IG G FG V +A   +    +A+K+      FH Q          E  +++++R +   
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-------AEEIRILEHLRKQDKD 156

Query: 783 NLVKIISSCSNDDFKA---LVLEYMSNGSLEDCLHSSNCA-LNIFCRLNIMIDIASALEY 838
           N + +I    N  F+    +  E +S  +L + +  +     ++         I   L+ 
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAH--LSDFGMA 873
           LH      IIHCDLKP N+LL +   +   + DFG +
Sbjct: 216 LH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 21/86 (24%), Positives = 31/86 (36%), Gaps = 3/86 (3%)

Query: 415 NLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNG 474
           N      L L G  +   I      L +   +D + N++   +     LL RL  L +N 
Sbjct: 17  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNN 73

Query: 475 NKISGSISSCLGNLTSLQYLNLGSNR 500
           N+I          L  L  L L +N 
Sbjct: 74  NRICRIGEGLDQALPDLTELILTNNS 99

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 24/122 (19%), Positives = 47/122 (38%), Gaps = 18/122 (14%)

Query: 548 NLSGNIPTTLEGL----KSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPV 603
           +L G     +E L         I  + N +   + + F  +  L++L ++NN+I      
Sbjct: 25  DLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEG 82

Query: 604 SFEKLSYLKELNLSFNKLK--GEIPRGGPFANFTAESFMGNE----------LLCGLPNL 651
             + L  L EL L+ N L   G++       + T    + N           ++  +P +
Sbjct: 83  LDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQV 142

Query: 652 QV 653
           +V
Sbjct: 143 RV 144

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 49.3 bits (118), Expect = 9e-07
 Identities = 26/122 (21%), Positives = 42/122 (34%), Gaps = 13/122 (10%)

Query: 362 SSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLS---N 418
           +   N  + R L L G  +       I NL  +L++ +    + S N  + +        
Sbjct: 13  AQYTNAVRDRELDLRGYKI-----PVIENLGATLDQFDA--IDFSDNEIRKLDGFPLLRR 65

Query: 419 LIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICL--LSRLNELDLNGNK 476
           L  L +  N +          L  L  L L  N L   + D   L  L  L  L +  N 
Sbjct: 66  LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNP 124

Query: 477 IS 478
           ++
Sbjct: 125 VT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 25/120 (20%), Positives = 42/120 (35%), Gaps = 14/120 (11%)

Query: 264 NMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNL---GINSFSGTIPSSITNASKLILL 320
           N    +E+ L    +   +   +   L   + ++     I    G          +L  L
Sbjct: 17  NAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEIRKLDG-----FPLLRRLKTL 69

Query: 321 EMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPL 380
            + +N            L +L    +  N+L     ELG L  LA+ K L YL +  NP+
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLV----ELGDLDPLASLKSLTYLCILRNPV 125

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 24/120 (20%), Positives = 42/120 (35%), Gaps = 15/120 (12%)

Query: 91  PEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTS-SILD 149
            +  N    + LDL   K+   I +   T+     +   DN++   L  F        L 
Sbjct: 13  AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLL 70

Query: 150 IRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPS-----SLSKCKQLQELHLGYN 204
             ++ N++  ++ E +   L  L  L L  N     +        L+  K L  L +  N
Sbjct: 71  --VNNNRIC-RIGEGLDQALPDLTELILTNN----SLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 25/115 (21%), Positives = 42/115 (36%), Gaps = 5/115 (4%)

Query: 188 SSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVL 247
           +  +   + +EL L    +   I      L     I   +N++          L+ L  L
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 69

Query: 248 QLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLA-LPNLEFLNLGIN 301
            +  N +  +       +  L E+ L NNSL   L     LA L +L +L +  N
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 24/132 (18%), Positives = 46/132 (34%), Gaps = 26/132 (19%)

Query: 440 LQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSN 499
             + + LDL   K+   I +    L + + +D + N+I   +      L  L+ L + +N
Sbjct: 18  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNN 74

Query: 500 RFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEG 559
           R   +       L D+    +++N         +  L  +                 L  
Sbjct: 75  RICRIGEGLDQALPDLTELILTNNS--------LVELGDL---------------DPLAS 111

Query: 560 LKSLQNISLAYN 571
           LKSL  + +  N
Sbjct: 112 LKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 21/109 (19%), Positives = 38/109 (34%), Gaps = 13/109 (11%)

Query: 152 LSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPS--SLSKCKQLQELHLGYNNLSGA 209
           L   K+   + EN+   L     +   +N    +I         ++L+ L +  N +   
Sbjct: 26  LRGYKIP--VIENLGATLDQFDAIDFSDN----EIRKLDGFPLLRRLKTLLVNNNRICRI 79

Query: 210 IPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQ---NLDVLQLGFNNLT 255
                  L  L  + L NN L      ++  L    +L  L +  N +T
Sbjct: 80  GEGLDQALPDLTELILTNNSL--VELGDLDPLASLKSLTYLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 21/114 (18%), Positives = 42/114 (36%), Gaps = 11/114 (9%)

Query: 71  NSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSS--NIPSSIFTMSTLKVLYL 128
           N+ +   L+L        I    A L    ++D S N++      P     +  LK L +
Sbjct: 17  NAVRDRELDLRG-YKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPL----LRRLKTLLV 71

Query: 129 MDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICN--HLRYLKHLFLREN 180
            +N++             + ++ L+ N L      ++     L+ L +L +  N
Sbjct: 72  NNNRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSLTYLCILRN 123

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 38/159 (23%), Positives = 69/159 (43%), Gaps = 25/159 (15%)

Query: 731 NNIIGIGGFGSVYRAR-LEDGVEIAIKV------FHPQCASTLKSFEAECEVIKNIRHR- 782
           +++IG G FG V +A    +   +AIK+      F  Q        + E  +++ +    
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-------QIEVRLLELMNKHD 111

Query: 783 -----NLVKIISSCSNDDFKALVLEYMSNGSLEDCL-HSSNCALNIFCRLNIMIDIASAL 836
                 +V +       +   LV E +S  +L D L +++   +++         + +AL
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170

Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAH--LSDFGMA 873
            +L     + IIHCDLKP N+LL     +   + DFG +
Sbjct: 171 LFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 50.1 bits (120), Expect = 4e-07
 Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 3/81 (3%)

Query: 542 IDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSI 601
           +D  ++N  G I        +L+ +SL    L      +   +  L+ L+LS N+I G +
Sbjct: 31  LDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFGGL 87

Query: 602 PVSFEKLSYLKELNLSFNKLK 622
            +  EKL  L  LNLS NKLK
Sbjct: 88  DMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 30/115 (26%), Positives = 43/115 (37%), Gaps = 11/115 (9%)

Query: 71  NSHKVTTLNLSSFNLQ-GTIPPEIANLSSLKSLDLSHNKLSS--NIPSSIFTMSTLKVLY 127
               V  L L +     G I    A   +L+ L L +  L S  N+P     +  LK L 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPK----LPKLKKLE 77

Query: 128 LMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICN--HLRYLKHLFLREN 180
           L +N++ G L        ++  + LS NKL       +     L  LK L L   
Sbjct: 78  LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 28/137 (20%), Positives = 56/137 (40%), Gaps = 28/137 (20%)

Query: 464 LSRLNELDLNGNKIS-GSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISS 522
            + + EL L+  K + G I        +L++L+L +             L  + +     
Sbjct: 23  PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINV-----------GLISVSNLP--- 68

Query: 523 NLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGP-IPESF 581
                        L  +  ++LS N + G +    E L +L +++L+ N+L+     E  
Sbjct: 69  ------------KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPL 116

Query: 582 GNMTSLESLDLSNNKIS 598
             +  L+SLDL N +++
Sbjct: 117 KKLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 46.3 bits (110), Expect = 7e-06
 Identities = 22/89 (24%), Positives = 38/89 (42%), Gaps = 3/89 (3%)

Query: 415 NLSNLIVLSLGGNNLS-GSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLN 473
             + +  L L     + G I         L+ L L    L  S+ + +  L +L +L+L+
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79

Query: 474 GNKISGSISSCLGNLTSLQYLNLGSNRFT 502
            N+I G +      L +L +LNL  N+  
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 46.3 bits (110), Expect = 8e-06
 Identities = 28/120 (23%), Positives = 45/120 (37%), Gaps = 12/120 (10%)

Query: 264 NMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNL---GINSFSGTIPSSITNASKLILL 320
             + ++E+ L N   +      +     NLEFL+L   G+ S S      +    KL  L
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN-----LPKLPKLKKL 76

Query: 321 EMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPL 380
           E+  N   G +      L NL   ++  N L      +  L  L   + L+ L L    +
Sbjct: 77  ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD----ISTLEPLKKLECLKSLDLFNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 23/106 (21%), Positives = 45/106 (42%), Gaps = 4/106 (3%)

Query: 143 NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLG 202
             +++ ++ L   K +    E +      L+ L L        + S+L K  +L++L L 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-ISV-SNLPKLPKLKKLELS 79

Query: 203 YNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQ 248
            N + G +      L  L  ++L  NKL  +    +  L+ L+ L+
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKL--KDISTLEPLKKLECLK 123

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 30/87 (34%), Positives = 44/87 (50%), Gaps = 3/87 (3%)

Query: 543 DLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIP 602
           +L  N L        + L  L  +SL+ N+++      F  +T L  L L  NK+  S+P
Sbjct: 34  ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SLP 92

Query: 603 VS-FEKLSYLKELNLSFNKLKGEIPRG 628
              F+KL+ LKEL L  N+LK  +P G
Sbjct: 93  NGVFDKLTQLKELALDTNQLKS-VPDG 118

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 27/78 (34%), Positives = 39/78 (50%), Gaps = 9/78 (11%)

Query: 552 NIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS-FEKLSY 610
            IP++   L+      L  N+L+      F  +T L  L LS N+I  S+P   F+KL+ 
Sbjct: 25  GIPSSATRLE------LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77

Query: 611 LKELNLSFNKLKGEIPRG 628
           L  L L  NKL+  +P G
Sbjct: 78  LTILYLHENKLQ-SLPNG 94

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 46.1 bits (110), Expect = 9e-06
 Identities = 41/183 (22%), Positives = 74/183 (40%), Gaps = 58/183 (31%)

Query: 97  SSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILD-IRLSKN 155
            S   +  +   L+S +P+ I +  +   L L  N+L  SL    F+  + L  + LS+N
Sbjct: 7   CSGTEIRCNSKGLTS-VPTGIPS--SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQN 62

Query: 156 KLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEI- 214
           ++   LP+ + + L  L  L+L EN              +LQ           ++P  + 
Sbjct: 63  QIQ-SLPDGVFDKLTKLTILYLHEN--------------KLQ-----------SLPNGVF 96

Query: 215 GNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIF-NMSTLKEIFL 273
             LT L+ ++L  N+L                           VP  IF  +++L++I+L
Sbjct: 97  DKLTQLKELALDTNQLKS-------------------------VPDGIFDRLTSLQKIWL 131

Query: 274 YNN 276
           + N
Sbjct: 132 HTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.8 bits (104), Expect = 6e-05
 Identities = 28/94 (29%), Positives = 42/94 (44%), Gaps = 2/94 (2%)

Query: 421 VLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEIC-LLSRLNELDLNGNKISG 479
            L L  N L       F  L +L  L L+ N++  S+PD +   L++L  L L+ NK+  
Sbjct: 32  RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQS 90

Query: 480 SISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLK 513
             +     LT L+ L L +N+   V    F  L 
Sbjct: 91  LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLT 124

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 34/108 (31%), Positives = 59/108 (54%), Gaps = 7/108 (6%)

Query: 76  TTLNLSSFNLQGTIPPEI-ANLSSLKSLDLSHNKLSSNIPSSIF-TMSTLKVLYLMDNQL 133
           T L L S  LQ ++P  +   L+ L  L LS N++ S +P  +F  ++ L +LYL +N+L
Sbjct: 31  TRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKL 88

Query: 134 SGSLSSFTF-NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLREN 180
             SL +  F   + + ++ L  N+L   +P+ I + L  L+ ++L  N
Sbjct: 89  Q-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 52.0 bits (125), Expect = 6e-07
 Identities = 40/311 (12%), Positives = 90/311 (28%), Gaps = 49/311 (15%)

Query: 319 LLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLA-----NCKKLRYL 373
             E  +  F      +   L +L+  ++    +T         + +A         L  +
Sbjct: 58  HYEFQNQRF------SAEVLSSLRQLNLAGVRMTPVK-----CTVVAAVLGSGRHALDEV 106

Query: 374 GLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIG-----NLSNLIVLSLGGNN 428
            L    LD     ++  + L   +L +   ++     K +      +   +  L L  N 
Sbjct: 107 NLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNP 166

Query: 429 LSGSIPVTFG-GL---QKLQGLDLAFNKL----AGSIPDEICLLSRLNELDLNGNKISGS 480
           L+ +       GL     +  L L    L       +  ++    +L EL++  N    +
Sbjct: 167 LTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDT 226

Query: 481 ----ISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNL 536
               ++       SL+ L+L  N  +         L+D+         +   +SL  G  
Sbjct: 227 AALALARAAREHPSLELLHLYFNELS---SEGRQVLRDLGGAAEGGARVV--VSLTEGTA 281

Query: 537 KAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGP---------IPESFGNMTSL 587
            +     +           + +  +  +++ L    LE             +       +
Sbjct: 282 VSEYWSVILSEVQRNL--NSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEV 339

Query: 588 ESLDLSNNKIS 598
            +L        
Sbjct: 340 RALLEQLGSSG 350

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.5 bits (116), Expect = 9e-07
 Identities = 28/137 (20%), Positives = 58/137 (42%), Gaps = 28/137 (20%)

Query: 464 LSRLNELDLNGNKIS-GSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISS 522
            S + EL L+ ++ + G +         L++L+  +             L  I      +
Sbjct: 16  PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV-----------GLTSI------A 58

Query: 523 NLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGP-IPESF 581
           NL           L  +  ++LS N +SG +    E   +L +++L+ N+++     E  
Sbjct: 59  NL---------PKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPL 109

Query: 582 GNMTSLESLDLSNNKIS 598
             + +L+SLDL N +++
Sbjct: 110 KKLENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 3/81 (3%)

Query: 542 IDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSI 601
           +D SR+N  G +    +  + L+ +S     L      +   +  L+ L+LS+N++SG +
Sbjct: 24  LDNSRSNE-GKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELSDNRVSGGL 80

Query: 602 PVSFEKLSYLKELNLSFNKLK 622
            V  EK   L  LNLS NK+K
Sbjct: 81  EVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.4 bits (113), Expect = 2e-06
 Identities = 26/120 (21%), Positives = 46/120 (38%), Gaps = 12/120 (10%)

Query: 264 NMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNL---GINSFSGTIPSSITNASKLILL 320
             S +KE+ L N+  +      +      LEFL+    G+ S +      +   +KL  L
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIAN-----LPKLNKLKKL 69

Query: 321 EMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPL 380
           E+  N  SG +        NL   ++  N +     +L  +  L   + L+ L L    +
Sbjct: 70  ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK----DLSTIEPLKKLENLKSLDLFNCEV 125

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.6 bits (111), Expect = 5e-06
 Identities = 21/89 (23%), Positives = 42/89 (47%), Gaps = 3/89 (3%)

Query: 415 NLSNLIVLSLGGN-NLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLN 473
             S++  L L  + +  G +       ++L+ L      L  SI + +  L++L +L+L+
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72

Query: 474 GNKISGSISSCLGNLTSLQYLNLGSNRFT 502
            N++SG +        +L +LNL  N+  
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 29/115 (25%), Positives = 45/115 (39%), Gaps = 11/115 (9%)

Query: 71  NSHKVTTLNLSSF-NLQGTIPPEIANLSSLKSLDLSHNKLSS--NIPSSIFTMSTLKVLY 127
               V  L L +  + +G +         L+ L   +  L+S  N+P     ++ LK L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPK----LNKLKKLE 70

Query: 128 LMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICN--HLRYLKHLFLREN 180
           L DN++SG L        ++  + LS NK+       I     L  LK L L   
Sbjct: 71  LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.9 bits (104), Expect = 4e-05
 Identities = 31/136 (22%), Positives = 52/136 (38%), Gaps = 12/136 (8%)

Query: 366 NCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNIS--GNIPKAIGNLSNLIVLS 423
               ++ L L  +  +      + +    LE L+     ++   N+PK    L+ L  L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPK----LNKLKKLE 70

Query: 424 LGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICL--LSRLNELDLNGNKISGSI 481
           L  N +SG + V       L  L+L+ NK+   +     L  L  L  LDL   +++   
Sbjct: 71  LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK-DLSTIEPLKKLENLKSLDLFNCEVTNLN 129

Query: 482 ---SSCLGNLTSLQYL 494
               +    L  L YL
Sbjct: 130 DYRENVFKLLPQLTYL 145

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.5 bits (103), Expect = 6e-05
 Identities = 24/114 (21%), Positives = 47/114 (41%), Gaps = 3/114 (2%)

Query: 143 NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLG 202
             S + ++ L  ++ +    E + +    L+ L          I ++L K  +L++L L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSI-ANLPKLNKLKKLELS 72

Query: 203 YNNLSGAIPKEIGNLTVLQRISLINNKLHG-EIPQEIGYLQNLDVLQLGFNNLT 255
            N +SG +         L  ++L  NK+      + +  L+NL  L L    +T
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 46/257 (17%), Positives = 91/257 (35%), Gaps = 48/257 (18%)

Query: 361 LSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLI 420
           L+   +  +++++ L  + ++      I +    L+ L++    +S  I   +   SNL+
Sbjct: 86  LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLV 145

Query: 421 VLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNG-NKIS- 478
            L     NLSG    +          + A   L  S         RL+EL+L+     + 
Sbjct: 146 RL-----NLSGCSGFS----------EFALQTLLSSCS-------RLDELNLSWCFDFTE 183

Query: 479 -GSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLK 537
                +      ++  LNL                          NL    +S  +    
Sbjct: 184 KHVQVAVAHVSETITQLNLS---------------------GYRKNLQKSDLSTLVRRCP 222

Query: 538 AVVGIDLSR-NNLSGNIPTTLEGLKSLQNISLAY-NRLEGPIPESFGNMTSLESLDLSNN 595
            +V +DLS    L  +       L  LQ++SL+    +        G + +L++L +   
Sbjct: 223 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282

Query: 596 KISGSIPVSFEKLSYLK 612
              G++ +  E L +L+
Sbjct: 283 VPDGTLQLLKEALPHLQ 299

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 44.9 bits (106), Expect = 9e-05
 Identities = 49/245 (20%), Positives = 81/245 (33%), Gaps = 44/245 (17%)

Query: 190 LSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISL-----INNKLHGEIPQEIGYLQNL 244
           LS+C +LQ L L    LS  I   +   + L R++L      +      +      L  L
Sbjct: 114 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 173

Query: 245 DVLQLGFNNLT--GVVPATIFNMSTLKEIFL--YNNSLSGSLPSRIDLALPNLEFLNLGI 300
           ++      + T   V  A      T+ ++ L  Y  +L  S  S +    PNL  L+L  
Sbjct: 174 NL--SWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL-- 229

Query: 301 NSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDI-FFNNLTSSTPELG 359
              S +    + N                        L  L+   +    ++   T    
Sbjct: 230 ---SDS--VMLKNDC----------------FQEFFQLNYLQHLSLSRCYDIIPET---- 264

Query: 360 FLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNL 419
            L  L     L+ L + G   DG    ++  L  +L  L I   + +      IGN  N 
Sbjct: 265 -LLELGEIPTLKTLQVFGIVPDG----TLQLLKEALPHLQINCSHFTTIARPTIGNKKNQ 319

Query: 420 IVLSL 424
            +  +
Sbjct: 320 EIWGI 324

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 46.5 bits (111), Expect = 3e-05
 Identities = 35/146 (23%), Positives = 59/146 (40%), Gaps = 30/146 (20%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKV------FHPQCASTLKSFEAECEVIKNIRHR--- 782
            +G G FG V   + +++    A+KV      +             E +++K I++    
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI-------EADILKKIQNDDIN 94

Query: 783 --NLVKIISSCSNDDFKA---LVLEYMSNGSLEDCLHSSNCA-LNIFCRLNIMIDIASAL 836
             N+VK         +     L+ E +   SL + +  +N    +I       I+I  AL
Sbjct: 95  NNNIVKYHGKF---MYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKAL 150

Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDED 862
            YL       + H DLKP N+LLD+ 
Sbjct: 151 NYLR---KMSLTHTDLKPENILLDDP 173

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.1 bits (108), Expect = 4e-05
 Identities = 21/168 (12%), Positives = 54/168 (32%), Gaps = 24/168 (14%)

Query: 440 LQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLG--NLTSLQYLNLG 497
           L  +  L+    K   ++         L  L++    +  S+   +   +L +L+ L L 
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVL- 226

Query: 498 SNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTL 557
                       +   +   FD   N+       +      +  + +        +    
Sbjct: 227 ------------YVGVEDYGFDGDMNVFRP--LFSKDRFPNLKWLGIVDAEEQNVVVEMF 272

Query: 558 ---EGLKSLQNISLAYNRL--EG--PIPESFGNMTSLESLDLSNNKIS 598
              + L  L+ + ++   L  EG   + +    +  L+ +++  N +S
Sbjct: 273 LESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.1 bits (108), Expect = 4e-05
 Identities = 23/159 (14%), Positives = 51/159 (32%), Gaps = 17/159 (10%)

Query: 479 GSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKA 538
             +S  L  +  L  L +       +      NLK  L              +   +L  
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKS-LEIISGGLPDSVVEDILGSDLPN 220

Query: 539 VVGIDLSRNNLSGNIPTTLEGL---------KSLQNISLAYNRLEGPIPESFGN---MTS 586
           +  + L            +             +L+ + +     +  + E F     +  
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280

Query: 587 LESLDLSNNKISGS----IPVSFEKLSYLKELNLSFNKL 621
           LE++D+S   ++      +    +K+ +LK +N+ +N L
Sbjct: 281 LETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 43.4 bits (101), Expect = 2e-04
 Identities = 21/140 (15%), Positives = 45/140 (32%), Gaps = 18/140 (12%)

Query: 172 LKHLFLRENMFYGKIPSSL--SKCKQLQELHL--GYNNLSGAIPKEI-------GNLTVL 220
           LK L +        +   +  S    L++L L  G  +        +            L
Sbjct: 195 LKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNL 254

Query: 221 QRISLINNKLHGEIPQEIG---YLQNLDVLQLGFNNLTGVVPATIF----NMSTLKEIFL 273
           + + +++ +    + +       L  L+ + +    LT      +      +  LK I +
Sbjct: 255 KWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINM 314

Query: 274 YNNSLSGSLPSRIDLALPNL 293
             N LS  +   +  +LP  
Sbjct: 315 KYNYLSDEMKKELQKSLPMK 334

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 45.4 bits (108), Expect = 6e-05
 Identities = 28/171 (16%), Positives = 57/171 (33%), Gaps = 32/171 (18%)

Query: 733 IIGIGGFGSVYRA--RLEDGVEIAIKV------FHPQCASTLKSFEAECEVIKNIRHR-- 782
            +G G FG V           ++A+K+      +             E  V+K I+ +  
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-------EINVLKKIKEKDK 78

Query: 783 ----NLVKIISSCSNDDFKA---LVLEYMSNGSLEDCL-HSSNCALNIFCRLNIMIDIAS 834
                 V +       +F     +  E +   +  + L  ++     +    ++   +  
Sbjct: 79  ENKFLCVLMSDWF---NFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCH 134

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR 885
           AL +LH      + H DLKP N+L        L +   +        +++R
Sbjct: 135 ALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 44.9 bits (106), Expect = 1e-04
 Identities = 38/145 (26%), Positives = 62/145 (42%), Gaps = 28/145 (19%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEA---ECEVIKNIR-----HRNL 784
           +G G F +V+ +  ++    +A+KV      S     E    E  ++K++R       N 
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKV----VKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100

Query: 785 VKIISSCSNDDFK---------ALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIAS 834
             ++     DDFK          +V E + +  L   +  SN   L + C   I+  +  
Sbjct: 101 EMVVQLL--DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQ 157

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLL 859
            L+YLH      IIH D+KP N+LL
Sbjct: 158 GLDYLH--TKCRIIHTDIKPENILL 180

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 43.9 bits (104), Expect = 3e-04
 Identities = 27/114 (23%), Positives = 50/114 (43%), Gaps = 20/114 (17%)

Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
           + D K +++ Y++    +D +            L+I   I   +  LH      +IH DL
Sbjct: 410 DLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDL 457

Query: 853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDEST-----MRTQTLATIGYMAPDEIF 901
             SN + D+D+   + DFG+ K +S  DE       +  + + +  +   DEI+
Sbjct: 458 TTSNFIFDKDLY--IIDFGLGK-ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIW 508

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 42.3 bits (100), Expect = 6e-04
 Identities = 27/148 (18%), Positives = 53/148 (35%), Gaps = 32/148 (21%)

Query: 733 IIGIGGFGSVYRA--RLEDGVEIAIKV------FHPQCASTLKSFEAECEVIKNIRHR-- 782
            +G G FG V         G  +A+K+      +     S       E +V++++     
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS-------EIQVLEHLNTTDP 73

Query: 783 ----NLVKIISSCSNDDFKA---LVLEYMSNGSLEDCLHSSNCA-LNIFCRLNIMIDIAS 834
                 V+++      +      +V E +   S  D +  +      +     +   I  
Sbjct: 74  NSTFRCVQMLEWF---EHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICK 129

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDED 862
           ++ +LH   S  + H DLKP N+L  + 
Sbjct: 130 SVNFLH---SNKLTHTDLKPENILFVQS 154

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	985
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.98
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.98
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.98
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.98
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.98
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.98
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.98
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.98
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.98
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.98
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.98
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.97
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.97
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.94
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.92
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.9
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.89
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.88
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.86
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.86
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.85
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.84
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.84
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.83
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.83
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.82
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.81
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.8
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.8
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.8
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.8
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.79
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.79
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.79
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.79
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.78
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.77
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.76
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.76
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.76
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.76
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.75
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.74
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.73
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.72
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.71
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.71
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.66
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.63
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.63
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.63
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.62
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.62
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.61
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.61
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.6
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.59
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.59
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.57
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.55
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.54
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.53
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.51
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.46
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.43
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.43
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.41
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.35
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.32
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.32
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.29
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.26
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.22
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.21
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.11
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.02
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.01
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	99.0
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.97
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.93
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.89
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.56
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.52
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.45
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.43
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.4
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.38
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.36
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.31
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.26
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.19
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.97
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.92
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.75
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.68
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.63
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.6
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.5
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.37
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.3
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.17
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.15
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.09
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.06
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.06
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.98
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.67
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.64
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.58
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.55
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.25
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.11
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.7
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.17
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.52

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=5.2e-89  Score=847.23  Aligned_cols=627  Identities=33%  Similarity=0.525  Sum_probs=540.4

Q ss_pred             hccCChhHHHHHHHHHHhcccCCCCcccCCCCCCCCcceeeeEEEeCCCCeEEEEEecCCccccc---Cch---------
Q 001988           24 AASNISTDQQALLALKDHITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGT---IPP---------   91 (985)
Q Consensus        24 ~~~~~~~~~~aLl~~k~~~~~~~~~~~~s~w~~~~~~c~w~gv~c~~~~~~v~~l~L~~~~l~g~---~~~---------   91 (985)
                      ++...++|++||++||+++. ||. .+++ |+.++|||+|.||+|+  ++||+.|||++++++|.   +|+         
T Consensus         6 ~~~~~~~~~~all~~k~~~~-~~~-~l~~-W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~   80 (768)
T 3rgz_A            6 PSQSLYREIHQLISFKDVLP-DKN-LLPD-WSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLE   80 (768)
T ss_dssp             --CCHHHHHHHHHHHHTTCS-CTT-SSTT-CCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCC
T ss_pred             cccCCHHHHHHHHHHHhhCC-Ccc-cccC-CCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccc
Confidence            33445889999999999997 887 7776 9888899999999999  68999999999999987   554         


Q ss_pred             --------------hcccccccceecccCCcCCCCCCc--ccccCCCCcEEEccCcccCCCCcccc-ccCCccceeeecc
Q 001988           92 --------------EIANLSSLKSLDLSHNKLSSNIPS--SIFTMSTLKVLYLMDNQLSGSLSSFT-FNTSSILDIRLSK  154 (985)
Q Consensus        92 --------------~l~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~n~l~~~~~~~~-~~~~~L~~L~ls~  154 (985)
                                    .++++++|++|||++|.++|.+|.  .++++++|++|+|++|.+++.+|..+ .++++|++|++++
T Consensus        81 ~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~  160 (768)
T 3rgz_A           81 SLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA  160 (768)
T ss_dssp             EEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCS
T ss_pred             ccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCC
Confidence                          567778888888888888888888  88888888888888888888777665 6788888888888


Q ss_pred             ccccCCCChhH--hhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccC
Q 001988          155 NKLSGKLPENI--CNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHG  232 (985)
Q Consensus       155 n~l~g~lp~~~--~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  232 (985)
                      |++++..|..+  +.++++|++|++++|.+++.+|.  +++++|++|+|++|++++.+|. ++++++|++|++++|++++
T Consensus       161 n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~  237 (768)
T 3rgz_A          161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSG  237 (768)
T ss_dssp             SCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCS
T ss_pred             CccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCC
Confidence            88887777653  46788888888888888876654  7888899999999999887777 8889999999999999998


Q ss_pred             CchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCcccc
Q 001988          233 EIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSIT  312 (985)
Q Consensus       233 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  312 (985)
                      .+|..++.+++|++|++++|++++.+|..  .+++|++|+|++|++++.+|..++..+++|++|+|++|++++.+|..++
T Consensus       238 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~  315 (768)
T 3rgz_A          238 DFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG  315 (768)
T ss_dssp             CHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGG
T ss_pred             cccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHh
Confidence            88999999999999999999888877765  7888888888888888888887765568888888888888888888888


Q ss_pred             CCCCccEEEccCcccccccCCc-ccCCCCCceEeccCCcccCCCC-cccc-------------------cccccc--cCc
Q 001988          313 NASKLILLEMGSNSFSGFIPSA-IGNLRNLKLFDIFFNNLTSSTP-ELGF-------------------LSSLAN--CKK  369 (985)
Q Consensus       313 ~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~~-~~~~-------------------~~~l~~--l~~  369 (985)
                      ++++|++|++++|++++.+|.. ++++++|++|++++|++++..+ .+..                   +..+..  +++
T Consensus       316 ~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~  395 (768)
T 3rgz_A          316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT  395 (768)
T ss_dssp             GCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCC
T ss_pred             cCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCC
Confidence            8888888888888888777765 7888888888888888763322 2110                   011122  567


Q ss_pred             ccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecc
Q 001988          370 LRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLA  449 (985)
Q Consensus       370 L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  449 (985)
                      |++|++++|++++.+|..+..++ +|+.|++++|.+++.+|..+..+++|++|++++|++++.+|..|..+++|++|+++
T Consensus       396 L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~  474 (768)
T 3rgz_A          396 LQELYLQNNGFTGKIPPTLSNCS-ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD  474 (768)
T ss_dssp             CCEEECCSSEEEEECCGGGGGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred             ccEEECCCCccccccCHHHhcCC-CCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEec
Confidence            88888888888888888888887 89999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCc
Q 001988          450 FNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPI  529 (985)
Q Consensus       450 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~  529 (985)
                      +|++++.+|..+..+++|++|+|++|++++.+|..++.+++|++|+|++|++++.+|..+.++++|++|++++|++.+.+
T Consensus       475 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~i  554 (768)
T 3rgz_A          475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI  554 (768)
T ss_dssp             SSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBC
T ss_pred             CCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998766


Q ss_pred             ccc----------------------------------------------------------------------ccCCCcc
Q 001988          530 SLA----------------------------------------------------------------------IGNLKAV  539 (985)
Q Consensus       530 ~~~----------------------------------------------------------------------~~~l~~L  539 (985)
                      |..                                                                      ++.+++|
T Consensus       555 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L  634 (768)
T 3rgz_A          555 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM  634 (768)
T ss_dssp             CGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCC
T ss_pred             ChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccc
Confidence            643                                                                      3446789


Q ss_pred             cEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccc
Q 001988          540 VGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFN  619 (985)
Q Consensus       540 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  619 (985)
                      +.|||++|+++|.+|..|+++++|+.|+|++|+++|.+|..|+++++|++|||++|+++|.+|..+..+++|++||+++|
T Consensus       635 ~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N  714 (768)
T 3rgz_A          635 MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN  714 (768)
T ss_dssp             CEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSS
T ss_pred             cEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCCCcccccccccCCccccCCCCCCCCCCCCCCCCcc
Q 001988          620 KLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPCKHSQPRAQ  664 (985)
Q Consensus       620 ~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~~~~~~~~~  664 (985)
                      +++|.||.+++|.++...+|.||+++||.|+   ++|.......+
T Consensus       715 ~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l---~~C~~~~~~~~  756 (768)
T 3rgz_A          715 NLSGPIPEMGQFETFPPAKFLNNPGLCGYPL---PRCDPSNADGY  756 (768)
T ss_dssp             EEEEECCSSSSGGGSCGGGGCSCTEEESTTS---CCCCSCC----
T ss_pred             cccccCCCchhhccCCHHHhcCCchhcCCCC---cCCCCCccCCC
Confidence            9999999999999999999999999999984   48976655443

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.4e-69  Score=672.99  Aligned_cols=540  Identities=34%  Similarity=0.498  Sum_probs=436.3

Q ss_pred             CeEEEEEecCCcccccCch--hcccccccceecccCCcCCCCCCccc-ccCCCCcEEEccCcccCCCCccc---cccCCc
Q 001988           73 HKVTTLNLSSFNLQGTIPP--EIANLSSLKSLDLSHNKLSSNIPSSI-FTMSTLKVLYLMDNQLSGSLSSF---TFNTSS  146 (985)
Q Consensus        73 ~~v~~l~L~~~~l~g~~~~--~l~~l~~L~~L~L~~n~l~~~~p~~~-~~l~~L~~L~Ls~n~l~~~~~~~---~~~~~~  146 (985)
                      .+++.|||++|+++|.+|.  .++++++|++|||++|.+++.+|..+ .++++|++|+|++|++++..+..   +.++++
T Consensus       100 ~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~  179 (768)
T 3rgz_A          100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE  179 (768)
T ss_dssp             TTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTT
T ss_pred             CCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCC
Confidence            3688999999999999998  99999999999999999999999876 78899999999999988777665   555555


Q ss_pred             cceeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccc-------
Q 001988          147 ILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTV-------  219 (985)
Q Consensus       147 L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-------  219 (985)
                      |++|++++|.+++.+|.   ..+++|++|+|++|.+++.+|. ++++++|++|+|++|++++.+|..++++++       
T Consensus       180 L~~L~Ls~n~l~~~~~~---~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls  255 (768)
T 3rgz_A          180 LKHLAISGNKISGDVDV---SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNIS  255 (768)
T ss_dssp             CCEEECCSSEEESCCBC---TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECC
T ss_pred             CCEEECCCCcccccCCc---ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECC
Confidence            66666666555554443   3455555555555555544444 555555555555555555555555555444       


Q ss_pred             ---------------cceEeeccccccCCchhhhcCC-CCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCC
Q 001988          220 ---------------LQRISLINNKLHGEIPQEIGYL-QNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLP  283 (985)
Q Consensus       220 ---------------L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p  283 (985)
                                     |++|++++|+++|.+|..+..+ ++|++|+|++|++++.+|..+.++++|++|+|++|+++|.+|
T Consensus       256 ~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip  335 (768)
T 3rgz_A          256 SNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP  335 (768)
T ss_dssp             SSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred             CCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCC
Confidence                           4455555555555666666554 777777777777777777777777777777777777777777


Q ss_pred             hhhhhcCCCCcEEEecCccCCCcCCccccCCC-CccEEEccCcccccccCCcccC--CCCCceEeccCCcccCCCCcccc
Q 001988          284 SRIDLALPNLEFLNLGINSFSGTIPSSITNAS-KLILLEMGSNSFSGFIPSAIGN--LRNLKLFDIFFNNLTSSTPELGF  360 (985)
Q Consensus       284 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~--l~~L~~L~L~~N~l~~~~~~~~~  360 (985)
                      ...+..+++|++|+|++|++++.+|..+.+++ +|+.|++++|++++.+|..+..  +++|++|++++|++++..+    
T Consensus       336 ~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p----  411 (768)
T 3rgz_A          336 MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP----  411 (768)
T ss_dssp             HHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECC----
T ss_pred             HHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccC----
Confidence            76556777777777777777777777777766 7777777777777777776666  6777777777777765433    


Q ss_pred             cccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCcccccc
Q 001988          361 LSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGL  440 (985)
Q Consensus       361 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  440 (985)
                       ..+.++++|++|++++|++++.+|..+..++ +|+.|++++|.+++.+|..+..+++|++|+|++|++++.+|.+|.++
T Consensus       412 -~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l  489 (768)
T 3rgz_A          412 -PTLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC  489 (768)
T ss_dssp             -GGGGGCTTCCEEECCSSEEESCCCGGGGGCT-TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred             -HHHhcCCCCCEEECcCCcccCcccHHHhcCC-CCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcC
Confidence             3578889999999999999999999999887 89999999999999999999999999999999999999999999999


Q ss_pred             ccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCC------------
Q 001988          441 QKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPST------------  508 (985)
Q Consensus       441 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~------------  508 (985)
                      ++|++|+|++|++++.+|..++.+++|++|+|++|++++.+|..+.++++|++|++++|++++.+|..            
T Consensus       490 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~  569 (768)
T 3rgz_A          490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANF  569 (768)
T ss_dssp             TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCST
T ss_pred             CCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhc
Confidence            99999999999999999999999999999999999999999999999999999999999988766643            


Q ss_pred             ----------------------------------------------------------ccCccceeEEeecCCcccCCcc
Q 001988          509 ----------------------------------------------------------FWNLKDILSFDISSNLLDGPIS  530 (985)
Q Consensus       509 ----------------------------------------------------------~~~l~~L~~L~ls~N~l~~~~~  530 (985)
                                                                                |..+++|+.||+++|++++.+|
T Consensus       570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip  649 (768)
T 3rgz_A          570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIP  649 (768)
T ss_dssp             TCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCC
T ss_pred             cccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCC
Confidence                                                                      4446789999999999999999


Q ss_pred             ccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcccccccc
Q 001988          531 LAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSY  610 (985)
Q Consensus       531 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  610 (985)
                      ..+++++.|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..++++++|++|||++|+++|.+|.. ..+.+
T Consensus       650 ~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~  728 (768)
T 3rgz_A          650 KEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFET  728 (768)
T ss_dssp             GGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGG
T ss_pred             HHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999975 45566


Q ss_pred             cccccccccc-ccC
Q 001988          611 LKELNLSFNK-LKG  623 (985)
Q Consensus       611 L~~L~ls~N~-l~~  623 (985)
                      +....+.+|+ |.|
T Consensus       729 ~~~~~~~gN~~Lcg  742 (768)
T 3rgz_A          729 FPPAKFLNNPGLCG  742 (768)
T ss_dssp             SCGGGGCSCTEEES
T ss_pred             CCHHHhcCCchhcC
Confidence            7777888886 555

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.1e-63  Score=614.57  Aligned_cols=575  Identities=23%  Similarity=0.231  Sum_probs=492.4

Q ss_pred             CeEEEEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeee
Q 001988           73 HKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRL  152 (985)
Q Consensus        73 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l  152 (985)
                      .+++.|||++|++++..+..+.++++|++|+|++|.+++..|..++++++|++|+|++|++++..+..+.++++|++|++
T Consensus        25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  104 (680)
T 1ziw_A           25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL  104 (680)
T ss_dssp             TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence            46889999999999877778999999999999999999888889999999999999999999877778889999999999


Q ss_pred             ccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccc--cccccceEeeccccc
Q 001988          153 SKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIG--NLTVLQRISLINNKL  230 (985)
Q Consensus       153 s~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~N~l  230 (985)
                      ++|++++ +|+..++++++|++|+|++|.+++..|..++++++|++|+|++|.+++..|..++  .+++|++|++++|++
T Consensus       105 ~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l  183 (680)
T 1ziw_A          105 MSNSIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI  183 (680)
T ss_dssp             CSSCCCC-CCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred             CCCccCc-cChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence            9999974 5544457899999999999999988888899999999999999999987777665  458899999999999


Q ss_pred             cCCchhhhcCCCCCCEEEecCCcCcccCccccc---CCCCCCEEEccCCcCcccCChhhhhcC--CCCcEEEecCccCCC
Q 001988          231 HGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIF---NMSTLKEIFLYNNSLSGSLPSRIDLAL--PNLEFLNLGINSFSG  305 (985)
Q Consensus       231 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~---~l~~L~~L~L~~N~l~~~~p~~~~~~l--~~L~~L~Ls~N~l~~  305 (985)
                      ++..|..++.+++|+.|++++|.+.+.....+.   ..++|++|++++|++++..|..+. .+  ++|+.|+|++|++++
T Consensus       184 ~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~-~l~~~~L~~L~Ls~n~l~~  262 (680)
T 1ziw_A          184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL-GLKWTNLTMLDLSYNNLNV  262 (680)
T ss_dssp             CCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTG-GGGGSCCCEEECTTSCCCE
T ss_pred             cccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhh-ccCcCCCCEEECCCCCcCc
Confidence            988888999999999999999887754332221   357899999999999977666543 44  459999999999999


Q ss_pred             cCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCccccc----ccccccCcccEEEecCCCCC
Q 001988          306 TIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFL----SSLANCKKLRYLGLGGNPLD  381 (985)
Q Consensus       306 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~----~~l~~l~~L~~L~L~~N~l~  381 (985)
                      ..|..++.+++|++|++++|++++..|..++++++|+.|++++|..........+.    ..+..+++|++|++++|.+.
T Consensus       263 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~  342 (680)
T 1ziw_A          263 VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP  342 (680)
T ss_dssp             ECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBC
T ss_pred             cCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccC
Confidence            88999999999999999999999999999999999999999987654321100011    14778999999999999999


Q ss_pred             ccCCCCccchhhcccceecccccccc--ccCCcCCCC--CCccEEEccCCCCCCCCCccccccccccceecccccccCCc
Q 001988          382 GFLPSSIGNLSLSLERLNIAFCNISG--NIPKAIGNL--SNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSI  457 (985)
Q Consensus       382 ~~~p~~~~~l~~~L~~L~L~~n~l~~--~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  457 (985)
                      +..|..+..++ +|++|++++|.++.  ..+..|..+  ++|++|++++|++++..|.+|..+++|+.|++++|.+.+.+
T Consensus       343 ~~~~~~~~~l~-~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  421 (680)
T 1ziw_A          343 GIKSNMFTGLI-NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL  421 (680)
T ss_dssp             CCCTTTTTTCT-TCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEEC
T ss_pred             CCChhHhcccc-CCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCcccc
Confidence            98888898887 89999999998543  333445443  58999999999999999999999999999999999998766


Q ss_pred             h-hhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceee--eecCCCccCccceeEEeecCCcccCCcccccc
Q 001988          458 P-DEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFT--FVIPSTFWNLKDILSFDISSNLLDGPISLAIG  534 (985)
Q Consensus       458 p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~  534 (985)
                      | ..+..+++|++|++++|++++..+..|..+++|+.|++++|.++  +..|..|.++++|+.|++++|+++++.+..|.
T Consensus       422 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~  501 (680)
T 1ziw_A          422 TGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLE  501 (680)
T ss_dssp             CSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             CcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhc
Confidence            5 68899999999999999999999999999999999999999987  46889999999999999999999999999999


Q ss_pred             CCCcccEEEccCCccCccCc--------hhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcccc
Q 001988          535 NLKAVVGIDLSRNNLSGNIP--------TTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFE  606 (985)
Q Consensus       535 ~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  606 (985)
                      .+++|+.|+|++|++++..+        ..|.++++|++|+|++|+++...+..|.++++|+.|||++|+|++..+..|.
T Consensus       502 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~  581 (680)
T 1ziw_A          502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFN  581 (680)
T ss_dssp             TCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             cccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhC
Confidence            99999999999999986522        2478899999999999999976667799999999999999999987777889


Q ss_pred             ccccccccccccccccCCCCCCC--CCcccccccccCCccccCCCC
Q 001988          607 KLSYLKELNLSFNKLKGEIPRGG--PFANFTAESFMGNELLCGLPN  650 (985)
Q Consensus       607 ~l~~L~~L~ls~N~l~~~~p~~~--~~~~~~~~~~~~n~~lc~~~~  650 (985)
                      .+++|+.|++++|++++.+|...  .+.++....+.+||+.|+++.
T Consensus       582 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          582 NQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             TCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             CCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            99999999999999999877531  456777888999999999874

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=5.1e-60  Score=581.80  Aligned_cols=556  Identities=24%  Similarity=0.265  Sum_probs=490.7

Q ss_pred             EEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeecccc
Q 001988           77 TLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNK  156 (985)
Q Consensus        77 ~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~  156 (985)
                      .+|.++++++ .+|..+.  +++++|+|++|.+++..|..|.++++|++|+|++|.+++..|..+.++++|++|+|++|+
T Consensus         8 ~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~   84 (680)
T 1ziw_A            8 VADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE   84 (680)
T ss_dssp             EEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSC
T ss_pred             eeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCc
Confidence            4677777887 6887665  799999999999998777889999999999999999999999999999999999999999


Q ss_pred             ccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchh
Q 001988          157 LSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQ  236 (985)
Q Consensus       157 l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  236 (985)
                      ++ .+|+..++++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..++++++|++|++++|++++..|.
T Consensus        85 l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  163 (680)
T 1ziw_A           85 LS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE  163 (680)
T ss_dssp             CC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred             cC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence            99 67877668999999999999999977778999999999999999999999999999999999999999999988888


Q ss_pred             hhc--CCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhh--hcCCCCcEEEecCccCCCcCCcccc
Q 001988          237 EIG--YLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRID--LALPNLEFLNLGINSFSGTIPSSIT  312 (985)
Q Consensus       237 ~~~--~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~  312 (985)
                      .++  .+++|++|++++|++++..|..+..+.+|+.|++++|++.+.....+.  ...++|+.|++++|++++..|..+.
T Consensus       164 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~  243 (680)
T 1ziw_A          164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL  243 (680)
T ss_dssp             HHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTG
T ss_pred             HhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhh
Confidence            765  568999999999999999999999999999999999998754333221  1358999999999999999999999


Q ss_pred             CCCC--ccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCcc-----CC
Q 001988          313 NASK--LILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGF-----LP  385 (985)
Q Consensus       313 ~l~~--L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~-----~p  385 (985)
                      ++..  |+.|++++|++++..|..++.+++|++|++++|++++..+.     .+.++++|++|++++|...+.     +|
T Consensus       244 ~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L~~~~~~~~~~~~~lp  318 (680)
T 1ziw_A          244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH-----SLHGLFNVRYLNLKRSFTKQSISLASLP  318 (680)
T ss_dssp             GGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTT-----TTTTCTTCCEEECTTCBCCC------CC
T ss_pred             ccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChh-----hhcCCCCccEEeccchhhhccccccccc
Confidence            8865  99999999999999999999999999999999999876553     478899999999998866542     23


Q ss_pred             C----CccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCC--CCCcccccc--ccccceecccccccCCc
Q 001988          386 S----SIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSG--SIPVTFGGL--QKLQGLDLAFNKLAGSI  457 (985)
Q Consensus       386 ~----~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l--~~L~~L~Ls~N~l~~~~  457 (985)
                      .    .+..++ +|++|++++|.+++..+..|..+++|++|++++|.+..  ..+..|..+  ++|+.|++++|++++..
T Consensus       319 ~i~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~  397 (680)
T 1ziw_A          319 KIDDFSFQWLK-CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIE  397 (680)
T ss_dssp             EECTTTTTTCT-TCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEEC
T ss_pred             ccChhhcccCC-CCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEC
Confidence            2    566666 89999999999999999999999999999999998653  233455544  58999999999999998


Q ss_pred             hhhhhhccCCCeEEccCCccccccC-CCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCccc--CCcccccc
Q 001988          458 PDEICLLSRLNELDLNGNKISGSIS-SCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLD--GPISLAIG  534 (985)
Q Consensus       458 p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~--~~~~~~~~  534 (985)
                      |..+..+++|+.|+|++|++++.+| ..|.++++|++|++++|++++..+..|..+++|+.|++++|.+.  +..|..+.
T Consensus       398 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~  477 (680)
T 1ziw_A          398 SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ  477 (680)
T ss_dssp             TTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTT
T ss_pred             hhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccc
Confidence            9999999999999999999987666 68999999999999999999999999999999999999999987  56788999


Q ss_pred             CCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchh--------hhhhcccccCeEecCCCcccCCCCcccc
Q 001988          535 NLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIP--------ESFGNMTSLESLDLSNNKISGSIPVSFE  606 (985)
Q Consensus       535 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  606 (985)
                      ++++|+.|+|++|+|++..|..|.++++|++|+|++|++++..+        ..|.++++|++|+|++|+++...+..|.
T Consensus       478 ~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~  557 (680)
T 1ziw_A          478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFK  557 (680)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             cCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcc
Confidence            99999999999999999888899999999999999999997532        2388999999999999999965556799


Q ss_pred             ccccccccccccccccCCCCCC-CCCcccccccccCC
Q 001988          607 KLSYLKELNLSFNKLKGEIPRG-GPFANFTAESFMGN  642 (985)
Q Consensus       607 ~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~n  642 (985)
                      .+++|+.|++++|++++.+|.. ..+.++....+.+|
T Consensus       558 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N  594 (680)
T 1ziw_A          558 DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN  594 (680)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             cccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCC
Confidence            9999999999999999766543 34456666666666

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=9.7e-61  Score=579.99  Aligned_cols=511  Identities=18%  Similarity=0.258  Sum_probs=291.0

Q ss_pred             hhHHHHHHHHHHhcccCCCCccc------CCCCCCCCccee---eeEEEeCCCCeEEEEEecCCcccccCchhccccccc
Q 001988           29 STDQQALLALKDHITYDPTNLLG------TNWTSNASICSW---IGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSL   99 (985)
Q Consensus        29 ~~~~~aLl~~k~~~~~~~~~~~~------s~w~~~~~~c~w---~gv~c~~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L   99 (985)
                      ..|++||.+||+++..+++...+      .+|+.+++||.|   .||+|+.. +||+.|+|++++++|.+|+++++|++|
T Consensus        29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~~L  107 (636)
T 4eco_A           29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTEL  107 (636)
T ss_dssp             HHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCTTC
T ss_pred             HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCccc
Confidence            47999999999998644332111      259989999999   99999865 899999999999999999999999999


Q ss_pred             ceecccCCcC------CC------CCCcccccCCCCcEEEccCcccCCCCcccccc-CCccceeeeccccccCCCChhHh
Q 001988          100 KSLDLSHNKL------SS------NIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFN-TSSILDIRLSKNKLSGKLPENIC  166 (985)
Q Consensus       100 ~~L~L~~n~l------~~------~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-~~~L~~L~ls~n~l~g~lp~~~~  166 (985)
                      ++|||++|.+      .|      .+|...  +..|+ +++++|.+.+.++..+.. +..+..+++....+..       
T Consensus       108 ~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~-------  177 (636)
T 4eco_A          108 EVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK-------  177 (636)
T ss_dssp             CEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC-------
T ss_pred             eEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc-------
Confidence            9999999987      33      344443  44555 666666665554443321 1122222222222210       


Q ss_pred             hhccccceeccc--CccccccCCcccCCCCCceEEEcccccCCCc-----------------cccccc--cccccceEee
Q 001988          167 NHLRYLKHLFLR--ENMFYGKIPSSLSKCKQLQELHLGYNNLSGA-----------------IPKEIG--NLTVLQRISL  225 (985)
Q Consensus       167 ~~l~~L~~L~L~--~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~L  225 (985)
                      .....++.+.+.  .|+++| +|+.|+++++|++|+|++|+++|.                 +|+.++  ++++|++|+|
T Consensus       178 ~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L  256 (636)
T 4eco_A          178 SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEV  256 (636)
T ss_dssp             CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEE
T ss_pred             ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEe
Confidence            011122223332  456665 666666666666666666666654                 555555  5555555555


Q ss_pred             ccccccCCchhhhcCCCCCCEEEecCCc-Ccc-cCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccC
Q 001988          226 INNKLHGEIPQEIGYLQNLDVLQLGFNN-LTG-VVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSF  303 (985)
Q Consensus       226 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l  303 (985)
                      ++|++.|.+|+.|+++++|++|++++|+ ++| .+|..++++.                   -+..+++|++|+|++|++
T Consensus       257 ~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~-------------------~~~~l~~L~~L~L~~n~l  317 (636)
T 4eco_A          257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA-------------------DAPVGEKIQIIYIGYNNL  317 (636)
T ss_dssp             ECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHH-------------------HSGGGGTCCEEECCSSCC
T ss_pred             cCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhh-------------------ccccCCCCCEEECCCCcC
Confidence            5555555555555555555555555555 555 5555554430                   000124455555555555


Q ss_pred             CCcCCc--cccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCc-ccEEEecCCCC
Q 001988          304 SGTIPS--SITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKK-LRYLGLGGNPL  380 (985)
Q Consensus       304 ~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~-L~~L~L~~N~l  380 (985)
                      + .+|.  .++++++|+.|++++|+++|.+| .++.+++|++|++++|+++.++.      .+.++++ |++|++++|++
T Consensus       318 ~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp~------~l~~l~~~L~~L~Ls~N~l  389 (636)
T 4eco_A          318 K-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPA------NFCGFTEQVENLSFAHNKL  389 (636)
T ss_dssp             S-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEECCT------TSEEECTTCCEEECCSSCC
T ss_pred             C-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccccccH------hhhhhcccCcEEEccCCcC
Confidence            4 4454  55555555555555555555555 55555555555555555542221      1333444 44444444444


Q ss_pred             CccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCcccc-------ccccccceecccccc
Q 001988          381 DGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFG-------GLQKLQGLDLAFNKL  453 (985)
Q Consensus       381 ~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~Ls~N~l  453 (985)
                      + .+|..+...                       .+++|++|++++|++++..|..|.       .+++|++|+|++|++
T Consensus       390 ~-~lp~~~~~~-----------------------~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l  445 (636)
T 4eco_A          390 K-YIPNIFDAK-----------------------SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQI  445 (636)
T ss_dssp             S-SCCSCCCTT-----------------------CSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCC
T ss_pred             c-ccchhhhhc-----------------------ccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCcc
Confidence            4 233222211                       122555555555555555555555       555666666666666


Q ss_pred             cCCchhhhhhccCCCeEEccCCccccccCCCCcCc-------CcCceEeeccceeeeecCCCcc--CccceeEEeecCCc
Q 001988          454 AGSIPDEICLLSRLNELDLNGNKISGSISSCLGNL-------TSLQYLNLGSNRFTFVIPSTFW--NLKDILSFDISSNL  524 (985)
Q Consensus       454 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~ls~N~  524 (985)
                      ++..+..+..+++|++|+|++|+++...+..+...       ++|++|+|++|+++ .+|..+.  .+++|+.|++++|+
T Consensus       446 ~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~  524 (636)
T 4eco_A          446 SKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNS  524 (636)
T ss_dssp             CSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSC
T ss_pred             CcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCC
Confidence            63333334446666666666666663222223222       25555555555555 2333333  44444444444444


Q ss_pred             ccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcc
Q 001988          525 LDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS  604 (985)
Q Consensus       525 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  604 (985)
                      +++ +|..+..+++|+.|+|++|+                  ++++|++.+.+|..+.++++|++|+|++|+| +.+|..
T Consensus       525 l~~-ip~~~~~l~~L~~L~Ls~N~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~  584 (636)
T 4eco_A          525 FSK-FPTQPLNSSTLKGFGIRNQR------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK  584 (636)
T ss_dssp             CSS-CCCGGGGCSSCCEEECCSCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC
T ss_pred             CCC-cChhhhcCCCCCEEECCCCc------------------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh
Confidence            444 33344444444444443333                  2356667777777777777777777777777 466666


Q ss_pred             ccccccccccccccccccCCC
Q 001988          605 FEKLSYLKELNLSFNKLKGEI  625 (985)
Q Consensus       605 ~~~l~~L~~L~ls~N~l~~~~  625 (985)
                      +.  ++|+.||+++|++...-
T Consensus       585 ~~--~~L~~L~Ls~N~l~~~~  603 (636)
T 4eco_A          585 IT--PNISVLDIKDNPNISID  603 (636)
T ss_dssp             CC--TTCCEEECCSCTTCEEE
T ss_pred             Hh--CcCCEEECcCCCCcccc
Confidence            55  67777788877776433

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=2.5e-59  Score=567.86  Aligned_cols=534  Identities=21%  Similarity=0.236  Sum_probs=462.4

Q ss_pred             EEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeecccc
Q 001988           77 TLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNK  156 (985)
Q Consensus        77 ~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~  156 (985)
                      .+|.++.+++ .+|..+..  .+++|||++|.+++..|..|+++++|++|+|++|++++..|..+..+++|++|++++|+
T Consensus        16 ~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~   92 (606)
T 3t6q_A           16 TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP   92 (606)
T ss_dssp             EEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             eEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence            3455666666 67776653  78999999999998888899999999999999999999889999999999999999999


Q ss_pred             ccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchh
Q 001988          157 LSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQ  236 (985)
Q Consensus       157 l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  236 (985)
                      +++..|..+ +++++|++|+|++|.+++..|..++++++|++|+|++|++++..+..+..+++|++|++++|++++..|.
T Consensus        93 l~~~~~~~~-~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  171 (606)
T 3t6q_A           93 LIFMAETAL-SGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE  171 (606)
T ss_dssp             CSEECTTTT-SSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHH
T ss_pred             ccccChhhh-cccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChh
Confidence            997666655 7899999999999999977788899999999999999999975544555599999999999999988899


Q ss_pred             hhcCCCCCC--EEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCc-----CCc
Q 001988          237 EIGYLQNLD--VLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGT-----IPS  309 (985)
Q Consensus       237 ~~~~l~~L~--~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~-----~p~  309 (985)
                      .|+.+++|+  .|++++|++++..|..+.. .+|++|++++|..   ++. .+..+.++....+..+.+.+.     .+.
T Consensus       172 ~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~---~~~-~~~~l~~~~l~~l~~~~~~~~~~~~i~~~  246 (606)
T 3t6q_A          172 DMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQN---LLV-IFKGLKNSTIQSLWLGTFEDMDDEDISPA  246 (606)
T ss_dssp             HHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSC---HHH-HHHHTTTCEEEEEECCCCTTSCCCCCCGG
T ss_pred             hhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchh---HHH-HhhhccccchhheechhhccccccccChh
Confidence            999999999  8999999999877776554 6899999999872   222 233556666555554443321     122


Q ss_pred             cccCCC--CccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCC
Q 001988          310 SITNAS--KLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSS  387 (985)
Q Consensus       310 ~~~~l~--~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~  387 (985)
                      .+..+.  +|+.|++++|.+++..+..|+.+++|++|++++|+++.++.      .+.++++|++|++++|++.+..|..
T Consensus       247 ~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~------~l~~l~~L~~L~l~~n~l~~~~~~~  320 (606)
T 3t6q_A          247 VFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPS------GLVGLSTLKKLVLSANKFENLCQIS  320 (606)
T ss_dssp             GGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCS------SCCSCTTCCEEECTTCCCSBGGGGC
T ss_pred             HhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCCh------hhcccccCCEEECccCCcCcCchhh
Confidence            333332  78999999999999888889999999999999999987654      3678899999999999999888888


Q ss_pred             ccchhhcccceeccccccccccCC-cCCCCCCccEEEccCCCCCCCC--CccccccccccceecccccccCCchhhhhhc
Q 001988          388 IGNLSLSLERLNIAFCNISGNIPK-AIGNLSNLIVLSLGGNNLSGSI--PVTFGGLQKLQGLDLAFNKLAGSIPDEICLL  464 (985)
Q Consensus       388 ~~~l~~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  464 (985)
                      +..++ +|++|++++|.+.+.+|. .+..+++|++|++++|++++..  +..+.++++|++|++++|++.+..|..+..+
T Consensus       321 ~~~l~-~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  399 (606)
T 3t6q_A          321 ASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKEC  399 (606)
T ss_dssp             GGGCT-TCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTC
T ss_pred             hhccC-cCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCC
Confidence            88887 899999999999866654 5899999999999999998776  7889999999999999999998889999999


Q ss_pred             cCCCeEEccCCccccccCC-CCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCC---ccccccCCCccc
Q 001988          465 SRLNELDLNGNKISGSISS-CLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGP---ISLAIGNLKAVV  540 (985)
Q Consensus       465 ~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~---~~~~~~~l~~L~  540 (985)
                      ++|++|++++|++++..+. .+.++++|++|++++|.+++..|..|..+++|++|++++|++.+.   .+..+..+++|+
T Consensus       400 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~  479 (606)
T 3t6q_A          400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE  479 (606)
T ss_dssp             TTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCC
T ss_pred             ccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCcc
Confidence            9999999999999987665 489999999999999999999999999999999999999999872   335789999999


Q ss_pred             EEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcccccccccccccccccc
Q 001988          541 GIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNK  620 (985)
Q Consensus       541 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~  620 (985)
                      .|++++|++++..|..|+.+++|++|+|++|++++..|..|.++++| .|+|++|++++.+|..+..+++|+.|++++|+
T Consensus       480 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  558 (606)
T 3t6q_A          480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNP  558 (606)
T ss_dssp             EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCC
T ss_pred             EEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCC
Confidence            99999999999999999999999999999999999999999999999 99999999999999999999999999999999


Q ss_pred             ccCCCCC
Q 001988          621 LKGEIPR  627 (985)
Q Consensus       621 l~~~~p~  627 (985)
                      +++.++.
T Consensus       559 ~~c~c~~  565 (606)
T 3t6q_A          559 LDCTCSN  565 (606)
T ss_dssp             EECSGGG
T ss_pred             ccccCCc
Confidence            9988774

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.6e-58  Score=560.74  Aligned_cols=529  Identities=21%  Similarity=0.225  Sum_probs=456.7

Q ss_pred             EEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeecccc
Q 001988           77 TLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNK  156 (985)
Q Consensus        77 ~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~  156 (985)
                      .++.++++++ .+|..+.  ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..+..+++|++|+|++|+
T Consensus        15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~   91 (606)
T 3vq2_A           15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP   91 (606)
T ss_dssp             EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence            5677788887 6777665  789999999999998777789999999999999999998888888899999999999999


Q ss_pred             ccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCC-ccccccccccccceEeeccccccCCch
Q 001988          157 LSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSG-AIPKEIGNLTVLQRISLINNKLHGEIP  235 (985)
Q Consensus       157 l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p  235 (985)
                      +++..|..+ +++++|++|+|++|.+++..|..++++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..|
T Consensus        92 l~~~~p~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~  170 (606)
T 3vq2_A           92 IQSFSPGSF-SGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV  170 (606)
T ss_dssp             CCCCCTTSS-TTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECT
T ss_pred             ccccChhhc-CCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecCh
Confidence            986666665 789999999999999987777889999999999999999986 578999999999999999999998888


Q ss_pred             hhhcCCCCCC----EEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCc-----
Q 001988          236 QEIGYLQNLD----VLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGT-----  306 (985)
Q Consensus       236 ~~~~~l~~L~----~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~-----  306 (985)
                      ..|+.+++|+    +|++++|++++..+..+... +|++|++++|.+++......+..+++|+.+++..+.+.+.     
T Consensus       171 ~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~  249 (606)
T 3vq2_A          171 NDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI  249 (606)
T ss_dssp             TTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSC
T ss_pred             hhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccc
Confidence            8888777665    89999999997666655544 8999999999987555555567889999999877665532     


Q ss_pred             ----CCccccCCCCccEEEc-cCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCC
Q 001988          307 ----IPSSITNASKLILLEM-GSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLD  381 (985)
Q Consensus       307 ----~p~~~~~l~~L~~L~L-~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~  381 (985)
                          .+..+..+ .++.+++ ..|.+.+.+|. +..+++|+.|++++|.+...+       .+..+++|++|++++|.+ 
T Consensus       250 ~~~~~~~~l~~l-~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~-------~l~~~~~L~~L~l~~n~l-  319 (606)
T 3vq2_A          250 FEPSIMEGLCDV-TIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE-------DVPKHFKWQSLSIIRCQL-  319 (606)
T ss_dssp             CCGGGGTTGGGS-EEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC-------CCCTTCCCSEEEEESCCC-
T ss_pred             cChHHhhhhhhc-cHhheeccccccccccccc-cccCCCCCEEEecCccchhhh-------hccccccCCEEEcccccC-
Confidence                12222222 5667777 78889988888 999999999999999998765       367889999999999999 


Q ss_pred             ccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCC--CCccccccccccceecccccccCCchh
Q 001988          382 GFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGS--IPVTFGGLQKLQGLDLAFNKLAGSIPD  459 (985)
Q Consensus       382 ~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~p~  459 (985)
                      +.+|. + .++ +|+.|++++|...+..  .+..+++|++|++++|++++.  .|..+..+++|++|++++|.+++ +|.
T Consensus       320 ~~lp~-~-~l~-~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~  393 (606)
T 3vq2_A          320 KQFPT-L-DLP-FLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSA  393 (606)
T ss_dssp             SSCCC-C-CCS-SCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECC
T ss_pred             ccccc-C-CCC-ccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chh
Confidence            67784 4 666 8999999999665444  678999999999999999876  37889999999999999999985 668


Q ss_pred             hhhhccCCCeEEccCCccccccC-CCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccC-CccccccCCC
Q 001988          460 EICLLSRLNELDLNGNKISGSIS-SCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDG-PISLAIGNLK  537 (985)
Q Consensus       460 ~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~~~~~~~l~  537 (985)
                      .+..+++|+.|++++|++++..| ..+.++++|++|++++|++++..|..|.++++|++|++++|++.+ ..|..+..++
T Consensus       394 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~  473 (606)
T 3vq2_A          394 NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTT  473 (606)
T ss_dssp             CCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCT
T ss_pred             hccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCC
Confidence            88999999999999999998877 689999999999999999999999999999999999999999998 5788899999


Q ss_pred             cccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccc-ccccccc
Q 001988          538 AVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLS-YLKELNL  616 (985)
Q Consensus       538 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~l  616 (985)
                      +|+.|+|++|++++..|..|+++++|++|+|++|++++.+|..|.++++|++|||++|+|+ .+|..+..++ +|++|++
T Consensus       474 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l  552 (606)
T 3vq2_A          474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNL  552 (606)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEc
Confidence            9999999999999999999999999999999999999988999999999999999999999 6777799997 5999999


Q ss_pred             ccccccCCCCC
Q 001988          617 SFNKLKGEIPR  627 (985)
Q Consensus       617 s~N~l~~~~p~  627 (985)
                      ++|++.+.++.
T Consensus       553 ~~N~~~c~c~~  563 (606)
T 3vq2_A          553 TNNSVACICEH  563 (606)
T ss_dssp             CSCCCCCSSTT
T ss_pred             cCCCcccCCcc
Confidence            99999988774

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=6.8e-58  Score=555.23  Aligned_cols=527  Identities=20%  Similarity=0.186  Sum_probs=461.7

Q ss_pred             eeeEEEeCC---------CCeEEEEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCccc
Q 001988           63 WIGIICDVN---------SHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQL  133 (985)
Q Consensus        63 w~gv~c~~~---------~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l  133 (985)
                      +.-|.|...         ...++.|||++|++++..|..++++++|++|+|++|.+++..|..|.++++|++|+|++|++
T Consensus        14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   93 (606)
T 3t6q_A           14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL   93 (606)
T ss_dssp             TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence            445778642         24689999999999988888999999999999999999998899999999999999999999


Q ss_pred             CCCCccccccCCccceeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccc
Q 001988          134 SGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKE  213 (985)
Q Consensus       134 ~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~  213 (985)
                      ++..|..+..+++|++|++++|++++..|.. ++++++|++|+|++|.+++..++.+..+++|++|+|++|++++..|..
T Consensus        94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  172 (606)
T 3t6q_A           94 IFMAETALSGPKALKHLFFIQTGISSIDFIP-LHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED  172 (606)
T ss_dssp             SEECTTTTSSCTTCCEEECTTSCCSCGGGSC-CTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred             cccChhhhcccccccEeeccccCcccCCcch-hccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence            9999999999999999999999999643444 488999999999999999754455556999999999999999888899


Q ss_pred             cccccccc--eEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcc----cCChhhh
Q 001988          214 IGNLTVLQ--RISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSG----SLPSRID  287 (985)
Q Consensus       214 ~~~l~~L~--~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~----~~p~~~~  287 (985)
                      ++.+++|+  .|++++|++++..|..+.. .+|+.|++++|.   .++..+..+..++...+.-+.+.+    .++...+
T Consensus       173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~  248 (606)
T 3t6q_A          173 MSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVF  248 (606)
T ss_dssp             HHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGG
T ss_pred             hhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhHh
Confidence            99999999  8999999999877777665 689999999997   345556666655544443333221    3334444


Q ss_pred             hcCC--CCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCccccccccc
Q 001988          288 LALP--NLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLA  365 (985)
Q Consensus       288 ~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~  365 (985)
                      ..+.  +|+.|++++|++++..+..|.++++|++|++++|+++ .+|..++++++|++|++++|+++...+.     .+.
T Consensus       249 ~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~-----~~~  322 (606)
T 3t6q_A          249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQI-----SAS  322 (606)
T ss_dssp             GGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGG-----CGG
T ss_pred             chhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchh-----hhh
Confidence            3443  7999999999999888888999999999999999998 6788899999999999999999876542     478


Q ss_pred             ccCcccEEEecCCCCCccCCCC-ccchhhcccceecccccccccc--CCcCCCCCCccEEEccCCCCCCCCCcccccccc
Q 001988          366 NCKKLRYLGLGGNPLDGFLPSS-IGNLSLSLERLNIAFCNISGNI--PKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQK  442 (985)
Q Consensus       366 ~l~~L~~L~L~~N~l~~~~p~~-~~~l~~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  442 (985)
                      ++++|++|++++|.+.+.+|.. +..++ +|++|++++|.+++..  +..+..+++|++|++++|++.+..|..|..+++
T Consensus       323 ~l~~L~~L~l~~n~~~~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  401 (606)
T 3t6q_A          323 NFPSLTHLSIKGNTKRLELGTGCLENLE-NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ  401 (606)
T ss_dssp             GCTTCSEEECCSCSSCCBCCSSTTTTCT-TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTT
T ss_pred             ccCcCCEEECCCCCcccccchhhhhccC-cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCcc
Confidence            8999999999999998777665 77776 8999999999999876  888999999999999999999999999999999


Q ss_pred             ccceecccccccCCchhh-hhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeee---cCCCccCccceeEE
Q 001988          443 LQGLDLAFNKLAGSIPDE-ICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFV---IPSTFWNLKDILSF  518 (985)
Q Consensus       443 L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~p~~~~~l~~L~~L  518 (985)
                      |+.|++++|++.+..|.. +..+++|++|++++|++++..|..+..+++|++|++++|++++.   .+..|..+++|+.|
T Consensus       402 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L  481 (606)
T 3t6q_A          402 LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL  481 (606)
T ss_dssp             CSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEE
T ss_pred             CCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEE
Confidence            999999999999876654 88999999999999999999999999999999999999999862   33678999999999


Q ss_pred             eecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCccc
Q 001988          519 DISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKIS  598 (985)
Q Consensus       519 ~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  598 (985)
                      ++++|++++..|..|..+++|+.|+|++|++++..|..|..+++| +|+|++|++++.+|..+..+++|+.|+|++|+++
T Consensus       482 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  560 (606)
T 3t6q_A          482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLD  560 (606)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEE
T ss_pred             ECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcc
Confidence            999999999999999999999999999999999999999999999 9999999999999999999999999999999998


Q ss_pred             CCCC
Q 001988          599 GSIP  602 (985)
Q Consensus       599 ~~~p  602 (985)
                      +..+
T Consensus       561 c~c~  564 (606)
T 3t6q_A          561 CTCS  564 (606)
T ss_dssp             CSGG
T ss_pred             ccCC
Confidence            7544

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=2e-57  Score=569.63  Aligned_cols=510  Identities=20%  Similarity=0.199  Sum_probs=328.5

Q ss_pred             cccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCC-ccccccCCccceeeeccccccCCCChhHhhhcccccee
Q 001988           97 SSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSL-SSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHL  175 (985)
Q Consensus        97 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L  175 (985)
                      ++|++|||++|.+++..|..|.++++|++|+|++|...+.+ |..+.++++|++|+|++|.+++..|..+ +++++|++|
T Consensus        24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L  102 (844)
T 3j0a_A           24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAF-QGLFHLFEL  102 (844)
T ss_dssp             TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSS-CSCSSCCCE
T ss_pred             CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHc-cCCcccCEe
Confidence            44555555555555444445555555555555555443333 3444445555555555555543333333 445555555


Q ss_pred             cccCccccccCCcc--cCCCCCceEEEcccccCCCccc-cccccccccceEeeccccccCCchhhhcCC--CCCCEEEec
Q 001988          176 FLRENMFYGKIPSS--LSKCKQLQELHLGYNNLSGAIP-KEIGNLTVLQRISLINNKLHGEIPQEIGYL--QNLDVLQLG  250 (985)
Q Consensus       176 ~L~~n~l~~~~p~~--l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls  250 (985)
                      +|++|.+++.+|..  |+++++|++|+|++|.+++..| ..|+++++|++|+|++|++++..|..++.+  ++|+.|+++
T Consensus       103 ~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~  182 (844)
T 3j0a_A          103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA  182 (844)
T ss_dssp             ECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEEC
T ss_pred             eCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECC
Confidence            55555555444443  5555555555555555554433 345555555555555555555555555544  455555555


Q ss_pred             CCcCcccCcccccCCCC------CCEEEccCCcCcccCChhhhhc--CCCCcEEEec---------CccCCCcCCccccC
Q 001988          251 FNNLTGVVPATIFNMST------LKEIFLYNNSLSGSLPSRIDLA--LPNLEFLNLG---------INSFSGTIPSSITN  313 (985)
Q Consensus       251 ~N~l~~~~p~~l~~l~~------L~~L~L~~N~l~~~~p~~~~~~--l~~L~~L~Ls---------~N~l~~~~p~~~~~  313 (985)
                      .|.+++..|..+..+.+      |++|++++|.+++.+|..+...  .++++.|.++         .|.+.+..+..+..
T Consensus       183 ~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~  262 (844)
T 3j0a_A          183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAG  262 (844)
T ss_dssp             CSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTT
T ss_pred             CCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhc
Confidence            55555555544444333      5555555555555444443322  2345555544         23333333444444


Q ss_pred             C--CCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccch
Q 001988          314 A--SKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNL  391 (985)
Q Consensus       314 l--~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l  391 (985)
                      +  ++|+.|++++|.+.+..|..++.+++|+.|++++|+++...+.     .+..+++|++|++++|++++..|..+..+
T Consensus       263 l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~-----~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  337 (844)
T 3j0a_A          263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADE-----AFYGLDNLQVLNLSYNLLGELYSSNFYGL  337 (844)
T ss_dssp             TTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTT-----TTTTCSSCCEEEEESCCCSCCCSCSCSSC
T ss_pred             cccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChH-----HhcCCCCCCEEECCCCCCCccCHHHhcCC
Confidence            3  5677777777777777777777777777777777777665443     35667777777777777777777777777


Q ss_pred             hhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEE
Q 001988          392 SLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELD  471 (985)
Q Consensus       392 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  471 (985)
                      + +|+.|++++|.+++..+..|..+++|++|+|++|.+++..     .+++|+.|++++|+++ .+|..   ..+++.|+
T Consensus       338 ~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~-----~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~  407 (844)
T 3j0a_A          338 P-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIH-----FIPSIPDIFLSGNKLV-TLPKI---NLTANLIH  407 (844)
T ss_dssp             T-TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCS-----SCCSCSEEEEESCCCC-CCCCC---CTTCCEEE
T ss_pred             C-CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCccc-----CCCCcchhccCCCCcc-ccccc---ccccceee
Confidence            6 6778888888777777777788888888888888877432     2677888888888887 44432   45677888


Q ss_pred             ccCCccccccC-CCCcCcCcCceEeeccceeeeecCC-CccCccceeEEeecCCccc-----CCccccccCCCcccEEEc
Q 001988          472 LNGNKISGSIS-SCLGNLTSLQYLNLGSNRFTFVIPS-TFWNLKDILSFDISSNLLD-----GPISLAIGNLKAVVGIDL  544 (985)
Q Consensus       472 L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~-----~~~~~~~~~l~~L~~L~L  544 (985)
                      +++|++++... ..+.++++|++|+|++|++++..+. .+..+++|+.|++++|.++     +..+..|.++++|+.|+|
T Consensus       408 ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~L  487 (844)
T 3j0a_A          408 LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL  487 (844)
T ss_dssp             CCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCC
T ss_pred             cccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEEC
Confidence            88888875322 1245777888888888888765443 4556778888888888876     344456888889999999


Q ss_pred             cCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCC
Q 001988          545 SRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGE  624 (985)
Q Consensus       545 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~  624 (985)
                      ++|+|++..|..|.++++|+.|+|++|+|++..|..+.  ++|+.|||++|+|++.+|..|.   +|+.|++++|++.+.
T Consensus       488 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np~~C~  562 (844)
T 3j0a_A          488 NHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICE  562 (844)
T ss_dssp             CHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---SCCEEEEEEECCCCS
T ss_pred             CCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC---CcCEEEecCCCcccc
Confidence            99999988888888999999999999999887776665  7899999999999988887764   678889999999887


Q ss_pred             CCC
Q 001988          625 IPR  627 (985)
Q Consensus       625 ~p~  627 (985)
                      ++-
T Consensus       563 c~~  565 (844)
T 3j0a_A          563 CEL  565 (844)
T ss_dssp             SSC
T ss_pred             ccc
Confidence            764

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=4.8e-58  Score=564.21  Aligned_cols=505  Identities=20%  Similarity=0.265  Sum_probs=351.3

Q ss_pred             ChhHHHHHHHHHHhcccCCCCcccCCCCCCC-----Cc--cee------------eeEEEeCCCCeEEEEEecCCccccc
Q 001988           28 ISTDQQALLALKDHITYDPTNLLGTNWTSNA-----SI--CSW------------IGIICDVNSHKVTTLNLSSFNLQGT   88 (985)
Q Consensus        28 ~~~~~~aLl~~k~~~~~~~~~~~~s~w~~~~-----~~--c~w------------~gv~c~~~~~~v~~l~L~~~~l~g~   88 (985)
                      ..+|++||++||+++. +|     + |+.+.     +|  |.|            .||+|+. ++||+.|+|++++++|.
T Consensus       267 ~~~d~~ALl~~k~~l~-~~-----~-W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~  338 (876)
T 4ecn_A          267 YIKDYKALKAIWEALD-GK-----N-WRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGR  338 (876)
T ss_dssp             HHHHHHHHHHHHHHTT-GG-----G-CCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEE
T ss_pred             chHHHHHHHHHHHHcC-CC-----C-CCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCc
Confidence            3579999999999995 65     2 65433     55  999            9999987 68999999999999999


Q ss_pred             Cchhcccccccceecc-cCCcCCCCCCcccccC----CC-----CcEEEc-------cCcccC-----------CCCccc
Q 001988           89 IPPEIANLSSLKSLDL-SHNKLSSNIPSSIFTM----ST-----LKVLYL-------MDNQLS-----------GSLSSF  140 (985)
Q Consensus        89 ~~~~l~~l~~L~~L~L-~~n~l~~~~p~~~~~l----~~-----L~~L~L-------s~n~l~-----------~~~~~~  140 (985)
                      +|+++++|++|++||| ++|.++|..|-.....    ..     ++..++       ....+.           ...+..
T Consensus       339 ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~  418 (876)
T 4ecn_A          339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK  418 (876)
T ss_dssp             ECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCC
T ss_pred             CchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccc
Confidence            9999999999999999 8999988755332111    00     000000       000000           001111


Q ss_pred             cccCCccceeeecc--ccccCCCChhHhhhccccceecccCccccc-----------------cCCcccC--CCCCceEE
Q 001988          141 TFNTSSILDIRLSK--NKLSGKLPENICNHLRYLKHLFLRENMFYG-----------------KIPSSLS--KCKQLQEL  199 (985)
Q Consensus       141 ~~~~~~L~~L~ls~--n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~-----------------~~p~~l~--~l~~L~~L  199 (985)
                      ......++.+.++.  |+++| +|..+ +++++|++|+|++|.++|                 .+|+.++  ++++|++|
T Consensus       419 ~~~~l~l~~l~l~~~~N~L~~-IP~~l-~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L  496 (876)
T 4ecn_A          419 KDSRISLKDTQIGNLTNRITF-ISKAI-QRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDV  496 (876)
T ss_dssp             CCCCCCCCTTTTTCCSCEEEE-ECGGG-GGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE
T ss_pred             cccccchhhceeccccCcccc-hhHHH-hcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEE
Confidence            12233455555544  88887 88875 778999999999999987                 3788877  88888888


Q ss_pred             EcccccCCCccccccccccccceEeecccc-ccC-CchhhhcCCC-------CCCEEEecCCcCcccCcc--cccCCCCC
Q 001988          200 HLGYNNLSGAIPKEIGNLTVLQRISLINNK-LHG-EIPQEIGYLQ-------NLDVLQLGFNNLTGVVPA--TIFNMSTL  268 (985)
Q Consensus       200 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~Ls~N~l~~~~p~--~l~~l~~L  268 (985)
                      +|++|++.+.+|..|+++++|+.|+|++|+ ++| .+|..++.++       +|++|+|++|+++ .+|.  .+.++++|
T Consensus       497 ~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L  575 (876)
T 4ecn_A          497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKL  575 (876)
T ss_dssp             EEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTC
T ss_pred             ECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCC
Confidence            888888888888888888888888888887 777 7777776665       7777777777777 6676  77777777


Q ss_pred             CEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCC-ccEEEccCcccccccCCcccCCCC--CceEe
Q 001988          269 KEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASK-LILLEMGSNSFSGFIPSAIGNLRN--LKLFD  345 (985)
Q Consensus       269 ~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~  345 (985)
                      ++|+|++|+++ .+|  .+..+++|+.|+|++|+++ .+|..+.++++ |+.|+|++|+++ .+|..+..++.  |+.|+
T Consensus       576 ~~L~Ls~N~l~-~lp--~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~  650 (876)
T 4ecn_A          576 GLLDCVHNKVR-HLE--AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVD  650 (876)
T ss_dssp             CEEECTTSCCC-BCC--CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEE
T ss_pred             CEEECCCCCcc-cch--hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEE
Confidence            77777777776 666  3345667777777777766 66666666666 666666666666 45555555433  55555


Q ss_pred             ccCCcccCCCCccccccccc--ccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEE
Q 001988          346 IFFNNLTSSTPELGFLSSLA--NCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLS  423 (985)
Q Consensus       346 L~~N~l~~~~~~~~~~~~l~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  423 (985)
                      +++|++++..+...  ..+.  .++                         +|+.|++++|.++...+..+..+++|++|+
T Consensus       651 Ls~N~l~g~ip~l~--~~l~~~~~~-------------------------~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~  703 (876)
T 4ecn_A          651 FSYNKIGSEGRNIS--CSMDDYKGI-------------------------NASTVTLSYNEIQKFPTELFATGSPISTII  703 (876)
T ss_dssp             CCSSCTTTTSSSCS--SCTTTCCCC-------------------------CEEEEECCSSCCCSCCHHHHHTTCCCSEEE
T ss_pred             CcCCcCCCccccch--hhhccccCC-------------------------CcCEEEccCCcCCccCHHHHccCCCCCEEE
Confidence            55555554332210  0011  112                         456666666666633222334677777777


Q ss_pred             ccCCCCCCCCCccccc-------cccccceecccccccCCchhhhh--hccCCCeEEccCCccccccCCCCcCcCcCceE
Q 001988          424 LGGNNLSGSIPVTFGG-------LQKLQGLDLAFNKLAGSIPDEIC--LLSRLNELDLNGNKISGSISSCLGNLTSLQYL  494 (985)
Q Consensus       424 L~~N~l~~~~~~~~~~-------l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  494 (985)
                      |++|+|+.+.+..+..       +++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++ +|..+.++++|+.|
T Consensus       704 Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L  781 (876)
T 4ecn_A          704 LSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAF  781 (876)
T ss_dssp             CCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEE
T ss_pred             CCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEE
Confidence            7777777433333332       338888888888888 6777776  78888888888888886 67778888888888


Q ss_pred             eeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceec
Q 001988          495 NLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLE  574 (985)
Q Consensus       495 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  574 (985)
                      +|++|+                  ++++|++.+.+|..+.++++|+.|+|++|+| +.+|..+.  ++|+.|+|++|++.
T Consensus       782 ~Ls~N~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~  840 (876)
T 4ecn_A          782 GIRHQR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNI  840 (876)
T ss_dssp             ECCCCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTC
T ss_pred             ECCCCC------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCC
Confidence            888876                  5667777777777777788888888888888 56777665  57888888888887


Q ss_pred             cchhhhhhcccccCeEecCCCccc
Q 001988          575 GPIPESFGNMTSLESLDLSNNKIS  598 (985)
Q Consensus       575 ~~~p~~~~~l~~L~~L~Ls~N~l~  598 (985)
                      ...+..+.....+..+.|++|++.
T Consensus       841 ~i~~~~~~~~~~~~~~~L~~n~~~  864 (876)
T 4ecn_A          841 SIDVTSVCPYIEAGMYVLLYDKTQ  864 (876)
T ss_dssp             EEECGGGHHHHHTTCCEEECCTTS
T ss_pred             ccChHHccccccchheeecCCCcc
Confidence            766777777777777888887765

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=2e-56  Score=542.23  Aligned_cols=531  Identities=21%  Similarity=0.221  Sum_probs=459.5

Q ss_pred             cceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccceeccc
Q 001988           99 LKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLR  178 (985)
Q Consensus        99 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~  178 (985)
                      .++++.+++.++ .+|..+.  ++|++|+|++|++++..+..+..+++|++|++++|++++..|.. ++++++|++|+|+
T Consensus        13 ~~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~-~~~l~~L~~L~Ls   88 (606)
T 3vq2_A           13 NITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKA-WHGLHHLSNLILT   88 (606)
T ss_dssp             TTEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTT-TTTCTTCCEEECT
T ss_pred             CCceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHH-hhchhhcCEeECC
Confidence            457899999998 6887665  89999999999999999989999999999999999999654544 4889999999999


Q ss_pred             CccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccC-CchhhhcCCCCCCEEEecCCcCccc
Q 001988          179 ENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHG-EIPQEIGYLQNLDVLQLGFNNLTGV  257 (985)
Q Consensus       179 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~  257 (985)
                      +|.+++..|..|+++++|++|+|++|++++..|..++++++|++|++++|++++ .+|..|+++++|++|++++|++++.
T Consensus        89 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~  168 (606)
T 3vq2_A           89 GNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI  168 (606)
T ss_dssp             TCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEE
T ss_pred             CCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceec
Confidence            999998889999999999999999999998777899999999999999999986 6799999999999999999999998


Q ss_pred             CcccccCCCCCC----EEEccCCcCcccCChhhhhcCCCCcEEEecCccCC-CcCCccccCCCCccEEEccCccccc---
Q 001988          258 VPATIFNMSTLK----EIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFS-GTIPSSITNASKLILLEMGSNSFSG---  329 (985)
Q Consensus       258 ~p~~l~~l~~L~----~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~---  329 (985)
                      .|..+..+++|+    +|++++|.++ .+|...+.. .+|+.|++++|.++ +.+|..+.+++.|+.+++..+.+.+   
T Consensus       169 ~~~~~~~l~~L~~~l~~L~l~~n~l~-~~~~~~~~~-~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~  246 (606)
T 3vq2_A          169 TVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQG-IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERN  246 (606)
T ss_dssp             CTTTTHHHHHCTTCCCEEECTTCCCC-EECTTTTTT-CEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCC
T ss_pred             ChhhhhhhhccccccceeeccCCCcc-eeCcccccC-ceeeeeeccCCccchhHHHHHhccccccccccccccccccCCc
Confidence            888888777665    8999999998 555555543 48999999999987 4677889999999999987665543   


Q ss_pred             ---ccCCcccCCC--CCceEec-cCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceecccc
Q 001988          330 ---FIPSAIGNLR--NLKLFDI-FFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFC  403 (985)
Q Consensus       330 ---~~p~~l~~l~--~L~~L~L-~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n  403 (985)
                         ..+..+..+.  .++.+++ ..|.+.+..+      .+..+++|+.|++++|.+.. +| .+..++ +|+.|++++|
T Consensus       247 l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~------~~~~l~~L~~L~l~~~~~~~-l~-~l~~~~-~L~~L~l~~n  317 (606)
T 3vq2_A          247 LEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIV------KFHCLANVSAMSLAGVSIKY-LE-DVPKHF-KWQSLSIIRC  317 (606)
T ss_dssp             CSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGG------SCGGGTTCSEEEEESCCCCC-CC-CCCTTC-CCSEEEEESC
T ss_pred             ccccChHHhhhhhhccHhheecccccccccccc------ccccCCCCCEEEecCccchh-hh-hccccc-cCCEEEcccc
Confidence               1222333333  3556666 5566655433      26789999999999999974 55 777776 8999999999


Q ss_pred             ccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCC--chhhhhhccCCCeEEccCCcccccc
Q 001988          404 NISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGS--IPDEICLLSRLNELDLNGNKISGSI  481 (985)
Q Consensus       404 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~  481 (985)
                      .+ +.+| .+ .+++|++|++++|...+..  .+..+++|++|++++|++++.  +|..+..+++|++|++++|.+++ +
T Consensus       318 ~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~  391 (606)
T 3vq2_A          318 QL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-M  391 (606)
T ss_dssp             CC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-E
T ss_pred             cC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-c
Confidence            99 5777 45 9999999999999665433  678999999999999999976  38889999999999999999986 5


Q ss_pred             CCCCcCcCcCceEeeccceeeeecC-CCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCc-cCchhhcc
Q 001988          482 SSCLGNLTSLQYLNLGSNRFTFVIP-STFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSG-NIPTTLEG  559 (985)
Q Consensus       482 ~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~  559 (985)
                      |..+.++++|++|++++|++++..| ..|.++++|++|++++|.+.+..|..+..+++|+.|++++|++++ .+|..|+.
T Consensus       392 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~  471 (606)
T 3vq2_A          392 SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN  471 (606)
T ss_dssp             CCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT
T ss_pred             hhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhcc
Confidence            6889999999999999999999888 789999999999999999999999999999999999999999998 47899999


Q ss_pred             cccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCCCCCCCCCc-cccccc
Q 001988          560 LKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFA-NFTAES  638 (985)
Q Consensus       560 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~-~~~~~~  638 (985)
                      +++|++|+|++|++++..|..|.++++|++|+|++|++++.+|..|..+++|++|++++|+++..++....+. ++....
T Consensus       472 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~  551 (606)
T 3vq2_A          472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFN  551 (606)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEE
T ss_pred             CCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEE
Confidence            9999999999999999999999999999999999999999999999999999999999999995443323333 467778


Q ss_pred             ccCCccccCCCC
Q 001988          639 FMGNELLCGLPN  650 (985)
Q Consensus       639 ~~~n~~lc~~~~  650 (985)
                      +.+|++.|+++.
T Consensus       552 l~~N~~~c~c~~  563 (606)
T 3vq2_A          552 LTNNSVACICEH  563 (606)
T ss_dssp             CCSCCCCCSSTT
T ss_pred             ccCCCcccCCcc
Confidence            899999998874

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=5.6e-56  Score=556.54  Aligned_cols=526  Identities=21%  Similarity=0.231  Sum_probs=460.8

Q ss_pred             eecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccceecccCc
Q 001988          101 SLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLREN  180 (985)
Q Consensus       101 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n  180 (985)
                      ..|.++++++ .+|.   -.++|++|||++|.+++..+..+.++++|++|+|++|.+.+.+++..++++++|++|+|++|
T Consensus         8 ~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N   83 (844)
T 3j0a_A            8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS   83 (844)
T ss_dssp             EEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred             EEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence            4556666776 4776   45899999999999999999999999999999999998888997777799999999999999


Q ss_pred             cccccCCcccCCCCCceEEEcccccCCCccccc--cccccccceEeeccccccCCch-hhhcCCCCCCEEEecCCcCccc
Q 001988          181 MFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKE--IGNLTVLQRISLINNKLHGEIP-QEIGYLQNLDVLQLGFNNLTGV  257 (985)
Q Consensus       181 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~  257 (985)
                      .+++..|+.|+++++|++|+|++|.+++.+|..  |+++++|++|+|++|++++..| ..|+++++|++|+|++|.+++.
T Consensus        84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~  163 (844)
T 3j0a_A           84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV  163 (844)
T ss_dssp             CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred             cCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence            999999999999999999999999999877765  9999999999999999987765 6899999999999999999999


Q ss_pred             CcccccCC--CCCCEEEccCCcCcccCChhhhhcCC------CCcEEEecCccCCCcCCccccCC---CCccEEEccC--
Q 001988          258 VPATIFNM--STLKEIFLYNNSLSGSLPSRIDLALP------NLEFLNLGINSFSGTIPSSITNA---SKLILLEMGS--  324 (985)
Q Consensus       258 ~p~~l~~l--~~L~~L~L~~N~l~~~~p~~~~~~l~------~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~--  324 (985)
                      .|..+..+  ++|+.|+|++|.+.+..|..+. .++      +|+.|++++|++++.++..+...   .+++.|.++.  
T Consensus       164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~-~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~  242 (844)
T 3j0a_A          164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWG-KCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI  242 (844)
T ss_dssp             CSGGGHHHHHCSSCCCEECCSBSCCCCCCCCC-SSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSC
T ss_pred             CHHHcccccCCccceEECCCCccccccccchh-hcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccc
Confidence            99999888  8999999999999987776532 222      49999999999999888877654   6788888873  


Q ss_pred             -------cccccccCCcccCC--CCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcc
Q 001988          325 -------NSFSGFIPSAIGNL--RNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSL  395 (985)
Q Consensus       325 -------N~l~~~~p~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L  395 (985)
                             |.+.+..+..|..+  ++|+.|++++|.++...+.     .+.++++|+.|+|++|++.+..|..+..++ +|
T Consensus       243 ~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~-----~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~-~L  316 (844)
T 3j0a_A          243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSR-----VFETLKDLKVLNLAYNKINKIADEAFYGLD-NL  316 (844)
T ss_dssp             CBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSC-----CSSSCCCCCEEEEESCCCCEECTTTTTTCS-SC
T ss_pred             ccccccccccCCCChhhhhccccCCccEEECCCCcccccChh-----hhhcCCCCCEEECCCCcCCCCChHHhcCCC-CC
Confidence                   44444555566665  7899999999999877554     478899999999999999999999999988 89


Q ss_pred             cceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCC
Q 001988          396 ERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGN  475 (985)
Q Consensus       396 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  475 (985)
                      ++|++++|.+++..|..|..+++|++|++++|++++..+..|.++++|+.|+|++|.+++. +    .+++|+.|++++|
T Consensus       317 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~----~~~~L~~L~l~~N  391 (844)
T 3j0a_A          317 QVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-H----FIPSIPDIFLSGN  391 (844)
T ss_dssp             CEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-S----SCCSCSEEEEESC
T ss_pred             CEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-c----CCCCcchhccCCC
Confidence            9999999999999999999999999999999999998899999999999999999999853 3    3789999999999


Q ss_pred             ccccccCCCCcCcCcCceEeeccceeeeecC-CCccCccceeEEeecCCcccCCccc-cccCCCcccEEEccCCccC---
Q 001988          476 KISGSISSCLGNLTSLQYLNLGSNRFTFVIP-STFWNLKDILSFDISSNLLDGPISL-AIGNLKAVVGIDLSRNNLS---  550 (985)
Q Consensus       476 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~---  550 (985)
                      +++. +|..   ..+++.|++++|++++... ..+.++++|+.|++++|++++..+. .+..+++|+.|+|++|.++   
T Consensus       392 ~l~~-l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~  467 (844)
T 3j0a_A          392 KLVT-LPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAW  467 (844)
T ss_dssp             CCCC-CCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSC
T ss_pred             Cccc-cccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCcccccc
Confidence            9984 4543   4679999999999987532 2345899999999999999976543 4667899999999999997   


Q ss_pred             --ccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCCCCCC
Q 001988          551 --GNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRG  628 (985)
Q Consensus       551 --~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  628 (985)
                        +..|..|.++++|+.|+|++|+|++.+|..|.++++|+.|+|++|+|++..|..+.  ++|+.|||++|++++.+|..
T Consensus       468 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~  545 (844)
T 3j0a_A          468 ETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV  545 (844)
T ss_dssp             CSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC
T ss_pred             ccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH
Confidence              45567799999999999999999999999999999999999999999988777776  89999999999999999964


Q ss_pred             CCCcccccccccCCccccCCCC
Q 001988          629 GPFANFTAESFMGNELLCGLPN  650 (985)
Q Consensus       629 ~~~~~~~~~~~~~n~~lc~~~~  650 (985)
                        +.++....+.+||+.|.++.
T Consensus       546 --~~~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          546 --FVSLSVLDITHNKFICECEL  565 (844)
T ss_dssp             --CSSCCEEEEEEECCCCSSSC
T ss_pred             --hCCcCEEEecCCCccccccc
Confidence              66788888999999998775

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-52  Score=502.71  Aligned_cols=508  Identities=21%  Similarity=0.254  Sum_probs=381.2

Q ss_pred             EEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccc
Q 001988           78 LNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKL  157 (985)
Q Consensus        78 l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l  157 (985)
                      ++-++.+++ .+|..+.  +++++|||++|.+++..|..|.++++|++|+|++|++++..+..+..+++|++|+|++|++
T Consensus        12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l   88 (570)
T 2z63_A           12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI   88 (570)
T ss_dssp             EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence            444555666 5666543  5788999999999877777888899999999999988877777777778888888888887


Q ss_pred             cCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCC-ccccccccccccceEeeccccccCCchh
Q 001988          158 SGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSG-AIPKEIGNLTVLQRISLINNKLHGEIPQ  236 (985)
Q Consensus       158 ~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~  236 (985)
                      ++ +|+..++.+++|++|++++|.+++..+..++++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..|.
T Consensus        89 ~~-~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~  167 (570)
T 2z63_A           89 QS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT  167 (570)
T ss_dssp             CE-ECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGG
T ss_pred             Cc-cCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHH
Confidence            74 444444778888888888888875555568888888888888888876 4678888888888888888888877777


Q ss_pred             hhcCCCCC----CEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCc------
Q 001988          237 EIGYLQNL----DVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGT------  306 (985)
Q Consensus       237 ~~~~l~~L----~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~------  306 (985)
                      .++.+++|    +.|++++|.+++..|..+... +|++|++++|......-......+++++.+.+..+.+...      
T Consensus       168 ~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~  246 (570)
T 2z63_A          168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF  246 (570)
T ss_dssp             GGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEEC
T ss_pred             HccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhc
Confidence            77777777    788888888887777666655 6888888877554322223334566776666654443311      


Q ss_pred             CCccccCCC--CccEEEccCc-ccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCcc
Q 001988          307 IPSSITNAS--KLILLEMGSN-SFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGF  383 (985)
Q Consensus       307 ~p~~~~~l~--~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~  383 (985)
                      ....+..+.  .++.+++++| .+.+..|..+.                             .+++|++|++++|.+. .
T Consensus       247 ~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~-----------------------------~l~~L~~L~l~~~~l~-~  296 (570)
T 2z63_A          247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN-----------------------------CLTNVSSFSLVSVTIE-R  296 (570)
T ss_dssp             CTTTTGGGGGSEEEEEEEEETTEEESCSTTTTG-----------------------------GGTTCSEEEEESCEEC-S
T ss_pred             chhhhccccccchhhhhhhcchhhhhhchhhhc-----------------------------CcCcccEEEecCccch-h
Confidence            111111111  1333444444 34444444444                             4455555555555554 3


Q ss_pred             CCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCc--hhhh
Q 001988          384 LPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSI--PDEI  461 (985)
Q Consensus       384 ~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--p~~~  461 (985)
                      +|..+..+  +|+.|++++|.+. .+|.  ..+++|++|++++|.+.+..+.  ..+++|++|++++|++++..  |..+
T Consensus       297 l~~~~~~~--~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~  369 (570)
T 2z63_A          297 VKDFSYNF--GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSD  369 (570)
T ss_dssp             CCBCCSCC--CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHH
T ss_pred             hhhhhccC--CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccc
Confidence            44444444  4666666666665 3333  3567888888888888766554  67888888888888887554  6778


Q ss_pred             hhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecC-CCccCccceeEEeecCCcccCCccccccCCCccc
Q 001988          462 CLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIP-STFWNLKDILSFDISSNLLDGPISLAIGNLKAVV  540 (985)
Q Consensus       462 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~  540 (985)
                      ..+++|++|++++|++++..+. +..+++|++|++++|.+++..| ..|.++++|++|++++|.+.+..+..+..+++|+
T Consensus       370 ~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  448 (570)
T 2z63_A          370 FGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE  448 (570)
T ss_dssp             HTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC
T ss_pred             cccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCc
Confidence            8889999999999998876555 8889999999999999988766 5788899999999999999988888999999999


Q ss_pred             EEEccCCccC-ccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccc
Q 001988          541 GIDLSRNNLS-GNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFN  619 (985)
Q Consensus       541 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  619 (985)
                      .|++++|+++ +.+|..+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|+.|++++|
T Consensus       449 ~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N  528 (570)
T 2z63_A          449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN  528 (570)
T ss_dssp             EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCC
Confidence            9999999997 578999999999999999999999988999999999999999999999988888999999999999999


Q ss_pred             cccCCCCCC
Q 001988          620 KLKGEIPRG  628 (985)
Q Consensus       620 ~l~~~~p~~  628 (985)
                      +++|.+|..
T Consensus       529 ~~~~~~~~~  537 (570)
T 2z63_A          529 PWDCSCPRI  537 (570)
T ss_dssp             CBCCCTTTT
T ss_pred             cccCCCcch
Confidence            999999874

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=2.7e-53  Score=508.57  Aligned_cols=498  Identities=20%  Similarity=0.228  Sum_probs=321.2

Q ss_pred             cceeeeEEEeCCCCeEEEEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCcc
Q 001988           60 ICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSS  139 (985)
Q Consensus        60 ~c~w~gv~c~~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~  139 (985)
                      .|.|.|| |+.          ++++++ .+|+.+.  ++|++|||++|++++..|..+.++++|++|+|++|++++..++
T Consensus         3 ~C~~~~~-c~~----------~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~   68 (549)
T 2z81_A            3 SCDASGV-CDG----------RSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD   68 (549)
T ss_dssp             EECTTSE-EEC----------TTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT
T ss_pred             cCCCCce-EEC----------CCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh
Confidence            5999999 964          456676 6787665  7999999999999988888999999999999999999977777


Q ss_pred             ccccCCccceeeeccccccCCCChhHhhhccccceecccCccccc-cCCcccCCCCCceEEEcccccCCCccc-cccccc
Q 001988          140 FTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYG-KIPSSLSKCKQLQELHLGYNNLSGAIP-KEIGNL  217 (985)
Q Consensus       140 ~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l  217 (985)
                      .+..+++|++|++++|++++ +|+..++++++|++|+|++|.+++ .+|..++++++|++|++++|++.+.+| ..|+++
T Consensus        69 ~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l  147 (549)
T 2z81_A           69 AFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL  147 (549)
T ss_dssp             TTTTCTTCCEEECTTSCCCS-CCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred             hccccccCCEEECCCCccCc-cCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcc
Confidence            77777777777777777764 333333566666666666666664 345566666666666666666433444 456666


Q ss_pred             cccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccC--ChhhhhcCCCCcE
Q 001988          218 TVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSL--PSRIDLALPNLEF  295 (985)
Q Consensus       218 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~--p~~~~~~l~~L~~  295 (985)
                      ++|++|++++|++++.+|..++.+++|++|+++.|.+....+..+..+++|++|++++|++++..  |..+         
T Consensus       148 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~---------  218 (549)
T 2z81_A          148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPV---------  218 (549)
T ss_dssp             CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSS---------
T ss_pred             cccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccch---------
Confidence            66666666666666666666666666666666666654222222234555555555555554311  1111         


Q ss_pred             EEecCccCCCcCCccccCCCCccEEEccCcccccccC----CcccCCCCCceEeccCCcccCCCCcc-cccccccccCcc
Q 001988          296 LNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIP----SAIGNLRNLKLFDIFFNNLTSSTPEL-GFLSSLANCKKL  370 (985)
Q Consensus       296 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p----~~l~~l~~L~~L~L~~N~l~~~~~~~-~~~~~l~~l~~L  370 (985)
                                     ...+++|+.|++++|.+++..+    ..+..+++|+.+++++|.+.+...-. .....+..+.+|
T Consensus       219 ---------------~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L  283 (549)
T 2z81_A          219 ---------------DEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV  283 (549)
T ss_dssp             ---------------CCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTC
T ss_pred             ---------------hhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhccc
Confidence                           1234455555555555544322    23345556666666666655432110 001124456677


Q ss_pred             cEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccc-cccccccceecc
Q 001988          371 RYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTF-GGLQKLQGLDLA  449 (985)
Q Consensus       371 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls  449 (985)
                      +.|++.++.+.....  +.                  .++..+...++|++|++++|+++ .+|..+ .++++|++|+++
T Consensus       284 ~~L~l~~~~i~~~~~--~~------------------~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls  342 (549)
T 2z81_A          284 ETVTIRRLHIPQFYL--FY------------------DLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLS  342 (549)
T ss_dssp             CEEEEESCBCSCGGG--SC------------------CCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECC
T ss_pred             ccccccccccchhhh--cc------------------cchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEcc
Confidence            777777776542110  00                  01111223456667777777766 344433 456777777777


Q ss_pred             cccccCCchhh---hhhccCCCeEEccCCccccccC--CCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCc
Q 001988          450 FNKLAGSIPDE---ICLLSRLNELDLNGNKISGSIS--SCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNL  524 (985)
Q Consensus       450 ~N~l~~~~p~~---~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~  524 (985)
                      +|++++.+|..   ++.+++|++|+|++|++++..+  ..+..+++|++|++++|+++. +|..+..+++|++|++++|+
T Consensus       343 ~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~~~~L~~L~Ls~N~  421 (549)
T 2z81_A          343 ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTG  421 (549)
T ss_dssp             SSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCC-CCSCCCCCTTCCEEECTTSC
T ss_pred             CCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCcc-CChhhcccccccEEECCCCC
Confidence            77776655432   4566677777777777765432  346667777777777777763 56666677777777777777


Q ss_pred             ccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcc
Q 001988          525 LDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS  604 (985)
Q Consensus       525 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  604 (985)
                      ++++....   .++|+.|+|++|+|++.+    ..+++|++|+|++|+|+ .+|. ...+++|++|||++|+|++.+|..
T Consensus       422 l~~l~~~~---~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~  492 (549)
T 2z81_A          422 IRVVKTCI---PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGI  492 (549)
T ss_dssp             CSCCCTTS---CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTG
T ss_pred             cccccchh---cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHH
Confidence            76543221   257888888888888653    46788899999999988 4665 467889999999999999888888


Q ss_pred             ccccccccccccccccccCCCCC
Q 001988          605 FEKLSYLKELNLSFNKLKGEIPR  627 (985)
Q Consensus       605 ~~~l~~L~~L~ls~N~l~~~~p~  627 (985)
                      |..+++|+.|++++|++.|.+|.
T Consensus       493 ~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          493 FDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             GGGCTTCCEEECCSSCBCCCHHH
T ss_pred             HhcCcccCEEEecCCCccCCCcc
Confidence            89999999999999999888874

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-50  Score=488.37  Aligned_cols=491  Identities=21%  Similarity=0.210  Sum_probs=399.9

Q ss_pred             CeEEEEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeee
Q 001988           73 HKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRL  152 (985)
Q Consensus        73 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l  152 (985)
                      .+++.|||++|++++..+.++.++++|++|||++|++++..|..|.++++|++|+|++|++++..+..+..+++|++|++
T Consensus        28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (570)
T 2z63_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (570)
T ss_dssp             SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence            46899999999999888889999999999999999999877888999999999999999999988899999999999999


Q ss_pred             ccccccCCCChhHhhhccccceecccCccccc-cCCcccCCCCCceEEEcccccCCCcccccccccccc----ceEeecc
Q 001988          153 SKNKLSGKLPENICNHLRYLKHLFLRENMFYG-KIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVL----QRISLIN  227 (985)
Q Consensus       153 s~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L----~~L~L~~  227 (985)
                      ++|++++ +|...++++++|++|++++|.+++ .+|..|+++++|++|++++|++++..|..++.+++|    +.|++++
T Consensus       108 ~~n~l~~-l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~  186 (570)
T 2z63_A          108 VETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL  186 (570)
T ss_dssp             TTSCCCC-STTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred             ccccccc-CCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence            9999984 554345889999999999999997 579999999999999999999998888899999999    8999999


Q ss_pred             ccccCCchhhhcCCCCCCEEEecCCcCcc-cCcccccCCCCCCEEEccCCcCcc-----cCChhhhhcCC--CCcEEEec
Q 001988          228 NKLHGEIPQEIGYLQNLDVLQLGFNNLTG-VVPATIFNMSTLKEIFLYNNSLSG-----SLPSRIDLALP--NLEFLNLG  299 (985)
Q Consensus       228 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~-----~~p~~~~~~l~--~L~~L~Ls  299 (985)
                      |.+++..|..+..+ +|+.|++++|.... .+|..+..++.++.+.+..+.+..     .++...+..++  .++.++++
T Consensus       187 n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~  265 (570)
T 2z63_A          187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA  265 (570)
T ss_dssp             CCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred             CCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence            99998888888776 89999999986542 456777888888877665433221     23333333333  46788888


Q ss_pred             Cc-cCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCC
Q 001988          300 IN-SFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGN  378 (985)
Q Consensus       300 ~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N  378 (985)
                      +| .+.+.+|..+..+++|+.|++++|.++ .+|..+..+ +|++|++++|++...+.        ..+++|++|++++|
T Consensus       266 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~l~~--------~~l~~L~~L~l~~n  335 (570)
T 2z63_A          266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQFPT--------LKLKSLKRLTFTSN  335 (570)
T ss_dssp             ETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCSSCCB--------CBCSSCCEEEEESC
T ss_pred             cchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCcccccCc--------ccccccCEEeCcCC
Confidence            88 788899999999999999999999998 578888888 99999999998875443        24566777777777


Q ss_pred             CCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCC--CccccccccccceecccccccCC
Q 001988          379 PLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSI--PVTFGGLQKLQGLDLAFNKLAGS  456 (985)
Q Consensus       379 ~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~  456 (985)
                      .+.+..+.                           ..+++|++|++++|++++..  |..+.++++|++|++++|.+.+.
T Consensus       336 ~~~~~~~~---------------------------~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~  388 (570)
T 2z63_A          336 KGGNAFSE---------------------------VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM  388 (570)
T ss_dssp             BSCCBCCC---------------------------CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEE
T ss_pred             cccccccc---------------------------ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccc
Confidence            65543322                           44566666777766666443  55666777777777777777754


Q ss_pred             chhhhhhccCCCeEEccCCccccccC-CCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCccc-CCcccccc
Q 001988          457 IPDEICLLSRLNELDLNGNKISGSIS-SCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLD-GPISLAIG  534 (985)
Q Consensus       457 ~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~~~~~~  534 (985)
                      .+. +..+++|+.|++++|++++..+ ..+.++++|++|++++|++++..|..|.++++|++|++++|.+. +..|..+.
T Consensus       389 ~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~  467 (570)
T 2z63_A          389 SSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT  467 (570)
T ss_dssp             EEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCT
T ss_pred             ccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhh
Confidence            433 6777777777777777776555 46777778888888888887777777778888888888888876 46677888


Q ss_pred             CCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCc
Q 001988          535 NLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPV  603 (985)
Q Consensus       535 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  603 (985)
                      .+++|+.|++++|++++..|..|+.+++|++|+|++|++++.+|..|.++++|+.|++++|++++..|.
T Consensus       468 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  536 (570)
T 2z63_A          468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  536 (570)
T ss_dssp             TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             cccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence            889999999999999988899999999999999999999988888899999999999999999987664

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=5.5e-50  Score=488.74  Aligned_cols=529  Identities=23%  Similarity=0.243  Sum_probs=419.4

Q ss_pred             EecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeecccccc
Q 001988           79 NLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLS  158 (985)
Q Consensus        79 ~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~  158 (985)
                      |=++.+|+ .+|+.+.  +++++|||++|+|++..|.+|.++++|++|||++|+|++..++.+.++++|++|+|++|+++
T Consensus        37 ~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~  113 (635)
T 4g8a_A           37 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ  113 (635)
T ss_dssp             ECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred             ECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC
Confidence            44555677 6777653  47999999999999766778999999999999999999988889999999999999999998


Q ss_pred             CCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCC-ccccccccccccceEeeccccccCCchhh
Q 001988          159 GKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSG-AIPKEIGNLTVLQRISLINNKLHGEIPQE  237 (985)
Q Consensus       159 g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  237 (985)
                       .+|+..|.++++|++|+|++|++++..+..|+++++|++|+|++|.+++ .+|..++++++|++|++++|++++..|..
T Consensus       114 -~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  192 (635)
T 4g8a_A          114 -SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD  192 (635)
T ss_dssp             -EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred             -CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccc
Confidence             6788888999999999999999997777789999999999999999985 46888999999999999999999888888


Q ss_pred             hcCCCCC----CEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCC------CcC
Q 001988          238 IGYLQNL----DVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFS------GTI  307 (985)
Q Consensus       238 ~~~l~~L----~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~------~~~  307 (985)
                      |..+.++    ..++++.|.++...+.. .....++.+++++|.....++...+..++.++...+..+...      ...
T Consensus       193 l~~L~~l~~~~~~~~ls~n~l~~i~~~~-~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~  271 (635)
T 4g8a_A          193 LRVLHQMPLLNLSLDLSLNPMNFIQPGA-FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD  271 (635)
T ss_dssp             GHHHHTCTTCCCEEECTTCCCCEECTTT-TTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCC
T ss_pred             ccchhhhhhhhhhhhcccCcccccCccc-ccchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccc
Confidence            8776654    47899999999655544 445568889999998876666667778888888887655433      233


Q ss_pred             CccccCCCCccEEEccCccccc---ccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccC
Q 001988          308 PSSITNASKLILLEMGSNSFSG---FIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFL  384 (985)
Q Consensus       308 p~~~~~l~~L~~L~L~~N~l~~---~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~  384 (985)
                      ...+.....+...++..+....   ..+..+..+.+++.+++..+.+....       .+..+..|+.|++.+|.+.+..
T Consensus       272 ~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~-------~~~~~~~L~~L~l~~~~~~~~~  344 (635)
T 4g8a_A          272 KSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK-------DFSYNFGWQHLELVNCKFGQFP  344 (635)
T ss_dssp             TTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG-------GGGSCCCCSEEEEESCEESSCC
T ss_pred             ccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc-------ccccchhhhhhhcccccccCcC
Confidence            4455556666666666554432   33455677788888888888776543       2455678888888888887654


Q ss_pred             CCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCC--CCCccccccccccceecccccccCCchhhhh
Q 001988          385 PSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSG--SIPVTFGGLQKLQGLDLAFNKLAGSIPDEIC  462 (985)
Q Consensus       385 p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  462 (985)
                      +..+   . .|+.+++..|.+...  .....+++|+.|++++|.+..  ..+..+..+.+|+.|+++.|.+.. .+..+.
T Consensus       345 ~~~l---~-~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~  417 (635)
T 4g8a_A          345 TLKL---K-SLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFL  417 (635)
T ss_dssp             CCBC---T-TCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCT
T ss_pred             cccc---h-hhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-cccccc
Confidence            4333   2 577888888877643  234578888888888888853  345566677888888888888774 455677


Q ss_pred             hccCCCeEEccCCccccccC-CCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcc-cCCccccccCCCccc
Q 001988          463 LLSRLNELDLNGNKISGSIS-SCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLL-DGPISLAIGNLKAVV  540 (985)
Q Consensus       463 ~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l-~~~~~~~~~~l~~L~  540 (985)
                      .+++|+.+++++|......+ ..|.++++++.++++.|.+++..+..+..+++++.|++++|.+ .+..|..|..+++|+
T Consensus       418 ~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~  497 (635)
T 4g8a_A          418 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT  497 (635)
T ss_dssp             TCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCC
T ss_pred             ccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccC
Confidence            78888888888887765544 4677888888888888888888888888888888888888874 456777888888888


Q ss_pred             EEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcccccc-ccccccccccc
Q 001988          541 GIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKL-SYLKELNLSFN  619 (985)
Q Consensus       541 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~ls~N  619 (985)
                      .|+|++|+|++..|..|+++++|++|+|++|+|++..|..|.++++|++|||++|+|++..|..|..+ ++|++|+|++|
T Consensus       498 ~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~N  577 (635)
T 4g8a_A          498 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN  577 (635)
T ss_dssp             EEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTC
T ss_pred             EEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCC
Confidence            88888888888888888888888888888888888888888888888888888888888888888887 57888888888


Q ss_pred             cccCCCC
Q 001988          620 KLKGEIP  626 (985)
Q Consensus       620 ~l~~~~p  626 (985)
                      ++.+.+.
T Consensus       578 p~~C~C~  584 (635)
T 4g8a_A          578 DFACTCE  584 (635)
T ss_dssp             CBCCSGG
T ss_pred             CCcccCC
Confidence            8887664

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=4.4e-50  Score=493.50  Aligned_cols=483  Identities=19%  Similarity=0.232  Sum_probs=263.3

Q ss_pred             cccceecccCCcCCCCCCcccccCCCCcEEEc-cCcccCCCCccccccC----Cc--cceeee----------ccccccC
Q 001988           97 SSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYL-MDNQLSGSLSSFTFNT----SS--ILDIRL----------SKNKLSG  159 (985)
Q Consensus        97 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-s~n~l~~~~~~~~~~~----~~--L~~L~l----------s~n~l~g  159 (985)
                      .+++.|+|++|.++|.+|++|++|++|++|+| ++|.++|..+-.....    +.  ++.++.          ....+++
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            57899999999999999999999999999999 9999987643221111    00  000000          0011111


Q ss_pred             CCChhHh----------hhccccceecccC--ccccccCCcccCCCCCceEEEcccccCCCc-cccccccccccceEeec
Q 001988          160 KLPENIC----------NHLRYLKHLFLRE--NMFYGKIPSSLSKCKQLQELHLGYNNLSGA-IPKEIGNLTVLQRISLI  226 (985)
Q Consensus       160 ~lp~~~~----------~~l~~L~~L~L~~--n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~  226 (985)
                      .++..+.          .....++.+.++.  |.+++ +|+.|+++++|++|+|++|+|+|. +|..+..        .+
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~--------~s  473 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWED--------AN  473 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSC--------TT
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccc--------cc
Confidence            1111110          1122344444444  77776 777788888888888888888762 1111100        01


Q ss_pred             cccccCCchhhhc--CCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCc-Ccc-cCChhhh------hcCCCCcEE
Q 001988          227 NNKLHGEIPQEIG--YLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNS-LSG-SLPSRID------LALPNLEFL  296 (985)
Q Consensus       227 ~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~-~~p~~~~------~~l~~L~~L  296 (985)
                      .|.++|.+|+.++  ++++|++|+|++|++.+.+|..+.++++|++|+|++|+ ++| .+|..+.      ..+++|++|
T Consensus       474 ~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L  553 (876)
T 4ecn_A          474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF  553 (876)
T ss_dssp             SHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEE
T ss_pred             cccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEE
Confidence            1222223444444  44444444444444444444444444444444444444 444 3443321      123455666


Q ss_pred             EecCccCCCcCCc--cccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCc-ccEE
Q 001988          297 NLGINSFSGTIPS--SITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKK-LRYL  373 (985)
Q Consensus       297 ~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~-L~~L  373 (985)
                      +|++|+++ .+|.  .++++++|+.|+|++|+++ .+| .++.+++|+.|++++|+++.++.      .+.++++ |++|
T Consensus       554 ~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~lp~------~l~~l~~~L~~L  624 (876)
T 4ecn_A          554 YMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPE------DFCAFTDQVEGL  624 (876)
T ss_dssp             ECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCSCCCT------TSCEECTTCCEE
T ss_pred             EeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccccchH------HHhhccccCCEE
Confidence            66666555 5555  5566666666666666665 445 56666666666666666653332      2455555 6666


Q ss_pred             EecCCCCCccCCCCccchh-hcccceeccccccccccCCc---CC--CCCCccEEEccCCCCCCCCCcccccccccccee
Q 001988          374 GLGGNPLDGFLPSSIGNLS-LSLERLNIAFCNISGNIPKA---IG--NLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLD  447 (985)
Q Consensus       374 ~L~~N~l~~~~p~~~~~l~-~~L~~L~L~~n~l~~~~~~~---~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  447 (985)
                      +|++|+++ .+|..+.... .+|+.|++++|++++.+|..   +.  .+++|++|+|++|+++...+..+..+++|+.|+
T Consensus       625 ~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~  703 (876)
T 4ecn_A          625 GFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII  703 (876)
T ss_dssp             ECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEE
T ss_pred             ECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEE
Confidence            66666665 4454444332 12445555555554433321   11  223566666666666633333334555666666


Q ss_pred             cccccccCCchhhhhh--------ccCCCeEEccCCccccccCCCCc--CcCcCceEeeccceeeeecCCCccCccceeE
Q 001988          448 LAFNKLAGSIPDEICL--------LSRLNELDLNGNKISGSISSCLG--NLTSLQYLNLGSNRFTFVIPSTFWNLKDILS  517 (985)
Q Consensus       448 Ls~N~l~~~~p~~~~~--------l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  517 (985)
                      |++|+|+ .+|..+..        +++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++ +|..+.++++|+.
T Consensus       704 Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~  780 (876)
T 4ecn_A          704 LSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKA  780 (876)
T ss_dssp             CCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCE
T ss_pred             CCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCE
Confidence            6666655 33333221        114555555555554 3344443  44445555555554444 3444444444444


Q ss_pred             EeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcc
Q 001988          518 FDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKI  597 (985)
Q Consensus       518 L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  597 (985)
                      |++++|+                  ++++|++.+.+|..|..+++|+.|+|++|+| +.+|..+.  ++|+.|||++|++
T Consensus       781 L~Ls~N~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l  839 (876)
T 4ecn_A          781 FGIRHQR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPN  839 (876)
T ss_dssp             EECCCCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTT
T ss_pred             EECCCCC------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCC
Confidence            4444443                  3345777777777777777777777777777 46666654  5777777777777


Q ss_pred             cCCCCcccccccccccccccccccc
Q 001988          598 SGSIPVSFEKLSYLKELNLSFNKLK  622 (985)
Q Consensus       598 ~~~~p~~~~~l~~L~~L~ls~N~l~  622 (985)
                      ....+..+.....+..+.|++|++.
T Consensus       840 ~~i~~~~~~~~~~~~~~~L~~n~~~  864 (876)
T 4ecn_A          840 ISIDVTSVCPYIEAGMYVLLYDKTQ  864 (876)
T ss_dssp             CEEECGGGHHHHHTTCCEEECCTTS
T ss_pred             CccChHHccccccchheeecCCCcc
Confidence            7666666666666666677766554

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.8e-50  Score=489.98  Aligned_cols=472  Identities=19%  Similarity=0.285  Sum_probs=302.0

Q ss_pred             cccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccceec
Q 001988           97 SSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLF  176 (985)
Q Consensus        97 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~  176 (985)
                      .+++.|+|++|.++|.+|+++++|++|++|+|++|.+.... ..+..           -.+.-.+|...   +..|+ ++
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~-~~~~~-----------~~~~~~~~~~~---~~~l~-l~  144 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNE-RLFGP-----------KGISANMSDEQ---KQKMR-MH  144 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTC-CSBST-----------TSBCTTCCHHH---HHHHH-TH
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCC-ccccc-----------cccccCchHHH---HHHHH-hh
Confidence            47889999999999999999999999999999999873110 00000           00001333333   23333 45


Q ss_pred             ccCccccccCCcccCC-CCCceEEEcccccCCCccccccccccccceEeec--cccccCCchhhhcCCCCCCEEEecCCc
Q 001988          177 LRENMFYGKIPSSLSK-CKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLI--NNKLHGEIPQEIGYLQNLDVLQLGFNN  253 (985)
Q Consensus       177 L~~n~l~~~~p~~l~~-l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~--~N~l~~~~p~~~~~l~~L~~L~Ls~N~  253 (985)
                      +++|.+.+.+|..+.. +.++..+++....+..      .....++.+.+.  +|+++| +|..|+++++|++|+|++|+
T Consensus       145 l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~  217 (636)
T 4eco_A          145 YQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSP  217 (636)
T ss_dssp             HHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCC
T ss_pred             HHHhhhccCchhhHHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCc
Confidence            5555555444444431 1122222222222110      111112222222  344554 55555555555555555555


Q ss_pred             Cccc-----------------Cccccc--CCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCcc-CCC-cCCcccc
Q 001988          254 LTGV-----------------VPATIF--NMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINS-FSG-TIPSSIT  312 (985)
Q Consensus       254 l~~~-----------------~p~~l~--~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~  312 (985)
                      +++.                 +|..++  ++++|++|+|++|++.+.+|..+ ..+++|++|+|++|+ ++| .+|..++
T Consensus       218 l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~Ls~n~~l~~~~lp~~~~  296 (636)
T 4eco_A          218 FVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL-KALPEMQLINVACNRGISGEQLKDDWQ  296 (636)
T ss_dssp             CCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTT-TTCSSCCEEECTTCTTSCHHHHHHHHH
T ss_pred             cccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHH-hcCCCCCEEECcCCCCCccccchHHHH
Confidence            5543                 555555  55555555555555555555443 245566666666665 665 5666665


Q ss_pred             CC------CCccEEEccCcccccccCC--cccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccC
Q 001988          313 NA------SKLILLEMGSNSFSGFIPS--AIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFL  384 (985)
Q Consensus       313 ~l------~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~  384 (985)
                      ++      ++|++|++++|+++ .+|.  .++++++|++|++++|+++                             |.+
T Consensus       297 ~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~-----------------------------g~i  346 (636)
T 4eco_A          297 ALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLE-----------------------------GKL  346 (636)
T ss_dssp             HHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCE-----------------------------EEC
T ss_pred             hhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCc-----------------------------cch
Confidence            55      89999999999999 7888  8998887777777766655                             334


Q ss_pred             CCCccchhhcccceeccccccccccCCcCCCCCC-ccEEEccCCCCCCCCCccccccc--cccceecccccccCCchhhh
Q 001988          385 PSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSN-LIVLSLGGNNLSGSIPVTFGGLQ--KLQGLDLAFNKLAGSIPDEI  461 (985)
Q Consensus       385 p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~p~~~  461 (985)
                      | .+..++ +|++|++++|+++ .+|..+..+++ |++|++++|+++ .+|..+..+.  +|+.|++++|++++.+|..+
T Consensus       347 p-~~~~l~-~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l  422 (636)
T 4eco_A          347 P-AFGSEI-KLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNF  422 (636)
T ss_dssp             C-CCEEEE-EESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSS
T ss_pred             h-hhCCCC-CCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhh
Confidence            4 444444 5666666666666 66777888888 999999999988 6777777654  88899999999888888777


Q ss_pred             h-------hccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCcccccc
Q 001988          462 C-------LLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIG  534 (985)
Q Consensus       462 ~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~  534 (985)
                      .       .+++|++|+|++|++++..+..+..+++|++|+|++|+++.+.+..+....                 ..+.
T Consensus       423 ~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~-----------------~~~~  485 (636)
T 4eco_A          423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN-----------------ENFK  485 (636)
T ss_dssp             CTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETT-----------------EECT
T ss_pred             cccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhcccc-----------------cccc
Confidence            7       667788888888888754444455677788888888887744333333221                 0112


Q ss_pred             CCCcccEEEccCCccCccCchhhc--ccccceeeeeecceeccchhhhhhcccccCeEec------CCCcccCCCCcccc
Q 001988          535 NLKAVVGIDLSRNNLSGNIPTTLE--GLKSLQNISLAYNRLEGPIPESFGNMTSLESLDL------SNNKISGSIPVSFE  606 (985)
Q Consensus       535 ~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~  606 (985)
                      ++++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++ +|..+.++++|++|+|      ++|++.+.+|..+.
T Consensus       486 ~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~  563 (636)
T 4eco_A          486 NTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGIT  563 (636)
T ss_dssp             TGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGG
T ss_pred             ccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHh
Confidence            2335555566666555 4555554  56666666666666665 5555666666666666      77999999999999


Q ss_pred             ccccccccccccccccCCCCCCCCCcccccccccCCccccC
Q 001988          607 KLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCG  647 (985)
Q Consensus       607 ~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~  647 (985)
                      .+++|++|+|++|++ +.+|... +.++....+.+|+..|-
T Consensus       564 ~l~~L~~L~Ls~N~l-~~ip~~~-~~~L~~L~Ls~N~l~~~  602 (636)
T 4eco_A          564 LCPSLTQLQIGSNDI-RKVNEKI-TPNISVLDIKDNPNISI  602 (636)
T ss_dssp             GCSSCCEEECCSSCC-CBCCSCC-CTTCCEEECCSCTTCEE
T ss_pred             cCCCCCEEECCCCcC-CccCHhH-hCcCCEEECcCCCCccc
Confidence            999999999999999 7888753 36777788888887664

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.7e-49  Score=475.58  Aligned_cols=481  Identities=18%  Similarity=0.195  Sum_probs=401.0

Q ss_pred             eeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccc
Q 001988          151 RLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKL  230 (985)
Q Consensus       151 ~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  230 (985)
                      |.++|.++ .+|..++   ++|++|+|++|.+++..|..|+++++|++|+|++|++++..|+.|+++++|++|+|++|++
T Consensus        11 ~~~~~~l~-~ip~~~~---~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   86 (549)
T 2z81_A           11 DGRSRSFT-SIPSGLT---AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL   86 (549)
T ss_dssp             ECTTSCCS-SCCSCCC---TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             ECCCCccc-cccccCC---CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence            44445554 6777663   6899999999999988889999999999999999999988888999999999999999999


Q ss_pred             cCCchhhhcCCCCCCEEEecCCcCcc-cCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCc
Q 001988          231 HGEIPQEIGYLQNLDVLQLGFNNLTG-VVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPS  309 (985)
Q Consensus       231 ~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~  309 (985)
                      ++..|..|+++++|++|++++|++++ ..|..+.++++|++|++++|++.+.+|...+..+++|++|++++|++++.+|.
T Consensus        87 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  166 (549)
T 2z81_A           87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ  166 (549)
T ss_dssp             CSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred             CccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChh
Confidence            98888889999999999999999987 46788999999999999999966678776667899999999999999999999


Q ss_pred             cccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCc-
Q 001988          310 SITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSI-  388 (985)
Q Consensus       310 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~-  388 (985)
                      .+..+++|+.|+++.|.+....+..+..+++|++|++++|++++.....  ......+++|+.|++++|.+.+..+..+ 
T Consensus       167 ~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~--~~~~~~~~~L~~L~l~~n~l~~~~~~~l~  244 (549)
T 2z81_A          167 SLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSP--LPVDEVSSPMKKLAFRGSVLTDESFNELL  244 (549)
T ss_dssp             TTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCC--CSSCCCCCCCCEEEEESCEEEHHHHHHHH
T ss_pred             hhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccc--cchhhhhhcccceeccccccchhHHHHHH
Confidence            9999999999999999987544444567999999999999998763211  1123467899999999999886544333 


Q ss_pred             ---cchhhcccceecccccccccc------CCcCCCCCCccEEEccCCCCCCC-----CCccccccccccceeccccccc
Q 001988          389 ---GNLSLSLERLNIAFCNISGNI------PKAIGNLSNLIVLSLGGNNLSGS-----IPVTFGGLQKLQGLDLAFNKLA  454 (985)
Q Consensus       389 ---~~l~~~L~~L~L~~n~l~~~~------~~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~  454 (985)
                         ..+. +|+.+++++|.+.+..      ...+..+++|+.|++.++.+...     .+..+....+|+.|++++|.+.
T Consensus       245 ~~~~~~~-~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~  323 (549)
T 2z81_A          245 KLLRYIL-ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF  323 (549)
T ss_dssp             GGGGGCT-TCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC
T ss_pred             HHhhhhc-cccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc
Confidence               3333 7999999999987642      23457788999999999987642     1222345678999999999998


Q ss_pred             CCchhhh-hhccCCCeEEccCCccccccC---CCCcCcCcCceEeeccceeeeecC--CCccCccceeEEeecCCcccCC
Q 001988          455 GSIPDEI-CLLSRLNELDLNGNKISGSIS---SCLGNLTSLQYLNLGSNRFTFVIP--STFWNLKDILSFDISSNLLDGP  528 (985)
Q Consensus       455 ~~~p~~~-~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~ls~N~l~~~  528 (985)
                       .+|..+ ..+++|++|+|++|++++.+|   ..+..+++|++|++++|+++++.+  ..+..+++|++|++++|++++ 
T Consensus       324 -~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-  401 (549)
T 2z81_A          324 -LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-  401 (549)
T ss_dssp             -CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCC-
T ss_pred             -cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCcc-
Confidence             566665 679999999999999998763   458899999999999999997643  568899999999999999995 


Q ss_pred             ccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcccccc
Q 001988          529 ISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKL  608 (985)
Q Consensus       529 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  608 (985)
                      +|..+..+++|+.|++++|+|++ +|..+  .++|++|+|++|+|++.+    ..+++|++|+|++|+|+ .+|. ...+
T Consensus       402 lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l  472 (549)
T 2z81_A          402 MPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLF  472 (549)
T ss_dssp             CCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGC
T ss_pred             CChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccC
Confidence            56688999999999999999984 44444  268999999999999753    57899999999999999 6776 5789


Q ss_pred             ccccccccccccccCCCCCC-CCCcccccccccCCccccCCC
Q 001988          609 SYLKELNLSFNKLKGEIPRG-GPFANFTAESFMGNELLCGLP  649 (985)
Q Consensus       609 ~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~  649 (985)
                      ++|++|++++|++++.+|.. ..+.++....+.+|++.|.++
T Consensus       473 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          473 PVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             TTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             ccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence            99999999999999988863 556777888899999988765

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.4e-49  Score=472.96  Aligned_cols=437  Identities=20%  Similarity=0.224  Sum_probs=320.7

Q ss_pred             cccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEe
Q 001988          170 RYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQL  249 (985)
Q Consensus       170 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  249 (985)
                      ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|+.|+++++|++|+|++|+++ .+|..  .+++|++|+|
T Consensus        21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L   97 (520)
T 2z7x_B           21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL   97 (520)
T ss_dssp             TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred             ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence            45556666666665555555666666666666666666555556666666666666666665 44444  5666666666


Q ss_pred             cCCcCcc-cCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCC--cEEEecCccC--CCcCCccccCCC-CccEEEcc
Q 001988          250 GFNNLTG-VVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNL--EFLNLGINSF--SGTIPSSITNAS-KLILLEMG  323 (985)
Q Consensus       250 s~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~-~L~~L~L~  323 (985)
                      ++|++++ .+|..++++++|++|++++|++++    ..+..+++|  +.|++++|++  .+..|..+..+. +...++++
T Consensus        98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~  173 (520)
T 2z7x_B           98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK----SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP  173 (520)
T ss_dssp             CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG----GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECC
T ss_pred             cCCccccccchhhhccCCcceEEEecCcccch----hhccccccceeeEEEeecccccccccccccccccccceEEEEec
Confidence            6666655 345666666666666666666653    112345555  7777777766  566666666655 34456677


Q ss_pred             CcccccccCC-cccCCCCCceEeccCCc-------ccCCCCcccccccccccCcccEEEecCCCCCccCCCCccch--hh
Q 001988          324 SNSFSGFIPS-AIGNLRNLKLFDIFFNN-------LTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNL--SL  393 (985)
Q Consensus       324 ~N~l~~~~p~-~l~~l~~L~~L~L~~N~-------l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~  393 (985)
                      +|.+.+.++. .+.++++|+.|+++.|.       +.+      ..+.+..+++|+.|++++|.+++..+..+...  ..
T Consensus       174 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~------~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~  247 (520)
T 2z7x_B          174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS------ILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT  247 (520)
T ss_dssp             SSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHH------HHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTS
T ss_pred             cCcchhhhhhhhhhcccceeeccccccccccccceeec------chhhhccccchhhccccccccCHHHHHHHHHHhhhC
Confidence            7776655443 46677777777777775       221      12246677788888888777765332222110  12


Q ss_pred             cccceeccccccccccCCcC-----CCCCCccEEEccCCCCCCCCC-cccccc---ccccceecccccccCCchhhhhhc
Q 001988          394 SLERLNIAFCNISGNIPKAI-----GNLSNLIVLSLGGNNLSGSIP-VTFGGL---QKLQGLDLAFNKLAGSIPDEICLL  464 (985)
Q Consensus       394 ~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~-~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l  464 (985)
                      +|++|++++|++++.+|..+     ..+++|+.+++++|.+  .+| ..+..+   .+|+.|++++|.+.+..  .+..+
T Consensus       248 ~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l  323 (520)
T 2z7x_B          248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKI  323 (520)
T ss_dssp             SCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSC
T ss_pred             cccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhC
Confidence            68899999999988888888     8999999999999999  344 556555   67999999999987542  12578


Q ss_pred             cCCCeEEccCCccccccCCCCcCcCcCceEeeccceeee--ecCCCccCccceeEEeecCCcccC-CccccccCCCcccE
Q 001988          465 SRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTF--VIPSTFWNLKDILSFDISSNLLDG-PISLAIGNLKAVVG  541 (985)
Q Consensus       465 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~-~~~~~~~~l~~L~~  541 (985)
                      ++|++|++++|++++.+|..+.++++|++|++++|++++  .+|..|..+++|++|++++|.+.+ +.+..+..+++|+.
T Consensus       324 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~  403 (520)
T 2z7x_B          324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS  403 (520)
T ss_dssp             CCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCE
T ss_pred             CcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCE
Confidence            999999999999999889999999999999999999997  456789999999999999999998 44456889999999


Q ss_pred             EEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcc-cccccccccccccccc
Q 001988          542 IDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS-FEKLSYLKELNLSFNK  620 (985)
Q Consensus       542 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ls~N~  620 (985)
                      |++++|++++.+|..+.  ++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++ +|.. |..+++|++|++++|+
T Consensus       404 L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~  479 (520)
T 2z7x_B          404 LNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNP  479 (520)
T ss_dssp             EECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSC
T ss_pred             EECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCC
Confidence            99999999988887765  79999999999999 688888899999999999999995 5554 9999999999999999


Q ss_pred             ccCCCCC
Q 001988          621 LKGEIPR  627 (985)
Q Consensus       621 l~~~~p~  627 (985)
                      +++.++.
T Consensus       480 ~~c~c~~  486 (520)
T 2z7x_B          480 WDCSCPR  486 (520)
T ss_dssp             BCCCHHH
T ss_pred             CcccCCc
Confidence            9988763

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.4e-48  Score=462.22  Aligned_cols=460  Identities=22%  Similarity=0.218  Sum_probs=245.6

Q ss_pred             EEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeecccc
Q 001988           77 TLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNK  156 (985)
Q Consensus        77 ~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~  156 (985)
                      .+|+++++++ .+|..+.  ++|++|+|++|.+++..|..|..+++|++|+|++|++++..|+.+..+++|++|+|++|+
T Consensus         4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~   80 (520)
T 2z7x_B            4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK   80 (520)
T ss_dssp             EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred             eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence            5788888888 5777665  788888888888887666777888888888888887776656665555555555555555


Q ss_pred             ccCCCChhHhhhccccceecccCccccc-cCCcccCCCCCceEEEcccccCCCcccccccccccc--ceEeeccccc--c
Q 001988          157 LSGKLPENICNHLRYLKHLFLRENMFYG-KIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVL--QRISLINNKL--H  231 (985)
Q Consensus       157 l~g~lp~~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~  231 (985)
                      ++ .+|..   .+++|++|+|++|.+++ .+|..|+++++|++|+|++|++++   ..++.+++|  ++|++++|++  .
T Consensus        81 l~-~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~  153 (520)
T 2z7x_B           81 LV-KISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE  153 (520)
T ss_dssp             CC-EEECC---CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred             ee-ecCcc---ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence            55 34443   34555555555555544 244555555555555555555543   233444444  5555555555  4


Q ss_pred             CCchhhhcCCC-CCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCcc-------C
Q 001988          232 GEIPQEIGYLQ-NLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINS-------F  303 (985)
Q Consensus       232 ~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~-------l  303 (985)
                      +..|..+..+. +...+++++|++                        .+.++...+..+++|+.|++++|.       +
T Consensus       154 ~~~~~~l~~l~~~~l~l~l~~n~~------------------------~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~  209 (520)
T 2z7x_B          154 KEDPEGLQDFNTESLHIVFPTNKE------------------------FHFILDVSVKTVANLELSNIKCVLEDNKCSYF  209 (520)
T ss_dssp             SCCTTTTTTCCEEEEEEECCSSSC------------------------CCCCCCCCCTTCSEEEECCEEECCSTTTTHHH
T ss_pred             ccccccccccccceEEEEeccCcc------------------------hhhhhhhhhhcccceeecccccccccccccee
Confidence            44444444433 122334444444                        333333333334444444444443       3


Q ss_pred             CCcCCccccCCCCccEEEccCcccccccCCccc---CCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCC
Q 001988          304 SGTIPSSITNASKLILLEMGSNSFSGFIPSAIG---NLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPL  380 (985)
Q Consensus       304 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~---~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l  380 (985)
                      .+.+| .+..+++|+.|++++|.+++..+..+.   ..++|++|++++|++++..+...+.....++++|+.+++++|.+
T Consensus       210 ~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~  288 (520)
T 2z7x_B          210 LSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF  288 (520)
T ss_dssp             HHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC
T ss_pred             ecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce
Confidence            32222 333344444444444433322111110   01233333333333332111100000013344444444444444


Q ss_pred             CccCC-CCccchh--hcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccC--
Q 001988          381 DGFLP-SSIGNLS--LSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAG--  455 (985)
Q Consensus       381 ~~~~p-~~~~~l~--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--  455 (985)
                        .+| ..+..+.  .+|+.|++++|.+....  .+..+++|++|++++|++++..|..|+.+++|++|++++|++++  
T Consensus       289 --~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~  364 (520)
T 2z7x_B          289 --GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELS  364 (520)
T ss_dssp             --CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHH
T ss_pred             --ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccc
Confidence              222 1222220  02444445444443221  11455566666666666666556666666666666666666654  


Q ss_pred             CchhhhhhccCCCeEEccCCccccccC-CCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCcccccc
Q 001988          456 SIPDEICLLSRLNELDLNGNKISGSIS-SCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIG  534 (985)
Q Consensus       456 ~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~  534 (985)
                      .+|..+..+++|++|+|++|++++.+| ..+..+++|++|++++|++++                        ..+..+.
T Consensus       365 ~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~------------------------~~~~~l~  420 (520)
T 2z7x_B          365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD------------------------TIFRCLP  420 (520)
T ss_dssp             HHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCG------------------------GGGGSCC
T ss_pred             cchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCc------------------------chhhhhc
Confidence            334455555666666666666555233 234455555555555555543                        3333332


Q ss_pred             CCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCC
Q 001988          535 NLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIP  602 (985)
Q Consensus       535 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  602 (985)
                        ++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+
T Consensus       421 --~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          421 --PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             --TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             --ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence              57778888888887 677777788889999999999885444448888999999999999886533

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9.3e-49  Score=424.97  Aligned_cols=249  Identities=26%  Similarity=0.415  Sum_probs=214.7

Q ss_pred             cCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ++|...+.||+|+||+||+|++.      +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56778899999999999999863      578899999987666667889999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEE
Q 001988          800 VLEYMSNGSLEDCLHSS------------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHL  867 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~------------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl  867 (985)
                      |||||++|+|.++++..            ...++|.++.+|+.|||+||+||   |+++||||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCccCHhhEEECCCCcEEE
Confidence            99999999999999764            24689999999999999999999   7889999999999999999999999


Q ss_pred             ecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------
Q 001988          868 SDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------  934 (985)
Q Consensus       868 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------  934 (985)
                      +|||+|+...............||++|||||.+.++.++.++|| |++|++++|+++ |+.++.....            
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DV-wS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~  248 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV-WSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV  248 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999987654433333445579999999999999999999999 999999999998 6765543211            


Q ss_pred             hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          935 FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       935 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                      .+.++.+++++.+++.+||+.||++||||.|+++.|+++.+..+
T Consensus       249 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p  292 (299)
T 4asz_A          249 LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP  292 (299)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence            12345578899999999999999999999999999999887644

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=427.37  Aligned_cols=249  Identities=23%  Similarity=0.397  Sum_probs=207.5

Q ss_pred             cCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ++|...++||+|+||+||+|+++      +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45677789999999999999864      578899999987766667889999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcE
Q 001988          800 VLEYMSNGSLEDCLHSSN--------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  865 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~  865 (985)
                      |||||++|+|.++++...              ..++|.++.+|+.|||+||+||   |+++||||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecccccHhhEEECCCCcE
Confidence            999999999999997642              3589999999999999999999   78899999999999999999999


Q ss_pred             EEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcch-----------
Q 001988          866 HLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEK-----------  933 (985)
Q Consensus       866 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~-----------  933 (985)
                      ||+|||+|+.+...+........+||+.|||||++.+..++.++|| |++|++++|+++ |+.++....           
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDv-wS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g  276 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDV-WSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG  276 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHH-HHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccc-cchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999998754444444455679999999999999999999999 999999999998 676554321           


Q ss_pred             -hhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          934 -HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       934 -~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                       ..+.++.+++++.+++.+||+.||++||||.||++.|+.+.+..+
T Consensus       277 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp  322 (329)
T 4aoj_A          277 RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP  322 (329)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred             CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence             122344578899999999999999999999999999999987644

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=414.57  Aligned_cols=249  Identities=24%  Similarity=0.405  Sum_probs=207.1

Q ss_pred             HhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ..++|...+.||+|+||+||+|++++  .||||+++...  ....+.|.+|++++++++|||||+++|+|.+ +..+|||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            34677888999999999999999753  59999987543  2345789999999999999999999999865 5689999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      |||+||+|.++++.....+++.++.+|+.|||+||+||   |+++||||||||+|||+++++.+||+|||+|+.......
T Consensus       111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yL---H~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYL---HAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            99999999999988777899999999999999999999   688999999999999999999999999999987654443


Q ss_pred             cceeccccccccccccccccc---CccchhhhcccccccchhhhcccccccCcchhh-----------------hhHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFV---GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-----------------AAKEQC  941 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-----------------~~~~~~  941 (985)
                      .......+||+.|||||++..   +.++.++|| |++|++++|+++|+.++......                 ..+..+
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDV-wS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  266 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDV-YSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC  266 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHH-HHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHh-HhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence            444456689999999999864   468999999 99999999999998876432110                 112357


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          942 LLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       942 ~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                      ++++.+++.+||+.||++||||.||++.|+.+++.+++
T Consensus       267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk  304 (307)
T 3omv_A          267 PKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK  304 (307)
T ss_dssp             CHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence            78899999999999999999999999999999877654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.9e-48  Score=419.52  Aligned_cols=244  Identities=25%  Similarity=0.376  Sum_probs=207.9

Q ss_pred             cCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      ++++..+.||+|+||+||+|++.      +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34566788999999999999863      568899999976533 34578999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC
Q 001988          799 LVLEYMSNGSLEDCLHSS---------------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM  863 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~  863 (985)
                      ||||||++|+|.+++...               ...++|.++.+|+.|||+||+||   |+++||||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCCCCCCccccceEECCCC
Confidence            999999999999999653               23589999999999999999999   789999999999999999999


Q ss_pred             cEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcch---------
Q 001988          864 VAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEK---------  933 (985)
Q Consensus       864 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~---------  933 (985)
                      .+||+|||+|+.+...+........+||++|||||.+.++.++.++|| |++|++++|+++ |..++....         
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDV-wSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~  261 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDI-WSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR  261 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchh-hhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            999999999987754443334455679999999999999999999999 999999999998 565443321         


Q ss_pred             ---hhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          934 ---HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       934 ---~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                         ..+.++.|++++.++|.+||+.||++||+|.||+++|+..
T Consensus       262 ~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          262 NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence               1223456888999999999999999999999999998753

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=3.3e-46  Score=455.38  Aligned_cols=512  Identities=20%  Similarity=0.198  Sum_probs=428.8

Q ss_pred             CeEEEEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeee
Q 001988           73 HKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRL  152 (985)
Q Consensus        73 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l  152 (985)
                      ..++.|||++|+|++..+.+|.++++|++|||++|+|++..|.+|.+|++|++|+|++|+|++..++++..+++|++|+|
T Consensus        52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L  131 (635)
T 4g8a_A           52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  131 (635)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence            36899999999999766678999999999999999999877778999999999999999999988899999999999999


Q ss_pred             ccccccCCCChhHhhhccccceecccCccccc-cCCcccCCCCCceEEEcccccCCCccccccccccccc----eEeecc
Q 001988          153 SKNKLSGKLPENICNHLRYLKHLFLRENMFYG-KIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQ----RISLIN  227 (985)
Q Consensus       153 s~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~L~~  227 (985)
                      ++|+++ .+|+..++++++|++|+|++|.+++ .+|..++++++|++|+|++|++++..|..+..+.+++    .++++.
T Consensus       132 s~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~  210 (635)
T 4g8a_A          132 VETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL  210 (635)
T ss_dssp             TTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred             CCCcCC-CCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhccc
Confidence            999999 5676667899999999999999986 4688999999999999999999998898888877654    688999


Q ss_pred             ccccCCchhhhcCCCCCCEEEecCCcCcc-cCcccccCCCCCCEEEccCCcCcc-----cCChhhhhcCCCCcEEEecCc
Q 001988          228 NKLHGEIPQEIGYLQNLDVLQLGFNNLTG-VVPATIFNMSTLKEIFLYNNSLSG-----SLPSRIDLALPNLEFLNLGIN  301 (985)
Q Consensus       228 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~-----~~p~~~~~~l~~L~~L~Ls~N  301 (985)
                      |.++...+..+ ....++.+++++|.... ..+..+..+..++...+..+....     ......+..+..+..+++..+
T Consensus       211 n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~  289 (635)
T 4g8a_A          211 NPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA  289 (635)
T ss_dssp             CCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEE
T ss_pred             CcccccCcccc-cchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhh
Confidence            99985544444 45577889999987664 345667788888877765443321     112222334566777777666


Q ss_pred             cCCC---cCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCC
Q 001988          302 SFSG---TIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGN  378 (985)
Q Consensus       302 ~l~~---~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N  378 (985)
                      ....   .++..+....+++.+++.+|.+....  .+....+|+.|++.+|++.....        ..++.|+.+++++|
T Consensus       290 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~--------~~l~~L~~l~l~~n  359 (635)
T 4g8a_A          290 YLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPT--------LKLKSLKRLTFTSN  359 (635)
T ss_dssp             CCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCC--------CBCTTCCEEEEESC
T ss_pred             hhcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCc--------ccchhhhhcccccc
Confidence            5443   23455667788999999999887543  36677889999999999887654        24678999999999


Q ss_pred             CCCccCCCCccchhhcccceecccccccc--ccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCC
Q 001988          379 PLDGFLPSSIGNLSLSLERLNIAFCNISG--NIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGS  456 (985)
Q Consensus       379 ~l~~~~p~~~~~l~~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  456 (985)
                      .+....+  ...++ +|+.|++++|.+..  ..+..+..+.+|+++++..|.+.. .+..+..+++|+.++++.|.....
T Consensus       360 ~~~~~~~--~~~l~-~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~  435 (635)
T 4g8a_A          360 KGGNAFS--EVDLP-SLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQM  435 (635)
T ss_dssp             CSCCBCC--CCBCT-TCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEEST
T ss_pred             cCCCCcc--ccccc-ccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhcccccc
Confidence            8875432  33455 79999999998863  456667788999999999999874 556788999999999999988765


Q ss_pred             ch-hhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeecccee-eeecCCCccCccceeEEeecCCcccCCcccccc
Q 001988          457 IP-DEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRF-TFVIPSTFWNLKDILSFDISSNLLDGPISLAIG  534 (985)
Q Consensus       457 ~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l-~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~  534 (985)
                      .+ ..+..+++++.++++.|.+.+..+..+..++.|++|++++|++ .+..|..|..+++|++|++++|+|+++.|..|.
T Consensus       436 ~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~  515 (635)
T 4g8a_A          436 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN  515 (635)
T ss_dssp             TSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHc
Confidence            54 4678899999999999999999999999999999999999985 457889999999999999999999999999999


Q ss_pred             CCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcc-cccCeEecCCCcccCC
Q 001988          535 NLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNM-TSLESLDLSNNKISGS  600 (985)
Q Consensus       535 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~  600 (985)
                      ++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++.+|+.|..+ ++|++|+|++|+++..
T Consensus       516 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~  582 (635)
T 4g8a_A          516 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  582 (635)
T ss_dssp             TCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred             CCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence            99999999999999999999999999999999999999999999999998 6899999999999853

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.1e-46  Score=451.80  Aligned_cols=448  Identities=20%  Similarity=0.214  Sum_probs=333.5

Q ss_pred             CCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhc
Q 001988          160 KLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIG  239 (985)
Q Consensus       160 ~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  239 (985)
                      .+|..++   ++|++|+|++|.+++..|..|+++++|++|+|++|++++..|+.|+++++|++|+|++|+++ .+|..  
T Consensus        45 ~ip~~~~---~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--  118 (562)
T 3a79_B           45 HVPKDLP---PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--  118 (562)
T ss_dssp             SCCTTSC---TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--
T ss_pred             cCCCCCC---CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--
Confidence            3554442   56677777777777666667777777777777777777666777777777777777777776 55655  


Q ss_pred             CCCCCCEEEecCCcCcc-cCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCC--cEEEecCccC--CCcCCccccCC
Q 001988          240 YLQNLDVLQLGFNNLTG-VVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNL--EFLNLGINSF--SGTIPSSITNA  314 (985)
Q Consensus       240 ~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l  314 (985)
                      .+++|++|+|++|++++ .+|..|.++++|++|+|++|++++..    +..+++|  +.|++++|++  ++..|..+..+
T Consensus       119 ~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~----~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l  194 (562)
T 3a79_B          119 PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLD----LLPVAHLHLSCILLDLVSYHIKGGETESLQIP  194 (562)
T ss_dssp             CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTT----TGGGTTSCEEEEEEEESSCCCCSSSCCEEEEC
T ss_pred             ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCc----hhhhhhceeeEEEeecccccccccCccccccc
Confidence            67777777777777775 34567777777777777777776421    2234455  8888888877  77777777665


Q ss_pred             C-CccEEEccCcccccccCC-cccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCcc---
Q 001988          315 S-KLILLEMGSNSFSGFIPS-AIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIG---  389 (985)
Q Consensus       315 ~-~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~---  389 (985)
                      . ....+++++|.+.+.++. .+..+++|+.+++++|+.... .-.+....+..+++|+.|+++++.+.+.....+.   
T Consensus       195 ~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~-~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~  273 (562)
T 3a79_B          195 NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ-RLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF  273 (562)
T ss_dssp             CEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH-HHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH
T ss_pred             CcceEEEEecCccchhhhhhhcccccceEEEecccccccccc-hHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhh
Confidence            4 222557778877765544 456778888888888752100 0011223466777888888887776642111110   


Q ss_pred             chhhcccceeccccccccccCCcC-----CCCCCccEEEccCCCCCCCCC-cccccc---ccccceecccccccCCchhh
Q 001988          390 NLSLSLERLNIAFCNISGNIPKAI-----GNLSNLIVLSLGGNNLSGSIP-VTFGGL---QKLQGLDLAFNKLAGSIPDE  460 (985)
Q Consensus       390 ~l~~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~-~~~~~l---~~L~~L~Ls~N~l~~~~p~~  460 (985)
                      ... +|++|++++|.+++.+|..+     ..++.|+.++++.|.+  .+| ..+..+   .+|+.|++++|.+.....  
T Consensus       274 ~~~-~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~--  348 (562)
T 3a79_B          274 WPR-PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMVC--  348 (562)
T ss_dssp             TTS-SEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCCC--
T ss_pred             hcc-cccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCcccccC--
Confidence            112 78999999999998888887     7788888888888887  344 334333   579999999999874321  


Q ss_pred             hhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeee--cCCCccCccceeEEeecCCcccC-CccccccCCC
Q 001988          461 ICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFV--IPSTFWNLKDILSFDISSNLLDG-PISLAIGNLK  537 (985)
Q Consensus       461 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~ls~N~l~~-~~~~~~~~l~  537 (985)
                      ...+++|++|++++|++++.+|..+.++++|++|++++|+++++  .|..|.++++|++|++++|++++ ..+..+..++
T Consensus       349 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~  428 (562)
T 3a79_B          349 PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE  428 (562)
T ss_dssp             CSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCT
T ss_pred             ccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcc
Confidence            25789999999999999998999999999999999999999974  45778999999999999999998 5555688999


Q ss_pred             cccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcc-cccccccccccc
Q 001988          538 AVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVS-FEKLSYLKELNL  616 (985)
Q Consensus       538 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~l  616 (985)
                      +|+.|++++|+|++.+|..+.  ++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++ +|.. +..+++|+.|++
T Consensus       429 ~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l  504 (562)
T 3a79_B          429 SILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWL  504 (562)
T ss_dssp             TCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEEC
T ss_pred             cCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEe
Confidence            999999999999988777664  79999999999999 577777799999999999999995 5555 999999999999


Q ss_pred             ccccccCCCCC
Q 001988          617 SFNKLKGEIPR  627 (985)
Q Consensus       617 s~N~l~~~~p~  627 (985)
                      ++|+++|.+|.
T Consensus       505 ~~N~~~c~c~~  515 (562)
T 3a79_B          505 HDNPWDCTCPG  515 (562)
T ss_dssp             CSCCBCCCHHH
T ss_pred             cCCCcCCCcch
Confidence            99999988874

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.4e-46  Score=409.40  Aligned_cols=235  Identities=23%  Similarity=0.272  Sum_probs=207.7

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      +.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46888899999999999999975 79999999998665556677899999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      +||+|.+++...  .+++.+...++.||+.||+||   |++|||||||||+|||++.+|.+||+|||+|+.+....  ..
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~  226 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR  226 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CC
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Cc
Confidence            999999999864  589999999999999999999   78999999999999999999999999999999875332  23


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--------------hhHHHHHHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQCLLSIFSLAL  950 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~~~~l~~l~~  950 (985)
                      ....+||+.|||||++.+..|+.++|+ |++|++++||++|+.++......              .....+++++.+++.
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~Di-WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  305 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDI-WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  305 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHH-HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHH-HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence            456789999999999999999999999 99999999999998876543211              122345678999999


Q ss_pred             HccCCCCCCCCCHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~  968 (985)
                      +||..||++|||+.|+++
T Consensus       306 ~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          306 RLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             HHSCSSTTTSCCHHHHTT
T ss_pred             HHcCCChhHCcCHHHHhc
Confidence            999999999999999876

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=6.7e-46  Score=444.95  Aligned_cols=465  Identities=20%  Similarity=0.208  Sum_probs=252.6

Q ss_pred             EEEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccc
Q 001988           76 TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKN  155 (985)
Q Consensus        76 ~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n  155 (985)
                      ..+|++++++++ +|..+.  ++|++|+|++|.+++..|..|..+++|++|+|++|++++..|+.+..+++|++|+|++|
T Consensus        34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  110 (562)
T 3a79_B           34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN  110 (562)
T ss_dssp             CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence            689999999994 887765  89999999999999877889999999999999999998776776666666666666666


Q ss_pred             cccCCCChhHhhhccccceecccCccccc-cCCcccCCCCCceEEEcccccCCCcccccccccccc--ceEeeccccc--
Q 001988          156 KLSGKLPENICNHLRYLKHLFLRENMFYG-KIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVL--QRISLINNKL--  230 (985)
Q Consensus       156 ~l~g~lp~~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--  230 (985)
                      +++ .+|..   .+++|++|+|++|.+++ .+|..|+++++|++|+|++|++++.   .+..+++|  ++|++++|++  
T Consensus       111 ~l~-~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~  183 (562)
T 3a79_B          111 RLQ-NISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI  183 (562)
T ss_dssp             CCC-EECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred             cCC-ccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence            665 45544   45555555655555554 2345555555555555555555532   23333333  5555555555  


Q ss_pred             cCCchhhhcCCC--CCCEEEecCCcCcccCcc-cccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcC
Q 001988          231 HGEIPQEIGYLQ--NLDVLQLGFNNLTGVVPA-TIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTI  307 (985)
Q Consensus       231 ~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~  307 (985)
                      ++..|..+..+.  .| .++++.|.+.+.++. .+.++++|+.|++++|+..-.                    .+.+ .
T Consensus       184 ~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~--------------------~l~~-~  241 (562)
T 3a79_B          184 KGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ--------------------RLMT-F  241 (562)
T ss_dssp             CSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH--------------------HHHH-H
T ss_pred             cccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccc--------------------hHHH-H
Confidence            455555544433  22 334444544443322 223344444444444431000                    0110 0


Q ss_pred             CccccCCCCccEEEccCccccccc----CCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCcc
Q 001988          308 PSSITNASKLILLEMGSNSFSGFI----PSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGF  383 (985)
Q Consensus       308 p~~~~~l~~L~~L~L~~N~l~~~~----p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~  383 (985)
                      ...+..+++|+.|+++++.+++..    +..+ ..++|++|++++|++++..+...+.....+++.|+.++++.|.+  .
T Consensus       242 ~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~  318 (562)
T 3a79_B          242 LSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--L  318 (562)
T ss_dssp             HHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--S
T ss_pred             HHHHhccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--e
Confidence            112233333333333333332210    0000 11234444444444432211110000113444555555555554  2


Q ss_pred             CC-CCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhh
Q 001988          384 LP-SSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEIC  462 (985)
Q Consensus       384 ~p-~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  462 (985)
                      +| ..+..+.                      ...+|++|++++|.+....  .+..+++|++|++++|++++.+|..+.
T Consensus       319 ~p~~~~~~~~----------------------~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~  374 (562)
T 3a79_B          319 FSKEALYSVF----------------------AEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCS  374 (562)
T ss_dssp             SCHHHHHHHH----------------------HTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCC
T ss_pred             cChhhhhhhh----------------------ccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhc
Confidence            23 1111110                      0123444455444443211  013444555555555555544444455


Q ss_pred             hccCCCeEEccCCccccc--cCCCCcCcCcCceEeeccceeee-ecCCCccCccceeEEeecCCcccCCccccccCCCcc
Q 001988          463 LLSRLNELDLNGNKISGS--ISSCLGNLTSLQYLNLGSNRFTF-VIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAV  539 (985)
Q Consensus       463 ~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L  539 (985)
                      .+++|++|+|++|++++.  +|..+.++++|++|++++|++++ +.+..|..+++|++|++++|++++..+..+.  ++|
T Consensus       375 ~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L  452 (562)
T 3a79_B          375 TLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKV  452 (562)
T ss_dssp             SCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTC
T ss_pred             ccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcC
Confidence            555555555555555431  23345555555555555555555 3333455555666666666665544443332  578


Q ss_pred             cEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCC
Q 001988          540 VGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIP  602 (985)
Q Consensus       540 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  602 (985)
                      +.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..|
T Consensus       453 ~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             SEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             CEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence            88888888887 566666688888888888888885433348888889999999998886544

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.5e-46  Score=412.82  Aligned_cols=259  Identities=21%  Similarity=0.326  Sum_probs=219.9

Q ss_pred             cCHHHHHHHhcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCC-CCeeeE
Q 001988          716 FSYFELLRATDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRH-RNLVKI  787 (985)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h-~niv~l  787 (985)
                      +...+++...++|+..+.||+|+||+||+|++.      +++.||||+++.... ...+.|.+|++++++++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            445666667789999999999999999999864      246799999976543 345679999999999976 899999


Q ss_pred             EeeeecC-CceEEEEeccCCCChHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCC
Q 001988          788 ISSCSND-DFKALVLEYMSNGSLEDCLHSS---------------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCD  851 (985)
Q Consensus       788 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrD  851 (985)
                      +|+|.+. +..+||||||++|+|.++++..               ...+++.++..++.|||+||+||   |+++|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL---H~~~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH---HHTTCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH---hhCCeecCc
Confidence            9999764 5689999999999999999753               23478999999999999999999   789999999


Q ss_pred             CCCCCEEEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccC
Q 001988          852 LKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSG  930 (985)
Q Consensus       852 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~  930 (985)
                      |||+|||+++++.+||+|||+|+.+............+||+.|||||.+.++.++.++|| |++|++++|+++ |..++.
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDV-wS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV-WSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHTTTSCCSST
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccE-eehHHHHHHHHhCCCCCCC
Confidence            999999999999999999999998765555555566789999999999999999999999 999999999997 666554


Q ss_pred             cch-------------hhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          931 EEK-------------HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       931 ~~~-------------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                      ...             ....++.+++++.+++.+||+.||++||||.|+++.|+++.+.-.
T Consensus       290 ~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~  350 (353)
T 4ase_A          290 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  350 (353)
T ss_dssp             TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             CCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence            321             112234577899999999999999999999999999999887644

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.4e-46  Score=409.16  Aligned_cols=237  Identities=21%  Similarity=0.285  Sum_probs=200.8

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++++...  ...+.+.+|++++++++|||||++++++++++..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999965 799999999976532  345678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          803 YMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       803 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+||+|.+++... +..+++.....|+.||+.||+||   |++|||||||||+|||++++|.+||+|||+|+.+..  .
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV---HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--T  178 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--H
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHHHEEECCCCCEEEcccccceeecC--C
Confidence            99999999999765 34578999999999999999999   789999999999999999999999999999987632  1


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh------------hHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------AKEQCLLSIFSLA  949 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------~~~~~~~~l~~l~  949 (985)
                      .......+||+.|||||++.+..|+.++|+ |++|++++++++|+.++.......            .+..+++++.+++
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~Di-wSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li  257 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDI-WALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV  257 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHH-HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence            222345679999999999999999999999 999999999999998765432111            1233567899999


Q ss_pred             HHccCCCCCCCCCHHHHHH
Q 001988          950 LECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+||..||++|||+.|+++
T Consensus       258 ~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          258 SQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HHHTCSSGGGSCCHHHHHT
T ss_pred             HHHccCChhHCcCHHHHhc
Confidence            9999999999999999976

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.5e-46  Score=401.54  Aligned_cols=237  Identities=26%  Similarity=0.345  Sum_probs=209.1

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|+..+.||+|+||+||+|+.. +++.||||++.+..   ....+.+.+|++++++++|||||++++++++++..||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999965 79999999997542   233567899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      |||+||+|.+++...+ .+++.+...++.||+.||+||   |++|||||||||+|||++.++.+||+|||+|+.+.....
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            9999999999998764 689999999999999999999   789999999999999999999999999999998865554


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLAL  950 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~  950 (985)
                      .......+||+.|||||++.+..++.++|+ |++|+++++|++|..++.......           .++..++++.+++.
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~Di-WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~  266 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDL-WALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVE  266 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHH
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHH
Confidence            445567789999999999999999999999 999999999999998765432211           12345678999999


Q ss_pred             HccCCCCCCCCCHHHHH
Q 001988          951 ECTMESPEKRIDAKDTI  967 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~  967 (985)
                      +|+..||++|||+.|+.
T Consensus       267 ~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          267 KLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHSCSSGGGSTTSGGGT
T ss_pred             HHccCCHhHCcChHHHc
Confidence            99999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.2e-46  Score=406.23  Aligned_cols=243  Identities=20%  Similarity=0.202  Sum_probs=207.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .+.|...++||+|+||+||+|+++ +|+.||||+++.+..     ..+|++++++++|||||++++++.+++..||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            356788889999999999999975 799999999976532     24699999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-cEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~~~~~~~~~  882 (985)
                      |+||+|.++++..+ .+++.....++.||+.||+||   |+++||||||||+|||++.+| ++||+|||+|+.+......
T Consensus       132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYL---HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            99999999998764 689999999999999999999   799999999999999999998 6999999999987543221


Q ss_pred             ---ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcch--------------hhhhHHHHHHHH
Q 001988          883 ---TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK--------------HFAAKEQCLLSI  945 (985)
Q Consensus       883 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~--------------~~~~~~~~~~~l  945 (985)
                         ......+||+.|||||++.+..++.++|+ |++|+++++|++|+.++....              ....++.+++++
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~Di-wSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~  286 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDI-WSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT  286 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHH-HHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHH-HHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence               12234679999999999999999999999 999999999999987754321              112234577889


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      .+++.+||..||++|||+.|+++.+.++.+..
T Consensus       287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence            99999999999999999999999998877653

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.7e-45  Score=408.96  Aligned_cols=235  Identities=23%  Similarity=0.272  Sum_probs=208.3

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      +.|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56899999999999999999975 79999999998776666678999999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      +||+|.+++...  .+++.....|+.||+.||+||   |++|||||||||+|||++.+|.+||+|||+|+.+....  ..
T Consensus       231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~yl---H~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~  303 (423)
T 4fie_A          231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR  303 (423)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CC
T ss_pred             CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHH---HHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--cc
Confidence            999999999764  589999999999999999999   78999999999999999999999999999999875332  23


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh--------------hHHHHHHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--------------AKEQCLLSIFSLAL  950 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--------------~~~~~~~~l~~l~~  950 (985)
                      ....+||+.|||||++.+..|+.++|+ |++|++++||++|+.++.......              ....+++++.+++.
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~Di-WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  382 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDI-WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  382 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHH-HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHH-HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence            456789999999999999999999999 999999999999998765432111              12235678999999


Q ss_pred             HccCCCCCCCCCHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~  968 (985)
                      +||..||++|||+.|+++
T Consensus       383 ~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          383 RLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             HHSCSSTTTSCCHHHHTT
T ss_pred             HHcCCChhHCcCHHHHhc
Confidence            999999999999999876

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.1e-44  Score=400.07  Aligned_cols=293  Identities=31%  Similarity=0.518  Sum_probs=205.0

Q ss_pred             cCChhHHHHHHHHHHhcccCCCCcccCCCCCCCCcce--eeeEEEeCCC--CeEEEEEecCCcccc--cCchhccccccc
Q 001988           26 SNISTDQQALLALKDHITYDPTNLLGTNWTSNASICS--WIGIICDVNS--HKVTTLNLSSFNLQG--TIPPEIANLSSL   99 (985)
Q Consensus        26 ~~~~~~~~aLl~~k~~~~~~~~~~~~s~w~~~~~~c~--w~gv~c~~~~--~~v~~l~L~~~~l~g--~~~~~l~~l~~L   99 (985)
                      .|.++|++||++||+++. ||. .+++ |..+++||.  |.||+|+..+  ++|+.|+|++++++|  .+|+.++++++|
T Consensus         2 ~c~~~~~~aL~~~k~~~~-~~~-~l~~-W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L   78 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLG-NPT-TLSS-WLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL   78 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTT-CCG-GGTT-CCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred             CCCHHHHHHHHHHHHhcC-Ccc-cccC-CCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence            467999999999999995 776 5666 887889998  9999998765  899999999999999  999999999999


Q ss_pred             ceecccC-CcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccceeccc
Q 001988          100 KSLDLSH-NKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLR  178 (985)
Q Consensus       100 ~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~  178 (985)
                      ++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..+..+++|++|++++|.+++                   
T Consensus        79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-------------------  139 (313)
T 1ogq_A           79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG-------------------  139 (313)
T ss_dssp             SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEES-------------------
T ss_pred             CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCC-------------------
Confidence            9999995 99999999999999999999999998887666665555555555555555554                   


Q ss_pred             CccccccCCcccCCCCCceEEEcccccCCCcccccccccc-ccceEeeccccccCCchhhhcCCCCCCEEEecCCcCccc
Q 001988          179 ENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLT-VLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGV  257 (985)
Q Consensus       179 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  257 (985)
                            .+|..++++++|++|+|++|++++.+|..+++++ +|++|++++|++++.+|..++.++ |++|++++|++++.
T Consensus       140 ------~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~  212 (313)
T 1ogq_A          140 ------TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGD  212 (313)
T ss_dssp             ------CCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEEC
T ss_pred             ------cCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCc
Confidence                  4444455555555555555555544555555544 455555555555555555555554 55555555555555


Q ss_pred             CcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccC
Q 001988          258 VPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGN  337 (985)
Q Consensus       258 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~  337 (985)
                      .|..+..+++|++|+|++|++++.+|.  +..+++|++|+|++|++++.+|..+..+++|+.|++++|++++.+|.. ++
T Consensus       213 ~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~  289 (313)
T 1ogq_A          213 ASVLFGSDKNTQKIHLAKNSLAFDLGK--VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GN  289 (313)
T ss_dssp             CGGGCCTTSCCSEEECCSSEECCBGGG--CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TT
T ss_pred             CCHHHhcCCCCCEEECCCCceeeecCc--ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-cc
Confidence            555555555555555555555544443  234566666666666666666666777777777777777777777665 67


Q ss_pred             CCCCceEeccCCc
Q 001988          338 LRNLKLFDIFFNN  350 (985)
Q Consensus       338 l~~L~~L~L~~N~  350 (985)
                      +++|+.+++++|+
T Consensus       290 l~~L~~l~l~~N~  302 (313)
T 1ogq_A          290 LQRFDVSAYANNK  302 (313)
T ss_dssp             GGGSCGGGTCSSS
T ss_pred             ccccChHHhcCCC
Confidence            7777777777776

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=9.6e-45  Score=396.50  Aligned_cols=246  Identities=23%  Similarity=0.324  Sum_probs=196.7

Q ss_pred             cCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCC----ceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD----FKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----~~~lv~  801 (985)
                      ++|...+.||+|+||+||+|++ +|+.||||+++.... ....++.|+..+.+++|||||+++++|.+++    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4577788999999999999998 589999999975421 1222345566667889999999999997654    579999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG-----HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~-----h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      |||++|+|.++++..  .+++..+.+++.|+++||+|||..     |.++||||||||+|||+++++++||+|||+|+..
T Consensus        81 Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            999999999999865  589999999999999999999742     3569999999999999999999999999999987


Q ss_pred             cCCCCcc--eecccccccccccccccccC------ccchhhhcccccccchhhhcccccccCcch---------------
Q 001988          877 SGEDEST--MRTQTLATIGYMAPDEIFVG------ELSLKRWVNDLLPVSLVEVVDKSLLSGEEK---------------  933 (985)
Q Consensus       877 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~---------------  933 (985)
                      .......  .....+||+.|||||++.+.      .++.++|| |++|++++|++++..+.+...               
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DV-wS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI-YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHH-HHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhh-hhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            5433321  22345799999999998654      47889999 999999999998765432110               


Q ss_pred             ------------------hhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          934 ------------------HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       934 ------------------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                                        ......++++.+.+++.+||..||++||||.||++.|+++.+.
T Consensus       238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence                              0001123567899999999999999999999999999998865

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.6e-44  Score=383.40  Aligned_cols=234  Identities=23%  Similarity=0.321  Sum_probs=190.3

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++++...   .....+.+|++++++++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999864 799999999976532   23467899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+ +|+|.+++...+ .+++.+...++.||+.||+||   |++||+||||||+|||+++++.+||+|||+|+.....  
T Consensus        93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYC---HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--  165 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--
Confidence            999 689999998764 689999999999999999999   7899999999999999999999999999999876432  


Q ss_pred             cceecccccccccccccccccCcc-chhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGEL-SLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLA  949 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~  949 (985)
                       ......+||+.|||||++.+..+ +.++|+ |++|++++++++|+.++.......           .++.+++++.+++
T Consensus       166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~Di-wSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  243 (275)
T 3hyh_A          166 -NFLKTSCGSPNYAAPEVISGKLYAGPEVDV-WSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLI  243 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred             -CccCCeeECcccCChhhhcCCCCCCChhhh-HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence             22345689999999999988876 578999 999999999999998765432211           1233567899999


Q ss_pred             HHccCCCCCCCCCHHHHHH
Q 001988          950 LECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+|+..||++|||+.|+++
T Consensus       244 ~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          244 KRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HHHSCSSGGGSCCHHHHHH
T ss_pred             HHHccCChhHCcCHHHHHc
Confidence            9999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2e-44  Score=387.90  Aligned_cols=230  Identities=23%  Similarity=0.336  Sum_probs=193.2

Q ss_pred             cCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeec----CCceEEEE
Q 001988          729 AENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSN----DDFKALVL  801 (985)
Q Consensus       729 ~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~lv~  801 (985)
                      +..++||+|+||+||+|.+. +++.||+|++....  ....+.|.+|++++++++|||||+++++|.+    ++..||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999875 78999999997542  2345679999999999999999999999865    34579999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCEEEc-CCCcEEEecccCceeccC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP--IIHCDLKPSNVLLD-EDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~--ivHrDlk~~Nill~-~~~~~kl~DfGla~~~~~  878 (985)
                      |||+||+|.+++...+ .+++.....|+.||+.||+||   |+++  ||||||||+|||++ ++|.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~yl---H~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999998754 689999999999999999999   5666  99999999999997 489999999999986432


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh--------------hhhHHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH--------------FAAKEQCLLS  944 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~--------------~~~~~~~~~~  944 (985)
                          ......+||+.|||||++. +.++.++|+ |++|++++++++|+.++.....              ...+..++++
T Consensus       185 ----~~~~~~~GTp~YmAPE~~~-~~y~~~~Di-wSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  258 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAPEMYE-EKYDESVDV-YAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGG-TCCCTHHHH-HHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             ----CccCCcccCccccCHHHcC-CCCCcHHHH-HHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHH
Confidence                2234568999999999875 579999999 9999999999999887643211              1112234567


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHH
Q 001988          945 IFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       945 l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +.+++.+||..||++|||+.|+++
T Consensus       259 ~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          259 VKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999999875

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=3.9e-43  Score=406.97  Aligned_cols=422  Identities=23%  Similarity=0.253  Sum_probs=201.9

Q ss_pred             cccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccce
Q 001988           95 NLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKH  174 (985)
Q Consensus        95 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~  174 (985)
                      +.++|++|++++|.+ |.+|++++++++|++|++++|+++|.+|..++++.+|+.++++.|.            ..++++
T Consensus         9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~------------~~~l~~   75 (454)
T 1jl5_A            9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL------------DRQAHE   75 (454)
T ss_dssp             --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHH------------HHTCSE
T ss_pred             ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhh------------ccCCCE
Confidence            445666666666666 5666666666666666666666666666666666655555555442            145667


Q ss_pred             ecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcC
Q 001988          175 LFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNL  254 (985)
Q Consensus       175 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  254 (985)
                      |++++|.+++ +|..   .++|++|++++|++++ +|+.   +++|++|++++|++++ +|..   .++|++|++++|++
T Consensus        76 L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l  143 (454)
T 1jl5_A           76 LELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQL  143 (454)
T ss_dssp             EECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCC
T ss_pred             EEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCC
Confidence            7777777663 4442   2567777777777775 5543   2567777777777764 2321   15677777777777


Q ss_pred             cccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCc
Q 001988          255 TGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSA  334 (985)
Q Consensus       255 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  334 (985)
                      ++ +| .+.++++|++|++++|++++ +|..    .++|++|++++|++++ +| .++++++|+.|++++|++++ +|..
T Consensus       144 ~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~  213 (454)
T 1jl5_A          144 EK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL  213 (454)
T ss_dssp             SS-CC-CCTTCTTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC
T ss_pred             CC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC
Confidence            75 55 47777777777777777763 5532    2467777777777665 44 46666666666666666664 2322


Q ss_pred             ccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCC
Q 001988          335 IGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIG  414 (985)
Q Consensus       335 l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~  414 (985)
                      .   ++|++|++++|+++.++       .+..+++|++|++++|++++ +|..                           
T Consensus       214 ~---~~L~~L~l~~n~l~~lp-------~~~~l~~L~~L~l~~N~l~~-l~~~---------------------------  255 (454)
T 1jl5_A          214 P---LSLESIVAGNNILEELP-------ELQNLPFLTTIYADNNLLKT-LPDL---------------------------  255 (454)
T ss_dssp             C---TTCCEEECCSSCCSSCC-------CCTTCTTCCEEECCSSCCSS-CCSC---------------------------
T ss_pred             c---CcccEEECcCCcCCccc-------ccCCCCCCCEEECCCCcCCc-cccc---------------------------
Confidence            1   35566666666555332       13455555555555555553 2221                           


Q ss_pred             CCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceE
Q 001988          415 NLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYL  494 (985)
Q Consensus       415 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  494 (985)
                       +++|++|++++|++++ +|..   .++|+.|++++|++++. |.   ..++|+.|++++|++++. +..   .++|++|
T Consensus       256 -~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~---~~~~L~~L~l~~N~l~~i-~~~---~~~L~~L  322 (454)
T 1jl5_A          256 -PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SE---LPPNLYYLNASSNEIRSL-CDL---PPSLEEL  322 (454)
T ss_dssp             -CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SC---CCTTCCEEECCSSCCSEE-CCC---CTTCCEE
T ss_pred             -ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cC---cCCcCCEEECcCCcCCcc-cCC---cCcCCEE
Confidence             1344455555555443 2221   24455555555555531 11   014566666666666542 211   1356666


Q ss_pred             eeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCc--cCchhhcccccceeeeeecce
Q 001988          495 NLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSG--NIPTTLEGLKSLQNISLAYNR  572 (985)
Q Consensus       495 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~  572 (985)
                      ++++|++++ +|..   +++|++|++++|+++++..    .+++|+.|++++|++++  .+|..++.+        +.|.
T Consensus       323 ~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~lp~----~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~  386 (454)
T 1jl5_A          323 NVSNNKLIE-LPAL---PPRLERLIASFNHLAEVPE----LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNS  386 (454)
T ss_dssp             ECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC
T ss_pred             ECCCCcccc-cccc---CCcCCEEECCCCccccccc----hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcc
Confidence            666666665 3332   3567777777777765433    36778888888888887  566666543        3466


Q ss_pred             eccchhhhhhcccccCeEecCCCcccC--CCCccccccccccccccccccccCCCCC
Q 001988          573 LEGPIPESFGNMTSLESLDLSNNKISG--SIPVSFEKLSYLKELNLSFNKLKGEIPR  627 (985)
Q Consensus       573 l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~  627 (985)
                      +.+.+|..   +++|+.||+++|++++  .+|..      ++.|.+++|.+.+.+|.
T Consensus       387 ~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~s------l~~L~~~~~~~~~~~~~  434 (454)
T 1jl5_A          387 HLAEVPEL---PQNLKQLHVETNPLREFPDIPES------VEDLRMNSERVVDPYEF  434 (454)
T ss_dssp             ---------------------------------------------------------
T ss_pred             cccccccc---cCcCCEEECCCCcCCccccchhh------HhheeCcCcccCCcccc
Confidence            77777764   4788999999999987  56643      56677888988887774

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.2e-44  Score=389.29  Aligned_cols=231  Identities=23%  Similarity=0.256  Sum_probs=193.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc----CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ++|+..+.||+|+||+||+|+..    +++.||||++++...  .....+.+|++++++++|||||++++++++++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999862    578899999976522  234568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      |||||+||+|.+++...+ .+++.+...++.||+.||+||   |++|||||||||+|||++++|.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999998764 689999999999999999999   7899999999999999999999999999999875432


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSL  948 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l  948 (985)
                      .  ......+||+.|||||++.+..++.++|+ |++|++++++++|+.++.......           .++.+++++.++
T Consensus       180 ~--~~~~~~~GT~~YmAPE~~~~~~y~~~~Di-wSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  256 (304)
T 3ubd_A          180 E--KKAYSFCGTVEYMAPEVVNRRGHTQSADW-WSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL  256 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             C--ccccccccCcccCCHHHhccCCCCCCCcc-cchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            2  22345689999999999999999999999 999999999999998775432211           223467789999


Q ss_pred             HHHccCCCCCCCCCH
Q 001988          949 ALECTMESPEKRIDA  963 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~  963 (985)
                      +.+||..||++||++
T Consensus       257 i~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          257 LRMLFKRNPANRLGA  271 (304)
T ss_dssp             HHHHTCSSGGGSTTC
T ss_pred             HHHHcccCHHHCCCC
Confidence            999999999999985

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=8.9e-43  Score=403.98  Aligned_cols=403  Identities=24%  Similarity=0.304  Sum_probs=240.5

Q ss_pred             CCccceeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceE
Q 001988          144 TSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRI  223 (985)
Q Consensus       144 ~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  223 (985)
                      .++|+.|+++.|++ |.+|+.+ +++++|++|++++|.++|.+|++++++++|+.+++++|..           .++++|
T Consensus        10 ~~~L~~L~l~~n~l-~~iP~~i-~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L   76 (454)
T 1jl5_A           10 NTFLQEPLRHSSNL-TEMPVEA-ENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHEL   76 (454)
T ss_dssp             --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEE
T ss_pred             cccchhhhcccCch-hhCChhH-hcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEE
Confidence            45666677777766 5666665 5666677777777766666676666666665444443321           345777


Q ss_pred             eeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccC
Q 001988          224 SLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSF  303 (985)
Q Consensus       224 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l  303 (985)
                      ++++|++++ +|..   .++|++|++++|++++ +|..   +++|++|++++|++++ +|..    .++|++|++++|++
T Consensus        77 ~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~----~~~L~~L~L~~n~l  143 (454)
T 1jl5_A           77 ELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL----PPLLEYLGVSNNQL  143 (454)
T ss_dssp             ECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC----CTTCCEEECCSSCC
T ss_pred             EecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC----CCCCCEEECcCCCC
Confidence            777777764 3431   3577777777777776 5543   3677777777777763 3321    25778888888888


Q ss_pred             CCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCcc
Q 001988          304 SGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGF  383 (985)
Q Consensus       304 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~  383 (985)
                      ++ +| .++++++|++|++++|++++ +|..+   .+|++|++++|++++.+       .+.++++|++|++++|++++ 
T Consensus       144 ~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l~-------~~~~l~~L~~L~l~~N~l~~-  209 (454)
T 1jl5_A          144 EK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEELP-------ELQNLPFLTAIYADNNSLKK-  209 (454)
T ss_dssp             SS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSCC-------CCTTCTTCCEEECCSSCCSS-
T ss_pred             CC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcCc-------cccCCCCCCEEECCCCcCCc-
Confidence            75 56 47778888888888888775 45433   47888888888877643       25677888888888888875 


Q ss_pred             CCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhh
Q 001988          384 LPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICL  463 (985)
Q Consensus       384 ~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  463 (985)
                      +|...    .+|++|++++|.++ .+| .+..+++|++|++++|++++ +|..   +++|+.|++++|++++ +|..   
T Consensus       210 l~~~~----~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---  275 (454)
T 1jl5_A          210 LPDLP----LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---  275 (454)
T ss_dssp             CCCCC----TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---
T ss_pred             CCCCc----CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---
Confidence            44332    26888888888887 556 48888888888888888885 3432   3678888888888885 4442   


Q ss_pred             ccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEE
Q 001988          464 LSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGID  543 (985)
Q Consensus       464 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~  543 (985)
                      +++|++|++++|++++. |..   .++|++|++++|+++++ +..   .++|++|++++|+++++.+ .   +++|+.|+
T Consensus       276 ~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i-~~~---~~~L~~L~Ls~N~l~~lp~-~---~~~L~~L~  343 (454)
T 1jl5_A          276 PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSL-CDL---PPSLEELNVSNNKLIELPA-L---PPRLERLI  343 (454)
T ss_dssp             CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEE-CCC---CTTCCEEECCSSCCSCCCC-C---CTTCCEEE
T ss_pred             cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCcc-cCC---cCcCCEEECCCCccccccc-c---CCcCCEEE
Confidence            47788888888888863 221   15788888888888763 221   2478888888888876432 2   57788888


Q ss_pred             ccCCccCccCchhhcccccceeeeeecceecc--chhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccc
Q 001988          544 LSRNNLSGNIPTTLEGLKSLQNISLAYNRLEG--PIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKL  621 (985)
Q Consensus       544 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l  621 (985)
                      +++|++++ +|.   .+++|++|++++|++++  .+|.++..        |+.|++.+.+|..   +++|++|++++|++
T Consensus       344 L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l  408 (454)
T 1jl5_A          344 ASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPL  408 (454)
T ss_dssp             CCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC-------------------------
T ss_pred             CCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcC
Confidence            88888874 555   46778888888888887  56665543        2346666777653   47899999999999


Q ss_pred             cC--CCCC
Q 001988          622 KG--EIPR  627 (985)
Q Consensus       622 ~~--~~p~  627 (985)
                      +|  .+|.
T Consensus       409 ~~~~~iP~  416 (454)
T 1jl5_A          409 REFPDIPE  416 (454)
T ss_dssp             --------
T ss_pred             Cccccchh
Confidence            98  7775

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2.1e-42  Score=403.96  Aligned_cols=384  Identities=19%  Similarity=0.222  Sum_probs=239.0

Q ss_pred             EEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccC-cccccCCCCCCEEEccCC
Q 001988          198 ELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVV-PATIFNMSTLKEIFLYNN  276 (985)
Q Consensus       198 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~L~~N  276 (985)
                      .++.+++.++ .+|. +.  ++|++|+|++|++++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|++|
T Consensus        14 ~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n   89 (455)
T 3v47_A           14 NAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN   89 (455)
T ss_dssp             EEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC
T ss_pred             ccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCC
Confidence            4556666665 4444 22  45566666666665555555666666666666666554333 344555555555555555


Q ss_pred             cCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCc--ccCCCCCceEeccCCcccCC
Q 001988          277 SLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSA--IGNLRNLKLFDIFFNNLTSS  354 (985)
Q Consensus       277 ~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--l~~l~~L~~L~L~~N~l~~~  354 (985)
                      +++                         +..|..++++++|++|++++|++++..|..  ++.+++|++|++++|+++..
T Consensus        90 ~l~-------------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~  144 (455)
T 3v47_A           90 QFL-------------------------QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKI  144 (455)
T ss_dssp             TTC-------------------------EECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSC
T ss_pred             ccC-------------------------ccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCcc
Confidence            554                         444444444444444444444444422222  44444444444444444443


Q ss_pred             CCcccccccccccCcccEEEecCCCCCccCCCCccchh-hcccceeccccccccccCCc--------CCCCCCccEEEcc
Q 001988          355 TPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLS-LSLERLNIAFCNISGNIPKA--------IGNLSNLIVLSLG  425 (985)
Q Consensus       355 ~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~~L~~L~L~~n~l~~~~~~~--------~~~l~~L~~L~L~  425 (985)
                      .+..    .+.++++|++|++++|++.+..|..+..+. .+|+.|++++|.+.+..+..        +..+++|++|+++
T Consensus       145 ~~~~----~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls  220 (455)
T 3v47_A          145 QPAS----FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLS  220 (455)
T ss_dssp             CCCG----GGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECT
T ss_pred             Cccc----ccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecC
Confidence            2210    133444455555555554444444443331 13444444444444332222        2344556666666


Q ss_pred             CCCCCCCCCcccccc---ccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCc--CcCceEeeccce
Q 001988          426 GNNLSGSIPVTFGGL---QKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNL--TSLQYLNLGSNR  500 (985)
Q Consensus       426 ~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~  500 (985)
                      +|++++..|..|...   .+|+.|++++|.+.+..              +..+.+.+..+..+..+  ++|++|++++|+
T Consensus       221 ~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~  286 (455)
T 3v47_A          221 GNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSK  286 (455)
T ss_dssp             TSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSC
T ss_pred             CCcccccchhhhhccccccceeeEeeccccccccc--------------cchhhhccCcccccccccccCceEEEecCcc
Confidence            666655555554433   55566666655544321              11122222223333333  578888888888


Q ss_pred             eeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhh
Q 001988          501 FTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPES  580 (985)
Q Consensus       501 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  580 (985)
                      +++..|..|..+++|++|++++|++.+..+..|.++++|+.|+|++|+|++..|..|+++++|++|+|++|++++..|..
T Consensus       287 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  366 (455)
T 3v47_A          287 IFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQS  366 (455)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTT
T ss_pred             ccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhh
Confidence            88888888888888888888888888888888888999999999999998888889999999999999999999888999


Q ss_pred             hhcccccCeEecCCCcccCCCCccccccccccccccccccccCCCCCC
Q 001988          581 FGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRG  628 (985)
Q Consensus       581 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  628 (985)
                      |.++++|++|+|++|+|++..+..|..+++|++|++++|+++|.+|..
T Consensus       367 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  414 (455)
T 3v47_A          367 FLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  414 (455)
T ss_dssp             TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             ccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence            999999999999999999877777899999999999999999999864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.4e-43  Score=385.01  Aligned_cols=238  Identities=24%  Similarity=0.362  Sum_probs=186.6

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCC-------
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDD-------  795 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-------  795 (985)
                      .++|+..+.||+|+||+||+|+.+ +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            356899999999999999999975 799999999975533 34567899999999999999999999986543       


Q ss_pred             -----ceEEEEeccCCCChHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 001988          796 -----FKALVLEYMSNGSLEDCLHSSNC--ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLS  868 (985)
Q Consensus       796 -----~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~  868 (985)
                           +.|+|||||++|+|.+++.....  ..++..++.++.||++||+||   |++|||||||||+|||++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yl---H~~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHH---HHCcCccccCcHHHeEECCCCcEEEc
Confidence                 36899999999999999986532  346677889999999999999   78999999999999999999999999


Q ss_pred             cccCceeccCCCCc----------ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcch-----
Q 001988          869 DFGMAKLLSGEDES----------TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK-----  933 (985)
Q Consensus       869 DfGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~-----  933 (985)
                      |||+|+.+......          ......+||+.|||||++.+..++.++|+ |++|++++|++++  +.+...     
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~Di-wSlGvilyell~P--f~~~~~~~~~~  237 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDI-FSLGLILFELLYP--FSTQMERVRTL  237 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHH-HHHHHHHHHHHSC--CSSHHHHHHHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHH-HHHHHHHHHHccC--CCCccHHHHHH
Confidence            99999987543221          12234579999999999999999999999 9999999999862  111110     


Q ss_pred             -------hhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          934 -------HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       934 -------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                             ..+......+...+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                   11122334456778999999999999999999986

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=4.4e-42  Score=401.15  Aligned_cols=389  Identities=21%  Similarity=0.229  Sum_probs=246.5

Q ss_pred             eeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCcc-ccccccccccceEeecc
Q 001988          149 DIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAI-PKEIGNLTVLQRISLIN  227 (985)
Q Consensus       149 ~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~  227 (985)
                      .++.+++.++ .+|. +   .++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..|+++++|++|+|++
T Consensus        14 ~~~c~~~~l~-~lp~-l---~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~   88 (455)
T 3v47_A           14 NAICINRGLH-QVPE-L---PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY   88 (455)
T ss_dssp             EEECCSSCCS-SCCC-C---CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred             ccCcCCCCcc-cCCC-C---CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence            3444555544 4444 2   144555555555555544555555555555555555554433 23455555555555555


Q ss_pred             ccccCCchhhhcCCCCCCEEEecCCcCcccCccc--ccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCC
Q 001988          228 NKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPAT--IFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSG  305 (985)
Q Consensus       228 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~  305 (985)
                      |++++..|..|+++++|++|+|++|++++..|..  +.++++|++|+|++|++++..|..+                   
T Consensus        89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-------------------  149 (455)
T 3v47_A           89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF-------------------  149 (455)
T ss_dssp             CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGG-------------------
T ss_pred             CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccc-------------------
Confidence            5555444555555555555555555555433332  4444455555555554443334333                   


Q ss_pred             cCCccccCCCCccEEEccCcccccccCCcccCC--CCCceEeccCCcccCCCCccc---ccccccccCcccEEEecCCCC
Q 001988          306 TIPSSITNASKLILLEMGSNSFSGFIPSAIGNL--RNLKLFDIFFNNLTSSTPELG---FLSSLANCKKLRYLGLGGNPL  380 (985)
Q Consensus       306 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~L~~N~l~~~~~~~~---~~~~l~~l~~L~~L~L~~N~l  380 (985)
                           +.++++|++|++++|++++..|..+..+  .+|+.|+++.|.+....+...   ....+..+++|++|++++|++
T Consensus       150 -----~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l  224 (455)
T 3v47_A          150 -----FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGF  224 (455)
T ss_dssp             -----GGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCC
T ss_pred             -----cCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcc
Confidence                 4444455555555555554444444444  445555555555554432210   011123345566666666666


Q ss_pred             CccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhh
Q 001988          381 DGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDE  460 (985)
Q Consensus       381 ~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  460 (985)
                      .+..|..+...                      ...++|+.|++++|.+.+...              ..+.+.+..+..
T Consensus       225 ~~~~~~~~~~~----------------------~~~~~L~~L~l~~~~~~~~~~--------------~~~~~~~~~~~~  268 (455)
T 3v47_A          225 KESMAKRFFDA----------------------IAGTKIQSLILSNSYNMGSSF--------------GHTNFKDPDNFT  268 (455)
T ss_dssp             CHHHHHHHHHH----------------------TTTCCEEEEECTTCTTTSCCT--------------TCCSSCCCCTTT
T ss_pred             cccchhhhhcc----------------------ccccceeeEeecccccccccc--------------chhhhccCcccc
Confidence            55444333221                      112667777777776654211              122222222222


Q ss_pred             hhh--ccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCc
Q 001988          461 ICL--LSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKA  538 (985)
Q Consensus       461 ~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~  538 (985)
                      +..  .++|+.|++++|++++..|..+..+++|++|++++|++++..|..|.++++|++|++++|++.+..+..+..+++
T Consensus       269 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  348 (455)
T 3v47_A          269 FKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDK  348 (455)
T ss_dssp             TGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTT
T ss_pred             cccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCccc
Confidence            332  367889999999998888888889999999999999999888888999999999999999998888888999999


Q ss_pred             ccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCC
Q 001988          539 VVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIP  602 (985)
Q Consensus       539 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  602 (985)
                      |+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..|
T Consensus       349 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          349 LEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            9999999999998889999999999999999999998778888999999999999999998777

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=2.9e-40  Score=383.27  Aligned_cols=363  Identities=18%  Similarity=0.171  Sum_probs=196.9

Q ss_pred             cccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhH
Q 001988           86 QGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENI  165 (985)
Q Consensus        86 ~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~  165 (985)
                      .+..+..++++++|++|+|++|.+++ +| .++.+++|++|+|++|++++. +  +..+                     
T Consensus        31 ~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l---------------------   84 (457)
T 3bz5_A           31 QATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQN---------------------   84 (457)
T ss_dssp             CTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTC---------------------
T ss_pred             CcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccC---------------------
Confidence            34445567777778888888887775 35 577777777777777777753 1  3344                     


Q ss_pred             hhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCC
Q 001988          166 CNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLD  245 (985)
Q Consensus       166 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  245 (985)
                          ++|++|++++|.+++. |  ++++++|++|+|++|++++ +|  ++++++|++|++++|++++. +  ++.+++|+
T Consensus        85 ----~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~  151 (457)
T 3bz5_A           85 ----TNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLT  151 (457)
T ss_dssp             ----TTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCC
T ss_pred             ----CCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCC
Confidence                4444444444444432 2  4444555555555555543 22  44455555555555555432 1  44455555


Q ss_pred             EEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCc
Q 001988          246 VLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSN  325 (985)
Q Consensus       246 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  325 (985)
                      +|++++|+..+.+  .+..+++|++|++++|++++ +|   +..+++|+.|++++|++++.   .++.+++|+.|++++|
T Consensus       152 ~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N  222 (457)
T 3bz5_A          152 ELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSN  222 (457)
T ss_dssp             EEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSS
T ss_pred             EEECCCCCccccc--ccccCCcCCEEECCCCccce-ec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCC
Confidence            5555555333333  24445555555555555543 33   23445555555555555543   2555566666666666


Q ss_pred             ccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceecccccc
Q 001988          326 SFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNI  405 (985)
Q Consensus       326 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l  405 (985)
                      ++++ +|  ++.+++|+.|++++|++++.+        +..+++|+.|++++|               +|+.|++++|.+
T Consensus       223 ~l~~-ip--~~~l~~L~~L~l~~N~l~~~~--------~~~l~~L~~L~l~~n---------------~L~~L~l~~n~~  276 (457)
T 3bz5_A          223 KLTE-ID--VTPLTQLTYFDCSVNPLTELD--------VSTLSKLTTLHCIQT---------------DLLEIDLTHNTQ  276 (457)
T ss_dssp             CCSC-CC--CTTCTTCSEEECCSSCCSCCC--------CTTCTTCCEEECTTC---------------CCSCCCCTTCTT
T ss_pred             cccc-cC--ccccCCCCEEEeeCCcCCCcC--------HHHCCCCCEEeccCC---------------CCCEEECCCCcc
Confidence            6665 33  556666666666666666543        234556666666554               244566666666


Q ss_pred             ccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCC
Q 001988          406 SGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCL  485 (985)
Q Consensus       406 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  485 (985)
                      .+.+|  ++.+++|++|++++|...+.+|.   ...+|+.|++++|             ++|++|++++|++++. +  +
T Consensus       277 ~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l  335 (457)
T 3bz5_A          277 LIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--V  335 (457)
T ss_dssp             CCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--C
T ss_pred             CCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--c
Confidence            55555  35566666777776666555553   2344555555444             4566666666666653 2  5


Q ss_pred             cCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchh
Q 001988          486 GNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTT  556 (985)
Q Consensus       486 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  556 (985)
                      .++++|+.|++++|+|+++        +.|..|++++|.+.|.     ..+..|..+++++|+++|.+|..
T Consensus       336 ~~l~~L~~L~l~~N~l~~l--------~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          336 SHNTKLKSLSCVNAHIQDF--------SSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             TTCTTCSEEECCSSCCCBC--------TTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred             ccCCcCcEEECCCCCCCCc--------cccccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence            5666666666666666541        2333444555555443     23334444555555555555544

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.7e-41  Score=376.71  Aligned_cols=238  Identities=26%  Similarity=0.318  Sum_probs=197.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeec------CC
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSN------DD  795 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~------~~  795 (985)
                      .++|+..+.||+|+||+||+|++. +|+.||||+++....  ...+.+.+|+++|++++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            367999999999999999999975 799999999976532  335678899999999999999999998754      35


Q ss_pred             ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          796 FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      ..|||||||+ |+|.+++...+ .+++..+..++.||+.||+||   |++|||||||||+|||++.+|.+||+|||+|+.
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~yl---H~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYM---HSAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            7899999995 68999998754 789999999999999999999   789999999999999999999999999999987


Q ss_pred             ccCCC--CcceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhhhH--------------
Q 001988          876 LSGED--ESTMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK--------------  938 (985)
Q Consensus       876 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~--------------  938 (985)
                      +....  ........+||+.|||||++.+. .++.++|+ |++|++++|+++|+.++.........              
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~Di-WSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDL-WSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHH-HHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhhe-ehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            64322  12234567899999999998875 56899999 99999999999998766432211100              


Q ss_pred             ----------------------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          939 ----------------------------EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       939 ----------------------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                  ...++++.+++.+||..||.+|||+.|+++
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                                        112467889999999999999999999876

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.4e-40  Score=368.44  Aligned_cols=235  Identities=21%  Similarity=0.265  Sum_probs=194.0

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc----CCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~  798 (985)
                      ..++|+..+.||+|+||+||+|+.+    +++.||||++....  ...++.+|+++++++ +|||||++++++.+.++.|
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            4578999999999999999999853    56889999987553  345788999999998 6999999999999999999


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-CcEEEecccCceecc
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAKLLS  877 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~-~~~kl~DfGla~~~~  877 (985)
                      +||||++||+|.+++.    .+++.+...++.|++.||+||   |++|||||||||+|||++.+ +.+||+|||+|+...
T Consensus        97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~yl---H~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRI---HQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            9999999999999985    478999999999999999999   78999999999999999877 799999999998764


Q ss_pred             CCCCc--------------------------ceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccC
Q 001988          878 GEDES--------------------------TMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSG  930 (985)
Q Consensus       878 ~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~  930 (985)
                      +....                          ......+||+.|||||++.+. .++.+.|+ |++|++++++++|+.+..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~Di-WSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDM-WSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHH-HHHHHHHHHHHHTCSSSS
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccch-hhhHHHHHHHHHCCCCCC
Confidence            32211                          112345799999999998875 48899999 999999999999986542


Q ss_pred             cch-hhhh-----------------------------------------------------------------HHHHHHH
Q 001988          931 EEK-HFAA-----------------------------------------------------------------KEQCLLS  944 (985)
Q Consensus       931 ~~~-~~~~-----------------------------------------------------------------~~~~~~~  944 (985)
                      ... ....                                                                 ....+++
T Consensus       249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~  328 (361)
T 4f9c_A          249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE  328 (361)
T ss_dssp             CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred             CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence            211 0000                                                                 0012456


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHH
Q 001988          945 IFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       945 l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ..+++.+|+..||++|||+.|+++
T Consensus       329 a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          329 AYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhc
Confidence            789999999999999999999875

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=4.7e-39  Score=373.05  Aligned_cols=354  Identities=19%  Similarity=0.193  Sum_probs=199.2

Q ss_pred             hhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCE
Q 001988          167 NHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDV  246 (985)
Q Consensus       167 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  246 (985)
                      +++++|++|++++|.+++ +| .++.+++|++|+|++|++++. |  ++++++|++|++++|++++. |  ++++++|++
T Consensus        39 ~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~  110 (457)
T 3bz5_A           39 EQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTY  110 (457)
T ss_dssp             HHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCE
T ss_pred             hHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCE
Confidence            445555566665555553 23 455555555555555555542 2  55555555555555555542 2  555555555


Q ss_pred             EEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcc
Q 001988          247 LQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNS  326 (985)
Q Consensus       247 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  326 (985)
                      |++++|++++ +|  +.++++|++|++++|++++ ++   ...+++|++|++++|+..+.+  .+..+++|+.|++++|+
T Consensus       111 L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~---l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~  181 (457)
T 3bz5_A          111 LNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID---VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNK  181 (457)
T ss_dssp             EECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC---CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSC
T ss_pred             EECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec---cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCc
Confidence            5555555554 22  4555555555555555553 22   223445555555555333333  24444444555555444


Q ss_pred             cccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccc
Q 001988          327 FSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNIS  406 (985)
Q Consensus       327 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~  406 (985)
                      +++. |  ++.+                             ++|+.|++++|++++.   .+..++ +|+.|++++|+++
T Consensus       182 l~~l-~--l~~l-----------------------------~~L~~L~l~~N~l~~~---~l~~l~-~L~~L~Ls~N~l~  225 (457)
T 3bz5_A          182 ITEL-D--VSQN-----------------------------KLLNRLNCDTNNITKL---DLNQNI-QLTFLDCSSNKLT  225 (457)
T ss_dssp             CCCC-C--CTTC-----------------------------TTCCEEECCSSCCSCC---CCTTCT-TCSEEECCSSCCS
T ss_pred             ccee-c--cccC-----------------------------CCCCEEECcCCcCCee---ccccCC-CCCEEECcCCccc
Confidence            4432 2  4444                             4455555555544432   133333 4555555555555


Q ss_pred             cccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCc
Q 001988          407 GNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLG  486 (985)
Q Consensus       407 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  486 (985)
                      + +|  +..+++|++|++++|++++..   ++.+++|+.|++++|              +|+.|++++|.+.+.+|  +.
T Consensus       226 ~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~  283 (457)
T 3bz5_A          226 E-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AE  283 (457)
T ss_dssp             C-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CT
T ss_pred             c-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--cc
Confidence            4 23  555666666666666666543   234455555555544              24455666666555555  35


Q ss_pred             CcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceee
Q 001988          487 NLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNI  566 (985)
Q Consensus       487 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  566 (985)
                      .+++|+.|++++|.+.+.+|.   ..++|+.|++++|             ++|+.|++++|+|++. +  ++.+++|+.|
T Consensus       284 ~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L  344 (457)
T 3bz5_A          284 GCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSL  344 (457)
T ss_dssp             TCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEE
T ss_pred             ccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEE
Confidence            566667777776665555553   2234444444433             5677777777777764 2  7777788888


Q ss_pred             eeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCCCCC
Q 001988          567 SLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPR  627 (985)
Q Consensus       567 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  627 (985)
                      ++++|+|++        ++.|+.|++++|+++|.     ..+..|..+++++|+++|.+|.
T Consensus       345 ~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~  392 (457)
T 3bz5_A          345 SCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSP  392 (457)
T ss_dssp             ECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCT
T ss_pred             ECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcCh
Confidence            888888775        24566777888888765     3556677788888888888885

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2e-38  Score=370.75  Aligned_cols=345  Identities=26%  Similarity=0.401  Sum_probs=166.2

Q ss_pred             ccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEE
Q 001988          169 LRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQ  248 (985)
Q Consensus       169 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  248 (985)
                      +++|+.|++++|.+. .+|. +..+++|++|+|++|.+++..|  ++++++|++|++++|++++..|  ++++++|++|+
T Consensus        45 l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~  118 (466)
T 1o6v_A           45 LDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT  118 (466)
T ss_dssp             HHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             hccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence            455666666666555 3442 5555666666666666654332  5555566666666665554333  55555555555


Q ss_pred             ecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccc
Q 001988          249 LGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFS  328 (985)
Q Consensus       249 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  328 (985)
                      +++|++++..+  +.++++|++|++++|.+++ ++                          .+..+++|+.|+++ |.+.
T Consensus       119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~--------------------------~~~~l~~L~~L~l~-~~~~  168 (466)
T 1o6v_A          119 LFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS--------------------------ALSGLTSLQQLSFG-NQVT  168 (466)
T ss_dssp             CCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG--------------------------GGTTCTTCSEEEEE-ESCC
T ss_pred             CCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch--------------------------hhccCCcccEeecC-Cccc
Confidence            55555554322  4455555555555555442 22                          24444444444443 2333


Q ss_pred             cccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccc
Q 001988          329 GFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGN  408 (985)
Q Consensus       329 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~  408 (985)
                      +..+  ++++++|++|++++|+++..+       .+.++++|++|++++|.+.+..|  +..++ +|+.|++++|.+++.
T Consensus       169 ~~~~--~~~l~~L~~L~l~~n~l~~~~-------~l~~l~~L~~L~l~~n~l~~~~~--~~~l~-~L~~L~l~~n~l~~~  236 (466)
T 1o6v_A          169 DLKP--LANLTTLERLDISSNKVSDIS-------VLAKLTNLESLIATNNQISDITP--LGILT-NLDELSLNGNQLKDI  236 (466)
T ss_dssp             CCGG--GTTCTTCCEEECCSSCCCCCG-------GGGGCTTCSEEECCSSCCCCCGG--GGGCT-TCCEEECCSSCCCCC
T ss_pred             Cchh--hccCCCCCEEECcCCcCCCCh-------hhccCCCCCEEEecCCccccccc--ccccC-CCCEEECCCCCcccc
Confidence            2221  455555555555555544331       23445555555555555543322  22222 333444444433321


Q ss_pred             cCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCc
Q 001988          409 IPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNL  488 (985)
Q Consensus       409 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  488 (985)
                        ..+..+++|++|++++|.+++..+  +..+++|+.|++++|.+++..+  +..+++|+.|++++|++++..+  +..+
T Consensus       237 --~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l  308 (466)
T 1o6v_A          237 --GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNL  308 (466)
T ss_dssp             --GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGC
T ss_pred             --hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCC
Confidence              134444555555555555544333  4444555555555555543322  4444445555555554443322  3444


Q ss_pred             CcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeee
Q 001988          489 TSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISL  568 (985)
Q Consensus       489 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  568 (985)
                      ++|++|++++|+++                        +..+  +..+++|+.|++++|++++.  ..+..+++|++|++
T Consensus       309 ~~L~~L~L~~n~l~------------------------~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l  360 (466)
T 1o6v_A          309 KNLTYLTLYFNNIS------------------------DISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSA  360 (466)
T ss_dssp             TTCSEEECCSSCCS------------------------CCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEEC
T ss_pred             CCCCEEECcCCcCC------------------------Cchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeC
Confidence            44444444444444                        4333  34445555555555555433  24455555555555


Q ss_pred             ecceeccchhhhhhcccccCeEecCCCcccC
Q 001988          569 AYNRLEGPIPESFGNMTSLESLDLSNNKISG  599 (985)
Q Consensus       569 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  599 (985)
                      ++|++++..|  +..+++|+.|++++|++++
T Consensus       361 ~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          361 GHNQISDLTP--LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             CSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred             CCCccCccch--hhcCCCCCEEeccCCcccC
Confidence            5555555444  5555555555555555554

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.1e-39  Score=384.18  Aligned_cols=237  Identities=19%  Similarity=0.247  Sum_probs=208.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .++|...+.||+|+||.||+|+.+ +|+.||+|++........+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            368999999999999999999975 7999999999877666677899999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC--CcEEEecccCceeccCCCC
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED--MVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~--~~~kl~DfGla~~~~~~~~  881 (985)
                      |+||+|.+++......+++.+...++.||+.||+||   |+++|+||||||+|||++.+  +.+||+|||+|+.+.... 
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~yl---H~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-  311 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  311 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence            999999999987666799999999999999999999   78999999999999999854  899999999999875322 


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh---------------hhHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AAKEQCLLSIF  946 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~~~~~~~~l~  946 (985)
                        .....+||+.|||||++.+..++.++|+ |++|+++++|++|..++......               .....+++++.
T Consensus       312 --~~~~~~GT~~y~APEv~~~~~y~~~~Di-WSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  388 (573)
T 3uto_A          312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDM-WSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  388 (573)
T ss_dssp             --EEEEECSSGGGCCHHHHTTCCBCHHHHH-HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred             --ceeeeEECccccCHHHhCCCCCCcHHHH-HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence              2345679999999999999999999999 99999999999998766433211               11233567889


Q ss_pred             HHHHHccCCCCCCCCCHHHHHH
Q 001988          947 SLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +++.+||..||.+||++.|+++
T Consensus       389 dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          389 DFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999976

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=4.5e-38  Score=367.76  Aligned_cols=346  Identities=25%  Similarity=0.370  Sum_probs=248.1

Q ss_pred             cCCccceeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccce
Q 001988          143 NTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQR  222 (985)
Q Consensus       143 ~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  222 (985)
                      .+.+++.|++++|.+. .+|.  +..+++|++|+|++|.+++. |. ++++++|++|++++|++++..|  ++++++|++
T Consensus        44 ~l~~l~~L~l~~~~i~-~l~~--~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~  116 (466)
T 1o6v_A           44 DLDQVTTLQADRLGIK-SIDG--VEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP--LANLTNLTG  116 (466)
T ss_dssp             HHHTCCEEECCSSCCC-CCTT--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred             HhccccEEecCCCCCc-cCcc--hhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence            4678999999999998 5775  47899999999999999955 44 9999999999999999997655  999999999


Q ss_pred             EeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCcc
Q 001988          223 ISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINS  302 (985)
Q Consensus       223 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~  302 (985)
                      |++++|++++..+  ++.+++|++|++++|.+++ ++ .+..+++|++|+++ |.+.+ ++.  +..+++|+.|++++|+
T Consensus       117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~-~~~--~~~l~~L~~L~l~~n~  188 (466)
T 1o6v_A          117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTD-LKP--LANLTTLERLDISSNK  188 (466)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCC-CGG--GTTCTTCCEEECCSSC
T ss_pred             EECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccC-chh--hccCCCCCEEECcCCc
Confidence            9999999996543  9999999999999999986 34 48999999999997 45553 332  4578889999999998


Q ss_pred             CCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCc
Q 001988          303 FSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDG  382 (985)
Q Consensus       303 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~  382 (985)
                      +++.  ..+..+++|+.|++++|.+++..|  ++.+++|++|++++|+++..+       .+..+++|++|++++|.+.+
T Consensus       189 l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~-------~l~~l~~L~~L~l~~n~l~~  257 (466)
T 1o6v_A          189 VSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG-------TLASLTNLTDLDLANNQISN  257 (466)
T ss_dssp             CCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG-------GGGGCTTCSEEECCSSCCCC
T ss_pred             CCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccch-------hhhcCCCCCEEECCCCcccc
Confidence            8754  347778888888888888876655  677778888888887776542       35566667777766666654


Q ss_pred             cCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhh
Q 001988          383 FLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEIC  462 (985)
Q Consensus       383 ~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  462 (985)
                      ..|                           +..+++|++|++++|++++..+  +..+++|+.|++++|++++..+  +.
T Consensus       258 ~~~---------------------------~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~  306 (466)
T 1o6v_A          258 LAP---------------------------LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--IS  306 (466)
T ss_dssp             CGG---------------------------GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GG
T ss_pred             chh---------------------------hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hc
Confidence            322                           4455666666666666665433  5566666666666666665433  55


Q ss_pred             hccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEE
Q 001988          463 LLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGI  542 (985)
Q Consensus       463 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L  542 (985)
                      .+++|+.|+|++|++++..|  +..+++|++|++++|++++.  ..+..+++|+.|++++|++++..|  +..+++|+.|
T Consensus       307 ~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L  380 (466)
T 1o6v_A          307 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQL  380 (466)
T ss_dssp             GCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEE
T ss_pred             CCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEE
Confidence            66666666666666665544  55666666666666666653  234555555555555555554444  4555555555


Q ss_pred             EccCCccCc
Q 001988          543 DLSRNNLSG  551 (985)
Q Consensus       543 ~Ls~N~l~~  551 (985)
                      ++++|.+++
T Consensus       381 ~l~~n~~~~  389 (466)
T 1o6v_A          381 GLNDQAWTN  389 (466)
T ss_dssp             ECCCEEEEC
T ss_pred             eccCCcccC
Confidence            555555553

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.8e-39  Score=380.36  Aligned_cols=235  Identities=22%  Similarity=0.246  Sum_probs=196.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHH---HHHHHHhcCCCCeeeEEeeeecCCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEA---ECEVIKNIRHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~---E~~il~~l~h~niv~l~~~~~~~~~~  797 (985)
                      .++|...+.||+|+||+||+|+.+ +|+.||||++++..   ......+.+   ++++++.++|||||++++++++.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            367999999999999999999975 79999999997542   112233334   45566677899999999999999999


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      |+|||||+||+|.+++...+ .+++.....++.||+.||+||   |++|||||||||+|||++.+|++||+|||+|+.+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yL---H~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999998764 689999999999999999999   79999999999999999999999999999999875


Q ss_pred             CCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhh--------------hhHHHHH
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQCL  942 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~~  942 (985)
                      ...    ....+||+.|||||++.. ..++.++|+ |++|+++++|++|..++......              ..+...+
T Consensus       344 ~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDi-WSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S  418 (689)
T 3v5w_A          344 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADW-FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS  418 (689)
T ss_dssp             SCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHH-HHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             CCC----CCCccCCcCccCHHHHhCCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCC
Confidence            332    344689999999999975 478999999 99999999999999877542111              1122356


Q ss_pred             HHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 001988          943 LSIFSLALECTMESPEKRID-----AKDTIT  968 (985)
Q Consensus       943 ~~l~~l~~~cl~~~P~~RPt-----~~ev~~  968 (985)
                      +++.+++.+|+..||.+|++     +.|+.+
T Consensus       419 ~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            78999999999999999998     677654

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=9.2e-39  Score=354.72  Aligned_cols=258  Identities=32%  Similarity=0.467  Sum_probs=221.9

Q ss_pred             cCHHHHHHHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 001988          716 FSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD  795 (985)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~  795 (985)
                      +++.++..++++|...+.||+|+||.||+|+.++++.||||++........+.+.+|++++++++||||+++++++.+.+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            34445556788999999999999999999998889999999988776667788999999999999999999999999999


Q ss_pred             ceEEEEeccCCCChHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccC
Q 001988          796 FKALVLEYMSNGSLEDCLHSSN---CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGM  872 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGl  872 (985)
                      ..++||||+++|+|.+++....   ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHh---cCCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            9999999999999999997653   3589999999999999999999   789999999999999999999999999999


Q ss_pred             ceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcch-------------------
Q 001988          873 AKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK-------------------  933 (985)
Q Consensus       873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~-------------------  933 (985)
                      ++...............||+.|+|||.+.++.++.++|+ |++|++++++++++.+.....                   
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDV-YSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHH-HHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccch-HhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            987643333333344568999999999999999999999 999999999999876443210                   


Q ss_pred             ---------hhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          934 ---------HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       934 ---------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                               .......++.++.+++.+||..||++||++.|+++.|+.+.+..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence                     01123557888999999999999999999999999999987653

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-38  Score=370.46  Aligned_cols=348  Identities=22%  Similarity=0.225  Sum_probs=263.0

Q ss_pred             CCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEecc
Q 001988          268 LKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIF  347 (985)
Q Consensus       268 L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  347 (985)
                      -+.+++++++++ .+|..+.   ++++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|+
T Consensus        13 ~~~v~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~   88 (477)
T 2id5_A           13 DRAVLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLR   88 (477)
T ss_dssp             TTEEECCSCCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEEeCCCCcC-cCCCCCC---CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECC
Confidence            457888888887 7777543   578888888888888778888888888888888888888778888888888888887


Q ss_pred             CCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCC
Q 001988          348 FNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGN  427 (985)
Q Consensus       348 ~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  427 (985)
                      +|+++.+++.     .|.++++|++|+|++|++                         ++..+..|..+++|++|+|++|
T Consensus        89 ~n~l~~~~~~-----~~~~l~~L~~L~Ls~n~i-------------------------~~~~~~~~~~l~~L~~L~l~~n  138 (477)
T 2id5_A           89 SNRLKLIPLG-----VFTGLSNLTKLDISENKI-------------------------VILLDYMFQDLYNLKSLEVGDN  138 (477)
T ss_dssp             SSCCCSCCTT-----SSTTCTTCCEEECTTSCC-------------------------CEECTTTTTTCTTCCEEEECCT
T ss_pred             CCcCCccCcc-----cccCCCCCCEEECCCCcc-------------------------ccCChhHccccccCCEEECCCC
Confidence            7777765543     244555555555555554                         4455566677777777777777


Q ss_pred             CCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCC
Q 001988          428 NLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPS  507 (985)
Q Consensus       428 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  507 (985)
                      .+++..+..|.++++|+.|+|++|++++..+..+..+++|+.|+|++|.+++..+..|..+++|++|++++|.+.+.+|.
T Consensus       139 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~  218 (477)
T 2id5_A          139 DLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP  218 (477)
T ss_dssp             TCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECT
T ss_pred             ccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCc
Confidence            77777777777777777777777777766666777788888888888888777777788888888888888776666666


Q ss_pred             CccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhccccc
Q 001988          508 TFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSL  587 (985)
Q Consensus       508 ~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  587 (985)
                      .+....+|++|++++|+++++.+..+..+++|+.|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|
T Consensus       219 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  298 (477)
T 2id5_A          219 NCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL  298 (477)
T ss_dssp             TTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTC
T ss_pred             ccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccC
Confidence            66666688888888888887776778888888888888888888777788888888888888888888888888888888


Q ss_pred             CeEecCCCcccCCCCccccccccccccccccccccCCCCCCCCCcccccccccCCccccCCC
Q 001988          588 ESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLP  649 (985)
Q Consensus       588 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~  649 (985)
                      +.|+|++|+|++..+..|..+++|++|++++|++++.++....+.......+.++...|..|
T Consensus       299 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p  360 (477)
T 2id5_A          299 RVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP  360 (477)
T ss_dssp             CEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred             CEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence            88888888888777777888888888888888888766532111122233455666666554

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=350.84  Aligned_cols=250  Identities=25%  Similarity=0.365  Sum_probs=214.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .++|...+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            467889999999999999999975 7899999998766666678899999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +++|+|.+++......+++.++..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++.+.......
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL---HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            999999999998767899999999999999999999   78999999999999999999999999999998865332211


Q ss_pred             ------------eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--------------hh
Q 001988          884 ------------MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AA  937 (985)
Q Consensus       884 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~  937 (985)
                                  ......||+.|+|||.+.+..++.++|+ |++|+++++++++..+.......              ..
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDV-FSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC  244 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHH-HHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTC
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHH-HHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccC
Confidence                        1114579999999999999999999999 99999999999887654332100              01


Q ss_pred             HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          938 KEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       938 ~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                      +..+++++.+++.+||+.||++||++.|+++.|+++++...
T Consensus       245 ~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~  285 (310)
T 3s95_A          245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA  285 (310)
T ss_dssp             CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence            23356779999999999999999999999999999987654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.7e-38  Score=349.87  Aligned_cols=260  Identities=35%  Similarity=0.498  Sum_probs=222.0

Q ss_pred             cccccCHHHHHHHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEee
Q 001988          712 TIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISS  790 (985)
Q Consensus       712 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~  790 (985)
                      ..+.+++.++....++|...+.||+|+||.||+|+..+++.||||++...... ....+.+|++++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            35788999999999999999999999999999999888999999999765322 23478999999999999999999999


Q ss_pred             eecCCceEEEEeccCCCChHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEE
Q 001988          791 CSNDDFKALVLEYMSNGSLEDCLHSSN---CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHL  867 (985)
Q Consensus       791 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl  867 (985)
                      +...+..++||||+++|+|.+++....   ..+++..+..++.|++.||+|||..+..||+||||||+||+++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999998652   34899999999999999999996544459999999999999999999999


Q ss_pred             ecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcch--------------
Q 001988          868 SDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK--------------  933 (985)
Q Consensus       868 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~--------------  933 (985)
                      +|||+++...... ........||+.|+|||.+.+..++.++|+ |++|+++++++++..+.....              
T Consensus       176 ~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          176 GDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDV-FGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             CCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHH-HHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             ccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccc-hhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            9999998875333 223344569999999999999999999999 999999999999887653110              


Q ss_pred             ----------------hhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          934 ----------------HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       934 ----------------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                                      .......++.++.+++.+||+.||.+||++.|+++.|+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence                            0112345678899999999999999999999999999863

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.9e-38  Score=352.75  Aligned_cols=250  Identities=24%  Similarity=0.375  Sum_probs=212.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEc--------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE--------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLVKIISSCSND  794 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~  794 (985)
                      .++|...+.||+|+||.||+|+..        ++..||||+++.... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            468899999999999999999852        456799999976533 3456789999999999 899999999999999


Q ss_pred             CceEEEEeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSN---------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL  859 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill  859 (985)
                      +..++||||+++|+|.+++....               ..+++..+..++.||+.||+||   |++||+||||||+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCeeccccchhhEEE
Confidence            99999999999999999998653               2478999999999999999999   78999999999999999


Q ss_pred             cCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh---
Q 001988          860 DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF---  935 (985)
Q Consensus       860 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~---  935 (985)
                      +.++.+||+|||+++.+.............+|+.|+|||.+.+..++.++|+ |++|++++++++ +..++......   
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv-wslG~il~ellt~g~~p~~~~~~~~~~  315 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV-WSFGVLMWEIFTLGGSPYPGIPVEELF  315 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHH-HHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHH-HHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9999999999999998754443333344567899999999999999999999 999999999998 66554432211   


Q ss_pred             ---------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          936 ---------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       936 ---------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                               ..+..++.++.+++.+||..+|.+||++.|+++.|+++.+...
T Consensus       316 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          316 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence                     1223466789999999999999999999999999999886543

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-37  Score=362.56  Aligned_cols=322  Identities=22%  Similarity=0.222  Sum_probs=215.8

Q ss_pred             CCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEcc
Q 001988          244 LDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMG  323 (985)
Q Consensus       244 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  323 (985)
                      -+.++.+++.++ .+|..+.  ++++.|+|++|++++..| ..+..+++|++|+|++|++++..|..|.++++|++|+|+
T Consensus        13 ~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~   88 (477)
T 2id5_A           13 DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQ-DEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLR   88 (477)
T ss_dssp             TTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECT-TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECH-hHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECC
Confidence            357899999998 5776664  589999999999995444 445689999999999999999999999999999999999


Q ss_pred             CcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceecccc
Q 001988          324 SNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFC  403 (985)
Q Consensus       324 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n  403 (985)
                      +|++++..+..|+++++|++|++++|+++...+.     .+.++++|++|++++|.+.+..|..+..++ +|+.|++++|
T Consensus        89 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n  162 (477)
T 2id5_A           89 SNRLKLIPLGVFTGLSNLTKLDISENKIVILLDY-----MFQDLYNLKSLEVGDNDLVYISHRAFSGLN-SLEQLTLEKC  162 (477)
T ss_dssp             SSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTT-----TTTTCTTCCEEEECCTTCCEECTTSSTTCT-TCCEEEEESC
T ss_pred             CCcCCccCcccccCCCCCCEEECCCCccccCChh-----HccccccCCEEECCCCccceeChhhccCCC-CCCEEECCCC
Confidence            9999988888899999999999999999876543     367778888888888877765555555554 5555555555


Q ss_pred             ccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCC
Q 001988          404 NISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISS  483 (985)
Q Consensus       404 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  483 (985)
                      ++++..+..|..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|.......+|+.|+|++|++      
T Consensus       163 ~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l------  236 (477)
T 2id5_A          163 NLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL------  236 (477)
T ss_dssp             CCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCC------
T ss_pred             cCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcc------
Confidence            55544444455555555555555555555455555555555555555554444444433334455555555544      


Q ss_pred             CCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccc
Q 001988          484 CLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSL  563 (985)
Q Consensus       484 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  563 (985)
                                        +.+.+..|..+++|+.|++++|.+++..+..|..+++|+.|+|++|++++..|..|.++++|
T Consensus       237 ------------------~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  298 (477)
T 2id5_A          237 ------------------TAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL  298 (477)
T ss_dssp             ------------------CSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTC
T ss_pred             ------------------cccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccC
Confidence                              44333344444455555555555544444455555555555555555555555566666666


Q ss_pred             eeeeeecceeccchhhhhhcccccCeEecCCCcccC
Q 001988          564 QNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISG  599 (985)
Q Consensus       564 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  599 (985)
                      ++|+|++|+|++..+..|..+++|++|+|++|++..
T Consensus       299 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c  334 (477)
T 2id5_A          299 RVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC  334 (477)
T ss_dssp             CEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred             CEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence            666666666665555555666666666666666653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.9e-38  Score=357.40  Aligned_cols=250  Identities=24%  Similarity=0.359  Sum_probs=211.8

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ..++|...+.||+|+||.||+|++. +++.||||+++..... ....+.+|++++++++||||+++++++...+..++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            4567888999999999999999986 7899999998755322 3456889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++|+|.+++...+..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.......
T Consensus       192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            99999999999987666789999999999999999999   789999999999999999999999999999987532211


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSIFSL  948 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l~~l  948 (985)
                      ........+++.|+|||.+..+.++.++|+ |++|++++|+++ +..+......            .+.++.+++++.++
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-wslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  347 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDV-WSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRL  347 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHH-HHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            111112235778999999999999999999 999999999997 6655443211            11233467889999


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          949 ALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      +.+||..||++||++.++++.|++++++.
T Consensus       348 i~~cl~~dP~~Rps~~~i~~~L~~i~~~~  376 (377)
T 3cbl_A          348 MEQCWAYEPGQRPSFSTIYQELQSIRKRH  376 (377)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence            99999999999999999999999998764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.4e-37  Score=340.75  Aligned_cols=236  Identities=25%  Similarity=0.328  Sum_probs=207.2

Q ss_pred             hcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .++|...+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999985 47899999999766555667889999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +++|+|.+++...  .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.......  
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence            9999999999875  588999999999999999999   788999999999999999999999999999988653322  


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh--------------hhhHHHHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH--------------FAAKEQCLLSIFSLA  949 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~--------------~~~~~~~~~~l~~l~  949 (985)
                      ......||+.|+|||.+.+..++.++|+ |++|+++++++++..++.....              ...++.+++.+.+++
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  250 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYGPKVDI-WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL  250 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBCTHHHH-HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHH
T ss_pred             ccCCccCCcCccChhhhcCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHH
Confidence            2344579999999999999999999999 9999999999999876644321              112344567799999


Q ss_pred             HHccCCCCCCCCCHHHHHH
Q 001988          950 LECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+||..||++||++.|+++
T Consensus       251 ~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          251 NRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HHHSCSSTTTSCCHHHHTT
T ss_pred             HHHccCChhHCcCHHHHhh
Confidence            9999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.7e-37  Score=337.51  Aligned_cols=260  Identities=31%  Similarity=0.498  Sum_probs=220.3

Q ss_pred             CCcccccCHHHHHHHhcCccCC------ceeeccCceeEEEEEEcCCcEEEEEEeccCC----cchHHHHHHHHHHHHhc
Q 001988          710 QPTIRRFSYFELLRATDNFAEN------NIIGIGGFGSVYRARLEDGVEIAIKVFHPQC----ASTLKSFEAECEVIKNI  779 (985)
Q Consensus       710 ~~~~~~~~~~~~~~~~~~~~~~------~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~il~~l  779 (985)
                      ......|++.++..++++|...      +.||+|+||.||+|.. +++.||||++....    ....+.+.+|+++++++
T Consensus         9 ~~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l   87 (307)
T 2nru_A            9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC   87 (307)
T ss_dssp             --CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC
T ss_pred             CCCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc
Confidence            3446789999999999999887      8999999999999987 58899999987542    23356789999999999


Q ss_pred             CCCCeeeEEeeeecCCceEEEEeccCCCChHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCE
Q 001988          780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSS--NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNV  857 (985)
Q Consensus       780 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Ni  857 (985)
                      +||||+++++++.+.+..++||||+++|+|.+++...  ...+++..+..++.|++.||+||   |++||+||||||+||
T Consensus        88 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dlkp~Ni  164 (307)
T 2nru_A           88 QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL---HENHHIHRDIKSANI  164 (307)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGE
T ss_pred             CCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHE
Confidence            9999999999999999999999999999999998743  34689999999999999999999   788999999999999


Q ss_pred             EEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--
Q 001988          858 LLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--  935 (985)
Q Consensus       858 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--  935 (985)
                      +++.++.+||+|||+++...............||+.|+|||.+. +.++.++|+ |++|+++++++++..+.......  
T Consensus       165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv-~slG~il~~l~~g~~p~~~~~~~~~  242 (307)
T 2nru_A          165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDI-YSFGVVLLEIITGLPAVDEHREPQL  242 (307)
T ss_dssp             EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHH-HHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred             EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchh-HHHHHHHHHHHHCCCCcccCcchHH
Confidence            99999999999999998875444333344567999999999765 468899999 99999999999987655432110  


Q ss_pred             ------------------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          936 ------------------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       936 ------------------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                                              ..+..+++.+.+++.+||+.+|.+||++.++++.|+++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             TTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence                                    0123466789999999999999999999999999998754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.9e-38  Score=345.29  Aligned_cols=249  Identities=26%  Similarity=0.402  Sum_probs=207.2

Q ss_pred             hcCccCCceeeccCceeEEEEEE-----cCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeec--CCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-----EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN--DDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~  797 (985)
                      .++|+..+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46788999999999999999984     2688999999987766666789999999999999999999999855  3568


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ++||||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            999999999999999988766799999999999999999999   78999999999999999999999999999998875


Q ss_pred             CCCCc-ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh---------------------
Q 001988          878 GEDES-TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------------  935 (985)
Q Consensus       878 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------------  935 (985)
                      ..... .......++..|+|||.+.+..++.++|+ |++|+++++++++..+....+..                     
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDV-WSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  244 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHH-HHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence            43322 22233457888999999999999999999 99999999999976544332110                     


Q ss_pred             -------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          936 -------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       936 -------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                             +.+..+++++.+++.+||..||++||++.|++++|+++++.+
T Consensus       245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence                   112235678999999999999999999999999999998765

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=344.22  Aligned_cols=250  Identities=23%  Similarity=0.371  Sum_probs=209.9

Q ss_pred             hcCccCCceeeccCceeEEEEEEc----CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      .++|...+.||+|+||.||+|++.    .+..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            357888899999999999999974    45569999998653 3345678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++|+|.+++......+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||+++.+...
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            9999999999999987766899999999999999999999   7899999999999999999999999999999987543


Q ss_pred             CCc-ceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHH
Q 001988          880 DES-TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSI  945 (985)
Q Consensus       880 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l  945 (985)
                      ... .......+|+.|+|||.+.+..++.++|+ |++|++++++++ +..++......            +.+..+++++
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di-~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  283 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDV-WSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHAL  283 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHH-HHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHH-HHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHH
Confidence            322 12233456889999999999999999999 999999999998 66655332211            1123457789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                      .+++.+||..||.+||++.|+++.|+.+.+...
T Consensus       284 ~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          284 HQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence            999999999999999999999999999887544

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-37  Score=335.74  Aligned_cols=246  Identities=24%  Similarity=0.354  Sum_probs=212.1

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .++|+..+.||+|+||.||+|+..+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            467888999999999999999998899999999986533 3467899999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      ++|+|.+++......+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  163 (269)
T 4hcu_A           88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  163 (269)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHH---HhCCeecCCcchheEEEcCCCCEEeccccccccccccc-ccc
Confidence            99999999987777799999999999999999999   78999999999999999999999999999998764221 122


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhhh------------HHHHHHHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFAA------------KEQCLLSIFSLALE  951 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~~------------~~~~~~~l~~l~~~  951 (985)
                      .....+|+.|+|||.+....++.++|+ |++|++++++++ +..+.........            +..+++++.+++.+
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  242 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDV-WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH  242 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhh-HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHH
Confidence            233457889999999999999999999 999999999998 6765543322111            12246779999999


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          952 CTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       952 cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      ||..+|.+||++.|+++.|+++.+.
T Consensus       243 ~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          243 CWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HccCCcccCcCHHHHHHHHHHHHHc
Confidence            9999999999999999999998763

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2e-37  Score=343.94  Aligned_cols=244  Identities=23%  Similarity=0.292  Sum_probs=205.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCC----ceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD----FKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----~~~lv  800 (985)
                      .++|+..+.||+|+||.||+|+.. ++.||||++.... .......+|+.++++++||||+++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            468899999999999999999886 7999999997542 33445677999999999999999999998754    36999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CeEeCCCCCCCEEEcCCCcEEEecc
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST----------PIIHCDLKPSNVLLDEDMVAHLSDF  870 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~----------~ivHrDlk~~Nill~~~~~~kl~Df  870 (985)
                      |||+++|+|.+++...  .+++..+..++.|++.||+||   |+.          ||+||||||+||+++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~L---H~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYL---HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHH---TCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            9999999999999875  489999999999999999999   677          9999999999999999999999999


Q ss_pred             cCceeccCCCCcceeccccccccccccccccc-----CccchhhhcccccccchhhhcccccccCcchh-----------
Q 001988          871 GMAKLLSGEDESTMRTQTLATIGYMAPDEIFV-----GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-----------  934 (985)
Q Consensus       871 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-----------  934 (985)
                      |+++.+.............||+.|+|||.+.+     ..++.++|+ |++|+++++++++..++.....           
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di-wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  254 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM-YAMGLVLWELASRCTAADGPVDEYMLPFEEEIG  254 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHH-HHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchh-HHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence            99988765444334445679999999999876     466778899 9999999999998765432100           


Q ss_pred             ----h-------------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          935 ----F-------------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       935 ----~-------------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                          .                   .....+++++.+++.+||..||++|||+.|+++.|+++++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                0                   01123456799999999999999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.5e-37  Score=333.76  Aligned_cols=246  Identities=24%  Similarity=0.344  Sum_probs=212.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .++|+..+.||+|+||.||+|+.+++..||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            467889999999999999999998888999999986533 3467899999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      ++++|.+++...+..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~  161 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVS  161 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH---HHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEE
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hhc
Confidence            99999999987766789999999999999999999   78999999999999999999999999999998764332 222


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh------------hHHHHHHHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA------------AKEQCLLSIFSLALE  951 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~------------~~~~~~~~l~~l~~~  951 (985)
                      .....+|+.|+|||.+.+..++.++|+ |++|++++++++ +..+........            .+..+++++.+++.+
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  240 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDV-WAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYS  240 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHH-HHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhh-HHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHH
Confidence            334457788999999999999999999 999999999998 776654322111            122246779999999


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          952 CTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       952 cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      ||..+|.+||++.|+++.|+.++++
T Consensus       241 ~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          241 CWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             TTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             HcCCChhhCcCHHHHHHHHHHhhhc
Confidence            9999999999999999999998764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.9e-37  Score=349.92  Aligned_cols=261  Identities=21%  Similarity=0.316  Sum_probs=217.6

Q ss_pred             cccCHHHHHHHhcCccCCceeeccCceeEEEEEE------cCCcEEEEEEeccCCc-chHHHHHHHHHHHHhc-CCCCee
Q 001988          714 RRFSYFELLRATDNFAENNIIGIGGFGSVYRARL------EDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLV  785 (985)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv  785 (985)
                      ..+...++....++|...+.||+|+||.||+|++      .+++.||||+++.... ...+.+.+|+++++++ +||||+
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            3455666667789999999999999999999974      2568899999986533 3356789999999999 789999


Q ss_pred             eEEeeeecCC-ceEEEEeccCCCChHHHhhcCCC----------------------------------------------
Q 001988          786 KIISSCSNDD-FKALVLEYMSNGSLEDCLHSSNC----------------------------------------------  818 (985)
Q Consensus       786 ~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------  818 (985)
                      ++++++.+.+ ..++||||+++|+|.+++.....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            9999998765 48999999999999999976532                                              


Q ss_pred             -------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          819 -------------------ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       819 -------------------~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                                         .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+...
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                               188999999999999999999   7889999999999999999999999999999877544


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh-------------hhHHHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF-------------AAKEQCLLSI  945 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~-------------~~~~~~~~~l  945 (985)
                      ..........||+.|+|||.+.+..++.++|+ |++|++++++++ +..++......             ..+..+++++
T Consensus       247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di-~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  325 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDV-WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEM  325 (359)
T ss_dssp             TTCEEC--CEECGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred             ccchhccccCCCceeEChhhhcCCCCCchhhh-hhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHH
Confidence            44444455678999999999999999999999 999999999997 77655432111             1122356789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                      .+++.+||..||.+||++.|+++.|+++.+...
T Consensus       326 ~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  358 (359)
T 3vhe_A          326 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  358 (359)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHccCChhhCCCHHHHHHHHHHHHHHhc
Confidence            999999999999999999999999999987643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.2e-37  Score=338.11  Aligned_cols=247  Identities=26%  Similarity=0.356  Sum_probs=202.2

Q ss_pred             HhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ..++|+..+.||+|+||.||+|+. +++.||||++.....  ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            457889999999999999999987 588999999976543  23467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          802 EYMSNGSLEDCLHSSNC--ALNIFCRLNIMIDIASALEYLHFGHSTP--IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~Lh~~h~~~--ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ||+++|+|.+++.....  .+++..+..++.|++.||+||   |++|  |+||||||+||+++.++.+||+|||+++...
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL---HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHH---HTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH---HcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            99999999999986532  389999999999999999999   7888  9999999999999999999999999998653


Q ss_pred             CCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-------------hHHHHHHH
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------AKEQCLLS  944 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------~~~~~~~~  944 (985)
                      ..  ........||+.|+|||.+.+..++.++|+ |++|+++++++++..++.......             .+..++.+
T Consensus       191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (309)
T 3p86_A          191 ST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDV-YSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ  267 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHH-HHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred             cc--ccccccCCCCccccChhhhcCCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence            22  122334569999999999999999999999 999999999999987665432111             12335678


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          945 IFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       945 l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      +.+++.+||..+|.+||++.++++.|+.+.+..
T Consensus       268 l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            999999999999999999999999999987643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.1e-36  Score=337.41  Aligned_cols=248  Identities=21%  Similarity=0.262  Sum_probs=212.5

Q ss_pred             cccCHHHHHHHhcC----------ccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCC
Q 001988          714 RRFSYFELLRATDN----------FAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHR  782 (985)
Q Consensus       714 ~~~~~~~~~~~~~~----------~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~  782 (985)
                      ..+++.++..+++.          |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45778888777764          666789999999999999976 7999999999877666677899999999999999


Q ss_pred             CeeeEEeeeecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC
Q 001988          783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED  862 (985)
Q Consensus       783 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~  862 (985)
                      ||+++++++...+..++||||+++|+|.+++...  .+++..+..++.|++.||+||   |+.||+||||||+||+++.+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYL---HAQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCC
Confidence            9999999999999999999999999999998754  589999999999999999999   78899999999999999999


Q ss_pred             CcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh-------
Q 001988          863 MVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-------  935 (985)
Q Consensus       863 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-------  935 (985)
                      +.+||+|||+++.+....  .......||+.|+|||.+.+..++.++|+ |++|+++++++++..+.......       
T Consensus       178 ~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv-~slG~il~el~~g~~pf~~~~~~~~~~~~~  254 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDI-WSLGIMVIEMVDGEPPYFSDSPVQAMKRLR  254 (321)
T ss_dssp             CCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHH-HHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             CcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence            999999999998865322  22344579999999999999999999999 99999999999988765432211       


Q ss_pred             -------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          936 -------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       936 -------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                             .....+++++.+++.+||..||++||++.|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          255 DSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   1122356779999999999999999999999873

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.3e-37  Score=336.93  Aligned_cols=247  Identities=21%  Similarity=0.357  Sum_probs=209.8

Q ss_pred             HhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ..++|+..+.||+|+||.||+|.+.+++.||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            4578899999999999999999999889999999986533 346789999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...... ..
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~  176 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YT  176 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HH
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCccceEEEcCCCCEEEccccccccccccc-cc
Confidence            999999999987656799999999999999999999   78999999999999999999999999999998764221 12


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh------------hHHHHHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA------------AKEQCLLSIFSLAL  950 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~------------~~~~~~~~l~~l~~  950 (985)
                      ......+|+.|+|||.+....++.++|+ |++|++++++++ +..++.......            .+..+++.+.+++.
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  255 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSKSDI-WAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY  255 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHHHHH-HHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cccCCccCcccCCHHHhccCCCCchhhH-HHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHH
Confidence            2233457888999999999999999999 999999999997 776654332111            12224677999999


Q ss_pred             HccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          951 ECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      +||+.+|.+||++.|+++.|.++.++
T Consensus       256 ~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          256 SCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             HTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHccCChhHCcCHHHHHHHHHHHhhc
Confidence            99999999999999999999998865

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-37  Score=345.34  Aligned_cols=256  Identities=25%  Similarity=0.382  Sum_probs=210.8

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDD  795 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~  795 (985)
                      ...++|...+.||+|+||.||+|+..      +++.||||+++..... ..+.+.+|++++++++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            34578999999999999999999874      3488999999865332 3567899999999999999999999999999


Q ss_pred             ceEEEEeccCCCChHHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 001988          796 FKALVLEYMSNGSLEDCLHSSN-----------------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL  852 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDl  852 (985)
                      ..++||||+++|+|.+++....                       ..+++.+++.++.|+++||+||   |++||+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCC
Confidence            9999999999999999997642                       4689999999999999999999   7889999999


Q ss_pred             CCCCEEEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCc
Q 001988          853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGE  931 (985)
Q Consensus       853 k~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~  931 (985)
                      ||+||+++.++.+||+|||+++.+.............+|+.|+|||.+.+..++.++|+ |++|++++++++ +..+...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di-~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV-WAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTTCCTTTT
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCccccc-HHHHHHHHHHHhcCCCcCCC
Confidence            99999999999999999999987643332223344568999999999999999999999 999999999998 6654433


Q ss_pred             chhh------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhccccC
Q 001988          932 EKHF------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSKRIG  982 (985)
Q Consensus       932 ~~~~------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~~~~  982 (985)
                      ....            ..++.++.++.+++.+||..||.+||++.++++.|+++.+.....+|
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~~~~  342 (343)
T 1luf_A          280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGTVG  342 (343)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-------
T ss_pred             CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhhhcC
Confidence            2111            11234567899999999999999999999999999999887765543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=6.9e-36  Score=341.09  Aligned_cols=296  Identities=21%  Similarity=0.249  Sum_probs=200.4

Q ss_pred             CCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhc
Q 001988          160 KLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIG  239 (985)
Q Consensus       160 ~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  239 (985)
                      .+|..++..+++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|++++|+++...+..|+
T Consensus        59 ~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~  138 (390)
T 3o6n_A           59 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFH  138 (390)
T ss_dssp             EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhc
Confidence            45555556666677777777776655566777777777777777777766666777777777777777777744444467


Q ss_pred             CCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccE
Q 001988          240 YLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLIL  319 (985)
Q Consensus       240 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  319 (985)
                      ++++|++|++++|++++..|..+.++++|++|++++|++++ ++.   ..+++|+.|++++|.+++.     ....+|+.
T Consensus       139 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~---~~l~~L~~L~l~~n~l~~~-----~~~~~L~~  209 (390)
T 3o6n_A          139 NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDL---SLIPSLFHANVSYNLLSTL-----AIPIAVEE  209 (390)
T ss_dssp             TCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB-CCG---GGCTTCSEEECCSSCCSEE-----ECCSSCSE
T ss_pred             CCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCc-ccc---ccccccceeeccccccccc-----CCCCcceE
Confidence            77777777777777777777777777777777777777763 331   3466777777777766532     22345666


Q ss_pred             EEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhccccee
Q 001988          320 LEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLN  399 (985)
Q Consensus       320 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~  399 (985)
                      |++++|.+......   ..++|+.|++++|++++.                               ..+..++ +|++|+
T Consensus       210 L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~-------------------------------~~l~~l~-~L~~L~  254 (390)
T 3o6n_A          210 LDASHNSINVVRGP---VNVELTILKLQHNNLTDT-------------------------------AWLLNYP-GLVEVD  254 (390)
T ss_dssp             EECCSSCCCEEECC---CCSSCCEEECCSSCCCCC-------------------------------GGGGGCT-TCSEEE
T ss_pred             EECCCCeeeecccc---ccccccEEECCCCCCccc-------------------------------HHHcCCC-CccEEE
Confidence            66666666543221   124455555555554432                               2333333 455555


Q ss_pred             ccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCcccc
Q 001988          400 IAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISG  479 (985)
Q Consensus       400 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  479 (985)
                      +++|.+++..|..|..+++|++|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++
T Consensus       255 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~  332 (390)
T 3o6n_A          255 LSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT  332 (390)
T ss_dssp             CCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC
T ss_pred             CCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccce
Confidence            55566666667777778888888888888874 4556677888888888888887 566667788888888888888875


Q ss_pred             ccCCCCcCcCcCceEeeccceeeee
Q 001988          480 SISSCLGNLTSLQYLNLGSNRFTFV  504 (985)
Q Consensus       480 ~~~~~~~~l~~L~~L~L~~N~l~~~  504 (985)
                      . +  +..+++|++|++++|+++..
T Consensus       333 ~-~--~~~~~~L~~L~l~~N~~~~~  354 (390)
T 3o6n_A          333 L-K--LSTHHTLKNLTLSHNDWDCN  354 (390)
T ss_dssp             C-C--CCTTCCCSEEECCSSCEEHH
T ss_pred             e-C--chhhccCCEEEcCCCCccch
Confidence            4 2  66777888888888888753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8e-37  Score=338.93  Aligned_cols=238  Identities=25%  Similarity=0.280  Sum_probs=204.7

Q ss_pred             HhcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      ..++|...+.||+|+||.||+|++ .+|+.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            356899999999999999999997 589999999997552  23456788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++|+|.+++...+ .+++.....++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+....
T Consensus        93 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYC---HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             EECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            99999999999997754 689999999999999999999   78999999999999999999999999999998764322


Q ss_pred             CcceecccccccccccccccccCccc-hhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELS-LKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSIFSL  948 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l~~l  948 (985)
                         .....+||+.|+|||.+.+..+. .++|+ |++|+++++++++..++........           +..++.++.++
T Consensus       169 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di-wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  244 (328)
T 3fe3_A          169 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDV-WSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL  244 (328)
T ss_dssp             ---GGGTTSSSGGGCCHHHHHTCCCCSHHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             ---ccccccCCcceeCcccccCCCcCCchhhh-hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence               23456799999999999888875 78999 9999999999999887654322211           12245778999


Q ss_pred             HHHccCCCCCCCCCHHHHHHH
Q 001988          949 ALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      +.+|+..||.+|||+.|+++.
T Consensus       245 i~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          245 LKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             HHHHCCSSTTTSCCHHHHTTC
T ss_pred             HHHHCCCChhHCcCHHHHhcC
Confidence            999999999999999999763

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-36  Score=345.75  Aligned_cols=251  Identities=25%  Similarity=0.365  Sum_probs=213.2

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc--------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhc-CCCCeeeEEeeeec
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE--------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLVKIISSCSN  793 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~  793 (985)
                      ..++|...+.||+|+||.||+|+..        ++..||||+++.... .....+.+|+++++++ +||||+++++++.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            3468899999999999999999852        346799999976533 3456789999999999 89999999999999


Q ss_pred             CCceEEEEeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEE
Q 001988          794 DDFKALVLEYMSNGSLEDCLHSSN---------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVL  858 (985)
Q Consensus       794 ~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nil  858 (985)
                      ++..++||||+++|+|.+++....               ..+++..+..++.|++.||+||   |++||+||||||+||+
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCcceEE
Confidence            999999999999999999998653               3589999999999999999999   7889999999999999


Q ss_pred             EcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh-
Q 001988          859 LDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA-  936 (985)
Q Consensus       859 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~-  936 (985)
                      +++++.+||+|||+++...............+|+.|+|||.+.+..++.++|+ |++|++++++++ +..+........ 
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di-wslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV-WSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHH-HHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHH-HHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999987754443333445568899999999999999999999 999999999998 766554332111 


Q ss_pred             -----------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          937 -----------AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       937 -----------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                                 .+..+++++.+++.+||..||++||++.|+++.|+++.....
T Consensus       303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          303 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence                       122356789999999999999999999999999999987543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.1e-37  Score=347.15  Aligned_cols=248  Identities=23%  Similarity=0.410  Sum_probs=198.6

Q ss_pred             hcCccCCceeeccCceeEEEEEEc----CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      .++|...+.||+|+||.||+|+..    ++..||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357899999999999999999864    577899999976532 345678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++|+|.++++..+..+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++.+...
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            9999999999999988776799999999999999999999   7889999999999999999999999999999887533


Q ss_pred             CCcc-eecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHH
Q 001988          880 DEST-MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSI  945 (985)
Q Consensus       880 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l  945 (985)
                      .... ......+++.|+|||.+....++.++|+ |++|++++++++ ++.+.......            +.+..++.++
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  279 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV-WSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL  279 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHH
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcH-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence            2211 1222346788999999999999999999 999999999887 66554322111            1122456789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      .+++.+||+.+|.+||++.++++.|+++.+.
T Consensus       280 ~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          280 YQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            9999999999999999999999999998764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-36  Score=334.39  Aligned_cols=237  Identities=18%  Similarity=0.227  Sum_probs=205.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .++|...+.||+|+||.||+|... +++.||+|.+... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999976 6889999998754 33456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC--CCcEEEecccCceeccCCCC
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE--DMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~--~~~~kl~DfGla~~~~~~~~  881 (985)
                      +++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.  ++.+||+|||+++.+.... 
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-  158 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence            999999999987766799999999999999999999   7889999999999999987  7899999999998875322 


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQCLLSIF  946 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~~~~~l~  946 (985)
                        ......||+.|+|||.+.+..++.++|+ |++|+++++++++..++.......               ....++.++.
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T 1tki_A          159 --NFRLLFTAPEYYAPEVHQHDVVSTATDM-WSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHH-HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             --ccccccCChhhcCcHHhcCCCCCchhhH-HHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence              2334569999999999999889999999 999999999999887654432111               1123567899


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHH
Q 001988          947 SLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      +++.+|+..||.+|||+.|+++.
T Consensus       236 ~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          236 DFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHcCCChhHCcCHHHHhcC
Confidence            99999999999999999999873

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-37  Score=347.21  Aligned_cols=249  Identities=22%  Similarity=0.351  Sum_probs=209.1

Q ss_pred             hcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  797 (985)
                      .++|...+.||+|+||.||+|++.      +++.||||+++... ......+.+|+.++++++||||+++++++.+.+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467888999999999999999843      56789999997543 33456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC---cEEEe
Q 001988          798 ALVLEYMSNGSLEDCLHSSN------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM---VAHLS  868 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~---~~kl~  868 (985)
                      ++||||+++|+|.+++....      ..+++.+++.++.|++.||+||   |++||+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999998643      3589999999999999999999   789999999999999999555   59999


Q ss_pred             cccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------
Q 001988          869 DFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------  935 (985)
Q Consensus       869 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------  935 (985)
                      |||+++.+.............+|+.|+|||.+.+..++.++|+ |++|++++++++ +..++......            
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv-wslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~  305 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT-WSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  305 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            9999986543333233344568999999999999999999999 999999999997 76655433211            


Q ss_pred             hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          936 AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       936 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      ..+..++.++.+++.+||+.+|.+||++.++++.++.+.+..
T Consensus       306 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          306 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            112345678999999999999999999999999999988743

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2e-36  Score=334.65  Aligned_cols=252  Identities=21%  Similarity=0.347  Sum_probs=214.8

Q ss_pred             HhcCccCCceeeccCceeEEEEEE------cCCcEEEEEEeccCCc-chHHHHHHHHHHHHhc-CCCCeeeEEeeeecCC
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARL------EDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLVKIISSCSNDD  795 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~  795 (985)
                      ..++|...+.||+|+||.||+|+.      .+++.||+|+++.... ...+.+.+|+++++++ +||||+++++++.+.+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            456899999999999999999985      3578899999986543 3457789999999999 9999999999999999


Q ss_pred             ceEEEEeccCCCChHHHhhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEE
Q 001988          796 FKALVLEYMSNGSLEDCLHSSNC-----------------ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVL  858 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nil  858 (985)
                      ..++||||+++|+|.+++.....                 .+++..+..++.|+++||+||   |++||+||||||+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCccceEE
Confidence            99999999999999999986532                 489999999999999999999   7889999999999999


Q ss_pred             EcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh-
Q 001988          859 LDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA-  936 (985)
Q Consensus       859 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~-  936 (985)
                      ++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|+ |++|++++++++ +..+........ 
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV-WSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHH-HHHHHHHHHHHhCCCCCCCcccchhH
Confidence            99999999999999988765444334445568889999999999999999999 999999999998 766554322111 


Q ss_pred             ------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          937 ------------AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       937 ------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                                  .+..+++++.+++.+||..||.+||++.|+++.|+++.+....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  311 (313)
T 1t46_A          257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN  311 (313)
T ss_dssp             HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred             HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence                        1223567899999999999999999999999999998876544

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.8e-36  Score=335.21  Aligned_cols=249  Identities=26%  Similarity=0.378  Sum_probs=211.8

Q ss_pred             HhcCccCCceeeccCceeEEEEEE------cCCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCc
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARL------EDGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDF  796 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  796 (985)
                      ..++|...+.||+|+||.||+|..      .+++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            457889999999999999999986      2457899999976532 345678999999999999999999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 001988          797 KALVLEYMSNGSLEDCLHSSN-----------------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLK  853 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk  853 (985)
                      .++||||+++|+|.+++....                       ..+++.+++.++.|+++||+||   |++||+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHH---HHTTEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHH---HHCCCcccccc
Confidence            999999999999999998643                       2378999999999999999999   78899999999


Q ss_pred             CCCEEEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcc
Q 001988          854 PSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEE  932 (985)
Q Consensus       854 ~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~  932 (985)
                      |+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|+ |++|++++++++ +..+....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDV-WSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHH-HHHHHHHHHHHTTSCCSSTTC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhH-HHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999988754443333344567889999999999999999999 999999999998 76554432


Q ss_pred             hhhh------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          933 KHFA------------AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       933 ~~~~------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      ....            .+..+++++.+++.+||..||.+||++.|+++.|+++.+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          257 PPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             CGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            2111            1224567899999999999999999999999999998765

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-36  Score=339.78  Aligned_cols=254  Identities=21%  Similarity=0.303  Sum_probs=209.9

Q ss_pred             HHhcCccCCceeeccCceeEEEEEE------cCCcEEEEEEeccCC-cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARL------EDGVEIAIKVFHPQC-ASTLKSFEAECEVIKNI-RHRNLVKIISSCSND  794 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~  794 (985)
                      ...++|...+.||+|+||.||+|+.      .+++.||+|+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            3567899999999999999999986      246689999997552 23456789999999999 899999999999999


Q ss_pred             CceEEEEeccCCCChHHHhhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSNC----------------------ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL  852 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDl  852 (985)
                      +..++||||+++|+|.+++.....                      .+++..+..++.|++.||+||   |++||+||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH---HHTTEEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCC
Confidence            999999999999999999986532                      378999999999999999999   7899999999


Q ss_pred             CCCCEEEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCc
Q 001988          853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGE  931 (985)
Q Consensus       853 k~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~  931 (985)
                      ||+||+++.++.+||+|||+++.+.............+|+.|+|||.+.++.++.++|+ |++|++++++++ +..+...
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di-~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV-WSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHTTTSCCSSTT
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhH-HHHHHHHHHHHcCCCCCccc
Confidence            99999999999999999999987754444444455568899999999999999999999 999999999997 7655443


Q ss_pred             chhh-------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhccc
Q 001988          932 EKHF-------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSKR  980 (985)
Q Consensus       932 ~~~~-------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~~  980 (985)
                      ....             ..+..+++++.+++.+||..||.+||++.|+++.|+.+......+
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  339 (344)
T 1rjb_A          278 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA  339 (344)
T ss_dssp             CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred             CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence            2211             112235678999999999999999999999999999988765543

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.3e-35  Score=357.45  Aligned_cols=296  Identities=21%  Similarity=0.237  Sum_probs=208.3

Q ss_pred             CCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhc
Q 001988          160 KLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIG  239 (985)
Q Consensus       160 ~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  239 (985)
                      .+|+.+++++++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|++++..+..|+
T Consensus        65 ~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~  144 (597)
T 3oja_B           65 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFH  144 (597)
T ss_dssp             EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhc
Confidence            45666666777777777777777766667778888888888888888877777778888888888888888755555567


Q ss_pred             CCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccE
Q 001988          240 YLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLIL  319 (985)
Q Consensus       240 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  319 (985)
                      ++++|++|+|++|.+++..|..|.++++|++|+|++|.+++ ++.   ..+++|+.|++++|.+++.     ....+|+.
T Consensus       145 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~---~~l~~L~~L~l~~n~l~~l-----~~~~~L~~  215 (597)
T 3oja_B          145 NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDL---SLIPSLFHANVSYNLLSTL-----AIPIAVEE  215 (597)
T ss_dssp             TCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB-CCG---GGCTTCSEEECCSSCCSEE-----ECCTTCSE
T ss_pred             cCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC-cCh---hhhhhhhhhhcccCccccc-----cCCchhhe
Confidence            88888888888888887777778888888888888887774 332   3467777777777776632     23345666


Q ss_pred             EEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhccccee
Q 001988          320 LEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLN  399 (985)
Q Consensus       320 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~  399 (985)
                      |++++|.+....+..   .+                             +|+.|++++|.+++  +..+..++ +|+.|+
T Consensus       216 L~ls~n~l~~~~~~~---~~-----------------------------~L~~L~L~~n~l~~--~~~l~~l~-~L~~L~  260 (597)
T 3oja_B          216 LDASHNSINVVRGPV---NV-----------------------------ELTILKLQHNNLTD--TAWLLNYP-GLVEVD  260 (597)
T ss_dssp             EECCSSCCCEEECSC---CS-----------------------------CCCEEECCSSCCCC--CGGGGGCT-TCSEEE
T ss_pred             eeccCCccccccccc---CC-----------------------------CCCEEECCCCCCCC--ChhhccCC-CCCEEE
Confidence            666666665332221   13                             34444444444443  23344444 566666


Q ss_pred             ccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCcccc
Q 001988          400 IAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISG  479 (985)
Q Consensus       400 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  479 (985)
                      |++|.+++.+|..|..+++|++|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|++++
T Consensus       261 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~  338 (597)
T 3oja_B          261 LSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT  338 (597)
T ss_dssp             CCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC
T ss_pred             CCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCC
Confidence            66666666677777888888888888888875 4666677888888888888888 567777888888888888888875


Q ss_pred             ccCCCCcCcCcCceEeeccceeeee
Q 001988          480 SISSCLGNLTSLQYLNLGSNRFTFV  504 (985)
Q Consensus       480 ~~~~~~~~l~~L~~L~L~~N~l~~~  504 (985)
                      ..   +..+++|+.|++++|.+++.
T Consensus       339 ~~---~~~~~~L~~L~l~~N~~~~~  360 (597)
T 3oja_B          339 LK---LSTHHTLKNLTLSHNDWDCN  360 (597)
T ss_dssp             CC---CCTTCCCSEEECCSSCEEHH
T ss_pred             cC---hhhcCCCCEEEeeCCCCCCh
Confidence            42   56677888888888887753

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.2e-37  Score=339.32  Aligned_cols=247  Identities=22%  Similarity=0.358  Sum_probs=202.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCc----EEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGV----EIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      .++|+..+.||+|+||.||+|++. +++    +||+|.++... ....+.+.+|+.++++++||||++++++|.+.+ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            367889999999999999999864 444    36888876442 234578999999999999999999999998765 67


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +|+||+++|+|.+++......+++..++.++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+..
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            99999999999999998777899999999999999999999   788999999999999999999999999999988765


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSI  945 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l  945 (985)
                      ...........+|+.|+|||.+.+..++.++|+ |++|++++++++ +..++......            ..+..++.++
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di-~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDV-WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  248 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhh-hhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence            444444444567889999999999999999999 999999999998 77665432211            1223366789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      .+++.+||..+|.+||++.|+++.|+++.+.
T Consensus       249 ~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          249 YMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            9999999999999999999999999988764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.7e-36  Score=331.79  Aligned_cols=237  Identities=22%  Similarity=0.307  Sum_probs=198.6

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .++|+..+.||+|+||.||+|+..+++.||+|++.....  .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            478999999999999999999998899999999975532  234678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |++ |+|.+++......+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||+++.+....  
T Consensus       100 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--  173 (311)
T 3niz_A          100 FME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC---HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--  173 (311)
T ss_dssp             CCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--
T ss_pred             CCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc--
Confidence            997 489998887766799999999999999999999   78999999999999999999999999999998864322  


Q ss_pred             ceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh------------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA------------------------  937 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~------------------------  937 (985)
                      .......||+.|+|||.+.+ ..++.++|+ |++|+++++++++..++........                        
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  252 (311)
T 3niz_A          174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDI-WSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL  252 (311)
T ss_dssp             C---CCCCCCTTCCHHHHTTCCSCCTHHHH-HHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred             ccccCCcccCCcCCHHHhcCCCCCCchHHh-HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence            22334568999999999876 568999999 9999999999998865543211110                        


Q ss_pred             -----------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 -----------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 -----------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                       .+.+.+++.+++.+|+..||++|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                             0113457889999999999999999999986

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.9e-36  Score=335.35  Aligned_cols=237  Identities=24%  Similarity=0.282  Sum_probs=203.1

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|+..+.||+|+||.||+|+.+ +++.||+|++++..   ......+.+|++++++++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            367899999999999999999975 78999999997542   23456788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||++||+|.+++...+ .+++.....++.||+.||+||   |++||+||||||+||+++.+|.+||+|||+++......
T Consensus        84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            99999999999998654 688999999999999999999   78999999999999999999999999999998643222


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSIFSLA  949 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l~~l~  949 (985)
                        ......+||+.|+|||.+.+..++.++|+ |++|++++++++|..+.........           +...++++.+++
T Consensus       160 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  236 (337)
T 1o6l_A          160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDW-WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL  236 (337)
T ss_dssp             --CCBCCCEECGGGCCGGGGSSSCBCTTHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             --CcccccccChhhCChhhhcCCCCCchhhc-ccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence              22345679999999999999999999999 9999999999999876644322111           123467889999


Q ss_pred             HHccCCCCCCCC-----CHHHHHH
Q 001988          950 LECTMESPEKRI-----DAKDTIT  968 (985)
Q Consensus       950 ~~cl~~~P~~RP-----t~~ev~~  968 (985)
                      .+|+..||.+||     ++.|+++
T Consensus       237 ~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          237 AGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHHc
Confidence            999999999999     8888875

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1e-36  Score=337.92  Aligned_cols=240  Identities=23%  Similarity=0.296  Sum_probs=202.9

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .++|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999876 789999999875532 234668899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+......
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999997653 689999999999999999999   7899999999999999999999999999999876543333


Q ss_pred             ceecccccccccccccccccCcc-chhhhcccccccchhhhcccccccCcchhh--------------hhHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGEL-SLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQCLLSIFS  947 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~~~~l~~  947 (985)
                      ......+||+.|+|||.+.+..+ +.++|+ |++|+++++++++..++......              .....++.++.+
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di-wslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDV-WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA  240 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHH-HHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccH-HHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHH
Confidence            33445679999999999988776 778999 99999999999998766432211              112335678899


Q ss_pred             HHHHccCCCCCCCCCHHHHHHH
Q 001988          948 LALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      ++.+|+..||.+||++.|+++.
T Consensus       241 li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          241 LLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHccCChhhCcCHHHHhhC
Confidence            9999999999999999999763

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=100.00  E-value=2e-36  Score=335.96  Aligned_cols=280  Identities=21%  Similarity=0.268  Sum_probs=200.0

Q ss_pred             cCChhHHHHHHHHHHhcccCCCCcccCCC----CCCCCcceeeeEEEeC--------CCCeEEEEEecCCcccccCchhc
Q 001988           26 SNISTDQQALLALKDHITYDPTNLLGTNW----TSNASICSWIGIICDV--------NSHKVTTLNLSSFNLQGTIPPEI   93 (985)
Q Consensus        26 ~~~~~~~~aLl~~k~~~~~~~~~~~~s~w----~~~~~~c~w~gv~c~~--------~~~~v~~l~L~~~~l~g~~~~~l   93 (985)
                      ....+|++||++||+++..||.+.+++ |    ....++|.|.|++|+.        ...+|+.|+|++++++ .+|+.+
T Consensus        23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~-w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l  100 (328)
T 4fcg_A           23 TALRPYHDVLSQWQRHYNADRNRWHSA-WRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA  100 (328)
T ss_dssp             CCCCCHHHHHHHHHHHHHHCCTTHHHH-HHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred             ccCchHHHHHHHHHHhccCCchhhhhh-hcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence            455789999999999998788888776 8    4567899999999952        3467899999999988 888888


Q ss_pred             ccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccc
Q 001988           94 ANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLK  173 (985)
Q Consensus        94 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~  173 (985)
                      +++++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..+..+++|++|++++|++.+.+|..+..      
T Consensus       101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~------  172 (328)
T 4fcg_A          101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS------  172 (328)
T ss_dssp             GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEE------
T ss_pred             hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhh------
Confidence            88999999999999988 78888888888999988888887 55666666666666666666666555554311      


Q ss_pred             eecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCc
Q 001988          174 HLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNN  253 (985)
Q Consensus       174 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  253 (985)
                                ..++..|+++++|++|+|++|+++ .+|..++++++|++|++++|++++ +|..++.+++|++|+|++|+
T Consensus       173 ----------~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~  240 (328)
T 4fcg_A          173 ----------TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCT  240 (328)
T ss_dssp             ----------EC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCT
T ss_pred             ----------ccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCc
Confidence                      011223445777777777777777 667777777777777777777773 55567777777777777777


Q ss_pred             CcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccc
Q 001988          254 LTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFS  328 (985)
Q Consensus       254 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  328 (985)
                      +.+.+|..+.++++|++|+|++|++.+.+|..+ ..+++|++|+|++|++.+.+|..++++++|+.+++..|.+.
T Consensus       241 ~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          241 ALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDI-HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             TCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTG-GGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             chhhhHHHhcCCCCCCEEECCCCCchhhcchhh-hcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            777777777777777777777666666666553 35566666666666666666666666666666655554443

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.8e-36  Score=329.12  Aligned_cols=248  Identities=16%  Similarity=0.162  Sum_probs=212.5

Q ss_pred             hcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .++|...+.||+|+||.||+|+. .+++.||||++....  ....+.+|+++++++ +|++++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999996 579999999986542  335678999999999 79999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc-----EEEecccCceecc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV-----AHLSDFGMAKLLS  877 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~-----~kl~DfGla~~~~  877 (985)
                      |+ +++|.+++...+..+++..+..++.|+++||+||   |++||+||||||+||+++.++.     +||+|||+++.+.
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 9999999998766799999999999999999999   7899999999999999987776     9999999999876


Q ss_pred             CCCCc-----ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh----------------h
Q 001988          878 GEDES-----TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF----------------A  936 (985)
Q Consensus       878 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~----------------~  936 (985)
                      .....     .......||+.|+|||.+.+..++.++|+ |++|++++++++++.++......                .
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDL-EALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  241 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHH-HHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHH-HHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence            43321     12345579999999999999999999999 99999999999998876542110                0


Q ss_pred             h---HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          937 A---KEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       937 ~---~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                      .   ...+++++.+++.+||..+|++||++.++++.|+++.++...
T Consensus       242 ~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~  287 (298)
T 1csn_A          242 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  287 (298)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence            0   013467899999999999999999999999999999886544

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.3e-36  Score=332.61  Aligned_cols=246  Identities=24%  Similarity=0.351  Sum_probs=205.5

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++.....   ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467899999999999999999865 789999999865422   2346789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++|+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+....
T Consensus        90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHA---HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999998764 689999999999999999999   78999999999999999999999999999998764322


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh----------------hHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA----------------AKEQCLLS  944 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~----------------~~~~~~~~  944 (985)
                       ........||+.|+|||.+.+..++.++|+ |++|++++++++++.++.......                ....+++.
T Consensus       166 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (294)
T 4eqm_A          166 -LTQTNHVLGTVQYFSPEQAKGEATDECTDI-YSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS  243 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHH-HHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred             -ccccCccccCccccCHhHhcCCCCCchHhH-HHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence             222344569999999999999999999999 999999999999987765432111                11235678


Q ss_pred             HHHHHHHccCCCCCCCC-CHHHHHHHHHHhHhh
Q 001988          945 IFSLALECTMESPEKRI-DAKDTITRLLKIRDT  976 (985)
Q Consensus       945 l~~l~~~cl~~~P~~RP-t~~ev~~~L~~i~~~  976 (985)
                      +.+++.+|+..||.+|| ++.++.+.|..+...
T Consensus       244 l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          244 LSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             HHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             HHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            99999999999999999 999999999887654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.7e-36  Score=325.47  Aligned_cols=246  Identities=24%  Similarity=0.350  Sum_probs=211.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .++|+..+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            467888999999999999999998899999999986643 3467899999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      ++++|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++..... ....
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~  161 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTS  161 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHS
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCchheEEECCCCCEEEcccccccccccc-cccc
Confidence            99999999988766789999999999999999999   7899999999999999999999999999999876321 1112


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh------------hHHHHHHHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA------------AKEQCLLSIFSLALE  951 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~------------~~~~~~~~l~~l~~~  951 (985)
                      .....+++.|+|||.+....++.++|+ |++|++++++++ +..+........            .+..++.++.+++.+
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~  240 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDV-WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH  240 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred             cccccccccccChhhhcCCCccchhch-hhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHH
Confidence            233457889999999999999999999 999999999998 666544322111            112246779999999


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          952 CTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       952 cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      ||..+|.+||++.|+++.|+++.+.
T Consensus       241 ~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          241 CWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HccCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999998763

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.5e-36  Score=353.01  Aligned_cols=254  Identities=23%  Similarity=0.403  Sum_probs=213.9

Q ss_pred             HHHHHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          720 ELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       720 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ++....++|...+.||+|+||.||+|.++++..||||+++... ...+.+.+|++++++++||||+++++++. .+..++
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l  259 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI  259 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence            3444667899999999999999999999888999999998653 44678999999999999999999999987 567899


Q ss_pred             EEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          800 VLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      ||||+++|+|.+++... ...+++..+..++.||+.||+||   |+++|+||||||+|||++.++.+||+|||+++.+..
T Consensus       260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            99999999999999854 23578899999999999999999   788999999999999999999999999999987642


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSI  945 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l  945 (985)
                      .. ........+++.|+|||.+..+.++.++|+ |++|++++|+++ +..+.......            +.+..+++++
T Consensus       337 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-wslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  414 (454)
T 1qcf_A          337 NE-YTAREGAKFPIKWTAPEAINFGSFTIKSDV-WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL  414 (454)
T ss_dssp             HH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred             Cc-eeccCCCcccccccCHHHhccCCCCcHHHH-HhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            21 112233346789999999999999999999 999999999998 77655432111            1233467889


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhccc
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRDTLSKR  980 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~~  980 (985)
                      .+++.+||..||++||++.++++.|+.+.......
T Consensus       415 ~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~  449 (454)
T 1qcf_A          415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ  449 (454)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred             HHHHHHHccCChhHCcCHHHHHHHHHHHHhccccc
Confidence            99999999999999999999999999987654443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5e-36  Score=336.52  Aligned_cols=236  Identities=21%  Similarity=0.277  Sum_probs=203.6

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc------hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS------TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  797 (985)
                      .++|...+.||+|+||.||+|+.. +|+.||+|+++.....      ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999976 7899999999765322      246789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC----cEEEecccCc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM----VAHLSDFGMA  873 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~----~~kl~DfGla  873 (985)
                      ++||||++||+|.+++...+ .+++..+..++.||+.||+||   |+.||+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            99999999999999997654 689999999999999999999   789999999999999998877    7999999999


Q ss_pred             eeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hH
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AK  938 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~  938 (985)
                      +.+....   .....+||+.|+|||.+....++.++|+ |++|++++++++|..++.......               ..
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  242 (361)
T 2yab_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADM-WSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF  242 (361)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHH-HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred             eEcCCCC---ccccCCCCccEECchHHcCCCCCccccH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence            8875322   2334579999999999999999999999 999999999999887664332111               11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          939 EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       939 ~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ...++++.+++.+|+..||.+||++.|+++
T Consensus       243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          243 SQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            234677899999999999999999999884

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.1e-36  Score=333.92  Aligned_cols=251  Identities=24%  Similarity=0.378  Sum_probs=211.2

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc--------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhc-CCCCeeeEEeeeec
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE--------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLVKIISSCSN  793 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~  793 (985)
                      ..++|...+.||+|+||.||+|+..        +++.||||+++.... ...+.+.+|+++++++ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3578999999999999999999863        567899999976533 3456789999999999 89999999999999


Q ss_pred             CCceEEEEeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEE
Q 001988          794 DDFKALVLEYMSNGSLEDCLHSSN---------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVL  858 (985)
Q Consensus       794 ~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nil  858 (985)
                      .+..++||||+++|+|.+++....               ..+++..++.++.|++.||+||   |++||+||||||+||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCccceEE
Confidence            999999999999999999998653               2488999999999999999999   7889999999999999


Q ss_pred             EcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh-
Q 001988          859 LDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA-  936 (985)
Q Consensus       859 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~-  936 (985)
                      ++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|+ |++|++++++++ +..+........ 
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~ellt~g~~p~~~~~~~~~  268 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV-WSFGVLMWEIFTLGGSPYPGIPVEEL  268 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHH-HHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHH-HHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence            99999999999999988754443333344567889999999999999999999 999999999998 666544322111 


Q ss_pred             -----------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          937 -----------AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       937 -----------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                                 .+..++.++.+++.+||..+|.+||++.|+++.|+++.+...
T Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          269 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence                       122356789999999999999999999999999999887543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.8e-36  Score=332.93  Aligned_cols=245  Identities=21%  Similarity=0.205  Sum_probs=209.5

Q ss_pred             hcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .++|...+.||+|+||.||+|+. .+++.||||++.....  .+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46789999999999999999996 4789999999875532  34688999999999 99999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc-----EEEecccCceecc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV-----AHLSDFGMAKLLS  877 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~-----~kl~DfGla~~~~  877 (985)
                      |+ +++|.+++......+++..+..++.|++.||+||   |+.||+||||||+||+++.++.     +||+|||+++.+.
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYV---HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 9999999987666899999999999999999999   7889999999999999999887     9999999999875


Q ss_pred             CCCCcc-----eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh--------------H
Q 001988          878 GEDEST-----MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA--------------K  938 (985)
Q Consensus       878 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~--------------~  938 (985)
                      ......     ......||+.|+|||.+.+..++.++|+ |++|+++++++++..++........              +
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  240 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDL-EALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP  240 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHH-HHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHH-HHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence            433221     1245679999999999999999999999 9999999999999877654211100              0


Q ss_pred             -----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          939 -----EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       939 -----~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                           +.++ ++.+++..||..+|.+||++.++.+.|+++.++.
T Consensus       241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence                 0134 8999999999999999999999999999888764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.1e-36  Score=331.32  Aligned_cols=246  Identities=22%  Similarity=0.415  Sum_probs=205.5

Q ss_pred             hcCccCCceeeccCceeEEEEEE-----cCCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecC--Cc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-----EDGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSND--DF  796 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~  796 (985)
                      .+.|+..+.||+|+||.||+|++     .+++.||+|+++... ....+.+.+|++++++++||||+++++++...  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            35688899999999999999984     378999999998553 23457789999999999999999999999876  66


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      .++||||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHh---hcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            8999999999999999977766799999999999999999999   7899999999999999999999999999999887


Q ss_pred             cCCCCc-ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcch------------h---------
Q 001988          877 SGEDES-TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK------------H---------  934 (985)
Q Consensus       877 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~------------~---------  934 (985)
                      ...... .......||..|+|||.+.+..++.++|+ |++|+++++++++..+.....            .         
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDV-WSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHH-HHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhH-HHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            544332 22344568889999999999999999999 999999999999765432110            0         


Q ss_pred             ------hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhH
Q 001988          935 ------FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       935 ------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~  974 (985)
                            ...+..+++++.+++.+||..||.+||++.|+++.|+++.
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence                  0011234578999999999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.7e-36  Score=327.53  Aligned_cols=242  Identities=26%  Similarity=0.355  Sum_probs=197.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHh--cCCCCeeeEEeeeec----CCceE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKN--IRHRNLVKIISSCSN----DDFKA  798 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~--l~h~niv~l~~~~~~----~~~~~  798 (985)
                      .++|+..+.||+|+||.||+|+. +++.||||++...   ....+.+|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46899999999999999999998 6899999998643   34566778887777  799999999998754    34578


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEeCCCCCCCEEEcCCCcEEEecccCc
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF-----GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA  873 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~-----~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla  873 (985)
                      +||||+++|+|.++++..  .+++..+.+++.|++.||+|||.     .++++|+||||||+||+++.++.+||+|||++
T Consensus        83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999999654  68999999999999999999942     11899999999999999999999999999999


Q ss_pred             eeccCCCCcc--eecccccccccccccccccC------ccchhhhcccccccchhhhccc----------ccccCcc-h-
Q 001988          874 KLLSGEDEST--MRTQTLATIGYMAPDEIFVG------ELSLKRWVNDLLPVSLVEVVDK----------SLLSGEE-K-  933 (985)
Q Consensus       874 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~dv~~~~g~~~~~i~~~----------~~~~~~~-~-  933 (985)
                      +.........  ......||+.|+|||.+.+.      .++.++|+ |++|+++++++++          ..+.... + 
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dv-wslG~il~el~tg~~~~~~~~~~~~pf~~~~~~  239 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI-WAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN  239 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHH-HHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhH-HHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence            8765433321  12334799999999998876      56688999 9999999999988          2222110 0 


Q ss_pred             ---------------------hhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          934 ---------------------HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       934 ---------------------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                                           .......+++++.+++.+||..||.+||++.|+++.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence                                 0001234678899999999999999999999999999876

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.8e-36  Score=332.89  Aligned_cols=260  Identities=21%  Similarity=0.320  Sum_probs=217.1

Q ss_pred             ccCHHHHHHHhcCccCCceeeccCceeEEEEEE------cCCcEEEEEEeccCCcc-hHHHHHHHHHHHHhc-CCCCeee
Q 001988          715 RFSYFELLRATDNFAENNIIGIGGFGSVYRARL------EDGVEIAIKVFHPQCAS-TLKSFEAECEVIKNI-RHRNLVK  786 (985)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l-~h~niv~  786 (985)
                      ++...++....++|...+.||+|+||.||+|+.      .+++.||||+++..... ..+.+.+|+++++++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            345556666778999999999999999999974      35688999999865332 346789999999999 7899999


Q ss_pred             EEeeeecCC-ceEEEEeccCCCChHHHhhcCCCC---------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeC
Q 001988          787 IISSCSNDD-FKALVLEYMSNGSLEDCLHSSNCA---------------LNIFCRLNIMIDIASALEYLHFGHSTPIIHC  850 (985)
Q Consensus       787 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~---------------~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHr  850 (985)
                      +++++...+ ..++||||+++|+|.+++......               +++..+..++.|+++||+||   |++||+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHH---HHTTCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHH---HhCCcccc
Confidence            999987754 589999999999999999875432               78999999999999999999   78899999


Q ss_pred             CCCCCCEEEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-ccccc
Q 001988          851 DLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLS  929 (985)
Q Consensus       851 Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~  929 (985)
                      ||||+||+++.++.+||+|||+++.+.............+|+.|+|||.+.+..++.++|+ |++|++++++++ +..+.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~t~g~~p~  251 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV-WSFGVLLWEIFSLGASPY  251 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCSS
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHH-HHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999987755444444455668999999999999999999999 999999999997 76655


Q ss_pred             Ccchhh-------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          930 GEEKHF-------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       930 ~~~~~~-------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                      ......             ..+..+++++.+++.+||..||.+||++.|+++.|+.+.+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          252 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             TTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             cccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            332111             1122356789999999999999999999999999999987644

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5e-36  Score=325.98  Aligned_cols=248  Identities=21%  Similarity=0.321  Sum_probs=197.3

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc----CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      ..++|+..+.||+|+||.||+|...    .+..||+|+++.... ...+.+.+|+.++++++||||+++++++. .+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            3468899999999999999999864    345799999876432 33567899999999999999999999985 45678


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +||||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            99999999999999987766799999999999999999999   788999999999999999999999999999987643


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSI  945 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l  945 (985)
                      ... .......+|+.|+|||.+....++.++|+ |++|++++++++ +..++......            ..+..+++++
T Consensus       169 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l  246 (281)
T 1mp8_A          169 STY-YKASKGKLPIKWMAPESINFRRFTSASDV-WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL  246 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHH-HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccc-cccccCCCcccccChhhcccCCCCCccCc-hHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            222 12233457889999999999999999999 999999999986 66544322111            1223457789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      .+++.+||..||++||++.|+++.|+++.+..
T Consensus       247 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          247 YSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999987653

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7e-36  Score=329.05  Aligned_cols=243  Identities=25%  Similarity=0.345  Sum_probs=200.5

Q ss_pred             cCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccC
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      ++|+..+.||+|+||.||+|+.. ++.||||++...  ...+.+.+|++++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            57888999999999999999985 789999998644  345788999999999999999999999874  4789999999


Q ss_pred             CCChHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc-EEEecccCceeccCCCCc
Q 001988          806 NGSLEDCLHSSNC--ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV-AHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       806 ~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~-~kl~DfGla~~~~~~~~~  882 (985)
                      +|+|.+++.....  .+++..++.++.|+++||+|||..|.+||+||||||+||+++.++. +||+|||+++.....   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999986542  4788999999999999999997655589999999999999998886 799999999765321   


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--------------hhHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQCLLSIFSL  948 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~~~~l~~l  948 (985)
                        .....||+.|+|||.+.+..++.++|+ |++|++++++++++.+.......              .....++..+.++
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  236 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDV-FSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL  236 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHH-HHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHH
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHH-HHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHH
Confidence              123459999999999999999999999 99999999999988765432110              1122356789999


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          949 ALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                      +.+||..||.+||++.|+++.|+.+.+.+..
T Consensus       237 i~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          237 MTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             HHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence            9999999999999999999999999876543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.6e-36  Score=345.92  Aligned_cols=241  Identities=28%  Similarity=0.397  Sum_probs=205.7

Q ss_pred             HhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCC-ceEEEEe
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD-FKALVLE  802 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~lv~e  802 (985)
                      ..++|+..+.||+|+||.||+|.+. ++.||||+++...  ..+.+.+|++++++++||||+++++++.+.+ ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3467888999999999999999985 7899999998653  4578999999999999999999999987655 7899999


Q ss_pred             ccCCCChHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          803 YMSNGSLEDCLHSSNC-ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      |+++|+|.+++...+. .+++..+..++.|++.||+||   |+++|+||||||+||+++.++.+||+|||+++.....  
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            9999999999987643 468999999999999999999   7899999999999999999999999999999864321  


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSIFSL  948 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l~~l  948 (985)
                         .....+++.|+|||.+.+..++.++|+ |++|++++++++ +..+......            ...+..+++++.++
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDv-wslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l  418 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDV-WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDV  418 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHH-HHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence               112357889999999999999999999 999999999997 7665543211            11234567889999


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          949 ALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      +.+||+.||.+||++.++++.|+++.+.
T Consensus       419 i~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          419 MKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            9999999999999999999999998753

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.6e-36  Score=333.73  Aligned_cols=249  Identities=26%  Similarity=0.404  Sum_probs=211.1

Q ss_pred             hcCccCCceeeccCceeEEEEEE-----cCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCC--ce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-----EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD--FK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~--~~  797 (985)
                      .++|+..+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688899999999999999984     368999999998776666778999999999999999999999987654  78


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ++||||+++|+|.+++......+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++...
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            999999999999999988766799999999999999999999   78999999999999999999999999999999875


Q ss_pred             CCCCcce-ecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh----------------------
Q 001988          878 GEDESTM-RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH----------------------  934 (985)
Q Consensus       878 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~----------------------  934 (985)
                      ....... .....++..|+|||.+.+..++.++|+ |++|+++++++++..+......                      
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDV-WSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  275 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHH-HHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhH-HHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence            4332211 223457888999999999999999999 9999999999997654432110                      


Q ss_pred             ------hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          935 ------FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       935 ------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                            .+.+..+++++.+++.+||..||.+||++.|+++.|+++++.+
T Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence                  0012235678999999999999999999999999999998765

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5e-36  Score=334.37  Aligned_cols=241  Identities=24%  Similarity=0.332  Sum_probs=196.9

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCC------
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD------  795 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------  795 (985)
                      ..++|+..+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3567999999999999999999976 89999999997543 335678999999999999999999999986543      


Q ss_pred             ---------------------------------------------------ceEEEEeccCCCChHHHhhcCC--CCCCH
Q 001988          796 ---------------------------------------------------FKALVLEYMSNGSLEDCLHSSN--CALNI  822 (985)
Q Consensus       796 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~--~~~~~  822 (985)
                                                                         ..++||||+++|+|.+++....  ...++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               3789999999999999998753  23566


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc----------ceeccccccc
Q 001988          823 FCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES----------TMRTQTLATI  892 (985)
Q Consensus       823 ~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~gt~  892 (985)
                      ..++.++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++........          .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHH---HhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            77899999999999999   7899999999999999999999999999999987543221          1223456999


Q ss_pred             ccccccccccCccchhhhcccccccchhhhcccccccCcch----------hhhhHHHHHHHHHHHHHHccCCCCCCCCC
Q 001988          893 GYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK----------HFAAKEQCLLSIFSLALECTMESPEKRID  962 (985)
Q Consensus       893 ~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt  962 (985)
                      .|+|||.+.+..++.++|+ |++|+++++++++........          .........+++.+++.+||..||++||+
T Consensus       241 ~y~aPE~~~~~~~~~~~Di-~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  319 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDI-FSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPE  319 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHH-HHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred             CccChHHhcCCCCcchhhH-HHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCC
Confidence            9999999999999999999 999999999998654321110          11122345567899999999999999999


Q ss_pred             HHHHHH
Q 001988          963 AKDTIT  968 (985)
Q Consensus       963 ~~ev~~  968 (985)
                      +.|+++
T Consensus       320 ~~~~l~  325 (332)
T 3qd2_B          320 ATDIIE  325 (332)
T ss_dssp             HHHHHH
T ss_pred             HHHHhh
Confidence            999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.8e-36  Score=333.97  Aligned_cols=250  Identities=24%  Similarity=0.397  Sum_probs=193.5

Q ss_pred             HhcCccCCceeeccCceeEEEEEEcC-C---cEEEEEEeccC--CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCce
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLED-G---VEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~~-~---~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  797 (985)
                      ..++|...+.||+|+||.||+|+... +   ..||||+++..  .....+.+.+|++++++++||||+++++++...+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            45689999999999999999998653 3   27999999765  334567899999999999999999999999877655


Q ss_pred             ------EEEEeccCCCChHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEE
Q 001988          798 ------ALVLEYMSNGSLEDCLHSS-----NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH  866 (985)
Q Consensus       798 ------~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~k  866 (985)
                            ++||||+++|+|.+++...     ...+++..+..++.|++.||+||   |++||+||||||+||++++++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHH---HcCCcccCCCCcceEEEcCCCCEE
Confidence                  8999999999999998653     22589999999999999999999   788999999999999999999999


Q ss_pred             EecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh----------
Q 001988          867 LSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF----------  935 (985)
Q Consensus       867 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~----------  935 (985)
                      |+|||+++...............+++.|+|||.+.+..++.++|+ |++|++++++++ +..+.......          
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~  256 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDV-WAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN  256 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccch-hhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence            999999987654433333344457889999999999999999999 999999999998 66655432211          


Q ss_pred             --hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          936 --AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       936 --~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                        ..+..+++++.+++.+||..||.+||++.++++.++++.+..
T Consensus       257 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence              122345678999999999999999999999999999988643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-36  Score=332.57  Aligned_cols=235  Identities=21%  Similarity=0.225  Sum_probs=194.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|+..++||+|+||+||+|+.. +++.||||++......  .......|+..+.++ +||||++++++|.+++..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            367999999999999999999976 7999999998765332  334455666666665 899999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+ +++|.+++...+..+++..+..++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++......
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL---HSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            9999 7799999988777799999999999999999999   68899999999999999999999999999998764322


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh----------hhHHHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF----------AAKEQCLLSIFSLAL  950 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~  950 (985)
                         ......||+.|+|||.+.+ .++.++|+ |++|+++++++++..+.......          ..+..+++++.+++.
T Consensus       212 ---~~~~~~gt~~y~aPE~~~~-~~~~~~Di-wslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  286 (311)
T 3p1a_A          212 ---AGEVQEGDPRYMAPELLQG-SYGTAADV-FSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLV  286 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT-CCSTHHHH-HHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred             ---CCcccCCCccccCHhHhcC-CCCchhhH-HHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHH
Confidence               2334569999999998765 78999999 99999999999985433221111          112335678999999


Q ss_pred             HccCCCCCCCCCHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~  968 (985)
                      +|+..||++||++.|+++
T Consensus       287 ~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          287 MMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHSCSSTTTSCCHHHHHT
T ss_pred             HHcCCChhhCcCHHHHHh
Confidence            999999999999999985

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=330.35  Aligned_cols=236  Identities=22%  Similarity=0.296  Sum_probs=203.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc------hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS------TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  797 (985)
                      .++|...+.||+|+||.||+|... +++.||+|++......      ..+.+.+|++++++++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            457899999999999999999975 7899999999765322      356789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC----cEEEecccCc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM----VAHLSDFGMA  873 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~----~~kl~DfGla  873 (985)
                      ++||||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++    .+||+|||++
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHH---HHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            99999999999999997653 689999999999999999999   789999999999999999887    8999999999


Q ss_pred             eeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hH
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AK  938 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~  938 (985)
                      +.+....   ......||+.|+|||.+....++.++|+ |++|+++++++++..+........               ..
T Consensus       166 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (326)
T 2y0a_A          166 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADM-WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF  241 (326)
T ss_dssp             EECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHH-HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred             eECCCCC---ccccccCCcCcCCceeecCCCCCcHHHH-HHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc
Confidence            8874322   2234569999999999998999999999 999999999999887654332111               11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          939 EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       939 ~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ..++..+.+++.+||..||.+||++.|+++
T Consensus       242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            234677899999999999999999999986

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.3e-36  Score=343.15  Aligned_cols=238  Identities=21%  Similarity=0.256  Sum_probs=202.9

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      ..++|+..+.||+|+||.||+|... +|+.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4578999999999999999999864 789999999976543  2346789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc---CCCcEEEecccCceecc
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~---~~~~~kl~DfGla~~~~  877 (985)
                      |||++||+|.+.+...+ .+++.....++.||+.||+||   |++||+||||||+||+++   +++.+||+|||+++...
T Consensus        89 ~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~l---H~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHC---HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            99999999999998764 689999999999999999999   789999999999999998   46789999999998765


Q ss_pred             CCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hHHHHH
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQCL  942 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~~~  942 (985)
                      ...  ......+||+.|+|||.+.+..++.++|+ |++|++++++++|..++.......               ....++
T Consensus       165 ~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DI-wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  241 (444)
T 3soa_A          165 GEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDL-WACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT  241 (444)
T ss_dssp             TTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred             CCC--ceeecccCCcccCCHHHhcCCCCCCcccc-HHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCC
Confidence            332  22344679999999999999999999999 999999999999987654332111               112356


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          943 LSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       943 ~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +++.+++.+|+..||.+||++.|+++
T Consensus       242 ~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          242 PEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            78999999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.2e-36  Score=346.96  Aligned_cols=246  Identities=19%  Similarity=0.220  Sum_probs=207.2

Q ss_pred             HHHHHHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 001988          718 YFELLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSN  793 (985)
Q Consensus       718 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~  793 (985)
                      +.++....++|+..++||+|+||+||+|+.+ +++.||+|++++..   ......+.+|+.++++++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            4455556789999999999999999999976 57889999997531   1123348899999999999999999999999


Q ss_pred             CCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCc
Q 001988          794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA  873 (985)
Q Consensus       794 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla  873 (985)
                      .+..++||||++||+|.+++......+++..+..++.|++.||+||   |++|||||||||+|||++.++.+||+|||+|
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~L---H~~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence            9999999999999999999987666799999999999999999999   7899999999999999999999999999999


Q ss_pred             eeccCCCCcceecccccccccccccccc-----cCccchhhhcccccccchhhhcccccccCcchhhhh-----------
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIF-----VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------  937 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------  937 (985)
                      +...... .......+||+.|+|||++.     .+.++.++|+ |++|++++|+++|..++........           
T Consensus       223 ~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~Dv-wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  300 (437)
T 4aw2_A          223 LKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDW-WSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF  300 (437)
T ss_dssp             EECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHH-HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred             hhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCee-HHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc
Confidence            8765332 22334467999999999987     5678999999 9999999999999877654321111           


Q ss_pred             --H---HHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 001988          938 --K---EQCLLSIFSLALECTMESPEK--RIDAKDTIT  968 (985)
Q Consensus       938 --~---~~~~~~l~~l~~~cl~~~P~~--RPt~~ev~~  968 (985)
                        +   ..+++++.+++++|+..+|++  ||++.|+++
T Consensus       301 ~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          301 QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence              0   124678999999999888888  999999876

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-36  Score=337.68  Aligned_cols=237  Identities=19%  Similarity=0.270  Sum_probs=206.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .++|...+.||+|+||.||+|... +++.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467999999999999999999875 7899999999876555667889999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC--CCcEEEecccCceeccCCCC
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE--DMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~--~~~~kl~DfGla~~~~~~~~  881 (985)
                      +++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.  ++.+||+|||+++.+.....
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            999999999987766789999999999999999999   7899999999999999974  57899999999998753322


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh---------------HHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA---------------KEQCLLSIF  946 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~---------------~~~~~~~l~  946 (985)
                         .....||+.|+|||.+.+..++.++|+ |++|+++++++++..+.........               ...+++++.
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  282 (387)
T 1kob_A          207 ---VKVTTATAEFAAPEIVDREPVGFYTDM-WAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  282 (387)
T ss_dssp             ---EEEECSSGGGCCHHHHTTCCBCHHHHH-HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             ---eeeeccCCCccCchhccCCCCCCcccE-eeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence               233469999999999999999999999 9999999999999876654321111               123567899


Q ss_pred             HHHHHccCCCCCCCCCHHHHHH
Q 001988          947 SLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +++.+||..||.+||++.|+++
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          283 DFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHcCCChhHCcCHHHHhh
Confidence            9999999999999999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.7e-36  Score=327.40  Aligned_cols=236  Identities=22%  Similarity=0.315  Sum_probs=196.9

Q ss_pred             cCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ++|...+.||+|+||.||+|+..+++.||+|++......  ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            578899999999999999999988999999999765322  246788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +++ +|.+++......+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence            975 99999987766789999999999999999999   78899999999999999999999999999998764222  1


Q ss_pred             eeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh-------------------------
Q 001988          884 MRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-------------------------  937 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-------------------------  937 (985)
                      ......||+.|+|||.+.+ ..++.++|+ |++|+++++++++..+.........                         
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDI-WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence            2234468999999999876 458999999 9999999999998866543211110                         


Q ss_pred             ---------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 ---------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 ---------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                     ....++++.+++.+|+..||++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                           0124567889999999999999999999875

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3e-36  Score=337.43  Aligned_cols=233  Identities=24%  Similarity=0.244  Sum_probs=194.9

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~  798 (985)
                      ..++|+..+.||+|+||.||+|+.+ +++.||||++++..   ......+.+|.++++++ +||||+++++++.+.+..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3478999999999999999999975 68999999997542   22345678999999988 7999999999999999999


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +||||++||+|.+++...+ .+++..+..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+....
T Consensus       101 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            9999999999999998754 689999999999999999999   788999999999999999999999999999986432


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSIFS  947 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l~~  947 (985)
                      .  .......+||+.|+|||.+.+..++.++|+ |++|++++++++|..++........           +...++++.+
T Consensus       177 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  253 (353)
T 3txo_A          177 N--GVTTATFCGTPDYIAPEILQEMLYGPAVDW-WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATG  253 (353)
T ss_dssp             -----------CCGGGCCHHHHHHHHCTTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             C--CccccccCCCcCeEChhhcCCCCcCCccCC-CcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            2  223445679999999999999999999999 9999999999999877654322211           1224577899


Q ss_pred             HHHHccCCCCCCCCCH
Q 001988          948 LALECTMESPEKRIDA  963 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~  963 (985)
                      ++.+|+..||.+||++
T Consensus       254 li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          254 ILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             HHHHHTCSSGGGSTTS
T ss_pred             HHHHHhhhCHHHccCC
Confidence            9999999999999998

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.7e-36  Score=336.88  Aligned_cols=248  Identities=22%  Similarity=0.362  Sum_probs=204.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcE----EEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVE----IAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~----vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      .++|+..+.||+|+||.||+|++. +++.    ||+|.+.... ......+.+|+.++++++||||+++++++.+ +..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence            357888999999999999999864 4443    8888876442 2234567889999999999999999999864 5688


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +||||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+..
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHH---HHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHH---HhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            99999999999999987766789999999999999999999   788999999999999999999999999999998765


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh------------hHHHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA------------AKEQCLLSI  945 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~------------~~~~~~~~l  945 (985)
                      ...........+|+.|+|||.+.++.++.++|+ |++|++++++++ +..++.......            .+..++.++
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDV-WSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV  246 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTT
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHh-HHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHH
Confidence            444444455668889999999999999999999 999999999998 776654332111            122345678


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      .+++.+||..||.+||++.|+++.|+++.+..
T Consensus       247 ~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          247 YMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             THHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            89999999999999999999999999987643

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.7e-36  Score=334.65  Aligned_cols=249  Identities=24%  Similarity=0.310  Sum_probs=209.0

Q ss_pred             hcCccCCceeeccCceeEEEEEE-----cCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeee--cCCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-----EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS--NDDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~--~~~~~  797 (985)
                      .++|+..+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            36788899999999999999984     368899999998776666678999999999999999999999886  45668


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ++||||+++++|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            899999999999999987655789999999999999999999   78999999999999999999999999999999875


Q ss_pred             CCCCcc-eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh---------------------
Q 001988          878 GEDEST-MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------------  935 (985)
Q Consensus       878 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------------  935 (985)
                      ...... ......+|+.|+|||.+.+..++.++|+ |++|+++++++++..++......                     
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDV-WSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL  257 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHH-HHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhH-HHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence            433322 2233458889999999999999999999 99999999999986654322110                     


Q ss_pred             ------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          936 ------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       936 ------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                            ..+..+++++.+++.+||..||.+||++.|+++.|+++....
T Consensus       258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence                  011234578999999999999999999999999999886543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.2e-36  Score=327.96  Aligned_cols=245  Identities=24%  Similarity=0.389  Sum_probs=194.6

Q ss_pred             HhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ..++|...+.||+|+||.||+|+..  ..||+|+++....  ...+.+.+|++++++++||||+++++++. ....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence            3567999999999999999999875  3599999976533  23567899999999999999999999764 45678999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++++|.+++......+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||+++.......
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            99999999999987777899999999999999999999   789999999999999999999999999999987653333


Q ss_pred             cceecccccccccccccccc---cCccchhhhcccccccchhhhcccccccCcchhhh-----------------hHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIF---VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------------AKEQC  941 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------------~~~~~  941 (985)
                      ........||+.|+|||.+.   ...++.++|+ |++|+++++++++..++.......                 ....+
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di-~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDV-YAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC  254 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHH-HHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccch-HHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence            33334557999999999886   6678889999 999999999999887665422111                 11245


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          942 LLSIFSLALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       942 ~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                      ++++.+++.+||..+|.+||++.|+++.|+++.+
T Consensus       255 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          255 PKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            6789999999999999999999999999998865

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.1e-36  Score=335.82  Aligned_cols=238  Identities=23%  Similarity=0.263  Sum_probs=201.5

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-----cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-----ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      .++|+..+.||+|+||.||+|... +++.||||++....     ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            467999999999999999999875 78999999986431     123577899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc---EEEecccC
Q 001988          799 LVLEYMSNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV---AHLSDFGM  872 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~---~kl~DfGl  872 (985)
                      +||||+++|+|.+++...   +..+++..+..++.||+.||+||   |++||+||||||+||+++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC---HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999887643   34589999999999999999999   7899999999999999987654   99999999


Q ss_pred             ceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--------------hhH
Q 001988          873 AKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAK  938 (985)
Q Consensus       873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~  938 (985)
                      ++.+....  ......+||+.|+|||.+.+..++.++|+ |++|+++++++++..+.......              ...
T Consensus       180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~  256 (351)
T 3c0i_A          180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDV-WGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQW  256 (351)
T ss_dssp             CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHH-HHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred             eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhh-HHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCcccc
Confidence            98875322  22344579999999999999999999999 99999999999988765433211              111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          939 EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       939 ~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ..+++++.+++.+||..||++||++.|+++
T Consensus       257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          257 SHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            234678999999999999999999999985

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.2e-36  Score=349.69  Aligned_cols=250  Identities=25%  Similarity=0.398  Sum_probs=206.5

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ...++|...+.||+|+||.||+|.++++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            3557788999999999999999999888889999998654 335689999999999999999999999976 67899999


Q ss_pred             ccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          803 YMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       803 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      |+++|+|.+++... +..+++..+..++.|++.||+||   |+++|+||||||+||++++++.+||+|||+++...... 
T Consensus       259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  334 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-  334 (452)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-
Confidence            99999999999754 34689999999999999999999   78999999999999999999999999999998764322 


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSIFSL  948 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l~~l  948 (985)
                      ........+++.|+|||.+..+.++.++|+ |++|++++++++ +..+......            .+.+..+++++.++
T Consensus       335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv-wslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  413 (452)
T 1fmk_A          335 YTARQGAKFPIKWTAPEAALYGRFTIKSDV-WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL  413 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred             eecccCCcccccccCHhHHhcCCCCccccH-HhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            222233457889999999999999999999 999999999998 6665543211            11234567889999


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          949 ALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                      +.+||..+|++||++.++++.|+.+......
T Consensus       414 i~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~  444 (452)
T 1fmk_A          414 MCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  444 (452)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence            9999999999999999999999988764433

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5.9e-36  Score=351.20  Aligned_cols=245  Identities=23%  Similarity=0.393  Sum_probs=209.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .++|...+.||+|+||.||+|.+. +++.||||+++... ...+.+.+|++++++++||||++++++|.+.+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            467888899999999999999976 48899999997653 3467899999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      +++|+|.+++... ...+++..+..++.||+.||+||   |+++|+||||||+|||++.++.+||+|||+++...... .
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-Y  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-E
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-e
Confidence            9999999999864 34689999999999999999999   78999999999999999999999999999998864322 2


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSIFSLA  949 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l~~l~  949 (985)
                      .......+++.|+|||.+..+.++.++|+ |++|++++++++ +..+......            ...+..+++++.+++
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDv-wSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  452 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDV-WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM  452 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHH-HHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhH-HhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            22334457789999999999999999999 999999999998 6554432211            112334678899999


Q ss_pred             HHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          950 LECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                      .+||..||.+||++.++++.|+.+.+
T Consensus       453 ~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          453 RACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             HHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            99999999999999999999988754

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=5.5e-36  Score=330.42  Aligned_cols=255  Identities=35%  Similarity=0.568  Sum_probs=195.0

Q ss_pred             cccceecccccccc--ccCCcCCCCCCccEEEccC-CCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeE
Q 001988          394 SLERLNIAFCNISG--NIPKAIGNLSNLIVLSLGG-NNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNEL  470 (985)
Q Consensus       394 ~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  470 (985)
                      +++.|++++|++++  .+|..|..+++|++|+|++ |++.+.+|..|+++++|++|+|++|++++.+|..+..+++|++|
T Consensus        51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  130 (313)
T 1ogq_A           51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence            35555555555555  5566666666666666663 66666666666666666666666666666666666666677777


Q ss_pred             EccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCcc-ceeEEeecCCcccCCccccccCCCcccEEEccCCcc
Q 001988          471 DLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLK-DILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNL  549 (985)
Q Consensus       471 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  549 (985)
                      +|++|++++.+|..+..+++|++|++++|++++.+|..|..++ +|++|++++|++++..|..+..+. |+.|++++|++
T Consensus       131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l  209 (313)
T 1ogq_A          131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred             eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence            7777776666666666677777777777777666666666666 677777777777766666777776 88888888888


Q ss_pred             CccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCCCCCCC
Q 001988          550 SGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGG  629 (985)
Q Consensus       550 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~  629 (985)
                      ++.+|..|..+++|++|+|++|++++.+|. +..+++|++|+|++|+|++.+|..|..+++|++|++++|+++|.+|..+
T Consensus       210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~  288 (313)
T 1ogq_A          210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence            888888888888999999999999876665 7888999999999999998899999999999999999999999999888


Q ss_pred             CCcccccccccCCccccCCCC
Q 001988          630 PFANFTAESFMGNELLCGLPN  650 (985)
Q Consensus       630 ~~~~~~~~~~~~n~~lc~~~~  650 (985)
                      .+.++....+.+|+++||.|.
T Consensus       289 ~l~~L~~l~l~~N~~lc~~p~  309 (313)
T 1ogq_A          289 NLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             TGGGSCGGGTCSSSEEESTTS
T ss_pred             cccccChHHhcCCCCccCCCC
Confidence            888888888999999999874

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.1e-36  Score=324.43  Aligned_cols=249  Identities=24%  Similarity=0.394  Sum_probs=209.6

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ...++|+..+.||+|+||.||+|...+++.||+|+++... ...+.+.+|++++++++||||+++++++.. +..++|||
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   87 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence            3457889999999999999999999888899999997653 345788999999999999999999999874 45789999


Q ss_pred             ccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          803 YMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      |+++++|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||++++++.+||+|||+++...... 
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  163 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-  163 (279)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred             cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-
Confidence            999999999997642 2589999999999999999999   78999999999999999999999999999998875322 


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh------------hHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA------------AKEQCLLSIFSL  948 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~------------~~~~~~~~l~~l  948 (985)
                      ........+++.|+|||.+..+.++.++|+ |++|++++++++ +..+........            .+..+++++.++
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  242 (279)
T 1qpc_A          164 YTAREGAKFPIKWTAPEAINYGTFTIKSDV-WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL  242 (279)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHH-HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cccccCCCCccCccChhhhccCCCCchhhh-HHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHH
Confidence            222234457889999999999999999999 999999999998 666544322111            122356789999


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          949 ALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                      +.+|+..+|++||++.++++.|+++.....
T Consensus       243 i~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          243 MRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             HHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence            999999999999999999999999876543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-35  Score=329.28  Aligned_cols=246  Identities=23%  Similarity=0.357  Sum_probs=207.4

Q ss_pred             ccCCceeeccCceeEEEEEEc-----CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecC--CceEE
Q 001988          728 FAENNIIGIGGFGSVYRARLE-----DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSND--DFKAL  799 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~-----~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~l  799 (985)
                      |+..+.||+|+||.||+|.+.     +++.||||+++.... ...+.+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488899999999999998653     688999999986633 3456789999999999999999999999874  56789


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++|+|.+++...  .+++..++.++.|++.||+||   |+.||+||||||+||+++.++.+||+|||+++.+...
T Consensus       113 v~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~L---H~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYL---HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            99999999999999875  489999999999999999999   7899999999999999999999999999999987543


Q ss_pred             CCc-ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh-----------------------
Q 001988          880 DES-TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-----------------------  935 (985)
Q Consensus       880 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-----------------------  935 (985)
                      ... .......+|+.|+|||.+.+..++.++|+ |++|+++++++++..++......                       
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDV-WSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER  266 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHH-HHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHH-HHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence            322 12334458889999999999999999999 99999999999987654432111                       


Q ss_pred             ----hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          936 ----AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       936 ----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                          ..+..++.++.+++.+||..||.+||++.|+++.|+++.+.+..
T Consensus       267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  314 (318)
T 3lxp_A          267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG  314 (318)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred             ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence                01123567899999999999999999999999999999987654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.2e-36  Score=327.80  Aligned_cols=248  Identities=23%  Similarity=0.385  Sum_probs=212.6

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ...++|+..+.||+|+||.||+|.+. +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            35678999999999999999999976 5889999999755 345678899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          802 EYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       802 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      ||+++++|.+++... ...+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus        89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHH---HHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHH---HHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            999999999999864 34689999999999999999999   78899999999999999999999999999998765332


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFS  947 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~  947 (985)
                       ........+|+.|+|||.+.+..++.++|+ |++|++++++++ +..+.......            ..+..+++++.+
T Consensus       166 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  243 (288)
T 3kfa_A          166 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDV-WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE  243 (288)
T ss_dssp             -SEEETTEEECGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             -cccccCCccccCcCChhhhccCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHH
Confidence             233344557889999999999999999999 999999999998 66554432111            112345678999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          948 LALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      ++.+|+..||.+||++.|+++.|+.+.++
T Consensus       244 li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          244 LMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            99999999999999999999999987764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.7e-36  Score=332.71  Aligned_cols=248  Identities=22%  Similarity=0.349  Sum_probs=201.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCc----EEEEEEeccC-CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGV----EIAIKVFHPQ-CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vAvK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      .++|+..+.||+|+||.||+|++. +++    +||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            467899999999999999999864 444    3578877544 2345678999999999999999999999998765 78


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +|+||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+..
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            99999999999999988777899999999999999999999   788999999999999999999999999999988754


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSI  945 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l  945 (985)
                      ...........+|+.|+|||.+.+..++.++|+ |++|++++++++ +..++......            ..+..++.++
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di-~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDV-WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  248 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHH-HHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence            443333444557889999999999999999999 999999999998 77665443211            1223356789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      .+++.+||..||.+||++.|+++.|+++.+..
T Consensus       249 ~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          249 YMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence            99999999999999999999999999988543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.6e-36  Score=333.12  Aligned_cols=254  Identities=20%  Similarity=0.297  Sum_probs=212.4

Q ss_pred             HHHhcCccCCceeeccCceeEEEEEEc-C-----CcEEEEEEeccCCc-chHHHHHHHHHHHHhc-CCCCeeeEEeeeec
Q 001988          722 LRATDNFAENNIIGIGGFGSVYRARLE-D-----GVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLVKIISSCSN  793 (985)
Q Consensus       722 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~-----~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~  793 (985)
                      ....++|...+.||+|+||.||+|... +     .+.||+|.+..... ...+.+.+|+++++++ +||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            345678999999999999999999864 2     24799999976533 3456789999999999 89999999999999


Q ss_pred             CCceEEEEeccCCCChHHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc
Q 001988          794 DDFKALVLEYMSNGSLEDCLHSS-------------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD  860 (985)
Q Consensus       794 ~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~  860 (985)
                      .+..++||||+++|+|.+++...             ...+++..+..++.|++.||+||   |++||+||||||+||+++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHH---hcCCcccCCcccceEEEC
Confidence            99999999999999999998753             23578999999999999999999   788999999999999999


Q ss_pred             CCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh----
Q 001988          861 EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF----  935 (985)
Q Consensus       861 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~----  935 (985)
                      .++.+||+|||+++...............+|+.|+|||.+.+..++.++|+ |++|++++++++ +..+.......    
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~el~t~g~~p~~~~~~~~~~~  277 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV-WSYGILLWEIFSLGLNPYPGILVNSKFY  277 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHH-HHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHH-HHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence            999999999999987654443333444567889999999999999999999 999999999998 65544322111    


Q ss_pred             ---------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          936 ---------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       936 ---------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                               ..+..+++++.+++.+||+.||.+||++.|+++.|+++.+..++
T Consensus       278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  330 (333)
T 2i1m_A          278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR  330 (333)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence                     01222567899999999999999999999999999998876554

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3e-36  Score=329.20  Aligned_cols=241  Identities=21%  Similarity=0.295  Sum_probs=203.9

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CC-------cEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DG-------VEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDF  796 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~-------~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  796 (985)
                      .++|...+.||+|+||.||+|+.. ++       +.||+|++........+.+.+|++++++++||||+++++++.+++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            467889999999999999999865 33       5799999987666667889999999999999999999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc--------EEEe
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV--------AHLS  868 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~--------~kl~  868 (985)
                      .++||||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---hhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            9999999999999999988766689999999999999999999   7899999999999999998887        9999


Q ss_pred             cccCceeccCCCCcceeccccccccccccccccc-Cccchhhhcccccccchhhhccccc-ccCcchhhhh---------
Q 001988          869 DFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSL-LSGEEKHFAA---------  937 (985)
Q Consensus       869 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~-~~~~~~~~~~---------  937 (985)
                      |||++.....      .....||+.|+|||.+.+ ..++.++|+ |++|+++++++++.. +.........         
T Consensus       164 Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di-wslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (289)
T 4fvq_A          164 DPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDK-WSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ  236 (289)
T ss_dssp             CCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHH-HHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred             cCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHH-HHHHHHHHHHHcCCCCCccccchHHHHHHhhccCC
Confidence            9999875421      123458899999999987 778999999 999999999999543 3222211110         


Q ss_pred             -HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          938 -KEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       938 -~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                       +...++++.+++.+||+.||.+||++.|+++.|+++..
T Consensus       237 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence             11134568899999999999999999999999998765

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.1e-35  Score=336.79  Aligned_cols=232  Identities=22%  Similarity=0.239  Sum_probs=197.1

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l  799 (985)
                      .++|+..+.||+|+||.||+|+.+ +++.||+|++++...   .....+.+|..+++++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            467999999999999999999976 688899999976522   2345678999999887 89999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++|+|.+++...+ .+++..+..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+.....
T Consensus       131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            999999999999998754 689999999999999999999   7899999999999999999999999999999863222


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--------------------hhHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------------AAKE  939 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------------~~~~  939 (985)
                        .......+||+.|+|||++.+..++.++|+ |++|++++++++|..++......                    ..+.
T Consensus       207 --~~~~~~~~gt~~Y~aPE~l~~~~~~~~~Di-wslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~  283 (396)
T 4dc2_A          207 --GDTTSTFCGTPNYIAPEILRGEDYGFSVDW-WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR  283 (396)
T ss_dssp             --TCCBCCCCBCGGGCCHHHHTTCCBCTHHHH-HHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred             --CCccccccCCcccCCchhhcCCCCChHHHH-HHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence              223445689999999999999999999999 99999999999998876421100                    0112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCH
Q 001988          940 QCLLSIFSLALECTMESPEKRIDA  963 (985)
Q Consensus       940 ~~~~~l~~l~~~cl~~~P~~RPt~  963 (985)
                      ..+.++.+++.+||..||.+||++
T Consensus       284 ~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          284 SLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             cCCHHHHHHHHHHhcCCHhHcCCC
Confidence            245778999999999999999996

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.4e-35  Score=325.53  Aligned_cols=251  Identities=23%  Similarity=0.379  Sum_probs=206.1

Q ss_pred             hcCccCCceeeccCceeEEEEEEcC----CcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeee-cCCceE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLED----GVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCS-NDDFKA  798 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~-~~~~~~  798 (985)
                      ..+|...+.||+|+||.||+|+..+    ...||+|.+..... ...+.+.+|++++++++||||+++++++. .++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3567888999999999999998642    33589999876433 34567899999999999999999999864 456789


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +||||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+..
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999999999999987777789999999999999999999   789999999999999999999999999999987643


Q ss_pred             CCC--cceecccccccccccccccccCccchhhhcccccccchhhhccc-ccccCcchhhh------------hHHHHHH
Q 001988          879 EDE--STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDK-SLLSGEEKHFA------------AKEQCLL  943 (985)
Q Consensus       879 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~-~~~~~~~~~~~------------~~~~~~~  943 (985)
                      ...  ........+|+.|+|||.+.+..++.++|+ |++|+++++++++ ..+........            .+..+++
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDV-WSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD  259 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCH
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHH-HHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCH
Confidence            221  112234457889999999999999999999 9999999999984 43333221111            1233567


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          944 SIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                      ++.+++.+||..+|.+||++.|+++.|+++.+.+..
T Consensus       260 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          260 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            899999999999999999999999999999886543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.4e-35  Score=322.52  Aligned_cols=236  Identities=20%  Similarity=0.276  Sum_probs=196.9

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ++|+..+.||+|+||+||+|+.. +++.||+|++.....  .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57889999999999999999975 789999999976533  234678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |+++ ++.+.+......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......  
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--
Confidence            9975 77777766666799999999999999999999   78899999999999999999999999999998764322  


Q ss_pred             ceecccccccccccccccccCc-cchhhhcccccccchhhhcccccccC-cchhhhh-----------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFVGE-LSLKRWVNDLLPVSLVEVVDKSLLSG-EEKHFAA-----------------------  937 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~~~~g~~~~~i~~~~~~~~-~~~~~~~-----------------------  937 (985)
                      .......||+.|+|||.+.+.. ++.++|+ |++|+++++++++..+.. .......                       
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDM-WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHH-HHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHH-HHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence            2233456899999999988766 7999999 999999999997655421 1111000                       


Q ss_pred             -----------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 -----------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 -----------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                       ....++++.+++.+|+..||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                             0124567889999999999999999999875

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.5e-35  Score=333.64  Aligned_cols=238  Identities=23%  Similarity=0.322  Sum_probs=203.3

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      ..++|...+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4568999999999999999999875 789999999976532  3456788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC---cEEEecccCceecc
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM---VAHLSDFGMAKLLS  877 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~---~~kl~DfGla~~~~  877 (985)
                      |||+++|+|.+++.... .+++..+..++.||++||+||   |++||+||||||+||+++.++   .+||+|||+++...
T Consensus       107 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            99999999999987654 689999999999999999999   788999999999999998654   59999999998765


Q ss_pred             CCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh---------------hhHHHHH
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AAKEQCL  942 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~~~~~~  942 (985)
                      ...   .....+||+.|+|||++.+..++.++|+ |++|+++++++++..++......               .....++
T Consensus       183 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  258 (362)
T 2bdw_A          183 DSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDI-WACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT  258 (362)
T ss_dssp             TCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSC
T ss_pred             CCc---ccccCCCCccccCHHHHccCCCCchhhH-HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence            322   2234579999999999999999999999 99999999999998765432111               1112356


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          943 LSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       943 ~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      +++.+++.+||..||++||++.|+++.
T Consensus       259 ~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          259 PEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            789999999999999999999998764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.9e-36  Score=336.36  Aligned_cols=233  Identities=19%  Similarity=0.292  Sum_probs=197.3

Q ss_pred             cCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCCC
Q 001988          729 AENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNG  807 (985)
Q Consensus       729 ~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  807 (985)
                      ...+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            34678999999999999864 78999999998776566778999999999999999999999999999999999999999


Q ss_pred             ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE--cCCCcEEEecccCceeccCCCCccee
Q 001988          808 SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL--DEDMVAHLSDFGMAKLLSGEDESTMR  885 (985)
Q Consensus       808 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill--~~~~~~kl~DfGla~~~~~~~~~~~~  885 (985)
                      +|.+++......+++..+..++.|++.||+||   |+.||+||||||+||++  +.++.+||+|||+++.+.....   .
T Consensus       172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~  245 (373)
T 2x4f_A          172 ELFDRIIDESYNLTELDTILFMKQICEGIRHM---HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L  245 (373)
T ss_dssp             EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence            99999987666789999999999999999999   78999999999999999  5678999999999998753322   2


Q ss_pred             cccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hHHHHHHHHHHHHH
Q 001988          886 TQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQCLLSIFSLAL  950 (985)
Q Consensus       886 ~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~~~~~l~~l~~  950 (985)
                      ...+||+.|+|||.+..+.++.++|+ |++|+++++++++..+........               ....+++++.+++.
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  324 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDM-WSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS  324 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHH-HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHH
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHH
Confidence            33469999999999999999999999 999999999999887654332111               11235678999999


Q ss_pred             HccCCCCCCCCCHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~  968 (985)
                      +|+..||.+||++.|+++
T Consensus       325 ~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          325 KLLIKEKSWRISASEALK  342 (373)
T ss_dssp             TTSCSSGGGSCCHHHHHH
T ss_pred             HHcCCChhhCCCHHHHhc
Confidence            999999999999999987

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-35  Score=325.87  Aligned_cols=243  Identities=22%  Similarity=0.282  Sum_probs=204.9

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCC--ceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD--FKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~--~~~lv  800 (985)
                      .++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            467899999999999999999976 68999999997543 234567889999999999999999999998765  77999


Q ss_pred             EeccCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE----cCCCcEEEecccCce
Q 001988          801 LEYMSNGSLEDCLHSSN--CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL----DEDMVAHLSDFGMAK  874 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill----~~~~~~kl~DfGla~  874 (985)
                      |||+++|+|.+++....  ..+++..+..++.|++.||+||   |++||+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999998653  2389999999999999999999   78999999999999999    888899999999998


Q ss_pred             eccCCCCcceecccccccccccccccc--------cCccchhhhcccccccchhhhcccccccCcchhh-----------
Q 001988          875 LLSGEDESTMRTQTLATIGYMAPDEIF--------VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-----------  935 (985)
Q Consensus       875 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-----------  935 (985)
                      .+.....   .....||+.|+|||.+.        ...++.++|+ |++|+++++++++..++......           
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Di-wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL-WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHH-HHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            8753332   23456999999999886        5788999999 99999999999988665321100           


Q ss_pred             -----------------------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhH
Q 001988          936 -----------------------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       936 -----------------------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~  974 (985)
                                                   ......++.+.+++.+||..||++||++.|+++...+..
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence                                         112456778999999999999999999999999887654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.2e-36  Score=335.85  Aligned_cols=254  Identities=21%  Similarity=0.310  Sum_probs=211.6

Q ss_pred             HHHHHHHhcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEee
Q 001988          718 YFELLRATDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISS  790 (985)
Q Consensus       718 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~  790 (985)
                      ..++....++|...+.||+|+||.||+|+..      +++.||+|++..... .....+.+|++++++++||||++++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            3444556788999999999999999999754      467899999975533 344578899999999999999999999


Q ss_pred             eecCCceEEEEeccCCCChHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC
Q 001988          791 CSNDDFKALVLEYMSNGSLEDCLHSSN---------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE  861 (985)
Q Consensus       791 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~  861 (985)
                      +.+.+..++||||+++|+|.+++...+         ..+++..+.+++.|++.||+||   |++||+||||||+||+++.
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~NIli~~  173 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAE  173 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCSGGGEEECT
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCCccCCCccceEEEcC
Confidence            999999999999999999999987531         3568999999999999999999   7889999999999999999


Q ss_pred             CCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh-----
Q 001988          862 DMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF-----  935 (985)
Q Consensus       862 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~-----  935 (985)
                      ++.+||+|||+++...............+|+.|+|||.+.+..++.++|+ |++|++++++++ +..+.......     
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~el~~~g~~p~~~~~~~~~~~~  252 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV-WSFGVVLWEIATLAEQPYQGLSNEQVLRF  252 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred             CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhH-HHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence            99999999999987643332222334457899999999999999999999 999999999998 55544332111     


Q ss_pred             -------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          936 -------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       936 -------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                             ..+..++..+.+++.+||..+|.+||++.|+++.|+++.+
T Consensus       253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          253 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence                   1123456789999999999999999999999999988754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.9e-36  Score=333.74  Aligned_cols=238  Identities=22%  Similarity=0.273  Sum_probs=201.4

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCce
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~  797 (985)
                      ...++|...+.||+|+||.||+|+.+ +++.||+|++++..   ......+..|.++++++ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            45688999999999999999999975 78999999997542   22345678899999987 899999999999999999


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ++||||++||+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+||+++.+|.+||+|||+++...
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            99999999999999998654 689999999999999999999   78899999999999999999999999999998643


Q ss_pred             CCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHHH
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSIF  946 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l~  946 (985)
                      ...  ......+||+.|+|||.+.+..++.++|+ |++|++++++++|..+.........           +...++++.
T Consensus       170 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  246 (345)
T 1xjd_A          170 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDW-WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAK  246 (345)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             cCC--CcccCCCCCcccCChhhhcCCCCCChhhh-HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHH
Confidence            222  22345679999999999999999999999 9999999999999876644322111           122457899


Q ss_pred             HHHHHccCCCCCCCCCHH-HHH
Q 001988          947 SLALECTMESPEKRIDAK-DTI  967 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~-ev~  967 (985)
                      +++.+|+..||++||++. |+.
T Consensus       247 ~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          247 DLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGG
T ss_pred             HHHHHHhcCCHhHcCCChHHHH
Confidence            999999999999999997 554

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.2e-36  Score=333.67  Aligned_cols=236  Identities=22%  Similarity=0.305  Sum_probs=200.8

Q ss_pred             hcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|...+.||+|+||.||+|+. .+++.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36789999999999999999996 578999999987542   12235789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+ +|+|.+++...+ .+++..+..++.|++.||+||   |+.||+||||||+||++++++.+||+|||+++......
T Consensus        88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYC---HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 789999987654 689999999999999999999   78899999999999999999999999999998764322


Q ss_pred             CcceecccccccccccccccccCcc-chhhhcccccccchhhhcccccccCcch-----------hhhhHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGEL-SLKRWVNDLLPVSLVEVVDKSLLSGEEK-----------HFAAKEQCLLSIFSL  948 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~~~~g~~~~~i~~~~~~~~~~~-----------~~~~~~~~~~~l~~l  948 (985)
                         .....+||+.|+|||.+.+..+ +.++|+ |++|+++++++++..++....           ....++..++++.++
T Consensus       163 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di-wslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  238 (336)
T 3h4j_B          163 ---FLKTSCGSPNYAAPEVINGKLYAGPEVDV-WSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSL  238 (336)
T ss_dssp             ---TTCCCTTSTTTSCGGGSCCSGGGCHHHHH-HHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHH
T ss_pred             ---ccccccCCcCcCCHHHHcCCCCCCCccch-hHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence               2234579999999999988776 688999 999999999999887654321           111233456779999


Q ss_pred             HHHccCCCCCCCCCHHHHHHH
Q 001988          949 ALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      +.+|+..||.+|||+.|+++.
T Consensus       239 i~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          239 IRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             HHTTSCSSGGGSCCHHHHTTC
T ss_pred             HHHHcCCChhHCcCHHHHHhC
Confidence            999999999999999999763

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-35  Score=325.89  Aligned_cols=234  Identities=21%  Similarity=0.270  Sum_probs=201.6

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|++++..   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367899999999999999999975 79999999997542   12346678999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++|+|.+++.... .+++.....++.|++.||+||   |++||+||||||+||+++.+|.+||+|||+++..... 
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            99999999999998754 689999999999999999999   7899999999999999999999999999999876421 


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSIFSLA  949 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l~~l~  949 (985)
                          ....+||+.|+|||.+.+..++.++|+ |++|+++++++++..+.........           +...++++.+++
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  234 (318)
T 1fot_A          160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDW-WSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL  234 (318)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHH-HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             ----cccccCCccccCHhHhcCCCCCcccch-hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence                234579999999999999999999999 9999999999999876543322111           122456799999


Q ss_pred             HHccCCCCCCCC-----CHHHHHH
Q 001988          950 LECTMESPEKRI-----DAKDTIT  968 (985)
Q Consensus       950 ~~cl~~~P~~RP-----t~~ev~~  968 (985)
                      .+|+..||.+||     ++.|+++
T Consensus       235 ~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          235 SRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHhccCHHHcCCCcCCCHHHHhc
Confidence            999999999999     7888874

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-35  Score=324.14  Aligned_cols=236  Identities=25%  Similarity=0.326  Sum_probs=194.0

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--------------------------hHHHHHHHHHHHH
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--------------------------TLKSFEAECEVIK  777 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--------------------------~~~~~~~E~~il~  777 (985)
                      .++|...+.||+|+||.||+|+.. +++.||||++......                          ..+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            467999999999999999999865 7899999998754211                          1356889999999


Q ss_pred             hcCCCCeeeEEeeeec--CCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 001988          778 NIRHRNLVKIISSCSN--DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPS  855 (985)
Q Consensus       778 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~  855 (985)
                      +++||||+++++++.+  .+..++||||+++++|.+++..  ..+++..+..++.|+++||+||   |++||+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYL---HYQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHH
Confidence            9999999999999986  5678999999999999887654  3689999999999999999999   7889999999999


Q ss_pred             CEEEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCc---cchhhhcccccccchhhhcccccccCcc
Q 001988          856 NVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE---LSLKRWVNDLLPVSLVEVVDKSLLSGEE  932 (985)
Q Consensus       856 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~dv~~~~g~~~~~i~~~~~~~~~~  932 (985)
                      ||+++.++.+||+|||+++.+....  .......||+.|+|||.+.+..   ++.++|+ |++|+++++++++..++...
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di-~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDV-WAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHH-HHHHHHHHHHHHSSCSSCCS
T ss_pred             HEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhh-HhHHHHHHHHHHCCCCCCCc
Confidence            9999999999999999998875332  2234457999999999987665   4778899 99999999999998765433


Q ss_pred             hhhh-------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          933 KHFA-------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       933 ~~~~-------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ....             ....+++++.+++.+||..||++||++.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            2111             11235678999999999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.1e-35  Score=319.08  Aligned_cols=239  Identities=20%  Similarity=0.310  Sum_probs=204.0

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecC--CceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSND--DFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lv  800 (985)
                      .++|...+.||+|+||.||+|+++ ++.||||+++....  ...+.+.+|++++++++||||+++++++.+.  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            367888999999999999999985 89999999986532  3356789999999999999999999999887  788999


Q ss_pred             EeccCCCChHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          801 LEYMSNGSLEDCLHSSNC-ALNIFCRLNIMIDIASALEYLHFGHSTP--IIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~Lh~~h~~~--ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      |||+++|+|.+++..... .+++..+..++.|++.||+||   |+++  |+||||||+||+++.++.++++|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL---HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHH---TTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH---hcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999987643 589999999999999999999   7888  9999999999999999999999999876532


Q ss_pred             CCCCcceecccccccccccccccccCccch---hhhcccccccchhhhcccccccCcchhhh-------------hHHHH
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFVGELSL---KRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------AKEQC  941 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------~~~~~  941 (985)
                      .       ....||+.|+|||.+.+..++.   ++|+ |++|+++++++++..+........             .+..+
T Consensus       165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di-~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (271)
T 3kmu_A          165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADM-WSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI  236 (271)
T ss_dssp             C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHH-HHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTC
T ss_pred             c-------cCccCCccccChhhhccCCCCCCCchhhH-HHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCC
Confidence            1       2245899999999988765544   7999 999999999999887665432111             12335


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          942 LLSIFSLALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       942 ~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                      ++++.+++.+||+.||++||++.|+++.|+++.+
T Consensus       237 ~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          237 SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            6789999999999999999999999999998865

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-36  Score=337.39  Aligned_cols=249  Identities=22%  Similarity=0.380  Sum_probs=197.5

Q ss_pred             CccCCceeeccCceeEEEEEEc--CC--cEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeec-CCceEEE
Q 001988          727 NFAENNIIGIGGFGSVYRARLE--DG--VEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSN-DDFKALV  800 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~--~~--~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~~lv  800 (985)
                      .|...+.||+|+||.||+|+..  ++  ..||+|.++... ....+.+.+|+.++++++||||+++++++.. ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4667789999999999999864  22  358999987543 3346789999999999999999999998754 5678999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++|+|.+++......+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++.+....
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            999999999999988777789999999999999999999   78899999999999999999999999999998764332


Q ss_pred             Ccc--eecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHH
Q 001988          881 EST--MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSI  945 (985)
Q Consensus       881 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l  945 (985)
                      ...  ......+|+.|+|||.+.+..++.++|+ |++|++++++++ +..++.....            ...++.+++++
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-wSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l  325 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDV-WSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL  325 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHH-HHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            211  1233457889999999999999999999 999999999998 4444332211            11233467889


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                      .+++.+||..+|++||++.|+++.|+++...+..
T Consensus       326 ~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          326 YEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence            9999999999999999999999999999887654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.7e-35  Score=322.92  Aligned_cols=238  Identities=24%  Similarity=0.353  Sum_probs=201.6

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcch-------HHHHHHHHHHHHhcCCCCeeeEEeeeecCCc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAST-------LKSFEAECEVIKNIRHRNLVKIISSCSNDDF  796 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  796 (985)
                      .++|...+.||+|+||.||+|+.. +++.||+|++.......       .+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            467889999999999999999974 78999999987543221       167899999999999999999999997665 


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCEEEcCCCc-----EEEec
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP--IIHCDLKPSNVLLDEDMV-----AHLSD  869 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~--ivHrDlk~~Nill~~~~~-----~kl~D  869 (985)
                       ++||||+++|+|.+++......+++..+..++.|++.||+||   |++|  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM---QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH---HTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHH---HhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             699999999999999988777899999999999999999999   6788  999999999999988776     99999


Q ss_pred             ccCceeccCCCCcceeccccccccccccccc--ccCccchhhhcccccccchhhhcccccccCcchhh------------
Q 001988          870 FGMAKLLSGEDESTMRTQTLATIGYMAPDEI--FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF------------  935 (985)
Q Consensus       870 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~------------  935 (985)
                      ||+++....     ......||+.|+|||.+  ....++.++|+ |++|+++++++++..++......            
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di-~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  246 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADT-YSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG  246 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHH-HHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhH-HHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence            999975432     23345699999999998  45567889999 99999999999988766432211            


Q ss_pred             ---hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          936 ---AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       936 ---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                         ..+..+++++.+++.+||..||.+||++.|+++.|+++
T Consensus       247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence               11234667899999999999999999999999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-35  Score=320.15  Aligned_cols=247  Identities=23%  Similarity=0.345  Sum_probs=207.8

Q ss_pred             cCccCCc-eeeccCceeEEEEEEc---CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          726 DNFAENN-IIGIGGFGSVYRARLE---DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       726 ~~~~~~~-~ig~G~~g~V~~~~~~---~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      ++|...+ .||+|+||.||+|.+.   +++.||||+++.... ...+.+.+|++++++++||||+++++++. .+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEE
Confidence            4566665 8999999999999853   678899999986532 34567899999999999999999999994 5568999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++++|.+++......+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||+++......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            999999999999987766799999999999999999999   78899999999999999999999999999998875333


Q ss_pred             Ccc-eecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHH
Q 001988          881 EST-MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIF  946 (985)
Q Consensus       881 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~  946 (985)
                      ... ......+|+.|+|||.+.+..++.++|+ |++|++++++++ +..+.......            ..+..+++++.
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  243 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDV-WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY  243 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHH-HHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhH-HHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHH
Confidence            221 1233357899999999998999999999 999999999998 77655432211            11234678899


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          947 SLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      +++.+||..+|.+||++.|+++.|+++....
T Consensus       244 ~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          244 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            9999999999999999999999999987643

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.5e-35  Score=325.82  Aligned_cols=252  Identities=22%  Similarity=0.356  Sum_probs=197.9

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEc----CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCC-
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDD-  795 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-  795 (985)
                      ...++|...+.||+|+||.||+|...    +++.||+|+++....  ...+.+.+|++++++++||||+++++++.+.+ 
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            34578899999999999999999754    355899999876532  33567899999999999999999999997754 


Q ss_pred             ----ceEEEEeccCCCChHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEE
Q 001988          796 ----FKALVLEYMSNGSLEDCLHS-----SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH  866 (985)
Q Consensus       796 ----~~~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~k  866 (985)
                          ..++||||+++|+|.+++..     ....+++..++.++.|+++||+||   |++||+||||||+||+++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHH---HTTTCCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCcEE
Confidence                34899999999999999853     235689999999999999999999   789999999999999999999999


Q ss_pred             EecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh----------
Q 001988          867 LSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF----------  935 (985)
Q Consensus       867 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~----------  935 (985)
                      |+|||+++.+.............+++.|+|||.+.+..++.++|+ |++|++++++++ +..+.......          
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  266 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDV-WAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH  266 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHH-HHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhh-HHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence            999999987654332233334457889999999999999999999 999999999998 66544332111          


Q ss_pred             --hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          936 --AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       936 --~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                        ..+..+++++.+++.+||..+|.+||++.++++.|+++.+.++
T Consensus       267 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          267 RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence              1223456789999999999999999999999999999987654

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=4.3e-35  Score=334.50  Aligned_cols=336  Identities=21%  Similarity=0.239  Sum_probs=245.2

Q ss_pred             CCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCce
Q 001988          264 NMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKL  343 (985)
Q Consensus       264 ~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~  343 (985)
                      .+++++.|++++|.++ .+|..++..+++|++|+|++|++++..+..|..+++|++|++++|.+++..|..++++++|++
T Consensus        43 ~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  121 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV  121 (390)
T ss_dssp             GGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             ccCCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence            4578888888888887 678777778888888888888888777778888888888888888888777777788888888


Q ss_pred             EeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEE
Q 001988          344 FDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLS  423 (985)
Q Consensus       344 L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  423 (985)
                      |++++|+++.+++.     .+.++++|++|++++|++.                         +..|..|..+++|++|+
T Consensus       122 L~L~~n~l~~l~~~-----~~~~l~~L~~L~L~~n~l~-------------------------~~~~~~~~~l~~L~~L~  171 (390)
T 3o6n_A          122 LVLERNDLSSLPRG-----IFHNTPKLTTLSMSNNNLE-------------------------RIEDDTFQATTSLQNLQ  171 (390)
T ss_dssp             EECCSSCCCCCCTT-----TTTTCTTCCEEECCSSCCC-------------------------BCCTTTTSSCTTCCEEE
T ss_pred             EECCCCccCcCCHH-----HhcCCCCCcEEECCCCccC-------------------------ccChhhccCCCCCCEEE
Confidence            87777777765543     1345555555555555554                         44455566666666666


Q ss_pred             ccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeee
Q 001988          424 LGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTF  503 (985)
Q Consensus       424 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  503 (985)
                      +++|++++.   .+..+++|+.|++++|.+++.     ...++|+.|++++|+++.....   ..++|++|++++|++++
T Consensus       172 l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~  240 (390)
T 3o6n_A          172 LSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTD  240 (390)
T ss_dssp             CCSSCCSBC---CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCC
T ss_pred             CCCCcCCcc---ccccccccceeeccccccccc-----CCCCcceEEECCCCeeeecccc---ccccccEEECCCCCCcc
Confidence            666666643   244556667777777766532     2335677777777777654322   23677777888877775


Q ss_pred             ecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhc
Q 001988          504 VIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGN  583 (985)
Q Consensus       504 ~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  583 (985)
                      .  ..+..+++|++|++++|.+++..+..+..+++|+.|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..
T Consensus       241 ~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~  316 (390)
T 3o6n_A          241 T--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ  316 (390)
T ss_dssp             C--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHH
T ss_pred             c--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccc
Confidence            4  467777788888888888887777788888888888888888875 5666778899999999999998 46777888


Q ss_pred             ccccCeEecCCCcccCCCCccccccccccccccccccccCCCCCCCCCcccccccccCCccccCCC
Q 001988          584 MTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLP  649 (985)
Q Consensus       584 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~  649 (985)
                      +++|++|+|++|+|++. |  +..+++|+.|++++|++++.... ..+..+....+.+++..|..+
T Consensus       317 l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~  378 (390)
T 3o6n_A          317 FDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID  378 (390)
T ss_dssp             HTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTT
T ss_pred             cCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceeccc
Confidence            99999999999999854 3  67788999999999999875432 234445555566777777754

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-35  Score=328.05  Aligned_cols=249  Identities=23%  Similarity=0.405  Sum_probs=201.9

Q ss_pred             cCccCCceeeccCceeEEEEEEcC-----CcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLED-----GVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~-----~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ++|...+.||+|+||.||+|....     +..||||+++.... .....+.+|++++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            467778999999999999998642     34699999976533 235578899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            9999999999999988766899999999999999999999   7889999999999999999999999999999876533


Q ss_pred             CCcc-eecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHH
Q 001988          880 DEST-MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSI  945 (985)
Q Consensus       880 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l  945 (985)
                      .... ......+|+.|+|||.+....++.++|+ |++|++++++++ +..+.......            +.+..++.++
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l  279 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDV-WSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI  279 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHH-HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhh-HHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHH
Confidence            2211 1223346889999999999999999999 999999999987 66554322111            1123356789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                      .+++.+||..+|.+||++.++++.|+++.+...
T Consensus       280 ~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          280 YQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            999999999999999999999999999876543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.7e-35  Score=319.90  Aligned_cols=238  Identities=26%  Similarity=0.407  Sum_probs=192.5

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCc----chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA----STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|+..+.||+|+||.||+|.+. ++.||||+++....    ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            367888999999999999999985 89999999875432    2246789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC---eEeCCCCCCCEEEcC--------CCcEEEec
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP---IIHCDLKPSNVLLDE--------DMVAHLSD  869 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~---ivHrDlk~~Nill~~--------~~~~kl~D  869 (985)
                      |||+++++|.+++...  .+++..+..++.|+++||+||   |++|   |+||||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~l---H~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYL---HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHH---HHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999998643  689999999999999999999   5666   999999999999986        77899999


Q ss_pred             ccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-------------
Q 001988          870 FGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------  936 (985)
Q Consensus       870 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------  936 (985)
                      ||+++.+....    .....||+.|+|||.+.+..++.++|+ |++|+++++++++..+........             
T Consensus       160 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  234 (271)
T 3dtc_A          160 FGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDV-WSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP  234 (271)
T ss_dssp             CCC-----------------CCGGGSCHHHHHHCCCSHHHHH-HHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC
T ss_pred             CCccccccccc----ccCCCCccceeCHHHhccCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC
Confidence            99998764322    223469999999999999999999999 999999999999887655432111             


Q ss_pred             hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          937 AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       937 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                      .+..+++++.+++.+||+.+|.+||++.|+++.|+++
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          235 IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            1234567899999999999999999999999999764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.4e-35  Score=335.01  Aligned_cols=251  Identities=17%  Similarity=0.188  Sum_probs=203.3

Q ss_pred             HhcCccCCceeeccCceeEEEEEEcC------CcEEEEEEeccCCcchH-----------HHHHHHHHHHHhcCCCCeee
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLED------GVEIAIKVFHPQCASTL-----------KSFEAECEVIKNIRHRNLVK  786 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vAvK~~~~~~~~~~-----------~~~~~E~~il~~l~h~niv~  786 (985)
                      ..++|...+.||+|+||.||+|.+.+      ++.||||++........           ..+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35689999999999999999998764      47899999876532111           12334555666778999999


Q ss_pred             EEeeeecC----CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc--
Q 001988          787 IISSCSND----DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD--  860 (985)
Q Consensus       787 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~--  860 (985)
                      +++++...    ...++||||+ +++|.+++......+++..+..++.|++.||+||   |++||+||||||+|||++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~l---H~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYI---HEHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeEEecCCHHHEEEecC
Confidence            99998764    4579999999 9999999988767899999999999999999999   788999999999999999  


Q ss_pred             CCCcEEEecccCceeccCCCCcc-----eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh
Q 001988          861 EDMVAHLSDFGMAKLLSGEDEST-----MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF  935 (985)
Q Consensus       861 ~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~  935 (985)
                      .++.+||+|||+++.+.......     ......||+.|+|||.+.+..++.++|+ |++|+++++++++..++......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDL-EILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHH-HHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhH-HHHHHHHHHHHhCCCCccccccC
Confidence            88999999999998865322111     1133459999999999999999999999 99999999999998876532110


Q ss_pred             h----------------hH------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          936 A----------------AK------EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       936 ~----------------~~------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                      .                ..      ..+++++.+++..||..+|.+||++.++++.|+++.+....
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  333 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS  333 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            0                01      11267899999999999999999999999999998876543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=8.8e-36  Score=339.38  Aligned_cols=244  Identities=19%  Similarity=0.222  Sum_probs=205.0

Q ss_pred             HHHHHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 001988          719 FELLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSND  794 (985)
Q Consensus       719 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~  794 (985)
                      .++....++|...+.||+|+||.||+|+.+ +++.||+|++++..   ......+.+|+++++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344456789999999999999999999976 68899999986531   12234578999999999999999999999999


Q ss_pred             CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCce
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK  874 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~  874 (985)
                      +..|+||||++||+|.+++...  .+++.....++.||+.||+||   |++||+||||||+|||++.+|.+||+|||+|+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~L---H~~givHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence            9999999999999999999764  588999999999999999999   78999999999999999999999999999998


Q ss_pred             eccCCCCcceecccccccccccccccccCc----cchhhhcccccccchhhhcccccccCcchhhh--------------
Q 001988          875 LLSGEDESTMRTQTLATIGYMAPDEIFVGE----LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--------------  936 (985)
Q Consensus       875 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--------------  936 (985)
                      .+.... .......+||+.|+|||++....    ++.++|+ |++|++++++++|..++.......              
T Consensus       217 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~Di-wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~  294 (410)
T 3v8s_A          217 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW-WSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF  294 (410)
T ss_dssp             ECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHH-HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred             eeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceE-ecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC
Confidence            864322 22334568999999999988665    7889999 999999999999987765432111              


Q ss_pred             -hHHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 001988          937 -AKEQCLLSIFSLALECTMESPEK--RIDAKDTITR  969 (985)
Q Consensus       937 -~~~~~~~~l~~l~~~cl~~~P~~--RPt~~ev~~~  969 (985)
                       .....+.++.+++.+|+..+|.+  ||++.|+++.
T Consensus       295 p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          295 PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence             11124678999999999999988  9999998863

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-35  Score=326.20  Aligned_cols=252  Identities=23%  Similarity=0.329  Sum_probs=200.9

Q ss_pred             HHHHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhc--CCCCeeeEEeeeecC----
Q 001988          721 LLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI--RHRNLVKIISSCSND----  794 (985)
Q Consensus       721 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l--~h~niv~l~~~~~~~----  794 (985)
                      .....++|+..+.||+|+||.||+|+.. ++.||||++...   ....+.+|.+++...  +||||+++++++...    
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            3345578999999999999999999986 899999998643   234555666666655  899999999999877    


Q ss_pred             CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeCCCCCCCEEEcCCCcEEEec
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG-----HSTPIIHCDLKPSNVLLDEDMVAHLSD  869 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~-----h~~~ivHrDlk~~Nill~~~~~~kl~D  869 (985)
                      ...++||||+++|+|.++++..  .+++..+..++.|++.||+|||..     |..||+||||||+||+++.++.+||+|
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             CceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence            6789999999999999999765  589999999999999999999421     133999999999999999999999999


Q ss_pred             ccCceeccCCCCcc--eecccccccccccccccccCccchh------hhcccccccchhhhccccccc----------Cc
Q 001988          870 FGMAKLLSGEDEST--MRTQTLATIGYMAPDEIFVGELSLK------RWVNDLLPVSLVEVVDKSLLS----------GE  931 (985)
Q Consensus       870 fGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~dv~~~~g~~~~~i~~~~~~~----------~~  931 (985)
                      ||+++.+.......  ......||+.|+|||.+.+......      +|+ |++|+++++++++..+.          ..
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di-wslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM-YSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHH-HHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccch-HHHHHHHHHHHhccCcccccccccccHhh
Confidence            99998765333221  1224579999999999877666554      899 99999999999983322          11


Q ss_pred             c----h-------------------hhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          932 E----K-------------------HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       932 ~----~-------------------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                      .    .                   .....+.+++++.+++.+||..||.+||++.|+++.|+++.+....
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  335 (337)
T 3mdy_A          265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI  335 (337)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTC
T ss_pred             hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhccc
Confidence            0    0                   0001236788899999999999999999999999999999887543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.4e-36  Score=339.77  Aligned_cols=245  Identities=22%  Similarity=0.244  Sum_probs=204.9

Q ss_pred             HHHHHHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 001988          718 YFELLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSN  793 (985)
Q Consensus       718 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~  793 (985)
                      +.+.....++|+..+.||+|+||.||+|+.+ +++.||+|++++..   ......+.+|.+++.+++||||+++++++++
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444556789999999999999999999975 79999999997532   1223457899999999999999999999999


Q ss_pred             CCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCc
Q 001988          794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA  873 (985)
Q Consensus       794 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla  873 (985)
                      .+..|+||||++||+|.+++...+..+++..+..++.||+.||+||   |++||+||||||+|||++.++++||+|||++
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV---HRLGYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccCHHHeeecCCCCEEEeechhh
Confidence            9999999999999999999987666789999999999999999999   7899999999999999999999999999999


Q ss_pred             eeccCCCCcceecccccccccccccccc-------cCccchhhhcccccccchhhhcccccccCcchhhh----------
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIF-------VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA----------  936 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~----------  936 (985)
                      +.+..... ......+||+.|+|||++.       .+.++.++|+ |++|++++|+++|+.++.......          
T Consensus       210 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~Di-wSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  287 (412)
T 2vd5_A          210 LKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDW-WALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE  287 (412)
T ss_dssp             EECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHH-HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred             eeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhh-hHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence            88753322 2233467999999999987       4678999999 999999999999987664332111          


Q ss_pred             ------hHHHHHHHHHHHHHHccCCCCCCC---CCHHHHHH
Q 001988          937 ------AKEQCLLSIFSLALECTMESPEKR---IDAKDTIT  968 (985)
Q Consensus       937 ------~~~~~~~~l~~l~~~cl~~~P~~R---Pt~~ev~~  968 (985)
                            ....+++++.+++++|+. +|.+|   |++.|+.+
T Consensus       288 ~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          288 HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence                  012356789999999998 99998   58888764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.3e-35  Score=331.64  Aligned_cols=232  Identities=23%  Similarity=0.237  Sum_probs=197.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l  799 (985)
                      .++|...+.||+|+||.||+|+.+ +++.||+|++++...   ...+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            367889999999999999999975 688999999976532   2345678999999988 89999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++|+|.+++...+ .+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus        88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            999999999999998654 689999999999999999999   7899999999999999999999999999999864322


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh---------h-----------hhHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH---------F-----------AAKE  939 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~---------~-----------~~~~  939 (985)
                      .  ......+||+.|+|||.+.+..++.++|+ |++|+++++++++..++.....         .           ..+.
T Consensus       164 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~  240 (345)
T 3a8x_A          164 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDW-WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR  240 (345)
T ss_dssp             T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHH-HHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT
T ss_pred             C--CcccccCCCccccCccccCCCCCChHHhH-HHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC
Confidence            2  22345679999999999999999999999 9999999999999876642100         0           0112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCH
Q 001988          940 QCLLSIFSLALECTMESPEKRIDA  963 (985)
Q Consensus       940 ~~~~~l~~l~~~cl~~~P~~RPt~  963 (985)
                      ..+.++.+++.+||..||.+||++
T Consensus       241 ~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          241 SLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCCHHHHHHHHHHhcCCHhHCCCC
Confidence            245778999999999999999996

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.1e-35  Score=333.30  Aligned_cols=235  Identities=24%  Similarity=0.298  Sum_probs=199.4

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|...+.||+|+||.||+|+.. +++.||+|++.+..   ......+.+|++++++++|||||++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            367899999999999999999865 68899999987542   22346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||++||+|.+++.... .+++..+..++.|++.||+||   |+.||+||||||+||+++.+|.+||+|||+++.+... 
T Consensus        94 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  168 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYL---QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-  168 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence            99999999999998753 689999999999999999999   7899999999999999999999999999999886432 


Q ss_pred             Ccceeccccccccccccccccc---CccchhhhcccccccchhhhcccccccCcchhhh--------------hHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFV---GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--------------AKEQCLL  943 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--------------~~~~~~~  943 (985)
                        ......+||+.|+|||.+..   ..++.++|+ |++|++++++++|..++.......              .+..++.
T Consensus       169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~Di-wSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~  245 (384)
T 4fr4_A          169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDW-WSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ  245 (384)
T ss_dssp             --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHH-HHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             --CceeccCCCccccCCeeeccCCCCCCCcccee-echHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCH
Confidence              22345679999999999864   458889999 999999999999987764321111              1223457


Q ss_pred             HHHHHHHHccCCCCCCCCC-HHHHH
Q 001988          944 SIFSLALECTMESPEKRID-AKDTI  967 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt-~~ev~  967 (985)
                      ++.+++.+||..||.+||+ +.++.
T Consensus       246 ~~~~li~~lL~~dP~~R~s~~~~l~  270 (384)
T 4fr4_A          246 EMVSLLKKLLEPNPDQRFSQLSDVQ  270 (384)
T ss_dssp             HHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred             HHHHHHHHHhcCCHhHhcccHHHHH
Confidence            8999999999999999998 55554

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.1e-35  Score=319.75  Aligned_cols=247  Identities=22%  Similarity=0.372  Sum_probs=204.6

Q ss_pred             HhcCccCCceeeccCceeEEEEEEcC----CcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLED----GVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      ..++|...+.||+|+||.||+|++.+    +..||+|.+.... ....+.+.+|++++++++||||+++++++.++ ..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence            35688999999999999999998542    3469999998653 23457789999999999999999999998754 568


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +||||+++++|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            99999999999999987766789999999999999999999   789999999999999999999999999999987643


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSI  945 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l  945 (985)
                      ... .......+|+.|+|||.+....++.++|+ |++|++++++++ +..+.......            ..+..+++.+
T Consensus       166 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (281)
T 3cc6_A          166 EDY-YKASVTRLPIKWMSPESINFRRFTTASDV-WMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVL  243 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHH
T ss_pred             ccc-cccccCCCCcceeCchhhccCCCCchhcc-HHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHH
Confidence            222 12233457889999999999999999999 999999999997 77654322111            1122356779


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      .+++.+||..+|++||++.|+++.|+++.+.
T Consensus       244 ~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          244 YTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            9999999999999999999999999998764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.6e-35  Score=327.42  Aligned_cols=237  Identities=24%  Similarity=0.293  Sum_probs=192.4

Q ss_pred             hcCccCCceeeccCceeEEEEEE----cCCcEEEEEEeccCC----cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL----EDGVEIAIKVFHPQC----ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDF  796 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  796 (985)
                      .++|+..+.||+|+||.||+|+.    .+++.||+|++++..    ......+.+|++++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46799999999999999999987    478999999997652    2234567899999999999999999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      .++||||+++|+|.+++...+ .+++.....++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHL---HQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHH---HhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999999999998654 688999999999999999999   7889999999999999999999999999999764


Q ss_pred             cCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHH
Q 001988          877 SGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSI  945 (985)
Q Consensus       877 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l  945 (985)
                      ....  ......+||+.|+|||.+.+..++.++|+ |++|+++++++++..++........           +...+.++
T Consensus       172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~  248 (327)
T 3a62_A          172 IHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDW-WSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEA  248 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred             ccCC--ccccccCCCcCccCHhhCcCCCCCCcccc-hhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence            3222  22344579999999999999999999999 9999999999999877654322211           12245789


Q ss_pred             HHHHHHccCCCCCCCC-----CHHHHHH
Q 001988          946 FSLALECTMESPEKRI-----DAKDTIT  968 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RP-----t~~ev~~  968 (985)
                      .+++.+||..||.+||     ++.|+++
T Consensus       249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          249 RDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            9999999999999999     6677764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-35  Score=322.61  Aligned_cols=249  Identities=20%  Similarity=0.316  Sum_probs=206.4

Q ss_pred             CccCCceeeccCceeEEEEEEc-C---CcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCce-EEE
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-D---GVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFK-ALV  800 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~---~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~-~lv  800 (985)
                      .|...+.||+|+||.||+|++. +   +..||+|++..... ...+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4566789999999999999853 2   33799999976433 3456789999999999999999999999876654 999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++|+|.+++......+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||+++.+....
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            999999999999988777889999999999999999999   78899999999999999999999999999998764322


Q ss_pred             C--cceecccccccccccccccccCccchhhhcccccccchhhhcccccc-cCcchhh------------hhHHHHHHHH
Q 001988          881 E--STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLL-SGEEKHF------------AAKEQCLLSI  945 (985)
Q Consensus       881 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~-~~~~~~~------------~~~~~~~~~l  945 (985)
                      .  ........+|+.|+|||.+.+..++.++|+ |++|+++++++++..+ .......            ..+..+++++
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  257 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDV-WSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL  257 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHH-HHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhch-hhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHH
Confidence            1  112234468899999999999999999999 9999999999995443 3222111            1122356789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                      .+++.+||..+|.+||++.++++.|+++.+.+..
T Consensus       258 ~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          258 YQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            9999999999999999999999999999887654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.8e-35  Score=329.43  Aligned_cols=234  Identities=22%  Similarity=0.255  Sum_probs=202.1

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|...+.||+|+||.||+|+.. +|+.||+|++.+..   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367889999999999999999975 78999999997542   12346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++|+|.+++...+ .+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++..... 
T Consensus       120 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            99999999999998754 689999999999999999999   7899999999999999999999999999999876432 


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSIFSLA  949 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l~~l~  949 (985)
                          ....+||+.|+|||.+.+..++.++|+ |++|+++++++++..+.........           +..++.++.+++
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  269 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKAVDW-WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL  269 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHH
T ss_pred             ----cccccCCccccCHHHhcCCCCCCcCCE-ecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence                234579999999999999999999999 9999999999999876544322111           123567899999


Q ss_pred             HHccCCCCCCCCC-----HHHHHH
Q 001988          950 LECTMESPEKRID-----AKDTIT  968 (985)
Q Consensus       950 ~~cl~~~P~~RPt-----~~ev~~  968 (985)
                      .+||..||.+||+     +.|+.+
T Consensus       270 ~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          270 RNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHhhcCHHhccCCccCCHHHHHh
Confidence            9999999999998     777764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.8e-35  Score=325.79  Aligned_cols=237  Identities=22%  Similarity=0.319  Sum_probs=184.9

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .++|+..+.||+|+||.||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467899999999999999999865 789999999975532 234678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          803 YMSNGSLEDCLHSS-----NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       803 ~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      |++ |+|.+++...     ...+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+.
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC---HENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 5999988754     23588999999999999999999   78999999999999999999999999999998864


Q ss_pred             CCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh-------------------
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-------------------  937 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-------------------  937 (985)
                      ....  ......||+.|+|||.+.+ ..++.++|+ |++|+++++++++..++........                   
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDI-WSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            3221  2234568999999999876 468999999 9999999999998865533211100                   


Q ss_pred             --------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 --------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 --------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                .+..+.++.+++.+|+..||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                                      0123467899999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.8e-35  Score=352.45  Aligned_cols=251  Identities=22%  Similarity=0.344  Sum_probs=205.5

Q ss_pred             CccCCc-eeeccCceeEEEEEEc---CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          727 NFAENN-IIGIGGFGSVYRARLE---DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       727 ~~~~~~-~ig~G~~g~V~~~~~~---~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++...+ .||+|+||.||+|.+.   ++..||||+++.... ...+.+.+|++++++++|||||++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            333344 7999999999999864   567799999986532 356789999999999999999999999976 5689999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++|+|.+++......+++..+..++.||+.||+||   |+++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            99999999999987777799999999999999999999   789999999999999999999999999999987643322


Q ss_pred             c-ceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHH
Q 001988          882 S-TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFS  947 (985)
Q Consensus       882 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~  947 (985)
                      . .......+++.|+|||.+..+.++.++|+ |++|++++|+++ |..++......            ..+..+++++.+
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDv-wSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  570 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFSSRSDV-WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA  570 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCCcHHHH-HHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence            1 11222346789999999999999999999 999999999997 77655432211            122346789999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHHhHhhhccccC
Q 001988          948 LALECTMESPEKRIDAKDTITRLLKIRDTLSKRIG  982 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~~~~  982 (985)
                      +|.+||..+|++||++.++++.|+.+......+..
T Consensus       571 li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~  605 (613)
T 2ozo_A          571 LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE  605 (613)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCC
T ss_pred             HHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccC
Confidence            99999999999999999999999998877665543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.3e-35  Score=329.62  Aligned_cols=246  Identities=25%  Similarity=0.346  Sum_probs=195.4

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHH--HHhcCCCCeeeEEeeee-----cCCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEV--IKNIRHRNLVKIISSCS-----NDDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~i--l~~l~h~niv~l~~~~~-----~~~~~  797 (985)
                      .++|+..+.||+|+||.||+|+. +++.||||++....   ...+..|.++  +..++||||+++++++.     .....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            47889999999999999999987 58999999987442   2344445544  44589999999998553     23356


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CeEeCCCCCCCEEEcCCCcEEEe
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST---------PIIHCDLKPSNVLLDEDMVAHLS  868 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~---------~ivHrDlk~~Nill~~~~~~kl~  868 (985)
                      ++||||+++|+|.+++....  .++..+.+++.|+++||+||   |+.         ||+||||||+||+++.++.+||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~L---H~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYL---HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHH---HCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHH---HhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            89999999999999997654  48899999999999999999   566         99999999999999999999999


Q ss_pred             cccCceeccCCCC------cceeccccccccccccccccc-------CccchhhhcccccccchhhhcccccccCcchh-
Q 001988          869 DFGMAKLLSGEDE------STMRTQTLATIGYMAPDEIFV-------GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-  934 (985)
Q Consensus       869 DfGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-  934 (985)
                      |||+++.+.....      ........||+.|+|||.+.+       ..++.++|+ |++|+++++++++..+...... 
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di-wslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDM-YALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHH-HHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccch-HHHHHHHHHHHhcCCcCCCccch
Confidence            9999988753221      112234569999999999876       467788999 9999999999987543211100 


Q ss_pred             ----------------h--------------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          935 ----------------F--------------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       935 ----------------~--------------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                                      .                    .....++.++.+++.+||..||++|||+.|+++.|+++.+.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence                            0                    0011255679999999999999999999999999999998877


Q ss_pred             cc
Q 001988          979 KR  980 (985)
Q Consensus       979 ~~  980 (985)
                      +.
T Consensus       322 ~~  323 (336)
T 3g2f_A          322 RN  323 (336)
T ss_dssp             C-
T ss_pred             hc
Confidence            64

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=6.2e-35  Score=351.63  Aligned_cols=335  Identities=21%  Similarity=0.242  Sum_probs=250.3

Q ss_pred             CCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceE
Q 001988          265 MSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLF  344 (985)
Q Consensus       265 l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  344 (985)
                      +++++.|++++|.+. .+|..++..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|
T Consensus        50 l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  128 (597)
T 3oja_B           50 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  128 (597)
T ss_dssp             GCCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence            567888888888887 6777777788888888888888887777788888888888888888888777777888877777


Q ss_pred             eccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEc
Q 001988          345 DIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSL  424 (985)
Q Consensus       345 ~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  424 (985)
                      +|++|+++.+++..     |.++++|++|+|++|.+.                         +..|..|..+++|++|+|
T Consensus       129 ~L~~n~l~~l~~~~-----~~~l~~L~~L~Ls~N~l~-------------------------~~~~~~~~~l~~L~~L~L  178 (597)
T 3oja_B          129 VLERNDLSSLPRGI-----FHNTPKLTTLSMSNNNLE-------------------------RIEDDTFQATTSLQNLQL  178 (597)
T ss_dssp             ECCSSCCCCCCTTT-----TTTCTTCCEEECCSSCCC-------------------------BCCTTTTTTCTTCCEEEC
T ss_pred             EeeCCCCCCCCHHH-----hccCCCCCEEEeeCCcCC-------------------------CCChhhhhcCCcCcEEEC
Confidence            77777777655431     345555555555555554                         445555666666666666


Q ss_pred             cCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeee
Q 001988          425 GGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFV  504 (985)
Q Consensus       425 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  504 (985)
                      ++|.+++..   ++.+++|+.|++++|.+++.     ...++|+.|++++|.++...+...   ++|+.|+|++|.+++ 
T Consensus       179 ~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~~---~~L~~L~L~~n~l~~-  246 (597)
T 3oja_B          179 SSNRLTHVD---LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPVN---VELTILKLQHNNLTD-  246 (597)
T ss_dssp             TTSCCSBCC---GGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECSCC---SCCCEEECCSSCCCC-
T ss_pred             cCCCCCCcC---hhhhhhhhhhhcccCccccc-----cCCchhheeeccCCcccccccccC---CCCCEEECCCCCCCC-
Confidence            666666432   34456666777777766532     234567777777777765443322   567788888887775 


Q ss_pred             cCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcc
Q 001988          505 IPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNM  584 (985)
Q Consensus       505 ~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  584 (985)
                       +..+..+++|+.|++++|.+.+..|..|+.+++|+.|+|++|+|++ +|..+..+++|+.|+|++|.++ .+|..+..+
T Consensus       247 -~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l  323 (597)
T 3oja_B          247 -TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF  323 (597)
T ss_dssp             -CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHH
T ss_pred             -ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccC
Confidence             3567778888888888888888778888888888888888888885 5777788999999999999999 577888999


Q ss_pred             cccCeEecCCCcccCCCCccccccccccccccccccccCCCCCCCCCcccccccccCCccccCCC
Q 001988          585 TSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLP  649 (985)
Q Consensus       585 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~  649 (985)
                      ++|+.|+|++|+|++. |  +..+++|+.|++++|+++|..+. ..+..+....+.+++..|+.+
T Consensus       324 ~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~  384 (597)
T 3oja_B          324 DRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID  384 (597)
T ss_dssp             TTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred             CCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence            9999999999999864 3  67788999999999999987543 245566666778888899865

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.4e-35  Score=330.45  Aligned_cols=247  Identities=15%  Similarity=0.137  Sum_probs=206.4

Q ss_pred             HhcCccCCceeeccCceeEEEEE------EcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcC---CCCeeeEEeeeecC
Q 001988          724 ATDNFAENNIIGIGGFGSVYRAR------LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR---HRNLVKIISSCSND  794 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~------~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~  794 (985)
                      ..++|...+.||+|+||.||+|.      ..+++.||||+++..   ...++..|++++++++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            45779999999999999999994      447889999999754   3457788899988887   99999999999999


Q ss_pred             CceEEEEeccCCCChHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---------
Q 001988          795 DFKALVLEYMSNGSLEDCLHS----SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE---------  861 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~---------  861 (985)
                      +..++||||+++|+|.+++..    ....+++..++.++.|++.||+||   |++|||||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~l---H~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV---HDCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH---hhCCeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999975    345799999999999999999999   7899999999999999998         


Q ss_pred             --CCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---
Q 001988          862 --DMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---  936 (985)
Q Consensus       862 --~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---  936 (985)
                        ++.+||+|||+|+.+............+||+.|+|||++.+..++.++|+ |++|++++++++|+.+........   
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~elltg~~pf~~~~~~~~~~  295 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDY-FGVAATVYCMLFGTYMKVKNEGGECKP  295 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHH-HHHHHHHHHHHHSSCCCEEEETTEEEE
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccH-HHHHHHHHHHHhCCCccccCCCCceee
Confidence              89999999999987654444444566789999999999999999999999 999999999999986543221100   


Q ss_pred             ----hHHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHHhHhhh
Q 001988          937 ----AKEQCLLSIFSLALECTMESPEKR-IDAKDTITRLLKIRDTL  977 (985)
Q Consensus       937 ----~~~~~~~~l~~l~~~cl~~~P~~R-Pt~~ev~~~L~~i~~~~  977 (985)
                          ......+.+.+++..|+..+|.+| |++.++.+.|+++.+..
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          296 EGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             CSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             chhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                000124567889999999999988 58888888888877653

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.6e-35  Score=329.60  Aligned_cols=238  Identities=21%  Similarity=0.210  Sum_probs=200.7

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~  798 (985)
                      ..++|...+.||+|+||.||+|+.+ +++.||+|++++..   ......+..|.++++.+ +||+|+++++++++.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            4578999999999999999999976 57889999997542   22346678999999988 7999999999999999999


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +||||++||+|.+++...+ .+++..+..++.||+.||+||   |++||+||||||+||+++.+|.+||+|||+++....
T Consensus        98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999999998654 689999999999999999999   788999999999999999999999999999986432


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSIFS  947 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l~~  947 (985)
                      ..  ......+||+.|+|||.+.+..++.++|+ |++|++++++++|..+.........           +...+.++.+
T Consensus       174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  250 (353)
T 2i0e_A          174 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDW-WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA  250 (353)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             CC--cccccccCCccccChhhhcCCCcCCcccc-cchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            22  22345679999999999999999999999 9999999999999876654322111           1234678999


Q ss_pred             HHHHccCCCCCCCCC-----HHHHHH
Q 001988          948 LALECTMESPEKRID-----AKDTIT  968 (985)
Q Consensus       948 l~~~cl~~~P~~RPt-----~~ev~~  968 (985)
                      ++.+|+..||.+||+     +.|+.+
T Consensus       251 li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          251 ICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            999999999999996     455553

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.7e-35  Score=330.18  Aligned_cols=235  Identities=22%  Similarity=0.272  Sum_probs=186.6

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ..++|...+.||+|+||.||+|+.. +++.||||+++...  ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3567899999999999999999976 68899999997553  34678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---CCcEEEecccCceeccCC
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE---DMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~---~~~~kl~DfGla~~~~~~  879 (985)
                      |+++|+|.+++...+ .+++..+..++.|++.||+||   |+.||+||||||+||+++.   ++.+||+|||+++.....
T Consensus       129 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYL---HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            999999999998654 689999999999999999999   7889999999999999975   889999999999876422


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh----------------hHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA----------------AKEQCLL  943 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~----------------~~~~~~~  943 (985)
                         .......||+.|+|||.+.+..++.++|+ |++|+++++++++..+........                ....++.
T Consensus       205 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  280 (349)
T 2w4o_A          205 ---VLMKTVCGTPGYCAPEILRGCAYGPEVDM-WSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL  280 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHH-HHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred             ---cccccccCCCCccCHHHhcCCCCCcccch-HHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence               12234569999999999999999999999 999999999999876654322111                0123567


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ++.+++.+|+..||++||++.|+++
T Consensus       281 ~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          281 NAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhc
Confidence            8999999999999999999999886

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-35  Score=331.48  Aligned_cols=238  Identities=22%  Similarity=0.306  Sum_probs=194.0

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCC--CCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRH--RNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|+..+.||+|+||.||+|...+++.||||++.....  ...+.+.+|++++++++|  |||+++++++.+++..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            467899999999999999999998899999999875533  234678999999999986  9999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      ||| .+|+|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++ ++.+||+|||+++.+....
T Consensus        88 ~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            995 5889999998754 689999999999999999999   788999999999999997 6789999999998875444


Q ss_pred             Ccceeccccccccccccccccc-----------CccchhhhcccccccchhhhcccccccCcchhh-h------------
Q 001988          881 ESTMRTQTLATIGYMAPDEIFV-----------GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-A------------  936 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-~------------  936 (985)
                      ........+||+.|+|||.+.+           ..++.++|+ |++|+++++++++..++...... .            
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di-wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  240 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV-WSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  240 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHH-HHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhH-HHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence            3333445679999999999865           778999999 99999999999998765432111 0            


Q ss_pred             -hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          937 -AKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       937 -~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                       .+..++.++.+++.+||..||.+||++.|+++.
T Consensus       241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence             111234678999999999999999999999864

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.8e-35  Score=333.91  Aligned_cols=242  Identities=16%  Similarity=0.237  Sum_probs=201.9

Q ss_pred             HhcCccCCceeecc--CceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          724 ATDNFAENNIIGIG--GFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       724 ~~~~~~~~~~ig~G--~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      ..++|+..+.||+|  +||.||+|+.. +++.||||+++....  ...+.+.+|++++++++|||||++++++.+++..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            34678999999999  99999999976 799999999976532  23467889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          799 LVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      +||||+++|+|.+++... ...+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999999865 34689999999999999999999   78999999999999999999999999999987653


Q ss_pred             CCCC-----cceeccccccccccccccccc--CccchhhhcccccccchhhhcccccccCcchhhh--------------
Q 001988          878 GEDE-----STMRTQTLATIGYMAPDEIFV--GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA--------------  936 (985)
Q Consensus       878 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~--------------  936 (985)
                      ....     .......+||+.|+|||.+.+  ..++.++|+ |++|+++++++++..++.......              
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di-wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI-YSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHH-HHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHH-HHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            2211     111223468999999999987  678999999 999999999999887654321110              


Q ss_pred             -------------------------------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          937 -------------------------------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       937 -------------------------------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                                                 .+..+++++.+++.+||..||++|||+.|+++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                                                       112234678999999999999999999999853

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.7e-35  Score=319.59  Aligned_cols=251  Identities=21%  Similarity=0.238  Sum_probs=205.8

Q ss_pred             HHhcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeee-ecCCceEEE
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSC-SNDDFKALV  800 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~-~~~~~~~lv  800 (985)
                      ...++|...+.||+|+||.||+|+. .+++.||||++....  ....+.+|++++++++|++++..++++ ...+..++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            3457899999999999999999996 578999999876542  224578999999999988877766655 667788999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE---cCCCcEEEecccCceecc
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill---~~~~~~kl~DfGla~~~~  877 (985)
                      |||+ +++|.+++......+++..+..++.|++.||+||   |++||+||||||+||++   ++++.+||+|||+++.+.
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999 9999999987666799999999999999999999   78899999999999999   889999999999999875


Q ss_pred             CCCCc-----ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--------------hhH
Q 001988          878 GEDES-----TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAK  938 (985)
Q Consensus       878 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~  938 (985)
                      .....     .......||+.|+|||.+.+..++.++|+ |++|+++++++++..++......              ..+
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDL-ESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHH-HHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHH-HHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            43321     12234579999999999999999999999 99999999999998776532110              000


Q ss_pred             -----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhccc
Q 001988          939 -----EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSKR  980 (985)
Q Consensus       939 -----~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~~  980 (985)
                           ..+++++.+++.+||..+|++||++.++++.|+++.++....
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~  285 (296)
T 4hgt_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred             hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence                 223678999999999999999999999999999998876543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.5e-35  Score=330.65  Aligned_cols=236  Identities=22%  Similarity=0.240  Sum_probs=191.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .++|...+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999999976 78999999997653 2346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc--EEEecccCceeccCCCC
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV--AHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~--~kl~DfGla~~~~~~~~  881 (985)
                      +++|+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+||+++.++.  +||+|||+++.....  
T Consensus        98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~L---H~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--  171 (361)
T 3uc3_A           98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYC---HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--  171 (361)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence            99999999997654 689999999999999999999   7899999999999999987775  999999999754221  


Q ss_pred             cceecccccccccccccccccCccchh-hhcccccccchhhhcccccccCcchhhh-----------------hHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLK-RWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------------AKEQCLL  943 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------------~~~~~~~  943 (985)
                       ......+||+.|+|||.+.+..+..+ +|+ |++|+++++++++..++.......                 ....+++
T Consensus       172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di-wslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  249 (361)
T 3uc3_A          172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADV-WSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP  249 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHH-HHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred             -CCCCCCcCCCCcCChhhhcCCCCCCCeeee-ehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence             22234569999999999988888666 788 999999999999987665422110                 0112457


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      ++.+++.+||..||.+|||+.|+++.
T Consensus       250 ~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          250 ECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHhC
Confidence            78999999999999999999999864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=320.40  Aligned_cols=236  Identities=22%  Similarity=0.331  Sum_probs=194.0

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++......  ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            67899999999999999999975 6899999998765332  24667899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  157 (311)
T 4agu_A           83 YCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFC---HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-  157 (311)
T ss_dssp             CCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence            999999998877553 689999999999999999999   788999999999999999999999999999988653222 


Q ss_pred             ceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhhH-----------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK-----------------------  938 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~-----------------------  938 (985)
                       ......||+.|+|||.+.+ ..++.++|+ |++|+++++++++..+..........                       
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          158 -YYDDEVATRWYRSPELLVGDTQYGPPVDV-WAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             -ccCCCcCCccccChHHHhcCCCCCcchhh-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence             2234569999999999876 667999999 99999999999987765433211100                       


Q ss_pred             -------------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          939 -------------------EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       939 -------------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                         ..++.++.+++.+||..||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                               123456889999999999999999999985

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7.1e-35  Score=316.18  Aligned_cols=235  Identities=22%  Similarity=0.245  Sum_probs=202.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .++|...+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            467999999999999999999975 6778999999876556678899999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE---cCCCcEEEecccCceeccCCC
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill---~~~~~~kl~DfGla~~~~~~~  880 (985)
                      +++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||++   +.++.+||+|||++..+....
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYC---HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            99999999987654 689999999999999999999   78999999999999999   888999999999998865322


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh---------------HHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA---------------KEQCLLSI  945 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~---------------~~~~~~~l  945 (985)
                         ......||+.|+|||.+.+ .++.++|+ |++|+++++++++..+.........               ...+++++
T Consensus       164 ---~~~~~~~t~~y~aPE~~~~-~~~~~~Di-~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T 3f3z_A          164 ---MMRTKVGTPYYVSPQVLEG-LYGPECDE-WSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA  238 (277)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTT-CBCTTHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred             ---chhccCCCCCccChHHhcc-cCCchhhe-hhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence               2234569999999998754 58999999 9999999999998876654321110               11356789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHH
Q 001988          946 FSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+++.+|+..||.+||++.|+++
T Consensus       239 ~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          239 ESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHccCChhhCcCHHHHhc
Confidence            99999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-34  Score=317.87  Aligned_cols=251  Identities=20%  Similarity=0.226  Sum_probs=209.7

Q ss_pred             HhcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeee-ecCCceEEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSC-SNDDFKALVL  801 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~-~~~~~~~lv~  801 (985)
                      ..++|...+.||+|+||.||+|+. .+++.||||++.....  .+.+.+|++++++++|++++..+.++ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            357899999999999999999996 5899999999875532  35688999999999988877666655 5667789999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE---cCCCcEEEecccCceeccC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill---~~~~~~kl~DfGla~~~~~  878 (985)
                      ||+ +++|.+++......+++..+..++.|++.||+||   |++||+||||||+||++   ++++.+||+|||+++....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            999 9999999986666799999999999999999999   78899999999999999   5889999999999988754


Q ss_pred             CCCcc-----eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--------------h---
Q 001988          879 EDEST-----MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------A---  936 (985)
Q Consensus       879 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~---  936 (985)
                      .....     ......||+.|+|||.+.+..++.++|+ |++|++++++++++.++......              .   
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDL-ESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHH-HHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhh-HHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence            33211     1234579999999999999999999999 99999999999998766532110              0   


Q ss_pred             --hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhcccc
Q 001988          937 --AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSKRI  981 (985)
Q Consensus       937 --~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~~~  981 (985)
                        ....+++++.+++.+||+.||.+||++.++++.|+++.++.....
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~  286 (296)
T 3uzp_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY  286 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred             HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcc
Confidence              012346789999999999999999999999999999988765443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.7e-35  Score=327.72  Aligned_cols=257  Identities=22%  Similarity=0.239  Sum_probs=203.5

Q ss_pred             HHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccC-----CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 001988          722 LRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ-----CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD  795 (985)
Q Consensus       722 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~-----~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~  795 (985)
                      ....++|...+.||+|+||.||+|... +++.||+|++...     .....+.+.+|++++++++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            445678999999999999999999874 7889999998643     2345578899999999999999999999999999


Q ss_pred             ceEEEEeccCCCChHHHhhcC---------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 001988          796 FKALVLEYMSNGSLEDCLHSS---------------------------------------NCALNIFCRLNIMIDIASAL  836 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~~L  836 (985)
                      ..++||||+++|+|.+++...                                       ...+++..+..++.|++.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999998521                                       11235677888999999999


Q ss_pred             HHHHhcCCCCeEeCCCCCCCEEEcCCC--cEEEecccCceeccCCCC--cceeccccccccccccccccc--Cccchhhh
Q 001988          837 EYLHFGHSTPIIHCDLKPSNVLLDEDM--VAHLSDFGMAKLLSGEDE--STMRTQTLATIGYMAPDEIFV--GELSLKRW  910 (985)
Q Consensus       837 ~~Lh~~h~~~ivHrDlk~~Nill~~~~--~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~d  910 (985)
                      +||   |+++|+||||||+||+++.++  .+||+|||+++.+.....  ........||+.|+|||.+.+  ..++.++|
T Consensus       182 ~~L---H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYL---HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHH---HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHH---HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999   788999999999999998776  899999999987643222  112345569999999999865  67889999


Q ss_pred             cccccccchhhhcccccccCcchhhh---------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          911 VNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       911 v~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                      + |++|+++++++++..++.......               ....+++++.+++.+|+..+|.+||++.|+++.  ..-+
T Consensus       259 i-wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h--p~~~  335 (345)
T 3hko_A          259 A-WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH--PWIS  335 (345)
T ss_dssp             H-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS--HHHH
T ss_pred             H-HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC--hhhc
Confidence            9 999999999999987764432211               111246789999999999999999999999873  2223


Q ss_pred             hhccccCCC
Q 001988          976 TLSKRIGNL  984 (985)
Q Consensus       976 ~~~~~~~~~  984 (985)
                      .+..++-.+
T Consensus       336 ~~~~~~~~~  344 (345)
T 3hko_A          336 QFSDKIYKM  344 (345)
T ss_dssp             TTSSCSSCC
T ss_pred             cChHhhEec
Confidence            344444433

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.5e-35  Score=326.82  Aligned_cols=249  Identities=22%  Similarity=0.353  Sum_probs=203.9

Q ss_pred             hcCccCCceeeccCceeEEEEEE------cCCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL------EDGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  797 (985)
                      .++|...+.||+|+||.||+|++      .+++.||||++.... ......+.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46889999999999999999984      257789999997543 33456789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---CCcEEEe
Q 001988          798 ALVLEYMSNGSLEDCLHSSN------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE---DMVAHLS  868 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~---~~~~kl~  868 (985)
                      ++||||+++|+|.+++....      ..+++..++.++.|++.||+||   |++||+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999998653      3588999999999999999999   7889999999999999984   4469999


Q ss_pred             cccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh-----------
Q 001988          869 DFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA-----------  936 (985)
Q Consensus       869 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~-----------  936 (985)
                      |||+++...............+|+.|+|||.+.+..++.++|+ |++|++++++++ +..+........           
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~  264 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT-WSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  264 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhH-HHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence            9999986644333333344568999999999999999999999 999999999997 665544322111           


Q ss_pred             -hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          937 -AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       937 -~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                       .+..++..+.+++.+||..||.+||++.|+++.+..+.+..
T Consensus       265 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          265 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence             12235678999999999999999999999999999887643

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.5e-35  Score=338.80  Aligned_cols=236  Identities=25%  Similarity=0.350  Sum_probs=203.0

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|...+.||+|+||.||+|+.. +|+.||||++.....   .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            367889999999999999999976 899999999975421   2346789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++|+|.+++...+ .+++.....++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus        95 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYC---HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            99999999999998654 689999999999999999999   78999999999999999999999999999998864322


Q ss_pred             CcceecccccccccccccccccCcc-chhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGEL-SLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSL  948 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l  948 (985)
                         .....+||+.|+|||.+.+..+ +.++|+ |++|++++++++|..++.......           .+...+.++.++
T Consensus       171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di-wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L  246 (476)
T 2y94_A          171 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDI-WSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISL  246 (476)
T ss_dssp             ---CBCCCCSCSTTCCHHHHTTCCBCSHHHHH-HHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHH
T ss_pred             ---cccccCCCcCeEChhhccCCCCCCCccee-hhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHH
Confidence               2334579999999999988766 688999 999999999999987665432111           112245779999


Q ss_pred             HHHccCCCCCCCCCHHHHHH
Q 001988          949 ALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +.+||..||.+|||+.|+++
T Consensus       247 i~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          247 LKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHcCCCchhCcCHHHHHh
Confidence            99999999999999999987

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.2e-34  Score=322.48  Aligned_cols=256  Identities=22%  Similarity=0.332  Sum_probs=208.1

Q ss_pred             CHHHHHHHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHh--cCCCCeeeEEeeeecC
Q 001988          717 SYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKN--IRHRNLVKIISSCSND  794 (985)
Q Consensus       717 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~--l~h~niv~l~~~~~~~  794 (985)
                      .+.......++|...+.||+|+||.||+|+. +++.||||++...   ....+.+|+++++.  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3333445667899999999999999999998 4899999998643   34667889999988  6899999999999877


Q ss_pred             C----ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeCCCCCCCEEEcCCCcE
Q 001988          795 D----FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG-----HSTPIIHCDLKPSNVLLDEDMVA  865 (985)
Q Consensus       795 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~-----h~~~ivHrDlk~~Nill~~~~~~  865 (985)
                      +    ..++||||+++|+|.+++...  .+++..++.++.|++.||+|||..     |+++|+||||||+||+++.++.+
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence            5    789999999999999999864  588999999999999999999521     18999999999999999999999


Q ss_pred             EEecccCceeccCCCCcc--eecccccccccccccccccC------ccchhhhcccccccchhhhcccc----------c
Q 001988          866 HLSDFGMAKLLSGEDEST--MRTQTLATIGYMAPDEIFVG------ELSLKRWVNDLLPVSLVEVVDKS----------L  927 (985)
Q Consensus       866 kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~dv~~~~g~~~~~i~~~~----------~  927 (985)
                      ||+|||+++.........  ......||+.|+|||.+.+.      .++.++|+ |++|+++++++++.          .
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di-~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI-YAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHH-HHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccH-HHHHHHHHHHHhccCcCCccccccc
Confidence            999999998875433221  22445699999999998765      34578899 99999999999873          2


Q ss_pred             ccCcch--------------------hhh---hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          928 LSGEEK--------------------HFA---AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       928 ~~~~~~--------------------~~~---~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                      +.....                    ..+   ....+++.+.+++.+||..||++||++.|+++.|+++.+....
T Consensus       266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~  340 (342)
T 1b6c_B          266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  340 (342)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred             CccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence            221110                    000   1124667899999999999999999999999999999876543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.5e-35  Score=325.49  Aligned_cols=246  Identities=22%  Similarity=0.378  Sum_probs=195.7

Q ss_pred             hcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcc---hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCc----
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHRNLVKIISSCSNDDF----  796 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~----  796 (985)
                      .++|+..+.||+|+||.||+|+. .+++.||||+++.....   ....+.+|++++++++||||+++++++...+.    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46799999999999999999996 57899999999865332   24578899999999999999999999876544    


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      .++||||+++|+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            399999999999999998654 689999999999999999999   7889999999999999999999999999999876


Q ss_pred             cCCCCc-ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hHHH
Q 001988          877 SGEDES-TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQ  940 (985)
Q Consensus       877 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~  940 (985)
                      ...... .......||+.|+|||.+.+..++.++|+ |++|+++++++++..++.......               ..+.
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV-YSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG  245 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhH-HHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence            543222 22334569999999999999999999999 999999999999887664432111               1122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHH-HHHHHHHhHh
Q 001988          941 CLLSIFSLALECTMESPEKRIDAKD-TITRLLKIRD  975 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~~RPt~~e-v~~~L~~i~~  975 (985)
                      +++++.+++.+||..||.+||++.+ +.+.+.++..
T Consensus       246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            5678999999999999999996555 5556666544

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=6.7e-34  Score=319.28  Aligned_cols=307  Identities=26%  Similarity=0.405  Sum_probs=226.7

Q ss_pred             ccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCC
Q 001988          262 IFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNL  341 (985)
Q Consensus       262 l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L  341 (985)
                      +..+++|++|++++|.+. .+|.  +..+++|++|++++|++++..+  +..+++|++|++++|.+++.  +.+..+++|
T Consensus        40 ~~~l~~L~~L~l~~~~i~-~~~~--~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L  112 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVA-SIQG--IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNL  112 (347)
T ss_dssp             HHHHTTCSEEECCSSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTC
T ss_pred             chhcccccEEEEeCCccc-cchh--hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcC
Confidence            456778888888888887 4554  3457778888888887775433  77777777777777777643  246667777


Q ss_pred             ceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccE
Q 001988          342 KLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIV  421 (985)
Q Consensus       342 ~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  421 (985)
                      ++|++++|+++..++       +..+++|++|++++|....                         .+ ..+..+++|++
T Consensus       113 ~~L~l~~n~i~~~~~-------~~~l~~L~~L~l~~n~~~~-------------------------~~-~~~~~l~~L~~  159 (347)
T 4fmz_A          113 RELYLNEDNISDISP-------LANLTKMYSLNLGANHNLS-------------------------DL-SPLSNMTGLNY  159 (347)
T ss_dssp             SEEECTTSCCCCCGG-------GTTCTTCCEEECTTCTTCC-------------------------CC-GGGTTCTTCCE
T ss_pred             CEEECcCCcccCchh-------hccCCceeEEECCCCCCcc-------------------------cc-cchhhCCCCcE
Confidence            777777776665432       4455666666666654332                         22 22666777777


Q ss_pred             EEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeecccee
Q 001988          422 LSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRF  501 (985)
Q Consensus       422 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  501 (985)
                      |++++|.+.+..+  +..+++|+.|++++|.+.+..+  +..+++|+.|++++|.+++..+  +..+++|++|++++|++
T Consensus       160 L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l  233 (347)
T 4fmz_A          160 LTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI  233 (347)
T ss_dssp             EECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred             EEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCcc
Confidence            7777777775444  6777778888888887775433  6777788888888888776544  77778888888888888


Q ss_pred             eeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhh
Q 001988          502 TFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESF  581 (985)
Q Consensus       502 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  581 (985)
                      ++..+  +..+++|++|++++|.+++.  ..+..+++|+.|++++|++++.  ..+..+++|++|++++|++++..|..|
T Consensus       234 ~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l  307 (347)
T 4fmz_A          234 TDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVI  307 (347)
T ss_dssp             CCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHH
T ss_pred             CCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHh
Confidence            76554  77788888888888888765  3578888999999999999865  468889999999999999998889999


Q ss_pred             hcccccCeEecCCCcccCCCCcccccccccccccccccccc
Q 001988          582 GNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLK  622 (985)
Q Consensus       582 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  622 (985)
                      .++++|++|+|++|++++..|  +..+++|++|++++|+++
T Consensus       308 ~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          308 GGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             HTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             hccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            999999999999999997666  888999999999999886

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4e-35  Score=319.30  Aligned_cols=246  Identities=24%  Similarity=0.380  Sum_probs=204.3

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeec---------
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN---------  793 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~---------  793 (985)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|+++...    ..+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4567999999999999999999976 79999999997553    356789999999999999999998854         


Q ss_pred             -------CCceEEEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcE
Q 001988          794 -------DDFKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  865 (985)
Q Consensus       794 -------~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~  865 (985)
                             ....++||||+++|+|.+++... ...+++..+..++.|++.||+||   |++||+||||||+||++++++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYI---HSKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCCHHHEEEcCCCCE
Confidence                   34578999999999999999754 34689999999999999999999   78899999999999999999999


Q ss_pred             EEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-------hH
Q 001988          866 HLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------AK  938 (985)
Q Consensus       866 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------~~  938 (985)
                      ||+|||+++.......   .....||+.|+|||.+.+..++.++|+ |++|+++++++++..+........       .+
T Consensus       162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDL-YALGLILAELLHVCDTAFETSKFFTDLRDGIIS  237 (284)
T ss_dssp             EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHH-HHHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCC
T ss_pred             EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhh-HHHHHHHHHHHhcCCcchhHHHHHHHhhccccc
Confidence            9999999988753322   233469999999999999999999999 999999999998765432211100       11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhccc
Q 001988          939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSKR  980 (985)
Q Consensus       939 ~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~~  980 (985)
                      ..++.++.+++.+||+.||.+||++.|+++.+..+++...+.
T Consensus       238 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~  279 (284)
T 2a19_B          238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN  279 (284)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence            224567889999999999999999999999999998776543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.1e-34  Score=321.79  Aligned_cols=236  Identities=21%  Similarity=0.278  Sum_probs=203.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc------hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS------TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  797 (985)
                      .++|...+.||+|+||.||+|+.. +++.||+|++......      ..+.+.+|++++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467899999999999999999975 7899999999765322      356789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC----cEEEecccCc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM----VAHLSDFGMA  873 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~----~~kl~DfGla  873 (985)
                      ++||||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~l---H~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            99999999999999998653 688999999999999999999   788999999999999999888    7999999999


Q ss_pred             eeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hH
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AK  938 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~  938 (985)
                      +......   ......||+.|+|||.+.+..++.++|+ |++|+++++++++..+........               ..
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  242 (321)
T 2a2a_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADM-WSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF  242 (321)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHH-HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred             eecCccc---cccccCCCCCccCcccccCCCCCCcccc-HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh
Confidence            8865322   2234569999999999999999999999 999999999999887654332111               11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          939 EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       939 ~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ...++.+.+++.+|+..||++||++.|+++
T Consensus       243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          243 SHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            234577899999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.5e-35  Score=349.11  Aligned_cols=250  Identities=26%  Similarity=0.388  Sum_probs=210.7

Q ss_pred             HHHHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          721 LLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       721 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      +....++|+..+.||+|+||.||+|.+.++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++|
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            334567889999999999999999999888899999998654 345689999999999999999999999976 678999


Q ss_pred             EeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          801 LEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      |||+++|+|.+++... +..+++..+..++.||+.||+||   |+++|+||||||+|||+++++.+||+|||+++.+...
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            9999999999999754 34689999999999999999999   7899999999999999999999999999999876421


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIF  946 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~  946 (985)
                       .........++..|+|||.+..+.++.++|+ |++|++++++++ +..++......            ..+..+++++.
T Consensus       417 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv-wSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  494 (535)
T 2h8h_A          417 -EYTARQGAKFPIKWTAPEAALYGRFTIKSDV-WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH  494 (535)
T ss_dssp             -HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHH-HHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             -ceecccCCcCcccccCHHHhccCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence             1111223447789999999999999999999 999999999998 66654432111            12234678899


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          947 SLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      ++|.+||..||++||++.++++.|+.+....
T Consensus       495 ~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          495 DLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             HHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence            9999999999999999999999999876543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=7.4e-35  Score=321.61  Aligned_cols=249  Identities=25%  Similarity=0.334  Sum_probs=198.8

Q ss_pred             hcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|+..+.||+|+||.||+|.. .+++.||+|+++...   ......+.+|++++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            46789999999999999999986 479999999997532   23456788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          801 LEYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      |||+++|+|.+++..   ....+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999864   345689999999999999999999   78999999999999999999999999999998764


Q ss_pred             CCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--h-------------hHHHHH
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--A-------------AKEQCL  942 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--~-------------~~~~~~  942 (985)
                      ...  .......|++.|+|||.+.+..++.++|+ |++|+++++++++..+.......  .             ....++
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDI-WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS  264 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHH-HHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSC
T ss_pred             CCC--ccccccCCCeeEeChHHhCCCCCCchhhH-HHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccC
Confidence            322  12234568999999999999999999999 99999999999988755322100  0             012356


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          943 LSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       943 ~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                      +++.+++.+||..||.+||++.++++.+++++.....
T Consensus       265 ~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~  301 (310)
T 2wqm_A          265 EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS  301 (310)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence            7899999999999999999999999999999876543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.5e-35  Score=318.09  Aligned_cols=237  Identities=23%  Similarity=0.286  Sum_probs=199.9

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      +.++|+..+.||+|+||.||+|... +++.||+|++.....   .....+.+|++++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3578999999999999999999865 677899999865421   224678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++......
T Consensus        87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            999999999999997654 689999999999999999999   7899999999999999999999999999998654321


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSIFSL  948 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l~~l  948 (985)
                          ......||+.|+|||.+.+..++.++|+ |++|+++++++++..+.........           +..+++++.++
T Consensus       163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (279)
T 3fdn_A          163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDL-WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL  237 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHH-HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred             ----cccccCCCCCccCHhHhccCCCCccchh-HhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence                2234569999999999999999999999 9999999999998876654322111           12245778999


Q ss_pred             HHHccCCCCCCCCCHHHHHHH
Q 001988          949 ALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      +.+||..||.+||++.|+++.
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHC
T ss_pred             HHHHhccChhhCCCHHHHhhC
Confidence            999999999999999999975

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.2e-34  Score=315.49  Aligned_cols=237  Identities=23%  Similarity=0.322  Sum_probs=202.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      .++|+..+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            578999999999999999999875 689999999975532  34567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc---EEEecccCceeccC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV---AHLSDFGMAKLLSG  878 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~---~kl~DfGla~~~~~  878 (985)
                      ||+++++|.+.+.... .+++..+..++.|++.||+||   |+.||+||||||+||+++.++.   +||+|||++.....
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            9999999999887654 689999999999999999999   7899999999999999987665   99999999987643


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQCLL  943 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~~~~  943 (985)
                      ..   ......||+.|+|||.+.+..++.++|+ |++|+++++++++..+........               ....+++
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T 3kk8_A          161 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDI-WACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP  236 (284)
T ss_dssp             SC---BCCCSCSCGGGCCHHHHTTCCBCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             Cc---cccCCCCCcCCcCchhhcCCCCCcccch-HHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence            22   2234569999999999999999999999 999999999999887654332111               1123567


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      ++.+++.+|++.||++||++.|+++.
T Consensus       237 ~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          237 EAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHHHHHHHHcccChhhCCCHHHHhcC
Confidence            89999999999999999999999873

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3e-35  Score=319.25  Aligned_cols=238  Identities=22%  Similarity=0.343  Sum_probs=183.9

Q ss_pred             hcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|...+.||+|+||.||+|+. .+++.||+|++.....   .....+.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46789999999999999999987 4799999999865421   2246789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++++|.+++......+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL---HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            999999999999988766789999999999999999999   78899999999999999999999999999998764322


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh-----------hhhHHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-----------FAAKEQCLLSIFSLA  949 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-----------~~~~~~~~~~l~~l~  949 (985)
                      .  ......||+.|+|||.+.+..++.++|+ |++|+++++++++..+......           ...+..++.++.+++
T Consensus       167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  243 (278)
T 3cok_A          167 E--KHYTLCGTPNYISPEIATRSAHGLESDV-WSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI  243 (278)
T ss_dssp             ---------------------------CTHH-HHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHH
T ss_pred             C--cceeccCCCCcCCcchhcCCCCCchhhH-HHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHH
Confidence            2  2233568999999999999999999999 9999999999998876543211           111233567799999


Q ss_pred             HHccCCCCCCCCCHHHHHH
Q 001988          950 LECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+|+..||++||++.++++
T Consensus       244 ~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          244 HQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             HHHSCSSGGGSCCHHHHTT
T ss_pred             HHHcccCHhhCCCHHHHhc
Confidence            9999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.4e-35  Score=329.37  Aligned_cols=245  Identities=24%  Similarity=0.274  Sum_probs=205.2

Q ss_pred             ccccCHHHHHHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-----CCCeee
Q 001988          713 IRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-----HRNLVK  786 (985)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-----h~niv~  786 (985)
                      ...+++.+.....++|...+.||+|+||.||+|+.. +++.||||+++.. ......+..|++++++++     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            445555666667789999999999999999999974 7899999999743 334566788999999996     999999


Q ss_pred             EEeeeecCCceEEEEeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC----
Q 001988          787 IISSCSNDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE----  861 (985)
Q Consensus       787 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~----  861 (985)
                      +++++...+..++||||+ +++|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.    
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYL---RKMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCTTCC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCcccEEEcccccc
Confidence            999999999999999999 999999998763 3589999999999999999999   7899999999999999975    


Q ss_pred             ---------------------CCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchh
Q 001988          862 ---------------------DMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLV  920 (985)
Q Consensus       862 ---------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~  920 (985)
                                           ++.+||+|||+++......     ....||+.|+|||.+.+..++.++|+ |++|++++
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~  250 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDM-WSFGCVLA  250 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHH-HHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccch-HHHHHHHH
Confidence                                 8899999999998754222     24569999999999999999999999 99999999


Q ss_pred             hhcccccccCcchhhhhH---------------------------------------------------------HHHHH
Q 001988          921 EVVDKSLLSGEEKHFAAK---------------------------------------------------------EQCLL  943 (985)
Q Consensus       921 ~i~~~~~~~~~~~~~~~~---------------------------------------------------------~~~~~  943 (985)
                      +++++..++.........                                                         ....+
T Consensus       251 ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (360)
T 3llt_A          251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE  330 (360)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred             HHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence            999998765432111100                                                         00115


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+.+++.+||+.||.+|||+.|+++
T Consensus       331 ~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          331 LFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHhc
Confidence            6779999999999999999999874

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.7e-35  Score=333.06  Aligned_cols=245  Identities=22%  Similarity=0.280  Sum_probs=206.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCC--ceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD--FKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~--~~~lv  800 (985)
                      .++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            467899999999999999999976 68999999997543 233567889999999999999999999998765  67999


Q ss_pred             EeccCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE----cCCCcEEEecccCce
Q 001988          801 LEYMSNGSLEDCLHSSN--CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL----DEDMVAHLSDFGMAK  874 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill----~~~~~~kl~DfGla~  874 (985)
                      |||+++|+|.+++....  ..+++..++.++.|++.||+||   |++||+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999998653  2389999999999999999999   78999999999999999    788889999999998


Q ss_pred             eccCCCCcceeccccccccccccccccc--------CccchhhhcccccccchhhhcccccccCcchh------------
Q 001988          875 LLSGEDESTMRTQTLATIGYMAPDEIFV--------GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH------------  934 (985)
Q Consensus       875 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~------------  934 (985)
                      ......   ......||+.|+|||.+..        ..++.++|+ |++|+++++++++..++.....            
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Di-wSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL-WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHH-HHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHH-HHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            864322   2334569999999998865        677889999 9999999999998876532110            


Q ss_pred             ----------------------------hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          935 ----------------------------FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       935 ----------------------------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                                                  ....+..+..+.+++.+||..||++||++.|+++.+.++.+.
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence                                        001245677899999999999999999999999999888764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.6e-35  Score=324.99  Aligned_cols=228  Identities=20%  Similarity=0.240  Sum_probs=177.5

Q ss_pred             CceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceEEEEeccCCCC
Q 001988          731 NNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALVLEYMSNGS  808 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs  808 (985)
                      .+.||+|+||.||+|... +++.||||++...   ....+.+|+.+++++. ||||+++++++.+.+..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            578999999999999975 7899999998643   3467789999999997 9999999999999999999999999999


Q ss_pred             hHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC---cEEEecccCceeccCCCCccee
Q 001988          809 LEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM---VAHLSDFGMAKLLSGEDESTMR  885 (985)
Q Consensus       809 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~---~~kl~DfGla~~~~~~~~~~~~  885 (985)
                      |.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++   .+||+|||+++......  ...
T Consensus        93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~  166 (325)
T 3kn6_A           93 LFERIKKKK-HFSETEASYIMRKLVSAVSHM---HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPL  166 (325)
T ss_dssp             HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Ccc
Confidence            999998764 689999999999999999999   789999999999999998766   89999999998764322  223


Q ss_pred             cccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh----------------------hhhHHHHHH
Q 001988          886 TQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH----------------------FAAKEQCLL  943 (985)
Q Consensus       886 ~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~----------------------~~~~~~~~~  943 (985)
                      ...+||+.|+|||.+.+..++.++|+ |++|+++++++++..++.....                      ......+++
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~Di-wslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  245 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDL-WSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ  245 (325)
T ss_dssp             -----------------CCCCHHHHH-HHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCH
T ss_pred             cccCCCcCccCHHHhcCCCCCCccch-HHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCH
Confidence            34568999999999999999999999 9999999999998876543211                      011133577


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ++.+++.+|+..||.+||++.|+++
T Consensus       246 ~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          246 EAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             HHHHHHHHHCCCChhHCCCHHHHhc
Confidence            8999999999999999999998863

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-34  Score=318.71  Aligned_cols=237  Identities=25%  Similarity=0.342  Sum_probs=195.2

Q ss_pred             HhcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCc-----chHHHHHHHHHHHHhcC---CCCeeeEEeeeecC
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCA-----STLKSFEAECEVIKNIR---HRNLVKIISSCSND  794 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~-----~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~  794 (985)
                      ..++|+..+.||+|+||.||+|+. .+++.||||++.....     .....+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999996 4789999999874321     12346778888887774   99999999999775


Q ss_pred             C-----ceEEEEeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 001988          795 D-----FKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLS  868 (985)
Q Consensus       795 ~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~  868 (985)
                      .     ..++||||++ |+|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCEEEe
Confidence            5     4789999996 59999998764 3489999999999999999999   78999999999999999999999999


Q ss_pred             cccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhhH----------
Q 001988          869 DFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK----------  938 (985)
Q Consensus       869 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~----------  938 (985)
                      |||+++.+....   ......||+.|+|||.+.+..++.++|+ |++|+++++++++..++.........          
T Consensus       163 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (308)
T 3g33_A          163 DFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDM-WSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  238 (308)
T ss_dssp             SCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHH-HHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             eCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999998764222   2344679999999999999999999999 99999999999988765433221111          


Q ss_pred             ----------------------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          939 ----------------------------EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       939 ----------------------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                  .++++++.+++.+|+..||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence                                        123467889999999999999999999876

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.2e-35  Score=328.88  Aligned_cols=238  Identities=24%  Similarity=0.295  Sum_probs=202.6

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--------hHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--------TLKSFEAECEVIKNIRHRNLVKIISSCSND  794 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~~  794 (985)
                      ..++|...+.||+|+||.||+|+.. +++.||||+++.....        ....+.+|++++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4578999999999999999999864 7899999999765321        234577899999999999999999999999


Q ss_pred             CceEEEEeccCCC-ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCc
Q 001988          795 DFKALVLEYMSNG-SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA  873 (985)
Q Consensus       795 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla  873 (985)
                      +..++||||+.+| +|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYL---RLKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999777 9999988654 689999999999999999999   7889999999999999999999999999999


Q ss_pred             eeccCCCCcceecccccccccccccccccCcc-chhhhcccccccchhhhcccccccCcchhh-----hhHHHHHHHHHH
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFVGEL-SLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-----AAKEQCLLSIFS  947 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~l~~  947 (985)
                      +.+.....   .....||+.|+|||.+.+..+ +.++|+ |++|+++++++++..++......     ..+..+++++.+
T Consensus       178 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di-wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~~  253 (335)
T 3dls_A          178 AYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEM-WSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMS  253 (335)
T ss_dssp             EECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHH-HHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHHH
T ss_pred             eECCCCCc---eeccCCCccccChhhhcCCCCCCCcccc-hhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHHH
Confidence            88653322   234569999999999988877 788899 99999999999988765442211     112235677999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHH
Q 001988          948 LALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      ++.+||..||++||++.|+++.
T Consensus       254 li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          254 LVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHC
T ss_pred             HHHHHccCChhhCcCHHHHhcC
Confidence            9999999999999999999874

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.5e-34  Score=316.07  Aligned_cols=247  Identities=21%  Similarity=0.285  Sum_probs=203.4

Q ss_pred             hcCccCCc-eeeccCceeEEEEEEc---CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          725 TDNFAENN-IIGIGGFGSVYRARLE---DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       725 ~~~~~~~~-~ig~G~~g~V~~~~~~---~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      .++|...+ .||+|+||.||+|.+.   +++.||||+++....  ...+.+.+|++++++++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45677777 9999999999999642   568899999976532  2356789999999999999999999999 556789


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +||||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus        94 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHH---HhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            9999999999999998754 689999999999999999999   788999999999999999999999999999988754


Q ss_pred             CCCcc-eecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh------------hHHHHHHH
Q 001988          879 EDEST-MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA------------AKEQCLLS  944 (985)
Q Consensus       879 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~------------~~~~~~~~  944 (985)
                      ..... ......+++.|+|||.+.+..++.++|+ |++|++++++++ +..+........            .+..++++
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV-WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE  248 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHH-HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            33322 1223346789999999999999999999 999999999998 776654332111            12335678


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          945 IFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       945 l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      +.+++.+||..||.+||++.++++.|+++-...
T Consensus       249 l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          249 MYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999887543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=8.4e-35  Score=315.37  Aligned_cols=240  Identities=22%  Similarity=0.292  Sum_probs=204.1

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            4578999999999999999999976 78999999987543 334577899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++++|.+++... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+..+.....
T Consensus        85 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            999999999998764 3689999999999999999999   789999999999999999999999999999987653333


Q ss_pred             cceecccccccccccccccccCcc-chhhhcccccccchhhhcccccccCcchhh--------------hhHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGEL-SLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQCLLSIF  946 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~~~~l~  946 (985)
                      ........||+.|+|||.+.+..+ +.++|+ |++|+++++++++..+.......              ......+..+.
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDV-WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  239 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHH-HHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchH-HHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence            233345679999999999987775 778999 99999999999988765432211              11223567899


Q ss_pred             HHHHHccCCCCCCCCCHHHHHH
Q 001988          947 SLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +++.+|+..||.+||++.|+++
T Consensus       240 ~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          240 ALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHCCCCchhCCCHHHHhc
Confidence            9999999999999999999876

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-34  Score=315.44  Aligned_cols=236  Identities=25%  Similarity=0.348  Sum_probs=195.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            367899999999999999999875 78999999987653 2345788999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE---cCCCcEEEecccCceec
Q 001988          803 YMSNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       803 ~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill---~~~~~~kl~DfGla~~~  876 (985)
                      |+++|+|.+++...   ...+++..+..++.|++.||+||   |++||+||||||+||++   +.++.+||+|||+++.+
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF---HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999998643   45789999999999999999999   78999999999999999   45688999999999876


Q ss_pred             cCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhhH--------------HHHH
Q 001988          877 SGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK--------------EQCL  942 (985)
Q Consensus       877 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~--------------~~~~  942 (985)
                      ....   ......||+.|+|||.+. +.++.++|+ |++|+++++++++..++.........              ...+
T Consensus       178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di-~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (285)
T 3is5_A          178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDI-WSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT  252 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCC
T ss_pred             CCcc---cCcCcccccCcCChHHhc-cCCCcccCe-ehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCC
Confidence            4322   233456999999999864 678999999 99999999999988766543211111              1135


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          943 LSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       943 ~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +++.+++.+|+..||++||++.|+++
T Consensus       253 ~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          253 PQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            77899999999999999999999975

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.5e-35  Score=327.17  Aligned_cols=233  Identities=24%  Similarity=0.321  Sum_probs=198.4

Q ss_pred             cCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcc---hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      +.|...+.||+|+||.||+|+. .+++.||||++......   ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588889999999999999986 57999999999755322   2356889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||++ |++.+.+......+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++.....  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9997 688888876666799999999999999999999   7889999999999999999999999999999875321  


Q ss_pred             cceecccccccccccccccc---cCccchhhhcccccccchhhhcccccccCcchhhh-------------hHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIF---VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------AKEQCLLSI  945 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------~~~~~~~~l  945 (985)
                          ....||+.|+|||.+.   .+.++.++|+ |++|+++++++++..+........             ....+++.+
T Consensus       208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~Di-wslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  282 (348)
T 1u5q_A          208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDV-WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF  282 (348)
T ss_dssp             ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHH-HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred             ----CcccCCcceeCHhhhccccCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence                2346999999999885   5778999999 999999999999887654322111             112356778


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHH
Q 001988          946 FSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      .+++.+||..||.+||++.++++.
T Consensus       283 ~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          283 RNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             HHHHHHHcccChhhCcCHHHHhhC
Confidence            999999999999999999999753

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.2e-35  Score=332.77  Aligned_cols=238  Identities=21%  Similarity=0.301  Sum_probs=194.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCc--chHHHHHHHHHHHHhcC--CCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIR--HRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~--h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|...+.||+|+||.||+|...+++.||||++.....  ...+.+.+|++++++++  ||||+++++++...+..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            356999999999999999999988899999999976532  34567899999999996  59999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      || +.+++|.+++.... .+++..+..++.||+.||+||   |++||+||||||+|||++ ++.+||+|||+++.+....
T Consensus       135 ~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHH---HTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             Ee-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            99 56889999998764 688999999999999999999   789999999999999995 5899999999998875433


Q ss_pred             Ccceeccccccccccccccccc-----------CccchhhhcccccccchhhhcccccccCcchhh-h------------
Q 001988          881 ESTMRTQTLATIGYMAPDEIFV-----------GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-A------------  936 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-~------------  936 (985)
                      ........+||+.|+|||++.+           ..++.++|+ |++|+++++++++..++...... .            
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di-wSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~  287 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDV-WSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  287 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHH-HHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhH-HHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence            3333445679999999999865           468899999 99999999999988765432110 0            


Q ss_pred             -hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          937 -AKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       937 -~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                       .+...+.++.+++.+||..||.+||++.|+++.
T Consensus       288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence             111234678999999999999999999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.6e-35  Score=331.96  Aligned_cols=239  Identities=28%  Similarity=0.287  Sum_probs=192.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHH-HHhcCCCCeeeEEeeeecCCceEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEV-IKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~i-l~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      .++|...+.||+|+||.||+|+.+ +++.||+|++++...   .....+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            367899999999999999999976 688999999976532   233456677776 467899999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||++||+|.+++...+ .+++.....++.||+.||+||   |++||+||||||+||+++.+|++||+|||+++.....
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999998654 678999999999999999999   7899999999999999999999999999999864322


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSIFSL  948 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l~~l  948 (985)
                      .  ......+||+.|+|||.+.+..++.++|+ |++|++++++++|..++........           +...+.++.++
T Consensus       193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  269 (373)
T 2r5t_A          193 N--STTSTFCGTPEYLAPEVLHKQPYDRTVDW-WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHL  269 (373)
T ss_dssp             C--CCCCSBSCCCCCCCHHHHTTCCCCTHHHH-HHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHH
T ss_pred             C--CccccccCCccccCHHHhCCCCCCchhhh-HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Confidence            2  22345679999999999999999999999 9999999999999876644322111           12245778999


Q ss_pred             HHHccCCCCCCCCCHHHHHHHH
Q 001988          949 ALECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~~L  970 (985)
                      +.+|+..||.+||++.+.++.+
T Consensus       270 i~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          270 LEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             HHHHTCSSGGGSTTTTTTHHHH
T ss_pred             HHHHcccCHHhCCCCCCCHHHH
Confidence            9999999999999986544443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.1e-35  Score=316.88  Aligned_cols=240  Identities=28%  Similarity=0.387  Sum_probs=197.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecC-CceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSND-DFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-~~~~lv~e~  803 (985)
                      .++|+..+.||+|+||.||+|+.. ++.||||+++..  ...+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            468899999999999999999885 889999998754  2457789999999999999999999997554 578999999


Q ss_pred             cCCCChHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSSNC-ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      +++|+|.+++..... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......  
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  171 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHH---HhCCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence            999999999976532 378899999999999999999   78899999999999999999999999999988653221  


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh------------hHHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA------------AKEQCLLSIFSLA  949 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~------------~~~~~~~~l~~l~  949 (985)
                         ....+++.|+|||.+.+..++.++|+ |++|++++++++ +..+........            .+..+++++.+++
T Consensus       172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  247 (278)
T 1byg_A          172 ---DTGKLPVKWTAPEALREKKFSTKSDV-WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM  247 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred             ---cCCCccccccCHHHhCCCCCCchhcH-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHH
Confidence               22357889999999999999999999 999999999997 766554322111            1234567899999


Q ss_pred             HHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          950 LECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      .+||+.||.+||++.|+++.|++++..
T Consensus       248 ~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          248 KNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            999999999999999999999999864

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.1e-34  Score=322.90  Aligned_cols=246  Identities=25%  Similarity=0.398  Sum_probs=203.3

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcE--EEEEEeccCC-cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVE--IAIKVFHPQC-ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~--vAvK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv  800 (985)
                      ++|...+.||+|+||.||+|+.. +++.  ||+|.++... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            67889999999999999999864 5665  4999987542 23456789999999999 899999999999999999999


Q ss_pred             EeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcE
Q 001988          801 LEYMSNGSLEDCLHSSN---------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  865 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~  865 (985)
                      |||+++|+|.+++....               ..+++..++.++.|+++||+||   |++||+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCccceEEEcCCCeE
Confidence            99999999999997653               4689999999999999999999   78999999999999999999999


Q ss_pred             EEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh---------
Q 001988          866 HLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF---------  935 (985)
Q Consensus       866 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~---------  935 (985)
                      ||+|||+++....   ........+++.|+|||.+....++.++|+ |++|++++++++ +..+.......         
T Consensus       182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~  257 (327)
T 1fvr_A          182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDV-WSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  257 (327)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHH-HHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcc-hHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence            9999999875321   111223357889999999999999999999 999999999997 76654332111         


Q ss_pred             ---hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          936 ---AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       936 ---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                         ..+..+++++.+++.+||..+|.+||++.|+++.|.++.++..
T Consensus       258 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          258 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence               1122356789999999999999999999999999999887643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.3e-35  Score=341.17  Aligned_cols=237  Identities=24%  Similarity=0.268  Sum_probs=193.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccC---CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ---CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|+..+.||+|+||.||+|+.. +++.||||+++..   .......+.+|++++++++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999865 7899999999754   223345678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS-TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      |||+++|+|.+++.... .+++..+..++.|++.||+||   |+ +||+||||||+|||++.++.+||+|||+|+.....
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYL---HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---hhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999997654 689999999999999999999   66 89999999999999999999999999999864322


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSIFSL  948 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l~~l  948 (985)
                        .......+||+.|+|||++.+..++.++|+ |++|+++++++++..++........           +...++++.++
T Consensus       303 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  379 (446)
T 4ejn_A          303 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDW-WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSL  379 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             --CcccccccCCccccCHhhcCCCCCCCccch-hhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence              222345679999999999999999999999 9999999999999877654322211           22356779999


Q ss_pred             HHHccCCCCCCCC-----CHHHHHH
Q 001988          949 ALECTMESPEKRI-----DAKDTIT  968 (985)
Q Consensus       949 ~~~cl~~~P~~RP-----t~~ev~~  968 (985)
                      +.+||..||.+||     ++.|+++
T Consensus       380 i~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          380 LSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHcccCHHHhCCCCCCCHHHHHh
Confidence            9999999999999     9999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-34  Score=330.55  Aligned_cols=239  Identities=21%  Similarity=0.337  Sum_probs=188.4

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcC-CCCeeeEEeeeecCC--ce
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIR-HRNLVKIISSCSNDD--FK  797 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~--~~  797 (985)
                      ..++|+..+.||+|+||.||+|... +++.||||++....  ......+.+|+.+++++. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4578999999999999999999865 78999999986542  334567789999999997 999999999997544  68


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      |+||||++ |+|.+++...  .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+.+.
T Consensus        87 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYL---HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             EEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            99999997 5899998864  688999999999999999999   78999999999999999999999999999998764


Q ss_pred             CCC-------------------Ccceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh
Q 001988          878 GED-------------------ESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA  937 (985)
Q Consensus       878 ~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~  937 (985)
                      ...                   ........+||+.|+|||.+.+ ..++.++|+ |++|++++++++|..++........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di-wSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDM-WSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHH-HHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhH-HHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            311                   1122344579999999999876 678999999 9999999999998876543211110


Q ss_pred             H----------------------------------------------------------HHHHHHHHHHHHHccCCCCCC
Q 001988          938 K----------------------------------------------------------EQCLLSIFSLALECTMESPEK  959 (985)
Q Consensus       938 ~----------------------------------------------------------~~~~~~l~~l~~~cl~~~P~~  959 (985)
                      .                                                          ..+++++.+++.+||..||++
T Consensus       240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~  319 (388)
T 3oz6_A          240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK  319 (388)
T ss_dssp             HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence            0                                                          023567899999999999999


Q ss_pred             CCCHHHHHHH
Q 001988          960 RIDAKDTITR  969 (985)
Q Consensus       960 RPt~~ev~~~  969 (985)
                      |||+.|+++.
T Consensus       320 R~t~~e~l~H  329 (388)
T 3oz6_A          320 RISANDALKH  329 (388)
T ss_dssp             SCCHHHHTTS
T ss_pred             CCCHHHHhCC
Confidence            9999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.3e-35  Score=325.55  Aligned_cols=251  Identities=19%  Similarity=0.210  Sum_probs=205.5

Q ss_pred             HhcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeee----cCCceE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS----NDDFKA  798 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~----~~~~~~  798 (985)
                      ..++|+..+.||+|+||.||+|+. .+++.||||++........+.+.+|++++++++||||+++++++.    .....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            346899999999999999999997 589999999997765566778999999999999999999999986    334788


Q ss_pred             EEEeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          799 LVLEYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      +||||+++|+|.+++..   .+..+++..++.++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI---HAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            99999999999999876   355789999999999999999999   788999999999999999999999999999887


Q ss_pred             ccCCCCcc-------eecccccccccccccccccCc---cchhhhcccccccchhhhcccccccCcchh-----------
Q 001988          876 LSGEDEST-------MRTQTLATIGYMAPDEIFVGE---LSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-----------  934 (985)
Q Consensus       876 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-----------  934 (985)
                      ........       ......||+.|+|||.+....   ++.++|+ |++|+++++++++..+......           
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di-~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  262 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDV-WSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN  262 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHH-HHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhH-HHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence            53211110       112335799999999987543   6889999 9999999999998865432100           


Q ss_pred             ---hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          935 ---FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       935 ---~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                         .+....++.++.+++.+||..||.+||++.|+++.|+.+....+
T Consensus       263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence               01112356789999999999999999999999999999876443

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.1e-34  Score=321.08  Aligned_cols=239  Identities=21%  Similarity=0.244  Sum_probs=194.6

Q ss_pred             hcCccCC-ceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEE
Q 001988          725 TDNFAEN-NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       725 ~~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      .+.|... +.||+|+||.||+|+.. +++.||||++..........+.+|++++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3567774 78999999999999854 7899999999876555667899999999985 7999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc---EEEecccCceeccC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV---AHLSDFGMAKLLSG  878 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~---~kl~DfGla~~~~~  878 (985)
                      ||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.   +||+|||+++.+..
T Consensus        91 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFL---HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            9999999999998754 689999999999999999999   7889999999999999998776   99999999987642


Q ss_pred             CCC-----cceeccccccccccccccccc-----CccchhhhcccccccchhhhcccccccCcchhh-------------
Q 001988          879 EDE-----STMRTQTLATIGYMAPDEIFV-----GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-------------  935 (985)
Q Consensus       879 ~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-------------  935 (985)
                      ...     .......+||+.|+|||.+..     ..++.++|+ |++|+++++++++..++......             
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di-wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDL-WSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHH-HHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCccccc-HhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            221     111233469999999999875     568889999 99999999999988765432100             


Q ss_pred             -----------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          936 -----------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       936 -----------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                       .....++.++.+++.+|+..||.+||++.|+++
T Consensus       246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                             001124567899999999999999999999987

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.2e-34  Score=336.82  Aligned_cols=234  Identities=23%  Similarity=0.261  Sum_probs=190.4

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccC--CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecC------C
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQ--CASTLKSFEAECEVIKNIRHRNLVKIISSCSND------D  795 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~  795 (985)
                      .++|+..+.||+|+||.||+|+.. +++.||||++...  .....+.+.+|++++++++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478999999999999999999865 7899999999754  233456788999999999999999999999654      3


Q ss_pred             ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          796 FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      ..|+||||+++ ++.+.+..   .+++..+..++.|++.||+||   |++||+||||||+|||++.++.+||+|||+|+.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            56999999976 56666653   478999999999999999999   788999999999999999999999999999987


Q ss_pred             ccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-------------------
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------------  936 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------------  936 (985)
                      ....   ......+||+.|+|||.+.+..++.++|+ |++|++++++++++.++.......                   
T Consensus       214 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          214 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDI-WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             ---C---CCC----CCCTTCCHHHHTTCCCCTTHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             cCCC---cccCCCcccccccCHHHHcCCCCCHHHHH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            6432   22344679999999999999999999999 999999999999887654321110                   


Q ss_pred             ----------------------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          937 ----------------------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       937 ----------------------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                                        .......++.+++.+|+..||++|||+.|+++.
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                                              001125678999999999999999999999863

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.6e-35  Score=325.51  Aligned_cols=235  Identities=21%  Similarity=0.284  Sum_probs=198.1

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ..++|...+.||+|+||.||+|..+ +++.||||++.+...    ...+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4577999999999999999999976 789999999976532    235788889888 7999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC----CcEEEecccCceecc
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED----MVAHLSDFGMAKLLS  877 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~----~~~kl~DfGla~~~~  877 (985)
                      ||++||+|.+++...+ .+++.....++.||+.||+||   |++||+||||||+||++.++    +.+||+|||+++.+.
T Consensus        96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~l---H~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYL---HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999998654 689999999999999999999   78899999999999998443    359999999999865


Q ss_pred             CCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh------------------hHH
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------------AKE  939 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------------~~~  939 (985)
                      ....  .....+||+.|+|||.+.+..++.++|+ |++|++++++++|..++.......                  ...
T Consensus       172 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  248 (342)
T 2qr7_A          172 AENG--LLMTPCYTANFVAPEVLERQGYDAACDI-WSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN  248 (342)
T ss_dssp             CTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHH-HHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred             CCCC--ceeccCCCccccCHHHhcCCCCCCccCe-eeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence            3322  2334579999999999998889999999 999999999999987664321110                  012


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          940 QCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       940 ~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      .+++++.+++.+|+..||++||++.|+++.
T Consensus       249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            356789999999999999999999998863

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.1e-35  Score=321.93  Aligned_cols=248  Identities=21%  Similarity=0.249  Sum_probs=199.0

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc---hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ..++|...+.||+|+||.||+|+.. +++.||+|++......   ..+.+.+|++++++++||||+++++++..++..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3478999999999999999999975 7899999999765322   24678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++++|.+++...+ .+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||++......
T Consensus       112 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAA---HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            999999999999998654 689999999999999999999   7889999999999999999999999999999876432


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--------------hhHHHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQCLLSI  945 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~~~~l  945 (985)
                      . ........||+.|+|||.+.+..++.++|+ |++|+++++++++..++......              ..+..++.++
T Consensus       188 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  265 (309)
T 2h34_A          188 K-LTQLGNTVGTLYYMAPERFSESHATYRADI-YALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAF  265 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHH-HHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred             c-cccccccCCCcCccCHHHHcCCCCCchHhH-HHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHH
Confidence            2 122234569999999999999999999999 99999999999988765443211              1122356779


Q ss_pred             HHHHHHccCCCCCCCC-CHHHHHHHHHHhHhhh
Q 001988          946 FSLALECTMESPEKRI-DAKDTITRLLKIRDTL  977 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RP-t~~ev~~~L~~i~~~~  977 (985)
                      .+++.+||..||++|| ++.++++.|+++.+..
T Consensus       266 ~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          266 DAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             HHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            9999999999999999 9999999999876544

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=2.7e-33  Score=314.35  Aligned_cols=304  Identities=25%  Similarity=0.381  Sum_probs=161.5

Q ss_pred             hccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEE
Q 001988          168 HLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVL  247 (985)
Q Consensus       168 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  247 (985)
                      .+++|++|++++|.+. .+|. +..+++|++|++++|++++. |. +.++++|++|++++|++++ +| .+..+++|++|
T Consensus        42 ~l~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L  115 (347)
T 4fmz_A           42 ELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLREL  115 (347)
T ss_dssp             HHTTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred             hcccccEEEEeCCccc-cchh-hhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEE
Confidence            4566666666666665 3443 66666666677766666643 33 6666666666666666663 33 46666666666


Q ss_pred             EecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCccc
Q 001988          248 QLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSF  327 (985)
Q Consensus       248 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  327 (985)
                      ++++|++++..+  +..+++|++|++++|.....++.  +..+++|++|++++|.+.+..+  +..+++|+.|++++|.+
T Consensus       116 ~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~--~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l  189 (347)
T 4fmz_A          116 YLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP--LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI  189 (347)
T ss_dssp             ECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCC
T ss_pred             ECcCCcccCchh--hccCCceeEEECCCCCCcccccc--hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcc
Confidence            666666664332  56666666666666654433333  3355666666666666554333  55556666666666665


Q ss_pred             ccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceecccccccc
Q 001988          328 SGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISG  407 (985)
Q Consensus       328 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~  407 (985)
                      .+..+  +..+++|+.|++++|+++...+       +..+++|++|++++|++++..+  +..++ +|++|++++|.+++
T Consensus       190 ~~~~~--~~~l~~L~~L~l~~n~l~~~~~-------~~~~~~L~~L~l~~n~l~~~~~--~~~l~-~L~~L~l~~n~l~~  257 (347)
T 4fmz_A          190 EDISP--LASLTSLHYFTAYVNQITDITP-------VANMTRLNSLKIGNNKITDLSP--LANLS-QLTWLEIGTNQISD  257 (347)
T ss_dssp             CCCGG--GGGCTTCCEEECCSSCCCCCGG-------GGGCTTCCEEECCSSCCCCCGG--GTTCT-TCCEEECCSSCCCC
T ss_pred             ccccc--ccCCCccceeecccCCCCCCch-------hhcCCcCCEEEccCCccCCCcc--hhcCC-CCCEEECCCCccCC
Confidence            54333  5555666666666665554332       3445555555555555543222  33333 34444444444443


Q ss_pred             ccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcC
Q 001988          408 NIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGN  487 (985)
Q Consensus       408 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  487 (985)
                      .  ..+..+++|++|++++|++++.  ..+..+++|+.|++++|++++..|..+..+++|++|++++|++++..|  +..
T Consensus       258 ~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~  331 (347)
T 4fmz_A          258 I--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LAS  331 (347)
T ss_dssp             C--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGG
T ss_pred             C--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhh
Confidence            2  2344445555555555555432  234444455555555555544444444445555555555555444333  444


Q ss_pred             cCcCceEeecccee
Q 001988          488 LTSLQYLNLGSNRF  501 (985)
Q Consensus       488 l~~L~~L~L~~N~l  501 (985)
                      +++|++|++++|.|
T Consensus       332 l~~L~~L~l~~N~i  345 (347)
T 4fmz_A          332 LSKMDSADFANQVI  345 (347)
T ss_dssp             CTTCSEESSSCC--
T ss_pred             hhccceeehhhhcc
Confidence            44444444444444

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.7e-34  Score=315.00  Aligned_cols=235  Identities=21%  Similarity=0.302  Sum_probs=197.9

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l  799 (985)
                      ..++|...+.||+|+||.||+|+.. +++.||+|++....  ......+.+|+.++.++ +||||+++++++.+++..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4578999999999999999999976 79999999997642  23456788999999999 89999999999999999999


Q ss_pred             EEeccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC--------------
Q 001988          800 VLEYMSNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED--------------  862 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~--------------  862 (985)
                      ||||+++|+|.+++...   ...+++..+..++.|++.||+||   |++||+||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI---HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH---HhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            99999999999999764   24689999999999999999999   78999999999999999844              


Q ss_pred             -----CcEEEecccCceeccCCCCcceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhh
Q 001988          863 -----MVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA  936 (985)
Q Consensus       863 -----~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~  936 (985)
                           ..+||+|||.++......      ...||+.|+|||.+.+. .++.++|+ |++|+++++++++..+........
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di-~slG~il~~l~~~~~~~~~~~~~~  238 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADI-FALALTVVCAAGAEPLPRNGDQWH  238 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHH-HHHHHHHHHHTTCCCCCSSSHHHH
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhH-HHHHHHHHHHhcCCCCCcchhHHH
Confidence                 479999999998864322      23499999999998766 56689999 999999999998876543322111


Q ss_pred             ---------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 ---------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 ---------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                               .+..+++++.+++.+||..||++||++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          239 EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                     12235678999999999999999999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-34  Score=337.45  Aligned_cols=194  Identities=23%  Similarity=0.348  Sum_probs=154.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeec-----CCc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSN-----DDF  796 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~-----~~~  796 (985)
                      .++|...+.||+|+||.||+|+.. +++.||||++.....  ...+.+.+|++++++++||||+++++++..     .+.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999865 789999999975432  345678999999999999999999999943     356


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      .|+||||+ +|+|.+++... ..+++..+..++.||+.||+||   |++|||||||||+|||++.++.+||+|||+|+..
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~L---H~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYV---HSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHH---HhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 57999998765 3689999999999999999999   7889999999999999999999999999999876


Q ss_pred             cCCCCc-------------------------ceeccccccccccccccc-ccCccchhhhcccccccchhhhcc
Q 001988          877 SGEDES-------------------------TMRTQTLATIGYMAPDEI-FVGELSLKRWVNDLLPVSLVEVVD  924 (985)
Q Consensus       877 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~dv~~~~g~~~~~i~~  924 (985)
                      ......                         ......+||+.|+|||++ ....++.++|+ |++|++++|+++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~Di-wSlG~il~ellt  279 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDV-WSIGCIFAELLN  279 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHH-HHHHHHHHHHHT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHH-HHHHHHHHHHHH
Confidence            432211                         123445789999999976 45679999999 999999999996

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=9.8e-35  Score=340.77  Aligned_cols=237  Identities=23%  Similarity=0.298  Sum_probs=202.4

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|...+.||+|+||.||+|+.. +|+.||+|++.+..   ......+.+|++++++++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467888999999999999999975 79999999996542   22345688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          801 LEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      |||++||+|.+++...+ ..+++..+..++.||+.||+||   |++||+||||||+||+++.+|.+||+|||+++.+...
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yL---H~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL---HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999998653 3589999999999999999999   7889999999999999999999999999999886432


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hHHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQCLLS  944 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~~~~~  944 (985)
                      .   .....+||+.|+|||++.+..++.++|+ |++|++++++++|..++.......               .+...+.+
T Consensus       340 ~---~~~~~~GT~~Y~APEvl~~~~~~~~~Di-wSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~  415 (576)
T 2acx_A          340 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDW-WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ  415 (576)
T ss_dssp             C---CEECCCSCGGGCCHHHHTTCEESSHHHH-HHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             c---cccccCCCccccCHHHHcCCCCCccchH-HHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHH
Confidence            2   2234579999999999999999999999 999999999999987665431100               11224578


Q ss_pred             HHHHHHHccCCCCCCCC-----CHHHHHH
Q 001988          945 IFSLALECTMESPEKRI-----DAKDTIT  968 (985)
Q Consensus       945 l~~l~~~cl~~~P~~RP-----t~~ev~~  968 (985)
                      +.+++.+|+..||.+||     ++.|+++
T Consensus       416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          416 ARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             HHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            89999999999999999     6788764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.9e-35  Score=324.94  Aligned_cols=236  Identities=20%  Similarity=0.277  Sum_probs=192.0

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ++|...+.||+|+||.||+|+.. +++.||+|++...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999976 7899999999754322 122456799999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      ++ |+|.+++...+..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC---HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K  155 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence            97 599999988777799999999999999999999   78999999999999999999999999999998654222  2


Q ss_pred             eeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh-------------------------
Q 001988          884 MRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-------------------------  937 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-------------------------  937 (985)
                      ......||+.|+|||.+.+ ..++.++|+ |++|+++++++++..++........                         
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDM-WGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence            2234568999999999876 568999999 9999999999998866543221110                         


Q ss_pred             ----------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 ----------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 ----------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                      ....++++.+++.+|+..||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                            0123467889999999999999999999987

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-34  Score=324.38  Aligned_cols=240  Identities=24%  Similarity=0.335  Sum_probs=194.1

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCc
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS-----TLKSFEAECEVIKNIRHRNLVKIISSCSNDDF  796 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  796 (985)
                      ...++|...+.||+|+||.||+|+.. +|+.||||++......     ....+.+|++++++++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999975 6899999998754221     12467899999999999999999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      .++||||+++ +|.+++......+++..+..++.|+++||+||   |+.||+||||||+||+++.++.+||+|||+++.+
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999975 89999987766789999999999999999999   7899999999999999999999999999999876


Q ss_pred             cCCCCcceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhhh------------------
Q 001988          877 SGEDESTMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA------------------  937 (985)
Q Consensus       877 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~------------------  937 (985)
                      ....  .......||+.|+|||.+.+. .++.++|+ |++|+++++++++..+.........                  
T Consensus       163 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          163 GSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDM-WAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             TSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred             cCCc--ccCCcccccccccCchHhhCCCCCCchhhh-HhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence            4322  223345699999999998764 47899999 9999999999998765433211110                  


Q ss_pred             ---------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          938 ---------------------KEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       938 ---------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                           ...+++++.+++.+|+..||.+|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence                                 01234679999999999999999999999863

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1e-34  Score=317.27  Aligned_cols=247  Identities=23%  Similarity=0.347  Sum_probs=197.1

Q ss_pred             hcCccCCceeeccCceeEEEEEEc--CCc--EEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE--DGV--EIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~--~~~--~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  797 (985)
                      .++|+..+.||+|+||.||+|++.  +++  .||||+++...   ....+.+.+|++++++++||||+++++++...+ .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            467899999999999999999853  333  69999987652   234567899999999999999999999998765 7


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ++||||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHH---HhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            899999999999999987656789999999999999999999   78899999999999999999999999999998875


Q ss_pred             CCCCcc-eecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh-------------hhHHHHH
Q 001988          878 GEDEST-MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF-------------AAKEQCL  942 (985)
Q Consensus       878 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~-------------~~~~~~~  942 (985)
                      ...... ......+|+.|+|||.+.+..++.++|+ |++|++++++++ +..+.......             ..+..++
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT-WMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP  251 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHH-HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhH-HHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence            433322 2234457889999999999999999999 999999999998 77655432111             1123456


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          943 LSIFSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       943 ~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      .++.+++.+||..+|.+||++.++++.|+++.+.
T Consensus       252 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          252 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            7899999999999999999999999999988754

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.9e-34  Score=311.33  Aligned_cols=244  Identities=23%  Similarity=0.308  Sum_probs=203.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc------hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS------TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  797 (985)
                      .++|...+.||+|+||.||+|+.. +++.||+|+++.....      ..+.+.+|++++++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357889999999999999999976 7899999998755321      357789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC----cEEEecccCc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM----VAHLSDFGMA  873 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~----~~kl~DfGla  873 (985)
                      ++||||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++    .+||+|||++
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYL---HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            99999999999999997653 689999999999999999999   788999999999999998877    8999999999


Q ss_pred             eeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hH
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AK  938 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~  938 (985)
                      +......   ......||+.|+|||.+....++.++|+ |++|+++++++++..+........               ..
T Consensus       160 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T 3bhy_A          160 HKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADM-WSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF  235 (283)
T ss_dssp             EECC-----------CCCGGGCCHHHHTTCCCCTHHHH-HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred             eeccCCC---cccccCCCcCccCcceecCCCCCcchhh-hhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhc
Confidence            8764322   2234569999999999999999999999 999999999999887654322111               11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhHhh
Q 001988          939 EQCLLSIFSLALECTMESPEKRIDAKDTIT--RLLKIRDT  976 (985)
Q Consensus       939 ~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~--~L~~i~~~  976 (985)
                      ..+++.+.+++.+|+..||.+||++.|+++  .++.++++
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          236 SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence            234677999999999999999999999997  45555443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.5e-35  Score=328.32  Aligned_cols=245  Identities=17%  Similarity=0.166  Sum_probs=197.5

Q ss_pred             hcCccCCceeeccCceeEEEEEEc----CCcEEEEEEeccCCcch-----------HHHHHHHHHHHHhcCCCCeeeEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCAST-----------LKSFEAECEVIKNIRHRNLVKIIS  789 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vAvK~~~~~~~~~-----------~~~~~~E~~il~~l~h~niv~l~~  789 (985)
                      .++|...+.||+|+||.||+|+..    ++..||+|++.......           ...+.+|+.+++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467899999999999999999975    57789999987653221           123567888899999999999999


Q ss_pred             eeec----CCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC--
Q 001988          790 SCSN----DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM--  863 (985)
Q Consensus       790 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~--  863 (985)
                      ++..    ....++||||+ +++|.+++...+ .+++..++.++.|++.||+||   |++||+||||||+||+++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYI---HENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCcCHHHEEEccCCCC
Confidence            9987    67889999999 999999998765 789999999999999999999   788999999999999999887  


Q ss_pred             cEEEecccCceeccCCCCc-----ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh-h-
Q 001988          864 VAHLSDFGMAKLLSGEDES-----TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-A-  936 (985)
Q Consensus       864 ~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-~-  936 (985)
                      .+||+|||+++.+......     .......||+.|+|||.+.+..++.++|+ |++|+++++++++..++...... . 
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDV-EILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHH-HHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhH-HHHHHHHHHHHhCCCCccccccccHH
Confidence            9999999999886432211     11234579999999999999999999999 99999999999998776331100 0 


Q ss_pred             -----------hHH---------HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          937 -----------AKE---------QCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       937 -----------~~~---------~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                                 .+.         .+++++.+++.+||..||++||++.++++.|++..-
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence                       011         345589999999999999999999999999987653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.3e-34  Score=330.35  Aligned_cols=232  Identities=21%  Similarity=0.250  Sum_probs=188.5

Q ss_pred             cCccCC-ceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHh-cCCCCeeeEEeeeec----CCceE
Q 001988          726 DNFAEN-NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKN-IRHRNLVKIISSCSN----DDFKA  798 (985)
Q Consensus       726 ~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~-l~h~niv~l~~~~~~----~~~~~  798 (985)
                      ++|... +.||+|+||.||+|... +++.||||+++..     ..+.+|++++.+ .+||||+++++++..    .+..+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456655 68999999999999875 7899999998633     467789998755 489999999999865    56789


Q ss_pred             EEEeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---CCcEEEecccCce
Q 001988          799 LVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE---DMVAHLSDFGMAK  874 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~---~~~~kl~DfGla~  874 (985)
                      +||||++||+|.+++.... ..+++..+..++.||+.||+||   |++||+||||||+||+++.   ++.+||+|||+++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            9999999999999998753 4689999999999999999999   7899999999999999997   7899999999998


Q ss_pred             eccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh-------------------
Q 001988          875 LLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-------------------  935 (985)
Q Consensus       875 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-------------------  935 (985)
                      ......   .....+||+.|+|||++.+..++.++|+ |++|++++++++|..++......                   
T Consensus       213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~  288 (400)
T 1nxk_A          213 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDM-WSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  288 (400)
T ss_dssp             ECC--------------CTTCCGGGSCCCCSSSHHHH-HHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred             ccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccH-HHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence            764222   2334579999999999999999999999 99999999999988765432110                   


Q ss_pred             hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          936 AAKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       936 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      .....+++++.+++.+||..||++||++.|+++.
T Consensus       289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0112356789999999999999999999999874

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=8e-35  Score=327.30  Aligned_cols=246  Identities=14%  Similarity=0.112  Sum_probs=204.6

Q ss_pred             hcCccCCceeeccCceeEEEEEEcC---------CcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeee---------
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLED---------GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVK---------  786 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~---------~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~---------  786 (985)
                      .++|...+.||+|+||.||+|+...         ++.||+|++...     ..+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3688999999999999999998763         788999998754     46789999999999999987         


Q ss_pred             ------EEeeeec-CCceEEEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEE
Q 001988          787 ------IISSCSN-DDFKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVL  858 (985)
Q Consensus       787 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nil  858 (985)
                            +++++.. ++..++||||+ +++|.+++... ...+++..+..++.|++.||+||   |++||+||||||+||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFL---HENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCHHHEE
Confidence                  5667765 67889999999 99999999875 34789999999999999999999   7889999999999999


Q ss_pred             EcCCC--cEEEecccCceeccCCCCc-----ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCc
Q 001988          859 LDEDM--VAHLSDFGMAKLLSGEDES-----TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGE  931 (985)
Q Consensus       859 l~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~  931 (985)
                      ++.++  .+||+|||+++.+......     .......||+.|+|||.+.+..++.++|+ |++|+++++++++..++..
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDL-QSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHH-HHHHHHHHHHHHSCCTTGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhH-HHHHHHHHHHHhCCCCccc
Confidence            99998  9999999999876432211     11233479999999999999999999999 9999999999998876554


Q ss_pred             ch-hhhhH---------------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhccc
Q 001988          932 EK-HFAAK---------------------EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSKR  980 (985)
Q Consensus       932 ~~-~~~~~---------------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~~  980 (985)
                      .. .....                     ..+++++.+++.+||..||.+||++.++++.|+++.+.....
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  341 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS  341 (352)
T ss_dssp             GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence            32 11100                     012678999999999999999999999999999998876543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=6.4e-35  Score=324.75  Aligned_cols=239  Identities=21%  Similarity=0.306  Sum_probs=189.9

Q ss_pred             HHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          722 LRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       722 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      ....++|...+.||+|+||.||+|+.. +++.||||+++.....  ....+.+|++++++++||||+++++++.+.+..+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            345678999999999999999999865 7899999999755332  2456789999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE-----cCCCcEEEecccCc
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL-----DEDMVAHLSDFGMA  873 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill-----~~~~~~kl~DfGla  873 (985)
                      +||||++ |+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||++     +.++.+||+|||++
T Consensus       110 lv~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFC---HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEEECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEEecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            9999997 59999998764 589999999999999999999   78899999999999999     45556999999999


Q ss_pred             eeccCCCCcceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhhhH--------------
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK--------------  938 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~--------------  938 (985)
                      +.+....  .......||+.|+|||.+.+. .++.++|+ |++|+++++++++..+..........              
T Consensus       185 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          185 RAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDI-WSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT  261 (329)
T ss_dssp             HHHC-------------CCTTCCHHHHTTCCCCCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHH-HHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence            8764322  223345689999999998874 48999999 99999999999988765433211110              


Q ss_pred             ---------------------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          939 ---------------------------EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       939 ---------------------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                 ..+++++.+++.+|+..||.+|||+.|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                                       013467889999999999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.9e-34  Score=332.89  Aligned_cols=195  Identities=24%  Similarity=0.353  Sum_probs=164.5

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----Cc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSND-----DF  796 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~  796 (985)
                      .++|...+.||+|+||.||+|+.. +++.||||++.....  ...+.+.+|++++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            478999999999999999999865 788999999976432  3456789999999999999999999999766     56


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      .|+||||++ |+|.+++... ..+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+|+..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~L---H~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFI---HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999996 5999999865 3689999999999999999999   7889999999999999999999999999999987


Q ss_pred             cCCCCc--------------------ceeccccccccccccccc-ccCccchhhhcccccccchhhhccc
Q 001988          877 SGEDES--------------------TMRTQTLATIGYMAPDEI-FVGELSLKRWVNDLLPVSLVEVVDK  925 (985)
Q Consensus       877 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~dv~~~~g~~~~~i~~~  925 (985)
                      ......                    ......+||+.|+|||.+ ....++.++|+ |++|+++++++++
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~Di-wSlG~il~ell~g  248 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDI-WSTGCIFAELLNM  248 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHH-HHHHHHHHHHHTT
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCccccc-chHHHHHHHHHhc
Confidence            533211                    123556799999999986 56669999999 9999999999963

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2e-34  Score=325.57  Aligned_cols=245  Identities=18%  Similarity=0.248  Sum_probs=197.7

Q ss_pred             cCHHHHHHHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcc-----------hHHHHHHHHHHHHhcCCCCe
Q 001988          716 FSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAS-----------TLKSFEAECEVIKNIRHRNL  784 (985)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~~E~~il~~l~h~ni  784 (985)
                      ....++....++|...+.||+|+||.||+|...+++.||||++......           ..+.+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            3456778889999999999999999999999888999999998654221           13678999999999999999


Q ss_pred             eeEEeeeec-----CCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE
Q 001988          785 VKIISSCSN-----DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL  859 (985)
Q Consensus       785 v~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill  859 (985)
                      +++++++..     ....++||||++ |+|.+++......+++..+..++.|++.||+||   |++||+||||||+||++
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVL---HEAGVVHRDLHPGNILL  167 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCcCEecCCChHHEEE
Confidence            999999843     346799999997 699999887766899999999999999999999   78899999999999999


Q ss_pred             cCCCcEEEecccCceeccCCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh-
Q 001988          860 DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-  937 (985)
Q Consensus       860 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-  937 (985)
                      +.++.+||+|||+++.....   .......||+.|+|||.+.+ ..++.++|+ |++|+++++++++..+......... 
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wslG~il~~l~~g~~pf~~~~~~~~~  243 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDM-WSAGCVMAEMFNRKALFRGSTFYNQL  243 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHH-HhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999864322   22334569999999999877 778999999 9999999999998876544321111 


Q ss_pred             ------------------------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 ------------------------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 ------------------------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                                ....++.+.+++.+|+..||.+|||+.|+++
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence                                                      0112456889999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.3e-34  Score=346.38  Aligned_cols=240  Identities=22%  Similarity=0.296  Sum_probs=198.3

Q ss_pred             ceeeccCceeEEEEEEc---CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLE---DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~---~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||.||+|.+.   +++.||||+++....  ...+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999653   567899999976532  235789999999999999999999999975 457899999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc-cee
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES-TMR  885 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~  885 (985)
                      |+|.+++.... .+++..+..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+++.+...... ...
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yL---H~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHH---HHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999997653 689999999999999999999   7889999999999999999999999999999877543321 222


Q ss_pred             cccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHHHHHHc
Q 001988          886 TQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFSLALEC  952 (985)
Q Consensus       886 ~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~l~~~c  952 (985)
                      ....+|+.|+|||.+....++.++|+ |++|++++++++ +..++......            ..+..+++++.+++.+|
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDv-wSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c  608 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDV-WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC  608 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            33457889999999999999999999 999999999998 77665443211            12334678899999999


Q ss_pred             cCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          953 TMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       953 l~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      |+.||++||++.+++++|+++..+.
T Consensus       609 l~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          609 WTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             TCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             cCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            9999999999999999999887654

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.6e-34  Score=314.62  Aligned_cols=238  Identities=19%  Similarity=0.231  Sum_probs=203.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|...+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467889999999999999999976 68889999987542   22456788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++++|.+++.... .+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYL---HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            99999999999887653 689999999999999999999   78899999999999999999999999999998864322


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLA  949 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~  949 (985)
                      .  ......||+.|+|||.+.+..++.++|+ |++|+.+++++++..+........           .+..++.++.+++
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  246 (294)
T 2rku_A          170 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDV-WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLI  246 (294)
T ss_dssp             C--CBCCCCSCCSSCCHHHHTTSCBCTHHHH-HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHH
T ss_pred             c--ccccccCCCCcCCcchhccCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHH
Confidence            2  2234569999999999999999999999 999999999999887655432111           1223457789999


Q ss_pred             HHccCCCCCCCCCHHHHHHH
Q 001988          950 LECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~~  969 (985)
                      .+||..||++||++.|+++.
T Consensus       247 ~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          247 QKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             HHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHcccChhhCcCHHHHhhC
Confidence            99999999999999999874

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.2e-34  Score=330.61  Aligned_cols=246  Identities=20%  Similarity=0.207  Sum_probs=207.4

Q ss_pred             hcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCC-CCeeeEEeeeecCCceEEEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRH-RNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .++|...+.||+|+||.||+|+. .+++.||||++.....  ..++.+|+++++.++| +++..+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999996 4789999998875532  2457899999999987 566667777778888999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE---cCCCcEEEecccCceeccCC
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill---~~~~~~kl~DfGla~~~~~~  879 (985)
                      |+ +++|.+++......+++.+++.++.||+.||+||   |++|||||||||+|||+   +.++.+||+|||+++.+...
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV---HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 9999999987666899999999999999999999   78899999999999999   68999999999999987644


Q ss_pred             CCcc-----eecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh-------------------
Q 001988          880 DEST-----MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-------------------  935 (985)
Q Consensus       880 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-------------------  935 (985)
                      ....     ......||+.|+|||.+.+..++.++|+ |++|+++++++++..++......                   
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDv-wSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDL-ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE  238 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHH-HHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHH-HHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence            3221     1235679999999999999999999999 99999999999998876542110                   


Q ss_pred             hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          936 AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       936 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      .....+++++.+++..||..+|++||++.++++.|+++....
T Consensus       239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            011234678999999999999999999999999999987643

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.8e-34  Score=321.78  Aligned_cols=240  Identities=22%  Similarity=0.315  Sum_probs=197.6

Q ss_pred             hcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeec--------
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSN--------  793 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~--------  793 (985)
                      .++|+..+.||+|+||.||+|+. .+++.||||++......  ....+.+|++++++++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46899999999999999999997 47899999998655322  34578899999999999999999999976        


Q ss_pred             CCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCc
Q 001988          794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA  873 (985)
Q Consensus       794 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla  873 (985)
                      .+..++||||+++ ++.+.+......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            3468999999975 88888877666799999999999999999999   7899999999999999999999999999999


Q ss_pred             eeccCCCC--cceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhhH------------
Q 001988          874 KLLSGEDE--STMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK------------  938 (985)
Q Consensus       874 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~------------  938 (985)
                      +.+.....  ........||+.|+|||.+.+ ..++.++|+ |++|+++++++++..+..........            
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di-wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDL-WGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHH-HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            88753222  122344568999999998876 457999999 99999999999987765432111100            


Q ss_pred             --------------------------H-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          939 --------------------------E-----QCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       939 --------------------------~-----~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                                +     ...+.+.+++.+|+..||++||++.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence                                      0     014568899999999999999999999863

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.9e-35  Score=320.08  Aligned_cols=239  Identities=22%  Similarity=0.303  Sum_probs=198.6

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|++..........+.+|++++++++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3578899999999999999999976 689999999987766667889999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |+++++|.+++......+++..+..++.|++.||+||   |+.|++||||||+||+++.++.+||+|||++......  .
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL---HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--L  171 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--H
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--c
Confidence            9999999999887666799999999999999999999   7889999999999999999999999999987643211  1


Q ss_pred             ceecccccccccccccccc-----cCccchhhhcccccccchhhhcccccccCcchhh--------------hhHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIF-----VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQCLL  943 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~~~  943 (985)
                      .......||+.|+|||.+.     ...++.++|+ |++|+++++++++..+.......              ..+..++.
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADI-WSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV  250 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHH-HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhH-HHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence            1123346999999999884     6678899999 99999999999988765433211              11234567


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ++.+++.+||..||.+||++.|+++
T Consensus       251 ~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          251 EFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHHcccChhhCCCHHHHhc
Confidence            8999999999999999999999975

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.5e-34  Score=321.22  Aligned_cols=250  Identities=23%  Similarity=0.254  Sum_probs=191.4

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-CCCeeeEEeeee--------c
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKIISSCS--------N  793 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~--------~  793 (985)
                      ...+|+..+.||+|+||.||+|+.. +++.||||++........+.+.+|+.+++++. ||||+++++++.        .
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            3457899999999999999999965 78999999987665556678899999999996 999999999984        3


Q ss_pred             CCceEEEEeccCCCChHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCEEEcCCCcEEEec
Q 001988          794 DDFKALVLEYMSNGSLEDCLHS--SNCALNIFCRLNIMIDIASALEYLHFGHSTP--IIHCDLKPSNVLLDEDMVAHLSD  869 (985)
Q Consensus       794 ~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~--ivHrDlk~~Nill~~~~~~kl~D  869 (985)
                      ....++||||++ |+|.+++..  ....+++..++.++.|++.||+||   |+.+  |+||||||+||+++.++.+||+|
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM---HRQKPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHH---HTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HhCCCCEEEccCCcccEEECCCCCEEEec
Confidence            345789999995 799998865  344689999999999999999999   6778  99999999999999999999999


Q ss_pred             ccCceeccCCCCcc----------eeccccccccccccccc---ccCccchhhhcccccccchhhhcccccccCcchhhh
Q 001988          870 FGMAKLLSGEDEST----------MRTQTLATIGYMAPDEI---FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA  936 (985)
Q Consensus       870 fGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~  936 (985)
                      ||+++.+.......          ......||+.|+|||.+   ....++.++|+ |++|+++++++++..+........
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv-~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDI-WALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHH-HHHHHHHHHHHHSSCCC-------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhH-HHHHHHHHHHHhCCCCCcchhHHH
Confidence            99998765432211          11234589999999998   56778899999 999999999999887654321111


Q ss_pred             ---------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhc
Q 001988          937 ---------AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLS  978 (985)
Q Consensus       937 ---------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~  978 (985)
                               ....++..+.+++.+||..||.+||++.|+++.|+++.....
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          261 IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             -----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence                     112234568899999999999999999999999999987543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=9.1e-34  Score=319.78  Aligned_cols=242  Identities=24%  Similarity=0.332  Sum_probs=203.7

Q ss_pred             HHHHHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--------hHHHHHHHHHHHHhc-CCCCeeeEE
Q 001988          719 FELLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--------TLKSFEAECEVIKNI-RHRNLVKII  788 (985)
Q Consensus       719 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l-~h~niv~l~  788 (985)
                      .......++|...+.||+|+||.||+|+.. +|+.||||+++.....        ..+.+.+|+.+++++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            334456678999999999999999999975 7999999998765321        135678999999999 799999999


Q ss_pred             eeeecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 001988          789 SSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLS  868 (985)
Q Consensus       789 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~  868 (985)
                      +++...+..++||||+++++|.+++.... .+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~L---H~~gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFL---HANNIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEEE
Confidence            99999999999999999999999998653 689999999999999999999   78899999999999999999999999


Q ss_pred             cccCceeccCCCCcceeccccccccccccccccc------CccchhhhcccccccchhhhcccccccCcchhhh------
Q 001988          869 DFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV------GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------  936 (985)
Q Consensus       869 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------  936 (985)
                      |||++..+....   .....+||+.|+|||.+.+      ..++.++|+ |++|+++++++++..++.......      
T Consensus       243 DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di-~slG~il~ell~g~~pf~~~~~~~~~~~i~  318 (365)
T 2y7j_A          243 DFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDL-WACGVILFTLLAGSPPFWHRRQILMLRMIM  318 (365)
T ss_dssp             CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             ecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhH-HhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            999998875332   2234579999999998863      357889999 999999999999987654322111      


Q ss_pred             ---------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 ---------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 ---------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                               ....++.++.+++.+|+..||++||++.|+++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          319 EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                     11234567999999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.7e-34  Score=320.59  Aligned_cols=238  Identities=19%  Similarity=0.231  Sum_probs=203.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|...+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467889999999999999999976 67899999987542   23456788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++++|.+++.... .+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYL---HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999999887653 689999999999999999999   78899999999999999999999999999998864322


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLA  949 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~  949 (985)
                      .  ......||+.|+|||.+.+..++.++|+ |++|+++++++++..++.......           .+..++.++.+++
T Consensus       196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  272 (335)
T 2owb_A          196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDV-WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLI  272 (335)
T ss_dssp             C--CBCCCCSCCSSCCHHHHHTSCBCTHHHH-HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred             c--cccccCCCccccCHHHhccCCCCchhhH-HHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence            2  2234569999999999999999999999 999999999999887655432111           1123457789999


Q ss_pred             HHccCCCCCCCCCHHHHHHH
Q 001988          950 LECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~~  969 (985)
                      .+||..||++||++.|+++.
T Consensus       273 ~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          273 QKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             HHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHccCChhHCcCHHHHhcC
Confidence            99999999999999999863

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.4e-34  Score=315.33  Aligned_cols=235  Identities=23%  Similarity=0.289  Sum_probs=199.5

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .++|...+.||+|+||.||+|+.. +++.||+|+++.........+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            467899999999999999999975 7999999999866444556789999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE---cCCCcEEEecccCceeccCCC
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill---~~~~~~kl~DfGla~~~~~~~  880 (985)
                      +++++|.+++...+ .+++.....++.|++.||+||   |+.||+||||||+||++   +.++.+||+|||+++..... 
T Consensus        88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-  162 (304)
T 2jam_A           88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYL---HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-  162 (304)
T ss_dssp             CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred             CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence            99999999987654 688999999999999999999   78899999999999999   78899999999998764321 


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQCLLSI  945 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~~~~~l  945 (985)
                         ......||+.|+|||.+.+..++.++|+ |++|+++++++++..+........               ....+++++
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (304)
T 2jam_A          163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDC-WSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA  238 (304)
T ss_dssp             ---TTHHHHSCCCBCCTTTBSSCSCCHHHHH-HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred             ---ccccccCCCCccChHHhccCCCCchhhH-HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence               2233469999999999999999999999 999999999999887654322111               112356789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHH
Q 001988          946 FSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+++.+|+..||.+||++.|+++
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          239 KDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHcCCChhHCcCHHHHhc
Confidence            99999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.7e-34  Score=317.71  Aligned_cols=237  Identities=25%  Similarity=0.322  Sum_probs=199.6

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ..++|...+.||+|+||.||+|... +|+.||+|.+....  ....+.+|++++++++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4567999999999999999999876 68999999997653  34678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |+++++|.+++......+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||++..+....  
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--  179 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL---HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--  179 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--
Confidence            9999999999986666789999999999999999999   78999999999999999999999999999998764322  


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--------------hhHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQCLLSIFSL  948 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~~~~l~~l  948 (985)
                      .......||+.|+|||.+.+..++.++|+ |++|+++++++++..+.......              ..+..++..+.++
T Consensus       180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  258 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQEIGYNCVADI-WSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF  258 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHSSSCBCTTHHH-HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             cccCccCCCCCccChhhcCCCCCCccccH-HHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence            12234569999999999999999999999 99999999999988765432211              1123356789999


Q ss_pred             HHHccCCCCCCCCCHHHHHH
Q 001988          949 ALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +.+||..||.+||++.++++
T Consensus       259 i~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          259 VKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHccCChhhCcCHHHHHh
Confidence            99999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.9e-34  Score=311.55  Aligned_cols=235  Identities=23%  Similarity=0.277  Sum_probs=201.9

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|...+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            367899999999999999999876 68889999986532   12246789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++|+|.+++...+ .+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus        93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYC---HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            99999999999998754 689999999999999999999   78999999999999999999999999999997754221


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLLSIFSLA  949 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~l~~l~  949 (985)
                          .....|++.|+|||.+.+..++.++|+ |++|+++++++++..+.........           +...+.++.+++
T Consensus       169 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  243 (284)
T 2vgo_A          169 ----RRTMCGTLDYLPPEMIEGKTHDEKVDL-WCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLI  243 (284)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTCCBCTTHHH-HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHH
T ss_pred             ----cccccCCCCcCCHHHhccCCCCcccch-hhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHH
Confidence                234569999999999999999999999 9999999999998876544322111           123457789999


Q ss_pred             HHccCCCCCCCCCHHHHHH
Q 001988          950 LECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+|+..||.+||++.|+++
T Consensus       244 ~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          244 SKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhhcCHhhCCCHHHHhh
Confidence            9999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.9e-34  Score=321.39  Aligned_cols=238  Identities=25%  Similarity=0.367  Sum_probs=195.0

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      .++|+..+.||+|+||.||+|+.. +++.||||++......  ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            367889999999999999999975 6899999998655333  2456789999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++++|.++..... .+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||+++.+.....
T Consensus       104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFC---HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHH---HHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            9999988888766543 689999999999999999999   788999999999999999999999999999987643222


Q ss_pred             cceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhhh-----------------------
Q 001988          882 STMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------------------  937 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------------------  937 (985)
                        ......||+.|+|||.+.+. .++.++|+ |++|+++++++++..+.........                       
T Consensus       180 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          180 --VYDDEVATRWYRAPELLVGDVKYGKAVDV-WAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             --ccCCCcCCccccCcccccCCCCcchHHHH-HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence              22345699999999998775 68899999 9999999999999876543321110                       


Q ss_pred             -------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          938 -------------------KEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       938 -------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                         ...+++++.+++.+||..||.+||++.|+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                               01245779999999999999999999998863

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7.7e-34  Score=311.02  Aligned_cols=237  Identities=27%  Similarity=0.353  Sum_probs=196.5

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      ++|.....||+|+||.||+|... +++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            34555669999999999999964 78899999998765556678999999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-CCcEEEecccCceeccCCCC
Q 001988          805 SNGSLEDCLHSSN--CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       805 ~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~-~~~~kl~DfGla~~~~~~~~  881 (985)
                      ++++|.+++....  ..+++..+..++.|++.||+||   |++||+||||||+||+++. ++.+||+|||+++...... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL---HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHH---HhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            9999999998653  3457888999999999999999   7889999999999999987 8999999999998764322 


Q ss_pred             cceecccccccccccccccccCc--cchhhhcccccccchhhhcccccccCcchhh--------------hhHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGE--LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQCLLSI  945 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~~~~l  945 (985)
                       .......||+.|+|||.+..+.  ++.++|+ |++|+++++++++..+.......              ..+..++.++
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADI-WSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA  255 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHH-HHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHH
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHH-HHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHH
Confidence             2223456999999999987654  7889999 99999999999988765432111              1122356789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHH
Q 001988          946 FSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+++.+||..||++||++.|+++
T Consensus       256 ~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          256 KAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHccCChhhCCCHHHHhc
Confidence            99999999999999999999975

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.2e-34  Score=330.89  Aligned_cols=236  Identities=23%  Similarity=0.299  Sum_probs=189.6

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--------chHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--------STLKSFEAECEVIKNIRHRNLVKIISSCSND  794 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~  794 (985)
                      ..++|...+.||+|+||.||+|... +++.||||++.....        .....+.+|++++++++||||+++++++...
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  212 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE  212 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            4678999999999999999999865 789999999875421        1123578999999999999999999998654


Q ss_pred             CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC---cEEEeccc
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM---VAHLSDFG  871 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~---~~kl~DfG  871 (985)
                       ..++||||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++   .+||+|||
T Consensus       213 -~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          213 -DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             -EEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             -ceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence             5789999999999999987654 689999999999999999999   788999999999999997544   59999999


Q ss_pred             CceeccCCCCcceecccccccccccccccc---cCccchhhhcccccccchhhhcccccccCcchhh-------------
Q 001988          872 MAKLLSGEDESTMRTQTLATIGYMAPDEIF---VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-------------  935 (985)
Q Consensus       872 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-------------  935 (985)
                      +|+.+...   ......+||+.|+|||.+.   ...++.++|+ |++|+++++++++..++......             
T Consensus       288 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di-wslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~  363 (419)
T 3i6u_A          288 HSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC-WSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN  363 (419)
T ss_dssp             TTTSCC--------------CTTCCTTTTC----CTTHHHHHH-HHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC
T ss_pred             cceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhh-HhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC
Confidence            99876422   2234467999999999985   3678889999 99999999999988766432111             


Q ss_pred             ---hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          936 ---AAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       936 ---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                         .....+++++.+++.+|+..||.+||++.|+++
T Consensus       364 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          364 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence               111235678999999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.6e-34  Score=313.45  Aligned_cols=238  Identities=25%  Similarity=0.328  Sum_probs=204.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .+.|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            456888999999999999999864 78999999997653 3346788999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |+++++|.+++...  .+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||++..+....  
T Consensus       101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  173 (303)
T 3a7i_A          101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  173 (303)
T ss_dssp             CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred             eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence            99999999998753  689999999999999999999   78899999999999999999999999999998865322  


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh------------hHHHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------AKEQCLLSIFSLAL  950 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------~~~~~~~~l~~l~~  950 (985)
                      .......||+.|+|||.+.+..++.++|+ |++|+++++++++..+........            ....++.++.+++.
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  252 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADI-WSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE  252 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHH-HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHH
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhh-HHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHH
Confidence            12234569999999999999999999999 999999999999887654332111            11134567999999


Q ss_pred             HccCCCCCCCCCHHHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTITRL  970 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~L  970 (985)
                      +||..+|.+||++.|+++..
T Consensus       253 ~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          253 ACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             HHCCSSGGGSCCHHHHTTCH
T ss_pred             HHcCCChhhCcCHHHHhhCh
Confidence            99999999999999998753

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.7e-34  Score=325.78  Aligned_cols=236  Identities=22%  Similarity=0.336  Sum_probs=199.5

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .++|...+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            367889999999999999999976 789999999986532 335678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST-PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~-~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      |+++|+|.+++...+ .+++..+..++.|++.||+||   |+. ||+||||||+||+++.++.+||+|||+++.+...  
T Consensus       112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~l---h~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYL---REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999999998754 688999999999999999999   554 8999999999999999999999999999765321  


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh------------------------
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA------------------------  937 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~------------------------  937 (985)
                        ......||+.|+|||.+.+..++.++|+ |++|+++++++++..+.........                        
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDI-WSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHH-HHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence              2234569999999999999999999999 9999999999998866543211000                        


Q ss_pred             -------------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          938 -------------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       938 -------------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                                     ...++.++.+++.+||..||.+|||+.|+++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                                           01135678999999999999999999999863

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.1e-34  Score=336.02  Aligned_cols=233  Identities=24%  Similarity=0.298  Sum_probs=199.1

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|...+.||+|+||.||+|+.+ +|+.||+|++.+...   .....+.+|++++++++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367888999999999999999975 799999999975421   2346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          801 LEYMSNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      |||++||+|.+++...   ...+++.....++.||+.||+||   |++||+||||||+||+++.+|.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~L---H~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL---HQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHH---HHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999998764   34689999999999999999999   78999999999999999999999999999998865


Q ss_pred             CCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh---------------hhHHHHH
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AAKEQCL  942 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~~~~~~  942 (985)
                      ....  .....+||+.|+|||++.+..++.++|+ |++|++++++++|..++......               ..+...+
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~Di-wSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s  417 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDY-FALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS  417 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHH-HHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhc-CcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccC
Confidence            3322  2334579999999999999999999999 99999999999998766442110               0112356


Q ss_pred             HHHHHHHHHccCCCCCCCCCH
Q 001988          943 LSIFSLALECTMESPEKRIDA  963 (985)
Q Consensus       943 ~~l~~l~~~cl~~~P~~RPt~  963 (985)
                      .++.+++.+|+..||.+||++
T Consensus       418 ~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          418 PASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCC
T ss_pred             HHHHHHHHHhccCCHhHCCCC
Confidence            788999999999999999975

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.8e-35  Score=334.13  Aligned_cols=242  Identities=14%  Similarity=0.153  Sum_probs=193.7

Q ss_pred             hcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccC---CcchHHHHHHHHH---HHHhcCCCCeeeEE-------ee
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQ---CASTLKSFEAECE---VIKNIRHRNLVKII-------SS  790 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~E~~---il~~l~h~niv~l~-------~~  790 (985)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...   .....+.+.+|++   ++++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999996 57999999999743   2334678899995   45555899999998       56


Q ss_pred             eecCC-----------------ceEEEEeccCCCChHHHhhcCCC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 001988          791 CSNDD-----------------FKALVLEYMSNGSLEDCLHSSNC------ALNIFCRLNIMIDIASALEYLHFGHSTPI  847 (985)
Q Consensus       791 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~i~~~i~~~L~~Lh~~h~~~i  847 (985)
                      +.+++                 ..++||||+ +|+|.+++...+.      .+++..+..++.||+.||+||   |++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL---HHYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHH---HHTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHH---HhCCe
Confidence            55543                 278999999 6899999986421      223588889999999999999   78899


Q ss_pred             EeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccC-----------ccchhhhcccccc
Q 001988          848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG-----------ELSLKRWVNDLLP  916 (985)
Q Consensus       848 vHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~dv~~~~g  916 (985)
                      +||||||+|||++.++.+||+|||+|+....     .....+| +.|+|||.+.+.           .++.++|+ |++|
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv-wSlG  300 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA-WALG  300 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH-HHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhH-HHHH
Confidence            9999999999999999999999999986421     2334567 999999999887           89999999 9999


Q ss_pred             cchhhhcccccccCcchhh-------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhHhhh
Q 001988          917 VSLVEVVDKSLLSGEEKHF-------AAKEQCLLSIFSLALECTMESPEKRIDAKDTIT--RLLKIRDTL  977 (985)
Q Consensus       917 ~~~~~i~~~~~~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~--~L~~i~~~~  977 (985)
                      ++++++++++.++......       .....+++++.+++.+||..||++||++.|+++  .+.++++..
T Consensus       301 ~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~  370 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL  370 (377)
T ss_dssp             HHHHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred             HHHHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHH
Confidence            9999999988765432211       111345678999999999999999999999986  555555543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.9e-34  Score=318.12  Aligned_cols=244  Identities=18%  Similarity=0.206  Sum_probs=201.7

Q ss_pred             HHHHHHhcCccCC-ceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcC-CCCeeeEEeeeec
Q 001988          719 FELLRATDNFAEN-NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIR-HRNLVKIISSCSN  793 (985)
Q Consensus       719 ~~~~~~~~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~  793 (985)
                      .......++|... +.||+|+||.||+|+.. +++.||+|++....  ......+.+|+.++++++ ||||+++++++.+
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3344556677777 88999999999999876 78999999987542  233578899999999995 6999999999999


Q ss_pred             CCceEEEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---CCcEEEec
Q 001988          794 DDFKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE---DMVAHLSD  869 (985)
Q Consensus       794 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~---~~~~kl~D  869 (985)
                      .+..++||||+++|+|.+++... ...+++..+..++.|++.||+||   |++||+||||||+||+++.   ++.+||+|
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~L---H~~givH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL---HQNNIVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCcCChHHEEEecCCCCCcEEEee
Confidence            99999999999999999998654 45689999999999999999999   7889999999999999988   78999999


Q ss_pred             ccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-------------
Q 001988          870 FGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------  936 (985)
Q Consensus       870 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------  936 (985)
                      ||+++......   ......||+.|+|||.+....++.++|+ |++|+++++++++..++.......             
T Consensus       178 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  253 (327)
T 3lm5_A          178 FGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDM-WNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS  253 (327)
T ss_dssp             GGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             CccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC
Confidence            99998864322   2234579999999999999999999999 999999999999887654332111             


Q ss_pred             --hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          937 --AKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       937 --~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                        ....+++.+.+++.+|+..||.+||++.|+++.
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence              112356779999999999999999999999763

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.3e-34  Score=333.63  Aligned_cols=237  Identities=21%  Similarity=0.280  Sum_probs=200.5

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      ..++|...+.||+|+||.||+|+.. +++.||||++....  ......+.+|++++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3467999999999999999999975 78999999986432  23457789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc---CCCcEEEecccCceecc
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~---~~~~~kl~DfGla~~~~  877 (985)
                      |||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++   .++.+||+|||+++.+.
T Consensus       100 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            99999999999987654 689999999999999999999   789999999999999995   56689999999998764


Q ss_pred             CCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh---------------hhHHHHH
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AAKEQCL  942 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~~~~~~  942 (985)
                      ...   .....+||+.|+|||.+.+ .++.++|+ |++|+++++++++..++......               +....++
T Consensus       176 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~Di-wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  250 (486)
T 3mwu_A          176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDV-WSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS  250 (486)
T ss_dssp             CC-------CCTTGGGGCCGGGGGS-CCCHHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSC
T ss_pred             CCC---ccCCCcCCCCCCCHHHhCC-CCCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCC
Confidence            322   2334579999999998764 68999999 99999999999998776443211               1223456


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          943 LSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       943 ~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      +++.+++.+||..+|.+|||+.|+++.
T Consensus       251 ~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          251 DDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            789999999999999999999999874

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.3e-34  Score=308.52  Aligned_cols=237  Identities=25%  Similarity=0.348  Sum_probs=194.0

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|...+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            467899999999999999999976 79999999986542   12345788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYC---HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            99999999999997654 588999999999999999999   78899999999999999999999999999998764322


Q ss_pred             CcceecccccccccccccccccCcc-chhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGEL-SLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSL  948 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l  948 (985)
                         ......||+.|+|||.+.+..+ +.++|+ |++|+++++++++..+........           .+..++.++.++
T Consensus       166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di-~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  241 (276)
T 2h6d_A          166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDI-WSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATL  241 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             ---ceecccCCccccCHHHHcCCCCCCccchH-HHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHH
Confidence               2234468999999999887765 688999 999999999999887654432111           112245779999


Q ss_pred             HHHccCCCCCCCCCHHHHHHH
Q 001988          949 ALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       949 ~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      +.+|++.||.+||++.|+++.
T Consensus       242 i~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          242 LMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHccCChhhCCCHHHHHhC
Confidence            999999999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-33  Score=310.39  Aligned_cols=240  Identities=18%  Similarity=0.275  Sum_probs=197.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC----cchHHHHHHHHHHHHhcCCCCeeeEEeeee--cCCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC----ASTLKSFEAECEVIKNIRHRNLVKIISSCS--NDDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~----~~~~~~~~~E~~il~~l~h~niv~l~~~~~--~~~~~  797 (985)
                      .++|...+.||+|+||.||+|... +++.||+|+++...    ......+.+|++++++++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999974 78999999997542    234577899999999999999999999984  45678


Q ss_pred             EEEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          798 ALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      ++||||++++ +.+++... ...+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL---HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 77776653 45689999999999999999999   7889999999999999999999999999999887


Q ss_pred             cCCCCcceecccccccccccccccccCc--cchhhhcccccccchhhhcccccccCcchhhhh-----------HHHHHH
Q 001988          877 SGEDESTMRTQTLATIGYMAPDEIFVGE--LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------KEQCLL  943 (985)
Q Consensus       877 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~  943 (985)
                      .............||+.|+|||.+.+..  ++.++|+ |++|+++++++++..+.........           +..+++
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  238 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDI-WSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGP  238 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCH
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhH-HHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCH
Confidence            5433333344556999999999987643  4779999 9999999999998876654322111           123567


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      ++.+++.+|+..||.+||++.|+++.
T Consensus       239 ~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          239 PLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcC
Confidence            79999999999999999999999864

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-34  Score=320.22  Aligned_cols=232  Identities=22%  Similarity=0.305  Sum_probs=190.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCC------
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDD------  795 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------  795 (985)
                      .++|...+.||+|+||.||+|... +|+.||||++.....  ...+.+.+|++++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467899999999999999999974 799999999965432  23567889999999999999999999997653      


Q ss_pred             ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          796 FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      ..++||||+ +++|.+++...  .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            459999999 88999998863  588999999999999999999   789999999999999999999999999999987


Q ss_pred             ccCCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhhH----------------
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK----------------  938 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~----------------  938 (985)
                      ....     ....++|+.|+|||.+.+ ..++.++|+ |++|+++++++++..++.........                
T Consensus       178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDI-WSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            6422     234568999999999887 778999999 99999999999998765432211100                


Q ss_pred             --------------------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          939 --------------------------EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       939 --------------------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                ...++.+.+++.+|+..||.+|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                                      112567889999999999999999999987

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.5e-34  Score=312.19  Aligned_cols=244  Identities=20%  Similarity=0.275  Sum_probs=201.0

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeee--cCCceEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCS--NDDFKAL  799 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~--~~~~~~l  799 (985)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++.....  ...+.+.+|++++++++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468899999999999999999975 789999999976532  34567899999999999999999999874  4567899


Q ss_pred             EEeccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEeCCCCCCCEEEcCCCcEEEeccc
Q 001988          800 VLEYMSNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGHSTP-----IIHCDLKPSNVLLDEDMVAHLSDFG  871 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~-----ivHrDlk~~Nill~~~~~~kl~DfG  871 (985)
                      ||||+++|+|.+++...   ...+++..++.++.|++.||+||   |+.+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC---HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHH---hcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999998754   33589999999999999999999   5666     9999999999999999999999999


Q ss_pred             CceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh------------hHH
Q 001988          872 MAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------AKE  939 (985)
Q Consensus       872 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------~~~  939 (985)
                      +++......  .......||+.|+|||.+.+..++.++|+ |++|+++++++++..+........            .+.
T Consensus       162 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  238 (279)
T 2w5a_A          162 LARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDI-WSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY  238 (279)
T ss_dssp             HHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCT
T ss_pred             hheeecccc--ccccccCCCccccChHHhccCCCCchhhH-HHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCc
Confidence            998764222  12233468999999999999999999999 999999999999887654432111            112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhH
Q 001988          940 QCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       940 ~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~  974 (985)
                      .+++++.+++.+||..||.+||++.|+++......
T Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence            35678999999999999999999999998664433

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.3e-33  Score=333.02  Aligned_cols=237  Identities=22%  Similarity=0.278  Sum_probs=199.1

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-------------chHHHHHHHHHHHHhcCCCCeeeEEe
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-------------STLKSFEAECEVIKNIRHRNLVKIIS  789 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-------------~~~~~~~~E~~il~~l~h~niv~l~~  789 (985)
                      ..++|...+.||+|+||.||+|+.. +++.||+|++.....             ...+.+.+|++++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999975 688999999975421             23467889999999999999999999


Q ss_pred             eeecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC---cEE
Q 001988          790 SCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM---VAH  866 (985)
Q Consensus       790 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~---~~k  866 (985)
                      ++.+.+..++||||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYL---HKHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCcHHHEEEecCCCCccEE
Confidence            9999999999999999999999987654 689999999999999999999   788999999999999998776   699


Q ss_pred             EecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh----------
Q 001988          867 LSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA----------  936 (985)
Q Consensus       867 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~----------  936 (985)
                      |+|||+++.+....   .....+||+.|+|||.+. +.++.++|+ |++|+++++++++..+........          
T Consensus       190 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di-wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  264 (504)
T 3q5i_A          190 IVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDV-WSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY  264 (504)
T ss_dssp             ECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             EEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999998875322   233457999999999876 578999999 999999999999987765432111          


Q ss_pred             -----hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          937 -----AKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       937 -----~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                           ....+++++.+++.+|+.+||.+|||+.|+++.
T Consensus       265 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          265 YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                 112356789999999999999999999999863

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=9.3e-34  Score=333.28  Aligned_cols=236  Identities=24%  Similarity=0.319  Sum_probs=196.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++....  ......+.+|++++++++||||+++++++.+.+..++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457899999999999999999976 78999999997653  234567899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---CCcEEEecccCceeccC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE---DMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~---~~~~kl~DfGla~~~~~  878 (985)
                      ||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.   ++.+||+|||+++.+..
T Consensus       116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYL---HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999999999887653 689999999999999999999   7889999999999999976   45599999999988753


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQCLL  943 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~~~~  943 (985)
                      ..   .....+||+.|+|||.+. +.++.++|+ |++|+++++++++..++.......               ....+++
T Consensus       192 ~~---~~~~~~gt~~y~aPE~l~-~~~~~~~Di-wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  266 (494)
T 3lij_A          192 QK---KMKERLGTAYYIAPEVLR-KKYDEKCDV-WSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE  266 (494)
T ss_dssp             TB---CBCCCCSCTTTCCHHHHT-TCBCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCH
T ss_pred             Cc---cccccCCCcCeeCHHHHc-ccCCCchhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCH
Confidence            22   234457999999999865 679999999 999999999999987765432111               1123567


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      ++.+++.+||..+|.+|||+.|+++.
T Consensus       267 ~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          267 GAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHHHHHHHHCCCChhhCccHHHHhcC
Confidence            89999999999999999999999853

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-33  Score=341.87  Aligned_cols=247  Identities=21%  Similarity=0.323  Sum_probs=204.1

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc----CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      ..++|...+.||+|+||.||+|.+.    .+..||+|+++.... ...+.+.+|+.++++++||||+++++++.+ +..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence            3577899999999999999999864    356799999875433 234678999999999999999999999854 5689


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +||||+++|+|.+++...+..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus       467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            99999999999999987766789999999999999999999   788999999999999999999999999999987643


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSI  945 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l  945 (985)
                      ... .......+|+.|+|||.+....++.++|+ |++|++++++++ +..+.......            +.+..+++.+
T Consensus       544 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di-wSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l  621 (656)
T 2j0j_A          544 STY-YKASKGKLPIKWMAPESINFRRFTSASDV-WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL  621 (656)
T ss_dssp             -----------CCGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred             Ccc-eeccCCCCCcceeCHHHhcCCCCCchhhH-HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence            322 22233457889999999999999999999 999999999986 66544322111            1223456789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      .+++.+||..||.+||++.|+++.|+++.+.
T Consensus       622 ~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          622 YSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999999999998765

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.4e-33  Score=319.35  Aligned_cols=234  Identities=21%  Similarity=0.254  Sum_probs=187.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCC------
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDD------  795 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------  795 (985)
                      .++|...+.||+|+||.||+|... +++.||||++.....  ...+.+.+|+.++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            467999999999999999999865 789999999975432  33567889999999999999999999997654      


Q ss_pred             ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          796 FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      ..++||||++ |+|.+.+..   .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHH---HHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            6799999996 478888863   478999999999999999999   788999999999999999999999999999987


Q ss_pred             ccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-------------------
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------------  936 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------------  936 (985)
                      ....   .......||+.|+|||.+.+..++.++|+ |++|+++++++++..++.......                   
T Consensus       177 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          177 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDI-WSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             cccc---cccCCceecCCccCHHHhcCCCCCchHhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            5422   12334579999999999999999999999 999999999999886553321100                   


Q ss_pred             ----------------------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          937 ----------------------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       937 ----------------------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                                        .....+.++.+++.+|+..||++|||+.|+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                                              012236778999999999999999999999873

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-34  Score=323.12  Aligned_cols=239  Identities=25%  Similarity=0.298  Sum_probs=198.6

Q ss_pred             hcCccCCceeeccCceeEEEEEE----cCCcEEEEEEeccCC----cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCC
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL----EDGVEIAIKVFHPQC----ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDD  795 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~  795 (985)
                      .++|...+.||+|+||.||+|+.    .+++.||||+++...    ......+.+|+++++++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46899999999999999999987    378999999987542    12345677899999999 6999999999999999


Q ss_pred             ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          796 FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      ..++||||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999999999999998654 689999999999999999999   788999999999999999999999999999987


Q ss_pred             ccCCCCcceeccccccccccccccccc--CccchhhhcccccccchhhhcccccccCcchhh---------------hhH
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFV--GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AAK  938 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~~  938 (985)
                      +.... .......+||+.|+|||.+.+  ..++.++|+ |++|+++++++++..+.......               ..+
T Consensus       209 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv-wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  286 (355)
T 1vzo_A          209 FVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDW-WSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP  286 (355)
T ss_dssp             CCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHH-HHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred             cccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhH-HHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC
Confidence            64222 222334579999999999885  347889999 99999999999998765422110               112


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 001988          939 EQCLLSIFSLALECTMESPEKRI-----DAKDTITR  969 (985)
Q Consensus       939 ~~~~~~l~~l~~~cl~~~P~~RP-----t~~ev~~~  969 (985)
                      ..++..+.+++.+||..||.+||     ++.|+++.
T Consensus       287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            23456789999999999999999     89998864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-34  Score=318.91  Aligned_cols=246  Identities=24%  Similarity=0.322  Sum_probs=196.8

Q ss_pred             cCHHHHHHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeec
Q 001988          716 FSYFELLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSN  793 (985)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~  793 (985)
                      +++.++....++|+..+.||+|+||.||+|+.. +++.||||++.... .....+.+|+++++++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            334444456788999999999999999999974 78999999987543 3457889999999999 79999999999976


Q ss_pred             ------CCceEEEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEE
Q 001988          794 ------DDFKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH  866 (985)
Q Consensus       794 ------~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~k  866 (985)
                            .+..++||||+++|+|.+++... ...+++..+..++.|++.||+||   |++||+||||||+||+++.++.+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL---HQHKVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTCCEE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCcHHHEEEcCCCCEE
Confidence                  46789999999999999999864 34688999999999999999999   788999999999999999999999


Q ss_pred             EecccCceeccCCCCcceecccccccccccccccc-----cCccchhhhcccccccchhhhcccccccCcchhhhh----
Q 001988          867 LSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF-----VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA----  937 (985)
Q Consensus       867 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~----  937 (985)
                      |+|||++..+....  .......||+.|+|||.+.     ...++.++|+ |++|+++++++++..+.........    
T Consensus       170 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (326)
T 2x7f_A          170 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDL-WSLGITAIEMAEGAPPLCDMHPMRALFLI  246 (326)
T ss_dssp             ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHH-HHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             EeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchH-HHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence            99999998764221  1223456999999999987     5678899999 9999999999998876543221111    


Q ss_pred             ---------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 ---------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 ---------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                               ...++..+.+++.+||..||.+||++.++++
T Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          247 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                     1124577999999999999999999999987

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.6e-33  Score=307.75  Aligned_cols=233  Identities=22%  Similarity=0.328  Sum_probs=193.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeec----CCceE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSN----DDFKA  798 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~  798 (985)
                      ..|...+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            34677788999999999999865 78899999987543  2345678999999999999999999998865    45689


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCEEEc-CCCcEEEecccCcee
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP--IIHCDLKPSNVLLD-EDMVAHLSDFGMAKL  875 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~--ivHrDlk~~Nill~-~~~~~kl~DfGla~~  875 (985)
                      +||||+++|+|.+++.... .+++..+..++.|++.||+||   |+.+  |+||||||+||+++ +++.+||+|||+++.
T Consensus       106 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHH---HcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            9999999999999998653 688999999999999999999   6777  99999999999997 889999999999976


Q ss_pred             ccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--------------hhHHHH
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQC  941 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~  941 (985)
                      ....    ......||+.|+|||.+. +.++.++|+ |++|+++++++++..+.......              ..+...
T Consensus       182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di-~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (290)
T 1t4h_A          182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDV-YAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA  255 (290)
T ss_dssp             CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHH-HHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred             cccc----ccccccCCcCcCCHHHHh-ccCCCcchH-HHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCC
Confidence            4322    223456999999999765 568999999 99999999999988765432111              111223


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          942 LLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       942 ~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ++++.+++.+||..||.+||++.|+++
T Consensus       256 ~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          256 IPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            467999999999999999999999985

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.4e-34  Score=334.88  Aligned_cols=235  Identities=24%  Similarity=0.345  Sum_probs=202.4

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|...+.||+|+||.||+|+.. +++.||||++....   ......+.+|++++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467999999999999999999976 88999999996542   23467789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE---cCCCcEEEecccCceecc
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill---~~~~~~kl~DfGla~~~~  877 (985)
                      |||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||++   +.++.+||+|||+++.+.
T Consensus       105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYM---HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999997654 689999999999999999999   78899999999999999   567899999999998765


Q ss_pred             CCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh---------------hhHHHHH
Q 001988          878 GEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AAKEQCL  942 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~~~~~~  942 (985)
                      ....   ....+||+.|+|||.+.+ .++.++|+ |++|+++++++++..++......               +....++
T Consensus       181 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~Di-wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  255 (484)
T 3nyv_A          181 ASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDV-WSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS  255 (484)
T ss_dssp             CCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSC
T ss_pred             cccc---cccCCCCccccCceeecC-CCCCccee-HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCC
Confidence            3322   234569999999998755 78999999 99999999999998776543211               1223456


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          943 LSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       943 ~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +++.+++.+|+..+|.+|||+.|+++
T Consensus       256 ~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          256 ESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            78999999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.7e-33  Score=308.88  Aligned_cols=237  Identities=23%  Similarity=0.301  Sum_probs=201.0

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---------chHHHHHHHHHHHHhcC-CCCeeeEEeeee
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---------STLKSFEAECEVIKNIR-HRNLVKIISSCS  792 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---------~~~~~~~~E~~il~~l~-h~niv~l~~~~~  792 (985)
                      ..++|...+.||+|+||.||+|... +++.||||+++....         ...+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999975 789999999975531         12356789999999995 999999999999


Q ss_pred             cCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccC
Q 001988          793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGM  872 (985)
Q Consensus       793 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGl  872 (985)
                      ..+..++||||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            9999999999999999999998653 689999999999999999999   789999999999999999999999999999


Q ss_pred             ceeccCCCCcceecccccccccccccccc------cCccchhhhcccccccchhhhcccccccCcchhhh----------
Q 001988          873 AKLLSGEDESTMRTQTLATIGYMAPDEIF------VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA----------  936 (985)
Q Consensus       873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~----------  936 (985)
                      +..+....   ......||+.|+|||.+.      ...++.++|+ |++|+++++++++..+........          
T Consensus       171 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di-~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  246 (298)
T 1phk_A          171 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDM-WSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY  246 (298)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             hhhcCCCc---ccccccCCccccCHHHhccccccccccCCccccc-HhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence            98865322   223456999999999875      4567889999 999999999999887654322111          


Q ss_pred             -----hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 -----AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 -----~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                           ....++.++.+++.+|+..||.+||++.|+++
T Consensus       247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                 11245678999999999999999999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.8e-33  Score=322.49  Aligned_cols=233  Identities=19%  Similarity=0.254  Sum_probs=196.0

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhc------CCCCeeeEEeeeecCCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNI------RHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l------~h~niv~l~~~~~~~~~~  797 (985)
                      ..+|...+.||+|+||.||+|... +++.||||+++.. ......+.+|+++++.+      +|+||+++++++...++.
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457899999999999999999865 6899999999754 23346778899999887      577999999999999999


Q ss_pred             EEEEeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc--EEEecccCce
Q 001988          798 ALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV--AHLSDFGMAK  874 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~--~kl~DfGla~  874 (985)
                      ++||||++ ++|.+++.... ..+++..+..++.||+.||+||   |++||+||||||+|||++.++.  +||+|||+++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL---HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999995 69999988763 4589999999999999999999   6889999999999999999987  9999999998


Q ss_pred             eccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhhH----------------
Q 001988          875 LLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK----------------  938 (985)
Q Consensus       875 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~----------------  938 (985)
                      .....     ....+||+.|+|||.+.+..++.++|+ |++|+++++++++..+..........                
T Consensus       251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDM-WSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ecCCc-----ccccCCCCCccChHHHhCCCCCchHHH-HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            75322     223579999999999999999999999 99999999999987655332111100                


Q ss_pred             ------------------------------------------------------HHHHHHHHHHHHHccCCCCCCCCCHH
Q 001988          939 ------------------------------------------------------EQCLLSIFSLALECTMESPEKRIDAK  964 (985)
Q Consensus       939 ------------------------------------------------------~~~~~~l~~l~~~cl~~~P~~RPt~~  964 (985)
                                                                            ....+++.+++.+||..||++|||+.
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence                                                                  00145688999999999999999999


Q ss_pred             HHHH
Q 001988          965 DTIT  968 (985)
Q Consensus       965 ev~~  968 (985)
                      |+++
T Consensus       405 e~L~  408 (429)
T 3kvw_A          405 QALR  408 (429)
T ss_dssp             HHHT
T ss_pred             HHhC
Confidence            9986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-33  Score=321.20  Aligned_cols=235  Identities=21%  Similarity=0.304  Sum_probs=190.6

Q ss_pred             HHHhcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeec-------
Q 001988          722 LRATDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN-------  793 (985)
Q Consensus       722 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-------  793 (985)
                      ....++|...+.||+|+||.||+|+. .+|+.||||++.....    ...+|++++++++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999986 4899999999865422    23479999999999999999999843       


Q ss_pred             -------------------------------CCceEEEEeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHH
Q 001988          794 -------------------------------DDFKALVLEYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALEYL  839 (985)
Q Consensus       794 -------------------------------~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~L  839 (985)
                                                     ..+.++||||++ |+|.+.+..   .+..+++..+..++.|+++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334789999997 588777653   345789999999999999999999


Q ss_pred             HhcCCCCeEeCCCCCCCEEEc-CCCcEEEecccCceeccCCCCcceecccccccccccccccccC-ccchhhhccccccc
Q 001988          840 HFGHSTPIIHCDLKPSNVLLD-EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPV  917 (985)
Q Consensus       840 h~~h~~~ivHrDlk~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~  917 (985)
                         |++||+||||||+||+++ +++.+||+|||+|+.+.....   .....||+.|+|||.+.+. .++.++|+ |++|+
T Consensus       158 ---H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wslG~  230 (383)
T 3eb0_A          158 ---HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDL-WSIGC  230 (383)
T ss_dssp             ---HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHH-HHHHH
T ss_pred             ---HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhh-hhHHH
Confidence               789999999999999998 689999999999997643322   2345689999999998765 48999999 99999


Q ss_pred             chhhhcccccccCcchhhhh----------------------------------------HHHHHHHHHHHHHHccCCCC
Q 001988          918 SLVEVVDKSLLSGEEKHFAA----------------------------------------KEQCLLSIFSLALECTMESP  957 (985)
Q Consensus       918 ~~~~i~~~~~~~~~~~~~~~----------------------------------------~~~~~~~l~~l~~~cl~~~P  957 (985)
                      ++++++++..++........                                        ++.++.++.+++.+||..||
T Consensus       231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            99999998876654321111                                        11235668999999999999


Q ss_pred             CCCCCHHHHHH
Q 001988          958 EKRIDAKDTIT  968 (985)
Q Consensus       958 ~~RPt~~ev~~  968 (985)
                      .+|||+.|+++
T Consensus       311 ~~R~t~~e~l~  321 (383)
T 3eb0_A          311 DLRINPYEAMA  321 (383)
T ss_dssp             GGSCCHHHHHT
T ss_pred             hhCCCHHHHhc
Confidence            99999999984

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.4e-34  Score=311.86  Aligned_cols=240  Identities=25%  Similarity=0.306  Sum_probs=190.6

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeec---------
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN---------  793 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~---------  793 (985)
                      ..++|+..+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            4578999999999999999999975 7999999998643 3345678999999999999999999998854         


Q ss_pred             ----CCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 001988          794 ----DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSD  869 (985)
Q Consensus       794 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~D  869 (985)
                          .+..++||||+++|+|.+++......+++..++.++.|+++||+||   |++||+||||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYI---HSQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHH---HhCCeecccCCHHhEEEcCCCCEEEee
Confidence                3567899999999999999987766788899999999999999999   788999999999999999999999999


Q ss_pred             ccCceeccCCCC------------cceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcch---
Q 001988          870 FGMAKLLSGEDE------------STMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEK---  933 (985)
Q Consensus       870 fGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~---  933 (985)
                      ||+++.......            ........||+.|+|||.+.+. .++.++|+ |++|+++++++++........   
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di-~slG~il~~l~~p~~~~~~~~~~~  238 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDM-YSLGIIFFEMIYPFSTGMERVNIL  238 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHH-HHHHHHHHHHHSCCSSHHHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhH-HHHHHHHHHHHhccCCchhHHHHH
Confidence            999987642210            1122345699999999998754 68999999 999999999987221100000   


Q ss_pred             ----------hhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          934 ----------HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       934 ----------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                .......+++.+.+++.+||..||.+||++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence                      00011224566899999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.4e-33  Score=316.68  Aligned_cols=237  Identities=22%  Similarity=0.294  Sum_probs=196.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----Cce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSND-----DFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~  797 (985)
                      .++|+..+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            467999999999999999999865 788999999975432 2346788999999999999999999999654     368


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ++||||++ |+|.+++...  .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...
T Consensus       106 ~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            99999996 5999998764  589999999999999999999   78999999999999999999999999999998764


Q ss_pred             CCCCcc-eecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhhhH-----------------
Q 001988          878 GEDEST-MRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK-----------------  938 (985)
Q Consensus       878 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~-----------------  938 (985)
                      ...... .....+||+.|+|||.+.++ .++.++|+ |++|+++++++++..++.........                 
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di-wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI-WSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  258 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHH-HHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhH-HHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            322211 12345799999999987654 48999999 99999999999988765433211110                 


Q ss_pred             -------------------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          939 -------------------------EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       939 -------------------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                               ..++.++.+++.+|+..||.+|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                                     123467899999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.7e-33  Score=312.07  Aligned_cols=230  Identities=19%  Similarity=0.289  Sum_probs=194.5

Q ss_pred             hcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-CCCeeeEEeeeec--CCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKIISSCSN--DDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~--~~~~~lv  800 (985)
                      .++|+..+.||+|+||.||+|+. .+++.||||+++..   ..+.+.+|++++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36789999999999999999986 47899999999743   3467899999999997 9999999999987  5678999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-cEEEecccCceeccCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAKLLSGE  879 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~~~~~~  879 (985)
                      |||+++++|.+++..    +++..+..++.|++.||+||   |++||+||||||+||+++.++ .+||+|||+++.+...
T Consensus       112 ~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999998863    78899999999999999999   789999999999999999777 8999999999876533


Q ss_pred             CCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhh-h---------------------
Q 001988          880 DESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-A---------------------  936 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-~---------------------  936 (985)
                      ..   .....||+.|+|||.+.+ ..++.++|+ |++|+++++++++..+....... .                     
T Consensus       185 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di-wslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          185 QE---YNVRVASRYFKGPELLVDYQMYDYSLDM-WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHH-HHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             Cc---cccccccccccChhhhcCCCcCCchhhH-HHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence            22   234569999999999877 678999999 99999999999988655221100 0                     


Q ss_pred             ---------------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 ---------------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 ---------------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                 .....++++.+++.+|+..||.+|||+.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                                       00014677899999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=9.5e-34  Score=343.38  Aligned_cols=233  Identities=21%  Similarity=0.207  Sum_probs=200.1

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~  798 (985)
                      ..++|...+.||+|+||.||+|+.. +++.||||++++..   ......+..|.+++..+ +||+|+++++++++.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4578999999999999999999965 68889999997541   23346678899999987 7999999999999999999


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +||||++||+|.+++...+ .+++..+..++.||+.||+||   |++|||||||||+|||++.++++||+|||+|+....
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999999998764 689999999999999999999   789999999999999999999999999999987432


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFS  947 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~  947 (985)
                      ..  ......+||+.|+|||++.+..++.++|+ |++|++++|+++|..++.......           .+...++++.+
T Consensus       495 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~Dv-wSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  571 (674)
T 3pfq_A          495 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDW-WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA  571 (674)
T ss_dssp             TT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHH
T ss_pred             CC--cccccccCCCcccCHhhhcCCCCCccceE-echHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Confidence            22  23445689999999999999999999999 999999999999988765432221           12235678999


Q ss_pred             HHHHccCCCCCCCCCH
Q 001988          948 LALECTMESPEKRIDA  963 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~  963 (985)
                      ++.+|+..||.+||++
T Consensus       572 li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          572 ICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             HHHHHSCSSSTTCTTC
T ss_pred             HHHHHccCCHHHCCCC
Confidence            9999999999999997

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.9e-33  Score=317.08  Aligned_cols=198  Identities=25%  Similarity=0.327  Sum_probs=170.3

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-CC-----CeeeEEeeeecCCc
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HR-----NLVKIISSCSNDDF  796 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h~-----niv~l~~~~~~~~~  796 (985)
                      ..++|...+.||+|+||.||+|+.. +++.||||+++.. .....++..|+++++.++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            4678999999999999999999865 7889999999754 234567788999999885 55     49999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc--CCCcEEEecccCc
Q 001988          797 KALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD--EDMVAHLSDFGMA  873 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~--~~~~~kl~DfGla  873 (985)
                      .++||||++ |+|.+++.... ..+++..+..++.|++.||+|||. |+.||+||||||+||+++  .++.+||+|||++
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            999999996 59999998763 468999999999999999999953 478999999999999994  5788999999999


Q ss_pred             eeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccC
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSG  930 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~  930 (985)
                      +.....     .....||+.|+|||.+.+..++.++|+ |++|+++++++++..++.
T Consensus       209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di-wSlG~il~elltg~~pf~  259 (382)
T 2vx3_A          209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDM-WSLGCILVEMHTGEPLFS  259 (382)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHH-HHHHHHHHHHHHSSCSSC
T ss_pred             eecccc-----cccccCCccccChHHHcCCCCCcHHHH-HHHHHHHHHHHhCCCCCC
Confidence            886422     234569999999999999999999999 999999999999887654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.9e-34  Score=319.91  Aligned_cols=235  Identities=20%  Similarity=0.269  Sum_probs=200.4

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcch-----------------HHHHHHHHHHHHhcCCCCeeeE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAST-----------------LKSFEAECEVIKNIRHRNLVKI  787 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~-----------------~~~~~~E~~il~~l~h~niv~l  787 (985)
                      .++|...+.||+|+||.||+|+. +++.||||++.......                 .+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 89999999987542111                 1789999999999999999999


Q ss_pred             EeeeecCCceEEEEeccCCCChHHH------hhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEE
Q 001988          788 ISSCSNDDFKALVLEYMSNGSLEDC------LHSS-NCALNIFCRLNIMIDIASALEYLHFGHS-TPIIHCDLKPSNVLL  859 (985)
Q Consensus       788 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivHrDlk~~Nill  859 (985)
                      ++++.+.+..++||||+++|+|.++      +... ...+++..+..++.|++.||+||   |+ +||+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI---HNEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH---HHTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH---hccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      6543 45789999999999999999999   66 999999999999999


Q ss_pred             cCCCcEEEecccCceeccCCCCcceecccccccccccccccccC-ccch-hhhcccccccchhhhcccccccCcchh-hh
Q 001988          860 DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG-ELSL-KRWVNDLLPVSLVEVVDKSLLSGEEKH-FA  936 (985)
Q Consensus       860 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~dv~~~~g~~~~~i~~~~~~~~~~~~-~~  936 (985)
                      +.++.+||+|||.+......    ......||+.|+|||.+.+. .++. ++|+ |++|+++++++++..+...... ..
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDI-WSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHH-HHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhH-HHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            99999999999999886432    33445699999999999877 6666 8899 9999999999998876543211 00


Q ss_pred             -----------hH-------------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 -----------AK-------------------EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 -----------~~-------------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                 .+                   ..++.++.+++.+||..||.+||++.|+++
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                       01                   345678999999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.2e-33  Score=313.57  Aligned_cols=236  Identities=24%  Similarity=0.307  Sum_probs=193.8

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--------chHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--------STLKSFEAECEVIKNIRHRNLVKIISSCSND  794 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~  794 (985)
                      ..++|...+.||+|+||.||+|... +++.||||++.....        .....+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467999999999999999999875 688999999875421        1223578999999999999999999999766


Q ss_pred             CceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc---EEEeccc
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV---AHLSDFG  871 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~---~kl~DfG  871 (985)
                      + .++||||+++|+|.+++.... .+++.....++.|++.||+||   |++||+||||||+||+++.++.   +||+|||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             c-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            5 799999999999999987653 689999999999999999999   7889999999999999987664   9999999


Q ss_pred             CceeccCCCCcceecccccccccccccccc---cCccchhhhcccccccchhhhcccccccCcchhh-------------
Q 001988          872 MAKLLSGEDESTMRTQTLATIGYMAPDEIF---VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-------------  935 (985)
Q Consensus       872 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-------------  935 (985)
                      +++.....   .......||+.|+|||.+.   ...++.++|+ |++|+++++++++..+.......             
T Consensus       163 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (322)
T 2ycf_A          163 HSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC-WSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN  238 (322)
T ss_dssp             TCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHH-HHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC
T ss_pred             cceecccc---cccccccCCcCccCchhhccCCCCCCCchhhH-HHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc
Confidence            99876422   2223456999999999874   5678889999 99999999999988765432111             


Q ss_pred             ---hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          936 ---AAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       936 ---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                         .....+++++.+++.+||..||++||++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          239 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence               011234678999999999999999999999984

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.7e-34  Score=325.45  Aligned_cols=244  Identities=13%  Similarity=0.083  Sum_probs=184.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHHHHHHHhc--CCCCeeeEE-------eee
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAECEVIKNI--RHRNLVKII-------SSC  791 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l--~h~niv~l~-------~~~  791 (985)
                      ..+|...+.||+|+||.||+|++. +++.||||++.....   ...+.+.+|+++++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345888999999999999999965 789999999987643   2345677886555555  699988855       343


Q ss_pred             ecC-----------------CceEEEEeccCCCChHHHhhcCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCeE
Q 001988          792 SND-----------------DFKALVLEYMSNGSLEDCLHSSNCALNIFCR------LNIMIDIASALEYLHFGHSTPII  848 (985)
Q Consensus       792 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~------~~i~~~i~~~L~~Lh~~h~~~iv  848 (985)
                      ...                 ...++||||++ |+|.+++...+..+++..+      ..++.|++.||+||   |++||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~L---H~~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL---QSKGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHH---HHTTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHH---HHCCCc
Confidence            322                 23799999998 8999999875444555666      77889999999999   789999


Q ss_pred             eCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceeccccccccccccccccc--Cccchhhhcccccccchhhhcccc
Q 001988          849 HCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV--GELSLKRWVNDLLPVSLVEVVDKS  926 (985)
Q Consensus       849 HrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~dv~~~~g~~~~~i~~~~  926 (985)
                      ||||||+|||++.++.+||+|||+|+....     ......+|+.|+|||.+.+  ..++.++|+ |++|++++++++++
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~Di-wSlG~il~elltg~  290 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNA-WQLGLSIYRVWCLF  290 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHH-HHHHHHHHHHHHSS
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccH-HHHHHHHHHHHhCC
Confidence            999999999999999999999999987531     1113457799999999987  779999999 99999999999988


Q ss_pred             cccCcchh--------------------hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhHhhhc
Q 001988          927 LLSGEEKH--------------------FAAKEQCLLSIFSLALECTMESPEKRIDAKDTIT--RLLKIRDTLS  978 (985)
Q Consensus       927 ~~~~~~~~--------------------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~--~L~~i~~~~~  978 (985)
                      .++.....                    .+....+++++.+++.+||..||++||++.|+++  .+.++....+
T Consensus       291 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  364 (371)
T 3q60_A          291 LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEIS  364 (371)
T ss_dssp             CSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHHH
T ss_pred             CCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHHh
Confidence            76544310                    1111245788999999999999999999999975  4455544433

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.9e-34  Score=317.22  Aligned_cols=242  Identities=23%  Similarity=0.316  Sum_probs=182.6

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      ...++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34678999999999999999999854 78999999987543 23456788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCc
Q 001988          801 LEYMSNGSLEDCLHS-------SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA  873 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla  873 (985)
                      |||+++++|.+++..       ....+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL---HKNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999874       234689999999999999999999   7889999999999999999999999999998


Q ss_pred             eeccCCCC---cceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh------------
Q 001988          874 KLLSGEDE---STMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA------------  937 (985)
Q Consensus       874 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~------------  937 (985)
                      +.+.....   ........||+.|+|||.+.. ..++.++|+ |++|+++++++++..+.........            
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  247 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADI-WSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL  247 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHH-HHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhH-HHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence            77643221   112234569999999999876 568899999 9999999999998876543211110            


Q ss_pred             ---------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 ---------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 ---------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                               ...++.++.+++.+||..||.+||++.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                     0124567899999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.3e-34  Score=319.04  Aligned_cols=251  Identities=22%  Similarity=0.257  Sum_probs=200.2

Q ss_pred             HHHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          722 LRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       722 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ....++|+..+.||+|+||.||+|+.++  .||+|+++....  ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            3346789999999999999999999863  499999875422  234567889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++++|.+++...+..+++..+..++.|++.||+||   |++||+||||||+||+++ ++.+||+|||+++.....
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHH---HHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            9999999999999988766789999999999999999999   788999999999999998 689999999998765321


Q ss_pred             CC---cceeccccccccccccccccc---------CccchhhhcccccccchhhhcccccccCcchhhhhH---------
Q 001988          880 DE---STMRTQTLATIGYMAPDEIFV---------GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK---------  938 (985)
Q Consensus       880 ~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~---------  938 (985)
                      ..   ........||+.|+|||.+..         ..++.++|+ |++|+++++++++..+..........         
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di-~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  261 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDV-FALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP  261 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHH-HHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence            11   112233458999999998864         457889999 99999999999988765543211111         


Q ss_pred             ----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          939 ----EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       939 ----~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                          ..++.++.+++.+||..+|.+||++.++++.|+++.++..+
T Consensus       262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~  306 (319)
T 2y4i_B          262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR  306 (319)
T ss_dssp             CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred             CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                12456799999999999999999999999999998876543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.5e-33  Score=310.75  Aligned_cols=237  Identities=22%  Similarity=0.307  Sum_probs=190.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeee-----------
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS-----------  792 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~-----------  792 (985)
                      .++|...+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467899999999999999999976 58999999998766566778899999999999999999999874           


Q ss_pred             ---cCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc-CCCcEEEe
Q 001988          793 ---NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHLS  868 (985)
Q Consensus       793 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~-~~~~~kl~  868 (985)
                         +.+..++||||++ |+|.+++...  .+++..+..++.|++.||+||   |++||+||||||+||+++ +++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYI---HSANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               3467899999997 6999998753  588999999999999999999   788999999999999997 56799999


Q ss_pred             cccCceeccCCCC-cceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh---------
Q 001988          869 DFGMAKLLSGEDE-STMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA---------  937 (985)
Q Consensus       869 DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~---------  937 (985)
                      |||+++....... ........+|+.|+|||.+.. ..++.++|+ |++|++++++++++.+.........         
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di-~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  242 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDM-WAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP  242 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhh-HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999987643211 112234457999999998876 678999999 9999999999998876543321110         


Q ss_pred             --------------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 --------------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 --------------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                      ...++.++.+++.+|+..||.+||++.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence                                            0124677999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=9.5e-34  Score=313.14  Aligned_cols=247  Identities=21%  Similarity=0.292  Sum_probs=196.2

Q ss_pred             cCHHHHHHHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCc--chHHHHHHHHHHHHhcC--CCCeeeEEeee
Q 001988          716 FSYFELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIR--HRNLVKIISSC  791 (985)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~--h~niv~l~~~~  791 (985)
                      +.+..+....++|+..+.||+|+||.||+|...+++.||||++.....  ...+.+.+|++++++++  ||||+++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            333334445678999999999999999999988899999999975532  34567899999999997  59999999999


Q ss_pred             ecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEeccc
Q 001988          792 SNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFG  871 (985)
Q Consensus       792 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfG  871 (985)
                      ...+..++||| +.+++|.+++.... .+++..+..++.|+++||+||   |++||+||||||+||++++ +.+||+|||
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEEEEC-CeEEEeecc
Confidence            99999999999 55889999998754 689999999999999999999   7889999999999999965 899999999


Q ss_pred             CceeccCCCCcceeccccccccccccccccc-----------CccchhhhcccccccchhhhcccccccCcchhh-h---
Q 001988          872 MAKLLSGEDESTMRTQTLATIGYMAPDEIFV-----------GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-A---  936 (985)
Q Consensus       872 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-~---  936 (985)
                      +++.+.............||+.|+|||.+..           ..++.++|+ |++|+++++++++..+....... .   
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di-~slG~il~el~~g~~pf~~~~~~~~~~~  250 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV-WSLGCILYYMTYGKTPFQQIINQISKLH  250 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHH-HHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHH-HHHHHHHHHHHhCCCchhhHHHHHHHHH
Confidence            9987754333333344569999999999865           578889999 99999999999988765432111 0   


Q ss_pred             ----------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          937 ----------AKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       937 ----------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                .+..++.++.+++.+||..||.+||++.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          251 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                      111235679999999999999999999999864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.8e-33  Score=307.32  Aligned_cols=236  Identities=21%  Similarity=0.264  Sum_probs=183.0

Q ss_pred             hcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcc-hHH-HHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCAS-TLK-SFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~-~~~-~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      .++|+..+.||+|+||.||+|+. .+++.||+|+++..... ... .+..+...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            47899999999999999999997 47899999999765322 222 3344555577789999999999999999999999


Q ss_pred             eccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          802 EYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALEYLHFGHST-PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       802 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~-~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ||++ |+|.+++..   ....+++..+..++.|++.||+||   |++ ||+||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL---HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 588877754   355789999999999999999999   676 99999999999999999999999999998764


Q ss_pred             CCCCcceeccccccccccccccc----ccCccchhhhcccccccchhhhcccccccCcchh-hh-------------hHH
Q 001988          878 GEDESTMRTQTLATIGYMAPDEI----FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-FA-------------AKE  939 (985)
Q Consensus       878 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-~~-------------~~~  939 (985)
                      ...   ......||+.|+|||.+    ....++.++|+ |++|+++++++++..+...... ..             ...
T Consensus       162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  237 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDI-WSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD  237 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHH-HHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred             ccc---cccccCCCccccChhhcChhhcCcCCCcHHHH-HHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence            322   22334699999999995    56778999999 9999999999999876643211 10             112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          940 QCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       940 ~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .++.++.+++.+|+..||++||++.|+++
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          238 KFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            35678999999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.4e-33  Score=318.00  Aligned_cols=233  Identities=23%  Similarity=0.298  Sum_probs=178.4

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecC------C
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSND------D  795 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~  795 (985)
                      .++|...+.||+|+||.||+|... +|+.||||++.....  ...+.+.+|++++++++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            468999999999999999999864 789999999975432  3456788999999999999999999998654      5


Q ss_pred             ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          796 FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      ..++||||+ +++|.+++..  ..+++..+..++.||++||+||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            679999999 7899998876  3689999999999999999999   789999999999999999999999999999987


Q ss_pred             ccCCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhhH----------------
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK----------------  938 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~----------------  938 (985)
                      ....     ....+||+.|+|||.+.+ ..++.++|+ |++|++++++++|..++.........                
T Consensus       182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  255 (367)
T 2fst_X          182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDI-WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  255 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             cccc-----CCCcCcCcCccChHHHcCCcCCCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            5321     234579999999999877 678999999 99999999999998765432211100                


Q ss_pred             --------------------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          939 --------------------------EQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       939 --------------------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                                ...++.+.+++.+|+..||.+|||+.|+++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                                      0124568899999999999999999999863

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.3e-32  Score=304.59  Aligned_cols=288  Identities=23%  Similarity=0.274  Sum_probs=177.3

Q ss_pred             CceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEcc
Q 001988          195 QLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLY  274 (985)
Q Consensus       195 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~  274 (985)
                      +|+.+++++|.++ .+|..+.  ++|+.|++++|++++..|..|+++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            4555666666555 4555443  455666666666665555556666666666666666666556666666666666666


Q ss_pred             CCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccc--cccCCcccCCCCCceEeccCCccc
Q 001988          275 NNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFS--GFIPSAIGNLRNLKLFDIFFNNLT  352 (985)
Q Consensus       275 ~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~L~~N~l~  352 (985)
                      +|+++ .+|..++   ++|++|++++|++++..+..+.++++|+.|++++|.++  +..|..+..+ +|++|++++|+++
T Consensus       111 ~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~  185 (332)
T 2ft3_A          111 KNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT  185 (332)
T ss_dssp             SSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred             CCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence            66665 4554432   56666666666666555555666777777777777764  2555566665 6666666666665


Q ss_pred             CCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCC
Q 001988          353 SSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGS  432 (985)
Q Consensus       353 ~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  432 (985)
                      .++..                              +.   .+|++|++++|.+++..+..|..+++|++|+|++|++++.
T Consensus       186 ~l~~~------------------------------~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~  232 (332)
T 2ft3_A          186 GIPKD------------------------------LP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMI  232 (332)
T ss_dssp             SCCSS------------------------------SC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCC
T ss_pred             ccCcc------------------------------cc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcC
Confidence            54332                              11   1455555555555555556666666666667766666666


Q ss_pred             CCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCc------CcCceEeeccceee--ee
Q 001988          433 IPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNL------TSLQYLNLGSNRFT--FV  504 (985)
Q Consensus       433 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~L~~N~l~--~~  504 (985)
                      .+.+|..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+|++..+..|...      ..|+.|++++|.+.  .+
T Consensus       233 ~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~  311 (332)
T 2ft3_A          233 ENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEV  311 (332)
T ss_dssp             CTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGS
T ss_pred             ChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccccc
Confidence            6666666667777777777766 556666666777777777777766555555442      45677777777766  45


Q ss_pred             cCCCccCccceeEEeecCCc
Q 001988          505 IPSTFWNLKDILSFDISSNL  524 (985)
Q Consensus       505 ~p~~~~~l~~L~~L~ls~N~  524 (985)
                      .|..|..+++|+.+++++|+
T Consensus       312 ~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          312 QPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             CGGGGTTBCCSTTEEC----
T ss_pred             Ccccccccchhhhhhccccc
Confidence            66667777777777777664

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=7.3e-36  Score=349.16  Aligned_cols=361  Identities=19%  Similarity=0.150  Sum_probs=185.6

Q ss_pred             CCceEEEcccccCCCccccc-cccccccceEeeccccccC----CchhhhcCCCCCCEEEecCCcCcccCcccccCCCCC
Q 001988          194 KQLQELHLGYNNLSGAIPKE-IGNLTVLQRISLINNKLHG----EIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTL  268 (985)
Q Consensus       194 ~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L  268 (985)
                      ++|++|+|++|+++...... +..+++|++|++++|++++    .++..+..+++|++|+|++|.+++..+         
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~---------   73 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGV---------   73 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHH---------
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHH---------
Confidence            45666666666665433222 4555666666666666553    234445555555555555555554333         


Q ss_pred             CEEEccCCcCcccCChhhhhcCC----CCcEEEecCccCCC----cCCccccCCCCccEEEccCcccccccCCccc----
Q 001988          269 KEIFLYNNSLSGSLPSRIDLALP----NLEFLNLGINSFSG----TIPSSITNASKLILLEMGSNSFSGFIPSAIG----  336 (985)
Q Consensus       269 ~~L~L~~N~l~~~~p~~~~~~l~----~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~----  336 (985)
                                     ..+...++    +|++|+|++|+++.    .++..+..+++|++|++++|.+++..+..+.    
T Consensus        74 ---------------~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~  138 (461)
T 1z7x_W           74 ---------------HCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLL  138 (461)
T ss_dssp             ---------------HHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHT
T ss_pred             ---------------HHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHh
Confidence                           22222233    35555555555542    3355555666666666666666543333222    


Q ss_pred             -CCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCC
Q 001988          337 -NLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGN  415 (985)
Q Consensus       337 -~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~  415 (985)
                       ..++|++|++++|+++..... .+...+..+++|++|++++|.+....+..+.....                    ..
T Consensus       139 ~~~~~L~~L~L~~n~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~--------------------~~  197 (461)
T 1z7x_W          139 DPQCRLEKLQLEYCSLSAASCE-PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLK--------------------DS  197 (461)
T ss_dssp             STTCCCCEEECTTSCCBGGGHH-HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHH--------------------HS
T ss_pred             cCCCcceEEECCCCCCCHHHHH-HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHh--------------------cC
Confidence             244566666666665543211 12233455667777777777665432222211000                    01


Q ss_pred             CCCccEEEccCCCCCCC----CCccccccccccceecccccccCCchh-----hhhhccCCCeEEccCCccccc----cC
Q 001988          416 LSNLIVLSLGGNNLSGS----IPVTFGGLQKLQGLDLAFNKLAGSIPD-----EICLLSRLNELDLNGNKISGS----IS  482 (985)
Q Consensus       416 l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~-----~~~~l~~L~~L~L~~N~l~~~----~~  482 (985)
                      .++|++|++++|.+++.    ++..+..+++|++|++++|.+.+....     .+..+++|++|++++|++++.    ++
T Consensus       198 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~  277 (461)
T 1z7x_W          198 PCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC  277 (461)
T ss_dssp             CCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred             CCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHH
Confidence            23445555555554432    233444445555555555554432111     111244555555555555432    33


Q ss_pred             CCCcCcCcCceEeeccceeeeecCCCccC-----ccceeEEeecCCcccCC----ccccccCCCcccEEEccCCccCccC
Q 001988          483 SCLGNLTSLQYLNLGSNRFTFVIPSTFWN-----LKDILSFDISSNLLDGP----ISLAIGNLKAVVGIDLSRNNLSGNI  553 (985)
Q Consensus       483 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~  553 (985)
                      ..+..+++|++|++++|.++...+..+..     .++|++|++++|.+++.    .+..+..+++|+.|+|++|++++..
T Consensus       278 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~  357 (461)
T 1z7x_W          278 RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG  357 (461)
T ss_dssp             HHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHH
T ss_pred             HHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccccc
Confidence            34444555555555555554332222221     23555555555555543    2334555667777777777766554


Q ss_pred             chhhcc-----cccceeeeeecceecc----chhhhhhcccccCeEecCCCcccC
Q 001988          554 PTTLEG-----LKSLQNISLAYNRLEG----PIPESFGNMTSLESLDLSNNKISG  599 (985)
Q Consensus       554 p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~  599 (985)
                      +..+..     .++|++|+|++|++++    .+|..+..+++|++|||++|++++
T Consensus       358 ~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~  412 (461)
T 1z7x_W          358 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD  412 (461)
T ss_dssp             HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             HHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence            544443     4577777777777775    567777777777777777777764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.5e-33  Score=315.10  Aligned_cols=232  Identities=22%  Similarity=0.288  Sum_probs=192.1

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCce----
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFK----  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~----  797 (985)
                      .++|...+.||+|+||.||+|... +|+.||||++......  ..+.+.+|+.++++++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467889999999999999999865 7899999999765332  356788999999999999999999999877654    


Q ss_pred             --EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          798 --ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       798 --~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                        ++||||++ ++|.+.+..   .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYI---HSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999996 688887753   489999999999999999999   788999999999999999999999999999986


Q ss_pred             ccCCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh-----------------
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------------  937 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------------  937 (985)
                      ....     .....||+.|+|||.+.+ ..++.++|+ |++|+++++++++..++........                 
T Consensus       194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (371)
T 4exu_A          194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDI-WSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  267 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             cccC-----cCCcccCccccCHHHhcCCCCCCcHHhH-HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence            5322     234568999999999887 788999999 9999999999998876643321110                 


Q ss_pred             -------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          938 -------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       938 -------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                               ...+++++.+++.+|+..||.+||++.|+++.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                                     01235778999999999999999999999864

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.1e-33  Score=313.68  Aligned_cols=237  Identities=22%  Similarity=0.284  Sum_probs=194.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----Cce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSND-----DFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~  797 (985)
                      .++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999975 789999999975432 2356788999999999999999999988654     678


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceecc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLS  877 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~  877 (985)
                      ++||||++ |+|.+++...  .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+.
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVL---HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999996 6999998764  589999999999999999999   78899999999999999999999999999998865


Q ss_pred             CCCCcc--------eeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhh------------
Q 001988          878 GEDEST--------MRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------  936 (985)
Q Consensus       878 ~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------  936 (985)
                      ......        .....+||+.|+|||.+.. ..++.++|+ |++|+++++++++..+........            
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDV-WSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhH-HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            322111        1223468999999998765 778999999 999999999999886554321100            


Q ss_pred             -------------------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 -------------------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 -------------------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                     ....++.++.+++.+||..||++||++.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                                           00134567889999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7e-33  Score=309.75  Aligned_cols=234  Identities=19%  Similarity=0.268  Sum_probs=196.9

Q ss_pred             hcCccCCceeeccCceeEEEEEE-c-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCC------CeeeEEeeeecCCc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-E-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHR------NLVKIISSCSNDDF  796 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~------niv~l~~~~~~~~~  796 (985)
                      .++|+..+.||+|+||.||+|.. . +++.||||+++.. ....+.+.+|++++++++|+      +++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999986 3 6889999999754 33456788999999998765      49999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC--------------
Q 001988          797 KALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE--------------  861 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~--------------  861 (985)
                      .++||||+ +++|.+++...+ ..+++..+..++.|++.||+||   |++||+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL---HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 889999998764 3688999999999999999999   7889999999999999987              


Q ss_pred             -----CCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh
Q 001988          862 -----DMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA  936 (985)
Q Consensus       862 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~  936 (985)
                           ++.+||+|||+++.....     .....||+.|+|||.+.+..++.++|+ |++|+++++++++..+........
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDV-WSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHH-HHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhh-HHHHHHHHHHHhCCCCCCCCChHH
Confidence                 678999999999875322     233569999999999999999999999 999999999999876554321110


Q ss_pred             h-------------------------------------------------------HHHHHHHHHHHHHHccCCCCCCCC
Q 001988          937 A-------------------------------------------------------KEQCLLSIFSLALECTMESPEKRI  961 (985)
Q Consensus       937 ~-------------------------------------------------------~~~~~~~l~~l~~~cl~~~P~~RP  961 (985)
                      .                                                       ...+++++.+++.+||..||.+||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            0                                                       112357789999999999999999


Q ss_pred             CHHHHHHH
Q 001988          962 DAKDTITR  969 (985)
Q Consensus       962 t~~ev~~~  969 (985)
                      ++.|+++.
T Consensus       322 t~~ell~h  329 (339)
T 1z57_A          322 TLREALKH  329 (339)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99999853

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=8.1e-33  Score=312.18  Aligned_cols=244  Identities=21%  Similarity=0.268  Sum_probs=186.3

Q ss_pred             HHHHHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCc-
Q 001988          719 FELLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDF-  796 (985)
Q Consensus       719 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-  796 (985)
                      .+.....++|...+.||+|+||.||+|+.. +++.||||++.... .......+|++.++.++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            455667789999999999999999999975 78999999986542 233456778888899999999999999965433 


Q ss_pred             ------eEEEEeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-CCcEE
Q 001988          797 ------KALVLEYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAH  866 (985)
Q Consensus       797 ------~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~-~~~~k  866 (985)
                            .++||||+++ ++.+.+..   ....+++..+..++.|++.||.|||. |++||+||||||+||+++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEE
Confidence                  7899999976 55544432   34568899999999999999999942 3999999999999999997 89999


Q ss_pred             EecccCceeccCCCCcceecccccccccccccccccCc-cchhhhcccccccchhhhcccccccCcchhhhhHH------
Q 001988          867 LSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE-LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKE------  939 (985)
Q Consensus       867 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~~------  939 (985)
                      |+|||+++.+.....   .....||+.|+|||.+.+.. ++.++|+ |++|+++++++++..++..........      
T Consensus       173 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di-~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDI-WSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             ECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHH-HHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            999999987653322   23456899999999987654 8999999 999999999999987654432111110      


Q ss_pred             -------------------------------------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          940 -------------------------------------QCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       940 -------------------------------------~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                                           .+++++.+++.+||..||.+||++.|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                                                 035679999999999999999999999863

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.7e-33  Score=320.61  Aligned_cols=233  Identities=20%  Similarity=0.257  Sum_probs=194.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcC--------CCCeeeEEeeee---
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIR--------HRNLVKIISSCS---  792 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~--------h~niv~l~~~~~---  792 (985)
                      .++|...+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|++++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            467999999999999999999864 7889999999754 334567889999999985        788999999987   


Q ss_pred             -cCCceEEEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCEEEcCCC------
Q 001988          793 -NDDFKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHST-PIIHCDLKPSNVLLDEDM------  863 (985)
Q Consensus       793 -~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~-~ivHrDlk~~Nill~~~~------  863 (985)
                       .....++||||+ ++++.+++... ...+++..+..++.||+.||+||   |++ ||+||||||+|||++.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL---HTKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HHhCCEecCCCCHHHeeEeccchhhhhh
Confidence             556789999999 56676666544 35689999999999999999999   677 999999999999999775      


Q ss_pred             -------------------------------------------cEEEecccCceeccCCCCcceeccccccccccccccc
Q 001988          864 -------------------------------------------VAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI  900 (985)
Q Consensus       864 -------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~  900 (985)
                                                                 .+||+|||+++.....     ....+||+.|+|||.+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence                                                       7999999999876422     2334699999999999


Q ss_pred             ccCccchhhhcccccccchhhhcccccccCcchhh---------------------------------------------
Q 001988          901 FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------------------------------------  935 (985)
Q Consensus       901 ~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------------------------------------  935 (985)
                      .+..++.++|+ |++|+++++++++..++......                                             
T Consensus       266 ~~~~~~~~~Di-wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          266 IGSGYNTPADI-WSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HTSCCCTHHHH-HHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             cCCCCCcHHHH-HHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            99999999999 99999999999998765421100                                             


Q ss_pred             --------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          936 --------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       936 --------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                    ..+...+..+.+++.+||..||++|||+.|+++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                          012345677899999999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.2e-33  Score=317.67  Aligned_cols=234  Identities=24%  Similarity=0.342  Sum_probs=188.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCC------ceE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDD------FKA  798 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------~~~  798 (985)
                      ..+|...+.||+|+||.||+|+..++..||+|++.....    ...+|++++++++||||+++++++...+      ..+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            357889999999999999999988777899998865422    2247999999999999999999985433      378


Q ss_pred             EEEeccCCCChHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc-CCCcEEEecccCcee
Q 001988          799 LVLEYMSNGSLEDCLH--SSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHLSDFGMAKL  875 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~-~~~~~kl~DfGla~~  875 (985)
                      +||||++++.+.....  .....+++..+..++.|+++||+||   |++||+||||||+||+++ .++.+||+|||+|+.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI---HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999998754333322  2245789999999999999999999   789999999999999999 899999999999988


Q ss_pred             ccCCCCcceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhhhH----------------
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK----------------  938 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~----------------  938 (985)
                      +.....   .....||+.|+|||.+.+. .++.++|+ |++|+++++++++..++.........                
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDI-WSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            643322   2345689999999998764 58999999 99999999999998766543211110                


Q ss_pred             ------------------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          939 ------------------------EQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       939 ------------------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                              ...++++.+++.+||..||.+||++.|+++.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                                    1145679999999999999999999999863

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=8.2e-33  Score=307.53  Aligned_cols=237  Identities=24%  Similarity=0.345  Sum_probs=196.2

Q ss_pred             HhcCccCCceeeccCceeEEEEEE--cCCcEEEEEEeccCCcc--hHHHHHHHHHHHHhc---CCCCeeeEEeeee----
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARL--EDGVEIAIKVFHPQCAS--TLKSFEAECEVIKNI---RHRNLVKIISSCS----  792 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l---~h~niv~l~~~~~----  792 (985)
                      +.++|...+.||+|+||.||+|+.  .+++.||+|+++.....  ....+.+|+.+++++   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            567899999999999999999997  46889999998754221  234567888888776   8999999999987    


Q ss_pred             -cCCceEEEEeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 001988          793 -NDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDF  870 (985)
Q Consensus       793 -~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~Df  870 (985)
                       .....++||||++ |+|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCHHHeEEcCCCCEEEecC
Confidence             4567899999997 69999998653 3589999999999999999999   7889999999999999999999999999


Q ss_pred             cCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh-------------
Q 001988          871 GMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-------------  937 (985)
Q Consensus       871 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-------------  937 (985)
                      |+++....   ........||+.|+|||.+.+..++.++|+ |++|+++++++++..++........             
T Consensus       165 g~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (326)
T 1blx_A          165 GLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDL-WSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  240 (326)
T ss_dssp             CSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             cccccccC---CCCccccccccceeCHHHHhcCCCCcchhH-HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence            99987532   122334568999999999999999999999 9999999999998876543221110             


Q ss_pred             -------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 -------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 -------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                               ...++..+.+++.+||..||.+||++.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                                     0124567889999999999999999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.2e-33  Score=318.33  Aligned_cols=232  Identities=24%  Similarity=0.338  Sum_probs=187.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecC------Cce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSND------DFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~~~  797 (985)
                      ..+|...+.||+|+||.||+|++. +++.||||++....    ....+|++++++++||||+++++++...      .+.
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            346888999999999999999975 68999999986542    2234799999999999999999988532      236


Q ss_pred             EEEEeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-CcEEEecccCc
Q 001988          798 ALVLEYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMA  873 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~-~~~kl~DfGla  873 (985)
                      ++||||+++ ++.+.+..   ....+++..+..++.||++||+||   |++||+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999975 66665542   345789999999999999999999   78999999999999999965 67899999999


Q ss_pred             eeccCCCCcceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhhhH--------------
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK--------------  938 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~--------------  938 (985)
                      +.+.....   ....+||+.|+|||++.+. .++.++|+ |++|++++++++|+.++.........              
T Consensus       205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDV-WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhh-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            98643222   2345689999999998764 78999999 99999999999998765433211100              


Q ss_pred             --------------------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          939 --------------------------EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       939 --------------------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                ...+.++.+++.+||..||.+||++.|+++
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                                      112467899999999999999999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.4e-33  Score=301.50  Aligned_cols=237  Identities=21%  Similarity=0.275  Sum_probs=199.8

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ...++|+..+.||+|+||.||+|+.. +++.||+|++....  ......+.+|++++++++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34578999999999999999999976 78999999987542  2345778999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC---CcEEEecccCceec
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED---MVAHLSDFGMAKLL  876 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~---~~~kl~DfGla~~~  876 (985)
                      ||||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.+   +.+||+|||+++..
T Consensus        99 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            999999999999887654 689999999999999999999   78899999999999999754   47999999999876


Q ss_pred             cCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh---------------hhHHHH
Q 001988          877 SGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AAKEQC  941 (985)
Q Consensus       877 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~~~~~  941 (985)
                      .....   .....||+.|+|||.+.+ .++.++|+ |++|+++++++++..+.......               +....+
T Consensus       175 ~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di-~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (287)
T 2wei_A          175 QQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDV-WSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI  249 (287)
T ss_dssp             CCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTS
T ss_pred             cCCCc---cccccCcccccChHHhcC-CCCCchhh-HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhc
Confidence            43222   223458999999998754 58899999 99999999999988765432211               111235


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          942 LLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       942 ~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ++++.+++.+|+..||.+||++.|+++
T Consensus       250 ~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          250 SDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            678999999999999999999999987

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=7.5e-32  Score=300.42  Aligned_cols=295  Identities=22%  Similarity=0.298  Sum_probs=184.7

Q ss_pred             cccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEe
Q 001988          170 RYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQL  249 (985)
Q Consensus       170 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  249 (985)
                      .+|+.++++++.++ .+|..+.  ++|++|+|++|++++..|..|+++++|++|++++|++++..|..|+++++|++|++
T Consensus        33 c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  109 (332)
T 2ft3_A           33 CHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI  109 (332)
T ss_dssp             EETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred             ccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence            36777777777776 6776664  57788888888887666677888888888888888887777777888888888888


Q ss_pred             cCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCC--CcCCccccCCCCccEEEccCccc
Q 001988          250 GFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFS--GTIPSSITNASKLILLEMGSNSF  327 (985)
Q Consensus       250 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l  327 (985)
                      ++|+++ .+|..+.  ++|++|++++|+++ .+|...+..+++|+.|++++|.++  +..+..+..+ +|+.|++++|++
T Consensus       110 ~~n~l~-~l~~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l  184 (332)
T 2ft3_A          110 SKNHLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL  184 (332)
T ss_dssp             CSSCCC-SCCSSCC--TTCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred             CCCcCC-ccCcccc--ccCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence            888877 4555554  67888888888887 566555667888888888888875  3567777777 888888888888


Q ss_pred             ccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceecccccccc
Q 001988          328 SGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISG  407 (985)
Q Consensus       328 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~  407 (985)
                      ++ +|..+.  ++|++|++++|+++...+.     .+.++++|++|++++|++.+..+..+..++ +|++|++++|+++ 
T Consensus       185 ~~-l~~~~~--~~L~~L~l~~n~i~~~~~~-----~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~-  254 (332)
T 2ft3_A          185 TG-IPKDLP--ETLNELHLDHNKIQAIELE-----DLLRYSKLYRLGLGHNQIRMIENGSLSFLP-TLRELHLDNNKLS-  254 (332)
T ss_dssp             SS-CCSSSC--SSCSCCBCCSSCCCCCCTT-----SSTTCTTCSCCBCCSSCCCCCCTTGGGGCT-TCCEEECCSSCCC-
T ss_pred             Cc-cCcccc--CCCCEEECCCCcCCccCHH-----HhcCCCCCCEEECCCCcCCcCChhHhhCCC-CCCEEECCCCcCe-
Confidence            85 444443  6777777777777765432     245555666666666655544444444443 4444444444444 


Q ss_pred             ccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccc--cccCCCC
Q 001988          408 NIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKIS--GSISSCL  485 (985)
Q Consensus       408 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~~~~~  485 (985)
                      .+|..+..+++|++|++++|+|++..+..|....-                  -....+|+.|++++|.+.  +..|..|
T Consensus       255 ~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~------------------~~~~~~l~~L~l~~N~~~~~~~~~~~~  316 (332)
T 2ft3_A          255 RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGF------------------GVKRAYYNGISLFNNPVPYWEVQPATF  316 (332)
T ss_dssp             BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSC------------------CSSSCCBSEEECCSSSSCGGGSCGGGG
T ss_pred             ecChhhhcCccCCEEECCCCCCCccChhHcccccc------------------ccccccccceEeecCcccccccCcccc
Confidence            33444444444444444444444433333332100                  000234555666666554  4445556


Q ss_pred             cCcCcCceEeeccce
Q 001988          486 GNLTSLQYLNLGSNR  500 (985)
Q Consensus       486 ~~l~~L~~L~L~~N~  500 (985)
                      ..+++|+.+++++|+
T Consensus       317 ~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          317 RCVTDRLAIQFGNYK  331 (332)
T ss_dssp             TTBCCSTTEEC----
T ss_pred             cccchhhhhhccccc
Confidence            666666666666553

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.98  E-value=4.9e-33  Score=318.90  Aligned_cols=237  Identities=20%  Similarity=0.269  Sum_probs=177.9

Q ss_pred             cCccC-CceeeccCceeEEEEEEc---CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeee--cCCceEE
Q 001988          726 DNFAE-NNIIGIGGFGSVYRARLE---DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS--NDDFKAL  799 (985)
Q Consensus       726 ~~~~~-~~~ig~G~~g~V~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~--~~~~~~l  799 (985)
                      +.|.. +++||+|+||.||+|+..   +++.||||++.....  ...+.+|++++++++||||+++++++.  .....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34555 568999999999999965   578899999975532  356889999999999999999999994  4678899


Q ss_pred             EEeccCCCChHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE----cCCCcEEE
Q 001988          800 VLEYMSNGSLEDCLHSS--------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL----DEDMVAHL  867 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill----~~~~~~kl  867 (985)
                      ||||++ |+|.+++...        ...+++..++.++.||+.||+||   |++||+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999996 5888877532        22489999999999999999999   78999999999999999    77899999


Q ss_pred             ecccCceeccCCCC-cceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhh---------h
Q 001988          868 SDFGMAKLLSGEDE-STMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------A  936 (985)
Q Consensus       868 ~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------~  936 (985)
                      +|||+|+.+..... .......+||+.|+|||.+.+ ..++.++|+ |++|+++++++++..++......         .
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di-wSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDI-WAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHH-HHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhh-HHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            99999987653221 122344679999999999887 458999999 99999999999988765321100         0


Q ss_pred             h------------------------HH-------------------------HHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001988          937 A------------------------KE-------------------------QCLLSIFSLALECTMESPEKRIDAKDTI  967 (985)
Q Consensus       937 ~------------------------~~-------------------------~~~~~l~~l~~~cl~~~P~~RPt~~ev~  967 (985)
                      .                        ..                         ...+++.+++.+||..||.+|||+.|++
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            0                        00                         0145678999999999999999999998


Q ss_pred             HH
Q 001988          968 TR  969 (985)
Q Consensus       968 ~~  969 (985)
                      +.
T Consensus       333 ~h  334 (405)
T 3rgf_A          333 QD  334 (405)
T ss_dssp             TS
T ss_pred             cC
Confidence            63

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.98  E-value=8.7e-32  Score=299.70  Aligned_cols=290  Identities=23%  Similarity=0.259  Sum_probs=155.4

Q ss_pred             cccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEe
Q 001988          170 RYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQL  249 (985)
Q Consensus       170 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  249 (985)
                      .+++.++++++.++ .+|..+.  ++|++|+|++|++++..+..|+++++|++|++++|++++..|..|+.+++|++|++
T Consensus        31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (330)
T 1xku_A           31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL  107 (330)
T ss_dssp             EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence            35666666666665 4555443  45566666666666544445555666666666666655555555555555555555


Q ss_pred             cCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCccccc
Q 001988          250 GFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSG  329 (985)
Q Consensus       250 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  329 (985)
                      ++|+++ .+|..+.  +                         +|++|++++|++++..+..+.++++|+.|++++|.+..
T Consensus       108 s~n~l~-~l~~~~~--~-------------------------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  159 (330)
T 1xku_A          108 SKNQLK-ELPEKMP--K-------------------------TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS  159 (330)
T ss_dssp             CSSCCS-BCCSSCC--T-------------------------TCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG
T ss_pred             CCCcCC-ccChhhc--c-------------------------cccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc
Confidence            555555 2333322  3                         44444444444444444444555555555555555532


Q ss_pred             --ccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceecccccccc
Q 001988          330 --FIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISG  407 (985)
Q Consensus       330 --~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~  407 (985)
                        ..+..+.++++|++|++++|+++.++...        .++                         |++|++++|.+++
T Consensus       160 ~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~--------~~~-------------------------L~~L~l~~n~l~~  206 (330)
T 1xku_A          160 SGIENGAFQGMKKLSYIRIADTNITTIPQGL--------PPS-------------------------LTELHLDGNKITK  206 (330)
T ss_dssp             GGBCTTGGGGCTTCCEEECCSSCCCSCCSSC--------CTT-------------------------CSEEECTTSCCCE
T ss_pred             cCcChhhccCCCCcCEEECCCCccccCCccc--------ccc-------------------------CCEEECCCCcCCc
Confidence              44555556666666666666555433211        133                         4444444444444


Q ss_pred             ccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcC
Q 001988          408 NIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGN  487 (985)
Q Consensus       408 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  487 (985)
                      ..|..|..+++|++|+|++|++++..+..|..+++|++|+|++|+++ .+|..+..+++|++|++++|+|++..+..|..
T Consensus       207 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~  285 (330)
T 1xku_A          207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP  285 (330)
T ss_dssp             ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSC
T ss_pred             cCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCC
Confidence            44455555555566666666555555555555556666666666655 45555555566666666666665554444432


Q ss_pred             ------cCcCceEeeccceeee--ecCCCccCccceeEEeecCCc
Q 001988          488 ------LTSLQYLNLGSNRFTF--VIPSTFWNLKDILSFDISSNL  524 (985)
Q Consensus       488 ------l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls~N~  524 (985)
                            .+.|+.|++++|.+..  +.|..|..+.+++.+++++|+
T Consensus       286 ~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          286 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             SSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             cccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence                  2556666666666643  445566666666666666663

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.98  E-value=1.4e-35  Score=346.85  Aligned_cols=390  Identities=18%  Similarity=0.135  Sum_probs=205.3

Q ss_pred             ccceeeeccccccCCCChhHhhhccccceecccCccccc----cCCcccCCCCCceEEEcccccCCCccccccc-ccc--
Q 001988          146 SILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYG----KIPSSLSKCKQLQELHLGYNNLSGAIPKEIG-NLT--  218 (985)
Q Consensus       146 ~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~--  218 (985)
                      +|++|||++|+++......++..+++|++|+|++|.+++    .+|..+..+++|++|+|++|.+++..+..+. .++  
T Consensus         4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~   83 (461)
T 1z7x_W            4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   83 (461)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence            344444444444433334445666777777777777663    3455666667777777777777654443332 233  


Q ss_pred             --ccceEeeccccccC----CchhhhcCCCCCCEEEecCCcCcccCccccc-----CCCCCCEEEccCCcCcccCChh--
Q 001988          219 --VLQRISLINNKLHG----EIPQEIGYLQNLDVLQLGFNNLTGVVPATIF-----NMSTLKEIFLYNNSLSGSLPSR--  285 (985)
Q Consensus       219 --~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-----~l~~L~~L~L~~N~l~~~~p~~--  285 (985)
                        +|++|+|++|+++.    .+|..+..+++|++|+|++|.+++..+..+.     ..++|++|+|++|++++..+..  
T Consensus        84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~  163 (461)
T 1z7x_W           84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA  163 (461)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence              47777777777663    4566666777777777777776654333332     2445666666666666432211  


Q ss_pred             -hhhcCCCCcEEEecCccCCCcCCcccc-----CCCCccEEEccCcccccc----cCCcccCCCCCceEeccCCcccCCC
Q 001988          286 -IDLALPNLEFLNLGINSFSGTIPSSIT-----NASKLILLEMGSNSFSGF----IPSAIGNLRNLKLFDIFFNNLTSST  355 (985)
Q Consensus       286 -~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~  355 (985)
                       .+..+++|++|++++|.+++..+..+.     ..++|+.|++++|.+++.    ++..+..+++|++|++++|+++...
T Consensus       164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~  243 (461)
T 1z7x_W          164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG  243 (461)
T ss_dssp             HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred             HHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHH
Confidence             122356666666666665544333332     134556666666655542    3444455555555555555544321


Q ss_pred             Ccccccc-cccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCC
Q 001988          356 PELGFLS-SLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIP  434 (985)
Q Consensus       356 ~~~~~~~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  434 (985)
                      ... +.. .+..+++|++|++++|.++.....                     .++..+..+++|++|+|++|.+++..+
T Consensus       244 ~~~-l~~~~~~~~~~L~~L~L~~n~l~~~~~~---------------------~l~~~l~~~~~L~~L~Ls~n~i~~~~~  301 (461)
T 1z7x_W          244 MAE-LCPGLLHPSSRLRTLWIWECGITAKGCG---------------------DLCRVLRAKESLKELSLAGNELGDEGA  301 (461)
T ss_dssp             HHH-HHHHHTSTTCCCCEEECTTSCCCHHHHH---------------------HHHHHHHHCTTCCEEECTTCCCHHHHH
T ss_pred             HHH-HHHHHhcCCCCceEEECcCCCCCHHHHH---------------------HHHHHHhhCCCcceEECCCCCCchHHH
Confidence            100 000 011244455555555544421000                     023344445555666666655543333


Q ss_pred             cccccc-----ccccceecccccccCC----chhhhhhccCCCeEEccCCccccccCCCCcC-----cCcCceEeeccce
Q 001988          435 VTFGGL-----QKLQGLDLAFNKLAGS----IPDEICLLSRLNELDLNGNKISGSISSCLGN-----LTSLQYLNLGSNR  500 (985)
Q Consensus       435 ~~~~~l-----~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~  500 (985)
                      ..+...     ++|++|++++|.+++.    ++..+..+++|++|+|++|++++..+..+..     .++|++|++++|+
T Consensus       302 ~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~  381 (461)
T 1z7x_W          302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD  381 (461)
T ss_dssp             HHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred             HHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence            333221     4566666666665543    3444555566666666666665443333321     4566666666666


Q ss_pred             eee----ecCCCccCccceeEEeecCCcccCCccccc-----cCCCcccEEEccCCccCccCchhh
Q 001988          501 FTF----VIPSTFWNLKDILSFDISSNLLDGPISLAI-----GNLKAVVGIDLSRNNLSGNIPTTL  557 (985)
Q Consensus       501 l~~----~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~p~~~  557 (985)
                      +++    .+|..+..+++|++|++++|++++.....+     ....+|+.|++.++.+....+..+
T Consensus       382 i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~~l  447 (461)
T 1z7x_W          382 VSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL  447 (461)
T ss_dssp             CCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred             CChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHHHH
Confidence            664    455556666666777777766654321111     123457777777777665444433

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.98  E-value=2e-31  Score=296.78  Aligned_cols=253  Identities=21%  Similarity=0.250  Sum_probs=160.3

Q ss_pred             hccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEE
Q 001988          168 HLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVL  247 (985)
Q Consensus       168 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  247 (985)
                      ++++|++|+|++|.+++..|..|+++++|++|+|++|+++ .+|..+.  ++|++|++++|++++..+..|.++++|++|
T Consensus        74 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  150 (330)
T 1xku_A           74 NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVV  150 (330)
T ss_dssp             TCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEE
T ss_pred             cCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEE
Confidence            3444444444444554455666666677777777777766 4555444  567777777777776666677777777777


Q ss_pred             EecCCcCcc--cCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCc
Q 001988          248 QLGFNNLTG--VVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSN  325 (985)
Q Consensus       248 ~Ls~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  325 (985)
                      ++++|.++.  ..+..+.++++|++|++++|+++ .+|..+.   ++|++|++++|++++..|..+..+++|+.|++++|
T Consensus       151 ~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n  226 (330)
T 1xku_A          151 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN  226 (330)
T ss_dssp             ECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSS
T ss_pred             ECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCC
Confidence            777777753  56677777777777777777776 4555432   67777888877777777777777777888888888


Q ss_pred             ccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceecccccc
Q 001988          326 SFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNI  405 (985)
Q Consensus       326 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l  405 (985)
                      ++++..+..+..+++|++|++++|+++.++.      .+..+++|++|++++|++++..+..+....             
T Consensus       227 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~------~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~-------------  287 (330)
T 1xku_A          227 SISAVDNGSLANTPHLRELHLNNNKLVKVPG------GLADHKYIQVVYLHNNNISAIGSNDFCPPG-------------  287 (330)
T ss_dssp             CCCEECTTTGGGSTTCCEEECCSSCCSSCCT------TTTTCSSCCEEECCSSCCCCCCTTSSSCSS-------------
T ss_pred             cCceeChhhccCCCCCCEEECCCCcCccCCh------hhccCCCcCEEECCCCcCCccChhhcCCcc-------------
Confidence            7777766677777777777777777665443      244556666666666666544333332110             


Q ss_pred             ccccCCcCCCCCCccEEEccCCCCCC--CCCccccccccccceeccccc
Q 001988          406 SGNIPKAIGNLSNLIVLSLGGNNLSG--SIPVTFGGLQKLQGLDLAFNK  452 (985)
Q Consensus       406 ~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~  452 (985)
                            .....+.|+.|++++|.+..  ..|..|..+.+++.++|++|+
T Consensus       288 ------~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          288 ------YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             ------CCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             ------cccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence                  01123556667777776642  445566666666666666663

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.98  E-value=2.4e-33  Score=310.76  Aligned_cols=237  Identities=21%  Similarity=0.247  Sum_probs=199.0

Q ss_pred             HHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc------hHHHHHHHHHHHHhcC--CCCeeeEEeeeec
Q 001988          723 RATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS------TLKSFEAECEVIKNIR--HRNLVKIISSCSN  793 (985)
Q Consensus       723 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~--h~niv~l~~~~~~  793 (985)
                      ...++|+..+.||+|+||.||+|+.. +++.||||++......      ....+.+|++++++++  ||||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            34578999999999999999999864 7899999999755321      2245678999999996  5999999999999


Q ss_pred             CCceEEEEeccCC-CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc-CCCcEEEeccc
Q 001988          794 DDFKALVLEYMSN-GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHLSDFG  871 (985)
Q Consensus       794 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~-~~~~~kl~DfG  871 (985)
                      .+..++||||+.+ ++|.+++...+ .+++..+..++.|+++||+||   |+.||+||||||+||+++ +++.+||+|||
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            9999999999976 89999998753 689999999999999999999   789999999999999999 78999999999


Q ss_pred             CceeccCCCCcceecccccccccccccccccCcc-chhhhcccccccchhhhcccccccCcchhhh-----hHHHHHHHH
Q 001988          872 MAKLLSGEDESTMRTQTLATIGYMAPDEIFVGEL-SLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----AKEQCLLSI  945 (985)
Q Consensus       872 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----~~~~~~~~l  945 (985)
                      +++......    .....||+.|+|||.+....+ +.++|+ |++|+++++++++..++.......     .+..+++++
T Consensus       196 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di-~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  270 (320)
T 3a99_A          196 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAV-WSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC  270 (320)
T ss_dssp             TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHH-HHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHH
T ss_pred             ccccccccc----ccCCCCCccCCChHHhccCCCCCccchH-HhHHHHHHHHHHCCCCCCChhhhhcccccccccCCHHH
Confidence            998864322    233569999999999887776 678899 999999999999887654332110     112356779


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHH
Q 001988          946 FSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+++.+||..||++||++.|+++
T Consensus       271 ~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          271 QHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHccCChhhCcCHHHHhc
Confidence            99999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.98  E-value=4.4e-33  Score=307.69  Aligned_cols=238  Identities=21%  Similarity=0.274  Sum_probs=191.4

Q ss_pred             HHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc------hHHHHHHHHHHHHhc----CCCCeeeEEee
Q 001988          722 LRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS------TLKSFEAECEVIKNI----RHRNLVKIISS  790 (985)
Q Consensus       722 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~E~~il~~l----~h~niv~l~~~  790 (985)
                      ....++|...+.||+|+||.||+|+.. +++.||||+++.....      ....+.+|+++++++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            345678999999999999999999864 7899999999765322      223456799999999    89999999999


Q ss_pred             eecCCceEEEEec-cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc-CCCcEEEe
Q 001988          791 CSNDDFKALVLEY-MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHLS  868 (985)
Q Consensus       791 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~-~~~~~kl~  868 (985)
                      +...+..++|||| +++++|.+++...+ .+++..+..++.|+++||+||   |++||+||||||+||+++ .++.+||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHC---HSRGVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHHTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChhhEEEeCCCCeEEEE
Confidence            9999999999999 78999999998754 689999999999999999999   788999999999999999 89999999


Q ss_pred             cccCceeccCCCCcceecccccccccccccccccCccc-hhhhcccccccchhhhcccccccCcchhh-----hhHHHHH
Q 001988          869 DFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELS-LKRWVNDLLPVSLVEVVDKSLLSGEEKHF-----AAKEQCL  942 (985)
Q Consensus       869 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-----~~~~~~~  942 (985)
                      |||+++.+....    .....||+.|+|||.+.+..+. .++|+ |++|+++++++++..+.......     ..+..++
T Consensus       183 dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  257 (312)
T 2iwi_A          183 DFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATV-WSLGILLYDMVCGDIPFERDQEILEAELHFPAHVS  257 (312)
T ss_dssp             CCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHH-HHHHHHHHHHHHSSCSCCSHHHHHHTCCCCCTTSC
T ss_pred             EcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchH-HHHHHHHHHHHHCCCCCCChHHHhhhccCCcccCC
Confidence            999998875322    2345699999999998877764 58899 99999999999988765432211     1123356


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          943 LSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       943 ~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .++.+++.+||..+|++||++.|+++
T Consensus       258 ~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          258 PDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            77999999999999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.98  E-value=2.7e-32  Score=307.13  Aligned_cols=233  Identities=19%  Similarity=0.252  Sum_probs=194.5

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CC-cEEEEEEeccCCcchHHHHHHHHHHHHhcCCCC------eeeEEeeeecCCc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DG-VEIAIKVFHPQCASTLKSFEAECEVIKNIRHRN------LVKIISSCSNDDF  796 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~-~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~n------iv~l~~~~~~~~~  796 (985)
                      .++|...+.||+|+||.||+|... ++ +.||+|+++.. ......+.+|++++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999875 44 78999999754 334567889999999997665      9999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE----------------
Q 001988          797 KALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL----------------  859 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill----------------  859 (985)
                      .++||||+ ++++.+++... ...+++..+..++.|++.||+||   |++||+||||||+||++                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~l---H~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL---HENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 66777777655 35689999999999999999999   78999999999999999                


Q ss_pred             ---cCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh
Q 001988          860 ---DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA  936 (985)
Q Consensus       860 ---~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~  936 (985)
                         +.++.+||+|||+++.....     .....||+.|+|||.+.+..++.++|+ |++|+++++++++..+........
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDV-WSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHH-HHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccch-HHHHHHHHHHHhCCCCCCCCCHHH
Confidence               67889999999999875322     233569999999999999999999999 999999999999887654322111


Q ss_pred             h-------------------------------------------------------HHHHHHHHHHHHHHccCCCCCCCC
Q 001988          937 A-------------------------------------------------------KEQCLLSIFSLALECTMESPEKRI  961 (985)
Q Consensus       937 ~-------------------------------------------------------~~~~~~~l~~l~~~cl~~~P~~RP  961 (985)
                      .                                                       ...++.++.+++.+||..||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            0                                                       011245788999999999999999


Q ss_pred             CHHHHHH
Q 001988          962 DAKDTIT  968 (985)
Q Consensus       962 t~~ev~~  968 (985)
                      |+.|+++
T Consensus       327 t~~e~l~  333 (355)
T 2eu9_A          327 TLAEALL  333 (355)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999974

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.98  E-value=1.9e-32  Score=308.09  Aligned_cols=231  Identities=22%  Similarity=0.285  Sum_probs=191.0

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCc-----
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSNDDF-----  796 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-----  796 (985)
                      .++|...+.||+|+||.||+|+.. +|+.||||++......  ..+.+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367888999999999999999875 7899999999765332  34678899999999999999999999987654     


Q ss_pred             -eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          797 -KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       797 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                       .++||||++ ++|.+++..   .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~L---H~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYI---HSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999997 588887753   489999999999999999999   788999999999999999999999999999986


Q ss_pred             ccCCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh-----------------
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------------  937 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------------  937 (985)
                      ....     .....+|+.|+|||.+.+ ..++.++|+ |++|+++++++++..+.........                 
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di-~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDI-WSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHH-HHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhH-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            5321     233568999999999877 678899999 9999999999998876543221100                 


Q ss_pred             -------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 -------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 -------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                               ...++.++.+++.+|+..||++||++.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                                     0124567899999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.98  E-value=9.9e-33  Score=307.84  Aligned_cols=231  Identities=22%  Similarity=0.240  Sum_probs=172.0

Q ss_pred             hcCccCCc-eeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHH-HHHhcCCCCeeeEEeeeec----CCce
Q 001988          725 TDNFAENN-IIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECE-VIKNIRHRNLVKIISSCSN----DDFK  797 (985)
Q Consensus       725 ~~~~~~~~-~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~-il~~l~h~niv~l~~~~~~----~~~~  797 (985)
                      .++|...+ .||+|+||.||+|+.. +++.||||++...     ....+|+. .++.++||||+++++++..    ....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            56788854 6999999999999976 7999999998643     22233333 4566799999999999876    4458


Q ss_pred             EEEEeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---CCcEEEecccCc
Q 001988          798 ALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE---DMVAHLSDFGMA  873 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~---~~~~kl~DfGla  873 (985)
                      ++||||+++|+|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~L---H~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL---HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999998763 4689999999999999999999   7889999999999999976   456999999999


Q ss_pred             eeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------------
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------------  936 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------------  936 (985)
                      +.....    ......||+.|+|||.+....++.++|+ |++|+++++++++..+........                 
T Consensus       179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (336)
T 3fhr_A          179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDM-WSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP  253 (336)
T ss_dssp             EEC--------------------------CHHHHHHHH-HHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred             eecccc----ccccCCCCcCccChhhhCCCCCCchhhH-HHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence            876422    1234568999999999999999999999 999999999999887653321110                 


Q ss_pred             --hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 --AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 --~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                        ....+++++.+++.+|+..||.+||++.|+++
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              11235678999999999999999999999997

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.98  E-value=1.2e-32  Score=316.71  Aligned_cols=237  Identities=22%  Similarity=0.330  Sum_probs=186.4

Q ss_pred             HhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEEe
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ...+|...+.||+|+||+||.....+++.||||++.....   ..+.+|+++++++ +|||||++++++.+.+..++|||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            3456888899999999997766666899999999975432   2356899999999 79999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-----CCcEEEecccCceecc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE-----DMVAHLSDFGMAKLLS  877 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~-----~~~~kl~DfGla~~~~  877 (985)
                      |++ |+|.+++........+.....++.||+.||+||   |++||+||||||+||+++.     ...+||+|||+|+.+.
T Consensus        99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A           99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL---HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHH---HHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHH---HHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            996 699999987765566666788999999999999   7889999999999999953     2368899999998765


Q ss_pred             CCCCc-ceecccccccccccccccc---cCccchhhhcccccccchhhhcc-cccccCcchhh--------------hhH
Q 001988          878 GEDES-TMRTQTLATIGYMAPDEIF---VGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF--------------AAK  938 (985)
Q Consensus       878 ~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~--------------~~~  938 (985)
                      ..... ......+||+.|+|||.+.   ...++.++|+ |++|++++++++ +..+.+.....              ...
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~Di-wSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  253 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDI-FSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE  253 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHH-HHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTT
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHH-HHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcc
Confidence            33221 2234567999999999987   4667889999 999999999998 66655432111              011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          939 EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       939 ~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ......+.+++.+||..||.+||++.|+++
T Consensus       254 ~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          254 KHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            234566889999999999999999999984

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.98  E-value=1.2e-32  Score=312.33  Aligned_cols=233  Identities=18%  Similarity=0.287  Sum_probs=194.4

Q ss_pred             hcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-----------CCCeeeEEeeee
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-----------HRNLVKIISSCS  792 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-----------h~niv~l~~~~~  792 (985)
                      .++|...+.||+|+||.||+|+. .+++.||||++... ......+.+|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            46799999999999999999996 47899999999754 234567889999999886           899999999987


Q ss_pred             cCC----ceEEEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCEEEc------
Q 001988          793 NDD----FKALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHST-PIIHCDLKPSNVLLD------  860 (985)
Q Consensus       793 ~~~----~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~-~ivHrDlk~~Nill~------  860 (985)
                      ..+    ..++||||+ +++|.+++... ...+++..+..++.||+.||+||   |++ ||+||||||+||+++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM---HRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHH---HhcCCEEecCCChHHeEEeccCCCc
Confidence            654    789999999 89999999864 34589999999999999999999   676 999999999999994      


Q ss_pred             CCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh-----
Q 001988          861 EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-----  935 (985)
Q Consensus       861 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-----  935 (985)
                      ..+.+||+|||+++.....     .....||+.|+|||.+.+..++.++|+ |++|+++++++++..+.......     
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di-~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADI-WSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHH-HHHHHHHHHHHHSSCCC---------CH
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhH-HHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence            4458999999999876422     223469999999999999999999999 99999999999988765422100     


Q ss_pred             ------------------------------------------------------hhHHHHHHHHHHHHHHccCCCCCCCC
Q 001988          936 ------------------------------------------------------AAKEQCLLSIFSLALECTMESPEKRI  961 (985)
Q Consensus       936 ------------------------------------------------------~~~~~~~~~l~~l~~~cl~~~P~~RP  961 (985)
                                                                            ..+..+++++.+++.+||..||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence                                                                  01134577899999999999999999


Q ss_pred             CHHHHHH
Q 001988          962 DAKDTIT  968 (985)
Q Consensus       962 t~~ev~~  968 (985)
                      ++.|+++
T Consensus       327 t~~ell~  333 (373)
T 1q8y_A          327 DAGGLVN  333 (373)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhh
Confidence            9999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=2.8e-32  Score=314.80  Aligned_cols=234  Identities=23%  Similarity=0.273  Sum_probs=182.7

Q ss_pred             CccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEEeccC
Q 001988          727 NFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      .|...+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+++++++ +||||+++++++.+.+..++||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            45556889999999998877778999999998653   235678999999987 89999999999999999999999995


Q ss_pred             CCChHHHhhcCCCC------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-------------CcEE
Q 001988          806 NGSLEDCLHSSNCA------LNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED-------------MVAH  866 (985)
Q Consensus       806 ~gsL~~~l~~~~~~------~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~-------------~~~k  866 (985)
                       |+|.+++......      .++..++.++.||+.||+||   |++||+||||||+||+++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL---HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             6999999865321      12234567999999999999   78899999999999999754             4899


Q ss_pred             EecccCceeccCCCCcc--eeccccccccccccccccc-------Cccchhhhcccccccchhhhcc-cccccCcchhh-
Q 001988          867 LSDFGMAKLLSGEDEST--MRTQTLATIGYMAPDEIFV-------GELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF-  935 (985)
Q Consensus       867 l~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~-  935 (985)
                      |+|||+++.+.......  .....+||+.|+|||.+.+       ..++.++|+ |++|++++++++ +..+....... 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di-wSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI-FSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHH-HHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhh-HhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999875432211  2234579999999999865       678999999 999999999998 66655432110 


Q ss_pred             ---------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          936 ---------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       936 ---------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                     .....++.++.+++.+||..||.+||++.|+++
T Consensus       248 ~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                           012345688999999999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.97  E-value=1.8e-32  Score=304.91  Aligned_cols=236  Identities=22%  Similarity=0.278  Sum_probs=175.6

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHH-HHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECE-VIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      .++|...+.||+|+||.||+|... +++.||||+++.... ....++..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            478899999999999999999975 789999999976532 23445566666 666779999999999999999999999


Q ss_pred             eccCCCChHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          802 EYMSNGSLEDCLHS----SNCALNIFCRLNIMIDIASALEYLHFGHST-PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       802 e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~-~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      ||+++ +|.+++..    ....+++..+..++.|++.||.||   |+. ||+||||||+||+++.++.+||+|||+++.+
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL---KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHH---HHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHH---hccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 88777753    245789999999999999999999   566 9999999999999999999999999999876


Q ss_pred             cCCCCcceeccccccccccccccc----ccCccchhhhcccccccchhhhcccccccCcchhh-----------------
Q 001988          877 SGEDESTMRTQTLATIGYMAPDEI----FVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-----------------  935 (985)
Q Consensus       877 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-----------------  935 (985)
                      ....   ......||+.|+|||.+    .+..++.++|+ |++|+++++++++..+.......                 
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  252 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDV-WSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN  252 (327)
T ss_dssp             --------------------------------CCSHHHH-HHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCC
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhH-HHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC
Confidence            4322   12234699999999998    56678899999 99999999999988665432100                 


Q ss_pred             hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          936 AAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       936 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .....++.++.+++.+||..||.+||++.|+++
T Consensus       253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            001235678999999999999999999999976

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.97  E-value=5.3e-32  Score=299.83  Aligned_cols=236  Identities=22%  Similarity=0.290  Sum_probs=177.0

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc-hH-HHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS-TL-KSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~-~~-~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      .++|...+.||+|+||.||+|+.. +++.||||++...... .. +.+..+..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467888999999999999999975 7899999999765332 22 33444555678889999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST-PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~-~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      ||+ ++.+..........+++..+..++.|+++||+||   |++ ||+||||||+||+++.++.+||+|||+++.+....
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL---KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 5566665554455789999999999999999999   564 99999999999999999999999999998764322


Q ss_pred             Ccceecccccccccccccccc-----cCccchhhhcccccccchhhhcccccccCcchh-hhh--------------HHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIF-----VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-FAA--------------KEQ  940 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-~~~--------------~~~  940 (985)
                         ......||+.|+|||.+.     ...++.++|+ |++|+++++++++..+...... ...              ...
T Consensus       180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (318)
T 2dyl_A          180 ---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADV-WSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG  255 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHH-HHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred             ---cccccCCCccccChhhcccccccccCCccccch-hhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence               223346999999999984     5678889999 9999999999998876543211 110              012


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          941 CLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ++.++.+++.+||..||.+||++.|+++
T Consensus       256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          256 FSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            4677999999999999999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=6.4e-32  Score=329.84  Aligned_cols=236  Identities=21%  Similarity=0.278  Sum_probs=193.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc--CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCc-----
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE--DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDF-----  796 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-----  796 (985)
                      .++|.+.+.||+|+||.||+|++.  +++.||||++..... .....+.+|++++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            368999999999999999999975  689999999875432 345678899999999999999999999987665     


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      .|+||||++|++|.+++..   .+++.+++.++.||++||+||   |++||+||||||+||+++.+ .+||+|||+++..
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~l---H~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYL---HSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHH---HHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            6999999999999988764   689999999999999999999   78899999999999999985 8999999999886


Q ss_pred             cCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcc-----hhhhhHHHHHHHHHHHHHH
Q 001988          877 SGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEE-----KHFAAKEQCLLSIFSLALE  951 (985)
Q Consensus       877 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~-----~~~~~~~~~~~~l~~l~~~  951 (985)
                      ...      ....||+.|+|||++.++. +.++|+ |++|+++++++++..+....     +.........+.+.+++.+
T Consensus       232 ~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi-~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  303 (681)
T 2pzi_A          232 NSF------GYLYGTPGFQAPEIVRTGP-TVATDI-YTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRR  303 (681)
T ss_dssp             TCC------SCCCCCTTTSCTTHHHHCS-CHHHHH-HHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHHHHHHHHH
T ss_pred             ccC------CccCCCccccCHHHHcCCC-CCceeh-hhhHHHHHHHHhCCCCCcccccccccccccccccCHHHHHHHhh
Confidence            432      3356999999999887654 889999 99999999999876543321     1111223355779999999


Q ss_pred             ccCCCCCCCC-CHHHHHHHHHHhHh
Q 001988          952 CTMESPEKRI-DAKDTITRLLKIRD  975 (985)
Q Consensus       952 cl~~~P~~RP-t~~ev~~~L~~i~~  975 (985)
                      ||..||.+|| ++.++.+.+..+..
T Consensus       304 ~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          304 AIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             HTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             hccCChhhCCCHHHHHHHHHHHHHH
Confidence            9999999999 56677777766543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=2.4e-32  Score=323.19  Aligned_cols=243  Identities=23%  Similarity=0.278  Sum_probs=196.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeec------CCc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSN------DDF  796 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~------~~~  796 (985)
                      .++|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            478999999999999999999864 78999999987653 3345678999999999999999999999765      677


Q ss_pred             eEEEEeccCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCc---EEEeccc
Q 001988          797 KALVLEYMSNGSLEDCLHSSN--CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV---AHLSDFG  871 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~---~kl~DfG  871 (985)
                      .++||||+++|+|.+++....  ..+++..+..++.|++.||+||   |+.||+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yL---Hs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL---HENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHH---HHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999998653  2588889999999999999999   7899999999999999997765   9999999


Q ss_pred             CceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh-----------------
Q 001988          872 MAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-----------------  934 (985)
Q Consensus       872 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-----------------  934 (985)
                      +++......   ......||+.|+|||.+.+..++.++|+ |++|++++++++|..++.....                 
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDI-wSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDY-WSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHH-HHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             ccccccccc---ccccccCCcccCChHHhccCCCCchhHH-HHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence            998764322   2234579999999999999999999999 9999999999998766532100                 


Q ss_pred             ------------------hhhHHHHHHHHHHHHHHccCCCCCCCCCHHH-----HHHHHHHhH
Q 001988          935 ------------------FAAKEQCLLSIFSLALECTMESPEKRIDAKD-----TITRLLKIR  974 (985)
Q Consensus       935 ------------------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~e-----v~~~L~~i~  974 (985)
                                        .......++.+.+++.+|+..||++||++.|     ..+.+..+.
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence                              0012236788999999999999999999988     445555544

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=3.3e-32  Score=303.89  Aligned_cols=224  Identities=19%  Similarity=0.166  Sum_probs=176.4

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCc--------chHHHHHHHHHHHHhcC---------CCCeeeE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA--------STLKSFEAECEVIKNIR---------HRNLVKI  787 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~il~~l~---------h~niv~l  787 (985)
                      .++|+..+.||+|+||.||+|+. +|+.||||+++....        ...+.+.+|++++++++         |||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46789999999999999999998 689999999976532        23477899999999886         7777766


Q ss_pred             Eeee-----------------ec-------------CCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHH
Q 001988          788 ISSC-----------------SN-------------DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALE  837 (985)
Q Consensus       788 ~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~  837 (985)
                      .+.+                 .+             .+..++||||+++|++.+.+..  ..+++..+..++.||+.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            6653                 22             6789999999999987777654  35799999999999999999


Q ss_pred             HHHhcC-CCCeEeCCCCCCCEEEcCCC--------------------cEEEecccCceeccCCCCcceeccccccccccc
Q 001988          838 YLHFGH-STPIIHCDLKPSNVLLDEDM--------------------VAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA  896 (985)
Q Consensus       838 ~Lh~~h-~~~ivHrDlk~~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a  896 (985)
                      ||   | ++||+||||||+|||++.++                    .+||+|||+|+.....       ..+||+.|+|
T Consensus       176 ~l---H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~a  245 (336)
T 2vuw_A          176 VA---EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMD  245 (336)
T ss_dssp             HH---HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTC
T ss_pred             HH---HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccC
Confidence            99   6 89999999999999999887                    9999999999876421       2469999999


Q ss_pred             ccccccCccchhhhcccccccchhhhcccccccCc-------------------chhhhhHHHHHHHHHHHHHHccCCCC
Q 001988          897 PDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGE-------------------EKHFAAKEQCLLSIFSLALECTMESP  957 (985)
Q Consensus       897 PE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~-------------------~~~~~~~~~~~~~l~~l~~~cl~~~P  957 (985)
                      ||.+.+.. +.++|+|..++....++..+..+...                   .........+++++.+++.+|+..| 
T Consensus       246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-  323 (336)
T 2vuw_A          246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-  323 (336)
T ss_dssp             SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-
T ss_pred             hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-
Confidence            99988665 89999944344435555444332211                   1112234567889999999999966 


Q ss_pred             CCCCCHHHHH
Q 001988          958 EKRIDAKDTI  967 (985)
Q Consensus       958 ~~RPt~~ev~  967 (985)
                          |+.|++
T Consensus       324 ----sa~e~l  329 (336)
T 2vuw_A          324 ----SATDLL  329 (336)
T ss_dssp             ----SHHHHH
T ss_pred             ----CHHHHH
Confidence                888887

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=3.8e-31  Score=287.54  Aligned_cols=216  Identities=14%  Similarity=0.076  Sum_probs=182.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc---hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|+..+.||+|+||.||+|+.. +++.||||++......   ..+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367899999999999999999975 5899999999866332   246789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||++|++|.+++...   ....+..+++.|++.||+||   |++||+||||||+||+++.++.+||+++|         
T Consensus       110 ~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~l---H~~givH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAA---HRAGVALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             EEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHH---HHCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence            9999999999999653   35667889999999999999   78999999999999999999999998543         


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh------------------hhHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF------------------AAKEQCL  942 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~------------------~~~~~~~  942 (985)
                                   |++|       ++.++|+ |++|++++++++++.++......                  .....++
T Consensus       175 -------------~~~~-------~~~~~Di-~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T 3uqc_A          175 -------------TMPD-------ANPQDDI-RGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP  233 (286)
T ss_dssp             -------------CCTT-------CCHHHHH-HHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSC
T ss_pred             -------------ccCC-------CCchhHH-HHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCC
Confidence                         3333       6789999 99999999999998765432110                  1113467


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          943 LSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       943 ~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      +++.+++.+||..||++| |+.|+++.|+++....
T Consensus       234 ~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          234 FQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             HHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            889999999999999999 9999999999987643

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=4.3e-31  Score=296.96  Aligned_cols=287  Identities=22%  Similarity=0.232  Sum_probs=189.2

Q ss_pred             CCCCCCcceeeeEEEeCCCCeEEEEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCccc
Q 001988           54 WTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQL  133 (985)
Q Consensus        54 w~~~~~~c~w~gv~c~~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l  133 (985)
                      |.....+|.|.|+ |+          +++++++ .+|..+.  ++|++|+|++|.+++..+..+.++++|++|+|++|++
T Consensus        23 ~~~~~~~C~~~~~-c~----------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l   88 (353)
T 2z80_A           23 SNQASLSCDRNGI-CK----------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI   88 (353)
T ss_dssp             ----CCEECTTSE-EE----------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             CCccCCCCCCCeE-ee----------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCcc
Confidence            5455678999988 75          4566777 6777665  5899999999999976666899999999999999999


Q ss_pred             CCCCccccccCCccceeeeccccccCCCChhHhhhccccceecccCccccccCCc--ccCCCCCceEEEcccc-cCCCcc
Q 001988          134 SGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPS--SLSKCKQLQELHLGYN-NLSGAI  210 (985)
Q Consensus       134 ~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~--~l~~l~~L~~L~L~~N-~l~~~~  210 (985)
                      ++..+..+..+++|++|++++|+++ .+|...++++++|++|+|++|.++ .+|.  .+.++++|++|++++| .+++..
T Consensus        89 ~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~  166 (353)
T 2z80_A           89 NTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQ  166 (353)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred             CccCHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccC
Confidence            9877777777777888888888777 466665567777777777777777 3443  6777777777777777 355444


Q ss_pred             ccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcC
Q 001988          211 PKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLAL  290 (985)
Q Consensus       211 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l  290 (985)
                      |..|+++++|++|++++|++++..|..++.+++|++|++++|+++...+..+..+++|++|++++|++++..+..+.   
T Consensus       167 ~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~---  243 (353)
T 2z80_A          167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELS---  243 (353)
T ss_dssp             TTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------
T ss_pred             HHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccc---
Confidence            56677777777777777777766666777777777777777776543333334456666666666666533222111   


Q ss_pred             CCCcEEEecCccCCCcCCccccCCCCccEEEccCccccc----ccCCcccCCCCCceEeccCCcccCCCCcccccccccc
Q 001988          291 PNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSG----FIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLAN  366 (985)
Q Consensus       291 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~  366 (985)
                                         .......++.++++++.+++    .+|..+..+++|++|++++|+++.++..     .+.+
T Consensus       244 -------------------~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~-----~~~~  299 (353)
T 2z80_A          244 -------------------TGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDG-----IFDR  299 (353)
T ss_dssp             ----------------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTT-----TTTT
T ss_pred             -------------------cccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHH-----HHhc
Confidence                               01123344445555554443    2455566666666666666666655443     1456


Q ss_pred             cCcccEEEecCCCCCcc
Q 001988          367 CKKLRYLGLGGNPLDGF  383 (985)
Q Consensus       367 l~~L~~L~L~~N~l~~~  383 (985)
                      +++|++|++++|++.+.
T Consensus       300 l~~L~~L~L~~N~~~~~  316 (353)
T 2z80_A          300 LTSLQKIWLHTNPWDCS  316 (353)
T ss_dssp             CTTCCEEECCSSCBCCC
T ss_pred             CCCCCEEEeeCCCccCc
Confidence            66777777777776653

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.97  E-value=4.9e-33  Score=335.99  Aligned_cols=212  Identities=15%  Similarity=0.101  Sum_probs=119.5

Q ss_pred             CcceeeeEEEeCCCCeEEEEEecCCcccccCchhcccccccceecccCCcC---CCCCCcccc------------cCCCC
Q 001988           59 SICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKL---SSNIPSSIF------------TMSTL  123 (985)
Q Consensus        59 ~~c~w~gv~c~~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l---~~~~p~~~~------------~l~~L  123 (985)
                      -|++|.++.+..  .+  .+.+.+ .+....+..+..+++|++|+|+++..   .+.+|..++            .+++|
T Consensus        40 vck~W~~~~~~~--~~--~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L  114 (592)
T 3ogk_B           40 VCRRWFKIDSET--RE--HVTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQL  114 (592)
T ss_dssp             SCHHHHHHHHHH--CC--EEEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred             HhHHHHHhhhcc--cc--EEEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCC
Confidence            455899985432  22  222322 23334445667889999999988532   244554433            57788


Q ss_pred             cEEEccCcccCCCCccccccC--Cccceeeecccc-ccCCCChhHhhhccccceecccCcccccc----CCcccCCCCCc
Q 001988          124 KVLYLMDNQLSGSLSSFTFNT--SSILDIRLSKNK-LSGKLPENICNHLRYLKHLFLRENMFYGK----IPSSLSKCKQL  196 (985)
Q Consensus       124 ~~L~Ls~n~l~~~~~~~~~~~--~~L~~L~ls~n~-l~g~lp~~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L  196 (985)
                      ++|+|++|.+++..+.++...  .+|++|+|++|. ++..-...+..++++|++|+|++|.+++.    ++..+.++++|
T Consensus       115 ~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L  194 (592)
T 3ogk_B          115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL  194 (592)
T ss_dssp             CEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCC
T ss_pred             CeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCc
Confidence            888888887765555544442  347777777665 22111122334566677777777766544    33344556666


Q ss_pred             eEEEcccccCC----CccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCc---ccCcccccCCCCCC
Q 001988          197 QELHLGYNNLS----GAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLT---GVVPATIFNMSTLK  269 (985)
Q Consensus       197 ~~L~L~~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~---~~~p~~l~~l~~L~  269 (985)
                      ++|+|++|.++    +.++..+.++++|+.|++++|.+.+ +|..+..+++|+.|+++.+...   +..+..+..+++|+
T Consensus       195 ~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~  273 (592)
T 3ogk_B          195 EVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLC  273 (592)
T ss_dssp             CEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCC
T ss_pred             cEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhcccccc
Confidence            66666666665    2333344556666666666666663 5566666666666666643222   22333444455555


Q ss_pred             EEEccCC
Q 001988          270 EIFLYNN  276 (985)
Q Consensus       270 ~L~L~~N  276 (985)
                      .|+++++
T Consensus       274 ~L~l~~~  280 (592)
T 3ogk_B          274 RLGLSYM  280 (592)
T ss_dssp             EEEETTC
T ss_pred             ccCcccc
Confidence            5555543

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.97  E-value=4e-32  Score=328.02  Aligned_cols=434  Identities=15%  Similarity=0.116  Sum_probs=244.1

Q ss_pred             CCChhHhhhccccceecccCccc---cccCCcccC------------CCCCceEEEcccccCCCccccccccc--cccce
Q 001988          160 KLPENICNHLRYLKHLFLRENMF---YGKIPSSLS------------KCKQLQELHLGYNNLSGAIPKEIGNL--TVLQR  222 (985)
Q Consensus       160 ~lp~~~~~~l~~L~~L~L~~n~l---~~~~p~~l~------------~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~  222 (985)
                      ..|..++..+++|++|+|+++..   .+.+|..++            .+++|++|+|++|.+++..+..++..  .+|++
T Consensus        63 ~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~  142 (592)
T 3ogk_B           63 ATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLET  142 (592)
T ss_dssp             SCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCE
T ss_pred             cChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcE
Confidence            45677778888899999877532   234554444            56667777777776665555555543  33666


Q ss_pred             Eeecccc-cc-CCchhhhcCCCCCCEEEecCCcCccc----CcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEE
Q 001988          223 ISLINNK-LH-GEIPQEIGYLQNLDVLQLGFNNLTGV----VPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFL  296 (985)
Q Consensus       223 L~L~~N~-l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L  296 (985)
                      |+|++|. ++ ..++....++++|++|+|++|.+++.    ++..+.++++|++|++++|.+++.-+             
T Consensus       143 L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~-------------  209 (592)
T 3ogk_B          143 LKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISP-------------  209 (592)
T ss_dssp             EEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCH-------------
T ss_pred             EECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCH-------------
Confidence            6666665 11 11222233566666666666665544    23334455556666666555541111             


Q ss_pred             EecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEec
Q 001988          297 NLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLG  376 (985)
Q Consensus       297 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~  376 (985)
                              +.++..+.++++|+.|++++|.+.+ +|..+.++++|++|+++.......  .......+..+++|+.|+++
T Consensus       210 --------~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~--~~~~~~~l~~~~~L~~L~l~  278 (592)
T 3ogk_B          210 --------KDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIG--MPEKYMNLVFPRKLCRLGLS  278 (592)
T ss_dssp             --------HHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTT--CTTSSSCCCCCTTCCEEEET
T ss_pred             --------HHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccc--hHHHHHHhhccccccccCcc
Confidence                    1122222334444444444444443 334444445555555443111100  00111234455556666665


Q ss_pred             CCCCCccCCCCccchhhcccceeccccccccccC-CcCCCCCCccEEEccCCCCCC-CCCccccccccccceecc-----
Q 001988          377 GNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIP-KAIGNLSNLIVLSLGGNNLSG-SIPVTFGGLQKLQGLDLA-----  449 (985)
Q Consensus       377 ~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls-----  449 (985)
                      ++.. +.+|..+..++ +|++|++++|.+++... ..+..+++|++|+++ +.+.+ .++..+..+++|++|+++     
T Consensus       279 ~~~~-~~l~~~~~~~~-~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~  355 (592)
T 3ogk_B          279 YMGP-NEMPILFPFAA-QIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADE  355 (592)
T ss_dssp             TCCT-TTGGGGGGGGG-GCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCS
T ss_pred             ccch-hHHHHHHhhcC-CCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccc
Confidence            5422 23444444444 56666666666543322 234566777777777 33332 233334556777777777     


Q ss_pred             ------cccccCC-chhhhhhccCCCeEEccCCccccccCCCCcC-cCcCceEeec----cceeeee-----cCCCccCc
Q 001988          450 ------FNKLAGS-IPDEICLLSRLNELDLNGNKISGSISSCLGN-LTSLQYLNLG----SNRFTFV-----IPSTFWNL  512 (985)
Q Consensus       450 ------~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l  512 (985)
                            .|.+++. ++.....+++|++|+++.|++++..+..+.. +++|+.|+++    .|++++.     ++..+.++
T Consensus       356 ~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~  435 (592)
T 3ogk_B          356 QGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGC  435 (592)
T ss_dssp             STTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHC
T ss_pred             cccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhC
Confidence                  3555532 2222345677777777777777655555544 6777777775    5666653     33335567


Q ss_pred             cceeEEeecCC--cccCCcccccc-CCCcccEEEccCCccCcc-Cchhhcccccceeeeeecceeccc-hhhhhhccccc
Q 001988          513 KDILSFDISSN--LLDGPISLAIG-NLKAVVGIDLSRNNLSGN-IPTTLEGLKSLQNISLAYNRLEGP-IPESFGNMTSL  587 (985)
Q Consensus       513 ~~L~~L~ls~N--~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L  587 (985)
                      ++|++|+++++  .+++.....+. .+++|+.|++++|++++. ++..+.++++|++|+|++|.+++. ++..+..+++|
T Consensus       436 ~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L  515 (592)
T 3ogk_B          436 KKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSL  515 (592)
T ss_dssp             TTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSC
T ss_pred             CCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCcc
Confidence            77888888643  35443333333 377888888888888763 455567788899999999988754 44555678899


Q ss_pred             CeEecCCCcccCCCCccc-ccccccccccccccc
Q 001988          588 ESLDLSNNKISGSIPVSF-EKLSYLKELNLSFNK  620 (985)
Q Consensus       588 ~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~N~  620 (985)
                      ++|+|++|++++.--..+ ..++.+....+..++
T Consensus       516 ~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~~  549 (592)
T 3ogk_B          516 RYLWVQGYRASMTGQDLMQMARPYWNIELIPSRR  549 (592)
T ss_dssp             CEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC-
T ss_pred             CeeECcCCcCCHHHHHHHHHhCCCcEEEEecCcc
Confidence            999999999886533333 355666665555543

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=2.4e-30  Score=290.87  Aligned_cols=275  Identities=17%  Similarity=0.191  Sum_probs=222.3

Q ss_pred             eEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEE
Q 001988          343 LFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVL  422 (985)
Q Consensus       343 ~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  422 (985)
                      ..++++|.++.++...        .++|++|++++|.+++..+..+..++ +|++|++++|++++..|.+|..+++|++|
T Consensus        35 ~c~~~~~~l~~iP~~~--------~~~L~~L~l~~n~i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  105 (353)
T 2z80_A           35 ICKGSSGSLNSIPSGL--------TEAVKSLDLSNNRITYISNSDLQRCV-NLQALVLTSNGINTIEEDSFSSLGSLEHL  105 (353)
T ss_dssp             EEECCSTTCSSCCTTC--------CTTCCEEECTTSCCCEECTTTTTTCT-TCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             EeeCCCCCcccccccc--------cccCcEEECCCCcCcccCHHHhccCC-CCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence            3455555555554321        13677777777777765555666666 78888888888887778888999999999


Q ss_pred             EccCCCCCCCCCccccccccccceecccccccCCch-hhhhhccCCCeEEccCC-ccccccCCCCcCcCcCceEeeccce
Q 001988          423 SLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIP-DEICLLSRLNELDLNGN-KISGSISSCLGNLTSLQYLNLGSNR  500 (985)
Q Consensus       423 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~  500 (985)
                      +|++|++++..+..|.++++|++|++++|++++..+ ..+..+++|++|++++| .+++..+..|.++++|++|++++|+
T Consensus       106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~  185 (353)
T 2z80_A          106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD  185 (353)
T ss_dssp             ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred             ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence            999999997777778899999999999999985444 47888999999999998 5777777889999999999999999


Q ss_pred             eeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhc---ccccceeeeeecceecc--
Q 001988          501 FTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLE---GLKSLQNISLAYNRLEG--  575 (985)
Q Consensus       501 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~--  575 (985)
                      +++..|..|..+++|++|++++|++....+..+..+++|+.|++++|++++..+..+.   ....++.++|++|.+++  
T Consensus       186 l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~  265 (353)
T 2z80_A          186 LQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDES  265 (353)
T ss_dssp             CCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHH
T ss_pred             cCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcc
Confidence            9998899999999999999999999876666667789999999999999987665544   35667788888888776  


Q ss_pred             --chhhhhhcccccCeEecCCCcccCCCCcc-ccccccccccccccccccCCCCC
Q 001988          576 --PIPESFGNMTSLESLDLSNNKISGSIPVS-FEKLSYLKELNLSFNKLKGEIPR  627 (985)
Q Consensus       576 --~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~~~~p~  627 (985)
                        .+|..+.++++|++|||++|+|+. +|.. |..+++|++|++++|++++.+|.
T Consensus       266 l~~l~~~l~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~N~~~~~~~~  319 (353)
T 2z80_A          266 LFQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCPR  319 (353)
T ss_dssp             HHHHHHHHHTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             hhhhHHHHhcccCCCEEECCCCCCCc-cCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence              478899999999999999999994 5555 68999999999999999998874

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=2.3e-30  Score=283.94  Aligned_cols=212  Identities=20%  Similarity=0.252  Sum_probs=177.1

Q ss_pred             hcCccCC-ceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHH-HhcCCCCeeeEEeeeec----CCce
Q 001988          725 TDNFAEN-NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVI-KNIRHRNLVKIISSCSN----DDFK  797 (985)
Q Consensus       725 ~~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il-~~l~h~niv~l~~~~~~----~~~~  797 (985)
                      .++|... +.||+|+||.||+|... +++.||+|+++..     ..+.+|++++ +..+||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3566666 78999999999999874 7899999998643     5677899988 55589999999999876    6678


Q ss_pred             EEEEeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---CCcEEEecccCc
Q 001988          798 ALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE---DMVAHLSDFGMA  873 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~---~~~~kl~DfGla  873 (985)
                      ++||||+++|+|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999998763 4689999999999999999999   7899999999999999998   789999999998


Q ss_pred             eeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh-------------------
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-------------------  934 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-------------------  934 (985)
                      ....                        +..++.++|+ |++|+++++++++..+......                   
T Consensus       168 ~~~~------------------------~~~~~~~~Di-wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  222 (299)
T 3m2w_A          168 KETT------------------------GEKYDKSCDM-WSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  222 (299)
T ss_dssp             EECT------------------------TCGGGGHHHH-HHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred             cccc------------------------cccCCchhhH-HHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence            7642                        1346678999 9999999999998776532210                   


Q ss_pred             hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          935 FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       935 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                      ......+++++.+++.+||..||.+||++.|+++.
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            01113467889999999999999999999999873

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.97  E-value=2.1e-31  Score=305.44  Aligned_cols=233  Identities=14%  Similarity=0.153  Sum_probs=179.1

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc---hHHHHHHHHHHHHhcCC-CCeee-------------
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRH-RNLVK-------------  786 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~h-~niv~-------------  786 (985)
                      ...|...+.||+|+||.||+|++. +|+.||||++......   ..+.+++|+.+++.++| ++...             
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            455778899999999999999954 7999999998844322   35778999999999987 32111             


Q ss_pred             --------EEeeeec-----CCceEEEEeccCCCChHHHhh------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 001988          787 --------IISSCSN-----DDFKALVLEYMSNGSLEDCLH------SSNCALNIFCRLNIMIDIASALEYLHFGHSTPI  847 (985)
Q Consensus       787 --------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~------~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~i  847 (985)
                              +..++..     ....+++|+++ +++|.+++.      .....+++..+..++.|+++||+||   |++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL---HHYGL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH---HHTTE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH---HhCCc
Confidence                    1111111     12356777766 689999884      2234577889999999999999999   78999


Q ss_pred             EeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceeccccccccccccccc----------ccCccchhhhccccccc
Q 001988          848 IHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI----------FVGELSLKRWVNDLLPV  917 (985)
Q Consensus       848 vHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~dv~~~~g~  917 (985)
                      +||||||+|||++.++.+||+|||+++.....     ....+| +.|+|||.+          ....++.++|+ |++|+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv-wSlGv  305 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT-WTLGL  305 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH-HHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhH-HHHHH
Confidence            99999999999999999999999999875321     344567 999999998          55668899999 99999


Q ss_pred             chhhhcccccccCcchhh-------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          918 SLVEVVDKSLLSGEEKHF-------AAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       918 ~~~~i~~~~~~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +++++++++.++......       .....+++++.+++.+||..||++||++.|+++
T Consensus       306 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            999999988766543211       111235678999999999999999999877754

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=7e-32  Score=299.34  Aligned_cols=278  Identities=21%  Similarity=0.237  Sum_probs=207.8

Q ss_pred             cCCCCcccCCCCC--CCCcceeeeEEEeCCCCeEEEEEecCCcccccCchhc--ccccccceecccCCcCCCCCCccccc
Q 001988           44 YDPTNLLGTNWTS--NASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEI--ANLSSLKSLDLSHNKLSSNIPSSIFT  119 (985)
Q Consensus        44 ~~~~~~~~s~w~~--~~~~c~w~gv~c~~~~~~v~~l~L~~~~l~g~~~~~l--~~l~~L~~L~L~~n~l~~~~p~~~~~  119 (985)
                      .|+..++.+ |..  ..|+|.|.++-|+............+.... .++..+  ...+.++.|+|++|.++ .+|..++.
T Consensus        26 ~~~~~aLl~-~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~-~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~  102 (328)
T 4fcg_A           26 RPYHDVLSQ-WQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFR  102 (328)
T ss_dssp             CCHHHHHHH-HHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHH-HHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred             chHHHHHHH-HHHhccCCchhhhhhhcccccccccccccCCcchh-hhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence            355555665 764  357899998888432221000111111111 122222  23578999999999998 78888988


Q ss_pred             CCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEE
Q 001988          120 MSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQEL  199 (985)
Q Consensus       120 l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L  199 (985)
                      +++|++|+|++|.++ .+|..+                         +.+++|++|+|++|.++ .+|+.++++++|++|
T Consensus       103 l~~L~~L~L~~n~l~-~lp~~~-------------------------~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L  155 (328)
T 4fcg_A          103 LSHLQHMTIDAAGLM-ELPDTM-------------------------QQFAGLETLTLARNPLR-ALPASIASLNRLREL  155 (328)
T ss_dssp             GTTCSEEEEESSCCC-CCCSCG-------------------------GGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred             CCCCCEEECCCCCcc-chhHHH-------------------------hccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence            999999999888887 444444                         44555666666666665 556666666666666


Q ss_pred             EcccccCCCccccccc---------cccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCE
Q 001988          200 HLGYNNLSGAIPKEIG---------NLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKE  270 (985)
Q Consensus       200 ~L~~N~l~~~~p~~~~---------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~  270 (985)
                      +|++|++.+.+|..++         ++++|++|++++|+++ .+|..++.+++|++|+|++|++++ +|..+..+++|++
T Consensus       156 ~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~  233 (328)
T 4fcg_A          156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEE  233 (328)
T ss_dssp             EEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCE
T ss_pred             ECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCE
Confidence            6666666666666554         4899999999999998 888899999999999999999995 6667999999999


Q ss_pred             EEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCc
Q 001988          271 IFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNN  350 (985)
Q Consensus       271 L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  350 (985)
                      |+|++|++.+.+|..+ ..+++|++|+|++|++.+.+|..+.++++|+.|++++|.+.+.+|..++++++|+.+++..+.
T Consensus       234 L~Ls~n~~~~~~p~~~-~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~  312 (328)
T 4fcg_A          234 LDLRGCTALRNYPPIF-GGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL  312 (328)
T ss_dssp             EECTTCTTCCBCCCCT-TCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGG
T ss_pred             EECcCCcchhhhHHHh-cCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHH
Confidence            9999999998888765 478999999999999999999999999999999999999999999999999999999888776


Q ss_pred             ccCC
Q 001988          351 LTSS  354 (985)
Q Consensus       351 l~~~  354 (985)
                      +...
T Consensus       313 ~~~l  316 (328)
T 4fcg_A          313 QAQL  316 (328)
T ss_dssp             SCC-
T ss_pred             HHHH
Confidence            5543

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=5.1e-31  Score=290.70  Aligned_cols=265  Identities=18%  Similarity=0.172  Sum_probs=145.7

Q ss_pred             CCCCCCcceeeeEEEeCCCCeEEEEEecCCcccccCchhcccccccceecccCCcC-CCCCCcccc-------cCCCCcE
Q 001988           54 WTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKL-SSNIPSSIF-------TMSTLKV  125 (985)
Q Consensus        54 w~~~~~~c~w~gv~c~~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l-~~~~p~~~~-------~l~~L~~  125 (985)
                      |.....|+.|..+.......+++.+++++|++  .+|..+...  |+.|+|++|.+ .+.+|..++       .+++|++
T Consensus        24 ~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~   99 (312)
T 1wwl_A           24 WSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQE   99 (312)
T ss_dssp             GGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCE
T ss_pred             hHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccE
Confidence            66555666666554333334566666777776  566655544  67777777776 345666555       5667777


Q ss_pred             EEccCcccCCCCcccc--ccCCccceeeeccccccCCCChhHhhhc-----cccceecccCccccccCCcccCCCCCceE
Q 001988          126 LYLMDNQLSGSLSSFT--FNTSSILDIRLSKNKLSGKLPENICNHL-----RYLKHLFLRENMFYGKIPSSLSKCKQLQE  198 (985)
Q Consensus       126 L~Ls~n~l~~~~~~~~--~~~~~L~~L~ls~n~l~g~lp~~~~~~l-----~~L~~L~L~~n~l~~~~p~~l~~l~~L~~  198 (985)
                      |+|++|++++.+|..+  ..+++|++|+|++|++++. |..+ +.+     ++|++|+|++|++++..|..|+++++|++
T Consensus       100 L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~-~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  177 (312)
T 1wwl_A          100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWL-AELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALST  177 (312)
T ss_dssp             EEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHH-HHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCE
T ss_pred             EEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHH-HHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCE
Confidence            7777777766666544  5566666666666666654 4333 334     55555555555555555555555555555


Q ss_pred             EEcccccCCCc--ccccc--ccccccceEeeccccccC--Cch-hhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEE
Q 001988          199 LHLGYNNLSGA--IPKEI--GNLTVLQRISLINNKLHG--EIP-QEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEI  271 (985)
Q Consensus       199 L~L~~N~l~~~--~p~~~--~~l~~L~~L~L~~N~l~~--~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L  271 (985)
                      |+|++|++.+.  +|..+  +++++|++|++++|++++  .++ ..+..+++|++|+|++|++++..             
T Consensus       178 L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-------------  244 (312)
T 1wwl_A          178 LDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA-------------  244 (312)
T ss_dssp             EECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSC-------------
T ss_pred             EECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCccc-------------
Confidence            55555555543  22222  455555555555555542  111 22334455555555555555444             


Q ss_pred             EccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcc
Q 001988          272 FLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNL  351 (985)
Q Consensus       272 ~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  351 (985)
                                 |...+..+++|++|+|++|+|+ .+|..+.  ++|+.|++++|++++. |. +..+++|++|++++|++
T Consensus       245 -----------~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l  308 (312)
T 1wwl_A          245 -----------GAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPF  308 (312)
T ss_dssp             -----------CCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTT
T ss_pred             -----------chhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCC
Confidence                       3222233445555555555554 4444443  5555666666666544 43 56666666666666666


Q ss_pred             cC
Q 001988          352 TS  353 (985)
Q Consensus       352 ~~  353 (985)
                      ++
T Consensus       309 ~~  310 (312)
T 1wwl_A          309 LD  310 (312)
T ss_dssp             TC
T ss_pred             CC
Confidence            53

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=3.4e-31  Score=292.14  Aligned_cols=252  Identities=20%  Similarity=0.221  Sum_probs=207.8

Q ss_pred             cccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHh------
Q 001988           93 IANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENIC------  166 (985)
Q Consensus        93 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~------  166 (985)
                      ++..++|++|++++|.+  .+|..+...  |++|+|++|+++                       .+.+|..+.      
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~-----------------------~~~~~~~~~~~~~~~   91 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVR-----------------------AARIPSRILFGALRV   91 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEE-----------------------EEECBHHHHHHHHHH
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--Hhhccccccccc-----------------------CCCcCHHHHHHHHHh
Confidence            45566777777777777  566655443  555555555553                       335565552      


Q ss_pred             hhccccceecccCccccccCCccc--CCCCCceEEEcccccCCCccccccccc-----cccceEeeccccccCCchhhhc
Q 001988          167 NHLRYLKHLFLRENMFYGKIPSSL--SKCKQLQELHLGYNNLSGAIPKEIGNL-----TVLQRISLINNKLHGEIPQEIG  239 (985)
Q Consensus       167 ~~l~~L~~L~L~~n~l~~~~p~~l--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~  239 (985)
                      .++++|++|+|++|.+++.+|..+  +.+++|++|+|++|++++. |..++.+     ++|++|++++|++++..|..|+
T Consensus        92 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~  170 (312)
T 1wwl_A           92 LGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVR  170 (312)
T ss_dssp             HTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCC
T ss_pred             cCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhc
Confidence            158899999999999999999887  8999999999999999977 8888888     8999999999999988889999


Q ss_pred             CCCCCCEEEecCCcCccc--Ccccc--cCCCCCCEEEccCCcCcc--cCChhhhhcCCCCcEEEecCccCCCcCC-cccc
Q 001988          240 YLQNLDVLQLGFNNLTGV--VPATI--FNMSTLKEIFLYNNSLSG--SLPSRIDLALPNLEFLNLGINSFSGTIP-SSIT  312 (985)
Q Consensus       240 ~l~~L~~L~Ls~N~l~~~--~p~~l--~~l~~L~~L~L~~N~l~~--~~p~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~  312 (985)
                      .+++|++|+|++|++.+.  .|..+  ..+++|++|+|++|++++  .++..++..+++|++|+|++|++++.+| ..+.
T Consensus       171 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  250 (312)
T 1wwl_A          171 VFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD  250 (312)
T ss_dssp             CCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCC
T ss_pred             cCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhh
Confidence            999999999999998875  34445  889999999999999983  4555666788999999999999998875 5667


Q ss_pred             CCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCc
Q 001988          313 NASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDG  382 (985)
Q Consensus       313 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~  382 (985)
                      .+++|++|+|++|+++ .+|..+.  ++|++|++++|++++.+.       +..+++|++|++++|++++
T Consensus       251 ~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~p~-------~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          251 WPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPS-------PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSCCC-------TTTSCEEEEEECTTCTTTC
T ss_pred             hcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCChh-------HhhCCCCCEEeccCCCCCC
Confidence            7899999999999999 6777776  899999999999998732       5688999999999999985

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=1.6e-29  Score=278.27  Aligned_cols=251  Identities=23%  Similarity=0.270  Sum_probs=190.1

Q ss_pred             cEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCC--CCccccccccccceec
Q 001988          371 RYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGS--IPVTFGGLQKLQGLDL  448 (985)
Q Consensus       371 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L  448 (985)
                      +.++.+++.++ .+|..+.   .+|++|++++|+++...+..|..+++|++|+|++|+++..  .+..+.++++|++|+|
T Consensus        10 ~~l~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L   85 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL   85 (306)
T ss_dssp             TEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred             CEEEcCCCCcc-cCCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence            34555555554 3343332   2577777777777755555677788888888888887633  2556667788888888


Q ss_pred             ccccccCCchhhhhhccCCCeEEccCCccccccC-CCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccC
Q 001988          449 AFNKLAGSIPDEICLLSRLNELDLNGNKISGSIS-SCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDG  527 (985)
Q Consensus       449 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  527 (985)
                      ++|.+. .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..+..|.++++|++|++++|.+.+
T Consensus        86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  164 (306)
T 2z66_A           86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE  164 (306)
T ss_dssp             CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred             CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence            888877 456667778888888888888876554 567788888888888888887777778888888888888888876


Q ss_pred             -CccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcccc
Q 001988          528 -PISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFE  606 (985)
Q Consensus       528 -~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  606 (985)
                       ..|..+..+++|+.|++++|++++..|..|..+++|++|+|++|++++..+..+..+++|+.|||++|++++..|..+.
T Consensus       165 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  244 (306)
T 2z66_A          165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ  244 (306)
T ss_dssp             GEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCC
T ss_pred             ccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHH
Confidence             5677788888888888888888877788888888888888888888877777788888888888888888888888888


Q ss_pred             ccc-cccccccccccccCCCC
Q 001988          607 KLS-YLKELNLSFNKLKGEIP  626 (985)
Q Consensus       607 ~l~-~L~~L~ls~N~l~~~~p  626 (985)
                      .++ +|++|++++|++++..+
T Consensus       245 ~~~~~L~~L~L~~N~~~~~c~  265 (306)
T 2z66_A          245 HFPSSLAFLNLTQNDFACTCE  265 (306)
T ss_dssp             CCCTTCCEEECTTCCEECSGG
T ss_pred             hhhccCCEEEccCCCeecccC
Confidence            874 88888888888887654

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=5.2e-29  Score=289.76  Aligned_cols=251  Identities=24%  Similarity=0.290  Sum_probs=219.7

Q ss_pred             ccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecc
Q 001988          370 LRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLA  449 (985)
Q Consensus       370 L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  449 (985)
                      .+.++.+++.++ .+|..+.   .+++.|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus        56 ~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~  131 (452)
T 3zyi_A           56 FSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF  131 (452)
T ss_dssp             SCEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CcEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence            456666666666 3555443   378888999999888888899999999999999999998888899999999999999


Q ss_pred             cccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeecc-ceeeeecCCCccCccceeEEeecCCcccCC
Q 001988          450 FNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGS-NRFTFVIPSTFWNLKDILSFDISSNLLDGP  528 (985)
Q Consensus       450 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~  528 (985)
                      +|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|++++ |.++.+.+..|.++++|++|++++|++++.
T Consensus       132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~  211 (452)
T 3zyi_A          132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM  211 (452)
T ss_dssp             SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred             CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence            9999977777788899999999999999987778899999999999998 667777777899999999999999999876


Q ss_pred             ccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcccccc
Q 001988          529 ISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKL  608 (985)
Q Consensus       529 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  608 (985)
                      .  .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+
T Consensus       212 ~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  289 (452)
T 3zyi_A          212 P--NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL  289 (452)
T ss_dssp             C--CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred             c--cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence            3  58889999999999999999999999999999999999999999889999999999999999999998888889999


Q ss_pred             ccccccccccccccCCCC
Q 001988          609 SYLKELNLSFNKLKGEIP  626 (985)
Q Consensus       609 ~~L~~L~ls~N~l~~~~p  626 (985)
                      ++|+.|+|++|++.+...
T Consensus       290 ~~L~~L~L~~Np~~CdC~  307 (452)
T 3zyi_A          290 RYLVELHLHHNPWNCDCD  307 (452)
T ss_dssp             TTCCEEECCSSCEECSTT
T ss_pred             cCCCEEEccCCCcCCCCC
Confidence            999999999999987765

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=6.3e-29  Score=288.01  Aligned_cols=251  Identities=24%  Similarity=0.290  Sum_probs=219.9

Q ss_pred             ccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecc
Q 001988          370 LRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLA  449 (985)
Q Consensus       370 L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  449 (985)
                      .+.++.+++.++ .+|..+.   .+++.|+|++|+|++..+..|.++++|++|+|++|+|+++.+.+|.++++|++|+|+
T Consensus        45 ~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~  120 (440)
T 3zyj_A           45 FSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF  120 (440)
T ss_dssp             SCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred             CCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence            456666666666 4555443   368888899999888888899999999999999999998888899999999999999


Q ss_pred             cccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeecc-ceeeeecCCCccCccceeEEeecCCcccCC
Q 001988          450 FNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGS-NRFTFVIPSTFWNLKDILSFDISSNLLDGP  528 (985)
Q Consensus       450 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~  528 (985)
                      +|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|++++ |.++.+.+..|.++++|++|++++|+++.+
T Consensus       121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~  200 (440)
T 3zyj_A          121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI  200 (440)
T ss_dssp             SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC
T ss_pred             CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc
Confidence            9999977777888999999999999999988888899999999999998 567767777899999999999999999866


Q ss_pred             ccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcccccc
Q 001988          529 ISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKL  608 (985)
Q Consensus       529 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  608 (985)
                      .  .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+
T Consensus       201 ~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  278 (440)
T 3zyj_A          201 P--NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL  278 (440)
T ss_dssp             C--CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred             c--ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence            4  48889999999999999999989999999999999999999999889999999999999999999998888889999


Q ss_pred             ccccccccccccccCCCC
Q 001988          609 SYLKELNLSFNKLKGEIP  626 (985)
Q Consensus       609 ~~L~~L~ls~N~l~~~~p  626 (985)
                      ++|+.|+|++|++.+...
T Consensus       279 ~~L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          279 HHLERIHLHHNPWNCNCD  296 (440)
T ss_dssp             TTCCEEECCSSCEECSST
T ss_pred             cCCCEEEcCCCCccCCCC
Confidence            999999999999987654

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=4.7e-29  Score=274.47  Aligned_cols=278  Identities=20%  Similarity=0.272  Sum_probs=189.6

Q ss_pred             cEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccc
Q 001988          318 ILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLER  397 (985)
Q Consensus       318 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~  397 (985)
                      +.++++++.++. +|..+.  ++|++|++++|+++.++..     .+.++++|++|++++|+++..              
T Consensus        10 ~~l~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~~i~~~-----~~~~l~~L~~L~L~~n~l~~~--------------   67 (306)
T 2z66_A           10 TEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHG-----VFDKLTQLTKLSLSSNGLSFK--------------   67 (306)
T ss_dssp             TEEECCSSCCSS-CCSCCC--TTCCEEECCSSCCCCCCTT-----TTTTCTTCSEEECCSSCCCEE--------------
T ss_pred             CEEEcCCCCccc-CCCCCC--CCCCEEECCCCccCccCHh-----HhhccccCCEEECCCCccCcc--------------
Confidence            355666666653 333222  4555555555555544432     134455555555555544411              


Q ss_pred             eeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCch-hhhhhccCCCeEEccCCc
Q 001988          398 LNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIP-DEICLLSRLNELDLNGNK  476 (985)
Q Consensus       398 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~  476 (985)
                               +..+..+..+++|++|+|++|.++ .+|..|.++++|++|++++|++++..+ ..+..+++|++|++++|+
T Consensus        68 ---------~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~  137 (306)
T 2z66_A           68 ---------GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH  137 (306)
T ss_dssp             ---------EEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSC
T ss_pred             ---------cCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCc
Confidence                     112344555677777777777776 355567777777777777777775544 467777778888888887


Q ss_pred             cccccCCCCcCcCcCceEeeccceeee-ecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCch
Q 001988          477 ISGSISSCLGNLTSLQYLNLGSNRFTF-VIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPT  555 (985)
Q Consensus       477 l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  555 (985)
                      +++..+..+.++++|++|++++|.+++ ..|..|..+++|++|++++|++++..+..+..+++|+.|+|++|++++..+.
T Consensus       138 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  217 (306)
T 2z66_A          138 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF  217 (306)
T ss_dssp             CEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSG
T ss_pred             CCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChh
Confidence            777777777777888888888887776 5677777788888888888888777777788888888888888888877777


Q ss_pred             hhcccccceeeeeecceeccchhhhhhccc-ccCeEecCCCcccCCCC--ccccccccccccccccccccCCCCC
Q 001988          556 TLEGLKSLQNISLAYNRLEGPIPESFGNMT-SLESLDLSNNKISGSIP--VSFEKLSYLKELNLSFNKLKGEIPR  627 (985)
Q Consensus       556 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~ls~N~l~~~~p~  627 (985)
                      .+..+++|++|+|++|++++..|..+..++ +|++|+|++|++++..+  .....+...+.+.+..|.+.+..|.
T Consensus       218 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~  292 (306)
T 2z66_A          218 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS  292 (306)
T ss_dssp             GGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred             hccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence            788888888888888888887888888874 78888888888876432  1133455566677777777777665

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=3.5e-29  Score=298.40  Aligned_cols=282  Identities=26%  Similarity=0.347  Sum_probs=176.1

Q ss_pred             CCCCCCCcceeeeEEEe------CCCCeEEEEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEE
Q 001988           53 NWTSNASICSWIGIICD------VNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVL  126 (985)
Q Consensus        53 ~w~~~~~~c~w~gv~c~------~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  126 (985)
                      .|..+.+||.|+|..|.      .....++.|++++++++ .+|..+.  ++|++|+|++|.|+ .+|.   .+++|++|
T Consensus        14 ~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L   86 (622)
T 3g06_A           14 AWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTL   86 (622)
T ss_dssp             HHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEE
T ss_pred             HHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEE
Confidence            38878899999775432      12234788999999998 7887776  78999999999988 4676   57889999


Q ss_pred             EccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccC
Q 001988          127 YLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNL  206 (985)
Q Consensus       127 ~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l  206 (985)
                      +|++|++++. |.   .+++|++|++++|++++ +|.    .+++|++|++++|+++ .+|..   +++|++|+|++|++
T Consensus        87 ~Ls~N~l~~l-p~---~l~~L~~L~Ls~N~l~~-l~~----~l~~L~~L~L~~N~l~-~lp~~---l~~L~~L~Ls~N~l  153 (622)
T 3g06_A           87 EVSGNQLTSL-PV---LPPGLLELSIFSNPLTH-LPA----LPSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQL  153 (622)
T ss_dssp             EECSCCCSCC-CC---CCTTCCEEEECSCCCCC-CCC----CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCC
T ss_pred             EcCCCcCCcC-CC---CCCCCCEEECcCCcCCC-CCC----CCCCcCEEECCCCCCC-cCCCC---CCCCCEEECcCCcC
Confidence            9999988753 33   55777777777777773 454    3566777777777776 35553   36677777777777


Q ss_pred             CCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhh
Q 001988          207 SGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRI  286 (985)
Q Consensus       207 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~  286 (985)
                      ++ +|..   +++|+.|++++|++++ +|   ..+++|+.|++++|++++ +|..   +++|+.|++++|.++ .+|.  
T Consensus       154 ~~-l~~~---~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~--  218 (622)
T 3g06_A          154 AS-LPAL---PSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPA--  218 (622)
T ss_dssp             SC-CCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCC--
T ss_pred             CC-cCCc---cCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCC--
Confidence            63 4432   3456667777777763 44   345667777777777664 3332   356666666666666 4443  


Q ss_pred             hhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccc
Q 001988          287 DLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLAN  366 (985)
Q Consensus       287 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~  366 (985)
                        .+++|+.|+|++|+|++ +|   ..+++|+.|++++|+|+. +|.   .+++|+.|+|++|+|+.++.      .+.+
T Consensus       219 --~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~~lp~------~l~~  282 (622)
T 3g06_A          219 --LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLTRLPE------SLIH  282 (622)
T ss_dssp             --CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCCSCCG------GGGG
T ss_pred             --CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCCcCCH------HHhh
Confidence              23566666666666654 33   233555555666655553 232   34455555555555553322      2344


Q ss_pred             cCcccEEEecCCCCCccCC
Q 001988          367 CKKLRYLGLGGNPLDGFLP  385 (985)
Q Consensus       367 l~~L~~L~L~~N~l~~~~p  385 (985)
                      +++|+.|+|++|++++..|
T Consensus       283 l~~L~~L~L~~N~l~~~~~  301 (622)
T 3g06_A          283 LSSETTVNLEGNPLSERTL  301 (622)
T ss_dssp             SCTTCEEECCSCCCCHHHH
T ss_pred             ccccCEEEecCCCCCCcCH
Confidence            4555555555555544333

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=8.9e-29  Score=269.25  Aligned_cols=252  Identities=22%  Similarity=0.253  Sum_probs=193.8

Q ss_pred             cEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceeccc
Q 001988          371 RYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAF  450 (985)
Q Consensus       371 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  450 (985)
                      +.++.+++.++. +|..+   +.+|++|++++|.+++..+..|..+++|++|+|++|.+++..|.+|.++++|++|++++
T Consensus        14 ~~~~c~~~~l~~-ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           14 VTTSCPQQGLQA-VPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             CEEECCSSCCSS-CCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             eEEEcCcCCccc-CCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence            455555555552 34332   23677777777777777677778888888888888888777777788888888888888


Q ss_pred             cc-ccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCc
Q 001988          451 NK-LAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPI  529 (985)
Q Consensus       451 N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~  529 (985)
                      |. +....|..+..+++|++|++++|++++..+..|.++++|++|++++|+++++.+..|..+++|++|++++|++++..
T Consensus        90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  169 (285)
T 1ozn_A           90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (285)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence            86 77666777778888888888888888777777888888888888888888777777888888888888888888777


Q ss_pred             cccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccc
Q 001988          530 SLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLS  609 (985)
Q Consensus       530 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  609 (985)
                      +..+..+++|+.|++++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++....+.. .-..
T Consensus       170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~  248 (285)
T 1ozn_A          170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWA  248 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHH
T ss_pred             HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHH
Confidence            777888888888888888888888888888888888888888888877778888888888888888887644322 2334


Q ss_pred             cccccccccccccCCCCC
Q 001988          610 YLKELNLSFNKLKGEIPR  627 (985)
Q Consensus       610 ~L~~L~ls~N~l~~~~p~  627 (985)
                      .++.+..+.|.+.+..|.
T Consensus       249 ~l~~~~~~~~~~~c~~p~  266 (285)
T 1ozn_A          249 WLQKFRGSSSEVPCSLPQ  266 (285)
T ss_dssp             HHHHCCSEECCCBEEESG
T ss_pred             HHHhcccccCccccCCch
Confidence            567777888888888875

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=3.2e-28  Score=264.80  Aligned_cols=267  Identities=22%  Similarity=0.161  Sum_probs=203.4

Q ss_pred             ceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccE
Q 001988          342 KLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIV  421 (985)
Q Consensus       342 ~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  421 (985)
                      +.++.+.+.++.++..        -.++|++|++++|.+++..+..+..++ +|++|++++|.+++..|.+|..+++|++
T Consensus        14 ~~~~c~~~~l~~ip~~--------~~~~l~~L~l~~n~i~~~~~~~~~~~~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~   84 (285)
T 1ozn_A           14 VTTSCPQQGLQAVPVG--------IPAASQRIFLHGNRISHVPAASFRACR-NLTILWLHSNVLARIDAAAFTGLALLEQ   84 (285)
T ss_dssp             CEEECCSSCCSSCCTT--------CCTTCSEEECTTSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred             eEEEcCcCCcccCCcC--------CCCCceEEEeeCCcCCccCHHHcccCC-CCCEEECCCCccceeCHhhcCCccCCCE
Confidence            3455555555544432        124667777777777666666666666 6777777777777777788888888888


Q ss_pred             EEccCCC-CCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccce
Q 001988          422 LSLGGNN-LSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNR  500 (985)
Q Consensus       422 L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  500 (985)
                      |++++|. ++...|..|..+++|++|++++|++++..|..+..+++|++|++++|++++..+..|..+++|++|++++|+
T Consensus        85 L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  164 (285)
T 1ozn_A           85 LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR  164 (285)
T ss_dssp             EECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCc
Confidence            8888886 777767888888888888888888887777788888888888888888887777778888888888888888


Q ss_pred             eeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhh
Q 001988          501 FTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPES  580 (985)
Q Consensus       501 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  580 (985)
                      ++++.+..|.++++|+.|++++|.+.+..+..+..+++|+.|++++|+|++..+..+..+++|++|+|++|.+....+..
T Consensus       165 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~  244 (285)
T 1ozn_A          165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR  244 (285)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH
T ss_pred             ccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH
Confidence            88877778888888888888888888888888888999999999999999877778889999999999999998643321


Q ss_pred             hhcccccCeEecCCCcccCCCCccccc--ccccccccccc
Q 001988          581 FGNMTSLESLDLSNNKISGSIPVSFEK--LSYLKELNLSF  618 (985)
Q Consensus       581 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~--l~~L~~L~ls~  618 (985)
                       .-...++.+..+.|.+....|..+.+  +..++..++++
T Consensus       245 -~~~~~l~~~~~~~~~~~c~~p~~l~g~~l~~l~~~~l~~  283 (285)
T 1ozn_A          245 -PLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG  283 (285)
T ss_dssp             -HHHHHHHHCCSEECCCBEEESGGGTTCBGGGSCGGGSCC
T ss_pred             -HHHHHHHhcccccCccccCCchHhCCcChhhcCHHHhcc
Confidence             22244666678888888888877654  34444444443

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.96  E-value=5e-30  Score=300.00  Aligned_cols=234  Identities=22%  Similarity=0.236  Sum_probs=141.4

Q ss_pred             cccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceec
Q 001988          369 KLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDL  448 (985)
Q Consensus       369 ~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  448 (985)
                      +|++|+|++|.+++..|..+..++ +|+.|+|++|.+++..|  +..+++|++|+|++|.|++..+     .++|+.|++
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L  106 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFT-KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHA  106 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCT-TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEEC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCC-CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEEC
Confidence            455555555555544444444444 45555555555554443  5556666666666666653322     256666666


Q ss_pred             ccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCcc-CccceeEEeecCCcccC
Q 001988          449 AFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFW-NLKDILSFDISSNLLDG  527 (985)
Q Consensus       449 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~~  527 (985)
                      ++|.|++..+.   .+++|+.|+|++|.+++..|..+.++++|++|+|++|.+++..|..|. .+++|+.|++++|.|++
T Consensus       107 ~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~  183 (487)
T 3oja_A          107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD  183 (487)
T ss_dssp             CSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred             cCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence            66666654432   245666666666666666666666666666666666666666665554 56666666666666665


Q ss_pred             CccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCccc-CCCCcccc
Q 001988          528 PISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKIS-GSIPVSFE  606 (985)
Q Consensus       528 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~  606 (985)
                      ..+  ...+++|+.|+|++|+|++..| .+..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|.+. +.+|..+.
T Consensus       184 ~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~  259 (487)
T 3oja_A          184 VKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS  259 (487)
T ss_dssp             EEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHT
T ss_pred             ccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHH
Confidence            532  2346667777777777765433 36667777777777777774 5656667777777777777776 55566666


Q ss_pred             ccccccccccc
Q 001988          607 KLSYLKELNLS  617 (985)
Q Consensus       607 ~l~~L~~L~ls  617 (985)
                      .++.|+.++++
T Consensus       260 ~l~~L~~l~~~  270 (487)
T 3oja_A          260 KNQRVQTVAKQ  270 (487)
T ss_dssp             TCHHHHHHHHH
T ss_pred             hCCCCcEEecc
Confidence            66777766665

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.95  E-value=3.9e-27  Score=272.91  Aligned_cols=247  Identities=24%  Similarity=0.268  Sum_probs=134.8

Q ss_pred             cceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecC
Q 001988          172 LKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGF  251 (985)
Q Consensus       172 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  251 (985)
                      .+.++.+++.++ .+|..+.  +++++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++
T Consensus        45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~  121 (440)
T 3zyj_A           45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD  121 (440)
T ss_dssp             SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred             CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence            344555555555 4555443  4555555555555554445555555555555555555544445555555555555555


Q ss_pred             CcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCc-ccccc
Q 001988          252 NNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSN-SFSGF  330 (985)
Q Consensus       252 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~  330 (985)
                      |++++..+..|..+++|++|+|++|++                         ++..+..|.++++|+.|++++| .+...
T Consensus       122 n~l~~~~~~~~~~l~~L~~L~L~~N~i-------------------------~~~~~~~~~~l~~L~~L~l~~~~~l~~i  176 (440)
T 3zyj_A          122 NRLTTIPNGAFVYLSKLKELWLRNNPI-------------------------ESIPSYAFNRIPSLRRLDLGELKRLSYI  176 (440)
T ss_dssp             SCCSSCCTTTSCSCSSCCEEECCSCCC-------------------------CEECTTTTTTCTTCCEEECCCCTTCCEE
T ss_pred             CcCCeeCHhHhhccccCceeeCCCCcc-------------------------cccCHHHhhhCcccCEeCCCCCCCccee
Confidence            555544444444444444444444444                         4334444555555555555553 33333


Q ss_pred             cCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccC
Q 001988          331 IPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIP  410 (985)
Q Consensus       331 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~  410 (985)
                      .+..|.++++|++|++++|+++.++.       +..+++|++|+|++|++++                         ..|
T Consensus       177 ~~~~~~~l~~L~~L~L~~n~l~~~~~-------~~~l~~L~~L~Ls~N~l~~-------------------------~~~  224 (440)
T 3zyj_A          177 SEGAFEGLSNLRYLNLAMCNLREIPN-------LTPLIKLDELDLSGNHLSA-------------------------IRP  224 (440)
T ss_dssp             CTTTTTTCSSCCEEECTTSCCSSCCC-------CTTCSSCCEEECTTSCCCE-------------------------ECT
T ss_pred             CcchhhcccccCeecCCCCcCccccc-------cCCCcccCEEECCCCccCc-------------------------cCh
Confidence            34456666667777777666664431       3445555555555555554                         444


Q ss_pred             CcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccc
Q 001988          411 KAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKIS  478 (985)
Q Consensus       411 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  478 (985)
                      ..|..+++|++|+|++|+|++..+.+|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|.+.
T Consensus       225 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          225 GSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             TTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             hhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            45555555555555555555555555555566666666666665555555555666666666666554

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=3.2e-27  Score=274.64  Aligned_cols=247  Identities=25%  Similarity=0.282  Sum_probs=147.5

Q ss_pred             cceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecC
Q 001988          172 LKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGF  251 (985)
Q Consensus       172 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  251 (985)
                      ...++.+++.++ .+|..+.  ++|++|+|++|+|++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus        56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~  132 (452)
T 3zyi_A           56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD  132 (452)
T ss_dssp             SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence            455666666666 5666554  4667777777777766666666666677777776666666566666666666666666


Q ss_pred             CcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccC-cccccc
Q 001988          252 NNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGS-NSFSGF  330 (985)
Q Consensus       252 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~  330 (985)
                      |++++..+..|.++++|++|+|++|+++ .+|.                        ..|.++++|+.|++++ |.+...
T Consensus       133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~------------------------~~~~~l~~L~~L~l~~~~~l~~i  187 (452)
T 3zyi_A          133 NWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPS------------------------YAFNRVPSLMRLDLGELKKLEYI  187 (452)
T ss_dssp             SCCSBCCTTTSSSCTTCCEEECCSCCCC-EECT------------------------TTTTTCTTCCEEECCCCTTCCEE
T ss_pred             CcCCccChhhhcccCCCCEEECCCCCcc-eeCH------------------------hHHhcCCcccEEeCCCCCCcccc
Confidence            6666555555555666666666555555 3333                        3444445555555554 233333


Q ss_pred             cCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccC
Q 001988          331 IPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIP  410 (985)
Q Consensus       331 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~  410 (985)
                      .+..|.++++|++|++++|+++..+       .+..+++|++|+|++|+++                         +..|
T Consensus       188 ~~~~~~~l~~L~~L~L~~n~l~~~~-------~~~~l~~L~~L~Ls~N~l~-------------------------~~~~  235 (452)
T 3zyi_A          188 SEGAFEGLFNLKYLNLGMCNIKDMP-------NLTPLVGLEELEMSGNHFP-------------------------EIRP  235 (452)
T ss_dssp             CTTTTTTCTTCCEEECTTSCCSSCC-------CCTTCTTCCEEECTTSCCS-------------------------EECG
T ss_pred             ChhhccCCCCCCEEECCCCcccccc-------cccccccccEEECcCCcCc-------------------------ccCc
Confidence            3345666666666666666665442       1344455555555555554                         4445


Q ss_pred             CcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccc
Q 001988          411 KAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKIS  478 (985)
Q Consensus       411 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  478 (985)
                      ..|..+++|++|+|++|++++..+.+|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|.+.
T Consensus       236 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          236 GSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             GGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             ccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence            55555666666666666666666666666666666666666666555555566666666666666654

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=9e-29  Score=273.38  Aligned_cols=236  Identities=19%  Similarity=0.195  Sum_probs=118.7

Q ss_pred             CCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEE
Q 001988          193 CKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIF  272 (985)
Q Consensus       193 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  272 (985)
                      +++|++|+|++|++++..|..|+++++|++|+|++|++++..|  +..+++|++|++++|++++..     ..++|++|+
T Consensus        33 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~  105 (317)
T 3o53_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLH  105 (317)
T ss_dssp             GGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEE
T ss_pred             CCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEEE
Confidence            3344444444444444333444444444444444444443322  444455555555555544321     124555555


Q ss_pred             ccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcc-cCCCCCceEeccCCcc
Q 001988          273 LYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAI-GNLRNLKLFDIFFNNL  351 (985)
Q Consensus       273 L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~L~~N~l  351 (985)
                      +++|++++..+.    .+++|++|++++|++++..+..+..+++|+.|++++|.+++..+..+ ..+++|++|++++|++
T Consensus       106 l~~n~l~~~~~~----~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l  181 (317)
T 3o53_A          106 AANNNISRVSCS----RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI  181 (317)
T ss_dssp             CCSSCCSEEEEC----CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred             CCCCccCCcCcc----ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcC
Confidence            555555532221    24566666666666666666666667777777777777776666555 3567777777777766


Q ss_pred             cCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCC-
Q 001988          352 TSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLS-  430 (985)
Q Consensus       352 ~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-  430 (985)
                      +..+.       ...+++|++|++++|++++. |..+..++ +|+.|++++|+|+ .+|..+..+++|++|++++|.+. 
T Consensus       182 ~~~~~-------~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~-~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~  251 (317)
T 3o53_A          182 YDVKG-------QVVFAKLKTLDLSSNKLAFM-GPEFQSAA-GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC  251 (317)
T ss_dssp             CEEEC-------CCCCTTCCEEECCSSCCCEE-CGGGGGGT-TCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBH
T ss_pred             ccccc-------ccccccCCEEECCCCcCCcc-hhhhcccC-cccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccC
Confidence            65422       22345566666666655532 22233333 3444444444444 23334444444444444444444 


Q ss_pred             CCCCccccccccccceecc
Q 001988          431 GSIPVTFGGLQKLQGLDLA  449 (985)
Q Consensus       431 ~~~~~~~~~l~~L~~L~Ls  449 (985)
                      +..|.++..+++|+.|+++
T Consensus       252 ~~~~~~~~~~~~L~~l~l~  270 (317)
T 3o53_A          252 GTLRDFFSKNQRVQTVAKQ  270 (317)
T ss_dssp             HHHHHHHHTCHHHHHHHHH
T ss_pred             cCHHHHHhccccceEEECC
Confidence            3334444444444444444

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.95  E-value=2.9e-27  Score=254.96  Aligned_cols=218  Identities=29%  Similarity=0.371  Sum_probs=137.9

Q ss_pred             CCcceeeeEEEeCCCCeEEEEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCC
Q 001988           58 ASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSL  137 (985)
Q Consensus        58 ~~~c~w~gv~c~~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~  137 (985)
                      .++|.|.|+.|+... .++.+++++++++ .+|..+.  ++|++|+|++|++++..+..|..+++|++|+|++|+++...
T Consensus         2 ~~~C~~~~~~C~c~~-~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~   77 (270)
T 2o6q_A            2 EALCKKDGGVCSCNN-NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP   77 (270)
T ss_dssp             CCCBGGGTCSBEEET-TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred             CccCCCCCCCCEeCC-CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence            478999999987642 3568999999999 5777665  68999999999999766678899999999999999888544


Q ss_pred             ccccccCCccceeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccc
Q 001988          138 SSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNL  217 (985)
Q Consensus       138 ~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l  217 (985)
                      +..+..                         +++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|+++
T Consensus        78 ~~~~~~-------------------------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  132 (270)
T 2o6q_A           78 AGIFKE-------------------------LKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSL  132 (270)
T ss_dssp             TTTTSS-------------------------CTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTC
T ss_pred             hhhhcC-------------------------CCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcC
Confidence            444444                         4455555555555544333444555555555555555554444455555


Q ss_pred             cccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEE
Q 001988          218 TVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLN  297 (985)
Q Consensus       218 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~  297 (985)
                      ++|++|+|++|++++..+..|+.+++|++|+|++|++++..+..|.++++|++|+|++|+++ .+|...+..+++|+.|+
T Consensus       133 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~  211 (270)
T 2o6q_A          133 TKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQ  211 (270)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEE
T ss_pred             cCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCC-cCCHHHhccccCCCEEE
Confidence            55555555555555444444555555555555555555544445555555555555555555 34444444555666666


Q ss_pred             ecCccCCC
Q 001988          298 LGINSFSG  305 (985)
Q Consensus       298 Ls~N~l~~  305 (985)
                      |++|.+..
T Consensus       212 l~~N~~~c  219 (270)
T 2o6q_A          212 LQENPWDC  219 (270)
T ss_dssp             CCSSCBCC
T ss_pred             ecCCCeeC
Confidence            66665543

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=1.4e-28  Score=271.75  Aligned_cols=181  Identities=20%  Similarity=0.189  Sum_probs=110.1

Q ss_pred             ccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCcc-CccceeEEe
Q 001988          441 QKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFW-NLKDILSFD  519 (985)
Q Consensus       441 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~  519 (985)
                      ++|++|++++|++++..+.   .+++|++|++++|++++..+..+..+++|++|++++|++++..+..+. .+++|++|+
T Consensus        99 ~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~  175 (317)
T 3o53_A           99 PSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN  175 (317)
T ss_dssp             TTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred             CCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEE
Confidence            3444444444444432222   134455555555555544444455555555555555555554444442 445555555


Q ss_pred             ecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCccc-
Q 001988          520 ISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKIS-  598 (985)
Q Consensus       520 ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-  598 (985)
                      +++|.+++..+  ...+++|+.|+|++|+|++. |..+..+++|++|+|++|+|++ +|..+..+++|+.|+|++|+++ 
T Consensus       176 L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~  251 (317)
T 3o53_A          176 LQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC  251 (317)
T ss_dssp             CTTSCCCEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBH
T ss_pred             CCCCcCccccc--ccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccC
Confidence            55555554422  22366777777777777744 4447777888888888888874 6677778888888888888887 


Q ss_pred             CCCCccccccccccccccc-cccccCCCCCC
Q 001988          599 GSIPVSFEKLSYLKELNLS-FNKLKGEIPRG  628 (985)
Q Consensus       599 ~~~p~~~~~l~~L~~L~ls-~N~l~~~~p~~  628 (985)
                      +.+|..+..+++|+.|+++ .+.++|..|..
T Consensus       252 ~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~  282 (317)
T 3o53_A          252 GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE  282 (317)
T ss_dssp             HHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred             cCHHHHHhccccceEEECCCchhccCCchhc
Confidence            6677778888888888888 55677777654

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.94  E-value=1.7e-26  Score=275.29  Aligned_cols=268  Identities=26%  Similarity=0.300  Sum_probs=163.6

Q ss_pred             cccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEe
Q 001988          170 RYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQL  249 (985)
Q Consensus       170 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  249 (985)
                      .++++|++++|.++ .+|..+.  ++|++|+|++|+|+ .+|.   .+++|++|+|++|+|+ .+|.   .+++|++|+|
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~L  108 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSI  108 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred             CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEEC
Confidence            35778888888887 7777665  67888888888887 4555   4677888888888877 4554   5677888888


Q ss_pred             cCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCccccc
Q 001988          250 GFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSG  329 (985)
Q Consensus       250 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  329 (985)
                      ++|++++ +|.   .+++|+.|++++|+++ .+|.    .+++|++|+|++|++++ +|.   .+.+|+.|++++|.+++
T Consensus       109 s~N~l~~-l~~---~l~~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~  175 (622)
T 3g06_A          109 FSNPLTH-LPA---LPSGLCKLWIFGNQLT-SLPV----LPPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS  175 (622)
T ss_dssp             CSCCCCC-CCC---CCTTCCEEECCSSCCS-CCCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC
T ss_pred             cCCcCCC-CCC---CCCCcCEEECCCCCCC-cCCC----CCCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC
Confidence            8888775 333   4567777778777777 4554    24677777777777764 332   23456666666666664


Q ss_pred             ccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceecccccccccc
Q 001988          330 FIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNI  409 (985)
Q Consensus       330 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~  409 (985)
                       +|   ..+++|+.|++++|+++.++..         +++|+.|++++|.++.                          +
T Consensus       176 -l~---~~~~~L~~L~Ls~N~l~~l~~~---------~~~L~~L~L~~N~l~~--------------------------l  216 (622)
T 3g06_A          176 -LP---MLPSGLQELSVSDNQLASLPTL---------PSELYKLWAYNNRLTS--------------------------L  216 (622)
T ss_dssp             -CC---CCCTTCCEEECCSSCCSCCCCC---------CTTCCEEECCSSCCSS--------------------------C
T ss_pred             -Cc---ccCCCCcEEECCCCCCCCCCCc---------cchhhEEECcCCcccc--------------------------c
Confidence             33   3345566666666665544321         2345555555555442                          2


Q ss_pred             CCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcC
Q 001988          410 PKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLT  489 (985)
Q Consensus       410 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  489 (985)
                      |.   .+++|++|+|++|+|++ +|   ..+++|+.|+|++|+|++ +|.   .+++|+.|+|++|+|+ .+|..+.+++
T Consensus       217 ~~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~  284 (622)
T 3g06_A          217 PA---LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLS  284 (622)
T ss_dssp             CC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSC
T ss_pred             CC---CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhcc
Confidence            21   12455555555555554 23   234556666666666652 333   3455666666666665 4455566666


Q ss_pred             cCceEeeccceeeeecCCCccCc
Q 001988          490 SLQYLNLGSNRFTFVIPSTFWNL  512 (985)
Q Consensus       490 ~L~~L~L~~N~l~~~~p~~~~~l  512 (985)
                      +|+.|+|++|.+++..|..+..+
T Consensus       285 ~L~~L~L~~N~l~~~~~~~l~~L  307 (622)
T 3g06_A          285 SETTVNLEGNPLSERTLQALREI  307 (622)
T ss_dssp             TTCEEECCSCCCCHHHHHHHHHH
T ss_pred             ccCEEEecCCCCCCcCHHHHHhc
Confidence            66666666666666555554443

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.94  E-value=1.5e-29  Score=305.76  Aligned_cols=438  Identities=15%  Similarity=0.137  Sum_probs=247.2

Q ss_pred             CCChhHhhhccccceecccCccccc---cCCcc------------cCCCCCceEEEcccccCCCccccccc-cccccceE
Q 001988          160 KLPENICNHLRYLKHLFLRENMFYG---KIPSS------------LSKCKQLQELHLGYNNLSGAIPKEIG-NLTVLQRI  223 (985)
Q Consensus       160 ~lp~~~~~~l~~L~~L~L~~n~l~~---~~p~~------------l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L  223 (985)
                      ..|..++..+++|++|+++++....   ..|..            ...+++|++|+|++|.+++..+..+. .+++|++|
T Consensus        56 ~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L  135 (594)
T 2p1m_B           56 VSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVL  135 (594)
T ss_dssp             SCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEE
T ss_pred             cCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEE
Confidence            3455566677777777777764321   11211            23567888888888888877776665 67888888


Q ss_pred             eeccc-cccCC-chhhhcCCCCCCEEEecCCcCcccCccccc----CCCCCCEEEccCCc--CcccCChhhhhcCCCCcE
Q 001988          224 SLINN-KLHGE-IPQEIGYLQNLDVLQLGFNNLTGVVPATIF----NMSTLKEIFLYNNS--LSGSLPSRIDLALPNLEF  295 (985)
Q Consensus       224 ~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~----~l~~L~~L~L~~N~--l~~~~p~~~~~~l~~L~~  295 (985)
                      +|++| .++.. ++..+.++++|++|+|++|.+++..+..+.    .+++|++|++++|.  ++......+...+++|++
T Consensus       136 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~  215 (594)
T 2p1m_B          136 VLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKS  215 (594)
T ss_dssp             EEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCE
T ss_pred             eCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcE
Confidence            88888 45432 455555788888888888887765544443    56688888888886  221111223334688888


Q ss_pred             EEecCcc-CCCcCCccccCCCCccEEEccC-------cccccccCCcccCCCCCceE-eccCCcccCCCCcccccccccc
Q 001988          296 LNLGINS-FSGTIPSSITNASKLILLEMGS-------NSFSGFIPSAIGNLRNLKLF-DIFFNNLTSSTPELGFLSSLAN  366 (985)
Q Consensus       296 L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~-------N~l~~~~p~~l~~l~~L~~L-~L~~N~l~~~~~~~~~~~~l~~  366 (985)
                      |+|++|. ++ .++..+.++++|+.|+++.       |.+.+ ++..+.++++|+.| .+......      .+...+..
T Consensus       216 L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~~------~l~~~~~~  287 (594)
T 2p1m_B          216 LKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVPA------YLPAVYSV  287 (594)
T ss_dssp             EECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCGG------GGGGGHHH
T ss_pred             EecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccchh------hHHHHHHh
Confidence            8888873 43 3666777777888887443       33443 33356777777777 33222111      11112335


Q ss_pred             cCcccEEEecCCCCCccCCCC-ccchhhcccceeccccccccc-cCCcCCCCCCccEEEccCCCCCCCCCcccccccccc
Q 001988          367 CKKLRYLGLGGNPLDGFLPSS-IGNLSLSLERLNIAFCNISGN-IPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQ  444 (985)
Q Consensus       367 l~~L~~L~L~~N~l~~~~p~~-~~~l~~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  444 (985)
                      +++|++|++++|.+++..... +..++ +|+.|++++| ++.. ++.....+++|++|+++++.-.|             
T Consensus       288 ~~~L~~L~L~~~~l~~~~l~~~~~~~~-~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g-------------  352 (594)
T 2p1m_B          288 CSRLTTLNLSYATVQSYDLVKLLCQCP-KLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFV-------------  352 (594)
T ss_dssp             HTTCCEEECTTCCCCHHHHHHHHTTCT-TCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTC-------------
T ss_pred             hCCCCEEEccCCCCCHHHHHHHHhcCC-CcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccc-------------
Confidence            667777777777655321111 11222 4555555554 2211 11111234455555552210000             


Q ss_pred             ceecccccccCCchhhhh-hccCCCeEEccCCccccccCCCCc-CcCcCceEeec--c----ceeeee-----cCCCccC
Q 001988          445 GLDLAFNKLAGSIPDEIC-LLSRLNELDLNGNKISGSISSCLG-NLTSLQYLNLG--S----NRFTFV-----IPSTFWN  511 (985)
Q Consensus       445 ~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~-----~p~~~~~  511 (985)
                        ..+.|.+++.....+. .+++|+.|+++.|.+++.....+. .+++|+.|+++  +    |.++..     ++..+.+
T Consensus       353 --~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~  430 (594)
T 2p1m_B          353 --MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEH  430 (594)
T ss_dssp             --SSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHH
T ss_pred             --cccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhh
Confidence              0022233322112222 245555555555555443333332 34555555555  2    333311     1122445


Q ss_pred             ccceeEEeecCCcccCCccccccC-CCcccEEEccCCccCccCchhh-cccccceeeeeecceeccchhh-hhhcccccC
Q 001988          512 LKDILSFDISSNLLDGPISLAIGN-LKAVVGIDLSRNNLSGNIPTTL-EGLKSLQNISLAYNRLEGPIPE-SFGNMTSLE  588 (985)
Q Consensus       512 l~~L~~L~ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~  588 (985)
                      +++|+.|++++ .+++.....+.. +++|+.|+|++|.+++..+..+ .++++|++|+|++|.+++..+. ....+++|+
T Consensus       431 ~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~  509 (594)
T 2p1m_B          431 CKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMR  509 (594)
T ss_dssp             CTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSS
T ss_pred             CCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCC
Confidence            56677777765 444433334444 7778888888888876655555 6688888999998888654444 345588899


Q ss_pred             eEecCCCcccCCCCccc-cccccccccccccccccC
Q 001988          589 SLDLSNNKISGSIPVSF-EKLSYLKELNLSFNKLKG  623 (985)
Q Consensus       589 ~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~  623 (985)
                      .|++++|+++......+ ..+++|+...+..+.-..
T Consensus       510 ~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~~  545 (594)
T 2p1m_B          510 SLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAPD  545 (594)
T ss_dssp             EEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCGG
T ss_pred             EEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCccc
Confidence            99999988854322333 456777666666654433

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=3.4e-27  Score=275.97  Aligned_cols=237  Identities=19%  Similarity=0.185  Sum_probs=175.1

Q ss_pred             cccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccce
Q 001988           95 NLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKH  174 (985)
Q Consensus        95 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~  174 (985)
                      ..++|++|+|++|.+++..|..|..+++|++|+|++|.+++.+|  +..+++|++|+|++|.+++ +|     ..++|++
T Consensus        32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-----~~~~L~~  103 (487)
T 3oja_A           32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LL-----VGPSIET  103 (487)
T ss_dssp             TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEE-EE-----ECTTCCE
T ss_pred             cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCC-CC-----CCCCcCE
Confidence            34489999999999998888899999999999999999987665  7777888888888888874 22     2367888


Q ss_pred             ecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhc-CCCCCCEEEecCCc
Q 001988          175 LFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIG-YLQNLDVLQLGFNN  253 (985)
Q Consensus       175 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~  253 (985)
                      |++++|.+++..+.   .+++|++|+|++|.+++..|..++++++|++|+|++|++++.+|..+. .+++|++|+|++|.
T Consensus       104 L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~  180 (487)
T 3oja_A          104 LHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF  180 (487)
T ss_dssp             EECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred             EECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence            88888888765554   346788888888888877777788888888888888888877777775 67888888888888


Q ss_pred             CcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccc-cccC
Q 001988          254 LTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFS-GFIP  332 (985)
Q Consensus       254 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p  332 (985)
                      +++..+  +..+++|++|+|++|.+++ +|.. +..+++|+.|+|++|++++ +|..+..+++|+.|++++|.+. +.+|
T Consensus       181 l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~-~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~  255 (487)
T 3oja_A          181 IYDVKG--QVVFAKLKTLDLSSNKLAF-MGPE-FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLR  255 (487)
T ss_dssp             CCEEEC--CCCCTTCCEEECCSSCCCE-ECGG-GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHH
T ss_pred             cccccc--cccCCCCCEEECCCCCCCC-CCHh-HcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchH
Confidence            876532  3357777777777777774 3333 3466777777777777774 5666667777777777777776 5555


Q ss_pred             CcccCCCCCceEecc
Q 001988          333 SAIGNLRNLKLFDIF  347 (985)
Q Consensus       333 ~~l~~l~~L~~L~L~  347 (985)
                      ..+..++.|+.++++
T Consensus       256 ~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          256 DFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             HHHTTCHHHHHHHHH
T ss_pred             HHHHhCCCCcEEecc
Confidence            556666666555553

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=2.1e-26  Score=249.20  Aligned_cols=210  Identities=24%  Similarity=0.260  Sum_probs=152.9

Q ss_pred             CccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeec
Q 001988          418 NLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLG  497 (985)
Q Consensus       418 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  497 (985)
                      +|++|++++|++++..+..|.++++|++|++++|++++..+..+..+++|++|+|++|++++..+..|.++++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            45666666666665555556666666666666666665555556666666666666666666666666666777777777


Q ss_pred             cceeeeecCCCccCccceeEEeecCCcccCC-ccccccCCCcccEEEccCCccCccCchhhcccccce----eeeeecce
Q 001988          498 SNRFTFVIPSTFWNLKDILSFDISSNLLDGP-ISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQ----NISLAYNR  572 (985)
Q Consensus       498 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N~  572 (985)
                      +|++++..+..|..+++|++|++++|++++. .|..+..+++|+.|+|++|++++..+..|..+++|+    .|++++|+
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            7777666665667777777777777777664 467788888888888888888877777888877777    88999999


Q ss_pred             eccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCCCCCC
Q 001988          573 LEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRG  628 (985)
Q Consensus       573 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  628 (985)
                      +++..+..+.. .+|+.|+|++|++++..+..|..+++|+.|++++|++++.+|..
T Consensus       189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l  243 (276)
T 2z62_A          189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  243 (276)
T ss_dssp             CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred             ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence            98765555544 48999999999999777777888999999999999999888753

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.93  E-value=6.6e-27  Score=277.17  Aligned_cols=181  Identities=18%  Similarity=0.155  Sum_probs=128.7

Q ss_pred             eeccCceeEEEEE-EcCCcEEEEEEeccCCc----------chHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEEE
Q 001988          734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCA----------STLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       734 ig~G~~g~V~~~~-~~~~~~vAvK~~~~~~~----------~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      .+.|+.|.+..++ .-.|+.||||++.+...          ...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4567777666654 33688899999976521          2245799999999999 6999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||++|++|.+++...+ .++..   +|+.||+.||+|+   |++|||||||||+|||++++|.+||+|||+|+...... 
T Consensus       322 Eyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~yl---H~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-  393 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAAL---EKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-  393 (569)
T ss_dssp             ECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHH---HHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred             ecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHH---HHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-
Confidence            9999999999998764 55553   5899999999999   89999999999999999999999999999998764322 


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhccc
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDK  925 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~  925 (985)
                       ......+||+.|||||++.+ .+....|+ |+.|+..+++..+
T Consensus       394 -~~~~t~vGTp~YmAPE~l~g-~~~~~~d~-~s~g~~~~~l~~~  434 (569)
T 4azs_A          394 -SWPTNLVQSFFVFVNELFAE-NKSWNGFW-RSAPVHPFNLPQP  434 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC-------------------CCCCTT
T ss_pred             -ccccCceechhhccHHHhCC-CCCCcccc-cccccchhhhccc
Confidence             23445689999999998764 46667777 8888777666543

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.93  E-value=1.4e-28  Score=297.05  Aligned_cols=395  Identities=13%  Similarity=0.110  Sum_probs=197.1

Q ss_pred             cccccceecccCCcCCCCCCcccc-cCCCCcEEEccCc-ccCCC-CccccccCCccceeeeccccccCCCChhH---hhh
Q 001988           95 NLSSLKSLDLSHNKLSSNIPSSIF-TMSTLKVLYLMDN-QLSGS-LSSFTFNTSSILDIRLSKNKLSGKLPENI---CNH  168 (985)
Q Consensus        95 ~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~n-~l~~~-~~~~~~~~~~L~~L~ls~n~l~g~lp~~~---~~~  168 (985)
                      .+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++.....+++|++|++++|.+++..+..+   ...
T Consensus       103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~  182 (594)
T 2p1m_B          103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT  182 (594)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred             hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence            455666666666665554444444 4566666666665 33321 33333355566666666666554433222   123


Q ss_pred             ccccceecccCcc--cccc-CCcccCCCCCceEEEcccc-cCCCccccccccccccceEee-------ccccccCCchhh
Q 001988          169 LRYLKHLFLRENM--FYGK-IPSSLSKCKQLQELHLGYN-NLSGAIPKEIGNLTVLQRISL-------INNKLHGEIPQE  237 (985)
Q Consensus       169 l~~L~~L~L~~n~--l~~~-~p~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L-------~~N~l~~~~p~~  237 (985)
                      +++|++|++++|.  +... ++..+.++++|++|+|++| .+++ +|..+.++++|++|++       ..|.+.+ ++..
T Consensus       183 ~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~  260 (594)
T 2p1m_B          183 YTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVA  260 (594)
T ss_dssp             CCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHH
T ss_pred             CCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHH
Confidence            4466666666554  1110 1111233456666666655 3332 5555556666666653       2333332 3345


Q ss_pred             hcCCCCCCEE-EecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCc-CCccccCCC
Q 001988          238 IGYLQNLDVL-QLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGT-IPSSITNAS  315 (985)
Q Consensus       238 ~~~l~~L~~L-~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~  315 (985)
                      +.++++|+.| .+..... +.+|..+..+++|++|+|++|.+++.....+...+++|+.|++++| +++. ++.....++
T Consensus       261 l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~  338 (594)
T 2p1m_B          261 LSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCK  338 (594)
T ss_dssp             HHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCT
T ss_pred             HhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCC
Confidence            5566666665 2332221 2344444455566666666666543333333345566666666655 3221 111122355


Q ss_pred             CccEEEcc---------CcccccccCCccc-CCCCCceEeccCCcccCCCCcccccccc-cccCcccEEEec--C----C
Q 001988          316 KLILLEMG---------SNSFSGFIPSAIG-NLRNLKLFDIFFNNLTSSTPELGFLSSL-ANCKKLRYLGLG--G----N  378 (985)
Q Consensus       316 ~L~~L~L~---------~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~~~~~~~~~l-~~l~~L~~L~L~--~----N  378 (985)
                      +|+.|+++         .+.+++.....+. .+++|+.|+++.|+++....     ..+ ..+++|+.|+++  +    |
T Consensus       339 ~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~-----~~l~~~~~~L~~L~L~~~~~~~~~  413 (594)
T 2p1m_B          339 DLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAAL-----ITIARNRPNMTRFRLCIIEPKAPD  413 (594)
T ss_dssp             TCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHH-----HHHHHHCTTCCEEEEEESSTTCCC
T ss_pred             CCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHH-----HHHHhhCCCcceeEeecccCCCcc
Confidence            56666552         2334332222222 35666666665555543211     112 235666666666  2    3


Q ss_pred             CCCccC-----CCCccchhhcccceeccccccccccCCcCCC-CCCccEEEccCCCCCCCCCccc-cccccccceecccc
Q 001988          379 PLDGFL-----PSSIGNLSLSLERLNIAFCNISGNIPKAIGN-LSNLIVLSLGGNNLSGSIPVTF-GGLQKLQGLDLAFN  451 (985)
Q Consensus       379 ~l~~~~-----p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N  451 (985)
                      .++...     +..+..++ +|+.|++++ .+++..+..+.. +++|++|+|++|.+++..+..+ .++++|+.|+|++|
T Consensus       414 ~l~~~~~~~~~~~l~~~~~-~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n  491 (594)
T 2p1m_B          414 YLTLEPLDIGFGAIVEHCK-DLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDC  491 (594)
T ss_dssp             TTTCCCTHHHHHHHHHHCT-TCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESC
T ss_pred             cccCCchhhHHHHHHhhCC-CccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCC
Confidence            333110     01122233 566666655 555444444443 6677777777777765444444 55677777777777


Q ss_pred             cccCCchh-hhhhccCCCeEEccCCccccccCCCC-cCcCcCceEeeccce
Q 001988          452 KLAGSIPD-EICLLSRLNELDLNGNKISGSISSCL-GNLTSLQYLNLGSNR  500 (985)
Q Consensus       452 ~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~  500 (985)
                      .+++.... .+..+++|+.|++++|+++......+ ..+++|+...+..+.
T Consensus       492 ~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~  542 (594)
T 2p1m_B          492 PFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG  542 (594)
T ss_dssp             SCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred             CCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence            77533332 23446777777777777753322333 345666665555543

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.92  E-value=2.1e-25  Score=241.33  Aligned_cols=225  Identities=22%  Similarity=0.243  Sum_probs=185.8

Q ss_pred             EEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceeccccc
Q 001988          373 LGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNK  452 (985)
Q Consensus       373 L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  452 (985)
                      .+..+..+. .+|..+.   .+|++|++++|++++..+..|..+++|++|++++|++++..+..|.++++|++|+|++|+
T Consensus        12 ~~c~~~~l~-~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~   87 (276)
T 2z62_A           12 YQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP   87 (276)
T ss_dssp             EECTTSCCS-SCCSSSC---TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             EEecCCCcc-ccCCCCC---CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence            334444443 3444332   368888888888887777788888889999999998887777788888899999999999


Q ss_pred             ccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeee-cCCCccCccceeEEeecCCcccCCccc
Q 001988          453 LAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFV-IPSTFWNLKDILSFDISSNLLDGPISL  531 (985)
Q Consensus       453 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~~~  531 (985)
                      +++..+..+..+++|++|++++|++++..+..+.++++|++|++++|++++. +|..|.++++|++|++++|++++..+.
T Consensus        88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~  167 (276)
T 2z62_A           88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT  167 (276)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred             cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence            8877778888889999999999998877777888899999999999998875 588888999999999999999888877


Q ss_pred             cccCCCccc----EEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCC
Q 001988          532 AIGNLKAVV----GIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIP  602 (985)
Q Consensus       532 ~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  602 (985)
                      .+..+++|+    .|++++|++++..+..+.. .+|++|+|++|++++..+..|.++++|+.|+|++|++++..|
T Consensus       168 ~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             GGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             HhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence            888777777    8999999999776666654 589999999999998877788999999999999999996543

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.92  E-value=6.3e-25  Score=236.64  Aligned_cols=185  Identities=24%  Similarity=0.288  Sum_probs=109.1

Q ss_pred             cccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeec
Q 001988          442 KLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDIS  521 (985)
Q Consensus       442 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls  521 (985)
                      +|+.|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|++++|+++++.+..|.++++|++|+++
T Consensus        38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  117 (270)
T 2o6q_A           38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD  117 (270)
T ss_dssp             TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred             CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence            34444444444443333344444444444444444444333444455555555555555554444455555555555555


Q ss_pred             CCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCC
Q 001988          522 SNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSI  601 (985)
Q Consensus       522 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  601 (985)
                      +|++++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|+|++..
T Consensus       118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  197 (270)
T 2o6q_A          118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP  197 (270)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCC
Confidence            55555555555666666666666666666555555666777777777777777666666777777777777777777655


Q ss_pred             CccccccccccccccccccccCCCC
Q 001988          602 PVSFEKLSYLKELNLSFNKLKGEIP  626 (985)
Q Consensus       602 p~~~~~l~~L~~L~ls~N~l~~~~p  626 (985)
                      +..|..+++|+.|++++|++.+..+
T Consensus       198 ~~~~~~l~~L~~L~l~~N~~~c~c~  222 (270)
T 2o6q_A          198 EGAFDSLEKLKMLQLQENPWDCTCN  222 (270)
T ss_dssp             TTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred             HHHhccccCCCEEEecCCCeeCCCc
Confidence            5567777777777777777766554

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=3.2e-25  Score=239.09  Aligned_cols=222  Identities=20%  Similarity=0.237  Sum_probs=190.6

Q ss_pred             cccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEcc
Q 001988          394 SLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLN  473 (985)
Q Consensus       394 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  473 (985)
                      .+..+++..+.+....  .+..+++|+.|++++|.++..  ..+..+++|++|++++|.+++.  +.+..+++|++|+|+
T Consensus        20 ~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~   93 (272)
T 3rfs_A           20 ETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILT   93 (272)
T ss_dssp             HHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECT
T ss_pred             HHHHHHhcCccccccc--ccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECC
Confidence            3555666666655432  355678888999999888743  3578888999999999998863  368888999999999


Q ss_pred             CCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccC
Q 001988          474 GNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNI  553 (985)
Q Consensus       474 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  553 (985)
                      +|++++..+..|.++++|++|++++|+++++.+..|.++++|++|++++|++++..+..+..+++|+.|++++|+|++..
T Consensus        94 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  173 (272)
T 3rfs_A           94 GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLP  173 (272)
T ss_dssp             TSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccC
Confidence            99999888888899999999999999999888888899999999999999999888888899999999999999999888


Q ss_pred             chhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCCCCCC
Q 001988          554 PTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRG  628 (985)
Q Consensus       554 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  628 (985)
                      +..|+.+++|++|+|++|++++..|..|..+++|+.|+|++|.+.+.       +++|+.|+++.|+++|.+|..
T Consensus       174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~  241 (272)
T 3rfs_A          174 EGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS  241 (272)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred             HHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence            88889999999999999999998888899999999999999999865       447899999999999999974

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.91  E-value=2.7e-24  Score=233.76  Aligned_cols=206  Identities=22%  Similarity=0.234  Sum_probs=143.2

Q ss_pred             CCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCc
Q 001988          413 IGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQ  492 (985)
Q Consensus       413 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  492 (985)
                      +.++++++++++++|+++. +|..+.  ++++.|+|++|.+++..|..+..+++|++|+|++|+|++..+.  ..+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred             ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence            3455666677777776663 333332  4666777777777666666677777777777777777654332  5667777


Q ss_pred             eEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecce
Q 001988          493 YLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNR  572 (985)
Q Consensus       493 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  572 (985)
                      +|++++|+++ .+|..+.++++|++|++++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus        81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            7777777776 355666777777777777777777766777777777777777777776666667777777777777777


Q ss_pred             eccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCCC
Q 001988          573 LEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEI  625 (985)
Q Consensus       573 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~  625 (985)
                      |++..+..|.++++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++.+..
T Consensus       160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c  211 (290)
T 1p9a_G          160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (290)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence            77666666777777888888888777 56666777777777777777776543

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=2.2e-24  Score=232.64  Aligned_cols=209  Identities=22%  Similarity=0.278  Sum_probs=125.2

Q ss_pred             cCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceE
Q 001988          119 TMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQE  198 (985)
Q Consensus       119 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~  198 (985)
                      .+++|++|++++|.++..  ..+..+++|++|++++|.+++ ++ . +..+++|++|+|++|.+++..|..|+++++|++
T Consensus        39 ~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~-~~-~-l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  113 (272)
T 3rfs_A           39 ELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHD-IS-A-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKE  113 (272)
T ss_dssp             HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCC-CG-G-GTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred             cccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCC-ch-h-hcCCCCCCEEECCCCccCccChhHhcCCcCCCE
Confidence            344444444444444321  123334444444444444443 22 2 245666666666666666555555666666666


Q ss_pred             EEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcC
Q 001988          199 LHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSL  278 (985)
Q Consensus       199 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l  278 (985)
                      |+|++|++++..|..|+++++|++|++++|++++..+..|+.+++|++|++++|++++..+..+.++++|++|++++|++
T Consensus       114 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  193 (272)
T 3rfs_A          114 LVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQL  193 (272)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             EECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcC
Confidence            66666666655555566666666677766666655555566666677777777766666666666666777777777766


Q ss_pred             cccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCC
Q 001988          279 SGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRN  340 (985)
Q Consensus       279 ~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  340 (985)
                      ++ +|...+..+++|++|+|++|.+.+.       +++|+.|+++.|.++|.+|..++.+..
T Consensus       194 ~~-~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          194 KS-VPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             SC-CCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             Cc-cCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence            63 3334444566777777777766543       345666777777777777777666654

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=3.2e-24  Score=228.37  Aligned_cols=192  Identities=24%  Similarity=0.279  Sum_probs=144.1

Q ss_pred             CcceeeeEEEeCCCCeEEEEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCc
Q 001988           59 SICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLS  138 (985)
Q Consensus        59 ~~c~w~gv~c~~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~  138 (985)
                      +||.|.|++|....   ..+|+++++++ .+|..+.  +.|+.|+|++|.+++..|..+.++++|++|+|++|++++..+
T Consensus         3 ~Cp~~~gC~C~~~~---~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~   76 (251)
T 3m19_A            3 TCETVTGCTCNEGK---KEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA   76 (251)
T ss_dssp             -CHHHHSSEEEGGG---TEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred             cCCCCCceEcCCCC---eEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence            68999999996432   46899999998 6777665  689999999999998888889999999999999998886554


Q ss_pred             cccccCCccceeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCcccccccccc
Q 001988          139 SFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLT  218 (985)
Q Consensus       139 ~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~  218 (985)
                      ..+                         ..+++|++|+|++|.+++..|..|..+++|++|+|++|+|++..+..|++++
T Consensus        77 ~~~-------------------------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  131 (251)
T 3m19_A           77 GVF-------------------------DDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLT  131 (251)
T ss_dssp             TTT-------------------------TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             hHh-------------------------ccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCC
Confidence            444                         4556666666666666655556667777777777777777765555667777


Q ss_pred             ccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCccc
Q 001988          219 VLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGS  281 (985)
Q Consensus       219 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  281 (985)
                      +|++|+|++|++++..+..|+.+++|++|+|++|++++..+..+..+++|++|+|++|.+.+.
T Consensus       132 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          132 KLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             cccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            777777777777766666677777777777777777776666777777777888887777654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=7.5e-25  Score=258.16  Aligned_cols=169  Identities=17%  Similarity=0.191  Sum_probs=129.0

Q ss_pred             ccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcc--------hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          728 FAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAS--------TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       728 ~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      +...+.||+|+||.||+|.. .++.+|+|+.......        ..+.+.+|++++++++||||+++..++...+..++
T Consensus       338 ~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          338 KIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            34567899999999999955 5788999987544221        13457999999999999999966666667778899


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++++|.+++..         +..++.|+++||+||   |+++|+||||||+|||++.  .+||+|||+++.....
T Consensus       417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~L---H~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKL---HKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHH---HHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHH---HHCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            9999999999999886         457999999999999   7899999999999999999  9999999999987432


Q ss_pred             CCcc-----eeccccccccccccccccc--Cccchhhhc
Q 001988          880 DEST-----MRTQTLATIGYMAPDEIFV--GELSLKRWV  911 (985)
Q Consensus       880 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~dv  911 (985)
                      ....     .....+||+.|||||++..  ..|+...|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~  521 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDR  521 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTT
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhH
Confidence            2111     1235679999999999876  455555555

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=4.9e-25  Score=248.27  Aligned_cols=258  Identities=21%  Similarity=0.171  Sum_probs=137.9

Q ss_pred             EEEecCCcccccCchhcccccccceecccCCcCCCCCC----cccccCC-CCcEEEccCcccCCCCccccccC-----Cc
Q 001988           77 TLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIP----SSIFTMS-TLKVLYLMDNQLSGSLSSFTFNT-----SS  146 (985)
Q Consensus        77 ~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~~-----~~  146 (985)
                      ..+|+.++++|.+|..+...++|++|||++|.+++..+    ..+..++ +|++|+|++|++++..+..+..+     ++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            45778888888877777777778888888888876555    5666777 78888888888776555554443     55


Q ss_pred             cceeeeccccccCCCChhHhhhc----cccceecccCccccccCCcccC----C-CCCceEEEcccccCCCccccccccc
Q 001988          147 ILDIRLSKNKLSGKLPENICNHL----RYLKHLFLRENMFYGKIPSSLS----K-CKQLQELHLGYNNLSGAIPKEIGNL  217 (985)
Q Consensus       147 L~~L~ls~n~l~g~lp~~~~~~l----~~L~~L~L~~n~l~~~~p~~l~----~-l~~L~~L~L~~N~l~~~~p~~~~~l  217 (985)
                      |++|+|++|.+++..+..+...+    ++|++|+|++|.+++..+..++    . .++|++|+|++|++++..+..    
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~----  157 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDE----  157 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHH----
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHH----
Confidence            66666666666554444432211    4555555555555543333322    2 135555555555554322221    


Q ss_pred             cccceEeeccccccCCchhhhcCCC-CCCEEEecCCcCcccCccccc----CC-CCCCEEEccCCcCccc----CChhhh
Q 001988          218 TVLQRISLINNKLHGEIPQEIGYLQ-NLDVLQLGFNNLTGVVPATIF----NM-STLKEIFLYNNSLSGS----LPSRID  287 (985)
Q Consensus       218 ~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~----~l-~~L~~L~L~~N~l~~~----~p~~~~  287 (985)
                                      ++..+..++ +|++|+|++|++++..+..+.    .+ ++|++|+|++|.+++.    ++..+.
T Consensus       158 ----------------l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~  221 (362)
T 3goz_A          158 ----------------LIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFS  221 (362)
T ss_dssp             ----------------HHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred             ----------------HHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHh
Confidence                            122223333 444444444444443332222    22 3455555555544431    222222


Q ss_pred             hcCCCCcEEEecCccCCCcCC----ccccCCCCccEEEccCcccccc-------cCCcccCCCCCceEeccCCcccCC
Q 001988          288 LALPNLEFLNLGINSFSGTIP----SSITNASKLILLEMGSNSFSGF-------IPSAIGNLRNLKLFDIFFNNLTSS  354 (985)
Q Consensus       288 ~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~-------~p~~l~~l~~L~~L~L~~N~l~~~  354 (985)
                      ...++|++|+|++|++++..+    ..+..+++|+.|++++|.+.+.       ++..+..+++|++||+++|++...
T Consensus       222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~  299 (362)
T 3goz_A          222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS  299 (362)
T ss_dssp             HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred             cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence            112355555555555554332    2234445566666666653322       234566677777777777776544

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.90  E-value=1e-25  Score=251.44  Aligned_cols=212  Identities=18%  Similarity=0.264  Sum_probs=132.7

Q ss_pred             CCcceeeeEEEeCCCCeEEEEEecCCcccccCchhcccc--cccceecccCCcCCCCCCcccccCCCCcEEEccCcccCC
Q 001988           58 ASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANL--SSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSG  135 (985)
Q Consensus        58 ~~~c~w~gv~c~~~~~~v~~l~L~~~~l~g~~~~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~  135 (985)
                      .-|..|.++.|+.  ..++.+|++++++.   +..+..+  +.++.|++++|.+++..|. ++.+++|++|+|++|.+++
T Consensus        34 ~vc~~W~~~~~~~--~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~  107 (336)
T 2ast_B           34 GVCKRWYRLASDE--SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV  107 (336)
T ss_dssp             SSCHHHHHHHTCS--TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECH
T ss_pred             HHHHHHHHHhcCc--hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCH
Confidence            4566899998864  34678999998877   5667777  8999999999999876655 6678999999999888775


Q ss_pred             C-CccccccCCccceeeeccccccCCCChhHhhhccccceecccCc-ccccc-CCcccCCCCCceEEEcccc-cCCCc-c
Q 001988          136 S-LSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLREN-MFYGK-IPSSLSKCKQLQELHLGYN-NLSGA-I  210 (985)
Q Consensus       136 ~-~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n-~l~~~-~p~~l~~l~~L~~L~L~~N-~l~~~-~  210 (985)
                      . ++..+..+++|++|++++|.+++..|..+ +.+++|++|+|++| .+++. +|..+.++++|++|+|++| .+++. +
T Consensus       108 ~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l-~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~  186 (336)
T 2ast_B          108 STLHGILSQCSKLQNLSLEGLRLSDPIVNTL-AKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHV  186 (336)
T ss_dssp             HHHHHHHTTBCCCSEEECTTCBCCHHHHHHH-TTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHH
T ss_pred             HHHHHHHhhCCCCCEEeCcCcccCHHHHHHH-hcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHH
Confidence            4 55555555666666666665555444444 34555555555555 44432 4444555555555555555 55533 3


Q ss_pred             cccccccc-ccceEeeccc--ccc-CCchhhhcCCCCCCEEEecCCc-CcccCcccccCCCCCCEEEccCC
Q 001988          211 PKEIGNLT-VLQRISLINN--KLH-GEIPQEIGYLQNLDVLQLGFNN-LTGVVPATIFNMSTLKEIFLYNN  276 (985)
Q Consensus       211 p~~~~~l~-~L~~L~L~~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~L~~N  276 (985)
                      +..+..++ +|++|++++|  .++ +.+|..+..+++|++|++++|. +++..+..+..+++|++|++++|
T Consensus       187 ~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~  257 (336)
T 2ast_B          187 QVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC  257 (336)
T ss_dssp             HHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred             HHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCC
Confidence            44455555 5555555555  233 3445555555555555555555 44444555555555555555555

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.90  E-value=9e-24  Score=229.60  Aligned_cols=208  Identities=24%  Similarity=0.197  Sum_probs=184.8

Q ss_pred             cccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccce
Q 001988          436 TFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDI  515 (985)
Q Consensus       436 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  515 (985)
                      .+.++++++.+++++|.++ .+|..+  .++++.|+|++|+|++..+..|.++++|++|+|++|+|+++.+.  ..+++|
T Consensus         5 ~~~~l~~l~~l~~~~~~l~-~ip~~~--~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L   79 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL   79 (290)
T ss_dssp             EEECSTTCCEEECTTSCCS-SCCSCC--CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred             cccccCCccEEECCCCCCC-cCCCCC--CCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence            4678899999999999999 566544  37899999999999998899999999999999999999987554  789999


Q ss_pred             eEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCC
Q 001988          516 LSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNN  595 (985)
Q Consensus       516 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  595 (985)
                      ++|++++|+++. +|..+..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        80 ~~L~Ls~N~l~~-l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  158 (290)
T 1p9a_G           80 GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN  158 (290)
T ss_dssp             CEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             CEEECCCCcCCc-CchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence            999999999985 4668899999999999999999888899999999999999999999888888999999999999999


Q ss_pred             cccCCCCccccccccccccccccccccCCCCCCCCCcccccccccCCccccCCC
Q 001988          596 KISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLP  649 (985)
Q Consensus       596 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~  649 (985)
                      +|++..+..|..+++|+.|+|++|+++..++......++....+.+||+.|.+.
T Consensus       159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~  212 (290)
T 1p9a_G          159 NLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (290)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             cCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcCc
Confidence            999777777899999999999999999554444455567778889999988765

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=6e-25  Score=247.54  Aligned_cols=266  Identities=15%  Similarity=0.111  Sum_probs=191.4

Q ss_pred             ecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhcc-ccceecccCc
Q 001988          102 LDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLR-YLKHLFLREN  180 (985)
Q Consensus       102 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~-~L~~L~L~~n  180 (985)
                      ++|++|.++|.+|..+...++|++|||++|.+++..+..+                     ...+..++ +|++|+|++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l---------------------~~~l~~~~~~L~~L~Ls~N   61 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVEL---------------------IQAFANTPASVTSLNLSGN   61 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHH---------------------HHHHHTCCTTCCEEECCSS
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHH---------------------HHHHHhCCCceeEEECcCC
Confidence            4566667766666665555556666666666653222000                     02234455 6777777777


Q ss_pred             cccccCCcccCCC-----CCceEEEcccccCCCccccccccc-----cccceEeeccccccCCchhhhc----C-CCCCC
Q 001988          181 MFYGKIPSSLSKC-----KQLQELHLGYNNLSGAIPKEIGNL-----TVLQRISLINNKLHGEIPQEIG----Y-LQNLD  245 (985)
Q Consensus       181 ~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~----~-l~~L~  245 (985)
                      .+++..+..+..+     ++|++|+|++|++++..+..++..     ++|++|+|++|++++..+..++    . .++|+
T Consensus        62 ~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~  141 (362)
T 3goz_A           62 SLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT  141 (362)
T ss_dssp             CGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCC
T ss_pred             CCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCcee
Confidence            7776666666654     888888888888887777655543     7899999999998877666544    3 36999


Q ss_pred             EEEecCCcCcccC----cccccCCC-CCCEEEccCCcCcccCChhhh---hcC-CCCcEEEecCccCCCc----CCcccc
Q 001988          246 VLQLGFNNLTGVV----PATIFNMS-TLKEIFLYNNSLSGSLPSRID---LAL-PNLEFLNLGINSFSGT----IPSSIT  312 (985)
Q Consensus       246 ~L~Ls~N~l~~~~----p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~---~~l-~~L~~L~Ls~N~l~~~----~p~~~~  312 (985)
                      +|+|++|++++..    +..+..++ +|++|+|++|++++..+..+.   ... ++|++|+|++|++++.    ++..+.
T Consensus       142 ~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~  221 (362)
T 3goz_A          142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFS  221 (362)
T ss_dssp             EEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred             EEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHh
Confidence            9999999998643    44455665 999999999999866664432   234 5999999999999974    455555


Q ss_pred             C-CCCccEEEccCcccccccC----CcccCCCCCceEeccCCcccCCCCcc--cccccccccCcccEEEecCCCCCccCC
Q 001988          313 N-ASKLILLEMGSNSFSGFIP----SAIGNLRNLKLFDIFFNNLTSSTPEL--GFLSSLANCKKLRYLGLGGNPLDGFLP  385 (985)
Q Consensus       313 ~-l~~L~~L~L~~N~l~~~~p----~~l~~l~~L~~L~L~~N~l~~~~~~~--~~~~~l~~l~~L~~L~L~~N~l~~~~p  385 (985)
                      . .++|+.|+|++|.+++..+    ..+..+++|+.|++++|.+.......  .+...+.++++|+.|++++|++....+
T Consensus       222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~  301 (362)
T 3goz_A          222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS  301 (362)
T ss_dssp             HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred             cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence            5 4599999999999987655    44577899999999999977665431  133457788999999999999987654


Q ss_pred             CCc
Q 001988          386 SSI  388 (985)
Q Consensus       386 ~~~  388 (985)
                      ..+
T Consensus       302 ~~~  304 (362)
T 3goz_A          302 IPI  304 (362)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            433

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=9.8e-24  Score=222.91  Aligned_cols=196  Identities=18%  Similarity=0.240  Sum_probs=105.1

Q ss_pred             CccEEEccCCCCCCCCCccccccccccceeccccc-ccCCchhhhhhccCCCeEEccC-CccccccCCCCcCcCcCceEe
Q 001988          418 NLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNK-LAGSIPDEICLLSRLNELDLNG-NKISGSISSCLGNLTSLQYLN  495 (985)
Q Consensus       418 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~  495 (985)
                      +|++|++++|+++++.+.+|.++++|++|++++|+ +++..+..|..+++|++|++++ |++++..+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            44444444444444444444444444444444443 4433333444444555555554 455444444455555555555


Q ss_pred             eccceeeeecCCCccCcccee---EEeecCC-cccCCccccccCCCccc-EEEccCCccCccCchhhcccccceeeeeec
Q 001988          496 LGSNRFTFVIPSTFWNLKDIL---SFDISSN-LLDGPISLAIGNLKAVV-GIDLSRNNLSGNIPTTLEGLKSLQNISLAY  570 (985)
Q Consensus       496 L~~N~l~~~~p~~~~~l~~L~---~L~ls~N-~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  570 (985)
                      +++|++++ +|. |..+++|+   +|++++| +++++.+..|.++++|+ .|++++|+++...+..|.. ++|+.|+|++
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~  188 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK  188 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred             CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence            55555554 233 44444444   5555555 55555555555666666 6666666666333333443 6677777777


Q ss_pred             ce-eccchhhhhhcc-cccCeEecCCCcccCCCCccccccccccccccccc
Q 001988          571 NR-LEGPIPESFGNM-TSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFN  619 (985)
Q Consensus       571 N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  619 (985)
                      |+ +++..+..|.++ ++|+.|+|++|+|++. |..  .+++|+.|+++++
T Consensus       189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT  236 (239)
T ss_dssp             CTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred             CCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence            74 665556666666 7777777777777643 332  4556666666654

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=5.1e-24  Score=234.46  Aligned_cols=203  Identities=20%  Similarity=0.230  Sum_probs=156.8

Q ss_pred             CCCccEEEccCCCCCCCCCccc--cccccccceecccccccCCch----hhhhhccCCCeEEccCCccccccCCCCcCcC
Q 001988          416 LSNLIVLSLGGNNLSGSIPVTF--GGLQKLQGLDLAFNKLAGSIP----DEICLLSRLNELDLNGNKISGSISSCLGNLT  489 (985)
Q Consensus       416 l~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  489 (985)
                      +++|++|++++|.+++..|..+  ..+++|++|+|++|.+++..+    ..+..+++|++|+|++|++++..+..|.+++
T Consensus        90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~  169 (310)
T 4glp_A           90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP  169 (310)
T ss_dssp             HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred             cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence            3557778888888777777776  777788888888888776544    3345677888888888888877777888888


Q ss_pred             cCceEeeccceeeee---c-CCCccCccceeEEeecCCcccCCccc---cccCCCcccEEEccCCccCccCchhhccc--
Q 001988          490 SLQYLNLGSNRFTFV---I-PSTFWNLKDILSFDISSNLLDGPISL---AIGNLKAVVGIDLSRNNLSGNIPTTLEGL--  560 (985)
Q Consensus       490 ~L~~L~L~~N~l~~~---~-p~~~~~l~~L~~L~ls~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--  560 (985)
                      +|++|+|++|++.+.   . +..+..+++|++|++++|+++...+.   .++.+++|+.|+|++|+|++..|..+..+  
T Consensus       170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  249 (310)
T 4glp_A          170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW  249 (310)
T ss_dssp             TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred             CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence            888888888887642   2 23346778888888888888643322   35678899999999999998878777776  


Q ss_pred             -ccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccC
Q 001988          561 -KSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKG  623 (985)
Q Consensus       561 -~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  623 (985)
                       ++|++|+|++|+|+ .+|..+.  ++|++|||++|+|++. |. +..+++|+.|++++|+++.
T Consensus       250 ~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          250 SSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             CTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             cCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence             69999999999999 5677664  7999999999999964 43 6788999999999999874

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.89  E-value=1.1e-23  Score=234.76  Aligned_cols=255  Identities=16%  Similarity=0.159  Sum_probs=182.2

Q ss_pred             ceeeeccccccCCCChhHhhhc--cccceecccCccccccCCcccCCCCCceEEEcccccCCCc-cccccccccccceEe
Q 001988          148 LDIRLSKNKLSGKLPENICNHL--RYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGA-IPKEIGNLTVLQRIS  224 (985)
Q Consensus       148 ~~L~ls~n~l~g~lp~~~~~~l--~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~  224 (985)
                      +.+|++.|.+.    +..+..+  ++++.|++++|.+.+..|. +.++++|++|+|++|.+++. +|..+.++++|++|+
T Consensus        50 ~~l~l~~~~~~----~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~  124 (336)
T 2ast_B           50 QTLDLTGKNLH----PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS  124 (336)
T ss_dssp             SEEECTTCBCC----HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred             eeeccccccCC----HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence            34444444443    2333555  7788888888888866555 56788888888888888765 777788888888888


Q ss_pred             eccccccCCchhhhcCCCCCCEEEecCC-cCcc-cCcccccCCCCCCEEEccCC-cCcccCChhhhhcCC-CCcEEEecC
Q 001988          225 LINNKLHGEIPQEIGYLQNLDVLQLGFN-NLTG-VVPATIFNMSTLKEIFLYNN-SLSGSLPSRIDLALP-NLEFLNLGI  300 (985)
Q Consensus       225 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~-~~p~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~~l~-~L~~L~Ls~  300 (985)
                      +++|++++..|..++.+++|++|++++| .+++ .++..+.++++|++|++++| .+++.........++ +|++|+|++
T Consensus       125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~  204 (336)
T 2ast_B          125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG  204 (336)
T ss_dssp             CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred             CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence            8888888778888888888888888888 6775 36667778888888888888 777542223345678 888888888


Q ss_pred             c--cCC-CcCCccccCCCCccEEEccCcc-cccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEec
Q 001988          301 N--SFS-GTIPSSITNASKLILLEMGSNS-FSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLG  376 (985)
Q Consensus       301 N--~l~-~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~  376 (985)
                      |  .++ +.+|..+.++++|+.|++++|. +++..+..++++++|++|++++|.  ...+.  .+..+.++++|++|+++
T Consensus       205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~~~~--~~~~l~~~~~L~~L~l~  280 (336)
T 2ast_B          205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DIIPE--TLLELGEIPTLKTLQVF  280 (336)
T ss_dssp             CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TCCGG--GGGGGGGCTTCCEEECT
T ss_pred             CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CCCHH--HHHHHhcCCCCCEEecc
Confidence            8  455 4566677778888888888888 777777788888888888888885  21111  12346778889999988


Q ss_pred             CCCCCccCCCCccchhhcccceeccccccccccCCcCCC
Q 001988          377 GNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGN  415 (985)
Q Consensus       377 ~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~  415 (985)
                      +| +.   ...+..+...++.|++++|++++..|..++.
T Consensus       281 ~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          281 GI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             TS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             Cc-cC---HHHHHHHHhhCcceEEecccCccccCCcccc
Confidence            88 22   2244444445777777777777766665553

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=1.5e-23  Score=230.82  Aligned_cols=202  Identities=19%  Similarity=0.200  Sum_probs=158.1

Q ss_pred             ccccceecccCccccccCCccc--CCCCCceEEEcccccCCCccc----cccccccccceEeeccccccCCchhhhcCCC
Q 001988          169 LRYLKHLFLRENMFYGKIPSSL--SKCKQLQELHLGYNNLSGAIP----KEIGNLTVLQRISLINNKLHGEIPQEIGYLQ  242 (985)
Q Consensus       169 l~~L~~L~L~~n~l~~~~p~~l--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  242 (985)
                      +++|++|++++|.+++..|..+  +++++|++|+|++|.+++..|    ..+..+++|++|+|++|++++..|..|+.++
T Consensus        90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~  169 (310)
T 4glp_A           90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP  169 (310)
T ss_dssp             HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred             cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence            5678888888888888888888  888899999999999887655    3455788899999999999888888888899


Q ss_pred             CCCEEEecCCcCccc--C--cccccCCCCCCEEEccCCcCcccCCh---hhhhcCCCCcEEEecCccCCCcCCccccCC-
Q 001988          243 NLDVLQLGFNNLTGV--V--PATIFNMSTLKEIFLYNNSLSGSLPS---RIDLALPNLEFLNLGINSFSGTIPSSITNA-  314 (985)
Q Consensus       243 ~L~~L~Ls~N~l~~~--~--p~~l~~l~~L~~L~L~~N~l~~~~p~---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-  314 (985)
                      +|++|+|++|++.+.  +  +..+..+++|++|+|++|+++ .++.   .++..+++|++|+|++|++++..|..+..+ 
T Consensus       170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~  248 (310)
T 4glp_A          170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM  248 (310)
T ss_dssp             TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred             CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence            999999999987652  2  233467888999999999887 3333   245578899999999999988878777776 


Q ss_pred             --CCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCC
Q 001988          315 --SKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLD  381 (985)
Q Consensus       315 --~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~  381 (985)
                        ++|++|+|++|+++ .+|..+.  ++|++|++++|++++.+.       +..+++|+.|++++|+++
T Consensus       249 ~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~~-------~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          249 WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAPQ-------PDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCCC-------TTSCCCCSCEECSSTTTS
T ss_pred             CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCch-------hhhCCCccEEECcCCCCC
Confidence              58888888888888 5566654  688888888888876532       345677777777777775

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.89  E-value=2.4e-23  Score=219.87  Aligned_cols=197  Identities=16%  Similarity=0.164  Sum_probs=162.7

Q ss_pred             cccceeccccccccccCCcCCCCCCccEEEccCCC-CCCCCCccccccccccceeccc-ccccCCchhhhhhccCCCeEE
Q 001988          394 SLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNN-LSGSIPVTFGGLQKLQGLDLAF-NKLAGSIPDEICLLSRLNELD  471 (985)
Q Consensus       394 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~  471 (985)
                      ++++|++++|++++..+..|..+++|++|++++|+ ++++.+.+|.++++|++|++++ |++++..+..|..+++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            68888888888887777788888888888888886 8777777888888888888888 888876667788888888889


Q ss_pred             ccCCccccccCCCCcCcCcCc---eEeeccc-eeeeecCCCccCcccee-EEeecCCcccCCccccccCCCcccEEEccC
Q 001988          472 LNGNKISGSISSCLGNLTSLQ---YLNLGSN-RFTFVIPSTFWNLKDIL-SFDISSNLLDGPISLAIGNLKAVVGIDLSR  546 (985)
Q Consensus       472 L~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~  546 (985)
                      +++|++++ +|. |..+++|+   +|++++| +++++.+..|.++++|+ .|++++|+++.+.+..+.. ++|+.|+|++
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~  188 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK  188 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred             CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence            88888886 555 77788887   8999998 88888888888889999 9999999888666666666 8899999999


Q ss_pred             Cc-cCccCchhhccc-ccceeeeeecceeccchhhhhhcccccCeEecCCCc
Q 001988          547 NN-LSGNIPTTLEGL-KSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNK  596 (985)
Q Consensus       547 N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  596 (985)
                      |+ +++..+..|.++ ++|+.|++++|++++..+.   .+++|+.|+++++.
T Consensus       189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~~  237 (239)
T 2xwt_C          189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNTW  237 (239)
T ss_dssp             CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC-
T ss_pred             CCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCcc
Confidence            94 887777888888 9999999999999864443   56788899988763

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.89  E-value=9.6e-25  Score=248.34  Aligned_cols=244  Identities=20%  Similarity=0.237  Sum_probs=137.4

Q ss_pred             cCchhcccccccceecccCCcCCCCCC----cccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCCh
Q 001988           88 TIPPEIANLSSLKSLDLSHNKLSSNIP----SSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPE  163 (985)
Q Consensus        88 ~~~~~l~~l~~L~~L~L~~n~l~~~~p----~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~  163 (985)
                      .++..+..+++|++|+|++|.+++..+    ..+..+++|++|+|++|.+.                     ++.+.+|.
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~---------------------~l~~~~~~   81 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTG---------------------RVKDEIPE   81 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTT---------------------SCGGGSHH
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccC---------------------ccccchhH
Confidence            455666777777777777777765433    33556777777777775432                     33344444


Q ss_pred             hH------hhhccccceecccCccccc----cCCcccCCCCCceEEEcccccCCCccccccc----cc---------ccc
Q 001988          164 NI------CNHLRYLKHLFLRENMFYG----KIPSSLSKCKQLQELHLGYNNLSGAIPKEIG----NL---------TVL  220 (985)
Q Consensus       164 ~~------~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L  220 (985)
                      .+      +..+++|++|+|++|.+++    .+|..+.++++|++|+|++|.+++..+..++    .+         ++|
T Consensus        82 ~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L  161 (386)
T 2ca6_A           82 ALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPL  161 (386)
T ss_dssp             HHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             HHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCC
Confidence            43      2445666666666666665    3555666666666666666666543333333    22         566


Q ss_pred             ceEeecccccc-CCch---hhhcCCCCCCEEEecCCcCcc-----cCcccccCCCCCCEEEccCCcCc----ccCChhhh
Q 001988          221 QRISLINNKLH-GEIP---QEIGYLQNLDVLQLGFNNLTG-----VVPATIFNMSTLKEIFLYNNSLS----GSLPSRID  287 (985)
Q Consensus       221 ~~L~L~~N~l~-~~~p---~~~~~l~~L~~L~Ls~N~l~~-----~~p~~l~~l~~L~~L~L~~N~l~----~~~p~~~~  287 (985)
                      ++|++++|+++ +.+|   ..+..+++|++|++++|+++.     ..|..+..+++|++|+|++|.++    +.+|..+ 
T Consensus       162 ~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l-  240 (386)
T 2ca6_A          162 RSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL-  240 (386)
T ss_dssp             CEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG-
T ss_pred             cEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHH-
Confidence            66666666665 3344   345566666666666666652     23335566666666666666664    3344432 


Q ss_pred             hcCCCCcEEEecCccCCCc----CCccc--cCCCCccEEEccCccccc----ccCCcc-cCCCCCceEeccCCcccC
Q 001988          288 LALPNLEFLNLGINSFSGT----IPSSI--TNASKLILLEMGSNSFSG----FIPSAI-GNLRNLKLFDIFFNNLTS  353 (985)
Q Consensus       288 ~~l~~L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~L~~N~l~~----~~p~~l-~~l~~L~~L~L~~N~l~~  353 (985)
                      ..+++|++|+|++|++++.    ++..+  +.+++|+.|+|++|.+++    .+|..+ .++++|++|++++|+++.
T Consensus       241 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~  317 (386)
T 2ca6_A          241 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  317 (386)
T ss_dssp             GGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             ccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence            3455666666666665543    33444  225556666666665554    244444 344555555555555543

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.89  E-value=6.2e-23  Score=218.40  Aligned_cols=180  Identities=23%  Similarity=0.306  Sum_probs=97.7

Q ss_pred             CccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeec
Q 001988          418 NLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLG  497 (985)
Q Consensus       418 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  497 (985)
                      +.++++++++.++ .+|..+.  ++|+.|+|++|.+++..+..+..+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus        15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~   91 (251)
T 3m19_A           15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA   91 (251)
T ss_dssp             GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence            4556666666666 3333332  356666666666665555555556666666666666655555555555555555555


Q ss_pred             cceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccch
Q 001988          498 SNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPI  577 (985)
Q Consensus       498 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  577 (985)
                      +|+++++.+..|..+++|++|++++|+|++..+                        ..|..+++|++|+|++|+|++..
T Consensus        92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~------------------------~~~~~l~~L~~L~Ls~N~l~~~~  147 (251)
T 3m19_A           92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPS------------------------GVFDRLTKLKELRLNTNQLQSIP  147 (251)
T ss_dssp             TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT------------------------TTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCcccccChhHhcccCCCCEEEcCCCcCCCcCh------------------------hHhccCCcccEEECcCCcCCccC
Confidence            555555554555555555555555555544444                        44445555555555555555444


Q ss_pred             hhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCC
Q 001988          578 PESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGE  624 (985)
Q Consensus       578 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~  624 (985)
                      +..|..+++|++|+|++|+|++..+..|..+++|+.|++++|++++.
T Consensus       148 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          148 AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             HHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            44455555555555555555544444555555555555555555544

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=2.4e-24  Score=245.08  Aligned_cols=235  Identities=21%  Similarity=0.280  Sum_probs=159.3

Q ss_pred             CeEEEEEecCCcccccCc----hhcccccccceecccCC---cCCCCCCccc-------ccCCCCcEEEccCcccCC---
Q 001988           73 HKVTTLNLSSFNLQGTIP----PEIANLSSLKSLDLSHN---KLSSNIPSSI-------FTMSTLKVLYLMDNQLSG---  135 (985)
Q Consensus        73 ~~v~~l~L~~~~l~g~~~----~~l~~l~~L~~L~L~~n---~l~~~~p~~~-------~~l~~L~~L~Ls~n~l~~---  135 (985)
                      .+++.|+|++|++++..+    ..+..+++|++|+|++|   ++++.+|..+       ..+++|++|+|++|.+++   
T Consensus        32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~  111 (386)
T 2ca6_A           32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ  111 (386)
T ss_dssp             SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred             CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence            358899999999987644    45778999999999995   5666778766       688999999999999987   


Q ss_pred             -CCccccccCCccceeeeccccccCCCChhHhhhc------------cccceecccCcccc-ccCC---cccCCCCCceE
Q 001988          136 -SLSSFTFNTSSILDIRLSKNKLSGKLPENICNHL------------RYLKHLFLRENMFY-GKIP---SSLSKCKQLQE  198 (985)
Q Consensus       136 -~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l------------~~L~~L~L~~n~l~-~~~p---~~l~~l~~L~~  198 (985)
                       .++..+..+++|++|+|++|.+.+..+..+...+            ++|++|+|++|.++ +.+|   ..+..+++|++
T Consensus       112 ~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~  191 (386)
T 2ca6_A          112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT  191 (386)
T ss_dssp             HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred             HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCE
Confidence             4666777788888888888888654444443222            66777777777765 3344   35556667777


Q ss_pred             EEcccccCC--C---ccccccccccccceEeecccccc----CCchhhhcCCCCCCEEEecCCcCccc----Cccccc--
Q 001988          199 LHLGYNNLS--G---AIPKEIGNLTVLQRISLINNKLH----GEIPQEIGYLQNLDVLQLGFNNLTGV----VPATIF--  263 (985)
Q Consensus       199 L~L~~N~l~--~---~~p~~~~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~--  263 (985)
                      |+|++|+++  |   .+|..+..+++|++|+|++|+++    +.+|..+..+++|++|+|++|.+++.    +|..+.  
T Consensus       192 L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~  271 (386)
T 2ca6_A          192 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL  271 (386)
T ss_dssp             EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTC
T ss_pred             EECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhc
Confidence            777777666  2   33445666666677777766664    45666666666666666666666654    344442  


Q ss_pred             CCCCCCEEEccCCcCcc----cCChhhhhcCCCCcEEEecCccCCCcC
Q 001988          264 NMSTLKEIFLYNNSLSG----SLPSRIDLALPNLEFLNLGINSFSGTI  307 (985)
Q Consensus       264 ~l~~L~~L~L~~N~l~~----~~p~~~~~~l~~L~~L~Ls~N~l~~~~  307 (985)
                      .+++|++|+|++|.+++    .+|..++..+++|++|+|++|++++..
T Consensus       272 ~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          272 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             SSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             cCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence            26666666666666664    355555445566666666666655443

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=4.8e-23  Score=226.14  Aligned_cols=210  Identities=22%  Similarity=0.362  Sum_probs=147.3

Q ss_pred             ceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCc
Q 001988          397 RLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNK  476 (985)
Q Consensus       397 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  476 (985)
                      .+.+..+.+++.+  .+..+++|++|++++|.++.. | .+..+++|++|++++|.+++..+  +..+++|++|+|++|+
T Consensus        23 ~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~   96 (308)
T 1h6u_A           23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP   96 (308)
T ss_dssp             HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred             HHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCc
Confidence            3444455544332  234566777777777777642 3 46667777777777777764433  6677777777777777


Q ss_pred             cccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchh
Q 001988          477 ISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTT  556 (985)
Q Consensus       477 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  556 (985)
                      +++.  ..+..+++|++|++++|+++++.+  +..+++|++|++++|++++..+  +..+++|+.|++++|++++..+  
T Consensus        97 l~~~--~~~~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--  168 (308)
T 1h6u_A           97 LKNV--SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--  168 (308)
T ss_dssp             CSCC--GGGTTCTTCCEEECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred             CCCc--hhhcCCCCCCEEECCCCCCCCchh--hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--
Confidence            7653  246777777777777777776432  6777777777777777776654  7777888888888888875433  


Q ss_pred             hcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCC
Q 001988          557 LEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGE  624 (985)
Q Consensus       557 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~  624 (985)
                      +..+++|+.|+|++|++++..+  +..+++|+.|+|++|++++..|  +..+++|+.|++++|++++.
T Consensus       169 l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~  232 (308)
T 1h6u_A          169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ  232 (308)
T ss_dssp             GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred             hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence            7788888888888888886544  7788888888888888886543  77888888888888888753

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.88  E-value=3.7e-23  Score=243.37  Aligned_cols=204  Identities=24%  Similarity=0.325  Sum_probs=125.5

Q ss_pred             CCCCCCcc-----eeeeE-EEeCCCCeEEEEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEE
Q 001988           54 WTSNASIC-----SWIGI-ICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLY  127 (985)
Q Consensus        54 w~~~~~~c-----~w~gv-~c~~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  127 (985)
                      |..+.++|     .|.|+ .|..  .+++.|+|++|++++ +|+.+.  ++|++|+|++|.|+ .+|   ..+++|++|+
T Consensus        36 W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~  106 (571)
T 3cvr_A           36 WEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLD  106 (571)
T ss_dssp             HHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEE
T ss_pred             HhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEE
Confidence            66556667     79999 7864  368899999999987 887664  78999999999998 678   4578888999


Q ss_pred             ccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCC
Q 001988          128 LMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLS  207 (985)
Q Consensus       128 Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~  207 (985)
                      |++|+|++ +|. +..  +|+.|+|++|++++ +|.    .+++|++|+|++|.+++ +|.   .+++|++|+|++|+|+
T Consensus       107 Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~  173 (571)
T 3cvr_A          107 ACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE----LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLT  173 (571)
T ss_dssp             CCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS
T ss_pred             ccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC----cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCC
Confidence            98888886 444 322  55555555555554 444    24455555555555543 443   3344455555555544


Q ss_pred             CccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCC-------CEEEccCCcCcc
Q 001988          208 GAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTL-------KEIFLYNNSLSG  280 (985)
Q Consensus       208 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L-------~~L~L~~N~l~~  280 (985)
                      + +|. |+                          ++|++|+|++|+|+ .+|. +..  +|       +.|+|++|+|+ 
T Consensus       174 ~-lp~-l~--------------------------~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-  220 (571)
T 3cvr_A          174 F-LPE-LP--------------------------ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-  220 (571)
T ss_dssp             C-CCC-CC--------------------------TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-
T ss_pred             C-cch-hh--------------------------CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-
Confidence            3 333 33                          44555555555554 3333 322  34       66666666665 


Q ss_pred             cCChhhhhcCCCCcEEEecCccCCCcCCccccC
Q 001988          281 SLPSRIDLALPNLEFLNLGINSFSGTIPSSITN  313 (985)
Q Consensus       281 ~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  313 (985)
                      .+|..++. +++|+.|+|++|.+++.+|..+..
T Consensus       221 ~lp~~l~~-l~~L~~L~L~~N~l~~~~p~~l~~  252 (571)
T 3cvr_A          221 HIPENILS-LDPTCTIILEDNPLSSRIRESLSQ  252 (571)
T ss_dssp             CCCGGGGG-SCTTEEEECCSSSCCHHHHHHHHH
T ss_pred             ecCHHHhc-CCCCCEEEeeCCcCCCcCHHHHHH
Confidence            45655543 666666666666666666665554

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=2.2e-22  Score=220.94  Aligned_cols=190  Identities=26%  Similarity=0.380  Sum_probs=122.7

Q ss_pred             cccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEcc
Q 001988          394 SLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLN  473 (985)
Q Consensus       394 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  473 (985)
                      +|+.|++++|.++. ++ .+..+++|++|+|++|++++..+  +..+++|++|+|++|++++. + .+..+++|++|+|+
T Consensus        42 ~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~  115 (308)
T 1h6u_A           42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLT  115 (308)
T ss_dssp             TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECT
T ss_pred             CcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECC
Confidence            34444444444442 22 35556666666666666665443  66666666666666666643 2 46666667777777


Q ss_pred             CCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccC
Q 001988          474 GNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNI  553 (985)
Q Consensus       474 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  553 (985)
                      +|++++..  .+..+++|++|++++|+++++.+  +..+++|+.|++++|++++..+  +..+++|+.|++++|++++..
T Consensus       116 ~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~  189 (308)
T 1h6u_A          116 STQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDIS  189 (308)
T ss_dssp             TSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG
T ss_pred             CCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcCh
Confidence            77666532  26666777777777777665544  6666777777777777766544  667777777777777777543


Q ss_pred             chhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccC
Q 001988          554 PTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISG  599 (985)
Q Consensus       554 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  599 (985)
                      +  +..+++|++|+|++|++++..|  +..+++|+.|+|++|++++
T Consensus       190 ~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          190 P--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             G--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred             h--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence            3  6777777788888887776543  7777778888888887774

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.86  E-value=8.5e-22  Score=220.56  Aligned_cols=243  Identities=15%  Similarity=0.150  Sum_probs=146.2

Q ss_pred             ceeeeEEEeCCCCeEEEEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccc
Q 001988           61 CSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSF  140 (985)
Q Consensus        61 c~w~gv~c~~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~  140 (985)
                      |+|..|.|+            +++++ .+|..+  .+++++|+|++|+|+...+..|.++++|++|+|++|++.+     
T Consensus         9 C~~~~v~C~------------~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~-----   68 (350)
T 4ay9_X            9 CSNRVFLCQ------------ESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE-----   68 (350)
T ss_dssp             EETTEEEEE------------STTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCC-----
T ss_pred             eeCCEEEec------------CCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCC-----
Confidence            677777775            34555 677665  3578888888888884333467778888888887777654     


Q ss_pred             cccCCccceeeeccccccCCCChhHhhhccccce-ecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccc
Q 001988          141 TFNTSSILDIRLSKNKLSGKLPENICNHLRYLKH-LFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTV  219 (985)
Q Consensus       141 ~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~-L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  219 (985)
                                         .+|...|.++++|++ ++++.|++++..|..|.++++|++|++++|++++..+..+....+
T Consensus        69 -------------------~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~  129 (350)
T 4ay9_X           69 -------------------VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ  129 (350)
T ss_dssp             -------------------EECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSS
T ss_pred             -------------------ccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccch
Confidence                               344444455555443 455566676566677777777777777777777655555666666


Q ss_pred             cceEeecc-ccccCCchhhhcCCC-CCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEE
Q 001988          220 LQRISLIN-NKLHGEIPQEIGYLQ-NLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLN  297 (985)
Q Consensus       220 L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~  297 (985)
                      +..|++.+ |++....+..|..+. .+++|+|++|+|+. +|...+...+|++|++++|+..+.+|...+..+++|++|+
T Consensus       130 l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~Ld  208 (350)
T 4ay9_X          130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILD  208 (350)
T ss_dssp             CEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEE
T ss_pred             hhhhhhccccccccccccchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhh
Confidence            77777754 455544444555554 46777777777773 4444445566777777643333366666666666677777


Q ss_pred             ecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEecc
Q 001988          298 LGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIF  347 (985)
Q Consensus       298 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  347 (985)
                      |++|+|+...+..+.   +|+.|.+.++.--..+| .+.++++|+.+++.
T Consensus       209 Ls~N~l~~lp~~~~~---~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~  254 (350)
T 4ay9_X          209 ISRTRIHSLPSYGLE---NLKKLRARSTYNLKKLP-TLEKLVALMEASLT  254 (350)
T ss_dssp             CTTSCCCCCCSSSCT---TCCEEECTTCTTCCCCC-CTTTCCSCCEEECS
T ss_pred             cCCCCcCccChhhhc---cchHhhhccCCCcCcCC-CchhCcChhhCcCC
Confidence            777666643333333   33333333322222333 24445555555544

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.86  E-value=7.7e-22  Score=220.91  Aligned_cols=200  Identities=16%  Similarity=0.127  Sum_probs=110.6

Q ss_pred             cEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCC-ccccccccccc-eec
Q 001988          371 RYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIP-VTFGGLQKLQG-LDL  448 (985)
Q Consensus       371 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~-L~L  448 (985)
                      +.++.++++++ .+|..+   +.++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+| .+|.+++++.. +++
T Consensus        12 ~~v~C~~~~Lt-~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~   87 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   87 (350)
T ss_dssp             TEEEEESTTCC-SCCTTC---CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred             CEEEecCCCCC-ccCcCc---CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence            56777777776 455544   2356677777777765555566667777777777776654333 45666665543 445


Q ss_pred             ccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeecc-ceeeeecCCCccCcc-ceeEEeecCCccc
Q 001988          449 AFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGS-NRFTFVIPSTFWNLK-DILSFDISSNLLD  526 (985)
Q Consensus       449 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~ls~N~l~  526 (985)
                      +.|+|++..|..|..+++|++|++++|++++..+..+....++..|++.+ |+++.+.+..|..+. .++.|++++|+|+
T Consensus        88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~  167 (350)
T 4ay9_X           88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  167 (350)
T ss_dssp             EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence            55666655555566666666666666666655555555555555565543 455555555555443 3555555555555


Q ss_pred             CCccccccCCCcccEEEccC-CccCccCchhhcccccceeeeeecceecc
Q 001988          527 GPISLAIGNLKAVVGIDLSR-NNLSGNIPTTLEGLKSLQNISLAYNRLEG  575 (985)
Q Consensus       527 ~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  575 (985)
                      .+.+..|. ..+|+.|++++ |.++.+.+..|.++++|++|+|++|+|+.
T Consensus       168 ~i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~  216 (350)
T 4ay9_X          168 EIHNSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS  216 (350)
T ss_dssp             EECTTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCC
T ss_pred             CCChhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCc
Confidence            44333332 23455555543 33443333344555555555555555553

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=1.1e-21  Score=211.79  Aligned_cols=151  Identities=16%  Similarity=0.155  Sum_probs=121.2

Q ss_pred             HHHHHHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCc------------------chHHHHHHHHHHHHhcC
Q 001988          719 FELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA------------------STLKSFEAECEVIKNIR  780 (985)
Q Consensus       719 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~------------------~~~~~~~~E~~il~~l~  780 (985)
                      ..+......|...+.||+|+||.||+|...+|+.||+|+++....                  .....+.+|++++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344555666778899999999999999998899999999975321                  12456889999999999


Q ss_pred             CCCeeeEEeeeecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc
Q 001988          781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD  860 (985)
Q Consensus       781 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~  860 (985)
                        | +++.+++.. +..++||||++||+|.+ +...       ....++.|++.||+||   |++||+||||||+|||++
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~~-------~~~~i~~qi~~~l~~l---H~~giiHrDlkp~NILl~  227 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRVE-------NPDEVLDMILEEVAKF---YHRGIVHGDLSQYNVLVS  227 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCCS-------CHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cchh-------hHHHHHHHHHHHHHHH---HHCCCEeCCCCHHHEEEE
Confidence              4 566665543 55699999999999998 4321       2346999999999999   789999999999999999


Q ss_pred             CCCcEEEecccCceeccCCCCcceeccccccccccccccc
Q 001988          861 EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI  900 (985)
Q Consensus       861 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~  900 (985)
                       ++.+||+|||+|+.               +..|+|||.+
T Consensus       228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l  251 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE---------------VGEEGWREIL  251 (282)
T ss_dssp             -TTEEEECCCTTCEE---------------TTSTTHHHHH
T ss_pred             -CCcEEEEECCCCeE---------------CCCCCHHHHH
Confidence             99999999999864               3357888875

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.85  E-value=5e-21  Score=197.40  Aligned_cols=186  Identities=25%  Similarity=0.305  Sum_probs=112.5

Q ss_pred             CcceeeeEEEeCCCCeEEEEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCc
Q 001988           59 SICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLS  138 (985)
Q Consensus        59 ~~c~w~gv~c~~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~  138 (985)
                      ..|.|.+|.|+..            +++ .+|..+  .++|++|+|++|++++..+..+..+++|++|+|++|+++    
T Consensus         5 C~C~~~~v~c~~~------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~----   65 (208)
T 2o6s_A            5 CSCSGTTVECYSQ------------GRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ----   65 (208)
T ss_dssp             CEEETTEEECCSS------------CCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC----
T ss_pred             CEECCCEEEecCC------------Ccc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC----
Confidence            4589999999643            233 344333  346777777777776544444555555555555555444    


Q ss_pred             cccccCCccceeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCcccccccccc
Q 001988          139 SFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLT  218 (985)
Q Consensus       139 ~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~  218 (985)
                                                                   +..+..|.++++|++|+|++|++++..+..|++++
T Consensus        66 ---------------------------------------------~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  100 (208)
T 2o6s_A           66 ---------------------------------------------SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLT  100 (208)
T ss_dssp             ---------------------------------------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             ---------------------------------------------ccChhhcCCCCCcCEEECCCCcCCccCHhHhcCcc
Confidence                                                         22233345555555555555555544444455566


Q ss_pred             ccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEe
Q 001988          219 VLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNL  298 (985)
Q Consensus       219 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L  298 (985)
                      +|++|++++|++++..+..|..+++|++|++++|++++..+..+..+++|++|++++|.+.+        .+++|++|++
T Consensus       101 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~--------~~~~l~~L~~  172 (208)
T 2o6s_A          101 QLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC--------TCPGIRYLSE  172 (208)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC--------CTTTTHHHHH
T ss_pred             CCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec--------CCCCHHHHHH
Confidence            66666666666655555556666666666666666665555556666677777777776653        3456777777


Q ss_pred             cCccCCCcCCccccCCCC
Q 001988          299 GINSFSGTIPSSITNASK  316 (985)
Q Consensus       299 s~N~l~~~~p~~~~~l~~  316 (985)
                      +.|+++|.+|..++.++.
T Consensus       173 ~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          173 WINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             HHHHCTTTBBCTTSSBCT
T ss_pred             HHHhCCceeeccCccccC
Confidence            888888877777766544

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.84  E-value=1.4e-22  Score=247.54  Aligned_cols=219  Identities=21%  Similarity=0.260  Sum_probs=85.6

Q ss_pred             CChhHHHHHHHHHHhcccCCCCcccCCCC-CCCCcceeeeEEEeCCCCeEEEEEecCCcccccCchhcccccccceeccc
Q 001988           27 NISTDQQALLALKDHITYDPTNLLGTNWT-SNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLS  105 (985)
Q Consensus        27 ~~~~~~~aLl~~k~~~~~~~~~~~~s~w~-~~~~~c~w~gv~c~~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~  105 (985)
                      ....++++|+++.............. |. ..+..+.|.+++++.  .+|+.|+|.++++.. ++..+     |+.++|+
T Consensus       129 ~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~~~-----l~~l~Ls  199 (727)
T 4b8c_D          129 LVDCTKQALMEMADTLTDSKTAKKQQ-PTGDSTPSGTATNSAVST--PLTPKIELFANGKDE-ANQAL-----LQHKKLS  199 (727)
T ss_dssp             ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred             ccccchhhhhhhhhhcccccCcccCC-CcCCCCccccCCCceecC--CccceEEeeCCCCCc-chhhH-----hhcCccC
Confidence            44678999999998875443333333 64 345668899998865  579999999998885 34333     3444555


Q ss_pred             CCcCCC---------CCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccceec
Q 001988          106 HNKLSS---------NIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLF  176 (985)
Q Consensus       106 ~n~l~~---------~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~  176 (985)
                      .|.+++         ..|..+..++.|++|+|++|.+.                         .+|..++ .+++|++|+
T Consensus       200 ~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-------------------------~l~~~~~-~l~~L~~L~  253 (727)
T 4b8c_D          200 QYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-------------------------NISANIF-KYDFLTRLY  253 (727)
T ss_dssp             ----------------------CCCCCCEEECTTSCCS-------------------------CCCGGGG-GCCSCSCCB
T ss_pred             cccccCccccccceecChhhhccCCCCcEEECCCCCCC-------------------------CCChhhc-CCCCCCEEE
Confidence            554442         23555556666666666666555                         4444443 455555555


Q ss_pred             ccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcc
Q 001988          177 LRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTG  256 (985)
Q Consensus       177 L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  256 (985)
                      |++|.|+ .+|+.|+++++|++|+|++|+|+ .+|..|++|++|++|+|++|.|+ .+|..|+.|++|++|+|++|.|++
T Consensus       254 Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~  330 (727)
T 4b8c_D          254 LNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEK  330 (727)
T ss_dssp             CTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCS
T ss_pred             eeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCC
Confidence            5555555 55555555555555555555555 44555555555555555555554 445555555555555555555555


Q ss_pred             cCcccccCCCC-CCEEEccCCcCcccCC
Q 001988          257 VVPATIFNMST-LKEIFLYNNSLSGSLP  283 (985)
Q Consensus       257 ~~p~~l~~l~~-L~~L~L~~N~l~~~~p  283 (985)
                      .+|..+..+.. +..|+|++|.+++.+|
T Consensus       331 ~~p~~~~~~~~~~~~l~l~~N~l~~~~p  358 (727)
T 4b8c_D          331 QFLKILTEKSVTGLIFYLRDNRPEIPLP  358 (727)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred             CChHHHhhcchhhhHHhhccCcccCcCc
Confidence            55544433211 1123444444444333

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=2.2e-21  Score=228.28  Aligned_cols=189  Identities=25%  Similarity=0.326  Sum_probs=150.2

Q ss_pred             CCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEc
Q 001988          122 TLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHL  201 (985)
Q Consensus       122 ~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  201 (985)
                      +|++|+|++|++++ +|..+  .++|++|+|++|+|+ .+|    ..+++|++|+|++|.|++ +|. +.+  +|++|+|
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip----~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~L  127 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP----ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDV  127 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC----CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEEC
T ss_pred             CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc----cccCCCCEEEccCCCCCC-cch-hhc--CCCEEEC
Confidence            55555555555554 33322  145566666666665 566    336889999999999986 787 765  8999999


Q ss_pred             ccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCccc
Q 001988          202 GYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGS  281 (985)
Q Consensus       202 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  281 (985)
                      ++|+|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|++|+|++|+|++ +|. |.  ++|+.|+|++|+|+ .
T Consensus       128 s~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~  194 (571)
T 3cvr_A          128 DNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-S  194 (571)
T ss_dssp             CSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-S
T ss_pred             CCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-c
Confidence            9999996 776   67899999999999996 665   57899999999999997 676 65  89999999999999 7


Q ss_pred             CChhhhhcCCCC-------cEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCC
Q 001988          282 LPSRIDLALPNL-------EFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRN  340 (985)
Q Consensus       282 ~p~~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  340 (985)
                      +|. +..   +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|.+++.+|..+..++.
T Consensus       195 lp~-~~~---~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          195 LPA-VPV---RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             CCC-CC-----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             hhh-HHH---hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence            887 432   66       99999999999 68888889999999999999999999998887654

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.84  E-value=6.5e-21  Score=196.56  Aligned_cols=158  Identities=23%  Similarity=0.218  Sum_probs=75.3

Q ss_pred             CccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeec
Q 001988          418 NLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLG  497 (985)
Q Consensus       418 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  497 (985)
                      +|++|++++|++++..+..|.++++|++|++++|++++..+..+..+++|++|+|++|++++..+..|.++++|++|+++
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  108 (208)
T 2o6s_A           29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN  108 (208)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence            45555555555554444445555555555555555554444444455555555555555554444444555555555555


Q ss_pred             cceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccch
Q 001988          498 SNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPI  577 (985)
Q Consensus       498 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  577 (985)
                      +|+++++.+..|..+++|++|++++|++++..+..+..+++|+.|++++|.+.+.       +++|++|+++.|+++|.+
T Consensus       109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~L~~~~n~~~g~i  181 (208)
T 2o6s_A          109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVV  181 (208)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC-------TTTTHHHHHHHHHCTTTB
T ss_pred             CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC-------CCCHHHHHHHHHhCCcee
Confidence            5555544444444444444444444444444333344444444444444443321       223444444444444444


Q ss_pred             hhhhh
Q 001988          578 PESFG  582 (985)
Q Consensus       578 p~~~~  582 (985)
                      |.+++
T Consensus       182 p~~~~  186 (208)
T 2o6s_A          182 RNSAG  186 (208)
T ss_dssp             BCTTS
T ss_pred             eccCc
Confidence            44443

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.83  E-value=2.2e-20  Score=195.46  Aligned_cols=161  Identities=25%  Similarity=0.308  Sum_probs=97.2

Q ss_pred             CCCCCCcceeeeEEEeCCCCeEEEEEecCCcccccCchhcccccccceecccCCcCCCCCCcccccCCCCcEEEccCccc
Q 001988           54 WTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQL  133 (985)
Q Consensus        54 w~~~~~~c~w~gv~c~~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l  133 (985)
                      |..+.+.|+|.+|.|+..            +++ .+|..+.  ++|++|+|++|.+++..|..+..+++|++|+|++|++
T Consensus        12 ~~~~~~~Cs~~~v~c~~~------------~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l   76 (229)
T 3e6j_A           12 ACPSQCSCSGTTVDCRSK------------RHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL   76 (229)
T ss_dssp             CCCTTCEEETTEEECTTS------------CCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             cCCCCCEEeCCEeEccCC------------CcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCC
Confidence            445678899999999643            333 5666544  7888899999888887788888888888888877777


Q ss_pred             CCCCccccccCCccceeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccc
Q 001988          134 SGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKE  213 (985)
Q Consensus       134 ~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~  213 (985)
                      +                         .+|...+..+++|++|+|++|.+++..+..|..+++|++|+|++|+|+ .+|..
T Consensus        77 ~-------------------------~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~  130 (229)
T 3e6j_A           77 G-------------------------ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRG  130 (229)
T ss_dssp             C-------------------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTT
T ss_pred             C-------------------------CcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcc
Confidence            5                         333333344555555555555555444444555555555555555555 44555


Q ss_pred             cccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCc
Q 001988          214 IGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLT  255 (985)
Q Consensus       214 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  255 (985)
                      +.++++|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus       131 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  172 (229)
T 3e6j_A          131 IERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD  172 (229)
T ss_dssp             GGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred             cccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence            555555555555555555433344444444444444444444

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.83  E-value=4.2e-22  Score=235.87  Aligned_cols=235  Identities=22%  Similarity=0.220  Sum_probs=143.8

Q ss_pred             eeeeEEEeCCCCeEEEEEecCCcccc-------------------------cCch---hcccccccceecccCCcCCCCC
Q 001988           62 SWIGIICDVNSHKVTTLNLSSFNLQG-------------------------TIPP---EIANLSSLKSLDLSHNKLSSNI  113 (985)
Q Consensus        62 ~w~gv~c~~~~~~v~~l~L~~~~l~g-------------------------~~~~---~l~~l~~L~~L~L~~n~l~~~~  113 (985)
                      .|.++.|+...++|..++++.-.+.-                         ..+.   .+..+++|+.|+|++|+++ .+
T Consensus       286 ~W~~~~~~~~~~~vw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~L~~L~Ls~n~L~-~L  364 (567)
T 1dce_A          286 EWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VL  364 (567)
T ss_dssp             CCBCTTSSCCSEEEEEEECCGGGTSTTSSEEEEEEEETTTTEEEEEEEETTCSEEEEECCSTTTTSSSCCCCHHHHH-HH
T ss_pred             eeccCCcccccceeEEeecCccccccccccceEEEeeccCCCCccccccCCCchhhhcccccCccceeccCChhhHH-hh
Confidence            47777777666777777776543321                         1111   1367889999999999997 79


Q ss_pred             CcccccCCCCcEEEccCcc-------------cCCCCccccccCCccceee-eccccccCCCChhHhhhccccceecccC
Q 001988          114 PSSIFTMSTLKVLYLMDNQ-------------LSGSLSSFTFNTSSILDIR-LSKNKLSGKLPENICNHLRYLKHLFLRE  179 (985)
Q Consensus       114 p~~~~~l~~L~~L~Ls~n~-------------l~~~~~~~~~~~~~L~~L~-ls~n~l~g~lp~~~~~~l~~L~~L~L~~  179 (985)
                      |++++.|++|++|++++|.             +.+.+|..+..+++|+.|+ ++.|.+.            +|+.+.+++
T Consensus       365 p~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~------------~L~~l~l~~  432 (567)
T 1dce_A          365 QSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD------------DLRSKFLLE  432 (567)
T ss_dssp             HHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH------------HHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc------------hhhhhhhhc
Confidence            9999999999999998775             4566666677777777777 5555432            233334444


Q ss_pred             ccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCc
Q 001988          180 NMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVP  259 (985)
Q Consensus       180 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  259 (985)
                      |.+++ +|.     ..|++|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..|+.+++|++|+|++|+|++ +|
T Consensus       433 n~i~~-l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp  502 (567)
T 1dce_A          433 NSVLK-MEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD  502 (567)
T ss_dssp             HHHHH-HHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG
T ss_pred             ccccc-cCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc
Confidence            44442 111     135566666666664 454 666666666666666666 556666666666666666666664 44


Q ss_pred             ccccCCCCCCEEEccCCcCcccC-ChhhhhcCCCCcEEEecCccCCCcCCcc---ccCCCCccEEE
Q 001988          260 ATIFNMSTLKEIFLYNNSLSGSL-PSRIDLALPNLEFLNLGINSFSGTIPSS---ITNASKLILLE  321 (985)
Q Consensus       260 ~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~~l~~L~~L~Ls~N~l~~~~p~~---~~~l~~L~~L~  321 (985)
                       .+.++++|++|+|++|+|++.. |..+ ..+++|+.|+|++|++++.+|..   +..+++|+.|+
T Consensus       503 -~l~~l~~L~~L~Ls~N~l~~~~~p~~l-~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~  566 (567)
T 1dce_A          503 -GVANLPRLQELLLCNNRLQQSAAIQPL-VSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL  566 (567)
T ss_dssp             -GGTTCSSCCEEECCSSCCCSSSTTGGG-GGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred             -ccCCCCCCcEEECCCCCCCCCCCcHHH-hcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence             5666666666666666666443 4443 35666666666666666443321   22355666654

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.82  E-value=9.5e-21  Score=196.84  Aligned_cols=135  Identities=27%  Similarity=0.325  Sum_probs=79.2

Q ss_pred             ceEeeccceeeeecC-CCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeec
Q 001988          492 QYLNLGSNRFTFVIP-STFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAY  570 (985)
Q Consensus       492 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  570 (985)
                      ++|+|++|+|+++.| ..|..+++|++|++++|+|+++.+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus        35 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  114 (220)
T 2v70_A           35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS  114 (220)
T ss_dssp             SEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTT
T ss_pred             CEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCC
Confidence            444444444444422 2344445555555555555544444555555556666666666555555566666666666666


Q ss_pred             ceeccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCCCC
Q 001988          571 NRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIP  626 (985)
Q Consensus       571 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p  626 (985)
                      |+|++..|..|..+++|++|+|++|+|++..|..|..+++|++|++++|++.+.++
T Consensus       115 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          115 NRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             SCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            66666556666666666666666666666666666666666666666666666554

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.81  E-value=2.8e-20  Score=209.08  Aligned_cols=176  Identities=22%  Similarity=0.219  Sum_probs=107.7

Q ss_pred             cEEEccCCCCCCCCCccccccccccceecccccccCCchhhhh-hccCCCeEEccCCccccccCCCCcCcCcCceEeecc
Q 001988          420 IVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEIC-LLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGS  498 (985)
Q Consensus       420 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  498 (985)
                      +.+++++|+++. +|..+.  ..++.|+|++|+|++..+..+. .+++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus        21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            467777777764 444332  3466677777777665555555 666677777777777666666666666677777776


Q ss_pred             ceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhh---cccccceeeeeecceecc
Q 001988          499 NRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTL---EGLKSLQNISLAYNRLEG  575 (985)
Q Consensus       499 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~  575 (985)
                      |+|+.+.+..|.++++|+.|++++|+|.++.+..|..+++|+.|+|++|+|++..+..|   ..+++|+.|+|++|+|++
T Consensus        98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~  177 (361)
T 2xot_A           98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK  177 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred             CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence            66666666666666666666666666666656666666666666666666664433333   345566666666666665


Q ss_pred             chhhhhhcccc--cCeEecCCCccc
Q 001988          576 PIPESFGNMTS--LESLDLSNNKIS  598 (985)
Q Consensus       576 ~~p~~~~~l~~--L~~L~Ls~N~l~  598 (985)
                      ..+..|..++.  |+.|+|++|.+.
T Consensus       178 l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          178 LPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             cCHHHhhhccHhhcceEEecCCCcc
Confidence            55555555554  255566665554

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.80  E-value=4.1e-20  Score=200.88  Aligned_cols=172  Identities=26%  Similarity=0.328  Sum_probs=91.4

Q ss_pred             CCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCce
Q 001988          414 GNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQY  493 (985)
Q Consensus       414 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  493 (985)
                      ..+++|++|++++|.+... + .+..+++|++|++++|++++..+  +..+++|++|+|++|++++. + .+..+++|++
T Consensus        43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~  116 (291)
T 1h6t_A           43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL-S-SLKDLKKLKS  116 (291)
T ss_dssp             HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCE
T ss_pred             hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC-h-hhccCCCCCE
Confidence            3455566666666666533 2 25555666666666666654333  55555566666666655532 1 2555555555


Q ss_pred             EeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeeccee
Q 001988          494 LNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRL  573 (985)
Q Consensus       494 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  573 (985)
                      |++++|+++++  .                        .+..+++|+.|++++|++++.  ..++.+++|+.|+|++|++
T Consensus       117 L~L~~n~i~~~--~------------------------~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l  168 (291)
T 1h6t_A          117 LSLEHNGISDI--N------------------------GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI  168 (291)
T ss_dssp             EECTTSCCCCC--G------------------------GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred             EECCCCcCCCC--h------------------------hhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcc
Confidence            55555555442  2                        244444555555555555433  3455555555555555555


Q ss_pred             ccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccC
Q 001988          574 EGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKG  623 (985)
Q Consensus       574 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  623 (985)
                      ++..|  +..+++|+.|+|++|+|++ +| .+..+++|+.|++++|+++.
T Consensus       169 ~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          169 SDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred             ccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence            54433  5555555566666665553 23 25555566666666665554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.80  E-value=3e-20  Score=193.09  Aligned_cols=152  Identities=18%  Similarity=0.260  Sum_probs=88.1

Q ss_pred             cceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCC
Q 001988          444 QGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSN  523 (985)
Q Consensus       444 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  523 (985)
                      +.+++++|.++ .+|..+.  ++|+.|+|++|+|++..+..|..+++|++|+|++|+|+++.|..|.++++|++|++++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            45666666666 3444332  45666666666666655556666666666666666666666666666666666666666


Q ss_pred             cccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCccc
Q 001988          524 LLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKIS  598 (985)
Q Consensus       524 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  598 (985)
                      +|+.+.+..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++.
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            665555555555555555555555555555555555555555555555555444444555555555555555544

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.80  E-value=9.2e-20  Score=198.13  Aligned_cols=190  Identities=22%  Similarity=0.301  Sum_probs=145.2

Q ss_pred             ccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEee
Q 001988          441 QKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDI  520 (985)
Q Consensus       441 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  520 (985)
                      .++..+.+..+.+.+..+  +..+++|+.|++++|.+++. + .+..+++|++|++++|++++..+  +..+++|++|++
T Consensus        24 ~~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l   97 (291)
T 1h6t_A           24 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFL   97 (291)
T ss_dssp             HHHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             HHHHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEEC
Confidence            344555566666554322  34566677777777777643 2 36667777777777777776554  677777777777


Q ss_pred             cCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCC
Q 001988          521 SSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGS  600 (985)
Q Consensus       521 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  600 (985)
                      ++|+++++.  .+..+++|+.|++++|+|++.  ..+..+++|++|++++|++++.  ..+..+++|+.|+|++|++++.
T Consensus        98 ~~n~l~~~~--~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~  171 (291)
T 1h6t_A           98 DENKVKDLS--SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI  171 (291)
T ss_dssp             CSSCCCCGG--GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC
T ss_pred             CCCcCCCCh--hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccc
Confidence            777777643  388899999999999999864  5789999999999999999975  5799999999999999999976


Q ss_pred             CCccccccccccccccccccccCCCCCCCCCcccccccccCCccc
Q 001988          601 IPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELL  645 (985)
Q Consensus       601 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~l  645 (985)
                      .|  +..+++|+.|++++|++++. |....+.++....+.+|+..
T Consensus       172 ~~--l~~l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          172 VP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             GG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEEE
T ss_pred             hh--hcCCCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCccc
Confidence            55  99999999999999999974 54556677777777787643

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.80  E-value=1.7e-19  Score=214.77  Aligned_cols=191  Identities=21%  Similarity=0.382  Sum_probs=132.7

Q ss_pred             cceeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeec
Q 001988          147 ILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLI  226 (985)
Q Consensus       147 L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  226 (985)
                      +..++++.+.+.+.++.   ..+++|+.|++++|.+. .+| .++.+++|++|+|++|+|++..|  ++++++|+.|+|+
T Consensus        23 l~~l~l~~~~i~~~~~~---~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls   95 (605)
T 1m9s_A           23 TIKDNLKKKSVTDAVTQ---NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD   95 (605)
T ss_dssp             HHHHHTTCSCTTSEECH---HHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred             HHHHhccCCCcccccch---hcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence            34444555555543332   45777888888888776 344 47778888888888888876544  7778888888888


Q ss_pred             cccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCc
Q 001988          227 NNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGT  306 (985)
Q Consensus       227 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~  306 (985)
                      +|++++ +| .+..+++|++|+|++|++++.  ..+..+++|+.|+|++|++++ +  ..+..+++|+.|+|++|++++.
T Consensus        96 ~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~-l--~~l~~l~~L~~L~Ls~N~l~~~  168 (605)
T 1m9s_A           96 ENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD-I--TVLSRLTKLDTLSLEDNQISDI  168 (605)
T ss_dssp             SSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCC-C--GGGGSCTTCSEEECCSSCCCCC
T ss_pred             CCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCC-c--hhhcccCCCCEEECcCCcCCCc
Confidence            888774 33 677778888888888887753  347777778888888887774 3  2334677777777777777766


Q ss_pred             CCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCC
Q 001988          307 IPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSST  355 (985)
Q Consensus       307 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  355 (985)
                      .|  +..+++|+.|+|++|++++.  ..+..+++|+.|+|++|++...+
T Consensus       169 ~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p  213 (605)
T 1m9s_A          169 VP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKP  213 (605)
T ss_dssp             GG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCC
T ss_pred             hh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCc
Confidence            55  77777777777777777754  34677777777777777776544

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.79  E-value=2.1e-19  Score=202.00  Aligned_cols=177  Identities=24%  Similarity=0.236  Sum_probs=122.4

Q ss_pred             cceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCcccc-ccccccceecccccccCCchhhhhhccCCCeEEccC
Q 001988          396 ERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFG-GLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNG  474 (985)
Q Consensus       396 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  474 (985)
                      +.+++++++++. +|..+.  +.++.|+|++|+|++..+..|. ++++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus        21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            456777777763 454433  3467777777777766666666 777777777777777766666677777777777777


Q ss_pred             CccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccc---cCCCcccEEEccCCccCc
Q 001988          475 NKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAI---GNLKAVVGIDLSRNNLSG  551 (985)
Q Consensus       475 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~---~~l~~L~~L~Ls~N~l~~  551 (985)
                      |+|++..+..|.++++|++|+|++|+|+++.|..|.++++|+.|++++|+|+++.+..|   ..+++|+.|+|++|+|++
T Consensus        98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~  177 (361)
T 2xot_A           98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK  177 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred             CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence            77776666667777777777777777777777777777777777777777776666555   457777777777777776


Q ss_pred             cCchhhccccc--ceeeeeecceecc
Q 001988          552 NIPTTLEGLKS--LQNISLAYNRLEG  575 (985)
Q Consensus       552 ~~p~~~~~l~~--L~~L~Ls~N~l~~  575 (985)
                      ..+..|..++.  |+.|+|++|.+.-
T Consensus       178 l~~~~~~~l~~~~l~~l~l~~N~~~C  203 (361)
T 2xot_A          178 LPLTDLQKLPAWVKNGLYLHNNPLEC  203 (361)
T ss_dssp             CCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred             cCHHHhhhccHhhcceEEecCCCccC
Confidence            65566666665  3667777777763

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.79  E-value=2.1e-19  Score=186.63  Aligned_cols=155  Identities=23%  Similarity=0.293  Sum_probs=109.0

Q ss_pred             ceecccccccCCchhhhhhccCCCeEEccCCccccccC-CCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCC
Q 001988          445 GLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSIS-SCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSN  523 (985)
Q Consensus       445 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  523 (985)
                      .+++++|.++ .+|..+  ...+++|+|++|+|++..+ ..|..+++|++|+|++|+|+++.+..|.++++|++|++++|
T Consensus        15 ~l~~s~n~l~-~iP~~~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   91 (220)
T 2v70_A           15 TVDCSNQKLN-KIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN   91 (220)
T ss_dssp             EEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EeEeCCCCcc-cCccCC--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence            4555555554 233322  2335566666666665533 34666777777777777777666667777777777777777


Q ss_pred             cccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCC
Q 001988          524 LLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIP  602 (985)
Q Consensus       524 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  602 (985)
                      +++++.+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+++..+
T Consensus        92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A           92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            7777777777777788888888888887777788888888888888888887778888888888888888888876433

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.79  E-value=2.6e-19  Score=185.98  Aligned_cols=155  Identities=23%  Similarity=0.324  Sum_probs=110.6

Q ss_pred             CeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCC
Q 001988          468 NELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRN  547 (985)
Q Consensus       468 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  547 (985)
                      +.+++++|.++. +|..+.  ++|+.|++++|+|+++.+..|.++++|++|++++|+|+++.+..|.++++|+.|+|++|
T Consensus        14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            567777777763 444443  56777777777777766667777777777777777777777777777777777777777


Q ss_pred             ccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCCC
Q 001988          548 NLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEI  625 (985)
Q Consensus       548 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~  625 (985)
                      +|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++.+..
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c  168 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC  168 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence            777655556677777777777777777766777777777777777777777666666777777777777777776544

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.79  E-value=1.8e-19  Score=214.52  Aligned_cols=200  Identities=22%  Similarity=0.266  Sum_probs=125.7

Q ss_pred             ccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccC
Q 001988          395 LERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNG  474 (985)
Q Consensus       395 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  474 (985)
                      +..+.+..+.+....+  +..+++|+.|++++|.+... + .|..+++|+.|+|++|+|++..|  +..+++|+.|+|++
T Consensus        23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~   96 (605)
T 1m9s_A           23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE   96 (605)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred             HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence            3344455555443332  34556666666666666543 2 36666666666666666665433  66666777777777


Q ss_pred             CccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCc
Q 001988          475 NKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIP  554 (985)
Q Consensus       475 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  554 (985)
                      |+|++.  ..+..+++|+.|+|++|+++++  ..+..+++|+.|+|++|++.++  ..+..+++|+.|+|++|+|++..|
T Consensus        97 N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~  170 (605)
T 1m9s_A           97 NKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP  170 (605)
T ss_dssp             SCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred             CCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence            776642  2566677777777777776653  2366666777777777777665  356677777777777777776555


Q ss_pred             hhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcccccccc
Q 001988          555 TTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSY  610 (985)
Q Consensus       555 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  610 (985)
                        +..+++|+.|+|++|+|++. | .+..+++|+.|+|++|++++.....+..+..
T Consensus       171 --l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~  222 (605)
T 1m9s_A          171 --LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNKPINHQSNLVV  222 (605)
T ss_dssp             --GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEECCCCCCCSSCEE
T ss_pred             --hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcCCcccccccEEe
Confidence              77777777777777777753 3 4777777777777777777543333333333

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.78  E-value=5.1e-19  Score=185.07  Aligned_cols=156  Identities=24%  Similarity=0.288  Sum_probs=86.9

Q ss_pred             ccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecC
Q 001988          443 LQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISS  522 (985)
Q Consensus       443 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~  522 (985)
                      -+.++.+++.+. .+|..+  .++|++|+|++|+|++..|..|.++++|++|+|++|+|+.                   
T Consensus        21 ~~~v~c~~~~l~-~ip~~~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~-------------------   78 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-------------------   78 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-------------------
T ss_pred             CCEeEccCCCcC-ccCCCC--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCC-------------------
Confidence            344555555555 333322  2445555555555555445555555555555555555544                   


Q ss_pred             CcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCC
Q 001988          523 NLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIP  602 (985)
Q Consensus       523 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  602 (985)
                           +.+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+
T Consensus        79 -----i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~  152 (229)
T 3e6j_A           79 -----LPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPH  152 (229)
T ss_dssp             -----CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred             -----cChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCH
Confidence                 44444455555555555555555554555555666666666666665 455556666666666666666665555


Q ss_pred             ccccccccccccccccccccCCCC
Q 001988          603 VSFEKLSYLKELNLSFNKLKGEIP  626 (985)
Q Consensus       603 ~~~~~l~~L~~L~ls~N~l~~~~p  626 (985)
                      ..|..+++|+.|++++|++.+.++
T Consensus       153 ~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          153 GAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             TTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             HHHhCCCCCCEEEeeCCCccCCcc
Confidence            556666666666666666665554

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.77  E-value=6.7e-21  Score=225.58  Aligned_cols=190  Identities=22%  Similarity=0.206  Sum_probs=131.1

Q ss_pred             CCCCccEEEccCCCCCCCCCccccccccccceeccccc-------------ccCCchhhhhhccCCCeEE-ccCCccccc
Q 001988          415 NLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNK-------------LAGSIPDEICLLSRLNELD-LNGNKISGS  480 (985)
Q Consensus       415 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~~  480 (985)
                      .+++|+.|+|++|+++ .+|..++.+++|+.|++++|.             +.+.+|..++.+++|+.|+ ++.|.+.  
T Consensus       347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~--  423 (567)
T 1dce_A          347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD--  423 (567)
T ss_dssp             TTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH--
T ss_pred             cCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc--
Confidence            3444555555555554 345555555555555554443             4456666777777777777 5655542  


Q ss_pred             cCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhccc
Q 001988          481 ISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGL  560 (985)
Q Consensus       481 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  560 (985)
                               +|+.+.+++|.++.+.+.      .|+.|++++|+|+++ |. ++.+++|+.|+|++|+|+ .+|..|+.+
T Consensus       424 ---------~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l  485 (567)
T 1dce_A          424 ---------DLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTVL-CH-LEQLLLVTHLDLSHNRLR-ALPPALAAL  485 (567)
T ss_dssp             ---------HHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSSC-CC-GGGGTTCCEEECCSSCCC-CCCGGGGGC
T ss_pred             ---------hhhhhhhhcccccccCcc------CceEEEecCCCCCCC-cC-ccccccCcEeecCccccc-ccchhhhcC
Confidence                     455566666766654332      367788888888774 33 778888888888888887 667788888


Q ss_pred             ccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCC-CccccccccccccccccccccCCCCC
Q 001988          561 KSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSI-PVSFEKLSYLKELNLSFNKLKGEIPR  627 (985)
Q Consensus       561 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p~  627 (985)
                      ++|+.|+|++|+|++ +| .|+++++|+.|+|++|+|++.+ |..|..+++|+.|+|++|++++.+|.
T Consensus       486 ~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  551 (567)
T 1dce_A          486 RCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI  551 (567)
T ss_dssp             TTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred             CCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence            888888888888886 56 7888888888888888888766 78888888888888888888877764

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.76  E-value=8e-19  Score=187.60  Aligned_cols=172  Identities=22%  Similarity=0.295  Sum_probs=121.7

Q ss_pred             ccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEE
Q 001988          439 GLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSF  518 (985)
Q Consensus       439 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  518 (985)
                      .+.++..+++++|.+++. + .+..+++|+.|++++|+++. ++ .+..+++|++|+|++|+++++.+  |..+++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            345566666666666633 2 45566666666666666663 33 46666667777777776666544  6666777777


Q ss_pred             eecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCccc
Q 001988          519 DISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKIS  598 (985)
Q Consensus       519 ~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  598 (985)
                      ++++|++++..+.  .. ++|+.|+|++|+|++.  ..+..+++|+.|+|++|+|++. + .+..+++|+.|+|++|+++
T Consensus        91 ~L~~N~l~~l~~~--~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~  163 (263)
T 1xeu_A           91 SVNRNRLKNLNGI--PS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT  163 (263)
T ss_dssp             ECCSSCCSCCTTC--CC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred             ECCCCccCCcCcc--cc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence            7777777664432  22 7788888888888754  3588888888888888888864 3 6888888889999999888


Q ss_pred             CCCCccccccccccccccccccccCCC
Q 001988          599 GSIPVSFEKLSYLKELNLSFNKLKGEI  625 (985)
Q Consensus       599 ~~~p~~~~~l~~L~~L~ls~N~l~~~~  625 (985)
                      +.  ..+..+++|+.|++++|++++..
T Consensus       164 ~~--~~l~~l~~L~~L~l~~N~~~~~~  188 (263)
T 1xeu_A          164 NT--GGLTRLKKVNWIDLTGQKCVNEP  188 (263)
T ss_dssp             BC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred             ch--HHhccCCCCCEEeCCCCcccCCc
Confidence            66  66888888999999999888663

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.76  E-value=6.8e-19  Score=187.57  Aligned_cols=139  Identities=19%  Similarity=0.242  Sum_probs=108.1

Q ss_pred             hcCccCCceeeccCceeEEEEEE-cCCcE--EEEEEeccCCcc------------------------hHHHHHHHHHHHH
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-EDGVE--IAIKVFHPQCAS------------------------TLKSFEAECEVIK  777 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~--vAvK~~~~~~~~------------------------~~~~~~~E~~il~  777 (985)
                      ..-|...+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|+++++
T Consensus        46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~  125 (258)
T 1zth_A           46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE  125 (258)
T ss_dssp             TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred             CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence            33467788999999999999997 68999  999997643211                        1136789999999


Q ss_pred             hcCCCCe--eeEEeeeecCCceEEEEeccCC-C----ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCeEe
Q 001988          778 NIRHRNL--VKIISSCSNDDFKALVLEYMSN-G----SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH-STPIIH  849 (985)
Q Consensus       778 ~l~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h-~~~ivH  849 (985)
                      ++.|+++  +.++++    +..++||||+.+ |    +|.++...    .++.....++.|++.|+.||   | +.||+|
T Consensus       126 ~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~l---H~~~givH  194 (258)
T 1zth_A          126 RAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRL---YQEAELVH  194 (258)
T ss_dssp             HHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHH---HHTSCEEC
T ss_pred             HHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHH---HHHCCEEe
Confidence            9988754  344443    356899999942 4    67666443    12345678999999999999   7 899999


Q ss_pred             CCCCCCCEEEcCCCcEEEecccCceec
Q 001988          850 CDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       850 rDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      |||||+|||+++  .++|+|||+|...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999999764

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.76  E-value=1.1e-18  Score=186.58  Aligned_cols=168  Identities=20%  Similarity=0.300  Sum_probs=113.7

Q ss_pred             cccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEcc
Q 001988          394 SLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLN  473 (985)
Q Consensus       394 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  473 (985)
                      .+..+++++|.+++..  .+..+++|++|++++|+++. ++ .+..+++|+.|+|++|+|++..+  +..+++|+.|+|+
T Consensus        20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~   93 (263)
T 1xeu_A           20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN   93 (263)
T ss_dssp             HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred             HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence            4566667777666443  46677777788888777774 33 57777777778887777775443  7777777777777


Q ss_pred             CCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccC
Q 001988          474 GNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNI  553 (985)
Q Consensus       474 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  553 (985)
                      +|++++. |. +.. ++|++|++++|+++++  ..+..+++|+.|++++|++++..  .+..+++|+.|+|++|+|++. 
T Consensus        94 ~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~~--~l~~l~~L~~L~L~~N~i~~~-  165 (263)
T 1xeu_A           94 RNRLKNL-NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIV--MLGFLSKLEVLDLHGNEITNT-  165 (263)
T ss_dssp             SSCCSCC-TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBCG--GGGGCTTCCEEECTTSCCCBC-
T ss_pred             CCccCCc-Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCCh--HHccCCCCCEEECCCCcCcch-
Confidence            7777753 32 222 7777777777777764  24666777777777777776652  466677777777777777655 


Q ss_pred             chhhcccccceeeeeecceeccc
Q 001988          554 PTTLEGLKSLQNISLAYNRLEGP  576 (985)
Q Consensus       554 p~~~~~l~~L~~L~Ls~N~l~~~  576 (985)
                       ..+..+++|+.|++++|.+++.
T Consensus       166 -~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          166 -GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             -TTSTTCCCCCEEEEEEEEEECC
T ss_pred             -HHhccCCCCCEEeCCCCcccCC
Confidence             5566677777777777777654

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.76  E-value=1e-19  Score=222.39  Aligned_cols=197  Identities=20%  Similarity=0.224  Sum_probs=116.3

Q ss_pred             cccceecccCCcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccceec
Q 001988           97 SSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLF  176 (985)
Q Consensus        97 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~  176 (985)
                      +.++.|+|.+|.+.. +|..+     |+.++|++|.+.              .++++.|.+.  +|+..+..+++|+.|+
T Consensus       173 ~~~~~l~L~~n~~~~-~~~~~-----l~~l~Ls~~~i~--------------~~~~~~n~~~--~~~~~~~~l~~L~~L~  230 (727)
T 4b8c_D          173 PLTPKIELFANGKDE-ANQAL-----LQHKKLSQYSID--------------EDDDIENRMV--MPKDSKYDDQLWHALD  230 (727)
T ss_dssp             -----------------------------------------------------------------------CCCCCCEEE
T ss_pred             CccceEEeeCCCCCc-chhhH-----hhcCccCccccc--------------Ccccccccee--cChhhhccCCCCcEEE
Confidence            567888999998875 44433     666777777655              3456666665  5555667888999999


Q ss_pred             ccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcc
Q 001988          177 LRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTG  256 (985)
Q Consensus       177 L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  256 (985)
                      |++|.+. .+|..+.++++|++|+|++|.|+ .+|..|+++++|++|+|++|+|+ .+|..|+.|++|++|+|++|.|+ 
T Consensus       231 Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-  306 (727)
T 4b8c_D          231 LSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-  306 (727)
T ss_dssp             CTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-
T ss_pred             CCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-
Confidence            9999988 78888888999999999999998 78888999999999999999998 77888999999999999999987 


Q ss_pred             cCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCc
Q 001988          257 VVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSN  325 (985)
Q Consensus       257 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  325 (985)
                      .+|..|+++++|++|+|++|.|++.+|..+......+..|+|++|.+++.+|..      |..|+++.|
T Consensus       307 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n  369 (727)
T 4b8c_D          307 TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTD  369 (727)
T ss_dssp             CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred             ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecc
Confidence            678888899999999999999988777765432223345778888888877764      345556665

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.75  E-value=3.7e-18  Score=174.13  Aligned_cols=130  Identities=15%  Similarity=0.172  Sum_probs=73.8

Q ss_pred             hccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEE
Q 001988          168 HLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVL  247 (985)
Q Consensus       168 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  247 (985)
                      .+++|++|++++|.++  .++.+..+++|++|++++|++++..|..++.+++|++|++++|++++..|..++.+++|++|
T Consensus        64 ~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L  141 (197)
T 4ezg_A           64 YAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI  141 (197)
T ss_dssp             GCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEE
T ss_pred             cCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEE
Confidence            3444555555555332  22345556666666666666665555566666666666666666665556666666666666


Q ss_pred             EecCCc-CcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCC
Q 001988          248 QLGFNN-LTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFS  304 (985)
Q Consensus       248 ~Ls~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~  304 (985)
                      ++++|. ++ .+| .+..+++|++|++++|++++ ++  ....+++|+.|++++|+|.
T Consensus       142 ~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~--~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          142 DLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR--GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             ECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT--TGGGCSSCCEEEECBC---
T ss_pred             EccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH--HhccCCCCCEEEeeCcccC
Confidence            666665 43 333 45666666666666666653 33  2345666777777777665

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.74  E-value=2.9e-18  Score=190.12  Aligned_cols=221  Identities=13%  Similarity=0.062  Sum_probs=113.4

Q ss_pred             CCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcc----cCCCCccccccccc
Q 001988          290 LPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNL----TSSTPELGFLSSLA  365 (985)
Q Consensus       290 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l----~~~~~~~~~~~~l~  365 (985)
                      +++|+.|+|.+ +++...+..|.++++|+.|++++|.+..+.+.+|.+..++..+....+..    ..+..     .+|.
T Consensus       100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~-----~~f~  173 (329)
T 3sb4_A          100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEH-----FAFI  173 (329)
T ss_dssp             CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTT-----SCEE
T ss_pred             cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccc-----cccc
Confidence            56666666665 55544455566666666666666666656666666666555555444221    11111     1244


Q ss_pred             ccCccc-EEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccc-cccccc
Q 001988          366 NCKKLR-YLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTF-GGLQKL  443 (985)
Q Consensus       366 ~l~~L~-~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L  443 (985)
                      ++..|+ .+.+....   .++..+.                     ..-....+++.+.+.++-.. .....+ ..+++|
T Consensus       174 ~~~~L~~~i~~~~~~---~l~~~~~---------------------~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L  228 (329)
T 3sb4_A          174 EGEPLETTIQVGAMG---KLEDEIM---------------------KAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNL  228 (329)
T ss_dssp             ESCCCEEEEEECTTC---CHHHHHH---------------------HTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTC
T ss_pred             cccccceeEEecCCC---cHHHHHh---------------------hcccCccccceEEEeeeecH-HHHHHHHHhcCCC
Confidence            555555 34433221   1111000                     00011233334444333111 111111 124555


Q ss_pred             cceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCc-eEeeccceeeeecCCCccCccceeEEeecC
Q 001988          444 QGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQ-YLNLGSNRFTFVIPSTFWNLKDILSFDISS  522 (985)
Q Consensus       444 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~  522 (985)
                      +.|+|++|+++.+.+..|..+++|+.|+|.+| ++.+.+.+|.++++|+ .+++.+ +++.+.+.+|.++++|+.++++.
T Consensus       229 ~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~  306 (329)
T 3sb4_A          229 VSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATG  306 (329)
T ss_dssp             CEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECS
T ss_pred             eEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCC
Confidence            55666655555444455555666666666655 5545555666666666 666665 55556666666666666666666


Q ss_pred             CcccCCccccccCCCcccEEE
Q 001988          523 NLLDGPISLAIGNLKAVVGID  543 (985)
Q Consensus       523 N~l~~~~~~~~~~l~~L~~L~  543 (985)
                      |.++.+.+.+|.++++|+.++
T Consensus       307 n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          307 DKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             SCCCEECTTTTCTTCCCCEEE
T ss_pred             CccCccchhhhcCCcchhhhc
Confidence            666666666666666666664

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.73  E-value=9.9e-18  Score=170.92  Aligned_cols=131  Identities=15%  Similarity=0.256  Sum_probs=74.4

Q ss_pred             hhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCE
Q 001988          167 NHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDV  246 (985)
Q Consensus       167 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  246 (985)
                      +.+++|++|++++|.++ .+| .+..+++|++|++++|.++  .+..+..+++|++|++++|++++..|..++.+++|++
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            34556666666666665 445 4666666666666666554  2235556666666666666666555556666666666


Q ss_pred             EEecCCcCcccCcccccCCCCCCEEEccCCc-CcccCChhhhhcCCCCcEEEecCccCC
Q 001988          247 LQLGFNNLTGVVPATIFNMSTLKEIFLYNNS-LSGSLPSRIDLALPNLEFLNLGINSFS  304 (985)
Q Consensus       247 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~~l~~L~~L~Ls~N~l~  304 (985)
                      |++++|++++..|..+..+++|++|++++|. ++ .+|.  +..+++|++|++++|+++
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~~--l~~l~~L~~L~l~~n~i~  172 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIMP--LKTLPELKSLNIQFDGVH  172 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCGG--GGGCSSCCEEECTTBCCC
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccHh--hcCCCCCCEEECCCCCCc
Confidence            6666666665555556666666666666665 33 3331  234444455544444444

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.72  E-value=2.5e-18  Score=174.51  Aligned_cols=132  Identities=21%  Similarity=0.310  Sum_probs=89.4

Q ss_pred             CeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCC-CccCccceeEEeecCCcccCCccccccCCCcccEEEccC
Q 001988          468 NELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPS-TFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSR  546 (985)
Q Consensus       468 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~  546 (985)
                      +.+++++|+++ .+|..+..  +|++|++++|+|+++.+. .|..+++|++|++++|+|+++.|..|..+++|+.|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            67888888886 45554433  777888888887766554 466777777777777777766666666666677777777


Q ss_pred             CccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCC
Q 001988          547 NNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIP  602 (985)
Q Consensus       547 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  602 (985)
                      |+|++..|..|.++++|++|+|++|+|++.+|..|..+++|++|+|++|++++..+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            76666666666666666666666666666666666666666666666666665433

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.71  E-value=5.8e-18  Score=187.63  Aligned_cols=15  Identities=20%  Similarity=0.521  Sum_probs=8.4

Q ss_pred             CCCCcEEEecCccCC
Q 001988          290 LPNLEFLNLGINSFS  304 (985)
Q Consensus       290 l~~L~~L~Ls~N~l~  304 (985)
                      +++|+.|||++|++.
T Consensus        48 l~~L~~LdLs~n~i~   62 (329)
T 3sb4_A           48 FPSLKVLDISNAEIK   62 (329)
T ss_dssp             CTTCCEEEEEEEEEC
T ss_pred             hccCeEEecCcceeE
Confidence            455555555555554

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.71  E-value=2.9e-17  Score=166.54  Aligned_cols=132  Identities=26%  Similarity=0.313  Sum_probs=93.5

Q ss_pred             cceecccccccCCchhhhhhccCCCeEEccCCccccccCC-CCcCcCcCceEeeccceeeeecCCCccCccceeEEeecC
Q 001988          444 QGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISS-CLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISS  522 (985)
Q Consensus       444 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~  522 (985)
                      +.+++++|.++ .+|..+.  .+|++|+|++|+|++..+. .|..+++|++|+|++|+|+++.|..|.++++|++|++++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            56777777775 4555432  3677777777777765553 467777777777777777777777777777777777777


Q ss_pred             CcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchh
Q 001988          523 NLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIP  578 (985)
Q Consensus       523 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  578 (985)
                      |+|++..+..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|.+++..+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            77777777777777777777777777777777777777777777777777776443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.66  E-value=2.3e-16  Score=156.23  Aligned_cols=134  Identities=23%  Similarity=0.282  Sum_probs=90.7

Q ss_pred             cCCCeEEccCCccc-cccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEE
Q 001988          465 SRLNELDLNGNKIS-GSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGID  543 (985)
Q Consensus       465 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~  543 (985)
                      ++|+.|++++|+++ +.+|..+..+++|++|++++|.+++                        .  ..+..+++|+.|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~------------------------~--~~~~~l~~L~~L~   77 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS------------------------V--SNLPKLPKLKKLE   77 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCC------------------------C--SSCCCCSSCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCC------------------------h--hhhccCCCCCEEE
Confidence            45666666666665 4455555555555555555555544                        3  3455666677777


Q ss_pred             ccCCccCccCchhhcccccceeeeeecceeccch-hhhhhcccccCeEecCCCcccCCCC---ccccccccccccccccc
Q 001988          544 LSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPI-PESFGNMTSLESLDLSNNKISGSIP---VSFEKLSYLKELNLSFN  619 (985)
Q Consensus       544 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~ls~N  619 (985)
                      |++|++++.+|..+..+++|++|+|++|++++.. +..+..+++|+.|+|++|++++..+   ..+..+++|++|++++|
T Consensus        78 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n  157 (168)
T 2ell_A           78 LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDR  157 (168)
T ss_dssp             EESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEET
T ss_pred             CcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCC
Confidence            7777777666777777778888888888887642 2677788888888888888876554   46778888888888888


Q ss_pred             cccCC
Q 001988          620 KLKGE  624 (985)
Q Consensus       620 ~l~~~  624 (985)
                      .++..
T Consensus       158 ~~~~~  162 (168)
T 2ell_A          158 EDQEA  162 (168)
T ss_dssp             TSCBC
T ss_pred             Chhhc
Confidence            77643

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.65  E-value=4e-16  Score=154.57  Aligned_cols=132  Identities=23%  Similarity=0.264  Sum_probs=90.3

Q ss_pred             cccceecccCcccc-ccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEE
Q 001988          170 RYLKHLFLRENMFY-GKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQ  248 (985)
Q Consensus       170 ~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  248 (985)
                      ++|++|++++|.++ +.+|..+..+++|++|+|++|.+++.  ..++.+++|++|++++|++++.+|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            56777777777776 66777777777777777777777754  6677777777777777777766677777777777777


Q ss_pred             ecCCcCcccC-cccccCCCCCCEEEccCCcCcccCCh---hhhhcCCCCcEEEecCccCC
Q 001988          249 LGFNNLTGVV-PATIFNMSTLKEIFLYNNSLSGSLPS---RIDLALPNLEFLNLGINSFS  304 (985)
Q Consensus       249 Ls~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p~---~~~~~l~~L~~L~Ls~N~l~  304 (985)
                      +++|++++.. +..+..+++|++|++++|.+++ +|.   ..+..+++|++|++++|.+.
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~-~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTN-LNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGT-STTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcc-hHHHHHHHHHhCccCcEecCCCCChh
Confidence            7777777532 2566677777777777777763 333   34445666666666666655

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.63  E-value=3.4e-16  Score=151.65  Aligned_cols=128  Identities=23%  Similarity=0.306  Sum_probs=88.4

Q ss_pred             cCCCeEEccCCccc-cccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEE
Q 001988          465 SRLNELDLNGNKIS-GSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGID  543 (985)
Q Consensus       465 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~  543 (985)
                      ++|+.|++++|.++ +.+|..+..+++|++|++++|.++                        +.  ..+..+++|+.|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~------------------------~~--~~~~~l~~L~~L~   70 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT------------------------SI--ANLPKLNKLKKLE   70 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCC------------------------CC--TTCCCCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCC------------------------Cc--hhhhcCCCCCEEE
Confidence            44555555555555 444545555555555555555544                        43  3466677777777


Q ss_pred             ccCCccCccCchhhcccccceeeeeecceeccc-hhhhhhcccccCeEecCCCcccCCCC---cccccccccccccccc
Q 001988          544 LSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGP-IPESFGNMTSLESLDLSNNKISGSIP---VSFEKLSYLKELNLSF  618 (985)
Q Consensus       544 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~ls~  618 (985)
                      +++|+|++.+|..+..+++|++|++++|++++. .+..+..+++|++|++++|++++..+   ..+..+++|+.||+++
T Consensus        71 Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             CCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            777777766777777788888888888888863 34778888888888888888886655   4678888888888764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.63  E-value=6.3e-16  Score=170.35  Aligned_cols=143  Identities=15%  Similarity=0.194  Sum_probs=104.5

Q ss_pred             HHHHHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcc--------------hH--------HHHHHHHHHHH
Q 001988          720 ELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAS--------------TL--------KSFEAECEVIK  777 (985)
Q Consensus       720 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~--------------~~--------~~~~~E~~il~  777 (985)
                      .+.....-|++.+.||+|+||.||+|...+|++||||+++.....              ..        ....+|...+.
T Consensus        89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~  168 (397)
T 4gyi_A           89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK  168 (397)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence            333444458899999999999999999999999999997643100              00        11345677777


Q ss_pred             hcCCCCee--eEEeeeecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 001988          778 NIRHRNLV--KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPS  855 (985)
Q Consensus       778 ~l~h~niv--~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~  855 (985)
                      ++.+.++.  ..+++  .  ..+|||||++|++|.+.....       ....++.|++.++.||   |+.|||||||||.
T Consensus       169 rL~~~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~~~~-------~~~~l~~qll~~l~~l---H~~gIVHrDLKp~  234 (397)
T 4gyi_A          169 ALYEEGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVSSVP-------DPASLYADLIALILRL---AKHGLIHGDFNEF  234 (397)
T ss_dssp             HHHHTTCSCCCEEEE--E--TTEEEEECCSCEEGGGCCCCS-------CHHHHHHHHHHHHHHH---HHTTEECSCCSTT
T ss_pred             HHHhcCCCCCeeeec--c--CceEEEEecCCccHhhhcccH-------HHHHHHHHHHHHHHHH---HHCCCcCCCCCHH
Confidence            77544432  22222  1  237999999998887654321       2346789999999999   7889999999999


Q ss_pred             CEEEcCCC----------cEEEecccCceec
Q 001988          856 NVLLDEDM----------VAHLSDFGMAKLL  876 (985)
Q Consensus       856 Nill~~~~----------~~kl~DfGla~~~  876 (985)
                      |||+++++          .+.|+||+-+...
T Consensus       235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          235 NILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             HEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            99998877          4899999987664

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.63  E-value=6.7e-16  Score=149.57  Aligned_cols=129  Identities=20%  Similarity=0.250  Sum_probs=105.8

Q ss_pred             ccccceecccCcccc-ccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEE
Q 001988          169 LRYLKHLFLRENMFY-GKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVL  247 (985)
Q Consensus       169 l~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  247 (985)
                      .++|++|++++|.++ +.+|..+..+++|++|+|++|.+++.  ..++++++|++|++++|++++.+|..++.+++|++|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            467888899999888 78888888999999999999999865  778888999999999999987788888888999999


Q ss_pred             EecCCcCccc-CcccccCCCCCCEEEccCCcCcccCC--hhhhhcCCCCcEEEec
Q 001988          248 QLGFNNLTGV-VPATIFNMSTLKEIFLYNNSLSGSLP--SRIDLALPNLEFLNLG  299 (985)
Q Consensus       248 ~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p--~~~~~~l~~L~~L~Ls  299 (985)
                      ++++|++++. .+..+..+++|++|++++|.+++..+  ...+..+++|++|+++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            9999998863 45778888888888888888884433  1455677788887765

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.62  E-value=2.1e-16  Score=160.16  Aligned_cols=110  Identities=28%  Similarity=0.366  Sum_probs=65.1

Q ss_pred             eeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCC
Q 001988          515 ILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSN  594 (985)
Q Consensus       515 L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  594 (985)
                      |++|++++|+|+. +|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus        33 l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~  111 (193)
T 2wfh_A           33 VTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHG  111 (193)
T ss_dssp             CCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCC
Confidence            3444444444432 223455555555666666666555555566666666666666666665566666666666666666


Q ss_pred             CcccCCCCccccccccccccccccccccCCC
Q 001988          595 NKISGSIPVSFEKLSYLKELNLSFNKLKGEI  625 (985)
Q Consensus       595 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~  625 (985)
                      |+|++..+..|..+++|+.|++++|++.+..
T Consensus       112 N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c  142 (193)
T 2wfh_A          112 NDISVVPEGAFNDLSALSHLAIGANPLYCDC  142 (193)
T ss_dssp             SCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             CCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence            6666555555666666666666666666544

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.62  E-value=3.3e-15  Score=169.09  Aligned_cols=220  Identities=9%  Similarity=0.121  Sum_probs=154.0

Q ss_pred             cccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEcc
Q 001988          394 SLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLN  473 (985)
Q Consensus       394 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  473 (985)
                      +|+.+.+.+ .++.+.+.+|.++++|+.++|++|+++.+...+|. ..+|+.+.|..+ ++.+...+|..+++|+.+++.
T Consensus       158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~  234 (401)
T 4fdw_A          158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP  234 (401)
T ss_dssp             CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred             CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence            355555554 45555667777777788888877777766666666 467777777744 555556677777777777777


Q ss_pred             CCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCccc-----CCccccccCCCcccEEEccCCc
Q 001988          474 GNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLD-----GPISLAIGNLKAVVGIDLSRNN  548 (985)
Q Consensus       474 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~  548 (985)
                      +| ++.+...+|.+ .+|+.+.+ .|.++.+.+.+|.++++|+.+++.+|.+.     .+.+.+|.++++|+.++|. |.
T Consensus       235 ~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~  310 (401)
T 4fdw_A          235 EN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ES  310 (401)
T ss_dssp             TT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TT
T ss_pred             CC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-Cc
Confidence            65 45455667766 67888877 44566677777888888888887777665     4566677778888888887 44


Q ss_pred             cCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccc-ccccccccccccc
Q 001988          549 LSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLS-YLKELNLSFNKLK  622 (985)
Q Consensus       549 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~  622 (985)
                      ++.+...+|.++++|+.++|.+| ++...+.+|.++ +|+.+++++|.+....+..|..++ +++.|++..|.+.
T Consensus       311 i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          311 IRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             CCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             eEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            76666777888888888888555 665566777777 788888888877766666677764 5667776666543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.61  E-value=2.2e-15  Score=152.65  Aligned_cols=125  Identities=26%  Similarity=0.368  Sum_probs=62.1

Q ss_pred             eecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCc
Q 001988          174 HLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNN  253 (985)
Q Consensus       174 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  253 (985)
                      ++++++|.++ .+|..+.  ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus        14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            4444444444 4444332  34555555555555 444555555555555555555554444455555555555555555


Q ss_pred             CcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccC
Q 001988          254 LTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSF  303 (985)
Q Consensus       254 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l  303 (985)
                      |++..|..|.++++|++|+|++|+++ .+|...+..+++|+.|+|++|.+
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~  138 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPL  138 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCE
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccEEEeCCCCe
Confidence            55544445555555555555555554 33333333444444444444444

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.61  E-value=8.1e-16  Score=153.78  Aligned_cols=133  Identities=21%  Similarity=0.302  Sum_probs=74.4

Q ss_pred             CCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccC
Q 001988          467 LNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSR  546 (985)
Q Consensus       467 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~  546 (985)
                      .+.+++++|+++. +|..+.  ++|++|++++|+++++.+..                        +..+++|+.|++++
T Consensus         9 ~~~l~~~~~~l~~-~p~~~~--~~l~~L~l~~n~l~~~~~~~------------------------~~~l~~L~~L~l~~   61 (177)
T 2o6r_A            9 GTEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGV------------------------FDKLTQLTKLSLSQ   61 (177)
T ss_dssp             TTEEECCSSCCSS-CCTTCC--TTCSEEECCSSCCCCCCTTT------------------------TTTCTTCSEEECCS
T ss_pred             CCEEEecCCCCcc-CCCCCC--CCCcEEEeCCCcccEeCHHH------------------------hcCcccccEEECCC
Confidence            4556666666653 232221  45555555555555544444                        44455555555555


Q ss_pred             CccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCCCC
Q 001988          547 NNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIP  626 (985)
Q Consensus       547 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p  626 (985)
                      |+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..+..+++|++|++++|++++.+|
T Consensus        62 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           62 NQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            55554444445555666666666666665555555666666666666666665444445566666666666666665554

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.60  E-value=1.1e-14  Score=164.76  Aligned_cols=265  Identities=14%  Similarity=0.138  Sum_probs=138.3

Q ss_pred             CCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEe
Q 001988          266 STLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFD  345 (985)
Q Consensus       266 ~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  345 (985)
                      ..++.+.+.++ ++ .++...|.. .+|+.+.+..| ++......|.+ .+|+.+.+.. .++.+.+.+|.++++|+.++
T Consensus       113 ~~l~~i~ip~~-i~-~I~~~aF~~-~~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~  186 (401)
T 4fdw_A          113 KGYNEIILPNS-VK-SIPKDAFRN-SQIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKAD  186 (401)
T ss_dssp             SSCSEEECCTT-CC-EECTTTTTT-CCCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred             CCccEEEECCc-cC-EehHhhccc-CCccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeee
Confidence            45566666542 33 455555444 25666666544 44333444444 2455555543 34434444444444444444


Q ss_pred             ccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEcc
Q 001988          346 IFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLG  425 (985)
Q Consensus       346 L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  425 (985)
                      +..|+++.++                             ...|. .. +|+.+.+..+ ++.+...+|.++++|+.+++.
T Consensus       187 l~~n~l~~I~-----------------------------~~aF~-~~-~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~  234 (401)
T 4fdw_A          187 LSKTKITKLP-----------------------------ASTFV-YA-GIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP  234 (401)
T ss_dssp             CTTSCCSEEC-----------------------------TTTTT-TC-CCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred             cCCCcceEec-----------------------------hhhEe-ec-ccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence            4444443332                             22222 12 4455555422 444555666666666666666


Q ss_pred             CCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccc-----cccCCCCcCcCcCceEeeccce
Q 001988          426 GNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKIS-----GSISSCLGNLTSLQYLNLGSNR  500 (985)
Q Consensus       426 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~L~~N~  500 (985)
                      +| ++.+...+|.+ .+|+.+++ .|.++.+.+.+|..+++|+.+++.+|.+.     .+.+.+|.++++|+.+++. |.
T Consensus       235 ~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~  310 (401)
T 4fdw_A          235 EN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ES  310 (401)
T ss_dssp             TT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TT
T ss_pred             CC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-Cc
Confidence            53 44445555655 55666666 33444344455566666666666655543     3445566666666666666 33


Q ss_pred             eeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccc-cceeeeeecceec
Q 001988          501 FTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLK-SLQNISLAYNRLE  574 (985)
Q Consensus       501 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~  574 (985)
                      ++.+...+|.++.+|+.+++..| ++.+...+|.++ +|+.+++++|.+....+..|.+++ .++.|++..+.+.
T Consensus       311 i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          311 IRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             CCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             eEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            55555566666666666666433 444555556555 566666666655544445555553 4555555555443

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.59  E-value=7.3e-17  Score=164.61  Aligned_cols=138  Identities=23%  Similarity=0.294  Sum_probs=87.2

Q ss_pred             cccccccceecccCCcCCCCCCc------ccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHh
Q 001988           93 IANLSSLKSLDLSHNKLSSNIPS------SIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENIC  166 (985)
Q Consensus        93 l~~l~~L~~L~L~~n~l~~~~p~------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~  166 (985)
                      +.....++.++++.+.++|.+|.      .+..+++|++|+|++|++++                         +| . +
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-------------------------l~-~-~   66 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-------------------------IS-S-L   66 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-------------------------CC-C-H
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-------------------------cc-c-c
Confidence            55667788888888888877776      66667777777776666653                         33 1 2


Q ss_pred             hhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCch-hhhcCCCCCC
Q 001988          167 NHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIP-QEIGYLQNLD  245 (985)
Q Consensus       167 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~  245 (985)
                      ..+++|++|++++|.++ .+|..+..+++|++|+|++|++++ +| .++++++|++|++++|++++..+ ..+..+++|+
T Consensus        67 ~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~  143 (198)
T 1ds9_A           67 SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE  143 (198)
T ss_dssp             HHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCS
T ss_pred             ccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCC
Confidence            45566666666666665 455555556666666666666664 44 46666666666666666663222 3566666666


Q ss_pred             EEEecCCcCcccCcc
Q 001988          246 VLQLGFNNLTGVVPA  260 (985)
Q Consensus       246 ~L~Ls~N~l~~~~p~  260 (985)
                      +|++++|.+++.+|.
T Consensus       144 ~L~l~~N~l~~~~~~  158 (198)
T 1ds9_A          144 DLLLAGNPLYNDYKE  158 (198)
T ss_dssp             EEEECSCHHHHHHHT
T ss_pred             EEEecCCcccccccc
Confidence            666666666655443

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.59  E-value=5.2e-15  Score=147.84  Aligned_cols=109  Identities=27%  Similarity=0.291  Sum_probs=45.9

Q ss_pred             CceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEcc
Q 001988          195 QLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLY  274 (985)
Q Consensus       195 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~  274 (985)
                      +|++|++++|++++..+..|+++++|++|++++|++++..+..|+.+++|++|++++|++++..+..+.++++|++|+|+
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  108 (177)
T 2o6r_A           29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALD  108 (177)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECc
Confidence            44444444444443333334444444444444444443333334444444444444444444333334444444444444


Q ss_pred             CCcCcccCChhhhhcCCCCcEEEecCccCC
Q 001988          275 NNSLSGSLPSRIDLALPNLEFLNLGINSFS  304 (985)
Q Consensus       275 ~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~  304 (985)
                      +|+++ .+|...+..+++|++|+|++|.+.
T Consensus       109 ~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~  137 (177)
T 2o6r_A          109 TNQLK-SVPDGIFDRLTSLQKIWLHTNPWD  137 (177)
T ss_dssp             SSCCS-CCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CCcce-EeCHHHhcCCcccCEEEecCCCee
Confidence            44443 233332233333444444444333

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.57  E-value=1.4e-16  Score=162.51  Aligned_cols=155  Identities=21%  Similarity=0.275  Sum_probs=100.4

Q ss_pred             cccccccceecccccccCCchh------hhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccC
Q 001988          438 GGLQKLQGLDLAFNKLAGSIPD------EICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWN  511 (985)
Q Consensus       438 ~~l~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  511 (985)
                      .....++.++++.|.+.+.+|.      .+..+++|++|+|++|++++ +| .+.++++|++|++++|+++. +|..+  
T Consensus        15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~-l~~~~--   89 (198)
T 1ds9_A           15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLD--   89 (198)
T ss_dssp             HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECS-CSSHH--
T ss_pred             HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCccc-ccchh--
Confidence            3445566666666666665554      67777777777777777775 44 66777777777777777763 34333  


Q ss_pred             ccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchh-hhhhcccccCeE
Q 001988          512 LKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIP-ESFGNMTSLESL  590 (985)
Q Consensus       512 l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L  590 (985)
                                            ..+++|+.|+|++|+|++ +| .+..+++|++|++++|++++..+ ..+..+++|++|
T Consensus        90 ----------------------~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L  145 (198)
T 1ds9_A           90 ----------------------AVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDL  145 (198)
T ss_dssp             ----------------------HHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEE
T ss_pred             ----------------------hcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEE
Confidence                                  334555555555555554 23 56677777777777777775332 467777777777


Q ss_pred             ecCCCcccCCCCcc----------ccccccccccccccccccC
Q 001988          591 DLSNNKISGSIPVS----------FEKLSYLKELNLSFNKLKG  623 (985)
Q Consensus       591 ~Ls~N~l~~~~p~~----------~~~l~~L~~L~ls~N~l~~  623 (985)
                      ++++|++++.+|..          +..+++|+.||  +|+++.
T Consensus       146 ~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          146 LLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV  186 (198)
T ss_dssp             EECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred             EecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence            77777777665542          67777777776  666653

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.55  E-value=6.9e-14  Score=158.87  Aligned_cols=68  Identities=9%  Similarity=-0.039  Sum_probs=46.1

Q ss_pred             ccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecC
Q 001988          230 LHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGI  300 (985)
Q Consensus       230 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~  300 (985)
                      ++..-..+|.++.+|+.+.+..+ ++.....+|.++++|+.+++.++ ++ .++...|...++|+.+.+..
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~c~~L~~i~~p~  126 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VK-MIGRCTFSGCYALKSILLPL  126 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCCCCCCT
T ss_pred             EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ce-EccchhhcccccchhhcccC
Confidence            44334456888888888888643 66666777888888888888755 44 56666666666776665543

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.54  E-value=4.7e-15  Score=148.00  Aligned_cols=106  Identities=18%  Similarity=0.181  Sum_probs=72.0

Q ss_pred             ceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhh--hhhcccccCeEe
Q 001988          514 DILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPE--SFGNMTSLESLD  591 (985)
Q Consensus       514 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~  591 (985)
                      +|++|++++|.+++.  ..+..+++|+.|+|++|+|++..|..|..+++|++|+|++|+|+. +|.  .+..+++|+.|+
T Consensus        43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~  119 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLC  119 (176)
T ss_dssp             CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEE
T ss_pred             CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCc-chhhHhhhcCCCCCEEE
Confidence            444444444444443  345666677777777777775555555777788888888888763 554  677888888888


Q ss_pred             cCCCcccCCCCc----cccccccccccccccccccC
Q 001988          592 LSNNKISGSIPV----SFEKLSYLKELNLSFNKLKG  623 (985)
Q Consensus       592 Ls~N~l~~~~p~----~~~~l~~L~~L~ls~N~l~~  623 (985)
                      |++|+++ .+|.    .+..+++|+.||+++|....
T Consensus       120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A          120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            8888887 4455    37788888888888887653

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.53  E-value=2.3e-13  Score=154.52  Aligned_cols=310  Identities=12%  Similarity=0.057  Sum_probs=135.9

Q ss_pred             cccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCC
Q 001988          188 SSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMST  267 (985)
Q Consensus       188 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  267 (985)
                      .+|.++++|+++.|.. .++..-..+|.++++|+.+++.++ ++..-...|.++.+|+.+.+..+ ++.....+|.+...
T Consensus        65 ~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~  141 (394)
T 4fs7_A           65 AAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDF  141 (394)
T ss_dssp             TTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCC
T ss_pred             HHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccc
Confidence            4556666666666653 244333345666666666666543 33233344555555555544433 22233333433322


Q ss_pred             CCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEecc
Q 001988          268 LKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIF  347 (985)
Q Consensus       268 L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  347 (985)
                      ++........   .+..                        ..|.++.+|+.+.+.++. ..+...+|.++.+|+.+++.
T Consensus       142 ~~~~~~~~~~---~i~~------------------------~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~  193 (394)
T 4fs7_A          142 KEITIPEGVT---VIGD------------------------EAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLP  193 (394)
T ss_dssp             SEEECCTTCC---EECT------------------------TTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCC
T ss_pred             cccccCcccc---ccch------------------------hhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcC
Confidence            2211111110   1222                        234444444444444332 22334445555555555554


Q ss_pred             CCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCC
Q 001988          348 FNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGN  427 (985)
Q Consensus       348 ~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  427 (985)
                      .| ++.+..     .++.++..|+.+.+..+...  +.+...... +|+.+.+..+ ++.....+|..+..|+.+.+..+
T Consensus       194 ~~-~~~I~~-----~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~-~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~  263 (394)
T 4fs7_A          194 RN-LKIIRD-----YCFAECILLENMEFPNSLYY--LGDFALSKT-GVKNIIIPDS-FTELGKSVFYGCTDLESISIQNN  263 (394)
T ss_dssp             TT-CCEECT-----TTTTTCTTCCBCCCCTTCCE--ECTTTTTTC-CCCEEEECTT-CCEECSSTTTTCSSCCEEEECCT
T ss_pred             CC-ceEeCc-----hhhccccccceeecCCCceE--eehhhcccC-CCceEEECCC-ceecccccccccccceeEEcCCC
Confidence            33 222221     13455555555554443221  111111111 3444444322 22233445566666666666554


Q ss_pred             CCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCC
Q 001988          428 NLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPS  507 (985)
Q Consensus       428 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  507 (985)
                      ... +...+|..+..++.+....+.+.   ...|..+.+|+.+.+.++ ++.+...+|.++++|+.+++.++ ++.+...
T Consensus       264 ~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~  337 (394)
T 4fs7_A          264 KLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKR  337 (394)
T ss_dssp             TCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTT
T ss_pred             cce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHH
Confidence            332 44455555555555555444322   123444555555555443 33333445555555555555432 4444444


Q ss_pred             CccCccceeEEeecCCcccCCccccccCCCcccEEEcc
Q 001988          508 TFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLS  545 (985)
Q Consensus       508 ~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls  545 (985)
                      +|.++.+|+.+++..| ++.+...+|.++.+|+.+++.
T Consensus       338 aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp  374 (394)
T 4fs7_A          338 SFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELP  374 (394)
T ss_dssp             TTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred             hccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence            4444444444444433 333333344444444444443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.51  E-value=1.7e-14  Score=144.02  Aligned_cols=132  Identities=17%  Similarity=0.177  Sum_probs=63.5

Q ss_pred             cccccccceecccccccCCchhhhhhc-cCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCcccee
Q 001988          438 GGLQKLQGLDLAFNKLAGSIPDEICLL-SRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDIL  516 (985)
Q Consensus       438 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  516 (985)
                      ..+.+|+.|++++|+++. +|. +..+ ++|++|+|++|+|++.  ..+..+++|++|++++|+|+++.+..|..+++|+
T Consensus        16 ~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   91 (176)
T 1a9n_A           16 TNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   91 (176)
T ss_dssp             ECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             CCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence            334444444444444442 222 2222 2566666666666543  4555666666666666666655444445555555


Q ss_pred             EEeecCCcccCCcc-ccccCCCcccEEEccCCccCccCchh----hcccccceeeeeecceec
Q 001988          517 SFDISSNLLDGPIS-LAIGNLKAVVGIDLSRNNLSGNIPTT----LEGLKSLQNISLAYNRLE  574 (985)
Q Consensus       517 ~L~ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~  574 (985)
                      +|++++|+|....+ ..+..+++|+.|++++|.++ .+|..    +..+++|++|++++|.+.
T Consensus        92 ~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           92 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             EEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            55555555543221 13444444555555555544 22322    444444444444444443

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.46  E-value=6e-14  Score=138.92  Aligned_cols=90  Identities=21%  Similarity=0.258  Sum_probs=60.4

Q ss_pred             CcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcccccccccccccc
Q 001988          537 KAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNL  616 (985)
Q Consensus       537 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  616 (985)
                      ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  109 (170)
T 3g39_A           30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL  109 (170)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence            45666666666666666666666666777777777766665666666777777777777776655556667777777777


Q ss_pred             ccccccCCCC
Q 001988          617 SFNKLKGEIP  626 (985)
Q Consensus       617 s~N~l~~~~p  626 (985)
                      ++|++++.++
T Consensus       110 ~~N~~~c~c~  119 (170)
T 3g39_A          110 LNNPWDCACS  119 (170)
T ss_dssp             CSSCBCTTBG
T ss_pred             CCCCCCCCch
Confidence            7777766554

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.43  E-value=3.3e-13  Score=133.58  Aligned_cols=105  Identities=25%  Similarity=0.261  Sum_probs=72.0

Q ss_pred             cceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecC
Q 001988          172 LKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGF  251 (985)
Q Consensus       172 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  251 (985)
                      .+.+++++|.++ .+|..+.  ++|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            456666666666 4665553  6677777777777766666777777777777777777766566667777777777777


Q ss_pred             CcCcccCcccccCCCCCCEEEccCCcCc
Q 001988          252 NNLTGVVPATIFNMSTLKEIFLYNNSLS  279 (985)
Q Consensus       252 N~l~~~~p~~l~~l~~L~~L~L~~N~l~  279 (985)
                      |+|++..+..|.++++|++|+|++|.+.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence            7777666666666777777777777665

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.43  E-value=1.7e-13  Score=136.04  Aligned_cols=90  Identities=23%  Similarity=0.295  Sum_probs=53.5

Q ss_pred             CcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcccccccccccccc
Q 001988          537 KAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNL  616 (985)
Q Consensus       537 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  616 (985)
                      ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L  112 (174)
T 2r9u_A           33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL  112 (174)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence            45555566666665555555666666666666666666544445566666666666666666544444666666666666


Q ss_pred             ccccccCCCC
Q 001988          617 SFNKLKGEIP  626 (985)
Q Consensus       617 s~N~l~~~~p  626 (985)
                      ++|++.+.++
T Consensus       113 ~~N~~~c~~~  122 (174)
T 2r9u_A          113 YNNPWDCECR  122 (174)
T ss_dssp             CSSCBCTTBG
T ss_pred             CCCCcccccc
Confidence            6666665443

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.41  E-value=5.8e-13  Score=132.26  Aligned_cols=104  Identities=24%  Similarity=0.327  Sum_probs=69.2

Q ss_pred             ceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCC
Q 001988          173 KHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFN  252 (985)
Q Consensus       173 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  252 (985)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            45666666664 5666554  66777777777777666666777777777777777777555555667777777777777


Q ss_pred             cCcccCcccccCCCCCCEEEccCCcCc
Q 001988          253 NLTGVVPATIFNMSTLKEIFLYNNSLS  279 (985)
Q Consensus       253 ~l~~~~p~~l~~l~~L~~L~L~~N~l~  279 (985)
                      +|++..+..|..+++|++|+|++|.+.
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcc
Confidence            777555555666666666666666665

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.35  E-value=2.5e-11  Score=137.65  Aligned_cols=110  Identities=14%  Similarity=0.119  Sum_probs=62.7

Q ss_pred             CcccCCCC-CceEEEcccccCCCccccccccccccceEeecccc---ccCCchhhhcCCCCCCEEEecCCcCcccCcccc
Q 001988          187 PSSLSKCK-QLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNK---LHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATI  262 (985)
Q Consensus       187 p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l  262 (985)
                      ..+|.+++ .|+.+.+..+ ++..-..+|.++++|+.+.+.+|.   ++..-...|..+.+|+.+.+..+ ++.....+|
T Consensus        56 ~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF  133 (394)
T 4gt6_A           56 DRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAF  133 (394)
T ss_dssp             TTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTT
T ss_pred             HhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhh
Confidence            34566663 4777777643 554445567777777777777654   44333455666666666655443 343445556


Q ss_pred             cCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecC
Q 001988          263 FNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGI  300 (985)
Q Consensus       263 ~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~  300 (985)
                      .++.+|+.+.+..+- . .++...+....+|+.+.+..
T Consensus       134 ~~c~~L~~i~lp~~~-~-~I~~~~F~~c~~L~~i~~~~  169 (394)
T 4gt6_A          134 HHCEELDTVTIPEGV-T-SVADGMFSYCYSLHTVTLPD  169 (394)
T ss_dssp             TTCTTCCEEECCTTC-C-EECTTTTTTCTTCCEEECCT
T ss_pred             hhhccccccccccee-e-eecccceecccccccccccc
Confidence            666666666665332 2 34444444555555555543

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.32  E-value=4.6e-14  Score=158.07  Aligned_cols=165  Identities=21%  Similarity=0.253  Sum_probs=84.6

Q ss_pred             CCCccEEEccCCCCCCCCCcccccc-----ccccceecccccccCCchhhh-hhccCCCeEEccCCccccccCCCC----
Q 001988          416 LSNLIVLSLGGNNLSGSIPVTFGGL-----QKLQGLDLAFNKLAGSIPDEI-CLLSRLNELDLNGNKISGSISSCL----  485 (985)
Q Consensus       416 l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~~~~~----  485 (985)
                      ++.|++|+|++|.|+......+...     ++|+.|+|++|.+.......+ ..+++|+.|+|++|+|++.....+    
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            3567777787777765433333322     567777777777653322222 234566666666666654322222    


Q ss_pred             -cCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCcc----Cchhhccc
Q 001988          486 -GNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGN----IPTTLEGL  560 (985)
Q Consensus       486 -~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l  560 (985)
                       ...++|++|+|++|.|+.....                    .++..+...++|+.|+|++|.|++.    ++..+...
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~--------------------~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~  210 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVA--------------------VLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRN  210 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHH--------------------HHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGC
T ss_pred             HhcCCccceeeCCCCCCChHHHH--------------------HHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcC
Confidence             1234455555555544321111                    1111223444555555555555432    23444555


Q ss_pred             ccceeeeeecceeccc----hhhhhhcccccCeEecCCCcccCC
Q 001988          561 KSLQNISLAYNRLEGP----IPESFGNMTSLESLDLSNNKISGS  600 (985)
Q Consensus       561 ~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~  600 (985)
                      ++|++|+|++|.|+..    ++..+...++|++|||++|.|++.
T Consensus       211 ~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~  254 (372)
T 3un9_A          211 RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE  254 (372)
T ss_dssp             SCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred             CCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence            5666666666666542    333444556677777777766543

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.32  E-value=9.5e-14  Score=155.51  Aligned_cols=92  Identities=20%  Similarity=0.197  Sum_probs=48.5

Q ss_pred             cccceEeeccccccC----CchhhhcCCCCCCEEEecCCcCccc----CcccccCCCCCCEEEccCCcCcccCChhhh--
Q 001988          218 TVLQRISLINNKLHG----EIPQEIGYLQNLDVLQLGFNNLTGV----VPATIFNMSTLKEIFLYNNSLSGSLPSRID--  287 (985)
Q Consensus       218 ~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~--  287 (985)
                      ++|++|+|++|.|+.    .++..+..+++|++|+|++|.|+..    ++..+...++|++|+|++|.|++.....+.  
T Consensus       155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~  234 (372)
T 3un9_A          155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA  234 (372)
T ss_dssp             CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred             CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence            345555555555442    2333445556666666666666532    244455556666666666666532222211  


Q ss_pred             -hcCCCCcEEEecCccCCCcCCc
Q 001988          288 -LALPNLEFLNLGINSFSGTIPS  309 (985)
Q Consensus       288 -~~l~~L~~L~Ls~N~l~~~~p~  309 (985)
                       ...++|++|+|++|.|++....
T Consensus       235 L~~~~~L~~L~Ls~N~i~~~g~~  257 (372)
T 3un9_A          235 AREHPSLELLHLYFNELSSEGRQ  257 (372)
T ss_dssp             HHHCSSCCEEECTTSSCCHHHHH
T ss_pred             HHhCCCCCEEeccCCCCCHHHHH
Confidence             2346677777777776654333

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.29  E-value=1.5e-10  Score=131.18  Aligned_cols=335  Identities=13%  Similarity=0.144  Sum_probs=175.1

Q ss_pred             CCChhHhhhc-cccceecccCccccccCCcccCCCCCceEEEccccc---CCCccccccccccccceEeeccccccCCch
Q 001988          160 KLPENICNHL-RYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNN---LSGAIPKEIGNLTVLQRISLINNKLHGEIP  235 (985)
Q Consensus       160 ~lp~~~~~~l-~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~---l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  235 (985)
                      .|++.-|.+. ..|+.+.+..+ ++..-..+|.++++|+.+.++.|.   ++..-..+|.++.+|+.+.+.++ ++....
T Consensus        53 ~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~  130 (394)
T 4gt6_A           53 KIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDS  130 (394)
T ss_dssp             EECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECT
T ss_pred             EcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehh
Confidence            4555555555 35888888754 664556789999999999998874   55444567888899998888765 443445


Q ss_pred             hhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCC
Q 001988          236 QEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNAS  315 (985)
Q Consensus       236 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  315 (985)
                      ..|..+.+|+.+.+..+ ++......|..+..|+.+.+.++ ++ .+....|. ..+|+.+.+..+-.. .....+.++.
T Consensus       131 ~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~-~I~~~aF~-~~~l~~i~ip~~~~~-i~~~af~~c~  205 (394)
T 4gt6_A          131 EAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VT-AIEERAFT-GTALTQIHIPAKVTR-IGTNAFSECF  205 (394)
T ss_dssp             TTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTT-TCCCSEEEECTTCCE-ECTTTTTTCT
T ss_pred             hhhhhhcccccccccce-eeeecccceecccccccccccce-ee-Eecccccc-ccceeEEEECCcccc-cccchhhhcc
Confidence            67888999999999755 44466778888999999998765 33 44544443 245666655433211 2223333333


Q ss_pred             CccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcc
Q 001988          316 KLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSL  395 (985)
Q Consensus       316 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L  395 (985)
                      ++......                        .+.........     +........-....       |..     ..+
T Consensus       206 ~l~~~~~~------------------------~~~~~~~~~~~-----~~~~~~~~~~~~~~-------~~~-----~~~  244 (394)
T 4gt6_A          206 ALSTITSD------------------------SESYPAIDNVL-----YEKSANGDYALIRY-------PSQ-----RED  244 (394)
T ss_dssp             TCCEEEEC------------------------CSSSCBSSSCE-----EEECTTSCEEEEEC-------CTT-----CCC
T ss_pred             ccceeccc------------------------cccccccccee-----eccccccccccccc-------ccc-----ccc
Confidence            33333332                        22221111000     00000000000000       000     001


Q ss_pred             cceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCC
Q 001988          396 ERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGN  475 (985)
Q Consensus       396 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  475 (985)
                      ..+.+. +.+..+...+|.+++.|+.+.+.++... +...+|.++.+|                        +.+.+. +
T Consensus       245 ~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L------------------------~~i~l~-~  297 (394)
T 4gt6_A          245 PAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPAL------------------------QDIEFS-S  297 (394)
T ss_dssp             SEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTC------------------------CEEECC-T
T ss_pred             ceEEcC-CcceEcccceeeecccccEEecccccce-ecCccccccccc------------------------ccccCC-C
Confidence            111111 1122233445555555555555433222 333444444444                        444443 2


Q ss_pred             ccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCch
Q 001988          476 KISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPT  555 (985)
Q Consensus       476 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  555 (985)
                      .++.+...+|.++++|+.+++..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|.++.+|+.+++.+|....   .
T Consensus       298 ~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~  372 (394)
T 4gt6_A          298 RITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---N  372 (394)
T ss_dssp             TCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---H
T ss_pred             cccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---h
Confidence            233344445566666666666543 45555566666666666666433 555556667777777777777765431   3


Q ss_pred             hhcccccceeeeeecceec
Q 001988          556 TLEGLKSLQNISLAYNRLE  574 (985)
Q Consensus       556 ~~~~l~~L~~L~Ls~N~l~  574 (985)
                      .+....+|+.+.+..|.+.
T Consensus       373 ~~~~~~~L~~i~i~~~~~~  391 (394)
T 4gt6_A          373 AISTDSGLQNLPVAPGSID  391 (394)
T ss_dssp             TCBCCCCC-----------
T ss_pred             hhhccCCCCEEEeCCCCEE
Confidence            5566677777777666543

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.26  E-value=5.9e-12  Score=140.37  Aligned_cols=103  Identities=22%  Similarity=0.329  Sum_probs=78.6

Q ss_pred             eecccCc-cccccCCcccCCCCCceEEEccc-ccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecC
Q 001988          174 HLFLREN-MFYGKIPSSLSKCKQLQELHLGY-NNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGF  251 (985)
Q Consensus       174 ~L~L~~n-~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  251 (985)
                      .++++++ +++ .+|. |..+++|++|+|++ |+|++..|..|+++++|++|+|++|+|++..|..|++|++|++|+|++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4566666 676 5777 88888888888885 888876667788888888888888888877777888888888888888


Q ss_pred             CcCcccCcccccCCCCCCEEEccCCcCc
Q 001988          252 NNLTGVVPATIFNMSTLKEIFLYNNSLS  279 (985)
Q Consensus       252 N~l~~~~p~~l~~l~~L~~L~L~~N~l~  279 (985)
                      |+|++..+..+..++ |+.|+|++|.+.
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            888865555555554 888888888776

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.22  E-value=1e-11  Score=138.32  Aligned_cols=104  Identities=15%  Similarity=0.179  Sum_probs=67.3

Q ss_pred             eEeeccc-eeeeecCCCccCccceeEEeecC-CcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeec
Q 001988          493 YLNLGSN-RFTFVIPSTFWNLKDILSFDISS-NLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAY  570 (985)
Q Consensus       493 ~L~L~~N-~l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  570 (985)
                      .++++++ +++. +|. +..+++|+.|+|++ |+|+++.+..|.++++|+.|+|++|+|++..|..|.+|++|++|+|++
T Consensus        12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4566666 6664 455 66666677777764 666666666666666666666666666666666666666666666666


Q ss_pred             ceeccchhhhhhcccccCeEecCCCcccC
Q 001988          571 NRLEGPIPESFGNMTSLESLDLSNNKISG  599 (985)
Q Consensus       571 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  599 (985)
                      |+|++..+..|..++ |+.|+|++|.+..
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCccC
Confidence            666655555555544 6666666666653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.21  E-value=3.1e-11  Score=128.75  Aligned_cols=147  Identities=14%  Similarity=0.125  Sum_probs=115.2

Q ss_pred             HHHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceEEE
Q 001988          722 LRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       722 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv  800 (985)
                      ....+.|......+.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++...+..|+|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            344567877788888889999999865 6889999987532233346889999999984 67788999999888899999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG--------------------------------------  842 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~--------------------------------------  842 (985)
                      |||++|.++.+....      ......++.+++++++.||..                                      
T Consensus        89 ~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           89 MSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999999999876321      122346888999999999861                                      


Q ss_pred             ------------------CCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          843 ------------------HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       843 ------------------h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                                        +...++|+|++|.||+++++..+.|+||+.+..
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                              115589999999999998766677999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.11  E-value=1.4e-10  Score=123.39  Aligned_cols=137  Identities=13%  Similarity=0.113  Sum_probs=101.1

Q ss_pred             CccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCC--eeeEEeeeecCCceEEEEecc
Q 001988          727 NFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRN--LVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~~~~~~~~~lv~e~~  804 (985)
                      ++......+.|..+.||++...+|+.+++|.....   ....+.+|+++++.+.+.+  +.+++++...++..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            34433333456669999998877888999997644   2345788999999986444  556888888888889999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH-----------------------------------------  843 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h-----------------------------------------  843 (985)
                      +|.++.  ...    .+   ...++.++++.+..||...                                         
T Consensus        98 ~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           98 PGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             SSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            998884  211    11   2357788888888885321                                         


Q ss_pred             --------------CCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          844 --------------STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       844 --------------~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                                    ...++|+|++|.||++++++.+.|+|||.+..
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                          12399999999999998877778999998764

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.02  E-value=1.2e-08  Score=114.88  Aligned_cols=83  Identities=5%  Similarity=0.010  Sum_probs=48.4

Q ss_pred             cccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCC
Q 001988          212 KEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALP  291 (985)
Q Consensus       212 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~  291 (985)
                      +++....+|+.+.+.. .++..-..+|.++.+|+.++|..+ ++.....+|.++ +|+.+.+..+ +. .++...|.. .
T Consensus        40 ~~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~-~I~~~aF~~-~  113 (379)
T 4h09_A           40 PWYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VK-KFGDYVFQG-T  113 (379)
T ss_dssp             TTGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CC-EECTTTTTT-C
T ss_pred             cccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-ee-Eeccceecc-C
Confidence            3456667788877764 355344556788888888888644 554555666555 5666666543 33 344444422 3


Q ss_pred             CCcEEEecC
Q 001988          292 NLEFLNLGI  300 (985)
Q Consensus       292 ~L~~L~Ls~  300 (985)
                      +|+.+.+..
T Consensus       114 ~L~~i~lp~  122 (379)
T 4h09_A          114 DLDDFEFPG  122 (379)
T ss_dssp             CCSEEECCT
T ss_pred             CcccccCCC
Confidence            555555543

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.01  E-value=1.1e-08  Score=115.26  Aligned_cols=83  Identities=4%  Similarity=-0.008  Sum_probs=56.4

Q ss_pred             ccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCC
Q 001988          189 SLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTL  268 (985)
Q Consensus       189 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L  268 (985)
                      ++....+|+.+.+.. .++..-..+|.++.+|+.+.|.++ ++..-..+|.+. +|+.+.+..+ ++.....+|.+ .+|
T Consensus        41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L  115 (379)
T 4h09_A           41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDL  115 (379)
T ss_dssp             TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCC
T ss_pred             ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCc
Confidence            455667788888864 466444557889999999999754 664445667776 6777777644 55344444544 589


Q ss_pred             CEEEccCC
Q 001988          269 KEIFLYNN  276 (985)
Q Consensus       269 ~~L~L~~N  276 (985)
                      +.+.+.++
T Consensus       116 ~~i~lp~~  123 (379)
T 4h09_A          116 DDFEFPGA  123 (379)
T ss_dssp             SEEECCTT
T ss_pred             ccccCCCc
Confidence            99988765

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=99.00  E-value=1.1e-11  Score=130.14  Aligned_cols=50  Identities=12%  Similarity=0.147  Sum_probs=31.8

Q ss_pred             CcceeeeEEEeCCCCeEEEEEecC---CcccccCch-hcccccccceecccCCcCC
Q 001988           59 SICSWIGIICDVNSHKVTTLNLSS---FNLQGTIPP-EIANLSSLKSLDLSHNKLS  110 (985)
Q Consensus        59 ~~c~w~gv~c~~~~~~v~~l~L~~---~~l~g~~~~-~l~~l~~L~~L~L~~n~l~  110 (985)
                      ..|+|.|+.|+....+|+.+-..+   ..++|.+++ .+..++.  .|....|.-+
T Consensus        76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~  129 (267)
T 3rw6_A           76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQ  129 (267)
T ss_dssp             HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTT
T ss_pred             HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhc
Confidence            358999999998777888777766   455566653 3444443  3444444444

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.97  E-value=1.8e-10  Score=127.75  Aligned_cols=202  Identities=13%  Similarity=0.199  Sum_probs=107.6

Q ss_pred             CCeEEEEEecCCcccc-c-------CchhcccccccceecccCCcCC---------CCCCcccccCCCCcEEEccCcc-c
Q 001988           72 SHKVTTLNLSSFNLQG-T-------IPPEIANLSSLKSLDLSHNKLS---------SNIPSSIFTMSTLKVLYLMDNQ-L  133 (985)
Q Consensus        72 ~~~v~~l~L~~~~l~g-~-------~~~~l~~l~~L~~L~L~~n~l~---------~~~p~~~~~l~~L~~L~Ls~n~-l  133 (985)
                      ..+|+.|.+...++.| .       +..++..+++|+.|.+..+...         +.++..+..+++|+.|+|++|. +
T Consensus       106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l  185 (362)
T 2ra8_A          106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL  185 (362)
T ss_dssp             GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred             chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence            3467777777665553 2       2344667788888888765431         2244445567778888887762 2


Q ss_pred             CCCCccccccCCccceeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEccc--ccCCCc--
Q 001988          134 SGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGY--NNLSGA--  209 (985)
Q Consensus       134 ~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~--N~l~~~--  209 (985)
                      .  ++. + ..++|+.|+|+.+.+.......+..                       ..+++|++|+|+.  |...+.  
T Consensus       186 ~--l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~-----------------------~~lp~L~~L~L~~~~~~~~~~~~  238 (362)
T 2ra8_A          186 S--IGK-K-PRPNLKSLEIISGGLPDSVVEDILG-----------------------SDLPNLEKLVLYVGVEDYGFDGD  238 (362)
T ss_dssp             B--CCS-C-BCTTCSEEEEECSBCCHHHHHHHHH-----------------------SBCTTCCEEEEECBCGGGTCCSC
T ss_pred             e--ecc-c-cCCCCcEEEEecCCCChHHHHHHHH-----------------------ccCCCCcEEEEeccccccccchh
Confidence            1  111 1 2445555555554443221112211                       1344555555432  111110  


Q ss_pred             ---ccccc--ccccccceEeeccccccCCchhhhc---CCCCCCEEEecCCcCccc----CcccccCCCCCCEEEccCCc
Q 001988          210 ---IPKEI--GNLTVLQRISLINNKLHGEIPQEIG---YLQNLDVLQLGFNNLTGV----VPATIFNMSTLKEIFLYNNS  277 (985)
Q Consensus       210 ---~p~~~--~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~  277 (985)
                         +...+  ..+++|++|+|.+|.+....+..+.   .+++|++|+|+.|.+++.    ++..+.++++|+.|+|++|.
T Consensus       239 ~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~  318 (362)
T 2ra8_A          239 MNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNY  318 (362)
T ss_dssp             GGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBB
T ss_pred             HHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCc
Confidence               00111  2356677777777666544433333   466777888877777753    33444556778888888887


Q ss_pred             CcccCChhhhhcCCCCcEEEecCcc
Q 001988          278 LSGSLPSRIDLALPNLEFLNLGINS  302 (985)
Q Consensus       278 l~~~~p~~~~~~l~~L~~L~Ls~N~  302 (985)
                      ++...-..+...+  ...++++.|+
T Consensus       319 i~d~~~~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          319 LSDEMKKELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             CCHHHHHHHHHHC--CSEEECCSBC
T ss_pred             CCHHHHHHHHHHc--CCEEEecCCc
Confidence            7643333332222  3557777776

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.93  E-value=5.7e-10  Score=123.69  Aligned_cols=158  Identities=12%  Similarity=0.171  Sum_probs=93.2

Q ss_pred             chhhhhhccCCCeEEccCCc-cccccCCCCcCcCcCceEeeccceeeeecCCCcc--CccceeEEeecC--CcccCC---
Q 001988          457 IPDEICLLSRLNELDLNGNK-ISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFW--NLKDILSFDISS--NLLDGP---  528 (985)
Q Consensus       457 ~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~ls~--N~l~~~---  528 (985)
                      ++..+..+++|+.|+|++|. +.  ++. +. +++|+.|+|..+.++......+.  .+++|+.|+|+.  |...+.   
T Consensus       164 L~~ll~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~  239 (362)
T 2ra8_A          164 LSPVLDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDM  239 (362)
T ss_dssp             CHHHHHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCG
T ss_pred             HHHHHhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhH
Confidence            44555666777777777763 21  222 32 67777888777776543222232  567777777753  221111   


Q ss_pred             --ccccc--cCCCcccEEEccCCccCccCchhhc---ccccceeeeeecceeccc----hhhhhhcccccCeEecCCCcc
Q 001988          529 --ISLAI--GNLKAVVGIDLSRNNLSGNIPTTLE---GLKSLQNISLAYNRLEGP----IPESFGNMTSLESLDLSNNKI  597 (985)
Q Consensus       529 --~~~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l  597 (985)
                        +...+  ..+++|+.|+|++|.+.+..+..+.   .+++|++|+|+.|.|++.    ++..+..+++|+.|+|++|.|
T Consensus       240 ~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i  319 (362)
T 2ra8_A          240 NVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL  319 (362)
T ss_dssp             GGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred             HHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence              00112  2467888888888887654444443   467888888888888763    344445678888888888877


Q ss_pred             cCCCCccccc-ccccccccccccc
Q 001988          598 SGSIPVSFEK-LSYLKELNLSFNK  620 (985)
Q Consensus       598 ~~~~p~~~~~-l~~L~~L~ls~N~  620 (985)
                      +...-..+.. +  .-.+++++|+
T Consensus       320 ~d~~~~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          320 SDEMKKELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             CHHHHHHHHHHC--CSEEECCSBC
T ss_pred             CHHHHHHHHHHc--CCEEEecCCc
Confidence            6432222222 1  2456777776

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.89  E-value=3.8e-09  Score=118.03  Aligned_cols=141  Identities=14%  Similarity=0.198  Sum_probs=106.9

Q ss_pred             CceeeccCceeEEEEEEcCCcEEEEEEec--cCC-cchHHHHHHHHHHHHhcC--CCCeeeEEeeeecC---CceEEEEe
Q 001988          731 NNIIGIGGFGSVYRARLEDGVEIAIKVFH--PQC-ASTLKSFEAECEVIKNIR--HRNLVKIISSCSND---DFKALVLE  802 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~~~~vAvK~~~--~~~-~~~~~~~~~E~~il~~l~--h~niv~l~~~~~~~---~~~~lv~e  802 (985)
                      .+.++.|.++.||++...+ ..+++|+..  ... ......+.+|.++++.+.  +..+++++.++.+.   +..|+|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            4678999999999998764 678888775  332 122456789999999996  45688899998776   45899999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH---------------------------------------  843 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h---------------------------------------  843 (985)
                      |++|..+.+...   ..++...+..++.+++++|+.||...                                       
T Consensus       122 ~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          122 FVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             CCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             ecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            999987754221   23677888899999999999998520                                       


Q ss_pred             ----------------CCCeEeCCCCCCCEEEcCCCc--EEEecccCcee
Q 001988          844 ----------------STPIIHCDLKPSNVLLDEDMV--AHLSDFGMAKL  875 (985)
Q Consensus       844 ----------------~~~ivHrDlk~~Nill~~~~~--~kl~DfGla~~  875 (985)
                                      ...++|||+++.||+++.++.  +.|+||+.+..
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                            357999999999999997753  68999999875

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.56  E-value=8.7e-09  Score=108.14  Aligned_cols=105  Identities=25%  Similarity=0.318  Sum_probs=63.5

Q ss_pred             cCCCCCceE--EEcccccCCCcccc----ccccccccceEeeccccccC--CchhhhcCCCCCCEEEecCCcCcccCccc
Q 001988          190 LSKCKQLQE--LHLGYNNLSGAIPK----EIGNLTVLQRISLINNKLHG--EIPQEIGYLQNLDVLQLGFNNLTGVVPAT  261 (985)
Q Consensus       190 l~~l~~L~~--L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  261 (985)
                      |...+.|+.  ++++.|+.. .++.    ...++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..
T Consensus       137 l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~  213 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RE  213 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GG
T ss_pred             cCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hh
Confidence            444445554  566666433 2222    22456677777777777776  4456667777777777777777754  22


Q ss_pred             ccCCC--CCCEEEccCCcCcccCCh------hhhhcCCCCcEEE
Q 001988          262 IFNMS--TLKEIFLYNNSLSGSLPS------RIDLALPNLEFLN  297 (985)
Q Consensus       262 l~~l~--~L~~L~L~~N~l~~~~p~------~~~~~l~~L~~L~  297 (985)
                      +..+.  +|++|+|++|.+.+.+|.      .+...+|+|+.||
T Consensus       214 l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          214 LDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             GGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             hhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            33333  777777777777766652      2345667776664

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.45  E-value=6.6e-07  Score=97.21  Aligned_cols=136  Identities=18%  Similarity=0.211  Sum_probs=100.0

Q ss_pred             CceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-CCC--eeeEEeeeecCC---ceEEEEecc
Q 001988          731 NNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRN--LVKIISSCSNDD---FKALVLEYM  804 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  804 (985)
                      .+.++.|.+..||++.    ..+++|+-...  .....+.+|.++++.+. +..  +.+++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999864    45889985432  34567899999999883 332  445555544333   358999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG------------------------------------------  842 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~------------------------------------------  842 (985)
                      +|.++.+....   .++..++..++.++++.++.||..                                          
T Consensus        99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99888754332   356777778888888888888741                                          


Q ss_pred             -------------CCCCeEeCCCCCCCEEEcC--CCcEEEecccCcee
Q 001988          843 -------------HSTPIIHCDLKPSNVLLDE--DMVAHLSDFGMAKL  875 (985)
Q Consensus       843 -------------h~~~ivHrDlk~~Nill~~--~~~~kl~DfGla~~  875 (985)
                                   ....++|+|++|.||++++  ...+.|+||+.+..
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence                         1245899999999999998  56688999998875

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.40  E-value=6e-08  Score=96.85  Aligned_cols=66  Identities=14%  Similarity=0.116  Sum_probs=30.4

Q ss_pred             cCCCCCCEEEecCCcCccc----CcccccCCCCCCEEEc--cCCcCcccCChhh---hhcCCCCcEEEecCccCC
Q 001988          239 GYLQNLDVLQLGFNNLTGV----VPATIFNMSTLKEIFL--YNNSLSGSLPSRI---DLALPNLEFLNLGINSFS  304 (985)
Q Consensus       239 ~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L--~~N~l~~~~p~~~---~~~l~~L~~L~Ls~N~l~  304 (985)
                      ...++|++|+|++|.|+..    +...+...++|++|+|  ++|.+.......+   ....++|++|+|++|.+.
T Consensus        90 ~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A           90 KVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            3334455555555555432    2334444455555555  4455543211111   123355666666666554

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.38  E-value=2.6e-06  Score=92.40  Aligned_cols=136  Identities=14%  Similarity=0.114  Sum_probs=95.8

Q ss_pred             CceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCC---CeeeEEeeee-cCCceEEEEeccCC
Q 001988          731 NNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHR---NLVKIISSCS-NDDFKALVLEYMSN  806 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  806 (985)
                      .+.++.|....||+.    +..+++|+-.  .......+.+|.++++.+.+.   .+.+++.++. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356888999999998    5678888742  223456789999999999642   3566777764 45667899999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG--------------------------------------------  842 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~--------------------------------------------  842 (985)
                      .++.+....   .++..++..++.++++.|+.||..                                            
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            887663221   234444555555555555555531                                            


Q ss_pred             -------------CCCCeEeCCCCCCCEEEcC---CCc-EEEecccCcee
Q 001988          843 -------------HSTPIIHCDLKPSNVLLDE---DMV-AHLSDFGMAKL  875 (985)
Q Consensus       843 -------------h~~~ivHrDlk~~Nill~~---~~~-~kl~DfGla~~  875 (985)
                                   ....++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         3345799999999999987   455 58999998765

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.36  E-value=1.1e-07  Score=94.88  Aligned_cols=112  Identities=10%  Similarity=0.046  Sum_probs=55.7

Q ss_pred             hccccceecccCc-ccccc----CCcccCCCCCceEEEcccccCCCc----cccccccccccceEeeccccccCC----c
Q 001988          168 HLRYLKHLFLREN-MFYGK----IPSSLSKCKQLQELHLGYNNLSGA----IPKEIGNLTVLQRISLINNKLHGE----I  234 (985)
Q Consensus       168 ~l~~L~~L~L~~n-~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~  234 (985)
                      ..++|++|+|++| .+...    +...+...++|++|+|++|.|...    +...+...++|++|+|++|.|...    +
T Consensus        34 ~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l  113 (185)
T 1io0_A           34 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL  113 (185)
T ss_dssp             TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred             cCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHH
Confidence            3455666666665 55421    233444455566666666655432    122233334555666666655432    2


Q ss_pred             hhhhcCCCCCCEEEe--cCCcCccc----CcccccCCCCCCEEEccCCcCc
Q 001988          235 PQEIGYLQNLDVLQL--GFNNLTGV----VPATIFNMSTLKEIFLYNNSLS  279 (985)
Q Consensus       235 p~~~~~l~~L~~L~L--s~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~  279 (985)
                      .+.+...++|++|+|  ++|.|+..    +...+...++|++|+|++|.+.
T Consensus       114 ~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          114 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            344445555666666  55555532    2233344455666666655553

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.31  E-value=4.2e-06  Score=89.07  Aligned_cols=135  Identities=19%  Similarity=0.143  Sum_probs=98.1

Q ss_pred             eeeccCce-eEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceEEEEeccCCCCh
Q 001988          733 IIGIGGFG-SVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALVLEYMSNGSL  809 (985)
Q Consensus       733 ~ig~G~~g-~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL  809 (985)
                      .+..|..| .||+.... ++..+++|+-...   ....+.+|.++++.+. +--+.++++++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556665 59998765 5677999986532   3456788999999884 33477889999998999999999999887


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 001988          810 EDCLHSSNCALNIFCRLNIMIDIASALEYLHFG-----------------------------------------------  842 (985)
Q Consensus       810 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~-----------------------------------------------  842 (985)
                      .+.....     ......++.++++.|..||..                                               
T Consensus       108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            7654432     122334566666666666631                                               


Q ss_pred             --------CCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          843 --------HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       843 --------h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                              +...++|+|+.+.||++++++.+-|+||+.+..
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                    122378999999999999887778999998765

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.19  E-value=2.9e-06  Score=94.39  Aligned_cols=79  Identities=8%  Similarity=0.015  Sum_probs=56.5

Q ss_pred             cee-eccCceeEEEEEEc-------CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcC-C--CCeeeEEeeeecC---
Q 001988          732 NII-GIGGFGSVYRARLE-------DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIR-H--RNLVKIISSCSND---  794 (985)
Q Consensus       732 ~~i-g~G~~g~V~~~~~~-------~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~-h--~niv~l~~~~~~~---  794 (985)
                      +.| +.|..+.+|+....       +++.+++|+.....   ......+.+|+++++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 78889999998764       26789999765432   111245788999998884 2  3577888887665   


Q ss_pred             CceEEEEeccCCCChH
Q 001988          795 DFKALVLEYMSNGSLE  810 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~  810 (985)
                      +..++||||++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            4568999999987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.97  E-value=2.9e-05  Score=87.58  Aligned_cols=75  Identities=17%  Similarity=0.192  Sum_probs=50.3

Q ss_pred             CceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-------chHHHHHHHHHHHHhcCC--C-CeeeEEeeeecCCceEE
Q 001988          731 NNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-------STLKSFEAECEVIKNIRH--R-NLVKIISSCSNDDFKAL  799 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-------~~~~~~~~E~~il~~l~h--~-niv~l~~~~~~~~~~~l  799 (985)
                      .+.+|.|..+.||++... +++.|+||...+...       .....+..|.++++.+..  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457899999999999754 568899998654321       123456789999988742  3 34456654  3445689


Q ss_pred             EEeccCCC
Q 001988          800 VLEYMSNG  807 (985)
Q Consensus       800 v~e~~~~g  807 (985)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.92  E-value=4.1e-05  Score=84.40  Aligned_cols=139  Identities=16%  Similarity=0.192  Sum_probs=81.4

Q ss_pred             ceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCC--CCeeeEEe------eeecCCceEEEEec
Q 001988          732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRH--RNLVKIIS------SCSNDDFKALVLEY  803 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h--~niv~l~~------~~~~~~~~~lv~e~  803 (985)
                      +.|+.|..+.||++...+| .+++|+....    ...+..|.++++.+..  -.+.+++.      +....+..++||||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3466677899999988655 5899998752    2344556666665531  12334443      11345677899999


Q ss_pred             cCCCChH--------------HHhhcC--CC-----------CCCHHHHH------------------------------
Q 001988          804 MSNGSLE--------------DCLHSS--NC-----------ALNIFCRL------------------------------  826 (985)
Q Consensus       804 ~~~gsL~--------------~~l~~~--~~-----------~~~~~~~~------------------------------  826 (985)
                      ++|.++.              ..+|..  ..           ...|....                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              112211  00           01222110                              


Q ss_pred             -HHHHHHHHHHHHHHh----------cCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          827 -NIMIDIASALEYLHF----------GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       827 -~i~~~i~~~L~~Lh~----------~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                       .+...+..++++++.          .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             011123345666642          1367899999999999998888999999998764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.75  E-value=1.9e-05  Score=76.63  Aligned_cols=84  Identities=12%  Similarity=0.146  Sum_probs=59.8

Q ss_pred             CCceEEEcccccCCCccccccccccccceEeecccc-ccCCchhhhcCC----CCCCEEEecCCc-CcccCcccccCCCC
Q 001988          194 KQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNK-LHGEIPQEIGYL----QNLDVLQLGFNN-LTGVVPATIFNMST  267 (985)
Q Consensus       194 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~l~~l~~  267 (985)
                      .+|++|||+++.++..--..+.++++|++|+|++|. ++..--..++.+    ++|++|+|++|. |+..--..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            468888888888876655667778888888888875 664444456654    368888888874 77655556667777


Q ss_pred             CCEEEccCCc
Q 001988          268 LKEIFLYNNS  277 (985)
Q Consensus       268 L~~L~L~~N~  277 (985)
                      |++|+|+++.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            8888887774

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.68  E-value=0.00025  Score=76.40  Aligned_cols=136  Identities=14%  Similarity=0.133  Sum_probs=92.1

Q ss_pred             CceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcC---CCCeeeEEeeeecCCceEEEEeccCCC
Q 001988          731 NNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR---HRNLVKIISSCSNDDFKALVLEYMSNG  807 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  807 (985)
                      .+.|+.|....+|+... ++..+++|+....   ....+..|.+.|+.+.   ...+++++.++...+..++||||++|.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            35689999999999986 4678899987533   3467889999998883   366888999888888899999999987


Q ss_pred             ChHH-----------HhhcCCC---------------------CCCHHHHH---HHHHH----------------HHHH-
Q 001988          808 SLED-----------CLHSSNC---------------------ALNIFCRL---NIMID----------------IASA-  835 (985)
Q Consensus       808 sL~~-----------~l~~~~~---------------------~~~~~~~~---~i~~~----------------i~~~-  835 (985)
                      .+..           .++....                     .-+|....   ++..+                +.+. 
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6421           1222111                     01454321   11111                1111 


Q ss_pred             HHHHHh-cCCCCeEeCCCCCCCEEEcCCCcEEEeccc
Q 001988          836 LEYLHF-GHSTPIIHCDLKPSNVLLDEDMVAHLSDFG  871 (985)
Q Consensus       836 L~~Lh~-~h~~~ivHrDlk~~Nill~~~~~~kl~DfG  871 (985)
                      ...|.. .....++|+|+.+.|++++.++ +.|.||.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            123311 1256799999999999999887 8899984

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.63  E-value=0.00034  Score=74.91  Aligned_cols=78  Identities=17%  Similarity=0.191  Sum_probs=58.3

Q ss_pred             CccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-C--CCeeeEEeeeecCCceEEEEec
Q 001988          727 NFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-H--RNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h--~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .....+.+|.|..+.||+.+..||++|++|+-..........+..|.+.|+.+. .  --+++++++.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            344567789999999999999999999999876554444456889999999884 2  2345555542    24789999


Q ss_pred             cCCCC
Q 001988          804 MSNGS  808 (985)
Q Consensus       804 ~~~gs  808 (985)
                      ++++.
T Consensus        92 l~~~~   96 (288)
T 3f7w_A           92 VDERP   96 (288)
T ss_dssp             CCCCC
T ss_pred             ecccC
Confidence            98764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.60  E-value=5e-05  Score=73.71  Aligned_cols=84  Identities=17%  Similarity=0.114  Sum_probs=48.2

Q ss_pred             cceeEEeecCCcccCCccccccCCCcccEEEccCCc-cCccCchhhccc----ccceeeeeecce-eccchhhhhhcccc
Q 001988          513 KDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNN-LSGNIPTTLEGL----KSLQNISLAYNR-LEGPIPESFGNMTS  586 (985)
Q Consensus       513 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~  586 (985)
                      ..|+.||++++.|+...-..+..+++|+.|+|+++. |++.--..++.+    ++|++|+|++|. |+..--..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            345666666665554444445566666666666663 554333344443    356677776653 66544455666666


Q ss_pred             cCeEecCCCc
Q 001988          587 LESLDLSNNK  596 (985)
Q Consensus       587 L~~L~Ls~N~  596 (985)
                      |++|+|+++.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            7777776654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.50  E-value=0.00044  Score=78.45  Aligned_cols=73  Identities=15%  Similarity=0.148  Sum_probs=45.9

Q ss_pred             CceeeccCceeEEEEEEcCCcEEEEEEeccCCc------c---hHHHHHHHHHHHH-hcCCCCeeeEEeeeecCCceEEE
Q 001988          731 NNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCA------S---TLKSFEAECEVIK-NIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~------~---~~~~~~~E~~il~-~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .+.+|.|..+.||++.. +++.++||...+...      .   ....++.|+..+. ......+.+++.+.  .+..++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            45689999999999965 467899995332110      1   2233444443332 22334566777765  4567899


Q ss_pred             Eecc-CC
Q 001988          801 LEYM-SN  806 (985)
Q Consensus       801 ~e~~-~~  806 (985)
                      |||+ ++
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.37  E-value=0.00074  Score=73.47  Aligned_cols=157  Identities=15%  Similarity=0.161  Sum_probs=89.5

Q ss_pred             cCHHHHHHHhcCccCC-----ceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCC--eeeEE
Q 001988          716 FSYFELLRATDNFAEN-----NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRN--LVKII  788 (985)
Q Consensus       716 ~~~~~~~~~~~~~~~~-----~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~  788 (985)
                      ++..++......|...     +.|+.|....||+....+| .+++|.....  .....+..|+++++.+....  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            4455555555556542     3466788899999988665 6889988753  12345667888887774212  33333


Q ss_pred             ee------eecCCceEEEEeccCCCChHH--------------HhhcC----CCC----C---CHHHHHH----------
Q 001988          789 SS------CSNDDFKALVLEYMSNGSLED--------------CLHSS----NCA----L---NIFCRLN----------  827 (985)
Q Consensus       789 ~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~----~~~----~---~~~~~~~----------  827 (985)
                      ..      ....+..+++|||++|..+..              .++..    ...    .   .|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            22      122356789999999865321              12211    000    1   1221100          


Q ss_pred             --HHHHHHHHHHHHHhc----CCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          828 --IMIDIASALEYLHFG----HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       828 --i~~~i~~~L~~Lh~~----h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                        +...+.+.+++++..    ...+++|+|+.+.||++++++.+.|+||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              001134445555321    245799999999999999876678999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.30  E-value=0.0008  Score=73.64  Aligned_cols=139  Identities=13%  Similarity=0.156  Sum_probs=75.3

Q ss_pred             ceeeccCcee-EEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCC--CCeeeEEeeeecCCceEEEEeccCCCC
Q 001988          732 NIIGIGGFGS-VYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRH--RNLVKIISSCSNDDFKALVLEYMSNGS  808 (985)
Q Consensus       732 ~~ig~G~~g~-V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gs  808 (985)
                      +.++.|+... +|+....++..+++|.......   ..+..|+++++.+..  -.+.+++.+..+.+  ++|||++++..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            3455565554 6677664477788886544321   334567777777632  23556776644433  78999997766


Q ss_pred             hHHHhhcC-------------------------CCCCCHHHHH-------H-H------------HHHHHHHHHHHH---
Q 001988          809 LEDCLHSS-------------------------NCALNIFCRL-------N-I------------MIDIASALEYLH---  840 (985)
Q Consensus       809 L~~~l~~~-------------------------~~~~~~~~~~-------~-i------------~~~i~~~L~~Lh---  840 (985)
                      +.+++...                         ...++.....       . +            ...+...++.+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            65433211                         0112211100       0 0            001111222221   


Q ss_pred             hcCCCCeEeCCCCCCCEEEcCC----CcEEEecccCcee
Q 001988          841 FGHSTPIIHCDLKPSNVLLDED----MVAHLSDFGMAKL  875 (985)
Q Consensus       841 ~~h~~~ivHrDlk~~Nill~~~----~~~kl~DfGla~~  875 (985)
                      ..+...++|||+.+.||+++.+    +.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1245679999999999999875    7899999998876

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.17  E-value=0.0022  Score=69.92  Aligned_cols=157  Identities=13%  Similarity=0.141  Sum_probs=90.9

Q ss_pred             ccCHHHHHHHhcCcc-----CCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCC--CeeeE
Q 001988          715 RFSYFELLRATDNFA-----ENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHR--NLVKI  787 (985)
Q Consensus       715 ~~~~~~~~~~~~~~~-----~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~--niv~l  787 (985)
                      ..+.+++....+.|.     ....++ |....||++...+|+.+++|...... .....+..|..+++.+...  .++++
T Consensus        10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~   87 (328)
T 1zyl_A           10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAP   87 (328)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred             CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecce
Confidence            344455544444442     223566 88889999888778789999987442 2345677888888877422  24444


Q ss_pred             Eee-----eecCCceEEEEeccCCCChH-----HH---------hhcC--------CCCCCHHHH----HHH--------
Q 001988          788 ISS-----CSNDDFKALVLEYMSNGSLE-----DC---------LHSS--------NCALNIFCR----LNI--------  828 (985)
Q Consensus       788 ~~~-----~~~~~~~~lv~e~~~~gsL~-----~~---------l~~~--------~~~~~~~~~----~~i--------  828 (985)
                      +..     ....+..++||||++|..+.     ..         ++..        ...+++...    ..+        
T Consensus        88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  167 (328)
T 1zyl_A           88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  167 (328)
T ss_dssp             CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence            443     12245567899999875431     10         1110        011222211    001        


Q ss_pred             -------HHHHHHHHHHHHh----cCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          829 -------MIDIASALEYLHF----GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       829 -------~~~i~~~L~~Lh~----~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                             ...+...++.+..    .....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                   0111122333321    1356689999999999999 4 899999998764

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.15  E-value=0.00021  Score=70.64  Aligned_cols=86  Identities=19%  Similarity=0.186  Sum_probs=42.8

Q ss_pred             CCCCCceEEEcccc-cCCCc----cccccccccccceEeeccccccC----CchhhhcCCCCCCEEEecCCcCccc----
Q 001988          191 SKCKQLQELHLGYN-NLSGA----IPKEIGNLTVLQRISLINNKLHG----EIPQEIGYLQNLDVLQLGFNNLTGV----  257 (985)
Q Consensus       191 ~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----  257 (985)
                      .+-+.|++|+|++| +|...    +-+.+..-+.|+.|+|++|+|..    .+.+.+..-+.|++|+|++|.|+..    
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a  117 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR  117 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence            33445566666553 55421    22233334455555555555542    2233344455666666666666532    


Q ss_pred             CcccccCCCCCCEEEccCC
Q 001988          258 VPATIFNMSTLKEIFLYNN  276 (985)
Q Consensus       258 ~p~~l~~l~~L~~L~L~~N  276 (985)
                      +-.++..-+.|++|+|++|
T Consensus       118 la~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          118 LLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHHHTTTTCCCSEEECCCC
T ss_pred             HHHHHhhCCceeEEECCCC
Confidence            2233444455666666654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.09  E-value=0.0015  Score=70.35  Aligned_cols=136  Identities=15%  Similarity=0.177  Sum_probs=76.4

Q ss_pred             CceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCe-eeEEeeeecCCceEEEEecc-CCCC
Q 001988          731 NNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL-VKIISSCSNDDFKALVLEYM-SNGS  808 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gs  808 (985)
                      .+.|+.|....+|++     ..+++|+....... .....+|..+++.+....+ .+++++.  .+.-++|+||+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            678999999999998     45888987653211 1223568888877742222 4566554  33346899999 6544


Q ss_pred             hHH------------------HhhcCCCC----CCHHHH-HHHHH--------------HHHHHHH----HHH-hcCCCC
Q 001988          809 LED------------------CLHSSNCA----LNIFCR-LNIMI--------------DIASALE----YLH-FGHSTP  846 (985)
Q Consensus       809 L~~------------------~l~~~~~~----~~~~~~-~~i~~--------------~i~~~L~----~Lh-~~h~~~  846 (985)
                      +..                  .+|.....    .+.... ..+..              .+.+.+.    .+. ......
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            421                  01111110    111111 11100              0111111    111 113445


Q ss_pred             eEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       847 ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      ++|+|+.+.||+ ..++.+.++||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 6677889999998875

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.06  E-value=0.002  Score=71.33  Aligned_cols=139  Identities=14%  Similarity=0.168  Sum_probs=83.7

Q ss_pred             ceeeccCceeEEEEEEc--------CCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceEEEEe
Q 001988          732 NIIGIGGFGSVYRARLE--------DGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      +.+..|-...+|++...        +++.|++|+.... ........+|.++++.+. +.-..++++++..    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            45777889999999874        3578999986332 223455678999998884 3334567776654    28999


Q ss_pred             ccCCCChHHH-----------------hhcC----CCCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 001988          803 YMSNGSLEDC-----------------LHSS----NCALN--IFCRLNIMIDIAS-------------------ALEYLH  840 (985)
Q Consensus       803 ~~~~gsL~~~-----------------l~~~----~~~~~--~~~~~~i~~~i~~-------------------~L~~Lh  840 (985)
                      |++|.++...                 +|..    +....  +.+..++..++..                   .++.|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998654310                 1211    11222  3344444433321                   223332


Q ss_pred             -----hcCCCCeEeCCCCCCCEEEcCC----CcEEEecccCcee
Q 001988          841 -----FGHSTPIIHCDLKPSNVLLDED----MVAHLSDFGMAKL  875 (985)
Q Consensus       841 -----~~h~~~ivHrDlk~~Nill~~~----~~~kl~DfGla~~  875 (985)
                           ......++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                 1234568999999999999876    7899999998875

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.06  E-value=0.00014  Score=71.89  Aligned_cols=41  Identities=15%  Similarity=0.215  Sum_probs=21.3

Q ss_pred             hccCCCeEEccCC-ccccc----cCCCCcCcCcCceEeeccceeee
Q 001988          463 LLSRLNELDLNGN-KISGS----ISSCLGNLTSLQYLNLGSNRFTF  503 (985)
Q Consensus       463 ~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~  503 (985)
                      .-+.|++|+|++| +|...    +...+..-+.|+.|+|++|+|..
T Consensus        39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd   84 (197)
T 1pgv_A           39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISD   84 (197)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBH
T ss_pred             cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCCh
Confidence            3455667777664 55421    22333444555666666655543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.98  E-value=0.0023  Score=72.45  Aligned_cols=72  Identities=19%  Similarity=0.255  Sum_probs=49.9

Q ss_pred             ceeeccCceeEEEEEEcC--------CcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCC-eeeEEeeeecCCceEEEEe
Q 001988          732 NIIGIGGFGSVYRARLED--------GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRN-LVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~l~~~~~~~~~~~lv~e  802 (985)
                      +.|+.|....||++...+        ++.|++|+....  .....+.+|..+++.+...+ ..++++.+..    .+|||
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            567889899999998753        578999988432  11145567999998884333 3567776542    38999


Q ss_pred             ccCCCCh
Q 001988          803 YMSNGSL  809 (985)
Q Consensus       803 ~~~~gsL  809 (985)
                      |++|.++
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9986443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.67  E-value=0.0087  Score=68.05  Aligned_cols=74  Identities=18%  Similarity=0.219  Sum_probs=48.7

Q ss_pred             CceeeccCceeEEEEEEcC-CcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCe-eeEEeeeecCCceEEEEeccCCCC
Q 001988          731 NNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL-VKIISSCSNDDFKALVLEYMSNGS  808 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs  808 (985)
                      .+.|+.|-...+|++...+ +..|++|+....... ...-.+|..+++.+...++ .++++.+. +   .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCcc
Confidence            3568889999999998865 578999987543211 1112589999999864444 56777763 2   35999998754


Q ss_pred             h
Q 001988          809 L  809 (985)
Q Consensus       809 L  809 (985)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.64  E-value=0.0038  Score=69.30  Aligned_cols=73  Identities=14%  Similarity=0.262  Sum_probs=44.8

Q ss_pred             ceeeccCceeEEEEEEcC---------CcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCC-eeeEEeeeecCCceEEEE
Q 001988          732 NIIGIGGFGSVYRARLED---------GVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRN-LVKIISSCSNDDFKALVL  801 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~~---------~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~l~~~~~~~~~~~lv~  801 (985)
                      +.++.|....+|++...+         ++.+++|+..... ........|.++++.+...+ ..++++..  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            457788889999998754         2688888875432 11122467888888874333 44666554  2  36899


Q ss_pred             eccCCCCh
Q 001988          802 EYMSNGSL  809 (985)
Q Consensus       802 e~~~~gsL  809 (985)
                      ||++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.58  E-value=0.0013  Score=60.66  Aligned_cols=37  Identities=22%  Similarity=0.304  Sum_probs=19.8

Q ss_pred             ccCeEecCCCcccCCCCcccccccccccccccccccc
Q 001988          586 SLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLK  622 (985)
Q Consensus       586 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  622 (985)
                      +|+.|+|++|+|+...+..|..+++|+.|+|++|++.
T Consensus        32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            3555555555555444444555555555555555554

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.55  E-value=0.006  Score=66.74  Aligned_cols=66  Identities=15%  Similarity=0.157  Sum_probs=43.6

Q ss_pred             cCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcC---CCCeeeEEee------eecCCceEEEEeccCCC
Q 001988          737 GGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR---HRNLVKIISS------CSNDDFKALVLEYMSNG  807 (985)
Q Consensus       737 G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~~g  807 (985)
                      |....||+....+| .+++|+......      ..|+++++.+.   -|.+++++..      ....+..++||||++|.
T Consensus        34 g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~  106 (339)
T 3i1a_A           34 DTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP  106 (339)
T ss_dssp             CSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred             ccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence            33678999998777 899998765431      35666666552   2324555433      23356778999999987


Q ss_pred             Ch
Q 001988          808 SL  809 (985)
Q Consensus       808 sL  809 (985)
                      .+
T Consensus       107 ~~  108 (339)
T 3i1a_A          107 NG  108 (339)
T ss_dssp             BT
T ss_pred             cC
Confidence            55

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.25  E-value=0.0033  Score=58.01  Aligned_cols=56  Identities=21%  Similarity=0.328  Sum_probs=34.6

Q ss_pred             EEEccCCccC-ccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCccc
Q 001988          541 GIDLSRNNLS-GNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKIS  598 (985)
Q Consensus       541 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  598 (985)
                      .++.+++.++ ..+|..+.  ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            4555555554 23343322  35667777777777666666777777777777777664

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.70  E-value=0.026  Score=63.31  Aligned_cols=73  Identities=12%  Similarity=0.211  Sum_probs=48.3

Q ss_pred             ceeeccCceeEEEEEEcC--------CcEEEEEEeccCCcchHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceEEEEe
Q 001988          732 NIIGIGGFGSVYRARLED--------GVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      +.+..|-...+|+....+        ++.|++|+..... .....-.+|.++++.+. +.-..++++.+.    -+.|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            457778899999998753        5789999865432 11122357888888874 333455665432    268999


Q ss_pred             ccCCCCh
Q 001988          803 YMSNGSL  809 (985)
Q Consensus       803 ~~~~gsL  809 (985)
                      |++|.++
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.17  E-value=0.061  Score=53.34  Aligned_cols=143  Identities=13%  Similarity=0.044  Sum_probs=92.0

Q ss_pred             ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecc
Q 001988          808 SLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ  887 (985)
Q Consensus       808 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~  887 (985)
                      +|.+.|...+.++++.+.+.++.|.+.+|.-.-  +++.-..+=+.|..|++..+|.|...+ +.+.             
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~--~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAA--RRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhh--hcccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            799999988889999999999999999987762  111111233346899999999988764 1110             


Q ss_pred             cccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhhHHHHHHHHHHHHHHccCC------------
Q 001988          888 TLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTME------------  955 (985)
Q Consensus       888 ~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~------------  955 (985)
                       .....+.|||... ...+.+.-| +++|+.++..+++.+.....+....      .+.+|+..|...            
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~I-ysLG~tLY~ALDygL~e~eE~eLS~------~LE~LL~~Mt~~~~d~~~~DeG~~  168 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVI-ESLGIIIYKALDYGLKENEERELSP------PLEQLIDHMANTVEADGSNDEGYE  168 (229)
T ss_dssp             ----------CCSS-SSSCHHHHH-HHHHHHHHHHHTTTCCTTEEECCCH------HHHHHHHHHTTCCC----------
T ss_pred             -ccccCCCChhhcc-ccchHHHHH-HHHHHHHHHHhhcCCCcccchhhCH------HHHHHHHHHHhccccccccccccc
Confidence             1223567887753 334455556 9999999999999887665443333      244455555433            


Q ss_pred             -------------CCCCCCCHHHHHHHHHHhHh
Q 001988          956 -------------SPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       956 -------------~P~~RPt~~ev~~~L~~i~~  975 (985)
                                   .+..|++.++|++....-.+
T Consensus       169 ~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~  201 (229)
T 2yle_A          169 AAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLP  201 (229)
T ss_dssp             ----------CCSCCCCCCSHHHHHHHHHTTSS
T ss_pred             ccccccccccccccccCcCCHHHHHHHHHhhcc
Confidence                         35688999999988766544

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.52  E-value=0.58  Score=52.07  Aligned_cols=29  Identities=31%  Similarity=0.427  Sum_probs=25.2

Q ss_pred             eEeCCCCCCCEEE------cCCCcEEEecccCcee
Q 001988          847 IIHCDLKPSNVLL------DEDMVAHLSDFGMAKL  875 (985)
Q Consensus       847 ivHrDlk~~Nill------~~~~~~kl~DfGla~~  875 (985)
                      ++|+|+.+.||++      +++..++++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4567899999999875

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	985
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-51
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-48
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-47
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-46
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-46
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-46
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-45
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-44
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-44
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-43
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-43
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-42
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-42
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-42
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-42
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-42
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-41
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-41
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-41
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-41
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-41
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-41
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-40
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-40
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-40
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-39
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-39
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-38
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-38
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-38
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-38
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-37
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-36
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-36
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-35
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-35
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-35
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-33
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-33
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-31
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-31
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-31
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-31
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-31
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-30
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-30
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-30
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-30
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-30
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-29
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-28
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-28
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-28
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-28
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-27
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-27
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-26
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-04
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.003
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-26
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-25
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-24
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-22
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-09
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-22
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-22
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	9e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-16
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-21
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-21
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-13
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-12
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-11
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-10
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	9e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-09
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	9e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-08
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	8e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-07
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	6e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	8e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.001
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	5e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	5e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	5e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	6e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.004
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	7e-06
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	8e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.003
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	3e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	1e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	3e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	6e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.003
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	7e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.004
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.004
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	9e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.001
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.003
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	3e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.001
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.003
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 2e-51
 Identities = 61/277 (22%), Positives = 115/277 (41%), Gaps = 31/277 (11%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAST--LKSFEAECEVIKNIRHRN 783
                   IG G FG+VY+ +    V  A+K+ +    +   L++F+ E  V++  RH N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           ++  +   +     A+V ++    SL   LH       +   ++I    A  ++YLH   
Sbjct: 66  ILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-- 122

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG 903
              IIH DLK +N+ L ED+   + DFG+A + S    S    Q   +I +MAP+ I + 
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 904 E--------------------LSLKR-WVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCL 942
           +                    ++ +  + N      ++ +V +  LS +      +  C 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV--RSNCP 239

Query: 943 LSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK 979
            ++  L  EC  +  ++R      +  +  +  +L K
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  171 bits (435), Expect = 3e-48
 Identities = 56/296 (18%), Positives = 114/296 (38%), Gaps = 44/296 (14%)

Query: 713 IRRFSYFELLRATDNFAEN---------NIIGIGGFGSVYRARL----EDGVEIAIKVFH 759
           I  F++ +   A   FA+           +IG G FG V    L    +  + +AIK   
Sbjct: 4   IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63

Query: 760 PQ-CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNC 818
                   + F +E  ++    H N++ +    +      ++ E+M NGSL+  L  ++ 
Sbjct: 64  SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123

Query: 819 ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG 878
              +   + ++  IA+ ++YL   +    +H DL   N+L++ ++V  +SDFG+++ L  
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 879 EDESTMRTQTL---ATIGYMAPDEIFVGELSLK------------------RWVNDLLPV 917
           +      T  L     I + AP+ I   + +                    R   D+   
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240

Query: 918 SLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI 973
            ++  +++      +        C  ++  L L+C  +    R      +  L K+
Sbjct: 241 DVINAIEQ------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 1e-47
 Identities = 63/259 (24%), Positives = 116/259 (44%), Gaps = 21/259 (8%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           +       +G G FG V+        ++A+K       S   +F AE  ++K ++H+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHS-SNCALNIFCRLNIMIDIASALEYLHFGHS 844
           ++ +  + +    ++ EYM NGSL D L + S   L I   L++   IA  + ++     
Sbjct: 72  RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
              IH DL+ +N+L+ + +   ++DFG+A+L+  ++E T R      I + AP+ I  G 
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 905 LSLKRWVNDLLPVSLVEVV-----------DKSLLSGEEKHF--AAKEQCLLSIFSLALE 951
            ++K  V     + L E+V           +  ++   E+ +     + C   ++ L   
Sbjct: 187 FTIKSDVWS-FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245

Query: 952 CTMESPEKRIDAKDTITRL 970
           C  E PE R       + L
Sbjct: 246 CWKERPEDRPTFDYLRSVL 264

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 2e-46
 Identities = 59/283 (20%), Positives = 112/283 (39%), Gaps = 28/283 (9%)

Query: 720 ELLRATDNFAENNI-IGIGGFGSVYRARL---EDGVEIAIKVFHPQ-CASTLKSFEAECE 774
           +L    DN    +I +G G FGSV +      +  +++AIKV       +  +    E +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           ++  + +  +V++I  C  +    LV+E    G L   L      + +     ++  ++ 
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE-STMRTQTLATIG 893
            ++YL        +H DL   NVLL     A +SDFG++K L  +D   T R+     + 
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 894 YMAPDEIFVGELSLKRWVNDLLPV---------------SLVEVVDKSLLSGEEKHFAAK 938
           + AP+ I   + S +  V                        EV+   +  G+       
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECP-- 234

Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSKRI 981
            +C   +++L  +C +   E R D      R+     +L+ ++
Sbjct: 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 4e-46
 Identities = 54/263 (20%), Positives = 105/263 (39%), Gaps = 23/263 (8%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
            +      +G G FG V   +     ++AIK+      S    F  E +V+ N+ H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLV 62

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
           ++   C+      ++ EYM+NG L + L            L +  D+  A+EYL      
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---K 119

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGEL 905
             +H DL   N L+++  V  +SDFG+++ +  +DE T    +   + +  P+ +   + 
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 906 SLKRWVNDLLPVSLVEV---------------VDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
           S K  +     V + E+                 + +  G   +          ++++  
Sbjct: 179 SSKSDIWA-FGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR--PHLASEKVYTIMY 235

Query: 951 ECTMESPEKRIDAKDTITRLLKI 973
            C  E  ++R   K  ++ +L +
Sbjct: 236 SCWHEKADERPTFKILLSNILDV 258

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 4e-46
 Identities = 62/264 (23%), Positives = 104/264 (39%), Gaps = 19/264 (7%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
                   IG G FG V+     +  ++AIK      A + + F  E EV+  + H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLV 63

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
           ++   C       LV E+M +G L D L +          L + +D+   + YL      
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEA 120

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGEL 905
            +IH DL   N L+ E+ V  +SDFGM + +  +D+ T  T T   + + +P+       
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 906 SLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-------------KEQCLLSIFSLALEC 952
           S K  V     V + EV  +  +  E +  +                     ++ +   C
Sbjct: 180 SSKSDVWS-FGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238

Query: 953 TMESPEKRIDAKDTITRLLKIRDT 976
             E PE R      + +L +I ++
Sbjct: 239 WKERPEDRPAFSRLLRQLAEIAES 262

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 1e-45
 Identities = 62/264 (23%), Positives = 114/264 (43%), Gaps = 31/264 (11%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
           ++      +G G FG V+         +AIK   P   S  ++F  E +V+K +RH  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIF-CRLNIMIDIASALEYLHFGHS 844
           ++ +  S +    +V EYMS GSL D L             +++   IAS + Y+   + 
Sbjct: 76  QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGE 904
              +H DL+ +N+L+ E++V  ++DFG+A+L+  ++E T R      I + AP+    G 
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 905 LSLK------------------RWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIF 946
            ++K                       ++   +++ V++              +C  S+ 
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------RMPCPPECPESLH 244

Query: 947 SLALECTMESPEKRIDAKDTITRL 970
            L  +C  + PE+R   +     L
Sbjct: 245 DLMCQCWRKEPEERPTFEYLQAFL 268

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  159 bits (402), Expect = 5e-44
 Identities = 59/280 (21%), Positives = 113/280 (40%), Gaps = 31/280 (11%)

Query: 714 RRFSYFELLRATDNFAENNIIGIGGFGSVYRARLED-GVEIAIKVFHPQCASTLKSFEAE 772
              +Y +      +    + +G G +G VY    +   + +A+K         ++ F  E
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKE 63

Query: 773 CEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSN-CALNIFCRLNIMID 831
             V+K I+H NLV+++  C+ +    ++ E+M+ G+L D L   N   ++    L +   
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123

Query: 832 IASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLAT 891
           I+SA+EYL        IH DL   N L+ E+ +  ++DFG+++L++G D  T        
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFP 179

Query: 892 IGYMAPDEIFVGELSLK------------------RWVNDLLPVSLVEVVDKSLLSGEEK 933
           I + AP+ +   + S+K                       +    + E+++K        
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------ 233

Query: 934 HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI 973
                E C   ++ L   C   +P  R    +       +
Sbjct: 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 7e-44
 Identities = 67/266 (25%), Positives = 109/266 (40%), Gaps = 31/266 (11%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV 785
                   IG G FG V       G ++A+K       +T ++F AE  V+  +RH NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLV 63

Query: 786 KIISSCSNDDFK-ALVLEYMSNGSLEDCLHSSNC-ALNIFCRLNIMIDIASALEYLHFGH 843
           +++     +     +V EYM+ GSL D L S     L   C L   +D+  A+EYL    
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG 903
               +H DL   NVL+ ED VA +SDFG+ K       S+ +      + + AP+ +   
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREK 175

Query: 904 ELSLKRWVNDL--LPVSLVEVV-----------DKSLLS--GEEKHFAAKEQCLLSIFSL 948
           + S K   +D+    + L E+             K ++    +     A + C  +++ +
Sbjct: 176 KFSTK---SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV 232

Query: 949 ALECTMESPEKRIDAKDTITRLLKIR 974
              C       R        +L  I+
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 5e-43
 Identities = 43/187 (22%), Positives = 82/187 (43%), Gaps = 9/187 (4%)

Query: 724 ATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQ-CASTLKSFEAECEVIKNIRH 781
             D+F + + +G G  G V++      G+ +A K+ H +   +       E +V+     
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             +V    +  +D   ++ +E+M  GSL+  L  +   +       + I +   L YL  
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR- 121

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
                I+H D+KPSN+L++      L DFG++  L      +M    + T  YM+P+ + 
Sbjct: 122 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQ 176

Query: 902 VGELSLK 908
               S++
Sbjct: 177 GTHYSVQ 183

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 7e-43
 Identities = 56/253 (22%), Positives = 103/253 (40%), Gaps = 18/253 (7%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHP-QCASTLKSFEAECEVIKNIRHRN 783
           +++     +G G +G V  A        +A+K+    +     ++ + E  + K + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +VK        + + L LEY S G L D +   +  +           + + + YLH   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH--- 120

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG 903
              I H D+KP N+LLDE     +SDFG+A +    +   +  +   T+ Y+AP+ +   
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 904 ELSLKRWVNDL--LPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI 961
           E   +    D+    + L       +L+GE       + C         + T  +P K+I
Sbjct: 181 EFHAEP--VDVWSCGIVLTA-----MLAGELPWDQPSDSCQE-YSDWKEKKTYLNPWKKI 232

Query: 962 D--AKDTITRLLK 972
           D      + ++L 
Sbjct: 233 DSAPLALLHKILV 245

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 1e-42
 Identities = 55/281 (19%), Positives = 113/281 (40%), Gaps = 37/281 (13%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDG-----VEIAIKVFHPQCAS-TLKSFEAECEVIKNI 779
                  +IG G FG VY+  L+       V +AIK             F  E  ++   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 780 RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYL 839
            H N++++    S      ++ EYM NG+L+  L   +   ++   + ++  IA+ +   
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM--- 123

Query: 840 HFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA-TIGYMAPD 898
            +  +   +H DL   N+L++ ++V  +SDFG++++L  + E+T  T      I + AP+
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 899 EIFVGELSLK------------------RWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQ 940
            I   + +                    R   +L    +++ ++                
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------RLPTPMD 237

Query: 941 CLLSIFSLALECTMESPEKRIDAKD---TITRLLKIRDTLS 978
           C  +I+ L ++C  +   +R    D    + +L++  D+L 
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (393), Expect = 1e-42
 Identities = 65/307 (21%), Positives = 112/307 (36%), Gaps = 59/307 (19%)

Query: 715 RFSYFELLRATDNFAENNIIGIGGFGSVYRARL------EDGVEIAIKVFHPQC-ASTLK 767
           +    E  R  +N      IG G FG V++AR       E    +A+K+   +  A    
Sbjct: 4   KLLSLEYPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61

Query: 768 SFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNC--------- 818
            F+ E  ++    + N+VK++  C+      L+ EYM+ G L + L S +          
Sbjct: 62  DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121

Query: 819 --------------ALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMV 864
                          L+   +L I   +A+ + YL        +H DL   N L+ E+MV
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMV 178

Query: 865 AHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD 924
             ++DFG+++ +   D           I +M P+ IF    + +  V     V L E   
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA-YGVVLWE--- 234

Query: 925 KSLLSGEEKHFAAK------------------EQCLLSIFSLALECTMESPEKRIDAKDT 966
             + S   + +                     E C L +++L   C  + P  R      
Sbjct: 235 --IFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292

Query: 967 ITRLLKI 973
              L ++
Sbjct: 293 HRILQRM 299

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 1e-42
 Identities = 53/294 (18%), Positives = 101/294 (34%), Gaps = 58/294 (19%)

Query: 726 DNFAENNIIGIGGFGSVYRARLED------GVEIAIKVFHPQC-ASTLKSFEAECEVIKN 778
           +N     ++G G FG V  A           +++A+K+   +  +S  ++  +E +++  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 779 I-RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSN-------------------- 817
           +  H N+V ++ +C+      L+ EY   G L + L S                      
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 818 --CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL 875
               L     L     +A  +E+L        +H DL   NVL+    V  + DFG+A+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 876 LSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF 935
           +  +    +R      + +MAP+ +F G  ++K        + L E     + S     +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWE-----IFSLGVNPY 267

Query: 936 AAK-------------------EQCLLSIFSLALECTMESPEKRIDAKDTITRL 970
                                       I+ +   C      KR    +  + L
Sbjct: 268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 1e-42
 Identities = 57/262 (21%), Positives = 99/262 (37%), Gaps = 29/262 (11%)

Query: 730 ENNIIGIGGFGSVYRARLED---GVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNL 784
           E+  +G G FG+V +   +       +A+K+   +           AE  V++ + +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           V++I  C  + +  LV+E    G L   L   N  +     + ++  ++  ++YL   + 
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN- 127

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE-DESTMRTQTLATIGYMAPDEIFVG 903
              +H DL   NVLL     A +SDFG++K L  + +    +T     + + AP+ I   
Sbjct: 128 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 904 ELSLKRWVNDLLPVSLVEV---------------VDKSLLSGEEKHFAAKEQCLLSIFSL 948
           + S K  V     V + E                V   L  GE         C   ++ L
Sbjct: 186 KFSSKSDVWS-FGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC--PAGCPREMYDL 242

Query: 949 ALECTMESPEKRIDAKDTITRL 970
              C     E R        RL
Sbjct: 243 MNLCWTYDVENRPGFAAVELRL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (389), Expect = 3e-42
 Identities = 57/261 (21%), Positives = 107/261 (40%), Gaps = 26/261 (9%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRN 783
            D +     +G G FG VY+A+  E  V  A KV   +    L+ +  E +++ +  H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +VK++ +   ++   +++E+ + G+++  +      L       +      AL YL   H
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL---H 127

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG 903
              IIH DLK  N+L   D    L+DFG++   +       R   + T  +MAP E+ + 
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAP-EVVMC 184

Query: 904 ELSLKRWVN---DL--LPVSLVEVVD--------------KSLLSGEEKHFAAKEQCLLS 944
           E S  R  +   D+  L ++L+E+ +                +   E    A   +   +
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244

Query: 945 IFSLALECTMESPEKRIDAKD 965
                 +C  ++ + R     
Sbjct: 245 FKDFLKKCLEKNVDARWTTSQ 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-41
 Identities = 53/287 (18%), Positives = 104/287 (36%), Gaps = 43/287 (14%)

Query: 726 DNFAENNIIGIGGFGSVYRARL------EDGVEIAIKVFHP-QCASTLKSFEAECEVIKN 778
           +  +    +G G FG V  A        +  + +A+K+  P    +  ++  +E +V+  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 779 I-RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSS-----------------NCAL 820
           +  H N+V ++ +C+      ++ EY   G L + L                      AL
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 821 NIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED 880
           ++   L+    +A  + +L    S   IH DL   N+LL    +  + DFG+A+ +  + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK-- 938
              ++      + +MAP+ IF    + +  V     + L E+              +K  
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDV-WSYGIFLWELFSLGSSPYPGMPVDSKFY 258

Query: 939 ------------EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI 973
                       E     ++ +   C    P KR   K  +  + K 
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-41
 Identities = 57/283 (20%), Positives = 112/283 (39%), Gaps = 29/283 (10%)

Query: 720 ELLRATDNFAENNIIGIGGFGSVYRARL-----EDGVEIAIKVFHP-QCASTLKSFEAEC 773
            +L+ T+ F +  ++G G FG+VY+        +  + +AIK           K    E 
Sbjct: 4   RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62

Query: 774 EVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
            V+ ++ + ++ +++  C     + L+ + M  G L D +      +     LN  + IA
Sbjct: 63  YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121

Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
             + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I 
Sbjct: 122 KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178

Query: 894 YMAPDEIFVGELSLKRWVNDLLPVSLVEV---------------VDKSLLSGEEKHFAAK 938
           +MA + I     + +  V     V++ E+               +   L  GE       
Sbjct: 179 WMALESILHRIYTHQSDVWS-YGVTVWELMTFGSKPYDGIPASEISSILEKGE--RLPQP 235

Query: 939 EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSKRI 981
             C + ++ + ++C M   + R   ++ I    K+     + +
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 278

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 3e-41
 Identities = 58/275 (21%), Positives = 96/275 (34%), Gaps = 35/275 (12%)

Query: 726 DNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCAST---LKSFEAECEVIKN 778
            +      +G G FG V R   +      V +A+K   P   S    +  F  E   + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           + HRNL+++         K +V E    GSL D L        +       + +A  + Y
Sbjct: 68  LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAP 897
           L    S   IH DL   N+LL    +  + DFG+ + L   +D   M+        + AP
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 898 DEIFVGELSLK------------------RWVNDLLPVSLVEVVDKSLLSGEEKHFAAKE 939
           + +     S                         L    ++  +DK     E +     E
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-----EGERLPRPE 238

Query: 940 QCLLSIFSLALECTMESPEKRIDAKDTITRLLKIR 974
            C   I+++ ++C    PE R         LL+ +
Sbjct: 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 4e-41
 Identities = 79/280 (28%), Positives = 120/280 (42%), Gaps = 33/280 (11%)

Query: 710 QPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAST--- 765
           QP  +R   F+  +         I+G G F +V  AR L    E AIK+   +       
Sbjct: 1   QPRKKRPEDFKFGK---------ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK 51

Query: 766 LKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCR 825
           +     E +V+  + H   VK+  +  +D+     L Y  NG L   +       +  C 
Sbjct: 52  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCT 110

Query: 826 LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR 885
                +I SALEYLH      IIH DLKP N+LL+EDM   ++DFG AK+LS E +    
Sbjct: 111 RFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167

Query: 886 TQTLATIGYMAPDEIFVGELSLKR--WVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLL 943
              + T  Y++P+ +           W    L   + +     L++G     A  E    
Sbjct: 168 NSFVGTAQYVSPELLTEKSACKSSDLWA---LGCIIYQ-----LVAGLPPFRAGNEY--- 216

Query: 944 SIFSLALECTMESPEKRI-DAKDTITRLLKIRDTLSKRIG 982
            IF   ++   + PEK    A+D + +LL   D  +KR+G
Sbjct: 217 LIFQKIIKLEYDFPEKFFPKARDLVEKLLV-LDA-TKRLG 254

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (381), Expect = 6e-41
 Identities = 57/266 (21%), Positives = 93/266 (34%), Gaps = 41/266 (15%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHP---QCASTLKSFEAECEVIKNIR 780
              F++   IG G FG+VY AR + +   +AIK       Q     +    E   ++ +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H N ++       +    LV+EY    + +         L       +       L YLH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH 132

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
              S  +IH D+K  N+LL E  +  L DFG A ++            + T  +MAP+ I
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVI 183

Query: 901 F---VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLL-------------- 943
                G+   K  V   L ++ +E     L   +   F       L              
Sbjct: 184 LAMDEGQYDGKVDVWS-LGITCIE-----LAERKPPLFNMNAMSALYHIAQNESPALQSG 237

Query: 944 ----SIFSLALECTMESPEKRIDAKD 965
                  +    C  + P+ R  ++ 
Sbjct: 238 HWSEYFRNFVDSCLQKIPQDRPTSEV 263

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (376), Expect = 9e-41
 Identities = 56/259 (21%), Positives = 105/259 (40%), Gaps = 34/259 (13%)

Query: 731 NNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKI 787
           +  IG G F +VY+    E  VE+A      +  +    + F+ E E++K ++H N+V+ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 788 ISSC----SNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
             S            LV E M++G+L+  L      + I    +    I   L++LH   
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHT-R 131

Query: 844 STPIIHCDLKPSNVLL-DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV 902
           + PIIH DLK  N+ +        + D G+A L      ++     + T  +MAP E++ 
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAP-EMYE 186

Query: 903 GELSLKRWVNDL--LPVSLVEVVDKSLLSGEEKHFAAKEQCLLS--------------IF 946
            +        D+    + ++E+        E ++ A   + + S              + 
Sbjct: 187 EKYDES---VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243

Query: 947 SLALECTMESPEKRIDAKD 965
            +   C  ++ ++R   KD
Sbjct: 244 EIIEGCIRQNKDERYSIKD 262

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 2e-40
 Identities = 58/292 (19%), Positives = 110/292 (37%), Gaps = 55/292 (18%)

Query: 734 IGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN 793
           IG G FG V+R +   G E+A+K+F  +   +    EAE      +RH N++  I++ + 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 794 DDFKA----LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH-----FGHS 844
           D+       LV +Y  +GSL D L+     + +   + + +  AS L +LH         
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 845 TPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE--STMRTQTLATIGYMAPDEIFV 902
             I H DLK  N+L+ ++    ++D G+A       +         + T  YMAP E+  
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP-EVLD 185

Query: 903 GELSLKRWVNDL------LPVSLVEVVDKSLLSGEEKHF--------------------- 935
             +++K + +        + +   E+  +  + G  + +                     
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245

Query: 936 ------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRD 975
                           + L  +  +  EC   +   R+ A      L ++  
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 7e-40
 Identities = 59/299 (19%), Positives = 120/299 (40%), Gaps = 30/299 (10%)

Query: 701 LSNDIILSSQPTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRARLED----GVEIAIK 756
           L+ +++ + Q  +   S   +     +F  N +IG G FG VY   L D     +  A+K
Sbjct: 9   LNPELVQAVQHVVIGPSSLIV-----HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 61

Query: 757 VFHP-QCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA-LVLEYMSNGSLEDCLH 814
             +       +  F  E  ++K+  H N++ ++  C   +    +VL YM +G L + + 
Sbjct: 62  SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121

Query: 815 SSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK 874
           +      +   +   + +A  +    F  S   +H DL   N +LDE     ++DFG+A+
Sbjct: 122 NETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

Query: 875 LLSGEDESTM--RTQTLATIGYMAPDEIFVGELSLKRWVNDL------------LPVSLV 920
            +  ++  ++  +T     + +MA + +   + + K  V                P   V
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238

Query: 921 EVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK 979
              D ++   + +     E C   ++ + L+C     E R    + ++R+  I  T   
Sbjct: 239 NTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 7e-40
 Identities = 45/263 (17%), Positives = 96/263 (36%), Gaps = 27/263 (10%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHR 782
           +++     IG G +G   + R   DG  +  K       +    +   +E  +++ ++H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 783 NLVKIISSC--SNDDFKALVLEYMSNGSLEDCLHS---SNCALNIFCRLNIMIDIASALE 837
           N+V+         +    +V+EY   G L   +         L+    L +M  +  AL+
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 838 YLHFGH--STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYM 895
             H        ++H DLKP+NV LD      L DFG+A++L+   +++     + T  YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPYYM 181

Query: 896 APDEIFVGELSLK-------------RWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCL 942
           +P+++     + K               +         + +   +  G+ +      +  
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI--PYRYS 239

Query: 943 LSIFSLALECTMESPEKRIDAKD 965
             +  +           R   ++
Sbjct: 240 DELNEIITRMLNLKDYHRPSVEE 262

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 3e-39
 Identities = 55/279 (19%), Positives = 111/279 (39%), Gaps = 34/279 (12%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARL----EDGVEIAIKVFHPQCA-STLKSFEAEC 773
           +E+ R  +       IG G FG V++          + +AIK      + S  + F  E 
Sbjct: 2   YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 59

Query: 774 EVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIA 833
             ++   H ++VK+I   + ++   +++E  + G L   L     +L++   +     ++
Sbjct: 60  LTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118

Query: 834 SALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIG 893
           +AL YL    S   +H D+   NVL+  +    L DFG+++ +  +      ++    I 
Sbjct: 119 TALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIK 174

Query: 894 YMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLL---------- 943
           +MAP+ I     +    V     V + E+    L+ G +     K   ++          
Sbjct: 175 WMAPESINFRRFTSASDVWMFG-VCMWEI----LMHGVKPFQGVKNNDVIGRIENGERLP 229

Query: 944 -------SIFSLALECTMESPEKRIDAKDTITRLLKIRD 975
                  +++SL  +C    P +R    +   +L  I +
Sbjct: 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 7e-39
 Identities = 58/285 (20%), Positives = 116/285 (40%), Gaps = 44/285 (15%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDG---VEIAIKVFHPQCAST-LKSFEAECEVIKNI-R 780
           ++    ++IG G FG V +AR++     ++ AIK      +    + F  E EV+  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLH---------------SSNCALNIFCR 825
           H N++ ++ +C +  +  L +EY  +G+L D L                S+   L+    
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 826 LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR 885
           L+   D+A  ++YL        IH DL   N+L+ E+ VA ++DFG+++   G++    +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183

Query: 886 TQTLATIGYMAPDEIFVGELSLKRWVNDLLPV---------------SLVEVVDKSLLSG 930
           T     + +MA + +     +    V     +               +  E+ +K     
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--- 240

Query: 931 EEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRD 975
           +         C   ++ L  +C  E P +R      +  L ++ +
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 2e-38
 Identities = 62/253 (24%), Positives = 110/253 (43%), Gaps = 19/253 (7%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRN 783
              +     IG G  G+VY A  +  G E+AI+  + Q     +    E  V++  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +V  + S    D   +V+EY++ GSL D +  +           +  +   ALE+L   H
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ--IAAVCRECLQALEFL---H 133

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVG 903
           S  +IH D+K  N+LL  D    L+DFG    ++   E + R+  + T  +MAP+ +   
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRK 191

Query: 904 ELSLKRWVNDL--LPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK-R 960
               K    D+  L +  +E     ++ GE  +        L + +      +++PEK  
Sbjct: 192 AYGPK---VDIWSLGIMAIE-----MIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243

Query: 961 IDAKDTITRLLKI 973
              +D + R L +
Sbjct: 244 AIFRDFLNRCLDM 256

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-38
 Identities = 52/281 (18%), Positives = 102/281 (36%), Gaps = 37/281 (13%)

Query: 726 DNFAENNIIGIGGFGSVYRARL------EDGVEIAIKVFHPQCAST-LKSFEAECEVIKN 778
           +    +  +G G FG VY          E    +AIK  +   +      F  E  V+K 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLH---------SSNCALNIFCRLNIM 829
               ++V+++   S      +++E M+ G L+  L                ++   + + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 830 IDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTL 889
            +IA  + YL+   +   +H DL   N ++ ED    + DFGM + +   D      + L
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 890 ATIGYMAPDEIFVGELSLKRWVNDLLPV---------------SLVEVVDKSLLSGEEKH 934
             + +M+P+ +  G  +    V     V               S  +V+   +   E   
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM---EGGL 253

Query: 935 FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRD 975
               + C   +F L   C   +P+ R    + I+ + +  +
Sbjct: 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 2e-38
 Identities = 58/257 (22%), Positives = 101/257 (39%), Gaps = 28/257 (10%)

Query: 726 DNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHP---QCASTLKSFEAECEVIKNIRH 781
           ++F     +G G FG+VY AR  +    +A+KV      + A        E E+  ++RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
            N++++     +     L+LEY   G++   L   +   +       + ++A+AL Y H 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH- 123

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
             S  +IH D+KP N+LL       ++DFG +        S+ RT    T+ Y+ P+ I 
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMIE 177

Query: 902 VGELSLKRWVNDL--LPVSLVEVV-----------DKSLLSGEEKHFAAKEQCLLSIFSL 948
                 K    DL  L V   E +            ++        F   +        L
Sbjct: 178 GRMHDEK---VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 234

Query: 949 ALECTMESPEKRIDAKD 965
                  +P +R   ++
Sbjct: 235 ISRLLKHNPSQRPMLRE 251

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  143 bits (362), Expect = 5e-38
 Identities = 57/252 (22%), Positives = 96/252 (38%), Gaps = 17/252 (6%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
           D++  +  +G G FG V+R      G   A K       S  ++   E + +  +RH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           V +  +  +D+   ++ E+MS G L + +   +  ++    +  M  +   L ++H  + 
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 144

Query: 845 TPIIHCDLKPSNVLL--DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV 902
              +H DLKP N++          L DFG+   L   D       T  T  + AP+    
Sbjct: 145 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEG 199

Query: 903 GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRI- 961
             +       D   +  V V+   LLSG        +   L           +S    I 
Sbjct: 200 KPVGYY---TD---MWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 253

Query: 962 -DAKDTITRLLK 972
            D KD I +LL 
Sbjct: 254 EDGKDFIRKLLL 265

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  142 bits (358), Expect = 2e-37
 Identities = 56/266 (21%), Positives = 103/266 (38%), Gaps = 32/266 (12%)

Query: 716 FSYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECE 774
           + Y+++L           +G G FG V+R      G     K  +        + + E  
Sbjct: 28  YDYYDILE---------ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEIS 78

Query: 775 VIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           ++  + H  L+ +  +  +     L+LE++S G L D + + +  ++    +N M     
Sbjct: 79  IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 138

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLD--EDMVAHLSDFGMAKLLSGEDESTMRTQTLATI 892
            L+++   H   I+H D+KP N++ +  +     + DFG+A  L   +   +   T AT 
Sbjct: 139 GLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATA 192

Query: 893 GYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALEC 952
            + AP      E+  +  V     +  + V+   LLSG        +            C
Sbjct: 193 EFAAP------EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVKRC 243

Query: 953 TMESPEKRI-----DAKDTITRLLKI 973
             E  E        +AKD I  LL+ 
Sbjct: 244 DWEFDEDAFSSVSPEAKDFIKNLLQK 269

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  139 bits (352), Expect = 2e-36
 Identities = 65/268 (24%), Positives = 109/268 (40%), Gaps = 23/268 (8%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHP------QCASTLKSFEAECEVIKN 778
           ++F+ + IIG GGFG VY  R  + G   A+K          Q  +   +      ++  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
                +V +  +    D  + +L+ M+ G L   L           R     +I   LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR-FYAAEIILGLEH 122

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPD 898
           +H   +  +++ DLKP+N+LLDE     +SD G+A   S          ++ T GYMAP+
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPE 175

Query: 899 EIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPE 958
            +  G           L   L +     LL G       K +    I  + L   +E P+
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFK-----LLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 230

Query: 959 K-RIDAKDTITRLLKIRDTLSKRIGNLS 985
               + +  +  LL+ RD  ++R+G L 
Sbjct: 231 SFSPELRSLLEGLLQ-RDV-NRRLGCLG 256

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 5e-36
 Identities = 51/287 (17%), Positives = 100/287 (34%), Gaps = 44/287 (15%)

Query: 726 DNFAENNIIGIGGFGSVYRAR------LEDGVEIAIKVFHPQCAST-LKSFEAECEVIKN 778
           D       +G G FG V  A             +A+K+       +  ++  +E +++ +
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 779 IRHRNLVKII--SSCSNDDFKALVLEYMSNGSLEDCLHSSNC---------------ALN 821
           I H   V  +  +         +++E+   G+L   L S                   L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 822 IFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE 881
           +   +     +A  +E+L    S   IH DL   N+LL E  V  + DFG+A+ +  + +
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPV---------------SLVEVVDKS 926
              +      + +MAP+ IF    +++  V     +                + E   + 
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 927 LLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI 973
           L  G      A +     ++   L+C    P +R    + +  L  +
Sbjct: 250 LKEG--TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  134 bits (338), Expect = 1e-35
 Identities = 58/275 (21%), Positives = 113/275 (41%), Gaps = 28/275 (10%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCA---STLKSFEAECEVIKNIR 780
           +D +    I+G GG   V+ AR L    ++A+KV     A   S    F  E +    + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 781 HRNLVKIISSCSNDDFKA----LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL 836
           H  +V +  +   +        +V+EY+   +L D +H+    +     + ++ D   AL
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124

Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA-TIGYM 895
            + H      IIH D+KP+N+++       + DFG+A+ ++    S  +T  +  T  Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 896 APDEIFVGELSLKRWVNDLLPV--------------SLVEVVDKSLLSGEEKHFAAKEQC 941
           +P++     +  +  V  L  V              S V V  + +        A  E  
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241

Query: 942 LLSIFSLALECTMESPEKRI-DAKDTITRLLKIRD 975
              + ++ L+   ++PE R   A +    L+++ +
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  135 bits (340), Expect = 2e-35
 Identities = 60/264 (22%), Positives = 108/264 (40%), Gaps = 25/264 (9%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLK---SFEAECEVIKNIRH 781
            +F     +G G FG V+  R   +G   A+KV   +    LK       E  ++  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             ++++  +  +     ++++Y+  G L       +             ++      L +
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVC---LALEY 119

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
            HS  II+ DLKP N+LLD++    ++DFG AK +       +      T  Y+AP+ + 
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEVVS 174

Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK-R 960
               + K        + + E     +L+G    F       +  +   L   +  P    
Sbjct: 175 TKPYN-KSIDWWSFGILIYE-----MLAG-YTPFYDSNT--MKTYEKILNAELRFPPFFN 225

Query: 961 IDAKDTITRLLKIRDTLSKRIGNL 984
            D KD ++RL+  RD LS+R+GNL
Sbjct: 226 EDVKDLLSRLIT-RD-LSQRLGNL 247

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 5e-35
 Identities = 66/294 (22%), Positives = 117/294 (39%), Gaps = 46/294 (15%)

Query: 719 FELLRATDNFAENNIIGIGGFGSVYRARL--------EDGVEIAIKVFHPQCAST-LKSF 769
           +EL R  D       +G G FG V  A              ++A+K+         L   
Sbjct: 8   WELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 65

Query: 770 EAECEVIKNI-RHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLH-------------- 814
            +E E++K I +H+N++ ++ +C+ D    +++EY S G+L + L               
Sbjct: 66  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125

Query: 815 -SSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA 873
            +    L+    ++    +A  +EYL    S   IH DL   NVL+ ED V  ++DFG+A
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLA 182

Query: 874 KLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLK-------RWVNDLL-------PVSL 919
           + +   D     T     + +MAP+ +F    + +         + ++        P   
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242

Query: 920 VEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKI 973
           VE + K L  G          C   ++ +  +C    P +R   K  +  L +I
Sbjct: 243 VEELFKLLKEGHRMDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (323), Expect = 3e-33
 Identities = 43/186 (23%), Positives = 74/186 (39%), Gaps = 6/186 (3%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAST-LKSFEAECEVIKNIRHR 782
            D +   +++G G F  V  A        +AIK    +       S E E  V+  I+H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+V +     +     L+++ +S G L D +              ++  +  A++YLH  
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV 902
                           LDED    +SDFG++K+   ED  ++ +    T GY+AP+ +  
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQ 183

Query: 903 GELSLK 908
              S  
Sbjct: 184 KPYSKA 189

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  127 bits (319), Expect = 5e-33
 Identities = 60/260 (23%), Positives = 103/260 (39%), Gaps = 20/260 (7%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTL---------KSFEAECEV 775
           +N+    I+G G    V R        E A+K+       +          ++   E ++
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 776 IKNIR-HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIAS 834
           ++ +  H N++++  +   + F  LV + M  G L D L      L+      IM  +  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLE 121

Query: 835 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGY 894
            +  LH      I+H DLKP N+LLD+DM   L+DFG +  L   D      +   T  Y
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSY 175

Query: 895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLS-IFSLALECT 953
           +AP+ I              + +    V+  +LL+G    +  K+  +L  I S   +  
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235

Query: 954 MESPEK-RIDAKDTITRLLK 972
               +      KD ++R L 
Sbjct: 236 SPEWDDYSDTVKDLVSRFLV 255

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 4e-31
 Identities = 49/248 (19%), Positives = 88/248 (35%), Gaps = 22/248 (8%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAS------TLKSFEAECEVIKNIR--HRN 783
           ++G GGFGSVY    + D + +AIK       S             E  ++K +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +++++      D   L+LE            +   AL      +    +  A+ +    H
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---H 127

Query: 844 STPIIHCDLKPSNVLLDED-MVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV 902
           +  ++H D+K  N+L+D +     L DFG   LL    + T+ T    T  Y  P+ I  
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRY 183

Query: 903 GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFS-----LALECTMESP 957
                +      L + L ++V   +    ++     +       S     L   C    P
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRP 243

Query: 958 EKRIDAKD 965
             R   ++
Sbjct: 244 SDRPTFEE 251

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 4e-31
 Identities = 42/180 (23%), Positives = 74/180 (41%), Gaps = 11/180 (6%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAST---LKSFEAECEVI-KNIR 780
           ++F  + ++G G FG V+ A   +     AIK            ++    E  V+     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
           H  L  +  +    +    V+EY++ G L   + S +   ++        +I   L++LH
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
                 I++ DLK  N+LLD+D    ++DFGM K                T  Y+AP+ +
Sbjct: 121 SKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEIL 175

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  121 bits (305), Expect = 4e-31
 Identities = 41/178 (23%), Positives = 78/178 (43%), Gaps = 8/178 (4%)

Query: 726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAST--LKSFEAECEVIKNIRHRN 783
           + +     IG G +G VY+A+   G   A+K    +        +   E  ++K ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 784 LVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGH 843
           +VK+           LV E++ +  L+  L      L      + ++ + + + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117

Query: 844 STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
              ++H DLKP N+L++ +    ++DFG+A+           T  + T+ Y APD + 
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLM 173

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 6e-31
 Identities = 44/184 (23%), Positives = 79/184 (42%), Gaps = 8/184 (4%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHP-QCASTLKSFEAECEVIKNIRHR 782
              +   + IG G +G V  A    + V +AIK   P +  +  +    E +++   RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHS--SNCALNIFCRLNIMIDIASALEYLH 840
           N++ I         + +   Y+    +   L+       L+       +  I   L+Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 841 FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL-SGEDESTMRTQTLATIGYMAPDE 899
              S  ++H DLKPSN+LL+      + DFG+A++     D +   T+ +AT  Y AP+ 
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 900 IFVG 903
           +   
Sbjct: 184 MLNS 187

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 9e-31
 Identities = 53/254 (20%), Positives = 103/254 (40%), Gaps = 22/254 (8%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
           + +     +G G FG V+R            K    +  +     + E  ++   RHRN+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63

Query: 785 VKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHS 844
           + +  S  + +   ++ E++S   + + +++S   LN    ++ +  +  AL++L   HS
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HS 120

Query: 845 TPIIHCDLKPSNVLLDEDMVAH--LSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV 902
             I H D++P N++      +   + +FG A+ L   D   +         Y AP+    
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---APEYYAPEVHQH 177

Query: 903 GELSLKRWVNDL--LPVSLVEVVDKSLLSGEEKHFAAKEQCLLS-IFSLALECTMESPEK 959
             +S      D+  L   +       LLSG     A   Q ++  I +       E+ ++
Sbjct: 178 DVVSTA---TDMWSLGTLVYV-----LLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229

Query: 960 -RIDAKDTITRLLK 972
             I+A D + RLL 
Sbjct: 230 ISIEAMDFVDRLLV 243

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 1e-30
 Identities = 61/260 (23%), Positives = 103/260 (39%), Gaps = 26/260 (10%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHP------QCASTLKSFEAECEVIKN 778
           D +     +G G F  V + R    G++ A K          +   + +  E E  ++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 779 IRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEY 838
           I+H N++ +     N     L+LE ++ G L D   +   +L        +  I +    
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNG--- 125

Query: 839 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HLSDFGMAKLLSGEDESTMRTQTLATIGY 894
           +++ HS  I H DLKP N++L +  V      + DFG+A  +   D          T  +
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182

Query: 895 MAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLS-IFSLALECT 953
           +AP+ +    L L+  +   + V         LLSG        +Q  L+ + ++  E  
Sbjct: 183 VAPEIVNYEPLGLEADM-WSIGVITYI-----LLSGASPFLGDTKQETLANVSAVNYEFE 236

Query: 954 MESPEK-RIDAKDTITRLLK 972
            E        AKD I RLL 
Sbjct: 237 DEYFSNTSALAKDFIRRLLV 256

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  120 bits (301), Expect = 2e-30
 Identities = 52/270 (19%), Positives = 97/270 (35%), Gaps = 30/270 (11%)

Query: 722 LRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR 780
           LR  + +     IG G FG +Y    +  G E+AIK+   +  +       E ++ K ++
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQ 60

Query: 781 HRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLH 840
               +  I  C  +    +++  +   SLED  +  +   ++   L +   + S +EY+H
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 841 FGHSTPIIHCDLKPSNVL---LDEDMVAHLSDFGMAKLLSGEDESTM-----RTQTLATI 892
             +    IH D+KP N L     +  + ++ DFG+AK                     T 
Sbjct: 121 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 893 GYMAPDEIFVGELSLKRWVNDL--LPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLAL 950
            Y + +     E S +   +DL  L   L+         G       K       +    
Sbjct: 178 RYASINTHLGIEQSRR---DDLESLGYVLMY-----FNLGSLPWQGLKAATKRQKYERIS 229

Query: 951 ECTMESPEKRI------DAKDTITRLLKIR 974
           E  M +P + +      +    +     +R
Sbjct: 230 EKKMSTPIEVLCKGYPSEFATYLNFCRSLR 259

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 2e-30
 Identities = 48/176 (27%), Positives = 83/176 (47%), Gaps = 12/176 (6%)

Query: 732 NIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAST-----LKSFEAECEVIKNIRHRNLV 785
           + +G G F +VY+AR       +AIK       S       ++   E ++++ + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 786 KIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHST 845
            ++ +  +    +LV ++M        +  ++  L        M+     LEYLH     
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 846 PIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
            I+H DLKP+N+LLDE+ V  L+DFG+AK       +   T  + T  Y AP+ +F
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLF 173

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 3e-30
 Identities = 60/265 (22%), Positives = 104/265 (39%), Gaps = 26/265 (9%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAST---LKSFEAECEVIKNIRH 781
           ++F    ++G G FG V   R    G   A+K+   +       +     E  V++N RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             L  +  +    D    V+EY + G L   L                 +I SAL    +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSAL---EY 120

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
            HS  +++ D+K  N++LD+D    ++DFG+ K    +  +        T  Y+AP+ + 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLE 178

Query: 902 VGELSLKRWVNDL--LPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK 959
             +        D   L V + E     ++ G    +    +    +F L L   +  P  
Sbjct: 179 DNDYGRA---VDWWGLGVVMYE-----MMCGRLPFYNQDHE---RLFELILMEEIRFPRT 227

Query: 960 -RIDAKDTITRLLKIRDTLSKRIGN 983
              +AK  +  LLK +D   +R+G 
Sbjct: 228 LSPEAKSLLAGLLK-KDP-KQRLGG 250

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 8e-30
 Identities = 43/179 (24%), Positives = 82/179 (45%), Gaps = 8/179 (4%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHR 782
           +NF +   IG G +G VY+AR    G  +A+K       +     +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+VK++     ++   LV E++     +    S+   + +    + +  +   L + H  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
            S  ++H DLKP N+L++ +    L+DFG+A+           T  + T+ Y AP+ + 
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILL 175

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 3e-29
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 20/186 (10%)

Query: 726 DNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL 784
            ++ +  +IG G FG VY+A+L + G  +AIK          +    E ++++ + H N+
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNI 75

Query: 785 VKIISSC------SNDDFKALVLEYMSNGSLEDCLH--SSNCALNIFCRLNIMIDIASAL 836
           V++           ++ +  LVL+Y+         H   +   L +      M  +  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDED-MVAHLSDFGMAKLLSGEDESTMRTQTLATIGYM 895
            Y+   HS  I H D+KP N+LLD D  V  L DFG AK L            + +  Y 
Sbjct: 136 AYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV---RGEPNVSYICSRYYR 189

Query: 896 APDEIF 901
           AP+ IF
Sbjct: 190 APELIF 195

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 2e-28
 Identities = 56/251 (22%), Positives = 90/251 (35%), Gaps = 23/251 (9%)

Query: 733 IIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISS 790
           ++G+G  G V +        + A+K+              E E+     +  ++V+I+  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73

Query: 791 C----SNDDFKALVLEYMSNGSLEDCLHS-SNCALNIFCRLNIMIDIASALEYLHFGHST 845
                +      +V+E +  G L   +    + A        IM  I  A++YLH   S 
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 846 PIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV 902
            I H D+KP N+L      + +  L+DFG AK  +  +  T       T  Y+AP E+  
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAP-EVLG 186

Query: 903 GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALE-CTMESPEKRI 961
            E   K      L V +  ++            A        I     E    E  E   
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246

Query: 962 DAKDTITRLLK 972
           + K  I  LLK
Sbjct: 247 EVKMLIRNLLK 257

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 3e-28
 Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 18/198 (9%)

Query: 723 RATDNFAENNIIGIGGFGSVYRAR--LEDGVEIAIKVFHPQCASTLKSFEAECEV----- 775
           RA   +     IG G +G V++AR     G  +A+K    Q            EV     
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 776 IKNIRHRNLVKIISSCSNDDFKA-----LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMI 830
           ++   H N+V++   C+           LV E++               +      ++M 
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 831 DIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLA 890
            +   L++LH   S  ++H DLKP N+L+       L+DFG+A++          T  + 
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVV 177

Query: 891 TIGYMAPDEIFVGELSLK 908
           T+ Y AP+ +     +  
Sbjct: 178 TLWYRAPEVLLQSSYATP 195

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 3e-28
 Identities = 48/266 (18%), Positives = 100/266 (37%), Gaps = 17/266 (6%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHR 782
             + +   IG G +G+V++A+  E    +A+K             S   E  ++K ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 783 NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG 842
           N+V++     +D    LV E+      +     +    +     + +  +   L + H  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSR 120

Query: 843 HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFV 902
           +   ++H DLKP N+L++ +    L++FG+A+           +  + T+ Y  PD +F 
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAFG--IPVRCYSAEVVTLWYRPPDVLF- 174

Query: 903 GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAK--EQCLLSIFSLALECTMESPEKR 960
                 +  +  + +     +   L +     F     +  L  IF L    T E     
Sbjct: 175 ----GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230

Query: 961 IDAKDTIT-RLLKIRDTLSKRIGNLS 985
               D     +     +L   +  L+
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLN 256

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 6e-28
 Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 26/203 (12%)

Query: 711 PTIRRFSYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAST--LK 767
           P     S +E L           IG G FG V++AR  + G ++A+K    +        
Sbjct: 4   PFCDEVSKYEKLA---------KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI 54

Query: 768 SFEAECEVIKNIRHRNLVKIISSCSNDDFKA--------LVLEYMSNGSLEDCLHSSNCA 819
           +   E ++++ ++H N+V +I  C               LV ++  +       +     
Sbjct: 55  TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV---- 110

Query: 820 LNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE 879
           L  F    I   +   L  L++ H   I+H D+K +NVL+  D V  L+DFG+A+  S  
Sbjct: 111 LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA 170

Query: 880 DES--TMRTQTLATIGYMAPDEI 900
             S     T  + T+ Y  P+ +
Sbjct: 171 KNSQPNRYTNRVVTLWYRPPELL 193

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (281), Expect = 2e-27
 Identities = 66/264 (25%), Positives = 108/264 (40%), Gaps = 25/264 (9%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLK---SFEAECEVIKNIRH 781
           D F     +G G FG V   +  E G   A+K+   Q    LK       E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 782 RNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
             LVK+  S  ++    +V+EY++ G +   L       +          I    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH- 158

Query: 842 GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIF 901
             S  +I+ DLKP N+L+D+     ++DFG AK + G   +        T   +AP+ I 
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAPEIIL 211

Query: 902 VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEK-R 960
               +      D   +    V+   + +G    F A +   + I+   +   +  P    
Sbjct: 212 SKGYNKA---VDWWALG---VLIYEMAAG-YPPFFADQP--IQIYEKIVSGKVRFPSHFS 262

Query: 961 IDAKDTITRLLKIRDTLSKRIGNL 984
            D KD +  LL++   L+KR GNL
Sbjct: 263 SDLKDLLRNLLQVD--LTKRFGNL 284

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  111 bits (277), Expect = 2e-27
 Identities = 41/241 (17%), Positives = 79/241 (32%), Gaps = 26/241 (10%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           IG G FG ++    L +  ++AIK    +  S       E    K +     +  +    
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70

Query: 793 NDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL 852
            +    +++  +   SLED L       ++         + + ++ +   H   +++ D+
Sbjct: 71  QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDI 127

Query: 853 KPSNVLLDEDMVAH-----LSDFGMAKLLSGEDEST-----MRTQTLATIGYMAPDEIFV 902
           KP N L+      +     + DFGM K               +     T  YM+ +    
Sbjct: 128 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187

Query: 903 GELSLKRWVNDL--LPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTMESPEKR 960
            E S +   +DL  L    +       L G       K       +    E    +P + 
Sbjct: 188 REQSRR---DDLEALGHVFMY-----FLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239

Query: 961 I 961
           +
Sbjct: 240 L 240

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 4e-27
 Identities = 71/268 (26%), Positives = 114/268 (42%), Gaps = 22/268 (8%)

Query: 726 DNFAENNIIGIGGFGSVYRARL----EDGVEIAIKVFHP----QCASTLKSFEAECEVIK 777
           +NF    ++G G +G V+  R     + G   A+KV       Q A T +    E +V++
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 778 NIRHR-NLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASAL 836
           +IR    LV +  +   +    L+L+Y++ G L   L         F    + I +   +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIV 139

Query: 837 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
             L   H   II+ D+K  N+LLD +    L+DFG++K     DE+        TI YMA
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEYMA 198

Query: 897 PDEIFVGELSLKRWVNDL--LPVSLVEVVDKSLLSGEEKHFAAKEQCLLSIFSLALECTM 954
           PD +  G+    + V D   L V + E++  +     +    ++ +    I         
Sbjct: 199 PDIVRGGDSGHDKAV-DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257

Query: 955 ESPEKRIDAKDTITRLLKIRDTLSKRIG 982
           E       AKD I RLL  +D   KR+G
Sbjct: 258 EMSA---LAKDLIQRLLM-KDP-KKRLG 280

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  110 bits (276), Expect = 1e-26
 Identities = 81/386 (20%), Positives = 144/386 (37%), Gaps = 30/386 (7%)

Query: 241 LQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGI 300
           L       LG  N+T  V  +  ++  +  +      +  S+   ++  L NL  +N   
Sbjct: 21  LAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDG-VEY-LNNLTQINFSN 75

Query: 301 NSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGF 360
           N  +   P  + N +KL+ + M +N  +   P A                       L  
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 361 -------LSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAI 413
                   +++++   L  L        G   + +  L+       +   +   +    +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 414 GNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLN 473
             L+NL  L    N +S   P+       L  L L  N+L       +  L+ L +LDL 
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 474 GNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAI 533
            N+IS      L  LT L  L LG+N+ + + P     L  + + +++ N         I
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN--QLEDISPI 303

Query: 534 GNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLS 593
            NLK +  + L  NN+S   P  +  L  LQ +  A N++      S  N+T++  L   
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAG 359

Query: 594 NNKISGSIPVSFEKLSYLKELNLSFN 619
           +N+IS   P     L+ + +L L+  
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 97.4 bits (241), Expect = 4e-22
 Identities = 86/434 (19%), Positives = 142/434 (32%), Gaps = 65/434 (14%)

Query: 66  IICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKV 125
           I  D    +     L   N+  T+     +L  + +L      + S     +  ++ L  
Sbjct: 15  IFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQ 70

Query: 126 LYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGK 185
           +   +NQL+  ++     T       L    ++     +I           L        
Sbjct: 71  INFSNNQLTD-ITPLKNLTK------LVDILMNNNQIADITPLANLTNLTGLTLFNNQIT 123

Query: 186 IPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLD 245
               L     L  L L  N +      +I  L+ L  +  ++        + +  L  L+
Sbjct: 124 DIDPLKNLTNLNRLELSSNTI-----SDISALSGLTSLQQLSFGNQVTDLKPLANLTTLE 178

Query: 246 VLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSG 305
            L +  N       + +  ++ L+ +   NN +S   P  I     NL+ L+L  N    
Sbjct: 179 RLDISSNK--VSDISVLAKLTNLESLIATNNQISDITPLGIL---TNLDELSLNGNQLKD 233

Query: 306 TIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLA 365
               ++ + + L  L++ +N  S   P                               L+
Sbjct: 234 --IGTLASLTNLTDLDLANNQISNLAP-------------------------------LS 260

Query: 366 NCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLG 425
              KL  L LG N +    P     L+      N+            I NL NL  L+L 
Sbjct: 261 GLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQLEDISPISNLKNLTYLTLY 315

Query: 426 GNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCL 485
            NN+S   P     L KLQ L  A NK+  S    +  L+ +N L    N+IS      L
Sbjct: 316 FNNISDISP--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTP--L 369

Query: 486 GNLTSLQYLNLGSN 499
            NLT +  L L   
Sbjct: 370 ANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 91.2 bits (225), Expect = 4e-20
 Identities = 78/409 (19%), Positives = 139/409 (33%), Gaps = 62/409 (15%)

Query: 187 PSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDV 246
             S +   Q+  L      +       +  L  L +I+  NN+L    P  +  L  L  
Sbjct: 37  TVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 92

Query: 247 LQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGT 306
           + +  N +  + P       T   +F    +    L +  +L    L    +        
Sbjct: 93  ILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD------ 146

Query: 307 IPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLAN 366
               I+  S L  L+  S          + NL  L+  DI  N ++  +         A 
Sbjct: 147 ----ISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL-------AK 195

Query: 367 CKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGG 426
              L  L    N +    P  I     +L+ L++    +       + +L+NL  L L  
Sbjct: 196 LTNLESLIATNNQISDITPLGILT---NLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250

Query: 427 NNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLG 486
           N +S   P    GL KL  L L  N+++   P          EL+ N  +      S + 
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE----DISPIS 304

Query: 487 NLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSR 546
           NL +L YL L  N  + + P                          + +L  +  +  + 
Sbjct: 305 NLKNLTYLTLYFNNISDISP--------------------------VSSLTKLQRLFFAN 338

Query: 547 NNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNN 595
           N +S    ++L  L ++  +S  +N++    P    N+T +  L L++ 
Sbjct: 339 NKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.7 bits (125), Expect = 1e-07
 Identities = 22/106 (20%), Positives = 40/106 (37%), Gaps = 4/106 (3%)

Query: 46  PTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLS 105
           P   L        +      I    N   +T L L   N+    P  +++L+ L+ L  +
Sbjct: 280 PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFA 337

Query: 106 HNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIR 151
           +NK+S    SS+  ++ +  L    NQ+S           + L + 
Sbjct: 338 NNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLN 381

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.0 bits (118), Expect = 8e-07
 Identities = 45/267 (16%), Positives = 89/267 (33%), Gaps = 49/267 (18%)

Query: 397 RLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGS 456
           +  +   N++  + +   +L  +  L      +  SI      L  L  ++ + N+L   
Sbjct: 26  KTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDI 81

Query: 457 IPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQY----------------------- 493
            P  +  L++L ++ +N N+I+           +                          
Sbjct: 82  TP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLEL 139

Query: 494 ----LNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGN----------LKAV 539
               ++  S                +      +NL          N          L  +
Sbjct: 140 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNL 199

Query: 540 VGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISG 599
             +  + N +S   P  +    +L  +SL  N+L+     +  ++T+L  LDL+NN+IS 
Sbjct: 200 ESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 255

Query: 600 SIPVSFEKLSYLKELNLSFNKLKGEIP 626
             P     L+ L EL L  N++    P
Sbjct: 256 LAP--LSGLTKLTELKLGANQISNISP 280

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 5e-06
 Identities = 16/91 (17%), Positives = 33/91 (36%), Gaps = 4/91 (4%)

Query: 41  HITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLK 100
                P + L           +   I    +  K+  L  ++  +       +ANL+++ 
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD--VSSLANLTNIN 354

Query: 101 SLDLSHNKLSSNIPSSIFTMSTLKVLYLMDN 131
            L   HN++S   P  +  ++ +  L L D 
Sbjct: 355 WLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 5e-06
 Identities = 12/85 (14%), Positives = 36/85 (42%), Gaps = 6/85 (7%)

Query: 535 NLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSN 594
            L   +   L + N++  +  +   L  +  +      ++    +    + +L  ++ SN
Sbjct: 20  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75

Query: 595 NKISGSIPVSFEKLSYLKELNLSFN 619
           N+++   P   + L+ L ++ ++ N
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNN 98

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 3e-04
 Identities = 14/69 (20%), Positives = 26/69 (37%), Gaps = 4/69 (5%)

Query: 558 EGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLS 617
             L       L    +   + ++  ++  + +L      I  SI    E L+ L ++N S
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFS 74

Query: 618 FNKLKGEIP 626
            N+L    P
Sbjct: 75  NNQLTDITP 83

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.8 bits (89), Expect = 0.003
 Identities = 15/83 (18%), Positives = 32/83 (38%), Gaps = 6/83 (7%)

Query: 439 GLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGS 498
            L +     L    +  ++      L ++  L  +   I  SI   +  L +L  +N  +
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75

Query: 499 NRFTFVIPSTFWNLKDILSFDIS 521
           N+ T + P    NL  ++   ++
Sbjct: 76  NQLTDITP--LKNLTKLVDILMN 96

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  109 bits (272), Expect = 2e-26
 Identities = 41/181 (22%), Positives = 83/181 (45%), Gaps = 18/181 (9%)

Query: 726 DNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRN 783
           D++     +G G +  V+ A  + +  ++ +K+  P      K  + E ++++N+R   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPN 91

Query: 784 LVKIISSCSNDDFK--ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF 841
           ++ +     +   +  ALV E+++N   +    +    L  +     M +I  AL+Y H 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH- 146

Query: 842 GHSTPIIHCDLKPSNVLLD-EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEI 900
             S  I+H D+KP NV++D E     L D+G+A+      E  +R  +     +  P+ +
Sbjct: 147 --SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR---YFKGPELL 201

Query: 901 F 901
            
Sbjct: 202 V 202

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 1e-25
 Identities = 44/196 (22%), Positives = 78/196 (39%), Gaps = 18/196 (9%)

Query: 716 FSYFELLRATDNFAEN----NIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAST--LKS 768
           F   E+ +              +G G +G+V  A     G ++AIK  +    S    K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 769 FEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSNGSLEDCLHSS---NCALNIFCR 825
              E  ++K++RH N++ ++   + D+      ++                +  L     
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 826 LNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR 885
             ++  +   L Y+H   +  IIH DLKP N+ ++ED    + DFG+A+    E      
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----M 175

Query: 886 TQTLATIGYMAPDEIF 901
           T  + T  Y AP+ I 
Sbjct: 176 TGYVVTRWYRAPEVIL 191

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  102 bits (253), Expect = 3e-24
 Identities = 74/361 (20%), Positives = 126/361 (34%), Gaps = 69/361 (19%)

Query: 28  ISTDQQALLALKDHITYDPTNLLGTNWTSNASIC--SWIGIICDVNS--HKVTTLNLSSF 83
              D+QALL +K  +  +PT L  ++W      C  +W+G++CD ++  ++V  L+LS  
Sbjct: 4   NPQDKQALLQIKKDLG-NPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGL 60

Query: 84  NLQG--TIPPEIANLSSLKSLDLSHN-KLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSF 140
           NL     IP  +ANL  L  L +     L   IP +I  ++ L  LY+            
Sbjct: 61  NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN-------- 112

Query: 141 TFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELH 200
                                  +  + ++ L  L    N   G +P S+S    L  + 
Sbjct: 113 -----------------VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155

Query: 201 LGYNNLSGAIPKEIGNLTVLQR-ISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVP 259
              N +SGAIP   G+ + L   +++  N+L G+IP     L    V             
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASV 215

Query: 260 ATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLIL 319
               + +T                                  +        +  +  L  
Sbjct: 216 LFGSDKNT---------------------------QKIHLAKNSLAFDLGKVGLSKNLNG 248

Query: 320 LEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNP 379
           L++ +N   G +P  +  L+ L   ++ FNNL    P+ G      N ++        N 
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG------NLQRFDVSAYANNK 302

Query: 380 L 380
            
Sbjct: 303 C 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 97.5 bits (241), Expect = 1e-22
 Identities = 66/269 (24%), Positives = 103/269 (38%), Gaps = 29/269 (10%)

Query: 414 GNLSNLIVLSLGGNNLSG--SIPVTFGGLQKLQGLDLAFN-KLAGSIPDEICLLSRLNEL 470
                +  L L G NL     IP +   L  L  L +     L G IP  I  L++L+ L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 471 DLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPIS 530
            +    +SG+I   L  + +L  L+   N  +  +P +  +L +++      N + G I 
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 531 LAIGNLKAVVGIDLSRNN-----------------------LSGNIPTTLEGLKSLQNIS 567
            + G+   +        N                       +     + L G        
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226

Query: 568 LAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPR 627
                         G   +L  LDL NN+I G++P    +L +L  LN+SFN L GEIP+
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286

Query: 628 GGPFANFTAESFMGNELLCGLPNLQVPPC 656
           GG    F   ++  N+ LCG P   +P C
Sbjct: 287 GGNLQRFDVSAYANNKCLCGSP---LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 78.6 bits (192), Expect = 3e-16
 Identities = 69/260 (26%), Positives = 108/260 (41%), Gaps = 28/260 (10%)

Query: 369 KLRYLGLGGNPLDGF--LPSSIGNLSLSLERLNIAFC-NISGNIPKAIGNLSNLIVLSLG 425
           ++  L L G  L     +PSS+ NL   L  L I    N+ G IP AI  L+ L  L + 
Sbjct: 51  RVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYIT 109

Query: 426 GNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCL 485
             N+SG+IP     ++ L  LD ++N L+G++P  I  L  L  +  +GN+ISG+I    
Sbjct: 110 HTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169

Query: 486 GNLTSL-----------------------QYLNLGSNRFTFVIPSTFWNLKDILSFDISS 522
           G+ + L                             S        S  +           +
Sbjct: 170 GSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229

Query: 523 NLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFG 582
                     +G  K + G+DL  N + G +P  L  LK L ++++++N L G IP+  G
Sbjct: 230 KNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GG 288

Query: 583 NMTSLESLDLSNNKISGSIP 602
           N+   +    +NNK     P
Sbjct: 289 NLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 78.3 bits (191), Expect = 4e-16
 Identities = 74/278 (26%), Positives = 105/278 (37%), Gaps = 12/278 (4%)

Query: 188 SSLSKCKQLQELHLGYNNLSGA--IPKEIGNLTVLQRISLINN-KLHGEIPQEIGYLQNL 244
            + ++  ++  L L   NL     IP  + NL  L  + +     L G IP  I  L  L
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 245 DVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFS 304
             L +   N++G +P  +  + TL  +    N+LSG+LP  I  +LPNL  +    N  S
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS-SLPNLVGITFDGNRIS 162

Query: 305 GTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSL 364
           G IP S  + SKL      S +             NL   D+  N L      L      
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN 222

Query: 365 ANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSL 424
                L    L  +     L  ++  L L           I G +P+ +  L  L  L++
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLR-------NNRIYGTLPQGLTQLKFLHSLNV 275

Query: 425 GGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEIC 462
             NNL G IP   G LQ+      A NK     P   C
Sbjct: 276 SFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 58.6 bits (140), Expect = 1e-09
 Identities = 20/77 (25%), Positives = 32/77 (41%), Gaps = 2/77 (2%)

Query: 61  CSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTM 120
                +     S  +  L+L +  + GT+P  +  L  L SL++S N L   IP     +
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNL 290

Query: 121 STLKVLYLMDNQ-LSGS 136
               V    +N+ L GS
Sbjct: 291 QRFDVSAYANNKCLCGS 307

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 94.5 bits (234), Expect = 1e-22
 Identities = 27/163 (16%), Positives = 50/163 (30%), Gaps = 26/163 (15%)

Query: 732 NIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLK----------SFEAECEVIKNIRH 781
            ++G G   +V+    E   E  +K       S  K           F            
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 782 RNLVKIISSCSNDDF----KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALE 837
           R L K+        +     A+++E +    L            +     ++  I   + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVA 117

Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED 880
                +   I+H DL   NVL+ E+ +  + DF  +  +  E 
Sbjct: 118 KF---YHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEG 156

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 2e-22
 Identities = 44/184 (23%), Positives = 81/184 (44%), Gaps = 16/184 (8%)

Query: 725 TDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAST--LKSFEAECEVIKNIRH 781
            + +   + +G G +GSV  A   + G+ +A+K       S    K    E  ++K+++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 782 RNLVKIISSCSND----DFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALE 837
            N++ ++   +      +F  + L     G+  + +      L       ++  I   L+
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLK 135

Query: 838 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAP 897
           Y+H   S  IIH DLKPSN+ ++ED    + DFG+A+    E    +      T  Y AP
Sbjct: 136 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAP 187

Query: 898 DEIF 901
           + + 
Sbjct: 188 EIML 191

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.3 bits (241), Expect = 3e-22
 Identities = 46/193 (23%), Positives = 77/193 (39%), Gaps = 22/193 (11%)

Query: 717 SYFELLRATDNFAENNIIGIGGFGSVYRAR-LEDGVEIAIKVFHPQCAS--TLKSFEAEC 773
           S F +L     +     IG G  G V  A        +AIK       +    K    E 
Sbjct: 11  STFTVL---KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67

Query: 774 EVIKNIRHRNLVKIISSCSNDDFK------ALVLEYMSNGSLEDCLHSSNCALNIFCRLN 827
            ++K + H+N++ +++  +            LV+E M     +      +          
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER----MSY 123

Query: 828 IMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQ 887
           ++  +   +++LH   S  IIH DLKPSN+++  D    + DFG+A+       S M T 
Sbjct: 124 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTP 177

Query: 888 TLATIGYMAPDEI 900
            + T  Y AP+ I
Sbjct: 178 YVVTRYYRAPEVI 190

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 94.7 bits (234), Expect = 9e-22
 Identities = 52/259 (20%), Positives = 95/259 (36%), Gaps = 12/259 (4%)

Query: 370 LRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNL 429
              L L  N +         NL  +L  L +    IS   P A   L  L  L L  N L
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91

Query: 430 SGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLT 489
                     LQ+L+  +    K+  S+ + +  +  +  L  N  K SG  +     + 
Sbjct: 92  KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMK 150

Query: 490 SLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNL 549
            L Y+ +     T +      +L ++    +  N +    + ++  L  +  + LS N++
Sbjct: 151 KLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207

Query: 550 SGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSF---- 605
           S     +L     L+ + L  N+L   +P    +   ++ + L NN IS      F    
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266

Query: 606 --EKLSYLKELNLSFNKLK 622
              K +    ++L  N ++
Sbjct: 267 YNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 92.0 bits (227), Expect = 7e-21
 Identities = 51/263 (19%), Positives = 95/263 (36%), Gaps = 15/263 (5%)

Query: 390 NLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLA 449
           +L      L++    I+        NL NL  L L  N +S   P  F  L KL+ L L+
Sbjct: 28  DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87

Query: 450 FNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTF 509
            N+L          L  L   +    K+  S+ + L  +  +  L     + + +    F
Sbjct: 88  KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAF 146

Query: 510 WNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLA 569
             +K +    I+   +    ++  G   ++  + L  N ++     +L+GL +L  + L+
Sbjct: 147 QGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203

Query: 570 YNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGG 629
           +N +      S  N   L  L L+NNK+   +P       Y++ + L  N +        
Sbjct: 204 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS------- 255

Query: 630 PFANFTAESFMGNELLCGLPNLQ 652
                 +  F          +  
Sbjct: 256 ---AIGSNDFCPPGYNTKKASYS 275

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 89.3 bits (220), Expect = 6e-20
 Identities = 63/319 (19%), Positives = 106/319 (33%), Gaps = 49/319 (15%)

Query: 185 KIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNL 244
           K+P  L        L L  N ++     +  NL  L  + LINNK+    P     L  L
Sbjct: 24  KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 245 DVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFS 304
           + L L  N L                           LP ++   L  L      I    
Sbjct: 82  ERLYLSKNQLK-------------------------ELPEKMPKTLQELRVHENEITKVR 116

Query: 305 GTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSL 364
            ++ + +     + L        SG    A   ++ L    I   N+T+    L      
Sbjct: 117 KSVFNGLNQMIVVELGTN-PLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL------ 169

Query: 365 ANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSL 424
                L  L L GN +     +S+  L+ +L +L ++F +IS     ++ N  +L  L L
Sbjct: 170 --PPSLTELHLDGNKITKVDAASLKGLN-NLAKLGLSFNSISAVDNGSLANTPHLRELHL 226

Query: 425 GGNNLSGSIPVTFGGLQKLQGLDLAFNKLAG------SIPDEICLLSRLNELDLNGNKIS 478
             N L   +P      + +Q + L  N ++         P      +  + + L  N + 
Sbjct: 227 NNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

Query: 479 G-----SISSCLGNLTSLQ 492
                 S   C+    ++Q
Sbjct: 286 YWEIQPSTFRCVYVRAAVQ 304

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 84.3 bits (207), Expect = 3e-18
 Identities = 58/299 (19%), Positives = 102/299 (34%), Gaps = 24/299 (8%)

Query: 61  CSWIGIICDVNSHK---------VTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSS 111
           C    + C     +            L+L +  +      +  NL +L +L L +NK+S 
Sbjct: 10  CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69

Query: 112 NIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRY 171
             P +   +  L+ LYL  NQL             +        K+   +   +      
Sbjct: 70  ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQM--I 127

Query: 172 LKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLH 231
           +  L        G    +    K+L  + +   N++  IP+  G    L  + L  NK+ 
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT 184

Query: 232 GEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALP 291
                 +  L NL  L L FN+++ V   ++ N   L+E+ L NN L        D    
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD--HK 242

Query: 292 NLEFLNLGINSFSG------TIPSSITNASKLILLEMGSN--SFSGFIPSAIGNLRNLK 342
            ++ + L  N+ S         P   T  +    + + SN   +    PS    +    
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 301

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 79.7 bits (195), Expect = 1e-16
 Identities = 51/291 (17%), Positives = 95/291 (32%), Gaps = 11/291 (3%)

Query: 160 KLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTV 219
           K+P+++      L    L+ N             K L  L L  N +S   P     L  
Sbjct: 24  KVPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80

Query: 220 LQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLS 279
           L+R+ L  N+L     +    LQ L V +     +   V   +  M  ++       S  
Sbjct: 81  LERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 140

Query: 280 GSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLR 339
               +     +  L ++ +   + + TIP  +     L  L +  N  +    +++  L 
Sbjct: 141 IENGAFQG--MKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLN 195

Query: 340 NLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLN 399
           NL    + FN++++        +       L    L   P        I  + L    ++
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS 255

Query: 400 IAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGS--IPVTFGGLQKLQGLDL 448
            A  +     P      ++   +SL  N +      P TF  +     + L
Sbjct: 256 -AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 95.5 bits (236), Expect = 1e-21
 Identities = 42/228 (18%), Positives = 86/228 (37%), Gaps = 20/228 (8%)

Query: 734 IGIGGFGSVYRAR-LEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCS 792
           +G G F +V+ A+ + +   +A+K+       T ++ E E ++++ +   +  K  S  +
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 793 NDDFK---------------ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALE 837
           N   K                +V E +    L       +  + +     I   +   L+
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 838 YLHFGHSTPIIHCDLKPSNVLLD-EDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMA 896
           Y+H      IIH D+KP NVL++  D   +L    +A L +        T ++ T  Y +
Sbjct: 140 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 897 PDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAAKEQCLLS 944
           P+ +          +     +    +    L   +E H   K+   ++
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.6 bits (228), Expect = 4e-21
 Identities = 60/285 (21%), Positives = 105/285 (36%), Gaps = 8/285 (2%)

Query: 68  CDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLY 127
           C   +    T +     LQ  +P  I   ++ + + L  N++S    +S      L +L+
Sbjct: 6   CVCYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILW 62

Query: 128 LMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIP 187
           L  N L+   ++     + +  + LS N     +     + L  L  L L         P
Sbjct: 63  LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122

Query: 188 SSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVL 247
                   LQ L+L  N L         +L  L  + L  N++     +    L +LD L
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182

Query: 248 QLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTI 307
            L  N +  V P    ++  L  ++L+ N+LS +LP+     L  L++L L  N +    
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWVCDC 241

Query: 308 PSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLT 352
             +    + L      S+     +P     L    L  +  N+L 
Sbjct: 242 R-ARPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQ 282

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.7 bits (205), Expect = 4e-18
 Identities = 61/269 (22%), Positives = 95/269 (35%), Gaps = 11/269 (4%)

Query: 331 IPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGN 390
           +P  I      +   +  N ++          S   C+ L  L L  N L     ++   
Sbjct: 26  VPVGIP--AASQRIFLHGNRISHVPAA-----SFRACRNLTILWLHSNVLARIDAAAFTG 78

Query: 391 LSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAF 450
           L+L  +        +    P     L  L  L L    L    P  F GL  LQ L L  
Sbjct: 79  LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138

Query: 451 NKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFW 510
           N L     D    L  L  L L+GN+IS         L SL  L L  NR   V P  F 
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198

Query: 511 NLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAY 570
           +L  +++  + +N L    + A+  L+A+  + L+ N    +          LQ    + 
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSS 257

Query: 571 NRLEGPIPESFGNMTSLESLDLSNNKISG 599
           + +   +P+        +   L+ N + G
Sbjct: 258 SEVPCSLPQRLAG---RDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.0 bits (185), Expect = 2e-15
 Identities = 47/265 (17%), Positives = 79/265 (29%), Gaps = 26/265 (9%)

Query: 186 IPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLD 245
           +P  +      Q + L  N +S            L  + L +N L          L  L+
Sbjct: 26  VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 246 VLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSG 305
            L L  N     V    F+          +      L   +   L  L++L L  N+   
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 306 TIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPEL------- 358
               +  +   L  L +  N  S     A   L +L    +  N +    P         
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 359 ------------GFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNIS 406
                           +LA  + L+YL L  NP           L   L++   +   + 
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC--DCRARPLWAWLQKFRGSSSEVP 261

Query: 407 GNIPKAIGNLSNLIVLSLGGNNLSG 431
            ++P+    L+   +  L  N+L G
Sbjct: 262 CSLPQ---RLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.9 bits (177), Expect = 2e-14
 Identities = 57/242 (23%), Positives = 89/242 (36%), Gaps = 3/242 (1%)

Query: 409 IPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLN 468
           +P  I   +    + L GN +S     +F   + L  L L  N LA         L+ L 
Sbjct: 26  VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 469 ELDLNGNKISGSISS-CLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDG 527
           +LDL+ N    S+       L  L  L+L       + P  F  L  +    +  N L  
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 528 PISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSL 587
                  +L  +  + L  N +S        GL SL  + L  NR+    P +F ++  L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 588 ESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCG 647
            +L L  N +S     +   L  L+ L L+ N    +      +A         +E+ C 
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263

Query: 648 LP 649
           LP
Sbjct: 264 LP 265

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.3 bits (165), Expect = 6e-13
 Identities = 49/261 (18%), Positives = 84/261 (32%), Gaps = 11/261 (4%)

Query: 26  SNISTDQQALLALKDHITYDPTNLLG------TNWTSNASICSWIGIICDVNSHKVTTLN 79
             I    Q +    + I++ P             W  +  +           +       
Sbjct: 28  VGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87

Query: 80  LSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSS 139
             +  L+   P     L  L +L L    L    P     ++ L+ LYL DN L      
Sbjct: 88  SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147

Query: 140 FTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQEL 199
              +  ++  + L  N++S  +PE     L  L  L L +N      P +     +L  L
Sbjct: 148 TFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206

Query: 200 HLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVP 259
           +L  NNLS    + +  L  LQ + L +N    +          L   +   + +   +P
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLP 265

Query: 260 ATIFNMSTLKEIFLYNNSLSG 280
             +      +   L  N L G
Sbjct: 266 QRLAGRDLKR---LAANDLQG 283

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.5 bits (158), Expect = 4e-12
 Identities = 53/213 (24%), Positives = 83/213 (38%), Gaps = 9/213 (4%)

Query: 67  ICDV-NSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKV 125
           IC+V        +N    NL   +PP++        L LS N L +   +++   + L  
Sbjct: 3   ICEVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQ 59

Query: 126 LYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGK 185
           L L   +L+      T      LD+  ++     +    +   L  L  L +  N     
Sbjct: 60  LNLDRAELTKLQVDGTLPVLGTLDLSHNQL----QSLPLLGQTLPALTVLDVSFNRLTSL 115

Query: 186 IPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLD 245
              +L    +LQEL+L  N L    P  +     L+++SL NN L       +  L+NLD
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175

Query: 246 VLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSL 278
            L L  N+L   +P   F    L   FL+ N  
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.8 bits (151), Expect = 3e-11
 Identities = 41/207 (19%), Positives = 65/207 (31%), Gaps = 25/207 (12%)

Query: 436 TFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLN 495
               +     ++     L  ++P ++        L L+ N +     + L   T L  LN
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 496 LGSNRFTFVI---------------------PSTFWNLKDILSFDISSNLLDGPISLAIG 534
           L     T +                      P     L  +   D+S N L      A+ 
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 535 NLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSN 594
            L  +  + L  N L    P  L     L+ +SLA N L          + +L++L L  
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 595 NKISGSIPVSFEKLSYLKELNLSFNKL 621
           N +  +IP  F     L    L  N  
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.3 bits (142), Expect = 4e-10
 Identities = 45/196 (22%), Positives = 65/196 (33%), Gaps = 12/196 (6%)

Query: 186 IPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLD 245
           +P  L K      LHL  N L       +   T L +++L   +L     Q  G L  L 
Sbjct: 25  LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQVDGTLPVLG 80

Query: 246 VLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSG 305
            L L  N L  +        +       +N   S  LP      L  L+ L L  N    
Sbjct: 81  TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS--LPLGALRGLGELQELYLKGNELKT 138

Query: 306 TIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLA 365
             P  +T   KL  L + +N+ +      +  L NL    +  N+L +            
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFF------ 192

Query: 366 NCKKLRYLGLGGNPLD 381
               L +  L GNP  
Sbjct: 193 GSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.0 bits (136), Expect = 2e-09
 Identities = 41/187 (21%), Positives = 68/187 (36%), Gaps = 6/187 (3%)

Query: 409 IPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLN 468
           +P  +    +  +L L  N L      T     +L  L+L   +   +       L  L 
Sbjct: 25  LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE--LTKLQVDGTLPVLG 80

Query: 469 ELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGP 528
            LDL+ N++          L +L  L++  NR T +       L ++    +  N L   
Sbjct: 81  TLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139

Query: 529 ISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLE 588
               +     +  + L+ NNL+      L GL++L  + L  N L   IP+ F     L 
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198

Query: 589 SLDLSNN 595
              L  N
Sbjct: 199 FAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.0 bits (128), Expect = 3e-08
 Identities = 43/215 (20%), Positives = 71/215 (33%), Gaps = 14/215 (6%)

Query: 261 TIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILL 320
            +  +++  E+     +L+ +LP  +     +   L+L  N       +++   ++L  L
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 321 EMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPL 380
            +  +          G L  L   D+  N L S       L +L                
Sbjct: 61  NL--DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS---- 114

Query: 381 DGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGL 440
              LP         L+ L +    +    P  +     L  LSL  NNL+        GL
Sbjct: 115 ---LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171

Query: 441 QKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGN 475
           + L  L L  N L  +IP        L    L+GN
Sbjct: 172 ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.8 bits (112), Expect = 3e-06
 Identities = 38/205 (18%), Positives = 61/205 (29%), Gaps = 16/205 (7%)

Query: 297 NLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTP 356
              + +    +P   T       L +  N    F  + +     L   ++      +   
Sbjct: 19  KRNLTALPPDLPKDTTI------LHLSENLLYTFSLATLMPYTRLTQLNL-DRAELTKLQ 71

Query: 357 ELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNL 416
             G L  L               L   LP+            +++F  ++     A+  L
Sbjct: 72  VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL--------DVSFNRLTSLPLGALRGL 123

Query: 417 SNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNK 476
             L  L L GN L    P       KL+ L LA N L       +  L  L+ L L  N 
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183

Query: 477 ISGSISSCLGNLTSLQYLNLGSNRF 501
           +  +I         L +  L  N +
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (100), Expect = 8e-05
 Identities = 17/81 (20%), Positives = 29/81 (35%), Gaps = 1/81 (1%)

Query: 53  NWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSN 112
                 +    +       + K+  L+L++ NL       +  L +L +L L  N L + 
Sbjct: 128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT- 186

Query: 113 IPSSIFTMSTLKVLYLMDNQL 133
           IP   F    L   +L  N  
Sbjct: 187 IPKGFFGSHLLPFAFLHGNPW 207

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.5 bits (145), Expect = 2e-10
 Identities = 39/280 (13%), Positives = 95/280 (33%), Gaps = 9/280 (3%)

Query: 221 QRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSG 280
           Q + L    LH ++   +   Q +   +   + +   +    F+   ++ + L N+ +  
Sbjct: 3   QTLDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEV 60

Query: 281 SLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMG--SNSFSGFIPSAIGNL 338
           S    I      L+ L+L     S  I +++   S L+ L +   S      + + + + 
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 339 RNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYL-GLGGNPLDGFLPSSIGNLSLSLER 397
             L   ++ +    +       ++ ++       L G   N     L + +      +  
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 398 LNIAFCNISGNIPKAIGNLSNLIVLSLGG-NNLSGSIPVTFGGLQKLQGLDLAFNKLAGS 456
                  +  +  +    L+ L  LSL    ++     +  G +  L+ L +      G+
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240

Query: 457 IPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNL 496
           +     L   L  L +N +  +      +GN  + +   +
Sbjct: 241 LQL---LKEALPHLQINCSHFTTIARPTIGNKKNQEIWGI 277

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.3 bits (129), Expect = 2e-08
 Identities = 35/278 (12%), Positives = 86/278 (30%), Gaps = 11/278 (3%)

Query: 100 KSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSG 159
           ++LDL+   L  ++   + +   +       + +   L+   F+   +  + LS + +  
Sbjct: 3   QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV 60

Query: 160 KLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKE------ 213
                I +    L++L L        I ++L+K   L  L+L   +       +      
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 214 --IGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEI 271
             +  L +          +   +      +  L++     N     +   +     L  +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 272 FLYNNSLSGSLPSRIDLALPNLEFLNL-GINSFSGTIPSSITNASKLILLEMGSNSFSGF 330
            L ++ +  +   +    L  L+ L+L             +     L  L++      G 
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240

Query: 331 IPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCK 368
           +      L +L++    F  +   T        +   K
Sbjct: 241 LQLLKEALPHLQINCSHFTTIARPTIGNKKNQEIWGIK 278

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.4 bits (124), Expect = 9e-08
 Identities = 38/260 (14%), Positives = 88/260 (33%), Gaps = 37/260 (14%)

Query: 397 RLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKL-AG 455
            L++   N+  ++   + +   +I      + +   +   F    ++Q +DL+ + +   
Sbjct: 4   TLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVS 61

Query: 456 SIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDI 515
           ++   +   S+L  L L G ++S  I + L   ++L  LNL                   
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121

Query: 516 LSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSG------------------------ 551
              +++ +         +    A V   +++ NLSG                        
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181

Query: 552 ---------NIPTTLEGLKSLQNISLAY-NRLEGPIPESFGNMTSLESLDLSNNKISGSI 601
                    +       L  LQ++SL+    +        G + +L++L +      G++
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241

Query: 602 PVSFEKLSYLKELNLSFNKL 621
            +  E L +L+     F  +
Sbjct: 242 QLLKEALPHLQINCSHFTTI 261

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.2 bits (113), Expect = 2e-06
 Identities = 40/280 (14%), Positives = 91/280 (32%), Gaps = 14/280 (5%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSG 135
            TL+L+  NL   +   + +   + +     + +   +    F+   ++ + L ++ +  
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEV 60

Query: 136 -SLSSFTFNTSSILDIRLSKNKLSGKLPENI--CNHLRYLKHLFLRENMFYGKIP----- 187
            +L       S + ++ L   +LS  +   +   ++L  L          +         
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 188 SSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVL 247
           S L +            ++  A+      +T L       N    ++   +    NL  L
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 248 QLGFN-NLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGT 306
            L  +  L        F ++ L+ + L                +P L+ L +      GT
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240

Query: 307 IPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDI 346
           +         L +     + F+      IGN +N +++ I
Sbjct: 241 LQLLKEALPHLQIN---CSHFTTIARPTIGNKKNQEIWGI 277

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.9 bits (107), Expect = 1e-05
 Identities = 34/274 (12%), Positives = 81/274 (29%), Gaps = 20/274 (7%)

Query: 320 LEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNP 379
           L++   +     P   G L +  +            P     S      +++++ L  + 
Sbjct: 5   LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF----RVQHMDLSNSV 57

Query: 380 LDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLG--GNNLSGSIPVTF 437
           ++      I +    L+ L++    +S  I   +   SNL+ L+L         ++    
Sbjct: 58  IEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 117

Query: 438 GGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELD-------LNGNKISGSISSCLGNLTS 490
               +L  L+L++         ++ +      +            + S   +        
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177

Query: 491 LQYLNLGSNRFTFVIPSTFWNLKDILSFDISS-NLLDGPISLAIGNLKAVVGIDLSRNNL 549
           +      S          F+ L  +    +S    +     L +G +  +  + +     
Sbjct: 178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVP 237

Query: 550 SGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGN 583
            G +    E L  LQ   +  +        + GN
Sbjct: 238 DGTLQLLKEALPHLQ---INCSHFTTIARPTIGN 268

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.1 bits (105), Expect = 2e-05
 Identities = 39/259 (15%), Positives = 90/259 (34%), Gaps = 15/259 (5%)

Query: 65  GIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTL 123
            +   + S  V         +   +  E  +   ++ +DLS++ +  +    I +  S L
Sbjct: 15  DVTGRLLSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 73

Query: 124 KVLYLMDNQLSG----SLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRE 179
           + L L   +LS     +L+  +      L      ++ + +   + C+ L  L   +  +
Sbjct: 74  QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 133

Query: 180 NMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLI----NNKLHGEIP 235
                   +     + + +L+L     +         +     +  +    +  L  +  
Sbjct: 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 193

Query: 236 QEIGYLQNLDVLQL-GFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLE 294
           QE   L  L  L L    ++       +  + TLK + ++     G+L   +  ALP+  
Sbjct: 194 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ-LLKEALPH-- 250

Query: 295 FLNLGINSFSGTIPSSITN 313
            L +  + F+     +I N
Sbjct: 251 -LQINCSHFTTIARPTIGN 268

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 57.0 bits (136), Expect = 2e-09
 Identities = 37/217 (17%), Positives = 73/217 (33%), Gaps = 22/217 (10%)

Query: 415 NLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNG 474
            L+N I ++ G +N++    VT   L  +  L      +  +I   +  L+ L  L+L  
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72

Query: 475 NKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIG 534
           N+I+           +   L+    +    I          L+    +++        + 
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 535 NLKAVVGIDLSRNNL--------------SGNIPTTLEGLKSLQNISLAYNRLEGPIPES 580
            L   +    + + L                +  T L  L  L  +    N++    P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 581 FGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLS 617
             ++ +L  + L NN+IS   P      S L  + L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.6 bits (122), Expect = 1e-07
 Identities = 40/215 (18%), Positives = 75/215 (34%), Gaps = 22/215 (10%)

Query: 394 SLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKL 453
           +  ++     N++  + +A  +L  +  LS  G  ++ +I      L  L GL+L  N++
Sbjct: 20  NAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQI 75

Query: 454 AGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLK 513
               P +        EL  N  K   +I+      T        ++       S    L 
Sbjct: 76  TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLY 135

Query: 514 DILSFDISSNLLDGPI--------------SLAIGNLKAVVGIDLSRNNLSGNIPTTLEG 559
             L+   + + L G                   + NL  +  +    N +S   P  L  
Sbjct: 136 LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LAS 193

Query: 560 LKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSN 594
           L +L  + L  N++    P    N ++L  + L+N
Sbjct: 194 LPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.1 bits (113), Expect = 2e-06
 Identities = 37/223 (16%), Positives = 74/223 (33%), Gaps = 21/223 (9%)

Query: 66  IICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKV 125
           I  D        +     N+  T+    A+L  + +L      +++     +  ++ L  
Sbjct: 12  IFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIG 67

Query: 126 LYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRE------ 179
           L L DNQ++           + L++  +  K    +          L    + +      
Sbjct: 68  LELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127

Query: 180 -------NMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHG 232
                   +   +I +           +L   N   +    + NL+ L  +   +NK+  
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187

Query: 233 EIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYN 275
             P  +  L NL  + L  N ++ V P  + N S L  + L N
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 2e-04
 Identities = 35/222 (15%), Positives = 66/222 (29%), Gaps = 26/222 (11%)

Query: 313 NASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRY 372
             +  I +  G ++ +  +  A  +L  +     F   +T+       +  +     L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT-------IEGVQYLNNLIG 67

Query: 373 LGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGG------ 426
           L L  N +    P         LE       N+S           +L    +        
Sbjct: 68  LELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127

Query: 427 -------NNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISG 479
                        I              L+      S    +  LS+L  L  + NKIS 
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187

Query: 480 SISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDIS 521
                L +L +L  ++L +N+ + V P    N  ++    ++
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 5e-04
 Identities = 33/220 (15%), Positives = 70/220 (31%), Gaps = 27/220 (12%)

Query: 194 KQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNN 253
               ++  G +N++  + +   +L  +  +S     +     + + YL NL  L+L  N 
Sbjct: 19  ANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74

Query: 254 LTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLE-------------FLNLGI 300
           +T + P       T  E+         ++     +   +L                   +
Sbjct: 75  ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134

Query: 301 NSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGF 360
                 I +    A    L  +   +      + + NL  L       N ++        
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD------- 187

Query: 361 LSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNI 400
           +S LA+   L  + L  N +    P  + N S +L  + +
Sbjct: 188 ISPLASLPNLIEVHLKNNQISDVSP--LANTS-NLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 9e-04
 Identities = 18/80 (22%), Positives = 32/80 (40%), Gaps = 5/80 (6%)

Query: 53  NWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSN 112
               +        +    N  K+TTL      +    P  +A+L +L  + L +N++S  
Sbjct: 153 LQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDV 210

Query: 113 IPSSIFTMSTLKVLYLMDNQ 132
            P  +   S L ++ L  NQ
Sbjct: 211 SP--LANTSNLFIVTL-TNQ 227

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 56.4 bits (134), Expect = 7e-09
 Identities = 53/339 (15%), Positives = 101/339 (29%), Gaps = 29/339 (8%)

Query: 67  ICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVL 126
           + D    +   L L++  L  ++P    +L   +SL  S N L+  +P    ++ +L V 
Sbjct: 32  LRDCLDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLTE-LPELPQSLKSLLVD 86

Query: 127 YLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKI 186
                 LS       +   S   +       +    + I      LK L           
Sbjct: 87  NNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIA 146

Query: 187 PSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKL---------HGEIPQE 237
             +    +  +  +L +     A    +  L  L                      +P  
Sbjct: 147 AGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFL 206

Query: 238 IGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLN 297
                + ++L+   +    +    + +        L  +     +   I   L  L    
Sbjct: 207 TTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNL 266

Query: 298 LGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPE 357
             +N+ S  I S       L  L + +N     +P+    L  L      FN+L      
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHLAEVPEL 322

Query: 358 LGFLSSLANCKKLRYLGLGGNPLDGF--LPSSIGNLSLS 394
                       L+ L +  NPL  F  +P S+ +L ++
Sbjct: 323 PQ---------NLKQLHVEYNPLREFPDIPESVEDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.4 bits (121), Expect = 3e-07
 Identities = 18/91 (19%), Positives = 33/91 (36%), Gaps = 9/91 (9%)

Query: 402 FCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEI 461
               S  I        +L  L++  N L   +P     L++   L  +FN L   +P+  
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHL-AEVPE-- 321

Query: 462 CLLSRLNELDLNGNKISGSISSCLGNLTSLQ 492
            L   L +L +  N +         ++  L+
Sbjct: 322 -LPQNLKQLHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.6 bits (119), Expect = 5e-07
 Identities = 23/110 (20%), Positives = 46/110 (41%), Gaps = 25/110 (22%)

Query: 544 LSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPV 603
              N  S  I +  +   SL+ ++++ N+L   +P        LE L  S N ++  +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVP- 320

Query: 604 SFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQV 653
             E    LK+L++ +N L+ E P                ++   + +L++
Sbjct: 321 --ELPQNLKQLHVEYNPLR-EFP----------------DIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 48.3 bits (113), Expect = 3e-06
 Identities = 20/89 (22%), Positives = 36/89 (40%), Gaps = 9/89 (10%)

Query: 427 NNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLG 486
           N  S  I         L+ L+++ NKL   +P    L  RL  L  + N ++  +     
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPELPQ 324

Query: 487 NLTSLQYLNLGSNRFTFVIPSTFWNLKDI 515
           N   L+ L++  N      P    +++D+
Sbjct: 325 N---LKQLHVEYNPLRE-FPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.0 bits (107), Expect = 1e-05
 Identities = 17/83 (20%), Positives = 27/83 (32%), Gaps = 8/83 (9%)

Query: 53  NWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSN 112
                 +  S            +  LN+S+  L   +P        L+ L  S N L+  
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLAE- 318

Query: 113 IPSSIFTMSTLKVLYLMDNQLSG 135
           +P        LK L++  N L  
Sbjct: 319 VPELP---QNLKQLHVEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.0 bits (107), Expect = 2e-05
 Identities = 19/79 (24%), Positives = 31/79 (39%), Gaps = 10/79 (12%)

Query: 366 NCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLG 425
               L  L +  N L   LP+    L    ERL  +F +++  +P+   NL     L + 
Sbjct: 282 LPPSLEELNVSNNKLIE-LPALPPRL----ERLIASFNHLA-EVPELPQNLK---QLHVE 332

Query: 426 GNNLSGSIPVTFGGLQKLQ 444
            N L    P     ++ L+
Sbjct: 333 YNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.2 bits (105), Expect = 3e-05
 Identities = 22/93 (23%), Positives = 35/93 (37%), Gaps = 9/93 (9%)

Query: 472 LNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISL 531
              N  S  I S      SL+ LN+ +N+    +P+    L+       S N L   +  
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAE-VPE 321

Query: 532 AIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQ 564
              NLK    + +  N L    P   E ++ L+
Sbjct: 322 LPQNLKQ---LHVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 43.7 bits (101), Expect = 7e-05
 Identities = 17/113 (15%), Positives = 37/113 (32%), Gaps = 10/113 (8%)

Query: 61  CSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTM 120
              +         ++             I        SL+ L++S+NKL   +P+     
Sbjct: 248 FLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP--- 303

Query: 121 STLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLK 173
             L+ L    N     L+       ++  + +  N L  + P+   + +  L+
Sbjct: 304 PRLERLIASFNH----LAEVPELPQNLKQLHVEYNPLR-EFPDIPES-VEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.002
 Identities = 15/54 (27%), Positives = 24/54 (44%), Gaps = 5/54 (9%)

Query: 460 EICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLK 513
             CL  + +EL+LN   +S S+     +   L+ L    N  T  +P    +LK
Sbjct: 33  RDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLK 81

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.5 bits (127), Expect = 2e-08
 Identities = 43/203 (21%), Positives = 74/203 (36%), Gaps = 16/203 (7%)

Query: 415 NLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNG 474
             +  I  +L   +++ ++  T   L  +  +    + +       I  L  + +L LNG
Sbjct: 22  AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 475 NKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIG 534
           NK++      L NL +L +L L  N+   +           LS + +       +     
Sbjct: 78  NKLTDIK--PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135

Query: 535 NLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSN 594
                    L   N      T L  L  L  +SL  N++   +P     +T L++L LS 
Sbjct: 136 L------ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187

Query: 595 NKISGSIPVSFEKLSYLKELNLS 617
           N IS  +  +   L  L  L L 
Sbjct: 188 NHIS-DLR-ALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.2 bits (103), Expect = 2e-05
 Identities = 36/210 (17%), Positives = 77/210 (36%), Gaps = 17/210 (8%)

Query: 66  IICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKV 125
           I  D    +    NL   ++   +      L+S+  +  +++ + S     I  +  +  
Sbjct: 17  IFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTK 72

Query: 126 LYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGK 185
           L+L  N+L+                      L     +++ +     K   L        
Sbjct: 73  LFLNGNKLTDIKPLANLKNLGW-------LFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125

Query: 186 IPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLD 245
             + L    QL+ L+LG N ++      +  LT L  +SL +N++   +P  +  L  L 
Sbjct: 126 DINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ 181

Query: 246 VLQLGFNNLTGVVPATIFNMSTLKEIFLYN 275
            L L  N+++ +    +  +  L  + L++
Sbjct: 182 NLYLSKNHISDLRA--LAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 1e-04
 Identities = 35/213 (16%), Positives = 68/213 (31%), Gaps = 32/213 (15%)

Query: 306 TIPSSI------TNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELG 359
           T+P+ I         ++ I   +   S +  +      L ++       +++ S      
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS------ 60

Query: 360 FLSSLANCKKLRYLGLGGNPLDGFLPSS--------------IGNLSLSLERLNIAFCNI 405
            +  +     +  L L GN L    P +              + +LS   +   +   ++
Sbjct: 61  -VQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSL 119

Query: 406 SGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLS 465
             N    I  L +L  L       +    +T              +     I   +  L+
Sbjct: 120 EHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLT 178

Query: 466 RLNELDLNGNKISGSISSCLGNLTSLQYLNLGS 498
           +L  L L+ N IS  + + L  L +L  L L S
Sbjct: 179 KLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.1 bits (95), Expect = 3e-04
 Identities = 32/195 (16%), Positives = 61/195 (31%), Gaps = 24/195 (12%)

Query: 194 KQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNN 253
            +  + +L   +++ A+ +    L  + +I   N+ +       I YL N+  L L  N 
Sbjct: 24  AETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNK 79

Query: 254 LTG-----------VVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINS 302
           LT             +      +  L  +       S SL       +  L  L    + 
Sbjct: 80  LTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESL 139

Query: 303 FSGTIPSSITNASKLILLEMGSNSFSGFIPS--AIGNLRNLKLFDIFFNNLTSSTPELGF 360
           + G    +       +      +     I     +  L  L+   +  N+++        
Sbjct: 140 YLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD------- 192

Query: 361 LSSLANCKKLRYLGL 375
           L +LA  K L  L L
Sbjct: 193 LRALAGLKNLDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 8e-04
 Identities = 37/221 (16%), Positives = 72/221 (32%), Gaps = 29/221 (13%)

Query: 234 IPQEIGY------LQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRID 287
           +P  I                L   ++T  V  T   ++++ +I   N+ +      +  
Sbjct: 10  VPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQGIQ-- 65

Query: 288 LALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIF 347
             LPN+  L L  N  +   P +       + L+         +                
Sbjct: 66  -YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLK-----------DLKK 113

Query: 348 FNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISG 407
             +L+     +  ++ L +  +L  L LG N +      S      +L   +    +I  
Sbjct: 114 LKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV- 172

Query: 408 NIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDL 448
                +  L+ L  L L  N++S  +     GL+ L  L+L
Sbjct: 173 ----PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.8 bits (89), Expect = 0.002
 Identities = 38/246 (15%), Positives = 77/246 (31%), Gaps = 41/246 (16%)

Query: 349 NNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGN 408
           +   +    +  + S     +     L    +   +  +   L+ S++++     +I   
Sbjct: 5   SETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELN-SIDQIIANNSDIKSV 61

Query: 409 IPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLN 468
               I  L N+  L L GN L+   P     L+ L  L L  NK+      +     +  
Sbjct: 62  QG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSL 117

Query: 469 ELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGP 528
            L+ NG      +       +     N  ++            L  + +  +  N +   
Sbjct: 118 SLEHNGISDINGLVHLPQLESLYLGNNKITDIT------VLSRLTKLDTLSLEDNQISDI 171

Query: 529 ISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLE 588
           + LA                          GL  LQN+ L+ N +      +   + +L+
Sbjct: 172 VPLA--------------------------GLTKLQNLYLSKNHISD--LRALAGLKNLD 203

Query: 589 SLDLSN 594
            L+L +
Sbjct: 204 VLELFS 209

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.7 bits (124), Expect = 2e-07
 Identities = 15/86 (17%), Positives = 29/86 (33%), Gaps = 10/86 (11%)

Query: 542 IDLSRNNLSGN-IPTTLEGLKSLQNISLAYNRLEG----PIPESFGNMTSLESLDLSNNK 596
           +D+    LS       L  L+  Q + L    L       I  +     +L  L+L +N+
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 597 ISGSIPVSF-----EKLSYLKELNLS 617
           +                  +++L+L 
Sbjct: 67  LGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.5 bits (121), Expect = 4e-07
 Identities = 19/104 (18%), Positives = 35/104 (33%), Gaps = 10/104 (9%)

Query: 418 NLIVLSLGGNNLSGS-IPVTFGGLQKLQGLDLAFNKL----AGSIPDEICLLSRLNELDL 472
           ++  L +    LS +        LQ+ Q + L    L       I   + +   L EL+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 473 NGNKISGSISSCLG-----NLTSLQYLNLGSNRFTFVIPSTFWN 511
             N++      C+          +Q L+L +   T        +
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 106

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 5e-07
 Identities = 17/98 (17%), Positives = 38/98 (38%), Gaps = 13/98 (13%)

Query: 163 ENICNHLRYLKHLFLRENMFYGK----IPSSLSKCKQLQELHLGYNNLSGAIPKEIG--- 215
           + +      L+ L+L +          + ++L     L+EL L  N L  A   ++    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 216 --NLTVLQRISLINNKLHGEIPQEIGYLQ----NLDVL 247
                +L+++ L +     E+   +  L+    +L V+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 4e-06
 Identities = 14/85 (16%), Positives = 25/85 (29%), Gaps = 4/85 (4%)

Query: 152 LSKNKLSGKLPENICNHLRYLKHLFLRENMFYGK----IPSSLSKCKQLQELHLGYNNLS 207
           +   +LS      +   L+  + + L +          I S+L     L EL+L  N L 
Sbjct: 9   IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68

Query: 208 GAIPKEIGNLTVLQRISLINNKLHG 232
                 +          +    L  
Sbjct: 69  DVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 7e-06
 Identities = 12/71 (16%), Positives = 25/71 (35%), Gaps = 5/71 (7%)

Query: 562 SLQNISLAYNRL-EGPIPESFGNMTSLESLDLSNNKISG----SIPVSFEKLSYLKELNL 616
            +Q++ +    L +    E    +   + + L +  ++      I  +      L ELNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 617 SFNKLKGEIPR 627
             N+L      
Sbjct: 63  RSNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 1e-05
 Identities = 22/113 (19%), Positives = 39/113 (34%), Gaps = 10/113 (8%)

Query: 72  SHKVTTLNLSSFNLQGTIPPEIA-NLSSLKSLDLSHNKLS----SNIPSSIFTMSTLKVL 126
           S  + +L++    L      E+   L   + + L    L+     +I S++     L  L
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 127 YLMDNQLSGS-----LSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKH 174
            L  N+L        L      +  I  + L    L+G     + + LR L  
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPT 113

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 1e-05
 Identities = 15/80 (18%), Positives = 28/80 (35%), Gaps = 9/80 (11%)

Query: 557 LEGLKSLQNISLAYNRLEG----PIPESFGNMTSLESLDLSNNKISGSIPVSF-----EK 607
            +    L+ + LA   +       +  +     SL  LDLSNN +  +  +       + 
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 608 LSYLKELNLSFNKLKGEIPR 627
              L++L L       E+  
Sbjct: 425 GCLLEQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 1e-05
 Identities = 15/76 (19%), Positives = 27/76 (35%), Gaps = 9/76 (11%)

Query: 542 IDLSRNNLSGN----IPTTLEGLKSLQNISLAYNRLEGPIPESFG-----NMTSLESLDL 592
           + L+  ++S +    +  TL    SL+ + L+ N L                  LE L L
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433

Query: 593 SNNKISGSIPVSFEKL 608
            +   S  +    + L
Sbjct: 434 YDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 3e-05
 Identities = 19/95 (20%), Positives = 35/95 (36%), Gaps = 9/95 (9%)

Query: 337 NLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGF----LPSSIGNLS 392
               L++  +   +++ S+      ++L     LR L L  N L       L  S+    
Sbjct: 367 PGSVLRVLWLADCDVSDSSCS-SLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425

Query: 393 LSLERLNIAFCNISGNIPKAIGNLS----NLIVLS 423
             LE+L +     S  +   +  L     +L V+S
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 4e-05
 Identities = 19/92 (20%), Positives = 31/92 (33%), Gaps = 10/92 (10%)

Query: 514 DILSFDISSN-LLDGPISLAIGNLKAVVGIDLSRNNLSG----NIPTTLEGLKSLQNISL 568
           DI S DI    L D   +  +  L+    + L    L+     +I + L    +L  ++L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 569 AYNRLEGPIPESFG-----NMTSLESLDLSNN 595
             N L                  ++ L L N 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 6e-05
 Identities = 20/83 (24%), Positives = 30/83 (36%), Gaps = 9/83 (10%)

Query: 415 NLSNLIVLSLGGNNLSG----SIPVTFGGLQKLQGLDLAFNKLAGSIPDEIC-----LLS 465
             S L VL L   ++S     S+  T      L+ LDL+ N L  +   ++         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 466 RLNELDLNGNKISGSISSCLGNL 488
            L +L L     S  +   L  L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 2e-04
 Identities = 14/91 (15%), Positives = 28/91 (30%), Gaps = 5/91 (5%)

Query: 467 LNELDLNGNKISGS-ISSCLGNLTSLQYLNLGSNRFTFV----IPSTFWNLKDILSFDIS 521
           +  LD+   ++S +  +  L  L   Q + L     T      I S       +   ++ 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 522 SNLLDGPISLAIGNLKAVVGIDLSRNNLSGN 552
           SN L       +          + + +L   
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 15/76 (19%), Positives = 26/76 (34%), Gaps = 9/76 (11%)

Query: 441 QKLQGLDLAFNKL----AGSIPDEICLLSRLNELDLNGNKISGSISSCLG-----NLTSL 491
             L+ L LA   +      S+   +     L ELDL+ N +  +    L          L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 492 QYLNLGSNRFTFVIPS 507
           + L L    ++  +  
Sbjct: 429 EQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 15/84 (17%), Positives = 30/84 (35%), Gaps = 9/84 (10%)

Query: 394 SLERLNIAFCNISGN----IPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQK-----LQ 444
            L  L +A C++S +    +   +    +L  L L  N L  +  +      +     L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 445 GLDLAFNKLAGSIPDEICLLSRLN 468
            L L     +  + D +  L +  
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 15/90 (16%), Positives = 32/90 (35%), Gaps = 6/90 (6%)

Query: 320 LEMGSNSFSGF-IPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGN 378
           L++     S       +  L+  ++  +    LT +  +    S+L     L  L L  N
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKD-ISSALRVNPALAELNLRSN 65

Query: 379 PLDGF----LPSSIGNLSLSLERLNIAFCN 404
            L       +   +   S  +++L++  C 
Sbjct: 66  ELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 16/92 (17%), Positives = 29/92 (31%), Gaps = 9/92 (9%)

Query: 53  NWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGT----IPPEIANLSSLKSLDLSHNK 108
           N     +    +          +  L L+  ++  +    +   +    SL+ LDLS+N 
Sbjct: 349 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 408

Query: 109 LSSNIPSSIFT-----MSTLKVLYLMDNQLSG 135
           L       +          L+ L L D   S 
Sbjct: 409 LGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 4e-04
 Identities = 19/90 (21%), Positives = 28/90 (31%), Gaps = 5/90 (5%)

Query: 196 LQELHLGYNNLSGAIPKEI-GNLTVLQRISLINNKLHGEIPQEIG----YLQNLDVLQLG 250
           +Q L +    LS A   E+   L   Q + L +  L     ++I         L  L L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 251 FNNLTGVVPATIFNMSTLKEIFLYNNSLSG 280
            N L  V    +          +   SL  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 5e-04
 Identities = 15/88 (17%), Positives = 29/88 (32%), Gaps = 9/88 (10%)

Query: 370 LRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISG----NIPKAIGNLSNLIVLSLG 425
           ++ L +    L     + +  L    + + +  C ++     +I  A+     L  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 426 GNNLSGSIPVTFGGL-----QKLQGLDL 448
            N L                 K+Q L L
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 0.001
 Identities = 18/101 (17%), Positives = 32/101 (31%), Gaps = 23/101 (22%)

Query: 465 SRLNELDLNGNKISG----SISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDI 520
           S L  L L    +S     S+++ L    SL+ L+L +N              D     +
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG-----------DAGILQL 417

Query: 521 SSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLK 561
             ++      L          + L     S  +   L+ L+
Sbjct: 418 VESVRQPGCLLEQ--------LVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 11/96 (11%), Positives = 30/96 (31%), Gaps = 9/96 (9%)

Query: 340 NLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDG----FLPSSIGNLSLSL 395
           +++  DI    L+ +     +   L   ++ + + L    L       + S++     +L
Sbjct: 3   DIQSLDIQCEELSDA----RWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNP-AL 57

Query: 396 ERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSG 431
             LN+    +       +          +   +L  
Sbjct: 58  AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.002
 Identities = 16/92 (17%), Positives = 30/92 (32%), Gaps = 8/92 (8%)

Query: 259 PATIFNMSTLKEIFLYNNSLSGSLPSRIDLAL---PNLEFLNLGINSFSGTIPSSITNA- 314
                  S L+ ++L +  +S S  S +   L    +L  L+L  N         +  + 
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 315 ----SKLILLEMGSNSFSGFIPSAIGNLRNLK 342
                 L  L +    +S  +   +  L   K
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.003
 Identities = 14/92 (15%), Positives = 26/92 (28%), Gaps = 4/92 (4%)

Query: 313 NASKLILLEMGSNSFSG----FIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCK 368
             S L +L +     S      + + +    +L+  D+  N L  +       S      
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 369 KLRYLGLGGNPLDGFLPSSIGNLSLSLERLNI 400
            L  L L        +   +  L      L +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.003
 Identities = 13/111 (11%), Positives = 28/111 (25%), Gaps = 20/111 (18%)

Query: 268 LKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSF 327
           ++ + +    LS +  + +   L   + + L     +                       
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKD----------------- 46

Query: 328 SGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGN 378
              I SA+     L   ++  N L                 K++ L L   
Sbjct: 47  ---ISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.004
 Identities = 18/83 (21%), Positives = 34/83 (40%), Gaps = 8/83 (9%)

Query: 242 QNLDVLQLGFNNLTGV----VPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPN----L 293
             L VL L   +++      + AT+    +L+E+ L NN L  +   ++  ++      L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 294 EFLNLGINSFSGTIPSSITNASK 316
           E L L    +S  +   +    K
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEK 451

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.4 bits (121), Expect = 2e-07
 Identities = 32/216 (14%), Positives = 62/216 (28%), Gaps = 6/216 (2%)

Query: 409 IPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLN 468
           IP  +    N I L      L       F G   L+ ++++ N +   I  ++       
Sbjct: 23  IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80

Query: 469 ELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFV----IPSTFWNLKDILSFDISSNL 524
                    +    +            L  +         +       K +L    + N+
Sbjct: 81  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140

Query: 525 LDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNM 584
                +  +G     V + L++N +         G +  +      N LE    + F   
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200

Query: 585 TSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNK 620
           +    LD+S  +I        E L  L+  +    K
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 6e-05
 Identities = 30/236 (12%), Positives = 64/236 (27%), Gaps = 15/236 (6%)

Query: 61  CSWIGIICDVNSHK---------VTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSS 111
           CS    +C  +               L      L+       +    L+ +++S N +  
Sbjct: 8   CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67

Query: 112 NI---PSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNH 168
            I     S         +   +N L  +  +F    +    +  +           I + 
Sbjct: 68  VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127

Query: 169 LRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINN 228
            + L  +    N+   +  S +    +   L L  N +            + +     NN
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187

Query: 229 KLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPS 284
            L               +L +    +  +    + N+  L+    YN      LP+
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 5e-04
 Identities = 29/233 (12%), Positives = 60/233 (25%), Gaps = 9/233 (3%)

Query: 98  SLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLS----GSLSSFTFNTSSILDIRLS 153
           S +      +K++  IPS +        L  +  +L     G+ S F       +     
Sbjct: 9   SNRVFLCQESKVTE-IPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 154 KNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKE 213
              +   +  N+                   +   +L   + L   + G  +L       
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 214 IGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFL 273
                +L       N    E    +G      +L L  N +  +           +    
Sbjct: 126 SLQKVLLDIQD-NINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNL- 183

Query: 274 YNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNS 326
            +N+    LP+ +         L++            + N  KL      +  
Sbjct: 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (90), Expect = 0.001
 Identities = 31/226 (13%), Positives = 66/226 (29%), Gaps = 6/226 (2%)

Query: 223 ISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSL 282
                +K+  EIP ++   +N   L+     L  +          L++I +  N +   +
Sbjct: 13  FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69

Query: 283 PSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLK 342
            + +   LP L  + +   +    I          +   + SN+    +P         K
Sbjct: 70  EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129

Query: 343 LFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAF 402
           +     +N+   T E      L+    + +L   G         +        E      
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ---LDELNLSDN 186

Query: 403 CNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDL 448
            N+           S  ++L +    +          L+KL+    
Sbjct: 187 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.4 bits (112), Expect = 5e-07
 Identities = 21/122 (17%), Positives = 39/122 (31%), Gaps = 8/122 (6%)

Query: 100 KSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSG 159
           + L L+H  L+      +  +  +  L L  N+L     +        L++  + +    
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRC--LEVLQASDNALE 56

Query: 160 KLPENICNHLRYLKHLFLRENMF-YGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLT 218
            +          L+ L L  N          L  C +L  L+L  N+L          L 
Sbjct: 57  NVDGVANLP--RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLA 113

Query: 219 VL 220
            +
Sbjct: 114 EM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.6 bits (110), Expect = 8e-07
 Identities = 28/127 (22%), Positives = 48/127 (37%), Gaps = 12/127 (9%)

Query: 398 LNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSI 457
           L++A  +++  +   +  L  +  L L  N L    P     L+ L+ L  + N      
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LEN 57

Query: 458 PDEICLLSRLNELDLNGNKI-SGSISSCLGNLTSLQYLNLGSNRFTFV------IPSTFW 510
            D +  L RL EL L  N++   +    L +   L  LNL  N           +     
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117

Query: 511 NLKDILS 517
           ++  IL+
Sbjct: 118 SVSSILT 124

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.1 bits (106), Expect = 3e-06
 Identities = 22/146 (15%), Positives = 42/146 (28%), Gaps = 28/146 (19%)

Query: 470 LDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPI 529
           L L    ++  +   L  L  + +L+L  NR   + P+    L+ +     S N L+   
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59

Query: 530 SLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLES 589
            +A         + L  N L                             +   +   L  
Sbjct: 60  GVANLPRLQE--LLLCNNRLQQ-----------------------SAAIQPLVSCPRLVL 94

Query: 590 LDLSNNKISGSIPVSFEKLSYLKELN 615
           L+L  N +     +       L  ++
Sbjct: 95  LNLQGNSLCQEEGIQERLAEMLPSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.8 bits (100), Expect = 2e-05
 Identities = 22/106 (20%), Positives = 38/106 (35%), Gaps = 26/106 (24%)

Query: 542 IDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSL-------------- 587
           + L+  +L+  +   LE L  + ++ L++NRL    P +   +  L              
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59

Query: 588 --------ESLDLSNNKI-SGSIPVSFEKLSYLKELNLSFNKLKGE 624
                   + L L NN++   +          L  LNL  N L  E
Sbjct: 60  GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.8 bits (87), Expect = 0.001
 Identities = 20/112 (17%), Positives = 36/112 (32%), Gaps = 10/112 (8%)

Query: 320 LEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNP 379
           L +     +  +   +  L  +   D+  N L +  P L  L  L   +         N 
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDN--ALENV 58

Query: 380 LDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSG 431
                   +  L L   RL            + + +   L++L+L GN+L  
Sbjct: 59  DGVANLPRLQELLLCNNRLQ------QSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.8 bits (87), Expect = 0.001
 Identities = 22/121 (18%), Positives = 43/121 (35%), Gaps = 9/121 (7%)

Query: 246 VLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLG-INSFS 304
           VL L   +LT  V   +  +  +  + L +N L    P+     L  L  L +   +  +
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-----LAALRCLEVLQASDNA 54

Query: 305 GTIPSSITNASKLILLEMGSNSFSGF-IPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSS 363
                 + N  +L  L + +N          + +   L L ++  N+L         L+ 
Sbjct: 55  LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114

Query: 364 L 364
           +
Sbjct: 115 M 115

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 47.6 bits (111), Expect = 5e-06
 Identities = 31/332 (9%), Positives = 79/332 (23%), Gaps = 21/332 (6%)

Query: 78  LNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLS----SNIPSSIFTMSTLKVLYLMDNQL 133
           L+  +   + ++   +    S+K + LS N +       +  +I +   L++    D   
Sbjct: 12  LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71

Query: 134 SGSLSSFTFNTSSILDIRLSKNKLS------GKLPENICNHLRYLKHLFLRENMFYGKIP 187
                        +L   L   KL                 L             Y    
Sbjct: 72  GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 131

Query: 188 SSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVL 247
               +        L    ++          +++   + + N    E  +     + L  +
Sbjct: 132 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191

Query: 248 QLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTI 307
           ++  N +       +          L    L  +  + +  +   +   +       G  
Sbjct: 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 251

Query: 308 PSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANC 367
              ++      +++  S                L+   + +N +                
Sbjct: 252 DCLLSARGAAAVVDAFSK----------LENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301

Query: 368 KKLRYLGLGGNPLDGFLPSSIGNLSLSLERLN 399
             L +L L GN         +  +        
Sbjct: 302 PDLLFLELNGNRFSE-EDDVVDEIREVFSTRG 332

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.1 bits (102), Expect = 5e-05
 Identities = 47/315 (14%), Positives = 87/315 (27%), Gaps = 27/315 (8%)

Query: 186 IPSSLSKCKQLQELHLGYNNLSG----AIPKEIGNLTVLQRISLINN---KLHGEIPQEI 238
           + + L +   ++E+ L  N +       + + I +   L+     +    ++  EIP+ +
Sbjct: 23  VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82

Query: 239 GYL-------QNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALP 291
             L         L  ++L  N                K   L +  L  +       A  
Sbjct: 83  RLLLQALLKCPKLHTVRLSDNAFGPTAQ-EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141

Query: 292 NLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNL 351
                 L +N  +   P   +       LE GS         +   L  +K+        
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201

Query: 352 TSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPK 411
                 L  L+     K L         L     +       +L  L +  C +S     
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261

Query: 412 AIGN------LSNLIVLSLGGNNLSGSIPVT-----FGGLQKLQGLDLAFNKLAGSIPDE 460
           A+ +         L  L L  N +      T        +  L  L+L  N+      D 
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDV 320

Query: 461 ICLLSRLNELDLNGN 475
           +  +  +      G 
Sbjct: 321 VDEIREVFSTRGRGE 335

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.1 bits (102), Expect = 5e-05
 Identities = 45/317 (14%), Positives = 95/317 (29%), Gaps = 38/317 (11%)

Query: 339 RNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDG----FLPSSIGNLSLS 394
           ++LKL  I   +  S        + L     ++ + L GN +      +L  +I +    
Sbjct: 8   KSLKLDAITTEDEKS------VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK-D 60

Query: 395 LERLNIA---FCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFN 451
           LE    +      +   IP+A+  L   ++     + +  S        Q+     L+ +
Sbjct: 61  LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 120

Query: 452 KLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWN 511
                +      L       +       +++    N   L+ +  G NR        +  
Sbjct: 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 180

Query: 512 LKDILSFDISSNLLDGPISLAIGNLKAVVGID-------------LSRNNLSGNIPTTLE 558
                    +  ++   I         + G+                 +  S  +   L+
Sbjct: 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240

Query: 559 GLKSLQNISLAYNRLEGPIPESFGNM------TSLESLDLSNNKISGSIPVS-----FEK 607
              +L+ + L    L      +  +         L++L L  N+I      +      EK
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300

Query: 608 LSYLKELNLSFNKLKGE 624
           +  L  L L+ N+   E
Sbjct: 301 MPDLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.1 bits (102), Expect = 6e-05
 Identities = 13/95 (13%), Positives = 29/95 (30%), Gaps = 6/95 (6%)

Query: 556 TLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISG----SIPVSFEKLSYL 611
           ++EG KSL+  ++     +  +        S++ + LS N I       +  +      L
Sbjct: 4   SIEG-KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 61

Query: 612 KELNLSFNKLKGEIPRGGPFANFTAESFMGNELLC 646
           +    S                   ++ +    L 
Sbjct: 62  EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLH 96

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.9 bits (99), Expect = 1e-04
 Identities = 35/332 (10%), Positives = 82/332 (24%), Gaps = 25/332 (7%)

Query: 123 LKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRY---LKHLFLRE 179
           LK+  +         +    + S + +I LS N +  +    +  ++     L+     +
Sbjct: 10  LKLDAITTEDEKSVFAVLLEDDS-VKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 180 NMFYGKIPSSLSKCKQLQELHLGYNNLS---GAIPKEIGNLTVLQRISLINNKLHGEIPQ 236
                         + L +  L    L     +               L  +     +  
Sbjct: 69  IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128

Query: 237 EIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFL 296
               L      ++        V     N   L+ I    N L             +   L
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188

Query: 297 NLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTP 356
           +      +G  P            E   +     +             + F +  +S+  
Sbjct: 189 HTVKMVQNGIRP------------EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236

Query: 357 ELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAI--- 413
                        L    L        + +     ++ L+ L + +  I  +  + +   
Sbjct: 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 296

Query: 414 --GNLSNLIVLSLGGNNLSGSIPVTFGGLQKL 443
               + +L+ L L GN            ++++
Sbjct: 297 IDEKMPDLLFLELNGNRF-SEEDDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.2 bits (92), Expect = 0.001
 Identities = 14/91 (15%), Positives = 30/91 (32%), Gaps = 8/91 (8%)

Query: 443 LQGLDLAFNKL----AGSIPDEICLLSRLNELDLNGNKISG----SISSCLGNLTSLQYL 494
           ++G  L  + +      S+   +     + E+ L+GN I       +S  + +   L+  
Sbjct: 5   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64

Query: 495 NLGSNRFTFVIPSTFWNLKDILSFDISSNLL 525
                    V       L+ +L   +    L
Sbjct: 65  EFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.3 bits (87), Expect = 0.003
 Identities = 13/61 (21%), Positives = 21/61 (34%), Gaps = 6/61 (9%)

Query: 462 CLLSRLNELDLNGNKISGSISSCL-----GNLTSLQYLNLGSNRFTFVIPSTFWNLKDIL 516
                L  L L  N+I       L       +  L +L L  NRF+         ++++ 
Sbjct: 270 LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS-EEDDVVDEIREVF 328

Query: 517 S 517
           S
Sbjct: 329 S 329

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.3 bits (87), Expect = 0.004
 Identities = 10/96 (10%), Positives = 25/96 (26%), Gaps = 6/96 (6%)

Query: 41  HITYDPTNLLGTNWTSNASICSWIGIICDVNSHKVTTLNLSSFNLQGTIPPEIA-----N 95
                    L     S     + +     + +  + TL L    ++      +       
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300

Query: 96  LSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDN 131
           +  L  L+L+ N+ S      +  +  +        
Sbjct: 301 MPDLLFLELNGNRFSE-EDDVVDEIREVFSTRGRGE 335

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 7e-06
 Identities = 43/200 (21%), Positives = 85/200 (42%), Gaps = 16/200 (8%)

Query: 415 NLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNG 474
            L+  +   LG  N++    V+   L ++  L      +     D +  L+ L +++ + 
Sbjct: 16  ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 71

Query: 475 NKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIG 534
           N+++      L NLT L  + + +N+   + P         L+   +       I+    
Sbjct: 72  NQLTDIT--PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNN------QITDIDP 123

Query: 535 NLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSN 594
                    L  ++ + +  + L GL SLQ ++ + N++    P    N+T+LE LD+S+
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181

Query: 595 NKISGSIPVSFEKLSYLKEL 614
           NK+S        KL+ L+ L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 8e-05
 Identities = 35/197 (17%), Positives = 69/197 (35%), Gaps = 23/197 (11%)

Query: 66  IICDVNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKV 125
           I  D    +     L   N+  T+     +L  + +L      + S     +  ++ L  
Sbjct: 11  IFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQ 66

Query: 126 LYLMDNQLSG--SLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKH--------- 174
           +   +NQL+    L + T     +++     +        N+     +            
Sbjct: 67  INFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 126

Query: 175 ----LFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKL 230
                 L  +       S+LS    LQ+L+   N ++   P  + NLT L+R+ + +NK+
Sbjct: 127 LTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKV 184

Query: 231 HGEIPQEIGYLQNLDVL 247
                  +  L NL+ L
Sbjct: 185 SD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 32/198 (16%), Positives = 63/198 (31%), Gaps = 28/198 (14%)

Query: 312 TNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLR 371
           T  ++ +   +G  + +  +     +L  +         + S       +  +     L 
Sbjct: 15  TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS-------IDGVEYLNNLT 65

Query: 372 YLGLGGNPLDGFLPSS---------------IGNLSLSLERLNIAFCNISGNIPKAIGNL 416
            +    N L    P                      L+           +  I       
Sbjct: 66  QINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 125

Query: 417 SNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNK 476
           +   +  L  ++ + S      GL  LQ L+ + N++    P  +  L+ L  LD++ NK
Sbjct: 126 NLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNK 183

Query: 477 ISGSISSCLGNLTSLQYL 494
           +S    S L  LT+L+ L
Sbjct: 184 VSD--ISVLAKLTNLESL 199

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (100), Expect = 3e-05
 Identities = 24/133 (18%), Positives = 49/133 (36%), Gaps = 6/133 (4%)

Query: 70  VNSHKVTTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLM 129
            N+ +   L+L  + +   I    A L    ++D S N++          +  LK L + 
Sbjct: 15  TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVN 71

Query: 130 DNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKI--- 186
           +N++             + ++ L+ N L      +    L+ L +L +  N    K    
Sbjct: 72  NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYR 131

Query: 187 PSSLSKCKQLQEL 199
              + K  Q++ L
Sbjct: 132 LYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (96), Expect = 1e-04
 Identities = 16/136 (11%), Positives = 40/136 (29%), Gaps = 6/136 (4%)

Query: 91  PEIANLSSLKSLDLSHNKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDI 150
            +  N    + LDL   K+   I +   T+     +   DN++             +  +
Sbjct: 12  AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLKTL 68

Query: 151 RLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLG---YNNLS 207
            ++ N++               + +    ++        L+  K L  L +      N  
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128

Query: 208 GAIPKEIGNLTVLQRI 223
                 I  +  ++ +
Sbjct: 129 HYRLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (93), Expect = 3e-04
 Identities = 22/132 (16%), Positives = 54/132 (40%), Gaps = 4/132 (3%)

Query: 436 TFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLN 495
            +    + + LDL   K+   I +    L + + +D + N+I          L  L+ L 
Sbjct: 13  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLL 69

Query: 496 LGSNRFTFVIPSTFWNLKDILSFDIS-SNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIP 554
           + +NR   +       L D+    ++ ++L++      + +LK++  + + RN ++    
Sbjct: 70  VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129

Query: 555 TTLEGLKSLQNI 566
             L  +  +  +
Sbjct: 130 YRLYVIYKVPQV 141

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (91), Expect = 6e-04
 Identities = 18/109 (16%), Positives = 36/109 (33%), Gaps = 4/109 (3%)

Query: 548 NLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEK 607
            L          ++  + + L   ++   I      +   +++D S+N+I       F  
Sbjct: 6   ELIEQAAQYTNAVR-DRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDG--FPL 61

Query: 608 LSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLCGLPNLQVPPC 656
           L  LK L ++ N++               E  + N  L  L +L     
Sbjct: 62  LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLAS 110

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (86), Expect = 0.003
 Identities = 22/96 (22%), Positives = 32/96 (33%), Gaps = 3/96 (3%)

Query: 415 NLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNG 474
           N      L L G  +   I      L +   +D + N++     D   LL RL  L +N 
Sbjct: 16  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNN 72

Query: 475 NKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFW 510
           N+I          L  L  L L +N    +      
Sbjct: 73  NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPL 108

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.1 bits (97), Expect = 7e-05
 Identities = 22/107 (20%), Positives = 41/107 (38%), Gaps = 2/107 (1%)

Query: 541 GIDLSRNNLSGNIPTTLEGLKSLQNISLAYNR-LEGPIPESFGNMTSLESLDLSNNKISG 599
           G+  +R+    +    L G ++L  + +   + L+         +  L +L +  + +  
Sbjct: 12  GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF 70

Query: 600 SIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTAESFMGNELLC 646
             P +F     L  LNLSFN L+    +     +       GN L C
Sbjct: 71  VAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (86), Expect = 0.002
 Identities = 18/148 (12%), Positives = 43/148 (29%), Gaps = 5/148 (3%)

Query: 76  TTLNLSSFNLQGTIPPEIANLSSLKSLDLSHNKLSSNIPSSIFT-MSTLKVLYLMDNQLS 134
           + L  +           +    +L  L + + +   ++       +  L+ L ++ + L 
Sbjct: 11  SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69

Query: 135 GSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFY-GKIPSSLSKC 193
                    T  +  + LS N L   L          L+ L L  N  +       L + 
Sbjct: 70  FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTV-QGLSLQELVLSGNPLHCSCALRWLQRW 127

Query: 194 KQLQELHLGYNNLSGAIPKEIGNLTVLQ 221
           ++     +    L       + ++    
Sbjct: 128 EEEGLGGVPEQKLQCHGQGPLAHMPNAS 155

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (84), Expect = 0.004
 Identities = 24/162 (14%), Positives = 44/162 (27%), Gaps = 13/162 (8%)

Query: 242 QNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGIN 301
                L+   +         +     L E+++ N      L  R    L  L  L +  +
Sbjct: 8   HGSSGLRCTRDGALDS-LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 302 SFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFL 361
                 P +     +L  L +  N+    +        +L+   +  N L  S      L
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC----AL 121

Query: 362 SSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFC 403
             L   ++    G+    L              L  +  A C
Sbjct: 122 RWLQRWEEEGLGGVPEQKLQCHGQG-------PLAHMPNASC 156

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (84), Expect = 0.004
 Identities = 17/149 (11%), Positives = 33/149 (22%), Gaps = 2/149 (1%)

Query: 417 SNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICL-LSRLNELDLNGN 475
                L    +           G + L  L +   +    +       L  L  L +  +
Sbjct: 8   HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 476 KISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGN 535
            +             L  LNL  N    +   T   L         + L        +  
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126

Query: 536 LKAVVGIDLSRNNLSGNIPTTLEGLKSLQ 564
            +      +    L  +    L  + +  
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.7 bits (97), Expect = 9e-05
 Identities = 19/84 (22%), Positives = 37/84 (44%), Gaps = 2/84 (2%)

Query: 545 SRNNLSGNIPTTLEGLKSLQNISLAYNRLEG--PIPESFGNMTSLESLDLSNNKISGSIP 602
            R++++  +    E +  L +++L+ NRL     +        +L+ L+LS N++     
Sbjct: 49  RRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERE 108

Query: 603 VSFEKLSYLKELNLSFNKLKGEIP 626
           +   K   L+EL L  N L     
Sbjct: 109 LDKIKGLKLEELWLDGNSLSDTFR 132

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.3 bits (88), Expect = 0.001
 Identities = 20/117 (17%), Positives = 45/117 (38%), Gaps = 3/117 (2%)

Query: 413 IGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAG--SIPDEICLLSRLNEL 470
           +   +  +VL+   ++++ ++ +    + +L  L+L+ N+L     +   +     L  L
Sbjct: 38  LVAQNIDVVLNRR-SSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96

Query: 471 DLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDG 527
           +L+GN++             L+ L L  N  +         +  I         LDG
Sbjct: 97  NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDG 153

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (85), Expect = 0.003
 Identities = 27/136 (19%), Positives = 51/136 (37%), Gaps = 15/136 (11%)

Query: 369 KLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNN 428
             + L L G   D  L +   ++ L+         +++  +     N+  L+ L+L  N 
Sbjct: 23  SQQALDLKGLRSDPDLVAQNIDVVLNRRS------SMAATLRIIEENIPELLSLNLSNNR 76

Query: 429 LSG--SIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSI----- 481
           L     +         L+ L+L+ N+L      +     +L EL L+GN +S +      
Sbjct: 77  LYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQST 136

Query: 482 --SSCLGNLTSLQYLN 495
             S+       L  L+
Sbjct: 137 YISAIRERFPKLLRLD 152

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.9 bits (94), Expect = 3e-04
 Identities = 41/175 (23%), Positives = 69/175 (39%), Gaps = 7/175 (4%)

Query: 409 IPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQK-LQGLDLAFNKLAGSIPDEICLLSRL 467
           IP+ I    +   L L  N L         G    L  L+L  N+L G  P+     S +
Sbjct: 23  IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80

Query: 468 NELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDG 527
            EL L  NKI    +     L  L+ LNL  N+ + V+P +F +L  + S +++SN  + 
Sbjct: 81  QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140

Query: 528 PISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFG 582
              L     + +    L+        P+ +  ++      L ++  +     S G
Sbjct: 141 NCHL-AWFAEWLRKKSLNGGAARCGAPSKVRDVQIK---DLPHSEFKCSSENSEG 191

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 39.0 bits (89), Expect = 0.001
 Identities = 35/213 (16%), Positives = 71/213 (33%), Gaps = 34/213 (15%)

Query: 146 SILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSL-SKCKQLQELHLGYN 204
               +  +   L  ++P +I  H      L L +N         L  +   L +L L  N
Sbjct: 9   EGTTVDCTGRGLK-EIPRDIPLHTT---ELLLNDNELGRISSDGLFGRLPHLVKLELKRN 64

Query: 205 NLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFN 264
            L+G  P      + +Q + L  NK+     +    L  L  L L  N ++ V+P +  +
Sbjct: 65  QLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEH 124

Query: 265 MSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGS 324
           +++L  + L +N  + +               +L   +     PS               
Sbjct: 125 LNSLTSLNLASNPFNCNCHLAWFAEWLRK--KSLNGGAARCGAPSK-------------- 168

Query: 325 NSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPE 357
                        +R++++ D+  +    S+  
Sbjct: 169 -------------VRDVQIKDLPHSEFKCSSEN 188

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.9 bits (86), Expect = 0.003
 Identities = 33/157 (21%), Positives = 59/157 (37%), Gaps = 4/157 (2%)

Query: 370 LRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNL 429
              L L  N L       +      L +L +    ++G  P A    S++  L LG N +
Sbjct: 31  TTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90

Query: 430 SGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLT 489
                  F GL +L+ L+L  N+++  +P     L+ L  L+L  N  + +         
Sbjct: 91  KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAE 149

Query: 490 SLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLD 526
            L+  +L         PS    ++D+   D+  +   
Sbjct: 150 WLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFK 183

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.5 bits (85), Expect = 0.003
 Identities = 22/73 (30%), Positives = 33/73 (45%)

Query: 577 IPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGPFANFTA 636
             + F  +  L++L+L +N+IS  +P SFE L+ L  LNL+ N                 
Sbjct: 94  SNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRK 153

Query: 637 ESFMGNELLCGLP 649
           +S  G    CG P
Sbjct: 154 KSLNGGAARCGAP 166

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	985
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.89
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.88
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.84
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.83
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.83
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.81
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.81
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.78
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.77
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.76
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.76
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.76
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.73
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.73
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.72
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.72
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.71
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.59
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.53
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.51
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.5
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.49
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.49
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.47
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.45
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.37
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.34
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.28
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.24
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.41
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.37
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.35
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.84
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.54
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.52
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.48
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.94
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.78
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.73
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.63
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.35

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-46  Score=395.06  Aligned_cols=245  Identities=24%  Similarity=0.354  Sum_probs=203.5

Q ss_pred             cCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccC
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      ++|+..+.||+|+||+||+|++.+++.||||+++... ...+++.+|++++++++|||||+++|+|.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5688889999999999999999889999999997653 345789999999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCccee
Q 001988          806 NGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR  885 (985)
Q Consensus       806 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~  885 (985)
                      +|+|.+++......+++..+.+++.|||+||+||   |+++|+||||||+||++++++.+||+|||+|+.+..... ...
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~l---H~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~  159 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS  159 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhh---hccceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence            9999999988777899999999999999999999   789999999999999999999999999999987653332 223


Q ss_pred             cccccccccccccccccCccchhhhcccccccchhhhccc-ccccCcchhh------------hhHHHHHHHHHHHHHHc
Q 001988          886 TQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDK-SLLSGEEKHF------------AAKEQCLLSIFSLALEC  952 (985)
Q Consensus       886 ~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~-~~~~~~~~~~------------~~~~~~~~~l~~l~~~c  952 (985)
                      ....||+.|+|||.+.++.++.++|+ |++|+.++|++++ ..+.......            ..++.+++++.+++.+|
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k~DV-wS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c  238 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSKSDV-WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC  238 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHHHHH-HHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred             cceecCcccCChHHhcCCCCCchhhh-cchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHH
Confidence            34569999999999999999999999 9999999999984 4443332111            12234678899999999


Q ss_pred             cCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          953 TMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       953 l~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      |+.||++||+|+|+++.|+++++.
T Consensus       239 l~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         239 WKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccCCHhHCcCHHHHHHHHHHHHhC
Confidence            999999999999999999998763

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=399.88  Aligned_cols=248  Identities=25%  Similarity=0.401  Sum_probs=206.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .++|...+.||+|+||+||+|+++  ..||||+++...  ....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467899999999999999999875  369999987552  3456789999999999999999999999865 46799999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |+++|+|.+++...+..+++..+..++.||++||+||   |+++||||||||+|||++.++.+||+|||+|+........
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yL---H~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---hcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            9999999999987767899999999999999999999   7899999999999999999999999999999887544444


Q ss_pred             ceeccccccccccccccccc---CccchhhhcccccccchhhhcccccccCcchhh-----------------hhHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFV---GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-----------------AAKEQCL  942 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-----------------~~~~~~~  942 (985)
                      .......||+.|||||.+..   +.++.++|+ |++|++++|+++|+.++......                 ..+..++
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDi-wS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  239 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDV-YAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP  239 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHH-HHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhh-hhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence            44456679999999999864   457899999 99999999999998765432111                 1123467


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          943 LSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       943 ~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                      +++.+++.+||+.||++||||.|+++.|+.+++..++
T Consensus       240 ~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~Pk  276 (276)
T d1uwha_         240 KAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK  276 (276)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCCC
Confidence            8899999999999999999999999999999887653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-45  Score=396.40  Aligned_cols=249  Identities=23%  Similarity=0.391  Sum_probs=213.2

Q ss_pred             HHHHhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          721 LLRATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       721 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ++...++|+..+.||+|+||+||+|++. +++.||||+++... ...+++.+|++++++++|||||+++++|.+++..++
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            3334578999999999999999999976 68899999997653 445789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          800 VLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      ||||+++|+|.+++... ...+++..+..++.||++||+||   |++||+||||||+|||+++++.+||+|||+|+....
T Consensus        91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yL---H~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHH---HHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence            99999999999999764 45789999999999999999999   688999999999999999999999999999987653


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccC-cchh------------hhhHHHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSG-EEKH------------FAAKEQCLLSI  945 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~-~~~~------------~~~~~~~~~~l  945 (985)
                      .. ........||+.|+|||.+.++.++.++|+ |++|+.++|++++..+.. ....            .+.++.+++++
T Consensus       168 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~Di-wS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  245 (287)
T d1opja_         168 DT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDV-WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV  245 (287)
T ss_dssp             SS-SEEETTEEECGGGCCHHHHHHCCCSHHHHH-HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             CC-ceeeccccccccccChHHHcCCCCCchhhh-hhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHH
Confidence            32 233344568999999999999999999999 999999999998654332 2111            11233467889


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                      .+++.+||+.||++||||.|+++.|+.+.+
T Consensus       246 ~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         246 YELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            999999999999999999999999988754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-45  Score=390.93  Aligned_cols=239  Identities=23%  Similarity=0.300  Sum_probs=203.9

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .++|+..+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            467999999999999999999975 799999999976532 234578999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |+++|+|.+++... ..+++.++..++.|+++||+||   |++||+||||||+|||+++++.+||+|||+|+.+......
T Consensus        84 y~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~yl---H~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHH---HHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            99999999999765 3789999999999999999999   7899999999999999999999999999999987544444


Q ss_pred             ceecccccccccccccccccCcc-chhhhcccccccchhhhcccccccCcchhh--------------hhHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGEL-SLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQCLLSIFS  947 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~~~~l~~  947 (985)
                      ......+||+.|||||++.+..+ +.++|+ |++|++++++++|+.+.......              .....+++++.+
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~Di-wSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  238 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDV-WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA  238 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHH-HHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceee-eHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHH
Confidence            44456789999999999988876 577899 99999999999998766433211              112345678899


Q ss_pred             HHHHccCCCCCCCCCHHHHHH
Q 001988          948 LALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ++.+||+.||++|||+.|+++
T Consensus       239 li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         239 LLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHcCCChhHCcCHHHHhc
Confidence            999999999999999999865

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.6e-45  Score=393.92  Aligned_cols=247  Identities=21%  Similarity=0.375  Sum_probs=198.5

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CC---cEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DG---VEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~---~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      ++|+..+.||+|+||+||+|+++ ++   ..||||.+..... ...+.|.+|++++++++|||||+++|+|.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            34556789999999999999875 33   3589999876533 3456799999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++|+|.+++......+++.++.+++.||++||+||   |+++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHH---hhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            999999999999988777899999999999999999999   78999999999999999999999999999998875433


Q ss_pred             Ccc---eecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHH
Q 001988          881 EST---MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLS  944 (985)
Q Consensus       881 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~  944 (985)
                      ...   ......||+.|||||.+.++.++.++|+ |++|++++|+++ ++.++.....            .+.+..++++
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv-wS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDV-WSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA  261 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHH-HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCccccc-ccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHH
Confidence            221   1223457999999999999999999999 999999999997 6665443221            1223456788


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          945 IFSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       945 l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      +.+++.+||+.||++||+|.|+++.|+++.+.
T Consensus       262 l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         262 LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            99999999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-45  Score=391.09  Aligned_cols=245  Identities=24%  Similarity=0.407  Sum_probs=208.4

Q ss_pred             HhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ..++|+..+.||+|+||+||+|++++++.||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++||||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            346788899999999999999999888999999997653 345789999999999999999999998865 567899999


Q ss_pred             cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      +++|+|.+++... ...+++..+.+++.||++||+||   |+++|+||||||+|||+++++.+||+|||+|+.+.... .
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~l---H~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~  164 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y  164 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCccchhheeeecccceeeccccceEEccCCc-c
Confidence            9999999987654 33589999999999999999999   78999999999999999999999999999999875332 2


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhccccc-ccCcchh------------hhhHHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSL-LSGEEKH------------FAAKEQCLLSIFSLA  949 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~-~~~~~~~------------~~~~~~~~~~l~~l~  949 (985)
                      .......||+.|||||.+.++.++.++|+ |++|++++|++++.. +......            ...++.+++++.+++
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDv-wS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li  243 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDV-WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM  243 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHH-HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhh-hhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHH
Confidence            33445679999999999999999999999 999999999998543 3332211            112344678899999


Q ss_pred             HHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          950 LECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                      .+||+.||++||||.|+++.|+++-.
T Consensus       244 ~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         244 RLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            99999999999999999999988643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=388.52  Aligned_cols=235  Identities=26%  Similarity=0.327  Sum_probs=207.1

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            46999999999999999999864 79999999998765556678999999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      +||+|.+++...  .+++.++..++.||+.||+||   |++|||||||||+|||++.++.+||+|||+|+.+....  ..
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK  172 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CC
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHH---HHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--cc
Confidence            999999988764  589999999999999999999   78999999999999999999999999999999875332  22


Q ss_pred             ecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh--------------hhhHHHHHHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH--------------FAAKEQCLLSIFSLAL  950 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~--------------~~~~~~~~~~l~~l~~  950 (985)
                      ....+||+.|||||++.++.++.++|+ |++|++++++++|..++.....              ...++.+++++.+++.
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~Di-wSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  251 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDI-WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHH-HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred             ccccccCCCccChhhhcCCCCCchhce-ehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHH
Confidence            345679999999999999999999999 9999999999999876643321              1123446788999999


Q ss_pred             HccCCCCCCCCCHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~  968 (985)
                      +||..||++|||+.|+++
T Consensus       252 ~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         252 RCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             HHTCSSTTTSCCHHHHTT
T ss_pred             HHccCChhHCcCHHHHhc
Confidence            999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-44  Score=387.44  Aligned_cols=252  Identities=23%  Similarity=0.368  Sum_probs=212.4

Q ss_pred             cCccCCce-eeccCceeEEEEEEc---CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          726 DNFAENNI-IGIGGFGSVYRARLE---DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       726 ~~~~~~~~-ig~G~~g~V~~~~~~---~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      ++|...+. ||+|+||+||+|.++   ++..||||+++.... ...++|.+|++++++++|||||+++|++.+ +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45666664 999999999999764   456799999976543 345789999999999999999999999975 457899


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++|+|.+++...+..+++..+.+++.||++||+||   |+++|+||||||+||+++.++.+||+|||+|+.+....
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yl---H~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            999999999999887767899999999999999999999   78999999999999999999999999999999876433


Q ss_pred             Cc-ceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHHH
Q 001988          881 ES-TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSIF  946 (985)
Q Consensus       881 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l~  946 (985)
                      .. .......||+.|||||.+..+.++.++|| |++|+.++|+++ |+.++.....            .+.++.+++++.
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV-wS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~  242 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDV-WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY  242 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHH-HHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cccccccccccCccccChHHHhCCCCCccchh-hcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence            32 22334568999999999999999999999 999999999987 6665543211            122345778999


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHhHhhhccccC
Q 001988          947 SLALECTMESPEKRIDAKDTITRLLKIRDTLSKRIG  982 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~~~~  982 (985)
                      +++.+||..+|++||+|.+|++.|+.+...+..+..
T Consensus       243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~  278 (285)
T d1u59a_         243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE  278 (285)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccc
Confidence            999999999999999999999999988776655543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-44  Score=379.77  Aligned_cols=242  Identities=21%  Similarity=0.356  Sum_probs=211.3

Q ss_pred             cCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccC
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMS  805 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  805 (985)
                      ++|+..+.||+|+||+||+|++++++.||||+++.... ..+++.+|++++++++||||++++|+|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57889999999999999999999899999999986533 45789999999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCccee
Q 001988          806 NGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMR  885 (985)
Q Consensus       806 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~  885 (985)
                      +|++.+++......+++..+.+++.|+++||+||   |++||+||||||+||++++++.+||+|||+|+.+..... ...
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~L---H~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~  158 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSS  158 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHH---hhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-eee
Confidence            9999999887766789999999999999999999   688999999999999999999999999999987654332 233


Q ss_pred             cccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh------------hhHHHHHHHHHHHHHHc
Q 001988          886 TQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF------------AAKEQCLLSIFSLALEC  952 (985)
Q Consensus       886 ~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~------------~~~~~~~~~l~~l~~~c  952 (985)
                      ....||+.|+|||.+.++.++.++|+ |++|+.++|+++ ++.++......            ..++.+++++.+++.+|
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~ksDi-wS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c  237 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSSKSDI-WAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC  237 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred             cccCCCCCcCCcHHhcCCCCCcceee-cccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHH
Confidence            44569999999999999999999999 999999999987 56554432111            12334667899999999


Q ss_pred             cCCCCCCCCCHHHHHHHHHHh
Q 001988          953 TMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       953 l~~~P~~RPt~~ev~~~L~~i  973 (985)
                      |+.||++|||+.|+++.|.+|
T Consensus       238 l~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         238 WHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             TCSSGGGSCCHHHHHHHHHCC
T ss_pred             ccCCHhHCcCHHHHHHHhhCC
Confidence            999999999999999998654

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=3.8e-44  Score=393.85  Aligned_cols=293  Identities=31%  Similarity=0.502  Sum_probs=199.7

Q ss_pred             cCChhHHHHHHHHHHhcccCCCCcccCCCCCCCCcc--eeeeEEEeCCC--CeEEEEEecCCcccc--cCchhccccccc
Q 001988           26 SNISTDQQALLALKDHITYDPTNLLGTNWTSNASIC--SWIGIICDVNS--HKVTTLNLSSFNLQG--TIPPEIANLSSL   99 (985)
Q Consensus        26 ~~~~~~~~aLl~~k~~~~~~~~~~~~s~w~~~~~~c--~w~gv~c~~~~--~~v~~l~L~~~~l~g--~~~~~l~~l~~L   99 (985)
                      .|+++|++||++||+++. ||. .+++ |..++|||  .|+||+|+..+  +||+.|||++++++|  .+|+++++|++|
T Consensus         2 ~c~~~e~~aLl~~k~~~~-~~~-~l~s-W~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L   78 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLG-NPT-TLSS-WLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL   78 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTT-CCG-GGTT-CCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred             CCCHHHHHHHHHHHHHCC-CCC-cCCC-CCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence            378999999999999996 554 5676 87888999  49999998754  489999999999998  588999999999


Q ss_pred             ceecccC-CcCCCCCCcccccCCCCcEEEccCcccCCCCccccccCCccceeeeccccccCCCChhHhhhccccceeccc
Q 001988          100 KSLDLSH-NKLSSNIPSSIFTMSTLKVLYLMDNQLSGSLSSFTFNTSSILDIRLSKNKLSGKLPENICNHLRYLKHLFLR  178 (985)
Q Consensus       100 ~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~  178 (985)
                      ++|||++ |+++|.+|++|++|++|++|+|++|++.+..+..+..+..|+.++++.|.+.                    
T Consensus        79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~--------------------  138 (313)
T d1ogqa_          79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS--------------------  138 (313)
T ss_dssp             SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEE--------------------
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccccccc--------------------
Confidence            9999997 8999999999999999999999999988666655555555555555555544                    


Q ss_pred             CccccccCCcccCCCCCceEEEcccccCCCcccccccccccc-ceEeeccccccCCchhhhcCCCCCCEEEecCCcCccc
Q 001988          179 ENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVL-QRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGV  257 (985)
Q Consensus       179 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  257 (985)
                           +.+|..++++++|+++++++|.++|.+|+.+.++..+ +.+++++|++++..|..++.+..+ +++++.|.+.+.
T Consensus       139 -----~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~  212 (313)
T d1ogqa_         139 -----GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGD  212 (313)
T ss_dssp             -----SCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEEC
T ss_pred             -----ccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccc
Confidence                 4455555555555555555555555555555444443 445555555555555555544332 455555555555


Q ss_pred             CcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccC
Q 001988          258 VPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGN  337 (985)
Q Consensus       258 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~  337 (985)
                      +|..+..+++|+.+++++|.+.+.+|.  ...+++|+.|+|++|+++|.+|+.++++++|++|+|++|+|+|.+|+ +++
T Consensus       213 ~~~~~~~~~~l~~l~~~~~~l~~~~~~--~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~  289 (313)
T d1ogqa_         213 ASVLFGSDKNTQKIHLAKNSLAFDLGK--VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGN  289 (313)
T ss_dssp             CGGGCCTTSCCSEEECCSSEECCBGGG--CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STT
T ss_pred             ccccccccccccccccccccccccccc--cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-ccc
Confidence            555555555555555555555544332  22455666666666666666666666666666666666666666663 466


Q ss_pred             CCCCceEeccCCc
Q 001988          338 LRNLKLFDIFFNN  350 (985)
Q Consensus       338 l~~L~~L~L~~N~  350 (985)
                      +++|+.+++++|+
T Consensus       290 L~~L~~l~l~~N~  302 (313)
T d1ogqa_         290 LQRFDVSAYANNK  302 (313)
T ss_dssp             GGGSCGGGTCSSS
T ss_pred             CCCCCHHHhCCCc
Confidence            6777777777776

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=388.59  Aligned_cols=237  Identities=22%  Similarity=0.319  Sum_probs=206.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      +.|+..+.||+|+||+||+|+.. +++.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46888999999999999999975 78999999998776667788999999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcce
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTM  884 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~  884 (985)
                      ++|+|.+++......+++.++..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+....  ....
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~yl---H~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~~  166 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL---HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQR  166 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHHH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEEeecChhheeECCCCCEEEEechhhhccCC--Cccc
Confidence            99999999877666799999999999999999999   789999999999999999999999999999987532  1122


Q ss_pred             ecccccccccccccccc-----cCccchhhhcccccccchhhhcccccccCcchh--------------hhhHHHHHHHH
Q 001988          885 RTQTLATIGYMAPDEIF-----VGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH--------------FAAKEQCLLSI  945 (985)
Q Consensus       885 ~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~--------------~~~~~~~~~~l  945 (985)
                      ....+||+.|||||++.     ...++.++|+ |++|+.++++++|+.++.....              ...+..+++++
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~Di-wSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~  245 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADV-WSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF  245 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHH-HHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhH-HHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence            34567999999999884     5567899999 9999999999999876643221              12234567889


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHH
Q 001988          946 FSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+++.+||+.||.+|||+.|+++
T Consensus       246 ~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         246 KDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHccCChhHCcCHHHHhc
Confidence            99999999999999999999976

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-44  Score=385.50  Aligned_cols=247  Identities=23%  Similarity=0.407  Sum_probs=202.6

Q ss_pred             cCccCCceeeccCceeEEEEEEcCC-----cEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDG-----VEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~-----~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      +.|+..++||+|+||+||+|.++++     ..||||+++..... ...+|.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4678889999999999999987532     46999999765333 35578999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++|++.+++......+++.++.+++.||+.||+||   |+++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~l---H~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhc---cccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            9999999999999888777899999999999999999999   7899999999999999999999999999999887543


Q ss_pred             CCc-ceecccccccccccccccccCccchhhhcccccccchhhhcccccc-cCcch------------hhhhHHHHHHHH
Q 001988          880 DES-TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLL-SGEEK------------HFAAKEQCLLSI  945 (985)
Q Consensus       880 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~-~~~~~------------~~~~~~~~~~~l  945 (985)
                      ... .......||+.|||||.+.++.++.++|+ |++|++++|++++..+ .....            ..+.+..++.++
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI-~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  242 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDV-WSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI  242 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHH-HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccc-cccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHH
Confidence            322 22334568999999999999999999999 9999999999985443 32211            112234467889


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          946 FSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      .+++.+||+.+|++||+|.||++.|+++.+.
T Consensus       243 ~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         243 YQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            9999999999999999999999999988764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-44  Score=379.91  Aligned_cols=234  Identities=23%  Similarity=0.289  Sum_probs=204.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|+..+.||+|+||+||+|+.+ +++.||+|++.+..   ......+.+|++++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999975 78999999987542   223567899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++|+|.+++...+ .+++..+..++.||++||+||   |++|||||||||+|||++.++.+||+|||+|+...... 
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~l---H~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence            9999999999998654 689999999999999999999   78999999999999999999999999999998764322 


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLAL  950 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~  950 (985)
                         ....+||+.|||||++.+..++.++|+ |++|+.++++++|+.++.......           .++.+++++.+++.
T Consensus       161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~Di-wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  236 (263)
T d2j4za1         161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDL-WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS  236 (263)
T ss_dssp             ---CEETTEEGGGCCHHHHTTCCCCTTHHH-HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred             ---ccccCCCCcccCHHHHcCCCCCchhhh-hhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence               234579999999999999999999999 999999999999988765432111           12335788999999


Q ss_pred             HccCCCCCCCCCHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~  968 (985)
                      +||..||++|||+.|+++
T Consensus       237 ~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         237 RLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHT
T ss_pred             HHccCCHhHCcCHHHHHc
Confidence            999999999999999976

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-44  Score=382.15  Aligned_cols=238  Identities=26%  Similarity=0.357  Sum_probs=203.1

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|+..+.||+|+||+||+|+.. +++.||||++++..   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            67999999999999999999975 79999999997542   233467899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||++||+|.+++...+ .+++..+..++.|++.||+||   |++|||||||||+|||+++++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhh---ccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999988664 689999999999999999999   789999999999999999999999999999998765444


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh-----------hhHHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-----------AAKEQCLLSIFSLAL  950 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~  950 (985)
                      .......+||+.|||||++.+..++.++|+ |++|++++++++|..++......           ..++.+++++.+++.
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~Di-wSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  242 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDL-WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE  242 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred             ccccccccCCccccCceeeccCCCCcccce-ehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            444456689999999999999999999999 99999999999998876543211           122346788999999


Q ss_pred             HccCCCCCCCCCHHHHHH
Q 001988          951 ECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~  968 (985)
                      +||..||++|||+.|+..
T Consensus       243 ~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         243 KLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             TTSCSSGGGSTTSGGGTC
T ss_pred             HHccCCHhHCcCHHHHcC
Confidence            999999999999999754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-43  Score=388.46  Aligned_cols=244  Identities=22%  Similarity=0.337  Sum_probs=206.0

Q ss_pred             hcCccCCceeeccCceeEEEEEEcC------CcEEEEEEeccCC-cchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLED------GVEIAIKVFHPQC-ASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDF  796 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~  796 (985)
                      .++|+..+.||+|+||+||+|++..      ...||+|.+.... ......+.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            4688999999999999999998642      2369999987543 33456789999999998 89999999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCC
Q 001988          797 KALVLEYMSNGSLEDCLHSSN----------------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKP  854 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~  854 (985)
                      .++||||+++|+|.++++...                      ..+++..++.++.||++||+||   |+++||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yL---H~~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH---HHTTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCch
Confidence            999999999999999997643                      2478999999999999999999   789999999999


Q ss_pred             CCEEEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcch
Q 001988          855 SNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEK  933 (985)
Q Consensus       855 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~  933 (985)
                      +||+++.++.+||+|||+|+...............||+.|||||.+.++.++.++|+ |++|++++|+++ |..++....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Di-wS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV-WSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceec-cchhHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999988765554444556678999999999999999999999 999999999997 666543321


Q ss_pred             h-------------hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 001988          934 H-------------FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLK  972 (985)
Q Consensus       934 ~-------------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~  972 (985)
                      .             .+.+..+++++.+++.+||+.||++||||.||++.|..
T Consensus       272 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         272 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            1             12234567889999999999999999999999999853

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-43  Score=375.46  Aligned_cols=237  Identities=22%  Similarity=0.305  Sum_probs=197.5

Q ss_pred             ceeeccCceeEEEEEEc---CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEeccCC
Q 001988          732 NIIGIGGFGSVYRARLE---DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYMSN  806 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~---~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  806 (985)
                      +.||+|+||+||+|.++   +++.||||+++....  ...+++.+|++++++++|||||+++++|.++ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            46999999999999864   356899999975422  2356799999999999999999999999754 57899999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc-ee
Q 001988          807 GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST-MR  885 (985)
Q Consensus       807 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~  885 (985)
                      |+|.+++.... .+++..+.+++.||+.||+||   |+++||||||||+||+++.++.+||+|||+|+.+....... ..
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~yl---H~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhH---HhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999998754 689999999999999999999   78899999999999999999999999999999875443322 23


Q ss_pred             cccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHHHHHHHHc
Q 001988          886 TQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSIFSLALEC  952 (985)
Q Consensus       886 ~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l~~l~~~c  952 (985)
                      ....||+.|||||.+.++.++.++|+ |++|++++|+++ |+.++.....            .+.+..+++++.+++.+|
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDi-wS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~c  246 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDV-WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC  246 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHH-HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred             cccCCCceecCchhhcCCCCCchhhh-ccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHH
Confidence            34569999999999999999999999 999999999987 6765543211            122345778899999999


Q ss_pred             cCCCCCCCCCHHHHHHHHHHhH
Q 001988          953 TMESPEKRIDAKDTITRLLKIR  974 (985)
Q Consensus       953 l~~~P~~RPt~~ev~~~L~~i~  974 (985)
                      |+.||++||++.+|+++|+..-
T Consensus       247 l~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         247 WTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             TCSSTTTSCCHHHHHHHHHHHH
T ss_pred             cCCCHhHCcCHHHHHHHhhCHH
Confidence            9999999999999999887754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-44  Score=379.19  Aligned_cols=240  Identities=20%  Similarity=0.271  Sum_probs=191.1

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeec--CCceEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSN--DDFKALV  800 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lv  800 (985)
                      ++|+..+.||+|+||+||+|+.+ +|+.||||+++....  ...+.+.+|++++++++|||||++++++.+  ++..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            67999999999999999999875 789999999976633  235678899999999999999999999865  4568999


Q ss_pred             EeccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          801 LEYMSNGSLEDCLHSS---NCALNIFCRLNIMIDIASALEYLHFGH--STPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h--~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      |||+++|+|.+++...   ...+++..++.++.|++.||+|||..+  ..+||||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998643   457999999999999999999996422  24599999999999999999999999999988


Q ss_pred             ccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh------------hHHHHHH
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------AKEQCLL  943 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------~~~~~~~  943 (985)
                      +....  ......+||+.|||||.+.+..++.++|+ |++|+++++++++..++.......            .+..+++
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DI-wSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~  240 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDI-WSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD  240 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCH
T ss_pred             cccCC--CccccCCCCcccCCHHHHcCCCCChHHHH-HhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCH
Confidence            74322  22345679999999999999999999999 999999999999987654332111            1234678


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          944 SIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ++.+++.+||..||++|||+.|+++
T Consensus       241 ~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         241 ELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHh
Confidence            8999999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=379.57  Aligned_cols=244  Identities=26%  Similarity=0.416  Sum_probs=202.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      .++|+..+.||+|+||+||+|+++++++||||+++... ...+.|.+|+.++++++|||||+++++|.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            46899999999999999999999988899999997553 345789999999999999999999999965 5578999999


Q ss_pred             CCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          805 SNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       805 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      ++|+|.+++... ...+++.++..++.||++||+||   |+.+|+||||||+|||+|+++.+||+|||+|+.+.... ..
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~L---H~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  169 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHH---hhhheecccccceEEEECCCCcEEEcccchhhhccCCC-ce
Confidence            999999988754 34689999999999999999999   78899999999999999999999999999998764332 22


Q ss_pred             eecccccccccccccccccCccchhhhcccccccchhhhcccccc-cCcch------------hhhhHHHHHHHHHHHHH
Q 001988          884 MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLL-SGEEK------------HFAAKEQCLLSIFSLAL  950 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~-~~~~~------------~~~~~~~~~~~l~~l~~  950 (985)
                      ......||+.|+|||++..+.++.++|+ |++|++++|++++..+ .....            ..+.+..+++++.+++.
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI-~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  248 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDV-WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC  248 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred             eeccccccccccChHHHhCCCCCcHHhh-hcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHH
Confidence            3344569999999999999999999999 9999999999985433 22221            11233457788999999


Q ss_pred             HccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          951 ECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       951 ~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                      +||+.||++||+|.+|++.|++...
T Consensus       249 ~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         249 QCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             HHcccCHhHCcCHHHHHHHHhhhhc
Confidence            9999999999999999999887654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.3e-42  Score=383.58  Aligned_cols=237  Identities=19%  Similarity=0.247  Sum_probs=207.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .++|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            368999999999999999999975 7999999999877666677899999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc--CCCcEEEecccCceeccCCCC
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD--EDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~--~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ++||+|.+++......+++..+..++.||+.||+||   |++|||||||||+|||++  .++.+||+|||+|+.+.... 
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  180 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  180 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence            999999999977666799999999999999999999   789999999999999995  46889999999999875332 


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQCLLSIF  946 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~~~~~l~  946 (985)
                        ......||+.|||||++.+..++.++|+ |++|++++++++|..++.......               ....+++++.
T Consensus       181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~Di-wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDM-WSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             --CEEEECSCTTTCCHHHHHTCCBCHHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred             --ccceecCcccccCHHHHcCCCCChhHhh-hhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence              2334579999999999999999999999 999999999999988764332111               1123567899


Q ss_pred             HHHHHccCCCCCCCCCHHHHHH
Q 001988          947 SLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +++.+||..||++|||+.|+++
T Consensus       258 ~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         258 DFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-43  Score=383.84  Aligned_cols=252  Identities=25%  Similarity=0.398  Sum_probs=212.1

Q ss_pred             HHHHHhcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 001988          720 ELLRATDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCS  792 (985)
Q Consensus       720 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~  792 (985)
                      +++...++|+..+.||+|+||+||+|+++      +++.||||+++..... ..+++.+|++++++++||||++++++|.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            33345678999999999999999999864      4578999999765433 3567999999999999999999999999


Q ss_pred             cCCceEEEEeccCCCChHHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 001988          793 NDDFKALVLEYMSNGSLEDCLHSSN-----------------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIH  849 (985)
Q Consensus       793 ~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH  849 (985)
                      +.+..++||||+++|+|.+++....                       ..+++..+..|+.|++.||+||   |+++|||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yl---H~~~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhc---ccCCeEe
Confidence            9999999999999999999986431                       2478999999999999999999   7899999


Q ss_pred             CCCCCCCEEEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhccccc-c
Q 001988          850 CDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSL-L  928 (985)
Q Consensus       850 rDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~-~  928 (985)
                      |||||+|||+|.++.+||+|||+|+.+.............||+.|+|||.+.+..++.++|| |++|++++|++++.. +
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDV-wS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV-WAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTTCCT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhh-ccchhhHHHHHccCCCC
Confidence            99999999999999999999999987754444444455679999999999999999999999 999999999988754 2


Q ss_pred             cCcchh------------hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          929 SGEEKH------------FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       929 ~~~~~~------------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                      ......            .+.++.++.++.+++.+||+.+|++||||.||+++|+++.+
T Consensus       243 ~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         243 YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             TTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            222211            11234577889999999999999999999999999998864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-43  Score=386.18  Aligned_cols=237  Identities=22%  Similarity=0.333  Sum_probs=201.4

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC-cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ..++|+..+.||+|+||+||+|+.. +|+.||+|+++... ......+.+|+.++++++|||||+++++|.++++.++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3578999999999999999999975 78999999997653 334567899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||++||+|.+++...+ .+++..+..++.|+++||+|||  +.+||+||||||+|||++++|.+||+|||+|+.+.+   
T Consensus        84 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH--~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---  157 (322)
T ss_dssp             ECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred             EcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH--HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC---
Confidence            9999999999998664 6899999999999999999994  235899999999999999999999999999987642   


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-------------------------
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------------------  936 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------------------  936 (985)
                       ......+||+.|||||++.+..++.++|+ |++|++++|+++|+.++.......                         
T Consensus       158 -~~~~~~~GT~~Y~APEvl~~~~y~~~~Di-WSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         158 -SMANSFVGTRSYMSPERLQGTHYSVQSDI-WSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             -HTC---CCSSCCCCHHHHHCSCCCTTHHH-HHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             -CccccccCCccccCchHHcCCCCCcHHHH-HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence             12334689999999999999999999999 999999999999986653221000                         


Q ss_pred             -----------------hH-------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 -----------------AK-------------EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 -----------------~~-------------~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                       ..             ...+.++.+++.+||..||.+||||.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                             00             002357889999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-43  Score=381.98  Aligned_cols=246  Identities=22%  Similarity=0.364  Sum_probs=204.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCc----EEEEEEeccC-CcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGV----EIAIKVFHPQ-CASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vAvK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      ++|+..+.||+|+||+||+|.+. +|+    +||+|+++.. .....+++.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46899999999999999999864 444    6899988754 234567899999999999999999999999875 4678


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      +|||+.+|+|.+++......+++..+.+++.||+.||+||   |+++||||||||+||+++.++.+||+|||+|+.+...
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yL---H~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHH---HHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            8999999999999988877899999999999999999999   7889999999999999999999999999999987654


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSIF  946 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l~  946 (985)
                      ..........||+.|||||.+.++.++.++|+ |++|++++|+++ +..++.....            .+.++.+++++.
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDv-wS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~  243 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDV-WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY  243 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHH
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhh-hhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHH
Confidence            44444455569999999999999999999999 999999999997 5655543211            122345778899


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          947 SLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      +++.+||+.||.+|||+.|+++.+.++.+.
T Consensus       244 ~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         244 MIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            999999999999999999999999888654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-42  Score=377.17  Aligned_cols=236  Identities=23%  Similarity=0.277  Sum_probs=188.9

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .+.|+..+.||+|+||+||+|+.+ +++.||||++..... .....+.+|++++++++|||||++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            466899999999999999999975 789999999976532 234567899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc---CCCcEEEecccCceeccCC
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~---~~~~~kl~DfGla~~~~~~  879 (985)
                      |++||+|.+++...+ .+++.....++.||+.||+||   |++||+||||||+||++.   +++.+||+|||+|+.....
T Consensus        88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhh---hhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            999999999998654 689999999999999999999   789999999999999994   5789999999999876422


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh---------------hhHHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AAKEQCLLS  944 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~~~~~~~~  944 (985)
                         ......+||+.|||||++.+..++.++|+ |++|++++++++|..++......               +....++++
T Consensus       164 ---~~~~~~~GT~~y~APE~~~~~~~~~~~Di-wSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  239 (307)
T d1a06a_         164 ---SVLSTACGTPGYVAPEVLAQKPYSKAVDC-WSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS  239 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             ---CeeeeeeeCccccCcHHHcCCCCCcHHHh-hhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHH
Confidence               22344679999999999999999999999 99999999999998876543211               112345678


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHH
Q 001988          945 IFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       945 l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +.+++.+||..||++|||+.|+++
T Consensus       240 ~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         240 AKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhc
Confidence            999999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3e-42  Score=381.09  Aligned_cols=236  Identities=19%  Similarity=0.285  Sum_probs=208.0

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEecc
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEYM  804 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  804 (985)
                      ++|+..+.||+|+||.||+|+.. +|+.||||+++.........+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999974 79999999998776556678899999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc--CCCcEEEecccCceeccCCCCc
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD--EDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~--~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      +||+|.+++...+..+++.+...|+.||+.||+||   |++|||||||||+|||++  .++.+||+|||+|+.+....  
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--  183 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--  183 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccccccccccccCCCeEEEeecccceecCCCC--
Confidence            99999999887776799999999999999999999   789999999999999998  67899999999999875332  


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQCLLSIFS  947 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~~~~~l~~  947 (985)
                       ......||+.|||||++.+..++.++|+ |++|++++++++|..++.......               ....+++++.+
T Consensus       184 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  261 (352)
T d1koba_         184 -IVKVTTATAEFAAPEIVDREPVGFYTDM-WAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD  261 (352)
T ss_dssp             -CEEEECSSGGGCCHHHHTTCCBCHHHHH-HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred             -ceeeccCcccccCHHHHcCCCCCCccch-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence             2334569999999999999999999999 999999999999988765432111               11235678999


Q ss_pred             HHHHccCCCCCCCCCHHHHHH
Q 001988          948 LALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ++.+||..||.+|||+.|+++
T Consensus       262 li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         262 FIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999976

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-42  Score=366.84  Aligned_cols=230  Identities=23%  Similarity=0.336  Sum_probs=192.6

Q ss_pred             cCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeec----CCceEEEE
Q 001988          729 AENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSN----DDFKALVL  801 (985)
Q Consensus       729 ~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~lv~  801 (985)
                      +..+.||+|+||+||+|++. +++.||+|++....  ....+.+.+|++++++++|||||++++++.+    +...++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45568999999999999975 78899999987553  2345678999999999999999999999865    34579999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCEEEc-CCCcEEEecccCceeccC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTP--IIHCDLKPSNVLLD-EDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~--ivHrDlk~~Nill~-~~~~~kl~DfGla~~~~~  878 (985)
                      ||+++|+|.+++.... .+++..+..++.||++||+||   |+++  |+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yL---H~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHH---HHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999998754 689999999999999999999   6666  99999999999996 589999999999986432


Q ss_pred             CCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh--------------hhHHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQCLLS  944 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~~~~  944 (985)
                          ......+||+.|||||.+. +.++.++|+ |++|++++++++++.++......              ..+..++++
T Consensus       168 ----~~~~~~~GT~~Y~aPE~~~-~~~~~~~DI-wSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (270)
T d1t4ha_         168 ----SFAKAVIGTPEFMAPEMYE-EKYDESVDV-YAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE  241 (270)
T ss_dssp             ----TSBEESCSSCCCCCGGGGG-TCCCTHHHH-HHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             ----CccCCcccCccccCHHHhC-CCCCCcCch-hhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH
Confidence                2234567999999999875 569999999 99999999999998876432111              112235677


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHH
Q 001988          945 IFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       945 l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +.+++.+||++||++|||+.|+++
T Consensus       242 ~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         242 VKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhC
Confidence            999999999999999999999975

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-42  Score=375.42  Aligned_cols=232  Identities=23%  Similarity=0.287  Sum_probs=198.3

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc---hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      +.|+..+.||+|+||+||+|+.. +++.||||+++.....   ..+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35888999999999999999864 7899999999765432   2456889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      |||++|++..++... ..+++..+..++.||+.||+||   |++|||||||||+|||+++++.+||+|||+|+....   
T Consensus        95 E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             ECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             EecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence            999999987666554 4789999999999999999999   789999999999999999999999999999987532   


Q ss_pred             cceeccccccccccccccccc---CccchhhhcccccccchhhhcccccccCcchhhh-------------hHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFV---GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------AKEQCLLSI  945 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------~~~~~~~~l  945 (985)
                         ....+||+.|||||++.+   +.++.++|+ |++|+.++++++|..+........             ....+++++
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~Di-wSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~  243 (309)
T d1u5ra_         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDV-WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF  243 (309)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHH-HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHH
T ss_pred             ---CCccccCccccCHHHHhccCCCCcCchhhh-hhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHH
Confidence               223569999999999863   568899999 999999999999987654332111             112356789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHH
Q 001988          946 FSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       946 ~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      .+++.+||..||.+|||+.|+++
T Consensus       244 ~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         244 RNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHCcCChhHCcCHHHHHh
Confidence            99999999999999999999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-42  Score=377.60  Aligned_cols=256  Identities=21%  Similarity=0.326  Sum_probs=203.2

Q ss_pred             CHHHHHHHhcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhc-CCCCeeeEE
Q 001988          717 SYFELLRATDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLVKII  788 (985)
Q Consensus       717 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~  788 (985)
                      ...+++...++|+..+.||+|+||.||+|++.      +++.||||+++.... ...+.+.+|.+++.++ +|+|||.++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            33444444578999999999999999999863      356899999975533 3456788888888887 689999999


Q ss_pred             eeeecC-CceEEEEeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 001988          789 SSCSND-DFKALVLEYMSNGSLEDCLHSSN---------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDL  852 (985)
Q Consensus       789 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDl  852 (985)
                      +++.+. +..++||||+++|+|.++++...               ..+++.++..++.||++||+||   |+++||||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~ivHrDl  160 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL  160 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHH---HhCCCcCCcC
Confidence            998664 56899999999999999997542               3478999999999999999999   7899999999


Q ss_pred             CCCCEEEcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhccccc-ccCc
Q 001988          853 KPSNVLLDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSL-LSGE  931 (985)
Q Consensus       853 k~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~-~~~~  931 (985)
                      ||+|||+++++.+||+|||+|+...............||+.|||||.+.++.++.++|+ |++|++++|++++.. +...
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDi-wS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV-WSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccce-eehHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999988765544444556679999999999999999999999 999999999997643 3322


Q ss_pred             ch-------------hhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          932 EK-------------HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       932 ~~-------------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      ..             ....++.+++++.+++.+||+.||++||||.|+++.|+++.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            11             1112234678899999999999999999999999999998764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-42  Score=368.24  Aligned_cols=246  Identities=21%  Similarity=0.331  Sum_probs=198.5

Q ss_pred             hcCccCCceeeccCceeEEEEEEc----CCcEEEEEEeccCCcc-hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQCAS-TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKAL  799 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  799 (985)
                      .++|+..+.||+|+||.||+|++.    .+..||||.++..... ..+.+.+|++++++++|||||++++++.+ +..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            367899999999999999999864    2457999998755333 35678999999999999999999999964 67899


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCC
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~  879 (985)
                      ||||+++|++.+++......+++..+..++.||++||+||   |+++|+||||||+||+++.++.+||+|||+|+.+...
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhh---cccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            9999999999999887777899999999999999999999   7899999999999999999999999999999876432


Q ss_pred             CCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHHH
Q 001988          880 DESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSIF  946 (985)
Q Consensus       880 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l~  946 (985)
                      . ........||+.|+|||.+..+.++.++|+ |++|+.++|+++ +..+......            .+.+..+++++.
T Consensus       162 ~-~~~~~~~~gt~~y~apE~l~~~~~~~~~Di-wSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  239 (273)
T d1mp8a_         162 T-YYKASKGKLPIKWMAPESINFRRFTSASDV-WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY  239 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHH-HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             c-ceeccceecCcccchhhHhccCCCCCcccc-ccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            2 223344568999999999999999999999 999999999987 5654443221            122345778899


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          947 SLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      +++.+||..||++|||+.|+++.|+++.+.
T Consensus       240 ~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         240 SLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            999999999999999999999999998765

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-42  Score=365.52  Aligned_cols=239  Identities=28%  Similarity=0.397  Sum_probs=197.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeec-CCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSN-DDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~~lv~e~  803 (985)
                      .++|+..+.||+|+||.||+|+++ |++||||+++..  ...+.+.+|++++++++||||++++|+|.+ .+..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            356888899999999999999985 789999999754  345789999999999999999999999854 4668999999


Q ss_pred             cCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          804 MSNGSLEDCLHSSN-CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       804 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      +++|+|.+++.... ..+++..+++++.||+.||+||   |+++|+||||||+||+++.++.+|++|||+++.....   
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~yl---H~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccc---ccCceeccccchHhheecCCCCEeecccccceecCCC---
Confidence            99999999997652 3589999999999999999999   7899999999999999999999999999999875322   


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchh------------hhhHHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKH------------FAAKEQCLLSIFSLA  949 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~------------~~~~~~~~~~l~~l~  949 (985)
                        .....+|+.|+|||.+.++.++.++|+ |++|+.++|+++ ++.+......            .+.+..+++++.+++
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDI-wSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li  233 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDV-WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM  233 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred             --CccccccccCCChHHHhCCCCChHHHH-HhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence              223458899999999999999999999 999999999997 5654433211            122334668899999


Q ss_pred             HHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          950 LECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                      .+||+.||++||||.|++++|++++.
T Consensus       234 ~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         234 KNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-41  Score=367.76  Aligned_cols=236  Identities=22%  Similarity=0.295  Sum_probs=204.2

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc------chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCce
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA------STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFK  797 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  797 (985)
                      .++|+..+.||+|+||+||+|+.+ +|+.||||++++...      ...+.+.+|++++++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            467999999999999999999974 799999999975422      1356799999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC----cEEEecccCc
Q 001988          798 ALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM----VAHLSDFGMA  873 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~----~~kl~DfGla  873 (985)
                      |+||||+++|+|.+++...+ .+++..+..++.|++.||+||   |+++|+||||||+||+++.++    .+|++|||+|
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yL---H~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhh---hhcceeecccccceEEEecCCCcccceEecchhhh
Confidence            99999999999999998764 689999999999999999999   789999999999999998776    5999999999


Q ss_pred             eeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh---------------hhH
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AAK  938 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~~  938 (985)
                      +......   ......||+.|+|||++.+..++.++|+ |++|+.+++++++..++......               ..+
T Consensus       165 ~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~Di-wSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (293)
T d1jksa_         165 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADM-WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF  240 (293)
T ss_dssp             EECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred             hhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccc-hhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence            8874322   2334579999999999999999999999 99999999999998776533211               112


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          939 EQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       939 ~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ..++.++.+++.+||..||++|||+.|+++
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            235678899999999999999999999975

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-42  Score=365.55  Aligned_cols=243  Identities=23%  Similarity=0.350  Sum_probs=196.5

Q ss_pred             cCccCCceeeccCceeEEEEEEc--C--CcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE--D--GVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~--~--~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      ++|+..+.||+|+||+||+|++.  +  ...||||++++..   ....++|.+|++++++++|||||+++|++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            56888999999999999999864  2  2479999987652   23356899999999999999999999999764 678


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +||||+++|++.+++......+++..+.+++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+++.+..
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHh---hhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            99999999999999887766799999999999999999999   689999999999999999999999999999998765


Q ss_pred             CCCcc-eecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcch-------------hhhhHHHHHH
Q 001988          879 EDEST-MRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEK-------------HFAAKEQCLL  943 (985)
Q Consensus       879 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~-------------~~~~~~~~~~  943 (985)
                      ..... ......|++.|+|||.+.+..++.++|+ |++|+.++|+++ |+.++....             ..+.++.++.
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di-~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT-WMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  242 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHH-HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhh-hhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence            44333 2334568889999999999999999999 999999999997 666543221             1122345678


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 001988          944 SIFSLALECTMESPEKRIDAKDTITRLLKI  973 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i  973 (985)
                      ++.+++.+||+.||++||||.|+.+.|++.
T Consensus       243 ~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         243 DIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            899999999999999999999999988875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-41  Score=369.79  Aligned_cols=245  Identities=22%  Similarity=0.385  Sum_probs=206.4

Q ss_pred             CceeeccCceeEEEEEEcC----CcEEEEEEeccC-CcchHHHHHHHHHHHHhcCCCCeeeEEeeeec-CCceEEEEecc
Q 001988          731 NNIIGIGGFGSVYRARLED----GVEIAIKVFHPQ-CASTLKSFEAECEVIKNIRHRNLVKIISSCSN-DDFKALVLEYM  804 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~----~~~vAvK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~~lv~e~~  804 (985)
                      .++||+|+||+||+|++.+    ...||||+++.. .....++|.+|++++++++|||||+++|++.+ ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4689999999999998743    235999999754 33345789999999999999999999999875 46789999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc--
Q 001988          805 SNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES--  882 (985)
Q Consensus       805 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~--  882 (985)
                      ++|+|.+++.......++..+.+++.|+++||.|+   |+++|+||||||+|||+++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~l---H~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhh---cccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            99999999998877788999999999999999999   7899999999999999999999999999999886543222  


Q ss_pred             ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcch-------------hhhhHHHHHHHHHHHH
Q 001988          883 TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEK-------------HFAAKEQCLLSIFSLA  949 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~-------------~~~~~~~~~~~l~~l~  949 (985)
                      .......||+.|+|||.+..+.++.++|+ |++|+.++|++++..++....             ....++.+++++.+++
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI-~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li  267 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDV-WSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVM  267 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCChhHh-hhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHH
Confidence            12234568999999999999999999999 999999999998655433221             1112344678899999


Q ss_pred             HHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          950 LECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                      .+||+.||++||+|.||++.|+++.+++..
T Consensus       268 ~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~  297 (311)
T d1r0pa_         268 LKCWHPKAEMRPSFSELVSRISAIFSTFIG  297 (311)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             HHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence            999999999999999999999999887554

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-41  Score=370.90  Aligned_cols=237  Identities=24%  Similarity=0.274  Sum_probs=205.0

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      .++|+..+.||+|+||.||+|+.+ +|+.||||++++..   ....+.+.+|++++++++|||||++++++++.+..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            367999999999999999999974 89999999997542   23456789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||++||+|.+++...+ .+++...+.++.|++.||+||   |++|||||||||+|||++++|.+||+|||+|+......
T Consensus        84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~yl---H~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhh---hhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            99999999999988765 688999999999999999999   78999999999999999999999999999998764322


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLA  949 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~  949 (985)
                        ......+||+.|||||++.+..++.++|+ |++|+++++|++|..++.......           .+..+++++.+++
T Consensus       160 --~~~~~~~GT~~Y~aPE~~~~~~y~~~~Di-wSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli  236 (337)
T d1o6la_         160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDW-WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL  236 (337)
T ss_dssp             --CCBCCCEECGGGCCGGGGSSSCBCTTHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             --cccccceeCHHHhhhhhccCCCCChhhcc-cchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence              23345689999999999999999999999 999999999999987655432211           1233667899999


Q ss_pred             HHccCCCCCCCCC-----HHHHHH
Q 001988          950 LECTMESPEKRID-----AKDTIT  968 (985)
Q Consensus       950 ~~cl~~~P~~RPt-----~~ev~~  968 (985)
                      .+||.+||.+||+     +.|+++
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         237 AGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HhhccCCchhhcccccccHHHHHc
Confidence            9999999999995     777765

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-41  Score=365.49  Aligned_cols=245  Identities=23%  Similarity=0.335  Sum_probs=197.6

Q ss_pred             cCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHH--HHHHHHhcCCCCeeeEEeeeecCC----ceEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEA--ECEVIKNIRHRNLVKIISSCSNDD----FKAL  799 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~--E~~il~~l~h~niv~l~~~~~~~~----~~~l  799 (985)
                      ++|...+.||+|+||.||+|++ +|+.||||+++.+   ....+.+  |+..+.+++|||||+++++|.+.+    ..++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            4677788999999999999997 5899999999644   2233444  444556789999999999997654    5789


Q ss_pred             EEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEeCCCCCCCEEEcCCCcEEEecccCce
Q 001988          800 VLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHF-----GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAK  874 (985)
Q Consensus       800 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~-----~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~  874 (985)
                      ||||+++|+|.++++..  .++|..+.+++.|+|.||+|+|.     .|++|||||||||+|||+++++.+||+|||+++
T Consensus        79 v~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999999875  58999999999999999999974     256899999999999999999999999999999


Q ss_pred             eccCCCCcc--eecccccccccccccccccC------ccchhhhcccccccchhhhcccccccCcch-------------
Q 001988          875 LLSGEDEST--MRTQTLATIGYMAPDEIFVG------ELSLKRWVNDLLPVSLVEVVDKSLLSGEEK-------------  933 (985)
Q Consensus       875 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~-------------  933 (985)
                      .+.......  .....+||+.|||||.+.+.      .++.++|+ |++|++++|++++..+++...             
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di-~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI-YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHH-HHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhh-hhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            876443322  23456799999999987654      36778999 999999999998865432210             


Q ss_pred             --------------------hhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          934 --------------------HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       934 --------------------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                                          .......++..+.+++.+||..||++||||.||++.|+++.+.-
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence                                01112235567999999999999999999999999999998763

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-41  Score=367.91  Aligned_cols=249  Identities=21%  Similarity=0.353  Sum_probs=213.0

Q ss_pred             HhcCccCCceeeccCceeEEEEEE------cCCcEEEEEEeccCCc-chHHHHHHHHHHHHhc-CCCCeeeEEeeeecCC
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARL------EDGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLVKIISSCSNDD  795 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~  795 (985)
                      ..++|+.++.||+|+||.||+|++      .+++.||||+++.... .....+.+|+.+++++ +|||||+++++|.+++
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            346888999999999999999985      2567899999986533 3456789999999999 6999999999999999


Q ss_pred             ceEEEEeccCCCChHHHhhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEE
Q 001988          796 FKALVLEYMSNGSLEDCLHSSN-----------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVL  858 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nil  858 (985)
                      ..++||||+++|+|.++++...                 ..+++..+.+++.||++||+||   |+++||||||||+||+
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~L---H~~~ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccccccccc
Confidence            9999999999999999987542                 2588999999999999999999   7899999999999999


Q ss_pred             EcCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhhh-
Q 001988          859 LDEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHFA-  936 (985)
Q Consensus       859 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~~-  936 (985)
                      ++.++.+|++|||.++...............||+.|+|||.+.++.++.++|+ |++|++++||++ +..+........ 
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DI-wS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV-WSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccc-cchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998765555555566789999999999999999999999 999999999997 444433322111 


Q ss_pred             ------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          937 ------------AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       937 ------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                                  .++.+++++.+++.+||++||++||+|.|++++|+++.++
T Consensus       257 ~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence                        1233568899999999999999999999999999987654

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-41  Score=367.65  Aligned_cols=247  Identities=25%  Similarity=0.400  Sum_probs=204.3

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCc--EEEEEEeccC-CcchHHHHHHHHHHHHhc-CCCCeeeEEeeeecCCceEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGV--EIAIKVFHPQ-CASTLKSFEAECEVIKNI-RHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~--~vAvK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv  800 (985)
                      ++|+..+.||+|+||+||+|+++ ++.  .||||+++.. .....+.+.+|+++++++ +|||||+++++|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            67888899999999999999875 444  4788887644 233456799999999998 799999999999999999999


Q ss_pred             EeccCCCChHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcE
Q 001988          801 LEYMSNGSLEDCLHSS---------------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  865 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~  865 (985)
                      |||+++|+|.++++..               ...+++..+.+++.|||+||.|+   |+++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l---H~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh---hcCCccccccccceEEEcCCCce
Confidence            9999999999998753               35689999999999999999999   78999999999999999999999


Q ss_pred             EEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhccccc-ccCcch-----------
Q 001988          866 HLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSL-LSGEEK-----------  933 (985)
Q Consensus       866 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~-~~~~~~-----------  933 (985)
                      ||+|||+|+.....   .......||+.|+|||.+.++.++.++|+ |++|+.++|++++.. +.....           
T Consensus       167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDv-wSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~  242 (309)
T d1fvra_         167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDV-WSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  242 (309)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHH-HHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             EEcccccccccccc---ccccceecCCcccchHHhccCCCCcccee-ehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence            99999999865321   22234468999999999999999999999 999999999998643 332211           


Q ss_pred             -hhhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhhcc
Q 001988          934 -HFAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTLSK  979 (985)
Q Consensus       934 -~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~~~  979 (985)
                       ..+.+..+++++.+++.+||+.||++||+|.|+++.|+++.+....
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~  289 (309)
T d1fvra_         243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  289 (309)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence             1112334678899999999999999999999999999998876443

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.4e-41  Score=365.89  Aligned_cols=233  Identities=21%  Similarity=0.269  Sum_probs=202.9

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|+..+.||+|+||+||+|+.+ +|+.||||++++..   ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999975 79999999997542   233567899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||++||++..++.... .+++.....++.||+.||+||   |++||+||||||+|||++.+|.+||+|||+|+.....  
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhh---ccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            9999999999888764 678888899999999999999   7999999999999999999999999999999986432  


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLAL  950 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~  950 (985)
                         ....+||+.|||||++.+..++.++|+ |++|++++++++|+.++.......           .+...++++.+++.
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~Di-wSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  233 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDW-WSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS  233 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHH-HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhc-cccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence               234679999999999999999999999 999999999999998765432111           12335678999999


Q ss_pred             HccCCCCCCCC-----CHHHHHH
Q 001988          951 ECTMESPEKRI-----DAKDTIT  968 (985)
Q Consensus       951 ~cl~~~P~~RP-----t~~ev~~  968 (985)
                      +|+..||.+||     ++.|+++
T Consensus       234 ~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         234 RLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHhhhCHHhccccchhhHHHHHc
Confidence            99999999996     8888875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.8e-41  Score=361.06  Aligned_cols=246  Identities=22%  Similarity=0.375  Sum_probs=201.9

Q ss_pred             hcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCcc---hHHHHHHHHHHHHhcCCCCeeeEEeeeecCC----c
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCAS---TLKSFEAECEVIKNIRHRNLVKIISSCSNDD----F  796 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----~  796 (985)
                      .++|+..+.||+|+||+||+|+. .+|+.||||++++....   ....+.+|++++++++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            36799999999999999999986 48999999999865332   3457899999999999999999999997654    3


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      .|+||||++||+|.+++...+ .+++.++..++.||+.||+||   |++||+||||||+||+++.++.++++|||.+...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~l---H~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHH---HhCCccCccccCcccccCccccceeehhhhhhhh
Confidence            789999999999999887764 689999999999999999999   7899999999999999999999999999998876


Q ss_pred             cCCCC-cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hHHH
Q 001988          877 SGEDE-STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQ  940 (985)
Q Consensus       877 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~  940 (985)
                      ..... .......+||+.|||||++.+..++.++|+ |++|++++++++|..++.......               ..+.
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~Di-wSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV-YSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG  240 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceec-ccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence            43322 223445679999999999999999999999 999999999999988765432111               1123


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHhHh
Q 001988          941 CLLSIFSLALECTMESPEKRI-DAKDTITRLLKIRD  975 (985)
Q Consensus       941 ~~~~l~~l~~~cl~~~P~~RP-t~~ev~~~L~~i~~  975 (985)
                      +++++.+++.+|+.+||.+|| ++.++.+.|.+++.
T Consensus       241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            568899999999999999999 89999999988764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-41  Score=364.01  Aligned_cols=247  Identities=25%  Similarity=0.371  Sum_probs=206.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEc--------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE--------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNI-RHRNLVKIISSCSND  794 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~  794 (985)
                      .++|..++.||+|+||.||+|+..        ++..||||+++.+.. ....++.+|...+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            468888999999999999999853        234799999987643 3457788999999888 899999999999999


Q ss_pred             CceEEEEeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE
Q 001988          795 DFKALVLEYMSNGSLEDCLHSSN---------------CALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLL  859 (985)
Q Consensus       795 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill  859 (985)
                      +..++||||+++|+|.+++....               ..+++.++++++.||+.||+||   |+++||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~yl---H~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHh---hhCCEEeeeecccceee
Confidence            99999999999999999997553               3589999999999999999999   79999999999999999


Q ss_pred             cCCCcEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcc-cccccCcchhh---
Q 001988          860 DEDMVAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVD-KSLLSGEEKHF---  935 (985)
Q Consensus       860 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~-~~~~~~~~~~~---  935 (985)
                      +.++.+||+|||+++...............||+.|+|||.+.++.++.++|+ |++|++++|+++ +..+.......   
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~Di-wS~Gvvl~ell~~g~~p~~~~~~~~~~  247 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV-WSFGVLLWEIFTLGGSPYPGVPVEELF  247 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhh-HHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence            9999999999999998765554444556679999999999999999999999 999999999997 56544332211   


Q ss_pred             ---------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHh
Q 001988          936 ---------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRD  975 (985)
Q Consensus       936 ---------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~  975 (985)
                               +.+..+++++.+++.+||+.||.+||||.||++.|+++..
T Consensus       248 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence                     1223356789999999999999999999999999998864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-40  Score=363.86  Aligned_cols=236  Identities=18%  Similarity=0.222  Sum_probs=205.0

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      .++|...+.||+|+||+||+|... +++.||||+++... .+...+.+|++++++++|||||++++++++++..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            367999999999999999999975 78899999998653 3445688999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC--CcEEEecccCceeccCCCC
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDED--MVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~--~~~kl~DfGla~~~~~~~~  881 (985)
                      |+||+|.+++...+..+++.+...++.||++||+||   |++||+||||||+|||++.+  +.+||+|||+++...... 
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yL---H~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-  158 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence            999999999988766799999999999999999999   78999999999999999854  589999999998864322 


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------hHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------AKEQCLLSIF  946 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~~~~~~~~l~  946 (985)
                        ......+|+.|+|||...+..++.++|+ |++|++++++++|..++.......               ....+++++.
T Consensus       159 --~~~~~~~t~~y~ape~~~~~~~~~~~Di-WSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T d1tkia_         159 --NFRLLFTAPEYYAPEVHQHDVVSTATDM-WSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHH-HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             --cccccccccccccchhccCCCCCchhhc-ccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence              2334569999999999999999999999 999999999999988765432111               1123567789


Q ss_pred             HHHHHccCCCCCCCCCHHHHHH
Q 001988          947 SLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       947 ~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      +++.+|+..||.+|||+.|+++
T Consensus       236 ~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         236 DFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-41  Score=370.13  Aligned_cols=249  Identities=21%  Similarity=0.331  Sum_probs=210.4

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc------CCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCc
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE------DGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDDF  796 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  796 (985)
                      ..++|...+.||+|+||+||+|.+.      +++.||||+++.... .....+.+|++++++++|||||+++++|...+.
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence            4578889999999999999999863      357899999975532 344568999999999999999999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEE
Q 001988          797 KALVLEYMSNGSLEDCLHSS---------NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHL  867 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl  867 (985)
                      .++||||+++|+|.+++...         ...+++..+.+++.|+|+||.||   |+++|+||||||+|||+++++++||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~L---H~~~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeeceEcCCceeecCCceEEE
Confidence            99999999999999998643         13468999999999999999999   7889999999999999999999999


Q ss_pred             ecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccc-cccCcchh------------
Q 001988          868 SDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKS-LLSGEEKH------------  934 (985)
Q Consensus       868 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~-~~~~~~~~------------  934 (985)
                      +|||+|+.+.............||+.|+|||.+.++.++.++|+ |++|+.++|++++. .+......            
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv-~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~  253 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV-WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  253 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHccCCCCccccc-ccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence            99999988754444444455579999999999999999999999 99999999999874 33322211            


Q ss_pred             hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          935 FAAKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       935 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                      .+.+..+++.+.+++.+||+.+|++||||.+|++.|++..+.
T Consensus       254 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            112344668899999999999999999999999999887553

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-40  Score=355.59  Aligned_cols=236  Identities=23%  Similarity=0.309  Sum_probs=202.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc---------hHHHHHHHHHHHHhcC-CCCeeeEEeeeec
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS---------TLKSFEAECEVIKNIR-HRNLVKIISSCSN  793 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~---------~~~~~~~E~~il~~l~-h~niv~l~~~~~~  793 (985)
                      .++|+..+.||+|+||+||+|+.. +++.||||++++....         ..+.+.+|++++++++ |||||++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            368999999999999999999974 7999999999765321         1245789999999997 9999999999999


Q ss_pred             CCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCc
Q 001988          794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA  873 (985)
Q Consensus       794 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla  873 (985)
                      +++.|+||||+++|+|.+++...+ .+++.++..++.||++||+||   |++||+||||||+||+++.++.+||+|||+|
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHcCCcccccccceEEEcCCCCeEEccchhe
Confidence            999999999999999999998764 789999999999999999999   7899999999999999999999999999999


Q ss_pred             eeccCCCCcceeccccccccccccccccc------CccchhhhcccccccchhhhcccccccCcchhhh-----------
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFV------GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------  936 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------  936 (985)
                      +.+....   .....+||+.|+|||.+..      ..++.++|+ |++|++++++++|+.+........           
T Consensus       158 ~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~Di-wslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~  233 (277)
T d1phka_         158 CQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDM-WSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ  233 (277)
T ss_dssp             EECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             eEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheE-cccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC
Confidence            9875322   2344679999999998863      346788999 999999999999987765442111           


Q ss_pred             ----hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 ----AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 ----~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                          ....+++++.+++.+||.+||++||++.|+++
T Consensus       234 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                12246788999999999999999999999864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.6e-40  Score=365.56  Aligned_cols=233  Identities=22%  Similarity=0.256  Sum_probs=203.4

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  801 (985)
                      ++|+..+.||+|+||.||+|+.+ +|+.||||++.+..   ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999975 79999999987542   233467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDE  881 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~  881 (985)
                      ||+++|+|.+++...+ .+++..+..++.||+.||.||   |++|||||||||+|||++.+|.+||+|||+|+.+...  
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yL---H~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            9999999999998764 689999999999999999999   7899999999999999999999999999999987432  


Q ss_pred             cceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHHH
Q 001988          882 STMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLAL  950 (985)
Q Consensus       882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~  950 (985)
                         .....||+.|||||++.+..++.++|+ |++|++++++++|..++.......           .+..+++++.++++
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~Di-wSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  270 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDW-WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR  270 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccc-cchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence               234579999999999999999999999 999999999999988765432211           12335678999999


Q ss_pred             HccCCCCCCCC-----CHHHHHH
Q 001988          951 ECTMESPEKRI-----DAKDTIT  968 (985)
Q Consensus       951 ~cl~~~P~~RP-----t~~ev~~  968 (985)
                      +|+..||.+|+     ++.|+++
T Consensus       271 ~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         271 NLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHhhhCHHhccccccccHHHHHc
Confidence            99999999994     8999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-40  Score=361.76  Aligned_cols=235  Identities=23%  Similarity=0.282  Sum_probs=200.6

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC---cchHHHHHHHHHHHH-hcCCCCeeeEEeeeecCCceEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC---ASTLKSFEAECEVIK-NIRHRNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~il~-~l~h~niv~l~~~~~~~~~~~lv  800 (985)
                      ++|...+.||+|+||+||+|+.. +++.||||++++..   ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            67999999999999999999975 79999999997542   223456677777765 68999999999999999999999


Q ss_pred             EeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCC
Q 001988          801 LEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGED  880 (985)
Q Consensus       801 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~  880 (985)
                      |||+++|+|.+++.... .+++.++..++.||+.||+||   |+++|+||||||+|||+++++.+||+|||+|+......
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~yl---H~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            99999999999998764 688999999999999999999   78999999999999999999999999999998764322


Q ss_pred             CcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh-----------hHHHHHHHHHHHH
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-----------AKEQCLLSIFSLA  949 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~  949 (985)
                        .......||+.|+|||++.+..++.++|+ |++|++++++++|+.++.......           .+..+++++.+++
T Consensus       158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli  234 (320)
T d1xjda_         158 --AKTNTFCGTPDYIAPEILLGQKYNHSVDW-WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL  234 (320)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             --ccccccCCCCCcCCHHHHcCCCCCchhhh-hhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence              23344679999999999999999999999 999999999999988765432111           1223567899999


Q ss_pred             HHccCCCCCCCCCHH-HHH
Q 001988          950 LECTMESPEKRIDAK-DTI  967 (985)
Q Consensus       950 ~~cl~~~P~~RPt~~-ev~  967 (985)
                      ++||..||++||++. |++
T Consensus       235 ~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         235 VKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             HHHSCSSGGGSBTTBSCGG
T ss_pred             HHhcccCCCCCcCHHHHHH
Confidence            999999999999995 664

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-40  Score=360.56  Aligned_cols=232  Identities=21%  Similarity=0.244  Sum_probs=196.5

Q ss_pred             hcCccCCc-eeeccCceeEEEEEE-cCCcEEEEEEeccCCcchHHHHHHHHHHHHhc-CCCCeeeEEeeeec----CCce
Q 001988          725 TDNFAENN-IIGIGGFGSVYRARL-EDGVEIAIKVFHPQCASTLKSFEAECEVIKNI-RHRNLVKIISSCSN----DDFK  797 (985)
Q Consensus       725 ~~~~~~~~-~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~----~~~~  797 (985)
                      .++|.+.+ .||+|+||.||+|+. .+++.||||+++..     ..+.+|++++.++ +|||||++++++++    +.+.
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            35787764 699999999999986 47899999998643     5678899997665 89999999999865    4568


Q ss_pred             EEEEeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---CCcEEEecccCc
Q 001988          798 ALVLEYMSNGSLEDCLHSS-NCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE---DMVAHLSDFGMA  873 (985)
Q Consensus       798 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~---~~~~kl~DfGla  873 (985)
                      |+|||||+||+|.+++... ...+++.++..++.||+.||+||   |++||+||||||+|||+++   ++.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~yl---H~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHH---HHcCCcccccccccccccccccccccccccccee
Confidence            9999999999999999865 34689999999999999999999   7899999999999999975   567999999999


Q ss_pred             eeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh-------------------
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-------------------  934 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-------------------  934 (985)
                      +......   .....+||+.|||||++.+..++.++|+ |++|++++++++|..++.....                   
T Consensus       162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~Di-wSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~  237 (335)
T d2ozaa1         162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDM-WSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  237 (335)
T ss_dssp             EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHH-HHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred             eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHH-HhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            9865332   2344579999999999999999999999 9999999999999876533210                   


Q ss_pred             hhhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          935 FAAKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       935 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ......+++++.+++++|+..||++||++.|+++
T Consensus       238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1123456788999999999999999999999976

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.1e-40  Score=365.92  Aligned_cols=234  Identities=23%  Similarity=0.255  Sum_probs=195.8

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc---chHHHHHHH---HHHHHhcCCCCeeeEEeeeecCCceE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA---STLKSFEAE---CEVIKNIRHRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E---~~il~~l~h~niv~l~~~~~~~~~~~  798 (985)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++.+...   .....+.+|   +++++.++|||||++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            67999999999999999999975 799999999864321   122334444   56666778999999999999999999


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      +||||++||+|.+++.... .+++..+..++.||+.||+||   |++|||||||||+|||++.+|.+||+|||+|+.+..
T Consensus        84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~yl---H~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHH---HHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            9999999999999998764 678999999999999999999   789999999999999999999999999999998753


Q ss_pred             CCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhh--------------hhHHHHHH
Q 001988          879 EDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF--------------AAKEQCLL  943 (985)
Q Consensus       879 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~--------------~~~~~~~~  943 (985)
                      ..    ....+||+.|||||++.. ..++.++|+ |++|+++++|++|..++......              ..+..+++
T Consensus       160 ~~----~~~~~GT~~y~APE~~~~~~~~~~~~Di-wSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  234 (364)
T d1omwa3         160 KK----PHASVGTHGYMAPEVLQKGVAYDSSADW-FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP  234 (364)
T ss_dssp             SC----CCSCCSCGGGCCHHHHSTTCCCCTHHHH-HHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCH
T ss_pred             Cc----ccccccccccchhHHhhcCCCCCcccch-hHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCH
Confidence            22    234579999999999875 468999999 99999999999998876432111              11234677


Q ss_pred             HHHHHHHHccCCCCCCCCC-----HHHHHH
Q 001988          944 SIFSLALECTMESPEKRID-----AKDTIT  968 (985)
Q Consensus       944 ~l~~l~~~cl~~~P~~RPt-----~~ev~~  968 (985)
                      ++.+++.+||..||++||+     |.|+++
T Consensus       235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             HHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            8999999999999999999     677764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-40  Score=355.45  Aligned_cols=232  Identities=24%  Similarity=0.311  Sum_probs=189.6

Q ss_pred             CCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          730 ENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS-----TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       730 ~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ..++||+|+||+||+|+.+ +|+.||||+++.....     ..+.+.+|++++++++|||||++++++.++++.++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999965 7999999998754322     134688999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      ++++++..... ....+++..+..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+.......  
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--  155 (299)
T d1ua2a_          82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--  155 (299)
T ss_dssp             CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred             hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHh---hccceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence            98877666554 345688899999999999999999   789999999999999999999999999999987643322  


Q ss_pred             eecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhhh-------------------------
Q 001988          884 MRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-------------------------  937 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-------------------------  937 (985)
                      .....+||+.|+|||.+..+ .++.++|+ |++|++++++++|..++......+.                         
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Di-wSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDM-WAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhh-hhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence            23345799999999998754 57999999 9999999999998865533211110                         


Q ss_pred             --------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 --------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 --------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                    ....++++.+++.+|+..||++||||.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                          0123467899999999999999999999975

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-39  Score=352.68  Aligned_cols=238  Identities=24%  Similarity=0.313  Sum_probs=195.8

Q ss_pred             cCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          726 DNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++....  ...+++.+|++++++++|||||++++++.++++.|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            6899999999999999999996 4799999999975532  235688999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      |+.++.+..........+++..+..++.|++.||+||   |++|||||||||+|||++.++.+||+|||.|+......  
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yL---H~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--  156 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  156 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHh---hcCCEEccccCchheeecccCcceeccCCcceeccCCc--
Confidence            9976544444344456799999999999999999999   78999999999999999999999999999998764322  


Q ss_pred             ceecccccccccccccccccCc-cchhhhcccccccchhhhcccccccCcchhhhh------------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFVGE-LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA------------------------  937 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~------------------------  937 (985)
                      .......||+.|+|||.+.... ++.++|+ |++|+.++++++|+.++........                        
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~Di-wSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDI-WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccceeecccceeeehhhhccccCCCccccc-cccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence            2334457999999999877665 4789999 9999999999999876533211100                        


Q ss_pred             ----------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          938 ----------------KEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       938 ----------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                      ....++++.+++.+|+..||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                            01134678899999999999999999999874

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-40  Score=352.85  Aligned_cols=235  Identities=21%  Similarity=0.251  Sum_probs=196.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcc------hHHHHHHHHHHHHhcC--CCCeeeEEeeeecCC
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCAS------TLKSFEAECEVIKNIR--HRNLVKIISSCSNDD  795 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~--h~niv~l~~~~~~~~  795 (985)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++++....      ...++.+|+.++++++  |||||++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            357999999999999999999965 7999999999754221      1234678999999996  899999999999999


Q ss_pred             ceEEEEeccCC-CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-CCcEEEecccCc
Q 001988          796 FKALVLEYMSN-GSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHLSDFGMA  873 (985)
Q Consensus       796 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~-~~~~kl~DfGla  873 (985)
                      ..++||||+.+ +++.+++.... .+++.++..++.|+++||+||   |++||+||||||+|||++. ++.+||+|||+|
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCCccccCcccceEEecCCCeEEECccccc
Confidence            99999999976 57888877653 689999999999999999999   7899999999999999985 479999999999


Q ss_pred             eeccCCCCcceecccccccccccccccccCcc-chhhhcccccccchhhhcccccccCcchhh-----hhHHHHHHHHHH
Q 001988          874 KLLSGEDESTMRTQTLATIGYMAPDEIFVGEL-SLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-----AAKEQCLLSIFS  947 (985)
Q Consensus       874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~l~~  947 (985)
                      +.....    .....+||+.|+|||.+.+..+ +.++|+ |++|++++++++|+.++......     ..++.+++++.+
T Consensus       159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~Di-wSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~~  233 (273)
T d1xwsa_         159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAV-WSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH  233 (273)
T ss_dssp             EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHH-HHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHH
T ss_pred             eecccc----cccccccCCCcCCHHHHcCCCCCCccccc-ccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHHH
Confidence            875422    2345679999999999987776 567899 99999999999998876543211     112335678999


Q ss_pred             HHHHccCCCCCCCCCHHHHHH
Q 001988          948 LALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       948 l~~~cl~~~P~~RPt~~ev~~  968 (985)
                      ++.+||..||++|||+.|+++
T Consensus       234 li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         234 LIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCCHhHCcCHHHHhc
Confidence            999999999999999999976

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1e-38  Score=344.79  Aligned_cols=236  Identities=21%  Similarity=0.285  Sum_probs=194.8

Q ss_pred             cCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcc--hHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEec
Q 001988          726 DNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAS--TLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLEY  803 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  803 (985)
                      ++|...+.||+|+||+||+|++++|+.||||+++.....  ..+.+.+|+.++++++|||||++++++...+..++||||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            689999999999999999999999999999999765322  357899999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCcc
Q 001988          804 MSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDEST  883 (985)
Q Consensus       804 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~  883 (985)
                      +.++.+..+.. ....+++..+..++.||+.||+||   |+++||||||||+|||++.++.+|++|||.|.......  .
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~L---H~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~  155 (286)
T d1ob3a_          82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (286)
T ss_dssp             CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHh---ccCcEEecCCCCceeeEcCCCCEEecccccceecccCc--c
Confidence            97765555544 445799999999999999999999   78899999999999999999999999999998764322  2


Q ss_pred             eecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhhh-------------------------
Q 001988          884 MRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-------------------------  937 (985)
Q Consensus       884 ~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-------------------------  937 (985)
                      ......+++.|+|||.+... .++.++|+ |++|++++++++|+.++......+.                         
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~Di-wslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDI-WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceee-hhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence            23344689999999998754 56899999 9999999999999876543211110                         


Q ss_pred             ---------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 ---------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 ---------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                     .+..++++.+++++|+..||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                           1123467889999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-38  Score=347.01  Aligned_cols=238  Identities=23%  Similarity=0.318  Sum_probs=195.2

Q ss_pred             HhcCccCCceeeccCceeEEEEEEc-C-CcEEEEEEeccCCcc--hHHHHHHHHHHHHhc---CCCCeeeEEeeeec---
Q 001988          724 ATDNFAENNIIGIGGFGSVYRARLE-D-GVEIAIKVFHPQCAS--TLKSFEAECEVIKNI---RHRNLVKIISSCSN---  793 (985)
Q Consensus       724 ~~~~~~~~~~ig~G~~g~V~~~~~~-~-~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l---~h~niv~l~~~~~~---  793 (985)
                      ..++|++.+.||+|+||+||+|++. + ++.||||+++.....  ....+.+|+.+++.+   +||||+++++++..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            3578999999999999999999974 4 667999998754222  234567888887766   79999999999853   


Q ss_pred             --CCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEeccc
Q 001988          794 --DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFG  871 (985)
Q Consensus       794 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfG  871 (985)
                        ....+++|||+++|.+..........+++..+..++.|++.||+||   |+++||||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yL---H~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEEecCCCccEEEEcCCCCeeecchh
Confidence              3467899999998877766666666789999999999999999999   78999999999999999999999999999


Q ss_pred             CceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhhh--------------
Q 001988          872 MAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA--------------  937 (985)
Q Consensus       872 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~--------------  937 (985)
                      +++...   .........||+.|+|||++.+..++.++|+ |++|++++|+++|..++........              
T Consensus       162 ~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~Di-wSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         162 LARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDL-WSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             SCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             hhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehh-hchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence            988643   2223345679999999999999999999999 9999999999999876543211100              


Q ss_pred             ------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 ------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 ------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                              ....++.+.+++.+|+.+||++||||.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                                    1123467889999999999999999999875

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1e-37  Score=337.21  Aligned_cols=246  Identities=16%  Similarity=0.170  Sum_probs=208.7

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCC-CCeeeEEeeeecCCceEEEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRH-RNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~lv~e  802 (985)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....  ....+++|+++++.++| +|++.+++++.++...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            367999999999999999999965 78999999986542  23567889999999975 899999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-----CCcEEEecccCceecc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDE-----DMVAHLSDFGMAKLLS  877 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~-----~~~~kl~DfGla~~~~  877 (985)
                      |+ +++|.+++...+..+++.++..++.|++.||+||   |++||+||||||+||+++.     ++.+||+|||+|+.+.
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~l---H~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHH---HHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99 7899999988777899999999999999999999   8999999999999999974     5789999999999875


Q ss_pred             CCCCc-----ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh---------------h
Q 001988          878 GEDES-----TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA---------------A  937 (985)
Q Consensus       878 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~---------------~  937 (985)
                      .....     ......+||+.|||||.+.+..++.++|+ |++|++++++++|..++.......               .
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~Di-wSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDL-EALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHH-HHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHH-HHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            43221     12345679999999999999999999999 999999999999988764321100               0


Q ss_pred             H----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhhh
Q 001988          938 K----EQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDTL  977 (985)
Q Consensus       938 ~----~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~~  977 (985)
                      .    ..+++++.+++..|+..+|++||+++.+.+.++++.++.
T Consensus       237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            1    125678999999999999999999999999998877654

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-37  Score=338.81  Aligned_cols=245  Identities=20%  Similarity=0.214  Sum_probs=201.3

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCee-eEEeeeecCCceEEEEe
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLV-KIISSCSNDDFKALVLE  802 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv-~l~~~~~~~~~~~lv~e  802 (985)
                      .++|+..+.||+|+||+||+|++. +|+.||||++.....  ..++..|++++++++|++++ .+.++..+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            357999999999999999999864 789999999875532  34678999999999877655 55556677888899999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc---CCCcEEEecccCceeccCC
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHLSDFGMAKLLSGE  879 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~---~~~~~kl~DfGla~~~~~~  879 (985)
                      |+ +|++.+.+......+++..+..++.|++.||+||   |++|||||||||+|||++   .+..+|++|||+|+.+...
T Consensus        84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            99 6678887777667899999999999999999999   789999999999999985   4557999999999987643


Q ss_pred             CCc-----ceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhhh------------------
Q 001988          880 DES-----TMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA------------------  936 (985)
Q Consensus       880 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~------------------  936 (985)
                      ...     .......||+.|||||.+.+..++.++|+ |++|++++|+++|+.++.......                  
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDL-ESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  238 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHH-HHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhE-EecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence            322     22345579999999999999999999999 999999999999988764321110                  


Q ss_pred             -hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhHhh
Q 001988          937 -AKEQCLLSIFSLALECTMESPEKRIDAKDTITRLLKIRDT  976 (985)
Q Consensus       937 -~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~L~~i~~~  976 (985)
                       ....+++++.+++..||+.+|++||++.++.+.|+.+..+
T Consensus       239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence             0123568899999999999999999999999988887543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-37  Score=337.40  Aligned_cols=239  Identities=22%  Similarity=0.296  Sum_probs=190.6

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCC--cchHHHHHHHHHHHHhcCCCCeeeEEeeeec--------
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC--ASTLKSFEAECEVIKNIRHRNLVKIISSCSN--------  793 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--------  793 (985)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++....  .....++.+|++++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            378999999999999999999974 89999999986542  2345678899999999999999999999855        


Q ss_pred             CCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCc
Q 001988          794 DDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMA  873 (985)
Q Consensus       794 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla  873 (985)
                      .++.++||||++++.+.. .......+++..++.++.|+++||.||   |++||+||||||+|||++.++.+|++|||+|
T Consensus        89 ~~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~l---H~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHh---ccCCEEecCcCchheeecCCCcEEeeeccee
Confidence            346789999997765554 444455788999999999999999999   7899999999999999999999999999999


Q ss_pred             eeccCCCCc--ceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhhh-------------
Q 001988          874 KLLSGEDES--TMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-------------  937 (985)
Q Consensus       874 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-------------  937 (985)
                      +.+......  ......+||+.|+|||.+.+. .++.++|+ |++|+.++++++|..++........             
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~Di-wSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDL-WGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHc-ccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            877543322  223345799999999998765 68899999 9999999999998776532211000             


Q ss_pred             ------------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          938 ------------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       938 ------------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                    .....+++.+++.+||.+||++||||.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence                                          0112456778999999999999999999985

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-37  Score=340.91  Aligned_cols=239  Identities=21%  Similarity=0.277  Sum_probs=191.8

Q ss_pred             hcCccCCceeeccCceeEEEEEE-cCCcEEEEEEeccCCc-chHHHHHHHHHHHHhcCCCCeeeEEeeeecCC----ceE
Q 001988          725 TDNFAENNIIGIGGFGSVYRARL-EDGVEIAIKVFHPQCA-STLKSFEAECEVIKNIRHRNLVKIISSCSNDD----FKA  798 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----~~~  798 (985)
                      +++|+..+.||+|+||+||+|+. .+|+.||||++++... ...+.+.+|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999986 4899999999975532 34567899999999999999999999997643    234


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccC
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSG  878 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~  878 (985)
                      ++++|+.+|+|.+++...  .+++..+..++.|++.||+||   |++|||||||||+|||++.++.+||+|||+|+....
T Consensus        87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yL---H~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            555667799999999764  589999999999999999999   789999999999999999999999999999987643


Q ss_pred             CCCc-ceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh-------------------
Q 001988          879 EDES-TMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-------------------  937 (985)
Q Consensus       879 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-------------------  937 (985)
                      .... ......+||+.|+|||.+.. ..++.++|+ |++|++++++++|..++........                   
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~Di-wSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI-WSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhh-hccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            3221 12344579999999999855 456889999 9999999999999876543211000                   


Q ss_pred             -----------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          938 -----------------------KEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       938 -----------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                             ......++.+++.+|+..||.+||||.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                                   00123468899999999999999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-37  Score=341.47  Aligned_cols=237  Identities=24%  Similarity=0.343  Sum_probs=189.8

Q ss_pred             CccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCeeeEEeeeecC------CceEE
Q 001988          727 NFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNLVKIISSCSND------DFKAL  799 (985)
Q Consensus       727 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~~~~l  799 (985)
                      +|+..++||+|+||+||+|++. +|+.||||++.....    ...+|++++++++||||+++++++...      .+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5888899999999999999975 799999999975532    234799999999999999999998542      35789


Q ss_pred             EEeccCCCChHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-cEEEecccCceec
Q 001988          800 VLEYMSNGSLEDCLH--SSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAKLL  876 (985)
Q Consensus       800 v~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~~~  876 (985)
                      ||||++++.+.....  .....+++.+++.++.||+.||+||   |++||+||||||+|||++.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL---H~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHH---HhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998764433332  2345789999999999999999999   799999999999999999775 8999999999887


Q ss_pred             cCCCCcceeccccccccccccccccc-CccchhhhcccccccchhhhcccccccCcchhhhh------------------
Q 001988          877 SGEDESTMRTQTLATIGYMAPDEIFV-GELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA------------------  937 (985)
Q Consensus       877 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~------------------  937 (985)
                      ....   .....+||+.|+|||.+.+ ..++.++|+ |++|++++|+++|+.++........                  
T Consensus       174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DI-wSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDV-WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHH-HHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             cCCc---ccccccccccccChHHhhcccCCCcceee-cccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            4332   2234579999999998875 568999999 9999999999998876533211110                  


Q ss_pred             ----------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHhH
Q 001988          938 ----------------------KEQCLLSIFSLALECTMESPEKRIDAKDTITR--LLKIR  974 (985)
Q Consensus       938 ----------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~--L~~i~  974 (985)
                                            ....++++.+++.+|+..||++||||.|+++.  +++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence                                  01134678899999999999999999999863  44443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-37  Score=338.57  Aligned_cols=233  Identities=22%  Similarity=0.304  Sum_probs=189.1

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCC------
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDD------  795 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------  795 (985)
                      .++|++.+.||+|+||+||+|+.. +|+.||||+++....  ...+.+.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999965 799999999976532  23567889999999999999999999997654      


Q ss_pred             ceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          796 FKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       796 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      +.++||||+ +.+|....+..  .+++..++.++.|++.||+||   |++||+||||||+|||++.++.+|++|||+|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~L---H~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHH---HhCCCcccccCcchhhcccccccccccccceec
Confidence            569999999 66787777653  589999999999999999999   789999999999999999999999999999987


Q ss_pred             ccCCCCcceecccccccccccccccccC-ccchhhhcccccccchhhhcccccccCcchhhhh-----------------
Q 001988          876 LSGEDESTMRTQTLATIGYMAPDEIFVG-ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFAA-----------------  937 (985)
Q Consensus       876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~~-----------------  937 (985)
                      ....     .+...||+.|+|||.+.+. .++.++|+ |++|++++++++|..+.........                 
T Consensus       171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDI-WSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cCCc-----cccccccccccCHHHHcCCCCCCccchh-hcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            6422     2345699999999998764 56889999 9999999999999876543211110                 


Q ss_pred             -------------------------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          938 -------------------------KEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       938 -------------------------~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                               .....+++.+++.+|+..||++||||.|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                                     01124568899999999999999999999874

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.7e-36  Score=334.25  Aligned_cols=229  Identities=19%  Similarity=0.278  Sum_probs=190.7

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-CCCeeeEEeeeec--CCceEEEE
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKIISSCSN--DDFKALVL  801 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~--~~~~~lv~  801 (985)
                      ++|++.+.||+|+||+||+|+.. +++.||||+++..   ..+++.+|++++++++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            67999999999999999999974 7899999999754   3467899999999995 9999999999974  35689999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-cEEEecccCceeccCCC
Q 001988          802 EYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHLSDFGMAKLLSGED  880 (985)
Q Consensus       802 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~~~~~~~  880 (985)
                      ||+++++|.+..+    .+++..+..++.||+.||+||   |++|||||||||+|||++.++ .+||+|||+|+......
T Consensus       112 e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~L---H~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHH---hhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            9999999987643    589999999999999999999   799999999999999998655 69999999998865332


Q ss_pred             CcceecccccccccccccccccCc-cchhhhcccccccchhhhcccccccCcchhh-h----------------------
Q 001988          881 ESTMRTQTLATIGYMAPDEIFVGE-LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF-A----------------------  936 (985)
Q Consensus       881 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~-~----------------------  936 (985)
                         .....++|+.|+|||.+.+.. ++.++|+ |++|+.+++++.+..+....... .                      
T Consensus       185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         185 ---EYNVRVASRYFKGPELLVDYQMYDYSLDM-WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHH-HHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             ---cccccccCccccCcccccCCCCCCcccch-hhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence               234457999999999987654 7899999 99999999999987654321100 0                      


Q ss_pred             --------------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 --------------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 --------------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                                .....++++.+++++|+..||++|||+.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                                      01123467899999999999999999999975

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-36  Score=327.71  Aligned_cols=236  Identities=19%  Similarity=0.245  Sum_probs=197.1

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecCCceEEEEe
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSNDDFKALVLE  802 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  802 (985)
                      ++|+..+.||+|+||+||+|++. +++.||||+++....  ....++.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999974 789999999975532  346788999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceeccCCCCc
Q 001988          803 YMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLLSGEDES  882 (985)
Q Consensus       803 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  882 (985)
                      ++.++++..++... +.+++..+..++.|+++||+||   |++||+||||||+|||++.++.+|++|||.|+....... 
T Consensus        82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~l---H~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             eccccccccccccc-cccchhHHHHHHHHHHHHHHHh---hcCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            99998888877654 4778999999999999999999   789999999999999999999999999999998753332 


Q ss_pred             ceecccccccccccccccccCc-cchhhhcccccccchhhhcccccccCcchh-hh------------------------
Q 001988          883 TMRTQTLATIGYMAPDEIFVGE-LSLKRWVNDLLPVSLVEVVDKSLLSGEEKH-FA------------------------  936 (985)
Q Consensus       883 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~-~~------------------------  936 (985)
                       ......+++.|+|||.+.... ++.++|+ |++|+.+++++++..+...... ..                        
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Di-wSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDM-WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHH-HHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhc-cccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence             223345788899999887665 6899999 9999999999988764321100 00                        


Q ss_pred             ----------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 ----------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 ----------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                      ......+.+.+++.+|+.+||.+||||+|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                            01123457889999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-36  Score=332.95  Aligned_cols=237  Identities=26%  Similarity=0.302  Sum_probs=197.7

Q ss_pred             cCccCCceeeccCceeEEEEEEc----CCcEEEEEEeccCC----cchHHHHHHHHHHHHhcCC-CCeeeEEeeeecCCc
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE----DGVEIAIKVFHPQC----ASTLKSFEAECEVIKNIRH-RNLVKIISSCSNDDF  796 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vAvK~~~~~~----~~~~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~  796 (985)
                      ++|+..+.||+|+||+||+|+..    +|+.||||++++..    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999852    58899999987542    1234668899999999977 899999999999999


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      .++||||+.+|+|.+++...+ .+.+.....++.|++.|++|+   |+.+||||||||+||+++.++.+||+|||+|+.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~l---H~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHh---hcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            999999999999999998765 567888899999999999999   7899999999999999999999999999999876


Q ss_pred             cCCCCcceecccccccccccccccccC--ccchhhhcccccccchhhhcccccccCcchhh---------------hhHH
Q 001988          877 SGEDESTMRTQTLATIGYMAPDEIFVG--ELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------AAKE  939 (985)
Q Consensus       877 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------~~~~  939 (985)
                      .... ........|++.|+|||.+...  .++.++|+ |++|++++++++|..++......               ..+.
T Consensus       180 ~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDI-WSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~  257 (322)
T d1vzoa_         180 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDW-WSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ  257 (322)
T ss_dssp             CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHH-HHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred             cccc-cccccccccccccchhHHhhcCCcCCCchhhh-HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence            4322 2223445799999999998764  46778999 99999999999998775433111               1123


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 001988          940 QCLLSIFSLALECTMESPEKRID-----AKDTIT  968 (985)
Q Consensus       940 ~~~~~l~~l~~~cl~~~P~~RPt-----~~ev~~  968 (985)
                      .+++++.+++.+||.+||++||+     +.|+++
T Consensus       258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            46788999999999999999994     788765

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-36  Score=332.18  Aligned_cols=233  Identities=23%  Similarity=0.258  Sum_probs=184.4

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeec------CCc
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSN------DDF  796 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~------~~~  796 (985)
                      ++|++.++||+|+||+||+|++. +|+.||||+++....  .....+.+|+.++++++|||||++++++..      ..+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999975 799999999976532  334578899999999999999999999953      367


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      .|+||||+.++ +.+.+.   ..+++...+.++.|++.||+||   |++||+||||||+|||++.++.+|++|||+++..
T Consensus        97 ~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~L---H~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHh---hhcccccccCCccccccccccceeeechhhhhcc
Confidence            89999999765 444443   2578999999999999999999   7899999999999999999999999999998875


Q ss_pred             cCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchhh---------------------
Q 001988          877 SGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKHF---------------------  935 (985)
Q Consensus       877 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~---------------------  935 (985)
                      ...   ......++|+.|+|||.+.+..++.++|+ |++|+.++++++|..++......                     
T Consensus       170 ~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~Di-wSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         170 GTS---FMMTPYVVTRYYRAPEVILGMGYKENVDI-WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHH-HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             ccc---cccccccccccccChhhhcCCCCCCCccc-ccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            422   23344579999999999999999999999 99999999999998765321100                     


Q ss_pred             --------------------------------hhHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001988          936 --------------------------------AAKEQCLLSIFSLALECTMESPEKRIDAKDTITR  969 (985)
Q Consensus       936 --------------------------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~~  969 (985)
                                                      ......+.++.+++++|+..||++||||.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                                            0112346778999999999999999999999853

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-35  Score=330.54  Aligned_cols=233  Identities=21%  Similarity=0.274  Sum_probs=189.8

Q ss_pred             hcCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCc--chHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----Cc
Q 001988          725 TDNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCA--STLKSFEAECEVIKNIRHRNLVKIISSCSND-----DF  796 (985)
Q Consensus       725 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~  796 (985)
                      .++|+..+.||+|+||+||+|+.. +|+.||||++++...  ...+++.+|++++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            568999999999999999999864 799999999986533  2346788999999999999999999998643     33


Q ss_pred             eEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecccCceec
Q 001988          797 KALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKLL  876 (985)
Q Consensus       797 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~  876 (985)
                      .+++|||+.+|+|.+++...  .+++..+..++.||+.||+||   |++||+||||||+|||++.++.+|++|||+|...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~L---H~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHH---HhCCCcccccCCccccccccccccccccchhccc
Confidence            46677788899999998654  589999999999999999999   7899999999999999999999999999998764


Q ss_pred             cCCCCcceecccccccccccccccccCc-cchhhhcccccccchhhhcccccccCcchhhh-------------------
Q 001988          877 SGEDESTMRTQTLATIGYMAPDEIFVGE-LSLKRWVNDLLPVSLVEVVDKSLLSGEEKHFA-------------------  936 (985)
Q Consensus       877 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~~~-------------------  936 (985)
                      .     .......||+.|+|||...+.. ++.++|+ |++|++++++++|..++.......                   
T Consensus       172 ~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~Di-wSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         172 D-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDI-WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             T-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHH-HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             C-----cccccccccccccCchhhcCCccCCcccch-hhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            3     2223456999999999877654 5889999 999999999999987653221100                   


Q ss_pred             -----------------------hHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001988          937 -----------------------AKEQCLLSIFSLALECTMESPEKRIDAKDTIT  968 (985)
Q Consensus       937 -----------------------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev~~  968 (985)
                                             .....++++.+++.+|+..||.+||||.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                                   00123467889999999999999999999986

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=3.1e-33  Score=306.25  Aligned_cols=258  Identities=35%  Similarity=0.596  Sum_probs=199.4

Q ss_pred             ccceecccccccc--ccCCcCCCCCCccEEEccC-CCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEE
Q 001988          395 LERLNIAFCNISG--NIPKAIGNLSNLIVLSLGG-NNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELD  471 (985)
Q Consensus       395 L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  471 (985)
                      ++.|+|++|++++  .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.++
T Consensus        52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~  131 (313)
T d1ogqa_          52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD  131 (313)
T ss_dssp             EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred             EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence            4444555554444  3556666677777777765 666666677777777777777777777766666666677777777


Q ss_pred             ccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccce-eEEeecCCcccCCccccccCCCcccEEEccCCccC
Q 001988          472 LNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDI-LSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLS  550 (985)
Q Consensus       472 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  550 (985)
                      +++|++.+.+|..+.+++.|+.+++++|.+++.+|..+..+..+ +.+++++|++++..+..+..+..+ .+++++|...
T Consensus       132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~  210 (313)
T d1ogqa_         132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE  210 (313)
T ss_dssp             CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred             cccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence            77777776667777777777777777777777777666666654 667777777777666667666554 6888999998


Q ss_pred             ccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCCCCCCCC
Q 001988          551 GNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEIPRGGP  630 (985)
Q Consensus       551 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~  630 (985)
                      +.+|..+..+++|+.+++++|.+++.+| .+..+++|+.|+|++|+|+|.+|..|.++++|++|||++|+|+|.+|+.+.
T Consensus       211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~  289 (313)
T d1ogqa_         211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN  289 (313)
T ss_dssp             ECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred             cccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCccc
Confidence            8999999999999999999999987655 688899999999999999999999999999999999999999999998888


Q ss_pred             CcccccccccCCccccCCCCCCCCCCC
Q 001988          631 FANFTAESFMGNELLCGLPNLQVPPCK  657 (985)
Q Consensus       631 ~~~~~~~~~~~n~~lc~~~~~~~~~~~  657 (985)
                      +.++....+.||+.+||.|   .|+|.
T Consensus       290 L~~L~~l~l~~N~~l~g~p---lp~c~  313 (313)
T d1ogqa_         290 LQRFDVSAYANNKCLCGSP---LPACT  313 (313)
T ss_dssp             GGGSCGGGTCSSSEEESTT---SSCCC
T ss_pred             CCCCCHHHhCCCccccCCC---CCCCC
Confidence            8899999999999999988   45773

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=1.9e-31  Score=298.21  Aligned_cols=234  Identities=17%  Similarity=0.249  Sum_probs=184.4

Q ss_pred             cCccCCceeeccCceeEEEEEEc-CCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-----------CCCeeeEEeeeec
Q 001988          726 DNFAENNIIGIGGFGSVYRARLE-DGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-----------HRNLVKIISSCSN  793 (985)
Q Consensus       726 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-----------h~niv~l~~~~~~  793 (985)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35899999999999999999974 89999999998652 33467788999998875           5789999988864


Q ss_pred             --CCceEEEEeccCCCChHHH--hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC------
Q 001988          794 --DDFKALVLEYMSNGSLEDC--LHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDM------  863 (985)
Q Consensus       794 --~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~------  863 (985)
                        ....+++|+++..+.....  .......+++..+..++.||+.||+|||  |..||+||||||+|||++.++      
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh--~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh--hhcCcccccCChhHeeeeccCcccccc
Confidence              3455667776655543322  2233457889999999999999999996  458999999999999998765      


Q ss_pred             cEEEecccCceeccCCCCcceecccccccccccccccccCccchhhhcccccccchhhhcccccccCcchh---------
Q 001988          864 VAHLSDFGMAKLLSGEDESTMRTQTLATIGYMAPDEIFVGELSLKRWVNDLLPVSLVEVVDKSLLSGEEKH---------  934 (985)
Q Consensus       864 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~~~~g~~~~~i~~~~~~~~~~~~---------  934 (985)
                      .+|++|||.+......     ....+||+.|+|||.+....++.++|+ |++|+.++++++|+.++.....         
T Consensus       170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADI-WSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHH-HHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             eeeEeecccccccccc-----cccccccccccChhhccccCCCccccc-cchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence            4999999999875322     234579999999999999999999999 9999999999998765321100         


Q ss_pred             --------------------------------------------------hhhHHHHHHHHHHHHHHccCCCCCCCCCHH
Q 001988          935 --------------------------------------------------FAAKEQCLLSIFSLALECTMESPEKRIDAK  964 (985)
Q Consensus       935 --------------------------------------------------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~  964 (985)
                                                                        ....+..+.++.+++.+|+.+||.+||||.
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence                                                              000134567899999999999999999999


Q ss_pred             HHHH
Q 001988          965 DTIT  968 (985)
Q Consensus       965 ev~~  968 (985)
                      |+++
T Consensus       324 e~L~  327 (362)
T d1q8ya_         324 GLVN  327 (362)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9976

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=1e-28  Score=278.34  Aligned_cols=358  Identities=26%  Similarity=0.361  Sum_probs=229.4

Q ss_pred             eecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCc
Q 001988          174 HLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNN  253 (985)
Q Consensus       174 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  253 (985)
                      ...++.+.+++.++  ...+.+|++|++++|.|+. + +.++.+++|++|+|++|+|++. | .++++++|++|++++|+
T Consensus        26 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~   99 (384)
T d2omza2          26 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQ   99 (384)
T ss_dssp             HHHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSC
T ss_pred             HHHhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCC-c-cccCCcccccccccccc
Confidence            34666777776554  3466778888998888874 3 4577888888888888888854 3 28888888888888888


Q ss_pred             CcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCC
Q 001988          254 LTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPS  333 (985)
Q Consensus       254 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  333 (985)
                      +++..|  +.++++|+.|++++|.+++..+.   .....+..+....|.+....+.............            
T Consensus       100 i~~i~~--l~~l~~L~~L~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~------------  162 (384)
T d2omza2         100 IADITP--LANLTNLTGLTLFNNQITDIDPL---KNLTNLNRLELSSNTISDISALSGLTSLQQLSFG------------  162 (384)
T ss_dssp             CCCCGG--GTTCTTCCEEECCSSCCCCCGGG---TTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEE------------
T ss_pred             cccccc--ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc------------
Confidence            875433  67777777777777777632221   1234555555555554432221111111111111            


Q ss_pred             cccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcC
Q 001988          334 AIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAI  413 (985)
Q Consensus       334 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~  413 (985)
                                  .....+.          .+...+........                         .|..  .....+
T Consensus       163 ------------~~~~~~~----------~~~~~~~~~~~~~~-------------------------~~~~--~~~~~~  193 (384)
T d2omza2         163 ------------NQVTDLK----------PLANLTTLERLDIS-------------------------SNKV--SDISVL  193 (384)
T ss_dssp             ------------ESCCCCG----------GGTTCTTCCEEECC-------------------------SSCC--CCCGGG
T ss_pred             ------------cccchhh----------hhcccccccccccc-------------------------cccc--cccccc
Confidence                        0000000          01111111122222                         2211  122344


Q ss_pred             CCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCce
Q 001988          414 GNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQY  493 (985)
Q Consensus       414 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  493 (985)
                      ..+++++.+++++|.+++..|  +...++|+.|++++|+++. + +.+..+++|+.|++++|++++..+  +..+++|++
T Consensus       194 ~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~  267 (384)
T d2omza2         194 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE  267 (384)
T ss_dssp             GGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSE
T ss_pred             ccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCE
Confidence            556666777777777765544  3455667777777777764 2 246667777777777777775433  666777777


Q ss_pred             EeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeeccee
Q 001988          494 LNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRL  573 (985)
Q Consensus       494 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  573 (985)
                      |++++|++++..+  +.+++.++.++++.|.+++..  .+..+++++.|++++|+|++..  .+..+++|++|++++|+|
T Consensus       268 L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~~~--~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l  341 (384)
T d2omza2         268 LKLGANQISNISP--LAGLTALTNLELNENQLEDIS--PISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKV  341 (384)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCG--GGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCC
T ss_pred             eeccCcccCCCCc--ccccccccccccccccccccc--ccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCC
Confidence            7777777775533  566777777888888777643  4677788888888888888653  378888889999999988


Q ss_pred             ccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccc
Q 001988          574 EGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFN  619 (985)
Q Consensus       574 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  619 (985)
                      ++ ++ .|+++++|++|+|++|+|++..|  +.++++|++|+|++|
T Consensus       342 ~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         342 SD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            85 34 58888889999999999887654  788888999999887

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=6.3e-29  Score=280.06  Aligned_cols=358  Identities=23%  Similarity=0.319  Sum_probs=211.0

Q ss_pred             eeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccc
Q 001988          149 DIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINN  228 (985)
Q Consensus       149 ~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  228 (985)
                      ..+++.+.+++.++.   ..+.+|++|+++++.++. + +.+..+++|++|+|++|+|++. |+ ++++++|++|++++|
T Consensus        26 ~~~l~~~~~~~~~~~---~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~~-l~~L~~L~~L~L~~n   98 (384)
T d2omza2          26 KTVLGKTNVTDTVSQ---TDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNN   98 (384)
T ss_dssp             HHHTTCSSTTSEECH---HHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSS
T ss_pred             HHHhCCCCCCCccCH---HHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCC-cc-ccCCccccccccccc
Confidence            346777788877765   357899999999999984 4 5688999999999999999964 43 999999999999999


Q ss_pred             cccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCC
Q 001988          229 KLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIP  308 (985)
Q Consensus       229 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p  308 (985)
                      ++++..|  ++.+++|+.|++++|.+++..+  ......+..+....|.+....+. ................     ..
T Consensus        99 ~i~~i~~--l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~-----~~  168 (384)
T d2omza2          99 QIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISAL-SGLTSLQQLSFGNQVT-----DL  168 (384)
T ss_dssp             CCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGG-TTCTTCSEEEEEESCC-----CC
T ss_pred             ccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc-cccccccccccccccc-----hh
Confidence            9996533  8999999999999999986544  44567888888888888633222 2111222222222111     12


Q ss_pred             ccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCc
Q 001988          309 SSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSI  388 (985)
Q Consensus       309 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~  388 (985)
                      ..+.............|...  ....+..                             +++++.+++++|.+++..|.  
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~-----------------------------l~~~~~l~l~~n~i~~~~~~--  215 (384)
T d2omza2         169 KPLANLTTLERLDISSNKVS--DISVLAK-----------------------------LTNLESLIATNNQISDITPL--  215 (384)
T ss_dssp             GGGTTCTTCCEEECCSSCCC--CCGGGGG-----------------------------CTTCSEEECCSSCCCCCGGG--
T ss_pred             hhhccccccccccccccccc--ccccccc-----------------------------ccccceeeccCCccCCCCcc--
Confidence            23333344444444444332  1222333                             44444444444444432211  


Q ss_pred             cchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCC
Q 001988          389 GNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLN  468 (985)
Q Consensus       389 ~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  468 (985)
                      ...+ +|++|++++|.++..  +.+..+++|+.|++++|.+++..+  ++.+++|+.|++++|++++.            
T Consensus       216 ~~~~-~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~------------  278 (384)
T d2omza2         216 GILT-NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI------------  278 (384)
T ss_dssp             GGCT-TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC------------
T ss_pred             cccC-CCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCC------------
Confidence            1111 233333333333321  123444455555555555543322  34444444444444444432            


Q ss_pred             eEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCc
Q 001988          469 ELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNN  548 (985)
Q Consensus       469 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  548 (985)
                                  .  .+.+++.++.++++.|++++.  ..+..+++++.|++++|+++++.+  +..+++|+.|++++|+
T Consensus       279 ------------~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~  340 (384)
T d2omza2         279 ------------S--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNK  340 (384)
T ss_dssp             ------------G--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSC
T ss_pred             ------------C--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCC
Confidence                        2  133444444444444444432  124444555555555555554432  5666777777777777


Q ss_pred             cCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCC
Q 001988          549 LSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNN  595 (985)
Q Consensus       549 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  595 (985)
                      |++ ++ .|+++++|++|++++|+|++.+|  +.++++|++|+|++|
T Consensus       341 l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         341 VSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            764 33 57777888888888888876554  777888888888877

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=1.8e-25  Score=242.96  Aligned_cols=280  Identities=25%  Similarity=0.263  Sum_probs=158.2

Q ss_pred             ccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEec
Q 001988          171 YLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLG  250 (985)
Q Consensus       171 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  250 (985)
                      .++.+|-++++++ .+|..+.  +++++|+|++|+|+...+.+|.++++|++|++++|++....|..|.++++|++|+++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            4566677777776 6666654  567777777777774444467777777777777777776556667777777777777


Q ss_pred             CCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccc
Q 001988          251 FNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGF  330 (985)
Q Consensus       251 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  330 (985)
                      +|+++. +|..+  ...++.|++++|.+. .++...+.....+..++...|...                      ....
T Consensus        88 ~n~l~~-l~~~~--~~~l~~L~~~~n~l~-~l~~~~~~~~~~~~~l~~~~n~~~----------------------~~~~  141 (305)
T d1xkua_          88 KNQLKE-LPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK----------------------SSGI  141 (305)
T ss_dssp             SSCCSB-CCSSC--CTTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCC----------------------GGGB
T ss_pred             CCccCc-Cccch--hhhhhhhhccccchh-hhhhhhhhcccccccccccccccc----------------------ccCC
Confidence            777663 33332  235556666666655 344433333344444444443321                      1112


Q ss_pred             cCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccC
Q 001988          331 IPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIP  410 (985)
Q Consensus       331 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~  410 (985)
                      .+..+..+++|+.++++.|+++..+..        .++                         +|+.|++++|.+++..+
T Consensus       142 ~~~~~~~l~~L~~l~l~~n~l~~l~~~--------~~~-------------------------~L~~L~l~~n~~~~~~~  188 (305)
T d1xkua_         142 ENGAFQGMKKLSYIRIADTNITTIPQG--------LPP-------------------------SLTELHLDGNKITKVDA  188 (305)
T ss_dssp             CTTGGGGCTTCCEEECCSSCCCSCCSS--------CCT-------------------------TCSEEECTTSCCCEECT
T ss_pred             CccccccccccCccccccCCccccCcc--------cCC-------------------------ccCEEECCCCcCCCCCh
Confidence            233444555555555555554433221        123                         34445555555555555


Q ss_pred             CcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCC------
Q 001988          411 KAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSC------  484 (985)
Q Consensus       411 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~------  484 (985)
                      ..|..++.+++|++++|.+++..+.+|.++++|++|+|++|+|+ .+|+.+..+++|++|+|++|+|+.+....      
T Consensus       189 ~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~  267 (305)
T d1xkua_         189 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY  267 (305)
T ss_dssp             GGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSC
T ss_pred             hHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcch
Confidence            55556666666666666666555666666666666666666665 34555666666666666666666443322      


Q ss_pred             CcCcCcCceEeeccceee--eecCCCccCcc
Q 001988          485 LGNLTSLQYLNLGSNRFT--FVIPSTFWNLK  513 (985)
Q Consensus       485 ~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~  513 (985)
                      +..+.+|+.|+|++|.++  .+.|.+|.-+.
T Consensus       268 ~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~  298 (305)
T d1xkua_         268 NTKKASYSGVSLFSNPVQYWEIQPSTFRCVY  298 (305)
T ss_dssp             CTTSCCCSEEECCSSSSCGGGSCGGGGTTCC
T ss_pred             hcccCCCCEEECCCCcCccCcCCHhHhcccc
Confidence            234566777777777664  34555554443

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=2.2e-25  Score=242.34  Aligned_cols=284  Identities=24%  Similarity=0.288  Sum_probs=151.9

Q ss_pred             CCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEec
Q 001988          267 TLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDI  346 (985)
Q Consensus       267 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  346 (985)
                      .++.++.++++++ ++|..+.   +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l   86 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL   86 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             cCCEEEecCCCCC-ccCCCCC---CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence            3456666666666 5665542   46777777777777555556777777777777777777666777777777777777


Q ss_pred             cCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccC
Q 001988          347 FFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGG  426 (985)
Q Consensus       347 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  426 (985)
                      ++|+++.++..        ....++.|++++|.+.+..+.                         .+.....+..++...
T Consensus        87 ~~n~l~~l~~~--------~~~~l~~L~~~~n~l~~l~~~-------------------------~~~~~~~~~~l~~~~  133 (305)
T d1xkua_          87 SKNQLKELPEK--------MPKTLQELRVHENEITKVRKS-------------------------VFNGLNQMIVVELGT  133 (305)
T ss_dssp             CSSCCSBCCSS--------CCTTCCEEECCSSCCCBBCHH-------------------------HHTTCTTCCEEECCS
T ss_pred             cCCccCcCccc--------hhhhhhhhhccccchhhhhhh-------------------------hhhcccccccccccc
Confidence            77777665432        124556666666655543222                         222223333333333


Q ss_pred             CCCC--CCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeee
Q 001988          427 NNLS--GSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFV  504 (985)
Q Consensus       427 N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  504 (985)
                      |...  ...+..|..+++|+.+++++|.+. .+|..  .+++|+.|++++|.+++..+..|.+++.+++|++++|.++++
T Consensus       134 n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~  210 (305)
T d1xkua_         134 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV  210 (305)
T ss_dssp             SCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEE
T ss_pred             ccccccCCCccccccccccCccccccCCcc-ccCcc--cCCccCEEECCCCcCCCCChhHhhcccccccccccccccccc
Confidence            3221  122233444444444444444444 22221  134455555555555444444455555555555555555555


Q ss_pred             cCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchh------hcccccceeeeeecceec--cc
Q 001988          505 IPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTT------LEGLKSLQNISLAYNRLE--GP  576 (985)
Q Consensus       505 ~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~------~~~l~~L~~L~Ls~N~l~--~~  576 (985)
                      .+.+|.++++|++|++++|+|+.+ |..+..+++|+.|+|++|+|+......      +..+.+|+.|+|++|.++  ..
T Consensus       211 ~~~~~~~l~~L~~L~L~~N~L~~l-p~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~  289 (305)
T d1xkua_         211 DNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI  289 (305)
T ss_dssp             CTTTGGGSTTCCEEECCSSCCSSC-CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGS
T ss_pred             ccccccccccceeeeccccccccc-ccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcC
Confidence            455555555555555555555433 334555555555555555555432222      234566777777777664  34


Q ss_pred             hhhhhhcccccCeEe
Q 001988          577 IPESFGNMTSLESLD  591 (985)
Q Consensus       577 ~p~~~~~l~~L~~L~  591 (985)
                      .|.+|..+.....++
T Consensus       290 ~~~~f~~~~~~~~~~  304 (305)
T d1xkua_         290 QPSTFRCVYVRAAVQ  304 (305)
T ss_dssp             CGGGGTTCCCGGGEE
T ss_pred             CHhHhcccccCcccc
Confidence            566666555544443

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.4e-25  Score=241.11  Aligned_cols=250  Identities=22%  Similarity=0.250  Sum_probs=167.1

Q ss_pred             EEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecc-cc
Q 001988          373 LGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLA-FN  451 (985)
Q Consensus       373 L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls-~N  451 (985)
                      ++.+++.++ .+|..+.   .++++|+|++|+|++..+.+|.++++|++|++++|++..+.+..+.++..+..++.. .|
T Consensus        16 v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~   91 (284)
T d1ozna_          16 TSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA   91 (284)
T ss_dssp             EECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred             EEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence            344444444 3444332   356677777777766666667777777777777777776666667777777766553 55


Q ss_pred             cccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccc
Q 001988          452 KLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISL  531 (985)
Q Consensus       452 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~  531 (985)
                      .++...|..+..+++|++|++++|.+....+..+...++|+.+++++|+|+++.+..|..+++|+.|++++|+++++.+.
T Consensus        92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~  171 (284)
T d1ozna_          92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER  171 (284)
T ss_dssp             TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred             ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence            56655566677777777777777777666666666777777777777777766666777777777777777777776667


Q ss_pred             cccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccccc
Q 001988          532 AIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYL  611 (985)
Q Consensus       532 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  611 (985)
                      +|.++++|+.+++++|++++..|..|.++++|++|++++|++++..|..|+++++|++|+|++|.+...-+ ...-...+
T Consensus       172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l  250 (284)
T d1ozna_         172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWL  250 (284)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHH
T ss_pred             hhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHHH
Confidence            77777777777777777777777777777777777777777777777777777777777777777765322 11112345


Q ss_pred             cccccccccccCCCCC
Q 001988          612 KELNLSFNKLKGEIPR  627 (985)
Q Consensus       612 ~~L~ls~N~l~~~~p~  627 (985)
                      +.+....+++++..|.
T Consensus       251 ~~~~~~~~~~~C~~p~  266 (284)
T d1ozna_         251 QKFRGSSSEVPCSLPQ  266 (284)
T ss_dssp             HHCCSEECCCBEEESG
T ss_pred             HhCcCCCCceEeCCch
Confidence            5666666666665554

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=3.8e-25  Score=237.61  Aligned_cols=250  Identities=23%  Similarity=0.198  Sum_probs=184.1

Q ss_pred             cccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEcc-CCCCCCCCCcccccccccccee
Q 001988          369 KLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLG-GNNLSGSIPVTFGGLQKLQGLD  447 (985)
Q Consensus       369 ~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~  447 (985)
                      .+++|+|++|+|++..+..|..++ .|+.|++++|++....+..+..++.++.++.. .|.++...+.+|.++++|++|+
T Consensus        33 ~~~~L~Ls~N~i~~i~~~~f~~l~-~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~  111 (284)
T d1ozna_          33 ASQRIFLHGNRISHVPAASFRACR-NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (284)
T ss_dssp             TCSEEECTTSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCEEECcCCcCCCCCHHHhhccc-cccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence            455556666665544444555555 56666666666666666677777777777654 5566666677788888888888


Q ss_pred             cccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccC
Q 001988          448 LAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDG  527 (985)
Q Consensus       448 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  527 (985)
                      +++|.+....+..+....+|+.+++++|+|+++.+..|..+++|+.|++++|+++++.+.+|.++++|+.+++++|++.+
T Consensus       112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~  191 (284)
T d1ozna_         112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (284)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence            88888776666667777788888888888887767778888888888888888888888888888888888888888888


Q ss_pred             CccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccc
Q 001988          528 PISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEK  607 (985)
Q Consensus       528 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  607 (985)
                      +.|..|.++++|+.|++++|++.+..|..|+++++|++|+|++|.+...-+ .-.-...++.+....+++....|..+.+
T Consensus       192 i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~l~g  270 (284)
T d1ozna_         192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAG  270 (284)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGGTT
T ss_pred             cChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchHHcC
Confidence            888888888888888888888888888888888899999999998885432 1112234666777778887777776654


Q ss_pred             cccccccccccccccC
Q 001988          608 LSYLKELNLSFNKLKG  623 (985)
Q Consensus       608 l~~L~~L~ls~N~l~~  623 (985)
                         +...+++.+.|+|
T Consensus       271 ---~~l~~l~~~~l~g  283 (284)
T d1ozna_         271 ---RDLKRLAANDLQG  283 (284)
T ss_dssp             ---CBGGGSCGGGSCC
T ss_pred             ---CccccCCHHHCCC
Confidence               4566777777776

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=1.5e-23  Score=222.41  Aligned_cols=201  Identities=23%  Similarity=0.226  Sum_probs=127.3

Q ss_pred             CCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEee
Q 001988          417 SNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNL  496 (985)
Q Consensus       417 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  496 (985)
                      ..+.+++.++++|+. +|..+.  ++|++|+|++|+|++..+..|..+++|++|+|++|+|+.. + .++.+++|++|+|
T Consensus        10 ~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~L   84 (266)
T d1p9ag_          10 ASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDL   84 (266)
T ss_dssp             TTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEEC
T ss_pred             CCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccccc
Confidence            344445555555552 343331  3455556666665544445555566666666666666532 2 2345666666666


Q ss_pred             ccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccc
Q 001988          497 GSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGP  576 (985)
Q Consensus       497 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  576 (985)
                      ++|+++. .+..+.++++|+.|++++|.+.+..+..+..+.+++.|++++|.+++..+..+..+++|+.|++++|+|++.
T Consensus        85 s~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~  163 (266)
T d1p9ag_          85 SHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL  163 (266)
T ss_dssp             CSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred             ccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccccc
Confidence            6666654 344566666666666666666666666666677777777777777766666667777777777777777776


Q ss_pred             hhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCC
Q 001988          577 IPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGE  624 (985)
Q Consensus       577 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~  624 (985)
                      .++.|..+++|++|||++|+|+ .+|..+..+++|+.|+|++|++.+.
T Consensus       164 ~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd  210 (266)
T d1p9ag_         164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN  210 (266)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             CccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence            6677777777777777777777 6676677777777777777776654

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=6.6e-23  Score=217.50  Aligned_cols=177  Identities=23%  Similarity=0.218  Sum_probs=110.7

Q ss_pred             CccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeec
Q 001988          418 NLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLG  497 (985)
Q Consensus       418 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  497 (985)
                      ++++|+|++|+|+++.+.+|.++++|++|+|++|+|+. +| .++.+++|++|+|++|++++ .+..+.++++|++|+++
T Consensus        32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~  108 (266)
T d1p9ag_          32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVS  108 (266)
T ss_dssp             TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECC
T ss_pred             CCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccccccccccccc-ccccccccccccccccc
Confidence            34455555555544444445555555555555555542 22 13445555555555555553 34455566666666666


Q ss_pred             cceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeeecceeccch
Q 001988          498 SNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPI  577 (985)
Q Consensus       498 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  577 (985)
                      +|.+..+.+..+..+.+++.|++++|.+..+.+..+..+++++.|++++|+|++..+..|..+++|++|+|++|+|+ .+
T Consensus       109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~l  187 (266)
T d1p9ag_         109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI  187 (266)
T ss_dssp             SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred             ccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-cc
Confidence            66666655666666666666666666666666666667777777777777777666677777777777777777777 56


Q ss_pred             hhhhhcccccCeEecCCCccc
Q 001988          578 PESFGNMTSLESLDLSNNKIS  598 (985)
Q Consensus       578 p~~~~~l~~L~~L~Ls~N~l~  598 (985)
                      |+.+..+++|+.|+|++|.+.
T Consensus       188 p~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         188 PKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             CTTTTTTCCCSEEECCSCCBC
T ss_pred             ChhHCCCCCCCEEEecCCCCC
Confidence            666777777888888888765

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.84  E-value=2.7e-19  Score=197.64  Aligned_cols=77  Identities=26%  Similarity=0.289  Sum_probs=36.9

Q ss_pred             ccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEec
Q 001988          171 YLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLG  250 (985)
Q Consensus       171 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  250 (985)
                      .|++|++++|.++ .+|. ++.+++|++|++++|.++. .|...   ..+..+.+.++...  .+..++.++.++.|+++
T Consensus        99 ~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~~---~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~  170 (353)
T d1jl5a_          99 LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLE--ELPELQNLPFLTAIYAD  170 (353)
T ss_dssp             TCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCS--SCCCCTTCTTCCEEECC
T ss_pred             ccccccccccccc-cccc-hhhhccceeeccccccccc-ccccc---ccccchhhcccccc--ccccccccccceecccc
Confidence            3556666666655 4443 4556666666666665552 22222   23334444433332  12234444555555555


Q ss_pred             CCcCc
Q 001988          251 FNNLT  255 (985)
Q Consensus       251 ~N~l~  255 (985)
                      +|.+.
T Consensus       171 ~n~~~  175 (353)
T d1jl5a_         171 NNSLK  175 (353)
T ss_dssp             SSCCS
T ss_pred             ccccc
Confidence            55444

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.83  E-value=6.2e-21  Score=191.07  Aligned_cols=133  Identities=19%  Similarity=0.229  Sum_probs=105.9

Q ss_pred             cCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcc------------------hHHHHHHHHHHHHhcCCCCeeeEEee
Q 001988          729 AENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCAS------------------TLKSFEAECEVIKNIRHRNLVKIISS  790 (985)
Q Consensus       729 ~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~------------------~~~~~~~E~~il~~l~h~niv~l~~~  790 (985)
                      .+++.||+|+||+||+|+..+|++||||+++.....                  ....+.+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            457899999999999999889999999987642110                  12345678899999999999988876


Q ss_pred             eecCCceEEEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 001988          791 CSNDDFKALVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHLSDF  870 (985)
Q Consensus       791 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivHrDlk~~Nill~~~~~~kl~Df  870 (985)
                      ..    .++||||++++.+.+        ++.....+++.|++++++||   |++||+||||||+|||+++++ ++|+||
T Consensus        83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~l---H~~giiHrDiKP~NILv~~~~-~~liDF  146 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKF---YHRGIVHGDLSQYNVLVSEEG-IWIIDF  146 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEETTE-EEECCC
T ss_pred             cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHH---hhCCEEEccCChhheeeeCCC-EEEEEC
Confidence            42    379999998865543        22334567899999999999   789999999999999999754 899999


Q ss_pred             cCceecc
Q 001988          871 GMAKLLS  877 (985)
Q Consensus       871 Gla~~~~  877 (985)
                      |.|+...
T Consensus       147 G~a~~~~  153 (191)
T d1zara2         147 PQSVEVG  153 (191)
T ss_dssp             TTCEETT
T ss_pred             CCcccCC
Confidence            9998753

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.83  E-value=6.4e-19  Score=194.60  Aligned_cols=138  Identities=25%  Similarity=0.338  Sum_probs=80.8

Q ss_pred             cccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEE
Q 001988          218 TVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLN  297 (985)
Q Consensus       218 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~  297 (985)
                      .++++|+|++|.++ .+|+.   +++|++|+|++|+|+ .+|..+   .+|++|++++|+++ .++.    -.+.|++|+
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~----lp~~L~~L~  104 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD----LPPLLEYLG  104 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS----CCTTCCEEE
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh----hcccccccc
Confidence            35778888888887 56753   467888888888887 566543   46778888888776 4442    123577777


Q ss_pred             ecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEecC
Q 001988          298 LGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGG  377 (985)
Q Consensus       298 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~  377 (985)
                      +++|.++ .+|. ++.+++|+.|++++|.+.... .   ....+..+.+..+......       .+..++.++.+++++
T Consensus       105 L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~-~---~~~~l~~l~~~~~~~~~~~-------~l~~l~~l~~L~l~~  171 (353)
T d1jl5a_         105 VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLP-D---LPPSLEFIAAGNNQLEELP-------ELQNLPFLTAIYADN  171 (353)
T ss_dssp             CCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCC-C---CCTTCCEEECCSSCCSSCC-------CCTTCTTCCEEECCS
T ss_pred             ccccccc-cccc-hhhhccceeeccccccccccc-c---ccccccchhhccccccccc-------cccccccceeccccc
Confidence            7777766 3343 455666666666666665322 1   1233444444444333221       133444555555555


Q ss_pred             CCCC
Q 001988          378 NPLD  381 (985)
Q Consensus       378 N~l~  381 (985)
                      |...
T Consensus       172 n~~~  175 (353)
T d1jl5a_         172 NSLK  175 (353)
T ss_dssp             SCCS
T ss_pred             cccc
Confidence            5443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=1.7e-22  Score=232.28  Aligned_cols=111  Identities=23%  Similarity=0.242  Sum_probs=76.9

Q ss_pred             ccceeeeccccccCCCChhHhhhccccceecccCccccc----cCCcccCCCCCceEEEcccccCCCc----cccccc-c
Q 001988          146 SILDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYG----KIPSSLSKCKQLQELHLGYNNLSGA----IPKEIG-N  216 (985)
Q Consensus       146 ~L~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~-~  216 (985)
                      +|+.||+++|++++..-..++..+++|++|+|++|.++.    .++..+..+++|++|||++|+|+..    +...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            455666666666654445566778888889998888773    3456677888899999999888632    222222 2


Q ss_pred             ccccceEeeccccccCC----chhhhcCCCCCCEEEecCCcCcc
Q 001988          217 LTVLQRISLINNKLHGE----IPQEIGYLQNLDVLQLGFNNLTG  256 (985)
Q Consensus       217 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~  256 (985)
                      ..+|++|+|++|+++..    ++..+..+++|++|+|++|.++.
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence            24688888888887643    45566777888888888888764

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=2.5e-22  Score=230.89  Aligned_cols=111  Identities=24%  Similarity=0.224  Sum_probs=68.3

Q ss_pred             CCceEEEcccccCCCcc-ccccccccccceEeeccccccC----CchhhhcCCCCCCEEEecCCcCccc----Cccccc-
Q 001988          194 KQLQELHLGYNNLSGAI-PKEIGNLTVLQRISLINNKLHG----EIPQEIGYLQNLDVLQLGFNNLTGV----VPATIF-  263 (985)
Q Consensus       194 ~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~-  263 (985)
                      .+|++||+++|++++.. .+.+..+++++.|+|++|.++.    .++..+..+++|++|||++|+|+..    +...+. 
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            36888888888888532 3445677888888888888762    3445567778888888888877632    122222 


Q ss_pred             CCCCCCEEEccCCcCcccCChh---hhhcCCCCcEEEecCccCC
Q 001988          264 NMSTLKEIFLYNNSLSGSLPSR---IDLALPNLEFLNLGINSFS  304 (985)
Q Consensus       264 ~l~~L~~L~L~~N~l~~~~p~~---~~~~l~~L~~L~Ls~N~l~  304 (985)
                      ...+|++|+|++|++++..-..   ....+++|++|+|++|.++
T Consensus        82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence            2245777777777765321111   1123455666666666554

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=4.3e-19  Score=185.05  Aligned_cols=220  Identities=17%  Similarity=0.133  Sum_probs=123.4

Q ss_pred             cEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCC-Cccccccccccceecc
Q 001988          371 RYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSI-PVTFGGLQKLQGLDLA  449 (985)
Q Consensus       371 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls  449 (985)
                      +.++.+++.++ .+|..+.   .++++|++++|+|+...+.+|.++++|++|++++|.+...+ +.+|.++++++++++.
T Consensus        11 ~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~   86 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   86 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred             CEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence            45666666665 4444332   24555555555555444445555555555555555554322 3345555555555543


Q ss_pred             c-ccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCC-CccCccceeEEeecCCcccC
Q 001988          450 F-NKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPS-TFWNLKDILSFDISSNLLDG  527 (985)
Q Consensus       450 ~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~  527 (985)
                      . |.+....+..|..+++|+.|++++|++.                        ...+. .+..+..+..+..+++.+..
T Consensus        87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~------------------------~~~~~~~~~~l~~l~~~~~~n~~l~~  142 (242)
T d1xwdc1          87 KANNLLYINPEAFQNLPNLQYLLISNTGIK------------------------HLPDVHKIHSLQKVLLDIQDNINIHT  142 (242)
T ss_dssp             CCTTCCEECTTSEECCTTCCEEEEESCCCC------------------------SCCCCTTTCBSSCEEEEEESCTTCCE
T ss_pred             ccccccccccccccccccccccccchhhhc------------------------cccccccccccccccccccccccccc
Confidence            2 3444344444444445555555554443                        32221 12233444444444555544


Q ss_pred             CccccccCCC-cccEEEccCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcccc
Q 001988          528 PISLAIGNLK-AVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFE  606 (985)
Q Consensus       528 ~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  606 (985)
                      +.+..|..++ .++.|++++|+++...+..|.....++.+++++|+|+...+..|.++++|++|||++|+|+...+..|.
T Consensus       143 i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~  222 (242)
T d1xwdc1         143 IERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE  222 (242)
T ss_dssp             ECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCT
T ss_pred             ccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHc
Confidence            4444444443 566677777777755444444333334445677788765566688888888888888888866666788


Q ss_pred             cccccccccccc
Q 001988          607 KLSYLKELNLSF  618 (985)
Q Consensus       607 ~l~~L~~L~ls~  618 (985)
                      ++++|+.+++.+
T Consensus       223 ~l~~L~~l~~~~  234 (242)
T d1xwdc1         223 NLKKLRARSTYN  234 (242)
T ss_dssp             TCCEEESSSEES
T ss_pred             CCcccccCcCCC
Confidence            888888887754

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=4.5e-19  Score=182.87  Aligned_cols=205  Identities=22%  Similarity=0.329  Sum_probs=147.5

Q ss_pred             cceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCC
Q 001988          396 ERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGN  475 (985)
Q Consensus       396 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  475 (985)
                      ..++++.+.+++..  .+..+.+|+.|++++|+|+.. + .+..+++|++|++++|++++..|  +..+++|+++++++|
T Consensus        22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n   95 (227)
T d1h6ua2          22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN   95 (227)
T ss_dssp             HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred             HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc-h-hHhcCCCCcEeecCCceeecccc--ccccccccccccccc
Confidence            44555666665443  345567777777777777743 2 46777777777777777775433  677777788888877


Q ss_pred             ccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCch
Q 001988          476 KISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPT  555 (985)
Q Consensus       476 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  555 (985)
                      .++..  ..+.++++|++++++++...+..  .+...+.+..+.++++.+....  .+...++|+.|++++|.+++.  .
T Consensus        96 ~~~~i--~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~--~  167 (227)
T d1h6ua2          96 PLKNV--SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL--T  167 (227)
T ss_dssp             CCSCC--GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC--G
T ss_pred             ccccc--ccccccccccccccccccccccc--hhccccchhhhhchhhhhchhh--hhccccccccccccccccccc--h
Confidence            77642  24667778888888777776542  3556677777888887776543  366778888888888888754  3


Q ss_pred             hhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcccccccccccccccc
Q 001988          556 TLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSF  618 (985)
Q Consensus       556 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~  618 (985)
                      .++++++|+.|+|++|++++. + .++++++|++|+|++|+|++..|  +.++++|+.|++++
T Consensus       168 ~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         168 PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN  226 (227)
T ss_dssp             GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred             hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence            478888999999999998864 3 38888999999999999885433  78888999998874

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=8.7e-19  Score=182.68  Aligned_cols=220  Identities=19%  Similarity=0.096  Sum_probs=163.5

Q ss_pred             CceEeccCCcccCCCCcccccccccccCcccEEEecCCCCCccCCCCccchhhcccceecccccccccc-CCcCCCCCCc
Q 001988          341 LKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNI-PKAIGNLSNL  419 (985)
Q Consensus       341 L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~-~~~~~~l~~L  419 (985)
                      .+.++.++++++.++...        .+++++|++++|+++...+..|.+++ +|++|++++|.+...+ +.+|..++++
T Consensus        10 ~~~i~c~~~~l~~iP~~l--------~~~l~~L~Ls~n~i~~l~~~~f~~l~-~L~~L~ls~n~~~~~i~~~~f~~l~~l   80 (242)
T d1xwdc1          10 NRVFLCQESKVTEIPSDL--------PRNAIELRFVLTKLRVIQKGAFSGFG-DLEKIEISQNDVLEVIEADVFSNLPKL   80 (242)
T ss_dssp             SSEEEEESCSCSSCCSCS--------CSCCSEEEEESCCCCEECTTTTTTCT-TCCEEEEESCTTCCEECSSSEESCTTC
T ss_pred             CCEEEEeCCCCCCcCCCC--------CCCCCEEECcCCcCCccChhHhhccc-hhhhhhhccccccceeecccccccccc
Confidence            368889999999887643        15799999999999876666788887 8999999999987644 5678999999


Q ss_pred             cEEEccC-CCCCCCCCccccccccccceecccccccCCchh-hhhhccCCCeEEccCCccccccCCCCcCcC-cCceEee
Q 001988          420 IVLSLGG-NNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPD-EICLLSRLNELDLNGNKISGSISSCLGNLT-SLQYLNL  496 (985)
Q Consensus       420 ~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L  496 (985)
                      +++++.. |++....+..|.++++|+.|++++|.+....+. .+..+..+..+..+++++....+..|.+++ .++.|++
T Consensus        81 ~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l  160 (242)
T d1xwdc1          81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL  160 (242)
T ss_dssp             CEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEEC
T ss_pred             ccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeec
Confidence            9999864 788888889999999999999999999854332 234456666777788888877777777764 7888888


Q ss_pred             ccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceeeeee
Q 001988          497 GSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLA  569 (985)
Q Consensus       497 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  569 (985)
                      ++|+++.+.+..|....-.+.+++++|+++.+.+..|.++++|+.|+|++|+|+...+..|.++++|+++++.
T Consensus       161 ~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~  233 (242)
T d1xwdc1         161 NKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY  233 (242)
T ss_dssp             CSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred             ccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence            8888887666655443333444566667776666666666777777777776665545556666666665553

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=2.6e-18  Score=176.99  Aligned_cols=204  Identities=25%  Similarity=0.348  Sum_probs=131.7

Q ss_pred             ceeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeecc
Q 001988          148 LDIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLIN  227 (985)
Q Consensus       148 ~~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  227 (985)
                      ..++++.+++++.++.   ..+.+|++|++.+|.++ .++ .+.++++|++|++++|++++..|  +..+++|+++++++
T Consensus        22 ~~~~l~~~~~~d~~~~---~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~   94 (227)
T d1h6ua2          22 IKIAAGKSNVTDTVTQ---ADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG   94 (227)
T ss_dssp             HHHHTTCSSTTSEECH---HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred             HHHHhCCCCcCCcCCH---HHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccc
Confidence            3445555555544332   44677777777777776 343 47777778888888777775433  67777777777777


Q ss_pred             ccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCCcC
Q 001988          228 NKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTI  307 (985)
Q Consensus       228 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~  307 (985)
                      |.++ .++ .++.+++|++++++++...+..  .+...+.++.+.++++.+....+   +...++|+.|++++|++++..
T Consensus        95 n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~---~~~~~~L~~L~l~~n~~~~~~  167 (227)
T d1h6ua2          95 NPLK-NVS-AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP---LAGLTNLQYLSIGNAQVSDLT  167 (227)
T ss_dssp             CCCS-CCG-GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCCCG
T ss_pred             cccc-ccc-cccccccccccccccccccccc--hhccccchhhhhchhhhhchhhh---hccccccccccccccccccch
Confidence            7776 333 4667777777777777766432  35566677777777777663322   235667777777777766432


Q ss_pred             CccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCcccCCCCcccccccccccCcccEEEec
Q 001988          308 PSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLTSSTPELGFLSSLANCKKLRYLGLG  376 (985)
Q Consensus       308 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L~  376 (985)
                        .+.++++|+.|++++|++++..  .++++++|++|++++|+++++++       +.++++|++|+++
T Consensus       168 --~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~~-------l~~l~~L~~L~ls  225 (227)
T d1h6ua2         168 --PLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVSP-------LANTSNLFIVTLT  225 (227)
T ss_dssp             --GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCGG-------GTTCTTCCEEEEE
T ss_pred             --hhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCcc-------cccCCCCCEEEee
Confidence              2666777777777777776532  26667777777777777665432       5566666666665

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.76  E-value=5.6e-19  Score=176.76  Aligned_cols=157  Identities=21%  Similarity=0.236  Sum_probs=79.8

Q ss_pred             CCCeEEccCCccccc-cCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEc
Q 001988          466 RLNELDLNGNKISGS-ISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDL  544 (985)
Q Consensus       466 ~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L  544 (985)
                      ++++|+|++|+|++. .+..|.++++|+.|+|++|+++.+.+..|..+++|++|++++|+|+++.+.+|.++++|+.|+|
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L  109 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence            344444444444332 2233444444444444444444444444444444444444444444444444555555555555


Q ss_pred             cCCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCC
Q 001988          545 SRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGE  624 (985)
Q Consensus       545 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~  624 (985)
                      ++|+|++..|..|..+++|++|+|++|.+....+.. .-...++.+.+..|.++...|..+   ..++.++|+.|.+++.
T Consensus       110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C~  185 (192)
T d1w8aa_         110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKCS  185 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCCC
T ss_pred             CCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCcCC
Confidence            555555555555555556666666666555322111 111235556667777766666543   4456777787777755


Q ss_pred             CC
Q 001988          625 IP  626 (985)
Q Consensus       625 ~p  626 (985)
                      .+
T Consensus       186 ~~  187 (192)
T d1w8aa_         186 SE  187 (192)
T ss_dssp             CC
T ss_pred             CC
Confidence            44

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.73  E-value=3.3e-18  Score=171.12  Aligned_cols=177  Identities=19%  Similarity=0.254  Sum_probs=147.0

Q ss_pred             CCeEEccCCccccccCCCCcCcCcCceEeeccceeee-ecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEcc
Q 001988          467 LNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTF-VIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLS  545 (985)
Q Consensus       467 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls  545 (985)
                      .+.++.++|+++ .+|..+.  +++++|+|++|+|++ +.+..|.++++|+.|++++|.+..+.+..+..+++|+.|+|+
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            457888899888 4565553  689999999999986 557788999999999999999999999999999999999999


Q ss_pred             CCccCccCchhhcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCccccccccccccccccccccCCC
Q 001988          546 RNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSFNKLKGEI  625 (985)
Q Consensus       546 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~  625 (985)
                      +|+|++..|..|.++++|++|+|++|+|++..|++|..+++|++|+|++|.+....+. ..-...++.+.+..|.+++..
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~  165 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGA  165 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCS
T ss_pred             cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCC
Confidence            9999998899999999999999999999998899999999999999999999854332 222345788899999999888


Q ss_pred             CCCCCCcccccccccCCccccCCC
Q 001988          626 PRGGPFANFTAESFMGNELLCGLP  649 (985)
Q Consensus       626 p~~~~~~~~~~~~~~~n~~lc~~~  649 (985)
                      |..  +....-..+..|..-|..+
T Consensus       166 p~~--l~~~~l~~L~~n~l~C~~~  187 (192)
T d1w8aa_         166 PSK--VRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             STT--TTTSBGGGSCTTTCCCCCC
T ss_pred             Chh--hcCCEeeecCHhhCcCCCC
Confidence            753  3444444555666666554

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=6.9e-18  Score=171.28  Aligned_cols=181  Identities=24%  Similarity=0.298  Sum_probs=104.4

Q ss_pred             eeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCcc
Q 001988          398 LNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKI  477 (985)
Q Consensus       398 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  477 (985)
                      .++..+.+++.++.  ..+.+|++|++++|.+++..  .+..+++|++|+|++|+|++..  .++.+++|++|++++|+|
T Consensus        29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i  102 (210)
T d1h6ta2          29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV  102 (210)
T ss_dssp             HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred             HHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence            44555555544332  23455666666666665432  2455566666666666665432  244555555555555555


Q ss_pred             ccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhh
Q 001988          478 SGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTL  557 (985)
Q Consensus       478 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  557 (985)
                      ++. + .+.++++|+.|++++|.+.                        ..  ..+..++.++.+++++|.+++  +..+
T Consensus       103 ~~l-~-~l~~l~~L~~L~l~~~~~~------------------------~~--~~l~~l~~l~~l~~~~n~l~~--~~~~  152 (210)
T d1h6ta2         103 KDL-S-SLKDLKKLKSLSLEHNGIS------------------------DI--NGLVHLPQLESLYLGNNKITD--ITVL  152 (210)
T ss_dssp             CCG-G-GGTTCTTCCEEECTTSCCC------------------------CC--GGGGGCTTCCEEECCSSCCCC--CGGG
T ss_pred             ccc-c-ccccccccccccccccccc------------------------cc--ccccccccccccccccccccc--cccc
Confidence            532 2 2445555555555555443                        22  134555666666666666653  2345


Q ss_pred             cccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcccccccccccccccc
Q 001988          558 EGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKELNLSF  618 (985)
Q Consensus       558 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~  618 (985)
                      ..+++|+++++++|++++..+  +.++++|++|+|++|+|+. +| .+.++++|++|+|++
T Consensus       153 ~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         153 SRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             GGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             ccccccccccccccccccccc--ccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence            667777777777777775332  6777777777777777763 44 477777777777764

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.72  E-value=1.9e-18  Score=173.94  Aligned_cols=178  Identities=28%  Similarity=0.402  Sum_probs=93.1

Q ss_pred             ceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccceecccccccCCchhhhhhccCCCeEEccCCc
Q 001988          397 RLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNK  476 (985)
Q Consensus       397 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  476 (985)
                      .+.++.+.+++.++  ...+.++++|++++|+++..  ..+..+++|++|++++|++++..|  ++.+++|++|++++|.
T Consensus        22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~   95 (199)
T d2omxa2          22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ   95 (199)
T ss_dssp             HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence            34455555554332  12345555566665555532  124445555555555555543222  4445555555555554


Q ss_pred             cccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchh
Q 001988          477 ISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTT  556 (985)
Q Consensus       477 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  556 (985)
                      +....  .+.+++.|+.|++++                        |.+....  .+..+++|+.|++++|++.. + +.
T Consensus        96 ~~~~~--~l~~l~~L~~L~l~~------------------------~~~~~~~--~~~~l~~L~~L~l~~n~l~~-~-~~  145 (199)
T d2omxa2          96 IADIT--PLANLTNLTGLTLFN------------------------NQITDID--PLKNLTNLNRLELSSNTISD-I-SA  145 (199)
T ss_dssp             CCCCG--GGTTCTTCSEEECCS------------------------SCCCCCG--GGTTCTTCSEEECCSSCCCC-C-GG
T ss_pred             ccccc--ccccccccccccccc------------------------ccccccc--ccchhhhhHHhhhhhhhhcc-c-cc
Confidence            44221  244444444444444                        4443322  24455666666666666653 2 24


Q ss_pred             hcccccceeeeeecceeccchhhhhhcccccCeEecCCCcccCCCCcccccccccccc
Q 001988          557 LEGLKSLQNISLAYNRLEGPIPESFGNMTSLESLDLSNNKISGSIPVSFEKLSYLKEL  614 (985)
Q Consensus       557 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  614 (985)
                      +..+++|++|++++|++++..  .++++++|++|++++|++++ +| .++++++|++|
T Consensus       146 l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         146 LSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             GTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             ccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            666667777777777776532  26677777777777777764 33 35666666654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.72  E-value=1.1e-17  Score=169.77  Aligned_cols=164  Identities=24%  Similarity=0.333  Sum_probs=80.7

Q ss_pred             CCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEE
Q 001988          193 CKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIF  272 (985)
Q Consensus       193 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  272 (985)
                      +.+|++|++++|.+++ ++ .+..+++|++|++++|++++. + .++.+++|++|++++|++++ +| .+.++++|+.|+
T Consensus        45 L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~  118 (210)
T d1h6ta2          45 LNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS  118 (210)
T ss_dssp             HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred             hcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-cccccccccccc
Confidence            3444555555555542 22 244455555555555555432 2 23445555555555555543 22 344555555555


Q ss_pred             ccCCcCcccCChhhhhcCCCCcEEEecCccCCCcCCccccCCCCccEEEccCcccccccCCcccCCCCCceEeccCCccc
Q 001988          273 LYNNSLSGSLPSRIDLALPNLEFLNLGINSFSGTIPSSITNASKLILLEMGSNSFSGFIPSAIGNLRNLKLFDIFFNNLT  352 (985)
Q Consensus       273 L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  352 (985)
                      +++|.+. .++.  +..+++++.+++++|.+++  +..+..+++|+++++++|++++..  .++++++|+.|++++|+++
T Consensus       119 l~~~~~~-~~~~--l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~  191 (210)
T d1h6ta2         119 LEHNGIS-DING--LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHIS  191 (210)
T ss_dssp             CTTSCCC-CCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             ccccccc-cccc--ccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCC
Confidence            5555544 2221  2244555555555555543  223444555555555555555432  2555666666666666655


Q ss_pred             CCCCcccccccccccCcccEEEec
Q 001988          353 SSTPELGFLSSLANCKKLRYLGLG  376 (985)
Q Consensus       353 ~~~~~~~~~~~l~~l~~L~~L~L~  376 (985)
                      .++       ++.++++|++|+|+
T Consensus       192 ~l~-------~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         192 DLR-------ALAGLKNLDVLELF  208 (210)
T ss_dssp             BCG-------GGTTCTTCSEEEEE
T ss_pred             CCh-------hhcCCCCCCEEEcc
Confidence            432       24555666666654

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.71  E-value=6.2e-18  Score=170.11  Aligned_cols=169  Identities=25%  Similarity=0.333  Sum_probs=122.9

Q ss_pred             cCcccEEEecCCCCCccCCCCccchhhcccceeccccccccccCCcCCCCCCccEEEccCCCCCCCCCccccccccccce
Q 001988          367 CKKLRYLGLGGNPLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIGNLSNLIVLSLGGNNLSGSIPVTFGGLQKLQGL  446 (985)
Q Consensus       367 l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  446 (985)
                      +++...+.++.+.+++.++  ...+. +++.|++++|.|+..  +.+..+++|++|++++|++++..|  ++++++|++|
T Consensus        17 l~~~i~~~l~~~~~~~~~~--~~~l~-~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L   89 (199)
T d2omxa2          17 LAEKMKTVLGKTNVTDTVS--QTDLD-QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI   89 (199)
T ss_dssp             HHHHHHHHTTCSSTTSEEC--HHHHT-TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HHHHHHHHhCCCCCCCccC--HHHhc-CCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccc
Confidence            3444556777888776543  23454 799999999999853  358889999999999999997654  8999999999


Q ss_pred             ecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCccc
Q 001988          447 DLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLD  526 (985)
Q Consensus       447 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  526 (985)
                      ++++|.+.. ++ .+..+++|+.|++++|.+...  ..+..+++|+.|++++|+++.+  ..+..+++|+.|++++|+++
T Consensus        90 ~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~  163 (199)
T d2omxa2          90 LMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVT  163 (199)
T ss_dssp             ECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC
T ss_pred             ccccccccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--cccccccccccccccccccc
Confidence            999999984 44 488999999999999998754  3477888899999988888743  23555666666666666555


Q ss_pred             CCccccccCCCcccEEEccCCccC
Q 001988          527 GPISLAIGNLKAVVGIDLSRNNLS  550 (985)
Q Consensus       527 ~~~~~~~~~l~~L~~L~Ls~N~l~  550 (985)
                      ++.  .++++++|+.|++++|+|+
T Consensus       164 ~l~--~l~~l~~L~~L~ls~N~i~  185 (199)
T d2omxa2         164 DLK--PLANLTTLERLDISSNKVS  185 (199)
T ss_dssp             CCG--GGTTCTTCCEEECCSSCCC
T ss_pred             CCc--cccCCCCCCEEECCCCCCC
Confidence            432  2444444444444444444

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=5e-16  Score=165.22  Aligned_cols=254  Identities=15%  Similarity=0.160  Sum_probs=149.3

Q ss_pred             eeeeccccccCCCChhHhhhccccceecccCccccccCCcccCCCCCceEEEcccccCCCc-cccccccccccceEeecc
Q 001988          149 DIRLSKNKLSGKLPENICNHLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGA-IPKEIGNLTVLQRISLIN  227 (985)
Q Consensus       149 ~L~ls~n~l~g~lp~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~  227 (985)
                      .|||+++.+.+.....+..  ..+..+.++.......+ .......+|++|||++|.++.. ++..+.++++|++|+|++
T Consensus         4 ~lDLs~~~l~~~~l~~l~~--~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~   80 (284)
T d2astb2           4 TLDLTGKNLHPDVTGRLLS--QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG   80 (284)
T ss_dssp             EEECTTCBCCHHHHHHHHH--TTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred             EEECCCCCCCchHHHHHHh--ccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence            4455555443222222221  23445555555554222 2334456788888888777643 344567778888888888


Q ss_pred             ccccCCchhhhcCCCCCCEEEecCC-cCccc-CcccccCCCCCCEEEccCC-cCccc-CChhhhhcCCCCcEEEecCc--
Q 001988          228 NKLHGEIPQEIGYLQNLDVLQLGFN-NLTGV-VPATIFNMSTLKEIFLYNN-SLSGS-LPSRIDLALPNLEFLNLGIN--  301 (985)
Q Consensus       228 N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~l~~l~~L~~L~L~~N-~l~~~-~p~~~~~~l~~L~~L~Ls~N--  301 (985)
                      +.+++..+..++.+++|++|+++++ .++.. +.....++++|++|+++++ .++.. +...+....++|+.|++++.  
T Consensus        81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~  160 (284)
T d2astb2          81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK  160 (284)
T ss_dssp             CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred             cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence            8877777777888888888888774 45532 2222346778888888875 34321 22223233467888888764  


Q ss_pred             cCCCc-CCccccCCCCccEEEccCc-ccccccCCcccCCCCCceEeccCC-cccCCCCcccccccccccCcccEEEecCC
Q 001988          302 SFSGT-IPSSITNASKLILLEMGSN-SFSGFIPSAIGNLRNLKLFDIFFN-NLTSSTPELGFLSSLANCKKLRYLGLGGN  378 (985)
Q Consensus       302 ~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~~~l~~l~~L~~L~L~~N  378 (985)
                      .++.. +.....++++|++|++++| .+++.....++++++|++|+++++ .+++..     +..+.++++|++|+++++
T Consensus       161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~-----l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPET-----LLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGG-----GGGGGGCTTCCEEECTTS
T ss_pred             ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHH-----HHHHhcCCCCCEEeeeCC
Confidence            34432 2223345677888888775 466666777777888888888874 454322     224667788888888776


Q ss_pred             CCCccCCCCccchhhcccceeccccccccccCCcCC
Q 001988          379 PLDGFLPSSIGNLSLSLERLNIAFCNISGNIPKAIG  414 (985)
Q Consensus       379 ~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~~~~~~  414 (985)
                       ++   ...+..+...+..|.+..+.++...+..++
T Consensus       236 -~~---d~~l~~l~~~lp~L~i~~~~ls~~~~~~~~  267 (284)
T d2astb2         236 -VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG  267 (284)
T ss_dssp             -SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred             -CC---HHHHHHHHHhCccccccCccCCCCCCCccC
Confidence             22   233334433455556655555554444443

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.53  E-value=1.7e-14  Score=131.89  Aligned_cols=119  Identities=23%  Similarity=0.297  Sum_probs=78.1

Q ss_pred             ceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCC
Q 001988          173 KHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFN  252 (985)
Q Consensus       173 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  252 (985)
                      |+|+|++|+++ .+| .+.++++|++|++++|+|+ .+|+.++.+++|+.|++++|+|++ +| .++.+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            45666777666 444 3677777777777777776 466667777777777777777763 34 3677777777777777


Q ss_pred             cCcccC-cccccCCCCCCEEEccCCcCcc--cCChhhhhcCCCCcEE
Q 001988          253 NLTGVV-PATIFNMSTLKEIFLYNNSLSG--SLPSRIDLALPNLEFL  296 (985)
Q Consensus       253 ~l~~~~-p~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~~l~~L~~L  296 (985)
                      +|+... ...+..+++|+.|++++|.++.  ..+..+...+|+|+.|
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            776433 2456677777777777777763  2344455556666655

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.51  E-value=2.9e-15  Score=159.25  Aligned_cols=60  Identities=25%  Similarity=0.214  Sum_probs=29.9

Q ss_pred             CCCccEEEccCC-CCCCCCCccccccccccceecccc-cccCCchhhhhhccCCCeEEccCC
Q 001988          416 LSNLIVLSLGGN-NLSGSIPVTFGGLQKLQGLDLAFN-KLAGSIPDEICLLSRLNELDLNGN  475 (985)
Q Consensus       416 l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N  475 (985)
                      +++|++|++++| .+++.....+..+++|++|+|+++ .+++.....+..+++|+.|+++++
T Consensus       174 ~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             cccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            445555555543 244444444555555555555552 344333344455555555555554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.50  E-value=8.2e-15  Score=140.98  Aligned_cols=127  Identities=16%  Similarity=0.134  Sum_probs=72.8

Q ss_pred             CcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEccCCccCccCchhhcccccceee
Q 001988          487 NLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLSRNNLSGNIPTTLEGLKSLQNI  566 (985)
Q Consensus       487 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  566 (985)
                      +..++++|+|++|+|+.+ +..+..+++|+.|++++|+|+.+  ..+..+++|+.|++++|+|+...+..+..+++|+.|
T Consensus        16 n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L   92 (162)
T d1a9na_          16 NAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL   92 (162)
T ss_dssp             CTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred             CcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccccc
Confidence            334444444444444432 33334444444444444444433  135556666666666666665555555667777777


Q ss_pred             eeecceeccchh-hhhhcccccCeEecCCCcccCCC---Ccccccccccccccc
Q 001988          567 SLAYNRLEGPIP-ESFGNMTSLESLDLSNNKISGSI---PVSFEKLSYLKELNL  616 (985)
Q Consensus       567 ~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~l  616 (985)
                      ++++|+|+.... ..+..+++|++|++++|.++...   +..+..+++|++||-
T Consensus        93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~  146 (162)
T d1a9na_          93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF  146 (162)
T ss_dssp             ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred             eeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence            777777764321 45677777777777777776332   124667777777763

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.49  E-value=7.3e-16  Score=169.26  Aligned_cols=135  Identities=16%  Similarity=0.211  Sum_probs=62.5

Q ss_pred             ccCCCeEEccCCccccc----cCCCCcCcCcCceEeeccceeeee-----cCCCccCccceeEEeecCCcccCC----cc
Q 001988          464 LSRLNELDLNGNKISGS----ISSCLGNLTSLQYLNLGSNRFTFV-----IPSTFWNLKDILSFDISSNLLDGP----IS  530 (985)
Q Consensus       464 l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~ls~N~l~~~----~~  530 (985)
                      .+.|+.+++++|+++..    +...+...+.|++|+|++|+++..     +...+...++|+.|++++|.++..    +.
T Consensus       157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~  236 (344)
T d2ca6a1         157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA  236 (344)
T ss_dssp             CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred             Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence            34566666666655421    112233445566666666655421     223344444555555555554321    12


Q ss_pred             ccccCCCcccEEEccCCccCccCchhhc----c--cccceeeeeecceeccc----hhhhhh-cccccCeEecCCCccc
Q 001988          531 LAIGNLKAVVGIDLSRNNLSGNIPTTLE----G--LKSLQNISLAYNRLEGP----IPESFG-NMTSLESLDLSNNKIS  598 (985)
Q Consensus       531 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~--l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~  598 (985)
                      ..+...++|++|+|++|.|++.....+.    .  .+.|+.|++++|+|+..    +...+. ++++|+.|+|++|++.
T Consensus       237 ~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             ccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence            2344455555555555555543222221    1  23455566666655432    222222 3445556666666554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.49  E-value=1.9e-14  Score=138.45  Aligned_cols=109  Identities=20%  Similarity=0.189  Sum_probs=53.4

Q ss_pred             ccccccceecccccccCCchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEE
Q 001988          439 GLQKLQGLDLAFNKLAGSIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSF  518 (985)
Q Consensus       439 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  518 (985)
                      +..+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+..  +.|..+++|++|++++|+++.+.+..+..+++|+.|
T Consensus        16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L   92 (162)
T d1a9na_          16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL   92 (162)
T ss_dssp             CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred             CcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccccc
Confidence            3444455555555554 2233344455555555555555532  235555566666666666655444444445555555


Q ss_pred             eecCCcccCCcc-ccccCCCcccEEEccCCccC
Q 001988          519 DISSNLLDGPIS-LAIGNLKAVVGIDLSRNNLS  550 (985)
Q Consensus       519 ~ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~  550 (985)
                      ++++|+|..... ..+..+++|+.|++++|.++
T Consensus        93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             eeccccccccccccccccccccchhhcCCCccc
Confidence            555555543221 23444444555555555444

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.47  E-value=5.1e-15  Score=162.36  Aligned_cols=241  Identities=21%  Similarity=0.268  Sum_probs=156.5

Q ss_pred             CchhcccccccceecccCCcCCCC----CCcccccCCCCcEEEccCcccCCCC----------ccccccCCccceeeecc
Q 001988           89 IPPEIANLSSLKSLDLSHNKLSSN----IPSSIFTMSTLKVLYLMDNQLSGSL----------SSFTFNTSSILDIRLSK  154 (985)
Q Consensus        89 ~~~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~~----------~~~~~~~~~L~~L~ls~  154 (985)
                      +...+...+.|+.|+|++|.+...    +-..+...++|+.|+++++......          .+.+...++|+.|+|++
T Consensus        23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~  102 (344)
T d2ca6a1          23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  102 (344)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence            344566667777777777766432    2334455677777777766544221          12233456677777777


Q ss_pred             ccccCCCChhH---hhhccccceecccCccccccCCc-------------ccCCCCCceEEEcccccCCCc----ccccc
Q 001988          155 NKLSGKLPENI---CNHLRYLKHLFLRENMFYGKIPS-------------SLSKCKQLQELHLGYNNLSGA----IPKEI  214 (985)
Q Consensus       155 n~l~g~lp~~~---~~~l~~L~~L~L~~n~l~~~~p~-------------~l~~l~~L~~L~L~~N~l~~~----~p~~~  214 (985)
                      |.+...-...+   +...++|++|++++|.+...-..             .....+.|+.|++++|+++..    +...+
T Consensus       103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l  182 (344)
T d2ca6a1         103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF  182 (344)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred             cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh
Confidence            77765432222   23457788888888776421111             113456788899998888633    23334


Q ss_pred             ccccccceEeeccccccCC-----chhhhcCCCCCCEEEecCCcCccc----CcccccCCCCCCEEEccCCcCcccCChh
Q 001988          215 GNLTVLQRISLINNKLHGE-----IPQEIGYLQNLDVLQLGFNNLTGV----VPATIFNMSTLKEIFLYNNSLSGSLPSR  285 (985)
Q Consensus       215 ~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~  285 (985)
                      ...+.|+.|+|++|+++..     +...+..+++|+.|+|++|.++..    +...+..+++|++|+|++|.|++.....
T Consensus       183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~  262 (344)
T d2ca6a1         183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA  262 (344)
T ss_dssp             HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred             hhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHH
Confidence            5667899999999988632     334567788899999999988643    4456678889999999999887543333


Q ss_pred             hhh-----cCCCCcEEEecCccCCCcC----Ccccc-CCCCccEEEccCccccc
Q 001988          286 IDL-----ALPNLEFLNLGINSFSGTI----PSSIT-NASKLILLEMGSNSFSG  329 (985)
Q Consensus       286 ~~~-----~l~~L~~L~Ls~N~l~~~~----p~~~~-~l~~L~~L~L~~N~l~~  329 (985)
                      +..     ..+.|+.|++++|+|+...    ...+. +.++|+.|+|++|++..
T Consensus       263 l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             HHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            221     2467999999999987532    33332 56789999999999864

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.45  E-value=1.2e-13  Score=126.10  Aligned_cols=102  Identities=30%  Similarity=0.467  Sum_probs=78.0

Q ss_pred             eEEEcccccCCCccccccccccccceEeeccccccCCchhhhcCCCCCCEEEecCCcCcccCcccccCCCCCCEEEccCC
Q 001988          197 QELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTLKEIFLYNN  276 (985)
Q Consensus       197 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N  276 (985)
                      |.|+|++|+++ .+| .++++++|++|++++|+|+ .+|+.++.+++|++|++++|+|++ +| .+.++++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            57899999998 455 4888889999999999998 577788889999999999999885 34 4778888888888888


Q ss_pred             cCcccCCh-hhhhcCCCCcEEEecCccCC
Q 001988          277 SLSGSLPS-RIDLALPNLEFLNLGINSFS  304 (985)
Q Consensus       277 ~l~~~~p~-~~~~~l~~L~~L~Ls~N~l~  304 (985)
                      +++ .+|. ..+..+++|++|++++|+++
T Consensus        76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCC-SSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccC-CCCCchhhcCCCCCCEEECCCCcCC
Confidence            887 3332 23345667777777776665

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.37  E-value=2.7e-14  Score=142.33  Aligned_cols=85  Identities=27%  Similarity=0.366  Sum_probs=45.8

Q ss_pred             hccccceecccCccccccCCcccCCCCCceEEEcccccCCCccccccccccccceEeeccccccCCch--hhhcCCCCCC
Q 001988          168 HLRYLKHLFLRENMFYGKIPSSLSKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGEIP--QEIGYLQNLD  245 (985)
Q Consensus       168 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~  245 (985)
                      .+++|++|+|++|.++ .+|..+..+++|++|++++|+++. ++ .+.++++|+.|++++|+++. ++  ..+..+++|+
T Consensus        68 ~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~  143 (198)
T d1m9la_          68 GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLE  143 (198)
T ss_dssp             HHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCS
T ss_pred             CCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccccccccchhcc-ccccccccCCCccc
Confidence            3444444444444444 344433334455666666666653 22 35556666666666666653 22  3456666666


Q ss_pred             EEEecCCcCcc
Q 001988          246 VLQLGFNNLTG  256 (985)
Q Consensus       246 ~L~Ls~N~l~~  256 (985)
                      +|+|++|.++.
T Consensus       144 ~L~L~~N~l~~  154 (198)
T d1m9la_         144 DLLLAGNPLYN  154 (198)
T ss_dssp             EEEECSSHHHH
T ss_pred             eeecCCCcccc
Confidence            66666666553

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.34  E-value=3.9e-14  Score=141.16  Aligned_cols=136  Identities=20%  Similarity=0.263  Sum_probs=85.5

Q ss_pred             CchhhhhhccCCCeEEccCCccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCCcccCCccccccC
Q 001988          456 SIPDEICLLSRLNELDLNGNKISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGN  535 (985)
Q Consensus       456 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~  535 (985)
                      .+|..+..+++|++|+|++|+|+.. + .+.++++|++|+|++|+|+.+ |..+                        ..
T Consensus        39 ~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~i-~~~~------------------------~~   91 (198)
T d1m9la_          39 KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKKI-ENLD------------------------AV   91 (198)
T ss_dssp             CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECSC-SSHH------------------------HH
T ss_pred             hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccccc-cccc------------------------cc
Confidence            3455666777777777777777643 2 366677777777777776532 2222                        22


Q ss_pred             CCcccEEEccCCccCccCchhhcccccceeeeeecceeccchh-hhhhcccccCeEecCCCcccCCCCcc----------
Q 001988          536 LKAVVGIDLSRNNLSGNIPTTLEGLKSLQNISLAYNRLEGPIP-ESFGNMTSLESLDLSNNKISGSIPVS----------  604 (985)
Q Consensus       536 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------  604 (985)
                      +++|+.|++++|+|+..  ..+..+++|+.|+|++|+|+.... ..+..+++|+.|+|++|++....+..          
T Consensus        92 ~~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~v  169 (198)
T d1m9la_          92 ADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV  169 (198)
T ss_dssp             HHHCCEEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHH
T ss_pred             ccccccccccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHH
Confidence            33455566666666532  346677778888888888775322 46777888888888888776543332          


Q ss_pred             cccccccccccccccccc
Q 001988          605 FEKLSYLKELNLSFNKLK  622 (985)
Q Consensus       605 ~~~l~~L~~L~ls~N~l~  622 (985)
                      +..+++|+.||  +.+++
T Consensus       170 i~~lp~L~~LD--~~~I~  185 (198)
T d1m9la_         170 VKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHHCSSCCEES--SGGGT
T ss_pred             HHHCCCcCEeC--CccCC
Confidence            56678888876  44443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.28  E-value=3.8e-12  Score=121.12  Aligned_cols=83  Identities=14%  Similarity=0.065  Sum_probs=38.3

Q ss_pred             CCeEEccCCccccccCCCCcCcCcCceEeeccc-eeeeecCCCccCccceeEEeecCCcccCCccccccCCCcccEEEcc
Q 001988          467 LNELDLNGNKISGSISSCLGNLTSLQYLNLGSN-RFTFVIPSTFWNLKDILSFDISSNLLDGPISLAIGNLKAVVGIDLS  545 (985)
Q Consensus       467 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls  545 (985)
                      .+.++.+++.+. ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|++++|+|+.+.+.+|..+++|+.|+|+
T Consensus        10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls   88 (156)
T d2ifga3          10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (156)
T ss_dssp             SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence            344555555544 23444555555555555433 2554444444444444444444444444444444444444444444


Q ss_pred             CCccC
Q 001988          546 RNNLS  550 (985)
Q Consensus       546 ~N~l~  550 (985)
                      +|+|+
T Consensus        89 ~N~l~   93 (156)
T d2ifga3          89 FNALE   93 (156)
T ss_dssp             SSCCS
T ss_pred             CCCCc
Confidence            44444

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.24  E-value=5.7e-12  Score=119.90  Aligned_cols=104  Identities=20%  Similarity=0.210  Sum_probs=62.8

Q ss_pred             ceecccccccCCchhhhhhccCCCeEEccCC-ccccccCCCCcCcCcCceEeeccceeeeecCCCccCccceeEEeecCC
Q 001988          445 GLDLAFNKLAGSIPDEICLLSRLNELDLNGN-KISGSISSCLGNLTSLQYLNLGSNRFTFVIPSTFWNLKDILSFDISSN  523 (985)
Q Consensus       445 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  523 (985)
                      .++.+++.+. ..|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.|.+|.++++|++|+|++|
T Consensus        12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N   90 (156)
T d2ifga3          12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (156)
T ss_dssp             CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence            3444444444 33444445556666666544 355555556666666666666666666666666666667777777777


Q ss_pred             cccCCccccccCCCcccEEEccCCccC
Q 001988          524 LLDGPISLAIGNLKAVVGIDLSRNNLS  550 (985)
Q Consensus       524 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~  550 (985)
                      +|+.+.+..|..+ .|+.|+|++|.+.
T Consensus        91 ~l~~l~~~~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          91 ALESLSWKTVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             CCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred             CCcccChhhhccc-cccccccCCCccc
Confidence            7666555555444 4667777777664

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.41  E-value=1.4e-08  Score=96.72  Aligned_cols=70  Identities=26%  Similarity=0.134  Sum_probs=32.5

Q ss_pred             hhhhcCCCCCCEEEecCCcCccc--CcccccCCCCCCEEEccCCcCcccCChhhhhcCCCCcEEEecCccCCC
Q 001988          235 PQEIGYLQNLDVLQLGFNNLTGV--VPATIFNMSTLKEIFLYNNSLSGSLPSRIDLALPNLEFLNLGINSFSG  305 (985)
Q Consensus       235 p~~~~~l~~L~~L~Ls~N~l~~~--~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~  305 (985)
                      +..+..+++|++|+|++|+|+..  ++..+..+++|+.|+|++|.++ .++...+....+|+.|++++|.++.
T Consensus        58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~  129 (162)
T d1koha1          58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSD  129 (162)
T ss_dssp             HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred             HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCc
Confidence            33334455555555555555532  1233444555555555555554 3333222233445555555555543

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.37  E-value=1.4e-08  Score=96.73  Aligned_cols=106  Identities=23%  Similarity=0.192  Sum_probs=63.0

Q ss_pred             CCCCCceEEEcccccCCCccccccccccccceEeeccccccCC--chhhhcCCCCCCEEEecCCcCcccCcccccCCCCC
Q 001988          191 SKCKQLQELHLGYNNLSGAIPKEIGNLTVLQRISLINNKLHGE--IPQEIGYLQNLDVLQLGFNNLTGVVPATIFNMSTL  268 (985)
Q Consensus       191 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L  268 (985)
                      ..+..+..++..+|... .++..+..+++|++|+|++|+|+..  ++..+..+++|+.|+|++|.|+...+-.+.....|
T Consensus        39 ~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L  117 (162)
T d1koha1          39 VAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL  117 (162)
T ss_dssp             TTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCC
T ss_pred             hhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhcccc
Confidence            33334444444444333 3444445667777777777777643  24456677777778888887775444344445567


Q ss_pred             CEEEccCCcCcccCCh------hhhhcCCCCcEEE
Q 001988          269 KEIFLYNNSLSGSLPS------RIDLALPNLEFLN  297 (985)
Q Consensus       269 ~~L~L~~N~l~~~~p~------~~~~~l~~L~~L~  297 (985)
                      ++|++++|.+......      .+...+|+|+.||
T Consensus       118 ~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1         118 EELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             SSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             ceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            8888888887754432      2344567777664

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.35  E-value=1.3e-06  Score=90.11  Aligned_cols=149  Identities=15%  Similarity=0.145  Sum_probs=101.4

Q ss_pred             HHHHHhcCccCCceeeccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceE
Q 001988          720 ELLRATDNFAENNIIGIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKA  798 (985)
Q Consensus       720 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~  798 (985)
                      ++.+..+.|+..+..+-++.+.||+... +++.+++|+...........+.+|...++.+. +--+.+++.+...++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            4444455665444433344568999875 46677889887554444456788999888774 434677888888888899


Q ss_pred             EEEeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------
Q 001988          799 LVLEYMSNGSLEDCLHSSNCALNIFCRLNIMIDIASALEYLHFG------------------------------------  842 (985)
Q Consensus       799 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~------------------------------------  842 (985)
                      +|||+++|.++.+.....      .....++.++++.++.||..                                    
T Consensus        87 lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            999999998876543321      11233455556666666521                                    


Q ss_pred             --------------------CCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          843 --------------------HSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       843 --------------------h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                                          ....++|+|+.|.||++++++.+-|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                122378999999999999877777999998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.84  E-value=3e-05  Score=78.98  Aligned_cols=131  Identities=16%  Similarity=0.178  Sum_probs=86.5

Q ss_pred             eeeccCc-eeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcC--CCCeeeEEeeeecCCceEEEEeccCCCCh
Q 001988          733 IIGIGGF-GSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIR--HRNLVKIISSCSNDDFKALVLEYMSNGSL  809 (985)
Q Consensus       733 ~ig~G~~-g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL  809 (985)
                      .+..|.. +.||+...+++..+++|......   ...+..|.+.++.+.  .-.+.+++.++.+++..++||||++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3445554 67999998888889999876543   234677888888773  23366788888888889999999988655


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------------
Q 001988          810 EDCLHSSNCALNIFCRLNIMIDIASALEYLHF------------------------------------------------  841 (985)
Q Consensus       810 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~------------------------------------------------  841 (985)
                      .+..      ...   ...+.++++.++.||.                                                
T Consensus        94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            3210      000   0111222222222221                                                


Q ss_pred             -------cCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          842 -------GHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       842 -------~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                             .....++|+|+.|.||+++++..+-|+||+.+..
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                   1123479999999999999887778999998754

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.54  E-value=1.4e-05  Score=75.57  Aligned_cols=86  Identities=20%  Similarity=0.193  Sum_probs=41.8

Q ss_pred             cCCCcccEEEccCCccCcc----Cchhhcccccceeeeeecceeccc----hhhhhhcccccCeEecCCCcccCC-----
Q 001988          534 GNLKAVVGIDLSRNNLSGN----IPTTLEGLKSLQNISLAYNRLEGP----IPESFGNMTSLESLDLSNNKISGS-----  600 (985)
Q Consensus       534 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-----  600 (985)
                      ...+.|+.|+|++|.+...    +...+...+.|+.|+|++|.|+..    +-..+...++|++|+|++|.+...     
T Consensus        41 ~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~  120 (167)
T d1pgva_          41 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVE  120 (167)
T ss_dssp             TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHH
T ss_pred             hhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHH
Confidence            3344455555555555422    112333345566666666666532    223344555666666666654421     


Q ss_pred             --CCccccccccccccccccc
Q 001988          601 --IPVSFEKLSYLKELNLSFN  619 (985)
Q Consensus       601 --~p~~~~~l~~L~~L~ls~N  619 (985)
                        +...+..-++|+.|+++++
T Consensus       121 ~~l~~~L~~n~sL~~l~l~~~  141 (167)
T d1pgva_         121 MDMMMAIEENESLLRVGISFA  141 (167)
T ss_dssp             HHHHHHHHHCSSCCEEECCCC
T ss_pred             HHHHHHHHhCCCccEeeCcCC
Confidence              1222333455555655544

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.52  E-value=1.9e-05  Score=74.72  Aligned_cols=18  Identities=17%  Similarity=0.372  Sum_probs=9.8

Q ss_pred             cCCCCCceEEEcccccCC
Q 001988          190 LSKCKQLQELHLGYNNLS  207 (985)
Q Consensus       190 l~~l~~L~~L~L~~N~l~  207 (985)
                      +...++|++|+|++|.+.
T Consensus        40 L~~n~~L~~L~Ls~n~l~   57 (167)
T d1pgva_          40 ACNSKHIEKFSLANTAIS   57 (167)
T ss_dssp             HTTCSCCCEEECTTSCCB
T ss_pred             HhhCCccceeeccccccc
Confidence            444455555566555554

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.48  E-value=0.00023  Score=77.13  Aligned_cols=75  Identities=19%  Similarity=0.211  Sum_probs=49.6

Q ss_pred             ceeeccCceeEEEEEEc-CCcEEEEEEeccCC-------cchHHHHHHHHHHHHhcC-C--CCeeeEEeeeecCCceEEE
Q 001988          732 NIIGIGGFGSVYRARLE-DGVEIAIKVFHPQC-------ASTLKSFEAECEVIKNIR-H--RNLVKIISSCSNDDFKALV  800 (985)
Q Consensus       732 ~~ig~G~~g~V~~~~~~-~~~~vAvK~~~~~~-------~~~~~~~~~E~~il~~l~-h--~niv~l~~~~~~~~~~~lv  800 (985)
                      +.||.|....||++... +++.|+||.-.+..       .....+...|.++++.+. +  ..+++++.+.  ++..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence            46899999999999865 46789999754321       112345667888888762 3  3455666554  4456799


Q ss_pred             EeccCCCC
Q 001988          801 LEYMSNGS  808 (985)
Q Consensus       801 ~e~~~~gs  808 (985)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.94  E-value=0.00086  Score=70.43  Aligned_cols=134  Identities=13%  Similarity=0.201  Sum_probs=78.3

Q ss_pred             ceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCCe--eeEEe-----eeecCCceEEEEeccCCCChH-
Q 001988          739 FGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRNL--VKIIS-----SCSNDDFKALVLEYMSNGSLE-  810 (985)
Q Consensus       739 ~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~-  810 (985)
                      -..||++..++|+.|++|+.++.. ...+++..|.+.+..+....+  +..+.     .....+..+.++++++|..+. 
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            357999999999999999987653 345678889998888742222  22111     223456678899999764221 


Q ss_pred             ----H---------Hhhc----C----CCCCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCCC
Q 001988          811 ----D---------CLHS----S----NCALNIF-------------------CRLNIMIDIASALEYLHF----GHSTP  846 (985)
Q Consensus       811 ----~---------~l~~----~----~~~~~~~-------------------~~~~i~~~i~~~L~~Lh~----~h~~~  846 (985)
                          .         .++.    .    ....++.                   .+..+...+.+.++.+..    .-..+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                0         0111    0    1111111                   111112222222333321    12457


Q ss_pred             eEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          847 IIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       847 ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      +||+|+.+.|||++++  ..++||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            8999999999999743  45899998764

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.78  E-value=0.00013  Score=68.56  Aligned_cols=86  Identities=17%  Similarity=0.254  Sum_probs=38.6

Q ss_pred             CCCcccEEEccCCccCccC----chhhcccccceeeeeecceeccc----hhhhhhcccccCeEec--CCCcccC----C
Q 001988          535 NLKAVVGIDLSRNNLSGNI----PTTLEGLKSLQNISLAYNRLEGP----IPESFGNMTSLESLDL--SNNKISG----S  600 (985)
Q Consensus       535 ~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~----~  600 (985)
                      ..+.|+.|+|++|.++...    -..+...+.++.+++++|.+...    +...+...++|+.++|  ++|.+..    .
T Consensus        44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~  123 (166)
T d1io0a_          44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME  123 (166)
T ss_dssp             TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred             cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHH
Confidence            3444445555555443321    12233345555555555555421    2234445555554333  3444432    1


Q ss_pred             CCcccccccccccccccccc
Q 001988          601 IPVSFEKLSYLKELNLSFNK  620 (985)
Q Consensus       601 ~p~~~~~l~~L~~L~ls~N~  620 (985)
                      +...+...++|+.|+++.|+
T Consensus       124 La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_         124 IANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             HHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHHhCCCcCEEeCcCCC
Confidence            22334445556666655443

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.73  E-value=0.00016  Score=68.03  Aligned_cols=43  Identities=7%  Similarity=0.087  Sum_probs=20.2

Q ss_pred             ccCCCCCceEEEcccccCCCcccc----ccccccccceEeecccccc
Q 001988          189 SLSKCKQLQELHLGYNNLSGAIPK----EIGNLTVLQRISLINNKLH  231 (985)
Q Consensus       189 ~l~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~  231 (985)
                      .+...++|++|+|++|.++...-.    .+...+.++.+++++|.+.
T Consensus        41 al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          41 ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             HHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence            344555566666666655432211    2223344555555554443

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.63  E-value=0.0042  Score=64.60  Aligned_cols=157  Identities=13%  Similarity=0.104  Sum_probs=86.5

Q ss_pred             cCHHHHHHHhcCccCCcee-----eccCceeEEEEEEcCCcEEEEEEeccCCcchHHHHHHHHHHHHhcCCCC--eeeEE
Q 001988          716 FSYFELLRATDNFAENNII-----GIGGFGSVYRARLEDGVEIAIKVFHPQCASTLKSFEAECEVIKNIRHRN--LVKII  788 (985)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~i-----g~G~~g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~  788 (985)
                      .+.+|+.....+|..++..     ..|--.+.|+.+..+|+ +++|++....  ..+++..|++++..+...+  +...+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            4567777778888776654     35656789999987664 8999986542  3355667777777774222  22221


Q ss_pred             ee------eecCCceEEEEeccCCCChHH--------------HhhcC--------CCCCCH------------------
Q 001988          789 SS------CSNDDFKALVLEYMSNGSLED--------------CLHSS--------NCALNI------------------  822 (985)
Q Consensus       789 ~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~--------~~~~~~------------------  822 (985)
                      ..      ....+....++.++++.....              .++..        ......                  
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            11      122344556777776642210              01100        000000                  


Q ss_pred             HHHHHHHHHHHHHHHHHH-hcCCCCeEeCCCCCCCEEEcCCCcEEEecccCcee
Q 001988          823 FCRLNIMIDIASALEYLH-FGHSTPIIHCDLKPSNVLLDEDMVAHLSDFGMAKL  875 (985)
Q Consensus       823 ~~~~~i~~~i~~~L~~Lh-~~h~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~  875 (985)
                      ......+......+...+ ..-..|+||+|+.+.||+++.+...-|+||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            001111222222222221 12467899999999999999988888999998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.35  E-value=0.0085  Score=64.37  Aligned_cols=73  Identities=18%  Similarity=0.195  Sum_probs=50.0

Q ss_pred             CceeeccCceeEEEEEEcC--------CcEEEEEEeccCCcchHHHHHHHHHHHHhcC-CCCeeeEEeeeecCCceEEEE
Q 001988          731 NNIIGIGGFGSVYRARLED--------GVEIAIKVFHPQCASTLKSFEAECEVIKNIR-HRNLVKIISSCSNDDFKALVL  801 (985)
Q Consensus       731 ~~~ig~G~~g~V~~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~  801 (985)
                      .+.|+.|-.-.+|++...+        .+.|.+++.. ... ......+|..+++.+. +.-..++++++..    .+||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3568889999999998753        3457777664 322 2344568999998884 4444577887753    5899


Q ss_pred             eccCCCCh
Q 001988          802 EYMSNGSL  809 (985)
Q Consensus       802 e~~~~gsL  809 (985)
                      ||++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987543